<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/browse?collection=3&amp;output=omeka-xml&amp;sort_field=added" accessDate="2026-06-07T23:00:07+00:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>100</perPage>
      <totalResults>30</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="6724" public="1" featured="0">
    <fileContainer>
      <file fileId="3781">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/4b34d77a93adfdf543aae63a1ead5831.pdf</src>
        <authentication>9a3d77013a79d7057f02f224ed583aa6</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104407">
                    <text>42.5.3.
gm
Standin- of tho
‘

alteration in

mum

the focus or

mufﬁns

1 laboratory

for olmtmnmphllompm

studying
A

or the Dona-“mm. of

Manley

during eh.

ambuahod,

and

”min manta]. oyndma m. introduced.

grasp

Band»,

dapreuivu

m

mm

ammmud with unplug“

illmaua, men-u,

man-hm.

We:

m

method-

for

on,

The

tha change in pal-cerium in

and following alactrocomulaivo therapy.

“fact. at barbiturate”, ”mun
um um intentiuly studied.
“new of the

Wan.

put you.

invents;pmimWe“
51113393“ to alwltmm stimulation buts, hogan

at tinted study

gationa or the raspame of
by Dr.

w

with changu in brain funeum wan

and

1.780er acid (181345)

on such

The

mammal

latter part or the year, a corn-3.1M
in brain function during data-woman“. thump: m
In tho

m psychologists. Dr.

march assistants to

the

Imam

Robert him and In; R. Karin worn uppointod

«Mt,

tad Dr.

in: link

a fellow of the

ﬁatiml

for Infmtiln Fanlyain mu appoinm to mum” the laboratory work.
oi: Databa- 1, 1953 am
charmmloganQ laboratory was cmbliahod
with a Man. 8 clam}. instrumnt. In the mum. mm month. 65 mount.

are

taken.

01'

than

19

um emulation muons m

M in the ovum of

th. integrated study an altered bran functian.
[mung tn. year. 55 consultation mum
matured. ﬁgure than half
of mania mental am.» “mated with amt-"sin 111m“,
were far
or mhtod to duotmnhook thonw‘ 301m awn». neuritic types of pain,
1nd abnoml involunm menu and. up the bulk of
mum.
81.: patients with «ism «11:0er um mum and controlled with anaemia
to the neurologiml service of mi. Sinai
amen. Thu. patient. are
fie-pita?! m further ima’oiauogu for nmlogim conditions chums»! at tho

m

mum:

We

mm

haapi talc

�~2-

m pmodural chm m introdum by an dmﬂunﬁ. u an Ad to
evaluating thu uremic mum sum, tn. «ma “but” no introduood m
Ivar
round
tbu
1m
thin
m1:
«as
worming an m
put
yaw,
mum.
'

folio-“mg the

am

of

ehktrolhm mutant”

and

the In part of the

in
maid». mu m at mmimlmholim
inugrltod study an olectrwhaoh
in
(month)
A: In Want
chlorich
new“
mmmm mum;

as mutated.
and

at

«Iv

m

tho

no!

emu)“

m1- want. 1: mm «amnion: in indumn; roux-Man

mum cum mining agent:

50mm.

121

Mates!

m:

or thetroﬂmck

wanmu. 3.. at 4:1: The damn“ an at maharhiul ”dim in
Mam” m. Jaw. Psych. zommm. (Jump) 1953.
Eu-

31131108.»

(1953)

Mr.

11.8.! Kit.“ of
link, I!" Harm, 9.3., Bath-awn, I. and
on Perception, Trans. Amer. Hm. used... Jun- 1953.

m,

it"

Green,

)1-

and Binder,

Simultaneous
3.3.x Perception of

&amp;
Malta,
am. mm mu. m».
mm»
5:
A
ma
a.
sum-um.
study
m:
a
ﬁnk.
Tmhw,

w mummy

Jour. 31mm. Hosp. 236%71 (Ha-ch) 1953.

117th34¢9

m
I

thtu

M11.

um.)

emu

1953.

momma mamas,

�October h

, 195“

Interin Report
Dear Dr. Miller,

requested I wish to report that the following projects have been in progress this summer in this
department.
1. Effect of electroshock on memory func»
tion tests. Twenty-four patients are now fully studied;
the data is beingA collected; and a report is planned
for the 1955 A P meetings.
2. Effect of Lysergic Acid on perceptual
functions, including Rorschach; and on blood chemistry.
These experiments are now in progress and will be completed by the end of the year.
‘E3iy Under the terms of the U.S.P.H.S. grant
a continuing study of perceptual changes in insuli n,
and EST patients is now in planning.
a. A psychiatric rating scale, modified
after Malamud, is in use. As soon as it is standardized
in this population, it will be presented to the Research
Eonmittee.
£5. The Funkenstein test (Hecholyl) in EST
and insulin therapy is being checked in our pop—
As you

ulation.

Sincerely,
HF33RB

�Obtober

Projects in Progress

as.

1954

/

,2-\

Relation of mental changes to behavior f‘
1'
(1) Effect of organic mental syndrOme on results of EST.
(3) Changes in perception with I92.
\
(3) Can ACTH. cortisone alter brain function and thereby

(a)

l

;

i

results of

(b)

EC!

or ICT?

\

\

Psychophysical measurements of Psychiatric terms - an operational
approach to terms of diagnosis.

(1) Denial: Relation to improvement in electroshock

Relation of premorbid character to change in
behavior in electroshock.
(2) Ambivalence:

Is

it possible

to measure ambivalence by

psychophysicel menad and relate to the past history of

the patient in choice of neurosis?

Relation of chemical agents to psychoses. psychological.

(o)

biochemical and behavioral aspects.
(d)
9

Rating Scale'

�October 1?, 195b
Dear Dr. Rachlin,

requested I wish to report the following
projects have been i n progress this summer.
(1) Effect of electroshock on memory f unction,
FRO, Amytal tests and nerceptual tests. Twenty
four patients have been fully shielded. The
first revert on the relation between the
response to treatment and the occonotal test is being
submitted to the A E A. The observat ion support
As you

the thesis that there is

a

relation between t

development of an organ.

he

Mental syndrome and

improvement.

Effect of lysergiv acid on perce ptual
functions. Rorschack and blood chemistry. The
psychiatric and psychologic tests are being
prepared for presentetnion at the American
Psychopathological Association.
(3) Under the terms of the U.S.P.H.S. gr ant
a continuing study of perceptual changes in
insulin and EST patient a is now i n planning.
(3) A psychiatric re.ing scale, modified after
Halemud, is i n use. As soon as it is standardized
in this population, it will be presented to the
(2)

Research Committee.

(5)

The Punkenetein

test (neohom) in

EST

and
__

�nsulin the rapy
population.
1

18

being checked

Since rely,

1

n our

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67234">
                <text>Progress and annual reports; research activities (folder title).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67235">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67236">
                <text>mfp-03-01-001-0-001</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67237">
                <text>1953-1954</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67238">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67239">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67240">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67241">
                <text>Annual report - department of neurology; Interim report to Dr. Miller; Progress Report; Letter to Dr. Rachlin;  </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67242">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67243">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80926">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87487">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94048">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100609">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6725" public="1" featured="0">
    <fileContainer>
      <file fileId="3782">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/e5d103cbe3dc9cd93159ddec488b3ecc.pdf</src>
        <authentication>022eaace568b7d0816980adc5ccaa74c</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104408">
                    <text>�nau-

mmmmtmw.mumntwmsm

Mmammmmawmatmmmummm

mmmwmmawmmwmmmamuwum
uwmmummmmmm. mammmmipwh
umummonm. mwwumwamm

vamwwmhym.mmm.

mmuummmmmmmmww
mmmmmmwmmuormmmm
1.

Wanna-m

mmmummwummwtw
wommwmmmumzmmmmmm
mamawaum. itmhmmummum
wm.mmm1mmmwm.mm,mmmm

Wm

W
W

M

as th-

an M: to» Manama.
at Bra. 13.311.313.31, a «mud

mam-1.
m

mgm.mmmmmmmﬁam.mmmruuw

u1wmmmamwmmmtmmmm. M
mmwmmmgmmwummmuzmw. m
W‘M‘MWMWmmwMWMMdm
msMMMmMmm-cmaammm.m
1mm».
smu‘mmmmuwmmmmmm
umwmmmwmdmmwwnmmm
mwumwmuwmwmamummuum.
'

mmummmmmmmwuammmm
ammmmam~mummdummum

mwummnmmmm.

�03¢

unmmmumswummmammau

wthmquduWMuMdehu-W

atmwmummthummmu-mum
ﬂat “mm. ”mum, mum... 'm man-om.
mm:
mmmummmmmmpmnymm
and

a;

W13M.Wﬂ
a.

WWW
mimnmmtmmmatﬁmmm

W(mm)maamum. Wmmmmm
minituamtmﬂtmmlymmsum.
mmmmmmmmmtmmanm M

1(th

m.w.muammmmammuumm

ﬂaw.

maem,nnmmwgmnhmtmnmu
Madmanhdtnmmmm. nmmmm,mm
Mmtmm)mmlwwm.nm,mmmnum
nu mm“ m madam ( mm mm. 31WCW319511}.
in.

thWWWMtWWthqu
man
up
man.
um),
mum
m
by the

(at... P.

mm um),
WMWWW‘WuM): Wmmmtzmm
mﬁmleohtaM
(mu.

3»

a.»

scam mum (in. A. mm) m:

mm
mm mm m

afﬁrm!

1*»

the

mama about»:

mlmumtomammumwmmmm

mmmuwmmumdmm mommamm

mwmmmmammmm

�ah-

m.nmmmmtm.amahmummm

mammwmmwmmumarmmmwnmwmm

ww-wwmmumzwmmmmdm-

mummmmmmm Ammaomwmt
.

mumermmmmmmd. mammalian
”wind to: m :mm mm, W Wm m1 momma-g.

Wammmmormmmw

mmmmmmmuma,mmmm
wuunmmu.m«smmormum. mummm

monarwmm,wmm9r£mgmtmrormwa

Wcmmummmuamumwm.
nmmuumymawwwmm
W..1tmwmtm‘uitr1nhmdmhm
mmmammmm. Mmmmemdin

mommmum. num-mmmummmu

immiwﬂmmmmg

nmwmmm.m.mmmwwm

mmwmmmotmummmmmmmm

PM!»

mmmmimhﬁmotuMMiﬂthmhm

wmmummmwmmmmnww
wwwmmtawmummwmwm.
Pu

WW
hammmwmamummmaaw

WWhmamﬁSﬁmmmnu-ammnh
«ma-W'mmmwmmhnmmmwmm hmuuaummumMmmwrm-um

unmmmm,m.m,wmmummm

��.ﬁ‘

V

mum
mum.
mm
am-ammummmrmmmam
ummmmmmmnmw
hr mum iii. W mumt WM AM}. 1955.
www.mmmmarumwanm
mnmwmmmwmmumummuw
mmmu‘mummm‘
WW.
8.
mMMMMWWWhNWW‘
mu m

in
nan-mm
m

:15

7.»

WW

Mmemm
3»

mm

.mumwmummmwbmmmmwm
«mmgmumﬂormwmwmmwu
mummuuwotmmumm
9'9me”.
mammmmdmuuatmummmmum

murwmwmuwuwmmmnr
ammmxmysa.

��Dr. Fink

January 18, 1955

To:

All Department Heads

'Re:

Annual Report

Please prepare
Report

all

-

l95h

of your data for the 195h Annual

at the earliest possible date.

All tables and other information should be turned in

to Mrs. Bailey, Office Manager, on or before February 10.

uith your statistical data, Dr. Miller requests
that in addition to any tables or general statistics
which you will furnish, that you write a succinct out—
line of the'work of your department for the calendar
which
comments
in
appeared
the
to
similar
l9Sh,
year
Along

the last Annual Report for your department. Please
submit

all

data in three copies.

I think that will be
Report in.March of this

With everyone's cooperation,

able to publish the Annual

year.
a report of

I
vities of the hospital similar to the
would

like you to

Janua RY 19 meeting.

make

all

research'acti—

one given

Maurice Bachrach

Administrator.

Mled

at the

�(33L
Biochemical Research

Material assistance was offered the laboratories during 1954
in the form of enlarged quarters, and by the award of a two-year
grant from the National Institutes of Health. The program initiated
the previous year by Dr. Harry Goldenberg, Director of Laboratories,
was continued along the following lines:

Clinical

Methodoloww

It

has become abundantly clear that the clinical laboratory can
no longer cope with the special problems of mental disease using ther
standard chemical tests carried out in general hospitals. Consequently
increased attention has been directed towards providing the clinical
laboratory with procedures for testing adrenal and carbohydrate
metabolic function as well as for determining the course of drug
and shock therapy. Reference has previously been made to ketosteroid
and corticoid analyses. A new direct colorimetric test for hormone
conjugates is nearing completion. Rapid micromethods have alib been
perfected for two standard analyses, viz. blood phosphorus and
which have hitherto been subject to large experimental
phosphatase,
A
simple technique is also being investigated for following
errors.
the course of chlorpromazine excretion in urine.
Metabolism of Steroid Sulfate Conjugates
Impetus to our earlier studies on the metabolism of sulfuric
acid—bound steroid hormones has been furnished by an InStitute of
Health Grant which makes provision for much needed equipment and
simple
personnel. At the outset of the grant period a remarkably
method was discovered for the colorimetric assay of steroid sulfates,
based on the use of basic dyes. Further inquiry shows that, aside
from its use in enzyme research, the method offers great promise for
the assay of bound steroids in blood and urine as an index of
these
lines.
Studies
along
continuing
are
stress.
physiological
Mechanism of Action of Lysergic Acid Diethylamide

and
from
drawn
have
been
vitro
conclusions
inc preliminary
ig
which
induces
LSD
mode
25,
a
of
of
drug
action
on
the
vivo
studies
in
a—transient psychotic state:
(l) LSD 25 is a powerful inhibitor of human serum cholinesterase.
(2) Parallel with a definitive response by the individual receiving
LSD 25 there is a rise 11),..38rum alpha keto acids.
Hormone Assay with Enzyme Systems
There appears to be little doubt but that hormones are implicated
The
in
establishing
deterrent
prime
mental
aberrations.
and
emotional
in
of
for
of
assay
suitable
procedures
this relationship is the lack
.

�function. Were such procedures available it should be possible
to catalog mental illness on a chemical basis and suggest corrective
action as an adjunct to the psychiatric services.
Since the effect of hormones on various organs is mediated via
enzyme systems, an extended study has been undertaken into the
The
hormone
for
systems
isolated
enzyme
of‘using
assay.
possibilitywould
involve incubating the test fluid with the appropriate
procedure
enzyme system in a test tube, and then determining the degree to
which the enzymes are altered by the hormone in question by measuring
conditions
the release of a colored product. To determine the choice of makuxx
been necessary to
for carrying out these measurements it has The
on
two
mathematical
studies.
papers
out
detailed
first
carry
in
Several
manuScripts
are
more
been
have
published.
this'subject of
preparation.
various stages
hormone

Bibliography
Goldenberg, Harry
"Rectification of Nonlinear Beer's
690 (1954).
Goldenberg, Harry

Law

Plots”, Anal. Chem., gg,

"Rectification of Nonlinear Enzyme Activity Curves.
Arch. Ricchem. and Biophys., §§, 288 (1954).

I. Preliminary"

�.;

and
Research
of
the
of
Publications
Department
Psychology
;/

Research in the Department of Psychology was oriented around several themes including: Refinement of psychological tests, the persis—
tent problem of schizophrenia, and the effect of maturation and agang as

measured by objective

criteria.

Certain aspects of the Rorschach test were dealt with more objectively
by a series of papers by Dr. Gurvitz and Mr. Eichler and Mr. Feinberg.
These set up for the first time objective adult standards for evaluating
many Rorschach criteria which were not available previously. Further
data was made available to experimenters illustrating the normal process
of aging and maturation to further extend the cancept that if people grow
older there are decrements in intellectual functioning and personality
ingegration.
In two new papers to be presented at the Eastern Psychological Association meeting, further progress was made in diagnosing schizophrenia by
teens of psychological tests.
The past and current research in psychology at Hillside has continued
to attract attention both in terms of the acceptability of papers in both
scientific meetings and professional journals, and also in terms of the
many hundreds of requests for reprints sent in by psychiatrists, psychologists and social workers.
These papers and research projects have also served as a training
medium for psychological internes in the Department of Psychology and the
past year was noteworthy for the fact that each one of the psychological
internes or staff members presented at least once at a psychological convention or participated in some published research.project.

��RESEARCH

During the calendar year l9Sh two projects were

in process. their families pay for hospitalization

a) Study of rates which patients and
as correlated with time Spent in the hospital.

b) The adjustment of applicants referred by psychiatrists found unsuitable
for admission to Hillside Hospital during period 1951/1953.

This latter study is a series of studies which is being done to determine the
adjustments in the community and the use of community resources for applicants
who have applied for admission to Hillside HOSpital but were found unsuitable.
It is planned to continue this series during the year 1955.

In addition, the joint project with the Jewish Community Services of long
Island concerning the placement of discharged patients in private residence
continues.

W3

research project is being set up at the Altro'work Shop to which patients
discharged from Hillside Hespital go in order to learn work habits.
A

Publications:

)/
&lt;3'“&gt;(
'21”
,~
63‘”
7
s====r
;)

Vocational Adjustment for the Emotionally Disturbed
Authors: Roland Baxt, Abraham.Lurie, and Joseph .A. Miller,
.

-

M.D.

Presentations at conferences:
a)

[pulse Pinsky presented a paper at the National Conference of Jewish Communal Service in May, 1951;, called, "The Impact of Medical Crisis on the
Family".

b)

AL:hd

‘

Abraham Lurie Spoke at the National Conference of Social‘Wbrk in may, 195h,
"The Implications for Psychiatric Social‘work of Team‘work Relationship
Between Social'workers and Psychologists".

�MEMORANDUM FROM THE

CREATIVE THERAPY DEPARTMENT

WWW

1955

Study on the constructive and/or
destructive use of passive and active aggression as a differential test for determining

schizophrenic responses.
Data for this research project had
been gathered for the past three years. Their
sifting and clinical evaluation is planned in
the near future.
The test is carried out within the
C.T. program and consists of 16 specific proand
number of

jects

EZ/r

#290

a

sub-tests.

“a
707

Ernest Zierer

�Fsbmary 2, 1955

Memorandum

from: Dr.
To:

Subject:

Fink

M.

Bondsr,

M. D.

24.1).

Anmsl Report of Hillsids Hospitals

and
medical
services
with
other
Coordination md cooperation

with the psydxiatrio staff

past you. With
in.
slsotmoncsphalogmm,
for
the
of
laboratory
sstsblishnsnt
tho
crossed use of this facility and of the consultation faoilitin m
was

incrsssed during

the:

ands by members of the resident and attsndim staff.
the
answered
attending
by
19
consultations
ssrs
the
yes“:
hiring

neurology oer-vies, and

1:0

consultations in addition vsrs anmrsd by

the rssidaxt neurologist. In the slootrosnoophahgramio laboratory
111:8

this nun":- 75 constituted consultstion
taken
rsoords
wars
the
0!
records.
maindsr,
follow-up

”cords vars taken.

rsqnssts and

01'

in tho oourss of two invsstigations

-

one

in tho effects of electro-

shosk on brain function; and the second on the

relationship between

treatinsulin
the
of
and
the
rssults
can
function
brain
in
changes

mt.
Evaluation of the organic mental mamas provided the major
with
three
Thurs
were
patients
consultations.
nourologio
Icons for
the
clinic.
followed
in
sud
who
controlled
wars
disordsrs
leisurs
Four

logic

nonrafurther
for
another
institution
to
transfsrod
sore
pstiants
work—up and

troatmnt.

when
direction
another
in
The neurologic service
nto
consultation
prior
for
aimissions
olinis
nods
tbs
tron
qussts ms

was extended

hospital admission.
your and

Sm

such

oomltstions

were dons during the

svnlustion
butts:for
s
an
upper-unity
ssrvioo
providsd
this

�of the patients problems before autumn“.
introduced to you in 1953

to evaluate organic

m

natal

The "

mail

test"

which was

mm richly used during the put year,

syndmmlg

.

�Fobmary 15', 1955

modem

Annual Report

of

Wt

of Neurology, 11111:“. Hospital

—

moperation with the psychiatric star! and other mdical gen-ion
by when of the neurology
was increased during the year.

63th

Fortyunino «nomination: by the attending neurologists, and

«agitation:

1:0

additionﬂ

were answered by the supervising neuropaychiatriut.

the eiootroenmphalographie laboratory

111:8

ream-ch

mm

m.

In

this

01'

lumber, 75 constim‘bod consultation requests and follow-up rewards.

Evaluation of the organic mantel syndrome provided the major
focus for ammlog‘io consultations. more were three patients with

mime

disorders

who

were controlled and followed in the

patients mm tranatemd to
work-up and treatment.

Hillsido in

1953 was

The

«3111116.

Four

guard hospitals for further nonmlogie
«um»; ﬁrst“ which to: introduced at

mm widely used to evaluate organic mental and»

must.
{the

mmlogic service uni also

extended when rogue“; worn

man from the admissions clinic for consultation prior to hospital
admission.
such consultations were answer-ad during the your and

Sm

this service provided
boron admission.
Under

tom

an

opporhnity for a batter evaluation of patients

of a U.S.P.H.S. grant, the electroencephalographic

laboratory was swarmed for taohirboscopy, and a number of basic nouns.
physiological problems were smdiod.

f

’13:“

��_

my}-

1955

Neurology

hmommmwumammmwumh
mes
in the visiting

a...

was noon
almond by

mm.
Wynn».

tndmtharrﬁ

m supervising

mailman

In th. metro-n

mphdographic laboratory, 210 mom an am, of which 7!; war;
consultaticn "quests. For the most put, the consultations in!" on)»

momentum
(6); pain syndma (3) and axiom cum
tit-onion (7); men-1
wt:
&gt;nenrnlng1c mum (10). 'th wk). test for organic bran dim”
Wmtinﬂpt’dnnu.
activities
mar-aura:
”sued
mm...
«momma-mt
uﬂmofuorganicmtalayﬁmﬂﬂ

ingpmmo.

mmormmmmommsmemzm

“Wmtmmmum
var.

mammotmmpaum

fonmddnringthairtmmtﬂth

aerial

Wanndawmtem.

numﬂtamsoam.tunmnn¢mdnmmm

ammunmummmmmmmmamm
mummiﬁufornm

�"...

u. p.-..

“N...
.

.

N,

~

mm .mu—mww."

wwmmw’mwm.

.,

W,

.vnx—

“‘Wn"

.7

m

as: u.-

momma!
Dr. H1110?

TO:

Dr. H. Fink

RESEARCH SERVICE,

smcrmmmya-pm-m.

Dummmtharmmhthemmamanumwmume

.

in organizing an mom nhctmshook

2mm,
the

and the

mam,

the

mm
m

Scrpuil project. Considerable mm

electron-Museum laboratczy,

and

sum

Public Health Bunion for adds!

lamb

Grant

“97.

penis“ w

mm

in

project with Dr.
spout in letting up

WMar

by the

equipment

mud

thu

no

,

Fonoving discussion with Dr. Embers and Dr.

known,

Dr. LnQuor

Wimudtoviaitiﬂllgidumdmmmm..Dr.LIQm15mchup
of the Luann unit at Grandma: State Hospital.

a: March 9th, Dr's. numbers,

mum and melt mum cm:- to as Dr. hQuor'I mam unit.

m

intended in his

that. Vinita, the

use or

split

mm mm: to induce com.

mm.

This '11]. be

mm

RobertluhnandnvaeuvisiudDr. hulﬂoehandnr.
thhtric Imtituto chitin-$133M. Wﬂaittonr. WWW
Dr.

undue for the

nut

Following

Med research emanate. at. Dr. Blmbarga suggestion din-

mud a similar project ban, and the protocol was
prumtod at the nut numb can-dun mating.
nth»

w.

purponoracqmmuthmmaentnumh

with Dr. Ismail

m

most helpful as

m.

second
Our

b. has had dmidunbla experience

in psychoplvaicq. tachniquu.

SW8 ut his ham and dime.“
withhmthemdforimmudmndsforthocmmm. Iupmssodtohiu
(h

March 17th

I Visited Dr.

Ismail

thodllinbﬂityofhlvingmummeo that Dr. ﬁlmmldbo
thoDuunPoundntionorthoPnaidcntamifm Public

mppomw

‘19de

that

��mm:
Glon om, no: Ia-k
KEPITAI.

April 28, 1955

to,

Dr. Josoph S.A.Hillor,llodioal Dix-sates

M8

Dr. Kl! Pink

8i:

subJoot:
'

hospital,

Honth

Promos Ropu-t and Room-noun".

Atthsondstthofirstsixnouthsasbirootorotnosoomhatth
1 should

libs to dosoribo tho prosont stoto of our rosoaroh program,

thhnsfathoﬂuturo,anitonkowonoouasndationsforsrosm
asparagus.
I:

Prosoat

m

dotinitivo report of tho rosooroh aotivitioo of tho dspsrtnsnts of
tho hospital was prooontod to tho nsdioal Board on April It, 1955. by tho chairman
of tho Itososroh Omittoo.
A

tho prosont tins, tho staff assisting tho Dirootor inoludos two
it
psychologists and a part-tins sscrotary ( supportod by norm and

Dausn Foundation
grants); and o half-tins no toohnioian. Port-tins roooorch ootivitios aro
cox-riot! out in tho various sorvicod sports-onto. In tho Doportuont at Ioborotorios,
two toohnioians oro assisting Dr.Goldonborg, undo:- tho tons of a noon-oh
grant
of tho USPRS. Of tho psychiatric staff, two supss‘visim psyohiatrists and two
rosidonts aro ootivoly oncogod in part-tins rosoaroh. Of tho ottonding staff,
tour labors of tho Hodicol Board as in diroct collaboration with hospital
psrsonnol in spocitio projects.

is octivo in tho following projootst
a. Following on tho sumoay of tho 1951; proJoot on thorolotion of altsrod
brain mnotion to
following olootroohook thorapy, a oooond
projoot has boon undsrtoksn to asaosa tho chorootomlogioal and bioehonioal factors in impromnt.
b. An snluotion of sorposil so a thoropoutio ogont hao boon undortakon
as an intomopsrtaontal projsot, with tho sotivo oooporotion of tho
.diool dopu-tmnt, onporvisim psychiatrist and a rosidont psychiatrist.
has Dinotor

imam.

o.

dosslopuont of moan-so of abivolonoo, both as a chorootonologiosl
factor and a symptom of psychiatric choc-ponsation. “his study is in
conjunction with a lambs: of tho Hodiool Board.

d.

and taoMstoooopio
”physiological
of tho new, is now noaring oonplotian.
Dnﬁont

Tho

'l'ho

laboratory, built with funds

Tho

hm m'ass stimlata's,
nocosoary for tachis-

mt.
mublod.

oscilloooops, and roloy and lons
tosoopy havo boon dolivorsd, on?! are being
boon outlinoo and will begin by slid-Mu.

Projects hovs

�4-2Bimltonoomly with thou motto, I havo boon participant in a
nunbor of tho dopartnontol projocto at the hoopitalp oooporatod with tho ﬁbcultun Study Omittoo in tho dmlop-ont of its protocol; and havo mlnatod
throo protocola which uoro oubnittod to tho Roaoaroh Conittoo from outoido
loot-coo, and out. opooifio roommdationa on oooh.

now
mum

problou of mohiatry involvo all aopooto of tho moo, oonroo,
for thoo'pocitio tonic
tron-int and provontion of tho Nor poyohoooo.
an! innmatory poychoooo, nothing is known of tho otioloy of ochioophronia,
involutional paycheck or antic-domain illnooo. Itch duoription of tho
oouroo of thooo illnooooo io availablo, but thio haa boon of littlo bola": in
troatnont or promotion moot in ioolatod inotonooo. mutant io omit-idol;
and

W

at boot, poi-ital".

'

"

control roam for hospitalisation in loot pationto in tho dmlomontvo! owning tonsion and anxiow, and pmhotio thoughto. lutorporoonal
rolaticnohipo havo boom diotortod, culmination blurrod, and otfootivo activity
oo to throotod oolf-prooorvation. rho vat-1m porchiotric thorapioo
oo
availablo today attack difforont aopoota of thooo problouo. A prion-y goal io
tho doovoaoo in tonoion and musty, and tho ovum-o of mohotio idoation. hob
offal-t in «pound ot chaining intorporoonalxolatimohipo and oodoo of omnioation; and nontual ”education and oupport d tho pationt in dirootim his
ootivitioo along «room ohannolo that lood to
on! meiot- prooorvotim.
Tho

m1

alto

0'thMom.

“ti-toot“: intho njority or
ma‘ont nothoda
portion.- in at loaot town-11y atomim tho poyohotio
rollovine tonnion
and indnoim a roturn to non offoctivo
In this prooooo, tho following nothodo are pennant at tho hoopitoln
Ont

1.

W.
By

2.

By

3.

By

hoopitolilation,

thoe pationt
'

is ”poo-om

pm,

and ioolatod

'

tron bio

»

.diootion,

barbitnratoo, oorpooil, and chlorpronaoino,
and by olootz-oohook and ubnlatory insulin trootnonto, ton-ion and
anxioty
are roduood.
dmg

W

oo

olootroohock, olootz-onaroooio and inmlin cola thorapy pontwtio
idoation in omod by altoring brain function.

It. By group and social

aotivitioa, om group thong, in a poniooivo
onvironoont, bottor communication io footorod.

5.

individual poyohothorapy intorporoonal rolationahipo oro tootorod
alom nan-tic line.

6.

onvironnmtal “Isolation, sob ”causation, and oooial oorvioo
bolp, offootivo mnotioning is

By

By

Onrnaoaroh

prom

W.

io dovotod to ltudyingthooo

Miovnda-otamthomwmt

moo.

diooiplimo aro omtmotivoly appliod at tho hoopital,
tho offootivonooo of aw hao not boen mftioiontly some»; nor hao tho undo
While thooo

'

�W.
mwummmammm
WﬂMWbW:
mmmmmwm-mmammm
mmmmmume-‘mmm
“aluminum”. ”Wmmuth-ﬁmm
ammuqumwn-mmmmwaw
mun-nuns
1mm
”mama-um
but...“
WWmWI-wb“
name:
Amara
naom:
Wabﬁofmmmwmmmmgm
ammphmaumammmmmugm
B.

nummhummmmwmmm.
Wm”.
ntmwnmwpmmwwwormm
ammmnmotmwtmpmormm
MMvoo-R'Wﬂmtbmofmmm
Waited-mum. imam-Malawian“umumormmwwmwm.
ammmwrmmmm:
mmmmmtormm.mumonam
wmmmmmuwmmtmmm
MW. mamwmvwmmwumm
www.mwmm-meummmrm
«mwgmnkmmmmmm
Sm:
mgwmmm'm*wmw
muwumwmmmmmmmu
mammanmmmmumwm

MW”.
Was mum W but“
mmammwmwmuﬂc
mmmmwmmmumsmmam
13.

of

(Iona-up):

MmmthotmmuWW-wh
.szthbmotMW,amwwm-amnmtu
mmuwmwm
nil-M.
nmmnmormm-mmnmwmuuot

:
Aummmuammmtommmumm

Immmmmusmmmmw
coucﬂohgyuthomnc. mums-unmet» nu
mmmmwamcmauwmmormw

numb-u;

�,

m
W

WV

'7,

,7.

_

7.- ‘av‘nnwf ”WIV

,

w

0.77 ——-r.,,~__.

mm Mm

7,7 .. ,_,_.w. w.
4.-.. x» -vuJ.

v

a...

»

“.:.y.

V

um

.t‘A—f»lw"‘.. 5;?u11VI/1‘IIKV

pom). devoted $0 and: Mn. 1 mm
Wthatmchuuuﬁcolnn'muoh‘uﬁammz
manna.at the urvioo (lupus-taunts aft!» hospital; mam 1t
abuzle
hm
would
mien
«are
of
mat
mural-u of th-

men

80m,

fun-tine

«mam

fund»

2;.
50

3.

with

-

Wmum
d. Boom

1mm.

a.

m
mm:"
mm
1n Manning

5.

‘3

fur ﬂu Ina-mix Its-den

’

i

,

‘

Wam

”W
'
Why
6.
WOW
in
'

in

"

'
8.8mm
7.

9.

' 10..

~

,

3mm

Mot

'1. Director
'0

which

at! «nan-1 ”um-1.

Aux-ml

2.

«mmw

1::

7m
It

soon).

’m
-m

(1/2

a
Comm-m. azppnu
m1
Equip-ant:

up)

wannabe!

mm
6.“
8.W¢
5.“
.
5.200 . 10,000.
mono . 6.000.
3,760 - 3.300.
It,“
6'”.
.
1,300 . 1,8001
.25
.
20:33:.
12.600 o.
8,000 a 10.000.
“ 103W.
.-

2.500.

1’”.

Immune-anthem
wumrollwimmtlumw:

MWWNUSSvaUSé.
mama-Manon

10m
2. hunch bout-m . Psychiatry
by
hog-kw
5:
suppuu
W1.
mm
6. m1
u

13:.

70

335.000.
7.500.
3.200.

W

&amp;

'

hmm(mmngmn)

2%:
1,000.
o

7m.
@3600.

��,

W,

‘

.

.

7.

20

TM.

“7

»

... ,

‘ ~- ...~ ”v-

.. -r “qt-u

—

rm.wnm,——«__..a.;

v,r~w-w—;m—u~,‘.wg-W.

“my“.

m’mwz’wvu-vwww‘,..w;v-—

”Mim.
mg}

_

v.

“VF

_.

.

.‘m

,romummmrmmmmuatmmmm;
23*
and to curry an moi: indupenduut‘
ruuponuthinty
projuutu;
um
a

um
«can.
um W

to

W
W
m
meugm;w mummmm.
amt-Assum-

his

at!

umumuwwuwmamupmum
in
in
woman-y
mommy,
nun-in
thuussoeiutu
dual-1w“ psychiatry.
A.

with

lb

both

and
uhenld luvu

I: cap-rum,

By

uumu rayon-winter for that portion of the function: of
ﬂu umicu "sigma ta him by ﬂu car-octet;
in th- diruétor'u
“111

um
Whmw
«tum mtmmuu, neetingu und um touching function: u moon-Mud
than”;
by ﬂu and».
M1.
mmmeym-mmmmum.
ma~812.0mt920,m0.
.

.

WWhmhnbh.
Munoz-1um.
“Minna-dc
Tb
is
m
Wuhan-vim
m
migudtohhhytbmm.v
«nation mung "than, nun-tun «nudism units,

withukluuutmyumuupurumu.
Thu

ﬂu

uumding ofAusooiuiu

uaoniuto in ”analogy

m

for than mantionuaf ﬂu
An
at
control. of
in
we Mu ruuponuibinw.

m

dam

to

guidu

ruuponuibmw

91'

:u nupuctu of ﬂu mum at

and u
mucus-uh

mmmnumuns

n- Mussocuuinmcholmnybuohouunfmthu mun-uh
azimuth
runa-~36,ooo to 10.000.
prod-uh
uupmtuu
mung-ad
hthudupurhunu WWutthurouidummchnw Mfg uusm
hundu u smut uid 1n cranium;
such
projuctu; «Mu
ﬂu 61mm of m aunt-uh puma“; uttund comm, ms. uportu und
on Inch
pupuru, um!
madman us ﬂu mutate:-

(£th

«mm
our:
my ”train.
Mama"
mmmummumummbymmm
MﬁWWofthWWundthuDimtorofﬂuuu-oh.
3.

thumb A3313

renumtthudmmmmwutmandwryon
thuwrkofthudupumm.Mushtmti-bbumpoau1bhtomdm
such
tutu,
reports, and pnunt thou
mun
manners
madam, mu
mududmtdbyﬂubimw.usmmtobumm1udbymmag
undupu‘iumuforﬂnupudﬁud Johan—u. Mus-etc!» oniutudbythu
mmmwnthu nuimﬁmdthnmofmch.

l. Aututunt 1n Puyohiutxy: For Inch mohiutdutu who hm bud thruu
thuoppu»
ormnyuuruoIIMpuyohmmonMt
mtmmm,
for
on.
team
on: and
Ruuuurcthmypz-widuthuau~
Mt:
ormuywu
for maturation in renewal:
uluo prom the dimtor with ﬂu
mutton
uuiutuneu at pcuomul
1n
buwuunthu

ruuidunt
ma
ﬂu
Memo
Mute
Thu “shunt.
1n puyuluutry uuu uuawu mpommnty for tho auction
'

"0001‘“.

�{a

&amp;1.th

7-

W

torthovmm prom; mum chuguinb-hmvuh
and
of
tho
int—Ewan“
“as.
in
tutor.
mom
mm”
«.111
the want Wear of th- p-thnt; Tho
"spanninw
um
fa. than aspects

“W
ofﬂmbhummu‘auonumiuhmhu
Hoﬂlluﬁhumhrm,~mmmuueh
mmwwmam.
mmttmummutwwm kmlnhmchm,hmm¢h
mm'mummmdmnmmwmmuMufmhapimummduuw-ﬂ'
aux-y nap-nuns
nap
mm. W.
’

neopo,

'

'

06.000 to 10,000.

on

twmpuyeholoyuﬂanm

mammal.
mmwamm,mummmpommwrortu
nothoda and
smut-hum at thbut

Newt.

smart.

duign

'

with tho soul- of thy

.

‘

'thryrumn-Sﬁﬁoommhwo

«Wotan.
”mam
Mat-311W
W,
build
can.
mmuw
“Wham
cm;
with tho parallel-exist inc
m maul-d) mat:
MW
”Wham
cup-rd..in
ohmic“
magnum"
mum
m.
b. mum: a); 1ft!» hbontcry u asp-aloe to
m.
manna-n
whatnot-chain studio’s. Wlmmmmtdﬂummool
con-urn.
Salary
to 30,900.
mg.
Mtg
",3‘

an

an

-, o

:7

.

sup-n13.
abducts-Inna;
Ia and: null-1 than“
1‘0

and

Wm
a-

85,200

W
1mm
wWad
cum
W
We
m,
um
”hum
1M
www.mmupmdmwmmw
mum
mm:
rem
um
mm
mm
Wwamn‘tarofthu “hm; wtocmmmumumhmungmmm
unioapnjocum toba-Iunhyﬂu ”Mummhmm; alum
d. And-mt

- Social

WI

3.5. (Seaman-k) with
yum
work.
on
use-sing funny nhtiennhipu. Pinon-1 ambit:
11' pmiou mun-ch «pox-hm. with
or
mum-nu
it should be Muﬂy might-d.
Aid-tut. u to
napouihdhty for
on binary tad
to obtain
{tantalum
ad
to the only you. of durum] to
with tho

mm

of

f1”

1-

in amusing

mum,
m1
new
mammal
Ihichhcwmoorgwuththnpm «mammal-am

follow up contact. undo. For :11 fellow-up touting an!
thc
1:111 like tin mos-cry contact- tad arrangunufor Hindu-actor.
“0mm
Tho
wot-hr
to th- aws-Itch amo- I111. 11‘ t1.- 13 mm]...
cooperate with the Dix-actor 3350:3111 8mm. in ﬂint
prawn
5%

WtuWNIIMMWtMDMrMMIWO.
aim-Monongooor

WmomMmuwW-innm

�hme-mlmm,aw0uommmwm
anuslupus. alum; m “not. In. "can!”mum «a! £11m;
“parts
WM
mmmegaMnmmp—m.
”00
I;thMtum-mhmmutbm.
‘9
”‘mo
“’m‘
1
.“
”m
m1.
PM
W,
2.
Gallop M00, WW1.
m.mehw.
huststthubmmm”
uthmmmnngarmm
mamwmmusimmmm.mmmmwnm
«.memgmummmmmormgwmua
mmmpamgmw,mnmmm1mm.
mrmdwmmmmmuémm.

ﬁmmmﬁmgmmmw
81

1''

m.ummumniymowu‘mumma
bmmamtimingfumtimmdukolomm

mum-norm.
plmning haiblo, it is mud-d 0h“

W
stummmormmmmmuwaecmmm
of
. nun-buds»
of 060,000 870,000; and with

.

3

luau-uh

1955-56

by

Ommhﬂl] ﬂat

836.100.

mmnwwmmmbmm-uﬂ,
lab-1M.
Wily

We!”
lam,

3.0.

I955.

�HILLSIDE HOSPITAL

Glen Oaks,

New

York

April 28, 1955
Tb:

Dr. Joseph S.A. Miller, Medical Director

From:

Dr.

Max

Fink

Six Month Progress Report and Recommendations.

Subject:

At the end of the

first six

months as Director of Research

at the

hospital, I should like to describe the present state of our research program,
our plans for the future, and to make specific recommendations for a research

department.

I: Present
'A

Proggam

definitive report of the research activities of the departments of

the hospital was presented to the Medical Board on April h, 1955, by the chairman
of the Research Committee.
At the present time, the staff assisting the Director includes two
psychologists and a part-time secretary (supported by USPHS and Dazian Foundation
grants); and a half~time EEG technician. Part-time research activities are
carried out in the various service departments. In the Department of Laboratories,
two technicians are assisting Dr. Goldenberg, under the terms of a research grant
of the USPHS. Of the psychiatric staff, two supervising psychiatrists and two
residents are actively engaged in part-time research. Of the attending staff,
four members of the medical Board are in direct collaboration with hospital

personnel in Specific projects.
The

Director is active in the following projects:

a. Following on the summary of the l95h project on the relation of altered
brain function to improvement following electroshock therapy, a second
project has been undertaken to assess the characterological and biochemical factors in improvement.

evaluation of serpasil as a therapeutic agent has been undertaken
as an interdepartmental project, with the active cooperation of the
medical department, supervising psychiatrist and a resident psychiatrist.

b.

An

c.

development of measures of ambivalence, both as a characterological
factor and a symptom of psychiatric decompensation. This study is in
conjunction with a member of the Medical Board.

d.

neurophysiological and-tachistoscopic laboratory, built with funds
of the USPHS, is now nearing completion. The two Grass stimulators,
DuMont oscilloscope, and relay and lens systems necessary for tachistoscopy have been delivered, and are being assembled. Projects have
been outlined and will begin by mid-May.

The

The

v'

/

�-2...
Simultaneously with these efforts, I have been a participant in a
number of the departmental projects at the hospital; cooperated with the Subculture Study Committee in the development of its protocol; and have evaluated
three protocols which were submitted to the Research Committee from outside
sources, and made specific recommendations on each.

II.

Future Programs

Present problems of psychiatry involve all aspects of the cause, course,
treatment and prevention of the major psychoses. Except for the specific toxic
and inflammatory psychoses, nothing is known of the etiology of schizophrenia,
involutional psychosis or manic-depressive illness. Much description of the
course of these illnesses is available, but this has been of little help in
treatment or prevention except in isolated instances. Treatment is empirical,
and

at best, primitive.

central reason for hospitalization in most patients is the devel~
opment of overwhelming tension and anxiety, and psychotic thoughts. Interpersonal
relationships have become distorted, communication blurred, and effective activity
so minimal as to threaten self-preservation. The various psychiatric therapies
available today attack different aspects of these problems. A primary goal is
the decrease in tension and anxiety, and the erasure of psychotic ideation. Much
effort is expended at clarifying interpersonal relationships and modes of communication; and eventual reeducation and support of the patient in directing his
activities along effective channels that lead to self- and social- preservation.
The

present methods are apparently satisfactory in the majority of
patients in at least temporarily stemming the psychotic process, relieving tension
and inducing a return to more effective functioning. In this process, the following methods are prominent at the hospital:
Our

1.

By

hospitalization, the patient is separated

environment.

and

isolated from his

2. By drug medication, as barbiturates, serpasil, and chlorpromaline,
and by electroshock and ambulatory insulin treatments, tension and
anxiety symptoms are reduced.
3. By electroshock, electronarcosis and insulin coma therapy psychotic
ideation is erased by altering brain function.

b.

By group and

5.

By

social activities,

environment, better

and group therapy
communication is fostered.

in a permissive

individual psychotherapy interpersonal relationships are fostered

along

realistic lines.

6. By environmental manipulation, job reeducation, and

help, effective functioning is strengthened.
Our

social service

research program is devoted to studying these processes.

A. To Understand

the'ﬂay Therapy'Horks:

disciplines are constructively applied at the hospital,
the effectiveness of any has not been sufficiently assessed, nor has the mode
While these

�.3mode
of
of
the
lhe
study
evaluated.r
present
been
adequately
of operation
has
Electroshock
of
our
interest.
example
an
electroshock
of
is
operation
By
assessing
in
many
from
patients.
depression
psychotic
resulted in improvement

be
works
will
electroshock
the various possibilities it
understood. If this is accomplished, then some ideas about the mental and
The understanding of
become
clear.
may
in
depression
physiological processes
A plan for a
of
service.
research
the
electroshock treatment is the first goal
similar study of insulin coma therapy is now in preparation; and others at the
environment
as a therapeutic
of
the
hospital
a
study
planning
hospital are

is

hoped

that the

way

mechanism.
B.

Relationship of Character Structure to Diagnosis:

child—
of
the
the
demonstrate
importance
to
devoted
been
study has
hood environment in the development of character, behaviour patterns under stress
conditions and the neuroses. Other investigators are actively involved in assess—
of
adult
in
the
variety
result
that
childhood
relationships
the
in
the
factors
ing
behaviour patterns. It is not possible to carry out such studies at Hillside,
but the important relationship between character and the type of mental illness
of
behavioural
to
of
the
character
patterns
the
relation
the patient shows;
change which we call 'improvement'; and the aspects of character that resist
treatment methods can be assessed. A prototype of such studies is now in progresselectroshock
in
therapy.
improvement
to
basic
of
character
the
in
aspects
much

C.

Biochemical and Physiological Factors in Mental

Illness:

ill

for long periods, appear to take on a stereoPersons who have been
and
chemistry
in
their
reflected
which
is ultimately
typed behaviour pattern,
by
neurologic,
'non—reactor'
and
patterns
such
of
'reactor'
Study
physiology.
the
failures
in
assessing
methods
important
and
are
drug
biochemical
physiologic,
and
physical
illness
between
psychiatric
the
relations
of present therapies;
Such
and
a
improvement.
between
therapies
'organic'
and
the relation
illness;
to
drugs
EST
and
reaction
where
second
project,
the
in
incorporated
study is
and
of
long
short
terms
in
be
assessed
will
electroencephalogram
changes in the
term improvement rates.
(Follow—up):
Results
Treatment
of
D. Continuing Evaluations
suffer
treatment
of
generally
of
present
the
results
studies
Follow-up
of
the
evaluation
done
an
without
are
only;
one
therapy
because they assess
control
to
standard
and
compared
not
are
improvement;
for
subject‘s potentialities
followcontinuing
a
be
to
organize
possible
With
may
active support, it
groups.
evaluated
on
admission;
assessed
are
the
in
hospital
which
patients
up program, in
followed
a
and
over
then
methods
at
discharge;
and
psychiatric
by psychologic
number of years with an evaluation as to sustained change and reasons for failure.
much
would
have
at
discharge,
the
to
predictions
Such an evaluation, if compared
base—line
for
and
a
provide
of
choice
therapies,
present
merit in assessing the
the evaluation of any future therapeutic methods.

III.

Recommendation

of
problems
the
methods
in
attacking
of
suggested
In this outline
the
treatment
best;
as
one
made
to
specific
specify
no
effort
have
I
psychiatry,
is
that
fragmentary
so
it
knowledge
is
Present
the
specific.
or one etiology as
of
psychoses.
the
major
to
the
eticlogy
make
as
only
a
to
poor guess
possible
A multidisciplinary approach with full freedom to follow many leads is the best
of
a
establishment
recommend
the
would
For
I
be
this
offered.
reason,
that can

�-

u

-

Research Service, with full-time personnel devoted to such studies. I would
suggest that such a service have "research" as its function; that it be independent of the service departments of the hospital; and that it have a basic
budget which would assure continuation regardless of the availability of outside
research funds.
A.

The

Research Service should have the following organization:

1. Director of Research -- Responsible to the Medical Director.
2. Research Associates in Psychiatry and Psychology.
3. Research Assistants:

a.
b.
c.
d.

Psychology
Neurophysiology

Psychiatry
Social Service

h. Secretarial and clinical personnel.
5. Technicians.
B.

Annual Budget recommendations

for the Research Service:

1. Director
2. Associate in Psychiatry
"
in Psychology
b. Assistant in Psychiatry
"
5.
in Psychology
“
6.
in Neurophysiology
"
7.
in Social Service

8. Secretary
9. Technician
n
10.

-

Lab
EEG

(1/2 time)

$20,000
12,000
8,000
6,000
5,200
5,200
h,000
2,760
h,000
1,300

Equipment: As warranted
Consumable Supplies

Travel

Overhead:

As

decided by Administrator.

- $25,000.
- 20,000.
- 10,000.
- 10,000.
—

-

-

8,h00.
10,000.
6,000.
3,300.
6,000.
1,800.
2,h00.
1,000.

available as a continuing commitment to
the Medical Director for long range planning of the Research Service.
These funds should be made

For the budget year 1955-1956. I should like to make the specific
recommendation that the following are the minimum requirements:

1.
2.
3.
h.
5.

Director

Research Assistant
"

"

Secretary

Consumable Supplies

6. Travel
7. Overhead
8.

EEG

- Psychiatry

- Psychology
&amp;

Equipment

Technician (in Operating budget)

$15,000.
7,500.
7,200.
3,000.
2,h00.
1,0000

-

$36,100.
1,600.
$37,700.

�0. Space:
Problems of space at the hospital are acute, and will provide an increasing measure of difficulty as the service is developed. It is suggested
that in the next capital outlay by the hospital for construction, some allowances
be made.
for the Research Service
‘

D.

Relation with Other Departments:

activities of the Research Service are to be those designated by
the Director. Interdepartmental projects will be carried out by the Research
Service, or in those instances where approval of the Research Committee is obtained, by the departments involved. Supervision of such interdepartmental
projects will lie with the Research Director.
The

Interdepartmental projects are to be fostered by the Director. Prior
approval by the Research Committee and the Medical Director is required. Such
projects as are consistent with the service functions of the departments involved
W111 be fostered. Presentations and reports are to be approved by the Research
Committee prior to publication.
E.

Job Description:

1. Director of Research:

objectives of the Director of Research will be to: (l) Organize
and maintain an active program of research and a Research Service; (2) Promote,
supervise and integrate research activities at the Hospital; (3) Educate hospital
personnel in research methods and progress; and (h) Administer research funds.
The

The

director of research will:

a. Organize a central project or series of projects appropriate to the
unique character of the Hospital and integrate this into the activities
(therapeutic) of the Hospital. Progress reports will be submitted to the Medical
Director and to each meeting of the Research Committee of the Medical Board; and
such data as is approved for presentation will be submitted by the Director or
his delegate at the appropriate scientific society.

all

staff to plan and carry out individual
research projects. Third year residents in psychiatry are to be specifically
encouraged to undertake research projects under his direct supervision, or that
of an attending psychiatrist. For these residents, and any other professional
members of the staff, the director of research is to assist in the planning of
b. Encourage

members

of the

the project; in its integration into the hospital program; and in
both technically and financially.

its

support

0. Carry on such educational activities as the supervision of third year
residents in research; monthly seminars in research problems and progress; and
periodical reports of important psychiatric meetings. The director will maintain
a calendar of meetings and lectures; stimulate attendance thereto; and foster the
He
such
of
is also to invite such
meetings.
at
Hospital
activities
presentation
guest lecturers and seminar leaders as are available.

d. Administer all research funds with the approval of the Medical Director.
This includes the stimulation of fund sources; the application for funds; and their

allocation to hospital projects.

�2. Research Associate:

Director in all projects at the hospital; to
assume responsibility for specified projects; and to carry on such independent
investigations as his training and experience dictate.
Tb

work with the

Associate in Psychiatry is to be a qualified diplomats in
psychiatry, with extensive experience both in psychoanalytic psychiatry and in
descriptive psychiatry. By training or experience, the associate should have
teaching qualifications; and some training in research methods.
A. Such an

assume responsibility for that portion of the functions of
the service assigned to him by the director; assume responsibility in the director's
absence; attend conferences, meetings and assume teaching functions as recommended
by the director.
He

range

—

will

Salary to be determined by qualification and experience. Probable
$12,000 to 20,000.

B. Such an Associate in Psychology is to be a qualified psychologist
with at least 10 years experience. Psychoanalytic experience is preferable.
The equivalent in academic standing of Associate Professor is the guide line.

research associate in psychology is to assume responsibility
for those functions of the Research Service assigned to him by the director.
An evaluation of testing methods. statistical evaluation of results. and a
of
the research
of
of
aspects
contr0l
the.functioning
procedure
in
all
rigorous
service are his responsibility.
The research associate in psychology may be chosen from the research
assistants. Salary range - $8,000 to 10,000.
The

will: organize and supervise projects
in the department; supervise projects of the resident psychiatric staff; assist
such department heads as request aid in organizing departmental projects; advise
the director of new research possibilities; attend conferences, write reports and
papers, and carry on such administrative activities as the Director may require.
Both Research Associates

Board

at

Appointments to Research Associate are to be made by the Medical
the recommendation of the Medical Director and the Director of Research.

3. Research Assistants:

assist the director in his research activities and carry on
the work of the department. Each assistant is to be responsible to the director,
and will carry on such tests, procedures, write such reports, and present those
To

papers designated by the Director. Assistants are to be qualified by training
and experience for the specified jobs named. They are to be appointed by the
Medical Director at the nomination of the Director of Research.

a. Assistant in Psychiatry: For such psychiatristswho have had three
or more years of formal psychiatric training but not yet certified, the opportunity to work for one or more years on a Research Service may provide the
stimulation for continuation in research and also provide the director with the
assistance of personnel intermediate in experience between the resident and the
associate. The assistant in psychiatry can assume responsibility for the selection

�-7of the patients for the various projects; evaluate changes in behaviour with
treatment; assess the importance of intrapsychic and environmental factors in
the present behaviour of the patient. the assistant.vill assume responsibility
for those aspects of the problems under investigation as are within his scope,
and assigned by the director. He will write such reports, papers and make such
presentations as the director may suggest. He will make such tests, learn such
technics and work with those members of the research service or the service departments of the hospital as his projects permit.
Salary is dependent on experience. Probable range $6,000 to 1C,000.
b. Assistant in Psychology: Graduate in psychology with a minimum
of doctorate. Preferable experience in research methods and publication experience
with some specialization in laboratory methods. Equivalent academic status of
assistant professor. The assistant in psychology is to carry on such psychologic
and laboratory tests, and make such statistical and methodological evaluations
as the projects of the service require; and to make such reports and presentations
as the director may suggest. He is to direct the laboratory technicians, organize
their work and assume responsibility for the maintenance of all testing equipment
and materials. In the design of projects, he is to assume responsibility for the
application of the best methods and design commensurate with the goals of the

project.

Salary range

~

$5,200 to 8,h00.

c. Assistant in Neurophysiology: M.D. or Ph.D., with a minimum of
three years experience in electroencephalography or neurophysiology. To supervise
and coordinate all neurophysiological studies, now being organized; develop and
build electrophysiological equipment; assume responsibility fer such animal studies
as are organized; cooperate with the psychologist in coordinated neuropsychological
investigations; and supervise technicians in electrical methods.
This position can be filled only if the laboratory is expanded to
include more basic studies. Personnel can then be recruited from medical school
training centers. Salary range - $5,200 to 10,000.

d. Assistant ~ Social Service: B.S. (Soc. Work) with minimum of five
years experience in field or administrative work. Emphasis on interviewing
technics and assessing family relationships. Personal analysis recommended.
If previous research experience with psychiatrists or psychiatric clinics is
noted, it should be heavily weighted.

Assistant is to assume responsibility for interviewing relatives
of patients and develop technics of assessing premorbid characteristics based
on history and interview; to obtain histories from relatives and patient relevant
to the early years of development; to cooperate with the psychologist in assessing
the personality of the subjects; and to coordinate research testing in the various
projects. Patients seen during their hospitalization in any of the research
service projects are to be seen by the social worker prior to discharge, and eVery
effort at follow up contact made. For all follOWbup testing and evaluation, the
assistant will make the necessary contacts and arrangements for the director.
The social worker assigned to the research service will, if time is available,
cooperate with the Director of Social Service in those interdepartmental projects
which he may have organized with the approval of the director of research.
Assistant is to be selected by the Director of Social Service.
Salary range proportionate to experience in research. Range - $h,000 to 6,000.

�e. Technicians:
EEG -~ High
l.
fundamentals

school graduate, although two years college preferred.
To learn the
of electroencephalography; make the necessary measurements and place electrodes; obtain artefact free records; maintain card files;
type reports; keep records in systematic way; and maintain equipment. Technician
is to be responsible to the assistant in neurophysiology or the director.

Salary

-- if

untrained,

$52,600;

if trained,

$33,060

to 353,600.

2. Lab. Technicianp-Neurophysiology. College graduate, preferably
with some engineering or physics experience. To assist the assistant in neurophysiology and/or the assistant in psychology, in the development and maintenance
of electrical equipment; to assist in the handling of animals; to cooperate in
the experimental procedures; to build, adjust and design special equipment.

Salary range dependent on training-- Rangeﬁ .000 to 6,000.
IV.

Summary:

Research Director is actively involved in a number of studies of
the mechanism of treatment. To maintain a continuing function and make long term
planning feasible, it is recommended that a Research Service be established; that
be an integral part of hospital organization with a continuing annual budget.
it
A proposed organization is included in this report, with a projected annual budget
of $60,000 ~ $70,000; and with a minimum budget 1955-56 of $36,100.
The

This report approved by the Research Committee April 27, 1955.

Respectfully submitted,
Max

Fink,

MoDo

Director of Research

�HILLSIDE HOSPITAL

Glen Oaks,

New

York

April 28, 1955
Th:

Dr. Joseph S.A. Miller, Medical Director

From:

Dr.

Max

subject: Six

Fink

Month

Progress Report and Recommendations.

first

six months as Director of Research at the
hospital, I should like to describe the present state of our research program,
our plans for the future, and to make specific recommendations for a research
At the end of the

department.

I: Present
A

Program

definitive report of the research activities of the departments of

the hospital was presented to the Medical Board on April 5, 1955, by the chairman
of the Research Committee.
At the present time, the staff assisting the Director includes two
psychologists and a part-time secretary (supported by USPHS and Dazian Foundation
grants); and a half-time EEG technician. Part-time research activities are

carried out in the various service departments. In the Department of Laboratories,
two technicians are assisting Dr. Goldenberg, under the terms of a research grant
of the USPHS. Of the psychiatric staff, two supervising psychiatrists and two
residents are actively engaged in part—time research. Of the attending staff,
four members of the l"ledical Board are in direct collaboration with hospital
personnel in specific projects.
The

Director is active in the following projects:

a. Following on the summary of the l9Sh project on the relation of altered
brain function to improvement following electroshock therapy, a second
project has been undertaken to assess the characterological and biochemical factors in improvement.

b.

evaluation of serpasil as a therapeutic agent has been undertaken
as an interdepartmental project, with the active cooperation of the
medical department, supervising psychiatrist and a resident psychiatrist.

c.

development of measures of ambivalence, both as a characterological
factor and a symptom of psychiatric decompensation. This study is in
Dmedical
member
of
the
with
Board.
a
conjunction

d.

neurophysiological and tachistoscopic laboratory, built with funds
of the USPHS, is now nearing completion. The two Grass stimulators,
DuMont oscilloscope, and relay and lens systems necessary for tachistoscopy have been delivered, and are being assembled. Projects have
been outlined and will begin by mid-May.

An

The

The

�-2...
Simultaneously with these efforts, I have been a participant in a
number of the departmental projects at the hospital; cooperated with the Subculture Study Committee in the development of its protocol; and have evaluated
three protocols which were submitted to the Research Committee from outside
sources, and made specific recommendations on each.

II.

Future Programs

Present problems of psychiatry involve all aspects of the cause, course,
treatment and prevention of the major psychoses. Except for the specific toxic
and inflammatory psychoses, nothing is known of the etiology of schizophrenia,
involutional psychosis or manic-depressive illness. Much description of the
course of these illnesses is available, but this has been of little help in
treatment or prevention except in isolated instances. Treatment is empirical,
and at best, primitive.
The

central reason for hospitalization in most patients is the devel-

opment of overwhelming tension and anxiety, and psychotic thoughts. Interpersonal
relationships have become distorted, communication blurred, and effective activity
so minimal as to threaten self-preservation. The various psychiatric therapies

available today attack different aspects of these problems. A primary goal is
the decrease in tension and anxiety, and the erasure of psychotic ideation. Much
effort is expended at clarifying interpersonal relationships and modes of commun—
ication; and eventual reeducation and support of the patient in directing his
activities along effective channels that lead to self- and social- preservation.

present methods are apparently satisfactory in the majority of
patients in at least temporarily stemming the psychotic process, relieving tension
and inducing a return to more effective functioning. In this process, the following methods are prominent at the hospital:
Our

1.

By

hOSpitalization, the patient is separated and isolated from his

environment.

2. By drug medication, as barbiturates, serpasil, and chlorpromaaine,
and by electroshock and ambulatory insulin treatments, tension and
anxiety symptoms are reduced.
'

3. By electroshock, electronarcosis and insulin coma therapy psychotic
ideation is erased by altering brain function.
'

b. By group and social activities, and group therapy in a permissive
environment, better communication is fostered.
5.

By

individual psychotherapy interpersonal relationships are fostered

along

realistic lines.

6. By environmental manipulation, job reeducation, and social service

help, effective functioning is strengthened.
Our

A. To

research program is devoted to studying these processes.

Understand the Hay Therapy Vorks:

disciplines are constructively applied at the hospital,
the effectiveness of any has not been sufficiently assessed; nor has the mode
While these

�.3mode
of
of
The
the
study
evaluated.
present
been
adequately
of operation
has
Electroshock
of
interest.
our
example
an
electroshock
of
is
operation

By
assessing
in
many
from
patients.
depression
psychotic
improvement
resulted in
be
works
will
electroshock
the
way
that
hoped
is
the various possibilities
and
mental
about
the
ideas
some
then
accomplished,
understood. If this is

it

The
of
become
understanding
clear.
may
in
depression
physiological processes
A plan for a
of
service.
the
research
electroshock treatment is the first goal
similar study of insulin coma therapy is now in preparation; and others at the
environment
as a therapeutic
of
the
hospital
study
a
planning
hospital are

mechanism.
B.

Relationship of Character Structure to Diagnosis:

study has been devoted to demonstrate the importance of the childhood environment in the development of character, behaviour patterns under stress
involved
in
assessOther
actively
are
and
investigators
the
neuroses.
conditions
of
adult
the
in
variety
result
that
childhood
relationships
the
in
factors
the
ing
behaviour patterns. It is not pOSSible to carry out such studies at Hillside,
mental
of
illness
and
the
between
type
character
the
but
important relationship
of
behavioural
to
of
the
patterns
character
the
relation
shows;
the patient
of
character that resist
and
the
aspects
'improvement‘;
we
which
call
change
A
be
prototype of such studies is now in progressmethods
assessed.
can
treatment
electroshock
therapy.
in
improvement
to
basic
of
character
the
in
aspects
Much

C.

Biochemical and Physiological Factors in Mental

Illness:

ill

for long periods, appear to take on a stereoPersons who have been
and
chemistry
in
their
reflected
which
is ultimately
typed behaviour pattern,
by
'non—reactor‘
neurologic,
and
patterns
of
such
'reactor'
Study
physiology.
the
failures
in
assessing
methods
important
and
are
drug
biochemical
physiologic,
and
physical
illness
between
psychiatric
the
relations
of present therapies;
Such
a
and
improvement.
between
therapies
'organic'
and
the relation
illness;
and
to
drugs
EST
reaction
where
second
project,
study is incorporated in the
and
of
long
short
terms
in
be
assessed
will
electroencephalogram
the
changes in
term improvement rates.
D. Continuing Evaluations of Treatment Results (Follow~up):
suffer
treatment
generally
of
of
present
the
results
studies
Follow-up
of
the
evaluation
done
an
without
because they assess one therapy only; are
control
standard
to
compared
and
not
are
improvement;
subject's potentialities for
followa
continuing
be
to
organize
possible
may
With
active support, it
groups.
evaluated
on
admission;
assessed
the
are
in
which
hospital
patients
up program, in
followed
a
and
over
then
methods
at
discharge;
and
psychiatric
by psychologic
number of years with an evaluation as to sustained change and reasons for failure.
much
would
have
at
discharge,
Such an evaluation, if compared to the predictions
for
base-line
and
a
provide
of
therapies,
choice
present
merit in assessing the
the evaluation of any future therapeutic methods.

III.

Recommendation

of
problems
the
methods
in
attacking
of
suggested
In this outline
the
treatment
best;
as
one
made
to
specific
specify
no
effort
have
I
psychiatry,
is
that
fragmentary
so
it
knowledge
is
Present
the
specific.
or one etiology as
of
the
psychoses.
major
to
the
etiology
make
as
only
a
to
guess
poor
possible
A multidisciplinary approach with full freedom to follow many leads is the best
of
a
establishment
recommend
the
would
For
I
this reason,
that can be offered.

�-

h

-

Research Service, with full-time personnel devoted to such studies. I would
be indesuggest that such a service have "research" as its function; that
have a basic
pendent of the service departments of the hospital; and that
budget which would assure continuation regardless of the availability of outside

it

it

research funds.
A.

The

Research Service should have the following organization:

1. Director of Research -- Responsible to the Medical Director.
2. Research Associates in Psychiatry and Psychology.
3. Research Assistants:

a. Psychology

b. Neurophysiology
c. Psychiatry
d. Social Service

h. Secretarial and clinical personnel.
5. Technicians.
B.

Annual Budget recommendations

for the Research Service:

1. Director
2. Associate in Psychiatry
"
3.
in Psychology
b. Assistant in Psychiatry
"
5.
in Psychology
"
6.
in Neurophysiology
"
7.
in Social Service
8. Secretary

9. Technician
"
10.

—

Lab
EEG

$20,000 - $25,000.
12,000 - 20,000.
8,000 - 10,000.
6,000 - 10,000.
5,200 - 8,h00.
5,200 - 10,000.
h,000 - 6,000.
2,760 - 3,300.
h,000 - 6,000.
1,300 - 1,800.

(1/2 time)

warranted
Consumable Supplies
Travel
Overhead: As decided by Administrator.

Equipment:

As

2,h00.
1,000.

available as a continuing commitment to
the Medical Director for long range planning of the Research Service.
For the budget year 1955-1956. I should like to make the specific
These funds should be made

recommendation

1.
2.
3.
h.
5.
6.

that the following are the

Director

Research Assistant
"

"

Secretary

Consumable Supplies

Travel

minimum

- Psychiatry

Psychology

~

&amp;

Equipment

7. Overhead
8.

EEG

Technician (in Operating budget)

requirements:

$15,000.
7,500.
7,200.
3,000.
2,h00.
1,000.

-

$36,100.
1,600.
$37,700.

�C.

Space:

Problems of space at the hospital are acute, and will provide an increasing measure of difficulty as the service is developed. It is suggested
that in the next capital outlay by the hospital for construction, some allowances
be made.
for the Research Service
'

D.

Relation with Other Departments:

activities of the Research Service are to be those designated by
the Director. Interdepartmental projects will be carried out by the Research
Service, or in those instances where approval of the Research Committee is obtained, by the departments involved. Supervision of such interdepartmental
projects will lie with the Research Director.
The

Interdepartmental projects are to be fostered by the Director. Prior
approval by the Research Committee and the Medical Director is required. Such
projects as are consistent with the service functions of the departments involved
will be fostered. Presentations and reports are to be approved by the Research
Committee prior to publication.
E.

Job Description:

1. Director of Research:

objectives of the Director of Research will be to: (l) Organize
and maintain an active program of research and a Research Service; (2) Promote,
supervise and integrate research activities at the Hospital; (3) Educate hospital
personnel in research methods and progress; and (h) Administer research funds.
The

The

director of research will:

a. Organize a central project or series of projects appropriate to the
unique character of the Hospital and integrate this into the activities
(therapeutic) of the Hospital. Progress reports will be submitted to the Medical
Director and to each meeting of the Research Committee of the Medical Board; and
such data as is approved for presentation will be submitted by the Director or
his delegate at the appropriate scientific society.

staff to plan and carry out individual
research projects. Third year residents in psychiatry are to be specifically
encouraged to undertake research projects under his direct supervision, or that
of an attending psychiatrist. For these residents, and any other professional
members of the staff, the director of research is to assist in the planning of
b. Encourage

all

members

of the

the project; in its integration into the hospital program; and in
both technically and financially.

its

support

c. Carry on such educational activities as the supervision of third year
residents in research; monthly seminars in research problems and progress; and
The
director will maintain
of
meetings.
important
psychiatric
periodical reports
a calendar of meetings and lectures; stimulate attendance thereto; and foster the
He
such
of
is also to invite such
meetings.
at
Hospital
activities
presentation
guest lecturers and seminar leaders as are available.
d. Administer all research funds with the approval of the Medical Director.
This includes the stimulation of fund sources; the application for funds; and their
allocation to hospital projects.

�2. Research Associate:

Director in all projects at the hospital; to
assume responsibility for specified projects; and to carry on such independent
investigations as his training and experience dictate.
Tb

work with the

Associate in Psychiatry is to be a qualified diplomats in
psychiatry, with extensive experience both in psychoanalytic psychiatry and in
descriptive psychiatry. By training or experience, the associate should have
teaching qualifications; and some training in research methods.
A. Such an

assume responsibility for that portion of the functions of
the service assigned to him by the director; assume responsibility in the director‘s
absence; attend conferences, meetings and assume teaching functions as recommended
by the director.

will

He

Salary to be determined by qualification and experience. Probable
range - $12,000 to 20,000.
‘

B. Such an Associate in Psychology is to be a qualified psychologist
with at least 10 years experience. Psychoanalytic experience is preferable.
The equivalent in academic standing of Associate Professor is the guide line.

research associate in psychology is to assume responsibility
for those functions of the Research Service assigned to him by the director.
An evaluation of testing methods, statistical evaluation of results. and a
rigorous control of procedure in all aspects of the functioning of the research
service are his responsibility.
The research associate in psychology may be chosen from the research
assistants. Salary range - b8,000 to 10,000.
The

will: organize and supervise projects
in the department; supervise projects of the resident psychiatric staff; assist
such department heads as request aid in organizing departmental projects; advise
the director of new research possibilities; attend conferences, write reports and
papers, and carry on such administrative activities as the Director may require.
Both Research Associates

Board

at

Appointments to Research Associate are to be made by the Medical
the recommendation of the Medical Director and the Director of Research.

3. Research Assistants:

assist the director in his research activities and carry on
the work of the department. Each assistant is to be responsible to the director,
and will carry on such tests, procedures, write such reports, and present those
To

papers designated by the Director. Assistants are to be qualified by training
and experience for the specified jobs named. They are to be appointed by the
Medical Director at the nomination of the Director of Research.

a. Assistant in Psychiatry: For such psychiatristswho have had three
or more years of formal psychiatric training but not yet certified, the opportunity to work for one or more years on a Research Service may provide the
stimulation for continuation in research and also provide the director with the
assistance of personnel intermediate in experience between the resident and the
associate. The assistant in psychiatry can assume responsibility for the selection

�-7of the patients for the various projects; evaluate changes in behaviour with
treatment; assess the importance of intrapsychic and environmental factors in
the present behaviour of the patient. the assistant will assume responsibility
for those aspects of the problems under investigation as are within his scope,
and assigned by the director. He will write such reports, papers and make such
presentations as the director may suggest. He will make such tests, learn such
technics and work with those members of the research service or the service departments of the hospital as his projects permit.

Salary is dependent on experience. Probable range $6,000 to 10,000.

b. Assistant in Psychology: Graduate in psychology with a minimum
of doctorate. Preferable experience in research methods and publication experience
with some specialization in laboratory methods. Equivalent academic status of
assistant professor. The assistant in psychology is to carry on such psychologic
and laboratory tests, and make such statistical and methodological evaluations
as the projects of the service require; and to make such reports and presentations
as the director may suggest. He is to direct the laboratory technicians, organize
their work and assume responsibility for the maintenance of all testing equipment
and materials. In the design of projects, he is to assume responsibility for the
application of the best methods and design commensurate with the goals of the

project.

Salary range - $5,200 to

8,hOO.

minimum
M.D.
of
with
a
Ph.D.,
or
Assistant
in
Neurophvsiology:
c.
three years experience in electroencephalography or neurophysiology. To supervise
and coordinate all neurophysiological studies, now being organized; develop and
build electrophysiological equipment; assume responsibility for such animal studies
as are organized; cooperate with the psychologist in coordinated neuropsychological
investigations; and supervise technicians in electrical methods.

This position can be filled only if the laboratory is expanded to
include more basic studies. Personnel can then be recruited from medical school
training centers. Salary range - $5,200 to 10,000.

d. Assistant - Social Service: B.S. (Soc. Work) with minimum of five
years experience in field or administrative work. Emphasis on interviewing
technics and assessing family relationships. Personal analysis recommended.
If previous research experience with psychiatrists or psychiatric clinics is
noted, it should be heavily weighted.

Assistant is to assume reaponsibility for interviewing relatives
of patients and develop technics of assessing premorbid characteristics based
on history and interview; to obtain histories from relatives and patient relevant
to the early years of development; to cooparate with the psychologist in assessing
the personality of the subjects; and to coordinate research testing in the various
projects, Patients seen during their hospitalization in any of the research
service projects are to be seen by the social worker prior to discharge, and every
effort at follow up contact made. For all followbup testing and evaluation, the
assistant will make the necessary contacts and arrangements for the director.
The social worker assigned to the research service will, if time is available,
cooperate with the Director of Social Service in those interdepartmental projects
which he may have organized with the approval of the director of research.
Assistant is to be selected by the Director of Social Service.
Salary range proportionate to experience in research. Range - th,000 to 6,000.

�e. Technicians:

l.

EEG

--

High school graduate, although two years college

preferred.

learn the fundamentals of electroencephalography; make the necessary measure—
ments and place electrodes; obtain artefact free records; maintain card files;
type reports; keep records in systematic way; and maintain equipment. Technician
is to be responsible to the assistant in neurophysiology or the director.
To

Salary --

if

untrained, $2,600;

if trained,

$3,000 to $3,600.

2. Lab. Technician--Neurophysiology. College graduate, preferably
with some engineering or physics experience. To assist the assistant in neurophysiology and/or the assistant in psychology, in the development and maintenance
of electrical equipment; to assist in the handling of animals; to cooperate in
the experimental procedures; to build, adjust and design special equipment.

Salary range dependent on training-~ Range$h,000 to 6,000.
IV.

Summary:

Research Director is actively involved in a number of studies of
the mechanism of treatment. To maintain a continuing function and make long term
planning feasible, it is recommended that a Research Service be established; that
be an integral part of hospital organization with a continuing annual budget.
it
A proposed organization is included in this report, with a projected annual budget
of 3,560,000 - $570,000; and with a minimum budget 1955—56 of $536,100.
The

This report approved by the Research Committee April 27, 1955.

Respectfully submitted,
Max

Fink,

M.D.

Director of Research

�Viva—v Wu'I-v-r

“IV 11; 1955

mom

DR. M. FINE

SUBJECT:

MOW

REPORT, RESEARCH SERVICE «- APRIL

1. My louder ectiviw this month has been the planning and preeentim to
the Director, the Research Committee end to the Medical Affairs
a
plan for a research department. This was discussed at length at the hoepdtel.
and then presented to the Research Omittee, April 27th and approved. It
was later presented on May 3rd to the Medical Affairs Oomittee.
2. Research pro cots underm:
a. BM 2: theetndy ienowinmllewingendueam followingconoeoutive patients with all our indiciee of change.

(30th

"

b. Ambivilence: Our equipment for techietoecopy hue been set
up. Correlations between clinical evaluations between embivilunce made by Dr.
Tmohow and tween, and the laboratory studies using the techietoecope and
the TAT test, are new in pmgmee.
\

electrouetimuletore and oscilloscope have been coordineted and preliminary measurements are being made in the alteration in tactile
perception in electnoehock patients.
(I. Serpaeil project continues despite some difficulties in the
choice of patients.

c.

The

'

e. Subculture: This comittee has continued ite work despite
a number of hwering developments. This eppointment of Dr. Navarro to the
adolescent pavilion hue limited the amount or time available for this project.
Simlteneouely, Dr. Outwits announced that because of the pressure of other
activities, he would be unable to devote the mountﬂ‘ time previously outin-

eted to the project. For the meanwhile, the committee
elucidating a protocol.

is

continuing and in

Projects begun: Dr's Ledemn end Emberg have begun a study or
the use of divided insulin doses and their effect on come levels.
3‘.

attended: Dr. Knhn attended the Eastern Psychological Asediction nee
e in Philedelphin, Ind participated in a panel and presented a
paper based npm his work at the hunt Sinai Hoepital. I attended the April
meeting of the New York Neurologic Society.
1;.

'

p

3

"

5. Pipers published: In the Joumel or the Hillside Hospital, the

”th1

Test

in

Mental Petientc' by Dr. Kuhn, Weinetein and myself.

.

�MEMORANDUM

Dr. Joseph so A. Miller, Mono
FROM: Dr. Max Fink
SUBJECT; Monthly report, Reaearoh Service
T08

1. Activities of

- Boy

of the Research Service during the month
have been attendance at various psychiatric matings; the presentation of
papers; and tho continuation of ongoing projects.
members

2. Papers Presented: (c)
The paper entitled "RelatiOn of
want in Eleotroshockﬂ was read,
~

Kwalwasser.

To

.
and Learning to Improve»

the Electroahcck Rosearoh Association

Changes in Memory
hy title, by Mr. Karin, Dr. Fink, and Dr.
This paper received the Annual Prize Award of the association.

(b) To the American Psychiatric Association, the paper entitled
"Relationship Betucon Altered Brain Function and Denial in Electroshook
Therapy“ was presented by Dr. Kahn and Dr. ?ink.

‘(c)

the resident's meeting of tho New York Neurologic Socioty,
Dr. Grnubert road the paper 'Daluaional Rodnplication of Parts of the Body
After Insulin Coma Thorapygﬁ
To

final manuscripts of these three paperc
Committee, at the end of the month.
The

3. Meetings uttendod:

were sent

to the Resoarch

or the Research Service attended the
following meetings: Amorican Psychosomatic Society, American Psychiatric
Association, Electroshock Ecuooroh Association - all at Atlantic City.

Also the

Nowhers

York Neurologic Society and the American Psychopathological
Association in New York City.

‘

How

h. Notes regarding ongoing projects: a. Further data has been con
llected for the two projects - EST # 2 and Ambivalence.
b. Serposil: Some difficulties in the selection were cleared
in conferences with Dr. Loderman and Dr; Blumberg. Later on in the month
Dr. Laderman requcsted that he be relieved of working on this project except in the aupervisony role since he has to many other activities. The
project will continue with Dr; chhspress assuming the major psychiatric
role.
0. Subculture: Furthor work in preparing a protocol has continued
during the month despite the hampering difficulty of the nooignaticn of
Dr. Gurvito and the increased activities of Dr. Navarre. It is my anticipaticn that a satisfactony protocol may be available by the and of the

month.

up

�S. New Projects: Following an initial meeting with Dr. Loon Helium:
of the Sloan Kettering Institute on April 25th further dismsions were
held at the hospital between Dr. Goldenberg and myself and a second visit
to the institute was made on May 23rd. With the elucidation of their
program, our own protocol is being prepared and will be submitted to the
Research Committee and Medical Dimctor within the next few days.
‘

The Annual Prim Award of
$100.00 was donated to the

the Electmshock Research
urea]. Strauss Research Fund,
Association for
also renewal mquest for tho grant. of the 0.3. Public Health Service were
submitted on May 3rd.

6. Funds:

7. Papers Published: None.

�DOW

0! 310011-131.” eeeeeeseeeeeeeeeeeeeeeeeeeeeeee Dr. 8.

mm

MW
1.

PROGRESS

mom,

m

Gold“

19”

WtionctchlorpromeineendSeryuilinSem,Urineend
embroepdnel Fluid.

Wire

inthodhesbemdevelopedrorthe detemiutionor
drugesnd
rented elheloidel compounds in blood end urine. The procedure involves extinction
orthe buiriedi‘luidwith heptsneendreextraetionottheecupoundfromthe

heptsne leyer with hydrochloric acid. an mixing the acid solution with methyl
orange e complex is formed which dissolved in ethyl.” dichloride to give I: soln.
whose color in directly proportionel to the amount of chlorpromssine, eerpcsil,

or other elkeloid origindqureeent intheteettluid. Adeteiled etudyhes
eleo bean nude or the specificity of the melytiecl method.

Prelim-:7 results

obtained with serum of petiente indicate an «trench
rapid rate of dieeppesrsnee or the mister-ed meterinl. Studies are being
mderteken to determine whether this 1e due to repid elimination, detonticetion,
or both, and whether the degree or retention of the drugs can be correlated in
em we: with their clinical effectiveneee.

2. Inhibition of Sena Cholinestereee by Hallucinogen»

stub wee reemd or en intereeting observation that had been made in
our lobe. lest Sept... 195:. but not subsequmtly followed up became of leek of
personnel. it that time it was noted that LSD 25 is e potmt inhibitor of mm
11;.
The

cholinesterese.
question eroee as to whether thie phenomenon correlates
in may we; with the echisogenic ection of LSD 25, end whether hallucinogenic in
general have 1 eimer effect on cholineetereee from serum, cells, end brain.
serum

Prelilinery results with serum cholineetereee indicate a perelleliem between
hallucinogenic eetivity of the 3 druge teeted, listed in the order or decreasing
activity, '13., lysergic acid diethylenide &gt; lyeergie seid monoethylamide &gt;
mecsline, end their ability to inhibit the anyone.
3. Steroid

3mm. Conjugate

Studies.

einple method hec been found for eliminating the protein and alkaloid
interference with steroid sulfate cnelyeis or biological fluids. Procedure
involves eddition of alkali to diesoeiete steroid sulfate bound to protein,
followed by extraction with lipid oolvente end treatment with e eulronie eeid
resin to remove excess bees as well a: tree alkaloid. Progreee along theee
lines has been extremely rapid and fruitful. It hes also been discovered that
the home sulfates ere synthesized by the liver. Chromtomphic end paper
electrophoretio methods are being adopted ee companion tools to our dye teehnie
in order to establish the identity or the component hormone conjugates.
A

�mm
.1..qu
MW
“mm.o
1. Papa

of

biological fluids to Maniac tho
1nd
alkaloidol
drugo,
prosciu- in
mm...

Italics

“mid

on

2. Preparation for following out. to ho conduct-d on blood and urino or
tor urinary “mid studios hy Slow-Kauai.“
mend
opp-oval): steroid sum». uhloido, phosphorus,
plating
'

fum- W151"

chemo-two, ma poooihly total

War;
of

1W

Wm.

W,
2.xuuam1cmmmmmmummnmidmum;

1.

K.
Board

with! ham Education “pm to
orients." July lot, 1955.

mmwﬂmﬁal

3mm}: Mo.

Hmoido
sponsorship by tho

�mm mm:

199N955

Themuumhmﬁuﬂoaatthohoammm

for-1mm

uiththeappdnhamtofﬂr.mnnkuninctorefﬁomm0¢tomg
mdmop‘muwuybytheostamahnntdnnmhurumbym

Humans-a.

what.

mmmmmmmamm
mud
sum mm
m
the

grunts

Health Service and

wmmmmmmrerhmmwmmmud

mmmmmrormumubymmunmm.

mummcemmamwlymmdmamr

otwwmgmlmwotfulds.whhstyeuamw«fthe

dehwkmmdam.meﬁmtstwmmd

mmntyotWMhWnMMmtanmmtefarm

Wtfommtmﬁmnt.

Thamsultaofthiaam

mummmmttmmwmmﬁmmwmpm
mumedtotmmamhockhmhsmmmdmu

wmmrmmmmmmhdem. Mummtha

um

of

am

toineludofurﬂmr

thanpym cumming;

and lave becnhroadamd

upcﬂnftheWsinﬁwedbyinsMasmuu

0W.mammal

studio! m the effects at

11:11am:

Wymlﬁudhsmmrpdmmdchlmmmgmd

anwamw «mm museum“!

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67244">
                <text>Progress and annual reports; research activities (folder title 1/2).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67245">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67246">
                <text>mfp-03-01-001-0-002</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67247">
                <text>1955</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67248">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67249">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67250">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67251">
                <text>Annual report - research; Biochemical research; Research and pUblications of the Department of Psychology; Annual Report of Department of Neurology, Hillside Hospital; Letters to Dr. Miller (Budget); Research Progress Report</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67252">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67253">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80927">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87488">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94049">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100610">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6726" public="1" featured="0">
    <fileContainer>
      <file fileId="3783">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/6d5d109f552158de5a99360da32ba4a2.pdf</src>
        <authentication>cbe6f09f352080376a08471f0e47212a</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104409">
                    <text>HILLSIDE HOSPITAL

FOR PSYCHIATRIC TREATMENT. TRAINING AND RESEARCH

75-59 263RD

GLEN OAKS. N. Y.

STREET

FIELDSTONE

3-7300

JOSEPH S. A. MILLER. M. D.

MAURICE BACHRACH

MEDICAL DIRECTOR

ADMINISTRATOR

SIMON KWALWASSER. M. D.

Assoc.

June 27’ 1955

MEDICAL DIR.

Dear Dr. Fink:
This

is to

I

sure that there

acknowledge,
with thanks, the receipt of $100
for the Research Fund, from
yourself and your Associates,
Hyman Karin and Simon Kwalwasser.
no need

am

for us to

tell

you

is

of the

importance of our research program.
The Directors are appreciative of
the sentiment underlying your gift
of this $100. to Hillside Hospital.
Very

sincerely yours

Maurice Bachrach
MBzhm

cc: Dr. Kwalwasser
Dr. Miller
Mr. Korin

AN AFFILIATE OF FEDERATION OF JEWISH PHILANTHROPIES OF NEW YORK

�June 30, 1955

Somatic Therapy'fbsearch Program 1955-57
From the Research

Service of the Hillside Hospital

mode
of
action
the
to
investigate
A. AIMS: It is the purpose of this study
We
do
by
this
to
plan
mental
illness.
of somatic therapies in
and
personality
behavioral
of
physiological,
the systematic investigation

factors which
B.

may

be involved.

mechanism
conc‘eming
the
therapeutic
Although many theories

BACKGROUND:

been
have
they
advanced,
been
have
of the somatic therapies

cannot
validity
their
that
either empirically disproved, or, are so vague

be

and
hypothesis,
meaningful
more
of
a
development
the
More
recently,
tested.
new methods of study have provided the opportunity

ion. In l952,'ﬂeinstein

and Kahn (Amer.

for a fruitful investigat-

Journal Psychiatry l923 22-26) sug-

of
milieu
a
creating
by
improvement
to
gested that the somatic therapies lead
Some
could
of
denial
operate.
anisms
mec
in.which
function
brain
altered

support for this

hypothesis has been found in the

literature. Carter

(Am.

earlier work of Janis,
unpleasant life memories after

the
of
some
confirmed
1953)
has
§5
330,
Psychologist
of
selective
forgetting
there
is
showing that

electroshock.

non—emotional
and
emotional
of
Using tachistoscopic presentation

demonstrated
1953)
hhS,
§5
(Am.
Psychologist
words, Teicher

that

of repression" to emotional stimuli occur in the post-shock

state.

For the past year and a half preliminary studies

"mechanisms

investigating this

done
been
have
hypothesis

at these laboratories at Hillside Hospital.

results to date

striking.

have been

patients were followed.with serial
taneous

tactile

Twenty—four

The

consecutive electroshock

electroencephalograms and amytal, simul-

perceptual and memory

tests.

A

marked

correlation between

�.02.
improvement and

early, persistent

alogram, and in the amytal

tests

was observed.

appear, improvement did not occur.

sistent

and severe changes on the electroenceph-

It is

If

such changes did not

our conclusion that early and per-

sufficient, prepossible to predict

changes in these indices are a necessary, though not

make
These
observations
improvement.
for
it
requisite
the short term response to therapy during the second and third

week of

treat-

ment.
A

report

on

the amytal test results was presented at the recent meet-

ing of the American Psychiatric Association (May 1955) and submitted fer public-

Electroshock
the
At
of
of
meeting
American
Journal
a
Psychiatry.
the
to
ation
Research Association on

May

8th, a report of the changes in

memory and

learn-

This
was
treatment
presented.
electroshock
of
the
course
ing occurring during
he
Award
citation
Association.
the
of
Annual
Prize
awarded
the
was
report

noted the methodology as exemplary, and offering a

fruitful

method of study-

ing electroshock.
Concomitant with these

studies,t7e

have followed

patients

on

insulin

therapy. Recent reports onthe value of prolonged coma as the basis for
improvement (Kwalwasser and Caplan: J. Hillside Hospital l; 1&amp;5, 1952; Revitch,
coma

E.

:

Neurol.
Arch
A.M.A.
Rowsell:
and
195h;
shagass
72,
Quart.
ﬁg;
Psychiat.

and Psychiat. 225 705, l95h; and Yeager
195h)

In one

gt 3;; J.

Nerv.

&amp;

Ment. Dis. llgg h35,

2
the
over
studies
past
in
years.
in our patients
unusual case report the direct relationship between altered brain fun-

have been confirmed

(Delusional
demonstrated
Reduplication
been
has
and
improvement
denial
ction,
of Parts of the Body After Insulin Coma Therapy, J. Hillside Hospital, 1955,

in press).
C.

METHOD:

1.

we

plan to verify and amplify our preliminary observations on

the relation of changes in behavior to altered brain function after
somatic treatment.

�-3”

E.A. and Kahn,

sease,

Am.

electroshock will be given amytal tests (heinstein,
DiBrain
Sodium
In
Organic
Use
Amobarbital
of
Diagnostic

Patients

(a)

3.:

on

J. Psychiatlggf

Test" for Brain Disease:

889—89h, 1953;

Its

Serial Administration of the

"Amytal

Arch
A.M.A.
Value,
and
Prognostic
Diagnostic

and
before
and
electroencephalograms
l95h)
Neurol. and Psychiat. 1;; 217-226,
treatment.
make
be
a
used
to
This
will
data
preat stated intervals during

diction of the short term response to treatment.
(b)

Double simultaneous

tactile perceptual tests will

using threshold electrical stimulation.

be

carried out

Using two Grass Sh-B stimulators,

to
be
his
for
tested
ability
the
will
patient
monitored by an oscillograph,
of
his
body.
different
parts
to
simultaneously
two
stimuli
applied
perceive
shown
to
been
previously
has
stimulation
simultaneous
double
of
technique
hé-SB,
g}
Neurology,
(Fink
function
3},
be a good index of altered brain
at
The

January, 1952).

By

applying this highly refined technique

it is hoped that

elicited.
be
will
patients
tests,

changes in brain function which are not otherwise apparent

will

be

and
amytal
of
electroencephalognmn
the
case
in
tested before and at stated intervals during treatment.

As

2.

Other Physiological procedures will be carried out in con-

junction with the tests above.
(a) Each patient will be given the mecholyl-epinephrine

cribed by Funkenstein and associates
The

results will

(J. Nerv.

(b)

sulin

coma

as des-

Ment. Dis. Egg: h09, Nov. 19h8).

be compared with the work of previous

as with the results of our other physiological

test

investigators as well

tests.

and
electroshock
of
undergoing
Biochemical testing
patients

treatment have been in progress for

some time

in-

in these laboratories.

In this series of patients, estimates of urinary ketosteroid excretionxates
Simultaneously
esexcretion
rate.
be
post-treatment
to
compared
their
will

timates of steroid sulphates; phosphatase; and blood levels of steroid sulphate,

�«hphosphorus, phosphatase and

total alkaloid will

be done.

of
many
that
investigation
3. It has been evident in our preliminary
months.
within
six
treatment
somatic
relapse
the patients tm.t improve after
imp
of
duration
the
to
involved
in
regard
The critical problem of the factors
provement

is also to

be

studied.

One

hypothesis

now

under investigation

is

related to the premorbid personality.
denial"
verbal
of
the
"explicit
characteristics
the
with
patients
Specifically,
Denial
Factors
in
Personality
R.L.:
and
Kahn,
personality (Mainstein, E.A.

that sustained improvement

may be

1953)
March,
1-13,
ﬁg:
Psychiat.

Illness, A.H.A. Arch. Neurol.
more likely to maintain improvement, than patients
&amp;

of

who do

will

be

not have this pre-

morbid personality makeup.

(a)
two

with
interviews
by
personality
of
premorbid
the
Evaluation

close relatives will

airre will

be used to

be made

elicit

dictive value such as need to

for each patient.

A

standardized question-

characterological factors, which
be

at least

may

have

pre-

right, prestige-consciousness, sensitivity

toczﬁticismand compulsive drive.
words:
and
of
pictures
(b) Tachistoscopic presentation

The

threshold

material
be
compared.with
will
illness
to
related
levels of subject matter
characterological
for
be
evaluated
data
This
will
of more indifferent nature.
assessed
be
as
quantwill
in
response
alterations
In
addition,
indications.

itative indices of denial.
(c)

and
be
Rorschach
given
will
and
the
Test
The Thematic Appereeption

evaluated for the

same

factors as the personality interviews.

to
of
response
predictions
material,
the
of
personality
(d)
the basis
of
treatment
the
to
start
Prior
made
at different periods..
treatment will be
1)
those
unthree
to
possibilities:
according
be
classified
patients will
On

and
temporarily;
moderately
or
to
improve
2)
those
likely
to
improve;
likely
3) those

improvement
and
sustained
marked
maintain
to
likely

(for at least

6

�.5.
Prediction will also be

months).

made

during the course of treatment (the

third weekfbr the electroshock patients) taking into account the physiological
At
the
of
factors.
the
premorbid
personality
well
analysis
indices as
as
conclusion of treatment patients will be evaluated for actual immediate response to the treatment. Those

who showed some improvement

ified again according to whether or not improvement will

will then

be

be

class-

sustained.

h. Evaluation of the change in behavior of patients undergoing treatment

will

Such

ratings will be

be made on the

basis of a modification of the

made

independently of

all

Malamud

the other

rating scales.

test results

by a

supervising psychiatrist.
D.

FACILITIES AVAILABLE:

l.

Hillside Hospital is a

200 bed

voluntary hospital

for psychiatric care. All patients subjected to phy—
siological therapies are available for study. Periods of hospitalization.are
2-8 months; and a h-6 week observation period is generally available prior to
the

institution
A

of physical therapy.

Research Service has been established, with a

full

time professional

staff of a Director (neuropsychiatrist); assistant in psychiatry; biochemist
EEG
and
technician
(Ph.D.)
research
and assistant chemist;
neurophysiologist
and secretary. A full time psychologist and two chemists are associated on a
project basis.
Laboratory
a Medcraft D-8,
two

S—hB

8

facilities include:

(a) Electroencephalographic unit with

channel instrument; (b) Neurophysiological laboratory with

Grass stimulators,

Du Mont

# 3&amp;0

R

oscillograph; two synchronized tach-

Biochemical
(0)
laband
equipment;
electronic
auxiliary
projectors
istoscopic
the
followwith
and
of
equipped
1000
with
feet
laboratory
space
square
oratory

ing major items:

Beckman

spectrophotometer,'Warburg respirator, Coleman Spect-

rophotometer, and radioisotope unit following the basic specifications of the
A.E.C.

�2. Personnel:
(a) Dr.

Max

Fink, M.D., Director of Research: After undergrad-

uate studies at the University College of

his

D-A.

New

York University where he received

cunllaude with Honors in Biology in l9h2, he attended the

New

York

University College of Medicine, graduating in 19h5. After a rotating interneship he served in the

U.SL Army, where he

attended the School of Military

Neuropsychiatry.

training

Formal neurologic
York

(19h8-l9h9) and

was

received at Montefiore Hospital in

at Bellevue Hospital

(

l9h9-1951). Formal psychiatric

training received at Bellevue Psychiatric HOSpital (6
Hillside Hospital (1952).
and
During 1951,
again

in 1953,

New

at

months 1950) and then

he was a research fellow of the Nat-

ional Foundation for Infantile Paralysis,

first at

of Medicine and then at Mount Sinai Hospital in

New

New

York University College

York.

Both periods of

study were under the supervision of Dr. Iorris B. Bender.

In 1952 he was certified in Neurology by the Amer. Board of Psychiatry
and Neurology, and was granted complementary
May

certification in Psychiatry in

l95h. Simultaneously he attended and.gsunnﬁndfrom the William Alanson

Institute of Psychoanalysis, Psychiatry
Certificate for Physicians in January 1953.

White

and Psychology, receiving

(b) Dr. Jeseph Jeffe, M.D., Assistant in Psychiatry:

undergraduate studies

at

their

Following

Columbia College (B.A., l9hh), Dr. Jaffe attended the

New

York University College of Medicine, and was granted

was

elected to Alpha

Omega

Alpha.

He was

an interne

his

M.D.

in 19h7.

He

at the Morrisania City

Hospital, and then began three years intensive study at the Bellevue Psychiatric

Hospital. First as a resident in psychiatry, theniizneurology, and he

com»

pleted his studies as a U.S.P.H.3. post-doctoral research fellow under the
supervision of Dr. Morris B. Bender.

�~7—

From 1951

to

1953 he was

in the United States Air Force.

He

graduated from

the School of Aviation Medicine and was Chief Psychiatrist at the Mitchell

Air Force Base Hospital.
Since discharge from the military service he has been in the private

practice of psychiatry.

He

was

certified in psychiatry

by the American Board

of Psychiatry and Neurology in 1953. Since 19h? he has been a candidate in
White
Psyof
Psychoanalysis,
Alanson
Institute
William
the
at
psychoanalysis
in
Research
Assistant
two
and
the
and
for
past
years
Peychology;
chiatry

Neurology at the Mount Sinai Hospital of
(0)

New

York.

Dr. Robert L. Kahn, Fh.D.: Assistant in Neurophysiology:

After graduation from Brooklyn College
Columbia University which was

United States Army.

in l9h0, he started graduate

interrupted

by

work

at

four years of service in the

In the army he went to Clinical Psychology School and

served as psychologist in various hOSpitals within this country and overseas.
On leaving the army he became a Research Psychologist in the Department of
Neurology of the Mount Sinai Hospital in

the supervision of Dr.
time.

To

date,

M. B.

New

York, where he has worked under

Bender and Dr. E. A. Weinstein up to the present

he has been an author of more than twenty

co-author of the monograph.

"Denial of Illness:

ASpects" which was published

in

Symbolic and Physiological

May, 1955.

received his Ph. D. from the

He

publications, and is

New

York University School of Graduate

Arts and Sciences in 1953, and was an instructor of psychology
and Hunter Colleges

sultant to the

New

for
York

at

Brooklyn

For the past two years he has been a con-

years.
State Department of Mental Hygiene and has conducted
two

training programs in several of thé mental hospitals.
(d)
Chemist:

A

Dr. Harry Goldenberg, Ph.D.: Director of Laboratories and Chief

Trethe
of
he
where
was
a
C.C.N.Y.
l9hh,
of
recipient
in
graduate

maine Scholarship and graduated cum laude, Dr. Goldenberg received

his Ph.D. in

�~8l9h9 from the Polytechnic Institute of Brooklyn.
(who-ll?)
Institute
the
Polytechnic
at
biochemistry

He

(1951 to date).' In l9h7-h9

National Institute
U.S.P.H.S. project

he was a Research Fellow

an
been
has
and

in

instructor in

at Brooklyn College
enzymology of the

of Health, and from 1950 to 1952 he was a chemist to a

at

Jewish Hospital of Broeklyn studying enzyme methods in

clinical chemistry.
(e)

Mr. Hyman Korin, Research

Assistant (Psychology): Following four
College of the City of

military service, he matriculated at
and received his B.S. in 19h? and his M.S. in 1950. During

years of

New

York

1951-52 he was

Ph.D.
his
for
and
matriculated
Sinai
Hospital
psychology interns at the
in
Research
Assistant
been
1953
has
he
June
Since
New
York
University.
at
thesis
doctoral
his
completed
and
has
recently
Psychology at Hillside Hospital
Mount

on "The

Effects of Electroshock on Retroactive Inhibaticn."
3. Publications:

Recent publications of the Research Service include:
The Amytal

Test in Patients with Mental Illness,

1955.
3-13,
ii:
Hospital,
Hillside
J.

Electroshock,
in
Improvement
and
to
Memory
Learning
of
in
Changes
Relation

press).

Conf. Neurologica, 1955 (In

Delusional reduplication of Parts of the Body After Insulin

J. Hillside Hospital,

1955

(

Therapy,

In press).

Relation Between Altered Brain Function and Denial
Amer.

Coma

in Electroshock Therapy,

J. Psychiatry (submitted).

Rectification of Nonlinear Beer's

Law

Plots, Anal.

Chem.

gé: 690, l9Sh.

Bioand
Biochem.
Arch
Curves,
Enzyme
Non-Linear
Activity
Rectification on

phys., ﬁg;

288, l95h.

�July 1, 1955
BUDGET

l.

-.

RESEARCH SERVICE,

PERSOM'EL

1955-56
EFF—ES.

Director of Research

15,000

-

BD OF DIRECTORS

15,000

in Psychiatry

7,200

Research Assistant in Neurophys.

7,500

Chief Chemist

8,200

Assistant Chemist

2,800

Research Assistant in Psychology

h,000

h,000

-

Assistant Chemist

h,000

h,000

~

Assistant Chemist

1,800

1,800

-

2,520

960

150

150

3,810

2,1uo

1,670

1,000

200

800

$ 57,980

$20,750

$37,230

Research Assistant

Secretary -

EEG

Technician

2.

EQUIPMENT

3.

CONSUMABLE

)4.

TMWBL-CONFERENCES

TOTAL

SUPPLIES

7,200

7,500

-

8,200

2,800

1,560

��your grant for the biochemm and neuroplvsiologiul
approved. A mpplamuzy grunt request fer $7992.00
apprum!
by the Public Health Serum for the 24—927 pmaeem This may will amt thsalary or Dr. R. him.

6.
grants were

A.

,

3

The ascend

In sdditionk protoccla were submitted thmgh Hr.

medatim.

m

Calm ta

the Hofheimr

�Department of Biochemistry

.................................

RESEARCH PROGRESS REPORT, JULY-AUGUST

A. Major work

Dr. H. Goldenberg

1955

in Progress

1. Determination of Chlorpromazine in Blood and Urine
procedure for the colorimetric estimation of chlorpromazine and related
alkaloids, described in the June 1955 progress report, has been further refined
to permit detection of the extremely small amounts of drug circulating in blood.
The method is based on two new features: (1) The finding that drugs can be
quantitatively extracted from biological fluids with a single portion of an
ethylene dichloride-ether solvent mixture, and (2) The use of a three—phase solvent
dye partition system of analysis.
The

Clinical data are also being obtained on bound as well as free circulating
promazine, based on the use of hot acid to liberate the conjugated drug.
2. Inhibition of Cholinesterase by Hallucinogens
These studies are being continued as indicated

in the prior report.

3. Steroid Sulfate Conjugates
All but one of the major problems involved in the assay of steroid sulfate
metabolism.in mental disease have now been solved. A novel device has been
introduced for eliminating the interference with our test due to phenol sulfates
in blood and urine. A two-phase system incorporating dicyclohexylamine (DCHA) as
a complexing agent effectively separates the steroid from the phenol sulfates,
permitting their unequivocal determination. The procedure for serum is now as
follows:

is treated with alkali to release the hormone conjugates.
b. A lipid solvent is added to precipitate the proteins and simultaneously
extract the hormones.
DCHA
The
and
between
to
brought
is
dryness
supernate
partitioned
c.
lipid
a.

Serum

and chloroform.

free steroid sulfates are released by shaking the chloroform extracts
with acidic resin.
e. Final assay of the sulfate conjugates is effected by adding dye and reading
the color.
d.

The

considerable amount of clinical data have already been obtained on normal
people and on patients selected for independent studies by the Sloan-Kettering
Institute. An immediate correlation has been established in our laboratory
between urinary conjugate levels and sex, males excreting about twice as much
conjugate as females. This ties in well with what is known of steroid metabolism
A

�and tends to confirm the

validity of the method.
Attention is now being devoted to fractionation of the steroid hormones in
conjugate form. Paper electrophoresis has proven inadequate for the purpose.
Paper chromatography is more successful and is under continuing study.
B. Papers, Lectures and Conferences

following papers are in preparation: (1) "Colorimetric Determination of
Alkaloids, with Particular Reference to Chlorpromazine", and (2) "Steroid Sulfate
Conjugates. II. Colorimetric Microestimation".
The

C. Funds and Personnel Changes

1. Research Grant #A-675 from the National Institutes of Health
the fiscal period Sept. 1955 - Aug. 1956.
2. Messrs. Michael Miller and Spencer Parness terminated
in the laboratory at the end of August.

cc. to: Dr. Fink
Dr. Miller

their

was renewed

for

summer employment

�Department of Biochemistry

.................................

RESEARCH PROGRESS REPORTI SEPTEMBER

-

A. Major werk

Dr. H. Goldenberg

12§§

in Progress

1. Determination of Chlorpromazine in Biological Fluids
As a result of repeated analyses of blood drawn from patients receiving
chlorpromazine, the circulating blood level has been established as less than
1 microgram per ml. serum. The three-phase solvent dye partition scheme of
analysis mentioned in the previous report has therefore been adopted as the only
method capable of detecting the extremely minute amounts of drug in peripheral
blood. A new shaking machine has just been obtained from the A.H. Thomas 60.,
Philadelphia, to permit application of the method on a broad scale.
question naturally arises as to the metabolic fate of chlorpromazine
in humans. We have recently detected in patients! urine an ether-soluble carboxylic acid which reacts with ferric chloride and appears to be an oxidative
byhproduct of chlorpromazine metabolism.
The

2. Inhibition of Cholinesterase by Hallucinogens

three-phase system mentioned above has been found applicable to the
analysis of LSD 25 as well as chlorpromazine and serpasil. By combining this
observation with the earlier discovery of the inhibitory effect of LSD 25 on
human serum cholinesterase, it is now possible to relate the enzyme inhibitory
action to the alkaloid concentration in "unknown" samples of fluid and so deter—
mine the specific molar inhibitory action at the 0.1 microgram level. This
amounts, in effectI to the first sensitive chemical test ever reported for the
detection of LSD 25 and related hallucinogens.
The

3. Steroid Sulfate Conjugates
work progressing

cc. to: Dr.

essentially as described in JulyhAugust report.

Fink
Dr. Joe. S.A. Miller
M.

�TJ'M‘

W10,”

kW!“ mmMume

mmﬁmmmam.mu¢wmtbmmmm
dﬁltﬂdmﬁord’pﬁiﬁﬁd‘ﬂ.
7

mauummm

�WW

Wmmtmmmunmmngmpm.
3.)

nmmmm
Wamwmm‘m M.anummt.mk

mmmwmmummmm.w.
mmrpmhmmmmdmdt

“Wumm
Mnuwhmwmmmmmmmunm

�.3.

«W.
wammnwunm-Wmum.
Athd.w.MMmmumngmmu

m ﬂui- num- um‘ «hummus. tad

but

mumummmwmmmmmmmm
mmmmmchob.
mmummmuummmw.
max-m:-

mmmdmwmmmmumm
arm-m
1

'

ranoummwmsmummmmsu

?

memum:mW.mm-n
mmmmupmmmruamrm

_

um

i

M

W’ mWrmmwn-m
A.)

awrmm.hmmmnmwmuuuuu
¥

.

McMrahmmwuﬂaMde-u
Itummumuumt
WWSMMWM
mmwumramn.
mum

women-mm
.thmmmmwmubaummmmpm
‘

‘

3.9

ammmammwmummmmam
Dr.3hu,nhobndhndm
WthathuhtaW.
Manama-.Wumwmmmmmm
’mmmnmmpammmmwwmmmu
thramutmm,mmmmmm-mm
rummsmum. mumnwmmwumm

‘

�.5.

nth-Wm
mmmummmwmwmoamm

mmpummmmrmmuu.

arm-«mmgmnwnmm.

Doughnuts-mam

W
bmmammwmmmmmmw,
«3.6mummam.
M

A.)

mwmmmwmwww

MiamﬁmmuVMWqutmcw

W‘tmhmmwmammmnmm
mmmammunmm‘mmrmunmm
I.) mmmmmmmwmhm¥
[wwlmmumumummummmm
ﬂan

«mama-Wm.
It.)

men-mmnmmwmw
umnwmmmmammmuunmmu
ﬁner-matey». nwmrmxmmmmwu
mmmmmammmmnwnma;mmnw
1.)

WW

mhmummunmm
Mud
1mm
m
Amuse.
“raw
W
0‘an
‘mmmwnmwmmmnbmm.
3.)

Du.'llhn.

mamwmtmpnmmummnmmwm
mm

mum
MWWW
muncd‘tblnnmSwuquMummmedm
mumsmmmuwwmmmwnm m
a.)

�kW3lemwhtb
Mun-dun
mrmmmwdthwmdmmm
A.)

nun-Moth.“
B.)

mammm,ummm
,1

ummumgmumwtummrmum
Mm'wm-mmuwmmmuvmm
wan.

wwwhummrww‘.’
c.)

magnum-1mm «numb-mu;

WuﬂthMWdhu-lmmiuuMN
“Widthmrdummnuuhmmm.
6-)

W
A.)

nan-13mm: ‘MmmMmam

Wmmwumnmammxpwm-w
wuuxabmummeuuumMW.Mumu‘mmmmum.hmc
n.)
hummus-«momma

0on1“...

wmmmwmmmumaAuumamm-w

Wmtquolmy
a.)
my:
Dr.

Project:

mum; our Manon

www.mxmwmawammounmpma.

Thaw

Wuwmawrunnmtmwmmmuw

�m1.4

Magnum-ma.
B.)

Marmara!

W’agmhuuamm

than”.
than:
mWaﬂhMcmﬁu
mummm

WatWMIMﬁummmum-Mamm.mm
www.mmmmrummpumnuua¢
mmacmﬂmﬁnmnﬁurwtm
30mm): Mum

mm. w.

�mm.”

thmx‘mmumummmumumum

thus

of

Dr.

awammmmuummmmmmm
ml
Mull”, t» n:
kin
Win.
www.mrammwwmdmmmm
«lulu-Man,

tho

In

m,ammwmmmmmutbnpmmetam

�4-

nm. www.maruummmmowmwmaotu

“www.mmmmdmpmmpm.
a.) 80mm:

m-pmmtmmummnnh

Wuwmmummmgm
dWﬂMmIﬁnmmmMMltﬂﬁlﬁl. Mamba“
animautthimdatMOmth.

uranium that thin prudential} manna
I.)

u

ammm

Wmduungthowttumthu

emu:- put.
hunma.»
MM:
&amp;

m

bun

Mmenuh-nnnpb

MMNMWWMWwWMIlimIn
1Mrumtothutmtmtm
Mothrpumumbmmwa

twpmmemmmuammmommumm

�¢
ummummmmmuuhgmmn
dam It
All um patient: an amt-ma.
hummmwagwmgmsmmm ﬂux-four

WW.

and

mammuwuumnmmam.
“Mnuummumm. humannhhhobo
wwwmwmmmrmummm
new-cut.
‘

'

’*)"W 3mm amusmmmm

mum,mmurmmwtmm.

“In!!!

Wu:mraummwummdmm
Mechanism-heathen“. thmatmmmmt
m,munumrudumix.

WWW
MMWMWmhbdumtamem
3.)

“than

«ummammec'mumMMta-am
Mahmuqmwktum. nr.8h~.mmmuu

Wdhmwuuwmmumm
mmmmmpmmmmwwmmm

”wrumzmmmmmwmm-mum
{crumbs-Itch mumnmmmwumw

�*,~b.«.4‘

_.x

:a:

h3-memmM1ﬂ-dwuﬂm

matmmmuwMWunmumcc-u

mmdmw-usmmwmmm,nan
Wasmnmmwawmmnwm
mmmmwnwmmmunnmm
mmwmmmwwmhm
a.)

thmuMnmdm.mummm
“mummy-norm.
13-)

,W
1.1

Dummy—unannmwwm

umumnr.m'mnsnmuu¢mumm
nmmmxmmmmwu
Warm
m’mmamm~mmnmmuaww
WWW-t. a.)

mmmdmmm
Wmmumumnn.mnmwwmwmmm

�«5-

muomMqurmtmmau—amw
ﬂawuﬂlm.mrwm
m: A.)
hmnmmmmmwm
muss-dam
mrmmtwmwmmmcm.um
It)

“unmanned”...

mummmgummw
namuuumapmmmmtammrm
mmmmmmma-Wmmwmm
_

n.)

Itmmmmtm'm
ummmmuw.
MmMuWammm-‘Wmmmtcm

com.

mmudmu‘mmrnw.
c.)

mmwzmnr.4omn.mua

”Waumhmmmawmmmmu‘

W

atmuambmmamummm.
a.)

A.)

.

Mata-whom: mambo-ammu-

WmhmﬂWRMEtm-Withmw
mwilmantoDr.Mumm1uw‘hn-ﬂurdw
mauwmummmm:
I.)
~

msmvamotanmnmm:

0min...

“WMMWWMWWNWMMW

erumvalm. Prom Fohovingmdimim
WI
nan-.mmxmngamu-emmampmu Mam
a.) Dr.

mmnuuudatwrmnummmmmhmmm

�mum-mu.

n.)

nun-rum WWII-luminous

mummmnmummmwmm.

mum

Wummmmomumsnnamw-m
www.mum.mmummmma:

’mmuem‘mwmrvwgm

W

m&amp;%

11.:an

.

�\ﬂ
October 20, 1955
MEMORAEDUM

TO:

Dr. Joseph S. A. Miller

mom: Max Fink, 14.1).
SUBJECT:

Six Months Report of Research Activities at Hillside Hospital

At the request of the Chairman of the Medical Affairs Committee,
I am submitting this six month report of the activities of the Research
Service and associated research activities at the hospital. During this
period, numerous projects have been under investigation, our staff has expanded, and our space requirements were met. Two projects are being completed, and one project has just been instituted.
A.

PROGRESS

l.

hmw2:
In

ONGOIﬁG PROJECTS:

ELECT§9§§QQK #

Our second electroshock project was undertaken in March
project had clearly demon-

in September. Our first
strated that cerebral changes were essential to improvement and that these

1955, and completed

could be measured by the electroencephalogram and by amytal tests. 'Ue
also concluded that memory tests were a poor index of improvement and believed that there were specific psychological patterns indicative of denial
which were more prominent in the improved group than in the unimproved.
Following this study, the second project was undertaken and was designed
to demonstrate the reliability of the electroencephalogram and the amytal
tests for prognostic purposes; and to ascertain the characterological as‘ﬂe
term
be
term
the
short
which
and
in
results.
long
factors
might
pects
have studied.twenty-seven patients to date. The data of this project is
now being processed, and will be available following our six month follow
up

period, (which is from November to January).

data from the first study was pres nted at various meetings,
including the American Psychiatric Association, the Electroshock Research
Association, and the Eastern Association of Electroencephalographers. The
memory data, presented by Mr. Korin at the Electroshocx Research Association
The

in

May, was awarded
The

their

annual prize.

electroshock project #

3

is

below), and will be instituted November 15.

now

in the planning stage (see

This project, which has been undertaken with Dr. Sidney Tarachow of
the Medical Board, has accomplished a considerable amount of its basic work.
Three approaches to the problem of measuring ambivalence have been accepted.
These include an interview evaluation; the thematic apperception test, and
tachistoscopic presentation of pictures. During this period of evaluating
methods, twenty-three patients have been studied. Dr. Tarachow has been
attending to this work, and the testing has been undertaken by dr. Korin.

2.

AMBIVALcNCE:
‘

�~2-

Serpasil evaluation study, undertaken at the end of last year, is com~
double
blind
a
by
been
have
studied
intensively
Seventeen
patients
pleted.
Blumberg
Drs.
andeachspress.
evaluated
by
The
now
data
being
is
technique.
To date, the clinical results are disappointing. Patients who were depressed,
who
were over-active
Patients
symptom.
of
this
manifested an eﬁag ration
disturbed/EnogIIeviation
of this activity but the psychotic ideation genand
of
secondary
induced
a
The
variety
intramuscular
dosages
erally persisted.
complaints. In the evaluation of'the mecholyl responses following serpasil,
The
blood
in
pressure response
all
subjects.
effect
consistent
was
a
there
of
this
presentation
considering
Dr.
and
Blumberg
is
lower
was significantly
data at the next meeting of the American Psychosomatic Society.
3.

SQRPASLL:

The

}

Preliminary studies by Dr. Laderman in
20 patients in a series of clinical
not
was
but
significant
this
alterations
and
behavioral
showed
symptom
studies
of
Shaw
evaluation
undertook
an
Dr.
In
mid-September,
in the doses used.
A
protocol
coma
therapy.
Thorazine as a possible substitute for insulin
French
and
Kline
submitted
Smith,
to
was
The
Research
Committee,
approved by
and approved, assuring us of adequate supplies for the duration of our proof
8,to
a
medication
for
period
receive
will
In
this
study,
patients
ject.
12 weeks, comparable to the insulin coma period. During this time, very
have
been
To
be
used.
patients
eight
date,
will
thorazine
of
doses
large
The
obser3600
1500
initial
from
to
The
daily.
mg.
dosages range
studied.
three
had
clinical
response;
a
show
significant
three
the
patients
vations

h.

THORAZINE:

and
one
symptoms,
toxic
developed
one
minimal
had
patient
changes;
patients
medthe
of
Cohen
and
Blumberg
Drs.
medication.
the
patient has just begun
our
using
to
permit
controls
the
have
contributed
necessary
ical department
such large doses of this potent drug.

Since June, Drs. Goldenberg
and Royce have been coopof
a
in
study
Sloan—Kettering
Institute
the
chemists
the
at
with
erating
the possible alteration in the keto-steroid excretion patterns in our patSince
June.
Committee
Research
in
by
our
This
was
approved
study
ients.
then five patients have been under investigation. The initial data is not
in
Dr.
Goldenberg
by
studied
Each
of
being
the
is
patients
available.
yet
his laboratory as well as by the chemists at the Institute.

5.

SLOAN KETTERIDG STUDY:

Dr. Goldenberg has been
occupied in studies measurand
acid
of
devising
the
effects
lysergic
estimating
ing chlorpromazine,
methods to measure steroid sulphate conjugates. This basic research is
to
which
to
we
apply
measurement
plan
of
methods
the
to
provide
necessary
our patients.
(a) Chlorpromazine: An ultra~sensitive technics has been
of
amounts
this drug.
microgram)
minute
(0.1
which
measure
can
developed
Golden—
Dr.
Thorazine,
of
number
By applying this to a
patients receiving
bloodstream.
the
amounts
in
small
appear
demonstrated
only
that
has
very
berg
LSD
has been
by
cholinesterase
The
LSD:
of
serum
(b)
inhibition
A
compounds.
demonstrated, and this test applied to other hallucinogenic
correlation between hallucinogenic activity and cholestestcrase inhibition
was found.

6.

BIOCHEMICAL RESEARCH:

�*3“

a

(c) Steroid Sulphate Conjugates: ‘Nith the grant support from the
USIHS, methods to estimate these compounds have been devised. By studying
hormone
demonstrated
sulphates are synthat
Dr.
Goldenberg
liver slices,
of
the
level
in
difference
and
a
there
sex
is
that
the
thesized by
liver,
steroid excretion. Both these observations are of fundamental significance,
and will be presented to various societies this winter.
In the Department of Medicine, hrs.
Cohen and Blumberg have continued
Durand
the
electroshock
of
the
patients.
serpasil
studies
their Mocholyl
and
than
more
been
have
studied
to
additional
an
patients
this
period
ing
half have had more than one such evaluation. The serpasil group demonstrated
a significant alteration in their blood pressure patterns following this
done
be
and
been
will
has
The
correlated
not
data
electroshock
yet
drug.
as soon .8 our electroshock # 2 data is available.
7.

MECHOLYL:

Following the approval of this project
by the Research Committee last spring,
Drs. Navarre and Graubert had a number of meetings with members of the
Medical Board. Following these discussions, they have begun a pilot study
of one patient, and intend to evaluate those factors in the hospital environment which may be contributory to the patient's improvement. This
satisfactory
pilot study was udertaken in an effort to clarify a protocol
to the Ibsearch Conmittee and of sufficient quality to be submitted for

8.

SUBCULTURE:

To
some extent, this project
outside
to
organizations.
financial support
was hampered by the multiple duties of members of the committee and by
the resignation of Dr. Gurvitz. Since September, however, the committee has
been working very actively and it is anticipated that a satisfactory protocol will be available by the end of the year.

In June, following some
discussions concerning the
Laderman
and
Drs.
coma
of
insulin
doses
for
insulin
treatment,
correct
doses
between
the
multiple
relation
into
undertook
an
Blumberg
investigation
05 insulin and the blood glucose level. lt was anticipated that multiple
small doses of insulin might reduce blood sugar significantly earlier and
large dose. It was quickly determined,
for longer periods than a single
.)
however, that multiple small doses, even if the sum total was equal to a
This
and
of
depth.
coma
degree
a
not
did
satisfactory
produce
dose,
single
project is now being prepared for publication.

9.

B.

DIVERE'

I

SULIN

D

SE8:

PROJECTS PLANI‘IED:

November
#
the
third
Electroshock
3:
Beginning
let,
l.
electroshock project will be
undertaken. This study is designed to extend our experience with the factors
which may be relevant in both the long and short term clinical reSponses
following electroshock. Also, in this study specific emphasis is placed on
the psychiatric and language changes which follow electroshock treatment
and which we have been accustomed to calling "improvement." Dr. Joseph
Jaffe has prepared a number of specific studies, including detailed interviews with patients prior to and during treatment, in which specific aspects
of behavior and language will be assessed.

�a...
In this study, also, a basic problem in the perception of multiple
simultaneous tacti e stimuli will be undertaken. Under our original grant
from the United States Public Health Service, we were given funds to study
the problem of Satisfactorily delivering single and multiple independent
and
The
completed
was
designed
equipment
wave
impulses.
electrical square
in Septemler and for the past few weeks has been undergoing rigorous clindur«
be
and
will
applied
found
been
has
satisfactory
highly
ical tests. It
between
changes
the
of
relation
the
with
question
specific
ing this project
the
in
and
in
behavior,
changes
stimulation
tests
simultaneous
double
in
electroencephalogram and in amytal tests following electroshock.

2.

EIOC

‘thAL

APPLICATION OF

HEM

TESTS:

’

Dr. Golden—
berg has

completed.the pilot studies necessary to devise measures of Specific compounds. He believes these should be applied to our clinical population over
the next year. A specific protocol for this application is being prepared.

3.

For more
than a year,
has been interested in form-

EEQQNOSTIC IdDIGATQE§ﬂIﬂ ELECTROSHOCK:
'

‘

Dr. Karliner of the attending psychiatric staff
electroshock.
would
be
in
which
helpful
factors
some
prognostic
ulating
Discussions were held in June and at the suggestion of Dr. Miller, Dr. Karlbe
This
scale
will
evaluate
scale
to
prognosis.
iner prepared a special
months.
next
the
six
and
Committee
assessed
over
Research
the
to
presented
C.

STAFF CHANGES:

Dr. Joseph daffe, a practicing peychoanalyst, was
and
in
research
psychiatry,
assistant
Service
Research
as
appointed to the
behavioral
the
in
is
Dr.
interest
Jaffe's
work
on
September
began
lst. induced altered brain function and the
by
and language changes which are
relation between such changes and premorbid personality.
were resolved effectively
Lowenstein
of
the
floor
the
on
the
of
first
extension
the
laboratory
by
The
reduced.
been
tachistoscopic
have
also
Our
problems
equipment
building.
be
able
now
to
works
and
well.
are
into
alignment
was
brought
equipment

During

this period our space problem

simultaneously.
two
or
individually
pictures
tachistoscopically
present
The electric stimulatorsale functioning satisfactoraly so that we are now
able to produce isolated simultaneous square wave stimuli with the ability
to vary any of the essential parameters.
D.

FUNDS:

In May, we submitted an application to the United
Sept—
In
of
Dr.
Jaffe's
Service
Health
program.
for
support
Public
States
an
in
the
and
staff
interviewed
the
Frank
Jerome
came
to
hospital
Dr.
ember,
USPHS
the
from
in
we
anticipate a response
evaluation of our program.
mid—December. In June, we also submitted the necessary forms for second
renewals
and
both
and
Dr.
Goldenberg
myself,
both
renewal
for
grants
year
the
these
both
renewals,
note
for
that
to
were approved. It is important
overhead allowances were increased to 15%.
At the suggestion of Mr. Coleman, specific protocols of our re»
search program were submitted to the Kaufman, hoffheimer, and lttleson

Foundations during this period.

�-5the
been
for
has
Service
writing
Research
the
which
The protocol
of
Committee
Research
the
submitted
to
was
Ford Foundation grant pr gram
was
the
protocol
that
the
consensus
was
the Medical Board in September. It
suggestions,
their
Following
be
submitted.
not
and
that it
unsatisfactory
of
Drs.
the
with
cooperation
Service
Research
made
the
by
changes are being
Lenzer and Luttrell.
another
submit
application
to
am
planning
I
present time,
re—
March
for
meetings
their
to the USth in January for consideration at
to
an
application
am
contemplating
also
I
newal of our present program.
ambivalence
study,
the
for
for
Fund
support
for
Psychiatry
Foundation
the
as soon as the basic work is completed.
At the

E.

Q?HER.ACTIJITIES:

l.

ISRAEL 5T3§p?§nF9§E§Ei9F THE JOURNLL QEWEELEEERE
HOSPITAL: Following diScussion with Dr. Tarachow,

the Research Service has undertaken the
Tarachow
issuin
Dr.
work
in
and
ssisting
editorial
necessary secretarial
Journal.
Volume
of
Hillside
the
Commemorative
the
special
ing
2. ISRAEL STRAUSS LECTURE: Consideration is being
given by members of the
at
Discussion
is
next
the
lecture.
Committee
for
Lecture
Strauss
Israel
should
decision
and
a
final
candidates
of
number
present centered about a
be available by the end of November.

Respectfully submitted,
.

i

"’ -,"
’-

4

H7

”.51
‘

‘)

{I

1

«I

g.“

,--‘or

,.

‘

j

.

If

‘f‘ \

Fink, M.D.
Director of Research

Max

.

.

�Department of Biochemistry

.................................

Research Pro ress Re
Major werk

l.

rt,

Dr. H. Goldenberg

November l9§§

in Pregress

Chlorpromazine Studies

previous work has been summarized in the report for the 6 month period
ending Oct. 1955. We have subsequently learned from two representatives of the
Smith, Kline and French Laboratories that Drs. Salzman and Brodie, working at
the National Institutes_of Health, have identified chlorpromazine sulfoxide in
the urine of dogs and men after treatment with chlorpromazine. A sample of the
sulfoxide was requested from Smith, Kline and French and arrived the end of Nov.
Our

ultraviolet absorption spectrum of the sulfoxide was determined in
aqueous solution and compared to the Spectrum obtained with extracts from
patients! urine. A remarkable similarity was noted. On the basis of this and
other data accumulated in our lab., there can be no doubt but that urine from
mental patients receiving chlorpromazine contains: (1) chlorpromazine, (2) the
sulfoxide, (3) one or two other alkaloids of related structure, and (A) at least
one break-down product which yields a violet color with sulfuric acid, as contrasted to the pink colors typical of chlorpromazine and its sulfoxide.
The

Using our dye—partition scheme, the sulfoxide yields a color which is
roughly 1/5 the value given by chlorpromazine in equimolar concentrations.
Hence our dye scheme is not applicable as such to the analysis of fluids con~

taining both derivatives, unless some additional information is available on
the relative amounts present.‘ Fortunately the relative proportions can be
estimated from the extent to which the color is depressed by the addition of
ether. Nonetheless, we are withholding a manuscript dealing with chlorpromazine
analysis until this question is completely resolved.
Ultraviolet and chromatographic studies are to be undertaken soon to
establish the various chlorpromazine derivatives in urine and their clinical
significance.
2. Role of Toxic Agents in Mental Diseas

:

An Enzyme

Test for

LSD

first draft

of a manuscript entitled "Inhibition of Serum Cholinesterase
by Lysergic Acid Derivatives. Submicro Detection of LSD 25" has been completed.
Copies are to be forwarded to the Research Committee on Dec. 8th.
The

3. Steroid

Hormone Conjugates

Little progress has been made in this area in the last 6 weeks because of
a delay in construction of our chromatography cabinet and unavailability of
electrical parts needed for the circuit. This situation should be remedied by

the middle of December.
cc. to:

Dr. M. Fink
Dr. Jos. S.A. Miller

�ELECTROSHOCK THERAPY EVALUATION PROGRAM

from the

Research Service of the Hillside Hospital

Glen Oaks,

New

York

December 20, 1955

Alvin E. Coleman, President
Joseph S.A. Miller,

M. D.

Iiedical Director

�Electroshock Therapy Evaluation Program

em
I.

Aim

II. Background
III. Previous Studies
Development
and
Progress
in
Studies
IV.

Tests of Altered Brain Function
Premorbid Personality
of
Adaptation
Patterns
NonAVerbal
Verbal,
Evaluation of Improvement
Steroid Excretion Studies
Autonomic Studies
V.

Program Summary
Method

Significance

VI. Facilities Available

Laboratories
Personnel

VII. Budget
Present Budget
Requested Support

VIII. Appendix
References
Bibliography of Personnel

Page

�I.

E:
During the past few decades there has been an

of various

new somatic

intensified development

therapies for mental illness. Jhile

some have

even-

been
an
has
established
as
electroshock
therapy
into
fallen
disrepute,
tually
important and successful method for both immediate and long term results (1).

Despite

its

empirical usefulness, the

many

theories concerning the

mechanism

of this therapy have been either disproven or are so vague that their validity

tested. In a comprehensive review, Kalinowsky and Koch (2) emphasize the lack of information in this regard stating: ".......the theoretical
cannot be

aspects of the various somatic treatments
in the case of the shock treatments,

still

.....

are poorly understood, or, as

entirely obscure in their

mode

of

action."
The aim

of this program is to study the therapeutic mechanisms in electro-

convulsive therapy by the systematic investigation of behavioral, personality,

physiological and biochemical factors. Thile the program has electroconvulsive
therapy as its focus, considerable theoretical and experimental information can
be derived

to relate the

phenomena observed

in this therapy to other somatic

treatments such as lobotomy, electronarcosis and insulin coma.

�II.

BACKGROUND:

of
abundance
has
stimulated
an
electroconvulsive
therapy
of
use
and
the
Both
kind
theories
of
the
much
and
research.
exper(3)
hypotheses
The

of
interest
the
reflect
however,
particular
undertaken,
imental investigations
the
origin
frame
reference
of
regarding
and
theoretical
his
the investigator
of mental disorders.

Thus, each has been usually limited to one aspect of the

problem. In general, these theories

may be

differentiated between those that

emphasize physiological, biochemical, or psychological constructs.
A

who

classical physiological construct is exemplified

suggests that the various

by Gellhorn (h)

forms of shock therapy "act on the centers of

the autonomic system, produce intensive and prolonged sympathetico-adrenal
mental
activity,
hypothalamic-cortical
augmented
and
alter, through
discharges
processes and behavior."
psychogalvanic reflex,

The

varying responses of blood pressure, heart rate,

and other physiological indices to chemical

stresses are

obtained
been
has
data
huch
of
sympathetic reactivity.
interpreted as indices
to
and

Show

autonomic
reactivity,
in
this
induces
change
a
electroshock
therapy
that

(5)
coaworkers
and
support this
his
Funkenstein
by
studies
recent

conclusion.
Much

illness

and

biochemical study has been devoted to the relation between mental

steroid metabolism.

between ketosteroid excretion

Numerous

rates

instances (6) in which a relation

and change

in mental state following

electroshock therapy are reported, but the clinical difficulties in the
measurement of steroids have left this issue unresolved. Kore recent studies

excretion
to
the
total
steroids
between
individual
the
relationship
exploring
rate (7) utilize elaborate chromatographic separation technics.

�In a good review of the biochemical and neurophysiological hypotheses,
mode
the
view
the
that
evidence
to
justify
Ashby (8) presents experimental
of action of electroconvulsive therapy

is

through effects on the adrenal

cortex mediated by direct stimulation of the hypothysis.
Psychologic constructs generally fall into three designs

- studies

of

the psychic significance of the loss of consciousness; the relative importance of

ities

memory

loss;

and an estimate of the

subject's re-integrating abil-

the
Numerous
unemphasize
studies
of
confusion.
following a period

conscious significance of the treatment as a “rebirth which eliminates reand
exneed
punishment
for
of
a
satisfaction
narcissism"
a
(9);
or
gressed

piation for committed sins (10).
Amnesic effects are a common concomitant of treatment but most studies
of
these
The
significance
of
impairment.
the
nature
emphasize the temporary
defects for therapeutic results is

emphasized by numerous authors.

Data

is

the
on
emotional
charge
patreduces
the
treatment
that
presented to
emotionallyfor
of
induces
familiarity
loss
a
associations
(ll),
ient's
show

toned associations (12), or a selective forgetting of unpleasant

life

memories (13).
These constructs are

further elaborated by authors

who

believe that the

as
behavioral
responses
confusionalemate
including
of
an organic
induction
im»
electroshock
the
for
basis
is
over-reacting
euphoria, impulsiveness or
provement (1h).

A

more

umerated by Weinstein

&amp;

recent elaboration of this explanation is that enKahn

(15), described subsequently.

�-h-

adaptive
in
changes
proregard
explanations
of
psychologic
Another group
describe
(16)
and
Frosch
Impastato
mechanism.
cesses as the basic therapeutic
on
a
which
then
re-integrates
the
of
ego
electroshock as causing a dissolution
suggestopinion
similar
has
a
Alexander
of
adaptation.
previous or higher level

ing that

defensive
operations.
enhances
active
and
electroshock arouses

For

this

in'whii1
conditions
those
in
effective
such
is
therapy
that
he
asserts
reason
conp
in
ineffective
but
are
low
ebb, as in depressions,
such operations are at a
(17).
alerted
highly
already
ditions in which defensive operations are
most

two
in.which
Kahn
(15)
and
Another hypothesis was developed by weinstein

were
the
process
of
therapeutic
aspects

related.

They

asserted that the thera-

of
altered
milieu
of
a
creation
the
in
convulsions
lay
induced
of
action
peutic
is
of
problems
his
expression
symbolic
brain function in which the patient's
Their
them.
studies,
denying
of
form
the
explicitly
altered, particularly in

cerebral
with
with
patients
documented by an extensive neurologic experience
behavior.
in
adaptive
of
changes
a
function, amply demonstrate great variety

dys—

attention
(l9),
orientation
(18),
They describe altered patterns in language
manifestations
(21)
as
defect
of
and
awareness
(15b)
(20), sexual behavior
the
patient's
constitute
mechanisms
these
conclude
that
and
of adaptive behavior
attempt to deny his illness or

striking

and enduring in those

its

meanings.

patients

Such

who had

most
were
denial
at
attempts

habitually used the defenses

with
their
of
coping
means
a
as
and
rationalization
of verbal denial
of
indicative
these
patterns
that
problems (22). They also demonstrated

administraintravenous
the
following
interview
"denial" could be elicited in an
interview
the
clinical
manifest
in
not
when
were
they
tion of sodium amytal
(23)-*
followdenial
and
explicit
disorientation
of
* This appearance of patterns
with
associated
so
clearly
sodium
is
amytal
ing the administration of
authors
these
by
described
been
has
diffuse cerebral dysfunction, that it
test."
named
"amytal
the
been
has
This
(23).
as a test for such dysfunction

�-5of
denial
between
a
patient's
noted
direct
relationship
a
they
cere—
of
the
of
and
signs
the
electroshock
appearance
therapy
pain following
test)
of
mechanism
the
that
suggested
they
amytal
bral dysfunction (positive

Thus, when

electroshock therapy

may be

the facilitation of patterns of denial by altered

brain function (15).
and
psychophysiological
at
integrating
This hypothesis is an attempt
which
terms
in
View
it
of
the
and
As
operational
in
such,
factors.
logical
have
which
studies
base
our
theoretical
upon
a
has
provided
is stated, it

been elaborated.

�III

PREVIOUS STUDIES:

of
altered
manifestations
studies
investigating
For the past three years,
cerebral function in psychiatric patients, have been in progress at Hillside

Hospital.

In 1952, the application of the amytal

was asseSSed

(2h).

test to psychiatric subjects

Positive responses were found only

in patients

who had had

electroshock therapy or had other indications of organic brain disease.

in order to test the relationship between altered brain
referred
consecutive
patients
electroshock
to
therapy,
and
the
function
response
electroencephalograms,
with
serial
intervals
weekly
at
tested
treatment
were
for
During 1953-195h%

amytal

tests,

simultaneous

tactile

perception%%

tests,

and

tests of recall

function.
A

marked

correlation

was found between improvement

therapy and early, persistent
the electroencephalograms.

following electroshock

and severe changes in both the amytal

If

no such

tests

such changes did not appear, improvement

and

failed

correlations were manifest between improvement

to occur. In contrast,
and tests of recall function or changes in simultaneous tactile tests.

WM
TWenty—four subjects were

tested in this first study, and were classified

improved
markedly
as
psychiatrist
the
supervising
by
independently

ately

improved (6) and unimproved (7)

at the

(ll),

moder-

end of one month post-treatment.

Paralysis
Infantile
for
Foundation
National
from
the
Aided
Fellowship
a
by
*
(Dr. Fink, 1953) and Grant K—927, National Institute of Fental Health,
National Institutes of Health lQSh-Sé.

stimuli
two
simultaneous
tactile
of
the
of
perception
as Previous studies
one
localize
to
or
of
perceive
failure
demonstrated characteristic patterns
of the stimuli in patients with diffuse cerebral dysfunction (25).

�-7Of

the markedly improved patients, every one had at least one positive amytal

reaction during treatment.

Of

the

50

tests

given to

this group,

38 (765) were

positive. In contrast, of the unimproved patients, five of the seven never
showed a

positive result,

positive.

6 (13%) were

and of the

The

LS

tests administered to this

group, only

moderately improved group showed more positive re-

sponses than the unimproved patients, but

fell far short

of the

much improved

group.

In addition, there were consistent changes in language and non-verbal as-

pects of behavior indicating alterations in adaptive mechanisms in the

in interviews not employing amytal. These alterations

improved group, even
were

much

either minimally or only transiently manifest in the

unimproved group and

then only under the influence of sodium amytal.*
Concomitant studies of the electroencephalograms taken on a day pre-

ceding the amytal

first

measured

test indicate

for per~cent time

a similar
31 w wave

relationship.

The 160

records were

(delta) activity, the extent of

burst activity and the amplitude and frequency of the slowest waves present.
They were then placed in a rank serial order. Those falling in the upper third
were

labelled "high abnormality"

abnormality."

ality after

Of

the

and those in the lower

much improved

patients,

one week of treatment; 80%

after

25% showed

third as "low
a high degree abnormp

two weeks and over 90%

after three

In the unimproved patients, however, none had a high degree abnormality
record during the first three weeks and only one had such a record by the fourth

weeks.

week of

treatment.

The

records of the moderately improved patients

fell

between

these two groups.*%
* Presented at the Annual Meeting of the American Psychiatric Association,
Kay 10, 1955.

** Presented at the joint meeting of the Eastern and Southern Electroencephalographic Societies, Bethesda, September 30, 1955.

�Changes

in

memory and

learning were tested in these subjects by using

the principle of retroactive inhibition.

3-letter originally learned

By

the serial testing of recall of

words following the

interpolated learning of nonsense

syllables, patterns of decrement in learning and recall

were

elicited.

As

a

week
of treatthe
showed
to
third
impairment
the
increasing
up
patients
group,
ment, and a rapid improvement after the cessation of treatment. No relation-

ship, however, could be established between impairment and reSponse to treatment.*
The

responses of these subjects to simultaneous

tactile tests using touch

stimuli were also assessed. While an increasing impairment in the ability to
be
two
demonstrated with increasing
could
and
stimuli
the
localize
identify

treatment, no relation to improvement was noted.
however, and

in anticipation that

more meaningful

The

tests

were extremely gross,

correlation for this index

of altered brain function could be obtained, a study using threshold electrical

stimuli has been undertaken (pg. 10).
As

ent and

result of these studies, it was our conclusion that early, persistsevere changes in both the electroencephalogram and in the amytal tests

a

are a necessary, though not sufficient pre—requisite for improvement following
electroshock therapy. These observations make it possible to predict the short
term response to electroshock, and such a study was undertaken

earlier this

year (pg.ll).
Concomitant with these studies,

we

have made some preliminary observations

in patients undergoing insulin coma therapy. Recent reports of the value of
prolonged coma as the basis for improvement (26) have been confirmed in our
patients. In

one unusual case

report

we

noted a direct relationship between

* Presented before the Electroshock Research Association,1;ay 8, 1955 and
awarded

their

Annual Prize award

for excellence in research design.

�altered brain function, altered patterns of adaptation in language and behavior,

clinical

and

improvement (27).

Concurrent with these psychologic investigations, basic studies have been
done

in

in biochemistry.

1950* with an

The

initial

biochemical research laboratory was established

program of study of the

relationship between steroid

excretion patterns and states of mental illness.

studies, utilizing alumina column chromatography, demonstrated atypical
The
number
excretion
of
a
levels
in
psychotic
ketosteroid
patients.
urinary
The

of B—steroids (particularly dehydroisoandrosterone) was found to be elevated,
and the etiocholanolone was depressed (7a). The ll-ketoetiocholanolone
values appeared to be sex-dependent: male patients excreted the steroid

metabolite in normal amounts, while the several female patients studied had
markedly elevated values.
During the past year, a collaborative study was

chemical department of the Sloan-Lettering

initiated with the

Institute of

new York.

bio~

Similar

steroid excretion pattern studies were undertaken utilizing paper chromatographic technics.

In the

first

phase of the study recently completed, the

elevated excretion of ll-ketoetiocholanolone was confirmed, with a severe

reduction in the excretion of this
when

compound

prior to discharge, at a time

the patient had shown considerable improvement from her

* Supported by grants from the Dazian Foundation

illness.

for Hedical Research.

�.10...
IV. §EUDIES IN PROGRESS

1.

Relation 2f

AND

Tests

IN DEVEILEEENT:

Improvement:
Function
Brain
33
Altered
3;

altered
between
relationship
direct
Our earlier studies
this
that
however,
apparent,
is
treatment.
It
to
and
function
response
brain
and
not
only
function
brain
altered
of
indices
certain
holds
for
relationship
and
elabconfirm
to
undertaken
been
has
for others. Further study, therefore,
have shown a

methods of measuring

orate these findings, as well as to investigate
improvement.
clinical
to
related
function which are more reliably

a.

cerebral

Amytal Test and Electroencephalogram:
Amytal

tests

and electroencephalograms are done

and
second
the
and
during
subjects before,

third

in all

weeks of electroshock treat—

make
a
used
predicto
data
is
the
findings
ment. On the basis of our earlier
those
that
predicted
is
treatment.
It
to
term
short
response
the
of
tion
and
with
positive
abnormality
electroencephalographic
patients with a high degree

amytal

test findings will

be most

likely to

show improvement;

while those with

amytal
and
with
negative
abnormality
a low degree electroencephalographic

results are considered unlikely to improve.
b. Tactile Perceptual Tests:
perceptual
tactile
simultaneous
the
As described before,
was
planned
inconclusive.
It
were
of
test results in our first series patients
conditions
under
stimulation,
electrical
to repeat this study using threshold
terms
Under
controlled.
be
could
rigidly
wherein the various stimulus parameters
two
of
consisting
assembly
instrument
(M—927)
an
USPHS
grant
of an existing

dewhich
can
devised
was
oscillograph
monitored
by
an
Grass Sh-B stimulators
the
assembly,
this
Using
stimuli.
electrical
wave
independent
square
liver

stimuli applied simul-

to
perceive
their
ability
for
tested
patients are
technique
refined
this
By
applying
body.
taneously to different parts of the
two

�.11be
may
otherwise
not
apparent
function
brain
in
it is anticipated that changes
and
of
improvement
the
be
to
degree
compared
will
observations
These
elicited.

to our other test~results.

As

in the case of the electroencephalogram and

the
and
intervals
during
stated
before
at
tested
are
amytal tests, patients
course of treatment.

c.

Hemory

Tests:
imp
and
loss
of
memory
of
relation
the
Numerous theories

provement have been described.

Our own

data to date

shows no

significant re-

and
words
and
simple
nonsense
syllables
for
lationship
forselective
a
there
is
evidence
that
considerable
But
there
is
improvement.
For
memories.
and
situations
of
life
significant
getting, during treatment,
between the memory loss

a record

this purpose,
may be

is

made

of events during the preceding six months which

of emotional significance to the patient. During treatment, inquiries

records
verbatim
of
these
events,
recollection
patient's
are
and these compared to the pre-treatment reports.
made

of the

2. Relation gf’Premorbid Personality

to Duration 3;

made,

Response:

has also been apparent that the relationship between altered

It

brain function and clinical response is valid only for the short term response
When
six
followed
a
for
treatment.
weeks
several
after
to treatment, ite.,

return
a
had
showing
relapsed,
the
of
improved
several
patients
period,
of their former symptoms, and in some instances requiring further hospital-

month

ization.
thesis

To

account for the varying duration of

was advanced

that the difference

personality patterns. Specifically,

it

was

clinical response, the

hypo-

related to differences in premorbid

was suggested

that patients

who showed

would
(22)
denial
verbal
personality"
the
of
"explicit
the characteristics

likely to maintain improvement.
premorbid personality of each patient is assessed

be those more
The

an interview with family members, psychologic
and

psychiatric interviews.

by

four procedures

tests, tachistoscopic tests

-

�a. Family Interviews:
At least two close relatives are seen in independent
interviews. A standardized questionnaire has been devised to elicit characterological factors indicative of the "explicit verbal denial" personality. For
this study fifteen characteristics defined as typically present or absent in
conscious—
Such
include
items
prestige
selected.
were
of
this type
personality

and
and
to
sex
attitudes
temper
to
imagination,
criticism,
ness, sensitivity
illness. Each patient is rated on a scale of 0 to 2 for each item - the higher

score signifying a greater tendency to denial.

b. Psychologic Tests:
Each

patient is tested

on a

standard psychologic eval-

uation battery including the Rorschach and Thematic Apperception TEStS. These
adap—
defense
of
and
usual
or
types
structure
character
assessed
for
tests are

tation.

Such

tests are repeated at the termination of the treatment

program and

again prior to discharge, to obtain additional information as to changes in
behavior in the course of treatment.
-

c. Tachistoscopic Tests:

tachistoscopic study has been devised; in which pairs
of emotional and non-emotional words are flashed on a screen at 10, 20, 50,
100, and 250 millisecond periods. The patient's ability to identify the words,
A

the reaction time, and the distortions are ascertained. This pre-treatment

data is

now

being explored as to

defense patterns.

The

its ability

to clarify the patient's usual

tests are repeated at the

end of greatment and again

prior to discharge for the possibility that characteristic changes in perception
develop with altered modes of adaptation..

�-13..

d. Psychiatric Interviews:
In the course of estimating changes in behavior, patients
are seen prior to treatment, and at intervals during treatment. In a clinical
interview setting, an assessment is made of the patient's symptoms, and usual
of adaptation. Changes in symptoms, behavior, language and modes of adap-

modes

tation are noted.

By

interviews with the patient's therapist, judgment as to

the significance of such changes and

bral states can
ment

their relation to treatment, or altered cere-

be made.

On

the basis of the data in a-d above a prediction of response to

is

made.

treat-

Prior to the start of treatment the patients are classified as:

1) those unlikely to improve;
2)

those likely to improve moderately or temporarily;

3)

those likely to maintain marked and sustained improvement (for at least

six months).
During the

third

week of

treatment, (after the patients have had

ments), a second prediction of the short term response
change

is

made

7—9

treat-

according to the

in the physiological indices.

3. Altered Patterns g£.Adaptation Kanifested in‘Verbal and NonéVerbal
Behavior:

In the earlier study on the amytal test

it

had been noted

that

specific changes in language and behavior indicative of altered adaptive responses occurred in the improved patients to a significantly greater degree than

in the unimproved patients. Further experimental procedures were
necessary to clarify the nature and significance of these changes.

deemed

�alb-

a.

The

is

a highly structured interview

of the patterns of language.

made

ients

who show

language

will

in émytgl Tests:
amytal test procedure is recorded. This

Language Changes Induced

situation,
The

and systematic observations are

hypothesis tested

is that those pat-

consistent, increasing use of the following types of adaptive

be more

likely

improve:
1) The use of the second or
to

third

person. In such instances the patient reports his main trouble as "the Doctors
say I'm depressed", or state the wish that "my family should be well." 2) The

selective response to questions, as answering readily questions about date and
location but failing to answer,

illness.
tive

mumbling or using neologisms when asked about

3) The use of conditional or qualifying expressions, or the subjunc-

mood which has

the effect of vitiating the patientis committment to the

is

I feel kind of dBpressed", in w hich
"sometimes" qualifies the temporal degree of illness, and "feel" and "kind of"

statement.

An example

"sometimes

‘qualify the intensity of the illness. Committment would be indicated by
the direct, unconditional statement of "I

am

depressed". h)

or stereotyped expressions in discussing illness, as "to
or "well, in a manner of speaking..." or "I didn't keep

wheel". 5) Language

antic statements. 6)
problems.

tell

my

The use

of cliches

you the

shoulder to the

filled with nonpsequiturs, circumlocution, ornate
The use

or pedp

of humor when talking about their illness or other

7) The use of metonymy or paraphasia, as

Dr. as a "recorder". 8 )The various forms of

ulation about the main problem

truth..."

referring to the examining

explicit denial including confab-

and temporal displacement.

9) changing the sym-

bolic frame of reference in response to questions, as replying to the question,

feel?", by stating, "with my hands." 10) The use of hyperbole, as
"you're the best Dr. in the whole eastern Atlantic seaboard area."
"how do you

�.15-

State:
Confusional
the
PostaShock
b. Language Changes in
Each

orientation
for
tested
is
patient

and awareness of

treatment.
a
following
immediately
awakening
of
the
period
in
his main problem
such
At
intervals.
weekly
and
then
at
treatment
the
initial
done after
@his

is

most severe, and a

defects
are
cerebral
neurologic
the
times,
These
of
language
appear.
tive changes in the pattern

variety of

may be comparable

adap—

to the

records
are
and
the
situations,
interview
other
the
in
noted
changes
language
and
changes
language
the
later
to
both
as
indications
assessed for prognostic
the degree of improvement.
Study:
Sentence
Completion
0.
in
language
in
and
changes
A way of studying the patterns

technique.
completion
sentence
a
devised
using
been
has
fashion
a quantitative
accordstructured
been
have
which
complete,
to
sentences
to
given
The patient is
the
in
first
been
have
put
sentences
the
of
Ten
different
patterns.
ing to four
when....",
criticized
am
"I
Wish that......",
such
"I
as
unconditional,
person,
the
in
expressed
are
they
that
except
meaning
in
identical
Ten others are

etc.

sometimes
"people
as
aspect,
qualifying
or
conditional
third person and with a
the
In
reetc.
When.....,"
criticized
wish that.....", "people are usually
these
of
senten
In
indicated.
maining twenty items no person is specifically
or
occurrence
exact
an
to
refers
or
direct
is
sentence
the
tences, however,

event as "every

time....",

”when the

doctor

comes

in.....",

etc.

The remainp

"at
times....",
as
aspect,
indefinite
or
qualifying
conditional,
have
a
ten
ing
etc.
when.....",
better
"things usually seem a little
for
analyzed
not
in
sentences
The response of patients to the incomplete
rated
is
each
response
Instead,
manner.
psychologic
content in the traditional

�16

the
whether
include
ratings
for its grammatical or syntactical structure.
or
conditional,
direct
or
is
second
third
person,
or
response is in the first,
The

1h).
(page
above
described
of
language
manifests aspects
1)
assumptions:
following
the
on
This study is based
begins in

the
to
most
obviously
applicable
a manner

A

sentence which

patient (e.g.,

first

person,

adaptive
reto
elicit
likely
unconditional) creates
conditional
is
or
the
third
in
person
A sentence which is expressed
2)
sponses.
and
least
minimal
is
stress
creates
is less applicable to the patient. It
complete
used
to
The
3)
person
syntactical
likely to elicit adaptive responses.
maximum

stress

and

is

most

of
indicative
is
to
person
in
regard
indeterminate
is
whose
beginning
sentence
a
shows
less
of
the
person
first
the
use
the degree of stress experienced (e.g.,

third
second
or
the
of
the
use
defensiveness,

person shows

greater defensive—

ness).
d. Attitude Interviews:
In

this

part of the study an attempt

the
of
mechanisms
ego.
adaptive
the
tionally

Two

is

made

to define

opera—

structured interviews

followed. The attitude of the

questionnaire is
interone
In
next.
the
to
interview
from
one
examiner, however, is reversed
and
the
in
concerned,
view the examiner is empathetic, pessimistic,
minimize
to
and
tends
insensitive
non-empathetic,
he
brusque,
is
other interview
are held, in which the

the patient's

same

difficulties.

In general, the

first attitude

produces good

a
in
grossly
results
latter
the
while
rapport with these disturbed patients,
each
asked
in
are
non-communicative situation. Although the same questions

to be appropriate to the examiner‘s

attitude.

interview, the wording is altered
"YOu
must
today?",
poorly
"feeling
as
such
he
questions
asks
In one interview
worse?.“
been
getting
"has
and
it
consider your condition pretty serious?",
don't
"you
today?",
well
While in another interview he asks, "feeling pretty
consider your condition serious,

do you?" and "have you been improving?".

�.11.:

The two structured.interviews are performed

just prior to electroshock

interviews
All
are
treatment.
of
treatment and repeated following the course
of
the
patient's
1)
alteration
the
study:
in
recorded. There are two variables
The
four
attitude.
examiner's
the
in
behavior by treatment, and 2) alteration
recordings are studied for

and
changes.
language
vocal
changes,
content,

The

it
defensive mechanisms of the patient
both
out
be
carried
can
that
transactions
of
the
of
terms
range
in
ationally,
and any changes

in

can be defined, oper-

be
commmay
patient
depressed
For
a
example,
very
treatment.
and
after
before
he
whereas
interview,
empathetic
concerned,
the
in
treatment
before
unicative
jovial,
mood
is
the
when
latter
examiner's
the
in
will be unable to participate

of
one
is
treatment
to
his
response
However,
if
and
minimizing.
bantering
becomes
he
sustreatment
Following
reversed.
be
euphoria, the situation may
and
empathetic,
concerned
examiner
is
when
the
anxious
or
hostile,
picious,
Thus
the
interview.
the
optimistic
in
stressful
less
communication
is
whereas
terms,
objective
in
be
stated
the defensive system of the patient can
change

i.e.,

in

of
interpersonal
standardized
range
to
a
in terms of his reactions

uations.

in

sit-

M

h. Clinical Ratings 2: "Improvement":
changes
evaluating
of
methods
and
test
These various experimental
ratthe
psychiatric
in
significance
further
have
may
and
behavior
language

considerable
experienced
we
studies
revious
In
our
:
rovement."
"im
of
P
ing
Or,
be
guide?
the
to
relief
symptomatic
Is
our
patients.
difficulty in rating
to
recovery
Is
be
the
goal?.
to
improvement"
"social
recovery"
or
is a "social

relief?

Agreement by

symptomatic
well
as
as
of
insight
be judged by the degree
"unimproved"
and
improved"
"much
"recovered",
of
definition
the
in

psychiatrists
is not available,

investigations,
to
further
crucial
is
issue
and yet, this

We

�they
terms
as
these
of
assessing
task
further
the
undertaken
have therefore
apply to the electroshock population.
of
incapacity
and
type
the
degree
are
Central to this problem of evaluation
and
the
the
of
therapist,
the
goal
personality,
of the patient, his premorbid
capacity
events,
intercurrent
as
Other
aspects,
therapy.
to
attitudes
patient's
environmental
the
patient's
of
therapy,
suitability
of the therapist, temporal
present.
at
encompassed
not
but
are
assessment,
to
important
also
assets are
To

are
studies
evaluation
following
the
"improvement",
of
meaning
clarify the

in progress.
Evaluation:
Pre-treatment
a.
the
by
therapy
electroshock
Patients are referred for
and

resident therapist.

supervising psychiatrist
evaluation is made by the research psychiatrist.

An
Two

independent psychiatric

aspects are specifically

decompensation
of
signs
clinical
encompassed in this study:
of
sympdegree
for
and
rated
mental
status
descriptive
a
recorded
in
which are
of
the
patient‘s
estimate
2)
an
(28);
scale
tomatology on a Kalamrd rating
1) the symptoms and

operations.
defensive
usual
his
of
with
description
a
develOpment
of
ego
level
Relationship:
Therapist—Patient
the
in
Changes
b.
to
held
prior
therapist
resident
the
with
interviews
In
and
the
therapist
between
relationship
the
therapy,
electroshock
of
the onset
recomp
the
for
the
reason
on
emphasis
with
specific
explored
the patient are
and
the
patient's
treatment,
the
of
the
goals
mendation for this form of therapy,
mental
of
treatment
of
method
Since the primary

attitude to the treatment.
electroshock
for
recommendation
the
disorders at this hospital is psychotherapy,
the
between
patient
communication
that
assumption
the
with
carries
it
generally
deis
the
exploration
For
this
reason,
meaningful.
no
longer
was
and therapist
and
recommendation,
the
led
to
that
relationship
the
in
voted to those changes

�19

and
symptoms that it is
behavior
of
of
those
aspects
statement
a definitive
We
the
in
interested
also
therapist's
affect.
treatment
are
may
the
anticipated

attitude to this
may

form of treatment, and attempt to assess the

role this attitude

play in the eventual results.

of
the
the
results
theories
relating
numerous
there
are
Furthermore,
made
being
are
attempts
and
in
our
inquiries,
therapy to its punitive aspects,

to assess the significance of this factor in the outcome. During the interviews with the resident therapist and with the patient, the patient's attitude
behavior)
and
against
(both
language
defensive
operations
to the treatment, his
his
in
and
alterations
the
electroshock
represents,
the reality threat that

attitude

during the weeks of treatment are

studied. Further information regard—

of
our
the
in
course
be
ascertained
will
of
factor
this
ing the significance

control study (page 21).

c.

Follow—up Study:

Crucial to the evaluation of "improvement" is the

oppor—

treatment
of
the
period
following
various
periods
tunity to repeat evaluations at
from
hosthis
discharged
of
the
patients
follow—up
report
Recently, a four-year
between
customary
the
disparity
indicated
and
(1)
this
pital was made available
of
inthis
the
In
course
illness.
discharge ratings
at
out
carried
being
observers
is
same
the
vestigation, repeat evaluations by
As
check
a
treatment.
months
after
and
six
various times during hospitalization
and eventual course of the

and
the
physiological
of
the
personality
basis
the
on the predictions
two—week
the
for
recorded
factors studied, specific follow—up evaluations are
(long-term
months
period
and
the
result)
six
post-treatment period (short-term
made on

ther—
the
resident
of
the
to
ratings
result). These evaluations are compared
each
In
instance,
medical
director.
and
the
apist, supervising psychiatrist

and
the
of
terms
projected
formulated
in
the ratings made in this study are
and
interpersonal
language
of
behavior,
those
noted
aspects
in
actual changes

�Excretion
23 Improvement:
5. Relation of Steroid
and
their
reof
steroids
excretion
patterns
of
The studies of the
More
recently
continuing.
is
9,
on
described
page
mental
to
states,
lation
of
measurement
the
for
of
techniques
development
the
on
been
has
emphasis
colorimetric
and
*
new
separative
steroid conjugates. During the past year

sulfate
steroid
measure
to
(29)
devised
techniques have been
these
for
patterns
excretion
blood and urine. Daily urinary

compounds

in

compounds

are

and
prior
again
electroshock
of
the
course
assayed prior to treatment, during
resolve
to
is
of
this
program
The
object
selected
patients.
in
to discharge

individual
total
the
with
values
these
and
compare
bound
steroids,
the sulfate excretion
hormone
between
relationship
the
elucidating
Besides
hormone levels.
which
to
extent
the
indicate
of mental illness, such studies
and

rates

states

hormones.
steroid
of
metabolism
the
the liver (30) participates in
Electroshock
Therapy:
Results
Functions
of
on
6. Effect of Autonomic
behas
studies,
it
electroencephalographic
of
our
In the course

alterations
the
typical
fail
of
number
patients
that
a
apparent
come
to
also
fail
These
patients
treatment.
extensive
in cerebral rhythms despite
and
frequently
tactile
tests,
in the amytal tests, simultaneous
to

show

show changes

reactivity
the
studies,
these
with
Simultaneous
periods.
confusional
evince no
mecholyl
of
administration
the
to
rate
and
the
pulse
blood
of the
pressure
to
done
was
prior
too,
This,
out.
carried
been
have
"Funkenstein—test")
(the
Marked
ended.
had
treatment
of
the
course
after
immediately
treatment and
two
test
these
found
in
were
medication
this
to
variations in the responses
the
of
earlier
the
reports
way
general
a
in
followed
observations
These
periods.
between
relationship
the
of
exploration
the
undertaking
workers, but we are now
tests.
physiological
and
these
function
brain
altered
of
tests
in
the alteration
* Aided by a grant (A-6YSC)
Public Health Service.

States
United
Health,
of
from the National Institutes

�v.

THE PROJECTED PROGRAM: SUMMARY

1.

3

21 -

Method:

the
along
and
development
continuation
The projected program is a
Our
ultimate
of
this
two
report.
sections
lines indicated in the preceding
the
systematic
by
therapy
electroshock
of
mechanism
goal is to clarify the
of
behavioral,
inter-relationship
the
of
and integrated investigation
biochemical
factors.
and
physiological
sonality,
This program

is

per—

rev
interdisciplinary
full-time
a
by
undertaken
being

neurophysiolpgist,
psychoanalyst,
of
psychiatrists,
search staff consisting
help.
technical
and
allied
biochemist
physiologist, experimental psychologist,
Some

in
scope
clear
already
are
the
in
program
of the specific studies

and
new
continues
the
program
as
become
apparent
Others
will
and outline.
Two new basic
develop.
leads
promising
further
or
problems
appear
critical

decided
been
upon.
already
have
methodological aspects

date
work
to
our
in
1. Control group:0ne of the major deficiencies
starting
Accordingly,
control
group.
has been the absence of an adequate
two
into
divided
be
will
electroshock
for
referred
January 1, 1956, patients
of
conusual
course
the
receive
will
One
group
fashion.
random
a
in
groups
treatments.
sub-convulsive
be
given
vulsive therapy; the other group will
Ulett
of
study
instructive
recommendation follows the recently reported
This

et a1. (31).

In other respects the two groups will

be

treated in the

same

will
each
group
in
are
patients
who
will
The
only
person
fashion.
of
The
purpose
treatments.
the
administering
be the supervising psychiatrist
in—
of
the
effects
physiological
the
differentiate
to
is
such a control group
know which

outcome.
therapeutic
the
affecting

Some

duced convulsions from other factors
disease
process,
the
of
particular
1)
nature
the
of these factors might include
2) the

attitude

and symbolic

etc.;
depression,
involutional
or
as schizophrenia
of
a
large
attention
3)
the
special
the
patient;
to
treatment
of
the
meaning

�~22:

numbers of observers

h) the

incident to being placed

on

the treatment program;

attitude of the patient's therapist toward the patient

and toward

electroshock therapy, including the expected goals in each case; and S) the

relative effectiveness of other forms of therapy provided for these patients
in the hospital milieu. The use of a control group will also clarify the
nature of "Spontaneous recovery" and

may

aid in the understanding of

"atypical" results in the patients actually receiving convulsive therapy.
2. Insulin

Coma:

It is

planned to extend the present methods of study

to an investigation of those patients receiving insulin

coma

therapy.

�~23.-

2. Significance
This program of study has both applied and theoretical significance.

there
since
electroshock
of
therapy
use
clinical
It can lead to the improved
be
mechanism.
will
It
the
of
therapeutic
will be a greater understanding
to
who
better
improve,
will
those
patients
more
skillfully
select
to
possible
and
to
predict
the
involved
therapeutic
in
process,
factors
other
manipulate
more

accurately future management problems.
of
the
psychounderstanding
to
a
greater
however,
also
This study
leads,

pathology of mental

picture
which

illness.

Through the various methods of study a

clearer

will be obtained
meaningful criteria for

of the mechanism of defense and modes of communication

may

contribute

more

operationally accurate and

"improvement".
of
determination
the
for
diagnostic classification
techtherapeutic
other
on
throw
light
may
Finally, the investigation
and

and
obserthe
function
cerebral
in
niques. The studies of the alteration
have
signifi—
damage
and
cerebral
behavior
between
vations on the relationship
also
is
It
electrocoagulation.
and
cerebral
cance for the studies in Ibbotomy
modes
of
and
in
language
the
changes
into
here
gained
the
insights
that
likely
of
psychotherapy.
study
eventual
significant
make
an
possible
adaptation may

�VI. FACILITIES

AVAILABLE:

1. Hillside Hespital is a

200 bed

non-profit psychiatric hospital.

All admissions are voluntary, with periods of hospitalization varying from
h-lZ months. All patients are available for study.
The

hospital

was

established in 1927, for the purpose of treating

ulatory psychiatric patients.

A

amb-

residency training program.was instituted

earxy, under the supervision of an active staff of psychoanalytic psychiatrists.
In 1950 the research biochemical laboratory was established, to be followed

in

1953 by

the neurophysiological research laboratory.

In 19Sh these laboratories were combined and expanded, and a Research
Service established as a:full-time operation of the hospital.
Research Director was appointed to integrate
program.

At this time, the

staff consists

all

A

full-time

the studies into a basic

of the Director, research assis—

tants in psychiatry and psychology, biochemist and assistant biochemist,

siologist,

and

EEG

technician. In addition, a psychologist and

phyb

two chemists

are associated on a project basis.
Laboratory
Medcraft D-8,
two S-hB Grass

8

facilities include:

(a) Electroencephalographic unit with a

channel instrument; (b) Neurophysiological laboratory with

stimulators,

tachistoscopic projectors

ical laboratory with

Du Mont # 3&amp;0 R

and

feet of laboratory space

Beckman

Coleman Spectrophotometer, and

ifications of the A.E.C.

two synchronized

auxiliary electronic equipment; (c)

1000 square

the following major items:

oscillograph;

Biochemp

and equipped with

Spectrophotometer,'Warburg respirator,

radioisotope unit following the basic spec-

�£2 5..
ﬂ

2. Personnel:*

studies
Undergraduate
Research:
of
(a) Dr. Max Fink, H.D., Director
the
and
degree
New
Yorn
College
University,
of
Universitv
were undertaken at the
{e
the
attended
l9h2.
in
was
granted
of B.A. cum laude with Honors in Biology
New

l9h5.
in
graduating
of
Hedicine,
York University College

interneship he served in

School
of
the
from
he
where
graduated
U.S.
Army,
the

Military Heuropsychiatry in
Knox

After a rotating

19h7, and was Chief of the

Psychiatric Section, Fort

Station Hospital during 1947.
Formal neurologic

training

was

received at hontefiore Hospital in

York

New

Formal
psychiatric
(l9h9«1951).
Hosoital
Bellevue
Dsychiatric
and
at
(l9h8-l9h9)

and
than
(1950)
at
Hospital
Bellevue
?svchiatric
undertaken
at
training was

Hillside Hoscital (1952).
During 1951, and again

in

1953, he

and then

at

Mount

In 1952, he was
American Board of

first at

Sinai Hospital in

a research fellow of the Hational

Both periods of study were under the

Foundation for Infantile Paralysis.

ection of Ur. horris 3. Bender,

Was

ﬂew York

dir-

University College of ﬂedicine

ﬂew York.

the
by
in
l95h,
and
Psychiatry,
in
Feurology,
in
certified

‘sychiatry and Neurology.

Simultaneously he attended and gradof Psychoanalysis, Psychiatry and

Institute
1953.
In
January,
in
Physicians
for
Psychology, receiving their Certificate
Mental
of
Institute
National
the
of
June, l9Sh, he was granted a research grant

uated from the ”illiam

Alanson Fhite

Health for a 2-vear study of electroshock processes.

In September, l95h, he was

Fink
Dr.
Hillside
Hospital.
Service
at
Research
appointed Director of the

is

33, married and has one son.
_____._.__.___.___________.___.____________.._._____._______._____________.______.
38.
apaended,
page
of
is
personnel
* Bibliography

�7-20Collowing
Psvcuiatry:
in
Assistant
(b) Dr. Joseph Jaffe, h.D.,
the
attended
Jaffe
Dr.
l9hh),
(B.A.,
Columbia
College
at
studies
undergraduate
Then
19b7.
M.D.
in
his
and.was
granted
of
hedicine,
College
New vorlr. University
he
began
interneship,
rotating
a
he was elected to Alpha Omega Alpha. Followinr
resident
a
as
First
Hospital.
DelleVue
Psychiatric
the
at
of
study
three years
U.S.P.H.S.
posta
as
studies
his
he
completed
in psychiatry, then in neurology,
lender.
3.
Morris
Dr.
of
doctoral research fellow under the supervision

from
graduating
Air
Force,
States
United
the
in
he
was
1953,
From 1951, to
Air
Eitchell
the
at
Psychiatrist
Chief
He
was
ﬁedicine.
Aviation
the School of

Force Base Hospital.
prac—
the
private
been
in
has
he
service
Since discharge from the military
of
Board
American
the
by
psychiatry
in
He
certified
was
tice of psychiatry.
psychoin
candidate
been
he
a
has
Since
l9h9,
1953.
in
and
Neurology
Psychiatry
Psychiatry
Psychoanalysis,
of
Institute
'hite
Alanson
analysis at the William
the
at
Assistant
Research
been
has
a
two
years
the
and
past
for
and Psychology
in
position
present
to
his
He
was appointed
Mount Sinai Hospital of New York.

September, 1955.
Chemist:
Chief
Ph.D.,
Goldenberg,
(0) Dr. Harry

A

graduate of the

Tremaine
of
a
recipient
York
New
in
of
the
City
of
College
D.
in
”h.
his
received
Goldenberg
Dr.
Scholarship and graduated cum laude.
in
instructor
He
been
has
an
Brooklyn.
of
Institute
from
‘olytechnic
the
l9h9

l9hh, he was the

College
Brooklyn
and
at
(l9h6-h7)
biochemistry at the Dolytechnic Institute
Natthe
of
enzymology
Fellow
in
Research
he
l9h7~h9
was
a
In
(1951 to date).

ional Institute

of Health, and from 1950

the
to
chemist
he
was
a
1952,
to

methods
enzyme
studying
of
Brooklyn
Hospital
Jewish
the
at
U.S.D.H.S. project

in clinical chemistry.

�...27..

Dr. Robert L. Iahn, Ph.D., Assistant in Psychology:

(d)

After

graduation from Brooklyn College in l9h0, he undertook graduate studies at
Columbia University. These studies were interrupted by four years of service
and
School
Dsyc‘hology
went
he
Clinical
to
where
United
Army,
States
in the
On
and
overseas.
country
in
this
various
hospitals
served as psychologist in
of
Neurology
the
Department
in
Research
T’syc‘iologist
became
he
the
army
leaving

of the

Mount

of Dr.

horris

Sinai Hospital in

New

York, where he wormed under the supervision

B. Bender and Dr. E. A.

"einstein until January, 1955.

is

He

of
monograph,
the
and
co-author
is
studies,
experimental
of
numerous
the author
"Denial of Illness:
He

Symbolic and Physiological Aspects" published

received his Ph.D. from the

New

in

May, 1955.

York University School of Graduate Arts

instructor of psychology at Brooklyn and Huntto
been
he
a.consultant
has
two
two
For
the
past
fbr
years
years.
er Colleges
conducted
and
has
training proMental
of
Hygiene
New
York
Department
State
the

and Sciences in 1953, and

was an

he
been
has
1955,
a
Since
January,
mental
the
of
several
hospitals.
in
grams
member

of this

staff.

(e) Dr.

Hyman

years of military service,
received his 3.8. in
ogy

interns at

York

four
Following
Psychology:
in
Assistant
Ph.D.,
Korin,
he matriculated

l9h9, and

at College of the City of

his H.S. in 1950. During 1951-52 he

the Hount Sinai Hospital and

University.

New

was

York and

psychol-

matriculated for his Ph.D. at

New

Since June, 1953, he has been Research Assistant in Psychology

at Hillside Hospital.

He

recently completed his doctoral thesis on

"The

Effects

of ﬁlectroshock on Retroactive Inhibition," and received his Ph.D. in October,
1955.

his'L.

F.

(f) Dr. Arnold Blumberg, H.D., Internist: Dr. Blumberg received
from the University of Pennsylvania in l9h2, for studies in physiology,

and in l9h5, received his E.D. from

the

Mew

York

University College of Medicine.

continued
he
two
of
and
service,
military
years
interneship
Following a rotating
1952.
l9h8
First
from
to
Memorial
Goldwater
Hospital
at
his residency training

�-28he
completed
Fellow
Medicine,
in
then
a
as
as a resident in neuropsychiatry,
He
has
1950-1952.
Division
Research
the
his studies as a Research Fellow in

been a Fellow in

Medicine

at the

New York

University College of Medicine,

1951-Sh.
He was

is

an

certified

Internal Medicine in l95h and
of Physicians. He is the associate

by the American Board of

associate of the American

Attending Internist at Hillside

Academy

Hospital and has'been

directly responsible fa'

of
coordinator
well
as
as
Research
Service,
the physiological studies of the
the biochemical programs.
3. Function of Research Service:

the
Research
Service,
the
of
research
programs
In addition to the
with
actively
They
cooperate
functions.
staff is active in two additional
research
who
on
part-time
carrying
are
those members of the hospital staff
In such instances, aid

nature.
of
clinical
a
chiefly
projects,
the
planning
of
goals,
project
clarification
the

is given in

and design of programs, and

is needed.
and
during
in
is
progress,
program
Secondly, an active resident training
independon
an
to
opportunity
carry
an
given
is
the third year, each resident
been
have
two
service
projects
of
this
ent project. Since the development
such technical assistance as

the
include
projects
completed, and three are
testosterone
of
and
the
use
states
anxiety
in
of
reserpine
clinical evaluation
include
resident
At
projects
present,
coma
therapy.
insulin
to
adjuvant
an
as
now

active.

The completed

a
factor,
therapeutic
milieu
a
as
the
of
hospital
a study

clinical evaluation

and
clinical,
coma
therapy
insulin
for
substitute
a
of chlorpromazine as
aMbivalence.
of
measures
and
tachistoscopic
psychologic

�-29In

May, 1955,

the Research Service established

a.

liason with the Sloan-

York
of
steroid
New
out
study
to
cooperative
a
of
Institute
carry
Kettering
excretion rates in psychotic patients, with emphasis on the patterns altered

during and following electroshock thefapy.

�-30..

VII,

M

PRESENT BUDGET AND REQUESTED SUPYOR :

Budget and Present Support:
1. Present anus—“u
The following is the full budget of the Research Service

for the fiscal year l9SSmS6. The major Share of the program is supported
by the Board of Directors, supplemented by grants of the United States Public Health Service. Under Grant M—927 of the National Institute of Mental
Health, $1h,807 of direct costs and $2221 of overhead costs was granted

for the year September 1, 1955 to August 31, 1956. This grant is the second
year of a 2-year grant for neurophysiological studies including the present
Electroshock Evaluation Study.
awarded $6500

The

National Institute of Arthritis has

for the second year of a twoayear grant for biochemical studies.

�~31-

1.

w.-

'

Board of Directors

U.S.P.H.S.

15,000‘

15,000

-——-

Psychiatry*

7,200

7,200

--—

Research Assistant in
Psychology

8,000

-——-—

8,000

Research Assistant in
Psychology

5,000

-—-—-

5,000

2,520

2,520

-————

Chief Chemist

8,600

8,600

-—-—-

Assistant

Chemist

h,000

__—-

h,000

Assistant Chemist

2,800

2,800

-——-

Assistant in Chemistry

1,800

-——-

1,800

h50

-—-—

h50

3,810

2,253

1,557

1,200

1,000

200

Personnel

Director of Research

Psychiatgz:
Research Assistant in

7E0 Technician

-

Secretary

Biochemistgz:

2.

Equipment

3. Consumable supplies

h. Travel - Conferences
Total
Overhead
TOTAL

* 3/5 time to September 1956.

60,380

39,373

21,007

2,521

______

2,521

62,901

39,373

23,528

�.32..

2. Requestegjg‘udgetagr Support:
A.

include

requirements of the Electroshock Therapy Evaluation Project

The

two

two
of
other
modification
the
to
professional staff,
additions

specific allocations of equipment funds.
(1) Psychiatrist: The cooperation of an additional full time psycoma
insulin
include
of
to
the
study
the
needed
to enlarge
scope
chiatrist is

positions,

and

of
evaluations
the
in
to
assist
control
the
study;
therapy; to supervise
diange in patients

and carry out follow-up

studies.

For

this position, an-

alytic experience is essential.
(2)

Physiologist or Heurophysiologist:

Present physiological studies

of
Further
physiostudy
and
the
Internist.
Director
the
out
by
carried
are
by
full-time
a
of
studies
these
coordination
the
changes
requires
logical

physiologist,
(3)

M.D.

or Ph.D.

Equipment:

and physiology.

For

Present needs are focused in two areas

-

biochemistry

further refined studies of the steroid sulfate patterns

mechanical
and
a
Beckman.Spectrophotometer
the
attachment
for
a recording

carry out the anticipated physiological
studies modifications and attachments to the electroencephalograph are

shaker (Dubnoff) are requested.

To

suggested.
following budget is one suggested to continue the present proneeded
completo
the
of
1956
personnel
addition
the
with
July
1,
gnmn after
ment the present staff. The budget is divided into three categories, followB.

The

Research
Serthe
coordinated
in
which
divisions
are
the
three
laboratory
ing
and
five
period,
a
for
the
for
year
Estimates
listed
first
year,
are
vice.

including projected salary increments.

�M

First

1. Psvchiatqz:

a. Director
Secretary

Conferences

13

Year

Five Year Total

(20,-25,000)

20,000

112,500

(2,6-3,100)

2,600
1,200

11,220

(15,-18,000)
(15,-18,000)

15,000
15,000
9,000
5,500

82,500
82,500
52,500
35,000

1,200

3,600

. Personnel

1. Psychiatrist
2. Psychiatrist
3. Eeychologist
13.. Psychologist

c. Supplies
Subtotal

-

&amp;

(

9"12:OOO)

(5’5' 8,500)

Equipment

388,820

69,500

Psychiatry

2. Neurophysiologx:

a. Personnel
9,000
3,600

52,500
12,000

b. Equipment

1,000

1,000

c. Supplies

1,200

6,000

1. Physiologist
2. Technician

(9,-12,000)

(3 : 641-31400)

71,500

10,800

Subtotal - Neurophysiology
3. Biochemistry:

a. Personnel
Chief Chemist (9,-11,000)

9,000
6,000
0,000
1,800

36,000
25,000
11,200

b . Equipment

7,000

7,000

0. Supplies

1,500

7,500

1.
2.
3.
h.

Chemist
Chemist

issistant

Subtotal - Biochemistry

(6,-8,h00)

(bu-6,000)

(1,8—2,600)

29,300

137,700

�Total

First

-

All Programs

..

All Programs

113,600

598,020

17,0h0

89,700

130,6h0

687,720

Overhead Allowance\(15%)

TOTAL

Five Year Total

Year

C. Budget Reconciliation:

1. Salaries:

The

salary range for each item is consistent with pre-

sent positions established at the hospital, or for

new

positions, with neighbor-

for supervising psychiatrists is
$12,-15,000, with a projected revision to the stated scale in 1956.
ing

institutions. Present salary
2. Equipment:

ment expenditure

ance

range

For psychiatry, the

initial year

includes the equip-

for tape recording system (#600) and an annual

for expenses.

The

$600 allow—

physiological equipment expense (51000) is to allow

modification of present electroencephalographic equipment to
record other physiological indices.

The

expenditure for supplies includes

allowances for consumable items and the provision for the building of specialIized equipment.

In biochemistry, the

a recording attachment for the

Beckman

intiial

expenditure includes $7,200 for

spectrophotometer and 9800 for a Dubnoff

shaker.
3. Conferences:

Present budgetary items include this

of the Director or members of the

sum

for the use

staff to attend appropriate scientific

meet-

ings.
h. Overhead: Consistent with hospital policy and recent administrative
changes in other

grants, a

15%

allowance

is requested.

This amount includes

hospital allocations for Social Security coverage; and for such contingencies
in the expenses of the program as not reg iring a significant alteration in the
budget.

5. Subtotals and Total: The budget is presented in three sections,
representing natural subdivisions of the program, thereby allowing for modifications in support.

�VII.

APPENDIX

A. REFERENCES:

from
Discharged
317
Patients
of
Study
Follow-up
H.L.
RACHLIN,
2E.§i:
1.
in
Hosp.,
Hillside
press.
l?50,
J.
in
Hillside Hospital
and
other
Psychosurgery
Shock
Treatment,
2. KALINOWSKY, L.B. and HOCH, P.H.:
New
York,
Grune
Stratton,
(2nd
a
ed.),
Somatic Treatment in Psychiatry

1952.

19h8.
397,
Mil.
Surg.
$92:
Theories,
Shock
Therapy
Fifth
GORDON,
H.L.:
3.
and
Dsvchiatry,
Neurology
of
Foundations
h. GELLHORN, E.' Physiological
1953.
Minneopblis,
Hinnesota
Press,
University of
Nervous
Autonomic
H.C.:
S.a FNNKENSTEIN, D.H.,
Ment.
3
Nerv.
J.
Shock
Treatment,
System Changes Following Electric
GREENBLATT, M.

Dis.

329%.: 2109,

and

SOLOMON,

19,480

Which
PreA
Test
H.C.:
5.b FUNKENSTEIN, D.H., GREENBLATT, M.,
Schizophrenic
on
Treatment
Shock
Electric
of
dicts the Clinical Effects
1950.
889,
Am.
199:
Psychiat.
J.
Patients,
AND SOLOMON,

5.0.

Autonomic
Changes
H.C.:
SOLOMON,
and
M.,
FUNKENSTEIN, D.H.,
&amp;
Nerv.
J.
Patients,
in
Mentally
Changes
Psychologic
Paralleling
GREENBLATT,

Ment. Dis.

6.a.

11;: 1, 1951.

Ill

Exthe
and
in
HOAGLAND, H. et al: Changes in the Electroencephalogram
of
AgitTherapy
Electro-shock
Accompanying
cretion of T7-Ketosteroids
19h6.
Med.
§32h6,
Psychosom.
ated Depression,

Excretion
on
Treatment
of
Effect
B.H.:
6.b. ALTSCHULE, N.D. and
&amp;
Neurol.
Arch.
Mental
Disease,
with
Patients
in
of l7-Ketosteroids
1950.
516,
éﬁ:
Psychiat.
Cortins
of
Excretion
the
on
Convulsive
Therapy
6.c. ASHBY,‘W. 1.: Effects of
19h9.
275,
Ment.
Sci.
23:
and Ketosteroids, J.
PARKHURST,

Excretl7-Ketosteroid
the
of
Studies
Chromatographic
H.
WERBIN,
7.a.
gt El:
Hosp.,
Hillside
Normal
J.
Individuals,
and
ion Datterns of Psychotic
195,40
2011,
2:
l7~
Neutral
of
Urinary
The
Fractionation
S.
R.:
M.
STITCH,
and
REISS,
7.b.
Ment.
$99:
Sci.,
J.
Male
Schizophrenics,
Chronic
from
Ketosteroids
7011, 195,40

8.

ASHBY, W.

R.:

Mode

22: 202, 1952.

of Action of Electro-Convulsive Therapy,

J.

Ment. Sci.

�.36...

9.

Shock
Therapy,
Hypoglycemic
and
JELLIFFE, S. E.: Discussion on Insulin
1937.
200,
&amp;
2Q:
Psychiat.
Arch. Neurol.

of
Aspects
Psychologic
Certain
0n
E.
MOSSE,
9.:
and
J.A.B.
10. MILLETT,
l9hh.
226,
Med.
6:
Electroshock Therapy, Psychosom.
Shock
Electric
with
Treated
Patients
in
Functioning
Memory
ZUBIN,
J.:
lla.
l9h8.
33,
Dersonality
Therapy, J.
ll:
on
Therapy
Convulsive
Electric
of
Effect
S.E.:
BARRERA,
and
ZUBIN,
11b.
J.,
596,
l9hl.
ﬁg:
Biol.
Soc.
Exper.
Hemory, Proc.
Assoword
the
on
Performance
on
Shock
Therapy
of
:
Effects
ZEAEAN,
J.
12,
19h7.
Association,
Psychological
Eastern
the
at
Presented
ciation Test.
J.
Treatments,
Convulsive
Electric
Following
Loss
Memory
JANIS,
I.L.:
13.
191.18.

Personality

1.1: 29,

der
mit
Erfabrungen
Psychopathologische
GROBE,’W.:
and
W.
BAEYER,
von,
lha.
l9h7.
163,
Psychiat.
$12:
Elektrokrampfmethode, Arch. f.
after
Patients
Mental
on
Observations
E.
STAINBROOK,
J.:
H.
and
LOWENBACH,
lhbg
l9h2.
828,
Am.
2g:
Psychiat.
J.
Electroshock,
Post—Convulsive
of
Immediate
Description
Rorschach
STAINBROOK,
E.J.:
Ibo.
19AM.
302,
&amp;
Personality'lg:
Mental Function, Char.
Electroshock
During
Psychosis
KAHN,
and
R.L.:
LIEN,
L.,
WEIWSTFIN,
E.A.,
15a.
Am.
Psychiat.
J.
Shock
Therapy,
of
the
Theory
to
Relation
Its
Therapy:

1952.
22,
$92:

and
PhysioSymbolic
of
Illness:
Denial
KAI-1H,
R.L.:
15b. mnrsmm, F..A and
1955.
Illinois,
C.
Springfield,
Thomas,
Charles
Aspects,
logical
Ego,
the
on
Treatment
Shock
of
Effects
D.:
IMPASTATO,
and
FROSCH,
J.
16.
Psychoan. Quart. I]; 226, l9h8.

l7.
18.
19.
20.

Recent
Under
"Normal"
Person
of Electroshock on a

L.: Effect
1953.
696,
Am.
J. Psychiat. $92:
Stress,
in
(Paraphasia)
Misnaming
Non—aphasic
UEINSTEIN, E.A. and KAHN, R.L.:
1959.
72,
61:
a
Psychiat.
Neurol.
Arch.
A.M.A.
Brain
Disease,
Organic
Organic
in
Disorientation
of
Patterns
KAHN,
R.L.:
WEINSTEIN, E. A. and
1951.
21h,
&amp;
Neurol.
I:
Brain Disease, J. Neuropath. Clin.
"47.1%.: 7-iithdrawal, Inattention,
310133,
and
mms'mm, E.A., ram-I, R.L.,
1955.
235,
&amp;
IA:
Psychiat.
and Pain Asymbolia, A.M.A. Arch. Neurol.
ALEXANDER,

�-3721.

T‘JEII‘YST‘EIN,
&amp;

E.

nsychiat.

A.
_6_L_l:

and mm,
772, 1950.

D.

Neurol.
Arch.
Anosognosia,
of
L.: Syndrome
"

of
Denial
Illness,
in
Factors
Personality
R.L.:
MEN,
and
22. IEINSTEIN, E.A.
1953.
§_9_:
355,
&amp;
T.‘Ieurol.
Psychiat.
11.14.11. Arch.
23.

L.A. and LINN,

R.L., SUGABI'JIAN,
Brain
Disease,
Sodium
Organic
in
Amobarbital
of

“IEINS'I'Em, 33.11., MEN,

Am.

Use
Diagnostic
1.:

J. Psychiat.

112:

889, 1953.

21;.

Test"
"Amytal
E.A.:
H.
and
vmmsmm,
KAI-1N, R.L., PINK,
1955.
3,
Hosp.
3:
Hillside
Mental Illness, J.

in Patients with

Differential
the
in
Tests
Perceptual
NJ: Tactile
25a. DEF-HER, MB. and
1952.
21,
Hosp.,
Hillside
1:
J.
Disorders,
Psvchiatric
of
Diagnosis
Sign
8.
Diagnostic
Test
as
Face-Hand
1.1.3.:
25b. PINK, M. GREEN, M. and BINDER,
1952.
h6,
2:
Neurology,
of Organic Mental Syndrome,
ImproveClinical
and
Damage
Brain
26a. REVITCE-I, 13.: Observations on Organic
195h.
§_8_:
72,
Quart.
ment Following Protracted Insulin Coma, Psychiat.
Coma:
TreatInsulin
A
Prolonged
Case
of
M.:
26b. IC-“IALEJASSER, S. and CAPLAN,
1952.
1115,
Hosp.
1:
ment, J. Hillside
and
ClinicElectroencephalographic
26c. SHAGASS, C. and ROFSML, P."T.: Serial
&amp;
Neurol.
A.Z"T.A.
Arch.
Coma,
Insulin
Prolonged
of
Case
al Studies in a
195b,.
705,
Psychiat. 12.:
Posthypoglycemic
in
Studies
26d. TRACER, C.L. at £1: Electroencephalographic
19530
1135,
1.32%:
Dis.
l‘ient.
Coma, Jo NerV.
Parts
of
1-5.:
Reduplication
Delusional
and
N.
FINE,
27. KAHN, R. L., GRAUBTE’ET, D.
1955.
13h,
Hosp.
g:
Hillside
Coma
Therapy, J.
Insulin
After
1Jody
the
of
Scale,
Rating
the
A
Psychiatric
of
Revision
28. MALAI‘EUD, 'T. and SANDS, S.L.:
Am. J. Psychiat. _l_9_l_l: 231, ram.
Colorimetric
Quantitative
the
for
Dyes
Basic
Use
of
29. GOLDENBERG, H.:
Chemical
Society
American
Conjugates,
Sulfate
Estimation of Steroid
1955.
'Iarch
31,
200,
Abstract,
Highspeed
by
Synthesis
Sulfate
Steriod
:
T4..
REIL’IANN,
J.
and
30. GOLDEHBERG,
Chem.
Soc.
in
Am.
press.
J.
,
Liver Supernates,
Convulof
Evaluation
the
in
Matched
Groups
Use
The
of
G.
A.
313
31.:
31. ULE'IT,
195h.
128.:
138,
July,
Menn.
Clin.
Bull.
Photoshock,
Subconvulsive
and
sive
F11 K,

(31‘.

�B.

Publications of Personnel:
Dr.

N

l.

x Fink:

Subdural Hematoma Developing during Hospitalization, Amer. J.
Psychiat., 191: 381-383, 1950 (with Dr. M. Green).

2. Patterns in Perception of Simultaneous Tests of Face and Hand,
Trans. Amer. Neurol. Assoc., 22; 250, 1950 (with Drs. M.B. Bender
and

M.

...,

Green).

ibid,

Arch. Neurol.

&amp;

Psychiat., éé: 355-362, 1951.

Test as a Diagnostic Sign of Organic Mental Syndrome,
Neurology, 2: hé-58, 1952 (with Drs. M. B. Bender and M. Green).
The Face-Hand

Tactile Perceptual Tests in the Differential IJiagnosis of Psychiatric Disorders, J. Hillside Hosp., 1; 21—31, 1952 (with Dr. M. B.

Bender).
A

Clinical Evaluation of Carotid Angiography, Conf. Neurol., 13:

Exosomesthesia, or Displacement of Cutaneous Sensation into Extrapersonal Space, Trans. Amer. Neurol. Assoc., lg; 1952 (with Drs.
M. F. Shapiro and M. B. Bender).

....

ibid, Arch. Neurol.

&amp;

Psychiat., éﬁ: h8l-h90 1952.

9. Order of Dominance in Cutaneous Perception, Trans. Amer. Neurol.
Assoc. 2E3 238~h0, 1952 (with Drs. M.B. Bender and M. Green).
10. Development of Perception of Simultaneous Tactile Stimuli in
Normal Uhildren, Neurology, 2; 27-3h, 1953 (with Dr. M. B. Bender).
11.

Perception of Simultaneous Tactile Stimuli by Mentally Retarded
Adults, J. Nerv. Ment. Dis. 111; h3-h9, 1953 (with Drs. M. B.
Bender and M. Green).

l2. Spinal Fluid Findings

2: 137, 1953 (I-rit‘n Dr.

13.

Following Cerebral Angiography, Neurology,
M.

Stein).

Statistical

Study of a Psychoanalytic Hypothesis; Absence of a
Parent as a Specific Factor Determining Choice of Neurosis, J.
Hillside Hospital, a; 67-71, 1953 (with Dr. S. Tarachow).

A

Effects of Barbiturates
15: 1953 (with Drs.

on Perception, Trans. Amer.
M. B. Bender, P. Bergman and M.

Neurol. Assoc.,
Nathanson).

Homosexuality with Panic and Paranoid States (Case Report)
Hillside Hosp., _2_: 16h-9o, 1953.

J.

16. Standardization of the Face-Hand Test, Neurology a; 211-217, 195h
(with Dr. M. Green).

�.3917.

Patterns of Perceptual Organization with Simultaneous Stimuli, Arch.
Neurol. &amp; Psychiat., 12: 233-255, 195A (with Drs. M. B. Bender and

H. Green).

18. The Amytal Test in Patients with Mental Illness, J. Hillside Hospital,
g; 3-13, 1955 (with R. L. Kahn and E. A. Heinstein).

l9. Delusional Reduplication of Parts of

Body

After Insulin

Coma

Therapy,

Dr. Joseeh Jaﬁig:

1.

Perceptual Patterns During Recovery From General Anesthesia, Jour. of
Neurol. Neurosurg. &amp; Psychiat., 1%; 316-321, 195l (with M. B. Bender).

2.

Factor of Symmetry in Tests of Double Simultaneous Stimulation, Brain,
15: 167-176, 1952 (with M.B. Bender).

Dr. Rdbert Kahn:

1. Toxicity of Quinacrine (atabrine) for Central Nervous System: Experimental
&amp;
Human
Neurol.
Arch.
on
Psychiat., 5g: 28h—299, l9h6
Study
Subjects,
(with Dr. T. Lidz).
2. After-Imagery in Defective Fields of Vision, J. Neurol., Neurosurg. and
Psychiat., lg: 196-20h, l9h9 (with Dr. M. B. Bender).
3. A Hereditary Syndrome Characterized by Mirror Movements, Left Handedness and Organic Mental Defect, Trans. Am. Neurol. A., ZS? 22h—226,
1919 (with Drs. I. Freiman and L. Michaels).
Tumors and Vascular
15: 277-278, 1950 (with

h. Correlation of Clinical and EEG-Abnormalities in
Disease of the Brain, Trans. Am. Neurol. A.,
Drs. E. A. ieinstein and H. Strauss).

5.

Syndrome of Anosognosia, Arch. Neurol.
(with Dr. E. A. Heinstein).

&amp;

Psychiat., ég: 772-791, 1950

6. Patterns of Disorientation in Organic Brain Bisease, J. Neuropath.
Clin. Neurol. 1; 21h-226, 1951 (with Dr. E. A. heinstein)

&amp;

7. Nonaphasic Misnaming (Paraphasia) in Organic Brain Disease, A.M.A. Arch.
Neurol. &amp; Psychiat., él: 72-79, 1952 (with Dr. E. A. Neinstein).

8. Preoperative and Postoperative Personality Changes Accompanying Frontal
Lobe Heningioma,
B. Schlesinger).

9.

J. Nerv.

&amp;

Hent. Bis.,

llh;

h92-510, 1952 (with Dr.

Phenomena of Reduplication, A.M.A. Arch. Neurol. &amp; Psychiat.,
81h, 1952 (with Drs. E. A.'Heinstein and L. A. Sugarman).

él:

808-

�uhO-

Shock Therapy, Am. J. Psychiat.,
heinstein and L. Linn).

Its Relation to the

Theory of
222; 22-26, 1952 (with Drs. E. A.

10. IBychosis During Electroshock Therhpy:
'

Brain
Sodium")
Sodium
("Amytal
Organic
in
Amobarbital
of
Diagnostic
Disease, Am. J. Psychiat., 109: 12, 889-89h, 1953 (with Drs. E. A.
Ueinstein, L. A. Sugarman and L. Linn).
Use

Neurol.
Arch.
of
Denial
Factors
in
Illness,
Personality
Q2: 355—367, 1953 (with E. A. Heinstein, M.D.).

&amp;

Psychiat.,

Behavior Disturbances Following Cataract Extraction, Am. J. Psychiat.,
and
L.
Linn).
E.
1953
A.‘
einstein
(with
Drs.
281—289,
219}

Delusional Reduplication of Parts of the Body, Brain, 7?: h5-60, l95h
(with Drs. s. A. deinstein, s. Halitz, and J. hozanshiT:

Serial Administration of the "Amytal Test" for Brain Disease: Its Diag195h
&amp;
217-226,
Neurol.
Arch.
and
Psychiat.,
Value,
Prognostic
nostic
ll:
(with Drs. E. A. Heinstein and S. Malitz).
16. Ludic Behavior in Patients with :rain Disease, J. Hillside Hospital,
A.
Sugarman).
and
L.
B.
A.'Heinstein
l95h
(with
Drs.
98-106,
2:

17.

Test in Mental Illness, J. Hillsiﬁe Hospital.,
(with Drs. M. Fink and E. A. ﬂeinstein).

The Amytal

Q;

3-13, 1955

Amer.
"Irritative"
Lesions,
in
of
Functioning
Intellectual
Patterns
18.
PSychologist, 25 h02, l95h (with Dr. E. A. Meinstein).

19.

"Spatial inattention" in Patients with Localized Lesions of the CereN.
S.
l95h
(with
327-328,
Drs.
Psychologist, 2:
Pollack and M. B. Bender).

brum, Amer.
M.

Batteery,

20. The Adaptive Role of Behavior Accompanying Brain Disease as Exemplified
by the Phenomena of Reduplication, Amer. Peychologist, 2; h90, l95h (with
Dr. E. A. ieinstein).
21.

Denial of Illness: Symbolic and Physiological ASpects, Springfield, I11.,
Charles C. Thomas, 1955 (with Dr. E. A. ;einstein).

22.

Coma
Therapy,
Insulin
Body
After
of
of
Parts
the
Jelusional [@dnplication
M.
and
Fink).
D.
Graubert
1955
(with
lBh—lh7,
Drs.
J. Hillside Hosp., g:

and Pain Asymbolia, A.M.A. Arch. Neurol.

23. ’kithdrawal, Inattention,
Psychiat., 1h: 235—2h8, 1955 (with Drs.

s.

A.

neinstein ana'h.

H.

&amp;

Slote).

Spatial Inattention in Focal Cerebral Lesions, Brain, in press (with
Drs. C. S. Battersby,

M. B.

Bender and.M. Pollack).

�25. Autokinetic Movement in Patients with Sensory and.Motor Disturbances, J.
M.
M.
and
B.
Pollack
S.
(with
Drs.
H.
Battersby,
Exp. Psychol., in press
Bender).
26. Relation Between Altered Brain thction and Denial in Electroshock Ther&amp; Peychiat., in press (with Drs. M. Fink and
A.M.A.
Meurol.
Arch.
apy,
E. A. heinstein).
27.

Mount
Sinai
of
J.
With
Picture
Schizophrenia,
Clinical
a
Encephalitis
Hosp., a1; 1955 (with Drs. E. A. Heinstein and L. Linn).

Korin:

Dr.
.1.

The
New

Effects of Electroshock
York University, 1955.

on

Retroactive Inhibition, Ph.D. Thesis,

Dr. Hargz Goldenberg:
and
of
Amino
Acid
Esterase
Trypsin
Activities
of
the
1.
Chymotrypsin, Arch. Biochem., 22; 15h, 1950 (with V. Goldenberg).
pH Depenﬁence

2.

Several Derivatives of Acetyl-dl-phenylalanine, J.
5317, 1950 (with V. Goldenberg and A. McLaren).

Am. Chem.

Soc., lg:

3. Effect of Ultraviolet Light on the Specific Activity of Chymotrypsin
and Trypsin, J. Am. Chem. Soc., 72: 1131, 1951 (with A. D. McLaren).

h.

An

Ester
Leucine
of
Ethyl
Hydrolysis
the
Enzyme-Catalyzed
Into
Inquiry

Gold1951
V.
(with
Biochem.
110,
Acta,
Biophys.
1;
et
Chymotrypsin,
by
enberg and A. D. McLaren).

5. Report D-12, April 1, l9h6; cf. pp. 117-119, concerning 8-Hydroxyquinoline Method (Alcohol Extraction), in C.J. Rodden's "Analytical Chemistry
of the Manhattan Project", (with J. Greenspan, M. J. Sohuler, D. Taub,
and A. S. Carlson).
6. Calcification. V. Influence of Fluoride and Cyanide Ions in the Presence
and Absence of Magnesium, Proc. Soc. Exp.
A. L. Sobel).

Biol., 19:

719, 1951 (with

kaline Earths on Survival of the Calcify1952
(with A. E. Sobel).
695,
Exp.
Soc.
Proc.
g1:
Mechanism,
Biol.,
ing

7. Calcification. IX.Inf1uence of

A

8. Calcification. IV. Influence of Strontium and Magnesium Ions on Calcification in vitro, Proc. Soc. Exp. Biol., IQ: 716, 1951 (with A. E.
Sobel and A. Hanok5.

9. Calcification. XI. Studies of the Incorporation of Citrate in Calcification in vitro J. Dent. Res., 3;: L97, 19Sh (with A. E. Sobel
and E. Schmeriler).

�~h2§

Ions
and
Cyanide
Fluride
by
Inhibition
10. Calcification. XII. Cation-Linked
&amp; Hed., éé: 27S,
Biol.
Soc.
Exp.
Proc.
in B-GlycerophOSphate Medium,
l9Sh (with A. E. Sobel).

19Sh.
26:
690,
Chem.,
Anal.
Plots,

ll.

Rectification of Nonlinear Beer's

12.

Curves.
Nonlinear
Activity
of
Rectification
Biochem. &amp; Biophys., ég; 288, 195h.
Enzyme

Law

I.

Preliminary, Arch.

�Studs.“
'1

tho room.
L

01‘

91‘

the

“mum

Width.

01‘

tn:

1::

Win

A

man}:

Wm

Wtm «mum,
01’

khanm tar claatraoncophﬂampw

W!
«mum “W

studying 01-min manta].

with

WW

in brain

during tin

mmmd.
m

and

Wm M

wt yaw.

W

method.

for

YMMMW
mmmmno
at Madam ta
stimulation

mm
W
m,mmmmuhhmmmmmmmmpumm
thew. m
Wu.
Mitmun.
mental
W
«mum
int-mm:
um
M m
huts, ham

gatima or tho

hymn

dam-uni"
affect: of

inn-ms,

and

human

um

cum-a.

tannin; haloahraaanmkin

acid (mp-was) an anal:

and

In tho

mm-

5:

yaw, a

my at tho was in brain function during mmmuw mm «I
Mpmholamu. Dre WWW”. Kmmlwomm
and
the
Pink
to
Dr.
fellow
of
tha
a
«mm.
m
mum
«mm.
Mutilation tar Inna“): Win an imam to sup-mu that kbonhary work.

“W.

Ha

rm
on

with a

Main: 1.

W

1953

In

a alumni

ultimatum

immut-

In tbs

Ané’t‘tmwmu
aluminum
tantalum
tho integrator! “My an

laboratory was «unnamed

mam than math!

Wamhéin

11W brain mum.

the

1mm
ammo:
65

m
W
of
{w
with
maul
mania
111mm,
dwmatu
”mum
3W
m mm
mum to mmm mime. Mam dim, mun WI ef pain;
mwnwmmmmumwmmotmmmmm»
mtkm; with «13m (litmus-I m tuna-Id ma amtralkd with anal-put:
drugs. may ammu- m
ta m mammal mm a:
am:
1m1uuoha
During tho yaw, $5

mutton

tum-Ind.

More than half.

aw

85.1:

mm}.

hospi'alk

m-

mmr

M

m mammal «mum

at...

am

an.

an.

�4-»

mmmaohmmmmwmwmmmm ”mutate
ermg
than
thﬂu
Ina
1mm
yum,
”we“.
macaw
«:1th
at

mum.

mmmwmnmmsunmmmmumm

:Mz‘mmwmmmmnwdwumﬂoftb

W.
«ammuﬁmmnsmmmmmmmuuumma
mm m

In addition. tan

on

m

at mammalian!!-

mmmmm McMithmmmmmmngnmm_

mmammmomrmmmammmmmammm

uttkﬂhoapim.

.

wmmm, s.

A.

at .1:

The

mm, M. am PM

o:
mama: mm in
m
damn

IWtSMﬂs (Jam)

Bibltoﬂ (1953)

1953:»

m.

mm. m. tau-m, 9.5.. Ramon. n. m
mm
on Pmopum,
Mm... Jam 1953.
il'ink. K...

m
m,

M; m.

u. and Bond», 11.3.: remap-um a:

w man-11y mm:

m

mm at mm.“-

51mm mm. Stimuli

Now.
a m. nu. mam-w (Jar-u) 1953.
am.
mm,
3. m: m, m A sumac-1 away ’or a mummm mom-m,
am. swam no». 2167*?! (March) 1953.

rm,

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67254">
                <text>Progress and annual reports; research activities (folder title 2/2).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67255">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67256">
                <text>mfp-03-01-001-0-003</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67257">
                <text>1955</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67258">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67259">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67260">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67261">
                <text>Letter to Fink; Somatic Therapy Research Program; Monthly report; Research Progress reports - Department of Biochemistry; Letters to Dr. Miller; Electroshock Therapy Evaluation Program; Annual Report - Department of Neurology; </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67262">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67263">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80928">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87489">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94050">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100611">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6727" public="1" featured="0">
    <fileContainer>
      <file fileId="6534">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/5fddf7ec4456da255de4e0d4b1d4c29a.pdf</src>
        <authentication>e18d9957071a91ab8e65015c0fde8e69</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107141">
                    <text>January 15, 1956

Perceptual Changes Induced
M

Prorress Report
Maximilian Fink,
Director of Research

M. D.

927

By Drugs and

Electroshock

(c)

September 1, 1954—January 1, 1956

'

Hillside Hospital
Glen Oaks,

New

York

aHEMRY:

Beginning with a study of perceptual changes induced by electroshock, emphasis has shifted to a study of the mechanism of electroshock
therapy. A marked relationship was demonstrated between clinical improve-

ment and certain indices of altered cerebral function. Early, persistent
and severe changes in amytal tests and the electroencephalograms were ob-

served; but no correlation was demonstrated for memory
double simultaneous stimulation.

tests or tests of

clinical

improvement did not alvays persist, further studies
to elucidate the relationship of premorbid personality to both short and
long term improvement were devised. Preliminary data demonstrate a relationship between persistent improvement and a specific character pattern.

Since

suprathreshold simultaneous tactile stimulation techniques failed
to discriminate in terms of clinical response, threshold studies utilizing
square—wave electrical stimuli were undertaken. This technique elicits patterns of altered function not clinically apiarent, and the relation of these
patterns to clinical improvement is under study.
As

�PROGREeS REPORT

The

inception of

M~927

in September

1954 permitted an expansion

of studies previously undertaken as a Fellow of the National Fbundation
for Infantile Paralysis. Three studies were in progress: (a) evaluation
of the amytal test(l) in psychiatric subjects; (b) relation between al~
tered cerebral function and tests of simultaneous tactile stimulation;

(c) effect of lysergic acid diethylamide, pervitin, and amytal on visual perception.
and

In the amytal

test, the patient is

asked

questions concerning

his illness, orientation, and recall before and immediately after the intravenous administration of amytal to the point of nystagmus and slurred
speech. In the original studies at the Nount Sinai Hospital, the development of disorientation and explicit denial of illness was
clearly associated with diffuse cerebral dysfunction(1).

As a

admissions to Hillside Hospital were tested.

patients

control study, consecutive

Of 68

interviews essayed a-

not had recent electroshock therapy, 56 were adequately completed. Of these, 51 were "negative" for brain dysfunction;
and of the five " positive" results, hree showed other
evidence of brain

mong

damage.

who

had

In addition to further defining the scope of

this test as

an

in-

dex of

cerebral dysfunction, the study demonstrated other differences from
a group of patients with physical disabilities but without brain
disease.
There was more

transient disorientation

and

denial,

more withdrawal and

ludic behavior and more changes in the syntactical aspects of language in
the psychiatric population.‘
._____.________________________..____.______________________________________
*Kahn, R.L., Fink, M., &amp; Heinstein, E.A.: The "Amytal Test"
in
Patients
with mental Illness, J. Hillside Hospital ﬂzﬁ-lj, January 1955.

�2.
When

such

tests

were applied

in patients

who

had

recently under-

gone electroshock

therapy, "positive" amytal reSponses were elicited.
This aberration had previously been reported by Weinstein, Linn, and

Kahn(2), and formed the basis for

their explanation of the

mode

of action

of electroshock therapy.
In a second study,

patients undergoing electroshock therapy

tested by simultaneous tactile stimulation methods(5).

With

were

increasing

amounts of electroshock therapy,

patients demonstrated consistent alterations in the perception of the two stimuli. Failure to report one stimulus and mislocalization of one or both stimuli in predictable patterns
were demonstrated.

These

patterns

were

transient, however. Electroence-

phalographic records were also obtained in these subjects at weekly

vals.

progressive appearance of delta activity,

The

first

inter-

as random, low

voltage activity, and later as symmetric, high voltage bursts, previously
described by numerous authors(4) was confirmed. Attempts at this time to

correlate changes in the electroencephalogram

tests

and the simultaneous

tactile

unsuccessful.

were

third

group of

studies, of the effects of d~lysergic acid die—
thylamide and pervitin on visual perception were inconclusive. A variety
of ill~defined subjective perceptual alterations which failed of objec—
tive verification were observed and the study was discontinued.
A

The

experiences with amytal tests and simultaneous

tactile tests

formed the background for the studies undertaken since September 1954 un-

der

H—927.

To

determine the relationship between various indices of a1-

tered brain function (the amytal test, the electroencephalogram, and

�5.

tactile tests)

simultaneous

a correlated study was undertaken.

Conse—

cutive patients referred for electroshock therapy were studied. Treatment was administered three times a week. Electroencephalograms
were done
weekly on a day following a treatment.

tests

Simultaneous

tactile stimulation

tests were done once a week immediately preceding a treatment and 48 hours after a previous treatment. In addition,
special tests
of memory and recall utilizing the technique of retroactive inhibition
were carried out at weekly intervals.
and amytal

In addition to

intercorrelations between these indices, we were
anxious to determine the relation between such changes and clinical alteration in behavior. For this purpose a clinical evaluation of improvement

at weekly intervals during treatment

was made

ing therapy.
and the

These

patients

and unimproved.
showed

by

the

ratings

were
The

symptoms

their therapists;

and up to one month follow~

were made independently

classified as markedly

of the other indices,

improved, moderately improved,

markedly improved patients were those

that brought
and the

who no

longer

to the hospital; were rated improved

them

nurses' notes confirmed such aspects as being

able to sleep without medication, better appetite and improved capacity to

participate in hospital activities.
showed no change

The unimproved

or only transient changes.

were those who had some imtrovement

in

The

patients

were those who

moderately improved patients

symptoms, but

in

whom

severe dis-

turbances as obsessional thinking, paranoid ideas or somatic preoccupation

persisted.
A

marked

correlation

was found between

clinical

improvement and

early, persistent and severe changes in both the amytal tests and the

�4.
electroencephalogramx

to occur.

No

If

such changes did not appear, improvement

failed

such correlations were manifest between improvement and the

tests of recall function or

changes in simultaneous

tactile tests.

Thirty patients were essayed in this study, but 24 were success-

fully concluded.

At one month

post-treatment, eleven were classified by

the supervising psychiatrist as markedly improved; six as moderately improved; and seven as unimproved.

the markedly improved patients, every
one had at least one positive amytal test during treatment. Of the 50
tests given to this group, 58 (76%) were positive. In contrast, of the
unimproved

of the 45

Of

patients, five of the seven never showed a positive result, and
tests administered to this group, only 6 (15%) were positive.

The

moderately improved group showed more positive responses than the unimproved patients, but fell far short of the much improved
group.
In addition, there were consistent'changes in language and
non-

verbal aspects of behavior indicating alterations in adaptive mechanisms
in the much improved group, even in interviews not employing amytal.
These

alterations

were

either minimally or only transiently manifest in

the unimproved group and then only under the influence of sodium amytal.*
Concomitant studies of the electroencephalograms taken on a day

preceding the amytal
cords were

first

test indicate

M

a similar

relationship.

measured for per-cent time slow wave

The 160

re-

(delta) activity,
frequency of the

the duration of burst activity and the amplitude and
slowest waves present. The records were then placed in a rank serial
order.
Presented at the annual meeting of the American Psychiatric Association,
May 10, 1955; and submitted to the Archives of
Neurology &amp; Psychiatry for
*

publication.

�5.

falling in the upoer third were labelled "high abnormality" and
those in the lower third as " low abnormality". Of the much improved
Those

patients,

25% showed a

ment; 80%

after

two weeks and 90%

patients, iowever,

first

after three

weeks.

The

treat-

In the unimproved

none had a high degree abnormality record during the

three weeks and only one had such a record by the fourth

treatment.
these

high degree abnormality after one week of

records of the moderately improved patients

week

fell

of

between

two groupsc*

Changes

in

memory and

learning were tested in these subjects by

using the principle of retroactive inhibition.

recall of three-letter originally learned

By

the serial testing of

words following the

interpola-

ted learning of nonsense syllables, patterns of decrement in learning and

recall
ment up

elicited. As a group, the patients showed increasing impairto the third week of treatment, and a rapid inorovement after the

were

cessation of treatment.

No

relationship, however, could

be

established

between impairment and resnonse to treatment.**
The

responses of these subjects to simultaneous

touch stimuli were also assessed.

ability to identify

and

While an

localize the

two

tactile tests using

increasing impairment in the

stimuli could be demonstrated

with increasing treatment, no relation to improvement was noted.
By

tent

the spring of 1955,

and severe changes

tal tests

it

was

our conclusion that early,

persis-

in both the electroencephalogram and in the

amy-

are a necessary, though not sufficient, pre~requisite for
..___....-—_.

m---_—.

»

Presented at the joint meeting of the Eastern and Southern E1ectroence~
phalographic Societies, Bethesda, September 50, 1955.
*

Presented before the Electroshock Research Association, May 8, 1955, and
awarded their Annual Prize Award and cited for excellence in research design.
**

�6.
improvement following electroshock therapy.

initial part of the

This obserVation confirmed the

hypothesis of weinstein, Linn and Kahn(2) ascribing the

therapeutic results of electroshock to the facilitation of patterns of denial by altered brain function. But was it true that the patient's improvement

resulted

from denial of

illness or denial of

other a-

More

symptoms?

daptive mechanisms manifest? Also, within a few months a number of the markedly improved patients had relapsed.
At

this time,

a second

Why?

electroshock population

was

studied.

First,

to confirm our previous observations on the relation between improvement
and changes

in the amytal tests and the electroencephalogram.

if exnlicit

denial is a mechanism in improvement,

it

post—treatment and directly related to improvement.
advanced

that those patients

who showed

cit verbal denial" personality

Secondly,

should be manifest
The

hypothesis

the characteristics of the

would be those more

was

“eXpli—

likely to maintain

im—

provement.
Between April and August,
were

studied. Satisfactory data

electroencephalograms and amytal
and again d

ring the second and

thirty consecutive electroshock patients
was

obtained in twenty-five subjects.

The

tests were carried out before treatment,
third week of treatment. The patients were

again independently rated for improvement by a supervising psychiatrist du-

ring treatment, and one month following treatment. These patients are also
now being seen in six month follow-up visits to assess the " long-term"
changes.
In addition to these

of subjects

was

tests, the

premorbid personality of

this

group

assessed by an interview with family members, psychologic

�7.

tests

and a

tachistoscopic study.

in independent interviews.
to

A

At

least

two

close relatives were seen

standardized questionnaire has been devised

den
verbal
"explicit
the
of
indicative
factors
characterological
elicit

this study fifteen characteristics defined as typiSuch
in
selected.
were
of
absent
in
this
personality
tyne
or
cally present
tons include prestige consciousness, sensitivity to criticism, imagination,
temper and attitudes to sex and illness. Each patient is rated on a scale

nial" personality.

of

0

to

denial

2

For

for each item - the higher score signifying a greater tendency to

o

l

Each

patient vas also tested

by a standard psychologic evaluation

These
Thematic
and
Tests.
Rorschach
the
Apperception
including
battery
tests were assessed for character structure and the usual tynes of defense

or adaptation.

tional

A

tachistoscopic study

was

devised, in which pairs of emo-

and non-emotional words were flashed on a screen

at

10, 20, 50, 100

patient's ability to identify the words,
the reaction time, and the distortions were ascertained. This pre-treat~
nent data is now being studied as to its ability to clarify the patient's
and 250 millisecond

periods.

The

usual defense patterns.
Only the short term

group nine

uatients

were

results of this study are available.

Of

this

rated as showing marked improvement; twelve as

mo-

derate inprovement; and four as unimproved.
Of

the physiological indices assessed in these patients, a signi-

ficant difference

was

again noted in the anytal tests and the electroence—

phalograms between the markedly improved and unimproved groups.
no

There was

difference between the markedly and moderately improved groups.

�8.

relation of personality ratings and improvement, an
indefinite correlation was manifest in this small group. Lcores expressive
of tendency to "oxalicit verbal denial" ranged from O to 25 in a scale of O
Asgarding the

to 50.

The

following table describes the natterns of each grouw

when "high"

and "low" scores are compared.

(10 and Below)

Low

ﬁarked Improvement (9)

Hoderate

"

"

Uninproved

High (Above 10)

2

7

(12)

7

5

(4)

e

0

Because the scores were unusually low

in this group, a sample of

consecutive private electroshock estients were studied.

lity ratings

and

clinical evaluations

were made.

To

Similar persona-

date, ten patients have

this study is continuing.
This study is still in progress. The six month follouaup is now
being undertaken and further correlations will be done. Kcanwhile, certain
conclusions can be entertained. The relationship between alteration in the
been studied and

physiological tests and improvement

It became apvarent that
the patients manifesting clinical exolicit denial of illness post-electro—
was

confirmed.

shock did not have the best long—term response.

Lesser degrees of adaptive

better prognostic value. This observation led to an analysis of the only verbatim recorded data for this series - the language changes

changes may have

in the amytal interviews.

The

data is

now

being analyzed for a variety of

adaptive language changes and correlations with clinical assessment are to
be made.

�9.
Chile these studies of the ohenbmena underlying improvement in

electroshock therapy have been under investigation, the

tual studies

have run concurrently.

group studied, the lack of

In the

first

(1954) electroshock

correlation between simultaneous tactile sti-

mulation tests and improvement

was

nuzsling.

The

tactile tests

tremely gross, hovever, and this might be a factor.
a more meaningful

was

developed.

anticipation that

be obtained from

Previous exteriences with von Frey hairs for

such threshold stimulation had convinced
mulus

In

were ex-

this index if threshused, equisnent for threshold electrical

correlation could

old stimulation techniques were

stimulation

tactile percen-

me

that the variation in the sti-

often exceeded the fluctuations in hreshold, and the studies were

inconclusive.

Reports by Segal(5) on the perception of square-wave elec-

trical stinuli

led to our development of similar equipment.

84~B

stimulators and isolation units monitored by a

deliver independent stimuli.

A

Dnnont

Two

Grass

oscillograph

switch box and l centimeter steel disc e-

Difficulties in isolating the stimuli
precluded this testing being carried out satisfactorily until septenber.
A continuation of the second electroshock group has been in prolectrodes corolete the assembly.

gress since September.

The same

nhysiological tests and personality assess~

patient's responses to simultaneous
hreshold electrical stimuli is tested before treatrent and at weekly intervals. To date, 18 patients have been studied. The same phenomena of exments are undertaken.

In addition, the

tinction, displacenent, nerseveration, and confabulrtion described in patients with organic mental syndrome with suprathreshold stimuli by Fink,
4.

�10.
Green, and Bender(6) are apparent

technique

elicits these patterns

in these natients during treatment. This

clinically manifest.
while extinction is also manifest in yrs-treatment testing, displacement
and perseveration are related to the extent of treatment. This study is

now

though they are not

in progress.
Concomitant with these studies, preliminary observations of a

milar nature have been

made

in patients undergoing insulin

coma

si—

therapy.

Recent reports of the value of prolonged come as the basis for improvement by Revitch, Kwalvasse? and Caplan, Sharass and Rowsell, and Yeager

gt

al&lt;7&gt; have been confirmed

in our patients. In

reported a direct relationship between altered brain function, altered patand
imnrovement.*
and
behavior
terns of adantation in lan mace
clinical
t:
.
'
-

one unusual case we

r

R.L., Graubert, D.H. and Fink, N.: Delusional Reduplication of Parts
of the Body After Insulin Coma Therapy, J. Hillside Hbsnital ﬂ;154v147, 1955.
*

Kahn,

�11‘
Summary

of
Our

Work

to Date and Plans for the Future:

studies of perceptual changes induced by electroshock are pro-

is in elucidating the
factors underlying improvement following electroshock therapy: changes in
shysiologiccl indices; adaptive changes in language and behavior in resnonse
ceeding in two concurrent and related courses.

One

to altered brain function; and the factor of personality.
study of the watterns of threshold

tactile perception

The second

is

a

under conditions of

altered cerebral function; their relation to "inprovenent" following

elec—

troshock; and the relation to other indices of altered cerebral function.
The problems

before this study are conylex.

The

rating of "improve-

is primitive and further vork alcnf this line is mandat ry. The delineution of the explicit verbal denial character is a gross anprOfination
of this problem. FUrther study of the role of personality and a descrip-

went"

tion of defensive operations other than denial which may
significance is in progress. To clarify in our data the

have therapeutic
203

beneficial

be
which
ascribed to "general interest",
electroshock
can
of
therany
result
"spontaneous cure" or "placebo" effect, a control study is being instituted
on February 1.

Titb the concurrence of the Sedical Board of Hillside Yos-

be
will
electroshock
referred
for
therauy
treated, by ranpital, pitients
dom selection, by either pentotbal-convulsive electroshock or jentothal—

subconvulsive stimulation.

The

cerebral chmnjcs induced by pentothal-

subcenvulsive stimulation are miniwal and result in a minimal inprovenent

rate(8)

o

�M

References

l. einstein,

E.A., Lahn, R.L., Sugarman, L.A., &amp; Linn, L.: Diagnostic Use
of Amobarbital sodium in Organic Brain Disease, Am. J. Tsychiat. 112:

889—894, 1955.

2. Heinstein, E.A., Linn, L. &amp; Kahn, R.L.: Psychosis During Electroshock
Therapy: Its Relation to a Theory of Shock Therapy, Am. J. Psychiat.
102:22-26, 1952.
5. Bender, H.B., Fink, H., &amp; Green, N.: Patterns in Perception of Simultaneous Tests of Face and Hand, Arch. Neurol. &amp; Psychiat. §§3555-362,
1951-

,

~

4. Pacella, B.L., Barrera, o.”., a Kalinowsky, L.: Variations in the Electroencephalogram Associated with Electric Shock Therapy of Patients with
Mental Disorders, Arch. Neurol. &amp; Psychiat., ﬂl:567~58#, 1942.
f‘!

5. Segal, Harry: Prick Threshold stimulation with Square ‘ave Current: A
New Heasure of Skin Sensibility, Yale Jour. Biol. &amp; Med., g§:145-154 1955.
A

6. Fink, 3., Green, D. &amp; Bender, U.B.: Face-Hand Test as a Diagnostic Sign
of Organic Mental Syndrome, Eeurology.g:46-58, 1952.

,

7. (a) Revitch, E.: Observations on Organic Brain Damage and Clinical Improvement Folloring rotracted Insulin Coma, Psychiat. auart. gé:
72, 1954.

(b) Kualwasser, S. and Caplan, M.: A Case_of Prolonged Insulin
Treatment, J. Hillside Hospital 35145, 1952.

Coma:

(c) Shagass, C. and Rowsell, P.W.: Serial Electroencephalographic and
Clinical Studies in a Case of Prolonged Insulin Coma, .M.A. Arch.
Neurol. &amp; Psychiat. 13:7059 1954.
(d) Yeager, C.L. 33 El:
glycemic Coma,

8. Ulett,

Electroencephalogranhic studies in PosthypoJ. Harv. &amp; Ment. Dis. 118:455, 1955.

of Matched Grougs in the Evaluation of
Convulsive and Subconvulsive Photoshock, Bull, Kenn. Olin. l§:158,
G. A.

gt_al:

The Use

�m

30, 1956

mama Ammm

m

mm
m

-

3.955

FollwingthsamﬂmdﬁnﬁamtheMamm,msmstyw
mrked by

integratim at um. 38mm with ongoing

15h.

mdnpamimotthsntaff. Maddiﬁmlgrantsm
wise rewind its first prize award.

Wk
left Ht. Sinai

In Jammy, Dr.

Service. ﬁr.
of

m

antivities

mummthe

un-

thyweloalt, swaths Ram

Kuhn,

Hospital after sighs

Weammma or altered mnbral

1103911131

Won.

yum durum to the

&amp; is author of

numerous

am

mus-

sum in mumpsycmogy and eo-mthar at tho mum, “Donna. at Illness,“
1955.
3a
these
1n
in
elsetmashock
is
the
waning
1121:“qu
mum

MWcmpopuhﬁm.

FM

Basin medatim for
at Heats}. Health.
In September, 19:.

Hiawarkhasbeensuppartodbyagrwtaf the
and by the U.S.P.H.3. Batimal Institute

W

MW
amiaammohpsycmmntamashwaxmbemwm
Joacph daft-e, 3.13., a graduate

the doctor-patient. nhtimﬁzip. In ntudias

.191qu the

at Baum

and tbs Ht. Sinai Heap-

mammmmwmsmwotmm Warsaw
mummmbm dmmﬁmmﬂjomedMs Mitosantim this

itals,Br.

am. ltmeMeftbumr,

mnmrmmgmwmmm.

thmwmtefizaﬁwwwthism.
In Bay, Dr.

W

..

Karin, 31.9.. of the Bemrch Service was

mama the

mporten
mammaemnmmmrm
mmmam
the

mmmacmammwmmwtmmcmma

Inthisstudy,usingtbatechnicofntmacﬁvninhibitimasammafmxy
change, Dr. Karin damnatmtad

W1.

and changes

in

that no connhtim existed

my.

In that Prize

Award

between the

citation, the

patient's

commitme

�wan-w.“—

m._-m_mm
.2...

wmmmmumothumhmumnaamchﬁw
ammuﬁm.
tho Iaml sums Instant-hip m
n:
an
April
m «mum
1951;,

19. 19559:.

W

mm.mw~amdtmtmthm. mummy

subject, “an Application of the

39% to

mums ﬂung.”

puma
mm.
min-rod for dammit”: meocMﬁomal
mandamus”

mus;- chum-mum: I proactive

3% m

consecutive

WWZMMBNWMWMt.Mamchsth

mummmmmtusiwwmamm
museum» cam,‘21 Maud
a: mum
25

signs

brain

mm

way

In

either:

mm,mm
arm‘iapmvmnt, «lawman chaudumratc undue, maimed.
mumawmuauormhmmmmuy.

or

‘tbfmpatientswithmt

Magic W,thmmnmimmudmdme

Winden’ummt. mmtmmmmunwmamw

www.m«mmmwucmumm
M‘mdﬁnas'mmu.‘

mmmmpmnumww
matthuoindimupwiﬁu,toarmwhimmmmmwmt
andmminpmod.

��mmwﬁainticnndlaur,mapomsﬁcatﬁtude. ﬁemmﬁadm-

W

his
mm 31me in 1mm Mam «new; and mommy
Muwmmammmtmm. hmmwmm
man-dad interview,

mks» of was recordings; or patimva mm at

mum'aomcrpumum; Mammmmmm

ﬁction test are in progress;

mgmw:
mmmwmmwmthn.manmmma.m
hwumunmmmmn

1:.

WW.Wmuumm.
smashmlsmbmmm. ammtnmmmmanmmm
chmtumpaﬁmtam

mm,mmmmmtomuom
MIMMWW.ItmmWartmmmmt

wawmmnnm.

mumm-mmmwmwamnm
mam.
”strata!
We
mama
pal”,
mm“
pm,

in this psyehintrm

Ounce-1m

lowering or blood

naming

studios

a: the

13

might

mm.
Amnammu
was
submitted
to ﬁn Journal at the man Emma. far publicaﬁm.
am
mdunﬁmafthoncholylhloodpnm

Wmm:
theﬁng
amt
5.

the

Institute, a working

mamueaumormwmat
fame

m

with tho

Munch

�”war-WW

wmmmmmm

WWI-mm »- W'rﬂm‘

-W~me_ m

.2..."

m

wiry previous 02&gt;an that alteration: in steroid heme excretion occurs timing mu natal illness, and that such alteration: rem ta

Service to

mm]. levels with

improvement. Brim Iii-amid

mention pettems are

bum

mama-MamdunngmdMaemotpmmwm.
hmmjecumnmrmdnmgm
I

km,
www.mrym. mmzuthmarmrpmm
W

em,mhe11mimgm,mdmetemidhomconjmm,thehnmtm
supported by a maximum grant rm Sb U.S.P.H.S.

Mitmfmdthatmmuemsmjmﬁcedtﬂmgﬂwwv
of
variant:
and
liver
mum urinary excretion tom
:15th Wine,

W

me mud 13 enter to establish: criteria tar rimang cmamazon”. mammwmmammatmubemmumsits.” macaw of channel 11m reacts-n1. the determinative is thereto“

PM

{@311th priorto marmMMgme.
ammmckudnmrnedoutmﬂnmmofommim.

prescribed

both

Soudthedmgistomﬂtoheemreﬁcdmcmedmmmusehrgumt
iscmfbdtutheenlﬂxiﬁyconﬂmgtheeaﬂiercbunaﬁmudeum

mumammgwutmthrmmnuammwm

the

WinchemextmlylmgmmmﬂWﬂewotthm.

Mammatwmfwtthatismmetchcmtedrwmaw
hemmemmmmmtcde»

mommwumm
ummmmmmummdmrmmmmmmmm.

InmﬁmﬁmcfmﬂermrkmmmmumetMaewchomautomate (an mm) by
a variety a! was new tee-ted for

mm,

their mums mummy: activity. Syaergic acid diethylaaidc (um) and ranto be far more
htea annﬁm were
than
inhibitem
other
can:

rm

MS

“adamant! with the «We! aux-me and pro-3m.

A

prom

�mWoumnmoa-ajmmumﬂm‘ummwmmm
mag mm manna 1w mm mm.

xmmmrmuuammummmwdmmum

A

m ”Wing was Mocha m- the ”106151“ mum of steroid sulfah

mm

rm biological fluids and for their colon-attic

«mum.

notw-

mmmmmummmmmnmabmwmnmmw
owe.

11mma
in
that
gamed:
cenjugam
It
tow
m
hem
mm. in
ﬁance
their urinary mam clearly nﬂocw
melanin.
a
m Wart-lathe

memuetmcﬁm.

hummumnulmuwrtou

Wmammnmmmummmanumtmm.

�.w—«w‘w-m. , . 3r

(b)
'

.mwvm-minmmﬂvw—W”w'w"w—vmWWWQVYHWW-mwzm'm mrw.

c 3

I

(:1)

I:

.W

3. Karin and s.

,.

From.

m:original

this»

Tim

may was conﬁned

by Dr.

WW

3.

nov‘

m‘!‘r‘rwm":’

me‘rmwt‘m

2mm,

hypothesis, reported in 1953. related

mmaamtmamtmormmmmmuymmw. mm

«antes of

mm

by clinical psychiatric ratings,

mm W

W
mummy:

tumﬁc

0.

by Dr. Kenn, and the
Appempum rear.
111$
figum
maﬁa: of piatums anti
minutiae. Late in tho yaw, having Moped indies: of

Wat“

swim

pro-

@0th

far

minim, a stack

«mmmmlammammumunommom.
(2)
anagram Wrath. R. Imam, super--

ﬁxing

mm
WM

an interdiawlplmzy

staff of Dr.

D.

Wrﬁ (mm:

(mm um) and mu
3. Patter {group activities} have unkind the Win).
as a the!»
apeutic agent. Wrath work has gone into tho Miami: of a behavioral
seal: that canine mite mm clinical change. In a pilot 3%, they d.-

must),

Dr. H. Koran (pmhology), Er. 1 12min

Wt

'mmmmaamqammmuuummurymmm
nations between patient
in patina”

W.

(3')

and thumpiaﬁ; and also he 9:131:13 manual

W
mm,

m:

onetime: with

In Septubor, {collating our

M. 3. shit and 6.

Gross,

alteratim

1313113112317

midmt mmnm,

Wasmdyatmmmuumaaapomwlmnmurormmm
Patients Mnmdforinmmmmdivimmtommm:
W.
unanimous” maivingmﬁminaulincmthanpy; andtuotherm-

Deaths. m: Indication is given in menacing
mommine
doses mm early toxic aims ataxia thn dingo for the period of obaemﬁcn.
The max-tormm,
Inmmgracionﬂygim.
mmmnco”

caving

for

3

�‘

~3-

W
aMdpmMenﬁmmmtmmmmeWmd
1h)

am.

WW£WM*
mm 3mm

he. Wmm lax-um,

W?

Win-15%.,

has

unbound

mamas-L. rummtm‘mmmmmmmpnb

é

!

I

i

i

mpmmunmmumuu.
mumrwm.
«Mammmbyuumwrummdamm.

�'V’R‘l-rmw‘vwm wwllﬂ-Nw-a. .rwawm-um—wzm.—

the

mm“:

In addition to tho

,

1m Whit ”Him,

I,“

tanning praise“

wars

—

I'w—

"tus-n—

Wmtion museum

WW:

MW
absenmum

in progress or

during 1955.
(1)

“Wu—raw...“ mu...“ ‘Irvﬁwwrva, wvwwku’J—w

In addition to the matted. and

vaﬁana of the patients undergoing margin! and cunt-gamma
Bumbag

m invesﬁgatod the following:
(a)
um:

W,

Dr. A.

Watch;
shockormum mnymumumtmmmmmviwm

mhalyl.

All

puma referred for electro-

mmmﬁmﬁonlterthe mmdﬂtymmm.

Mness of that» tons in

010::th
Wanna,

therapy results

Thurma-

is null

mmuan.
(b) mummmnma mmmwpomm that aim
¥

mdnr
‘

_

innlindomspmdamlnléhmnwgiunmre mtmmhumamirm
can periods, ms. P. Lam and A. washers tested 10 patina. It was my

mmmmwmmmommymuwm,
dosesotinomn.

tdodﬁomaminfadorto Minna-go
(2)

w m:“rim

inter-8161mm
of
the
were

mud,

and

SW

by

.th

armmm in Social

factors in patient care continued.

medita-

Sam at
Three lam”

m were tmdemm.

lass Edm Either, a candidate for 11.8 .83. at new 1014: mini-31w, startled
and
the length of
status at 1mignnt
the rolaﬁm
patients. a» reported that than no no «utterance batman tbs Meant manushorterandﬂu
Itanything,

mm

migmtm.

Wham

aim

mmmammnaumm

status mdiaehargabattarforthoiuigmt mp3. mnWobermmma
Prue by the kiwraiﬁ for tho ”mum at her study.

Inautudyutthomhtimatfaemdnghdnchugewalnaﬁemmum

�rﬁm.._—v
I

,_ ...

w‘w

WV..—

w"... r...

-

n... v.r—W~,. Sw‘~-,—w§zwrm—Im.

L-r-‘vQ‘m-W—w‘mm

cu:

'"m :gmnmmw—u—j

:1

~10;

ma,amdmttmmmcomga,npamﬁfﬂm¥atmotm-

mmmmawmm. mmmmmn,mmmm
ammmnmaummtwmmmmemm. teaWdamammmmmmnmﬁmmmmmm
magmgmdmrg patientsvithmmmpmin mononuinmmm
m.
'

1wmmm.m195§.wuamwupotpatmumemu

mmmmwmmatMuatmmmmmm his
mmumsm‘sgmwmsmmammuuamm

appumummbyumlam. ﬂﬂ.mmmps,mthommt

stMmmmmwmamunu-ammmw

:mwmnwm,mdmnrmwuobmmmmﬁmm
themﬂﬁergm.

mmw,rmmeMmmdu-m,bymu"mm

«wmxmmdwuam mmnawmm
fermdbyplvaicima otherthmpsycmmtu. £130,312

Immammnmmmmm.

“Wham;

.

���y‘ﬁ-WWWAMV'VUM amp"

Husky,

1min:

from

in “night and Roasttlmt‘ by
H. 3.8nw “3%; 3.3.3.3.c.o., 6.4.
MAL,
Imam, Shit!” 5.
The

Childm,

'

Putter,

Mm

sown.

Gsoop Hark st.

Killuidn Haunt-1,

Amer.
at
151.161.19553mw
Glam; lam,1955.

W,

J.

WM

Hosp.

g:

Orbhopaychiatric Ame...

�I

April 2, 1956
Corrected Copy
RESEARCH ACTIVITIES
ANNUAL REPORT

SAME AS ORIGINAL

-

1955

�IDENTICAI. UP TO END OF PARAGRAPH

1.

Research Programs were actively carried out by the Research Service,

resident and attending psychiatrists, and by departments at the hospital.
(a) Research Service:
With the two additions to the

expand

staff,

Dr. Fink was able to continue and

his studies of the changes in behavior'widch fallowed electroshock therapy.

These studies were directed

to understanding the effects of the treatment

on

the

brain, as well as trying to understand the changes in the patients behavior, language,and memory which might result from such changes in brain function. There
were

three different tests that were used.

The changes

that

occured in the brain

patterns (electroencephalogram) were studied and it was shown that it was
necessary to have some changes in the brain wave patterns before patients be-

wave

came

better

from electroshock.

Secondly, by giving the patients injections of

who
have
that
patients
it
changes in brain function show certain specific changes in language after the
drug. Thirdly, by special tests of the ability of the patients to perceive two
touches simultaneously applied to different body parts, it is possible to get

a seditive drug (sodium amytal)

is possible to

show

another index of brain function. These three indices, together, form the best
way

available today to demonstrate changes in brain function.
One way

of showing changes in a patient

is to study his language.

We

have

continued our studies of language following the administration of sodium amytal.

In addition, Dr. Jaffe has begun a study of the changes in language which follow
changes

in the doctors attitude to the patient. For this purpose

interviews between himself and the patient during which he changes

is recording
his own attitude

he

to the patient and then measures and examines the type of responses the patient
has to this change.

�-3-

interest has

Much

been aroused in the newer drugs in psychiatry.

A

pre-

vious study at Iﬂllside Hospital had shown that small doses of reserpine had very

little effect

on our

controlled study
and the

patients.

When

purified reserpine

was undertaken by one of

internist, Dr.

was made

available, a

the resident physicians, Dr. Wachspress

Blumberg, to determine whether high doses of reserpine

eleviate anxiety in our patients. It was the impression of the observers
that the reserpine failed to relieve anxiety symptoms regardless of dosage and,

would

that it increased the depressive symptoms. These observations will
reported in a forthcoming issue of the Journal of the Hillside Heepital.

moreover,

be

In the biochemical program, under the direction of Dr. Harry Goldenberg,
three projects were undertaken. In one study of the effects of chlorpromazine,
Dr. Goldenberé

carried out fundamental studies

azine to under-Stand where and

how

this

on

drug might

the metabolism of chlorprcm-

act. In this study

he was

us-

ing special techniques that he had developed.

In a study of the effect of

some new drugs

in inducing disturbed behavior

like schizophrenia, Dr. Goldenberg had studied a variety of alkaloids
for their ability to affect a special enzyme system (serum cholinesterase) he
reported that the most powerful of the new compounds (hallucinogens) known as

which looks

to be a very potent enzyme inhibitor as well.
the development of a very refined technique so that he can

lysergic acid diethylamide
Most remarkable was

measure very minute

was

quantities of drugs in the body. Thirdly,

fundamental studies on the function of the

liver in the

he made some

metabolism of hormones.

(b) Psychiatric Staff :

(1) Ambivalence Study: This study was continued by Dr. 3. Tarachow,
H. Karin and

5. Freidman. In this study, an effort is

patients develop the kind of neurosis that they do.
psychologic
measured.

tests as well as

made

to understnad

Emphasis

is

made by

why some

special

clinical interview, the degree of ambivalence is
This study attempts to prove a hypothesis that there is a relation bea

�tween the

loss of a parent early in life and the type or neurosis that developes

in adulthood.
(2) Subculture 5tugy: Under the directian of Dr. R. Navarre, supervising
Graubert
D.
Dr.
of
(resident therapist),
psychiatrist, an interdisciplinary staff
Dr. H. Korin (psychology), Mr; A. Lurie (social service) and.Miss Z. Putter (group

activities)

have

studied the hospital environment as a therapeutic agent.

They

are emphasizing the fact that just coming to a hospital has therapeutic value.
Also, that there are

many

agencies at the hospital which affect a patients change,

besides the specific psychiatric treatment that they are receiving from the phy-

sicians. In a pilot study, they demonstrated the value of a diary of patients
activities in clarifying the communications between patient and therapist, and
also to explain unusual changes in patients behavior. The staff has devoted a
good part of its time to understanding some of the aspects in thenhospital which
motivate changes in the patient.
In September, following our preliminary exper-

(3) Chlogprcmazine Study:

iences with chlorpromazine, one of the newer psychiatric drugs, two of the res-

ident psychiatrists Drs.
a

potential substitute for insulin

coma

coma

undertook a study of

are divided into two groups in a randem fashion

insulin

It is

this drug as
therapy. Patients referred for insulin

R. Shaw and G. Gross,

coma

hoped

-

one receiving

routine

therapy; and the other receiving chlorpromazine for three months.

that this study will

make a

little bit

clearer the usefulness of this

new drug.

(h) Prognostic creteria in Electroshock Therapy:
PARAGRAPH REMAINS UNCHANGED

�-5(0)

Departmental Research Programs: In addition to the cooperation between

various hospital services, the following projects were in progress or jndere
taken during 1955.
(1) Medical Demrtment: In addition to the medical and physiologic
observations of the patients undergoing treatment with the newer drugs, reserb
pine and chlorpromazine, Dr. A. Blumberg has investigated a new test-the

test has

Funkenstein Test. This

been described as being able to

a patient will improve following electroshock or insulin

coma

tell

whether

treatment. There-

fore, to find out whether this is true at Hillside Hospital, Dr. Blumberg has
been seeing all the patients prior to physical treatments. The test is harms
less and so far, the results are not available. Dr. Blumberg also studied the

possibility that insulin
a number of hours.

He

dosage could be made smaller

showed, both by

clinical

if it were

and laboratory

divided over

studies, that

divided doses were not as good as single large dosages of insulin.
(2) Social Service: Student affiliates in Social Service have been
studying the inter-relations of various factors in patient care. For the most

part these studies relate the length of hospital stay, discharge evaluation,
fee paying, and.a follow-up of patients who were unsuitable for Hillside HOSpital. These studies show great promise because they help us understand the
social factors in mental illness.

�Department of Biochemistry

..............................

April 30, 1956

Progress Report, MarchpApril 1256
A.

Active Projects

1. Steroid Sulfate Conjugates

It

that high speed liver supernates catalyze sulfate
conjugation with the following sterols: deso corticosterone, androsterone,
and cholesterol, as well as dehydroisoandrosterone, estrone, and testosterone.
The underlined sterols conjugate most readily. Considering the various positions in which the hydroxyl functions are located in these molecules, it may be
concluded that the conjugase(s) is nonspecific and can act at C 17, 21, 3a, 38,
has been established

and on phenolic compounds.

least four steroid sulfates have been separated from urine using paper
chromatography. The major conjugate has been identified as dehydroisoandroster—
one sulfate. The other conjugates are under investigation.
At

2. Chlogpromazine Study

of a hitherto unidentified metabolite of chlorpromazine have been
isolated from 9 liters of a pooled urine collected on the wards. The compound
crystallizes in beautiful colorless needles, m.p. 190°C. It has been sent out
for an element analysis. We suspect it is chlorpromazine mercapturic acid; the
analysis will reveal whether our hunch is correct. Another metabolite has been
separated electrophoretically and is believed to be an hydroxy derivative.
270 mg.

B.

Projects Planned

to study the metabolism of mescaline this Summer, provided funds
are forthcoming from the Dazian Foundation (see below). The investigation
would throw light on the mode of detoxication of hallucinogens in the body and
facilitate follow~up work dealing with trace endogenous alkaloid excretion in
mental disease.
We

C

hope

. Funds

grant application was submitted to the Dazian Foundation fer personnel
support and for the purchase of a spectrofluorometer. We were infonned that
funds are not available for instrumentation, but that personnel coverage may
be forthcoming. Further information is not available at this time.
A

—

cc. to: Dr.

Fink
Dr. Jos. S.A. Miller
Max

H.

Goldenberg, Ph.D.

�HILLSIDE HOSPITAL
GLEN OAKS,

N.Y.

geptember h, 1956.
Mr. George W. Galinger
170 East 79 Street
New York, New York

Dear ﬁr. Galinger:

is
Facilities".

a copy of the "Recommendations for Expansion of Research Space
and
This data has been compiled by Dr. Max Fink, who prepared an
original outline on the basis of the needs of the Department of Neurophysiology
and Neuropsychiatry, and on the basis also of a discussion with myself and with
the heads of the Departments of medicine and Biochemistry. The present draft also
was discussed in some detail at a special meeting of the Research Committee held
on Tuesday, August 28th.

Enclosed

I understand that

will refer these outlines, which include the main
functional uses to which thisnnew building will be put, to the architect. The
current plans are based on three floors of space (a basement and two floors)
with an approximate area of hO' x 100‘ for each floar. The data includes the
expected expansion during the next few years of the current projects of the
Department of Neurophysiology, the set-up and inclusion of a clinical laboratory,
projected space for dynamic and psychological research. The building plan should
include the possibility of establishing 12-20 interviewing or psychotherapy rooms
which would be housed on the first floor, either at the beginning of construction
or sometime later. Such space would be valuable in offering a replacement for the
present psychotherapy rooms used for in-patient psychotherapy and housed currently
on

you

the second floor of the Elizabeth Sloman Lowenstein Clinic Building.

where

Our

it

present plans are to leave the research and biochemistry department
presently is located, but to move the clinical laboratory into the new

research facilities.

If there is

any other data or clarification that you would 11g; from.n§;
the Research Committee or Dr. Fink, please feel free to communicate With me.~
Yours

JSAl-‘I:1b

encl.

sincerely,

Joseph S.A.Miller, M.D.
Medical Director

�TO:

DR.

1v .. 8-31-56

J.S.A.Miller

gear-1: Max

Fink,

q§UBJECT:

RECOMMENDﬁTIONS F R EXPANSIOT OF RESEARCB;§?ACE.

M.D.

“u.-

following recommendations for the development of facilities for research
summarize the consensus of meetings held by me with my staff; Dr. Miller, Dr.
ReCohen
and
the
to
Blumberg;
Dr.
Mr.
as
presented
Dr.
Bachrach,
Goldenberg,
search Committee of the Medical Board, at its meeting August 28, 1956, and apBoard
of Directors.
the
committees
of
the
them
to
for
appropriate
referral
by
proved
The

I,

INTRODUCTION:

A.) Eggatiggi - The major share of the work in the recommended facilities
who
and
are in the acute
be
with
patients
the
chiefly
population,
will
in-patient
services. For this reason, the research building should be in close proximity,
recommended
Lowenstein
for consideraBuilding.
Sites
Morris
the
to
attached
or
a3
LowenThe
Morris
between
the
include
order
area
the
in
ofusefulness,
tion,
stein Building and 76th Avenue;.b) The smaller area lying between the Morris
Loqenstein and Elizabeth Sloman Lowenstein Buildings, the connecting tunnel and
76th Avenue; and c) The field east of the Morris Lowenstein Building, and north
of the Israel Strauss Pavilion.

W

3.) Facilities: 1.) In the development of the Research Service, during the past

two

Anamet
have
been
various
by
measures.
temporary
the
space.requirements
years,
needs
the
for
reasonable
well
work
expansion
as
the
as
of
present
program,
lysis
next five years, has resulted in the following recommendations. The character of
the research program, at present, is along the lines of experimental psychiatry
and neurophysiology. Such a program requires neurophysiology laboratory space,
sound recording rooms, and special laboratory equipment as the first objective.

logical expansion of the research program.as
outlined by the Research Committee, by the development of a section in Clinical
Psychodynamic Psychiatry, the next need is for facilities for interviewing
patients and relatives; offices for staff members; and space for the observation
of the psychoﬂierapeutic interview. The latter should be capable both for the
observation of single patients and, also, groups.
3.) For the cooperation of staff members, conference rooms are needed.
These should be so placed and equipped that much of the interaction between staff
members will occur in that area.
b.) Another need lies in facilities for the 2h-hour physiologic observation of patients. A four-bed unit, next to the thSiOlogy laboratories,
will serve both as a recovery room for physiologic studies, as well as an observation unit for physiologic and biochemical studies.
2.) Keeping in

mind the

5.) Another recommendation is with regard to the potential growth
and utilization of the medical library. During the past few months, in which
we have had a librarian on a full-time basis, space in the library has beCome

�-2 '9

overtaxed. A major portion of the librarian's time is devoted to work in
conjunction with the Research Service. It would be advisable that pro—
vision be made in the same area of research expansion for the medical
library. Facilities for an adequate reprint file, and facilities for
microfilm reading are recommended.

6.) For

time, the present separation of the Medical Clinic
(in.Morris Lowenstein Building), the X—ray laboratories (in the Littauer
Building), and the @linical Chemistry Laboratories (in the Sloman Lowenstein
Building), has made adequate service cumbersome. It is recommended that the
Clinical Chemistry Laboratory be relocated in the Research Building, in
close proximity to the physiologic observation ward.
some

With the moving of the present neurophysiology offices from their
present position, on the first floor of the Morris Lowenstein Building to
the Research Building, three rooms adjacent to the present Medical Clinic
will be vacated. It is recommended that these rooms be converted to the
x-ray, fluoroscopy and radio~isotope laboratories of the Department of
Medicine. With the Research Building attached or in proximity to the
Morris Lonenstein Building, the present separated facilities will be

in close proximity.

Relocation of the Clinical Chemistry Laboratory, from the Sloman Lowenstein to the Research Building, will free an additional 300 ft. of laboratory
space for the expansion of the Research Biochemistry Laboratories.

7.) In the history of the growth of this hospital, it is ap—
parent that the growth rapidly outstrips the projected allowances. In the
development of this building, it is recommended that provisions for expansion be provided in the initial designs, by ind.uding a foundation strong
enough for the addition of 100% of the Space; space for elevators; and
utility resources adequate for this type of expansion. Also storage space
rapidly outstrips the needs of the laboratories. For this reason, a recommendation is made that a basement storage, equal to 15% of the initial floor
area, be provided.

0.)

Name:

is inadvisable
'It"Laboratories"

to apply to this building or wing the

name

or "Experimental". To follow the traditions
"Research",
of the hospital, the name of a benefactor may he applied, or other non-

specific designation.
D.)

Research Beds:

item of research need is not recommended. That item is a
To
ward.
research
provide facilities for the continual observaspecial
tion of a large number of patients, separated, even in name only, from the
rest of the hospital group, would dilute to potentialities for the utilization of all other patients, as well as provide a psychologic barrier to
the experimental program. For the present, it is inadvisable to admit
One

patients for "research.".

�.3.
II.

.

GENERAL OUTIINE

0F SPACE RELOCATIQE:

Taking into account the available fUnds and the potentiality of additional Public Health Service support, a three-story building, approximately of
the size 100 ft. x no ft. is projected.

A.)

Basement: To include space for the following:

1.;
2.
3.)

h.)

Library stacks.
Storage Space.
Clinical Chemistry laboratory and offices.
Space for expansion of Chemistry Research laboratories.

include utilities,
enlarged to 5,000 sq. ft.).
(To

it

may

be advisable

to have the basement area

B.) Egret Floor:

l.)

waiting room - receptionist.

2. Medical library.
3. Large conference room.
Small
conference
room.
h.)
5. Offices and interviewing rooms - 12.

6.) Secretaryfs office and filing room.
C.) Second Floor:

1.)
2.)
3.)
h.)
5.)
6.)

III.

Neurophysiology laboratories - 2 - and central recording room.
Physiology observation ward.
Psychophysical laboratory.
Psychotherapy experimental laboratories - 2 - and central
sound recording room.
Four offices.
Small conference room.

SPECIFICATIOIB:

A.)‘.Taboratories:

l.)

Physiologic and Neurophysiologic Laboratory: Two rooms for
the simultaneous observation of two subjects should be placed about a central
third room, which will contain the physiologic recording equipment. In such a
system, single pieces of recording equipment can serve dual functions. Such rooms
should have independent facilities for temperature and humidity control. Initially,
the central equipment room will contain a single EEG unit; but space for a second
unit and a frequency analyzer should be allowed. The equipment room should contain
recording equipment capable of continuous, simultaneous observation of a number of
physiologic variables, such as blood pressure, pulse rate, respiratory rate, and
galvanic skin reflex. The position of these three rooms should be in close proximity to the physiologic observation ward.

a.) Location - Second floor.
b.) Approximate size: each experimental

sq. ft.,
the equipment room of 180 sq. ft., with an adjoining
smaller repair laboratory of 120 sq. ft.
room of 150

�.h.
c.) Relationship
access to

and access: Each experimental room to have
the phySiology ward; and to the equipment room.

Equipment room to have large glass port into experimental
room. Port to slide into wall to allow direct communication between equipment and experimental rooms.

d.) Special construction:
(1) Individual temperature and humidity control for
experimental rooms.
(2) Sliding port.
(3) Double walls and ceiling for sound-proofing.
(h) water piping and sink in each experimental room.

2.) - Physiological Observation War ‘ Attached to the physiological laboratory, there should be a four-bed observation unit. Such a unit should
be equipped for the 2b hour study of patients for biochemical and hormonal studies.
A nursing unit should be provided, as well as storage
space for the medical equipment needed to protect patients who are under investigation.

a.) Location: second floor.
800 sq. ft.
Size:
b.)
c. Relationship and access: access from the main hall and
offices; as well as the two physiology laboratories.
d.) Special construction:
(1) Two two-bed units.
(2) Two lavatcries and one shower.
(3) opace for storage of clothes of patients; and nursing
equipment.
(h) Nurses station of desk, storage space, reirigerator
and 3 1m 0
(5) Doors wide enough

for stretchers or bed.

3.) - Esychophysical Laboratory: This laboratory should be equipped
for visual and tactile studies. he room should have windows with built-in light-

proof shutters, and the doors should be such that complete darkness can be achieved.
For a visual laboratory, the length should be at least 2h to 26 feet. This room
should have individual temperature and humidity control.

a.) Location: second floor.
250
Size:
Length
sq.
ft.
b.)
and
c. Relationship

should be 2h
access: access to the

logy equipment room and an office.

d.) Special construction:
El) Light-proof shutters

ft.

hall, the

and doors.
2) Individual temperature and humidity

control.

physio—

�-5h.

Psychotherapy Experimental Laboratory:
Sound Recording Unit.

For the proper observation of patient and therapist, two experimental
rooms about a central observation equipment room, should be provided. These rooms
should be sound-proof and isolated, preferably at the end of a hall, away from traffic . Lighting should be provided in experimental rooms so that filming of the
procedure can be done without additional lights. The central equipment room should
contain sound recording equipment which can be controlled either remotely from inside
the observation room or from the equipment room itself. A port should be provided
from the equipment room into each of the experimental rooms for filming. It would be
advisable that at least one of the two experimental rooms be of sufficient size to
permit a group of six or eight patients to be under continuous observation. Observation will go on from the central equipment room through one-way vision.windows.
should be possible to accommodate a large
By adjustable, one-nay vision mirrors,
group of observers in the large experimental room, to study the procedures in the
smaller experimental room, while recording is accomplished for the separate recording

it

room.

a.) Location‘ second floor (this facility may be placed
the first floor in exchange for officeS.)
b.) Size: three rooms:
(1) Experimental room, large - ZhO sq. ft.

on

(é) Experimental room, small - 100 sq. ft.
(3) Recording-observation room 150 sq. ft.
0.) Relationship and Access:
(1) Both experimental rooms are to have one-way ports from
the recording room.
(2) The large experimental room should have a one-way port
into the small experimental room.
(3) Access to hall from each experimental room and recording
'

room.
(h) Access from recording room

into large experimental room.

d.) Special Construction:
(1) Double walls, ceiling for soundproofing.
(2) One-way mirrors as in (c)

each
into
filming
Special
room.
experimental
port
(3;
(A Cable connections from each experimental room to
recording room.
(5) Loudspeaker connections from small experimental room

to large.

(6) Microphone location and outlets placed in original wall

brackets and fixtures.

5, Clinical Laboratory:

Relocation of the Laboratories for Clinical Chemistry in close proximity to
the physiology ward is advisable. The Clinical Laboratories should heprovided with
adequate benches for routine and special test procedures. In View of the space
recommendation for Research Biochemical Laboratories, it is advisable to locate the
Chemical Laboratories in the basement, with access bv open stairway to the first
floor reception room.

a.) Location:

basement near

stairwell.

b.) Size: 750 sq. ft.
c.) Access: from hallway in basement; to first floor reception
room and second floor laboratories through stairwell and
elevator.

�u6u

d.) Special construction:
(1) High ceiling to allow for hanging pipes and "false"
ceiling.
(2)'work benches, sinks, electrical, compressed air, hot
and cold water, gas outlets according to detailed specifications of biochemist.
6. Allowance for Expansion of Research Biochemistry:
1500-2000
recommended
that
is
allowances
of
the
this
In
building, it
expansion.
biochemistry
future
be
for
basement
incomplete,
of
left
area
sq. ft.
Such area should have higher than average ceiling to allow for the installation
of necessary piping.
B.

foice

Space:

Individual work space for each of the members of the research service
inpsychiatry
in
experimental
The
requirement
staff
be
present
should
provided.
and
two
provision
psychologists,
clﬁles two psychiatrists, a neurophysiologist,
and
additional
psychologist.
an
of
a
physiologist
addition
the
by
for expansion
into
would
requirements
I
space
picture
Clinical
Psychiatry,
In the section for
(anthropologist
scientist
social
two
a
psychologists,
clude three psychiatrists,
of
staff
makes
This
professional
a
total
worker.
and
a social
or sociologist),
One
three
persons.
1h. In addition, the secretarial services will require
in
she
act
also
receptionist
as
a
can
such
that
be
in
a position
secretary should
secretarial
Additional
of
offices.
section
the
of
entrance
the
a waiting room at
adv
In
be
where
records
will
kept.
section
and
filing
help should be in an office
pre-docresearch
fellows,
for
be
aside
set
two
additional
officesashould
dition,
research
the
with
who
become
associated
medical
students
may
toral psychologists or
nrqgram.
be
the
on
to
first floor,
largely
is
office
Location:
space
a.)
with some on the second.

b.) Size:
1.) Offices of
2.)
3.)

c.)

Access

1.)

2.)
3.)

ft.

are recommended.
Sixteen are required for the fourteen provisional
personnel and two additions.
A waiting roomplSO sq. ft.
A large secretarial office for two secretaries and
filing space - 150 sq. ft.
and Relationship:
Twelve offices on the first floor, each with access to.
two
of
sets
leave
advisable
be
to
may
a hallway. It
offices with an inter-connecting door for the administration heads of the two psychiatric sections.
The reception room should be at the entrance to the
and
staircommand
the
hallway
through
and
access
unit
case with the basement, second floor and all offices.
The

10x12 or 120 sq.

secretarial office should

be located close to the

reception room.
d.) §pggial construction:
Double walls and ceiling to establish privacy for the
patients under observation.

�C.) - Conference

Room:

important element in any research unit is a place where various
A
conference room so
and
discuss
activities.
their
workers can get together
This
would
be
workers
most
the
of
be
would
for
ideal.
central
placed that it
would prevent the use of one office, the lihary or a laboratory for group disand
slides
films; blackThere
be
for
should
projecting
provisions
cussions.
boards for discussions; and space for exhibits of projects under study.
An

A

second small conference room should be provided for similar purpose on

the second floor.

a.) Location: first floor for large
small.

room; second

floor for

180 sq. ft. and 120 sq. ft.
Access and Relationship}
(1) The large room should have access from the

b.)Size:

c.)

library.

(2) The small room needs access only from the

hall

and

hall.

centrally located on floor.
d.) Special construction: facilities for slide-projection,
blackboards, and exhibition space allocated on two walls
Both should be

of the room.

D.)

- Medical Library!

present Medical Library contains one thousand volumes. In
Committee
has been aware that the library
the
the
Library
assessing
collection,
be
obtained
during
volumes
thousand
will
that
one
approximately
by
deficient
is
the next two years. In addition, considering the number of journals now in subadded
and
texts
are
that
number
neurologic
of
and
the
psychiatric
scription,
hundred
hundred
four
to
of
three
the
rate
at
of
a
the
expansion
library
annually,
volumes per year is anticipated. In addition, the Library Committee anticipates
For
and
these
micro-cards.
micro-film
both
the
use
recommending that
library
removed
of
the
is
location
library
the
the
that
present
well
fact
as
reasons, as
from the main activities of both the resident and research staffs, it is recommended that space for the library be provided; the Space to be divided into a
main reading room; small librarian’s work room; and library stacks.
The

a.) Location:
1.) The main reading

room

to be

on the

first floor, The

preferably near the entrance to the building.
librarian's work room to be off the main reading room.
2.) Library stacks to be in the basement, preferably
under the main library.

b.) Size:
c.)

Main reading room
Librarian work room
Basement stacks:

900 sq.
100 sq.
750 sq.

ft.
ft.
ft.

Access and Relationship: The main reading room to have
access from the hall and from the large conference room.
The work room is to come off the main.reading room. The
stacks to have access from the basement hallway.

�.8d.) Special construction: In the main reading room, bookcases for current books, journal racks for current
journals; special equipment for microfilm reading.
Also a mechanical dumb-waiter to connect library and
the stacks.
E.) -;§nimal Laboratories:
Present studies on steroid metabolism, the role of cholinesterase and
acetylcholine, and the need for some experimental work on the threshholds of convulsions,hsve made me feel that facilities for animal studies diould be provided.
The space presently allocated in the Sloman Lowenstein Building is satisfactory;
and part of the funds allocated for this expansion should be utilized to equip

that space.

F.)

~

Storage Space:

Storage space for patient records, laboratory data and equipment,
should be provided. Such space should be considered in the basement. Minimal
allocation of 500 sq. ft. for the laboratories is suggested.
G.) - Egpansion:
._
Allowance should be made in the planning of this building, for the
addition of a third and fourth floors. For this reason, an elevator well should be
included in the original designs, as well as boiler and other facilities with expansion possibilities to accommodate doubling the original ﬂoor space.
an

Furthermore, to accommodate laboratories on the basement floor,

extra-high ceiling is recommended.

Also, construction of the foundation and supporting structures
should be such as to accommodate the increase in floor space.

�ham”.

nus-an 1.
\

um.

um.

”a.
“it.
W 1.. Ida. nun.
mu

m
u:

hm,

mm.

may M.
Wm

m
mm

mm

loam-moan

WWW

Wt

W
W
mm
mrmmmm

w

WMﬂmmWW—Mtuwrtw

“Wauﬂ'mpmmmtummtdw

wwnamuupumautwmmuaawtotm

www.mm‘wm
(NW)M
WKIWMaWOWnM.dWW-ofm

Mgwmnmmammwmmm
ﬁmﬁanﬁhﬂdWWﬂrﬁuwﬂnﬂmdm-u
Mummmuwmmmmmmmn

morn-nan—

mwtmﬂnmmummwmmmummm
amm.wmtuuuammmmuuwotmmm
mush-Item.
mmumunmumpm. hummhrm»
mmmwsumm-mmww
M.Mawmmm,mmnwxmtw

m

4W¢mmmmwaamuwmmnummm

ammuatmmzsmmxmmwmmmm

�at.

mm,nr.umm,mupmmmmwtuummo

mmmWWmm-mmmmm
muumuuunabmrmmmmmuotomMW
mWﬂudWthMWWqum
MWm‘unumm-hxmmmwunmm
smtormpmamwmrmuummuu
oftthMmbugml,rwthmm,atth-W

Mmmby’mlmmmnuammwamms.

Wtdmmmunmmg.uvmmmrm

“cannula.
1)

mg
m. mu

5». My mum

th-

inner 0W

mm m
mm
mmimwimmummwm
mm: '.)mm¢pmmmmwummnmm
:..

mu of name «when.

Wmmmgmmwumanumbmmm
mmmmmammnnmnumimaw-

WW¢)WIWMWWM¢
Mﬂummnlefmub-ummw
muummmmmm.mmma
mmmmmamumamm. amen
mammummwmtwwmmmw
but]: “an,
with!“
wW
who
m33-99mm

W
ammwumwmmm
with

Dr.

mmmummm.m.mmmaumd
«mums mum-Mp

m'mpmwwwmum

�EWIM,BIIQWMMWWWW&amp;
dun-«mam. MWMtuumummmmh

mmwmmu.mum.uuwm
mmmmmmmummmuuaum

was
gonna
«an,
am
um.
'm' mm We
Wet-1mm.” m'mmmmtnmmpomtm; a:

mammmmtmummmmrmmu

mumut‘mwmmsmmamwmmm
for «m of
than «humans an mm a
mm.
mm
'Oc—uumﬁ
Mun
mm min
tho

WW
h‘mrmaehmmmwuwunm
on

MW.M,£Wam&amp;quwuunm,
mmaWwMu-Wuuummw.mdam
In

ammummmmmuwaunmm
mmuunrﬂmmnmmamw
“swam-mum”.
hawtdmum,mwrmmwwam
mmmuchmmmothauu-u
ammmm,umahmmmuanmw
It m
pa-mpucu.
u'

,3.
aw
1m,
M
mmmumwwmmxmmmrorwm

mum,

1-

mmmﬁ'wma MWuotmmﬂw-IW

uwgmmmmmmpmmmm.
mum-mwummmmnwptm.

m.mm..ammcammmawmmuwm

“MIMOIWMWMWRMVW

�mumnuumgmam,mmzmwwm
Wench-taunt. wmmnmmmimmra
Mum. mmummmewmudmmw
M
mmwempmuummw.
wmtmum¢wruwmmumummm
mama-untanmumnmmmwuiu
mwuummmmummnm;

mum
WWWWW”W¢WWG£W
MW

nmmumswdmwp

3)

amummmuummmmurummmm

Wu-mdmmmmmyauum-mm
Wish-Macadam

wmmuthothwuw.
mumﬁmﬁmmmueh-mmamwwm
autumn-um. mmmmwmmmmumum
Mrmdmmutemx ramgmmmamw
methunsctmmm,uMaW
mmmummwummw.
qudncqleudmmudwwmw
MIIMWMtatMofmﬁmm.‘l-Wm
thathﬂdethuuw-mofamW
uwummw,mmmmummgm.mm

WuMMWMﬂWﬂwm-IM'

mg
m
muamummuuwammmmmqnanwm.
a)

3;,

WV

,

,

u a 1mm

mmmdnmmnhmm,u.muuummtm

W. Mummm,rm m
hMﬂnMdemWMIWWy
a

to

�cps.

mmumunwwm.mmmnmmmb
minim.
Waughammnmuumwnmm

mmwmnummwm.uuurmuwma
www.mhmmwummmmmum-m

mdmanMWWh
mg

m
mm:
mm:wm.mwmmmmm.mam
5)

1:11 w

”5

In

an

as:

m

wwummwmmm1mmmwm
mmamwotwwmmvawpmm

�mammmmw.

11mm

”MS.
ll.
Illa.
luminary!“
nah!”
£0»... 5'

8.3.11.1“

1956.

mangromunumm

Mum: mu;
Wmmuommrm
«a 1mm”: sauna.
suntan.
mam

13W 8, 1956.

mm mum.

m mum
manuswu
1956.
158.
can.
1'
mm; mm, m We}...

3) Fink.

a.

m mu,

of mm

8. I»:

W

Wmommmw
«Wag muatmmmmumo:

Mikhandnmma

Wu.

luv

W

Ion, Duo-bu 5.

m 0-. at

2956.

\

_

W.
W
(W4
m.
W)
a.
0mm.»
Woman.
Harem
m.
m,
W.
«3.1..

um,

H. A...

0mm am»

Duondou and

’0

27.31. 1956.

1.:
5;:

an.
am.

a.

W4
mm
M
W

196-198, 1956,

magma;

umm Nation
at. tho
April
meutmc 3m,

nimnohundMH.»
am

mummung

or

5'11", 4.: Eamon-onto;
15. 1956.

in

mum u

we:

1956.
Juo
1.
an.
1.1... m.u.
to» to caucu-

m.

19: 2349. 1956.

in

ac

memmmwm
mama: mm,

ham-n

w

In!

alumnus
in

mumatmmm

mm,

Arch.

hard. a mum...

�«ﬂu

mama‘md
mm, Wntmmmmmmm

m) v3.1.3.2. I...

n)

Hahlhandm. a.»

1353.415. 1956.

Kuhn.

a. I...

an.

13)

I.- 1m

m.
“91.31., mi mm, In

me... n. mm.

mu.

a

mm
3.

we.»

m.

15)

nu.
'

'

1956.

«me
Imam.
13mm:
w
i.
W.

Pm-

ram-m7 Na. 1956.

“Mum.

nattbuhéandﬁb

mum. 4.1:). Wu.

39W.._1956. (van:
n. 3.: rumm- a!

J. mount... 31:

13)

we:
mm.
mum-manna“;

mean

3.1;...

WWW
m it.
Wen my,
at.

12)

1..

H.

1956.

a

a.

may, a. 3.).

and

(um

in

1.

am Mm, m.

man).

may,
396. 1956. (with
x. m Ian“, 3.).
“3.3.1.“ Wmmsmmmmmmum a.
(um. mm. 2.1.
mad-n.
mum up... 2: 290-301,
0.).
m.n.uammmr,a.i
mlmmofchmgumm
ml...
W.

R. I»: ‘Gantahuhucn

m,

a

sum

$215836

Prom-I,

A.

-

and

1956,

@.

16)

and

Sam u ham-«at in

1956.
11)

and
I.
am.
hunt.

mu. m

13)

um,

n.

68-03. 1956,
15.,

mm,

1...:

W.

hum...

"a”

m.

‘,‘~

a. m

5.

and

an",

W,
a.
a.

«Whammwrwmmamm
no»... 2:
51.17, 1956.

35;: 68-96.

man: «mm mm.” (*hntmﬁm').

(we: mummy,
A.

Cont.

"

K.

In
.1.

3.).

mun

3mm.

�October 3, 1956
I‘m‘iORflrﬂJm‘E

22; medical Affairs Committee
ESE:

Dr. Joseph S. A. Miller

Subject:

Report of Research Service, Second Year

-

To

September 1, 1956

At the request of the Medical Affairs Committee Chairman, I am sub.
mitting this report of the Research Service, describing its activity during its
second year. During this year, the staff has increased; we renewed our grants
with the U.5.J.H.S. and through the efforts of members of the Board of Directors,
received grants from the Kaufmann and Dazian Fbundations; and we were encouraged
by the results in our electroshock evaluation, reserpine and chlorpromazineinsulin, and anbivalence studies.

distressing feature of the year was the denigratration of the Research Service to separate services without a Director. As of September 1, 1956,
the Research Service is divided into a Section of Experimental Peychiatry (under
my direction); a Section of Clinical (Psychodynamic) Psychiatry, to be created;
a section of Biochemistry headed by Dr. H. Geldenberg; and a section of Internal
Medicine unfer Dr. Cohen's direction. 'Uhile there is some theoretical justification for such a development in a large institution, the development here has
led to a diapersicn of activities and a lack of adequate supervision of ongoing
One

activities.

high note at the end of this year has been the recommendation by
the Board of Directors that the Ford Foundation funds be allocated to relieving
the space problems of the Research tervice. Following this recommendation, and
after discussion with interested members of the hospital staff, I drew up a
basic program for the Research Building. This program was approved by the Research Committee of the Medical Board at its meeting on August 28, 1956, and is
now in the hands of the hospital architect.
A

A.

PROGREjs l§*9HGOING PROJECTS

l.

Electroshock.Evaluation.Proaec

: We

have completed

Electroshock Project # 3 which demonstrated the dependence of the rating of improvement following electroshock on the patient‘s personality; as well as elicited definite
measures of language changes which were correlated with improvement.

result of these studies, we instituted a "control" study, designed to validate our hypotheses. we are new in the midst of this study, which
will continue until spring, 1957.
As a

believe that we now understand the neurophysiologic, personality
and psychologic factors in electroshock therapy. Our data has both prognostic
and theoretical significance; and I plan to present a definitive report before
the American Psychiatric Association in may,.1957.
We

presented the language changes in electroshock to the American Psychopathological Association; the EEG changes to the Eastern LEG Society;
and will present a report entitled "Relation of Tests of Altered Brain Function
we have

�92-

to Behavioral Change lolloning Electroshock" to the Divisional A.P.A. meeting
in November, 1956. Reports of the memory changes, amobarbital test and EEG
changes in electroshock have already appeared in press.
T?

Meanwhile, as part of the resident training program, we have encouraged
a senior resident, Dr. Harold Esecover, to undertake a study of the type of psychotherapy which is best suited to different types of electroshock patients.

Furthermore, as a consequence of data presented at the American ELG
Society in June, I have devoted considerable time to an elucidation of the biochemical changes underlying electroshock. Such reading has led me to elaborate
a theory of the relationship of acetylcholine and cholinesterase in blood and
spinal fluid to electroshock results. nith the cooperation of Dr. Goldenberg,
this study will be added to the ongoing control electroshock study.

(a) Thorazine - Insulin:
The control study instituted
a year ago has continued with dramatic results. To date hS patients have been
studied, 22 on Thorazine and 23 on insulin. All were insulin coma condidates.
The thorazine group has demonstrated a higher improvement rate, and a lower
refusal and complication rate than the insulin patients. we are impressed by
this data and plan to complete the study by the end of the year, for presentation to the staff.
2. Drug Evaluation ﬁfudies:

(b) Reserpine: See "com.

pleted projects."

(c) Anectine- Electroshock:
Continuing our studies of paralytic agents in electroshock, we utilized a technic for administration of anectine devised by ur. William Karliner of the Attend.
ing staff. ’Ue found it most useful and safe and the results prompted us to
recommend the adoption of this technic for our unit.‘
This study, undertaken by Dr.
Tarachow, has been successful in
defining enmivalence in operational terms, i.e., by the tests used to measure
A summary of the two
years work is being presented to the staff on Octit.
ober 7th.

3. émhiyalence Study:

In addition to Dr. Tarachow, Dr. H. Korin has beenzactive in this
project; and recently, under the resident training program, a senior resident,
Dr. Stanley Friedman, has been assigned to the project.

h. Commlication Studies: Aided by the grant from the

Foundation, Dr. J. Jaffe
has devoted this year to developing ways of measuring the verbal interaction between doctor and patient. To do this, he records his interviews with patient
before and after periods in which he modifies his attitude to the patient. At
one time he says little, later he may re-enforce the patient's positive (or
negative) comments. By noting changes in language, rate of speech and in mood,
Dr. Jaffe has developed an index of communication change.
Kaufmann

�-3...

present, he is testing the validity of his scoring methods, and
plans to apply them to doctor-patient interviews in the near future.
At

In addition, with Dr. Kahn, 3r; Jaffe has explored the possibility of
other technics, as sentence completion tests and the reading of'a standard parab
graph under conditions of immediate feed-back as measures of changes in commun-

ication patterns.

5. Autonomic Reactivity: In his

initial studies,

Dr. Blum»

berg demonstrated that the class;
ification of patients according to their blood pressure response to mecholyl was
meaningful for our population. He then applied the test to the patients on the
reserpine study, and noted a consistent and persistent lowering of blood pressure
11th an a-..
increase in the mecholyl response Iuring the period of reserpine action.

w“.

Host significant, however, has been his studies of the electroshock
He
has studied 100 patients, and established celrelations of their mechgroup.
olyl reactivity with age, diagnosis, and therapeutic result. He concluded that
the mecholyl responsivity is directly related to age - and that this is the determining factor, more than the primary illness. He is describing his observations in the forthcoming Israel Strauss Volume of the Journals

a consequence of these studies, he has recommended, and the Research Committee has approved, a study of better ways of measuring blood pressure;
and a collaborative biochemical venture (with
Goldenberg) inDC the chanes
As

.

r.

in adrenalinenoradrenalin in the blood.

6. Biochemistgy: (a) Steroid Sulfate Coniugates: As indicated earlier, the steroid studies were
undertaken because these hormones are known to be implicated both in the physiological response to stress as well as in the sexual processes. Three impartand observations have been made in the Hillside Hospital Laboratory. First,
has been noted that the steroids, which are manufactured by the adrenal and
it
sex glands, are converted in the liver to water-soluble steroid sulfate conjugu
ates. Since this is one of the major forms whereby the sex hormones are elim»
inated from the body (via urine), the liver evidently plays an important role
in maintaining hormonal balance. A second discovery in this area was made by

comparin“ male and female rat liver activity. Female rat liver was found to be
remarkably active in conjugating the steroids, particularly the male hormnnes.
This means that the female animal possess- a regulatory device whereby she
maintains her ielaleness by preierentic.lly excreting the male hormone which,
incidentally, are present in both senes.

s

Finally, in the first group of 18 normal human
observed that urinary steroid sulfate output is
a) so::-linked, being tnice as high in males as
b) appears to be low in value for calm people,
whoare innately tense, excitable, prone to

controls

it has

been

in females, and
but rises in subjects
anxiety.

(b) Psvchotomimetic and szchotherapeutic
Dru;s“
: Thesecond preject in the laboratory involves a study of the possible role of hallucinogens in the development
of mental disease. It has been hypothesized that indole-like compounds, comparable to LSD, acrenochrome, or a.crenolutine may be formed in vivo as a result
of faulty metabolism and give rise to the $3.rmptoms commonly.associated with the
psychoses. Initial studies in Our laboratory have failed to detect these alkalw

,

�.u.
oidal products in patient's urine. Ebssibly this is due to a poor choice of
patients, since none were actively hallucinating.

it

of
the
the
most
proportion
that
greater
likely
appears
suSpected alkaloids would be excreted in changed form, and very likely via the
feces. r‘his is suggested by metabolic studies which we have carried out to
is administered in known quantity.
determine shat happens to mescaline when
unaccounted
The
5%
the
rest
is
urine.
in
unchanged
comes
about
through
Only
carbon
diobe
A
as
of
expired
course
carbon
residues
might
of
the
portion
for.
LSD
the
isotope
the
drug.
in
would
account
not
nitrogen
for
xide, but this
hence
excretion
the
of
in
drug
accumulation
gut,
this
indicate
studios in Jurope
studies
For
subsequent
these
reasons
our
here.
seems
also
feces
the
likely
in
However,

it

will involve isotopically—labelled hallucinogens to determine their ultimate
decould
more
then
we
intelligently
these
at
our
facts
disposal,
Having
fate.
termine the excretion of related compounds by psychotics.

(c) 92lorpromazine project; Studies on
the metabolism of chlorpromazine by
psychotics were reported earlier, at which time chlorpromazine, chlorpromazine
were
derivative
alkaloidal
and
unidentified
an
chromogen,
the
purple
sulf Xide,
demonstrated in urine. A sufficient quantity of the last compound could not be
and
the project
conventional
methods,
by
identification
from
for
urine
isolated
was held up in April pending receipt of a continuous flow electrophoresis unit.
This item has been on order for h months but has not yet come in.
7. Tactile Perception: Following the technics devised by
Dr, Bender, Dr. Green and myself,
we have, with U.S.P.H.S. support, set up studies of tactile perception using
simultaneous threshold electrical stimuli. Patients have been studied before
and during electroshock. To date, the data amply demonstrates that the phenom!
ena of extinction, displacement and confabulation, noted clinically in childin
all
elicited
readily
are
cerebral
with
dysfunction,
and
organic
ren
patients
induced
the
organ—
with
electroshock,
Furthermore,
threshold
levels.
at
subjects
ic cerebral changes exaggerate the perceptual errors in identifiable patterns.
This study is continuing and it is planned to present the data before the appropriate neurologic societies.
'

8. Prognostic EngiCatorg g: glectrgshgggg This study,

designed by Dr.
Karliner to elucidate the relation between presenting symptoms and the results
of electroshock therapy, is continuing. Forty-five patients have been studied,
and it is anticipated that the results will be determined in the coming weeks.

�.5.
B.

COMPLETED PROJECTS:

collaborative study of
the urinary steroid pattern
changes with electroshock has been discontinued. The initial findings demonstrated a significant alteration in the steroid patterns after electroshock in
improved patients. After studying these results, Dr. Hellman of the SKI and
I prepared a protocol of experimental drug administration designed to clarify
these findings.
1. Sloan Ketterinr Study:

The

presentation of this protocol to the Research Committee, it was
their recommendation that, despite the merits of the research design, it not be
approved for this hospital. The chief criticism was one of the risk to the pat.
Upon

ient of the procedure.

these studies could not be meaningfully carried out at the hospital, the program.has been transferred to Creedmcor State Hospital, where the
cooperation of the Medical Director and the Commissioner of Mental Hygiene of
New York has been assured.
As

2. subculture:

project has been discontinued following the initial reports of the study group.
hour observation of a patient, islaeing prepared
The

primary study, that of a 2h
for the Research Committee by Dr. R. Navarre.
The

3. Reserpine Egalyation:

The high-dose reserpine evaluation study was completed in

harsh. The results demonstrated a limited usefulness of this drug in our population. Hhile it occasionally controlled overactivity, it did not reduce the
symptom of anxiety; and did increase existing feelings and states of depression.
The results were reported in the April issue of the Journal and summarized for
the administrator and staff in memoranda and meetings in April. As a result,
reserpine was made part of the hospital formulary, with specific recommendations
for its limited use.
C

.

PROJECTS Fulﬁl-ED:

0*.“

1. Cerebral Reactivity: In the course of our studies cf
electroshock, we have been imp
pressed by the differences in brain responsivity to electroshock. Some patients
show a quick and intense change in behavior and on our tests; while others require more frequent treatments, higher voltages, etc. to induce any change.
u

developed a series of hypotheses which ascribe the differences
in reactivity to (a) biochemical differences in acetylcholine-cholinesterase
metabolism; (b) personality differences; and (c) generalized hypo-responsivity
to all stresses. For this purpose, we are now elaborating protocols to test
these hypotheses. As developed, they will be submitted to appropriate granting agencies for support.
we have

2. Autonomic Reactivity: See "Ongoing ProjectS."

�3. Digghemistrv: Following the present studies it is
planned to continue the studies of bio-

chemical changes in mental

steroifs sulfate excretion

illness along the following lines.
end

a) Comprehensive survey of urinary

its relation to anxiety.

b) Circulating steroid sulfate

levels in blood and spinal fluid.

c) Enzymic and fluorometric evaluation of alkaloids excreted in feces, with particular reference to patients
who are hallucinating.

Cholinesterase and acetylcholine
levels in spinal fluid of patients undergoing electroshock therapy (as part of
the electroshock evaluation study).
d)

D.

STAFF CHANGES

essential change during this period has been the reorganization
of the hospital‘s research activities. As of SepteMber, 1956, the Section of
Experimental Psychiatry, which is one of the surviving sections of the Research
Service, consists of the following:
The

Dr. N. Fink

D?,

-

J, Jaffe

Dr. R. Kahn
Dr. H. Karin
Dr. H. Green

Research Associate
Research Assistant~Psychiatry
Sr. Research Assistant-Psychology
Research Assistantufsychology
Research Assistant-Neurophysiology

and a full
(Mrs. H. Hosquera).

time secretary (Miss Gayle Iankel) and 2/5

-

time

EEG

technician

chief addition has been the addition of the EEG technician and
the part time appointment of Dr. M. Green. For the present, and until December
1957
As
of
January
somatic
the
1,
Green
ﬁlerapies.
Dr.
1956,
supervising
is
31,
he will devote all his time at Hillside to experimental work.
The

E.

FUNDS:

for 1956-57 have been received from the U.S.P.H.S. From the
National Institute of Mental Health, support for Dre. Kahn and Karin, in the
electroshock evaluation study, and for biochemical studies in the relation of
alkaloids to mental disease. Also, from the National Institute of Arthritis,
funds for the study of steroid sulphates, now used to support one research
Grants

chemist (Hrs. Ruth Foley).

Also, a small grant from the Dazian Foundation supported the summer
employment of a chemist; while the Kaufmann Foundation has been supporting the
studies of Dr. J. Jaffe.

�I are planning to submit an application
for support of the studies in cerebral reactivity; while Hrs. Blumberg and
Miller are submitting one for their studies in autonomic reactivity. Both reAt present, Dr. H. Green and

quests are to

go

to the U.S.P.H.S. before
F.

OTHER

November

1, 1956.

ACTIVITIES

l.

hedical Library: In mic-1955, the hospital obtaineo
the services of a part-time 1110(l0a1
librarian. By the year's end, it was apparent that the acecuate utilization
of our library required a full time librarian, anc as of March 1956, miss Rosalind Lazarus was apppointed. I was appointed chairman of the Library Committee,
and through our joint efiorts, the medical library was activated. A definitive
budget was prepareC and approved; rules for library use established; and more
recently, a 2000 volume addition to the library was recommended to bring this
library up to the standard as the most complete psychiatric library in the North
Shore area.
of the Journal of the Hillsidee“
2. Israel gtreuﬁg_folune
S
ervice
Research*
m&lt;.1d3ers
o;t
of
the
the
By
active
aith Dr.
cooperation
HosEital:
S. Tarachov 3 the volume was orranized and editec. It is new in the hence of
the printer and fill appear in November, 1956.
3

3.

Isreal Strauss hemorial Lecture:

The appointment

of

the second lecturer,

Dr. Hilliam Halamud, an” the detailed arrangements for the lecture were made
by the Committee headed by Dr. Bender, with the active cooperation of members
of the Research Service.

Research Builcing: Following the recommendation of
the Board of Directors, the members
of the Research Service were most active in planninf the new structure; describA.

The
and
the
for
architect.
relationships
descriptive
ing its uses;
establishing
first blueprints were submitted and after considerable discussion, were returned

with corrections. Continued liason with the architect is planned.

5. Resident Training: During the past year, members of
the Research Service gave bimonthly
seminars on recent advances in psychiatric research. Two special lectures were
arranged; and the local Research Conference of the Nassau Heuropsychiatric Society'nas held at Hillside Hospital.
Respectfully submitted,

Mfﬁgw

Fink, M.D.
Research Associate
(bxperimental Psychiatry)

Max

�ﬁ—

-

Methods
New
Reports
.For Evaluating Electroshock
Hosﬁpifali

W
.

.

thropies, is engaged in a number of investigations into the
basic causes and treatment of
mental ailments.
Dr. Maximilian Fink, research associate at Hillside,
said that electroshock actual1y Fan change the way the
braln functions, and that
these Changes can be observed
and measured by electroencePhalography.
The change' in the brain also,
shows itself in the response to
dru es, M
s cholo gical testin e
and the weakening of unpleasant memories.
The Hillside researchers report new and definite methods
for measuring the extent of
these changes. In the successfully treated electroshock patient, these brain changes
enable the person to maintain
better control over his emotions and behave more like a
normal person.

An' important clue to how'to identify patients less likely
electric shock therapy affects to benefit from electroshock
the human brain has been un- so that they can be treated
covered by researchers at Hill- earlier by other methods.
side Hospital, Glen Oaks, it The electrOShock developwas announced today.
ment was described in the Hillisannual
report
side
Hospital
is
It expected that this discovery will increase the ability sued todayvto select patients most likely Hillside, a non-profit mental
to benefit from electroshock. hospital affiliated with the
This development also will help Federation of Jewish Philan‘

ll

llIlllllllllllllllllllllllllllllllllllllllllllllllllllll

.

For Free. Fast Delivery
On These Money-Savers

MARSLANO'S

C‘d’

I

I

REpuhho 9-6162

2:;

E

lllllllllllllllll|lllllllllllllllllllllllllllllllll||lllllllllllllllllllllllllllllllllllll

‘

gnuIlllllllllllllllllllllllll

;

m

IllIllllllllllllllllIlllllllllllllllllllllIlllllllllllllllllllllllllIlll|llll|lllllI|llllIlll|lllllllllIllllllIIIll|llllllllllllllllllmt

CLARK 8. CLIFFORD

"Black label"

B LEN DED
'

,"

‘

.

"

j

.

I,

I

,

'

t
4

H I SKEY

'

.‘

FULL

,

.

,3

,

.

.

&amp;

A

QUART

5.00 Value!

This is our tastest seller because it's such
“ excellent quality at such a fabulously low
price . . . a full quart for less than the
cost of a fifth! 30% straight whiskies
4' 5' 6 and 7 years old; 70% grain he“.
"a! SP'“*" 8" Pr°°£
‘

i

V

‘

3 QUARTS—‘l 1.75 0 CASE or

12—4650

.

r

nolh§§§£§§ZXt°£atlt°2§§§i§ 31;:

HEAR-OLD "MITCHELL" MARYLAND

RYE

patient to benefit more readily
from psychotherapy administered during and after the

.

tcourse of electroshock.

.tElectroshock therapy will
continue to be used in the
treatment of depressions occurring in patients in the 30
-to 60-year age groups, and
also in younger schezophrenics
showing mainly excitement
or stupor as symptoms.
In issuing the report, Dr.
Joseph s. A. Miller, medical
director, also presented the
following data about the
year’s activities at the hospital.
Among 575 patients treated
during the year, the average
length of hospitalization was
176 days. Of_ these, 32 patients were admittﬂd t0 the
Israel Strauss Adolescent Pavilion, a facility for adolescent
girls; which was founded in
October, 1954. The out-patient
service treated 224 patients.

‘

——~—

�.

following day-

BERNETHY—Elnia 1... on October 30,
1956. wife of the late Richard 3.. beloved mother at Gertrude Tobias and
1Estelie Abcrnethy.
ervices Thursday, November lst. 8:30 P.
M. at the Clarence F. Simonson Funeral
gall-[EL 1119-04 Hillside avenue. Richmond
ntermeni‘ Friday. 1]. A. M. Maple Grove
Cemetery.lALICCHlO—Raifaele, on October 30. 1956.
of 101-28 99 stret, Ozone Park, beloved
husband of Marianna, dear father of
.Vincent and Florence. dear brother of
Carmine. also survived by eight grand—
l
children.
Leposmg at the Cassese .Funeral‘ Home,
Inc.. 101-07 101 avenue, Ozone Park.
Funeral Saturday, 9:15 A. M. Solemn
requiem high mass St. Mary Gate of
Heaven
aterment St. John’s Cemetery.
IHRISTENSEN—Chauncy J., on October 30,
1956, after a long illness, belov‘ed husband of Amelia.‘ devoted father of the
late Dorothea C. Herold. loving grandfather of Barbara and Richard Herold.
‘uneral from the Walter B. Cooke Funeral
Home. 158-14‘ Northern boulevard. Flushing L. 1. Friday, 3 P. M.
nterment Cedar Grove Cemetery.
URClo—Lena. on October 28. 1956, of
73-11 Metropolitan avenue. Middle Village. devoted wile of Carl. loving mother
oi Salvatore and Joseph.
Leposing at the Phillips Funeral Home.
79-02 Metropolitan avenue. Middle Village. Funeral Friday at 10 A. M. Solemu mass of requiem at st. Margaret's
R. C. Church at 10:30 A. M.
nterment st. John's Cemetery.
“NAN—Elizabeth. on October 29. 1956. beloved wife of William. mother oi Lulu
Harrington and Mary Mattoe; also survived by two great-grandchildren.
teposing at the Walsh Funerar Home.
94-08 118th street. Richmond Hill. Services Friday. 1 P. M.
nterment Mount Olivet Cemetery.
HEDGE—Catherine V.. of 585 Seneca avenue. Ridgewood. on October 30. 1956.-age
66 years, beloved mother of Walter.
Joseph, Madeline, Frances Connell, Mary
Jo. (Dolly) Connell. devoted sister of
Ellen O'Loughlin, also survived by four
grandchildren.
’uneral Saturday. 9 A. M. from Charles
Morton Funeral Home. 578 Onderdonk
avenue, Ridgewood. Solemn requiem mass
St. Brigid’s R. C. Church. 9:30 A. M. e
nterment St. John’s Cemetery.
lAY—Laurance X, Staff Sgt. U.S.A.F..
suddenly at Carlisle. Mass. on Saturday.
October 27, 1956. beloved husband of
Patricia A. (nee Joerger). devoted father
of Donna Patricia. Laurance and Kevin
Gay, dear son of Lorraine and Margaret
,Gay. loving brother of James. Jere.
Patricia Papscun.
Marguerite
Clay.
Jeanne-Marie Dalessandro. and the late
Lorraine Edwina Gay.
uneral from the Gleason Funeral Home.
10-25 150th street. Whitestone. N. Y.
on Friday. November 2nd. at 10:30 A. M.
Solemn requiem mass st. Luke’s R. C.
Church at 11 A. M.
utennent United States National Cemetery,
Pinelawn. L. I.
lATCH—Helen Frances. on October 29.
1956. beloved wife of the late Lewis.
devoted mother of Ruth E.
ervices at Walter B. Cooke Mineral Home.
goaOSrgdena avenue. Brooklyn, Wednesday,
'

,

.

'

,

:iterment Walkill Valley Cemetery. Walden.
New York.
lAVERLY—Joseph. of 60-27 78 avenue.
Ridgewood. on October 28. 1956. age 76
years. beloved father of Joseph. Jr..
Henry and Robert Haverly. Catherine
Anastasia. Lucy Corrado. Lillian Caverler. Marie Roethel: also survived by 28
grandchildren and nine great-grandchildren.
uneral Friday. 9:30 A. M. from Charles
Morton Funeral Home. 578 Onderddnk
avenue. Ridgewood. Solemn requiem mass.
10 A. M at st. Matthias R. C: Church.
nterment St. Charles Cemetery. Pinelawn.
Long Island.

sum":

non

Until 5:39

in «m... or

I. IL Satori-y

llliib‘S—Mai‘ie (nee Gademann). on Octoher 30, 1956. beloved wife of Edward
Heiss. devoted mother of Carol Elizabeth.
Nancy Edwina and Bruce Edward G.
Heiss..deai sister of Frances. of Regen—
burg, Germany, loving daughter of Reinhold and Francisca Koob of Munich.
Reposing at the Leo F. Kearns Funeral
Home. 61-40 Woodhaven boulevard at
Dry Harbor road, Rego Park. Funeral
Friday, 9:30 A. M. Solemn requiem mass
at our Lady of Perpetual Help R. C.
Church. Richmond Hill, 10 A. M.
Interment St. Charles Cemetery.
Please omit ﬂowers.
.,
..
,
HOFFMAN—Augusta E., on October 29,
1956. beloved mother of Fhillip Pflug,
dear grandmother of William Pflug,
sister of Anna Uphoff and William
Warnke.
Services. at the Stutzmann Funeral'Home,
224-39 Jamaica avenue. Queens Village,
L. I., on Thursday. 8 P. M. Funeral
Friday, 1:30 P. M.
Interment Lutheran Cemetery.
Jun—Wilhelmina M.. on October 30. 1956.
Beloved wife of Ernest. dear mother of
Jr.. and grandmother of Leona
Ergest
u .
SerVices at the Stutzmann Funeral Home.
224-39 Jamaica avenue. Queens Village.
L.‘ 1.. on Thursday. 8:30 PM. Funeral

a,_

~

Friday. 10

AM.

BAECH’I‘OLD—Emil Albert.‘on October 30.
1956. beloved husband of Anna '1‘. (nee

Pfei er). dear father of Mrs. Ruth H.
Will and Elmer A. Baechtold. brother
01 Christian A. and Walter 0. Baechotld.
also survived by two grandchildren.
Reposing ,at the Floral Park Chapel of
Thomas F. Dalton. 29 Atlantic avenue.
Religious serVices Thursday. 8 P. M.
followed by Masonic services, Eureka
Lodge No. 243, F. a. A. M.. Machinists
Lodge, F. 8: A. M'.,
Interment Friday, 2 P. M._ Lutheran
Cemetery.
.

BURNS—Samuel J., of 84 New York avenue.
Baldwin. formerly of Brooklyn, on October
29, 1956, son of the late George J: Alice
O’Keefe Burns; dear brother
of. Belle

Burns.
Reposing at the Fullerton Funeral Home,
131
Merrick road. Baldwm. Solemn
R. C.
Eeguiegl Firiiiaiss €5.00C1Arilatopher'l
urc
r ay :
.
.
2312
Third Street.
KOLLlNS—John S., of
East Meadow, L. I.. suddenly, on Monday, October 29 1956 in his 45th Year.
beloved husband of Angela. devoted
ratherr of Adrienne. dear brother of Mrs.
Bertha Bowers, Stanley and Tony
Kollins.
R'posing at‘ the Catholic Chapel. 2100 3e11more avenue, Bellmore. L. I.
Notice of funeral later.
Under direction of John J. Mlchalek.
'

Interment Maple Grove Memorial Park.
KENNEDY—Thomas F.. 116-30 221 street,
FUNERAL HOME.
BELMORE
Cambria Heights, L. .I. Beloved husband
of Ethel (nee Huxley), father of Eileen CAROW—Edward, of Malverne. suddenly
Devlin. Kathleen Wilson.» Ethel Albert.
October 30. 1956. beloved
brother of Loretta McGivney. Adeline on Tuesday.
of Rayhusband of Jennie. dear father
Doyle.. Ethel Casey. Seven grandchildren.
'
of Dorothy Koenig and
Reposing at the Funeral Home of Lawrence mond. brother survived
by four grand"
Eldred. also
D. Rouse Inc. 191.02 Linden boulevard,
children,
St. Albans. L. I. Solemn requiem mass. Reposing
at the Flinch a. Bruns Funeral
.Friday. 10 A.M.. Sacred Heart R.C. Home. 34
Hempstead avenue. Lynbrook.
Church. Cambria Heights. L. I.
Interment st. John's Cemetery. Middle The family will receive friends between
the hours of 3 to 5 P. M. 8: 7:30 to
Village. L. I.
10 P. ,M. Masonic services on Thursday.
[ALLY—Philip E., on October 27. 156. 8:30 P. M. Religious services on Friday.
dea; uncle of William F. Lawkins.
10 A. M.
Funeral from the Queens Village Chapel Interment
Knolls Memorial Park.
Nassau
at Thomas M. Quinn a Sons, 214-65 Port Washington.
Jamaica. avenue. Queens Village. L. I..‘
on Friday, 9:30 A. M. Solemn requiem FLORENCE—John W.. on October 30. 1956.
ﬁes: Olﬁ Lady of Lourdes R. C. Church, of 315 Locust avenue. Unlondale. Beloved
husband of Frances. and loving father
Interment St. John’s Cemetery.
of John W. Jr.. Jeanne and Diane. SurLOMBARDO—Teresa
vived by one brother and two sisters.
(Rommanelli) ,
on
October 29, 1956, beloved wife of Angelo Reposing at the Martin Funeral Home. 412
Willis avenue. ,Williston Park. Solemn
Lombardo, devoted mother of Mary
requiem mass at St. Martha R.C. Church
Strollo, Anne Carro, Sue Cremona, John
Frank and Edmund Lombardo, dear sis- on Friday. 10 A.M.
ter of Rafiaela Genovese and Carmela Interment Holy.,Rood Cemetery.
Impci'ato, also survived by seven grand~
children.
KOLLINS—John S.. of 2312 {rm (1 street.
Reposing at the Leo F. Kearns Funeral
East Meadow, L.I.. suddenly n MonHome, 103-33 Lefierts boulevard near
day, October 29, 1956. in his 45th year.
Liberty avenue. Richmond Hil Funeral Beloved husband of Angela. devoted
Thursday. 10 A. M. Seryice at the father of Mrs. Sophie Kincinski AdriChristian Pentacostal Church 'of God, enne, dear brother of Mrs. Bertha Bowers.
Mrs. Ann Mankowskl. Stanley and Tony
10:30 A. M.
Also surviving are two
Interment “The Evergreensz”
Kalirdohlisllgi
en.
ran c
._
Regiaosing
1956.
29
BellOctober
2100
BeMAYER—Bertha. on
Catholic Chapel.
the
at
loved wrfe of Otto Mayer, active member
Bellmore. L. 1. Salem
avenue.
more
‘
of Ridgewood Heights Maenner Cbor.
high requiem mass on Friday Noyember
Memorial services at Buss-Avenius Funeral
2 at 11:15 A.M. at St. Rap leis R.C.
Home. 63-32 Forest avenue.
gewood.
Newbrldge road. East Meadow.
Church.
L. 1.. Wednesday. 8:30 P.
Funeral L. I.
Thursday, 11 AM.
Mt. Calvary Cemetery, Linden.
Inger-merit
Cremation Fresh Pond.
ew ersey.
Under direction of John J. Michalek
MEYER—George F., on Tuesday. October l
BELLMORE FUNERAL HOME
30. 1956. of 111~21 198 street. st. Albana.
L. I. Beloved husband of Florence Meyer.
149 w. Stanton
of
E.
and devoted father of Mrs. Florence McCRAI
Victoria
Combes. grandfather of Dorothy Combes. ,avenueltulaaldwin, on Monday. October 29.
SerVices at the Fairchild Chapel, 220-05
1956. beloved wife of Morton C. McHillside avenue. Queens Village on FriGraime; devoted mother of Douglaomnd
Kenneth: dear daughter of Eugenie and
_day at 8 PM.
Victor Fernandez.
NIGRl—Lucia. beloved mother of Edmund Reposlng
Funeral
Brother:
Weigand
at
oi”
the
ngl‘l
Nigrl Furniture House.
Home. 24 South Grand avenue, Baldwin.
Orstehnydia Mancino: in Italy. Gaetano. Services Wednesday. 8:30 P.M.
Elena. Dorotea, Teresna and Nicoletta. Interment Thursday. Milford Cemetery.
Reposmg at Robert Giordano Funeral Milford Connecticut.
Home. 2346 Pacific street. Brooklyn un-.
til Friday, 9:30 A. M. solemn requiem QUAGLIATo—Anita
Hill). on October
(nee
Our
of
Lady
Loretta
Church.
29. 1956. of 678 Franklin avenue. Massaf0“: alt/I
pequa. L. I. beloved wife of Ferdinando:
Interment St. John's Cemetery.
devoted mother of Mrs. Lucille Rubusto.
oasrﬁtLE—Aiwma. on-October 28, 1956. Mrs. Blanche Burns, Richard, Joseph.
Services Wednesday. October Slst. at and Ferdinand Quagliato; dear sister of
8 P. M. at the Clarence F. Simonson
Mrs. Rose Brandt. Mrs. Isabelle Snediker
Funeral Iﬂome, 119-04 Hillside
and William Hill; also: survived h- “-1-“
‘

___.__,_______———.
-

-

_

.

.

.

‘

�Wham”.

”mi”:
mashing”.
mm”;

'

WW

W
W
W

wmummwmmmw,w
WWatt-bMMuﬁ-mtdw
ww.nmmmumwm¢t:wum

mammwmm
(W)M
murmugmmmdmmam

wwummawmmm
mamam'mmmwmnmu

Whuumumwmmu mam

“anmmmmthWu-m
«mama-ammuuwmmuworbw

WW‘OM

.

manuumnbuwm. ramming-ma.
mamammaum.mmmm~p

mmmwummww
m
mummmcmpmwum.

Awuwmmwamummnmam

Wmuammmmmmmmm

�mmmmdmwmtmmmm
«mmummmmm.umm
memmmwuwwacmma.
Warm». mmuumummhmrw»

”

'maum

mmmummaawm. symmmuummu.mmmmmmm

ummwwmwmm
arm
Mcumumwmmmmumm

mmummmwwumum

�aW-uwwmmumwwmmb
mans-hem
Mmmumumomw

mmmmmmmnmmmnm
ma*m*mmw$nmmm.wm

Warm.“
mammmuanmumwmmmm
“W“W‘IMMWMCIMWMWW
twmdwmrm. ”Manama
WWWWWWnuWM‘
haWMdthWWhM
MM.MM&amp;m¢nManu-m.
mummmmmmmm~
wmawwmmnmmmmum
h
«wwnmmmmmwdmmmm
Wﬁﬁwgmwmdww
'mmnmuumm-

WWmmdMﬂwth

u.m&amp;amm.wsw:mmmtm

mmmuumsmmmmammuma
ammmumummnunmw
hum-1mm
mmmpummm,m.m

mmuawmwmmmmm-mm
mmumm‘ umuuwmmmu
«mammammmmmg
mummwamwwum. wmm’u.
mammawww.mummnmmmmum.
.v

ummewummW-m

�mummgmam,mmmwwm
Manama-nus. wwnm‘uwmm
Mum“. mmmmmwméammp
mu
achw-Mummw.
wmmmummmmumuumm

ﬁthuquﬂmnﬂWﬁﬁ
Wanton-MMMnmmMMA-ath
mwuu‘mwmm-mum

“gm:
.wwmvmwbymmwm
hum
ammunwmm-mw
3)

ammuhswumw

thumm.mmumammh
wwwormmmum mun-Mum

mdaumiwmmmmumamwmm
newsman)... mmumm~mnmnmm
erﬁmﬁmdaMrmwmuandmu

mmnmmunadmm.umum
mmuumumwwm
mmmmmmumww
sumo-m
mmmmuwmamm.
atmmwmmamw.uzmuouma.w

uwwmw.mmmm¢mmywmm

Wg,,,
mnsmummwammuommmm
-'
mmmuammmuuummmh
mapmummmmmu
mm.
unauumnmmmuuwm.
«whammmamuwwm
human
I.)

�a6.

”Wanna-www.mumummm
mmwmmmnumn-wumm
mmwhmmmyuucumumma
mwmmmuwummmmmmm
wdwpmummmw. h m if m

x

m
”1W8!
www.mmmmwnm‘mdw
Wyammmmmmww
-mwmwuwammumwm
S)

"I

�"1)

mammmmmu.m

mm
Wuxiamnm

a) ml.l..u.n.n.mxmi.n.s
’3)
h)

5)

v

/

mmgmunmm

‘Wummmmmmmmu
mmwmmmwwmmm.
W3.1956.

Wmnsmutmmumw
maximum nu
153.1956.
mm.
5:
mm
W...

W, Wuwm

v"

www.muuumm

umanmnmmummam
W.M%WS.I956G

V/

mmaWummm
Wmmamwmm,mnhm

9mm“:

v’

“317431.356.

meammumm.
um. a. mo.

”mun“
7)

”so.

mm
Wmmnumwmmw.m

m.

M arm-mm 11mm: a: scum-mm in

anmmm
mmnwmwwwmmh
15.1956.

a1m.n.n.uuu,u.a

"”
’

man-1.1956.

9}

mat-acme:
mhknm.u.mwhm

v

mumwumtm.mam.
museum.

�*7.
:9)

Mahmunnumumm Walnut-«Annual:

WthMWE-um.
“15.19%.

Km

Miriam

'memammmgm
M
mnmumwmmwmm
m.»u.nn,n.mmmn.l.a.o

mm.w..mmmm.
'11) Mun-“www.mc
mumwamrmm
.

wm$ummmmmw.wu
mom
at 39W.
1956.

13)

1h)

16)

and

a. lo).

a.mmmmm-m.nss.(uumt.mmh

Wannammmmm.ncm
(mm
t. nun-nu, 3.).
mam Wmmmwummmmu;

Imam

W

A.

‘

mum..gamm.mcumm,nu.um.
6.0.).
mun-mammal mammals-w

umummummw.m.wm /
‘

X956.-

m

maul-mum
mmmw'cﬁmmt).
/
Man. as 68-”.1956. (um mm, a.mm,x.n.).
Wu..m.h¢~mx.mmsu.mmmm
H.

m)

I

mum mumamnmumm.m.
396. 3.956.

15)

(um mummy. m a.

.

«Whammwm‘mmnmma.mmm
Wpiiﬂ'ﬂgm

�,v .7. vie .._.,.._..,-,_

"W

’3"“W". m.

..

a":r-x—z

var

Aﬁv

DCK

TERA?!

or
one
administered
third
in
electroshock
therapy
we
in previous years
the adult patients. For the meet pert, it was prescribed for peuente in the
As

forties

and

fifties

who

electroshock was used

manifested depressive symptoms.

(21:

To

a lesser extent,

patients) in schisophrenic patients to modify

ms-

active, essenltin er delusional behavior.
the
studies
the
of
earlier
results
of
that
was
in this group pstients
It
Psychietry were applied and extended. Patients
of the Departmnt or

W

received
series
a
the
electroshock
psychiatrist
by
supervising
for
mmmded
encberbital
test
These
included
electroencepmlogren,
of neurophysiologic tests.

for organic brain disease,

and pemeptusl

tests,

tactile. During
per week, the tests were

both visual and

the course of treatmentﬁhieh ms adminstered three times

periodically repeated.
with clinical

Based upon changes

"alustiens

in these mumplwsiologic tests ceabined

psMiatx-ist, the extent
«amines; In these instances in which the neuro-

by the resident and supervising

of electroshock tmmpy was

treatment
bed
been
not
behavior
obtrdned,
in
alteration
for
basis
physiologie
intensively.
week
and
acre
occasionally
times
modified
five
to
per
regimes were
Ch

this basis, the usual com-es of

tmmnt m

the patients meshing between 6 me lo

batsmen 11 and 19 with

m

percent of the patients received more than 20

of

mtients rescind less
an incomplete series. Twenty-five
treehnen’os .. The number of tmtnnnts

tmtmsnts.

than 5 treatments, which in each instmee

10%

Four

and
to
reference
with
diswosie
therapy
results
at
in chart
is
condition at time at discharge is seen in chart #9.
The original studies relating the alteration in brain function indueed by
electroshock to the short term clinical results, were confirmed in this series
amounts-sud
of
and
his
Fink
staff
Dr.
where
study.
of patients in a predictive
shown

#10 and the

I

that only these patients in

when

alteration in the electroencephalogram and

�#2

mbarbikl taste

had bean

to warrant the rating of
a umber

031‘

reports have

mud,

had

mm

D.

clung. in behavior sufficient

uprated or momma. A: a Insult. of these studies,
been presented before nation]. psychiatric societies.
much

�#3

During 1953 there had been considerable experience

at the hospital

with

of the newer chemotherapeutic agents, chlorprousine and reserpine. It
decided to evaluate ohlorpronasim as a potential substitute for insulin

tVo

was

em

therapy.

The

use of chlorpronnzine we suggested by the many reports

thst

mlcrpronasinc had been successful in schisophrenio psychoses. Also, the specie;
report of the Medical Board noting the course of patients disohnrged

roam

dmonstnted that the poorest long tom results were found in the
insulin cone population. For this reason, a control study was instituted.
Beginning Septenber, 1955, and continuing until Deomber 31, 1956, :11 patients
in

1950 had

referred for insulin

coma

therapy by the supervising psychintriste were divided

into tee groups: one group received insulin coma therapy in the established
doses
received
in
and
second
therapy
the
urge
chlorprmsine
group
newer;
over a four month period.

Insulin

coma

therapy was given for a course of 50 comes

in most instances.

treatedlcsees.
The results
Chart #llxoﬂects the number of cones in insulin
of insulin some therapy is noted in Chart #12 and it is seen that of the 15
much
of
inproved or recovered.
were
a
four
rating
given
patients ,.
In the patients who were given chlorpronesine, dosage ranged betueen

daily with a

800
600
of
milligrams.
to
mge
Treatment was oontimed for a period or shut four months. In this group

200

and 3600 tailligrsms

of patients,

who were

median

unselected except for having been candidates for insulin

of
the
insulin
to
that
were
of
improvement
equivalent
the
ratings
moment,
cone population. 01' 21: patients discharged during 1956, one was discharged as
riftem
miinprored.
and
much
as
improved,
as
em
recovered, three as
inpmd,

some

Guptring the complication rates of both treatments, it was noted that prolonged
of
nine
tones
and
in
were
insulin
resis
cmplications
reactions
ledondary
ems,
the insulin some patients. Wtansion airfioient to cause fainting and severe

demtitis

were complications

in five of the chlorpronasine group. Agitation

�#h

and penis, seizures and
numbers

It

refusal of further therapy were seen in muivalent

of patients in both groups.
was the opinion of the numbers of the Deparhuent of

peydtiatry

ami

Manual

the resident physicians, Doétora Robert Shaw, George Gross

Mean

for this study, that in
to insulin coma therapy, chlorpromasine was safer, easier to ldminater, more
controllable in its effects, and had fewer aid: effects. It was their
recommendation that chlorpmmine therapy would be warranted as the initial

and Fred Coleman, who had hem responsible

treatment for patients in the younger age group

who were

suffering with

schizophrenic disorders. In such cmditions, they anticipated that chlorpromuino
would be most

behavior.

effective in modifying overactive, as saultive and delusional

�#5

cogg sagx rmmr
01'

the ﬁfteen patients treated by insulin com therapy, the modification

of behavior was inadequate in ﬁve, loading to a
be combined with insulin come.

nemudntion

that. electroshock

of these, four patients were suffering

fm a

schizophrenic disorder and one from a manic-depressive
not one of the patients were mach improved

illness. In each instance,
or recovered after combined mutant.

Similarly, there were four patients or the insulin com group who had had metroshock therapy either prior to the insulin com or subsequent to the insulin con

moment.

Here

too, the mtinga or immemnt were in the lower
4

two

categories.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67264">
                <text>Progress and annual reports; research activities (folder title).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67265">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67266">
                <text>mfp-03-01-001-0-004</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67267">
                <text>1956</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67268">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67269">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1954-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67270">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67271">
                <text>Perceptual Changes Induced by Drugs and Electroshock - Progress Report; Research Activities - Annual report; Letters; Annual Reports - Department of Experimental Psychiatry; Newspaper clipping, Hospital reports new methods for evaluating electroshock, Long Island Daily Press, 1956-11-31; </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67272">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67273">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80929">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87490">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94051">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100612">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6728" public="1" featured="0">
    <fileContainer>
      <file fileId="3784">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/c825cf38265f35eaf923d1fdede27f5a.pdf</src>
        <authentication>8e37b7104043290b0428aed652df73e2</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104410">
                    <text>Manhasseit Medical Center Hospital
4CZ54@/¢/;ﬁé€rn.2%éui%§C}¢%;lﬂéd536/ c&lt;lgeyi

N ]E W Y O R K

PEARL A.KLICK
ADMINISTRATOR

35K

TELEPHONE

MANHASSET

7-4000

1:

"VINE

February 25, 1957
Dear Doctor:

Quarterly Medical Staff Meeting of the Manhasset Medical Center
Hospital will be held on Thursday, March 7, 1957, at 8:h5 P.M.,
promptly at THE ALLISON, 1583 Northern Boulevard, almost directly
opposite the hospital.

The

PART

faRT

1. Review and analysis of Clinical werk in the Surgical and
Medical Sections for the month of December 1956, and the
months of January, February 1957 inclusive.

2.

A.

Surgical Section - Ralph S. Emerson, M.D., Chairman

B.

Medical Section

-

3

‘§~
“

Lawrence S. Kryle, M.D., Chairman

Tissue Committee Report - Howard L. walker, M.D., Chairman

SCIENTIFIC

PROGRAM

-

Arnold G. Blumberg, M.D., Chairman

"THE TRANQUILIZERS IN PSYCHIATRIC PRACTICE
AND THEIR APPLICATION TO GENERAL PRACTICE."

Dr. Maximilian Fink
Director of Research in Experimental Psychiatry
Hillside Hospital, Glen Oaks, N. Y.
COLLNTION.

Respectfully yours,
John G. Connell, M.D.
President - Medical Board

Telephone number

The
MA 0

Allison is
7"558’4v

at

Harry H. Abrahams, M.D.
Secretary - Medical Board

~ﬁg

��mmmwm,wmpmmmmmmmm
at then obs-mum, w an
both» that

m.
WW
WMMwnwmmoma-pmiwhcwnmmw
Mx

«811.1%

unit-(unmask

mmmumtmwumatmimummmmm

”demhmlm,wmm
mummmmmmmaMaummmmwm
m
Intact.
WWWuloatmthm.
and

Minimum new

'4»

obmﬂw,

We!» afresh.

mmm»mwmmmt¢mhumo£mpmuyotmwb
mm and than mm). mm. m: max-minim at than m mt:
dWarinwclm,thntwhu-Wtomuswwmﬂd~
mwhmmmpemﬂmwhopawnmmwhmmml
behavior me:- that special

mum d um

brain {motion (we Seats.“ 6).

WWanhnwhduwmamtatolmkawm

mmwammmmmmmmmtdmzmmntmt.
shock a a manic mutant. Salaam” mug" in mm Maﬁa which

metro-v

mm

two
than
than
of
lengthlarva-yang
many
him,
mm.
persist
than
Mending
in
way:
his
to
almond!
wfamt
patent
mums

mmaponomiw.
M13,

am
whammpomnmummmmwm

his therapist, an! to other mum“.

mthrMha

when

M

oﬁurmple,musammutMnforhintoMo-nm,mmw
in
tutu
mum.
it
mam, mum tulinaorwnhomisut

by

an

mth

bother

muty

to

Man

with othon.

ma
£106th thaw

“Mammummtfortwmtmotwmma
'

_

studio: at

Mama.

m not“

mt

«that

:Inth-ooumurthau

32:”:me

had

am

that

mmwnwumummnmmmnmmrm,w

��«In

WW‘

AathtMpnviam momm
W338 in the mm at inﬂiﬂéml MW in «mm. Mﬂty Ml
.

ummmwmummekam. wmamuamum
mammnmammlma. nmlamamwuu

W

dummiom W

whom.
manummuumuhmormmmmuméapmrmwm
mt: or

or

induced by

mammm: Wmhhymmlﬁuut marmmmw,wuw
Wmuhtiam the,

response to

tin

«mm mama to 3551mm m boa

umwwmmummmm(mmm Win
In, itumuipum
thutmlmntarywmmmmsumhm

mmmuutnnmmmMmpmummum,mmtm

”munm'mummmw.
Gum
the
the
alumna-hip
mm «Mmmad
anmmmmamlmmummmnmwmw
mat of 01
tramway. we may in mum."
concurrently, Dr.

~

--

has

-

w

na-

3.

am, hu

mm

and ten

W
3.“

4

aw, under as:

013an

have

a: Dr. 31am mmbut: museum hero-m tho In

Mmmmmmmmm manmummmmmu

ammmchunamammmma‘nmsmwmawmm

chum.

'

4* m:
mmwmxmmmmmmmmmuor
.

,

magma...

mmnwmmuwummmmamwm
maxim/:31“.
hmm,‘§9‘pﬁmunhmdtwmmmm
1957.

ﬂammmmnmwmmmmwmmw
«Mammal!»
It
cmluim
”was

M.

«human
”mom” ﬂammable Warpatumulmmmtham.
mm

that.

as

�.5.

mm m

be
the
for
diseharge
to
better for the claim-pren—
ratings
team
uino group than for tho
um group. H. emclmd that, in
to 111M131: new therapy, ehloxpmine m mar, easier to
aura
contmlhbla in its effects. and had fmr $5.60 attach. We 3190 amended
tint n9 evidame had appear“ in the fiftm math: a! the study that. either
than” had altered thy basic. schiaaphmie process, nor did my real that either
tom of therapy had a greater speciﬁcity far schizophnnie illnesses. At the
concluaim of the stndy, the ladies). Biroctur placed
in tin for»

ulary and

a

um

13¢th
a.

its use

13m

IV

smut:

mm”,

the maidont staff.

W:

@10me

During this” period Dr. Green has

evaluﬂd

magma, for its ability to bring out
debuts in brain mum. The "port. at his findings mm meant-ad at. the
aid-winter muting of the Eutem lasaeiation of Bleetroancephalographam.
dials :6. Pro «aka
8:
It. is anticipated that tha mark now in prams: in we
will continue for the remainder of the year. The aleetmshock evaluation
study will be cmletod this spring and the next few months will ha spent in
a new agent in ulcetrooncepmlographg,

M

'

«muting

biannual: chained and writing the reports. As indicated
in the ongoing pmgraaa not”, a. War of development: have grown out. at these
studies and it. is anticipated that than will he immoramd in the mum n—
the

W

aeamh pmgrlm

1.
been

«aloud by

Diffomma 3.3; Wen}. Romam
pmtocol has
Dr. “a: Franck, which incorporates than pmblem or panama
11

dictating individual rosponsivity to abattoshoek. By entertaining than
subject‘ 8 patterns of perception in awfully devolopod arianhatim and visual

1uy

tasks, in hope to demonstrate

O.

“hump

batman: those pater-nu and the

bov-

both
havioral
under the. special conditim of altered brain funcuun.
and the general condition of hospitalisation and plywothompy. 8min a study

ream,

has bearing on tha problems of the personality

upset: of resume to

change

�«6.

in behavior wider stressful maniacs (us in forceful indactrimum, isolatim.
atarmtim); a3 well as an «imam at mimic madame fer various W“

chntric therapies.

ma
mamwwwm
me
mums“
W
w:
2.

with elootmahock have led us to

Em-

theua

mute personality factors in the patient and

which

ing the chain of treatment.
a workabla hypothasia.

We

He

of

a.

hypo—

the tharapi‘at affect»

am in the process of developing our ideas into

antiéipate mdertnking such

Mt

I

stuck by the and of the

last report this section has been mdeaigna‘bed an the
of Men-1mm thiatry. In addition to the panama]. listed

31am the
Department

the

timofﬂwwtmport,mhmappointad, maparttimbasis,

mm

at.

mm

assistant in psychalngy. Dr. Pomek, who has his 111.11.
from Kw York: University in 1955, has bean a mum-oh psychologist at tho Haunt
Sinai Hospital and the 145mm rmdaum for emu Research for the past six
Ha
is experienced in both pamanauty and perceptual ”pants in march.
years.
It. in anticipatod that he will be appoint“ an 2. m1 tin basis on My 131:.
A
the
individual
differences in bahavior with specific ambush
to
study
pram
Pamela, as

on tho

perceptual and

ation has been

made

pemmnty sweats

has teen

«“10de by his and applic-

to various foundations for support.

mauve April 131:, than

will be appeintod to the

Duparfanent, a

Assistant for linguistic analyses. Under the hem of the
E) funds warn and:

mm“
x.

devised ‘by

m:
21::

«:1th

Firm.”

far a technical assistant he carry
Dr. Jane.

manna»!

1mm

Grant (see
out.

Senna

the language

for Renaud: in Psyuhutry has gxmtad Dr. Jute
sun or [26,919 plml $5,700 overhud far continuum

Fund

support for two years in than
of the study “Language of the

Dyna“ which

has been dmlopod during hm past year.

�ﬂan

MMMMmWVWWrmum. mama-mm
«mumspm

1st.

3957

unmmmt.

1959.

mmmmmummmmuwudmmwm

mararmmawmmmwmam £100»,me

mumwmmmxmm-mwmmwmzwnmm
ammwmnmmummmsumw,wmmmm

InWr,;mawrthammkqu

atmmwmammmmmtmummm

mummuuwnhumamunumsmmumwwm

nmr,nr.ammmmnm
mmmmw.
inmwmmmmmwhgmwnwnmemum

mm‘dWomx-l. kWawﬂmWﬁs
dWWWWMMmmmmmammm
in
m Widv mom 153mm my.
autism
“MW
tho

Em

MWMWtWamrdmmawvmmmuMmr
ﬂammmrmmu»hpoumha1umtorpnmumu
an Week mum}: mama. th- smosy or Mom-1 WW, tho

Inumhiml Wan

of

RM

and the Imam-Mom}.

0mm! fer WW.‘

hmumnmmmmwwwumwunmmm
ma
for
humﬁml
Puma? ”W4.
Mm:
WM: mum

mummnnmmmmmammwnam
thrmthMme,uthw-omcmmmmm
summeodmga.
Womanhmmmmmwupummmma

mmwwm.hﬂo,umupmmungmormm

mum»“momwmdummotmmrdmwmmmm
Chum;

�vammamwmmmmmmamw
fowlmm. unnaommmwanmnmmum
or
J. Mt. 1:
in

Manny
mm}.
m
3mm
mm:

Dr.
anti-u”.
main
mum” at. an mum Alma: mu mum

means

with

an

W
Wthmmuthortmmmmho-

W,
matmwmmmmumum.

of

Dr.

a

mmmamnmsmvm‘mmmm

Morn a: thin-Baum: an «an in an «Mama and m...

other 19%.

numtatmthm;

WW:
mwmmwmm. DnlgmmbmnmngtMpmbhmof

smwwmmmmuhmm

0

Wm
wmwammmw‘mﬂammwhmmm.
mm
puma
pm:
mm
mm
is
um We
Wm
mmuwappmuwmmumm. hummmpmaaar
with

acumen ”mm.

Elam

during

typu of

no

bu been mpcmm

ﬂu «mm-hock
maniacal... 69min supports.“ an!

that.

and

In thin new: be

mmmwumum.
Dr. 3.

Fri-mm contributed mun-My to mmamm mm.

mmmmmmwwmw.

In

WWmnodWMme,mmofmmmtmm

mm

m a may

mm“ mm:

m- m

on
at
.m
u»
mam
mm:

mmmmmmmuw.
Manama,

WM”
W

1913!!

a: tum-3mm

Mammary:

Wm

Max

Pink.

11.13.

�March 1957

Personality Factors in Behavioral Beeponse to Electroshock Therapy
Robert L. Kahn, Ph. D. andMax Pink,

From
New

14.

D.

the Department of Experimental Psychiatry, Hillside Hospital, Glen Oaks,

York.

Aided by grant 14-927 of the National Institute of Mental Health, l“aﬁcional Institutes of Health, APublic Health Service.

Presented

a

the Electroshock Research Association, Chicago,

May

1957.

�INTRODUCTION

The

behavioral response of patients receiving electroshock therapy is

variable. In previous studies of the factors related to this variability

we

that patients who showed early, persistent and relatively marked degrees
of altered brain function, as measured by the e1ectroencephalogram.and the
amobarbital test for brain disease (10), were most likely to show a clinical
The
(h)
(6)
which
(7).
improved
rated
was
present study is an
as
response
investigation of the role of personality in the behavioral reSponse.
An explicit hypothesis concerning this relationship has been derived

noted

from previous studies of the patterns of behavioral change occurring with
EST.

In an analysis of language changes after electroshock (7),

that patients

who

we

reported

develop such language patterns as explicit denial of

ill-

and
of
and
symptoms;
displacement
qualifitemporal
Spatial
personal,
ness;
cation, evasion and minimization are rated as improved. These language patterns

are similar to those previously described by Weinstein and

Kahn (13)

in their

studies of neurological patients with cerebral dysfunction. They characteru
ized this behavior as the "language of denial" and demonstrated a relationship

to personality. In particular they described the characteristics of the "ex€M)On
the
of
these
the
denial"
basis
verbal
observations,
personalit
plicit
hypothesis was advanced that those patients

who most

closely approximated this

"explicit verbal denial" personality type would be more likely to
havioral changes after
The purpose

EST

show

the be-

which are rated as improved.

of the present study, therefore, was to determine:

1) whether personality characteristics related to the behavioral
reaponse

to electroshock therapy

show

proved.

differentiated; and

patients with greater "denial" tendencies are more likely
behavioral changes after electroshock therapy which are rated as imp
2) whether

to

can be

�.2POPULATION

Sixty-three consecutive patients referred for electroshock therapy were
studied.

staff,

The

selection of patients for treatment

was made by the

psychiatric

independent of the judgment of the authors. The patients ranged in age

from 20

to

66 with a mean of I47, and included 21 men and

142

women.

METHOD

Prior to treatment each patient

was evaluated according

to the following

methods :

l.

Structured

EM

Interviews: Personality was evaluated in inter-

patient' 3 family. At the opening of the interview,
the relative was asked to describe, in his own words, the patient's usual interests and attitudes. The relatives were encouraged to talk about any aspect
they wished, and the interviewer followed the trend of their talk, rather thm
proceeding in a serial fashion. The interviewer asked questions, however, to
been
15
obtain information in m
described as charspecific areas which have

views with members of the

acteristic of the "explicit verbal denial" personality,“.

The number and

withgibrelative
varied according to the degree of
type of questions required
spontaneous production and the infomant' 3 capacity to comprehend and 00mm:-

icate.

The

informant was encouraged to give concrete examples of

all state-

ments.

basic items included the presence and extent of each of the following
features: 1) stress verbal symbols such as resolutions, homilies, cliches and
The

rationalization; 2) are prestige and security conscious, and do not enjoy the
intrinsic benefits of health, work, leisure, money and property; 3) regard illness as an imperfection or disgrace, keeping

neighbors, and are

it

a secret from the family and

reluctant to seek medical care;

troubles and are considered practical persons

who

)4)

"shake off"

their

advise others; 5) have

drive and compulsive energr, and are guilty or uneasy

if

own

much

not occupied; 6) are

conscientious with a high sense of duty and responsibility; 7) are sensitive
.

�.3to criticism, regarding

it as

an

attack

on

their integrity;

8)

are proud and

avoid help from others; 9) are reserved rather than openly affectionate or
emotional; 10) emphasize being correct; 11) are not imaginative or creative;
12) are not seen as dependent by

their relatives;

1h) do not have temper outbursts; 15) and are not

After the interview, each item

if

score of 0 was given
1
2

was

rated

on a

13) do not discuss sex openly;

ludic (25).
scale of 0, 1 or 2.

A

the aSpect was noted to a minimal degree; a score of

indicated that the characteristic was moderately present; while a score of
indicated the definite and marked presence of the pattern. The scores for

each item were added and the

resultant score is termed the "denial personality

score".

2. Clinical Evaluation: Each patient
weekly intervals during and

evaluation

prior to and at
following the course of treatment. The clinical

was determined by

was interviewed

the patient's behavior in the few weeks following

the end of the course of treatment and

was

based on the evaluation of the pat-

ient's therapist, the therapist's supervising psychiatrist and the supervising
psychiatrist in charge of the electroshock treatment unit. Patients were
classed into three groups:

much improved,

moderately improved, or unimproved,

criteria outlined previously (6).
3. Language gtggy: In addition to the clinical interviews,

following the

each patient

standardized series of questions determining his attitude

was examined with a

toward his

illness.
trouble?" and "If you

Two

of the questions asked were,

“What

is

youi'mein

had one wish, what would you wish for?" The

patients

were

tested before and during treatment and the verbatim responses were analyzed for
changes in language according to the method previously described (7).
RESULTS

The

relatives of

scores ranged from

O

h?

patients were interviewed. The&lt;ienia1 personality

to 25, with a median of 11. For statistical comparison

�.14-

the patients were divided into two groups. Patients with scores ranging from
11
0

to
to

25 were

10 were

frm

considered the "high denial" group, while those with scores

classed as low in denial tendencies.

1. Personality score and clinical response: Patients with high denial
personality scores in these family interviews were most likely to be rated as
much improved, and

patients with

low scores, however, the

basis, with

chance

only one case was considered unimproved (Table

30%

I).

In

clinical response rating occurred

on a

of the patients being regarded as mimproved.

I

TABLE

Relation of Denial Personality Scores to Clinical Response to Electroshock
Much

Improved

Moderately
Improved

Total

Unimproved

Personality Score
11
0

-

25

1h

9

1

2h

10

7

9

7

23

21

18

8

it?

Total
The

proved

difference in the denial scores between the

patients,

when compared

sigzificant.* Although the

much and

moderately im-

to the unimproved patients is statistically

much improved

patients have a higher

mean

score

is not significant.
2. Qualitative observations: Although there is a relationship between
high denial personality scores and the clinical rating, 30% of patients with
than the moderately improved group, this difference

low denial scores were also evaluated as showing a marked improvement. While
trig/1:119 group

of seven patients

is

a small one , certain

common

characteristics can

be described. Although these subjects lack the competitive

security needs of the high denial subjects, they
or imaginative capacity or ability to think
Si
~K-

vb; { {ran-M

at

1%

level of confidence by

show

drive, prestige and
a similar lack of creative

critically of their

Mann-Whitney

U

Test.

own

or other's

�.5relate to the environment primarily by non-verbal forms of
commmication. They are described by their families as laughing or crying

feelings.

They

excessively; and as showing anger by muteness, ”go into a shell," ”walk out

of the room in a huff,” or by violent tempers with table-pounding, throwing
objects or direct physical assault. These patients are "ludic,"
by Weinstein and Kahn (12) to denote comic,

language analysis described in a

in clinical interviews

term used

tragic, or melodramatic behavior.*

1m:
previous study (7), the

3. Personality score and Meg

-a

Applying the technic of

i__n_

changes

in

language

were compared with the denial personality scores. Nine

patterns of language change, such as explicit denial of illness or

symptoms,

displacement, qualification, £33. have been described as characteristically

occurring

after electroshock.

ified according to the

plicit language

As

in the previous study, each patient

was

class-

dichotomy of whether or not he showed three or more ex-

changes. Patients with high denial personality scores showed

a greater number of language changes, than those with low denial personality

scores (Table

II).

The

coefficient of correlation between the personality

scores and the number of language changes

the

1%

is

.71, significant

+

at better than

level of confidence.
TABLE

II

Relation of Denial Personality Scores to Clinical Language Changes During
Treatment
Number Langggge Changes

0

-

2

3

or

more

Personality Scores
11 .- 25

(20)

8

12

-

(20)

17

3

25

15

o

10

Total
This term was taken from Piaget who applied
behavior of young children (8).

*-

it to

the play and imitative

�h. Illustrative Cases:
Case

1. High Denial Personality Score:
A

61-yearbold housewife was admitted to the hospital with a 15

history of insomnia, abdominal pain and fear of cancer. On admission
she was depressed, retarded, and seclusive, evincing little interest in her

month

surroundings, and wandering aimlessly about the ward.
The

patient

reaponsible person with
and was unable
home.

her husband as a conscientious, dependable,
integrity. She had no hobbies, outside interests,

was described by
much

to relax.

She was ”mortally

As

a consequence, she busied herself with chores

at

afraid" of doctors, minimized her illnesses and con-

cealed ailments, even from her husband. Very restrained, she openly showed no

affection or emotion, never discussed sex and rarely lost her temper. She had
"a long memory for little things if she felt that she was wronged," a ”streak
of stubborness," and would "just as soon hold another person responsible for

her mistakes." She was proud and would ”rather go without food" than borrow
or take money from others.
According to the denial

criteria, her score

After 20 electroshock treatments, she

was 20.

became euphoric, took an

interest

in her personal appearance and participated in hospital activities. Her doc"model"
”while
her
who,
a
reluctant to discuss her personal
patient
toi/called
feelings, asserted that she had no difficulties at

hue-'had
home,
a wonderful

band.uho was very good to her, considered herself lucky and eagerly anticipated

her discharge.”
Case

She was discharged with a

2.
A

Low

rating of

"much improved."

Denial Personality Score:

hl-year-old housewife

was admitted

to the hospital with a two

year history of depression following the birth of her fourth child. She cried

frequently, lost interest in social activities, found it increasingly difficult
to take care of her baby and had suicidal thoughts. On admission the patient

�was'

noted to pay

little attention

showed psychomotor

The
whom
He

it

patient

retardation

and was

was described by

was not easy

to her personal appearance, cried readily,
circumstantial in speech.

her husband as a "negative personality” with

to get along because she

was opinionated and argumentative.

regarded her as "completely impractical, with no

common

sense." She was a

poor housekeeper, constantly demanding help from other people, although not the
kind of person who would put herself out for others.

An

excessively talkative

person, she liked to engage in long, intellectual, pretentious conversations.
When

angry, however, she would become either completely mute, or "very nasty,

just don't know any better.” Although considered a “cold" person,
able to talk freely about sex. She frequently complained of physical

implying you
she was

ailments and went to physicians readily. She was ”naive" and "unrealistic,"

believing, for example, that she had a

flair for writing

although others con-

sidered her amateurish.
Her

personality score

was

rated as h.

patient received eighteen electroshock treatments, which were terminated at her own insistence because she was too frightened to take any more.
At the time of her discharge her doctor noted her as "quite depressed,” but
The

felt that
hospital.

it

was

doubtful that she could benefit from further treatment

She was discharged with

at

the

the recommendation for continued psychother-

apy.
DISCUSSION

The

structured family interview

was designed

to test the specific hypo-

thesis derived from earlier observations that patients with the "explicit
verbal denial” personality are most likely to Show both the language and behavioral changes to electroshock therapy which are rated as
the examiner.

The

much improved by

data supports this hypothesis and is also consistent with

�the theory of the

mode

of action of electroshock therapy advanced by Weinstein,

that “....the therapeutic efficacy of
electroconvulsive therapy....derives from the production of a state of brain
function in which the mechanism of denial is facilitated in characterologically

Linn and Kahn in 1952 (9).

They suggest

diaposed individuals."
The degree

of explicit verbal denial

is,

however, only one

personality

aspect affecting the behavioral response to treatment. 0n the basis of the

present data and methods of analysis a broader view of personality patterns in

relation to improvement with
as

clinically

EST

is

now

possible.

improved are characterized by such

Those

patients

who

are rated

features as: l) non-empathic

- unable to think critically or sensitively about the needs,feelings, or

-

commun-

ications of others; 2) non-introspective - - unable to think critically about
their own feelings or needs; unable to achieve insight even with the collaboration of others in a psychotherapeutic relationship; 3) rely heavily on nonverbal communication - - even

tial

when

they are talkative there is

little

referenp

communication, the words being cliched, stereotyped, or representative of

feelings and emotions rather than transmitters of information and h) highly
conventional - - without imaginative or creative capacity, and with few resources
to deal with stressful or
With
re8pond

new

this pattern as the

situations.

common

background, two classes of patients who

to treatment can be defined: a) the driving, conscientious, independent,

successful, emotionally-controlled person who can be characterized as the ”explicit verbal denial” personality type; b) the chronically inadequate, affectd::;;;&amp;rfrom
and
ively labile
ludic, dependent person,
an impoverished socio-

cultural background. While both types are rated as improved in their short
tenm response to electroshock, preliminary folloWhup observations indicate that
the "explicit verbal denial" personality type

clinical response, while the Indie

group

is

more

likely to sustain the

is likely to relapse quickly.

�Consistent with our previous studies

we have

found that altered brain fun-

ction is a necessary condition for behavioral change with electroshock therapy.
The kinds of behavioral change shown with altered brain function, however, vary
markedly in

different patients.

ment of symptoms and are

states,

become withdrawn,

Some Show mood

rated as improved. Others develop paranoid agitated
or show additional somatic or

are rated as unimproved. In this study

in those cases

we

who were

memory

complaints, and

here stressed the personality factors

whose behavioral reSponse was

considered the patients

changes and denial or diSplace-

rated as improved.

we have

not

rated as only moderately improved or unimproved.

If the basic hypothesis is correct,

we

should also find a relationship between

personality and the behavioral response in patients

who

are rated as unimproved.

Present information in this regard is minimal, as this problem has not'been
approached with a specific hypothesis.

raise questions concerning the relation of personality
to type of mental illness and choice of therapy. Clinical observations support
These observations

the concept of a characteristic predepressed personality. Abraham (I) noted

that states of depression occurred in obsessional persons. Arnot ‘2) describes
depressions as being overly conscientious and perfectionistic. Hamilton and

(5), reporting various aspects of the personality in involutional depression, include such features as "followed a rigid pattern of behavior....displayed a lack of imagination....narrow range of interests....thorough, cone

Mann

scientious, meticulous devotion to duty....lack of feeling for point of view
of others....hard, uncompromising drivers....oversensitive....reserved.“ Cohen,

et

a1 (3)

in an intensive study of manic-depressive psychosis, reported their

patients as being highly prestige-conscious;

little

concerned with prdblems of

interpersonal relatedness; stereotyped; conventional; having

for communicative interchange; and

unaware of

little

capacity

other persons' feelings toward

�.10himself or of his feelings toward others. They emphasized the patients' inability

to communicate verbally and suggested that the therapeutic relationship should
be in nandverbal terms rather than emphasizing the intellectual contents of the
exchange.
These studies of the personality background of depression show a

that is

pattern

similar to those personality asPects which have been described as
the "explicit verbal denial" personality. The factor of personality could thus
most

explain the fact that depression is the condition which responds best to electroshock treatment.

The same

personality factors which

to a depressive reaction are those which
forms of therapy.

These

factors enable

make him

him

make

a person susceptible

responsive to noneverbal

to respond, under the conditions

of altered brain function, with those language and other behavioral changes
which are evaluated as improved.

Thus, the same stereotypy, conventionality,

perfectionism, and prestige-consciousness, which produce a catastrophic response in the individual faced by the loss of a partner, job, business, or
loved one permit the development of denial, minimization and displacement under

the conditions of altered brain function and are deemed ”improved” by the family
and the

therapist.

�SUMMARY AND CONCLUSIONS

1. Personality factors in

63

consecutive patients referred for electro-

shock therapy were studied by means of a structured family interview.

2.

The

3.

The

which

results

that aSpects of personality can be differentiated
are significantly related to the response to treatment.
show

basic personality pattern of the patients who reSpond best can
be characterized as a) non-empathic, b) non-introspective, c) communicate non-

verbally, and d) highly conventional and stereotyped, with
or creative capacity.
h. 'Within the context of this
of improved patients.

One

group

is

common

little

imaginative

core, there are two main subdivisions

comparable to the

”explicit verbal denial"

personality, showingiﬁzch features as drive, conscientiousness, independence
and emotional control. The other group consists of persons apt to be chron-

ically inadequate

and dependent, coming from deprived socio-cultural back-

grounds, who are affectively

5.

labile

and

ludic.

relationship between these personality patterns and descriptions
of the personality of depressed persons is noted. The same personality factors
The

which contribute

to a depressive reaction, contribute to a behavioral change
under the conditions of altered brain function following electroshock therapy

which

is evaluated as

improvement.

�~12REFEEENCES

1. Abraham, K.: Selected Papers
Press Ltd., 1919.
Amot,

on

Psychoanalysis.

London: The Hogarth

Predepressed Personality, A.M.A. Arch. Neural.
Chiato, L6: 617-618, 1956.
The

12.:

&amp;

Psy-

3.,

Baker, G., Cohen, R. A., From—Reichmam, F. and Weigert,
E. V.: In Intensive Study of Twelve Cases of Manic-Depressive
Psychosis, Psychiat., 1.1: 103-137, 1951.

Cohen, M.

Pink,

and Kahn, R. L.:

Quantitative Studies of Slow Wave Activity
Following Electroshock, EEG Clin. Neurophysiol., Q: 158, 1956.

M.

Hamilton, D. M. and Mann, W. A.: The Hospital Treatment of Involutional
Psychoses, in Depression (Hock, P. and Zubin, J. , eds.) , New York:
Grune &amp; Stratton, 199-209, 1952.

L., Fink, M. and Weinstein, E. A.: Relation of Amobarbital
Test to Clinical Improvement in Electroshock, 11.14.11. Arch. Neurol.
&amp; Psydliato, 16-: 23-29, 1956.

Kahn, R.

7. Kahn, R. L. and Fink, 14.: Changes in Language During Electroshock Therapy, in Psychopatholog of Commication (Hock, P. and Zubin, J. ,
Eds.) in press.
‘

8. Piaget,

J.: Play,

Dreams and

Imitation in Childhood.

New

York: W. W.

9. Weimtein, E. 1., Linn, L. and Kahn, R. L.: Psychosis During Electroshock Therapy: Its Relation to the Theory of Shock Therapy, Am.

J.

PSYChiato’

3:99.:

22.26, 1952.

10. Weinstein, E. A., Kahn, R. L., Sugaman, L. A. and Linn, 1a.: Diagnostic
Use of Amobarbital Sodium ("Anwtal Sodium") in Organic Brain Dis-

ease,

ll. Weinstein,

Am.

J. Psychiat., 113:

889-891;, 1953.

E. A. and Kahn, R. L.: Personality Factors in Denial of
&amp;
A.M.A.
Arch.
Neural.
Psychiat., 92: 355-367, 1953.
ness,

Ill-

Weinstein, E. A., Kahn, R. L. and Sugarman, L. A.: Ludic Behavior in
Patients with Brain Disease, J. Hillside Hosp. , 2: 98-106, 1951;.
13. Weinstein, E. A. and Kahn, R. L.: Denial of Illness: Symbolic and Physiological Aspects. Springfield, 111.: Charles C. Thomas, 1955.

�April 1, 1957.
MEMORANDUM

TO:

Medical Affairs Committee

FOR:

Dr. Joseph S. A. Miller

FROM:

Department of Experimental Psychiatry

SUBJECT:

1957.
1956
to
April
1,
September
of
Departmental
Activities,
Report

Experimental
of
the
Department
of
the
of
activities
following report
since
the
period
covering
of’Dr.
Miller,
the
submitted
request
at
Psychiatry is
The

September 1956.
A.

Progress in Ongoing Projects:

the
evaluate
The
signifito
control
study
Evaluation:
1. Electroshock
be
com1956,
will
on
April
1,
instituted
electroshock
therapy,
cant elements in
been
has
been
have
studied.
It
1957.
Seventy
patients
pleted by the end of’May
the
electrointo
insights
have
we
and
gained
significant
successful
a most
group,
made
1955-56,
in
observation,
the
we
original
verified
shock process. First,
dethe
is
electroshock
therapy
behavior
in
in
change
that the prerequisite for
function.
brain
in
and
sustained
alteration
degree
velopment of a significant
Under the conditions of altered brain function, however, patients respond in
electroshock
is
follows
that
the
improvement
In
some
patients,
various ways.
the

that
was
opinion
our
It
disappears.
rapidly
while
in
others, it
sustained,
observations.
these
determinant
in
instrumental
the
was
patient's personality
in
the
of
patients
the
personality
studied
have
intensively
we
For this reason
standard
interview
developed
tests,
this last group. By applying specially
have
we
number
of
questionnaire
tests,
and
a
modifying
psychological tests,
and
of
type
between
personality
the
number
of
relationships
determined a
behavioral
the
we
At
predicting
are
time,
the present
behavioral response.
and
during
our
predictions
electroshock
to
therapy,
the
of
patients
response
As
a
result
chance.
than
better
been
have
months
significantly
the past few
include
to
personality
extend
study
our
to
we
planning
are
of these observations,
G).
Section
(see
results
psychotherapy
in
factors
changes
the
been
has
perceptual
of
patients
Our second interest in this group
to
deable
have
been
we
control
of
a
By
group,
virtue
induced by electroshock.
and
those
treatment
the
to
related
which
are
changes
termine those perceptual
im—
been
have
we
In
these observations,
which are related to practice effects.
and
their
the
of
the
patients
personality
close
interrelation.bf
the
pressed by
two
so
behavior
of
is
The
these
of
aspects
interrelation
perceptual processes.
in
differences
individual
of
undertake
study
a
decided
have
to
we
close, that
under
the
behavior
eventual
to
such
differences
and
to
relate
hope
perception
0).
Section
(see
function
brain
of
altered
special conditions
Our

which
electroshock
therapy
of
concept
a
to
have
led
develop
us
studies

Electrotreatment
unit.
of
this
management
the
in
has been of significant help
which
function
brain
in
induces
changes
treatment.
It
shock is a non-specific
Under
these
two
months.
than
less
of
usually
time,
persist for varying lengths
depending
environment
different
in
ways
to
his
the
responds
patient
conditions,
his
he
to
better
'With
relates
certain
a
personality,
upon his personality.

�-2The
and
better that he relates to
to
other
his
patients.
family,
therapist,
other people the less reason is there-for him to become tense, anxious or
6nce
the feeling of well-being is set into motion, it is sustained
depressed.
by the patient's better ability to function with others. Electroshock therapy
is not a specific treatment for a specific fbrm of mental illness.
2. Biochemical Changes in Electroshock: In the course of these studies
of electroshock, we noted that other investigators had reported that there were
and
the
one report
fluid
after
in
trauma,
in
Spinal
changes
enzymes
specific
noted similar changes after electroshock. Dr. Goldenberg and I undertook a
study of these enzymes in order to verify the previous reports and to clarify
our own picture of the electroshock process. To date, we have collected 30
spinal fluids. I anticipate that this phase of the work will continue until

the end of 1957.

3. Communication Studies: Our interest in communication problems has
led to two types of studies. In one, Dr. J. Jaffe has developed a technique for
the analysis of recorded interviews which provides us with an objective index of
change in behavior. Support for this phase of the work has been obtained from
the Foundations' Fund for Research in Psychiatry. At present, he is analyzing
the recordings of interviews with electroshock patients made earlier in the year,
and his findings are correlating very well with the clinical results. we antiand
the
in
of
language
changes
to
an
technique
analysis
this
applying
cipate
behavior that occur in ps;chotherapeutic interviews.

analysis of the structured amytal test intero
views according to changes in syntax and content. The original findings of this
study were presented to the AmeriCan Psychopathological Association in June.
Since then, all our amytal test interviews are being analyzed in like fashion
and the original findings have been verified and amplified. ”e have come to
understand that the language of our patients tells us readily whether or not
changes have occurred in brain function and in behavior. Furthermore, correlations between the personality evaluations and the language changes have shown
a direct relationship between high degree language changes and certain personwith
other personality types.
and
changes
minimal-to-no
language
types;
ality
Language is thus a recordable facet of behavior and we are ODtlmiStiC that a
combination of the language analyses developed by Drs. Jaffe and Kahn would be
a meaningful index of changes in behavior applicable to any form of psychiatric
therapy, including psychotherapy.
h. Egrebral Reactivity: As described in the previous report, our
interest in the question of individual variability in cerebral reactivity has
been stimulated by our electroshock studies. One part of this study is the
A second is the study of the
biochemical
in
changes
fluid.
of
spinal
study
rate of development of electroencephalographic change induced by electroshock.
Dr. Green has begun this phase of the work and since September has surveyed all
EEG
basic
of
their
by
records, and their
an
electroshock
analysis
our
patients
been
has
Mcgimide
to
the
cerebral
to
Also,
response
hyperventilation.
reSponse
A

second study

is

a language

assessed and this phase of the work completed (see Section B). Beginning in May,
the
admissions
new
hOSpital
the
to
that
will
screen
is
laboratory
anticipated
it
and that various activation procedures will be tested, so that the definitive
study can be undertaken in the Fall.

Concurrently, Dr. Green has assessed the relationship between the electroshock seizure threshhold and cranial resistance as factors influencing the development of electroencephalographic abnormality. This study is in progress.

�.3This study, under the direction of Dr. Sidney TaraNew
York
have
and
been
before
the
the
observations
continued
has
presented
chow,
Neurological Society in January. The observations have been summarized in a reand
A.M.A.
Archives
of
which
Neurology
the
in
Psychiatry.
will
shortly
appear
port
S.

B.

Ambivalence:

Completed

Projects:

1. Chlorpromazine-Insulin

Coma:

Control Study: An interim report on the results of this
control study was submitted to the Research Committee of the Medical Board on
January 31, 1957. In this study, 59 patients referred for insulin coma were
divided into two groups - one-half receiving insulin coma and the other half
receiving chlorpromazine therapy. It was our conclusion that chlorpromazine
is as effective in modifying psychotic behavior patterns as insulin coma therapy.
There was a tendency for the discharge ratings to be better for the chlorpromazine
,we
to
concluded
insulin
in
comparison
coma
the
than
for
insulin
that,
group.
group
coma therapy, chlorpromazine was safer, easier to administer, more controllable in
had
Tb
evidence
concluded
had
no
also
and
that
fewer
side
effects.
apits effects,
peared in the fifteen months of the study that either therapy had altered the basic
schizophrenic process, nor did we feel that either form of therapy had a greater
specificity for schizophrenic illnesses. At the conclusion of the study, the
Medical Director placed chlorpromazine in the formulary and permitted its use by
the Resident staff.

Insulin

Coma

2. Megimide Evaluation: During this period, Dr. Green has evaluated a
new agent in electroencephalography, megimide, for its ability to bring out defects in brain function. The report of his findings Twere presented at the midwinter meeting of the Eastern Association of Electroencephalographers.

0.

Projected Studies

It is

.

1957-58:

in progress in the Department will
The electroshock evaluation study will
be completed this Spring and the next few months will be spent in correlating
the information obtained and writing the reports. As indicated in the ongoing
and
have
of
studies
these
out
number
of
developments
grown
it
a
progress notes,
is anticipated that these will be incorporated in the_active research program.
anticipated that the work
continue for the remainder of the year.

now

A
Behavioral
Reapgggg:
protocol has been
1. £ndividual_Differences in
developed by Dr. Max Pollack, which incorporates the problem of personality affecting individual responsivity to electroshock. By determining the subject's patterns
of perception in specially developed orientation and visual tasks, we hope to demonstrate a relationship between these patterns and the behavioral response, both
under the special condition of altered brain function, and the general condition
of hospitalization and psychotherapy. Such a study has bearing on the problems of
the personality aspects of resistance to change in behavior under stressful conditions (as in forceful indoctrination, isolation, starvation); as well as the
definition of suitable candidates for various psychiatric therapies.

2. Personality Factors in Doctor and Patient Affecting Choice of Thera :
Our experiences with electroshock have led us to a unmber of hypotheses which relate personality factors in the patient and the therapist affecting the choice of
treatment. We are in the process of developing our ideas into a workable hypothesis.
We anticipate undertaking such a study by the end of the year.

�D.

Changes

in rersonnelz-

Since the last re\ort, this section has been redesignated as the Department
the
of
time
the
at
the
to
personnel
In
addition
listed
of Experimental Psychiatry.
Max
Research
Dr.
as
Pollack,
a
have
on
we
part-time
basis,
appointed,
last report,
New
York
from
who
University
has
his_Ph.D.
Dr.
Pollack,
Assistant in Psychology.
and
mount
the
Sinai
Hospital
the
at
research
been
has
psychologist
a
in 1955,
He
is experienced
the
six
for
Research
Child
past
years.
Ittleson Foundation for
he
that
is
anticipated
research.
in
and
It
perceptual aspects
in both personality
A
the
indito
study
July
on
program
basis
a
full-time
be
on
lst.
appointed
will
and
the
on
perceptual
personemphasis
with
behavior
specific
vidual differences in
made
various
been
has
to
and
him
been
application
by
developed
ality aspects has
foundations for support.

Technical
a
the
be
to
Department,
appointed
will
there
Effective April let,
FFRP
(see
Section
Grant
Under
the
of
terms
the
analyses.
Assistant for linguistic
E) funds were made available for a technical assistant to carry out the language
measurements devised by Dr. Jaffe.
E.

Funds:

Foundations' Fund for Research in Psychiatry has granted Dr. Jaffe
continuation
overhead
for
h5,700
a26,000
of
sum
plus
two
the
in
years
support for
the
been
has
developed
during
which
past year.
Dyad"
the
of
"Languahe
the
of
study
FFRP
The
Kaufmann
Foundation.
grant will exthe
This work had been supported by
tend from April 1, 1957 to March 31, 1959.
Health
Mental
fbr
of
National
made
Institute
the
been
to
have
Applications
subthe
Green.
Dr.
protocol
Also,
work
by
undertaken
of
support for the program
of
Division
and
Development
Research
the
to
been
has
sent
Pollack
mitted by Dr.
FoundaMalina
and
the
to
Army,
States
United
the
of
the Surgeon-General's Office
The

tion.

F.

Publications and rresentations:

In November, a summary of our studies on electroshock was presented at the
Montreal
a
in
Association
in
report
American
the
Psychiatric
of
Meeting
Divisional
FollowChange
Behavioral
to
Function
Brain
Altered
entitled "Relation of Tests of
"Electroencephalothe
Green
Dr.
report
December,
presented
Electroshock".
In
ing
Electroenceh
of
Association
Eastern
the
Negimide"
at
of
Lffects
and
Clinical
graphic
studies
during
the
of
electroencephalographic
In
a
summary
February
phalographers.
Differences
in
"Individual
entitled
a
two
in
was
report
presented
the past
years
EEG Besponsivity" before the Metropolitan EEG Society.
The Department has submitted a number of reports to various societies for the
the
at
for
been
have
presentation
accepted
Summer
Papers
and
meetings.
Spring

the
Psychiatry,
of
Biological
Society
the
Research
Association,
Electroshock
International Congress of Psychology and the International Congress for Psychiatry.
American
the
Psysymposia
at
in
to
been
have
invited
participate
In addition, we
These
meetings.
for
Psychiatry
International
Congress
and
chiatric Association
Department
of
this
the
experiences
considerable
detail
summarize
in
reports will
and
to
electroshock
to
with
regard
and
two
one-half
specific
the
years,
past
over
methods
of
the
language
anato
have
we
present
an
opportunity
also
will
drugs.
to
as
some
of
our
speculations
well
as
presenting
Dr.
as
devised
by
Jaffe,
lysis
the role and mode of action of the newer drug therapies in psychiatry.

�G.

Educationi_

Various members of this Department are continuing their education by
formal courses. Dr. H. Korin has been enrolled in courses at the Graduate
School of New York University with specific emphasis on statistics. Dr. J.
Jaffe is completing the formal training requirements at the William Alanson
White Institute of Psychoanalysis. Dr. Robert L. Kahn has been accepted for
training in psychoanalysis at the William Alanson White Institute.
H.

Other Activities:

1.

Israel Strauss

November 1953.

and

Members

Volume:

The

Israel Strauss

Volume appeared

in

of this Department were active in the development

fulfillment of that volume.

2. Resident Training: Since September 1956, two Residents have worked
H.
Esecover has been studying the problem of
Dr.
the
in
Department.
actively
psychotherapy with electroshock patients. In this study he has been supervised
He
made.
has
have
been
number
conclusions
and
of
a
members
the
Deiartment
of
by
demonstrated that patients differ considerably during the electroshock process
and that no single type of psychotherapy is meaningful. Certain supportive and
He is now in the process of
have
value.
definite
may
approaches
interpretive

describing his observations.

Dr. S. Friedman has contributed considerably to the ambivalence study.
this work he was supervised by Dr. Tarachow.

In

During the period September to February, members of the Department participated in a weekly lecture series for the Resident staff on the subjects of
research methodology and newer trends in psychiatry.

Respectfully submitted,
Max
MFzgw

Department of Experimental l’sychiatry
_

ﬂillside Hospital
Glen Oaks,

New

York

Fink,

M.D .

�HILLSIDE

HOSPITAL

FOR PSYCHIATRIC TREATMENT. TRAINING AND RESEARCH

JOSEPH S. A. MILLER,

75-59 263m:

M. D.

STREET. GLEN OAKS. NEw YORK
FIELD STONE

Medical Director

LEON

$7500

Lowwsrm

Honorary Chairman
Board of Directors

SIMON KWALWASSER, M. D.

ROY FOSTER

Assoc. Medical Director

Chairman
Board Of Directors

MAURICE BACHRACE

Administrator

E. COLEMAN
President

ALVIN

Dear Sir :

basis for the discussion of the research
activities at the meeting of the Medical Affairs
Committee on Monday, April 8th, I am herewith enclosing the following memoranda=
As a

1. Report of Dr. Fink for the Department of
Experimental Psychiatry.
2. Research activities in the Department of
Biochemistry, by Dr. Harry Goldenberg.

3. Research in the Department of Medicine,
by Dr. Arnold G. Blumberg

Aside from the regular Medical Board members of
the Medical Affairs Coxmnittee, there will also be present
Dr. H. L. Rachlin, Chairman of the Research Comittee of
the Medical Board and Dr. Max Fink, Director of the Department of Experimental t’sychia’cry.
Yours

sincerely,

f4,WIM,

Joseph S.A.Miller, M.D.

JSJALI:

11b

Medical Director

encl.

AN AFFILIATE OF FEDERATION OF JEWISH PHILANTHROPIES OF NEW YORK

�April 1, 1957.
MEMORANDUM

TO:

Medical Affairs Committee

FOR:

Dr. Joseph S. A. Miller

FROM:

Department of Experimental Psychiatry

SUBJECT:

Report of Departmental Activities,

September 1956 to April 1, 1957.

Experimental
of
the
Department
of
the
activities
of
following report
since
the
period
ofHDr.
covering
Miller,
the
request
Psychiatry is submitted at
The

September 1956.
A.

Proggess in Ongoing Projects:

the
evaluate
The
signifito
control
study
Evaluation:
1. Electroshock
be
com1956,
will
on
April
1,
instituted
electroshock
therapy,
cant elements in
been
has
studied.
been
have
It
pleted by the end ofTMay 1957. Seventy patients
the
electrointo
insights
have
we
and
significant
gained
a most successful group,
made
1955-56,
in
observation,
the
we
original
verified
shock process. First,
the
deis
electroshock
therapy
behavior
in
in
change
that the prerequisite for
function.
brain
in
and
sustained
alteration
velopment of a significant degree
Under the conditions of altered brain function, however, patients respond in
electroshock
is
follows
that
improvement
the
In
some
patients,
various ways.
that the

was
opinion
our
It
disappears.
rapidly
while
in
others, it
sustained,
observations.
these
in
determinant
instrumental
the
was
patient's personality
in
the
of
patients
the
personality
For this reason we have studied intensively
standard
interview
developed
tests,
this last group. By applying specially
have
we
number
of
questionnaire
tests,
a
and
modifying
psychological tests,
and
of
type
between
personality
the
number
of
relationships
determined a
behavioral
the
we
predicting
are
At
the present time,
behavioral response.
and
during
our
predictions
electroshock
therapy,
to
reSponse of the patients
As
a
result
chance.
than
better
been
have
significantly
the past few months
include
to
personality
extend
study
our
to
we
planning
are
of these Observations,
G).
Section
(see
results
factors in psychotherapy

changes
the
been
perceptual
has
of
patients
Our second interest in this group
deto
able
been
have
we
control
a
group,
induced by electroshock. By virtue of
and
those
treatment
the
to
which
related
are
termine those perceptual changes
imbeen
have
we
In
these
observations,
which are related to practice effects.
and
their
the
of
patients
the
personality
interrelation.of
close
the
pressed by
so
behavior
two
is
of
The
of
these
aspects
interrelation
perceptual processes.
in
differences
individual
of
undertake
study
a
decided
to
close, that we have
under
the
behavior
eventual
to
such
differences
and
to
relate
hope
perception
G).
Section
(see
function
brain
special conditions of altered
which
electroshock
therapy
of
a
concept
to
develop
have
led us
Our studies
Electrotreatment
unit.
this
of
management
the
in
has been of significant help
which
function
brain
in
changes
induces
shock is a non-specific treatment. It
Under
these
two
months.
than
less
of
usually
time,
persist for varying lengths
depending
environment
different
ways
in
his
to
responds
the
patient
conditions,
his
to
he
better
relates
With
certain
a
personality,
upon his personality.

�-2—

family, his therapist, and to other patients. The better that he relates to
other people, the less reason is there for him to become tense, anxious or
depressed. Once the feeling of well-being is set into motion, it is sustained
by the patient's better ability to function with others. Electroshock therapy
is not a specific treatment for a specific form of mental illness.
2. Biochemical Changes in Electroshock: In the course of these studies
of electroshock, we noted that other investigators had reported that there were
Specific changes in enzymes in the spinal fluid after trauma, and one report
noted similar changes after electroshock. Dr. Goldenberg and I undertook a
study of these enzymes in order to verify the previous reports and to clarify
our own picture of the electroshock process. To date, we have collected 30
spinal fluids. I anticipate that this phase of the work will continue until
the end of 1957.
Communication Studies:

interest in

communication problems has
led to two types of studies. Tn one, Dr. J. Jaffe has developed a technique for
the analysis of recorded interviews which provides us with an objective index of
change in behavior. Support for this phase of the work has been obtained from
the Foundations' Fund for Research in Psychiatry. At present, he is analyzing

3.

Our

the recordings of interviews with electroshock patients made earlier in the year,
and his findings are correlating very well with the clinical results. we antiand
the
in
of
language
changes
to
an
technique
analysis
this
applying
cipate
behavior that occur in pa chotherapeutic interviews.

analysis of the structured amytal test interviews according to changes in syntax and content. The original findings of this
study were presented to the American Psychopathological Association in June.
Since then, all our amytal test interviews are being analyzed in like fashion
and the original findings have been verified and amplified. We have come to
understand that the language of our patients tells us readily whether or not
changes have occurred in brain function and in behavior. Furthermore, correlations between the personality evaluations and the language changes have shown
a direct relationship between high degree language changes and certain personality types; and minimalvto-no language changes with other personality types.
Language is thus a recordable facet of behavior and we are optimistic that a
combination of the language analyses developed by Drs. Jaffe and Iahn would be
a meaningful index of changes in behavior applicable to any form of psychiatric
therapy, including psychotherapy.
h. Egrebral Reactivity: As described in the previous report, our
interest in the question of individual variability in cerebral reactivity has
been stimulated by our electroshock studies. One part of this study is the
A
second is the study of the
biochemical
in
of
changes
spinal fluid.
study
rate of development of electroencephalographic change induced by electroshock.
Dr. Green has begun this phase of the work and since September has surveyed all
our electroshock patients by an analysis of their basic EEG records, and their
reSponse to hyperventilation. Also, the cerebral response to Mcgimide has been
assessed and this phase of the work completed (see Section B). Beginning in May,
is anticipated that the laboratory will screen new admissions to the hospital
it
and that various activation procedures will be tested, so that the definitive
study can be undertaken in the Fall.
A

second study

is

a language

Concurrently, Dr. Green has assessed the relationship between the electroshock seizure threshhold and cranial resistance as factors influencing the development of electroencephalographic abnormality. This study is in progress.

�.3’
5. Ambivalence: This study, under the direction of Dr. Sidney TaraNew
York
have
before
been
and
the
the
observations
presented
chow, has continued
Neurological Society in January. The observations have been summarized in a report which will appear shortly in the A.M.A. Archives of Neurology and Psychiatry.
B.

Completed Progects:

1. Chlorpromazine-Insulin

Coma:

Control Study: An interim report on the results of this
control study was submitted to the Research Committee of the Medical Board on
January 31, 1957. In this study, 59 patients referred for insulin coma were
divided into two groups - one-half receiving insulin coma and the other half
receiving chlorpromazine therapy. It was our conclusion that chlorpromazine
is as effective in modifying psychotic behavior patterns as insulin coma therapy.
There was a tendency for the discharge ratings to be better fer the chlorprcmazine
we
concluded that, in comparison to insulin
coma
the
than
for
insulin
group.
group
coma therapy, chlorpromazine was safer, easier to administer, more controllable in
had
evidence
concluded
had
no
‘b
that
also
fewer
and
side
apeffects.
its effects,
peared in the fifteen months of the study that either therapy had altered the basic
schizophrenic process, nor did we feel that either form of therapy had a greater
specificity for schizophrenic illnesses. At the conclusion of the study, the
Medical Director placed chlorpromazine in the formulary and permitted its use by
the Resident staff.

Insulin

Coma

2. Megimide Evaluation: During this period, Dr. Green has evaluated a
new agent in electroencephalography, megimide, for its ability to bring out demidTJere
the
The
of
his
findinas
at
presented
function.
brain
in
report
fects
winter meeting of the Eastern.Association of Electroencephalographers.
C.

Projected Studies

7

l9§7~§8:

the
work
now
in
the
in
Department will
that
progress
anticipated
is
It
continue for the remainder of the year. The electroshock evaluation study will
be completed this Spring and the next few months will be spent in correlating

the information obtained and writing the reports. As indicated in the ongoing
and
have
of
studies
these
out
number
of
developments
grown
it
a
progress notes,
is anticipated that these will be incorporated in the active research program.
A
i“Response:
Behavioral
protocol has been
1. lgdividual Differences in
IVia}:
Dr.
Pollack, which incorporates the problem of personality affectdeveloped by
ing individual responsivity to electroshock. By determining the subject's patterns
of perception in specially developed orientation and visual tasks, we hOpe to demonstrate a relationship between these patterns and the behavioral response, both
under the special condition of altered brain function, and the general condition
of hospitalization and psychotherapy. Such a study has bearing on the problems of
the personality aspects of resistance to change in behavior under stressful conditions (as in forceful indoctrination, isolation, starvation); as well as the
definition of suitable candidates for various psychiatric therapies.

2. Personality Factors in Doctor and Patient Affecting Choice of Therapy:
Our experiences with electroshock have led us to a number of hypotheses which relate personality factors in the patient and the therapist affecting the choice of
treatment. We are in the process of developing our ideas into a workable hypothesis.
We anticipate undertaking such a study by the end of the year.
17

,

914.4 f 3
f

1

b

Va.

1,5

_.

�D.

Changes

in Fersonnel:

the
Department
been
as
has
redesignated
section
this
Since the last re ort,
the
time
of
the
at
listed
the
personnel
to
In
addition
of Experimental Psychiatry.
Max
Research
as
Dr.
Pollack,
a
basis,
last report, we have appointed, on part-time
New
York
University
from
Ph.D.
who
has
Dr.
Pollack,
his
Assistant in Psychologr.
and
the
mount
Sinai
Hospital
the
at
in 1955, has been a research psychologist
He
is experienced
six
the
Research
for
past
years.
Ittleson Foundation for Child
he
that
anticipated
is
It
in both personality and perceptual aspects in research.
A program to study the indiJuly
on
basis
lst. on the perceptual and personwill be appointed on a full-time
vidual differences in behavior with Specific emphasis
made
various
been
to
has
and
him
by
application
been
developed
ality aspects has

foundations for support.

Technical
a
the
Department,
to
be
appointed
will
there
Effective April lst,
FFRP
Section
(see
Grant
of
the
Under
terms
the
Assistant for linguistic analyses.
the
language
out
to
assistant
technical
a
carry
made
for
available
E) fUnds were
measurements devised by Dr. Jaffe.
3-

£211.42:

Dr.
Jaffe
has
granted
Fund
Research
Psychiatry
Foundations'
in
for
The
continuation
overhead
for
$5,700
u26,000
of
plus
sum
the
two
years in
support for
the
been
during
past
developed
has
which
year.
Dyad"
the
of
"Languace
the
of
study
FFRP
The
will
Fbundation.
exKaufmann
grant
the
by
been
had
work
supported
This
tend from April 1, 1957 to March 31, 1959.
Health
Mental
for
of
National
made
Institute
the
to
been
Applications have
subthe
Green.
protocol
Dr.
Also,
by
work
undertaken
support for the program of
of
Division
and
Development
Research
the
to
been
sent
mitted by Dr. Pollack has
FoundaMalino
and
the
to
Army,
States
United
the Surgeon-General's Office of the

tion.

F.

Publications and Presentations:

the
at
was
presented
electroshock
on
studies
of
our
In November, a summary
Montreal
a
in
Association
report
in
American
Psychiatric
the
of
Meeting
Divisional
FollowChange
Behavioral
to
Function
Brain
entitled "Relation of Tests of Altered
"Electroencephalothe
Green
report
Dr.
presented
December,
Electroshock".
In
ing
Electroenceb
of
Association
Eastern
the
Megimide"
of
at
graphic and Clinical Lffects
during
studies
electroencephalographic
the
of
In
a
February summary
phalographers.
Differences
in
"Individual
entitled
a
in
report
two
was
presented
the past
years
EEG Besponsivity" before the Metropolitan EEG Society.
the
for
societies
various
to
number
of
submitted
a
reports
The Department has
the
at
for
been
have
presentation
accepted
Summer
meetings. Papers
Spring and
the
Psychiatry,
Biological
of
Society
the
Research
Association,
Electroshock
for
Congress
Psychiatry.
International
and
the
Psychology
of
Congress
International
Psy—
American
the
symposia
at
in
In addition, we have been invited to participate
These
meetings.
for
Psychiatry
International
Congress
and
chiatric Association
Department
of
this
the
experiences
detail
considerable
summarize
in
reports will
and
to
electroshock
to
regard
with
and
one-half
specific
two
years,
over the past
methods
of
anathe
language
to
present
have
we
an
opportunity
also
will
drugs.
to
as
some
of
our
speculations
well
as
presenting
lysis devised by Dr. Jaffe, as
in
psychiatry.
therapies
the
newer
drug
of
mode
and
of
action
the role

�-5G.

Education:

Various members of this Department are continuing their education by
formal courses. Dr. H. Korin has been enrolled in courses at the Graduate
School of New York University with specific emphasis on statistics. Dr. J.
Jaffe is completing the formal training requirements at the William Alanson
White Institute of Psychoanalysis. Dr. Robert L. Kahn has been accepted for
training in psychoanalysis at the William Alanson White Institute.
H.

Other Activities:

1. Israel Strauss Volume:

November 1955.

and

Members

The

Israel Strauss

Volume appeared

in

of this Department were active in the development

fulfillment of that volume.

2. Resident Training: Since September 1956, two Residents have worked
H.
Dr.
Esecover has been studying the problem of
the
in
Departnent.
actively
psychotherapy with electroshock patients. In this study he has been supervised
He
has
made.
have
been
number
and
conclusions
of
a
members
of the Department
by
demonstrated that patients differ considerably during the electroshock process
and that no single type of psychotherapy is meaningful. Certain supportive and
He
of
the
now
have
in
value.
is
definite
process
may
approaches
interpretive

describing his observations.

Dr. S. Friedman has contributed considerably to the ambivalence study.
this yprk he was supervised by Dr. Tarachow.

In

During the period September to February, members of the Department participated in a weekly lecture series for the Resident staff on the subjects of
research methodology and newer trends in psychiatry.

Respectfully submitted,
Max
MFzgw

Department of Experimental i"sychiatry
&gt;

hillside Hospital
Glen Oaks,

New

York

Fink, M.D.

�April 1, 1957
Medical Affairs Cummittee

TO:

For: Dr. Joseph S.A.Miller
From:

Department of Biochemistry

Subject:

Report of Departmental Activities, July 1956 to March 31, 1957.

Steroid Studies
Studies were continued on the steroid hormones because of their importance
in the physiological response to stress. Experiments with rats showed that the
liver converts neutral and sex hormones to their sulfate conjugates which are
subsequently voided in the urine. Female rat~ liver was far more active than
male preparations in conjugating the steroids, particularly the male hormones.
These findings indicate that the liver plays a major role in the maintaining
hormonal balance, femalssbeing endowed with a regulatory device to dispose of
excess male hormones produced in their bodies.
Urinary steroid sulfate excretion studies on human subjects were carried out
The
and
total
chromatographic
techniques.
complexation
with our newly developed
sulfate output was found to be related to both sex and age. Interesting results
were obtained with urine from schizophrenics, the level of one fraction (dehydronumber
of cases.
elevated
sulfate)
in
a
being
epiandrosterone
Drugs and Alkaloids
New

colorimetric, chromatographic

electrophoretic techniques were establipsychothenpeutic drugs. These were recently

and

for both the psychotomimetic and
presented at the American Chemical Society
shed

Meeting (Brooklyn, February 15, 1957).

findings are now being applied to determining the role of trace urinary alkaloids in schizophrenia.
our earlier chlorpromazine studies, which were dropped for lack of suitable
instrumentation, are again under way with financial help from the National Institutes
much
throws
because
The
of
interest
it
light on
Health.
is
ver
great
of
subject
from
the
be
which
cannot
gained
(microsome
action
gross liver
function
liver
function tests in currentuse. we find the chlorpromazine molecule is in many ways
The
from
information
gleaned
to
some
in
isotopes.
ways
ideal
superior
an
tracer,
this study would also throw light on the Akerfeldt "six~minute blood test for
from
whether
suffer
a
decide
schizophrenics
should
to
and
us
help
schizophrenia"
defect in oxidative metabolism leading to the in vivo production of hailucinogens.
The

Electroshock
Lavels
Therapy.
in
gholinesterase

Earlier investi ations by Tower and others have indicated demonstrable changes
in acetylcholine, acetylcholinesterase, and pseudocholinesterase in spinal fluid
following electroshock therapy as well as other forms of head trauma. AccordingEEG
of
have
to
correlate
undertaken
Fink
patients
and
Ur.
patterns
associates
ly,
EST
values
cholinesterase
in
concurrent
and
with
alterations
after
during
before,
of spinal fluid. Simultaneous serum cholinesterase determinations on these patients
blood
red
to
extend
these
studies
and
cell
we
to
carried
plan
also
being
out,
are
(true)cholinesterase. The specific enzyme methods in use were developed at Hillside
Hospital and have recently been presented at the American Chemical Society Meeting
in Brooklyn. Further reference is made to Dr. Fink's progress report for findings
to date.
Future plans:

More

of the same.

Harry Goldenberg, Ph.D.

�April 1, 1957.
Medical Affairs Committee

TO

For: Dr. Joseph S.A.Miller
From:

Department of'Medicine

subject:

Report of Departmental Activities, July 1956 to March 31, 1957.

to
of
An
the
patients
of
psychiatric
Test:
response
l. Mecholylof mecholyl analysis
between
correlation
a
revealed
has
striking
subcutaneously
injections
electroshock
to
and
therapy.
and
diagnosis
response
age,
response
have
machine
blood
recording
automatic
of
an
studies
pressure
2. Preliminary
machine
for
and
of
this
the
evaluate
practicability
to
out
accuracy
been carried
now
seems
As
these
of
result
a
studies,
the
work
mecholyl
it
test.
on
further
of
the
evaluate
to
used
be
reproducibility
machine
usefully
can
likely that this
the mecholyl

test.

3. Drug evaluation studies on meprobamate are being carried out.
h. Chemical studies with the laboratory department are being conducted on possible
hepato-toxic effects of chlorpromazine in our patients.
Proposed Research for the coming year:

1. Evaluation of meprobamate in psychiatric patients.
three months).
2.

(to be completed within

Evaluation of reproducibility of mecholyl test employing a recording sphygmo-

mamometer.

by
chromatographic
with
therapy
chlorpromazine
alterations
of
Evaluation
3.
protein
techniques.

h. Evaluation of
or Trilafon.

a

substitute fbr chlorpromazine. This will be either Spaﬁine
Arnold Blumberg, M.D.

�HILLSIDE

HOSPITAL

FOR PSYCHIATRIC TREATMENT. TRAINING AND RESEARCH

JOSEPH S. A. MILLER,

75-59 263RD

M. D.

STREET. GLEN OAKS. NEw YORK
FIELDSTONE

Medical Director

LEON LOWENSTEIN

3-7800

Honorary Chairman
Board of Directors

M. D.
Assoc. Medical Director

SIMON KWALWASSER,

ROY FOSTER

Chairman
Board of Directors

MAURICE BACHRACH

E. COLEMAN
President

Administrator

ALVIN

A

Proposed Study

for the Behavioral

Max

From

Assay of

New

Drugs

Fink M.D.

the Department of Experimental PBychiatny

October 30, 1957.

AN AFFILIATE OF FEDERATION OF JEWISH PHILANTHROPIES OF NEW YORK

�AProposed Study for theBehavi9ralwg§§ay of

New

Dm
mgs

MaxFi‘nk M.D. *

1 . Problem:

is little disagreement that the newer psychopharmamode
of
these
drugs
of
action
the
behavior,
alter
cological agents
and factors in the marked individual variability in response are
unresolved problems. Difficulty in resolving these problems lies,
While there

in part, in the lack of a theoretic framework subject to operational
the
is
assay
perplexing
and
Particularly
experimentation.
analysis
of new, i;g., clinically untested agents capable of altering behavior.
Many

the
because
reports are
to
assess
studies
difficult
are
present

and
classifications
nosologic
defined;
the
poorly
population
subjective;

are unsatisfactory.
Based on our previous

studies,

we have

expressed the hypothesis

that the efficacy of psychopharmacological agents in psychotic states
measurable
changes
induce
to
persistent
to
their
related
ability
is
in cerebral function (1). Such alteration in cerebral function provides the milieu for changes in adaptation of the patient in his
environmento

In this view, alterations in cerebral function following

drug administration are not "complications," or "untoward

but the sing

SEE

293 of the

mode

effects,"

of action of these therapies.

Changes

condition
not
sufficient
but
a
a
cerebral
are
physiology
in
necessary,

for improvement.
* Director, Department of Experimental Psychiatry, Hillside Hospital,
Glen Oaks, N.Y.

�,2This hypothesis

is

a direct outgrowth of four years of experimental

investigations of electrcconvulsive, insulin

coma and

various drug

therapies in use at Hillside Hospital. These studies are summarized

in the appended report (1).
we have used a wide

t

variety of measures of brain function

(2, 3, h, 10, 12). Most successful have been changes in the frequency
spectrum of the

EEG,

patterns of language and perceptual tasks. In

our experiences with electroshock, slowing of
most

EEG

frequencies has been

helpful (2). In drug studies, however, this is less prominent,

although fundamental; Language and perceptual

tests,

however, have

given us clues as to ways of measuring brain changes, more subtle than

present electroencephalographic techniques.

It is

this study to
logic agents according to their effects
the purpose of

patterns and

on

perceptual tasks.

to test the following:

The

compare various psychopharmacoon

the

study

EEG, on

language

is specifically

designed

I

(a) Can the extent of behavioral change in psychopharmacologic
agents be related to the degree of
(b)

To

EEG

spectrum changes?

what extent can visual discrimination

measures of changes in language be

tests, and
refined to provide reliable,

predictablezueasures of changes in clinical behavior?
(c)

To what

extent can such measures predict the clinical

usefulness of psychopharmacologic agents?

�II.

Method:

1. Subjects:
All subjects are

drawn from the

adult impatient service

of the Hillside Hospital.

In general, these patients are

erative, well educated
good physical health.

intelligent. All are

and

alert,

coopT

ambulatory and in

2. Procedure:
Two

methods of drug assay are

in progress.

(a) Acutg_Experiments:

In the laboratory setting, with simultaneous

EEG

and

language recording in process, single intravenous or oral doses of
drugs are administered.

the period of drug

Patients are under constant observation for

activity.

(b) Clinical Experiments:

Patients are referred

by

their therapist to the super-

vising psychiatrist for treatment with psychopharmacologic agents.
Prior to drug administration,

EEG

and language recording interviews

are held. Perceptual tasks are completed. Drug administration then

until toxicity is manifest, and drug
reduced to a maintenance dose. Testing is repeated, and be-

proceeds
dosage

at

a rapid increment

havioral observations made, at frequent, defined intervals.

in previousstudies, subjects are randomly divided into

As

groups

-

an experimental and a

control.

The

experimental group

receives the medication, the control group placebo medication.

two

�3. measurements:
(a)

33.29.

is

Recording with an 8 channel Medcraft instrument

in progress. Records have been visually analyzed for changes in
frequency, voltage, symmetry and rhythmicity (2). Activation by
hyperventilation is routine.

validity of other activating
and
photic
hypoglycemia
megimide
(6),
intravenous
as
procedures
The

stimulation is being assessed.
(b) Perceptual.
Within the past decade certain perceptual procedures
have been shown to be

(11, 12, 13).

sensitive measures of cerebral dysfunction

Such techniques as

critical flicker fusion

(OFF), and

"embedded"
of
figures
polychromatic
the tachistoscopic recognition

in a
These

visual background are being assessed (10, 12, 13).
measures have the adVantage of giving a reliable quantitative

complex

measure of pretreatment functioning

in terms of a continuous variable,

rather than the qualitative dichotomy of "normal" versus "abnormal;"
imposing no undue

stress

on the

patient;

and the apparatus and

pro-

relatively inexpensive.
1) Critical flicker fusion SCFFZ: As the rate of
the
that
the
illusion
there
develops
of
increased,
flicker light is
point
this
at
of
The
the
light
flickering
frequency
steady.
is
light
cedure are simple, convenient and

is

the CFF. The

CFF

threshold is measured using a Sylvania glow

ratio is
brightness is varied to robtain thresholds at different

tube pulsed by an electronic power supply. The light—dark

fixed,

and

�-5-

levels.

The psychophysical method of

is

descending steps

limits using ascending

and

employed.

2) Tachistoscopic recognition of pseudoisochromatic

gigures:

The H—R-R

pseudoisochromatic plates (American Optical Company) con~

sisting of a series of cards with numerous small circles of various
sizesare used. The circles vary in color, and form outlines of
various geometric patterns, as ring, cross and triangle. These

patterns form a "figure"

on a

constant background. The

"neutral" plates are recognized by

all subjects -

blind." These plates have been photographed and
projection slides.

initial

normal and "color-

mounted as 2" x 2"

of exposure which permits accurate

The speed

identification of the figure is the index used.
(0)

Eggggggg.

Interviews with patients are recorded. Both unstructare
The
records
analyzed
included.
and
ured
structured periods are

for diversity (7) of the dyadic speech.
been found useful in analysis of changes in

for changes in syntax (9),
These methods have

and

behavior with other therapies.
(d) Evaluation of

clinical changes.

Psychiatric evaluations are

made

at fixed intervals

as to type and degree of changes in behavior, and a rating of
"improvement"
and

is

made.

in "improvement" are

The methods
now

of rating both change in behavior

under study.

Present ratings have been

based on the Malamud-Sands Rating Scales and have been of limited

usefulness.

The

present descriptive statements of the evaluator,

�-6following an outline of specific areas of behavior combined with
a review of the nurses' and resident

therapist's notes is being

continued.

h. Pharmacologic Agents:
Previous experience with amobarbital (8), megimide (6),

reserpine (IA) and chlorpromazine (5) provides the background for
the selection of new agents. At present, acute study of diethazine
(SKF 1026-A)

is in progress. Clinical studies of

meprobamate,

perphenazine and chlorpromazine are under investigation.
have been formulated

reaponse.

to test other agents, with different

spectral

Available:

The Department

of Experimental Psychiatry was established at the

Hillside Hospital in l95h.

clinical duties.

EEG

.

-

III. Facilities

Plans

of the department have no

Members

They devote

their full

at the institution to

time

the research prognmns.

Eight rooms of laboratories and offices in the principle medical

building of the hospital are provided. These include:
a)

EEG

Laboratory - equipped with Medcraft

encephalograph and Grass photic-stimulator.
on a

A

8

channel Electro-

technician is employed

full-time research basis.
b)

Psychophysical Laboratory

-

Two

Grass stimulators, Dumont

oscilloscope and step-up transformer power supply in a rack-mounted
assembly.

This equipment has been used for the past three years to

study threshold
and

after

for

simultaneous

tactile stimuli of patients before

induced states of altered cerebral function.

�.37.-

A

tachistoscopic assembly consisting of

two

projectors,

solenoidaactivated shutters, and opal glass screen is in use.
c) Psxcholinggistic Laboratogz:

A

third laboratory has been

established for the recording of interviews.
a Magnecord tape

recorder,

two

It is

equipped with

and
mixer.
microphones,
Electrovoice

auxilliary recorders for transcription are available.
The
available
for
study.
All patients in the hospital are
research programs have been well integrated into the hospital

Two

milieu so that manipulation of experimental variables are readily
accomplished.

�and Reggrts:

Iv. Publications

l.
2.

of
Physiodynamic
Action
of
the
Unified
Theory
Fink,
Therapies, J. Hillside Hosp. (in press).
M. : A

and Kahn, R.L.:' Relation of EEG Delta Activity to
Behavioral Response in Electroshock: Quantitative
Serial Studies, A.M.A. Arch. Neurol. and Pachiat.

(in press).

3.
h.

m:

Diffuse
of
Effects
and
H.:
Korin,
,
Altered Brain Function in Perception. Read at XV Int'l
Congress of Paychology, Brussels, 1957.
,

:

,

Relation of Tests of

Altered Brain Function to Behavioral Change Following
mectroshock. Read at the A.P.A. Divisional Meeting,
Montreal, November, 1956.

5.

and Coleman, F.S.:
Coma
and
Insulin
of
Chlorpromazine
Comparative Study
in the Therapy of Psychosis, J. Amer. Med. Assoc.

, Shaw, R., Cross,

6.,

(in press).

6. Green,

Fink, M.:

Megimide, EEG.

7.

Jaffe, J.:

Clinical Effects of

W

M.A. and
An

EEG

and

Clin. Neuromvsiolu g: 180-181, 1957.

Objective Study of Communication in Psychiatric

Interviews, J. Hillside Hosp. (in press).
8. Kahn, R.L., Fink, M. and Weinstein, E.A.: Relation of
Amobarbital Test to Clinical Improvement in Electro8c Psvchiat.
1956.
23-29,
Meurol.
A.M.A.
Arch.
lé:
shock,
9.

10.

ll.

Durinf-j Ele ctroLanguage
Changes
in
,
of Cormnunication,
shock Therapy, in P cho tholo
Ein
press).
Crune and Stratton
:

Em‘oedded Figures After
of
Perception
,
Induced Altered Brain Function, Am. Psychol” 1.3: 361
(Abst.) 1957.
:

Effects of Visual, Vestibular and Somatosensorimotor Deficit on Autokinetic Perception, J. @332.
§_2_: 398~LLlO, 1956 (with Battersby, 11.3.,
Pszchol.,

Pollack,

Mr:

Kahn, R.L. and Bender, 15.8.)

�0-9-

12. Pollack, M.: Tachistoscopic Identification of Contour in
Patients with Brain Damage, J, Cam . Ph 101.
szchol., 50: 220-227, 1957, {with Battersby,‘W.S.
and Bender, M.B.)

13.

Visual Deficit After Brain Damage in Man
as Measured with Rapidly Exposed Chematic Stimuli,
Amer. Peyphol., 12: h68,(Abst.) (with Battersby,‘w.s.
:

and Bender, M.B{7:

1h. WachSpress, M., Blumberg, A.G., Fink, M. and Miller,J.S.A.:
Evaluation of High Dose Reserpine Therapy for Relief
of Anxiety, J. Hillside HOSE. 5: 67-77, 1956.

�.10V.

Financial Support:
Support for the ongoing programsof the Department of Experimental

'

Psychiatry

is

provided by U.S, Public Health M-927, (Altered Brain

Function Following Electroshock), the Foundations' Fund for Research

in Psychiatry grant 56-151

(Language of the Dyed), and the Board of

Directors' Research Fund.

The

proper development of the specific

aspects of this protocol require support for the following, for a
two

year period.

19 8

Dr. M. P01130k, PhoD.
Senior Research Asst. Psychology
EEG

$
_

Technician - Hrs. Hannah Hosquera

12§9

8,250

$
‘

8,750

3,720

3,8u0

2,000

2,000

50

th

50

th

200

300

Equipment: (Over 2 year period).

Analyzer (Edin)
Flicker Fusion Apparatus

EEG

Projector, Slides
Calculator

(h,000)
(800)
(100)
(880)

hDO

hOO

Travel:
)
(Amer. Psychol. Assoc.
(Amer. Psychiatric ASSOC.)

$ 15,060

Overhead (15%)
TOTAL

$

d

15,h80

2,26h

2,327

17,32h

n 17,807

'

�\

KILLSIIE mSPITAL
Glen Oaks, NOYO

January 27, 1958.
MORAN!!! '10:

Medical Affairs Committee

FOR:

Joseph

FRCM:

Merimental Psychiatry
1958.
January
1957
1,
to
1,
Report of Activities, April

Miller,

M.D.

Deparhxent of

SUBJECT:

I.

30 A.

-~.—--

INTROIIJCTION:

achieved
has
professional
work
Department
the
of
the
nine
months,
In the past
various
of
understanding
We
our
reflecting
have
presented reports
recognition.
and
these
and
international
societies,
national
before
physiodynamic therapies
October
the
in
work
were
presented
of
Five
our
aspects
have been well received.
psychiatric
by
been
leading
have
accepted
and
other
Journal
reports
the
of
issue
Journals and will appear in 1958-59.
convulmode
of
of
action
the
of
Our studies have given us a clear picture
confidence
to
has
us
given
information
ibis
coma
and
therapies.
insulin
sive
to
these
in
therapies
which
were
fruitful
and
techniques
extend the hypotheses
behavioral
concerning
a
ideas
in
protocols
have
expressed our
drug therapy. We
Psychothe
both
by
received
been
well
These
having
new
ideas,
of
drugs.
assay
comand
various
pharmaceutical
U.S.P.H.S.
the
of
Center
Research
pharmacology
1958.
for
studies
new
the
in
been
implemented
have
panies,
.

, .
therapy, we were

,

.

.

number
a.
of
ancillary
led
to
electroshock
In evaluating
The
value
for
psychiatry.
have
which
basic
significance
broad,
investigations
found
and
assessed
were
change
behavioral
of
indices
of language measures as
While
a
studied.
"improvement"
was
The
of
defining
problem
satisfactory.
been
has
approach
operational
an
accomplished,
not
was
satisfactory resolution
which
the
criteria
Also,
studies.
recent
defined which was successful in our
has
an
to
led
Hillside
at
various
the
therapies
for
determine patient referral
of
choice
therapy.
factors
and
affecting
psychologic
the
sociologic
evaluation of

In addition, the ability of this department personnel to work together has
been
have
the
in
hospital
and
Our
relationships
roles
been amply demonstrated.
hosthe
from
at
staffs
all
cooperation
excellent
defined and we have received

pital.
II. PROGRESS IN
(A)

ONGOING PROJECTS:

Therapy Evaluations:

l.

Flectroshock.

We
electroshock
therapy.
Our studies have defined the process of
physiology;
brain
in
induced
changes
the
to
behavioral
the
have related
response
behavioral
of
the
type
affect
that
and
factors
sociologic
described personality
and
clinical
behavioral
between
response
the
and
defined
relationship
response;
of
various
the
types
to
relate
us
These
studies
permit
ratings of improvement.
PM
1090), electroshock and its varieties,
(metrazol
3,
convulsive therapy as drug
"convulsive
there.
of
concept
(Indoklon)
meaningful
into
a
and lately, inhalant
,

pies '.

�-2Based on these studies, reasonable criteria for the type of patient
"do well" with convulsive therapy can be defined. Continuing studies

will
behavioral
the
in
of
role
the
personality
amplify
designed.to
in this area are
non-electroshock
referbetween'out-patient
differences
the
define
to
response;
convulsive
inhalant
of
and
evaluation
an
(IIIc)
rals and in~patient populations
'

who

therapy (111a).
2.

.

£235 Therapy.

control
coma-chlorpromazine
insulin
of
conclusion
our
the
Following
1958.
and
.A.M.A.
in
early
will
appear
study, our report was accepted by he J
the
experimental
program.for
have
developed
a
we
months,
six
the
During
past
which
begun
was
(see
IIIb),
agents
psychopharmacological
new
of
evaluation
3.

Selection of therapies:

of
the
based
on
type
generally
is
of
therapy
While the selection
the
Such
as
aspects
decisions.
such
affect
factors
mental disorder, other
and
cultural
education
his
communicate
verbally,
to
facility of the patient
have
we
and
been
have
studied,
"authoritarianism”
background, and the degree of
rebear
significant
a
and
aspects
psychologic
such
historical
reported that
These
services.
for
ancillary
lationship to the choice of therapy or referral
of
the
in
factors
these
of
results
studies have led to an interest in the role
socioof
role
the
evaluate
further
to
therapy, and we have designed a study
(see
IIIc).
and
therapy
outpatient
of
inpatient
psychologic factors in results
(B)

Language as measurable behavior:

one.
complex
"in
is
a
'improvement
psychiatry
of
definition
and
change
behavioral
of
In evaluation of various therapies, the definition
have
sought
we
adequate,
are
While
descriptions
clinical
improvement is crucial.
Two
methods
of
our
behavior
patients.
the
language
in
guides
more
objective
for
interviews
of
structured
analysis
of analyses have been developed - a syntactic
and a dyadic of unstructured.
The

non-convulsive
and
convulsive
induced
by
changes
have described the
do
clinical
reflect
patterns
these
language
therapy, and find that changes in
to
these
techniques
of
the
have
application
to
led
Our
experiences
evaluation.
We

the drug evaluation studies.
effort
in
an
in
are
of
progress
language
other
analyses
In addition,
methods.
the
of
present
the
broaden
applicability
to
(C)
Neurophysiology of Behavior:
the
between
relationship
the
noted
we
In the electroshock studies
We
concluded
behavioral
response.
the
and
change
neurophysiologic
of
degree
and
behavior
in
change
to
a
essential
was
physiology
cerebral
in
change
that a
coma
therapy.
insulin
for
conclusion
We
same
the
come
had
to
to "improvement".
chlorpromazine
in
treatment
the
response
between
Since we had observed a similarity
was
mode
action
of
same
the
that
seemed
plausible
therapy and insulin coma, it
drugs.
newer
tranquilizing
the
for
operative

�-3review of the literature and some preliminary experiments supported
the
to
potent
are
agents
psychopharmacologic
newer
the
that
this hypothesis We
have
function.
brain
and
affect
predictably
extent that they measurably
and
in
of
Psychiatry
Congress
International
the
at
hypothesis
this
expressed
new
undertaken
have
we
As
a
a
Hillside
the
Hospital.
result,
the Journal of
(see
IIIb).
various
drugs
therapies
evaluating
project
.A

Concomitantly, our interest has continued in the biochemistry of
convulsive therapy. we have observed that diethazine, a potent anticholinergic
demonstrated
has
a
Further
analysis
electroshock
effect.
the
drug, reverses
These
observadiethazine.
LSDHZS
to
and
mescaline
between
marked similarity
as
system
cholinesterase-acetylcholine
the
of
confirm
the
significance
tions
which
behavior
of
psychotic
the
type
a basic mechanism for psychotic behavior may be affected by convulsive therapy.

Percgption:

(D)

have
change
behavioral
of
index
an
as
studies of perceptual tests
continued. We have defined the relationship between the degree of perceptual
demonstrated
Our
have
studies
function.
alteration and the degree of altered brain
Our

but
the
response,
in
perceptual
only
not
type
of
personality
the significance
also in the physiologic response, to convulsive therapy.
Our studies of tactile perception clarified the role of strength of
stimulus and of the type of instructions (set) in the reported reponses.

Individual Differences in Behavioral Responses:
The program of study of the ways in which individual differences in
various
to
of
subjects
and
affect
response
physiology
the
perception, personality
of
neurophysiologic
Green's
Dr.
studies
under
well
way.
is
psychiatric therapies
Dr.
emphasis
and
Pollack's
EEG
electroshock,
to
the
response
differences affecting
of
the
both
phase
in
are
drug
to
therapies
on perceptual aspects as they relate
collecting data in consecutive groups of subjects.
(E)

III.
(A)

New

Pro ects - Pro am.l 8

Inhalant Convulsive Therapz:

In the studies of electroshock, we have been puzzled by the significance
of the electric current in the treatment response. In the convulsive-subconvulsive
was
aftreatment
the
for
response
seizure
the
of
the
control study,
significance
compound,
inhalant
an
Recently,
clear.
not
was
current
of
the
role
but
firmed,
conﬂescribed
simple
was
as
a
safe,
of
ether
anesthesia,
the
to
ethyl
similar
vulsant. We visited the laboratory at Spring Grove State Hospital, Maryland, We
and observed the treatment. It was reliable, quick and easy for the patient.
have obtained a supply of this compound and are undertaking a study on February
of
biochemical
and
effects
psychologic
of
neurophysiologic,
the
clinical,
lst,
convulsive therapy using this compound.
(B)

Mbde

of Action of Psychophammaoologic agents:

experiences with other forms of therapy have led us to formulate a
the
In
agents.
essence,
psychopharmacologic
(see
IIc)
regarding
hypothesis
and
kind
of
effect
the
degree
to
related
behavior
which
is
affect
drugs
to
degree
EEG.
Fbr
this
the
purpose,we
by
measurable
in
part,
brain
have
on
function,
they
and
personnel
equipment
for
special
obtained
and
support
have written a protocol
from.the U.S.P.H.S. and various pharmaceutical concerns.
Our

�-l+-

In these studies, patients referred for drug therapies, as chlorpromazine,
promazine, reserpine, meprobamate, etc. , undergo special tests before and during
treatment, which may predict and reflect the treatment response.
(0) Psychologic and Sociologic Factors in Out Patient Therapy;

result of our studies in inpatients defining certain psychologic
sociologic factors as they affect treatment choice and treatment response,
As a

and
we have made predictions regarding the outpatient population.
to undertake a sociologic study of outpatients, and extend our

studies this Spring.
IV.
(A)

W318

We

are planning

inpatient

AND. I’UBLICATIONS:

Eigerimental Psychiatry Issue, Journal of Hillside Hospital:

of this Department wrote five
articles reflecting various aspects of our study program for the October 1957
issue of the Journal. This encompassed the whole issue. Such an effort is
unique in the Journal‘s history.
At Dr. Tarachow's

(B)

invitation,

members

Publications:

In addition to these five articles, our report on the relation between
EEG changes and treatment response in electroshock appeared in the Archives of
Neurology and Psychiatry. Seven other reports have been accepted for publi cation and two others are in the hands of editors as of January let.
(G)

Presentations:

Reports of our studies have been presented to psyc iatric, neurologic
and psychologic societies. Twelve reports were made before National societies
in the U.S. and three before International Congresses in Brussels and Zurich
during the summer. These reports have been generally well received.
V.

PERSONNEL:

changes in personnel have been made. We have requested, and the Research
Committee and Medical Director have approved, a restatement of the titles for
staff members from "Research Assistant" and "Senior Research Assistant" to
"Research Associate". The present staff consists of nine members including:
No

Martin A. Green, M. D.
Joseph Jaffe, M. D.
Robert L. Kahn, Ph.D.
Hyman Korin, Ph.D.
Max

Pollack, Ph.D.

Associate (Neurophysiology)
- Research
"
"
(Psychiatry)
-"
"
"
(Experimental Psychology;
"
"
(Experimental Psychology
"
"
(Ehcperimental Psychology)
-

and four technical assistants: Mrs. Hannah Mosque'ra (EEG) , Mrs. Jean Kolodw
and Mrs. Ann Horowitz(~?sycholinguistics) and Mrs. Janet Bowie (Secretary).

�-5VI.
(A)

TENTﬁIIVE BUDGEE PROJECTION:

1228-52.

Personnel:

In addition to the personnel listed above, we will request the addition
of a Research.Associate in Social Psychology; and a redesignation of the halftime neurophysiologist to a full-time status. These items will increase the
budget by $9500 above authorized annual increments for ongoing personnel.
(B)

Supplies.

Em

ment and Travel:

There will be an increase of $l000 in supplies and travel and a specific
equipment expense of $5200 for an EEG Analyzer. This instrument will provide
greater flexibility in EEG analysis. A supplementary request for this amount
has been asked of the U.S.P.H.S.
L

Total Egpensesz

(C)

av"

.

total

expenses for 1958-59
1957-58, an increase of $16,98h.
The

(D)

will be $95,796. as against $78,812

k"

"u.

Income:

In the past six months, this Department has been more successful than
anticipated in attracting research funds from private and governmental sources.
Fbr the current year, we anticipated $33,595 and so far have been advised that
we can expect $h3,h31 for 1957-58, an increase of $9,836 over expectations.
Fbr 1958-59; we have already been assured of $50,66h which is $7,233
more than 1957-58. It may be of interest that we already have funds for 1959-60
in the amount of $15,297. These grants totalling $115,235 have been made available to the Department for the period April 1, 1957 to December 1960.

Max

Mszb/b

Fink,

M. D.

A}\

fork¢3”4
We

Respectfully submitted,

V‘

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67274">
                <text>Progress and annual reports; research activities (folder title).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67275">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67276">
                <text>mfp-03-01-001-0-005</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67277">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67278">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67279">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67280">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67281">
                <text>Letters; Personality factors in behavioral response to electroshock therapy (draft) by Robert L. Kahn and Max Fink;  Progress reports of departmental activities; A proposed study for the behavioral assay of new drugs by Fink; Report of activities</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67282">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67283">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80930">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87491">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94052">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100613">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6729" public="1" featured="0">
    <fileContainer>
      <file fileId="3785">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/e160cd659a1c0564650ed815c2ffda05.pdf</src>
        <authentication>287e408e3d76bfef4519f4c1ea5b9ae6</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104411">
                    <text>(
g

,
a

n

I

E

.
!
r

l
,
E

i
P

me:
plated the
70110113;

Wt.
it. own»

1957. tho

ﬁrst wu-

of

of

W

mun-y oa-

of tho clan-pu- of

natal 1.1an“.

WW
with. W,
mun-mm-m

m mum

of th- buio

and

We”

pm
dandy!” wmmuﬁow WW $81957. m: CW
Mtnmwwmmtmunuhanmmmw
has. at an

a:

0.

mm}.

6103111

”My
W; N's-pm“
m
“ﬁrm"
mmuhm-M

muum

m
may.

for

in

and tho

«01015310

at!

rum-Mu, mmmacnzwm
mmtarmmmmmummmmm
can control study.
an. anon-mud in

6110me
Wanna Maturation, nWtdﬁzomuuﬂmd

Geno

a»

m
In.
3mm
mm, W
nun mum. mm.
m magma“,
manur- m mum

(Imp

and

0!

o.

with

the

Ward am

of nut

11.“.qu of we:

Into

applying

an

Into pitta-n- of cannula-ﬂan comma.
obs-euro mined: at
«unique! of

and

h

mmmWWu-W-mmmwm
when; mud. aunnmummmmpum. mn-

We
Wc
wimp-MW" mm,mummwsnmmnud
and

m

induced

mum

bu» for

continua.

mm

which“!

1n

mp”.

�.g......__‘-_,

&lt;. .

r._wr..v,... a.“

..

.

an“...

~.

My;

’1‘...” w

V

“rpm—c. v..-.~7.vv....v

”my—W..- m- 7 ~-‘ _ V-

w..."

,___ w'J—ln'n

.. ,_

—.-‘

\ ,u.,, .N

nu

.

vvvwmr

,.

»

w..,.._.v.....

d.
mummdthonmm,
unmask-Wt.
that
ad
{in
Was: manna. What“
umm
Journal
tho
of
thfor
'hponmnul
um
unk).
we)...
Why"

m

of tho

é

:

mnm- Hospital. ﬂu sun and“:

m “aA.

m,
W
am.
um
lab-n
11.9.

Edi.

11.».

m,
Ill: mm, m.
“lemma.
I»

Bub.

"

-

-..

_,

“mt mu (Wong)

W
"

"

*

.u

"

I

(me)
(Noun-um Why)
_

“

-

a

wzutmpmmwmmayuM7

E

i

‘

amurmwmmunnahrmummm,m
hum). mum at rum mu. an Wanna cm» at
munmmmanummmmumm.
mm,
mm
.

w m.

E

“n.—

ﬁ__.__4w-~m_——__V

O

”in.

n

,. —

�Richard Weiner

FROM:

FOR RELEASE

FINN INCORPORATED
13u.East 59 Street

RUDER &amp;

MAX

York 22, New York
PLaza 9-1800

New

FOR:

7, 1958

HILLSIDE HOSPITAL

A

Island psychiatrist whose research points to the underlying

Long

changes necessary to reverse the depressive type of mental
honored

this

Dr.

week by

Max

be

Fink, Director of the Department of Experimental Psychiatry

at Hillside Hospital,
A. E.

illness will
a major national psychiatric association.
Glen Oaks (Queens),

New

York,

will receive the first

Bennett Neuropsychiatric Research Foundation Award. The Society of

fé

Biological Psychiatry will present the award at the group's 13th Annual
Meeting in San Francisco, California, on May 11.

The meeting

is part of

:
'1‘

the American Psychiatric Association Annual Meeting.
Dr. Fink will present a paper on his work

Cholinergic Agent, Diethazine, on

EEG

titled, "Effect of Anti-

and Behavior:

Significance for

Theory of Convulsive Therapy."
The

report describes experimental studies of the neurophysiologic

for "shock" therapies. Dr. Fink and his associates
at Hillside Hospital have observed that changes inla specific enzyme

and biochemical bases

system of the brain, acetylcholine-cholinesterase, are intimately

to improvement in electroshock.

However, changes

related

in the opposite direction

are accompanied by hallucinations, delusions, and psychotic behavior.

that decrease the activity of the acetylcholine normally present,
in the brain excite psychotic activity. They also reverse the electroshock
Drugs

effect.

Some

of the newer hallucinogens, such as lysergic acid

(LSD) and

,

�-2mescaline, are most potent in this regard.

halts the hallucinogenic action of these
shock effect.
The

On

the other hand, chlorpromazine

compounds and enhances

Hillside research extends the understanding of the

the electro-

mode

of action

of convulsive therapies by defining the biochemical bases for the observed

neurophysiologic effects.
The

studies have been supported by the National Institute of Mental

Health and the Board of Directors' Research Fund of Hillside Hospital.
Dr. Fink is Secretary of the Section of Convulsive Disorders and

Brain Function of the American Psychiatric Association and President-

Elect of the Nassau Neuropsychiatric Society.

Hillside Hospital, an affiliate of the Federation of Jewish

is a non—profit, non-sectarian hospital
for psychiatric treatment, training and research.

Philanthropies of

New

York,

####

�_

»‘.&gt;\7"»

&gt;v.—

'—

~v-

16

Peace Missionary May
;’Have to Pacify “Family
'

i

i

.

'

i

Mrs. Lola Stone, pretty young Long Island. housewife
who’s on an interna—
tional peace mission to ban nuclear
tests, may have some pacifying to do when she
gets home.
The husband and two children of the globe-trotting
proud of her campaign, but they miss her and Wish she’d 'peace missionary are
hurry home to Kanes
Lane, Huntington Bay.
,

.TA Reiecis

1

"‘We think she’s wonderful,
we’re quite proud of her, but it
urts some time,” her husband,
Robert, said with a smile.
‘We’re counting the days.”
Mrs. Stone is one of a group
of five pacifists on a 4,000-

Protest

mile tour of European capitals
‘

By MBA

‘

They have been stalled in
Helsinki for a week because
of the reluctance cf the Soviet
Union to grant them entry
The Transit Authority today
visas.
brushed aside a Motorman’s
“We are hoping the visas
Benevolent Association protest
will come through,” Mrs. Stone
that it would be “dangerous”
told her husband by phone
for‘ motormen to leave their
from Helsinki. “The most imcontrols on the EMT Myrtle,
portant part of our mission
Avenue line to help operate the
lies ahead. We hope this is
doors.
just a routine delay.”
“The MBA is making a DR. MAXIMILLIAN
FINK
The group flew from Idlemountain out of a molehill,” a
wild April 14, and stopped at
TA spokesman said.
London, Paris, Bonn and West
Theodore Loos of Jamaica,
Berlin to interview national
the association’s president, proleaders and “just plain people.”
tested yesterday that a train’s
Despite a brush-off "at 10
brakes might slip -— and the
Downing St., official residence
train start rolling—while the
of British Brime Minister Harmotorman was out of his cab.
old Macmillan, the overall re“Under our order,” the Tranaction was “favorable and opsit Authority spokesman said,
timistic,” Mrs. Stone reported.
“the motormen will have to
l.The scheduled last lap of the
leave his cab only under cerjourney was to be Russia,
tain conditions . . . and those A Long Island
psychiatrist where the group hoped to perconditions Only crop up once will
receive the first A. E. Ben- suade Kremlin officials to
in a blue moon.
Even if the motorman leaves nett Neuropsychiatric Re- agree to an unconditional ban
on nuclear testing as “a demhis controls, he’ll never be search Foundation Award.
more than four feet from the He is Dr. Ma'ximillian Fink onstration of their sincerity.”
Expenses of the trip are
brake.”
of 13- Bayview Ave., Great being borne by “Non Violent
The TA said its order applied only to a few stations on Neck, director of experimental Action Against Nuclear Weapthe Myrtle Avenue line. At psychiatry at Hillside Hospital, ons,” the same group that
sponsored the voyage of the
those stations, there’s no Glen Oaks.
“Golden Rule,” stopped
change collector at night, so Dr. Fink ‘will receive the ketch,
the conductor on the train col- award. Sunday from the Soci- by the Coast Guard off Hawaii.
lects fares. The motorman will ety of Biological Psychiatry at
be asked to help the conductor its annual convention in San
Fishermen Angry
out when a “big crowd” boards Francisco.
the train.
Over Empty Pond
He is being honored for re“We only pick up an aver- search- into the
effect of HARTFORD, Conn. (UP)—
age of four persons per trip at “shock”
Red-faced officials of the State
all those stations put together,” “we’vetherapy.
been able to discover Fish and Game Department
the TA spokesman said. “We
the mentally ill respond admitted somebody
goofed
.
.
almost never get a crowd how
to shock therapy,” Dr. Fink when angry fishermen
pomt')
\ ' there."
explained. “And, just as im- ed out in a department-proportant, we’ve learned why vided pamphlet that Day Pond
some persons do not respond in Colchester was stocked with
”at
trout and open for fishing.
to such treatments.”
j t'Dr.’ Fink has livedtin Long The anglers had risen before
I
Island since 1950, and was ap- daWn! ion:- opening day and
made thetrip to the Mind,
'
r
3

_

'

‘

'

Psychiai‘risfs

Will Honor
L. Docfor

_

_

giteconsider

'11:,

,

Q

.

.

’

.

U

�1/15/59
Department of Egperimental Psychiatry
and
the
of
presentations
a
chronologic
Following is
list
of
members
Experimental
the
of
Department
of
the
publications
Psychiatry during 1958.

M
Publications:

A.

1.

Changes in Language During Electroshock Therapy, in
of Communication, Hoch, P. and Zubin,
Ps cho atholo
3. eds., Grune E Stratton, (Kaﬁn, R.L. and Fink, M.)

2.

Lateral

3.

h.
5.
6.

Gaze Nystagmus as an Index of Sedation Threshold,

Clin. Neurophysiol. l9: 162-163 (Fink, M.).
Effect of Diethazine on EEG and Significance h for Theory
8101. 19:
of Convulsive Therapy, EEG. Clin. Neuro
207-208 (abst.) (Fink, H.5.
Experimental Studies of the E1ectroshock Process, Dis.
Nerv. Syst. l2: 113-118 (Fink, M. and Kahn, R.L.).
Comparative Study of Chlorpromazine and Insulin Coma
18h6-1850
166:
J.A.M.A.
of
Psychosis,
Therapy
(Fink, M., Shaw, R., Gross, G. and Coleman, F.C.).
Eleotroencephalographic Correlates of the ElectroshockM.
227
(Abst.) (Fink,
Nerv.
Dis.
Syst.
12:
Process,
EEG.

and Green,

7.

8.

9.
10.

l1.

R.,.

Language of the Dyad, Psychiatry El: 2h9-258 (Jaffe, J.).
Clinical and EEG. Effects of Megimide in Patients without
M.
682-685
(Green,
Cerebral Disease, Neurology g:
and Pink, M.)

Effect of Anticholinergic Agent, Diethazine,
&amp;

on EEG and

Psych. ﬁg: 380-388,
Behavior, A.M.A. Arch. Neurol.
(Fink, M.).
Experimental Studies of Convulsive and Drug Therapies on
A.M.A.
Arch.
Theoretical
Implications,
Psychiatry:
Neurol. &amp; Ps ch. 80: 733-73h (Abst.) (FinE, R., Kahn,
R.E. and Green, M77.
Brain Damage, Mental Retardation and Childhood Schizophrenia,

12.

Oculomotor and Postural Patterns in Schizophrenic Children,
A.M.A. Arch. Neurol. &amp; Ps chiat.‘12: 720-726
(Pollack, M. and Krieger, H.P.5.

13.

A.M.A.
Arch.
of
Denial
in
Factors
Illness,
Interpersonal&amp;
Ps chiat. ﬁg: 653-656 (Jaffe, J. and
Neurol.
SiBtEj'W.H.).

�1h.

B.

Predictions of Outcome, in Youthful Offenders at
Hi hfields, Weeks, H. Ashley, e3. U. of
Michigan P ress, Ann Arbor (N. Siegel).

Presentations:
EEG Correlates of the Electroshock Process, at the
1.
Eastern Psychiatric Research Association, February,
M.
N.Y. (Fink,

3.

and Green, M.A.).

EEG
Changes
in
of
Individual Variability
Significance
During Electroshock Therapy, at Eastern Association
of Electroencephalographers, March, Montreal,
(Green, M.A.).
and
Drug Therapies
Convulsive
of
Studies
Experimental

in Psychiatry: Theoretical Implications, at
New
York Society of
and
Society
Neurological
Clinical Psychiatry, March, N.Y. (Fink, M., Kahn,
R.L. and Green, M.A.).

Abnormal
and
Normal
in
and
Attention
Visual Perception
’Children, at American Orthopsychiatric Association,
March, N.Y. (Pollack, M.).

Patterns with Altered Brain Function, at
Eastern Psychological Association, April,
and
M.).
R.L.
Fink,
Kahn,
(Jaffe,
Philadelphia
J.,
and
F
Behavioral
Physiological
Score
to
of
Relation
Response with Altered Brain Function, at Eastern
Psychological Association, April, Philadelphia,

Communication
The

(Kahn, R.L. and Fink, M.)

7.

Intellectual Deficits in Patients with

Space Occupying

Lesions of the Cerebrum, at Eastern Psychological
Association, April, Philadelphia (Pollack, M.,
Battersby, W.S., Kahn, R.L. and Bender, M.B.).
Simultaneous
of
and
of
Perception
Stimulation
Intensity
Stimuli in Cerebral Dysfunction, at Eastern Psychological Association, April, Philadelphia (Korin, H.).

�-3-

10.

Socio-Psychological Aspects of Diagnosis and Treatment:
Theoretical Implications, Symposium - Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Pollack, M.).
Drug Induced Changes in Interview Patterns, at
Conference on Psychodynamic, Psychoanalytic, and
Sociologic Aspects of the Neuroleptic (tranquilizing)
Drugs in Psychiatry, April, Montreal (Fink, M.
and

All.
12.

16.
17.

18.

19.

Psychological Factors Affecting Individual Differences
in Behavioral ResPonse to Convulsive Therapy, at
American Psychiatric Association, May, San
Francisco (Fink, M., Kahn, R.L. and Pollack, M.).
Prognostic Value of Rorschach Criteria in Clinical
Response to Convulsive Therapy, at Electroshock
Research Association, May, San Francisco (Kahn, R.L.
and Fink, M.).
Effects of Anticholinergic Agent, Diethazine, on EEG
and Behavior: Significance for Theory of Convulsive
Therapy, at Society of Biological Psychiatry, May,
San Francisco (Fink, M.).
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital, at American Psychiatric Association,
May, San Francisco (Kahn, R.L. and Pollack, M.)
A Critique of "Pre-Conscious" Perception and the
"Poetzl Phenomenon," at American Psychiatric
Association, May, San Francisco (Pollack, M.).
Role of EEG Frequency Shift in Behavioral Effects of
Drugs, at Section on Neurol. &amp; Psychiat. Queens.
County Medical Society, June, N.Y. (Fink, M.).
Effect of Anticholinergic Compounds on Post Convulsive
EEG and Behavior, American EEG Society, June,
Atlantic City (Fink, M.).
EEG and Behavioral Effects of Psychopharmacologic Agents,
at Collegium Internationale Neuro-Psycho Pharmacologicum, September, Rome, and Eastern Association of
Electroencephalographers, December, N.Y. (Fink, M.).
Prognostic Application of Psychological Techniques in
Convulsive Therapy, at Eastern Psychiatric Research
Association, October, N.Y. (Kahn, R.L. and Pollack,
M.).

20.

Jaffe, J.).

'

Relationship between Seizure Threshold and Duration of
Seizures to EEG Change During Electroshock, at
IEastern Association of Electroencephalographers,
December, New York (M.Green).

�uuucav twain; by»: anuunsu

.lmost as well as if he
:ould see. Here he climbs
the schdol steps with his

ypewriter to attend ‘ a
class.

\\\\\\

&amp;\\\\\\\\\\\\\\\\

\\\\\\\\\\\“
\\\\\\\

t
J}

\
MD Records
Brain Waves
Of Patients
,

A history written in brain

waves is telling the story
today 01' how successfully
the mentally ill are responding to electro-shock and

drug treatments.
Dr. Max. Fink, a Great
Neck psychiatrist who gave
up a proﬁtable private practice to “prospect for Iacts”,»~
has developed a method of
evaluating the brain waves
of patients at Hillside Hospital, Glen Oaks,_ where he’s
been leading an eight--man
research team for four
years.
The brain wave "history”,
recorded on graph paper
and transmitted by an. electroencephalogram, enables
the hospital's staff to “treat
patients with more direction” Fink says.
It works this way:
The encephalogram picks
up brain waves of a new
patient and records a “base
line” on the graph.
As the patient is treatedand repeatedly tested the
variations are recorded on
the graph. Comparisions
show whether a patient is
. or isn’t . . . responding
to a drug or shock treatment.
,

l

f

,

1

;
I
1

1

l
K

1

‘

.

-

-

3|!

1|:

1‘

“THE STUDY gives a
new and keener sense of
direction in treating the
patients,” Fink said.
For example: If a patient’s brain wave “history”
shows that his response to
is suddenly

'

'

�“1191110

Jemeqm 01 31110
Buons KlaA 8 S1,, 1112833 301s
Amman: amooaq 01 1113111
£11231

S1 911

-aonpu1

119011119110 9111

queued

.

12

s1s1sax

PWWI‘IXa 9H
'ppas 151111210st

1

'

ha]

um 112112, 51901u19110
01121190 puno; aA'eq 9AA”
3511;

'BO‘BId

mnsu! me

01111

111

11011

mm 1nd

219111

3111

lent
1elr

SSJBABJ KHJBIOG

9113,

g

3111
111911311

10 1110

[swam

K1219

1;

eu1uua1ap d19q
11mm

(111

Fsoq am

#4,!»

'.1c'[ 5111110111

Emma

9111

3,5121

sanp

seq wee],

91110:)

unease; s‘xum
ma;

1111111

19111311111

3,2111

’Ielld

sgqgepuno; [no
panoddns A11u1o§

p112

”3.190111 -‘Kq‘

s; 109(0ch 9111. was Hum
‘l‘summeu p003 KJIBA” paonp

v;

'-o.1d seq 21031on

Jeeﬁ-e-ooo‘oow

ép1s111H

112

pomém man

‘

'sKes

a:

$11.11

1101129591

9111

$1110
9111

i

“‘mou

919111“
pasn s1

as
avg
ii

13d 08

11190

AIa1'eu11x01dde”, o1 padumg

'

.seq eBe1uaJJad 3111,
1911qu 3111 mm; paseapx
aq 01 K11ua1o111ns pI—JJBAOOGJ
smemman 110qu .10 8111p

smeared 0111
10 “3,1130 13d 09 moqe” K1uo
‘1211dsoq 91.13, 12 pasn_ pue
paldope sem pomaux aAem
pa.11nb‘ax 011m

'

KING.
.‘mo
‘

”0198
“'Janeq smamman

51311113.

'JCI

sn smone

0),

az1111n

Apn1s

emem 1112.1q
PIPS RUM VICI «1-1qu

9111,,

qu

01

mammal; man

11

'UOIS

-SB.IBB.I 3111, 1199110 p118

An

A13131d

-1noa 'e 2193 52111 ‘wJo; [eu1
$1.10 511 o; xoeq ssa.1831 o1

su133q uo1z11puoo asoqm .10
‘luauxaAmduu JO nonessao
'e uaaq $911 91311), sa;eo1pu1
uo111p1100 asoqm waned V
911'),

-3AOJliﬁlt
_

Kauanbaa;

umoqs

qde
s1

3113111

mun aﬁesop
111

.10

peseaxou1 aq
—

!

B

33’

000i

u1ens pue’ ssans 10 p1.10m
9113, 01111 peseeﬁu uaqm 1121111

-soq

b1

11:10

aAeq em ssa.1

spun

1111M

-30.1d
4113;

ho

inmo- atn “‘1uaned

XOGN

e

or

01 39.1391)

1101112»

9111’ 19111

ZS

.r‘»_(’

’

�February 25, 1959.
Department of Experimental Paychiatry
Annual Report

-

1958

During 1958, the major emphasis of the

staff of the

Department of

Experimental Paychiatry shifted from evaluation of convulsive therapy to

systematic investigations of newer psychopharmacologic agents. These

investigations, derived from the successful evaluations of the

mode

of action

of convulsive therapy (l95h-l958), reserpine (1955), and chlorpromazine and

insulin

coma

(1956-1957), are based on the neurophysiologic-adaptive hypothesis

of physiodynamic therapies developed in the Department in 1957
ﬂggg. é? 197-206).

the

The

many new compounds

(J. Hillside

interrelationship of the neurophysiologic effects of

with the psychodynamic, perceptual, personality and

sociologic aSpects of patients' behavior provide the framework for these

investigations. In addition, linguistic indices developed in the Department
during the past two years by Drs. Kahn and Jaffe are being studied as measures

both of behavioral change and of neurophysiologic effect.
During the year, the evaluation of convulsive therapies was continued

effects of indoklon, an inhalant convulsant, with electroconvulsive therapy. 'This study was undertaken by two senior resident

by comparing the

psychiatrists,

B. Alan and H. Lefkowits, and Drs. Green and Fink.

While

indoklon therapy was a successful treatment, technicallimitations made
poor substitute for the established

electrical

methods.

The

it a

study was of

theoretic value in indicating that the significant element of convulsive
therapy was the induction of the grand mal convulsion, with

its attendant

neurophysiologic effects, independent of the type of agent employed.

�V

,

.2Investigations into the relations of sociologic factors to the

selection of therapies at Hillside Hospital were extended by Drs.

Kahn and

Pollack. Not only were the factors of age, education, birthplace, and score
on the California F Scale significantly related to the choice of therapy but
these factors were also related to the results of therapy, the diagnosis and
the duration of hOSpitalization. These observations were presented in the
Sunday Conference of October 16, 1958.
and

On

October

7

the study was repeated;

similar studies of the population of other primarily psychotherapeutic

hospitals,

and the Hillside Hospital Out-Fatient Department were undertaken.

To augment

these studies, Dr. Nathaniel Siegel was appointed as Research

Associate in Sociology, with the support of a grant from the Mental Health
Board of Nassau County.

In an extension of the communication studies, both the syntactic
content analysis and dyadic diversification measures of formal aSpects of
speech were applied to an evaluation of the changes in language patterns

following the acute administration of various new psychotropic compounds.
These measures demonstrated

and the neurophysiologic
The

consistent changes both with the induced behavioral

effects of the drugs.

acute drug interviews were but one asPect of the continuing

evaluation of the biochemistry of convulsive therapy. Previous studies had
indicated that repeated induced convulsions resulted in an increased level
of central nervous system acetylcholine activity.

€g¥:;;;;:;;;;:§
of various
anticholinergic
stages of convulsive therapy

we

compounds

By

the acute administration

to patients at various

elucidated the synaptic chemical events

which are the basis of the convulsive therapy process.

�-3In addition,

Mr. Karp and Drs. Kahn and

Pbllack continued their

perceptual studies in patients receiving psychodynamic therapies. The interrelation of psychotherapy with physiodynamic therapy was studied by Drs.
Esecover, Jaffe and Kahn; and in the
and H. Lefkowits began an

latter part

of the year, Drs. A. Kaplan

investigation into the interpersonal factors in

therapists, as well as patients, leading to the referral for physiodynannc
therapies.
During the year, Dr. H. Korin resigned, and was replaced by Mr. Eric
Karp.

TWO

new

staff

appointments include Dr. Nathaniel Siegel, Assistant

Professor of Sociology at Columbia University, as Research Associate in
Sociology; and Dr. Donald Klein, research

candidate at the

New

York Psychoanalytic

scientist at
Institute, as

Creedmoor

Institute

Research Associate in

Psychiatry.
Support for this extensive program was provided by the Board of

Directors, and continuing grants of the Foundations'

Fund

for Research in

Psychiatry and the National Institute of Mental Health. At year end, this
program received considerable Support from the Psychopharmacology Service
Center of the National

Institute of

Mental Health, which augmented

extensive commitment by a grant of $268,000. These

its

already

further

sums were

increased during the year by support from the Mental Health Board of Nassau
County which provided funds

Smith, Kline

&amp;

for sociologic studies;

and from

Bristol, Geigy,

French, and wyeth Laboratories ~ who aided the drug evaluation

program by grants as well as extensive supplies of the agents

During the year, fourteen reports of the work of

staff

to

be

studied.

members

appeared; and twenty reports were presented to major professional societies.

�-hIn addition to national societies, work of the Department was presented at
the Conference on Psychodynamic, Psychoanalytic and Sociologic Aspects of
Neuroleptic Drugs in Montreal, and the International Congress of Neuropsychopharmcology in Rome.

Staff

first

members were awarded two

prizes. Dr.

M.

Fink received the

annual A.E. Bennett Peychiatric Essearch Award of the Society of Biologic

Psychiatry for his report on the effects of anticholinergic agents on

EEG

and

behavior. Dr. J. Jaffe received the Gralnick Foundation annual award for his

report

on the

application of analysis of changes in fonnal aSpects of Speech

in psychotherapy.

�-5The

staff

of the Department of Experimental Psychiatry included,

at

year end:
MEX

Fink, M.D.

Direeees

Joseph Jeffe, M.D.

Research Associate (Peychiatry)

Donald F. Klein,

Research Associate (Peychiatry)

MQD.

Robert L. Kahn, Fh.D.
Max

Pollack,

Pth.

Research Associate
(Experimental Psychology)
Research Associate
(Experimental Paychology)

Nathaniel Siegel, Ph.D.

Research Associate (Sociology)

Eric Karp, B.A.

Research Assistant
(Experimental Peychology)

Martin A. Green, M.D.

Associate in Research

Abraham A. Kaplan, M.D.

Associate in Research (Paychiatry)

Barre Alan, M.D.

Fellow (1957-58)

Henry Lefkewits, M.D.

Fellow (1958-59)

The

(Neurophysiology)

technical staff included Mrs. Janet Bowie, Jean Kolodny,

Mbsquera and Blanche

Hannah

Zaitz.

addendum: In February Dr. George Krauthamer, Ph.D. was appointed

as Research Assistant (Experimental Psychology).

electroencephalography.

He

is a trainee in

�nan-{u

£55,

1959.

lupurtuoat at ngcriunutal rayshxttvr
‘lunaal Icpcrt

~ 1955

ﬁtting 1953, it: 3.3.9 atyhnstg I! it. i‘l!‘ at tho
ﬁapartunat it xxptriuaninl firth$¢%ry Ihlf‘ll tron utilisatog
at convulsivt thurupr to tru‘unsttc tavnu‘acatinua a: utuar
paynhnpitamnnoiauin attain. tunic tsvultxgntaill. inrtth
Iron in. littl8if§1 evaluaiiOII or ﬁt. and: of 30‘s.: it
nonralltvv thirty: (19$h~1956). IlllrpllO (1958). in: ohlcrv
prunastnn uni 13.31%: can. (1!5‘~1!S?). are biaad on th.
ultrtplftiﬂltilinlltpit?! lyptihovti at piyctudynugac shoIUplon
ilviaupul in it. ﬁdpnriutnt in 1’37 (3. lilgggdﬁ aggg.‘gi
191~!06).

{it zutirrtxitiluuhiv a:

it. noarophyltqlocso

uttccts at st; unnr'nou taupe-nan with ﬁt. ysywhodraunic.
pavuuyttnl. parlouulttr can 100301.110 Itpoc£a a: paﬁtunts’
ﬁchavtor pruvt‘o it. tranauurk (or that. tatto$1gtttona. In
I‘¢1$&amp;Qn. linguistic indict: Ctvtltptd In it. burnrtanat
during tho y‘at iii 3“?! h: ﬁra. its: an: anxta £33 icing
aﬁnlacd a: ltnntrns butt-o: snttvaornl gluugc and a: unuroatylaslal11_c££¢st§

Birlll

‘

30:», ‘hn nviltnssal ¢r cunvllutv. ihariaaao
It! «outlnnwd hr aiuparins tic ntIUuic a! xndokxou, ll intalint
Giuvnlnult. wait cioctitcinv‘lctvu ‘hirlpr. this Itu¢r'uua
Iatcrﬁnhtu i7 is. nonior routdnnt purittotrtgtc, I. 51:. an:
£33

I. Latiusita, int Ira. aroma and itat. “talc indctlnl thirty:
was a lltﬁillf‘l $roo$nnnt, tachataal ltnitutttna nut: tt 1

�up"

you

mama

{or

it. «mam alum“: with“. m
an
m» «mum “at a. “pianist

W:

It“: a
can» a: emu” “my in; a» mum or 1-» [mu
m mum. with in “Mt magnum: «In»,
a: u. tn» :1 “on min“.
«It
Mntmuuu at. a. mm. mans. rum:
to m «luau of “mm ct 3111“.“ “mm M:
an.»
hr
only
an
as
in
tum:
mm.
an
m
“W
or m. mum. sauna». and arm a m editors“
I Seal. “sauna!” villi“ to m ¢um .1 till”, b“
in" “can an an ”um u m m1” at
m «and: all m man at mustang... m»
was

Wt

’

W.

an 3mm
“was”1993.
and
7m
«mum
Mmmm;
mu,
any.» M1» at th- mum of «In» my pm!»
an
Mann.
mhnttut
mud:
ms»).
a.
wanan «arm. 9'. mt mu umm. am
an
an“:
lama
m
“man
a
am:
mm
a: 1 mt m ﬂu man:
analogy, with ﬂit
W
In!“ m .0: lam cm.
In a
a:
no
gun...
m
m
smut“
'2th
«nun»
in u:-

may Gal-(mu u

Wt

u-mu m in!“ “main“ mm:
at! (cm mat. a: ”all
0:
«911“
mutant:
u
an
a
”than «nun; m min mun»
tn Mn in
$11: 0! arm: nu ”mama
Mo
mmWu.
mnnua «Intuit «as» an an m an.“ mmra
mucus

m

�~30

Ind 58. attriptsiluiogln drrlnta a! ‘50 (tutu.
tho :tuto iris II‘.IVIGII airs Uni an: tivit§

ﬁnutaluinr uralnattan

ncmy.

a:

.3

it.

it. hinalnuttﬁry'at unwrilntvl

‘

mm- mm m mun-d mm mm

sudteod convalntuns runnittd in an incrtngod lattl or ¢¢ntral
larvana tyn‘tn asnirlthalnao activity. 31 $5. taut. ninth.

iytruttnu o: tartan: £urttumyunnano Il‘tttlﬂlliriii uuupguuda
i0 paticn$l at vtrinmc ittttl n: unnvulcirc thoraar u.

datum m mun:

W

«nu mu m m

of it. ssnvulltvc thnvnpy'yrnetut.
In tﬂlttiin, It. 1:13 Ind 3:1. (It: and fuzinnk
couiiaxnd $8.1! ycrtnptunl ctuiicn a: puatlutt rccctvinc
payuhcdynnato iharuptuo. its {starrolutt-I at ptfiha$harapr
tit! piwiiod’nauit ‘harulr III utudiad k7 bra. lltcuvur,

Silt.

In“. an an; ad in m m... u» or u. m, an.
lupin; Iii I. Latioulis began an invua‘lat‘tan tut. iii

1.

iv Ir. Ira. tarp. it. saw tint: appalltntata tlilﬁdﬂ Dr.
lithnnatl $13.1, ttoisttnt frotoccor c: sacialtur l‘ Guarani.

Unawaraity,

at Itnnutah ltuuctntc in

IOISOIII13 Ind Br.

Basalt Izctn, rootarct auiuuttit n! erauilsor Inniiﬁutc and
canlslato at $8: low lurk rqrcho:xllyﬁie Inltttlto. at

am! and“. a puma-y.

�4,.

mt
t
m
ﬂu
an
I!
autism:
fmﬂ‘mv
3mm,
all“
m
tu-

.1,

nu main

m 9min“ is

Inn-“ah
vacuum
m
"an":
at
a
m
mm
at
m
tu-

mm mu. an» m. an 9mm unit“ «a»
tun m Myth-awn.” 8min
«mm.
mm of a. bum tutu“. .2 mm m1», nut

W

«mm
“68mm.

its alum

M

om“

annual-nit 37

MM!
in”
m

a»

grant a:

m
mm m; m

wnwmummm mama-Inn‘smu

um mm: M. in mama Isms»; M 3m
tram, «m. mu, na- Mat. ml in“ 3.5mm”.
-m
a. nu walnut. "an: by an” a an u
«may. mm» at the am“ a In this“.
tho
may my", tum mu 0! a. an! a «at:
and
mun mama; m» mm: an yum-mm to “an
”wanna mun». In man u mum: sauna,
uni at a»
m mum“ at m man»: u
1:

m

mu
”whirls-u, "73W“

1min)“: ml
It

in

mm,
1:

and

autumn zap-uh

and tho

IanWlm
am: mun at" M

am.

or

Int-mum cum”

“It print. 3:.

R.

ﬂak

man“ m am mu). 1.». am“ human; Swami
am it it. “all“: st um“ “mum at Ma up»!
0!
an
m
an.»
u
m
w Witt.
mu
datum.
‘

�.s.
tantalum
mu! m
in
a. um mind emu
at
at
I» in mat a a. manual ”an“ than
in am mu“ .2 moth 1: ,WW.

J.

�«64-

150 3%.::

at tic ntynrtlcut if lupcrtncn.t§ rtythittry

Intliiad. at 33.! out:
an: vagu.

Bitiytar
ln-taruh tsuoctuit (ragthtttrr)

I.3.

Jenny! Jatfb. lb!»

mm:

‘1".

lthort

L.

III:

mm,

mm.

Illa. Pl.ﬁ.

"Mk'

Inn.

llﬂlﬂllnl itigul. thaa.
Wm..—

m. M,
‘O
”#3;
mm 0m.
30‘.

.

3",;
3"“;
AW
3.;

It!!! ”all, I’D;
lint: Luthuui‘s, lpﬂ.

ltﬂiﬁrti Aasuoiuﬁn (firthtttry)
Iliilfﬂh Atlliilii_
(lupotinuuttl rtvuhaztux)

Intonrnh snln¢tutn
(invtrilnttll P-vthnlacy)
inaalvuh Asaaitnﬁc (80:103.:71
Icaiirdh Aaltcﬁaut
.(lagnrlnnntul rurnlnlocy)
£::o¢tnto in nasatvcl
(lvuruphyntilugy)
guspntsia in Ittoarol (rsywhaatry)

villuu (19£?~$ﬁ)
Ibllov (1955-59)
‘15::
Juan
Janet
tuulllod
urn.
tastu1¢i1
loioinr,
Inuit.
It.
luntni aboqutti an: lxanaht 3a1$n.

�1/15/59
Department of Experimental Psychiatrz

list

and
the
of
presentations
a
chronologic
Following is
of
Experimental
members
of
the
Department
of
the
publications

Psychiatry during 1958.
A.“ Publications:
1.
Changes in Language During Electroshock Therapy, in
of Communication, Hoch, P. and Zubin,
Ps cho atholo
3. e38., Urune E Stratton, (Kaﬁn, R.L. and Pink, M.)
of Sedation Threshold,
2.
Lateral Gaze Nystagmus as an Index162-163
(Fink, M.).
EEG. Clin. Neurophysiol. lg:
EEG
and Significance for Theory
on
of
Diethazine
3.
Effect
of Convulsive Therapy, EEG. Clin. Neurophzsiol. l9:
207‘208 (abate) (Fink,
Process, his.
h.
Experimental Studies of the Electroshock
M.
and
Kahn,
R.L.).
113-118
(Fink,
Nerv.
l2:
Coma
and
Insulin
of
Chlorpromazine
5.
Comparative Study
18h6-1850
166:
J.A.M.A.
of
Psychosis,
Therapy
G.
and
Coleman, F.C.).
Shaw,
Gross,
M.,
R.,
(Fink,
6.
Electroencephalographic Correlates of the ElectroshockM.
S
Nerv.
Dis.
st. $2: 227 (Abst.) (Fink,
Process,
o

o

stt.

and Green, H.$.

7.
8.

9.
10.

(Jaffe, J.).
Pszchiatrz 3;:
Effects of Megimide in Patients without
M.

Language of the Dyed,

Clinical and

EEG.

2h9-258

Cerebral Disease, Neurologz Q: 682-685 (Green,
and Fink, M.)
EEG
and
on
Diethazine,
Agent,
of
Anticholinergic
Effect
&amp; Pszch. ﬁg: 380-388,
Arch.
Neurol.
L.M.A.
Behavior,
(Fink, M.).
on
and
Drug
Therapies
Convulsive
of
Studies
Experimental
Arch.
A.M.A.
Theoretical
Implications,
Psychiatry:
Neurol. &amp; Ps ch. 80: 733-73h (Abst.) (FInE, 3.. Kahn,

F.I.

and Green, M77.

ll.

Brain Damage, Mental Retardation and Childhood Schizophrenia,
Am. J. Pszchiat. 115: h22-h28 (Pollack, M.).

12.

Oculomotor and Postural Patterns in Schizophrenic Children,
A.M.A. Arch. Neurol. &amp; Ps chiat..12: 720-726
(Pollack, M. and Krieger, H.P.5.

13.

Arch.
A.M.A.
of
Denial
in
Factors
Illness,
Interpersonal&amp;
Ps chiat. ﬁg; 653-656 (Jaffe, . and
Neurol.

Slate,

W.H.$.

�1’40

B.

Predictions of Outcome, in Youthful Offenders at
Hi hfields, Weeks, H. Ashley, e3. U. of
Michigan P ress, Ann Arbor (N. Siegel .

Presentations:
1. EEG Correlates of the Electroshock Process, at the
Eastern Psychiatric Research Association, February,
N.Y. (Fink,

M.

and Green, M.A.).

2.

EEG
Changes
in
of
Individual Variability
Significance
During Electroshock Therapy, at Eastern Association
of Electroencephalographers, March, Montreal,
(Green, M.A.).

3.

and
Drug Therapies
Convulsive
of
Studies
Experimental
in Psychiatry: Theoretical Implications, at
New
York Society of
and
Society
Neurological
Clinical Psychiatry, March, N.Y. (Fink, M., Kahn,

R.L. and Green, M.A.).

Abnormal
and
Normal
and
in
Attention
Visual Perception
Children, at American Orthopsychiatric Association,
March, N.Y. (Pollack, M.).

Patterns with Altered Brain Function, at
Eastern Psychological Association, April,
and
M.).
R.L.
Fink,
Kahn,
Philadelphia (Jaffe, J.,
Relation of F Score to Behavioral and Physiological
Response with Altered Brain Function, at Eastern
Psychological Association, April, Philadelphia,

Communication

6.

The

(Kahn, R.L. and Fink, M.)

7.

Intellectual Deficits in Patients with Space Occupying
Lesions of the Cerebrum, at Eastern Psychological

Association, April, Philadelphia (Pollack, M.,
Battersby, W.S., Kahn, R.L. and Bender, M.B.).
Simultaneous
of
and
Stimulation
Perception
of
Intensity
Stimuli in Cerebral Dysfunction, at Eastern Psychological Association, April, Philadelphia (Korin, H.).

�-3-

10;

Socio-Psychological Aspects of Diagnosis and Treatment:
Theoretical Implications, Symposium - Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Pollack, M.).
Drug Induced Changes in Interview Patterns, at
Conference on Psychodynamic, Psychoanalytic, and
Sociologic ASpects of the Neuroleptic (tranquilizing)
M.
Montreal
(Fink,
Drugs in Psychiatry, April,
and

11.

12.

13.

16.
17.
18.

19.

Jaffe, J.).

Psychological Factors Affecting Individual Differences
in Behavioral Reaponse to Convulsive Therapy, at
American Psychiatric Association, May, San
Francisco (Fink, M., Kahn, R.L. and Pollack, M.).
Prognostic Value of Rorschach Criteria in Clinical
Response to Convulsive Therapy, at Electroshock
Research Association, May, San Francisco (Kahn, R.L.
and Fink, M.).
EEG
on
Diethazine,
of
Agent,
Anticholinergic
Effects
and Behavior: Significance for Theory of Convulsive
Therapy, at Society of Biological Psychiatry, May,
San Francisco (Fink, M.).
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital, at American Psychiatric Association,
May, San Francisco (Kahn, R.L. and Pollack, M.)
A Critique of "Pre-Conscious" Perception and the
"Poetzl Phenomenon," at American Psychiatric
Association, May, San Francisco (Pollack, M.).
Role of EEG Frequency Shift in Behavioral Effects of
&amp;
Neurol.
on
Section
Psychiat. Queens
Drugs, at
County Medical Society, June, N.Y. (Fink, M.).
on Post Convulsive
Effect of Anticholinergic Compounds
EEG and Behavior, American EEG Society, June,
Atlantic City (Fink, M.).
EEG and Behavioral Effects of Psychopharmacologic Agents,
at Collegium Internationale Neuro-Psycho Pharmacologicum, September, Rome, and Eastern Association of
Electroencephalographers, December, N.Y. (Fink, M.).
Prognostic Application of Psychological Techniques in
Convulsive Therapy, at Eastern Psychiatric Research
Association, October, N.Y. (Kahn, R.L. and Pollack,
M.).

20.

Relationship between Seizure Threshold and Duration of
Seizures to EEG Change During Electroshock, at
Eastern Association of Electroencephalographers,
December, New York (M.Green).

�law
HILLSIDE HOSPITAL

Glen Oaks,

New

York

March 16, 1959

MEMO TO RESEARCH

FROM:

RE:

'

COWITI'EE

JOSEPH S.A. MILLER, M.D., MEDICAL DIRECTOR
ATTACHED RESEARCH REPORT

I

herewith enclosing copy of Dr.
sending it a few days in advance of the meeting,
familiarize yourself with some of the main facts
position to discuss this when it is presented at
meeting on March 25th.
am

Fink's report,

so that you might
and be in a better

the forthcoming

�FebmaIy 25, 19590
Department of Experimental Peychiatry
Annual Report

-

1958

During 1958, the major emphasis of the

staff of the

Department of

Experimental Paychiatry shifted from evaluation of convulsive therapy to

systematic investigations of newer psychopharmacologic agents. These

investigations, derived from the successful evaluations of the

mode

of action

of convulsive therapy (l9Sh-l958), reserpine (1955), and chlorpromazine and

insulin

coma

(1956-1957), are based on the neurophysiologic-adaptive hypothesis

of physiodynamic therapies developed in the Department in 1957
Eggg.

the

ﬁg

197-206).

The

many new compounds

(J. Hillside

interrelationship of the neurophysiologic effects of

with the psychodynamic, perceptual, personality and

sociologic aspects of patients' behavior provide the framework for these

investigations. In addition, linguistic indices developed in the Department
during the past two years by Drs. Kahn and Jaffe are being studied as measures
both of behavioral change and of neurophysiologic effect.
During the year, the evaluation of convulsive therapies was continued
by comparing the

effects of indoklon, an inhalant convulsant, with electro-

convulsive therapy. This study was undertaken by two senior resident

psychiatrists,

B. Alan and H. Lefkowits, and Dre. Green and Fink.

'While

indoklon therapy was a successful treatment, technicallimitations made

it a

poor substitute for the established

electrical methods. The study was of
theoretic value in indicating that the significant element of convulsive

therapy was the induction of the grand mal convulsion, with

its attendant

neurophysiologic effects, independent of the type of agent employed.

�.2the
to
factors
of
the
sociologic
relations
into
Investigations
Kahn
and
Drs.
extended
by
were
Hillside
Hospital
of
at
selection
therapies

Pollack. Not only were the factors of age, education, birthplace, and score
on the California F Scale significantly related to the choice of therapy but
and
the
of
diagnosis
the
to
results
therapy,
related
also
these factors were
the duration of heapitalization. These observations were presented in the
Sunday Conference of October 16, 1958.
and

On

October

7

the study was repeated;

similar studies of the population of other primarily psychotherapeutic

undertaken.
were
Out-Patient
Department
and
HOSpital
Hillside
the
hoSpitals,
To augment

these studies, Dr. Nathaniel Siegel was appointed as Research

Associate in Sociology, with the support of a grant from the mental Health
Board of Nassau County.

In an extension of the communication studies, both the syntactic
content analysis and dyadic diversification measures of formal aspects of
epeech were applied to an evaluation of the changes in language patterns

following the acute administration of various new psychotropic compounds.
These measures demonstrated consistent changes both with the induced behavioral
and the neurophysiologic
The

effects of the drugs.

acute drug interviews were but one aspect of the continuing

evaluation of the biochemistry of convulsive therapy. Previous studies had
indicated that repeated induced convulsions resulted in an increased level
of central nervous system acetylcholine activity. By the acute administration
of various tertiary-amine anticholinergic compounds to patients at various

stages of convulsive therapy

we

elucidated the synaptic chemical events

which are the basis of the convulsive therapy process.

�-3In addition, Mr. Karp and Drs.

Kahn and

Pbllack continued their

perceptual studies in patients receiving psychodynamic therapies.

inter-

The

relation of psychotherapy with physiodynamic therapy was studied by Drs.
Esecover, Jaffe and Kahn; and in the latter part of the year, Drs. A. Kaplan
and H. Lefkowits began an

investigation into the interpersonal factors in

therapists, as well as patients, leading to the referral for physicdynamic
therapies.
During the year, Dr. H. Korin resigned, and was replaced by Mr. Eric
Karp.

TWO

new

staff

appointments include Dr. Nathaniel Siegel, Assistant

Professor of Sociology at Columbia University, as Research Associate in
Sociology; and Dr. Donald Klein, research

candidate

at the

New

York Psychoanalytic

scientist at
Institute, as

Creedmoor

Institute

Research Associate in

Psychiatry.
Support for this extensive program was provided by the Board of

Directors, and continuing grants of the Foundations'

Fund

for

Research in

Psychiatry and the National Institute of Mental Health. At year end, this
program received considerable support from the Psychopharmacclogy Service
Center of the National

Institute of

Mental Health, which augmented

extensive commitment by a grant of $268,000. These

its

already

further

sums were

increased during the year by support from the Mental Health Board of Nassau
County which provided funds

Smith, Kline

&amp;

for sociologic studies;

French, and wyeth Laboratories

- who

and from

Bristol, Geigy,

aided the drug evaluation

program by grants as well as extensive supplies of the agents

During the year, fourteen reports of the work of

staff

to

be

studied.

members

appeared; and twenty reports were presented to major professional societies.

�.1...

In addition to national societies, work of the Department was presented at
the Conference on Psychodynamic, Psychoanalytic and Sociologic Aspects of

Neuroleptic Drugs in Montreal, and the International Congress of Neuropsyohophamacology in Rome.

Staff

first

members were awarded two

prizes. Dr.

M.

Fink received the

annual A.E. Bennett Paychiatzic Research Award of the Society of Biologic

Psychiatry for his report

on the

effects of anticholinergic agents

on Em and

behavior. Dr. J. Jaffe received the Gralnick Foundation annual award for his

report

on the

application of analysis of changes in formal aspects of Speech

in psychotherapy.

�-5The

staff

of the Department of Experimental Psychiatry included,

year end:
Max

Fink, M.D.

M

Joseph Jaffe, MlD.

Research Associate (Peychiatry)

Donald F. Klein,

Research Associate (Psychiatry)

MgD.

Robert L. Kahn, Ph.D.

Research Associate
(Experimental Peychology)

Pollack, Ph.D.

Research Associate
(Experimental Psychology)

Max

Nathaniel Siegel, Ph.D.

Research Associate (Sociology)

Eric Karp, B.A.

Research Assistant
(Experimental Psychology)

Martin A. Green, M.D.

Associate in Research

Abraham.A. Kaplan, M.D.

Associate in Research (Paychiatry)

Barre Alan, M.D.

Fellow (1957-58)

Henry Lefkowits, M.D.

Fellow (1958-59)

The

(Neurophysiology)

technical staff included Mrs. Janet Bowie, Jean Kolodny,

Mosquera and Blanche
Addendum:

Hannah

Zaitz.

In February Dr. George Krauthamer, Ph.D. was appointed

as Research Assistant (Experimental Psychology).

electroencephalography.

at

He

is a trainee in

�1/15/59
Department of Experimental Psychiatry
and
the
of
presentations
a
chronologic list
Following is
of
members
Experimental
the
of
Department
of
the
publications
Psychiatry during 1958.

Publications:

A.

1.

Changes in Language During Electroshock Therapy, in
of Communication, Hoch, P. and Zubin,
Ps chopatholo
3. eds., Grune &amp; Stratton, (Kahn, R.L. and Fink, M.)

2.

Lateral

3.

h.
5.
6.

Gaze Nystagmus as an Index of Sedation Threshold,

Clin. Neurophysiol. 19: 162-163 (Fink, M.).
EEG
and Significance for Theory
on
of
Diethazine
Effect
of Convulsive Therapy, EEG. Clin. Neurophysiol. 19:
EEG.

Experimental Studies of the Electroshock Process, Dis.
M.
and Kahn, R.L.).
113-118
(Fink,
Nerv. Syst. 12:
Coma
and
Insulin
of
Chlorpromazine
Study
Comparative
Therapy of Psychosis, J.A.M.A. 166: 18h6-1850
G.
and
Coleman, F.C.).
Shaw,
Gross,
R.,
(Fink, M.,
Electroencephalographic Correlates of the ElectroshockM.
Process, Dis. Nerv. Syst. 12: 227 (Abst.) (Fink,
and GreenTWMTfT—___-—*—

(Jaffe, J.).

7.

Language of the Dyad, Psychiatry 31: 2h9-258

8.

without
Patients
in
of
Megimide
Effects
Clinical
M.
682-685
(Green,
Q:
Cerebral Disease, Neurology
and EEG.

and Fink, M.)

9.
10.

on EEG and

Effect of Anticholinergic Agent, Diethazine,
&amp; Psych. g9: 380-388,
Neurol.
A.M.A.
Arch.
Behavior,
(Fink, M.).
on
and
Drug
Therapies
Convulsive
of
Studies
Experimental
A.M.A.
Arch.
Theoretical
Implications,
Psychiatry:
Kahn,
M.,
&amp;
(FinE,
80:
733-73h
(Abst.)
Neurol.
Psych.
R.E. and Green, M77.

11.

Brain Damage, Mental Retardation and Childhood Schizophrenia,
Am. J. Psychiat. 115: h22-h28 (Pollack, M.).

12.

Oculomotor and Postural Patterns in Schizophrenic Children,
A.M.A. Arch. Neurol. &amp; Ps chiat. 12: 720-726
(Pollack, M. and Krieger, H.P.5.

13.

A.M.A.
Arch.
of
Denial
in
Factors
Illness,
Interpersonal&amp;
and
653-656
J.
Ps
(Jaffe,
ﬁg:
Neurol.
chiat.
Slote, W.H.§.

�1h.

B.

Predictions of Outcome, in Youthful Offenders at
H. Ashley, ed. 5. of
Highfields, Weeks,
Michigan Press, Ann Arbor (N. Siegel).

Presentations:
the
EEG
at
Electroshock
of
the
Process,
Correlates
l.
Eastern Psychiatric Research Association, February,
M.
N.Y. (Fink,

and Green, M.A.).

EEG
Changes
in
of
Individual
Variability
Significance
During Electroshock Therapy, at Eastern Association
of Electroencephalographers, March, Montreal,
(Green, M.A.).

Experimental Studies of Convulsive and Drug Therapies
in Psychiatry: Theoretical Implications, at
New
York Society of
and
Society
Neurological
Clinical Psychiatry, March, N.Y. (Fink, M., Kahn,
R.L. and Green, M.A.).
Visual Perception and Attention in Normal and Abnormal
Children, at American Orthopsychiatric Association,
March, N.Y. (Pollack, M.).
Communication Patterns with Altered Brain Function, at
Eastern Psychological Association, April,
and
M.).
R.L.
Fink,
Kahn,
(Jaffe,
Philadelphia
J.,

Relation of F Score to Behavioral and Physiological
Response with Altered Brain Function, at Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Fink, M.)
Intellectual Deficits in Patients with Space Occupying
Lesions of the Cerebrum, at Eastern Psychological
Association, April, Philadelphia (Pollack, M.,
Battersby, W.S., Kahn, R.L. and Bender, M.B.).
Simultaneous
of
and
of
Stimulation
Perception
Intensity
Stimuli in Cerebral Dysfunction, at Eastern Psychol~
ogical Association, April, Philadelphia (Korin, H.).

The

�-3-

10.

Socio-Psychological Aspects of Diagnosis and Treatment:
Theoretical Implications, Symposium - Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Pollack, M.).
Drug Induced Changes in Interview Patterns, at
Conference on Psychodynamic, Psychoanalytic, and
Sociologic Aspects of the Neuroleptic (tranquilizing)
M.
Montreal
(Fink,
Drugs in Psychiatry, April,
_

and

11.

12.

13.

16.
17.
18.

19.

Jaffe, J.).

Psychological Factors Affecting Individual Differences
in Behavioral Response to Convulsive Therapy, at
American Psychiatric Association, May, San
Francisco (Fink, M., Kahn, R.L. and Pollack, M.).
Prognostic Value of Rorschach Criteria in Clinical
Response to Convulsive Therapy, at Electroshock
Research Association, May, San Francisco (Kahn, R.L.
and Fink, M.).
EEG
on
of
Agent,
Diethazine,
Effects
Anticholinergic
and Behavior: Significance for Theory of Convulsive
Therapy, at Society of Biological Psychiatry, May,
San Francisco (Fink, M.).
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital, at American Psychiatric Association,
May, San Francisco (Kahn, R.L. and Pollack, M.)
A Critique of "Pre-Conscious" Perception and the
"Poetzl Phenomenon," at American Psychiatric
Association, May, San Francisco (Pollack, M.).
Role of EEG Frequency Shift in Behavioral Effects of
&amp;
Neurol.
on
Section
Psychiat. Queens
Drugs, at
County Medical Society, June, N.Y. (Fink, M.).
on Post Convulsive
Effect of Anticholinergic Compounds
EEG and Behavior, American EEG Society, June,
Atlantic City (Fink, M.).
EEG and Behavioral Effects of Psychopharmacologic Agents,
at Collegium Internationale Neuro-Psycho Pharmacologicum, September, Rome, and Eastern Association of
Electroencephalographers, December, N.Y. (Fink, M.).
Prognostic Application of Psychological Techniques in
Convulsive Therapy, at Eastern Psychiatric Research
Association, October, N.Y. (Kahn, R.L. and Pollack,
M.).

20.

Relationship between Seizure Threshold and Duration of
Seizures to EEG Change During Electroshock, at
Eastern Association of Electroencephalographers,
December,

New

York (M.Green).

�1/15/59
Department of Experimental Psychiatry
and
the
of
presentations
Following is a chronologic list
of
Experimental
the
members
Department
of
the
of
publications
Psychiatry during 1958.
A.

Publications:
in
Therapy,
Electroshock
During
Language
Changes in
1.
and
Zubin,
P.
Hoch,
Communication,
of
cho
Ps
atholo
3. eds., Grune &amp; Stratton, (Kaﬁn, R.L. and Fink, M.)
of Sedation Threshold,
2.
Lateral Gaze Nystagmus as an Index162-163
(Fink, M.).
EEG. Clin. Neurophysiol. 19:
EEG
and Significance for Theory
on
of
Diethazine
3.
Effect
of Convulsive Therapy, EEG. Clin. Neurophysiol. 19:
h.
5.
6.
7.

8.
9.
10.

11.
12.

13.

Process, Dis.
Experimental Studies of the Electroshock
M.
and Kahn, R.L.).
113-118
(Fink,
Nerv. Syst. 12:
Coma
and
Insulin
Comparative Study of Chlorpromazine
18h6-1850
166:
J.A.M.A.
of
Psychosis,
Therapy
and
G.
Coleman, F.C.).
Shaw,
Gross,
R.,
(Fink, M.,
Electroencephalographic Correlates of the ElectroshockM.
227
(Fink,
(Abst.)
Nerv.
Dis.
Syst.
12:
Process,
and Green, M.,.
2h9~258
21:
(Jaffe, J.).
the
Dyad, Psychiatry
Language of
without
in
Patients
of
EEG.
Megimide
and
Effects
Clinical
M.
682-685
(Green,
Cerebral Disease, Neurology g:
and Fink, M.)
EEG
and
on
Diethazine,
Agent,
Effect of Anticholinergic
&amp; Psych. ﬁg: 380-388,
Neurol.
Arch.
A.M.A.
Behavior,
(Fink, M.).
on
and
Drug
Therapies
Convulsive
of
Studies
Experimental
Arch.
A.M.A.
Implications,
Theoretical
Psychiatry:
(FEEET'MTT’Kahn,
733—73h
&amp;
80:
(Abst.)
Ps
ch.
Neurol.
ﬁ.f. and Green, M77.
Brain Damage, Mental Retardation and Childhood Schizophrenia,
Am. J. Psychiat. 115: h22—h28 (Pollack, M.).

W..—

Oculomotor and Postural Patterns in Schizophrenic Children,
A.M.A. Arch. Neurol. &amp; Ps chiat..12: 720-726
,fPollack, M. and Krieger, H.P.5.
Arch.
A.M.A.
of
Denial
in
Illness,
Interpersonal&amp; Factors
Ps chiat. ﬁg: 653-656 (Jaffe, J. and
Neurol.
Slote, W.H.$.

�1h.

B.

Predictions of Outcome, in Youthful Offenders at
Hi hfields, Weeks, H. Ashley, ed. U. of
Michigan Press, Ann Arbor (N. Siegel).

Presentations:
EEG Correlates of the Electroshock Process, at the
1.
Eastern Psychiatric Research Association, February,
M.
N.Y. (Fink,

and Green, M.A.).

EEG
Changes
in
of
Individual Variability
Significance
During Electroshock Therapy, at Eastern Association
of Electroencephalographers, March, Montreal,
(Green, M.A.).

and
Drug Therapies
of
Convulsive
Studies
Experimental
in Psychiatry: Theoretical Implications, at
New
York Society of
and
Society
Neurological
Clinical Psychiatry, March, N.Y. (Fink, M., Kahn,

R.L. and Green, M.A.).

Abnormal
and
Normal
and
in
Attention
Visual Perception
Children, at American Orthopsychiatric Association,
March, N.Y. (Pollack, M.).

Patterns with Altered Brain Function, at
Eastern Psychological Association, April,
and
M.).
R.L.
Fink,
Kahn,
(Jaffe,
Philadelphia
J.,
Relation of F Score to Behavioral and Physiological
Response with Altered Brain Function, at Eastern
Psychological Association, April, Philadelphia,

Communication
The

(Kahn, R.L. and Fink, M.)

Intellectual Deficits in Patients with

Space Occupying

Lesions of the Cerebrum, at Eastern Psychological
Association, April, Philadelphia (Pollack, M.,
Battersby, W.S., Kahn, R.L. and Bender, M.B.).
Simultaneous
of
and
of
Stimulation
Perception
Intensity
Stimuli in Cerebral Dysfunction, at Eastern Psychological Association, April, Philadelphia (Korin, H.).

�-3Socio—Psychological ASpects of Diagnosis and Treatment:

10.

Drug

Theoretical Implications, Symposium - Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Pollack, M.).
Induced Changes in Interview Patterns, at
Conference on Psychodynamic, Psychoanalytic, and
Sociologic ASpects of the Neuroleptic (tranquilizing)
M.
Montreal
(Fink,
Drugs in Psychiatry, April,
‘

and

11.

12.

16.
17.
18.

19.

Jaffe, J.).

Psychological Factors Affecting Individual Differences
in Behavioral Reaponse to Convulsive Therapy, at
American Psychiatric Association, May, San
Francisco (Fink, M., Kahn, R.L. and Pollack, M.).
Prognostic Value of Rorschach Criteria in Clinical
Response to Convulsive Therapy, at Electroshock
Research Association, May, San Francisco (Kahn, R.L.
and Fink, M.).
EEG
on
of
Agent,
Diethazine,
Effects
Anticholinergic
and Behavior: Significance for Theory of Convulsive
Therapy, at Society of Biological Psychiatry, May,
San Francisco (Fink, M.).
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital, at American Psychiatric Association,
May, San Francisco (Kahn, R.L. and Pollack, M.)
A Critique of "Pre-Conscious" Perception and the
"Poetzl Phenomenon," at American Psychiatric
Association, May, San Francisco (Pollack, M.).
Role of EEG Frequency Shift in Behavioral Effects of
&amp;
Neurol.
on
Section
Psychiat. Queens
Drugs, at
County Medical Society, June, N.Y. (Fink, M.).
Effect of Anticholinergic Compounds on Post Convulsive
EEG and Behavior, American EEG Society, June,
Atlantic City (Fink, M.).
EEG and Behavioral Effects of Psychopharmacologic Agents,
at Collegium Internationale Neuro-Psycho Pharmacologicum, September, Rome, and Eastern Association of
Electroencephalographers, December, N.Y. (Fink, M.).
Prognostic Application of Psychological Techniques in
Convulsive Therapy, at Eastern Psychiatric Research
Association, October, N.Y. (Kahn, R.L. and Pollack,
M.).

20.

Relationship between Seizure Threshold and Duration of
Seizures to ERG Change During Electroshock, at
Eastern Association of Electroencephalographers,
December, New York (M.Green).

�1/15/59
Department of Experimental Psychiatry
and
the
of
presentations
Following is a chronologic list
of
EXperimental
members
the
of
Department
of
the
publications
Psychiatry during 1958.

Publications:

A.

1.

Changes in Language During Electroshock Therapy, in
of Communication, Hoch, P. and Zubin,
Ps cho atholo
M.)
and
E
R.L.
(Kahn,
Fink,
Grune
Stratton,
J. eds.,

2.

Gaze Nystagmus as an Index of Sedation Threshold,

3.

h.
5.
6.
7.

8.
9.
10.

11.
12.
13.

Lateral

M.).
162-163
(Fink,
Clin. Neurophysiol. 19:
EEG
Theory
for
and
on
Significance
of
Diethazine
Effect
of Convulsive Therapy, EEG. Clin. Neurophysiol. lg:
EEG.

Process, Dis.
Experimental Studies of the Electroshock
Nerv. Syst. 12: 113-118 (Fink, M. and Kahn, R.L.).
Coma
and
Insulin
of
Chlorpromazine
Comparative Study
18b6-1850
166:
J.A.M.A.
of
Psychosis,
Therapy
and
G.
Coleman, F.C.).
Shaw,
R., Gross,
(Fink, M.,
Electroencephalographic Correlates of the ElectroshockM.
227
(Fink,
(Abst.)
Nerv.
Dis.
Syst.
12:
Process,
and Green, ﬁ.$.
2h9-258
(Jaffe, J.).
the
of
g1:
Dyed,
Psychiatry
Language
without
in
Patients
EEG.
Megimide
of
and
Effects
Clinical
M.
682~685
(Green,
Cerebral Disease, Neurology g:
and Fink, M.)
EEG
and
on
Diethazine,
Effect of Anticholinergic Agent, &amp;
380-388,
Q9:
Neurol.
Arch.
A.M.A.
Psych.
Behavior,
(Fink, M.).
on
and
Drug
Therapies
Convulsive
of
Studies
Experimental
Arch.
A.M.A.
Implications,
Theoretical
Psychiatry:
Kahn,
(Fink,
&amp;
ﬁ.,
80:
733-73h
(Abst.)
Ps
ch.
Neurol.
R.I. and Green, M77.
Childhood
and
Schizophrenia,
Mental
Retardation
Damage,
Brain
Am. J. Psychiat. 115: h22-h28 (Pollack, M.).
Oculomotor and Postural Patterns in Schizophrenic Children,
&amp;
Ps chiat._12: 720-726
Neurol.
Arch.
A.M.A.
(Pollack, M. and Krieger, H.P.5.
Arch.
A.M.A.
of
Denial
in
Illness,
Factors
Interpersonal&amp;
and
653-656
J.
Ps
(Jaffe,
chiat.
g9:
Neurol.
Slote, W.H.$.

�1h.

B.

at
Predictions of Outcome, in Youthful Offenders
U.
H.
of
Ashley,
ed.
Weeks,
Highfields,
ichigan Press, Ann Arbor (N. Siegel).

Presentations:
the
at
EEG
Electroshock
of
Process,
the
Correlates
1.
Eastern Psychiatric Research Association, February,
M.
N.Y.

2.

(Fink,

and Green, M.A.).

EEG
Changes
in
Significance of Individual Variability
During Electroshock Therapy, at Eastern Association
of Electroencephalographers, March, Montreal,

(Green, M.A.).

and
Drug Therapies
Convulsive
of
Studies
Experimental
in Psychiatry: TheoreticalNewImplications, at
York Society of
Neurological Society and
Clinical Psychiatry, March, N.Y. (Fink, M., Kahn,

R.L. and Green, M.A.).

Abnormal
and
Normal
and
in
Attention
Visual Perception
Children, at American OrthOpsychiatric Association,
March, N.Y. (Pollack, M.).

Patterns with Altered Brain Function, at
Eastern Psychological Association, April,
and
M.).
R.L.
Fink,
Kahn,
Philadelphia (Jaffe, J.,
and
F
Behavioral
Physiological
to
Score
of
Relation
Response with Altered Brain Function, at Eastern
Psychological Association, April, Philadelphia,

Communication
The

(Kahn, R.L. and Fink, M.)

7.

with Space Occupying
Intellectual Deficits in Patients Eastern
Psychological
Lesions of the Cerebrum, at

Association, April, Philadelphia (Pollack, M.,
Battersby, W.S., Kahn, R.L. and Bender, M.B.).
Simultaneous
of
and
of
Stimulation
Perception
Intensity
Stimuli in Cerebral Dysfunction, at Eastern Psychol—
ogical Association, April, Philadelphia (Korin, H.).

�-3-

10.

Socio-Psychological ASpects of Diagnosis and Treatment:
Theoretical Implications, Symposium - Eastern
Psychological Association, April, Philadelphia,
(Kahn, R.L. and Pollack, M.).
Drug Induced Changes in Interview Patterns, at
Conference on Psychodynamic, Psychoanalytic, and
Sociologic Aspects of the Neuroleptic (tranquilizing)
Drugs in Psychiatry, April, Montreal (Fink, M.
_

and

11.

12.

16.
17.

18.

19.

Jaffe, J.).

Psychological Factors Affecting Individual Differences
in Behavioral Response to Convulsive Therapy, at
American Psychiatric Association, May, San
Francisco (Fink, M., Kahn, R.L. and Pollack, M.).
Prognostic Value of Rorschach Criteria in Clinical
Response to Convulsive Therapy, at Electroshock
Research Association, May, San Francisco (Kahn, R.L.
and Fink, M.).
EEG
on
of
Agent,
Diethazine,
Effects
Anticholinergic
and Behavior: Significance for Theory of Convulsive
Therapy, at Society of Biological Psychiatry, May,
San Francisco (Fink, M.).
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital, at American Psychiatric Association,
May, San Francisco (Kahn, R.L. and Pollack, M.)
A Critique of "Pre-Conscious" Perception and the
"Poetzl Phenomenon," at American Psychiatric
Association, May, San Francisco (Pollack, M.).
Role of EEG Frequency Shift in Behavioral Effects of
&amp;
on
Neural.
Section
Psychiat. Queens
Drugs, at
County Medical Society, June, N.Y. (Fink, M.).
Effect of Anticholinergic Compounds on Post Convulsive
EEG and Behavior, American EEG Society, June,
Atlantic City (Fink, M.).
EEG and Behavioral Effects of Psychopharmacologic Agents,
at Collegium Internationale Neuro-Psycho Pharmacologicum, September, Rome, and Eastern Association of
Electroencephalographers, December, N.Y. (Fink, M.).
Prognostic Application of Psychological Techniques in
Convulsive Therapy, at Eastern Psychiatric Research
Association, October, N.Y. (Kahn, R.L. and Pollack,
MI).

20.

Relationship between Seizure Threshold and Duration of
Seizures to EEG Change During Electroshock, at
Eastern Association of Electroencephalographers,
December, New York (M.Green).

�\\.\"

‘\

Soptubor 1,

1959

rm m2
mm

H.927

Dumb-at of mparimntal Psychiatry
HWPM
WEE
Glen
H.
L.

m,

1.

thmm

3.

3mm
8mm,

h.

Publications,

1951:

- 1959

5.

Presentations,

1951;

6.

Smnmry #1,

September 1.

- 1959
1951::
-

7.

Sunny #2,

Mary 1.

8.

Smmry #3,

April 1, 1957

2.

#1:,

February 1, 1959

Five Years, 199;

-

-

Sophombor

1956 ~

January 1, 1956

Am; 1,

- February

March Asaoomboa
EEG

1957

1, 1958

Ha:

(kparmanul

1, 1959

1959

Principal Investigator
Research Associates

I.

I.)

Psychology)

(Neurophysiology)

Technician

Secretuy

m,n.n.

Robert L. Kahn.Ph.Do
Hymn Karin, £11.13.

Eda M,M¢A.

Martin A.

momma.

mummﬁub.

19%4953
1958 ’
1956 .1951;

1959

‘-

1957
1956
Joseph Jaffe,M.D.
Donald F. K1o1n,24..n.
1959
Nathaniel 319301,Ph.D. 1958

«-

Georgo
Hanna Mosquera
Janet Baltic

Associates, supported throng: other grants:
Research Associate

Mouth

Associate
amorob Associate
Research Associate

(kperimntal Paydnol.)

( Psychiatry)

(Psychiatry)

(Sociolm)

Max

Pollackﬁhon.

.

«-

-

�he mm:

Amwhmr
reporwd here would nab have has: possible without the

interact and support of the Ecuador of Hillside 808mm, Dr. 18ml Sinus,
ﬂu Hard of Directors and the
Hr. Maurice
when
faith sustain“! an. pmm aux-mg its only uwnmau.

W,

mutter,

Wemﬂsoindcbtodtothexmmnnandmm
Ina-k, the Pomdntiona' Fund

for

Board of Nassau County and the

um
and

Rosearoh

I

Waumdﬂu

in Psychiatry, the 1mm Health

mm sum.
My Wane-la,

tonamg pharmoouticll

and Ranch Laboratories, Wyeth Laboratories,

Bristol Laboratories, thou support in amt-fully achnﬂadgod.

�3m.
m

Dam“

me labor-mm- of on
of Exparimntsl Psychiatry
oatsblishad so musics Homul in Smtmber, 1951:. During this fivc
your period mumpbyuoloéio, psychologc (personality and

pamptm),

linguistic, and sociolcgio upsets of 'soutic" psychiatric
have been tho pmipu [£001.

mums

1.

WC

The

Thong:

=,

visit or the convulsive

mnpy

process as the induction of a

nonnspeciftc state of altered brain function, similar to omnioosrsbnl

trams was supportcd

and

upliﬂed

(10, 11. 21). Within this altered

osrobn}. milieu, subjects were seen to respond in variom ways (26) ,
”lino:
m9}:
post "successful" no explicit verbal dsnial (7. 31). This

lotto)? adsptation was most prominent in chamooerclogioﬂly disposed

indvidmls (36).
J? in altshﬂon

bran function was pro-requisite to boluvionl
orange
Grand
m1 scams were column]. to this
26).
11,
8,
(7*
The alterations
but
(26)
induction
was
(34:2).
not
electrical
pm:
in mmfunction were measured in various ways including doom(6.n,12,2h,39), language patterns (h.7.3h.31.h3; Mb).
pen-mm mu (2,16,17,37,h63 magma) and tests of real]. (8).
1n

Wham
"v

I".

316mb

numbers

tho appsndix.

on to publications or pneumatic”

(B- )

listed in

�variety of beluvieml changes lure eeen during convulsive therapy
(26; 8-17). Such patterns were viewed as edepteticne to altered brain
A

Motion,

and were believed dependant upon

chencterologic end environ-

mental tactore (7, 25, 26, 36, ho). Clinical

retina: of

improvement

cbeemr or the behavioral change. in
the subject (26). Adaptations chmcterieed by denied www.mm
1n behavim' (13.17) and in language (7.
WM—
Such adaptations! were related to habitual node.

were new as value Judgments by the

W
or conduct (character,
The

ML
(inability

per-MW)

BMW

(36; 3-11, 32).

of the altered behavioral nodes wee noted ee

dependant upon the degree and duration of

mm

alterec breln function. the

expectatlone, an! the type and degree of family and

medical support. Different behavioral patterns were beet supported by

WIt m eke

typee or psychothonpy (19)..

that the ’nemphwelolcglcel beele of
lie in on duration in central emptic

suggeeted

M?

commune therepy any
cholinerglc - cannot-31c relationship, with a predominant
to
incremd cholinergic activity as the operationally significant

wt

:3th.

illumination: were based on the nutimdllp of man voltage EEG
Olav wave activity to behavioral change (6, 11, 26) and the blocking at

Such

poet-mun

;

electmgrephic and behavioral changee by central

entichonnergic agents (21; 3h: 35;

bl.

1&amp;2)

and by centre].

unpethwmtic

agents (ha).

”664%?

;;;m

u—

00'“

? 4, @3.

M‘,£~§.

W

m

4/: “3/93,”?1

will,

’?.L&lt;»Jv%ué~éiy.i

�-3.‘
Become of linguistic behavior in structured (7, 31) and unstructured
(1h, 29 ;

13-21.)

creaeed denial,

interviews shoved characteristic alterations towards in-

minutiae,

displacement, stereotypy and repetitivemes,

related to the degree of altered brain function (8.214). These changes were
blocked or reversed by enticholinsrgic

mlucinogm (21.

ha) .

Various perceptual tasks provided indices of behavioral, change and

were related to the degree of altered brain function. These included the

perception of cinulteneoue tactile

figures (37; 3-16),
color tigorcs (1:1).

and

stimli

(17), embedded (Gottschsbdt)

techistoaoopioelly exposed words (37) and

embedded

upsets or age, years of education, nativity and
degree of stereotypy and conventionslity (measured by Column F Scale)
were related to selection of therapy, duration or hospitalisation, e
diegmeie and treetsent response in hospitalised patients (15, 36,. to, 1:5).
Sooiopsyohologic

2.

Nsmmmlogio—Adspuve mom-1e of Sonauc' Theron.
Based on these studies, a hypothesis of the node of action of other

psydxistx'ic therapies such as insulin coho, leucotoav and psychotropic
drugs, was expressed (10, 33, 38). This View holds that the efficacy of

these therapies depends upon the indiction of states of altered brain
The
become
which
prominent.
in
adoptive
varying
mttems
my
much,
adaptive pettem is releted to the type, degree end duration of altered

brain function, the personality of the subject, and tolersnoes end
expectaﬂons of the environmnt.

Elicitation of this Wthesis as applied to drug therapies is our

in progmss, supported

by uspm greats 111.2092 and 111-2715.

'

'

�3.

Eula

Gena

Thong.

in iniﬂal case

yettem

e'mdy showed the significance both or denial

and peraieten’e

in insulin

coma

altered brain function for the behavioral change

(3)}
thenpy

In an insulin

chlorpruesim control stuck, no differences in
hospital. immanent ratings were observed in the eve treatmnt gronpl (27).
Chlorpruuine was eater, easier to administer, pernitted continued
coma

«-

administration and allowed for greater degrees or concurrent relatimehip
therapy then insulin

insulin
In.

eon-a.

These observations

cm by psychotropic

drugs

led to a mlaoenent

d

in thin institution.

Phameabherapz.

in evelmting various peyohophamoeutieele is
derived from then methane
and linguistic analyses of
intmenone
of
effects acute
azhinietretien and chronic clinical emu-tration of variom nu compound: are in progress. EEG patterns, along such
The ongoing program

Mamie

continue as eynehmiaatien-deeynahroniuﬂun and tmqnency units are being

related to behavioral (21, 3h,
The neuromyeiologic

141, 1:2)

and

linguistic changes (21,

1:3).

basis of experimentally induced hallucinogenic

etetee have also been interpreted as an alteration in synaptic chemical
relations, such that the effective levels of cholinergic activity is
decreased (ha).

Initial work

on

this hypotheail (21. ha) in

now

being

�WERE
195,

'mmWnumucm-mmw
Mann

WIWQWMWW.
mwnmmmmmmmum
mmuaummmmamrm; Mahatma!

W
mmummmmmmmm,m

W,
wmmmuarmmmm. mama“:
“Wt. Mad. W3;
and

Mummmuwmeuvﬂ. awning”
mmmuammwmwmmmmu
WMoututmdm.

�“Wm
mmuwdmdmw.

ammawmm
mmnmummummmmmw
wmmbﬂtwmm.ndatm,$m
mmmummmm

mmummumamm
mwam-uwummmrw,ummm
m.m,mmmmwmammsm

WQMWQIWWWMSwtu-umw

wwmmwammpammmmvs?
“1959; nmumwwmmummm
ammwmmmm,mmawmm

”www.mwmnuumm
Wumnmwm.mmmuw
mammwmaasgmmm
nmnm,mmmtnmmmnm

mamamwmtmmmmwmu:m

-muramn.t.mnummungnrmmmww

vmwmmmmmmma
am
QWWM.WWMW”M¢:M,10§
wmumu. mammmuamsmaumu

Wuwmumdthynm.

WWWuﬁMWq anti-Hum

mmmmuumxmnmnmmmumm

�Wﬁmmum, unlimpmmting Watfmofiu
tho It»?! also participated in tho Intomtiml
New
W.
Allied sum held in
Mansion
in
m mm.
and

on

cm:

in out: during the your mama tin

£111:an or
George Knuth-gr,- am. :and Dmld P. mm, 11.1).
"as
to the Bowman Dr. mutt L. m. “hr the
ﬂares-Mao, htttommammumd'ma‘ mmucnof

WW,

waist

of
Dr.
Hospital.
mum
POM,
11me
Jam
MW
wanna. manning ammuummummpmh
«ma tho patina: of Faculty Huber and Wu Director of
the
White
Hanson
at
mums.
mun
mm
conﬁrming mmttorthommm obhinndfmamﬁoudot

of

mm
Hum: of

Dix-om,

mm

m

the

mm

ham). mum at
prom
the mud sum mus mu: serum, and
mu
supper: from the

Health Board of 13mm county.

�Why
Wm
M

aunt-m «

.. 199

In I‘m. 11.».
Ian-u 1. Dan.

11.8.

mran-u. 3.3.
L.

in:

am

m. M.

I. m1,

W(up.W.
I'd.

M.

m

m.
m

15.3.

3.9.

mum”.
unh- Mn.
A.

3.».
um.

mun-emu,

Maul am

m
(Wily)
mu
m
(ham m)
m m Mb
(Win
W)
m
m
(mm)
m
um um (W)
Wh‘
'W)
(W
m
Ann-cw.

W
ma:unm(W)
Must. a

um

:- mm (mm)

m(m~ml

an.

'

*

'

(may)

M M.

m
mm
Jun

mum

�Hillside Hospital
Department of Experimental Psychiatry

Following is a chronologic list of the presentations and
publications of the members of the Department of Emperimental Psychiatry
during 1959.
A.

Publications:
1. Effect of an Anticholinergic Agent, Diethazine, on EEG and Behavior:
Significance for Theory of Convulsive Therapy. Biological
&amp;
Grune
N. Y. pp. 18h-19h
ed.
Masserman,
chiat
P,
Stratton,
J.,
,
(Fink; Egg.
2. Alteration of Brain Fpnction in Therapy. Psychopharmacology Frontiers,
6d. Kline, No, Little, Brown &amp; COO, Boston, pp. 3 Fink, Mo .3. Significance of EEG Pattern Changes in Psychopharmacology.
g(Fink,
)
M. ).
2
:
398
(abst.
Neurophysiol._

EEG

Clin.

h. Effect of Electroconvulsive Therapy on Intractabie Pain. A.M.A. Arch.
Neurol. and Ps chiat. ﬁl: 37-b2 (weinstein, E. A., Kahn, R. L.,
and Eargman, P.5.
5. Electroencephalographic and Behavioral Effects of Tofranil.
Psych. Assoc. J. g; 1665-1718 (Fink, M.).
6.

Canad.

Psychological Factors Affecting Individual Differences in Behavioral
Response to Convulsive Therapy, J. N.M. D. 128: 2h3-2h8 (Fink, M.,
Kahn, R. L., and Pollack, M.).

7. Effects of Diffuse Altered Brain Function on Perception, Phat
Int. Con . Ps chol., Publ. North-Holland, Amsterdam, pp. 23 8- 239
(Fink, M., Kahn, R. L., and Korin, H. ).

8. Complex Visual Perception in Patients with Brain Tumor. Proc. XV Int.
Con . Ps chol., Pub1.North-Holland, Amsterdam, pp. 2 33-237
(gander, M. B., Battersby, w. 3., and Pollack, M. ).

1/5/60

�9. Therapy of Schizophrenia: Role of Alteration of Brain Function on
h92Behavior, Con ess Re orts II Int. Con . Ps chiat
II:
h93 (Abst.
nk, M., Kahn, R. L., and Karin, H.5.
10.

EEG
of
Seizures
of
and
Duration
to
Degree
Threshold
Relationship of
Delta Activity Induced During Electroshock, EEG. Clin. Neurophysiol.
g: 399 (Abst.) (Green, M.).

ll.

Prognostic Application of Psychological Techniques in Convulsive
Therapy, Dis. Nerv. Sys. g9: 180-184 (Kahn, R. L. and Pollack, M.).

12. Communication Networks in Freud's Interview Technique, Psych. Quat.
33: h56-h73 (Jeffe, J.).

13. Sociopsychologic ASpects of Psychiatric Treatment in a Voluntary
Mental Hospital: Duration of Hospitalization, Discha e Ratings
and Diagnosis, A.M.A. Arch. Gen. Ps chiat. l5 565-S7h Kahn, R. L.,
Pollack, M., and Fink, M.5.

Set in the Perception of Simultaneous Tactile Stimuli,
Jour. Psychol. 12.: 38h-392 (Korin, H. and Fink, M.).

The Role of
Am.

Perception Across Sensory Modalities,
(Abst.) (Krauthamer, G.).

Form

Am.

Psychol. lg; 396

16.

Relation of Tests of Altered Brain Function to Behavioral Change
Following Induced Convulsions, The First International Congress
of Neurolo ical Sciences (III: §EG Clinical Neurosﬁgsiology and
Epilepsy5, PBrgamon, London, pp. 513—519 (Fink, M., Kahn, R.L.,
and Karin, H.).

17.

Personality Factors in Behavioral Response to Electroshcnk Therapy,

J. Neuropsychiatgy l; h5-h9

(Kahn, R. L. and

fink,

M=).

18. Symbolic Reorganization in Brain Injuries, in Handbook of Paychiatgy,
ed. Arieti, 3., Basic BOOkS, No Yo, V01. I, pp. 9 "9 l
(Weinstein, E. A. and Kahn, R. L.).

�B.

Presentations:

l.

EEG

and Ebhavioral Effects of Tofranil, International Conference on
Depression and Allied States, Montreal (Fink, M.).

2. Sociopsychologic Factors Affecting Therapist-Patient Relationships,
American Academy of Psychoanalysis, Philadelphia (Kahn, R.L.).
3. Effect of Induced Cerebral Dysfunction in Man on Tachistoscopic
Perception of Embedded Color Figures, Eastern Psychologic
Association, Atlantic City (Pollack, M.).

h. Behavioral Changes with Different Methods of Induced Cerebral
Dysfunction, Eastern Psychological Association, Atlantic City
(Karp,

E.).

5. Sociopsychologic Aspects of Peychiatric Treatment, Eastern
R.
(Kahn,
L.).
City
Atlantic
Association,
Psychological

6. Language Patterns as Measures of Behavioral and Neurophysiologic
Change, American Psychiatric Association, Philadelphia (Fink, M.).
7. Personality Correlates of
(Krauthamer, G.).

EEG,

Metropolitan

EEG

Society,

8. Relation of Social Attitude to Psychiatric Treatment,
Meeting, A.P.A., New York (Kahn, R.L.).

9.

Comparison of

New York

N. Y.

Divisional

Intellectual Functioning in Childhood, Adolescent and

Adult Schizophrenics, N. Y. Divisional Meeting, A.P A.,
(Pollack, M.).

New York

10. Symposium on "Paycholinguistic Analysis of the Psychiai‘ic Interview",
N. Y. Divisional Meeting, A.P.A., New York (Jaffe, :.).
11. Social Background and the Doctor-Patient Relationship, Acad.
Psychoanalysis, New York (Jaffe, J.).

�Hillside Hospital
Department of Experimental Psychiatry

Following is a chronologic list of the presentations and
publications of the members of the Department of Experimental Psychiatry
during 1959.
A.

Publications:
1. Effect of an Anticholinergic Agent, Diethazine, on EEG and Behavior:
Significance for Theory of Convulsive Therapy. Biological
Ps chiat , ed. Masserman, J., Grune &amp; Stratton, N. Y. pp. 18h-19h
(F%:E, M.;.

Alteration of Brain Function in Therapy. Psychopharmacology Frontiers,
ed. Kline, N., Little, Brown &amp; 00., Boston, pp.
-3
, . .
3. Significance of EEG Pattern Changes in FBychopharmacology.
g(Fink,
)
M. ).
398
(abet.
Neurophysiol._2:

EEG

Clin.

.

Effect of Electroconvulsive Theraﬁg on Intr:1ctabm Pai A.M.A. Arch.
Neurol. and ngchiat. Ql: 37- (weinstein, E. A., hahn, R. L.,
and

rgman, P. .

Electroencephalographic and Behavioral Effects of Tofrénil. Canad.
14.3 1663“].715 (Fink, Mo).
ASSOC.
J.
szch.
Psychological Factors Affecting Individual Differences in Behavioral
Reaponse to Convulsive Therapy, J.N.M.D. lag; 2h3-2h8 (Fink, M.,
Kahn, R. L., and Pollack, M.).
7. Effects of Diffuse Altered Brain Function on PercWptio Prsc. XV
Int. Con . P chol., Publ. North-Holland, Amsterdam, pp. 53 3- 239
(335E, M., Kahn, R. L., and Korin, H. ).
Complex Visual Perception in Patients with Brain Tumor. Proc. XV
Cong. Psychol., Publ. North-Holland, Amsterdam, pp. 2 33-?37
n er, M. B., Battersby, w. 3., and Pollack, M. ).

1/5/60

Int.

�“beam,

9. Therapy of Schizophrenia:
Behavior,

h93

C

as

Re

14.,

Alteration of Brain Function on
1:92Con . Ps chia
rts II Int.
II:
,
H321
'£.""‘EER"',
orinL",
‘.
an
hn,

Role of

10.

Relationship of Threshold and Duration of Seizures to Degree of EEG
Delta Activity Induced During Electroshoclc, EEG. Olin. Neurophzsiol.
_2_: 399 (Abst.) (Green, M.).

11.

Progncs tic Application

of Psychological Techniques in Convulsive
Therapy, Dis. Nerv. Sys. g9: 180-184 (Kahn, R. L. and Pollack, M.).

12. Communication Networks in Freud’s Interview Technique, Psych. Bust.
23: 156-1473 (Jaﬁ‘e, J.).
13. Sociopsychologic Aspects of Psychiatric Treatment in a Voluntary
Mental Hospital: Duration of Hospitalization, Discha e Ratings
and Diag10818, AeMeAe Arch. Gene P3 Chiate ;: 565-571; Kahn, Re Lo,

Pollack,

M. '.
14., and—Tink"—‘T,

1h. The Role of Set in the Perception of Simultaneous Tactile Stimuli,
Am. Jour. Psychol. 1g: 38h-392 (Korin, H. and Fink, M.).

tion Across Sensory Modalities,

Psychol. 3;: 396

15.

Form Perce

16.

Relation of Tests of Altered Brain Function to Behavioral Change
Following Induced Convulsions, The First Internatior; 3.1 Congress
of Neurolo ica3_Sciences (LII: EEG, Clinical Neurop._,jsiolog and
Epilepsy), ﬁrgamon, London, pp. 13- 19 ink, M. , v-iahn, R.L.,
and Karin, H.) .

(Abst. (Krauthamer, G.).

Am.

1?. Personality Factors in Behavioral Response to Electroshntrk Therapy,
J. Neuropgychiatg l: h5-h9 (Kahn, R. L. and :nk, ).
18. Symbolic Reorganization in Brain Injuries, in Handbook of Pa hia
ed. Arieti, 3., Basic Books, N. Y., Vol. I, pp. '935-931
(Weinstein, E. A. and Kahn, Re Le).

;

�B.

Presentations:
1.

EEG

and Behavioral Effects of Tofranil, International Conference on
Depression and Allied States, Montreal (Fink, M.).

2. Sociopsychologic Factors Affecting Therapist-Patient Relationships,
American Academy of Psychoanalysis, Fhiladelphia (Kahn, R.L.).
Man
on Tachistoscopic
Cerebral
Induced
in
Dysfunction
of
3. Effect
Perception of Embedded Color Figures, Eastern Paychologic
Association, Atlantic City (Pollack, M.).

h. Behavioral Changes with Different Methods of Induced Cerebral
Dysfunction, Eastern Psychological Association, Atlantic City
(Karp, E0).

5. Sociopsychologic Aspects of Paychiatric Treatment, Eastern
R.
(Kahn,
L.).
City
Atlantic
Association,
Psycholqgical

6. Language Patterns as Measures of Behavioral and Neurophysiologic
M.).
(Fink,
American
Fhiladelphia
Association,
Paychiatric
Change,
7. Personality Correlates of
(Krauthamer, G.).

EEG,

Metropolitan

LEG

Society,

8. Relation of Social Attitude to Psychiatric Treatment,
Meeting, A.P.A., New York (Kahn, R.L.).

9.

Comparison of

New York

N. Y.

Divisional

Intellectual Functioning in Childhood, Adolescent and

Adult Schizophrenics, N. Y. Divisional Meeting, A.P,A.,
(Pollack, M.).

New York

10. Symposium on "Pbycholinguistic Analysis of the Piychiai-ic Interview",
N. Y. Divisional Meeting, A.P.A., New York (Jaffe, q.).
11. Social Background and the Doctor-Patient Relationship, Acad.
Psychoanalysis, New York (Jaffe, J.).

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67284">
                <text>Progress and annual reports; research activities (folder title).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67285">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67286">
                <text>mfp-03-01-001-0-006</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67287">
                <text>1958-1959</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67288">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67289">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67290">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67291">
                <text>Department of experimental psychiatry annual reports; Letter acknowledging that Fink will receive the first A. E. Bennett Neuropsychiatric Research Foundation award; Newspaper clipping, Long Island Daily Press, Psychiatrists will honor L.I. Doctor; Lists of publications of the members of the department of experimental psychiatry; Newspaper clipping, MD Records Brain Waves of Patients; Summary 1954-1959; </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67292">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67293">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80931">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87492">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94053">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100614">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6730" public="1" featured="0">
    <fileContainer>
      <file fileId="6538">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/c8ad48ee340bb2be9a377798690b07da.pdf</src>
        <authentication>3394a0c397923bbc0e9ed1a479ee352e</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107143">
                    <text>K

.

K.

K

K
K

.K

y

»

K

K

.

,

a

.

K

.
K

r

KK

.

K

K

K

K

.

K

K

.
K.

K

KKK

K

K

K

K

.

.

KI

.
_

KK

K

K

K

K

.

K

K

K
K

K

K

K

K

K

K
K

.

K
K

A

K

K
K

K

K

K
K

K

K

.

K

.K
K

K

K

_

K

K

K

K

K

K

S

.

K

K

.

KK
K

K

.

K

K

K

K.

_

K

K

K

K

K

.

_

K

K

K

K
K

KK

K
K

K

K

K

_

K.

K

_

K

K

K

‘
K

.K

K

K

K
K

_

K

K

.K

K

K

K

K

K

K

K

.

KK

K

.\

K

K

KKK.KK

I.

K.

K

.K
K
K

e? .p
.

K.

K

Jr
K.

.

K

K.

K

K

K

K

KK

.
.

w

.

K

_

.K

K

K.

K

.

K
K.

K

K
K
.

.

_
K

K

K

K
K

.

.

K

K

K

K.

KK

K
K

K
K

.

K

K

K

_

K

K

K

K

K
K

K

.K

K

_

K

K

.

K

K

K

K

K

K

K

K

K

K

K

K

_

K

K

K

.

.

K

K

K

K

K

K

K

K
K
K

K

K
K

K

K

K
K

K

K .

K

K

K

KK

.K

.
K

�2

9th

Annual Report

JANUARY 1, 1956—DECEMBER 31, 1956

Glen Oaks, Queens
FOUNDED 1927

Joseph S.

A.

Miller, M. D., Medical Director

AN AFFILIATE OF THE FEDERATION

OF NEW YORK

0F JEWISH PHILANTHROPIES

�Hillside Hospital is a non-profit, non-sectarian mental hospital for the treatment
of voluntary patients suffering from early and curable mental symptoms.
Patients are admitted regardless of their ability to pay.
Hillside provides training for physicians in post-graduate psychiatry and psychotherapy and puts major emphasis on research in all phases of treatment. The
hospital considers itself a pilot institution, pioneering in the human and efficacious application of psychiatry to the mentally ill.
The hospital is licensed in the New York State Department of Mental Hygiene.
It is approved for a two-year residency in psychiatry by the Council on Medical
Education of the American Medical Association, the American Board of Psychiatry and Neurology and the American College of Surgeons. The Dental
Department is certified by the American Dental Association as an approved
hospital department.
Hillside Hospital is an affiliate of the Federation of Jewish Philanthropies and a
participant of the United Hospital Fund and the Greater New York Fund.

HIGHLIGHTS
Page 3

Hillside gets Ford grants

Israel Strauss Adolescent Pavilion in its second year

.

.

.

.

Page 6

.

.

.

.

Page 10

Hillside affiliating institution for student nurses at Queens college

.

Page 11

Social Service strengthens rehabilitation program

.

Page 14

.

Chlorpromazine added to regular hospital drug formulary

Research program strengthened

.

.

.

.

.

Page 18

�1956 has been a year of “Shakedown" for Hillside during which its Board and
Executive Officers have experienced the first full year of operation without the
supporting advice of its founder, Dr. Israel Strauss, who died during 1955. In
view of the change throughout the organization of the hospital, it has been a
year of consolidation and improvement.
We are indebted to Dr. Dudley D. Shoenfeld, our Vice President, for his invaluable counsel in helping to reorganize the staff planning in the hospital. He was
greatly assisted in this work by Dr. Joseph S. A. Miller, Dr. Simon Kwalwasser

REPORT
OF THE
PRESIDENT
OF THE
BOARD
OF DIRECTORS

and Maurice Bachrach.

has frequently been necessary for the Governing Board to ask advice and
guidance from the Medical Board. We have had splendid cooperation from them.
The two presidents of the Medical Board serving through the calendar year,
Dr. Samuel Atkin and Dr. David Epstein, have been particularly helpful.
It

During 1956, the hospital has been able to expand its services in the OutPatient Department through the use of funds made available by the State Mental
Health Authority through the N. Y. State Department of Mental Hygiene, and
funds from the City of New York through the New York City Community Mental
Health Board. Further funds from the City of New York for indigent mentally ill
persons have enabled the hospital to maintain its services at a high level and to
serve that segment of the community which most needs the services of a philan-

thropic hospital.

The research program, conducted at Hillside under the guidance of Dr. Maximilian Fink, has made excellent progress. The directors continue their deep
interest in all areas of psychiatric research and anticipate further broadening of
these activities. Psychiatry as a science still is in a rather fluid state and many
new avenues of exploration offer hope and ideas. The compelling need is to look
intensely for new information. At long last, throughout the United States, substantial organizations have become cognizant of these needs. Among these, the
great Ford Foundation has allocated many millions specifically for research in
psychiatry. In addition, large sums have been allocated to the country’s hospitals. In 1956, Hillside received a grant of $104,000.
At Hillside we

bring a sympathetic attitude to our patients, solace and encouragement to their families and decided improvement to a large proportion of the
persons we treat. We make judicious use of all modern therapies available in the
field and our record of improvement is excellent. We can be proud of it. But we
aspire to find new and better techniques that will send more patients out of the
hospital completely “recovered” rather than “improved”; new methods that will
permit release of patients in a far shorter time than is now required.
to these goals that we at Hillside are dedicated and we firmly believe that,
as elsewhere in medicine, these aims can only be achieved by means of widespread and continued research.
It is

Alvin E. Coleman

�REPORT
OF THE
MEDICAL
DIRECTOR

During 1956, Hillside Hospital completed almost thirty years of continuous
operation, rendering high-level psychiatric services to the community. During
these three decades, the Hospital increased its bed capacity for inpatients fivefold, established a ranking place as a therapeutic center for both inpatients and
outpatients, became a notable hospital for resident training in the field of
psychiatry and, in the past few years, developed an important research department. For over eight years, it has been a proud member of the family of the
Federation of Jewish Philanthropies and, in conjunction with other agencies in
Federation, it has developed and rendered meaningful aftercare and rehabilitative services.
During the past year, there was an improvement in the coordination of professional services rendered in both the adult and adolescent inpatient departments.
There was considerable expansion in our outpatient service with improvement
of procedures and treatment in the aftercare clinic. Our practical experience
with the Adolescent Pavilion and our attempts to augment our research programs have pointed up the need for expansion, both in personnel and in space.
Every few years the advent of some special form of physical treatment—shock,
surgery, and now new drugs—has reopened the debate concerning so-called

specific versus non-specific treatments, short-term versus long-term hospitalization and therapy, treatment of many patients or clients rather than a few. All
of these can really be related to the general question of the importance of quality
versus quantity. One of the distinguishing features of American medicine is its
goal and also, think, its practice of rendering qualitatively better medical
services, as opposed to mere quantification.
I

Hillside Hospital has developed a distinctive philosophy which has led to the
creation of a unique structure to implement its philosophy. Since the field of
psychiatry is still in its developmental stages, it is characterized by frequent and
rapid changes in all phases of its thinking and practice. Each change is a challenge to the Hospital’s established structures and points of view and we must
continually decide whether a psychotherapy-centered, multi-disciplined treatment program such as ours delivers the best service that can be devised for the
relatively long-term curable patient.
How is a mental patient best served by a psychiatric hospital? This, of course,
will depend on the type of mental patient. Some patients are easily treated by a
consultation or two, by a course of shock treatment, or with tranquilizing drugs,
or with a rest or vacation. Some need only a course of physical treatment with

return within a month or two to their homes, to continue whatever treatment
they may need in a clinic or with a private psychiatrist. Others, and these are the
ones that Hillside has more experience with, require hospitalization of at least
six to twelve months. These are patients who cannot or should not remain at
home or in the community, and cannot therefore benefit from either a single
psychiatrist's or clinic’s ministrations but rather need the hospital milieu or
therapeutic environment of a team of professionals working with the patient, with

�a psychiatrist at the center to emotionally re-educate the patient. Such emotional re-education through the process of properly understood and related inliving experiences lead to a patient becoming aware of emotional aspects that
he did not suspect he had before and to recognize that there are more people
who care rather than so many who are hostile to him. If at the same time, as at
Hillside, important relatives, especially the nearest of kin are worked with by a

professional trained in that field, the psychiatric social worker, the family's
attitudes concerning the patient and his illness are changed for the better; and
if this happens, the patient now has not only regained much of his lest esteem
and self-confidence, but the very family environment has been improved and
guarantees that the patient may continue and even enlarge upon gains initially
made in the hospital. Thus, not only a single patient has been treated, but there
has been complete reorientation of an entire family.

Authorities in dynamic psychiatry, in child welfare and development, in community welfare, in the field of geriatrics, all agree that the most important ingredient in the total treatment of emotional problems at any age, is the psychological understanding and the meaning of the symptoms, even the physical ones,
as various ways of attempting to meet the problems of anxiety and emotional
crises. Of the various psychological and dynamic approaches to the problems of
behavior, none have contributed as much as psychoanalysis. Hence the practice
of hospital psychoanalytic psychiatry at Hillside. This is by no means to lessen
the importance of the adjunctive services and especially of the medical and
physical agents. The physical symptoms are often parallel or concomitant expressions of 'certain types of emotional distress and emotional disorder; and physical
agents like drugs, are often very effective in shortening periods of acute panic
or distress and thus allowing for earlier or more meaningful participation in
psychotherapy. Since the problems of emotional disorder are mainly interpersonal ones, problems of getting along properly or happily with other people,
psychotherapy whether in or out of a hospital is in our opinion the basis of all
therapy of persons with severe emotional disturbances.
The past year has been characterized by a rapid growth of psychiatric services
in general hospitals. These, by their very nature, deal with more acute physical
and mental disorders, while special psychiatric hospitals treat those psychiatric
problems which specifically require more extensive hospitalization, removal from
home and community for a long enough period to afford an opportunity for reeducation and resocialization of the patient. It is therefore clear that the two
types of hospitals deal with different problems and have different basic principles, precisely because they deal with different types of patients. The growth
of the general hospital practice of psychiatry is therefore not a factor toward

the displacement of the special hospital but rather for the widening and enrichment of the total constellation of treatment services available to psychiatry, so
that the general and special hospitals enhance and reinforce each other for the
benefit of all patients.

Joseph S. A. Miller, MD.

�ADOLESCENT PAVILION
Age range of patients

The Israel Strauss Adolescent Pavilion is now in its second year. It is a dramatic
example of the kind of pioneering Hillside Hospital does.
The Pavilion provides a treatment program for emotionally disturbed girls between the ages of 12 and 16. It is an unusual experiment in tackling a major
problem of our society . . . the rehabilitation of girls who are unable to live and
function successfully in the community.

Practical aspects of
treatment

Grave concern with the number of severely disturbed young people in our country
has not resulted in enough practical work. The Adolescent Pavilion is a brave
in
all
and
facilities
with
the
deal
this
experience
to
problem,
using
attempt
psychiatric therapy of the Hillside Hospital in a treatment program oriented to
the special needs of these patients. The number of girls who can be treated is
very small compared to the need. But the knowledge to be gained from experience with them should prove immensely valuable.

Flexibility of program

The Adolescent Pavilion has its own, specially-designed living quarters and
treatment facilities, and a separate staff. Its program is necessarily fluid and
flexible enough to allow the constant adjustments necessary in a new and
untried field. Some changes from original plans became necessary as work
progressed this year. Twenty patients were admitted in 1956 and 25 discharged. Capacity of the Pavilion was reduced to 16 since it proved impossible
to work successfully with the 20 originally planned.

Basic treatment philosophy

The basic treatment philosophy remains the same. The aim is to provide a
wholesome living experience within the Pavilion with as intensive psychotherapy
as seems advisable for the individual patient. But the concept of such a wholesome experience has gradually, step by step, taken in more areas, personnel
and facilities beyond the Pavilion’s confines. As soon as girls are able, they are
encouraged to use recreational and planned activities at the main hospital, to
make contacts with the other staff there and to socialize with adult patients. As
they are able, the girls are permitted to go to the nearby public high school and
out into the community. A basic concern is to try to help with those aspects of
the personality that are ill while never forgetting to encourage arid develop those
that remain healthy.

Family or family-type

Work with parents or parent substitutes is intensive and a very important part
of the treatment. When they are able, the girls are permitted and encouraged to
spend time with family or friends. Some girls, unfortunately, have no family to
go to. The use of volunteer help to fill this vacuum is being further explored.

After-care and follow-up

Another important need is the provision of after-care and follow-up. Unlike the
mature patient, the Pavilion deals with personalities not yet fully formed. Their
potential is unknown. It takes time to find out how fruitful the work will be. It
had been hoped that close follow-up would be possible by providing after-care

relationships

�for all the girls in the Hillside Out-Patient Clinic. This proved impractical because it interfered too much with the ordinary pursuits of young people who,
in most cases, lived at great distances from the hospital. For those girls who
cannot conveniently use the Clinic, a variety of good treatment facilities elsewhere are recommended.

encouraging to report that referrals to the Pavilion have come this year
from more widespread sources, including a variety of family and social agencies,
schools, treatment centers, private physicians and girls' residence clubs. It is
also encouraging to report that, while it is too soon to reach any conclusions
from the work in progress, the hospital does feel the work of the Adolescent
Pavilion is becoming increasingly helpful.
It is

Prognosis for the future

�I

7‘"

.

«F

‘
HillSIde
In 1956
treated 561
ts,
of ”709189 hospital days. The
e-‘ﬁ
Q‘ﬁt‘rhte were
patients. Of theﬁital treated», 365

ﬁne

Evaluatipnﬁg

discharged

:-

.

’

'

I

I;

eme

'.

I
Is

.

5

',

I

I

2
__

way f.

ou come

In

a

~

I.

’

gcomparison.

-

f

‘quOﬁ
rials».

"

ndon nt

'

‘

to denote mental condition at the time of
Idischarg
ient’ 5 condition gmbebaviqr
he
en
left This is g
'uII a}; I:
‘

1"7.”
:
'
o’

I

‘

_

I

I

.

I

I

no chan-e

I

"”3

'_

.'

.-

or

’

f

I

:
I

I

ﬁle-5V;

"j

'

m“

iable Rent; m

that symptoms have disapﬁbare nd the patient
conseemeﬁn
good
‘e'ans
Ion at the hospital, but there is no certainty of how he will function when he
Eats back into I own an ial and working community;
recovered means that, in
“i
has bee
ef‘mucharrlﬁrmd
reas
c

ad
.
tioma‘t

'

I.

atient will be
or better" I; he did befor
‘

1
-I

r

3“

.92
*I

f
_

"1""
.

_

I

’

.

mandfuw;¥

tmhﬁ

tateat

I

Mu

,,

.

lmpr.
4O

36
39

.

�m

O S PIT

�PSYCHOTHERAPY AND MEDICAL SERVICES
Major process of

Psychotherapy continues to be the major emphasis and the core of treatment
at Hillside Hospital. Other forms of therapy, each in its own way very important
to the patient’s progress, are all part of the treatment program and are prescribed according to the patient’s particular needs. However, one of the main
criteria for accepting patients at the hospital is their ability to participate
profitably in psychotherapy.

Analysis of hospital

Patients are seen individually by well-qualified psychiatrists for psychoanalytically oriented treatment three or four times a week. Each patient is assigned
to a specific psychiatrist who remains ”his doctor” for the length of his stay.
The psychiatrist is the leader of the hospital “team” that plans and supervises
the patient’s day-to-day treatment. The other members of the team are a psychiatric social worker, a psychologist, professional representatives of the
adjunctive services — Occupational Therapy, Group Activities and Creative
Therapy — and the Nursing Department.

Types of therapy in use,
including new drug
therapies . . . facilities for
treating the “whole" patient:
physically and
psychotherapeutically

Group therapy continues to be used for selected patients. The hospital continues
the use of electroshock therapy for about one-third of patients, especially those
suffering from more severe emotional disorders. The extent to which it is used
has, in many cases, been modified in accordance with the results of research
conducted by the Department of Experimental Psychiatry. During 1956, as a
result of a controlled research study, Chlorpromazine was substituted for insulin
coma in certain patients. It had been found safer, easier to administer, and to
have fewer side effects. For certain other patients at the hospital, insulin coma
is still the treatment of choice. Chlorpromazine has now been added to the drug
formulary of the hospital and made part of the regular therapeutic procedures.
There is continuing work and interest at Hillside in Reserpine and the other
newly developed drug therapies.

Growth of non-psychiatric

The Intra-mural Clinic and allied medical services of the hospital are concerned
with the non-psychiatric, physical problems of the patient. Close cooperation
between the medical staff and the psychiatric staff has brought the hospital
nearer its goal of “treating the whole patient.”

hospital treatment

treatment “team"

medical services

The lntra-mural Clinic

The continued cooperation of a large visiting staff in all the various branches
of medicine, made it possible for the clinic to see 411 patients for a total of
11,844 visits this year.
The Dental Department

10

The Dental Department, newly certified by the American Dental Association as
a qualified hospital dental department, anticipates adding a dental intern to
the staff. New equipment and a newly decorated interior have done much to
facilitate and improve treatment. The dental clinic treated 736 patients this
year, an increase of almost 25% over 1955.

�f

.

The Psychology Department, in response to increased demand for psychological
examinations, added one full-time psychologist this year and provided for the
addition of two more early in 1957. Almost twice as many tests were admin-

The Psychology Department

istered this year as last.

The department has been accepted and used as an integral member of the
hospital team. Its services have been called for in pre-testing hospital personnel,
and in connection with vocational counselling and rehabilitation plans worked
out by the Social Service Department.
The Nursing Department continues to pioneer in training nurses and aides in
the special skills required for proper care of the mentally ill. The nurse fulfills a
unique position in being in direct contact with the patient for long period of time.
And yet the only training she generally receives in psychiatry is a brief threemonth period during student training. This department has organized two special training programs, one for psychiatric aides and one for nurses, which
enable them to perform more effectively and with more understanding as working members of the hospital team.

addition, members of the professional nurse staff participated in trips to
various private and state psychiatric hospitals to observe new methods and
techniques.
In

During the past year, students from Central lslip continued visits to Hillside as
part of their psychiatric training. This year, Hillside became the affiliating institution for basic psychiatric experience for student nurses at Queens College. The
hospital was fortunate in acquiring for its own staff 10% of the college’s first

graduating class.

The Nursing Department

�Three departments of the hospital, make an essential contribution to each
patient’s therapy. Each has a specific function and each is prescribed as a
regular part of treatment planned in cooperation with the psychiatric staff.
Group Activities
Department

The Group Activities Department organizes meaningful social, educational and
work activities that draw patients into groups where they will have opportunities
to form relationships with other patients and deal with situations that mirror
community life.
Each member of the department’s staff of professional social group workers
is assigned as a member of a psychiatric team which plans a program designed
to meet a patient’s specific problems. The group worker reports on the patient’s

performance and reactions to group ‘and social situations.

.Under the guidance of the staff, patients participate in self-government groups,
special interest classes, a choral group, athletic activities, and current events
discussions; they publish a newspaper, operate a patients’ library and engage in
club activities suited to various age levels. In addition, they plan and take part
in social functions, attend religious services and enjoy a varied program of
evening entertainments which frequently include appearances by outstanding
celebrities who generously give their time and talent.
This year has seen the development of an adult education program, in conjunction with Adelphi College, which, in a ten-week course, offers popular subjects similar to those offered by the extension programs of universities and the
New York City Board of Higher Education.

Occupational Therapy
Department

Occupational Therapy the patient works in various crafts such as ceramics,
wood, metal, leather, jewelry making, weaving and needlework. They offer him
a creative outlet that increases his self-confidence, helps him to discover new
skills and has therapeutic value in relieving tensions. By observing the way a
patient reacts to tools and materials, how he copes with success or failure and
how he carries out instructions and responds to authority, the staff is able to
gauge his problems and his progress.
In

1956 two registered therapists were added to the staff, bringing the total to
six. Each therapist is part of the hospital team that plans the occupational program for each patient according to the patient's needs.
In

This year, for the first time, craft classes were scheduled which offer patients
interested in particular crafts an opportunity for more intensive and specialized
instruction. Another innovation was that the Commissary, a patient-run store,
was brought under the direction of this department and patients were assigned
there by doctor's prescription as a form of vocational training.

12

�distinguished visitor this year was Miss Ruth Shamah, Israeli delegate to the
World Federation of Occupational Therapists, who spent three months at Hillside
working and observing the methods used in the department.
A

Creative Therapy is a very special psychodiagnostic and therapeutic tool de~
vised by Dr. Ernest Zierer and his associate, Mrs. Edith Zierer. It consists of a
series of controlled painting tests designed to reveal the patient's unconscious
conflicts. The results are tabulated and interpreted in diagrams which present
a “personality profile” considered to be a reflection of the patient’s ability to
solve his life problems.

Creative Therapy
Department

The department administered 1,423 tests during the year. In addition to regular
consultations with the hospital team, progress reports were discussed at special
conferences with treating psychiatrists and the supervisors.

I3

�THE PATIENT

Work of the Social

Service Department

The Social Service Department is the patient’s most direct and constant link
with his family and the community outside the hospital. Its activities before
admission, during the patient’s stay at the hospital and after he leaves, make
easier both for the patient and for his family the many adjustments necessary
to meet the economic and emotional problems that complicate successful

treatment.

14

Number of yearly
interviews and contacts

the course of its work this year, the Social Service Department conducted
5,137 interviews with patients, 5,095 interviews with relatives, 7,555 telephone
contacts with social agencies and 6,701 telephone contacts with relatives of
patients. The department processes all admissions, functions actively throughout the patient’s stay and is intimately concerned with the patient’s welfare on
discharge and for several months thereafter.

Rehabilitation aspects of the
social service program

the past year the department has made a concentrated effort to strengthen
the rehabilitation aspects of the social service program of the hospital. Experience has shown that the best results are achieved when maximum support is
extended immediately on discharge and continued through the first six months
to a year. Future plans are particularly concerned with opening up new avenues
of cooperation with community agencies whose services can do so much to
help the patient again become a useful and happy member of his community.
In 1956 the following agencies have made marked and increased contributions
in this connection.

Contributing agencies
to rehabilitation programs

The Foster Home Program, which exists jointly with the Jewish Community
Service of Long Island, was used to place newly discharged patients in a supervised family environment. This year the program also was used for patients
awaiting admission to the hospital, with the result that hospitalization was
averted in at least one case.

In

In

'

�AND THE COMMUNITY
The Altro Workshop which provides discharged patients with transitional gainful
employment was used by thirteen patients during 1956.
Through a grant by Mrs. Israel Strauss and the Federation of Jewish Philanthropies, a joint program with the Jewish Family Service of New York was initiated. This service permits discharged patients who need further counseling to
get immediate help. Expansion of this service is expected to show the value of
continued and prompt counseling in averting rehospitalization.

Together with the Jewish Family Service of Long Island, the department developed a special program that helps keep the home intact when a mother has to
be hospitalized. Homemakers are assigned to fill the gap during the mother’s
absence and sometimes even after the mother returns, if this seems necessary.
The program with the Division of Vocational Rehabilitation has been expanded.
A vocational counselor is available to patients one day a week. Vocational guidance begins while the patient is still in the hospital and may continue after
discharge. Training facilities are provided for those whose adjustment to the
community might be made easier by learning new skills.
The department is especially appreciative of the cooperation of the New York
City Department of Education. The Home Instruction Program provides two
teachers who come to the hospital several days a week to give instruction to
patients under 21 who have not completed high school. The results have been
very successful; 40 patients received instruction this year and six were graduated. During the coming year the program will be expanded to include patients
over 21, who, on completing the work, will be able to take High School Equivalency examinations. Follow-up reports indicate that many patients develop an
interest in carrying their education further after leaving the hospital.
The Casework Program started last year in the After-Care Clinic, for the purpose
of coordinating rehabilitative planning, has proven its effectiveness and is now
an established service offered to patients and their families.
The Social Service Department has continued to work very closely with the
Federation Employment and Guidance Service. Their excellent facilities make it
possible for many patients to receive job placement and vocational guidance
soon after leaving the hospital.

15

�HILLSIDE LEAGUE
The Hillside League and the
work of “The Bridge"

The Hillside League is an organization of former patients of Hillside Hospital.
After facing almost certain extinction in 1954 and having an encouraging revival
in 1955, it has made astonishing strides in the past year. That many of its
planned goals have been achieved is due, in large measure, to the untiring and
selfless efforts of “The Bridge, Inc.", a group of women and their husbands who
conducted a successful fund raising drive and who continue in their wholehearted devotion to the League.

Activities at
Bridge headquarters

1956, the Hillside League moved to new quarters (supplied by “The Bridge”)
at 231 West 83rd Street, in Manhattan. Here, in an area many times the size of
its original rooms, members enjoy a comfortable, newly furnished lounge,
equipped with a phonograph, television, table games and cards. The area is
flexible enough to provide for large groups as well as intimate gatherings. The
League is open every evening from Monday through Friday and one week-end a
month for large social functions.

Help with personal

Hillside psychiatric social worker has been assigned as a full-time director of
the League and is available for individual consultation and for referral service
with regard to housing, employment, further treatment and other personal welfare problems. Thanks again to the efforts of “The Bridge,” the volunteer staff
of the League has grown to meet the needs of a much larger membership.

Membership

From a low of 38 in 1954, the active membership has grown to almost 200, and
in addition the League draws upon an active mailing list of almost 500. A club
program, with membership arranged according to age group and interest has
been an important development made possible by the increased membership

welfare problems

In

A

and staff.

The Hillside League looks forward to the next year as one in which it will be
well equipped to fulfill a vital function in helping patients continue the progress
made at the hospital.

QUEENS OUT-PATIENT CLINIC
Hillside Hospital believes that in the Queens Out-Patient Clinic it has developed
a pilot unit that demonstrates the highest level of clinical functioning and serves
as a center for stimulating interest and training in psychiatry.
Work of the clinic

16

The Clinic offers psychotherapy on a twice-a-week basis, up to a year’s duration,
to residents of Queens, Nassau and Suffolk Counties, who require treatment but

�are unable to pay for private care. For a family with an average income psychiatric service can become a severe economic burden. The Clinic meets an
urgent need in a community rapidly growing in population but relatively lacking
in out-patient psychiatric facilities. The Clinic setting, in addition, offers the
advantage of psychiatric social work consultation for members of the patient’s

family.

’

Intensive screening, by means of psychological tests and pre-admission consultation, make it easier for the treating psychiatrist to make early plans for
the patient's treatment program. In contrast to the usual lengthy course of
psychiatric treatment, the Clinic has developed a philosophy of attempting to
accomplish limited goals. Often, by relieving his symptoms, the Clinic frees a
patient to continue on with his life, with the strengths he utilized before he
became ill.
The Clinic treated 271 patients in 1956, the average length of treatment being
eight months. Thirty psychiatrists, accepted after very careful selection, work on

a part-time basis to make this extensive program possible. Permanent staff

Goal of the clinic's

treatment program

Number of patients
and staff members

members of the Hospital are always available for consultation.

1956, the Clinic initiated a separate service for administering electroshock
therapy on an out-patient basis. Recovery, on the whole, was dramatic, rapid
and tremendously appreciated by the patient and family since it meant avoiding
hospitalization.
In

MANHATI‘AN AFTER-CARE CLINIC
The Manhattan After-Care Clinic serves Hillside patients as a link between their
hospital stay and the resumption of community life. This is often a very trying
time because the patient may suddenly be subjected again to old family
stresses, job strains and social difficulties. The Clinic, conveniently located at
Mt. Sinai Hospital, is open five nights a week and the
average course of treatment is twice-a-week for a period of three months.

Function of the clinic

Successful accomplishment of the Clinic’s goals depends in good measure on
cooperation between Clinical Assistants and Social Service Caseworkers. The
Clinic takes this opportunity to acknowledge the extent to which that cooperation exists and functions.

Accomplishment of goals

l7

�THE HOSPITAL

treatment of the mentally ill
depends on intensive research . . . on a better understanding of why people
become mentally ill and a surer knowledge of how treatment effects improvement. Hope for this rests with a wide variety of professional research workers
in the many disciplines concerned with human behavior.
As in any other field of medicine, progress in the

Research and progress

Research in mental illness is spurred on by the grave and immediate need for
new insights and is complicated by the fact that the field of exploration is
limited, almost entirely, to human beings, rather than lower animals. Hillside's
hope is to include every possible approach. Work continues along those lines
that seem to offer the most promise.

Areas of basic study

Psychotherapy remains the area of basic study and treatment. But because past
experience has amply demonstrated that electroshock therapy is, for certain
conditions, the most valuable of the known physical therapies, the hospital has
devoted a major effort this year to study and further elaboration of its use and
effects. Three other studies whose purpose was to devise more clearly objective
methods of evaluating progress in therapy were developed, and a control study
of Chlorpromazine-insulin coma was completed.

Department of
Experimental Psychiatry

This year, the Research Service Was redesignated as the Department of Experimental Psychiatry, indicating its continued growth and anticipating the addition
of a Department of Clinical (Psychodynamic) Research. Two new members were
added to the staff in 1956. Support for the program came from contributions of
the Board of Directors, from the renewal, for three years, of the Electroshock
Study Program of the National Institute of Mental Health of the U. 8. Department of Health, Education and Welfare, and from the Kaufman Foundation of
New York.

Departmental research in
Medicine and Biochemistry

Research in the Department of Medicine concentrated chiefly on a study of new
drug therapies. The Department of Biochemistry continued work on studies of
hormonal balance and undertook a study of the relationship between certain
physiological defects and schizophrenia. Funds for the latter were provided by
the National Institutes of Health.

�AND THE COMMUNITY
During the year, increased recognition of the staff and work of the hospital came
from a large number of lay and professional publications. The hospital is keenly
aware of the value of this public interest because greater attention by the general public to the field of mental health will lead to greater support by govern-

Publications and
Presentations

ment and private agencies, foundations and institutions.

Berkowitz, Anne: A Study of the Caseworker’s Function at Hillside Hospital, J.
Hillside Hospital, 5: 56-60, 1956.
Fink, M: Denial of Blindness Following Cerebral Angiography, J. Hillside Hospital, 5: 238-245, 1956.
Fink, M., Kahn, R. L. and Korin, H.: Relation of Tests of Altered Brain Function
to Behavioral Change Following Electroshock; Presented at the Divisional Meeting, American Psychiatric Association, Montreal, November 8, 1956.
Fink, M. and Kahn, R. L.: Quantitative Studies of Slow Wave Activity Following
Electroshock, EEG Clin. Neurophysiol., 8: 158, 1956.
Goldenberg, H., and Goldenberg, V.: Inhibition of Serum Cholinesterase by
Lysergic Acid Derivatives. Sumicro Detection of LSD, J. Hillside Hospital, 5:

246-257, 1956.
Goldenberg, H.: Decantation as a Precision Step in Colorimetric Analysis, Anal.
Chem., 28: 1003, 1956.
Goldenberg, H.: Recent Advances in Enzyme Methodology; Presented at a Symposium sponsored by the American Association of Clinical Chemists at the
123rd Meeting of the American Association for the Advancement of Science,
New York, December 1956.
Goldenberg, H.: Concerning the Inhibition of Pseudocholinesterase by Hallucinogens; Presented at the New York Academy of Sciences, April 1956.
Green, M. A. and Fink, M.: Electroencephalographic and Clinical Effects of Megimide; Presented at the Eastern Association of Electroencephalographers, New
York, December 5, 1956.
Green, M. A.: The Use of Electroencephalography in Differentiating Psychogenic
Disorders and Organic Brain Diseases, Amer. J. Psychiat., 113: 27-31, 1956,
(with P. Bergman).
Green, M. A.: Neurological Manifestations of Conversion Hysteria, Trans. A.N.A.,
80: 196-198, 1956.
Jaffe, J.: Experimental Alteration of Communication in Doctor-Patient Relationship; Presented at the Nassau Neuropsychiatric Society, April 15, 1956.
Kahn, R. L. and Fink, M.: Changes in Language During Electroshock Therapy;
Presented at the American Psychopathological Association, New York, June 1,
1956.
Kahn, R. L., Fink, M. and Weinstein, E. A.: Relation of Amobarbital Test to Clinical Improvement in Electroshock, Arch. Neurol. &amp; Psychiat., 76: 23-29, 1956.
Kahn, R. L., Fink, M. and Korin, H.: Studies of Mode of Action of Electroshock;
Presented at the Nassau Neuropsychiatric Society, April 15, 1956.
Kahn, R. L., Linn, L. and Weinstein, E. A.: Personality Factors Influencing the
Rorschach Responses in Organic Brain Disease; Presented at the New York

19

�Neurological Society, February 14, 1956. Also, Arch. Neurol. &amp; Psychiat., 76:
226-267, 1956.
Kahn, R. L., and Pollack, M.: Effects of visual, vestibular and somatosensorimotor deficit on autokinetic perception, J. Exp. Psychol., 52: 398-410, 1956,
(with Battersby, W. S. and Bender, M. B.).
Kahn, R. L.: Patterns of Social Interaction in Brain Disease, Amer. J. Psychiat.,
113: 138-142, 1956, (with E. A. Weinstein).
Kahn, R. L.: Confabulation as a Social Process, Psychiatry, 19: 383-396, 1956,
(with Weinstein, E. A. and Malitz, S.).
Kahn, R. L.: Delusions About Children Following Brain Injury, J. Hillside Hosp.,
5: 290-301, 1956, (with Weinstein, E. A. and Morris, G. 0.).
Korin, H., Fink, M. and Kwalwasser, 8.: Relation of Changes in Memory and
Learning to Improvement in Electroshock, Conf. Neurol. 16: 88-96, 1956.
Lurie, Abraham, Miller, Joseph S. A., Bellak, L., Black, B. F.: Rehabilitation of
the Mentally Ill Through Controlled Transitional Employment, Amer. Orthopsychiatric Assoc., 1955 Annual Meeting. Also, Digest of Neurology and Psychiatry,
July 1956, Institute of Living.
Lurie, Abraham: Book review—Delinquent Boys by Dr. Albert K. Cohen, J. Jewish
Communal Services, Summer 1956.
Lurie, Abraham: Integrating Services for Improved Patient Care; Discussant at
50th Anniversary of Social Service Dept. of Mt. Sinai Hospital, October 18,
1956.
Lurie, Abraham: Identifying Casework Responsibility in a Multi-Discipline Health
Setting; Workshop Chairman, National Conference of Jewish Communal Service,
1956.
Pinsky, Louise: The Impact of Mental Illness on a Patient’s Family, Jewish Communal Service, Spring 1956.
Pollack, M. and Kahn, R. L.: Unilateral “Spatial Agnosia” (“lnattention”), Brain,
79: 68-93, 1956, (with Battersby, W. S. and Bender, M. B.).
Wachspress, M., Blumberg, A. G., Fink, M. and Miller, Joseph S. A.: Evaluation
of High-Dose Reserpine Therapy for the Relief of Anxiety, J. Hillside Hospital,
5: 67-77, 1956.
Zierer, Ernest and Zierer, Edith: Dynamics of Creative Therapy; Presented at the
University Clinic in Tubingen, Neckar, Germany.
Zierer, Ernest and Zierer, Edith: Structure and Utilization of Creative Therapy;
Presented at the Institute of Psychotherapy and Depth Psychology in Stuttgart,
Germany.
Zierer, Ernest and Zierer, Edith: Non Artistic Creative Activity; Presented at the
Art Academy of Stuttgart, Germany.
Zierer, Ernest and Zierer, Edith: Seminar on Creative Therapy as applied at
Hillside Hospital and Extramurally; Presented at the meetings of the Zierer
Study Group in Stuttgart, Germany.
Zierer, Ernest and Zierer, Edith: What is Creative Therapw Presented at the
broadcast over the Suddeutscher Rundflunk “Millelwelle.”
Zierer, Ernest: Dynamics of Creative Therapy; Presented at the National Psychological Institute for Psychoanalysis, New York.
Zierer, Ernest and Zierer, Edith: Structure and Therapeutic Utilization of Creative Activity, Amer. J. Psychotherapy, 10: 481-520, July 1956.
'

‘

20

�TEACHING AND TRAINING
The Resident Training Program at Hillside continues to emphasize the interrelation between the training program and the treatment program. Each resident
carries a case load of about 15 patients under the supervision of staff and
visiting instructors, and attends lecture conferences conducted by the medical
directors. Lecture seminars in the fields of psychopathology and psychotherapy,
and reading seminars, are conducted by special instructors chosen from the
hospital staff. Qualified residents are assigned to the department of Experimental Psychiatry for clinical and other psychiatrical research projects. During
the year there were 18 residents in training.

The Resident Training
Program

The hospital training program extends also to Clinical Assistants in the Outpatient and After-care clinics and on-the-job training of personnel. Regular lec-

Training for other
staff members

The Sunday Clinical Conferences, open to and attended by psychiatrists and
other professional personnel and by outstanding visiting physicians, are part of
the resident training program and are based on cases prepared by the residents.
They continue to make a significant contribution to the training picture on the
New York Psychiatric scene.

Sunday Clinical Conferences

The Annual Israel Strauss Lecture, established in 1955 in honor of Hillside’s
founder and late president, was delivered this year on April 8th. The speaker
was William Malamud, MD, Professor and Chairman of the Department of
Psychiatry and Neurology of the Boston University of School of Medicine. His

Israel Strauss Lecture

Hillside's Committee on Community Education continues active and its program
of lectures to the laity promote interest and understanding of mental hygiene
problems in the community.

Community Education

The Medical Library, considerably enlarged by the acquisition of the entire medical library of the late Dr. Israel Strauss, was able this year to increase its services and usefulness to the staff by the employment of a full-time librarian.

Medical Library

The Journal of the Hillside Hospital again showed an increase in the number
of its subscribers, an indication of the prestige and general acceptance it enjoys.
A 504 page Israel Strauss Memorial Volume containing articles by psychiatrists
and other friends of Dr. Strauss, was published in 1956.

Journal of the

tures and conferences are scheduled for nurses and attendants, social workers,
members of the various adjunctive services and for affiliating students from
other educational institutions.

subject was “Current trends in basic psychiatric research.”

Hillside Hospital

21

�REPORT OF THE ADMINISTRATOR
Deficits

While the cost of running the Hospital increased again, from $1,175,635 to

$1,326,454, the deficit this year has been substantially reduced because the
City of New York increased its contribution toward the care of the indigent
mentally ill from $14 to $16 a day.
The average number of patients per day. 192, remained the same as last year
—97% of capacity. However the length of stay increased somewhat and the
total number of patients treated was 561 this year compared to 575 in 1955.

Comparison of costs:
1955-1956 . . .

Salaries
Food

.

.

.

.

Maintenance and Grounds
Administrative EXpenses
Medical Supplies .
Repairs and Replacements
Clinics .

.
.

.
.

Total
Total No. Patients
Total Patient Days

.

.

.

.

Average income per patient day
Average cost per patient day
Average loss per patient per day

.

.

.

.

.

.

1955

1956

$732,977
106,397
50,551
67,017
28,130
25,279
165,284

$797,805
113,428
59,436
82,608
23,950
35,105
214,122

$1,175,635

$1,326,454

575
69,903

561

70,189

$14.45
$15.34

$15.44
$15.84

$

.89

$

.40

Costs of expanded
out-patient services

should be noted that the largest portion of the $150,819 increase was used
for expansion of the Out-patient service. This increase was entirely offset by
grants from the New York City Community Mental Health Board, the State
Mental Health Authority, and increased subvensions from the Federation of
Jewish Philanthropies. Increases in salaries reflect a rise in salaries and salary
rates rather than an increase in personnel. Other increases reflect the general
pattern of rising costs for goods and services.

Costs of the Israel Strauss
Adolescent Pavilion

1956 it was decided to compute the costs of running the Israel Strauss
Adolescent Pavilion separately from those of the main hospital. While the
pavilion operates as an integral part of the hospital, it is a new and costly
experiment, which, if included, somewhat distorts the general operating picture.

It

In

The operation of the Adolescent Pavilion showed a deficitof $37,752, an
increase of 13% over 1955. The difference is entirely accounted for by salaries
for additional personnel found necessary for successful operation.
Maurice Bachrach

22

�SOCIETY OF THE HILLSIDE HOSPITAL
‘President

. . .

Alvin E. Coleman

*Chairman of the Board Roy Foster
*Honorary Chairman of the Board Leon Lowenstein
*Vice-President Dudley D. Shoenfeld, M.D.
*Vice-President D. Herbert Beskind
‘Vice-President George W. Galinger

Manuel Lee Robbins
+Treasurer Alfred Levinger
‘Ass’t Treasurer Arnold S. Askin
Ass’t Secretary Hilda Strauss
Assistant Secretary Alfred Appel

'Secretary

Board of Directors
A.

Leon Lowenstein“

Roy Foster"

Jacob Abrams

George W. Galinger‘
Arthur Garson
Maurice Glinertt
Mrs. Henry Goldman, Jr.
Meyer Goldstein
Louis A. Green
M. Victor Leventritt
Alfred Levinger?
Morris L. Levinsonrl:
Milton B. Loeb
Sandor Lorand, M.D.

Alfred Appel
Arnold S. Askin“

John M. Bendheim
D. Herbert Beskind‘
Saul Blickman
Alvin E. Coleman
Morris David
Edwin Elson1~

Thomas Epstein
Arthur C. Fatt‘
David Finkle
David Finn:

Charles H. Meyer“
Arthur Murray
Manuel Lee Robbins”
lrving Rosenbaum
S. H. Scheuer“
Walter Scheuer
Dudley D. Shoenfeld, M.D.‘
Harry Silverson
Hilda Strauss
Nathan Wigod
Morton 8. Wolf
Walter D. Yankauer

Chairmen of Standing Committees
Medical Affairs Committee
D. Herbert Beskind

Executive Committee
Roy Foster

House and Grounds Committee
George W. Galinger
Co-Chairmen
Nathan Wigod

Jewish Hospital
Coleman

Liaison Committee—L.
Alvin E.

I.

Legal Committee
Charles H. Meyer

Publicity Committee
Arthur C. Fatt

Finance Committee
Arnold S. Askin
Social Service Committee
Hilda Strauss

Personnel Committee
Meyer Goldstein

‘Executive Committee Members

tDeceased in 1956
*Elected in 1956

23

�PROFESSIONAL AND ADMINISTRATIVE STAFF
Medical Director
Joseph S. A. Miller, MD.

Associate Medical Director
Simon Kwalwasser, M.D.

Administrator, Maurice Bachrach, B.S.
George Yessin, M.D.
Jack H. Tabor, M.D.

Supervising Psychiatrists
Gerhard Schauer, M.D.
Martin A. Green, M.D.

Robert Navarre, M.D.
Eugene Glynn, M.D.

Supervising Psychiatrist
Israel Strauss Adolescent Pavilion
Alice Slater Stahl, MD.
Director of Out-Patient Services
Robert R. Luttrell, MD.
Director of Research in Experimental Psychiatry
Maximilian Fink, M.D.

Internist, Arnold Blumberg, MD.
Director of Laboratories, Harry Goldenberg, Ph.D.

Resident Staff
Ruth Adams, M.D.*
Stanley Brodsky, M.D.
Frederick Coleman, M.D.
Warren Cox, M.D.
Ilhan Ermutlu, M.D.
Harold Esecover, M.D.

Stefano Fajrajzen, M.D.
Marie Friedman, MD.
Stanley M. Friedman, MD.
Ruth Fuchs, M.D.

Harold Galef, MD.
Robert S. Gilbert, M.D.
Eugene D. Glynn, M.D.“
Victor Goldin, MD.
Michael Gould, MD.
David N. Graubert, M.D.*
George E. Gross, M.D.*
Peter Guggenheim, M.D.+
A. Russell Lee, MD.

Joel Markowitz, M.D.*
Robert Nodine, MD.
Paul Pressman, M.D.
Arthur Root, M.D.
Jack R. Royce, M.D.*
Robert Shaw, M.D.*
Charles G. Silverman, M.D.*
Myron Stein, M.D.
Morton Wachspress, M.D.

Leon Lefer, M.D.

Other Professional St aff Heads
Nathalie Burbach, R.N., M.A. Director of Nursing
Abraham Lurie, M.S.S.W. Director of Social Service
Abraham Levine, Ph.D. Director of Psychology
Ernest Zierer, Ph.D. Director of Creative Therapy
Eileen P. Fisher, B.S. Director of Occupational Therapy
Zetta Putter, M.S. Director of Group Activities
Angelina Canavan, B.A. Dietician

Department Heads
Dorothy Croghan Accounting Supervisor
Lillian Dailey Office Manager
Thomas R. Lumley Superintendent of Buildings &amp; Grounds
Sarah Travers Executive Housekeeper
‘Completed residency in 1956
fin military service

24

�MEDICAL BOARD
*President
*Vice-President

‘Secretary

. . .

M. David

Sidney Tarachow, M.D.

Sidney

L.

Green, M.D.

Epstein, M.D.

*Treasurer
*

Ex-President

David Warshaw, M.D.

Samuel Atkin, M.D.

Psychiatrists
Samuel Atkin, M.D.‘
Arnold Eisendorfer, MD.
M. David Epstein, M.D.“
Margaret E. Fries, M.D.*
I. Peter Glauber, M.D.
George S. Goldman, M.D.
Sidney L. Green, M.D.‘

William Karliner, M.D.
Sylvan Keiser, M.D.

Sarah R. Kelman, MD.
Emanuel Klein, M.D.
Sidney Klein, M.D.“
Samuel 2. Orgel, M.D.
H. L. Rachlin, M.D.“

Lawrence J. Roose, M.D.
Irving J. Sands, MD.
Robert A. Savitt, M.D.*
Martin Schreiber, M.D.
l’sidor Silbermann, M.D.*
Otto Sperling, M.D.
Sidney Tarachow, M.D.‘

Non-Psychiatrists
Director of Department of Medicine
Lester Cohen, MD.

'Director of Department of Surgery

Director of Department of Neurology
Morris B. Bender, M.D.

Director of Department of Gynecology
Julius Jarcho, MD.

‘Department of Dentistry

David Warshaw, MD.

Paul Scheman, D.D.S.

Chairmen of Standing Committees
Adolescent Pavilion
Sidney L. Green, M.D.

Education of Resident Staff
Arnold Eisendorfer, M.D.

Community Education and Public Relations
Robert A. Savitt, M.D.

Group Psychotherapy
Samuel 2. Orgel, M.D.

Credentials Committee for Psychiatric
Staff and Promotions
Martin Schreiber, M.D.

Manhattan After-Care Clinic
Sarah R. Kelman, M.D.

Credentials Committee for Non-Psychiatric
Staff and Promotions
David Warshaw, M.D.

Credentials Committee for Resident Staff
Sidney Klein, M.D.

Queens Out-Patient Clinic
William Karliner, M.D.
Research Committee
Hyman L. Rachlin, M.D.
Publications Committee
I. Peter Glauber, M.D.

Journal Sub-Committee
Sidney Tarachow, MD.
'Ex-officio

25

�CONSULTING, ATTENDING AND
VISITING STAFFS: AND CLINICAL ASSISTANTS
Consultants
Psychiatry
Leonard Blumgart, M.D.
Sandor Lorand, M.D.
Nathaniel S. Selby, M.D.
Dudley D. Shoenfeld, M.D.
A. M.

Rabiner, M.D.

Medicine
Alfred Angrist, M.D.
Morris S. Bender, M.D.
Oscar Levin, MD.
I. Jesse Levy, MD.

Neurology
Hans Strauss, M.D.

I.

S. Wechsler, M.D.

Dentistry
Morris Fierstein, D.D.S.

Attending Psychiatrists
Samuel Atkin, M.D.
Arnold Eisendorfer, MD.
M. David Epstein, M.D.
Margaret E. Fries, MD.
I. Peter Glauber, M.D.
George S. Goldman, M.D.
Sidney L. Green, MD.

William Karliner, M.D.
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.
Emanuel Klein, M.D.
Sidney Klein, M.D.
Samuel 2. Orgel, M.D.

Hyman L. Rachlin, M.D.
Lawrence J. Roose, MD.

Robert A. Savitt, M.D.
Martin Schreiber, M.D.
lsidor Silbermann, M.D.
Otto Sperling, M.D.
Sidney Tarachow, M.D.

Associate Attending Psychiatrists
Frank Berchenko, M.D.
Cornelius Beukenkamp, M.D.
Mark L. Gerstle, Jr.+

Soll Goodman, M.D.
Attilio Laguardia, M.D.

Samuel R. Lehrman, M.D.
Abraham S. Lenzner, M.D.
Martin H. Orens, M.D.

Abraham Kaplan, M.D.
Louis Kaywin, M.D.
Bruce Kendall, M.D.
George P. Krupp, M.D.
Peter Laderman, M.D.
Nathaniel S. Lehrman, M.D.
Harold S. Leopold, MD.

William W. Pike, M.D.

Adjunct Attending Psychiatrists
Edward R. Adelson, M.D.
Renato J. Almansi, M.D.
Herman S. Alpert, M.D.
Irving L. Bauer, M.D.
Milton M. Berger, M.D.

Lionel H. Blackman, M.D.
Isadore H. Cohn, M.D.

Alexander J. Friedman, MD.
Albert E. Goldbert, M.D.
Albert Harrison, MD.
Thomas Hora, M.D.
tResigned in 1956

26

David Milrod, M.D.
Hugh Mullan, M.D.

Helene Papanek, MD.

Benjamin B. Rubenstein, M.D.+
Irvin Salan, M.D.
Frederick F. Shevin, M.D.
Jay Stanton, M.D.
Aaron Stein, M.D.
Samuel Tabbat, M.D.
Fred U. Tate, M.D.
Leonard Weinroth, M.D.
Herbert Wieder, M.D.
Arthur Zitrin, M.D.1-

�Visiting
Director Lester Cohen, MD.
Visiting Physician George Sabrin, M.D.
Visiting Physician L. Rosenblum, M.D.
Visiting Physician A. Blumberg, MD.
Associate Physician M. Kalkstein, M.D.
Associate Physician J. Weinstein, M.D.
Visiting Neurologist

Medicine
Adjunct Physician A. L. Berger, M.D.
Adjunct Physician W. B. Brett, M.D.
Visiting Dermatologist C. Stritzler, M.D.
Associate Dermatologist Joel Schweig, MD.
Adjunct Dermatologist N. Goldfarb, MD.
Neurology

Morris B. Bender, MD.
Associate Neurologist
Adjunct Neurologist Harry Harter, M.D.

Director David Warshaw, MD.
Visiting Surgeon Sidney Hirsch, M.D.
Visiting Neurosurgeon Joseph Siris, M.D.
Visiting Urologist L. G. Goldberg, MD.
Adjunct Urologist Albert Sutton, M.D.
Visiting Orthopedist A. H. Lewert, M.D.
Director Julius Jarcho, MD.
Visiting Gynecologist M. Warner, MD.
Visiting Gynecologist H. Dubrow, M.D.

Surgery

Kurt Adler, M.D.

Associate Orthopedist J. Schneiderman, M.D.
Visiting Proctologist B. Warner, M.D.
Visiting Ophthalmologist E. Seretan, M.D.
Associate Ophthalmologist A. Minsky, M.D.
Visiting Otolaryngologist S. Clayton, M.D.
Visiting Anesthesiologist Georges Bean, M.D.

Gynecology
Associate Gynecologist Jack Cohen, MD.
Associate Gynecologist B. Greenblat, M.D.
Adjunct Gynecologist Eugene Streim, M.D.

Radiology
Visiting Radiologist Bernard Epstein, M.D.

Director Paul Scheman, D.D.S.
Associate Director J. G. Rubin, D.D.S.
Associate Stanley Spiro, D.D.S.
Associate Dentist B. Schwaid, D.D.S.
Adjunct Dentist B. Lebow, D.D.S.
Adjunct Dentist H. Lewis, D.D.S.

Dentistry
Adjunct
Adjunct
Adjunct
Adjunct
Adjunct
Adjunct

Dentist
Dentist
Dentist
Dentist
Dentist
Dentist

H. Adler, D.D.S.

J. Goldberg, D.D.S.
S. Platt, D.D.S.
S. Plotnick, D.D.S.
E. Friedman, D.D.S.
M. Protell, D.D.S.

Optometry
Staff Optometrist Edward L. Steinberg, O'.D.
Podiatry
Staff Podiatrist Sam Sokolov, Pod.

D.

27

�Clinical Assistants in Manhattan and Queens Clinics
_

Lester I. Abend, ‘M.D.
Ruth Adams, M.D.
Romano Antonelli, M.D.
Howard Boskey, MD.
Paul Bradlow, M.D.
Arline Caldwell, M.D.
Mischa Caplan, M.D.
Dominick J. Carlisi, M.D.
Lionel Chertoff, M.D.
Rita M. Chalef, M.D.
Gloria Chung, MD.
Julius Colantuond, M.D.
Fred Dalton, M.D.
Edward Einhorn, M.D.1-

Joseph Feldman, M.D.+
Philip Friedland, M.D.t

Hans Freymuth, M.D.1Arthur Gillman, M.D.t
Harry Gonda, MD.
David Graubert, M.D.
Martin Hurvitz, M.D.
Howard Hess, M.D.
Gunthar Jacob, M.D.
Wilbur Jarvis, M.D.
Buck Luria, M.D.
Meyer Monchek, M.D.
Mathias Nachumi, M.D.1-

Beatrice Nachtigal, M.D.
Iris Orens, M.D.
Edward Pinney, Jr., MD.
Joshua Ramot, M.D.
Willem W. Roosen, M.D.
Henry Rosberger, M.D.
Joseph D. Rosen, M.D.
Gabriel Rubin, MD.
Herman Tannor, M.D.
Leon Tec, M.D.
Clara Torda, M.D.
Morton Wachspress, M.D.
Irving Waitzel, M.D.l‘

tResigned 1956

STSANDL
.

are necessary to a

v

TO THE HOSPITAL
he Society. The following form, however,

se of the Hillside Hospital, the sum of
-

rty, such as bonds, stocks, etcetera,

is

serted instead of the words “the sum of

28

�l

.,v

.

I
'

I

.,

‘

,-

.

.

�Glen Oaks, Queens, New York,

�Hillside Hospital is a non-proﬁt, non-sectarian mental hospital for the treatment of

from
Patients
mental
curable
and
are
early
symptoms.
voluntary patients suffering
admitted regardless of their ability to pay.

I

Hillside provides training for physi-

cians in post-graduate psychiatry and psychotherapy and puts major emphasis on
research in all phases of treatment. The hospital considers itself a pilot institution,
ill.
the
to
the
and
human
mentally
in
efﬁcacious application of psychiatry
pioneering

I

The hospital is licensed in the New York State Department

It

is approved

of Mental Hygiene.

Medical
Council
the
in
on
by
psychiatry
for a two-year residency

Education of the American Medical Association, The American Board of Psychiatry

and Neurology and the American College of Surgeons. The Dental Department is
Association
Dental
American
the
as an approved hospital department.
by
certiﬁed

I

Hillside Hospital is an afﬁliate of the Federation of Jewish Philanthropies and a

York
Fund.
New
Greater
the
and
Fund
United
the
Hospital
participant of

M. DAVID EPSTEIN, M.D.

�I

The responsibilities and functions of the Medical
Board fall roughly into two broad categories: 1. It is a
consultative and advisory body to the Medical Director
and the Board of Directors in all matters pertaining to
medical functioning of the Hospital. In this capacity, it
assists materially in the formulation of basic policy,
and in the establishment of both short-range and long2. In addition, it
range plans, directions and goals
performs duties relative to the implementation of these
plans and policies and plays an active role in the practical day-to-day operations and needs of the hospital,
whether this be in terms of active supervision of the
junior members of the staff, supervision of the Out
Patient Clinic or the After-Care Clinic, careful and methodical screening of all candidates for positions on the
professional staff, either House or Visiting, or working
with other departments within the hospital, such as Psychology or Social Work It is not possible to report on
all the activities of the Medical Board since the last
report was rendered. However, some of the more important areas of Board activity are worthy of individual
mention During the past year, the Liaison Committee
of the Medical Board, working with the Medical Director
and Lay Board, has been able, after long and delicate negotiations, to bring to a successful culmination
the question of the establishment of a Psychiatric Service at our neighbor institution, the Long Island Jewish
Hospital. One of Hillside’s Attending Psychiatrists will
organize a staff at Long Island Jewish Hospital and will
maintain liaison with Hillside Hospital. We will be glad
to continue to render whatever assistance we can, and
we look forward to a productive, progressive collaboration between the two institutions The Journal of the
Hillside Hospital, under its able editor, has continued to
grow and is achieving ever wider recognition in the
professional world. The caliber and standards of the
publication have remained consistently high. In the ﬁeld
of publication a new project has been recommended and
will shortly be carried out, viz. a series of monographs

I

I

I

I

on important psychiatric subjects to be issued under the
The Adolescent
imprimatur of Hillside Hospital

I

Pavilion, a pilot project established several years ago,
and a rather unique undertaking, has taken a great deal
of time and work. It has gone through a variety of growing pains in its early exploratory and experimental
period, but it is now an established and important aspect
of the Board’s interest and efforts. Although it continues
to present problems, or better, because it does, much
is being learned about problems of adolescent psychopathology and their treatment and a sizable body of
knowledge is being accumulated which will no doubt
lead to advances in understanding and to important research results. In addition, the Pavilion continues to
After much
serve as an important training facility
careful study and planning, the Medical Board has set
the machinery in motion to establish a new project. This
is to be a Child Therapy Unit, for the intensive treatment
of a selected group of children and their parents where
necessary, to be operated as part of the Out Patient Department. Such a unit would be a most valuable adjunct
to our training program and will also help in ﬁlling an
urgent need in the community. The basic set-up is ready
to start functioning as soon as one or two remaining
obstacles are overcome, and it is ardently hoped that this
plan will be brought to fruition in the very near future
Possibly two of the most important functions of the
Medical Board are the organization and supervision of
the Educational and Research Divisions of the Hospital.
Under the guiding hand of the Educational Committee,
our Resident Training Program continues to operate
most successfully and the program of formal and didactic training and supervision is more than adequate. The
Committee is constantly studying and re-evaluating the
educational program, always seeking ways and means
of reﬁning and improving teaching methods at the Resident level, a universal problem with which every training hospital has to cope. Currently, the Committee is
exploring ways of expanding and rounding out the train-

I

I

ing program, with a View to having Hillside accredited
for a three-year residency, possibly with the aid of affiliations with other institutions. Such a development would
be eminently desirable
In the area of Research, much
has been accomplished and the Committee or the Board
charged with this responsibility has functioned most
actively. In collaboration with the Directors of the various research divisions, a large number of projects have
been studied and evaluated. In addition, several members of the Board and Attending staff are engaged in
individual research projects of great interest and promise. The Board is still seeking ways of expanding the
Research Program, broadening it to make it more inclusive and comprehensive by adding a Research Division
devoted to the more purely psychological aspects of
mental disorders. Unfortunately, our efforts thus far
have not been successful, but the search for a suitable
and available person to head such a program goes on
actively. It is with profound regret that we are compelled
to note the loss through retirement of two of our oldest
and most respected Board members— Doctors Julius
Jarcho and David Warshaw, both of whom have become
Consultant Physicians, from which lofty eminence we
trust their invaluable advice and experience will continue to be available to us A closing word now about
our view of the future. We have no doubt that Hillside
Hospital now stands at a critical point in its historical
development and evolution.Great and important changes
can be expected and far-reaching decisions will have to
be made. These changes are made necessary by the need
to expand and to be prepared to meet the exigencies of
a rapidly expanding science of Psychiatry and even
more rapidly growing community needs for service and
for trained personnel. We must gear ourselves and plan
with foresight for these changes. Hillside can and should
become a vital element in the psychiatric world and an
important training and research center. To make it such
will require Vision, courage, perhaps even daring, and
cooperation on the part of all who are associated with it.

I

I

�//2

I

TQM/r/M'
e/0 poéra/

In 1957, Hillside saw many changes, some obvious,
some not yet evaluated, in attitude and treatment, in
ﬁnancial status, in acceptance in the eyes of the comI
of
am
constructive
these
For
signs
progress,
munity
happy to commend our staff, the professional and nonprofesslonal personnel, the Medical Board and the everready help and unselﬁsh interests of the Board of DirecAs a non-proﬁt, non-sectarian hospital for the
tors
treatment of voluntary patients suffering from early and
curable mental symptoms, the function of Hillside as a
teaching and research center has enabled it to pioneer
in many forms of therapy. To help in this area, an unusual number of grants were awarded to Hillside in 1957.
Some $256,400 were allocated for research and nonthe
contributions
Of
the
making
up
operating purposes.
grants, the largest was $104,800 from The Ford Foundation. Other sums were: Max Einhorn Estate, $50,000,
Hillside Hospital Board of Directors, $50,000, and the
US. Public Health, Institute of Mental Health, $35,000
Increasing attention from the nation’s press is being
focused on the research, training and therapy programs
of leading mental hospitals. We believe this is of great
help to everyone in the ﬁeld of mental health. No small
share of this publicity was directed at Hillside Hospital
during 1957 However successful this side of Hillside’s
remained
still
the
in
on
1957,
emphasis
was
program
the patient. At Hillside, the ﬁrst person a patient sees

I

I

I

I

is his doctor. The large medical staff is concerned with
various aspects of his recovery, but the doctor assigned
to each patient is the most important person to look to
for treatment, consultation, advice and help. The social
worker assigned to help with the problems of the

patient outside the hospital, as well as within its walls,
stays with him as long as needed. The nurses and
attendants offer to the patient the understanding of
A new
special training and constant association
booklet dealing with these aspects of a patient’s relationship with the staff, and endeavoring to answer his
questions and allay his doubts, has been written and
made available to patients and their doctors, as well
In 1957,
as consultants and interested researchers
the three alternate ways of dealing with Hillside’s
patients and their varied needs evolved more strongly.
A patient is helped to rejoin his family and the community not only by Hillside but by the various private
and state employment groups, interested voluntary
organizations, as well as the family which ideally gained
new insight and understanding under the guidance of
the social service worker He may need the continued
attention of a social service worker, sometimes for as
long as eight months. A continuous relationship such as
this gives anchorage and stability to the patient. Should
further psychotherapy be needed, he is referred to the
After-Care Clinic, the Jewish Family Service, or other

I

I

I

I

When the discharged patient cannot
be sent back home, because the original environment is
not suitable to maintaining recovery he is placed in
private residence care through our liaison with the
Jewish COmmunity Services of Long Island. Happily
settled in newer, more sympathetic surrounding, the
patient then can be seen in therapy for six to eight
months. This time limit is arbitrarily set in the belief
that the patient can be moved to a dynamic effort to
With the entire emphasis of
recover more quickly
Hillside on an “open hospital,” the tendency more and
more is to treat and hold the patient so far as possible
in his normal environment. Carrying this a step further,
Hillside now believes that its future lies not in enlarging
the hospital’s facilities, but in expanding the pré-hospital
The main orienguidance, and Out Patient Service
tation, therefore, of the patients and staff at Hillside
is to the inevitable return to the community and useful
citizenship. The goal of the hospital’s treatment services.

organizations

I

I

both at the in patient and out patient levels, is to provide
the best qualitative treatment for our patients, so that the
result, ideally, is not merely an improved or recovered
individual, but an improved or reclaimed family unit
or small segment of the present and future community.
Joseph S. A. Miller, M.D.

�I 1957 was a good year for Hillside Hospital, and no

apparent recession set in, with regard to the work of the
hospital, or the demands made upon it were concerned.
During the year, new ideas were presented and developed, such as the training of registered nurses in psychiatry at Hillside, in collaboration with the Queens
Medical College. This plan inured to the beneﬁt of the
hospital in that some of the nurses remained to practice
with us. Additional funds secured from the New York
City Community Mental Health Board and the Nassau
County Mental Health Board permitted the further expansion of services in the Out Patient Clinic where, at
the end of 1957, we were treating 205 patients each
week
We suffered a great loss through the death of
our long time Treasurer, Alfred Levinger, who had been
one of the original founders of the institution. During
1957, the Board of Directors created the new position
of Honorary Director, and the first Director so honored
was Mrs. Israel Strauss, the wife of the founder of our
institution. Saul Blickman, one of our directors ‘of long
One of the most
standing, was similarly honored
important events of the year was the appointment of
Dr. Lewis L. Robbins as Director of Professional Siervices. Dr. Robbins, a nationally known psychiatrist, who
has been with the Menninger Foundation for 18 years,
will join the Hillside staff in July 1958 Our research
work has continued and expanded through the ﬁnancial
aid of several government organizations and private

I

I

I

ﬂﬂﬂﬂﬂ/ﬂ

'

foundations, as well as donations of the Hillside Board
of Directors. During 1957, the staff of the Department
of Experimental Psychiatry extended our knowledge
of the way various treatments affect our patients and
have clariﬁed our understanding of electroshock, insulin
coma, and the newer tranquilizers. Their studies have
been presented before national and local psychiatric
and psychologic societies, and eight reports have been
published during the year. Three reports were presented
at the International Congress of Psychiatry in Zurich
and of Psychology in Brussels during the summer The
need for greater research efforts is apparent to all who
are even casually interested in this ﬁeld of health, and
it does seem incumbent upon the governments of the
United States and of each state, as well as private funds,
to offer more generous support for these efforts. But
surely, within the foreseeable future, progress will be
made and we, at Hillside, are not alone in believing
this. At the 1957 convention of the American Hospital
Association, Dr. Julian P. Price, Chairman of the Joint
Commission on Accreditation of Hospitals of the American Medical Association said: “The chemical nature of
certain mental diseases will be discovered and their
control brought about through the giving of drugs.”
RecognizingIthe tremendous human values this will
have, not to mention the enormous dollar savings, let us
try our best to hasten this day with our own efforts
and money.

I

ALVIN E. COLEMAN

�of
545
total
treated
patients.
Hillside
a
1957,
Admissions and Discharges—1n
with an average daily census of 192. New admissions totalled 81 and readmissions
after
been
an
had
discharged
351
of
the
end
patients
the
32.
totalled
By
year,
of
summaries
statistical
the
is
similar
to
data
This
average stay of 182 days.

recent years.

%/tm/

/
MARRIED
F

No. of patients treated

Males
Sex
Females

Admission (13-19
(20-29
Age
(30-39

(40-49
(50-59
(60 plus
No. of patients admitted
Average no. days hospitalized (adults)

WIDOWED
M

F

DIVORCED &amp; SEPARATED
M

F

�I

In any evaluation of discharges, it is important to
realize that the terms used to denote mental condition
at the time of discharge only signify a comparison between the patient’s condition and behavior when he came
to the hospital and when he left, a relatively short period
The following comparisons use terms which are
deﬁned as follows. Unimproved means there has been

I

no change; improved means that symptoms or problems
have been somewhat helped but still persist to an appre-

ciable extent; much improved means that symptoms
have disappeared and the patient seemed in good condition at the hospital, but there is no certainty Of how
he will function when he gets back into his own social
and working community; recovered means that in
addition to what has been said for much improved,
there is reasonable expectation that the patient will be
able to return tO his community and function as well,
or better than he did before he became ill.

%/
,

DIAGNOSIS

ADULTS

ADOLESCENTS

/lﬂﬂ//

a)
a

TOTAL
NO. OF
PATIENTS

WHOLE

SHOCK
THERAPY

5'2

0F

INSULIN
COMA
THERAPY

%
%
RECOVERED

MUCH
IMPROVED

IMPROVED

UNIMPROVED

Psychoneurosis

63

3

66

19%

12%

10%

46%

40%

4%

Manic depressive psychosis

84

1

85

24‘}

34%

27%

43%

27%

3%

Involutional psychosis

63

63

18%

39%

22%

49%

20%

9%

1

8%

26%

50%

16%

40%

20%

40%

39%

36%

12%

118

9

127

36‘)?

Others

8

2

10

3%

Totals

336

15

351

100%

Schizophrenia

%

76%

14%

18%

13%

�%y¢%/%¢Q/%

m/

giwzéw
%%éa/

I

One of the main criteria for accepting. patients at Hillside is their ability to
participate proﬁtably in psychotherapy. Patients are seen individually three
times a week for psychoanalytically oriented treatment by their assigned
psychiatrists. The psychiatrist is the leader of the hospital “team” that plans
and supervises the patient’s day-to-day treatment. The other members of the

team are a psychiatric social worker, a psychologist, professional representatives of the adjunctive services—Occupational Therapy, Group Activities and
At Hillside, the staff is
Creative Therapy—and the Nursing Department
much larger in proportion to the number of patients than in other mental
hospitals. Thus, Hillside’s emphasis is entirely on the patient as an individual.
Although all the latest physical and pharmaceutical techniques are used as
needed, such as electroshock, insulin, Serpasil, treatment does not revolve
the
to
since
these
supplementary
around
only
they
techniques
are
primarily
psychotherapeutic approach. All departments bring into play the tools of
treatment, prescribed according to the patient’s particular needs, and all aimed
not only at relieving him of symptoms, but getting at the causes as well, so
that he may be returned to full usefulness as a human being.
The Psychology Department. under the direction of Dr. Abraham Levine,
continued to expand both in staff and services. In addition to six new staff
Uma
Dr.
for
Hillside
training
a
diagnostic
year’s
provided
appointments,
The Vocational CounselChowdhury, a cultural anthropologist from India
ling Program was expanded through the addition of staff members. The Department conducted 222 new adult patient examinations, 21 examinations for the
adolescent patients and 248 Out Patient examinations. 117 psychological

I

I

discharge examinations were
administered for In Patient
adults, 8 for adolescents, and
19 for Out Patients.
The Nursing Department. under the direction of Mrs. Nathalie Burbach,
participated in all initial presentations, discharge conferences and team meetings, enabling them to offer more understanding and knowledgeable nursing
care. 36 Psychiatric Aides were trained, and 57 student nurses from Queens
College received psychiatric nursing experience. Central Islip School of Nursing continued to send student nurses for semi-weekly visits to compare opera‘
tion of state and private hospitals, and student nurses and nursing personnel
from St. Vincent’s Psychiatric Unit in Manhattan Visited to obtain information
generally helpful in the preparation of patients transferring from St. Vincent’s
The Intramural Clinic has continued to handle all major
to Hillside
An
of
hospitalization.
patients’
the
during
course
arising
physical problems
overall supervision of the effect of the drugs used in psychotherapy was conducted with special emphasis on Chlorpromazine and Meprobamate. 1756
examinations were conducted for treatment
in such specialized ﬁelds as Dermatology,
Gynecology, Medicine, Neurology, Ophthalmology, Orthopedics, Otolaryngology, Podiatry, Proctology, Radiology, Surgery and
The Dental Department made
Urology
1123 examinations including restorations,

I

I

�extractions, prosthetic treatments, and X-rays. Under the direction of Dr. Paul
Scheman, a staff of 12 Visiting dentists continued to adapt consultation and
treatment procedures to the special needs of the mental patient. The department,
certiﬁed by the American Dental Association, presented a series of lectures for
dentists who treat “problem patients”.

tMa/QMM/féze

gar/12w

The Occupational Therapy Department. under the direction of Eileen P.
Fisher, in order to give more intense individual treatment, registered no more
than 45 patients at a session. No therapist has more than twelve patients to
work with at a time. Though the Department treated fewer patients
per month,
the average daily attendance remained the same, since there was closer followa
up on all patients and a closer relationship with individual doctors. The Department works closely with all members of the psychiatric team, particularly the
social workers. A special class program was organized on a selective basis,
offering individual instruction in ceramics, jewelry and sewing. A student
training program is being planned as a result of approval as an alﬁliating
center for students from New York University
Lectures on the principles
and uses of Occupational Therapy in a psychiatric hospital were given to
student nurses, new personnel and visitors.

I

The Creative Therapy Department. under the direction of Dr. Ernest
Zierer and his associate, Mrs. Edith Zierer, continued experiments with con-

trolled painting tests, designed as a psychodiagnostic tool to stimulate the
patient into projecting his unconscious conﬂicts by painting. An
average of 42
patients were treated daily. A total of 4,509 paintings were analyzed and a
total of 1,593 tests administered A new questionnaire form of tests
was added
to help the patient gain insight into his actions and reactions. The
patients
are encouraged in regularly scheduled individual sessions to give verbal
interpretations of their paintings within the framework of the situation, also
tied in with the test results
Lectures were given to visiting psychiatrists,
social workers and students.

I

I

�@ﬁéﬂ/ [lﬂﬂ/
ﬂ

@ammmw/ /

�I Hillside Hospital believes in treating the mental

patient within the community, rather than in
isolation, away from family and familiar surroundings. Directly responsible for improving
communications between the patient, his family
and his community is Hillside’s Department of
Social Services. Under the direction of
Abraham Lurie, the Department works to help the
patient keep his place in society, and return to it
In 1957, the Dea better, more useful citizen
partment was reorganized to include the Group
Work Division. The Department, therefore, now
consists of two divisions: The Casework Division,
directed by Louise Pinsky, an assistant director
of the Department, and the Group Work Division,
directed by Arnold Eisen, also an assistant director of the Department As a result of this merger
of staffs, there have been several improvements
and developments in the program offered patients,
and it is believed that the goal of integrating the
patient with his family and the community is
closer through these changes.
The Casework Division. with the knowing cooperation of the patients and their families, works
to maintain and strengthen family ties, and to

I

I

solve, with the patients, their individual problems
of rehabilitation. Through the Division, the hospi-

tal reaches out from the patient to the family to
the community. This link is established and maintained before the patient enters Hillside and continues for as long after the patient has left the
hospital as seems necessary. In dealing with the
realities of the home and the community situations that have contributed to the problems of the
patient, the Division is concerned with such speciﬁcs as working opportunities, living arrangements, care of children, care of aged and interim
ﬁnancial support
Last year, a total of 1,566
applications for admission to the hospital were
received. The majority of referrals (89%) came
from the New York City area, but applications
were received from every geographic section in
this country and also as far away as Brazil As
in previous years, twice as many female applicants
as male applicants sought admission. Patients
were referred by psychiatrists, social agencies,
hospitals, churches, synagogues, courts, schools,
trade unions, as well as by communities, expatients, and through publicity. Of particular
signiﬁcance was the fact that the percentage of

I

I

patients not found suitable for admittance was
19.2%, as compared with 25% the previous year
and 26% in 1955. Thus, the trend, started two
years ago, after the establishment of an Intake
Service, continues to demonstrate the effectiveThe activity
ness of pre-screening applications
of the casework division is reﬂected in the following statistics:

I

Interviews with patients,
including Out Patient Dept.

and Adolescent Unit .................... 5,110
Interviews with relatives,
including Out Patient Dept.
and Adolescent Unit .................... 5,860
Collateral Interviews ............................ 186
Interviews with discharged patients ............ 253
Interviews with relatives of
discharged patients ...................... 256
Telephone contacts with social
agencies ...................................... 5,425
Telephone contacts with relatives
of patients .................................... 10,077

The Group Work Division is concerned with

�providing a milieu in which patients can form
social relationships, assume responsibilities, develop new interests and learn new skills and so
begin to ﬁnd places, ﬁrst in the hospital community, and then in the outside community Among
important developments this year was an orientation and intake program designed so that the new
patient, helped by the social group worker,
quickly learns the social structure of the hospital,
and examines some of the groups available to him.
With help, he makes preliminary choices based
on previous experience as well as current social
interest and need As part of the trip program,
another new development, patients go to bowling
alleys, ice and roller skating rinks, and restaurants. Some patients undertake longer trips to
museums, the United Nations, or other places.
Since this requires planning, it is a measure of
the group’s ability to unite in a common goal and
These new
to sustain interest in the activity
developments supplement the program which is
the patient’s most direct link with the community

I

I

I

he has voluntarily left behind. With a group
worker assigned as advisor, all patients meet regularly in democratic self-government. They work

to solve their problems in living together, assume
some responsibility for group discipline, and plan
their social life. Many activities are carried out
by delegated members who serve on planning
committees to choose books and records, plan
parties and dances, and other social activities
An important aspect of life at Hillside is the
chronological grouping based on age and similarity of interest. There are currently clubs serving
all ages and giving each patient a chance to be a
member of a social unit of his choice. The Library
Group, for example, selects new books and magazines for patients from a practically unlimited
list. The Newspaper Group is responsible for the
writing and production of a monthly literary
magazine, “Inside Hillside” and other publications In addition to these self-chosen activities,
all patients participate in a series of current events
discussion groups, in order to keep informed
about daily events in the community they hope
to rejoin. Patients are encouraged to assume
leadership in all matters—and share their skills
with each other. As a result, at varying intervals
during the year, there have been patient-conducted groups in such varied activities as tennis,

I

I

�bridge, play reading, and theatrical production
The Group Work Division operates with a
director, supervisor, four social group workers,
two graduate social work trainees, eleven undergraduate ﬁeld work students, two part-time musical teachers, and 25 part-time volunteer workers
Last year, ten graduate social workers were
placed at Hillside for specialized training. The
Division works closely with two outside organizations, The Bridge, a group of women who help
recently discharged patients to re-establish themselves socially, to find jobs, and to maintain themselves ﬁnancially while doing so, and The Hillside
League, a club for ex-patients of Hillside. Located
in quarters maintained by The Bridge, at 231
West 83 Street in Manhattan, the League offers
social club privileges to members, including
games, TV and meeting space, and, in addition,
provides special help in ﬁnding housing, employment, further treatment, and solving other personal problems in readjustment
The QueEns
OII‘I‘ Paﬁen‘l‘ Clinic. located at the
Hospital, provides psychotherapy for residents of Queens, Nassau and Suffolk Counties who are unable to afford
a private psychiatrist. Directed by Dr. Robert R.

I

I

I

Luttrell, the Out Patient Clinic insures the availability of qualiﬁed specialists who focus on early
treatment and prevention of emotional illness. The
geographical location of the hospital’s clinic, in
a corner of Queens, bordering on Nassau County,
makes a resource for psychiatric care available to
one of the country’s fastest growing population
In 1957, the clinic treated 316 patients
areas
in individual psychotherapy. Of these, 134 cases
were carried over from 1956 and 182 were started
in treatment. 163 were discharged during the
year
from individual psychotherapy. Group therapy, a
new development in 1957, has resulted in six discharged of the 23 patients in the group. Eight
patients received electroshock therapy and 67
patients were seen in continuous casework. 267
psychological tests were performed and 285
patients were evaluated by the “intake” team.

I

Diagnoses of discharged patients were:
Psychoneurosis ..............................................53

Schizophrenia and manic depressive ............ 46
Involutional melancholia .............................. 9
Character disorder ........................................55

Conditions at discharge were:
Improved ...................................................... 1 14
Much improved ............................................ 20
Not improved .............................................. 29

I Average length of treatment at the clinic was

about nine months. Because the clinic is an out
patient facility, families remained intact and there
was little or no loss of jobs. As with in patient
care, fees are based on ability to pay, with the
average fee about $6 per week. (The cost to
provide this service is approximately $30 per
week.)
Another out patient service provided by
the Hospital is the After Care Clinic which operates ﬁve evenings a week at Mt. Sinai Hospital,
a convenient location for most patients. The Clinic
assists the discharged Hillside patient to resume
his community status, and deals with the immediate problems of job replacement, living and
resumption of old environmental contacts that
may have originally contributed to the patient’s
illness
Group psychotherapy was instituted on
a trial basis in this clinic during 1957 in an effort
to meet some of the continuing needs of these
patients.

I

I

�17%
mm/

%ﬁ”2ﬂ7ﬂﬂlgy
Research. When one out of ten adults is hospitalized for mental
illness every year, it is obvious that much is still to be learned
about why people become mentally ill. As much as has been
learned about the care of the mentally ill in the past 20 years,
there are still new areas to be studied, such as blood chemistry
and the delayed effects of the electroshock treatment Hillside
believes that in addition to treating mental patients, it is obligated to undertake research. So advanced is the hospital’s outlook that it is one of the few mental hospitals with a biochemistry
laboratory. Although the amount of current research on the
subject of mental illness is inﬁnitesimally small, Hillside employs a staﬂ of scientists and trained researchers seeking the
answer to why people become mentally ill and a surer knowledge
of how treatment effects the improvement of mental patients
The Department- of Experimental Psychiatry. during 1957,
under the direction of Dr. Max Fink, completed the ﬁrst phase
of its studies on the mechanism and effects of therapeutic techniques presently employed. Following the elucidation of the
neurophysiologic and psychologic bases of the process of convulsive therapy, a control convulsive-subconvulsive study was
undertaken in 1956 and completed in 1957. This study clearly
demonstrated the changes in brain function which are the
necessary prerequisites for change in behavior; and the psychologic, sociologic and language aspects which are fundamental
In concurrent
to “improvement” after convulsive therapy
studies, the equivalence of chlorpromazine therapy for insulin
coma, and the advantages of newer drug therapies were demonstrated in a chlorpromazine-insulin coma control study. Consequent upon these observations, an hypothesis of the mode of
action of tranquilizers was described and a program of be-

I

I

I

I

havioral assay of new drugs undertaken
Basic studies into
patterns of communication continued. By applying new techniques of psycholinguistics, objective methods of evaluating
behavioral change and “improvement” were described and are
now being tested. Studies in tactile and visual perception, neurophysiologic and psychologic bases for individual differences
in response to drugs and convulsive therapy, and biochemical
changes in spinal fluid after induced convusions continued
Support for this program increased through grants from the
Foundation’s Fund for Research in Psychiatry, the National

I

�Institute of Mental Health, and the Psychopharmacology Center
of the National Institute of Health. A research grant of $31,700
was awarded to Hillside by the Foundation’s Fund for Research
in Psychiatry. The grant was given to Dr. Joseph Jaffe of the
hospital’s Department of Experimental Psychiatry for research
in the nature of the psychiatric interview.

The Biochemistry Department was concerned principally
with blood enzyme levels in the hospital patients and with their
urinary alkaloid excretion patterns. Results of a third study
ﬂatly contradicted European reports of a blood test for schizophrenia. Under the direction of Dr. Harry Goldenberg, laboratory co-workers determined that serum cholinesterase levels in
patients receiving electroshock therapy vary according to sex,

with female patients generally higher. Work with rats suggests
that these ﬁndings may be related to an abnormal adrenal
metabolism Preliminary studies on the more acutely ill mental
patients revealed an excessive excretion of aromatic metabolites
in the urine, in agreement with the reports of other workers.
It is not yet known whether this phenomenon has a causal
relationship to schizophrenia European claims of a blood test
for schizophrenia which is based on serum oxidase (ceruloplasmin) assay were unsubstantiated. Positive tests were
obtained in various conditions other than mental disease
(pregnancy, upper respiratory infections, cancer), while many
well-fed patients gave negative tests. It was concluded that the

I

I

European patients who were studied probably were suﬂering
from a Vitamin C deﬁciency.

M ~”‘waﬁrm/WNWwWa/WM‘ WM

l/lMWn/WWVWVWW

vv

4

MUM/WWWW4“:WM
WW “WA/WWW Mil/wk}

WWW «WWW-mekmrmwwvymmm
AWWx W'WWVWWWWWMrMWW/VW
MANN“

�I

During 1957, members of Hillside’s staff were much in

demand as guest lecturers and convention speakers. As the
hospital continues to prove its value as a pioneer in the
“open hospital” philosophy, more and more demands are
made on the staff for intensive training courses, lectures and
publications. Staff members spoke at meetings of national
organizations including the American Psychiatric Association, and the National Conference of Jewish Communal Service, state groups including the New York State Society for

Mental Health, and local groups including the North Queens
Mental Hygiene Association and the Queens County Mental

Health Society

I

Staff members reported on therapy and

research and other results in a large number of professional
publications, The Journal of the Hillside Hospital, edited by
Dr. Sidney Tarachow, included articles by staff members and
also outside contributors.

�Publications 1957:
R. L.

I

Esecover. H.. Juffe. J. and Kuhn.

R. L.: Psychotherapeutic Techniques with Electroshock Patients, J. Hillside Hosp. (in press)

and Green. M. A.: Experimental studies of the Electroshock Process Dis. Nerv. Syst. ( in press)

I

I

I

Fink. M.. Kuhn.

Fink. M.. Shuw. R.. Gross. G. and Colemun. F. 5.: Comparative

Study of Chlorpromazine and Insulin Coma in the Therapy of Psychosis, J. Amer. Med. Assoc. (in press)
Threshold, EEG Clin. Neurophysiol. (in press)

I

I

Fink. M.: Lateral Gaze Nystagmus as an Index of the Sedation

Fink. M.: Individual Differences in EEG Responsivity. Read at Metropolitan EEG Society, New York, February 1957

Fink. M.: Criteria in Evaluation of Clinical Behavioral Change: Neurophysiologic Aspects. Presented at A.P.A., Round Table, Chicago, May 1957

I

and Green. M. A.: Experimental Studies of the Electroshock Process. Read at the Society of Biological Psychiatry, Atlantic City, June 1957
Therapy of Schizophrenia: Role of Alteration in Brain Function in Behavior. Presented at Int. Congress of Psychiatry, Zurich, Sept. 1957
Korin. H.: Effects of Diffuse Altered Brain Function on Perception. Presented at the XV Int. Congress of Psychology, Brussels, August 1957
Behavioral Patterns in Induced States of Altered Brain Function. Read at the New York Divisional Meeting, A.P.A., Nov. 1957
Shift for Psychiatry. Read at Metropolitan EEG Society, N. Y., Nov. 1957

81

I

Fink. M.. Kuhn. R. L.

Fink. M. and Kuhn. R. I..:

Fink. M.. Kuhn. R. L. and
Fink. M. and Kuhn. R. L.:

Fink. M.: Signiﬁcance of EEG Frequency

I Fink. M.: Effects of Diethazine on EEG and Signiﬁcance for Theory of Process of Convulsive Therapy.

Read at Eastern Association of Electroencephalographers, New York, Dec. 1957
Electroshock: Quantitative Serial Studies, A.M.A. Arch. Neurol.

I

I

I

I

Fink. M. and Kuhn. R. L.: Relation of EEG Delta Activity to Behavioral Response in

Psychiat. 78: 516-525, 1957

I

Fink. M.: A Unified Theory of the Action of Physiodynamic Therapies,

�J. Hillside Hosp. 6: 197-206, 1957

I

Goldenberg. H.. and White.

D. L.: Chromatographic, Electrophoretic and Colorimetric Procedures for the Psychotomimetic and Psycho-

therapeutic Drugs; Presented at the Meeting-in-Miniature of the Metropolitan-Long Island Sub-section, New York Section, American Chemical Society, Brooklyn, New York,

February 15, 1957

I

Goldenberg. H.. and Goldenberg. V.: Speciﬁc Colorimetric Determination of Cholinesterase Activity in Blood and Spinal Fluid; Presented at the

Meeting-in-Miniature of the Metropolitan-Long Island Sub-section, New York Section, American Chemical Society, Brooklyn, New York, February 15, 1957

Inhibition of Serum Cholinesterase by Mental Drugs, Ann. N. Y. Acad. Sci., 66: 466-467, 1957
Electroshock, J. Hillside Hosp. 6: 229-240, 1957

Juffe. J.: Criteria in Evaluation

I

Juffe. J.:

I

Green. M. A.: Signiﬁcance of Individual Variability

Study of Communication in Psychiatric Interviews. Read at the New York Divisional Meeting, A.P.A. Nov. 1957
Response to Electroshock Therapy. Presented at Electroshock Research Association, Chicago, May 1957

Induced Altered Brain Function. Read at Amer. Psychol. Assoc., New York, August 1957

Hosp. 6: 216-228, 1957

I

I

I

I

in EEG Response to

Juffe. J.:

I

An Objective

Kuhn. R. L. and Fink. M.: Personality Factors in Behavorial

Kuhn. R. L. and Fink. M.: Perception of Embedded F igurm After

Kuhn. R. L. and Fink. M.: Perception of Embedded Figures After Induced Altered

Kuhn. R. L.. Pollack. M. and Fink. M.: Social Factors in Selection of Therapy in 3 Voluntary Mental Hospital, J. Hillside

Tarachaw. S. and Friedman. S.): Perception Experiments in

241-250, 1957

I

I

I

I

I

Kuhn. R. L. and Fink. M.: Personality Factors in Behavioral Response to Electroshock Therapy, Conf. Neurol. (in press)

N. Y. Neurol. Society, N. U., Jan. 1957

Goldenberg. H.:

An Objective Study of Communication in Psychiatric Interviews, J. Hillside Hosp. 6: 207-215, 1957

of Clinical Behavorial Change: Psycholinguistic Aspects. Presented at A.P.A., Round Table, Chicago, May 1957

Brain Function, Amer. Psychol. 12: 361, 1957

I

a Study of Ambivalence. Read at Section on Neurology

&amp;

Korin. H. (with

Psychiatry of N. Y. Academy of Medicine and

Karin. H. and Fink. M.: Role of Stimulus Intensity in Perception of Simultaneous Cutaneous Electrical Stimuli, J. Hillside Hosp. 6:

Korin. H. (with Tarachow. S. and Friedman. S.): Perception Experiments in a Study of Ambivalence, Arch. Neurol.

&amp;

Psychiat. 78: 167-176, 1957

I

Karin. H. (with Tarachow. S. and Friedman. S.): The Relation of Ambivalence to Aggression and Authority in Psychoneurotic Patients. Read at Amer. Psychol. Assoc., New
York, Sept. 1957

I Karin. H.

(with Tarachow. S. and Friendman. 5.): Studies in Ambivalence. Presented before Schilder Society, New York,

Oct. 1957

I

Pollack. M.

(with Goldfurb. W. and Dorsen. M.): Pain Reactions in Schizophrenic Children. Presented at Amer. Orthopsychiatric Assoc., Chicago, March 1957

I

Polluck. M. (with

Krieger. H. P.): Oculmotor and Postural Patterns in Schizophrenic Children. Presented at Amer. Academy of Neurology, Boston, April 1957

I

Pollack. M. (with

Buttersby. W. S. and Bender.

M.

3.): Figure-ground Perception in Patients with Cerebral Tumor. Read at Eastern Psychol. Assoc.,

N. Y., April 1957

I Pollack. M. (with

�Battersby. W. S. and Bender. M. B.): Defects in Visual Perception in Brain Tumor
Patients. Presented before Int. Congress of Psychol., Brussels, July 1957
M.

I

Pollack

(with Battersby. W. S. and Bender. M. B.): Visual Deﬁcit After Brain Damage

in

Man as Measured with Rapidly-Exposed Chromatic Stimuli. Presented at Amer. Psycho].
Assoc., New York, Sept. 1957

l

Pollack. M. (with Goldfurb. A.): Cultural and En-

Vironmental Factors Affecting Complex Perception in the Institutionalized Aged. Presented
at the Gerontological Society, Cleveland, Oct. 1957

l

Pollack. M.: Brain Damage, Mental

Retardation and Childhood Schizophrenia. Presented at New York Divisional Meeting, A.P.A.
Nov. 1957
and“;

a.

I

Pollack. M. (with Goldfarb. W.): Face-Hand Test in Schizophrenic Chil-

dren, AMA. Arch. Neurol.

&amp;

Psychiat. 77: 635-642, 1957

farb. W.): Patterns of Orientation

I

Pollack. M. (with Gold-

in Children in Residential Treatment for Severe

Behavior Disorders, Amer. J. Orthopsychiat. 27: 3, 538-552, 1957

Battersby. W. S. and Bender.

M.

I

Pollack. M. (with

BJ: Tachistoscopic Identiﬁcation of Contour in Patients

with Brain Damage, J. Comp. Physiol. Psychei. 50: 3, 220-227, 1957

(with Battersby. W.

S.

I

Pollack. M.

and Bender. M. 3.): Visual Deﬁcit After Brain Damage in Man

as Measured with Rapidly-Exposed Chromatic Stimuli, Amer. Psychol. 12: 7, 468, 1957

I

Pollack. M. (with Goldfarb. W.): Cultural and Environmental Factors Affecting Complex
Perception in the Institutionalized Aged, J. Gerontol., 12: 4, 437-438, 1957

I

Zierer.

E.

(with Zierer. Edith): Leonardo Da Vinci’s Artistic Proclivity and Creative Sterility, The
American Imago, Vol. 14, No.

4«,

1957.

Each publication is a tribute to the vision of the hospital’s founder, the late Dr. Israel Strauss.

�gar ZM/
*w

U
473/ c

Jywwﬂky

The Residenf Training Program at Hillside continues to
emphasize the interrelation between the training program and the
treatment program. Each Resident carries a case load of about 15
patients under the supervision of staff and visiting instructors.
and attends lecture conferences conducted by the medical director. Lecture seminars in the ﬁelds of psychopathology and psychotherapy, and reading seminars, are conducted by special
instructors chosen from the hospital staff. Qualiﬁed Residents
are assigned to the Department of Experimental Psychiatry for
clinical and other psychiatric research projects. During the year
there were 18 Residents in training, 15 in the adult in patient
service and three in the Israel Strauss Adolescent Pavilion
The hospital training program extends also to Clinical Assistants
in the Out Patient and After-Care Clinics and on-the-job training
of personnel. Regular lectures and conferences are scheduled
for nurses and attendants, social workers, members of the various adjunctive services and for afﬁliating students from other
educational institutions. Included in the latter was the establishment of a very important afﬁliated training program for student
The Sunday Clinical Connurses from Queens College
ferences. open to and attended by psychiatrists and other
professional personnel and by outstanding visiting physicians,
are part of the Resident training program and are based on
cases prepared by the Residents. They continue to make a signiﬁcant contribution to the training picture on the New York
The third annual Israel Strauss Lecture,
psychiatric scene
established in 1955 in honor of Hillside’s founder and late president, was delivered this year on May 5th. The speaker was
Norman Reider, M.D., Chairman, Education Committee of the
San Francisco Psychoanalytic Institute. The topic of his lecture
As anticipated, the Medical
was “Transference Psychosis"
Library has become a very important feature of the teaching
and research activities of the hospital
The Journal of the
Hillside Hospi‘l‘al again showed an increase in the number
of its subscribers and an indication of its greater inﬂuence and
wider acceptance in the ﬁeld. Thus the Journal has met the
expectations with which it was launched in 1952.

I

I

I

I

I

��The Israel Strauss Adolescen'l' Pavilion. in its third year,
continues as a resident treatment center for a selected group of
emotionally ill girls between the ages of 13 and 17. Due to the
experimental nature of work with adolescents, only a limited
number of applicants are accepted. Because of the intensiveness of
the program, adolescent girls are kept at the Pavilion under treatment for a much longer period of time than the adult patients.
In 1957, the average period of hospitalization for the adolescents
was 300 days, as compared to 192 days for the adults

I Although

there have been recurring problems with shortages of trained
personnel, the pilot program of the Adolescent Pavilion has
proceeded as planned, and many new discoveries have been
made
The seventeen girls who Were admitted in 1957 were
afforded the opportunity for intensive psychotherapy and a well-

I

structured living experience. In an atmosphere reminiscent of
a girls’ boarding school, a professional team has worked to

make this unique program succeed. The team, under the direction of Dr. Alice Slater Stahl, includes three psychiatrists, a
psychologist, nurses, teachers, an occupational therapist, a
group activity worker, plus the non-professional help of nurses’
aides, members of the housekeeping and kitchen departments
and volunteers. A two story building includes all therapy facilities as well as dining and lounging areas. The semi-private
rooms are furnished to allow for the fact that disturbed adolescents are often more destructive than adult patients

I It is

�believed that if Hillside can work out techniques for treating

emotionally ill adolescent girls, much can be learned about the
problems of child guidance and juvenile delinquency. Certainly
much of what has been learned in the past year can be applied
to adult treatment. During the year, it was discovered that the

original plan for isolating the girls did not work out as Well
as integrating certain aspects of the program with adult activities. It has also been found that certain adolescents made more
rapid recovery when transferred to adult cottages. The plan
to let the girls attend school in the outside community was
abandoned in favor of school inside the Hospital, though sep-

arate from the Pavilion since the experience of “going to
school” is important to the youngsters
The girls became in-

I

terested in sewing and put on two fashion shows of their handiwork. One of these fashion shows was the highlight of the 10th
Annual Hillside Hospital Field Day. They also made the drapes

for the dining and recreation rooms in the Pavilion. In addition, unusual work has been done in ceramics, painting and
metals

I

Of the 120 applications received during the
year,
26 patients were screened and 17 were admitted. An
attempt
was made to evaluate each applicant to determine suitability

of $52,400 from The Ford Foundation was used to expand the

research, training and patient facilities, including extensions
and improvements of the Adolescent Girls Pavilion
During
the year, the Out Patient Clinic of the Adolescent Unit provided

I

treatment for 22 girls. Four doctors worked to provide a total
of almost 450 psychotherapeutic sessions. Two social workers
continued their casework and counselling services with the
families, and helped with vocational planning, schooling, job
hunting and social problems
The After Care program has

I

provided short term aid in the transition period between the hospital and community life, as well as longer term psychotherapy.

Work With Other Organizations. No organization dealing
with patients can operate in a completely isolated manner. Hillside’s emphasis on treatment of the patient as a whole, with
particular regard to the family, pre-admission care, and post

discharge care and follow-up, has resulted in working relationship with the following agencies whose invaluable cooperation
has made these programs possible:
ALTRO WORKSHOP

FEDERATION EMPLOYMENT AND GUIDANCE SERVICE

based not only on the criteria of illness, but upon the patient’s
ability to beneﬁt from the hospital’s facilities, as well as the

DEPARTMENT OF PSYCHOLOGY OF COLUMBIA UNIVERSITY

existing group composition at the time. There was an average
waiting period of three months after acceptance
A grant

JEWISH FAMILY SERVICE OF NEW YORK

I

JEWISH COMMUNITY SERVICES OF LONG ISLAND

NEW YORK ASSOCIATION FOR NEW AMERICANS

�/%
ﬁﬁwl/ 7/

[Ma/whzm'éW/Mt

This Annual Report has given a great deal of data regarding service to
patients, treatment facilities and research. It has summed up a large complex
organization’s work on behalf of the mentally ill, their families and the
community which surrounds them. A most signiﬁcant aspect of our work
is the extent to which we have been able to mobilize ﬁnancial support from
many sources. Perhaps the most concrete and rigorous index of the adequacy
of a philanthropic organization’s performance can be gleaned from the way
in which it is supported in the realistic world of ﬁnance. It is therefore
signiﬁcant that we passed this rigorous test quite successfully during 1957.
Our work received excellent support from the City of New York, through
its contributions toward the care of the medically-indigent, mentally-ill
patient. The Federation of Jewish Philanthropies of New York gave substantial help in deﬁcit ﬁnancing. Without Federation’s tremendous interest,
its constant readiness to give advice and assistance, and its careful and
generous consideration of our ﬁnancial requirements, Hillside could not
have developed the excellent and challenging programs described in this
report. Our research programs, started only a few years ago, have begun
to command increasing attention in the psychiatric world and signiﬁcant
attention—support-wise—in the community at large. More than ﬁfty percent of our research expenditures were met by outside sources, such as the
United States Public Health Service and various foundations. The total
research deﬁcit was met by contributions from our Board of Directors
and their friends Our chief items of expense are for treatment and training programs. The table below gives the comparative total cost of these
programs for 1956 and 1957.

I

The In Patient Service continued to operate at 97% of capacity, while—
at the same time—the average income per patient day followed the trend
established several years ago of rising each year, in this case by 130 per
day. The average cost per patient day, however, rose by $1.53. Therefore,
the average loss per patient day in the In Patient Service rose from 40c to
$1.80. These changes rise out of the whole complex of increasing cost of
operation. In 1956, total expenses of $1,326,454. represented a rise of
12.82% over the previous year; in 1957, with expenditures rising by
$169,238, the percentage increase was virtually the same—13%. It is
interesting to note the extent to which this year’s increase is related to

inﬂationary forces in the community, or to actual improvement or changes
in services rendered. It is therefore signiﬁcant that those aspects of expense
which are most stable and most clearly related to the price index—Salaries,
Food, and Maintenance and Grounds—rose by 7%, 5% and 5% respectively,
while the following items more clearly related to quality and quantity of
service rendered rose as follows:
Administrative Expense
20%
Medical Supplies
Repairs and Replacements
Clinics (Out Patient Service)

24%
39%
30%

Again, as in the past several years, the Out Patient Clinic Services accounted
for the largest item of increase, reflecting the continued expansion of our
preventative programs. This expansion was made possible entirely by
grants from the New York City Community Mental Health Board, the
State Mental Health Authority, the Federation of Jewish Philanthropies
of New York and, during 1957 — for the ﬁrst time — by the participation
of the Nassau County Mental Health Board. Included in the increased cost
of Out Patient Services was the expansion of the Foster Home Care Program
for discharged patients, carried jointly with the Jewish Community Services
of Long Island and made possible by the Federation ofJewish Philanthropies.
MAURICE BACHRACH

COMPARISON OF COSTS 1956-1957
1956
Salaries ................................................................ $
Food ....................................................................
Maintenance and Grounds ................................
Administrative Expenses ....................................
Medical Supplies ..................................................
Repairs and Replacements ..................................
Clinics ..................................................................

1957

797,805.
113,428.
59,436.
82,608.
23,950.
35,105.
214,122.

3 855,848.

Tofal ............ 1.326.454.

1.495.692.

Total No. Patients ................................................
Total Patient Days ................................................
Average Income per patient day ........................ $
Average cost per patient day ..............................
Average loss per patient per day ........................ $5

119,350.
62,654.
98,952.
29,811.
49,021.
280,056.

561

545

70,189
15.44
15.84

$

.40

$

69,987
15.57
17.37
1.80

�PRESIDENT—Alvin E. Coleman*
CHAIRMAN OF THE BOARD—Roy

Foster*

HONoRARY CHAIRMAN OF THE BOARD—Leon

Lowenstein‘

VICE-PRESIDENT—Dudley D. Shoenfeld, M.D.*

Herbert Beskind”
VICE-PRESIDENT—George W. Galinger*
SECRETARY—Manuel Lee Robbins*
TREASURER—~Arn01d S. Askin“
VICE-PRESIDENT—D.

ASSISTANT SECRETARY—Alfred
ASSISTANT SECRETARY—~M.

Appel
Victor Leventritt

ASSISTANT TREASURER—Arthur

Carson
ASSISTANT TREASURER—Harry Silverson
HONORARY DIRECTORS—Hilda Strauss and Saul Blickman

Board of Directors
A. Jacob Abrams

Alfred Appel
Arnold S. Askin“
John M. Bendheim
D. Herbert Beskind“
Saul Blickman
Alvin E. Coleman"
Morris David
Thomas Epstein

Arthur C. Fatt"
David Finkle
David Finn
Roy Foster“
George W. Galinger“
Arthur Carson
Maurice Glinert
Meyer Goldstein
Jacob Epstein KatzT
M. Victor Leventritt

Budd LevinsonT
Morris L. Levinson
Milton B. Loeb
Sandor Lorand, M.D.
Leon Lowenstein*
Charles H. Meyer*

'

Walter Scheuer
Dudley D. Shoenfeld, M.D.*
Harry Silverson
Hilda Strauss

Irving Weissglassi
Nathan Wigod
Morton S. Wolf *
Walter D. Yankauer“

Arthur Murray
Manuel Lee Robbins*
Irving Rosenbaum
S. H. Seheuer‘

Chairmen of Standing Committees
Foster
MEDICAL AFFAIRS COMMITTEE—D. Herbert Beskind
FINANCE COMMITTEE—Arnold S. Askin
EXECUTIVE COMMITTEE—Roy

HOUSE AND GROUNDS COMMITTEE—

George W. Galinger, Nathan Wigod—Co-Chairmen
LEGAL COMMITTEE—Charles H. Meyer
SOCIAL SERVICE coMMITTEE—Hilda Strauss
LIAISON coMMITTEE—L. 1. Jewish Hospital—Alvin E. Coleman
PUBLICITY COMMITTEE—Arthur C. F att
PERSONNEL COMMITTEE—Meyer Goldstein
PLANNING coMMITTEE—Meyer Goldstein
GIFTS AND LEGACIES COMMITTEE—Walter D.
* Executive

Committee Members
T Elected in I957

Yankauer

�Miller, M.D.
ASSOCIATE MEDICAL DIRECTOR—~Simon Kwalwasser, M.D.
ADMINISTRATOR—Maurice Bachrach, B.S.
SUPERVISING PSYCHIATRISTS—George Yessin, M.D.
Gerhard Schauer, M.D.
Robert Navarre, M.D.
Zenos M. Linnell, M.D.
Harold Esecover, M.D.*
MEDICAL DIRECTOR—Joseph S. A.

DIRECTOR, ISRAEL STRAUSS ADOLESCENT PAVILION—

Alice Slater Stahl, M.D.
SUPERVISING PSYCHIATRIST, ISRAEL STRAUSS ADOLESCENT
PAVILION, OUT PATIENT DEP’T.—Eugene Glynn,
DIRECTOR OF OUT PATIENT SERVICES—Robert

M.D.

R. Luttrell, M.D.

DIRECTOR OF RESEARCH IN EXPERIMENTAL PSYCHIATRY—

Maxirriilian Fink, M.D.
INTERNIST—Arnold Blumberg, M.D.
DIRECTOR OF LABORATORIES—Harry

Resident Staff
Norman Ackerman, M.D.
Barre Alan, M.D.
Stanley Brodsky, M.D.*
Bernard Cohen, M.D.
Frederick Coleman, M.D.*
Warren Cox, M.D.
Alan Dobrow, M.D.
Necdet Ecder, M.D.

Ilhan Ermutlu, M.D.
Stefano Faj rajzen, M.D.
Marie Friedman, M.D.
Stanley M. Friedman, M.D.*
Ruth Fuchs, M.D.”
Harold Galef, M.D.*
Robert S. Gilbert, M.D.T
Victor Coldin, M.D.*

Michael Gould, M.D.
Sherwin Harris, M.D.
Edwin Kleinman, M.D.
A. Russell Lee, M.D.”
Leon .Lefer, M.D.*
Henry Lefkowits, M.D.
Sidney Lytton, M.D.
Robert Nodine, M.D.

Goldenberg, Ph.D.

Paul Pressman, M.D.
Arthur Root, M.D.*
Alvaro Rozo, MD.
Herbert Schulman, M.D.
Myron Stein, M.D.*
Carl Towbin, M.D.
Margery Wile, M.D.

Other Professional Staff Heads
Goldie Krupa, R.N.—DIRECTOR OF NURSING

Abraham Lurie, M.S.S.W.—DIRECTOR OF SOCIAL SERVICES
Abraham Levine, Ph.D.—DIRECTOR 0F PSYCHOLOGY
Ernest Zierer, Ph.D.—DIRECTOR 0F CREATIVE THERAPY
Eileen P. Fisher, B.S.—DIRECTOR OF OCCUPATIONAL THERAPY
Arnold Eisen, M.S.S.W.——DIRECTOR OF GROUP WORK DIVISION
Angelina Canavan, B.A.——DIETITIAN

n

Department Heads

*

Completed residency in 1957
1’ Deceased 1957

Dorothy Croghan—ACCOUNTING SUPERVISOR
Lillian Bailey—OFFICE MANAGER
Thomas R. Lumley—SUPERINTENDENT 0F BUILDINGS &amp; GROUNDS
Sarah Travers—EXECUTIVE HOUSEKEEPER

snag—hr,

g
..

f

�PRESIDENT—M. David Epstein, M.D.*

VICE-PRESIDENT—Robert A. Savitt, M.D.*
SECRETARY—Sidney L. Green, M.D.*
TREASURER—Paul Scheman, D.D.S.*

Ex-PRESIDENT—Samuel Atkin, M.D.*

Samuel Atkin, M.D.*
Arnold Eisendorfer, M.D.*
M. David Epstein, M.D.*
Margaret E. Fries, M.D.
I. Peter Glauber, M.D.*

Emanuel Klein, M.D.
Sidney Klein, M.D.
Samuel Z. Orgel, M.D.
H. L. Rachlin, M.D.*
Lawrence J. Roose, M.D.

George S. Goldman, M.D.
Sidney L. Green, M.D.*
William Karliner, M.D.
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.

Robert A. Savitt, M.D.*
Martin Schreiber, M_D_
Isidor Silbermann, M.D.*
Otto Sperling, M.D
Sidney Tarachow, M.D.*

Cohen, M.D.*
DEPARTMENT OF NEUROLOGY—Morris B. Bender, M.D.
DEPARTMENT OF DENTISTRY—Paul Scheman, D.D.S.

DIRECTOR OF DEPARTMENT OF MEDICINE—Lester
DIRECTOR OF
DIRECTOR OF

ADOLESCENT PAVILION—Sidney

L. Green, M.D.

COMMUNITY EDUCATION AND PUBLIC RELATIONS—Robert

A, Savitt, M.D.

C‘REDENTIALS; COMMITTEE FOR PSYCHIATRIC STAFF &amp; PROMOTIONS——

Martin Schreiber, M.D.
CREDENTIALS COMMITTEE FOR NON-PSYCHIATRIC STAFF &amp; PROMOTIONS:—

Paul Scheman, D.D.S.
STAFF—Arnold Eisendorfer, M.D.
GROUP PSYCHOTHERAPY—Samuel Z. Orgel, M.D.
MANHATTAN AFTER-CARE- CLINIC—Sarah R. Kelman, M.D.
EDUCATION OF RESIDENT

PATIENTCLINIC—William,Karliner, M.D.
RESEARCH COMMITTEE—Hyman L. Rachlin, M.D.
QUEENS OUT

Peter Glauber,M.D.
JOURNAL .SUB-COMMITTEE—Sidney Tarachow, M.D.
‘iTDQM;MIT-'I‘EE‘FOR ADIUNCTIVE‘ SERVICES—4'1. 'Peter Glauber, M.D.
PUBLICATIONS COMMITTEE—e41.

:CREDENTIALSCOMMI‘TTEE TORSUPERVISING- PSYCHIATRIC AND RESIDENT STAFF——

Sidney Klein, M.D..
COMMITTEE FOR LIAISON WITH LONG ,ISLANDRJEWYSH HOSPITAL..—

Arnold/Eisendorfe‘r, M.D.
,

‘*E’ixéé tsive :Coimmitte'e» M ember;

\

i"

'V

I

'

&gt;

v

,
‘

'

:

"

�%[7ZMW%

WWM/ W

Consultants

Psychiatry

up

OZ

Medicine

Neurology

Leonard Blumgart, M.D.
Sandor Lorand, M.D.
Irving J. Sands, M.D.
Nathaniel E. Selby, M.D.
Dudley D. Shoenfeld, M.D.

Alfred Angrist, M.D.
Morris S. Bender, M.D.
Oscar Levin, M.D.
.1. Jesse Levy, M.D.

A. M. Rabiner, M.D.

Surgery

Gynecology

Dentistry

Hans Strauss, M.D.
I. S. Wechsler, M.D.

David Warshaw, M.D.

Julius Jarcho, M.D.

Morris Fierstein, D.D.S.

George S. Goldman, M.D.
Sidney L. Green, M.D.
William Karliner, M.D.
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.

Emanuel Klein, M.D.
Sidney Klein, M.D.
Attilio Laguardia, M.D.
Samuel Z. Orgel, M.D.
Hyman L. Rachlin, M.D.

Lawrence J. Roose, M.D.
Robert A. Savitt, M.D.
Martin Schreiber, M.D.

5011

Goodman, M.D.
Samuel R. Lehrman, M.D.

Abraham S. Lenzner, M.D.
Martin H. Orens, M.D.

William W. Pike, M.D.
Aaron Stein, M.D.

Isadore H. Cohn, M.D.
Irving J. Crain, M.D.
Albert E. Goldberg, M.D.
Albert Harrison, M.D.
Thomas Hora, M.D.
Abraham Kaplan, M.D.
Louis Kaywin, M.D.

Bruce Kendall, M.D.
George P. Krupp, M.D.
Peter Laderman, M.D.
Harold S. Leopold, M.D.
David Milrod, M.D.

Irving Salan, M.D.
Frederick F. Shevin, M.D.
Jay Stanton, M.D.
Samuel Tabbat, M.D.
Fred U. Tate, M.D.
Leonard Weinroth, M.D.
Herbert Wieder, M.D.

Attending Psychiatrists

'

Samuel Atkin, M.D.
Frank Berchenko, M.D.
Arnold Eisendorfer, M.D.
M. David Epstein, M.D.
Margaret E. Fries, M.D.
I. Peter Glauber, M.D.

Isidor Silbermann, M.D.
Otto Sperling, M.D.
Sidney Tarachow, M.D.

Associate Attending Psychiatrists
Cornelius Beukenkamp, M.D.
Alexander J. Friedman, M.D.
Mark L. Gerstle, J r., M.D.

Adiunct Attending Phychiatrists
Edward R. Adelson, M.D.
Renato J. Almansi, M.D.
Herman S. Alpert, M.D.
Irving L. Bauer, M.D.
Benjamin J. Becker, M.D.
Julius Belinkoﬁ, M.D.
Milton M. Berger, M.D.
Lionel H. Blackman, M.D.

Hugh Mullan, M.D.
Helene Papanek, M.D.

�MD.
VISITING PHYSICIAN—George Sabrin, M.D.
DIRECTOR—Lester Cohen,

Rosenblum, M.D.
VISITING PHYSICIAN—A. Blumberg, M.D.
ASSOCIATE PHYSICIAN—M. Kalkstein, M.D.
ASSOCIATE PHYSICIAN—J. Weinstein, M.D.
ADJUNCT PHYSICIAN—A. L. Berger, M.D.
ADJUNCT PHYSICIAN—W. B. Brett, M.D.
VISITING DERMATOLOGIST—C. Stritzler, M.D.
ASSOCIATE DERMATOLOGIST—Joel Schweig, M.D.
ADJUNCT DERMATOLOGIST—N. Goldfarb, M.D.
VISITING PHYSICIAN—L.

VISITING NEUROLOGIST—Morris B.

Bender, M.D.T
ASSOCIATE NEUROLOGIST—Kurt Adler, M.D.
ADJUNCT NEUROLOGIST—Harry Harter, M.D.I

Hirsch, M.D.
VISITING NEUROSURGEON—Joseph Siris, M.D.
VISITING UROLOGIST—L. G. Goldberg, M.D.’r
VISITING UROLOGIST—Daniel Kaufman, M.D.
ADJUNCT UROLOGIST—Albert Sutton, M.D.
VISITING SURGEON—~Sidney

VISITING ORTHOPEDIST—A. H.

Lewert, M.D.

Schneiderman, M.D.
VISITING PROCLTOLOGIST—B. Warner, M.D.
VISITING-OPHTHALMOLOGIST——E. Seretan, M.D.

VISITING GYNECOLOGIST—M.
VISITING GYNECOLOGIST—H.

Warner, M.D.
Dubrow, M.D.

Cohen, MD.
ASSOCIATE GYNECOLOGIST—Bernard Greenblat, M.D.
ADJUNCT GYNECOLOGIST—Eugene Streim, M.D.
ASSOCIATE GYNECOLOGIST—Jack

VISITING RADIOLOGIST—Bernard

Epstein, M.D.

DIRECTOR—Paul Scheman, D.D.S.
ASSOCIATE DIRECTOR—J. G.

Rubin, D.D.S.
ASSOCIATE DENTIST—B. Schwaid, D.D.S.
ASSOCIATE DENTIST—B. Lebow, D.D.S.
ADJUNCT DENTIST—H. Lewis, D.D.S.
ADJUNCT DENTIST—H. Adler, D.D.S.’r
ADJUNCT DENTIST—S. Plotnick, D.D.S.
ADJ-UNCT DENTIST—E. Friedman, D.D.S.
ADJUNCT DENTIST—M. Protell, D.D.S.
ADJUNCT DENTIST—L. Basson, D.D.S.

STAFF OPTOMETRIST—-Edward L.
STA-FF

Steinberg, O.D_.
OPTOMETRIST—Bernard Attinson, O.D.

ASSOCIATE ORTHOPEDIST—J.

Minsky, M.D.
OTOLARYNGOLOGIST—S. Clayton, M."D.
ANE-S'THESIOLOGIST—Ceorges Bean, M.D.

ASSOCIATE OPHiTHALMOLOGIST——A.

VISITING
VISITING

STAFF 'PODIATRIST—Sam

Resigned 195;?
I Deceased 1795-7
T

Sokolov, Pod.0.

�Lester I. Abend, M.D.
Ruth Adams, M.D.*
Romano Antonelli, M.D.
Howard Boskey, M.D.

Paul Bradlow, M.D.
Stanley Brodsky, M.D.
Arline Caldwell, M.D.
Mischa Caplan, M.D.
Daniel Chansky, M.D.
Lionel Chertoﬁ, M.D.
Rita M. Chalef, M.D.
Gloria Chung, M.D.“

*

Resigned I 957

Ralph W. Clemments, M.D.
Julius Colantuono, M.D.*
Frances Colonna, M.D.
Fred Dalton, M.D.*
Irving J. Farber, M.D.
Robert D. Ferrell, M.D.
Philip Friedland, M.D.
Harvey Coldey, M.D.
Victor Goldin, M.D.
Sumner I. Goldstein, M.D.
Clara Gonda, M.D.
Harry Gonda, M.D.

David Graubert, M.D.
Howard Hess, M.D.*

Martin Hurvitz, M. D.
Gunthar Jacob, M.D.
Wilbur Jarvis, M.D.
Peritz Levinson, M.D.
Buck Luria, M.D.
Daniel Miller, M.D.
Meyer Monchek, M.D.
Beatrice Nachtigal, M.D.
Iris Orens, M.D.*
Edward Pinney, J r., M.D.

Joshua Ramot, M.D.*
William Roosen, M.D.
Phoebe Rosen, M.D.
Joseph D. Rosen, M.D.
Henry Rosberger, M.D.
J ehuda Rozanski, M.D.
Gabriel Rubin, M.D.
Charles Silberman, M.D.
Herman Tannor, M.D.“
Leon Tec, M.D.
David M. Tillim, M.D.
Clara Torda, M.D.
Aimee Wiggers, M.D.

�Hillside Hospital is a member of:
AMERICAN HOSPITAL ASSOCIATION
AMERICAN PSYCHIATRIC ASSOCIATION
FEDERATION OF JEWISH PHILANTHROPIES
GREATER NEW YORK HOSPITAL ASSOCIATION

HOSPITAL ASSOCIATION OF NEW YORK STATE
NATIONAL CONFERENCE OF JEWISH COMMUNAL SERVICE

NEW YORK STATE DEPARTMENT OF MENTAL HYGIENE
NEW YORK STATE DEPARTMENT OF SOCIAL WELFARE

NEW YORK STATE WELFARE CONFERENCE
QUEENSBORO COUNCIL FOR SOCIAL WELFARE

UNITED HOSPITAL FUND
WELFARE AND HEALTH COUNCIL OF NEW YORK CITY

We are fully accredited by:
JOINT COMMISSION ON ACCREDITATION OF HOSPITALS

1%gzlled/ZJ

”42/ QWMJ
.

OF THE UNITED STATES AND CANADA

(NO p recise words are necessar y to a valid le g ac y to the

We are approved for re51dent tralnlng by:
.

.

é % WM
.

.

Society. The following form, however, may be suggested.)

AMERICAN MEDICAL ASSOCIATION
AMERICAN DENTAL ASSOCIATION
'
We .C arr y Jom
t progr am S i n which 5 p eciﬁc s e rvice~b to p atients are ad,
,
,
mlnlstered by the hospltal and pald for by tax-supported publlc agenCIes:

I give to the Society of the Hillside Hospital, for the use 0/ the Hillside

'

_

_

Hospital, the sum of
_

$_—__—_(if

land or any speciﬁc property,

NASSAU COUNTY MENTAL HEALTH BOARD

such as bonds ’ stocks ’ ece
t ‘e r a, iS g i”e n ’ a b r'“3f

NEW YORK CITY COMMUNITY MENTAL HEALTH BOARD

should be inserted instead of the words “the sum of

NEW YORK STATE MENTAL HEALTH AUTHORITY
NEW YORK CITY DEPARTMENT OF HOSPITALS
DIVISION OF VOCATIONAL REHABILITATION, NEW YORK STATE

DEPARTMENT OF EDUCATION
NEW YORK CITY, BOARD OF EDUCATION
UNITED STATES PUBLIC HEALTH SERVICE,

INSTITUTES OF MENTAL HEALTH

We have established programs of community education and community

mental hygiene with:
QUEENS COUNTY MENTAL HEALTH SOCIETY
NASSAU COUNTY MENTAL HEALTH SOCIETY

'

descnp tio " 0/5 h 5 P r 0P3 r‘9’

$_____”).

�An aﬂiliate 0f the Federation of Jewish P/zilant/Lropies of New York

�31:!

ANNUAL REPORT

V~
A

FOR THE YEAR
1958
HILLSIDE HOSPITAL
GLEN OAKS, QUEENS, N.

Y.

��Federatwn

f

0

a partzczpant 0f- the
Fund and the Créat‘erg

��TABLE OF CONTENTS
report of the director of professional services
report of the medical director
report of the President of the Medical Board
report of the President of the Board of Trustees
treatment
psychotherapy and medical services
psychology department
intramural clinic
nursing department
department of dentistry
occupational and creative therapy
adolescent pavilion
organization chart insert
social service department
casework division
group work division
Manhattan after-care clinic
Israel and Hilda Strauss League
Queens out-patient service

Training programs
Sunday clinical conferences
Israel Strauss lectures
medical library
research
experimental psychiatry
department of biochemistry
medical department
Hillside publications
Hillside journal
grants and awards received 1958
report of the administrator
society of the Hillside Hospital

3
4
6
7

10-13
‘10

10
11
11
11

12
12
16-17

14-19
14
15
18
18
18
19
19
19
19

22-23
22
22
23
24-

25
25
27

30-32

�report of the
director of
professional services
LEWIS L. ROBBINS, M.D.

As a very new member of the staff of
Hillside Hospital, I should like to look

ahead rather than participate in a review
of the past year.
A forward-looking plan for the future
development of Hillside Hospital is essential if it is to serve best the needs of
the community today and tomorrow.
The three main areas of activity at
Hillside today are clinical service, education and research. We will never lose
sight of our primary day-to-day service,
which is the treatment of the mentally
ill. Yet to consider enlarging the capacity of Hillside—to help more of the
people who are psychiatrically ill—is
not the answer for the future. Experience of larger institutions indicates the
weakness of this approach.
When the capacity of a psychiatric
hospital is expanded beyond a certain
point, individualized treatment of patients gives way to regimentation. The
result is that the quality of clinical service falls.
It is more probable that Hillside can
best serve the community by striving to
advance our knowledge of psychiatry

for the greater good of everyone,

whether or not he is ever a patient at
Hillside Hospital; and by training professional personnel who will later make
use of what they have learned here in

other institutions throughout the
country.
The main shortage in psychiatry today
is knowledge. Although there have been
tremendous advances in the past 50
years, much remains to be learned. And
while much has been spent in the development of all types of psychiatric facilities, relatively little ﬁnancial support
has been given to psychiatric research.
It is therefore recommended that the
excellent facilities of Hillside Hospital
and its present and potential relationships with other institutions in the area
be utilized primarily for the advancement of psychiatric knowledge.
A unique and productive approach
would be the long-range goal of an

Institute for Advanced Psychiatric

Studies established at Hillside. Although
there exists today an excellent research
program at Hillside, it represents but
a small fraction of the many types of

AHEAD

research that could be successfully conducted here.
The clinical program of the hospital
provides a great variety of clinical problems, as well as opportunity for thorough observation. The forward-looking
philosophy of Hillside Hospital, along
with its utilization of personnel from
many different disciplines, constitute an
excellent foundation for the development of a broad research program.
Such a research program would develop spontaneously if personnel were
adequate—both qualitatively and quantitatively—to take care of our clinical
responsibilities. A staff must be developed who are not only good clinicians
but who also possess an interest in and
capacity for both teaching and research.
The need for trained personnel in
psychiatry is urgent. Hillside already
has accepted education as one of its
principal functions; and this function
could very well be expanded without
detracting from the research objectives
which may be established.
Hillside Hospital thus will continue
to be a pilot institution providing the
best psychiatric treatment currently
available, constantly striving to develop
newer and better methods, and sharing
its experience with others for the welfare
of the general community. Its future is
limited only by the imagination of its
staff, the leadership of its Board, and
the support of its community.

3

�the
of
report
medical director
JOSEPH S. A. MILLER, MD.

This will be my last Annual Report as
Medical Director of Hillside Hospital.
When I came to Hillside in 1947, there
was a one-half time Assistant Medical
Director, six Residents, one and a half
social workers, no psychologists, and
only a fair complement of nurses and
attendants. There were eighty-eight patients. There was no out-patient department, and only the beginnings of an
after-care program. There was no organized research. The teaching was carried on by the Medical Director and by
members of the Medical Board.
From about 1948 on, the services and
facilities of the hospital began to grow.
The new Lowenstein Pavilion was
opened in 1949 and practically doubled
the bed capacity. The number of Residents was increased to twelve and, in
addition to a full-time Associate Medical Director, Staff or Supervising Psychiatrists were added. More attention
was now paid to the discharge and rehabilitation plans and, with the interest
and support of the Federation of Jewish
Philanthropies, with whom we had just
become affiliated, we enlarged our
Social Service Department. In 1951,
we began a small out-patient clinic and
also improved the services of our aftercare clinic. With the construction of the
Elizabeth Sloman Lowenstein Building
in 1954, the small out-patient clinic was
developed into a service able to treat
some two hundred patients twice weekly.

That year, also, the Israel Strauss

Pavilion for Adolescent Girls was established. Supervised clinical training and
teaching of the Residents was enhanced;

teaching in basic clinical psychiatry,
clinical diagnosis and psychotherapy
was extended; regular stated clinical,
diagnostic and discharge conferences
were instituted; and we appointed special instructors to give didactic instruction in psychopathology and psychotherapy.
1951 saw the beginning of organized
research at Hillside with a biochemistry
research laboratory set up under Dr.
Werbin. He was succeeded in 1954 by
Dr. Harry Goldenberg, who now heads
our Bio-chemical Research Department
and who has made some original contributions which have been recognized
and supported by grants from the
United States Public Health Service and
by funds from our own Board of
Trustees.
The largest contributions in the ﬁeld
of organized research were made in the
area of experimental psychiatry, especially electroshock therapy and tranquilizers, headed since 1954 by Dr. Maximilian Fink.
There have been other signiﬁcant
changes and trends. First of all there
has been a change in the type of mental
patient coming to the hospital. Our patients now are of the borderline-psychotic type, although they still fall generally within the qualiﬁcations for voluntary admission. There has been a deﬁnite drop in the average age of the patients from the mid-thirties to the midtwenties. Signiﬁcant, this year was the
replacement of the insulin coma treat-

ment by the tranquilizer, chlorpromazine. We also improved and enlarged
our occupational therapy and group activity services, and, under the able direction of Dr. Aaron Stein, our group psychotherapy programs. Our out-patient
services, ably directed by Dr. Robert
Luttrell, and our community mental
health clinics, with support from the
New York City and Nassau County
Mental Health Boards, have been regarded as models of clinic operation.
Our attending psychiatrists, notably

Drs. Martin Orens and Abraham
Lenzner, have contributed greatly to the
teaching and clinic conferences. At the
close of the year a well-deﬁned program
for the out-patient treatment of school
age children was completed.
The Israel Strauss Adolescent Pavilion completed 4 years of operation. The
experiences gained there will mean not
only an improved teaching and treatment program, but also, in the not too
distant future, a worth-while research
program.
Our Resident Training Program has
maintained its high standards, but has
pointed up the need for more in-hospital or on-the-premises teaching and clinical supervision. This in turn has called
for a larger number of better qualiﬁed
supervising or staff psychiatrists, a call
we have begun to meet.
We have been aided to a generous
extent by National Institutes of Mental
Health in receiving a number of training grants for our Residents and teaching grants for our special instructors.
There is a need for a more comprehensive research program involving projects which will deal, in a more integrated fashion, with the physical, mental and ecological factors in development
and treatment of emotional disorders.
The Journal of Hillside Hospital has,
under the able direction of its editor-inchief, Dr. Sidney Tarachow, achieved a
national reputation in scientiﬁc circles.

�In the decade since Hillside joined
the family of Federation, we have beneﬁted not only from their planning and
other special committees, but even more
from the association with Federation’s
hospitals and agencies in common purposes. Mt. Sinai Hospital provided us
with space for processing and interviewing patients in our after-care clinic for
discharged patients. Since 1950, we
have had a rich and fruitful liaison with
the Jewish Community Services of Long
Island, through which we have been
able to establish supervised psychiatric
services as well as a very worth-while
family care or foster home program for
our discharged mental patients. This
program resulted in our winning the
Milton Weil Award from Federation in
1955. As soon as the Long Island Jewish Hospital had begun its operations,
we helped establish their psychiatric
service. We are indebted to them for
their outstanding help. Mention ought
to be made here too of our help from
the Federation Employment Service,
and our dual participation in a vocational rehabilitation program with the
Altro workshops. I want to mention also,
our ever-friendly relations with the Jewish Family Service, who have not only
provided ofﬁce space for our Social
Services Department in Manhattan, but
have also been cooperating with us in a
long-range case work guidance program
for our discharged patients.
In these days of the “open hospital”
and the establishment of psychiatric
services and out-patient clinics in general hospitals, the question arises about
the future of the separate or special
mental hospital. The answer is that there

will always be patients who will require
in-resident therapy in a controlled therapeutic environment. The small psychiatric hospital need not be separated—
indeed it should work in close relationship with the community and its hospitals, institutions and agencies. Hillside
will become more and more of an open
hospital in the modern sense, depending
largely upon the education of, and acceptance by, the community. However,
within the framework of its special treatment, teaching, and research services,
it ought to remain as far as possible,
autonomous. The mental hospital provides the essentials for the emotional
re-educative process in which the patient is able to re-live and review his
earlier and unsuccessful relationships.
He learns to become a better functioning part of the new and smaller society
of the hospital, and this in turn ﬁts him
for better or improved adjustment in
the larger society outside. The small
mental hospital employs facilities for

more individualized treatment—where
he may be observed in his behavior
toward others and taught how to live
with them, and how to exploit his own
personality assets.
Fortunately for Hillside, my successor, Dr. Lewis L. Robbins, has a rich
background of professional experience
in teaching, treatment, research and
administrative ability. His views and
attitudes in regard to the special mental
hospital—the types of psychiatric and
other professional personnel needed,
the hospital environment and the various adjunctive needs of the patients—
are salutory and knowing.
I close my ﬁnal report on Hillside
with the utmost conﬁdence in the future
that awaits this great institution. I am
proud of the many achievements made
during my stewardship. It is needless

to state that this could not have been
done except with the help of a marvelous staff as well as the cooperation of
the Medical Board and the Board of
Trustees. My thanks to all the professional staffs and employees of the hospital, and especially the heads of departments. And I want especially to thank
my two “Chief Lieutenants” who
worked with me for the good of the
hospital and contributed so much to its
success during the past decade: Dr.
Simon Kwalwasser, Associate Medical
Director and Mr. Maurice Bachrach,
able and talented Administrator. I greet
Dr. Lewis L. Robbins, with whom it is a
pleasure to have been thus brieﬂy associated in the common venture at Hillside, and who, I am sure, will raise the
hospital standards and services to even

greater heights.
Although this is my last Report on
the Hospital as Medical Director it is
not really a “bill of divorcement”. I am
happy and proud to have been asked to
continue as a general consultant to the
Hospital, and as a special instructor to
the Residents. I cannot close on a better
note than by greeting the more than a
hundred Residents who trained under
me during these past'12 years. Hillside
can well be proud of them, scattered as
they are over the United States, and
contributing, wherever they are, to the
treatment, teaching and research aspects
in the ﬁeld of psychiatry based on their
early training and treatment experiences
of their Alma Mater—Hillside.

�the
of
report
President of the
Medical Board
ROBERT A. SAVITT, M.D.

6

During the past year the Medical Board
has continued to function actively in its
role as an advisory and consultative
the
and
Director
Medical
the
to
group
Board of Directors. Through its standof
which
comprised
committees
are
ing
the various echelons of the attending
staff, the Board is directly involved
in all of the medical activities of the
hospital.
The Credentials Committee for the
Supervising and Resident Staif under
the chairmanship of Dr. Roose, has
spent countless hours interviewing and
processing applicants for psychiatric
residency training. Over a period of
collected
is
on
information
being
years
the method of choosing residents. It is
expected that when this is collated and
correlated, it will yield valuable guide
the
for
criteria
in
determining
posts
choice of psychiatric personnel.
As in previous years the residency
training program continues to be a
major interest of the Medical Board. In
this connection Dr. Arnold Eisendorfer’s committee has held periodic conferences with Dr. Miller, the Medical
Director, in order to further advance
the means whereby Hillside will become
accredited for a three year residency.
One of the important recent advances
in resident education and training has
come by way of the revised group psychotherapy program. This is expertly
directed by Dr. Aaron Stein and coordi-

nated by Dr. Samuel Orgel.’s committee.
Better liaison has been established
between the psychiatric attending staff
and the hospital’s adjunctive services.
Dr. I. Peter Glauber and his colleagues
are formulating a series of conferences
and lectures which will increase the
mutual exchange of educational and scientiﬁc information with the Psychology
and Social Service Departments.
Under the superb guidance of its editor, Dr. Sidney Tarachow, the Journal
of the Hillside Hospital has expanded
its circulation and widened its scientiﬁc
achievement in this country and abroad.

Currently, several manuscripts are

being carefully considered by the Publications Committee for selection in the
projected Hillside Hospital Monograph
Series.
On the basis of liaison agreements
entered into during the past year with
our neighbor, Long Island Jewish Hospital, a Psychiatric Service has been
established at that hospital. It is being
administered by Dr. Samuel Lehrman
of our Board in collaboration with a
number of additional psychiatrists from
our attending staff.
The Adolescent Pavilion has raised
many provocative questions and problems which are gradually approaching
resolution. It is expected that our experiences will serve as points of orientation
and enlightenment for other psychiatric
facilities dealing with the treatment of
adolescents. Dr. Margaret Fries and her
co-workers are elaborating a method of

organizing clinical data which will be
of great value in the study of adolescents, is expected to ﬁnd a place in the

total resident educational program

throughout the hospital.
The Medical Board activities also
reach out into the community of which
Hillside is an integral part. Many of its
attending psychiatrists render valuable
service to the Queens Out-Patient Clinic
and the Manhattan After-Care Clinic in
terms of training and supervision of
the
in
and
colleagues,
presenyounger
tation of periodic clinical conferences.
The Israel Strauss Memorial Lecture
has become a notable yearly medical
event which attracts a large audience
from the psychiatric and related scientiﬁc professions. The annual Hilda
Strauss Mental Health Lecture has also
reached deeply into the local community’s stream of mental hygiene activities.
It is with deep regret that the Board
reports the loss of its beloved member,
Dr. Sidney Klein. He died in August
1958, and left behind a legacy which exempliﬁed his love and loyalty to Hillside. Under the terms of his will this is
to be devoted to special studies in child
and adolescent psychiatry. A suitable
memorial in his honor is being planned.
I wish to express my deepest appreciation to my many colleagues on the
attending staff, to the Medical Director,
the Director of Professional Services,
to the Board of Directors and those too
numerous to mention, for their cooperation and devotion to Hillside Hospital.

�report of the
President of the
Board of Trustees
ALVIN E. COLEMAN
A milestone in the 31 year history of

Hillside Hospital was the appointment
of the internationally known psychiatrist, Dr. Lewis L. Robbins, as Director
of Professional Services. At the same
time that Dr. Robbins is helping us to
look ahead, he has helped to put the
current program of the hospital in a signiﬁcant perspective. Our prime object
is the continued improvement of the
quality of the treatment available to our
patients, and the scope and value of
the knowledge that we are able to
impart under our teaching and research
programs.
Each year it seems more evident that
the future of the treatment of mental
disease rests in the ability to conduct
extensive research in order to learn
entirely new methods. We are fortunate
to have on our staff capable and farseeing men who are leading us along
challenging pathways to the future.
During 1958, a Department of Medicine, headed by Dr. Arnold Blumberg,
was added to the research program. The
Department of Experimental Psychiatry, headed by Dr. Maximilian Fink,
did some outstanding work in the ﬁeld
of electroshock and tranquilizer drug
effects upon the patients’ personality
and behavior. The U. S. Public Health
Service allocated a 5 year grant of

$268,000 for this department and
appointed Dr. Fink to serve as a consultant to the Council of the National
Institute of Mental Health, which itself

passes upon applications for grants from
those working in this ﬁeld. Four pharmaceutical houses, Bristol Laboratories,
Wyeth Laboratories, Smith, Kline 81
French, and Geigy Chemical Company,
provide ﬁnancial grants for further detailed study of how the new psychotropic
drugs affect human behavior.
The general use of insulin as a mode
of treatment was discontinued because
it has proven to be too hazardous for
results obtained and that the same or
similar results are now apparently
available through the use of new drugs.
The Department of Biochemistry,
headed by Dr. Harry Goldenberg, made
substantial progress in further studies
based upon the premise that mental
illness is accompanied by metabolic and
other biochemical defects which can be
detected. Dr. Goldenberg’s work, too,
has received considerable recognition
by the U. S. Public Health Service in
the form of substantial public grants.
Further plans for the modiﬁcation of
the building and the treatment program
are now being studied. Six new ofﬁces
were added to the pavilion for adolescent girls at a cost of $35,000.
A joint psychiatric service with Long
Island Jewish Hospital, our neighbor,
was established through the appointment as Chief of this service of Dr.
Samuel Lehrman, Attending Psychiatrist of Hillside and a member of our
Medical Board.
Through the aid and encouragement
of the Nassau County Mental Health

Board, it was decided to open a Child
Therapy Unit in April, 1959. This will
be 50% supported by funds from Nassau County.
During 1958, Hillside received a
number of important bequests including
the balance of the funds left to it under
the will of the late Edwin Elson, our
former Trustee; the total of this bequest
was $52,000. We also received $20,000
from the estate of Dr. S. Klein, who had
for many years been a valued member
of our Medical Board; and $37,950
from the estate of Wilhelm Levinger,
brother of our beloved former Trustee,
Alfred Levinger, who had been one of
the founders of this hospital. We were
awarded a grant by the U. S. Public
Health Service of $150,000 toward the
minimum required sum of $300,000 for
the construction of a building to be
used solely for research in mental
health. One of our ever-loyal and generous trustees, Mr. Si Scheuer, made it
possible for us to promptly qualify and
accept this muniﬁcent grant by himself
giving us $50,000 towards the construction of this building, which will be
knOWn as the Scheuer Building for
Research.
A 75th birthday was celebrated by
one of our most distinguished trustees
who has done so much for the Hospital
by making possible the magniﬁcent
facilities it now enjoys, namely our
Honorary Chairman, Leon Lowenstein.
We all wish him many more happy
birthday anniversaries.

7

��N 1958, there

342 patients who had
this
Hillside
themselves
treatment.
admitted
to
numHospital
Of
for
voluntarily
ber, 211 were new admissions, and 131 were readmitted patients of whom 27
I

were

had previously received treatment at Hillside.
the
Included
in
males,
236
106
the
342
female
females.
were
patients,
0f
total are the 23 girls admitted to and treated in the Adolescent Pavilion.
The average daily census of patients was 195; and the average stay of each

‘

i

.‘

‘

9..

’v;'r‘{1

'v:

.2»

‘

.

-

“Amway-713w

v

,,

.

patient was for 196 days.
Upon discharge front the hospital, a patient’s condition is evaluated on a
he
when
behavior
mental
his
and
basis:
enthe
status
in
diﬂerence
comparative
tered the hospital, and when he left.
The ﬁve categories are listed below, (ﬁgures in parentheses indicate the number of patients who left Hillside in 1958)
Unimproved (41): no change in condition.
have
still
but
been
alleviated
persist
problems
or
Improved (137): symptoms
to an appreciable extent.
Much improved (134): symptoms have disappeared and the patient seemed
in good condition while hospitalized; however there is no certainty as to his behavior when he returns to his normal environment at home and at work outside

of the hospital.
Recovered (24). the prognosis is that the patient will be able to return to
his social and working community and function as well, or better than he did
before he became ill.

Without Mental disorder (5) Qied (1 )

OSPITAL

‘

�STAFF EXECUTIVES
Abraham Levine, Ph.D.
Sylvia Markham, M.A.

Leonette Vanderhost, M.A.

Director,
Psychology
Dept.
Associate
Psychologist
Senior
Psychologist

treatment
psychotherapy
and medical services
The center and core of the treatment
program at Hillside is psychotherapy.
The ability of the patient to beneﬁt considerably from psychotherapeutic treatment in this area is one of the main
criteria for admission. The patient must
voluntarily admit himself and be in an
early and incipient stage of mental illness. (The long-term, chronic case,
requiring custodial care, is referred to
other institutions.)
The Hillside patient has thus been
selectively admitted, receives psychotherapy a minimum of three times a
week. In addition, patients participate
in group therapy, and all of the other

accepted modern therapies, activity

therapy, occupational, creative and recreational, drug therapy, and milieu
therapy.
é

10

_

/

s

..

.4

.

Each team of psychiatric, nursing, social service and other professional personnel of Hillside Hospital meets regularly to pool its
knowledge to help its patient along the road
to mental health.

psychology

department

The department continued to make its
contribution to the understanding of a

In the concept of milieu therapy, the
whole life of the patient in the hospital,
including associations and activities are
designed to facilitate his treatment. The
therapeutic program thus changes as
the patient changes.
To conduct this extensive program,
Hillside utilizes a “team” approach integrating the skills of the specialists on its
staff, under the general supervision of
the medical director.
Leader of the team is the psychiatrist
who is assigned to a patient upon admission, and who remains in charge of the
patient for the duration of his stay.
Working closely with the psychiatrist,
and coordinating the efforts toward the
mental health and welfare of the patient
are consulting psychiatrists, psychologists, psychiatric nurses, occupational
and creative therapists, psychiatric
social workers and psychiatric attendants.
The team concept is a broad one, and
under it conferences are held at which
are presented initial diagnosis of newly
admitted patient; periodic reports on
status of patient and his response to
treatment; pre-discharge consultation
and rehabilitation, or after-care plans.

patient’s strengths, weaknesses, and

highly complex psychic states by means
of psycho-diagnostic examinations.
Objective results obtained through
these tests have been helpful to the hospital staff in delineating a history of
conﬂicts, defenses, personality. The tests
help to reconstruct and chart the patient’s life to show what forces were at
work to bring him to the hospital. They

provide much informative material

needed to plan treatment.
Psychological tests are administered
upon admission and before separation
from the hospital. Last year 541 tests
were administered to hospitalized
patients and out-patients.
Expansion of the department has
made possible the inclusion of a vocational counseling program. This program has been especially helpful in
developing a placement program within
the hospital where a patient may acquire
work experience that helps prepare him
for the future when he leaves the hospital and returns to his community.
In 1958, a doctoral candidate from the
Department of Psychological Foundations and Services at Teachers College,
Columbia University participated in the
psychological counseling program.

�STAFF EXECUTIVES
Mrs. Goldie Krupa
Miss Nancy Jeffries
Miss Jean Hendry
Miss Helen Schippincase

Miss Eleanor MacPhillips
Miss Flora McCartney
Mrs. Alice McDonough
Mrs. Edna Telesca

Director of
Nurses
Assistant
Director 0 f
Nurses
Nursing
Instructress
Day
Supervisor
Afternoon
Supervisor

Night
Supervisor
I ntra-M and
Clinic Nurse
Departmental Secretary

nursing department

intramural clinic
This department maintains the patient’s
physical health and cares for his non-

psychiatric medical needs. Frequent

consultations are held between Hillside’s staff and the Intramural Clinic’s
specialists to integrate the mental and
physical treatment programs.
Under the direction of Hillside internist, Dr. Arnold C. Blumberg, the Intramural Clinic handled 2184 patient visits
in 1958. The greatest number of patient
referrals to Clinic specialists, were in the
ﬁelds of Internal Medicine, closely followed by Opthamology, Dermatology
and Gynecology.
Important services also were rendered in Orthopedics, Otolaryngology,
Proctology, Surgery, Urology, Neurology, Podiatry and Radiology. Plans
have been made for the Intramural
Clinic specialists to take an active part
in a psychiatric training program for
non-psychiatric physicians.

Last year an In-Service Training Program for registered nurses was instituted. The program, which consists of
lectures by psychiatric supervisors and
doctors, has been of tremendous value
to the nursing staff. Knowledge gained
and shared has enabled the nurses to
perform more effectively to the beneﬁt
of the patients and the hospital.
The policy of conducting ﬁeld trips
through the hospital for students from
Central Islip and St. Vincent’s Schools
of Nursing was continued.
In addition, during 1958, for the
third consecutive year student nurses
from Queens College received their psychiatric nursing experience at Hillside.
F orty-four students participated in the
teaching-working program.
The training program for psychiatric
aides was recognized by the Queens
County Mental Health Society, which
presented awards and certiﬁcates of
honorable mention to four aides trained
by the Nursing Department. The awards
were made to focus public attention on
the important role played by the indispensable psychiatric aides, who contribute so much to the patient through
their interest, kindness, attention and
skill.

department of
dentistry
Approved by the American Dental
Association, it is the oldest intramural
department in the hospital. Its staff of
10 dentists, directed by Dr. Paul Scheman, last year received 1112 visits and
rendered professional services in orthodontia, periodontia, restorative dentistry and oral surgery and X-ray.
New dental equipment acquired in
1958 made it possible to vastly improve
the dental care to patients.
Members of the department frequently appeared before dental organizations
to read papers and give lectures on
methods of treating dental patients with
emotional problems.

‘

;

I

11

�O. T. STAFF EXECUTIVES
Director
Eileen P. Fisher
Joseph C. Chase
Senior
Occupational Therapist
Adult-Section
Esther Burack
Senior
Occupational Therapist
Adolescent Pavilion

occupational
and creative therapy

12

Two adjunctive services at Hillside, which make an
important contribution to the patient and staff are the
Occupational and the Creative Therapy departments. Each
of these departments has a speciﬁc function, and each is
prescribed as a regular part of
treatment in cooperation with the
psychiatric staff.
The OCCUPATIONAL THERAPY department, which is a member of the treatment team, performs
a dual function. It provides a program under which a patient can
work in various handicrafts, which
offer a creative outlet that increases
his self-conﬁdence. It also helps the
psychiatric staff by reporting on the
patient’s attitudes and reactions
while he is so engaged.
From these reports, which detail
responses to success or failure with
a project such as weaving, jewelry
making, ceramics, the psychotherapist gains further insight
to his patient not only at work, but also in his relationship
with others in the group.
In 1958, the department had maintained a close association with the hospital team. Occupational therapists attended meetings three times a week to contribute their
knowledge of a patient, and also submitted regular progress
reports to the psychiatric staff.
The addition of one therapist to the staff during the
year made possible the initiation of an occupational
therapy program right in the patient’s room. This enables
the therapist to reach a more disturbed patient more quickly
and to give him more individual attention.
At year’s end, a new prescription form was devised to
effect an even closer working relationship between the

C. T. STAFF EXECUTIVES
Director
Dr. Ernest Zierer
Creative Therapy
Associate
Edith Zierer

Director

doctor and the occupational therapist. The form contains
pertinent information which provides a direct guidance
line and a higher degree of integration between the psychiatrist and the occupational therapist, indicating areas of
concentration that will be most helpful to the patient.
CREATIVE THERAPY at Hillside is a specialized form
of art therapy devised and developed by Dr. Ernest Zierer.
Department Director and his associate, Mrs. Edith Zierer.
This therapeutic and psychodiagnostic tool involves the administration of a series of painting tests
that reveal a visual expression of
the patient’s attitudes toward recurrent life situations.
This unique program furnishes
a “personality profile” of the
patient. This proﬁle supplies the
psychiatric staff with documented
ﬁndings delineating the patient’s
stress and frustration tolerances,
strength of motiﬁcation, actual and
potential functional capacity and
his ability to “integrate” into the
societal structure.
During the year, an average of
49 patients took part in the program daily and a total of
1640 tests were administered.

adolescent pavilion
STAFF EXECUTIVES
Dr. Alice Stahl, Director
Dr. Zenos M. Linnell, Supervisor
Dr. Eugene Glynn, Director of After-Care Clinic
Dr. Sidney L. Green, Consultant
Mrs. Kathleen Cliggett, Head of Nursing
Mrs. Sylvia Riback, Senior Social Worker

The Israel Strauss Adolescent Pavilion, now in its ﬁfth
year, was a pioneering venture of Hillside Hospital. It was

1.

2;

�set up to treat and rehabilitate adolescent girls who need
hospitalization for emotional problems during a most crucial transistory period of their lives.

Hillside Hospital, in venturing into this hitherto
neglected ﬁeld, recognized that adolescence is an ideal

time to employ the knowledge and skill of modern psychiatric care to help young people when help can be decisive.
The Pavilion provides individual psychotherapy, milieu
therapy, a school program, a group
activities program and nursing care
for girls between the ages of .13 and
17. It also conducts an intensive
social work program with the families of all patients to create a healthier climate and better understanding at home, of the girls’ problems.
The 23 patients admitted to the
Pavilion in 1958 remained in the
hospital for an average of 315 days,
as compared to the 182 days for
adults. The conditions range from
transient behavior problems to the
major psychoses.
The staff includes a supervisor,

three resident physicians, three

registered nurses, two social workers, two school teachers,
a group activity worker, an occupational therapist and 16
psychiatric aides.
The patients live in a two-story building that includes
all therapy facilities, studio-type bedrooms for two girls,
dining rooms, lounge and recreation areas.
The girls, however, attend school classes in another
building to simulate as much as possible the atmosphere
of “going to school”. As soon as they are able to, girls
are
encouraged to join in recreational activities outside their
own group in the Pavilion.
There have been two notable advances during the
year.
The ﬁrst is a more structured and individualized
program.
Under this program the group work department offers a
.

variety of activities and each patient is required to sign
up for two of those activities. The structured program
helps the patient to do what she cannot do for herself.
The second advance has been to use the concept of
individual and group responsibility to foster growth.
Housekeeping duties have been assigned to girls and the
relationship between various privileges and the patients’
readiness to exercise self control has been stressed.
As the Pavilion gains wider recognition among members of the

4"

psychiatric profession, greater

numbers of referrals continue to
come in from distant parts of the
country.
However, to maintain its high
standard of individual attention,the
Pavilion restricts its patients to 16
at any given time.
The operation of the Adolescent
Pavilion is in conformance with
the basic thesis of Hillside Hospital; early treatment for those mentally ill patients who can beneﬁt in
a relatively short period of time.
Even though the adolescent years
are directly related to the Hillside orientation, it was
obvious at the time the Pavilion was set up, that the adolescent years are the “difﬁcult years.” This period of greatest individual change also is the period about which
relatively little is known to the psychiatrist.
Five years of treatment of adolescent girls have resulted
not only in the improvement of the patients involved but
also have led to insights and approaches to modiﬁed and
new treatment concepts. These results already have been
applied to adolescents, as well as young adults.
Follow-up studies of discharged adolescent patients
presently are being conducted. In summary, the operation
of the Adolescent Pavilion has provided an exciting area
for a combined treatment and research project.
i

13

�CASEWORK DIVISION EXECUTIVES
Abraham Lurie
Director, Dept. of
Louise Pinsky
Sylvia Solovey
Sylvia Riback
Seymour Silverberg

Social Service
Department
casework division

14

The Social Service Department is the
hospital’s most direct link between the
patient and his family.
The department’s function is to help
the patient and his family cope with
the personal, social and economic problems caused by the illness.
It helps a patient come into the hospital, to stay in the hospital by working
with the family members in an effort
to relieve pressures on the patient, and
ﬁnally, to leave the hospital, and return
to a good home climate. This is accomplished by participating directly and
actively in the planning that concerns
the patient.
To accomplish this, in the course of
1958, the Casework Division of the
Social Service Department conducted
11,593 interviews with patients, (including those in the Adolescent Pavilion
and the Out-Patient Department) and
their families. There were, in addition,
10,517 telephone contacts with relatives
of patients.
This represents an increase over last
year’s ﬁgures because a drop in median
age of patients, to include many more
teenagers, made it necessary for social
workers to spend more time with
patients and their families. About 35%
of the adult patients admitted in 1958 to
the hospital are between the ages of 17
and 25. This is due to two principal factors: the policy of selecting patients in
the early stages of mental illness, and
also the fact that young people are more

Social Services
Assistant Director,
in charge of
Casework
Supervisor
Supervisor
Executive Director
of the “Bridge”

likely to seek hospital help when they
are mentally ill. (Older people frequently reﬂect social taboos concerning
this type of hospitalization.) The preponderance of young people has
changed the social structure of the hospital in many ways including such things
as the types of group activities.
In 1958, a more intensive effort was
also made to screen the 790 male and
1220 female applicants to determine
those who could best beneﬁt from the
treatment of the hospital, prior to their
screening at the clinic.
Collaborative relationships with social agencies were continued. One of the
most active joint programs was with
the Jewish Family Service, which permits discharged patients who need further counseling to get immediate help.
At the close of the year, 18 patients
(and their families) were receiving aid.
Though still a pilot project, this two
year old program offers considerable
promise for further expansion.
Nineteen patients were placed during
the year through the F oster Home Program, conducted jointly with the Jewish
Community Services of Long Island.
This extremely active and important
program beneﬁts those patients who,
which
home
have
to
discharge
no
upon
to return, or who should not, for their
well-being return to the same environment in which they lived before admission to the hospital.
An invaluable service, which, on occasion, makes possible the hospitalization

of a mother, is the Homemaker Service,
conducted with the cooperation of the
two aforementioned Jewish agencies.
This service, supplied to temporarily

motherless children, enables the

mother-patient to derive maximum

beneﬁt from therapy by freeing her
from worry about the care of her children. In 1958, 10 families were helped
over this particularly difﬁcult time
through this program.
The Altro Workshop, in the East
Bronx provides transitional employment to discharged patients and was
used by 13 patients during 1958. The
work
gainful
providing
by
program,
in a protective shop where each employee works at a rate of speed that does
not tax him, makes it easier for the

�ex-patient to eventually resume normal
employement in the community.

The Federation Employment and
Guidance Service, the New York State
Employment Service and the Division
of Vocational Rehabilitation have continued to cooperate to the fullest in
helping patients secure job placement
soon after leaving the hospital.
The school program provided by the
New York City Board of Education was
particularly signiﬁcant in 1958 because
of the large number of young patients.
Sixty-two patients under the age of 21,
who had not yet completed their high
school educations were enrolled; 17
were graduated, and six patients passed
their high school equivalency examina-

tions.

The mental patient, unlike the general hospital patient, usually requires
longer care and long-time follow-up
after discharge. These social service
programs indicate Hillside’s recognition of this fact, and the hospital’s community responsibility to provide leadership and coordination of other agencies
who could help in the continued care of
mental patients during, and after hospitalization. Thus, dozens of private
agencies (particularly those afﬁliated
with the Federation of Jewish Philanthropies) and public agencies are able
to pool their resources.

work
division
group
The Group Work Division, under the
direction of Arnold Eisen, focuses on

the re-socialization of the patient,
re-orienting him to group living. The
patient is helped to function in an improved manner with his family, friends,
employer, fellow-employees and the

community in general.
A major change in 1958 has been the
increased development of community
links and a closer coordination with the
Casework Division.
During the year this division developed a number of new services, programs, ideas and approaches:
The New Patients Orientation Group,
formed to soften the impact of hospitalization on a new arrival and to supply
factual, comforting information to help
alleviate fears.

Development of Community Program Resources, under which community agencies open their doors to
patients on speciﬁed occasions. Trips
have been made to YMHA, YWHA,
YWCA and YMCA branches in Manhattan, Jamaica and North Hills.
Special Cooperative Services with
Community Agencies:
In cooperation with the Federation Employment and Guidance Service, Group
Vocational Guidance sessions were held
to discuss the job market, stimulating
patient interest in the post-discharge
period. Under the Discharge Plan expatients returned to the hospital to tell
patients of their experiences at the postdischarge social rehabilitation center,
the Hillside League. This has been most
effective in relieving separation anxiety.

Joint Patient-Family Programming is
an outgrowth of Field Days, at which
both visitors and patients participate
in recreational activities. As an experiment, patients were permitted to invite
members of their families to a dance at
the hospital. The success of this social
event has resulted in planning of other
joint events in the future.
Internal Programming in 1958 was
responsible for establishing several
additional lounges, dance therapy,
English lessons for foreign-language
speaking patients, and other similar
programs. A weekly newspaper, edited
and published by the patients is now
available in addition to their quarterly
literary magazine.

15

��.,

~

g

_

f

TAk

7.,

.

a

u,

1

.«f

~

.

. I

‘

1..

.

.

e.

.

at.

5,.

w

.,

,

&gt;11.

.K

.,,

.

.

m

7
.

,i

.

.m.«:,

¢

,

.

..

L
.

.w

.

.

.

m

k

.

v

.

.
¢iyu§$ta$ﬂw€u1qﬁm

.

.

\

_..

sub

A

w

~

m

.

.

v-

4%

..

.

A.

f,
.

.

is»

n

,

N

.

,

‘

g

.

‘

‘

.

/

,

_

«JD,

.
.

.

m

a a

h

.,

.

.

1:

,

..

2

I

1:“

K,

ﬂ

-

w

a

_

,.

x

.

.
.

V

.

.

\
g

_

.

.,

.

.
_

.

.

W

I
K

I

.

.

u

‘

.

.

&lt;

l

V

m

.

q
v

I

.

.

_

.

~
v.
..

o

.

.

.

:8

,
;

‘

V

.

‘

.

.P
A

‘

v

�L

,

Bid-"“1

'

.

Gﬁ'emiggry

R5e'sea-rqh:

Fé‘llby’ﬁ

Adjupptjve"

'
’

I

,

',

Therapies

v

V

'

"'

VCI'mlc'al
'

‘

V

SoCi’al

swipes

�‘

”

BOARD

'

;‘

COMMITIEES:

Medical Advisory Board

.

7,

Outside/Affiliations f

‘

Dietary

AVDM-IvNiS-TR'ATI'VE‘ SERV‘IQE

'

As'sT.
ADMINISTRATOR
‘

ADMINISTRATOR

Buildings
Grounds

_

Department

.

Auditing

Secreta rial

0“.

Pool»

Finance

Budgets
Diets
Menus

Dayshift
Night Shift
.,

rchasing
Inventory

Cleaning

1

P_u

1?

Linen

Decorating
Sto res

.- 7 ChefsStaff
"
.

Water
Gas
Heat
Buildings

~

Kitchen
Dining Rooms
”Po rters
Storekeeping

’

Payrblls
Reports

Construction
.Ma'i nte n anee

Craftsmen

Porters
Attendants

’La'bo‘re'rs

Gardeners.

Linen Room

Engineers

Laundry

‘

'

‘

.

Typing.

Personnel
Supplies
Purchases

~'

'7

.

Medical

Budgetary
Control

‘

Reports
0

_

'

.

Mail Room

_

Communications

-'

,

'1

.

Medical"

_

Statistics

'Grougnds

Maids

..

gitceou»nts._

:

'

i=Bookkee‘pers‘iv~
.
‘

,Audito rs
'QI e rks

Secre'ta ries

'
Q,

.'

Typists

-

Receptionist
Telephone
Operators ‘

Typing Pom

Trucks“

Cars

Gatem’en

security

A.

.4..._.

n
a

em.

Hillside Hospital a nd.
its Patients
.

_

'

��STAFF EXECUTIVES
Director of Out-Patient Services
Robert R. Luttrell. MD.
Assistant Director of
Robert Navarre, M.D.
Out-Patient Services
Miss Sylvia Solovey
Mrs. Joan Weisman
Mrs. Anne Wexler
Mrs. Ida Baumstein
Mrs. Estelle Pitts

Manhattan
after-care clinic
The Manhattan After-Care Clinic,
located
is
at
week,
ﬁve
a
nights
open
Mt. Sinai Hospital, a convenient location for most discharged patients. It
assists the Hillside discharged patient
to resume his role in the community
and to deal with the immediate problems of job adjustment and resumption
of old environmental contacts.
Approximately 30 patients are seen
twice Weekly in an effort to bridge their
adjustment from the hospital setting to
the community setting. The treatment is
intense but brief.
The importance of this Clinic cannot
be underestimated because this helps
people who come to the clinic to avoid
readmission to the hospital. If they can
be helped during the ﬁrst few months,
their chances of adjustment in the community are greatly improved. Group or
individual therapy is provided, depending on the needs of the patient.

Israel and
Hilda Strauss League
The Israel and Hilda Strauss League
is an organization maintained for the
social rehabilitation of former patients
of Hillside Hospital.
Situated in quarters at 231 West 83rd
Street, Manhattan, the League furnishes
a meeting place for social and recreational purposes. A lounge is equipped

Supervising Social Worker
Sta]? Psychologist
Caseworker
Caseworker
Caseworker

Queens

out-patient service

with a record player, radio, television,
magazines and table games.
Its existence is made possible through
the devotion and unﬂagging efforts of
a group of women volunteers from the
community who sponsor the League by
raising funds and by offering personal
services. The group name “The Bridge”,
is symbolic of the purpose of this volunteer organization; $30,000 was raised

last year by “The Bridge” for the

League.
A former Hillside psychiatric social
worker, Seymour Silverberg, is assigned
as a full-time director of the League. He
is available for individual consultation
and referral service relating to housing,

employment, further treatment and
other personal welfare problems.
Active membership in the League is
now 366, an impressive growth compared to its start in 1954 with 38 members. Devoted volunteer participation
has kept pace with the membership.

The Queens Out-Patient Service was
established to help the emotionally
disturbed person before his mental
health problems grow and require hospitalization.
Psychotherapy is offered to residents
of Queens, Nassau and Suffolk Counties who require treatment but cannot
assume the economic burden of private
care. Selection is made on the same
basis as that for in-patients: patients
suffering from acute emotional illness
are selected after careful screening to
determine their likelihood of responding to intensive treatment of a year or
less, based on twice-a-week visits.
In 1958, 33 psychotherapists worked
on a part-time basis to treat 306 patients
in individual psychotherapy and 30
patients in group therapy sessions.
Usual length of treatment consisted of
eleven months. Of the 306 patients
treated, 156 were patients admitted to
the Clinic in the previous year, and 150
were new patients. To select the 150,
222 patients were fully screened by
social workers, through psychological
tests and interviews with psychiatrists.
Statistics, however, do little to reveal
the amount of anguish and tension successfully resolved. They must be translated into the numbers of families kept

together, the jobs saved, the fears
allayed.

�Training programs
Hillside’s Resident Training Program

continues to emphasize the interrelation
between the training program and the
treatment program.
In 1958, there were 20 Residents in
training. Each Resident carried a case
load of about 15 patients under the
supervision of staff and visiting instructors. In addition, he atttended lecture
conferences conducted by the medical
director.
Instructors from the Medical Board
conducted lecture and reading seminars
in the ﬁelds of psychopathology and
psychotherapy.
Qualiﬁed Residents were assigned to
the Department of Experimental Psychiatry for clinical and other psychiatric research projects. Seven student
case workers from three schools of
Social Work were assigned to the Casework Division of the Social Services
Department; and six graduate students
received training in the Group Work
Division of the Department.

The training programs extend to
Clinical Assistants in the Out-Patient
and After-Care Clinics and on-the-job
training of personnel. Regular lectures
and conferences are scheduled for
psychologists, nurses and attendants,
social workers and members of the variOUS adj unctive services.

Israel Strauss lecture
The Annual Israel Strauss Lecture,
established in 1955 in honor of the
founder and late President of Hillside,
was delivered in 1958 on April 20. The
speaker was Dr. Paul H. Hoch, Commissioner of New York State Department of Mental Hygiene. His subject
was The Open Hospital.

Sunday clinical
conferences
The Sunday Clinical Conferences,
open to and attended by psychiatrists
and other professional personnel and
by outstanding visiting physicians are
part of the Resident Training Program
and are based on cases prepared by the
Residents. They make a signiﬁcant contribution to the training programs in
the ﬁeld of psychiatry in the metropolitan area.

Medical library
The Arany Lorand Memorial Library
with Miss Rosalind Lazarus as Librarian continued its rapid expansion program. During the year, 470 books and
monographs were added, and 110 periodicals subscribed to. The personal library of the late Dr. Sidney Klein was
incorporated. A generous bequest of
Joseph Meyer was applied to the psychiatric collection. A gift in the name of
Dr. Attlio Laguardia was used to augment the teaching collection.

l

19‘

��-

‘

,

».

V

,

ESEAR CH at Hillside Hospital
is a multi-disczplined combined approach of biochemists, chemists, physicists,
psychologists, psychiatrists, sociologists and statisticians. Even though the treatment program at Hillside is psychoanalytically oriented, the hospital recognizes
that every approach must be explored and utilized in order to increase knowledge
and improve the therapy of mental patients.
Serious mental illness, with all its disruptive influences, today touches one
family in three, since one person in 10 requires hospital treatment for a psychiatric disorder at some time during his life.
Hillside believes that the mental health problem requires a total approach,
and that progress in the treatment of the mentally ill depends vitally on a program of intensive, never-ending research.
A staﬁr of scientists and trained researchers is constantly engaged in the
laboratories, in a program of test-tube probing into the mental health program.
Research goes on at Hillside on three fronts: in the Department of Experimental Psychiatry, in the Department of Biochemistry and in the Department of
Medicine.

ESEAR0

�STAFF EXECUTIVES
Director
Max Fink, M.D.
Research Associate (Psychiatry)
Joseph .laf’fe, M.D.
Research Associate (Psychiatry)
Donald F. Klein, MD.
Sr. Research Associate (Experimental Psychology)
Robert L. Kahn, Ph.D.
Research Associate (Experimental Psychology)
Max Pollack, Ph.D.
Research Associate (Sociology)
Nathaniel Siegel, Ph.D.
Research Assistant (Experimental Psychology)
Eric Karp, B.A.
Associate in Research (Neurophysiology)
Martin A. Green, MD.
Associate in Research (Psychiatry)
Abraham A. Kaplan, MD.
Barre Alan, M.D.
Henry Lefkowitz, M.D.

TECHNICAL STAFF

Fellow (1 957-58)
Fellow (1958-59)

Mrs. Janet Bowie
.lean Kolodny

Hannah Mosquera
Blanche Zaitz

experimental
psychiatry

22

During 1958, the major emphasis of
the staff of the Department of Experimental Psychiatry shifted from the evaluation of convulsive therapy to systematic investigations of newer drug
therapies.
These investigations were based on
the theories developed in the Department in 1957, which derived from the
successful evaluation of the mode of
action of convulsive therapy. Studies
were conducted on measures of speech
behavior developed in the Department
during 1956 and 1957. In an extension
of the communication studies, the language indices were applied to drug
therapy.
The evaluation of convulsive therapies was continued in 1958, by comparing the effects of indoklon, an inhalant
convulsant, with electroconvulsive therapy. Results indicated that while the
indoklon worked, it was a poor substitute for ECT. The study was important because it illustrated graphically
that the convulsion was the important
factor, not the electrical stimulus.
Investigations into the relations of
sociologic factors to the selection of
therapies at the hospital showed that
not only were the factors of age, education and birthplace signiﬁcantly related
to the choice of therapy, but these factors were also related to the results of
therapy, the diagnosis and the duration
of hospitalization.
Similar studies of the population of
other primarily psychotherapeutic hos-

pitals, and the Hillside Out-Patient
Clinic were also undertaken. A grant
from the Mental Health Board of Nas-

sau County helped support and augment these studies.
The acute drug interviews were but
One aspect of the continuing evaluation
of the biochemistry of convulsive therapy.
Other research projects during the
year consisted of perceptual studies in
patients receiving psychodynamic therapies; the inter-relation of psychotherapy with physiodynamic therapy; and
the inter-personal factors in therapists,
as well as patients, leading to the referral for physiodynamic therapies.
Three members were added to the
staff during the year, and the department received support through continuing grants of the Foundations’ Fund
for Research in Psychiatry, the National Institute of Mental Health, the Psychopharmacology Service Center of the
National Institutes of Mental Health, the
Mental Health Board of Nassau County;
and from Bristol; Geigy; Smith, Kline
81 French; and Wyeth Laboratories.
Staff members were honored with
two awards: Dr. Maximilian Fink received the ﬁrst annual A. E. Bennett
Psychiatric Research Award of the Society of Biologic Psychiatry for his report on the effects of anticholinergic
agents on EEG and behavior; Dr. Joseph

Jaffe received the Cralnick annual
award for his report on the application
of analysis of changes in formal aspects
of speech in psychotherapy.

department of
biochemistry

The Department of Biochemistry,
headed by Dr. Harry Goldenberg as
Director and Dr. Vivian Fishman as

Senior Biochemist showed a major

growth during 1958, with the assistance
of three research grant awards from the
National Institutes of Mental Health.
The laboratory staff was increased to
seven members to make possible more
intensive fundamental biochemical studies as well as the initiation of several
collaborative clinical projects.
The change in the hospital treatment
program from shock therapy to chemotherapy introduced new problems which
required laboratory assistance.
As an aid to the drug therapy program, toxicological tests were set up to
detect various pharmaceutical preparations in body ﬂuids. The laboratory was
called upon periodically during the year
to conﬁrm suspected drug intoxication.
A chemical study was carried out
with Dr. Arnold Blumberg, of the Department of Medicine to assess the prognostic signiﬁcance of the physiological
response to mecholyl. While this study
was in progress, it was noted that mecholyl triggers the release of adrenaline
in the urine, as well as smaller amounts
of related substances. In connection with
adrenaline studies it was observed that
preferential excretion of adrenaline
occurred in normal subjects in the laboratory following the induction of a
stress reaction with the drug LSD.
Maj or emphasis in the laboratory continued on the premise that mental disease is accompanied by detectable
chemical changes in the body. Blood
and urine studies were undertaken to
determine whether there is any correlation between body chemistry and the
various psychiatric disorders.
Studies were also continued on enzyme systems concerned with the elimination of toxic substances from the
body.

�Intensive studies were also made to
demonstrate metabolic defect in the

liver whereby toxic substances are

formed but not eliminated at a sufﬁcient rate to maintain sanity.
At Hillside, it is felt that a balanced
biochemical program, involving both
chemical and other fundamental studies
will best serve the present and future
welfare of the hospital. Inter-departmental clinical studies help to bind the
various hospital activities into one fabric; and the theoretical studies provide
more lasting insight into the physical
aspects of mental disease, whose corrective treatment offers a more lasting support to psychotherapy.

medical
department
As new drugs are introduced into the
treatment of emotional disorders, studies of the basic physiology open new

vistas in the understanding of the pathology of mental disease.
During 1958, the Medical Department under the direction of Dr. Arnold
C. Blumberg collaborated with the Department of Biochemistry on studies of
the inter-relation of the adrenaline system and emotional disease.
All patients on drug therapies were
screened and medically controlled by
the Medical Department. Toxic reactions to the drugs were carefully scrutinized and a report on the hypotensive
response to toxic doses of meprobamate
were submitted for publication.
Alterations in liver function with the
phenothiazine derivatives were also observed in cooperative studies with the
Department of Biochemistry.

�Hillside
publications
During 1958, the Hillside Hospital Staff
made numerous appearances as guest
lecturers and speakers at conventions
in this country and abroad.
They appeared before major national
professional societies, as well as before
lay groups.
In addition to national and local societies, reports on hospital programs
were presented at conferences in Rome
and Montreal.
Staff members reported on therapy
and research in a large number of professional publications, and in the
Journal of the Hillside Hospital.
FINK, M.: Lateral Gaze Nystagmus as an

Index of Sedation Threshold, EEG. Clin.
Neurophysiol. 10: 162-163.

FINK, M.: Effect of Diethazine on EEG and

Signiﬁcance for Theory of Convulsive Therapy, EEG. Clin. Neurophysiol. 10: 207-208

(Abst.).

FINK, M.: Effect of Anticholinergic Agent,

Diethazine, on EEG and Behavior, A.M.A.
Arch. Neurol. &amp; Psych. 80: 380-388.

FINK, M.: Effects of Anticholinergic Agent,
Diethazine, on EEG and Behavior: Signiﬁ-

cance for Theory of Convulsive Therapy. Presented at the Society of Biological Psychiatry,
May, 1958 in San Francisco.

24

FINK, M.: Role of EEG Frequency Shift in

Behavioral Effects of Drugs. Presented at
Section on Neurol. &amp; Psychiat., Queens County
Medical Society, June, 1958 in New York.

FINK, M.: Effect of Anticholinergic Compounds on Post Convulsive EEG and Behavior. Presented at the American EEG Society, June, 1958 in Atlantic City.

FINK, M., SHAW, R., GROSS, G., COLEMAN, F.C.:

FINK, M.: EEG and Behavioral Effects of

Collegium Internationale Neuro-Psycho

M.: Clinical and EEG.
Effects of Megimide in Patients without Cerebral Disease, Neurology 8: 682-685.

FINK, M., GREEN, M. A.: EEG Correlates of

Signiﬁcance of Individual Variability in EEG Changes During Electroshock
Therapy. Presented at the Eastern Association
of Electroencephalographers, March, 1958 in
Montreal.

Psychopharmacologic Agents. Presented at

Pharmacologicum, September, 1958 in Rome;
and also at the Eastern Association of Electroencephalographers, December, 1958 in New
York.

the Electroshock Process. Presented at the
Eastern Psychiatric Research Association,
February, 1958 in New York.
FINK, M., GREEN, M. A.: Electroencephalo-

graphic Correlates of the Electroshock Process, Dis. Nerv. Syst. 19: 227 (Abst.).

FINK, M., JAFFE, J.: Drug Induced Changes
in Interview Patterns. Presented at the Conference on Psychodynamic, Psychoanalytic,

and Sociologic Aspects of the Neuroleptic
(tranquilizing) Drugs in Psychiatry, April,
1958 in Montreal.

Comparative Study of Chlorpromazine and
Insulin Coma Therapy of Psychosis, J .A.M.A.
166: 1846-1850.

GREEN, M., FINK,

GREEN, M. A.:

A.: Relationship between Seizure
Threshold and Duration of Seizures to EEG
Change During Electroshock. Presented at
the Eastern Association of Electroencephalographers, December, 1958 in New York.

GREEN, M.

H.: Chairman of Symposium on
Catechol Amines. Held at the New York
Academy of Sciences, October, 1958.

GOLDENBERG,

H.: Biochemical Aspects of
Mental Disease. Presented at the Jewish
GOLDENBERG,

Chronic Diseases Hospital, Brooklyn, New
York in February, 1958.

FINK, M., KAHN, R. L., GREEN, M. A.: Experi-

GOLDENBERG,

FINK, M., KAHN, R. L., POLLACK, M.: Psychological Factors Affecting Individual Differences in Behavioral Response to Convulsive

H., BLUMBERG, A. G., GOLDENBERG, V.: Inﬂuence of LSD and Vasotonic
Drugs on Urinary Excretion Patterns. Presented at the 125th Meeting of the American
Association for the Advancement of Science,
Washington, D.C., December, 1958.

FINK, M., KAHN, R. L.: Experimental Studies
of the Electroshock Process, Dis. Nerv. Syst.
19: 113-118.

H., GOLDENBERc, V.: Urinary
Excretion of Aromatic Metabolites in Mental
Disease. Presented at the 125th Meeting of
the American Association for the Advancement of Science, Washington, D.C., Decem-

mental Studies of Convulsive and Drug Therapies in Psychiatry: Theoretical Implications.
Presented at the Neurological Society and
New York Society of Clinical Psychiatry,
March, 1958 in New York.

Therapy. Presented at the American Psychiatric Association, May, 1958 in San Francisco.

FINK, M., KAHN, R. L., GREEN, M.: Experi-

mental Studies of Convulsive and Drug Therapies on Psychiatry: Theoretical Implications,
A.M.A. Arch. Neurol. &amp; Psych. 80: 733-734
(Abst.)

H.: New Analytical Procedures
Based on Dye Partition Analysis. Presented
at the Long Island Jewish Hospital, New
Hyde Park, New York in March, 1958.
GOLDENBERG,

GOLDENBERG,

ber, 1958.

H., WHITE, D. L.: Standardized
Method for the Assay of Serum Oxidase Activity (Ceruloplasmin) , Clin. Chem. 4: 551, 1958.
GOLDENBERG,

�Presented at the 10th Annual Meeting of the
American Association of Clinical Chemists,
Iowa City, September 1958.
V.: Colorimetric Determination
of Carboxylic Acid Derivatives as Hydroxamic Acids, Anal. Chem., 30: 1327, 1958.
GOLDENBERG,

GOLDENBERG,

V., GOLDENBERG, H.: An Im-

proved Method for the Estimation of Serum
Copper, Clin. Chem. 4: 551, 1958. Presented
at the 10th Annual Meeting of the American
Association of Clinical Chemists, Iowa City,

September 1958.

J., KAHN, R. L., FINK, M.: Communication Patterns with Altered Brain Function. Presented at the Eastern Psychological
Association, April, 1958 in Philadelphia.
JAEEE,

J., SLorE, W. H.: Interpersonal F actors in Denial of Illness, A.M.A. Arch. Neurol.
81
Psychiat. 80: 653-656.
JAFFE,

.IAFFE,

J.: Language of the Dyad, Psychiatry

21: 249-258.

F INK, M.: Changes in Language
During Electroshock Therapy, in Psychopathology of Communication, Hoch, P. and
Zubin, J., Eds., Grune 81 Stratton.
KAHN, R. L.,

M.: The Relation of F
Score to Behavioral and Physiological Response with Altered Brain Function. Pre-'
sented at the Eastern Psychological Association, April, 1958 in Philadelphia.
KAHN, R. L. FINK,

KAHN, R. L., FINK,

M.: Prognostic Value of
Rorschach Criteria in Clinical Response to
Convulsive Therapy. Presented at the Electroshock Research Association, May, 1958 in
San Francisco.
KAHN, R. L., POLLACK,

M.: Socio-Psycholog—
ical Aspects of Diagnosis and Treatment:
Theoretical Implications. Presented at the
Symposium—Eastern Psychological Association, April, 1958 in Philadelphia.
KAHN, R. L., POLLACK,

M.: Social Factors
in Selection of Therapy in a Voluntary Mental Hospital. Presented at the American

Psychiatric Association, May, 1958 in San
Francisco.
KAHN, R. L., POLLACK, M.:

Prognostic Application of Psychological Techniques in Convulsive Therapy. Presented at the Eastern
Psychiatric Research Association, October,
1958 in New York.

H.: Intensity of Stimulation and Perception of Simultaneous Stimuli in Cerebral
Dysfunction. Presented at the Eastern Psychological Association, April, Philadelphia.
KORIN,

LEVINE, A.:

A Comparative Evalution of

Latent Schizophrenic and Overt Schizophrenic Patients with Respect to Certain Personality Variables, J. Hillside Hosp. 7: 131-152.

P.:

Oculomotor
and Postural Patterns in Schizophrenic Children, A.M.A. Arch. Neurol. 81 Psychiat. 79:
POLLACK, M., KRIEGER, H.

720-726.

Predictions of Outcome, in Youthful Offenders at Highﬁelds, Weeks, H. Ashley, Ed. U. of Michigan Press, Ann Arbor.
SIECEL, N.:

L.: Juvenile Delinquency. Presented to the Sociology Department at Hofstra College on November 26th, 1958.

VANDERHOST,

Hillside Journal

POLLACK,

The Journal of the Hillside Hospital showed
once again an increase in the number of its
subscribers as an indication of its greater
inﬂuence and wider acceptance in the psy—
chiatric and related ﬁelds. In this country
and throughout the world about 1200 copies
are subscribed for by medical schools, training hospitals, social service agencies and
many institutions in other countries, particularly Israel.
In 1958, 15 major articles by members of
the Hillside staff and by other professional
contributors, were published in four issues.
Contributions come from various parts of the
US. and especially the West Coast.
The Journal offers an unusual feature by
reporting clinical conferences in full including the entire discussions. Now in its 7th
year the Journal is still under the able leadership of Dr. Sidney Tarachow.
The Editorial Advisory Board consists of
Morris B. Bender, M.D., Dudley D. Schoenfeld, M.D., and Sandor Lorand, MD.
The Associate Editors are Renato Almansi,
M.D., Abraham S. Lenzner, M.D., Samuel R.
Lehrman, M.D., Joseph S. A. Miller, M.D.,
Aaron Stein, M.D.

POLLACK, M., BATTERSBY, W. S., KAI-IN, R. L.,
BENDER, M. B.: Intellectual Deficits in Pa-

Grants and Awards
Received 1958

LEVINE, A., HARRIS, J., CAMINSKY, I., LURIE,
A., BACHRACH, M., MILLER, J.: An Explora-

tory Vocational Counseling Program in a
Mental Hospital, J. Hillside Hosp. 7: 153-161.

5.: Pathological Reactions in
Women After Parturition. Presented to the
Department of Obstetrics at St. Albans Naval
MARKHAM,

Hospital on December 13th, 1958 in New
York.
S.: The Dynamics of Post-Partum
Pathological Reactions as Revealed in Psychological Tests, J. Hillside Hosp. 7: 178-189.

MARKHAM,

POLLACK, M.: Visual

Perception and Attention in Normal and Abnormal Children. Presented at American Orthopsychiatric Association, March, 1958 in New York.
M.: A Critique of “Pre-Conscious”
Perception and the “Poetzl Phenomenon”.
Presented at the American Psychiatric Association, May, 1958 in San Francisco.
POLLACK,

M.: Brain Damage, Mental Retardation and Childhood Schizophrenia, Am.
J. Psychiat. 115: 442-428.

tients with Space Occupying Lesions of the
Cerebrum. Presented at the Eastern Psychological Association, April, 1958 in Philadelphia.

........
Foundations Fund for Research
U. 5. Public Health Service

in Psychiatry

..................

$74,460
16,250

25

�«saw».

�report of the administrator
“Kim.

MAURHIIBACHRACH

The 1958 Annual Report strikes a new note which reﬂects
the tremendous strides that are being made in the ﬁeld
of mental health. The hospital’s operations during 1958
were effected by the profound changes which came with
the introduction of the psychotropic drugs. Chemotherapy
has enabled us to entirely discontinue Insulin Shock Therapy and is reducing the use of Electro Shock Treatment
to a point where it may soon be eliminated. These changes
produced certain changes in our expense picture, in that
the cost of giving the physical therapies, which are being
abandoned, is reduced. But, there are attendant increases
in costs for drugs and, more importantly, a need for expansion of personnel in the adjunctive and activities

therapies.
Another profound inﬂuence is introduced by the
Professional Department program which our Director of
Professional Services, Dr. Lewis L. Robbins, had recommended at the end of 1958. It is almost certain that the
implementation of these recommendations including, as
they do, a considerable increase in the number of full time
Staff Psychiatrists, as well as expansion of the Social
Service, Occupational Therapy, Psychological and Group
Activities Staffs, will change our expense picture considerably, although they may have no impact on the 1958
experience as such.

Comparison of Costs 1957-1958
1957

Salaries .......................................... $855,848
Food .............................................. 119,350
Maintenance and Grounds ............ 62,654
Administrative Expenses .............. 98,952
Medical Supplies .......................... 29,811
Repairs and Replacements .......... 49,021
Clinics ............................................ 280,056
Total ................ $1,495,692

1958

$936,330
127,142
72,049
108,693
31,997
48,101
337,712
$1,662,024

The above table shows that the total cost for the entire
Hillside Hospital complex increased by 11% during 1958.
One-half of this total increase occurred in salaries which
increased by 9%. This is in keeping with our experience
for the past ten years, where salaries have been increasing
steadily at the rate of seven to ten percent per annum due

largely to the need of the Hospital to keep pace with the
increasing cost of living. Very little, if any, of this increase
during 1958 can be ascribed to additional staff. The largest percentage increase, 21%, was in the cost of Out-Patient
Services. This reﬂected a combination of increased costs
and continued expansion of clinical work from Out-Patient
Services, but this should be contrasted with the 307(increase in the cost of Out-Patient Services during 1957.
This indicates that although our Out-Patient Services are
still expanding, the rate of expansion is slowing down.
The other items, food, maintenance and grounds, administrative, medical supplies and repairs and replacements,
increased by varying amounts, but they are all in keeping with the general picture of roughly 1071 increase for
all expenses.

Service Statistics

1957
Total Number of Patients ........................ 545

Total Patient Days .................................. 69,987
Average Income per Patient Day ............ $15.57
Average cost per Patient Day .................. $17.37
Average loss per Patient Day .................. $ 1.80

1958
536

70,691
$16.58
$18.73
$ 2.15

The data given in the above table refer to ln-Patients
only.

The total number of patients treated and the number
of patient days show no signiﬁcant change over 1957.
The average income per patient day as well as average
cost per patient day increased with costs rising faster than
income, so that the average loss per patient day rose from
$1.80 to $2.15, an increase of 16%. The reason for this
increase in the average loss per patient was that, although
there was a slight increase in average income per patient
day, all of this increase coming from fees paid by patients
or the patient’s family, the per diem rate paid by the City
of New York remained the same during 1958, in spite of
increased costs.
Our research programs continued to expand with a
concurrent increase in cost; but these increases were almost
entirely absorbed by increased support by the National
Institutes of Mental Health, so that deficits arising out of
research operations were held to a relatively modest ﬁgure,
$35,000, which was made up by the Board of Trustees of
Hillside Hospital.

27

�Financial Support Picture
Hillside Hospital has been fortunate over the years
in the support it has received from the Federation of
Jewish Philanthropies. Year after year, since 1948, the
Federation has carefully reviewed the Hospital’s fees and
supplied a grant which was always consonant with the
Hospital’s deﬁcit requirements. Our gratitude to the Federation of Jewish Philanthropies is profound and we hope
that we will continue to deserve the support of the Jewish
Community, as it is expressed through the Federation.
We have received legacies from time to time, and as
our reputation and tradition grows, these are becoming
.increasingly more. The following is a list of legacies
received by the Society of the Hillside Hospital from 1948
to 1958. It is interesting to see that each year the number
and amounts of these legacies is growing. We hope that
a larger and larger number of persons who desire to beneﬁt humanity and especially to bring about some amelioration of the suffering of the mentally ill, will ﬁnd it possible
to name Hillside Hospital as a beneﬁciary in their Wills.
Amount
Simon Lefcort ................................ $ 2,000
Leonora Solinger Baum ................ 23,317 (A)
Florence Tim .................................. 1,000
Rose Simon ....................................
456
Max Richter .................................... 5,000
Solomon Rothfeld .......................... 10,000

Harry T. Epstein ............................

8,835
250

Year

1948
1949-1958
1949
1949
1950
1950
1952
1953

Beatrice S. Bowman ......................
1953
Aaron C. Horn ................................ 3,000
Flora Haas ...................................... 60,000 (B)
1954
250
Dora Monness Shapiro ..................
1955
Robert L. Leeds .............................. 2,500
Charles Benoff ................................
1956
380

28

Max Einhorn .................................. 77,155
897
Julius Grossman ............................

1956

Hermenia Goodman ...................... 2,000
Christine King ................................ 1,058
Wilhelm Levinger .......................... 37,950
Joseph Meyers ................................ 2,500 (C)

1957

Notes: (A) Approximately $2,300 per year in perpetuity
(B) Restricted for care of Adolescent Girls
(C) Restricted for Medical Library

1957
1958

1958
1958

During 1958, the following persons other than
Trustees made gifts to the Hospital as noted below:
Amount
Bernard M. Baruch, Jr ......................................... 3 500.00

Bristol Laboratories .............................................. 2,500.00
Grand Street Boys Foundation ............................ 675.00

Jack Bleibtreu ........................................................ 185.00
Wyeth Laboratories .............................................. 1,500.00
Lightolier .............................................................. 1,000.00
Susan Greenwall Foundation ................................ 200.00
Smith, Kline

81

French Laboratories .................... 2,500.00

Gustave Levy ..........................................................
Edward Goldberger ................................................
Alfred Hazan ..........................................................
J. A. Samuels ..........................................................
Gaisman Foundation ..............................................
Laurence Alexander ..............................................

100.00

500.00
100.00
100.00
100.00
150.00

William J. Hammerslaugh .................................... 500.00
Henry Homes ........................................................ 1,000.00
l.M.M. Charities .................................................... 500.00
Carol B. Loeb Foundation ...................................... 1,000.00
Blanche Ittleson ....................................................
Blanche Freeman ..................................................

100.00

Sylvia

100.00

Krohn

.............................

100.00

Arabel Foundation ................................................ 1,000.00
Eugene Blum .......................................................... 4,000.00

Edward L. Fabian .................................................. 5,000.00
Geigy Chemical Corp ............................................. 5,000.00
Lawrence Mark ...................................................... 100.00
Louis Neiweg .......................................................... 1,049.00
Samuel Silverman .................................................. 200.00
Our gratitude to these benefactors is of course profound. It is our hope that as our work becomes known
to a larger and larger circle of interested individuals, they
will send us gifts for the support of our work.

��Director, Israel Strauss
Adolescent Pavilion
Alice Slater Stahl, M.D.
Supervising Psychiatrist,
Israel Strauss
Adolescent Pavilion
Zenos M. Linnell, MD.
Director, half—time,
Adolescent After Care Clinic
Eugene Glynn, MD.

Society
of the

Hillside
Hospital
Officers
President

Alvin E. Coleman *

Chairman of the Board
Roy Foster*
Honorary Chairman of the Board
Leon Lowenstein*
Vice-President
Dudley D. Shoenfeld, M.D.*
Vice-President
D. Herbert Beskind *
Vice-President
George W. Galinger*

Secretary
Manuel Lee Robbins*
Treasurer
Arnold S. Askin *
Assistant Secretary
A. Jacob Abrams
Assistant Secretary
M. Victor Leventritt
Assistant Treasurer
Arthur Garson
Assistant Treasurer
Harry Silverson
Honorary Directors
Hilda Strauss and Saul Blickman

Board of Trustees
A. Jacob Abrams

Jonas AdlerT
Alfred Appel
Arnold S. Askin*
John M. Bendheim
D. Herbert Beskind*
Saul Blickman

30

David BunimT
Alvin E. Coleman*
Martin ColemanT
Morris David
Thomas Epstein

Arthur C. Fatt*
David Finkle
David Finn

Director of Out-Patient Services
Robert R. Luttrell, MD.
Assistant Director of
Out-Patient Services
Robert Navarre, MD.

Director of Research in
Experimental Psychiatry
Maximilian Fink, M.D.

Roy Foster*
George W. Galinger*
Arthur Garson

Maurice Glinert
Meyer Goldstein
Jacob Epstein Katz
Carl L. Kempner‘l'
Harold P. KurzmanT
M. Victor Leventritt
Budd Levinson
Morris L. Levinson
Milton B. Loeb
Sandor Lorand, M.D.
Leon Lowenstein*
Charles H. Meyer*
Arthur Murray
Manuel Lee Robbins*
Irving Rosenbaum
S. H. Scheuer*
Walter Scheuer
Dudley D. Shoenfeld, M.D.*
Harry Silverson
Hilda Strauss
Irving Weisglass
Nathan Wigod
Morton 5. Wolf*
Walter D. Yankauer*

Chairman of Standing
Committees
Executive Committee
Roy Foster
Medical Affairs Committee
D. Herbert Beskind

Finance Committee
Arnold S. Askin
House and Grounds Committee
George W. Galinger
Nathan Wigod, Co-Chairman
Legal Committee
Charles H. Meyer
Social Service Committee
Hilda Strauss, Honorary Chairman
M. Victor Leventritt, Chairman

Personnel Committee
Meyer Goldstein

Internist

Arnold G. Blumberg, MD.

Director of Laboratories
Harry Goldenberg, Ph.D.

Resident Staff

Nominating Committee
Walter Yankauer
Gifts and Legacies Committee
Walter Yankauer
Committee on
Administrative Savings
Arnold S. Askin

Building Committee
D. Herbert Beskind 81
George W. Galinger,
Co-Chairmen

*—-Executive Committee Members
f—Elected in I958

Professional and
Administrative Staﬁ'
Medical Director
Joseph S. A. Miller, MD.

Director of Professional Services
Lewis L. Robbins, MD.
Associate Medical Director
Simon Kwalwassr, M.D.

Administrator
Maurice Bachrach, B.S.
Supervising Psychiatrists
George Yessin, M.D.
Gerhard Schauer, M.D.
Harold Esecover, M.D.*
William Benjamin, M.D.
Morton Wachspress, MD.

Norman Ackerman, M.D.**
Barre Alan, M.D.
Reva Berstock, M.D.
Bernard Cohen, M.D.**
Warren Cox, M.D.**
Alan Dobrow, M.D.
Necdet Ecder, M.D.
Elhan Ermutlu, M.D.**
Marie Friedman, M.D.**
Michael Gould, M.D.**
Sherwin Harris, M.D.
Raymond Hollander, M.D.
Doris Kells, M.D.
Edwin Kleinman, M.D.
Henry Lefkowits, M.D.
Sidney Lytton, M.D.
Stanley Machlin, M.D.
Harvey Mandel, MD.
Robert Nodine, M.D.**
Paul Pressman, M.D.**
Henry Rosett, M.D.
Alvaro Rozo, M.D.
Mollie Schildkrout, M.D.
Jack Schnee, M.D.
Herbert Schulman, MD.
David Steinman, M.D.
Carl Towbin, M.D.
Margery Wile, M.D.

Other Prof esional
Staff Heads

Director of Nursing
Goldie Krupa, R.N.
Director of Social Services
Abraham Lurie, M.S.S.W.
Director of Psychology
Abraham Levine, Ph.D.

�.
.W.

&lt;|

',

Psychiatrists

afﬁx]

.4;

Director of Creative Therapy
Ernest Zierer, Ph.D.

Director of Occupational Therapy
Eileen P. Fisher, B.S.
Director of Group Work Division
Arnold Eisen, M.S.S.W.
Dietitian
Angelina Canavan, B.A.

Supervisor Clinical Laboratory
and X-Ray
John Croghan, R.T., M.T.

Department Heads
Accounting Supervisor
Dorothy Croghan

Manager
Lillian Dailey
Superintendent of Buildings
&amp; Grounds
Thomas R. Lumley
Executive Housekeeper
Sarah Travers
Oﬂ‘ice

*—Resigned in 1958
**—Completed residency in 1958

Medical Board
President
Robert A. Savitt, M.D.*
Vice President
Sidney Tarachow, M.D.*
Secretary

Sidney L. Green, M.D.*

Treasurer
Paul Scheman, D.D.S.*
Est-President
M. David Epstein, M.D.*

Manhattan After-Care Clinic
Sarah R. Kelman, M.D.

Samuel Atkin, M.D.
Arnold Eisendorfer, M.D.*
M. David Epstein, M.D.*
Margaret E. Fries, MD.
I. Peter Glauber, M.D.*
George S. Goldman, M.D.
Sidney L. Green, M.D.*
William Karliner, M.D.*
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.
Emanuel Klein, M.D.
Sidney Klein, M.D.iL
Samuel R. Lehrman, M.D.
Samuel Z. Orgel, M.D.
Hyman L. Rachlin, M.D.*
Lawrence J. Roose, MD.
Robert A. Savitt, M.D.*
Martin Schreiber, M.D.*
Isidor Silbermann, M.D.
Otto Sperling, M.D.
Sidney Tarachow, M.D.*

Consulting, Attending and
Visiting Staffs

Non-Psychiatrists

Psychiatry

Director of Department
of Medicine
Lester Cohen, M.D.*

Leonard Blumgart, M.D.
Sandor Lorand, M.D.
Irving J. Sands, M.D.l~
Nathaniel E. Selby, M.D.
Dudley D. Shoenfeld, M.D.

Director of Department
of Surgery
Sidney Hirsch, M.D.*
Director of Department
of Dentistry
Paul Scheman, D.D.S.*

Chairman of Standing
Committees
Adolescent Pavilion
Sidney L. Green, M.D.
Credentials Committee for
Psychiatric Attending
Staﬂ &amp; Promotions
Martin Schreiber, M.D.
Credentials Committee for
Non-Psychiatric Visiting
Staff &amp; Promotions
Paul Scheman, D.D.S.
Education of Resident Staﬂ
Arnold Eisendorfer, M.D.
Group Psychotherapy
Samuel Z. Orgel, M.D.

Queens Out-Patient Clinic
Martin H. Orens, M.D.

Sub-Committee for Child
Guidance Clinic
Isidor Bernstein, MD.
Research Committee
Sidney Tarachow, M.D.
Publications Committee
I. Peter Glauber, M.D.
Committee for
Adjunctive Services
I. Peter Glauber, M.D.
Credentials Committee for
Supervising Psychiatric
and Resident Staﬂ
Lawrence J. Roose, M.D.
*—Executiue Committee Members
i—Deceased in 1958

Medicine
Alfred Angrist, M.D.
Morris S. Bender, M.D.
Oscar Levin, MD.
I. Jesse Levy, MD.

Neurology
A. M. Rabiner, M.D.

Hans Strauss, MD.
I. S. Wechsler, M.D.

Surgery
David Warshaw, M.D.

Gynecology
Julius Jarcho, M.D.

Dentistry
Morris Fierstein, D.D.S.

Attending Psychiatrists
Samuel Atkin, M.D.
Frank Berchenko, M.D.
Isidor Bernstein, MD.
Arnold Eisendorfer, MD.
M. David Epstein, M.D.
Margaret E. Fries, MD.
I. Peter Glauber, M.D.
George S. Goldman, MD.
Paul Goolker, M.D.
Sidney L. Green, M.D.
William Karliner, M.D.
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.
Emanuel Klein, M.D.
Sidney Klein, M.D.T
Attilio LaGuardia, M.D.TT
Samuel R. Lehrman, M.D.
Samuel Z. Orgel, M.D.
Hyman L. Rachlin, M.D.
Lawrence J. Roose, MD.
Robert A. Savitt, M.D.
Martin Schreiber, M.D.
Isidor Silbermann, M.D.
Otto Sperling, M.D.
Aaron Stein, M.D.
Sidney Tarachow, MD.

Associate Attending

Psychiatrists

Renato J. Almansi, M.D.
Alexander J. Friedman, MD.
5011 Goodman, M.D.
Louis Kaywin, M.D.
Bruce Kendall, M.D.
Abraham S. Lenzner, M. D.
Martin H. Orens, M.D.
William W. Pike, M.D.
Geraldine Pederson-Krag, M.D.
i—Deceased in 1958
H—deceased I959

31

�Visitings

Optometry

Medicine

Staff Optometrist
Edward L. Steinberg, OD.

Director
Lester Cohen, M.D.

Staff Optometrist
Bernard Attinson, OD.

Visiting Physician
George Sabrin, M.D.
Visiting Physician
Louis Rosenblum, M.D.

Podiatry
Staff Podiatrist
Sam Sokolov. Pod.O.

Visiting Physician
Arnold G. Blumberg, M.D.

*—Resigned in 1958

Associate Physician
Jerome Weinstein, M.D.

Clinical Assistants in
Manhattan and
Queens Clinics

Adjunct Physician
Arnold L. Berger, M.D.
Adjunct Physician
Wilbur B. Brett, M.D.
Visiting Dermatologists
Conrad Stritzler, M.D.*
Associate Dermatologist
.loel Schweig, M.D.

Adjunct Dermatologist
Norman Goldfarb, M.D.

Neurology
Adjunct Attending
Psychiatrists

32

Edward R. Adelson, M.D.
Herman S. Alpert, M.D.
Alvin B. Balaban, M.D.
Irving L. Bauer, M.D.
Benjamin J. Becker, M.D.
Julius Belinkofi, M.D.
Milton M. Berger, M.D.
Lionel H. Blackman, M.D.
Isadore H. Cohn, M.D.
Irving J. Crain, M.D.
Joseph H. Feldman, M.D.
Jules Glenn, M.D.
Albert E. Goldberg, M.D.
Albert Harrison, M.D.
Thomas Hora, M.D.
Abraham Kaplan, M.D.
Eugene Kaplan, M.D.
George P. Krupp, M.D.
Peter Laderman, M.D.
Harold S. Leopold, M.D.
(on leave)
David Milrod, M.D.
Helene Papanek, M.D.
Irving Salan, M.D.
Frederick F. Shevin, M.D.
Jay Stanton, M.D.
Samuel Tabbat, M.D.
Fred U. Tate, M.D.
Leonard Weinroth, M.D.
Herbert Wieder, M.D.

Associate Neuroligist
Kurt Adler, M.D.

Surgery
Director
Sidney Hirsch, M.D.
Visiting Neurosurgeon
Joseph Siris, M.D.
Visiting Urologist
Daniel Kaufman, M.D.

Adjunct Urologist
Albert Sutton, M.D.
Visiting Orthopedist
A. H. Lewert, M.D.

Associate Orthopedist
Julius Schneiderman, M.D.
Visiting Proctologist
Benjamin Warner, M.D.
Visiting Ophthalmologist
Edward Seretan, M.D.
Associate Ophthalmologist
Arthur Minsky, M.D.
Visiting 0tolaryngologist
Sam Clayton, M.D.
Visiting Anesthesiologist
Georges Bean, M.D.
*—Resigned in 1958

Gynecology
Visiting Gynecologist
Marie P. Warner, M.D.
Visiting Gynecologist
Hilliard Dubrow, M.D. (on leave)

Associate Gynecologist
Jack Cohen, M.D.
Associate Gynecologist
Bernard Greenblat, M.D.

Adjunct Gynecologist
Eugene Streim, M.D.*

Radiology
Visiting Radiologist
Bernard Epstein, M.D.

Associate Radiologist
Paul Steinhorn, M.D.

Dentistry
Director
Paul Scheman, D.D.S.
Associate Director
J. Gordon Rubin, D.D.S.
Associate Dentist
Benjamin Schwaid, D.D.S.
Associate Dentist
Bernard Lebow, D.D.S.
Adjunct Dentist
Henry Lewis, D.D.S.
Adjunct Dentist
Samuel Plotnick, D.D.S.
Adjunct Dentist
Elsa Friedman, D.D.S.
Adjunct Dentist
Martin Protell, D.D.S.
Adjunct Dentist
Leon Basson, D.D.S.

Lester I. Abend, M.D.
Edward R. Adelson, M.D.
Romano Antonelli, M.D.
Howard Boskey, M.D.
Paul Bradlow, M.D.*
Stanley Brodsky, M.D.
Arline Caldwell, M.D.*
Daniel Chansky, M.D.
Lionel Chertoﬂ, M.D.
Ralph W. Clemments, M.D.
Frances Colonna, M.D.
Stefano Fajrajzen, M.D.
Irving J. Farber, M.D.
Philip Friedland, M.D.
Ruth Fuchs, M.D.
Harvey Goldey, M.D.
Sumner I. Goldstein, M.D.
Clara Gonda, M.D.
Harry Gonda, M.D.
Martin Hurvitz, M.D.
Gunthar Jacob, M.D.
Wilbur Jarvis, M.D.
Norman Levy, M.D.
Peritz Levinson, M.D.*
Zenos Linnell, M.D.
Buck Luria, M.D.
Howard Mele, M.D.
Daniel Miller, M.D.
Meyer Monchek, M.D.
Beatrice Nachtigal, M.D.
Iris Orens, M.D.
Edward Pinney, Jr., M.D.*
Phoebe Rosen, M.D.*
Joseph D. Rosen, M.D.*
Jehuda Rozanski, M.D.
Gabriel Rubin, M.D.*
Leon Tec, M.D.
David M. Tillim, M.D.
Clara Torda, M.D.
Aimee Wiggers, M.D.*
*—Resigned in 1958

��HIL LSIDE HOSPITAL

‘3

��JANUARY 1, 1960—JUNE

30, 1961

Society of the Hillside Hospital
Board of Trustees

GLEN OAKS, NEW YORK

OFFICERS
PresidentD. Herbert Beskind

Vice Presidents
George W. Galinger
Charles H. Meyer

'

S. H.

Chairman, of the Board
Alvin [3. Coleman

Scheuer

Walter

Honorary Chairmen of the Board
Roy Ecstie'r

Leon towenste‘in

Dudley‘D.-Shoenfeld, MD.

D.

Yankauer

Treasurer
Arnold .s. Askin

Assistant Treasurers
Arthur Garson
MauriCe Glinert

Secretary
Jacob Epstein Katz
Assistant Secretaries
A. Jacob Abrams
M. Victor Leventritt

M EM B EIR‘S'

A. Jaco‘b‘Abram's;

George W. G'alinger
Arthur Garson
Maurice Glinert
Meyer Goldstein"
Jacob Epstein Katz’r
Carl L. Kempner
Harold P. Kurzman
Robert L. Leeds, Jr.
M. Victor Leventritt
Budd Levinson
Milton B. Loeb
Sandor Lorand, M.D.

Jonas Adler

Alfred Ap'per
Arnold S. Askin*
John M. Bendheirn
D.

Herbert Beskind"
'

David Bunim
Alvin E. C'Ol'eman'

Martin Coleman
Thomas Epstein
Arthur C. Fatt
Roy

Foster“

Leon Lowenstein*

Charles H. Meyer
Charles Revrson
Manue‘lLee Robbins
S. H. Seheuer
Dudley D. Schoenfeld,
John W. Straus
Irving Weisglass
Nathan Wigod

M-.D.*

Morton 8,. Wolf
Adolph Woolner
Walter D. Yankauer

CHAIRME-N of STANDING COMMITTEES of THE BOARD of TRUSTEES

Executive committee
Alvin E; Coleman
Finance. Committees
Maurice Glin'ert
Sub-Committee on Investments
Adolph Woolner
Gifts &amp; Legacies Committee
Jacob E-.; Katz
-

*Executiv.e Cémmittge‘
'

”Deceased

House &amp; Grounds Committee
George W. Galinger
Nathan Wigod
Legal Committee
Charles H. Meyer
Medical Affairs Committee
M. Victor Leventritt
New Building Committee
David Bunim

Nominating Committee
Walter D. Yankauer
Personnel Committee
Harold P. Kurzman
Public Relations Committee
Arthur C. Fatt
Social SerVice- Committee
Maurice fGIin‘ert

�ever—changing approach to the treat-

President’s
Report

Hillside

Hospital was founded
in 1927 by Dr. Israel Strauss and his
colleagues of the Committee of Jews
for Mental Health, whose objective
was to provide good psychiatric care
to those who could not afford to pay
for the service. Today’s Hillside Hos—
pital is one of the few voluntary, nonprofit psychiatric hospitals in the
United States. In 1958, the Board of
Trustees determined to establish new
goals for their hospital.
Our physical size and personnel
resources anticipated recent recom—
mendations of the Joint Commission
on Mental Illness. We endorse these
recommendations and wish to participate in the solution of this major
health problem by continuing our
treatment program, by seeking an improved quality of patient care, and by
providing outstanding professional
training for doctors, nurses, social
workers and other professionals. To

accomplish these goals and to

broaden the treatment program as a
basis for fundamental research in
mental illness, Dr. Lewis L. Robbins
assumed the responsibilities of Medical Director.
Dedicated lay members of the
Board of Trustees together with the
staff and the distinguished physicians
who served on the Medical Board,
have been continually reviewing the

ment of mental illness and evaluating
new concepts of care. The character
of Hillside Hospital as a pilot institution seeking to broaden the frontiers of understanding mental illness
is now well integrated.
The years 1960 and 1961 saw the
planning of a new building program
designed to provide the physical facilities for current concepts of treatment, professional development and
research. An activities therapy build—
ing is needed to house the manifold
creative, occupational, athletic and
social activities which we know are
so vital in the treatment of our patients. Equally important, offices,
conference rooms and working areas
must be created for the broader research program which will include,
in addition to biochemical research
and experimental psychiatry, a comprehensive effort in dynamic psychiatry. Adequate residence facilities
are necessary to house our staff members. Funds toward the cost of these
physical improvements are substantially in prospect and it is entirely
possible to contemplate that construction can begin during 1962.
In this progress report of today’s
Hillside, I take great pleasure in the
accomplishment of the ﬁrst and major phase of progress toward the long
range goals we have set. The efforts,
wisdom and material support of the
trustees of the Society and the Federation of Jewish Philanthropies, and
the informed and dynamic leadership
which Dr. Robbins provides, instills
great conﬁdence that the image of
tomorrow’s Hillside will shine even
brighter than today’s.
D. HERBERT BESKIND
President, Society of
the Hillside Hospital

�Professional
and Administrative Staff
Samuel Davis
Assistant Administrator

ADMINISTRATION
Lewis L. Robbins, M.D.
Medical Director

STAFF PSYCHIATRISTS
William Benjamin, M.D.
Muriel Benton, M.D.
Max Fink, M.D.

Maurice Bachrach
Administrator

David Graubert, M.D.
Irwin Greenberg, M.D.
B. Bernie Herron, M.D.
Elsa Katz, M.D.
Donald Klein, M.D.

John c. Kramer, M.D.
Henry Lefkowits. M.D.

Robert R. Luttrell, M.D.
Robert Navarre, M.D.
Paul Salkin, M.D.
Alice S. Stahl, M.D.
Barbara Ure, M.D.
Morton Wachspress, M.D.
George Yessin, M.D.

PROFESSIONAL DEPARTMENT HEADS
ACTIVITIES THERAPIES
Morton Wachspress, M.D.

NURSING

EXPERIMENTAL

Jean Axten, R.N.
Director
Frances Anderson, R.N.
Associate Director

PSYCHIATRY

Director

Max Fink, M.D.

Eli Levy

Director

Assistant Director
Joseph Chase
Director,
Occupational Therapy

PSYCHOLOGY

LABORATORY

HarryrGoldenberg, Ph.D.
Director

Phyllis Hurteau, R.N.
Associate Director lnservice
Education

John Croghan
OUT-PATIENT DEPARTMENT

Supervisor

ADOLESCENT PAVILION
Alice S. Stahl, M.D.

MEDICAL LIBRARY

Director

James Montgomery
MEDICAL SERVICES

BIOCHEMISTRY

Arnold

Harry Goldenberg, Ph.D.

G.

Blumberg, M.D.

Director

Director

RODSrt R.

Luttrell, M.D.

DII'CCTDI'

Harvey Goldey, M.D.

Assistant Director
Hershey Marcus, M.D.
Director Child Therapy Unlt

Abraham Levine, Ph.D.
Director
CREATIVE THERAPY

Mrs. Edith Zierer

Director
SOCIAL SERVICES
Abraham Lurie

Director
Louise Pinsky
Assistant Director, Casework
Sidney Pinsky
Supervisor, Group Work
SOCIOLOGY

Nathaniel Siegel, Ph.D.

ADMINISTRATIVE DEPARTMENT HEADS
FOOD

ACCOUNTING

SERVICE

SERVICES

Sol Fuchs

Dorothy Croghan

HOUSEKEEPING

OFFICE

BUILDINGS and

SERVICES

GROUNDS

Robert Jones

May K. Bottomley

Thomas Lumley

CLINICAL ASSISTANTS
ADULT UNIT

Nobel Endicott, M.D..

Sumner Goldstein, M.D.
Curtis. Kendrick, M.D.

Lionel Chertoff, M.D.
Ralph Colp, Jr., M.D.
Alan Dobrow, M.D.
Raymond Edelman, M.D.

Dahiel Miller, M.D.
iris Orens, M,D.

Esther Robbins, M.D.
Jack Schnee, M.D.
Maurice Shilling, M.D.
JamesWatson, M.D.

CHILDREN’S UNIT

Sidney Finkel, M.D.
John Price, Jr., M.D.
Esther Robbins, M.D.
Mollie Schildkrout, M.D.

PSYCHIATRIC RESIDENTS
Lucie Arato, M.D.
Paul Ar'onow, M.D.

Peter Ferber, M.D.

Edward Gelardin, M.D.
Seymour Gers, M.D.
WarrenH. Goodman, M.D.
Joseph Gross,'M.D.
'

‘

Edward‘s. Hartmann, M.D.
Jerome L, Jacobs, M.D;
Abraham Jankowitz, M.D.
Henry K‘aminer, M.D.
Herbert J. Levo’witz; M.D.
Arnold Lieber, M.D.
Julia Mehlman, M.D.

Herman Oliver, M.D.
Raymond W. Rakow, M.D.
Rita S. Reuben, M.D.
Ger-aid D. Roberts, M.D.
Judy M. Roheim, M.D.
Bertram H. Rosen, M.D.
Ronald'Sa‘german, M.D.

DECEMBER

George Satran, M.D.
Martin Shepard, M.D.
Herbert J. Steinberg, M.D.
Dan'ield Weitzner, M.D.
Charlotte M. Zitrin. M.D.

31,1960-JUNE 30,1961

�Medical

Director’s Report
When one considers that there

are hundreds of thousands of patients
in public and private hospitals in the
United States, one is forced to the
conclusion that this represents a tremendous waste of human lives and
community resources.
The majority of these patients are
in large public hospitals which have
been viewed by the Joint Commission on Mental Illness as too large to
provide the necessary individualiza—
tion of treatment and the therapeutic
relationships which are so important.
Hillside Hospital with its 375 admissions and discharges per year does
provide the type of treatment needed,
but the service we can give is but a
mere drop of water in the vast ocean
of human misery. It would take us
forty—ﬁve years to treat as many patients as are currently in just one of
the nearby public institutions. The
solution to the problem of mental ill—
ness does not lie in the expanding of
treatment facilities as much as it does
in ﬁnding better answers to the causes
and treatment of emotional dis—
orders, and in passing on our knowledge to all those who are needed to
treat the mentally ill.
In accordance with these principles, Hillside Hospital has chosen
to make research and training its
primary goals. As always, it continues to be a pilot institution providing
the best psychiatric treatment that is
currently available, and is constantly

trying to develop new knowledge and
to share what we learn with others.
The development of research and
education are never any better than
the clinical programs on which they
are based. Conversely clinical pro—
grams which do not include educational and research activities become
sterile.
During these past three years, our
emphasis has been on further im—
proving our clinical services and concomitantly expanding the psychiatric
residency training program.

Although there has been much

progress in the several on—going research programs, the improvements
in our clinical and educational activities should provide opportunities for
considerable new effort in this important area.
This report treats of our progress
in connection with the restated goals
of our hospital. The problems in ﬁnding solutions to the questions of mental illness are enormous, but we are
taking steps towards assisting in the
ﬁnding of needed answers. The work,
the effort, support and dedication of
our trustees and staff augur well for
the future.
LEWIS L. ROBBINS, M.D.
Medical Director

�Progress Toward
Our Stated Goals

move from closed to open units as
was previously the practice.
An open hospital has been estab—
lished. Doors are rarely locked.

I
The
therapeutic activities now
I constitute
the major
of the
part

I
Goals

are quoted from the survey and report made by Dr. Robbins
in late 1958.
TREATMENT and TRAINING
“The psychiatric hospital should
be thought of primarily in terms of
its staff and of the facilities for occupational therapy, recreational therapy, educational therapy, group living experiences and the like; as a
total community in which the bed is
used only to sleep in at night. A psychiatric hospital should be a thera—
peutic community in which every
aspect of the patient’s stay is designed
to meet his therapeutic needs. To insure the best possible results includes
not only the prescription of the speciﬁc treatment procedures mentioned
. . .and the type of therapy best suited
to meet the needs . . . but also the
‘emotional atmosphere’ in which they
are to be carried out.”

Patient care has been much more
I individualized.
staff has been reor—
I Our treatment
and

treatment teams esganized
tablished. Led by a full time senior
staff psychiatrist the team is composed of staff psychiatrists, psychiatric residents, social caseworkers,

I

group workers, psychologists,
nurses, and activities therapists.
In order to stabilize patients in re—
lation to stall, patients now remain
on the same living unit, rather than

I

patients’ program.
The treatment program has been
approved by the Joint Commission on Hospital Accreditation.
A children’s outpatient clinic has
been opened.

“The patients admitted to Hillside
Hospital fall into the groups of those
patients with severe psychoneuroses,

early or incipient psychoses, and
rather severe character disorders.

Such patients require the optimum of
psychiatric talent for help and one
should be able to bring to bear in
their treatment the best skills that are
available. Even the most experienced
psychiatrists need to have the participating skill of an adequate staff both
qualitatively and quantitatively in all
the areas of psychology, psychiatric
social work, psychiatric nursing and
the adjunctive therapies.”
An Activities Therapy department
has been established.
The Occupational Therapy staff
has been increased.

I
I
Recreational Therapy staff
I The
has been increased.
has
been
A
work
patient
program
I initiated.
activities
therapy
Occupational
are
I related to work and to treatment

I
I

rather than just to arts and crafts
training.
A pilot vocational rehabilitation
program has been established with
Altro Workshops.
A program in which volunteers
plan and lead patient activities has
been established.

�“One fact which seems to work
against the success of the admission
policy is the accumulation of a waiting list for admission.”
The patient waiting list has been
eliminated.
The admission screening process
has been improved.

I
I

“The main shortage in psychiatry
today is knowledge. . . One of the
major responsibilities of every psychiatric facility is not only to provide
the best possible service to patients,
but also to train personnel. Psychiatry like all other branches of medicine, is best learned by intimate
contact with patients and with one’s
teachers, rather than in the classroom. Thus, the clinical staﬁ is simultaneously a faculty working in
close day to day personal contact
with the students The resident. . .can
only meet the clinical needs of the
patients in his care if he is given adequate supervision by more experienced teachers. The resident psychiatrist is a very busy person having on
an average twelve patients at a time
and admitting a new patient approximately every ten days. It is not possible to add some very necessary
experiences (such as outpatient psychotherapy) to the residency program
because of their already very heavy
schedules. It would be desirable to
increase the number of residents, not
only to provide training for more
doctors, but also to decrease the case—
load for each resident. There has
long been a desire to develop a full

three year residency training program at Hillside Hospital. Experi-

ence again has demonstrated that it
is better for residents to obtain all of
their psychiatric training in one place
rather than to move from place to

�place. This provides them with a
more integrated three year educational experience. Specialized experience in certain areas, such as psycho-

somatic medicine, geriatrics and

neurology can be developed through
liaison with other nearby institutions.
It is, therefore, recommended that
the excellent facilites of Hillside Hospital and its actual as well as potential relationships with other institutions be used primarily for the advancement of psychiatric knowledge.

I
I
I
I
I

The full time psychiatric staff has
been greatly enlarged.
The number of psychiatric resi—
dents has been increased.
The number of patients per doctor, and the number of residents
per supervisor has been reduced.
The quality of supervision has improved.
Residency training in psychiatry
has been approved by the American, Medical Association for three
years.

I dency training has increased qualiApplicants for psychiatric resi-

I
I

tatively and quantitatively.
The number of grants from the
United States Public Health Service for training has been increased.
Clinical training has been extend—
ed into the Adult and Children’s
Out-Patient clinics.

I been improved and increased.
of
function
Educational
voluntary
I non-paid attending staff increased.
afﬁliations
for
psychiatTraining
I ric residents established with
Formal classroom training has

I

Creedmoor, Long Island Jewish
Hospital, Monteﬁore Hospital and
Meadowbrook Hospital.
Graduate and undergraduate
training in psychiatric nursing in

I
I

afﬁliation with Queens College and
Adelphi College.

Inservice training program for
nursing personnel established.
Graduate training in Psychiatric
Social Work and Group Work in
afﬁliation with Adelphi College,
Columbia University, Yeshiva and
New York University.

RESEARCH

“A lthough millions and millions

of dollars have been spent in development of all kinds of psychiatric

facilities, only a small amount of

money has been spent in the important area of psychiatric research . . .
Far greater sums of money are being
spent for research and other illnesses
which have a much smaller incidence
than do psychiatric disorders . . . Re—
search is developed in most hopitals,
as a derivative of the clinical and educational activities in the institution
. . . investigations which must go forward on many fronts simultaneously;
physiological, psychological and social. Because man is a biological,
psychological and social being, the
ultimate.answers in respect to psychiatric illness will not be found in
any one area alone even though from
time to time one may seem more
promising than the others. Therefore, it is also encumbent upon every
psychiatric institution not only to
treat patients as well as our present
knowledge permits and to educate
psychiatric personnel, but also to
continue to investigate the nature of
psychiatric illnesses in order to eliminate many gaps in our knowledge.”

I

The research programs in experimental psychiatry, biochemistry
and medicine have been in existence for many years under the re-

�spective leadership of Dr. Max
Fink, Dr. Harry Goldenberg and
Dr. Arnold Blumberg. These programs have continued to produce
valuable achievements, some of
which are reported below. It is’
hoped that the next few years will
see even greater emphasis on the
research aspects of the goals for
Hillside Hospital.

I
I

Eight percent of the total Hillside
Hospital budget is currently devoted to research.
National recognition of the research work done at Hillside Hospital. Dr. Donald Klein was appointed as a United States Public
Health Service career investigator.
Dr. Max Fink was appointed to
the committee on Clinical Psychopharmacology of the National Institutes of Mental Health, who
sponsor a national program for the
screening of new drugs in the treatment of mental illness, joining Dr.
Lewis L. Robbins, who has continued as Consultant to the Review
Committee in Mental Health Research; and the sponsorship of the
ﬁrst International Conference on
the EEG and Human Psychopharmocology, at the World Congress
of Psychiatry, Montreal, June
1961 by the Department of Experimental Psychiatry.
Dr. Harry Goldenberg, was hon—
ored by appointment as Chairman
of the Van Slyke Awards Committee, Chairman of the divisional
meeting of the American Association for the Advancement of
Science, and panel member of the
Eastern Analytical Symposium.
Dr. Vivian Fishman’s drug research studies were recognized by
the National Institutes of Health

with an invitation to present her
ﬁndings before the Psychopharmacology Round Table in Atlantic
City.
EXPERIMENTAL PSYCHIATRY
Dr. Fink and his staff completed
their survey of forty psychotropic
compounds and showed the electroencephalogram (EEG) to be
the best available measure of psychotropic drug activity.
Typologies of patient response to

I

I two

major psychotropic

com—

pounds—chlorpromazine and imipramine were deﬁned. This work
enables psychiatrists to determine
the best drug for each patient.

BIOCHEMISTRY
Dr. Goldenberg and his staff investigated the chemical changes
which occur in chlorpromazine
due to glandular activity. Animal
trials led to the discovery that two
products (“metabolites”) derived
from chlorpromazine may be
equivalent or superior to the parent drug.
Other animal studies were carried
out in the laboratory dealing with
the stress phenomenon; these experiments have led to observations
that may be signiﬁcant to the solution of the problems of senile psychosis and atherosclerosis.

I

I

MEDICAL RESEARCH
Dr. Blumberg in his program of
medical research has developed a
ﬁrm basis for the mecholyl test.
He has demonstrated the stability
and the reliability of this test in
chemical use. It is now used as an
effective medical screening device
to determine the patients receptivity to somatic psychiatric treatment.

I

�Publications

A

FINK,

'M_.:

.EEG

Techniques in Study

of Psychotropic Drugs. Discussion.Actaiof Int.'I Meeting‘oh Techniques
for Study of Psychotropic Drugs,
Modena, Soc. Tip'o'grafic‘a Mo'de'nse,
1961.
FINK, M. and KAHN, R. L.: Behavioral

Reproducibility of
the Mecholyi Test, Psychosomatic
Med. 22: 1,1960.

Convulsive Therapy.
A.M.A. Arch. Gen. Psychiat. 5: 30-36,

BLUMBERG A. 'G., LADERMAN- P. and
FINK, M. Efficacy of Divided and

FINK, M., KAHN, R. L. KARP, E..
POLLACK, M., GREEN, M., ALAN, B.
and LEFKOWITS, H. 1.: Inhalant Induced Convulsions: Significance of
the Theory. of theConvulsive Therapy
Precess. A.M.A‘. Arch. Gen. Psychiat.

BLUMB_,ER,G

G.:

'Single Dose Schedules in Insulin'
Coma Therapy, Am. 1. Psychiatry
116: 839-40, March, 1960.;

and KLEIN, D F.:
Severe PapiIIedema Associated With
BLUMBERG, A. G.

Drug Therapy, Am. J. Psychiat. 116::
168- 170, 1961.
BLUMBERG, A, G. and GOLDENBERG.

H. Relation of the Mec‘hoiyl Test
to Catechoiamine Excretion, Proc.
Soc. Exp. Biol. 6: Med 106: 867-869,
1961.

H. Union and Management
Trainees: A Comparative Study of
BOGARD,

Personality and Occupational Choice,
1. of Applied Psychology 44: 56-63,
1-960.

Nursing Staff Functions in a Treatment Setting, 1.
Hillside Hosp. 9: 88-93,1960-.
CLIGGETT, K.:

Occupational Therapy at
the Adolescent PaVIIion, 1. Hillside
Hosp. 9: 80-87, 1960.
ENGEL, R.:

a Case of Depersonalization, 1. Hillside Hosp. 9:
106-127 1960.
FAJRAJZEN, 8.:

_On

Effect of Anticholinergic
Compounds on Post-Convulsive EEG
and Behavior of Psychiatric Patients,
EEG Clin. Neurophysiol. 12: 359-369,
FINK, M.:

1960.-

FINK, M.: EEG and BehaviOraI Effects

of Psychopharmacologic Agents. In.
Neuro-PsychopharmacoiQE-Yy ed. P,
Bradley. Amsterdam, Elsevier, pp.
441-446, 1960.

FINK, M., 1AFFE, 1. and KAHN, R. |:.:
Drug IndUCed Changes in Interview

Patterns: Linguistic an‘d Neurophysiologic lndices. In Dynamics of Psychiatric Drug Therapy. red. G. J. Sarwer-Foner, Springfield, "L, C. C.

Thomas, 1960, pp. 29-44.

FINK, M.: EEG and Behavioral

fects of Tofranii,

Ef-

EEG C-IiII. Neuro-

physiol. 12: 243-44 (abst.) 1960.
FINK, M.:

Differential Treatment and

Prognosis in schizophrenia, by R. D.
Wirt and W. Simon. Book Review,
A..M.A Arch. Gen. Psychiat. 2: 121-

122,1960.

Problems of Antagonists
to Psychotropic Drugs. Discussion.
Neuro—Psychophar‘macology 2: 30-32,
ed. E. Rothlin. Amsterdam, Eisevier,
1961.
FINK, M.:-

Patterns In
11961.

4: 259-266, 1961.

V. and‘GOLDENBERG,

FISHMAN,

H.:

MetaboIi-sm of Chiorpromazine: 0rganIc-Extractable Fraction from Human Urine. Proc. Soc. Exp. Biol. 6:

Med.104: 99,1960.

3.: Helping the Disturbed
Adolescent Acéept Hospitalizatibn.
Social Work 6.69 75.1951
FREEMAN,

M.‘E. and FRIEDMAN, M. R.:
.AfMethod-of Organizing Clinical Data:
A Teaching Aid for Training ResiFRIES."

dents

apy.

Psychoanalytic PsychotherHillside Hosp. ‘9: 25-47, 1960.

in

1.

GALE, M. .and SHATZKY, B.: P.S. 611
y—Queens Annex: ASchool in .a Psychiatric Hospital. 1. Hillside Hosp. 9:

94-99, 1960.

Aftercare Program for
Adolescents. 1. Hillside Hosp. 9,: 61'65, 1960.
GOLDENBER-G, H., FISHMAN, V.,
WH'ITTIER, 1. and BRINITZER, W.:

Urinary Aromatic Excretion Patterns

schizophrenia, A.M.A. Arch. Gen.
Psychiat. 2: 221.1960.
in

GOLDENBERG, H.

and

FISHMA-N, V.:

Species Dependence of Chiorpromazine Metabolism, Proc. Soc. Exp.
Biol. 8: Med. 106. #26884 1961.
GREEN, S. L., KWALWASSER, S., and
STAHL,.A. S.: The Role of the Psychiatrist in a Residential Treatment

Unit. for AdoleSCen'ts. PSychi‘at.
Quart. 34: 662-691, 1960.

Relation Between
Threshold and Duration of Seizures
a'nd Electrbgraphic Change During
Convulsive Therapy. 1. Nerv. Ment.
Dis. 130: 235-239, 1960.
M.

A.:

Approaches to Psychiatric Consultation in a Research
Hospital Setting. A.M.A. Arch. Gen.
Psychiat. 3: 691-697, 1960.
GREENBERG, I.:

I.: Acute lnterc-urrent
Psychosis During the Course -of Familial Periodic Paralysis. Am. 1.
GREENBERG,

Psychiat. 116: 260-263, 1961.

I.: Comparison; of the
Cross-Cultural Adaptive. Process with
Adolescence. compr. Psychiat. 2:

GREENBERG,

44-50, 1961.

1.:

ESECQVER, H., KAHN,
R: L. and FINK, M.: Modification of
1AFFE,

1..

Psychotherapeutic Transactions by
Altered Brain Function. Am. 1. Psychother. 15: 46-55, 1961.
1AFFE,1., FINK, M., and KAHN, R. L:
Changes in Verbal Transactions with
Induced Altered Brain Function. J.
Nerv. Ment. Dis. 130: 235-239, 1960:

Language Patterns as Character Defenses: Implications for Psychoanalytic Technique. Psychological' and, Psychiatric
Aspect of Speech and Hearing, Disorders, ed. D. A. Barbara. Springfield, III., C. C. Thomas, 1960. pp.
138-151.
1AFFE,

Formal

1.:

and FINK, M;: Prognostic Value of Rorschach Criteria
in Clinical Response to Convulsive
Therapy. J. Neuropsychiat. 1: 242245, 1960.
KAHN,

R.

L.

and FINK,
M.: Figure-Ground Discrimination after Induced Altered Brain Function.
A.M.A. Arch. Neurol. 2: 547-551,
1960.
KAHN, R. L., POLLACK, M.

and FINK,
M.: Social Attitude (California F
Scale) and Convulsive Therapy. J.
Nerv. Ment. Dis. 130: 187-192, 1960.
KAHN, R. L., POLLACK, M.

LGLYNN, E.: An

GREEN,

Social Factors in the
Doctor-Patient Relationship. In PsyChoanaly'sis and Social Process, ed.
1. Masserman. New York, Grune 8:
Stratton, 1961, pp‘. 81-88.

1AFFE,

and POLLACK, M.: Sociopsychological Factbrs Affecting Therapist-Patient Relationships. Psychoanalysis and Human Va'lues, ed. 1.
Masserman, New York, Grune 8:
Stratton, 1960. pp. 155-168.
KAHN, R. L.

and POLLACK, M.: The
Relationship of Mental and Physical
states in Institutionalized Aged Persons. Am. 1. Psychiat. 117: 120-124,
1960 (with Goldfarb, A. I. and Gerber, l. E.).
KAHN,

R.»

L.

and POLLACK, M.: Brief
Objective Measures for the Determination of Mental Status in the Aged.
Am. 1. Psychiat. 117:, 326-328, 1960
(with Goldfarb, A. I. and Peck, A.).
KAHN, R. L.

Staff Attitudes Toward
Psychiatric Treatment in .a Voluntary
Mental Hospital. 1. Hillside Hosp.
KAHN, R. L.:

10: 97-106, 1961.

KAHN, R. L., POLLACK, M. and GOLDFARB, A. I.: Factors Related to In-

dividual Differences in Mental Status
of Institutional Aged. In Psychopathology of Aging, New York, Grune
&amp; Stratton, 1961, pp. 104-113.

and LEFKOWITS, H. 1.:
Influence of Staff Attitudes and Environmental Factors on Treatment
Selection. 1. Hillside Hosp. 10: 8496, 1961.
KAPLAN, A. I.

�Alterations of Visual Excitability in Patients with Lesions
of the Cerebral Optic Pathways.
KARP, E.:

Trans. A.N.A. 156-159, 1959 (with
Battersby, W. S. and Wagman, I. H.).
Neural Limitations of Visual Excitability: Alterations Produced
by Cerebral Lesions. Arch. Rural. 3:
24-42, 1960 (with Battersby, W. 5.,
Wagman, I. H. and Bender, M. D.).
KARP, E.:

ROSEN, B. H.: Case Report of Auricu-

lar Fibrillation Following the Use
of Imipramine (Tofranil). J. Mount
Sinai Hosp. 27: 6, Nov.-Dec., 1960.
Effect of Interpersonal Relationships Upon Verbal
Conditioning. J. Abnormal I. Social
Psychology 60: 241-6, 1960.
SAPOLSKY, A.:

KAVAZANJIAN, T.: The Role of the
Clinical Psychologist in the Adoles-

and STAHL,
A. 3.: The Treatment Of “Provocative” Behavior in the Disturbed Adolescent. J. Hillside Hosp. 10: 67-81,
1961.

1960.

STAHL, A. 8.: The

cent Pavilion of the Hillside Hospital. J. Hillside Hosp. 9: 65-71,
F.: Mepazine (Pacatal):
Clinical Trial with Placebo Control
KLEIN,

D.

and Psychological Study. Psychopharm. 1: 280-287, 1960 (with J. R.
Whittier, G. Levine and D. Weiss).
and GREEN, 3. L.:
Treatment Program at the Israel
Strauss Pavilion for Adolescent Girls.
J. Hillside Hosp. 9: 14-24, 1960.
KWALWASSER, S.

LEVINE, A.:

Appraising Ego Strength
from the Projective Test Battery. J.
Hillside Hosp. 9: 228-240, 1960.
LINNELL, Z. M.: Authority

as 3 Treatment Modality with Adolescents in
a Psychiatric Hospital. J. Hillside
Hosp. 9: 48-60, 1960.

LURIE, A. and PINSKY, L.: Collabora-

tion between Psychiatric Hospital
and Community Agencies in the
Rehabilitation of Mental Patients.
Mental Patients in Transition, ed.
Milton Greenblatt, Springfield, ”L,
C. C. Thomas, 1951.

Effect of Brain Tumor
on Perception of Hidden Figures
Sorting Behavior and Problem Solving Performance. Dissertation Abstracts. 20: 8, 1960.
POLLACK, M.:

POLLACK, M.:

Comparison of Childhood, Adolescent and Adult Schizophrenias. A.M.A. Arch. Gen. Psychiat. 2: 652-660, 1960.
POLLACK, M.: The Face-Hand

Test in
Retarded and Non-retarded Emotionally Disturbed Children. Am. J. Ment.
Def. 64: 758-761, 1960 (with E.

Gordon).

and FINK, M.: Socio~
psychological Characteristics of Patients who Refuse Convulsive Therapy. J. Nerv. &amp; Ment. Dis. 132: 153157, 1961.
POLLACK, M.

POLLACK, M., KARP, E., KRAUTHAMER, 6., KLEIN, D. F. and FINK,

M.: Neuropsychologic Response Pat-

terns of Some Psychotropic Drugs.

Neuro-Psychopharmacology 2: 381384, ed. E. Rothlin. Amsterdam,
Elsevier, 1961.
ROBBINS, L. L. and WALLERSTEIN,
R. 8.: Operational Problems of Psychotherapy Research: 1. Initial Stud-

ies. Bull. Menninger Clin. 24: 164189, 19690.

SCHILDKROUT,

M.

S.

First Five Years
of the Israel Straus Adolescent Pavilion Program. J. Hillside Hosp. 9:
5-13, 1960.

WALLACH, S. S., WALLACH, M. B. and

6.: Observation of Involuntary Eye Movements in Certain
Schizophrenics. J. Hillside Hosp. 9:
224-227, 1961.
YESSlN,

ZIE‘RER, E. and ZIERER, E.: The Integration Quotient in Creative Ther—

apy. J. Hillside Hosp. 9: 156-170,
1960.

�Administration
and Finance
5‘

The extent of future development of Hillside Hospital will depend
upon the readiness of the community
to support its program. At this point
it is not possible to project our budget
for five or ten years in the future, but
it is possible to choose a course of
development and to have some general awareness of the fact that expansion of Hillside’s program .
could easily double . . . the current
budget. In addition to the staff augmentation, there will, of course, have
to be a concomitant increase in
housekeeping, administrative personnel and it is evident already that additional facilities, not only for staﬂ
but also for patients, are required.
The current dining facilities are already overtaxed and the areas for
occupational, educational and rec—
reational activities are much too limited and inadequate. Consideration

must be given, therefore, to con—
struction not only of a research building, but also more adequate facilities
for patient activities, staﬁ meeting
rooms, library and dining rooms.”
The charts graphically illustrate
the ﬁnancial operation of our hospital during the ﬁscal year ended June
30, 1961. Sizable deﬁcits were incurred in our in-patient and outpatient services because of the increase in the quality of patient care.
As we continue to make progress and
as we continue to improve wages and
salaries, we believe that these deﬁcits
will increase if we are to continue to
meet our stated objectives. Without
the ﬁnancial assistance of the Federation of Jewish Philanthropies and
our Board of Trustees, the progress
of which this report treats, would
have been impossible.

The professional development

program has required corresponding
expansion and improvement of administrative services. Housekeeping
and Maintenance services have been
enhanced through the application of
industrial management techniques.

HILLSIDE

Hospiut

GLEN OAKS

KIFF. COLEAN, VOSS 3 SOUDER
THE OFFlcE 0F YORK a SAWYER

N, Y.
ARCHITECTS

�Work measurement, preventative
maintenance, a planned painting program and modern equipment have
been emphasized. These programs
have resulted in signiﬁcant improvements in hospital appearance and
services so important to the “therapeutic community.”
To provide the base for effective
organization to achieve stated goals
of our hospital, an intensive personnel management program has been
planned and implemented. Personnel
policies have been developed, consolidated, and published, job analyses have been performed, a job
grading program has been established, a merit evaluation program
has been implemented, and salary
scales were increased for professional and service staff. The results of
these efforts have been an increas—
ingly stable and efﬁcient employee
group of high morale.
Our most immediate need is for
the space which will express the professional development program in
physical terms. Psychiatrists’ oﬂice
space is inadequate, teaching facilities including our Medical Library
are limited, Activities Therapies areas
are widely dispersed and insufﬁcient,
and Research space does not meet
current needs. To meet our space
needs, we have developed a master
plan for future construction. Our
plans provide for construction of an
Activities Therapies building, addi—
tional research facilities, and a staff
housing project. Following construction of these buildings, we will reconstruct presently existing facilities
so that they too, may meet present
and future space needs.

SERVICE COSTS
ln-Patient Service‘
COST

$26.65

L088

$1 .56

INCOME

*Average per patient-day

SERVICE STATISTICS

........................
Number of in-patients treated
...........
Number of out-patients treated
..........
Number of out visits
...................
ln-Patient days

69,941
539

659

14,614

INCREASE IN EXPENDITURES
TREATMENT

and TRAINING

1958-1959

$924,703

1960-1961

UP

42%

$1,310,908
RESEARCH

1956-1959
1960-1961

$ 152,638
$ 198,275 UP 30%

ADMINISTRATIVE SERVICES‘

1956-1959

$ 729,595

$904,863

1960-1961

UP

24%

MAURICE BACHRACH

Administrator

TOTALS

1958-1959

$1,806,936

1960-1961

$2,414,046

*lncludes Administration. Accounting, Food Service, Housekeeping,
Maintenance, Office Services and Medical Records.

�JANUARY 1,

1960—JUNE,30,

Jeena'

Attending Psychiatric Staff
ATTENDING PSYCHIATRISTS

Hyman L. Rachlin, M.D.‘
Lawrence J. Roose, M.D.*

Samuel Atkin, M.D.*
Frank Berchenko, M.D.

Robert Savitt, M.D.'
Martin Schreiber, M.D.*
Isid'or Silbermann, M.D."
Otto Sperling, M.D.t
Aaron Stein, M.D.*
Sidney Tarachow, M.D.*
A.

lsidor Bernstein, M.D.
Arnold Eisendorfer, M.D.'
M. David Epstein, M.D.I'
Margaret E. Fries, M.D.‘t
I. Peter Glauber, M.D.t
George S. Goldman, M.D.‘T
Paul Goolker, M.D.*
Sidney L. Green, M.D.*
William Karliner, M.D.‘
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.‘
Emanuel Klein, M.D.
Simon Kwalwasser, M.D.
Samuel R. Lehrman, M.D.‘
Abraham S. Lenzner, M.D.
Joseph s. A. Miller, MD!
Martin H. Orens, M.D.:
Samuel Z. Orgel, M.D.*

ASSOCIATE ATTENDING
PSYCHIATRISTS

Renato J. Almansi, M.D.
Alexander J. Friedman, M.D.
SoIl Goodman, M.D.
Abraham I. Kaplan, M.D.
Louis Kaywin, M.D.
Bruce Kendall, M.D.
Geraldine Pederson-Krag, M.D.
William W. Pike, M.D.
Jay Stanton, M.D.

ADJUNCT ATTENDING
PNYCNIATRISTS

’lebur Jarvis; M D_.

‘

Edward R. Adelson, M.D.
Herman S. Alpert, M.D.
Alvin B. Balaban, M.D.
Irving L. Bauer, M.D.
Benjamin J. Becker, M.D.
Julius Beli’nkoff, M.D..
Milton M. Berger, M.D.
Lionel H. Blackman, M.D.
Rita M. Chalef, M.D.
Isadore H. Cohn, M.D.
Irving J. Crain, M.D.
Joseph H. Feldman, M.D.
Jules Glenn, M.D.
Albert E. Goldberg, M.D.
Michael Gould, M.D.
Lebert Harris, M.D.
AIbErt Harrison, M.D.
Thomas Hora, M.D.
Martin Hurvitz, M.D.

Eugene H.Kaplan,.M.D.

.Paul Kay, M.D.
George R. Krupp, M. D.
Peter Laderma'n, M. D..
Myer D. Mendelson, M.Dd"
David Milrod, M. D.
Helene Pap‘anek, M.D
Henry Rasner, M.
Irving Salan, M. D.
Frjéd' U. Tate; M. D.
B. Frank Vogel, MDi.
Leonard Weinroth, M D
‘

.

D

Herbert Wie’de'r, M.D.

Consulting Physicians and Surgeons
MEDICINE

Lester Cohen, M.D.*
George Sabrin, M.D.
Louis Rosenblum, M.D.
Jerome Weinstein, M.D.
Wilbur 8. Brett, M.D.
Arnold L. Berger, M.D.
DERMATOLOGY

Joel Schweig, M.D.
Norman Goldfa’rb, M.D.
Eugene L. Bodian, M.D.

GENERAL SURGERY

Sidney Hirsch, M.D.*
Stephen Deckoff, M.D.
UROLOGY

Daniel Kaufman, M.D.

Albert Sutton, M.D.
ORTHOPEDICS
A. H. Lewert, M.D.

Julius Schneiderr‘n‘an, M.D.
PROCTOLOGY

Benjamin Warner, M.D.

NEUROLOGY

Kurt Adler, M.D.

Joseph Siris, M.D.
Martin Green, M.D.

OPHTHALMOLOGY

Edward Seretan, M.D.
Robert Jampel, M.D.

OTOLARYNOLOGY

DENTAL sen VICLE
Director
Palil Schemari, .:D D. S.- ‘
Associate Director
J. GordonRuDin, D'.‘D._S..
Associate Dentists
Benjamin S'c'hwai‘d} '73-'Bernard: Lebow, D. D.S.
Adjunct Dentists
Lepn Bas'son, D. D. S‘Carl Blacharsh D
Herbert Eormani‘
EISa Friedman,
Henry Lewis, D.
Martin Protéll, D S;
'

Sam Clayton, M.D.
Samuel Henken, M.D.
ANESTHESIOLOGY

Georges Bean, M.D.
GYNECOLOGY

Marie P. Warner, M.D.

Bernard Greenblat, M.D.
Jack Cohen, M.D.
RADIOLOGY

Bernard Epstein, M.D.

Paul S’teinhorn, M.D.
PODIATRY

William Rieder, Pod.0.

OPTOMETRYSERVICE
Edward Steinherg,

OJDf.

Professional and Non-Professional Employees
We wish to express our appreciation to the following professional

employees, who helped make our progress possible.

and non- professronal

PROFESSIONAL EMPLOYEES
ACTIVITIES THERAPY

Judith Conrad
Karen Diaslo
Laura Dunlap
Ann Elliott
Miriam Gozali
Phyllis Holland
Mona Jones
Mary Marrone
Lila Martin
Marion Sheffer
_

Richard Thaler
Joan Tucker
Yaeka Umemura
Alida Vasquez
CLINICAL LABORATORY

and

x41"

Kathryn Boone
carolyn siegel
DENTAL

Bertha Sckipp

MEDICAL RESEARCH

Stephen Deckoff, M.D.
Laura Zaves, R.N.
PHARMACY

Eleanor Palais

RESEARCH IN BIOCHEMISTRY

PSYCHOLOGISTS

Howard Bogar'd, Ph.D.
Eugene Friedman, Ph.D..
Benjamin Lapkin, Ph.D.
Ira Rosenblatt, Ph.D.

‘Formerly Member of the Medical Board

Allen Sapolsky, .Ph D‘.
Stanley Schlff, P D.'-.
Eelix Steiner, P
Leonette V‘anderhost”.
Florence Volkman‘

TR'es‘igneJ

Robert Burnett

.

Vivian Fishman Ph. D.
'
Audre Heater)
Michael Rabinowitz;
Daniel [White-

wgeeasea‘?

.

�RESEARCH IN
EXPERIMENTAL PSYCHIATRY

Ira Belmont, Ph.D.
Romeo .Cartolano
llana Goldschmidt
Abraham Kaplan, M.D.
Eric Karp, M.A.
Donald Klein, M.D.
Jean Kolodny
John C. Kramer, M.D.
Hanna Mosquera
Max Pollack, Ph.D.
Arthur Willner, Ph.D.
REGISTERED NURSES

Marie Cafiero
Isabelle Copeland
Ann Dispensa
Carol Enggasser

Maureen Rolston
Rose Schulbaum
Helen Stein

Zelda Feigenbaum
Evelyn Feminella
Marion Fitzgerald
Millicent Goldberg'
‘Ilse Hurst
Ann Kelley
Joseph Kelly
Patricia Kenney
Elaine Kirs’chenbaum
Ann Klemballa
Mar'y' ‘Kohnke

Kathleen Le'eFlora McCartney
Joann Mastrole
Martha Morey
Janet Moses

_

NanCy Steinhardt
Gladys :Stokes‘
.Cfa‘therine' Szakmary
Hele‘n Thrasher

EditthitoIo

Dorothy Urban
Helen Zeigler
LICENSED PRACTICAL
NURSES
Mar-y Corrigan
Maud Drun'canson

Heathlean English
Theresa Homrd
Betty Ann Kelly
Luverne Reeves

Mary Nigro
Myra Pesk0witz

MYrtle‘Re‘mbe‘rt

Shirl‘eyi Piot’nic‘k

Gloria Swan
Ruth Thiele‘
Catherine Wall

Sylvia :Riback
Nancy Rosenbaum
Lita Schmidt
S'eymotir Silverberg
Gisela Tauber
Alice Thompson
Ellen weinstein

Isabelle Young;
SOCIAL SERVICES

Casework Division
"Robert F ishman
BeatriCIe Freeman
“Sally Gold
Regina G‘oldstein
Beatrice 'Hartley
Grace HaWKi‘ns
Mildred Heller
Connie Israel

SarahKlionsky
Sondra Match
Anita Mehr

:SOCIAL

se‘nwces

Group Work DiVision
Ellen Brathwaite

Deugla‘s‘Glangw
Barbara ‘Goldstein
Robert'Handman
Elaine Heyman
Geraldine’Lauter
Beverly Luther
Adele Orlinsky

SERVICE AND NON-PROFESSIONAL EMPLOYEES
BUILDINGS and GROUNDS
Adam Biali'k

Edward Brady
John R. CivinSkas
Edward Fitzgerald
Gustavo Greco
Frank Greene
George Jungk
Bernard Keena
Salvatore Lav Manna
George Loblein
Nero Moyd
Stanley Novak
Walter Roland Jr.
Albert Schmid
Joseph Seagren’

Albert Senese
John-Skinder
Thomas- Slaton
Ignazio Taormina
Leroy Watkins
CLERICAL and BDOKKEEPING
Accounting Department
Arline Fle’ischmann
Lillian Ingbe‘r
Lillian Schaeffer
Ethel Siegelman
Jeannette Silver

Dorothy Streir
Office Services
Irene Attinson
Mary Benesta’d
John Borgner
Diane Brafm'an
Jane Buckley

Elizabeth cox
Irene Djinkin

Claire Dubin
Leonora Edelstein
Eugenia Fievss
Marlene Forman
,Norma’Friedman.
Shirlee G'alanty
Sara Gingold
EdWard Golove
Frances Gullo
James Hand

Norberto Medina

Adele Harris
Grace Hyams

Ida NoVick
Martin Novick
Gaspari Orlando

SyIVI'a Hymo‘witz

Belle Kapner
Edna Kappes.
Rose Landgarten
Esta Levy
Dorothy McClary
Inge Mai
Yetta Mintz
Catherine Muff
Florence Offsie
Aileen Olton
Elinor Paur
Mary Pignoni
Regina Pi'lchick
Gloria Podrid
Rita Rodon
Joseph Ryan
Dorothy Saults,
Rose Sa‘vader
Dorothy ‘Schnirman
Belle Schultz
Charlotte Sinovoi

B'ettyStarr
Edna Telesca
Walter Theisen
Crannie Weinstein
Edna Weis'sman
Lott‘e Wollman
BIanche-Zaitz

rooo seninces

Francesco Ca‘nnetto
Emma Casamassima
Walter Davis, Jr.
Arthur DWyer
Pardo Faro
Alphonse’Gross
Ella Jacobs
Jimmy Knight-

Barbera
Alfred Lemaire
Gustavo Lescouflair
Sarah Littles
Anna Lueatorto
Michael McDonough
Arthu’r Martin

Fortunate

La

Arthur Pitts

Irwin Powell
B'azil Allen Rivers
Walter Rodney
Eva Schwartz

Helen Thompson
Tindel Thompson
HDUSEKEEPINC
Low‘ell Booker

Louis Burgie
George Cables
Jesus Cora
James Cuozzo
Jimmy Lee Dasher
Nathaniel Glover

Charles T. Hill
Gerard Honore
Joseph Hope

‘

William Hyman
Heie'n Jackson,
Ruby Jackson
Marion Johnson
Ernest King
Harry‘Lewis
August Lo Piccolo
Annie Miller
Roosévelt Mitchell
Robert Reddick
Agnes Schuster
Willie Lee Skinner
Ray Warren
Blanche White
William Wood

PSYCHIATRIC AIDES
Olga Allen

Marion Bell
Althea Bing;
George"

‘Bi n‘gha‘m

William Black, Jr.
Beatrice Blake
Annie Bo‘n'd

Joseph Britt

Joan Brown
Lawrence Burger
Raymond Burger
Frances Butler
Sylvester campbell
Malcolm carter
Annie Clements
Alma Clinton
Frederick Coley
May Conrad
Teresa Cooney
Hatti'e'Cummings
Catherine Eames
Annie M. ‘Ervin
Ellen Es‘aw'
Guillaume Esse‘rs
Irish Ford
Herbert Franklin
Idella Gaston
Nettie Gordon
Dolores Griffin
Juliet Haipern
Mabel Harper

Essie Harris
Linda Hart
George Heller
Alberta Hopkins
Ethel HopWood
June Johnson
Anna Mae JonesThomas Kelson, Jr.
A‘s‘a’lee‘Kirby

Helen Olsen
Clemmie Palmer
Joseph Petty
Ida Pulliam
Elizabeth Rodriquez
Dorothy Schrantz
Carltdn Scott
Lessie Mae Scott

MildredShaw
Grace Shieh
Virginia'Smith
Chauncey smokton
Henrietta Strachan
Bessie Sumner

Louise Thiell
Marion Thomas
Walter T. Thomas
Clyde Trotman
Jean Trotman
Clarence Tully
Thomas Valentine, Jr.
Martha Visalli
Martha Welch
Hazel White
Leona Willett
LaWrence Williams
Anna Wolfberg
Leon Wolfberg
Clarence Young
Edgar Zephyrine

.

Barbara Knight
Doris Kraemer
Josephine Lafayette
Arthur Lanier

Leslie. Lee
Miriam Lee
.Alic‘e'Leliukevicz
Georgina Lohman
Grace Lozano
Thel‘matMac‘k

Mildred March
Laura Matthews
Dolores Mitchell
waiter Moore
Ronald Myles

designed and IIIUstrated by VISUAL SERVICES Inc.

�HILLSIDE HOSPITAL
..

is licensed by
the New York State Department of Mental Hygiene.
g

..

is approved for resident training by
Council on Medical Education, American Medical Assmiation.
American Board of Psychiatry and Neurology.

. . is

..

..

accredited by

American Psychiatric Association.
Joint Commission on Accreditation of Hospitals.

is a member of
American Hospital Association.
Hospital Association of New York State.
Greater New York Hospital Association.
Greater New York Fund.
Unite'd'Hospital Fund.
Welfare and Health Council of New York City.
National Conference of Jewish Communal ServiCes.

cooperates with

Adelphi College.
Altro Workshops.
Federation Employment and Guidance Service.Jewish Community Service of Long Island.
Jewish Family Service of New York.
Long Island Jewish Hospital.
New York City Board of Education.
New York State Employment Service.
New York State Department of VacatiOnal Rehabilitation.
Queens College of the City of New Yerk.
The Educational Alliance
.

-

_

is
.. a partieipating hospital
in Master Plan for Hospitals and Related Facilities:
for The Hospital Council of Greater New York.

A
‘

~

‘
A

‘

»

Hillside Hospital is a constituent agency of the Federation :of Jewish: Hiii'li'aothirepies

.of‘Neinork

�for
psychkunk:ﬂeaﬂnent
haﬂﬁhg
and
research

January 19, 1962

Dear Fellow Employee:

of the Hillside Hospital's Progress
Attached to this letter is a c
read
this
As
and
61.
1960
family
your
you
the
fiscal
for
Report
year
made
toward
have
we
that
reminded
of
the
be
progress
Report, you will
the establishment of Hillside as a leading hospital for psychiatric

treatment, training and research.

been
have
would
possible
not
which
Speaks,
Report
of
this
progress,
without the dedication, loyalty and effort which you and your fellow
would
we
For
few
shown
the
have
this,
last
during
years.
employees
like to extend our thanks.
The

Cordially,

W

X.

”m4/69/

Lewis L. Robbins, M. D.

Medica1.Director

',

Maurice Bachrach

Administrator

LLRﬁMB/SD/mb

�32nd Annual Report
HILLSIDE HOSPITAL
Glen Oaks,Queens,N.Y.

�Hillside Hospital is
a nonprofit,

nonsectarian
mental hospital
for the treatment
of voluntary patients,

suffering from early
and curable
mental symptoms and

admitted regardless
of ability to pay.

The Hospital is a
pilot institution,

pioneering in and
advancing the
scientific frontiers
of the human and

efficacious application
of psychiatry to the

mentally ill. Hillside
provides organized

training for physicians
in

postgraduate

psychiatry and

psychotherapy. Major

emphasis is placed on
advanced research in
all phases of treatment.

��...........
REPORT OF THE MEDICAL DIRECTOR
...................
PROFESSIONAL AND ADMINISTRATIVE STAFF MEMBERS.

5
6

TREATMENT

8

REPORT OF THE PRESIDENT OF THE HOSPITAL
3
SOCIETY OF THE HILLSIDE HOSPITAL BOARD OF TRUSTEES. 4

.

.

.

......................................
11
TRAINING
........................................
RESEARCH
14
.......................................
STAFF PUBLICATIONS
PRESENTATIONS
16
.............
REPORT OF THE PRESIDENT OF THE
18
......
MEMBERS OF THE
19
....................
REPORT OF THE ADMINISTRATOR
20
.....................
PROFESSIONAL
NONPROFESSIONAL
AND

MEDICAL BOARD

MEDICAL BOARD

AND

EMPLOYEES

......

1959
32nd Annual Report
HILLSIDE HOSPITAL
Glen Oaks, Queens, N.Y.

�______WHM._.._»

This is my ﬁfth and last annual report
as President of the Board of Trustees of
Hillside Hospital, and I am happy indeed
to be able to state that during this last
L.
Robbins
Lewis
Dr.
of
service,
my
year
has become Medical Director of the Hospital. His broad gauged plans have been
submitted to our Board, and accepted for
the future development and general planning of the treatment, teaching and research programs of the Hospital.
There have been many changes here at
Hillside since the death of our founder,
Dr. Israel Strauss in 1955, and my election as the second president. I am confident that the original ambitions of our
founder to improve treatment, to instruct
as many as we can, and above all to attempt to really learn the “why” and
“what” of mental illness have been
furthered. I believe that my able successor, D. Herbert Beskind, will follow these
same general pathways.
During this past year, among other interesting incidents, may be mentioned the
adoption by Hillside of the personnel
policy of the Greater New York Hospital
Association, the conversion of our insulin
recovery dormitory into offices and conference rooms for research, and the raising of the basic rate of compensation by
New York City from $16.00 to $20.00 per
day. Costs continue their unbroken upward course, and the day of the “lowcost” hospital seems doomed. Adequate
service combined with low cost appears
to be a paradox.
The need for additional buildings is,
of course, generally present with most
progressive hospitals, and we are no exception. During this year it has become
apparent that we simply must have an
Activities Therapy Building, since we just

do not have enough room for our patients
in the present quarters; and a specialized
research building is really necessary since
research is so obviously demanded to improve treatment results. Both of these
buildings will, hopefully, begin construction in 1960. We have been granted
$125,000 from the estate of our former

Trustee, Edwin Elson, for the Activities
Therapy Building; and we have been able
to match this amount with a grant of
$150,000 from the United States Public
Health Service, for a research building.
An incidental, but most important effect
of the construction of these buildings will
be to create space which may be used for
critically needed living-in quarters for
our personnel. Such quarters will improve
the well-being of our staff, something
which has always been of great importance to us.
Dr. Joseph S. A. Miller, our former
Medical Director, resigned during 1959
with plans to enter private practice; he
continues, fortunately, to serve the hospital as a consultant and teacher. We all
wish him every success in the years to
come.

In closing this, my last report, I wish
to refer to two principles affecting com—
munity activities which to me seem important. One that has guided me in my
own decisions, is that it is important to
rotate top board ofﬁcers. Such action not

REPORT OF THE
PRESIDENT
OF THE HOSPITAL

Alvin E. Coleman

only affords opportunity to more individuals 'to serve, more variety in ideas, but
probably, more efﬁciency, on the basis of
the old adage that “a new broom sweeps

clean”!

The second principle is possibly more
important since it refers to the motivation
of why “we seek to serve.” Laymen who
donate their time and thought to community affairs do so, of course, to be of
service to those less fortunate than themselves. However, an important additional
motive is the gain of ego gratiﬁcation from
having a controlling part in decisions vital
to their institution. Such emotions bring
satisfaction to us, and are no doubt an
important part of the broader life. It is
this drive which makes the boards of or—
ganizations so effective, and I believe that
the autonomy of each board of each organization is absolutely essential to maintain
this effectiveness. It seems to me that any
serious interference with this autonomy
would greatly weaken organizational actions, would make board memberships a
mere fiction, and would soon cause board
members to lose interest and drop active
participation in institutional activities.
This would be calamitous.
It is with mixed emotions that I pass
along the gavel of leadership. Mine is not
only a sense of great satisfaction and
pride in having been able to serve such an
outstanding institution, but also is a feeling of humility at the vastness of the
horizon and the smallness of the job accomplished thus far. May I express my
deep appreciation and friendship to the
professionals of the hopsital, and to the
members of the Board of Trustees who
have worked with me and so greatly
helped me, and with whom it has been a
privilege and a pleasure to serve.

�OFFICERS‘

President

Alvin E. Coleman
Chairman of the Board
Roy Foster
Honorary Chairman of the

Board
Leon Lowenstein
Vice Presidents

Dudley Shoenfeld, M.D.
D. Herbert Beskind
George W. Galinger

Secretary

Manuel Lee Robbins

Assistant Secretaries
A. Jacob Abrams
M. Victor Leventritt
Treasurer

David Finn
Roy Foster
George W. Galinger

Assistant Treasurer
Arthur Garson
Members:
A. Jacob Abrams
Jonas Adler
Alfred Appel

Meyer Goldstein

Arnold S. Askin

Arnold S. Askin
John M. Bendheim
D. Herbert Beskind
David Bunim
Alvin E. Coleman
Martin Coleman
Morris David
Thomas Epstein

Arthur

C.

Fatt

David Finkle

Arthur Gar-son
Maurice Glinert

Jacob Epstein Katz
Carl L. Kempner
Harold P. Kurzman
M. Victor Leventritt

Budd Levinson
Morris L. Levinson
Milton B. Loeb
Sandor Lorand, M.D.
Leon Lowenstein
Charles H. Meyer

Arthur Murray

Charles Revson
Manuel Lee Robbins
Irving Rosenbaum
S. H. Scheuer
Walter Scheuer
Dudley D. Shoenfeld, M.D.
Harry Silverson
John W. Straus
Irving Weisglass
Nathan Wigod
Morton S. Wolf
Walter D. Yankauer

Morton S. Wolf
Walter D. Yankauer
CHAIRMEN OF STANDING
COMMITTEES

Executive Committee
Roy Foster
Medical Affairs Committee
D. Herbert Beskind
Finance Committee
Arnold S. Askin
House &amp; Grounds Committee
George W. Galinger
Nathan Wigod

Legal Committee
Charles H. Meyer
Social Service Committee
Hilda N. Strauss,
Honorary Chairman
M. Victor Leventritt,
Chairman
Personnel Committee
Meyer Goldstein
Nominating Committee
Walter Yankauer
Gifts Jr Legacies Committee
Walter Yankauer
Committee On Administrative
Savings
Arnold S. Askin
Building Committee
D. Herbert Beskind,
George W. Galinger,
‘As a/ Novenlber 15, 1959

Honorary Trustees:
Saul Blickman
Hilda N. Strauss
Executive Committee

Members
Arnold S. Askin
D. Herbert Beskind
Alvin E. Coleman

Arthur C. Fatt
Roy Foster

George W. Galinger

M. Victor Leventritt

Leon Lowenstein
Charles H. Meyer
Manuel Lee Robbins
S. H. Scheuer
Dudley D. Shoenfeld M.D.

SOCIETY
OF THE
HILLSIDE
HOSPITAL
BOARD OF

TRUSTEES

A4.

‘,..

A

�The function of an annual report is to
look backward brieﬂy in order to assess
how well one is looking ahead. Much that
took place during this past year indicates
that Hillside Hospital has been making
steady progress toward achieving the best
clinical program that current knowledge
permits in order to provide a base for
achieving its research and training goals.
During the year, the staff was reorgan—
ized into sections consisting of members
of each of the professional disciplines:

phychiatry, psychology, social work,

activities therapies, and psychiatric nursing—and each section was given responsibility for all the patients living in a
particular ward and/or cottage. The patients are no longer being transferred
from one living area to another; they now
remain in contact with the same personnel
throughout the length of their hospital
stay. This plan permits the members of
the staff assigned to each section to integrate and co-ordinate their efforts much
more effectively, thus further facilitating
our goal of individualizing treatment.
Through administrative changes in our
intake procedures, we have eliminated our
long waiting list, making it possible for
many patients to enter the hospital within
twenty-four to forty-eight hours. All patients who are approved are admitted
within two weeks.
At the end of the year, Hillside Hospital
was ofﬁcially approved by the Central
Inspection Board of the American Psychiatric Association and by the Joint Commission on Accreditation of Hospitals.
These organizations regularly inspect
psychiatric hospitals to insure the maintenance of high levels of patient care. The
detailed report of their inspection indicated that, on all counts, our treatment
program, staff and physical plant met
their higher standards.
In April of this year the Children’s
Out-Patient Clinic was opened and is now
in full operation. In addition to providing

treatment for disturbed children and

their parents, this clinic offers supervised
experience in child psychiatry for psychiatrists practicing in the community, as
well as for physicians in our residency
training program. This additional clinical
activity will also serve as an important
part of future research.
Hillside Hospital has long accepted its
responsibilities for training psychiatric
personnel. In July, we increased the number of psychiatric residents in training
from eighteen to twenty-ﬁve and have
developed an educational program to
teach residents in each of the three years
of residency. In addition, training beyond
the residency level is being added for psychiatrists in the hospital as well as in our
out-patient clinics. During 1959, the Nursing Department instructed students from
several hospitals and nursing schools.
The Psychology Department provided
instruction in Vocational Counseling;
Occupational Therapy had students from
Columbia University; the Department of
Social Services maintained its training
programs with the New York School of
Social Work and with Adelphi College.
The Department of Experimental Psychiatry has been providing research training in connection with the psychiatric
residency. All these and other departments have been most active in many
aspects of training, further details of
which follow.
Above all, the staff of Hillside Hospital
has continued its interest in advancing
our knowledge through research. A list
of numerous presentations and publications indicating research being done at

REPORT OF
THE MEDICAL
DIRECTOR
Lewis

L.

Robbins, M.D.

Hillside is included in this report. It
should be noted that it is our determined
philosophy to carry out investigations in
all these three areas; psychology, biology
and sociology and to share our ﬁndings
with others in the hope that much-needed
advances in our ﬁeld can be achieved. It
is also gratifying to ﬁnd our judgments
about the value of our research activities
and the competence of our research staff
conﬁrmed by several foundations and
other agencies. Among those which have
generously supported our research programs are the Nassau County Commu-

nity Mental Health Board and the

National Institutes of Mental Health.
Numerous other developments have
taken place during the past year. We have
altered our former insulin unit to provide
class rooms, conference rooms, a one-way
viewing room, and ofﬁces. We have inaugurated a careful study of all of our
physical facilities in order to meet our
developing needs. Our volunteer program
has been considerably augmented and
staff has been added in several departments to further beneﬁt our patients.
Co-operative programs with Long Island
Jewish Hospital have added to both our
treatment and training programs and
give promise of valuable further collaborative activity.
All that has been accomplished during
the past year has been based on the ﬁne
work of many people over many years.
Outstanding have been the contributions
of Dr. Joseph S. A. Miller, who after
many years of distinguished service,
retired in August from the position of
Medical Director. To him, and to all the
staff, past and present, the writer is
indebted for providing such a solid base
on which to build our future. Also, to the
Medical Board and to the leadership of
its President, Dr. Robert A. Savitt; and
to the Board of Trustees which, under the
leadership of its President, Alvin E. Coleman, has given advice and support—~the
writer is gratefully indebted.

�ADMINISTRATION

Medical Director
Joseph S. A. Miller, M.D.*
Lewis L. Robbins, M.D.
Associate Medical Director
Simon Kwalwasser, M.D.

Administrator
Maurice Bachrach, B.S.
Assistant Administrator

Samuel Davis, B.A., M.S.

STAFF PSYCHIATRISTS

William Benjamin, M.D.
Muriel Benton, M.D.

Calvin Cheek, M.D.
David Graubert, M.D.
Henry Lefkowits, M.D.
Zenos M. Linnell, M.D.
Gerhard Schauer, M.D.
Barbara Ure, M.D.
Morton Wachspress, M.D.
George Yessin, M.D.

PROFESSIONAL DEPARTMENT
HEADS

Creative Therapy
Ernest Zierer, Ph.D., Director
Edith Zierer, Ass ’t Director
Experimental Psychiatry
Maximillian Fink, M.D.,
Director

Internal Medicine

Arnold Blumberg, M.D.,
Director
Israel Strauss Pavilion for
Adolescent Girls
Alice Slater Stahl, M.D.,
Director

Laboratories
Harry Goldenberg, Ph.D.,
Director
John Croghan, R.T., M.T.,
Supervisor
Nursing
Goldie Krupa, R.N., Director
Nancy J eﬁries, R.N.,
Assistant Director
Occupational Therapy
Eileen Fisher, B.S., Director
Out-Patient Services
Robert R. Luttrell, M.D.,
Director
Harvey Goldey, M.D.,
Assistant Director
Robert Navarre, M.D.,
Assistant Director
Aaron D. Weiner, M.D.,
Director
Child Therapy Unit

Psychology
Abraham Levine, Ph.D.,
Director
Social Services
Abraham Lurie, M.S.S.W.,
Director
Louise Pinsky, M.S.S.W.,
Assistant Director,
Case Work Division
Arnold Eisen, M.S.S.W.,
Assistant Director,
Group Work Division
CLINICAL ASSISTANTS

Lester I. Abend, M.D.
Edward R. Adelson, M.D.
Romano Antonelli, M.D.
Marion Axel, M.D.
Howard Boskey, M.D.
Stanley Brodsky, M.D.
Daniel Chansky, M.D.
Fred B. Charatan, M.D.
Lionel Chertoﬂ’, M.D.
Ralph W. Clemments, M.D.
Frances Colonna, M.D.
Stefano Fajrajzen, M.D.
Irving J. Farber, M.D.
Philip Friedland, M.D.
Ruth Fuchs, M.D.
Harold Galef, M.D.
Harvey Goldey, M.D.
Sumner I. Goldstein, M.D.
Clara Gonda, M.D.
Eugene Glynn, MD: Director
Adolescent After-Care Unit

Lebert Harris, M.D.
Martin Hurvitz, M.D.
Gunthar Jacob, M.D.
Norman Levy, M.D.
Zenos Linnell, M.D.
Buck Luria, M.D.
Howard Mele, M.D.
Daniel Miller, M.D.

Meyer Monchek, M.D.
Beatric Nachtigal, M.D.
Maurice Nadelman, M.D.
Iris Orens, M.D.
Joseph D. Rosen, M.D.
J ehuda Rozanski, M.D.
Leon Tec, M.D.
David M. Tillim, M.D.
Clara Torda, M.D.

PSYCHIATRIC RESIDENTS

Bruno Bellinfante, M.D.
Reva Berstock, M.D.
Richard Brown, M.D.
Sevin Eker, M.D.
Richard Frenkel, M.D.
Robert Glauboch, M.D.
Feridun Gunduy, M.D.
Halldor Hansen, M.D.

Harry Gonda, M.D.
Paul Hansch, M.D.

PROFESSIONAL
AND
ADMINISTRATIVE

STAFF
MEMBERS

Sherwin Harris, M.D.
Raymond Hollander, M.D.

John Kramer, M.D.
Leslie Langlois, M.D.
Jay Lefer, M.D.
Genesia Liu, M.D.
Dorothy Lieberman, M.D.
Harvey Mandel, M.D.
Mark N essel, M.D.
Richard Resnick, M.D.
Alvaro Rozo, M.D.
Mollie Schildkrout, M.D.
Jack Schnee, M.D.
David Steinman, M.D.
Michael Trupp, M.D.
Shirley Wallach, M.D.
Daniel Weitzner, M.D.
ADMINISTRATIVE
DEPARTMENT HEADS

Accounting Services
Dorothy Croghan
Buildings cf Grounds
Thomas R. Lumley
Dietary Services
Angelina Canavan, B.A.
Housekeeping
Sarah Travers
Oﬁ‘ice Services
Lillian Dailey
’Resigned I959

��The function of the Hillside Hospital InPatient Service is to provide treatment to
patients suffering from the early and
curable symptoms of mental illness. It is
not the intention of Hillside Hospital to
meet the overwhelming need of the com—
munity for psychiatric treatment facilities. Limitations of funds and the inability
to provide an expansive treatment pro—
gram compatible with the Hospital’s
training and research goals make limitation of the number of in-patients necestherathe
if
be
the
This
case
must
sary.
peutic community is to be a real treatment modality. It is therefore our purpose to provide a treatment program
which is consistent with Hillside Hospital’s image of itself as a pilot institution
in the field of mental health.
Basic to the treatment of patients at
Hillside Hospital is a concept of the
therapeutic community. The effective relationships between patients and staff,
as well as those between patients themselves is a basic element of the treatment
program. Moving psychiatric patients
from nursing unit to nursing unit, as
their conditions improved, meant changed
relationships as each move was made. This
structure did not provide the best therapeutic situation for our patients. Therefore, in 1959, it was decided to reorganize
the treatment service on the premise that
patients remain in the units to which they
are admitted throughout their entire hospital stay. This arrangement provides
further advantages to the treatment program. Not only are staff psychiatrists,
psychiatric residents and nursing person-

nel able to develop sustained relationships
as a therapeutic team, but the patients
are also able to develop such relationships
with each other, without having to face
the problems associated with a constantly
’s
patient
environment.
Further,
changing
self—government is stabilized by this arrangement. Finally, the entire administrative organization of the hospital has
been facilitated by this organizational
change in that sustained accountability
for the total treatment program is now
possible.
In connection with this reorganization,
several signiﬁcant changes took place
within the Nursing Service during 1959.
Provision of adequate nursing care within the revised organization required the
restructuring of staffing patterns. A major segment of the nursing service was
reassigned to provide the equal distribution of technical, semi-professional and
professional nursing skills to all patient
units. In the effort to improve staffing
patterns, two new personnel categories
were created in 1959—Counselor and
Senior Psychiatric Aide.
As a result of changes in the hospital
treatment program, there have been corresponding changes in the assignment of
the case work staff of the Social Services

TREATMENT
TRAl N l N

RES EA

Department. Two psychiatric social workers are now assigned to each administrative unit. It is now possible to co-ordinate
work—
social
the
of
work
the
closely
more
ers with the work of other members of
the team. The casework division has been
making increasing use of group counselling. The group approach is now used
by the case work in the Hillside Hospital After-Care Clinic. Social workers who
function in connection with the InoPatient
Service are supplementing individual
contacts with visits with patient ’s relatives with group counselling.
The admissions policy of the hospital
in
radically
and
reviewed
changed
was
1959. By making it possible to accept
appointments for patients applying for
admission during any week day, the delay in accepting patients has been drastically reduced. In addition, excessive
waiting lists for in-patient admission have
been virtually eliminated through the
efforts of the Social Work Division, and
the staff psychiatrists. Assessment of patient suitability for admission and rapid
processing of patients who are accepted
for admission is now possible.
1959 saw further expansion of the
services of the Group Work Division of
the Social Services Department in the
provision of additional social and recreational facilities to the in-patient group.
Patient government, social clubs, service
groups, special interest groups and the
the
from
comvolunteers
for
program
munity were considerably expanded.

�The Psychology Department in 1959
continued its program of diagnostic evaluation of the patient, in keeping with its
function within the treatment team. The
Vocational Counselling Unit of the Psychology Department continued to provide

vocational counselling, training and
placement services to our patients. The
Vocational Counselling Unit joined with
the Group Work Division in 1959, in the
establishment of a secretarial skills program which was taught to patients by
volunteers.
The Occupational Therapy Department
saw marked growth in 1959. To enable
this department to treat the entire patient population and to eliminate waiting
lists for this service, the staff was increased from ﬁve to twelve therapists.
This permitted more intensive function
by occupational therapists in the therapeutic team. Further, a high level of
individualized occupational therapy is
now possible. An Art Therapy program
was also inaugurated in 1959. The Creative Therapy Department continues to
perform its dual function as a diagnostic
and therapeutic unit.

_

Nonpsychiatric medical needs of Hillside Hospital patients are met through
the Intramural Clinic. The Hospital Internist participates in initial and dis—
charge conferences concerning patients
whose physical problems are signiﬁcant
in the planning of the total therapeutic
program. Consultants in every branch of
medicine give freely of their time to the
support of patient care. Further, the
services and facilities of the Long Island
Jewish Hospital are utilized wherever
indicated. An excellent Dental Unit is
also provided to meet the particular dental needs of the mentally ill patients. This
latter clinic is also fully staffed by dentists who serve voluntarily.
The Hillside Hospital Out-Patient Department provides psychiatric care to
residents of Queens, Nassau and Suffolk
Counties who cannot pay for private
psychiatric care. In 1959 an average of
over one hundred persons were treated
each week. In addition to individual
psychotherapy, three group psychotherapy programs were established. 1959 also
saw the staffing pattern of this clinic improved by the addition of more highly
qualiﬁed doctors to insure the provision
of a treatment program consonant with
the goals of the Hospital. The out-patient
selection process, too, was revised to
afford immediate consultation Within
twenty-four to forty-eight hours for all
applicants.
On April 1, 1959, the Child Therapy
Unit of Hillside Hospital Out-Patient
Department was opened with the help of
a grant from the Nassau County Mental

Health Board. A pilot project in the provision of psychotherapy for children, this
clinic is further intended to provide the
base for the expansion of future child
care services at Hillside Hospital. The
staff of the Child Therapy Unit consists
of a psychiatrist in-charge, three clinical
assistant psychiatrists, a psychologist
and a social worker. Major emphasis is
given to therapy or guidance for parents
of children under treatment. Such treatment is usually focused on considering
the parents’ reaction to the child’s prob—
lems, or the parents’ role in the origin
of the difﬁculty. In the nine months of
1959 during which this clinic was in
operation, forty children plus their parents were seen in complete diagnostic
evaluation. Fifteen children and their
parents were accepted for treatment in
this facility.
A variety of after-care services have
been developed for Hillside Hospital’s
former patients. The Foster Home Care
Project with the Jewish Community
Services of Long Island; the After-Care
Clinic which is part of our own Out-Patient service and is provided at Mt. Sinai
Hospital; a supportive social case work
service with the Jewish Family Services
of New York; and a rehabilitation center,
“The Bridge,” which provides a resocialization program and supports the
Hilda and Israel Strauss League of former patients.

�x»

�The need for well-trained personnel in
the ﬁeld of psychiatry cannot be overstated. Recent years have seen the devel—
oping awareness of the assistance which
psychiatric knowledge can bring to the
broad spectrum of human problems. All
of the specialties of medicine are becoming
increasingly aware of the psychiatric elements in the etiology and treatment of
physical disease. In the ﬁeld of public
health, education, and welfare, psychiatry
is playing a role of ever increasing importance. Further, public acceptance of the
practice of psychiatry and the advances
made in this ﬁeld make mandatory the
provision of suﬂicient personnel to meet
the nation ’s mental health needs.
Hillside Hospital, because of its relatively small size and carefully selected
patient population, is ideally suited to
develop and share psychiatric knowledge.
In accepting its responsibilities for the
training of psychiatric personnel, Hillside Hospital is helping to meet the need
not only for trained psychiatrists, but
also for related professional personnel in
the ﬁeld of mental health.
In order to meet the increased need for
psychiatrists, Hillside Hospital expanded
its teaching program in 1959. The number
of psychiatrists in training was increased
from eighteen to twenty-ﬁve in a teaching
program that is expected to require three
years for completion. The residency pro—

gram itself was improved by the inclusion
of training in out-patient care and in
research.
Historically, the In-Patient Service of
Hillside Hospital has not only provided
quality patient care, but has also afforded
the means for the training of psychiatric
staff. The reorganization of the treatment
service in 1959 provided for better patient
care. The development of discreet administrative patient units affords the psychiatrist in training an opportunity to
develop sound therapeutic relationships
with an integral patient group. Furthermore, this arrangement allows the development of equally sound relationships
between resident and supervising psychiatrists, resident and nursing staff, and
resident and activities therapist, thus providing not only a good therapeutic milieu,
but a more salutary training milieu.

TREATMENT
TRAINING

RESEARCH

To provide for the training of psychi-

atric residents in the treatment of other
than the hospitalized patients, the OutPatient Department now provides the
resident with a learning experience which
is similar to that which the psychiatrist
has in his ofﬁce practice. This program,
which was initiated in 1959, provides for
the training of ﬁve psychiatric residents,
who function part time during the third
year of their psychiatric residency. Supervision by the Director of the Out—Patient
Department and members of his staff
obtains in planned individual and group

conferences.
To provide for the development of increased knowledge and skills by practicing psychiatrists in the local community,
a planned program has been developed.
Clinical assistants who are actively in the
practice of psychiatry, receive further
training under the supervision of the Director of the Out-Patient Department and
members of the attending staff.
The Child Therapy Unit which was
initiated in 1959, also serves a signiﬁcant
additional training function for practicing psychiatrists in the community. Three
clinical assistants, who spend half their
time in this clinic, receive individual
supervision as a function of the Director
of the Child Therapy Unit and from other
highly trained psychiatrists. Clinical conferences, seminars and reading conferences, team meetings, planning conferences and psychiatric staff conferences
provide further for the teaching program.

���Research at Hillside Hospital in 1959 was
carried out not only in three departments
whose function lies primarily with re—
search, but in addition, clinical studies
were carried out by individuals of various
professional departments.
EXPERIMENTAL PSYCHIATRY

The study program in the Department
of Experimental Psychiatry increasingly
focused on the drug treatment process.
Based on an extensive experience with
newer drugs for mental illness, a detailed
drug evaluation study was started in
the fall. The selection of treatment, and
behavioral, psychiatric, psychologic, neurophysiologic and sociologic aspects of
change are being investigated. These examinations are undertaken to learn how
drugs inﬂuence mentally ill patients, and
to test a theory developed in this Department in 1956. In this theory, drugs are
seen to affect behavior by changing both
brain function and the psychologic attitudes of subjects.
In the experimental psychology studies,
increasing emphasis has been placed on
individual differences in perceptual and
cognitive behavior as related to the type
of behavioral response with treatment.
Study of these indices as predictors of
change in addition to the usual use of
indices of the effects of the treatment has
demonstrated signiﬁcant relationships.
The introduction of an electronic frequency analyzer of the Ulett-Loeffel type

in August, 1959—a device to rapidly
measure the various electrical waves
recorded from the brain—signiﬁcantly
expanded the electro-encephalographic
14

program. An analysis of changes in the
various patterns in the EEG made possible the critical and more precise determination of neurophysiologic effects of
various drugs. During the year, 404 records were recorded, and of these, 59 were
clinical consultation requests.
The sociologic programs undertook an
analysis of the differences in patient attitude to treatment of the various staff
groups, as the resident doctors, nurses,
social workers, etc. ; tolerance of the staff
for different types of emotional upset
and referral for somatic treatment; and
changes in the Hillside Hospital patient
population between 1957 and 1959. In
order to understand the relation of social
factors to the treatment of mental illness,
an elaborate tri-hospital study comparing
sociologic characteristics, treatment referral rates and discharge ratings in the
Menninger Foundation, the Massachus—
sets Mental Health Center and Hillside
Hospital was begun.

TREATMENT
TRAINING

RESEARCH

In language studies—an area that is
receiving increased attention in psychiatry—the staff organized and participated in a unique seminar at the New

York Divisional Meeting of the American
Psychiatric Association. Various psycholinguistic experts employing their individual methods of study, analyzed two
tapes of an analytic treatment, and compared their results. They showed the value
of combined methods in providing an
objective measure of the psychotherapy
process.
Eighteen reports were published during the year and eleven papers were presented before the national societies. The
staff was instrumental in the organization
of the New York Divisional Meeting of
the American Psychiatric Association,
and presented reports at four of its symposia. The staff also participated in the
International Conference on Depression
and Allied States that was held in March
in Montreal.
Changes in staff during the year included the appointment of George Krauthamer, Ph.D. as neurophysiologist, and
Donald F. Klein, MD. as psychiatrist to
the Department. Dr.' Robert L. Kahn,
after ﬁve years of service, left to assume
the position of Head of the Section of
Psychology, Division of Psychiatry of
Monteﬁore Hospital. Dr. Joseph Jaffe,
while continuing as an Associate in Research in this department, assumed the
position of Faculty Member and Associate
Director of Research of the William Alanson White Institute.

�Continuing support for the program
was obtained from the Board of Trustees,
extensive program support from the National Institute of Mental Health of the
United States Public Health Service, and
with grants from the Mental Health
Board of Nassau County.
BIOCHEMICAL RESEARCH

Biochemical research was focused on aromatic substances in the urine of psychiatric patients and on the metabolism of the
newer psychotropic and hallucinogenic
drugs. For many years, the possibility
that psychiatric patients excrete compounds not present in normal subjects
has provided the basis for special studies.
This program analyzes urine samples for
a wide range of chemical substances which
are similar to known hormones. It attempts to determine whether psychiatric

patients from Hillside Hospital and

Creedmoor State Hospital differ from
normal subjects.
With the widespread use of new drugs
in psychiatry, it has been important to
determine the way these compounds affect
metabolism. One program has been devoted to tracing the changes which chlorpromazine undergoes in the body. For
this study, special techniques of analysis
for chlorpromazine derivatives have been
developed. The focus now is in relating
the kinds of derivatives and the rate with
which they are produced to their clinical
effects.

The metabolites of adrenalin are the
object of another study with the Medical
Department. In patients receiving the
Mecholyl Test, urine samples are analyzed
before and after the test for various derivatives of adrenalin. Blood studies to
determine the enzymes responsible for
changing adrenalin are in progress. Recently, a special colorimetric technique
for O-methyl transferase was developed.
In experimental animals, as well as in
the laboratory, the metabolism of hallucinogenes has been studied. Derivatives of
lysergic acid related to the vitamin B
complex and have been produced and are
being tested for hallucinogenic activity
and metabolic pathways.
MEDICAL RESEARCH

The major efforts of medical research in
1959 continued to be directed toward an
understanding of the mechanism of the
Mecholyl Test. The reliability of the
Mecholyl Test, using newly developed
equipment for recording blood pressure,
ﬁrst was undertaken. These studies demonstrated that the two initial readings of
the test were reliable measures. They, furthermore, established the limits of change
in the test as a basis for continued studies.
In addition, in co-operation with the Biochemistry Department, a study of the
relation of metabolites of adrenalin to
this test was begun. In the drug evaluation program, the Medical Department
assumed control of new medications and
of a variety of physiological tests. These
included the electrocardiogram and liver
and thyroid function studies, as well as
the Mecholyl Test.

CLINICAL STUDIES

A study of the factors affecting the
selection of somatic treatment, Drs. A.

Kaplan and H. Lefkowits noted that the
recommendations for special treatment
were as often based on extra medical factors as on the type of behavior of the
patient. They described various degrees
of symptoms and tolerances for different

behaviors.
In the Out-Patient Department, Dr. R.
Luttrell and his staff have been interested
in the prognostic factors in selecting pa-

tients for Out-Patient Department treat-

ment.
Mr. Lurie and Miss Pinsky of the Social
Service Department have done a follow-up
study of Hillside Hospital patients who
have been referred to The Foster Care
Program. The results of this study have
been gratifying in terms of the evaluation
of the program and of the indication of
future direction.
In clinical psychology a special study
of the psychological characteristics of
post-partum depressive reactions was

instituted.
Toward the end of 1959, an extensive
review of the Pavilion for Adolescent
Girls, a pilot program in this ﬁeld, was
prepared for publication in the ensuing
year.

I5

�efforts of the
Hillside Hospital staff in the
area of research will be seen in
the following listing of
publications and presentations.
BLUMBERG, A.—Use of
An Automatic
Sphygmomanometer in the
Mecholyl Test,
Journal of Hillside Hospital,
Vol. 8, #3, pp 179,
An index of the

July, 1959

BLUMBEEG, A., ROSETT,
and DOBROW, A.—Severe

Holland, Amsterdam,
pp. 238-239
PINK, M. KAHN, R.L. and
KORIN, H.—Therapy of
Schizophrenia: Role of
Alteration of Brain Function
on Behavior, Congress
Reports, II Int. Cong.

Psychiatry,

II:

492-493

and
KORIN, H.—Relation of Tests
of Altered Brain Function to
Behavioral Change Following

FINK, M. KAHN, R.L.

In’duced Convulsions,

The First International
Congress of Neurological
Sciences (III: EEG, Clinical
of Internal Medicine, Vol 51, Neurophysiology and
#3, pp 607, September, 1959 Epilepsy), Pergamon,
613-619
London,
M.——Effect
pp.
of
an
PINK,
Anticholinergic Agent,
PINK, M.——EEG and
Behavioral Effects of
Diethazine, on EEG and
Tofranil, International
Behavior; Signiﬁcance for
Conference on Depression
Theory of Convulsive
and Allied States, Montreal
Therapy. Biological
Psychiatry, ed. Masserman, PINK, M.—Language
J ., Grune and Stratton, N. Y. Patterns as Measures of
pp. 184—194
Behavioral and
Neurophysiologic Change,
rINK, M.—Alteration of
Brain Function in Therapy. American Psychiatric
Association, Philadelphia
Psychopharmacology
Frontiers, ed. Kline, N.,
FISHMAN-GOLDENBERG,
Little, Brown 85 00., Boston, v., SPOERRI, mar—Coloripp. 325-332
metric Determination of
Dicarbozylic Acid
rINK, M.——Signiﬁcance of
Derivatives as Hydroxamic
EEG Pattern Changes in
Acids, Anal. Chem. 31:
Psychopharmacology. EEG
Clin. N europhysiol. 2:
1735, 1959.

Hypotensive Reactions
to Overdosage of
MeprobamatHThe Annals

398 (abst.)
rINK, M.—Electro-

encephalographic and
Behavioral Effects of
Tofranil. Canad. Psych.

Assoc. J. 4: 1668-1718
rINK, M. KAHN, R.L. and

GOLDENBERG, 11., FISHMAN, v.,
WHIT’I‘IER, J., BRINI'EZER, W.

—Urinary Aromatic
Excretion Patterns in
Schizophrenia A.M.A.
Arch Gen. Psychiat., in press
GOLDENBERG, H, WHITE,

D.L.--

Colorimetric Determination
Factors Affecting Individual of O-Methyl Transferase.
Diﬁerences in Behavioral
Presented at the 126th
Response to Convulsive
Meeting of the American
Association for the
Therapy, J .N .M.D. 128:
243-248
Advancement of Science,
1959
December
27,
Chicago,
and
R.L.
M.
KAHN,
PINK,
KORIN, H.—Eﬂ’ects of Diffuse GOLDENBERo, H., FISHMAN, v.
Altered Brain Function on
—Chromatographic Studies
Perception. Proc. X V Int.
of Chlorpromazine Metabolism in Man. Presented at
the 126th Meeting of the
American Association for
the Advancement of Science,
Chicago, Dec. 27, 1959

POLLACK, M.—-—Psychologica1

of
Threshold and Duration of Social Attitude to Psychiatric
Seizures to Degree of EEG
Treatment, N.Y. Divisional
Meeting, A.P.A., New York
Delta Activity Induced
During Electroshock, EEG.
KAHN, R. L., with WEINSTEIN,
Clin. N curophysiol. 2:
E. A. and BERGMAN, P.——Effect
(Abst.)
of Electroconvulsive
Therapy on Intractable Pain.
JAFFE, J.—-—Communication
A.M.A. Arch. Neurol. and
Networks in Freud’s
Psychiat. 81 : 37-42
Interview Technique,
Psych. Quat. 32: 456-473
KAHN, R. L., with WEINSTEIN,
E. A.——Symbolic ReorganizaJAFFE, J.——Symposium on
‘‘
tion in Brain Injuries, in
Psycholinguistic Analysis
Handbook of Psychiatry, ed.
of the Psychiatric
Interview ’ ’, Divisional
Arieti, S. Basic Books,
N. Y., Vol. I, pp. 964-981
Meeting, A.P.A. New York
KARP, E.—Behavioral Changes
JAF‘FE, J.——Social Backwith Different Methods of
ground and the DoctorPatient Relationship, Acad. Induced Cerebral Dysfunction, Eastern
Psychoanalysis, New York
Psychological Association,
KAHN, R.L. and BLACK, M.—
Atlantic
City
of
Application
Prognostic
Psychological Techniques in KORIN, H. and FINK, M.—
The role of Set in the
Convulsive Therapy,
Dis. N erv. Sys. 30: 180-184 Perception of Simultaneous
A.
Tactile
Jour,
Stimuli,
and
R.
POLLACK,
M.,
L.,
KAHN,
384-392
72:
Psychol.
M.—Sociopsychologic
FINK,
KRAUTHAMER, G.—Form
Aspects of Psychiatric
Perception Across Sensory
Treatment in a Voluntary
Mental Hospital; Duration Modalities, Am. Psychol. 14 :
of Hospitalization, Discharge 396 (Abst.)
Ratings and Diagnosis,
KRAU’I‘KAMER, G.———Personality
A.M.A. Arch. Gen. Psychiat. Correlates of EEG,
1 : 565-574
Metropolitan EEG Society,
New York
KAHN, R. L., and PINK, M.—
Personality Factors in
LEVINE, A.—A Comparative
Behavioral Response to
Evaluation of Latent and
Electroshock Therapy,
Overt Schizophrenic Patients
J. Neuropsychiatry 1: 45-49 with Respect to the Concept
KAHN, R. L.—Socioof Ego Strength. Journal
psychologic Factors
of Hillside Hospital, VIII,
Affecting Therapist-Patient No. 4, Oct. 1959, pp. 243-266
Relationships, American
LEVINE, A.—“App1'aising
Academy of Psychoanalysis, ego-strength from the
Philadelphia
projective test battery”
KAHN, R. L.—Socio——Society for
psychologic Aspects of
Projective Techniques,
Psychiatric Treatment,
New York, May 1959
Eastern Psychological
Association, Atlantic City

Cong. Psychol., Publ. North- GREEN, M.—Relationship of

KAHN, R. L.—Re1ation

STAFF
PUBLICATIONS
AND

.

.

16
.m_............,,....

PRESENTATIONS

LEVY,

E.—The Role of the

Volunteer In The Treatment
Program of a Mental
Hospital, Social Work with
Groups, 1959, (New York
Natl. Assoc. of Social
Workers), pp 109-119
LURIE, A., HIRSCH,

8.—

Establishing a Hospital
Social Service Department,
Journal of Social Work
(Vol. IV, No. 2—April 1959)
‘
A.-—‘
Structure of
LURIE,
Field Work Training”

Workshop, Council on Social
Work Education,

Philadelphia, Pa.,
January, 1959
LURIE, A.—“The Use of
Group Process Within
Medical Settings”. National
Conference of Jewish
Communal Service,
Pittsburgh, Pa., May 1959

‘Forecasting the
Place and Role of the Aging
in our Society during the
next decade”. Little White
House Conference on Aging,
sponsored by the Community
Council of Greater New York,
LURIE,

A.——‘

December 1959
POLLACK, M.—Effect of
Induced Cerebral Dysfunction in Man on
Tachistoscopic Perception of
Embedded Color Figures,
Eastern Psychologic
Association. Atlantic City

POLLACK, M. with BENDER,
M. B., and BATTERSBY, W. s.—

Complex Visual Perception

in Patients with Brain
Tumor. Proc. XV Int. Cong.
Psychol., Publ. NorthHolland, Amsterdam,
pp. 236-237
POLLACK, M.~—‘ ‘ Comparison
of Intellectual Functioning
in Childhood,” Adolescent
and Schizophrenics, N. Y.
Divisional Meeting, A.P.A.,
New York
STAHL, ALICE—”The Role of
the Psychiatrist in the
Adolescent Pavilion. ’ ’
Midwinter Divisional
Meeting of A.P.A.

��The past years has been one in which the
Medical Board has shared in the period
of transition now in progress at Hillside
Hospital. Acting in an advisory and consultative capacity, the Board has aided
the Medical Director and the Board of
Trustees in bringing into sharp focus the
aims and aspirations of Hillside Hospital :
to become a leading center for psychiatric
treatment, training and research.
In keeping with the current spirit of
transition at Hillside Hospital, the Medical Board has done considerable soul
searching in order to reappraise its role
in the affairs of the hospital. The Board
is comprised of people who are outstanding in the ﬁelds of psychiatry and psychoanalysis. Some of its members are
training analysts on the faculties of the
three Psychoanalytic Institutes in New
York City. Others have achieved aca-

demic distinction as members of medical
school faculties and hospital staffs. It is

expected that gradual evolutionary

changes will take place which will enhance the value of this reservoir of psychiatric experience and knowledge. In the
past it has made major contributions to
the academic deveIOpment of Hillside Hospital. Together with the devoted membership of our chiefs of Medicine, Surgery
and Dentistry, the Board is a source of
expert advice in the major activities of
the hospital.
The year has brought other changes,
too. Dr. Sidney Tarachow, the first editor of the Journal of Hillside Hospital,
has retired as the Journal’s guiding light,
after ten years of unﬂagging devotion.
Under his direction the Journal has become an outstanding contributor to the
body of scientiﬁc knowledge and literature. It is expected that in the near future
an issue of the Journal will be dedicated
to Dr. Tarachow, as a token of our appreciation, esteem and affection. Dr.
Aaron Stein of our Board has succeeded
as editor.
The various committees under the able
direction of their chairmen have continued to function energetically in the
many areas noted in previous years. To
them and to the attending and visiting

REPORT OF
THE PRESIDENT
OF THE
18

MEDICAL BOARD
Robert A. Savitt, M.D.

staffs I offer deepest thanks for their advice and co-operation. I particularly Wish
to express my compliments to Mr. Alvin
E. Coleman, the President of the Board
of Trustees, and to Dr. Lewis L. Robbins,
the Medical Director, for their valued and
rewarding relationship to the Board.
Conferences with these men and their
dedicated colleagues have always been
stimulating, informative and constructive.
In closing, I take extreme pleasure in
welcoming Dr. Sidney Tarachow to the
Presidency of the Medical Board. He will
give it the energetic devotion it so much
deserves.

�MEDICAL BOARD

President

Robert A. Savitt, M.D.*
President-Elect
Sidney Tarachow, M.D.*
Secretary
Sidney L. Green, M.D.*
Treasurer

Paul Scheman, D.D.S.*

Eat-President
M. David Epstein, M.D.*

Psychiatrists

Samuel Atkin, M.D.
Arnold Eisendorfer, M.D.*
M. David Epstein, M.D.*
Margaret E. Fries, M.D.
I. Peter Glauber, M.D.*
George S. Goldman, M.D.
Sidney L. Green, M.D.*
William Karliner, M.D.*
Sylvan Keiser, M.D.
Sarah B. Kelman, M.D.
Emanuel Klein, M.D.
Samuel R. Lehrman, M.D.
Joseph S. A. Miller, M.D.
Samuel Z. Orgel, M.D.
Hyman L. Rachlin, M.D.*
Lawrence J. Roose, M.D.
Robert A. Savitt, M.D.*
Martin Schreiber, M.D.*
Isidor Silbermann, M.D.
Otto Sperling, M.D.
Sidney Tarachow, M.D.*

Non-Psychiatrists
Director of
Department of Medicine
Lester Cohen, M.D.*
Director of
Department of Surgery
Sidney Hirsch, M.D.*

Director of
Department of Dentistry
Paul Scheman, D.D.S.*
CHAIRMAN OF
STANDING COMMITTEES

Adolescent Pavilion
Sidney L. Green, M.D.
Credentials Committee for

Psychiatric Attending Staff
Promotions
Martin Schreiber, M.D.
&amp;

Credentials Committee for
Non-Psychiatric Visiting
Staff &amp; Promotions

Paul Scheman, D.D.S.
Education of Resident Staﬂ"
Arnold Eisendorfer, M.D.
Group Psychotherapy
Samuel Z. Orgel, M.D.

Manhattan A fter-Care Clinic
Sarah B. Kelman, M.D.
Queens Out-Patient Clinic
Martin H. Orens, M.D.
Sub-Committee for Child

Guidance Clinic
Isidor Bernstein, M.D.
Research Committee
Sidney Tarachow, M.D.
Publications Committee
I. Peter Glauber, M.D.
Committee for
Adjunctive Services
I. Peter Glauber, M.D.
Credentials Committee for
Supervising Psychiatric
and Resident Staﬂ‘
Lawrence J. Roose, M.D.
CONSULTING, A‘ITENDING
AND VISITING STAFF-'5

Consultants

Psychiatry
Leonard Blumgart, M.D.?
Sandor Lorand, M.D.
Nathaniel E. Selby, M.D.

Dudley D. Schoenfeld, M.D.
Medicine

Alfred Angrist, M.D.
Morris S. Bender, M.D.

Oscar Levin, M.D.
I. Jesse Levy, M.D.

YNeurology
A. M. Rabiner, M.D.
Hans Strauss, M.D.
I. S. Wechsler, M.D.

Surgery
David Warshaw, M.D.
Gynecology

Julius Jarcho, M.D.
Dentistry
Morris Fierstein, D.D.S.
Attendings

Attending Psychiatrists
Samuel Atkin, M.D.
Frank Berchenko, M.D.
Isidor Bernstein, M.D.
Arnold Eisendorfer, M.D.

M. David Epstein, M.D.
Margaret E. Fries, M.D.
I. Peter Glauber, M.D.
George S. Goldman, M.D.
Paul Goolker, M.D.
Sidney L. Green, M.D.
William Karliner, M.D.
Sylvan Keiser, M.D.
Sarah R. Kelman, M.D.
Emanuel Klein, M.D.
Samuel R. Lehrman, M.D.
Abraham S. Lenzner, M.D.
Joseph S. A. Miller, M.D.

Martin H. Orens, M.D.

Samuel Z. Orgel, M.D.

Hyman L. Rachlin, M.D.
Lawrence J. Roose, M.D.
Robert A. Savitt, M.D.
Martin Schreiber, M.D.
Isidor Silbermann, M.D.
Otto Sperling, M.D.
Aaron Stein, M.D.
Sidney Tarachow, M.D.
Associate Attending

Psychiatrists

Renato J. Almansi, M.D.
Alexander J. Friedman, M.D.

Soll Goodman, M.D.
Louis Kaywin, M.D.
Bruce Kendall, M.D.

Geraldine Pederson-Krag, M.D.
William W. Pike, M.D.
Jay Stanton, M.D.
Adjunct Attending

Psychiatrists
Edward R. Adelson, M.D.
Herman S. Alpert, M.D.
Alvin B. Balaban, M.D.
Irving L. Bauer, M.D.
Benjamin J. Becker, M.D.
Julius Belinkoff, M.D.

Milton M. Berger, M.D.
Lionel H. Blackman, M.D.

Rita M. Chalef, M.D.:t
Isadore H. Cohn, M.D.
Irving J. Crain, M.D.
Joseph H. Feldman, M.D.
Jules Glenn, M.D.
Albert E. Goldberg, M.D.
Michael Gould, M.D.i
Albert Harrison, M.D.
Thomas Hora, M.D.
Wilbur Jarvis, M.D.i
Abraham I. Kaplan, M.D.
Eugene H. Kaplan, M.D.
George R. Krupp, M.D.
Peter Laderman, M.D.

Myer D. Mendelson, M.D.*
David Milrod, M.D.
Helene Papanek, M.D.

Henry Rosner, M.D.t
Irving Salan, M.D.
Frederick F. Shevin, M.D.
Fred U. Tate, M.D.

B. Frank Voge], M.D.*
Leonard Weinroth, M.D.
Herbert Wieder, M.D.
VISITINGS

Medicine

Director
Lester Cohen, M.D.
Visiting Physicians
George Sabrin, M.D.
Louis Rosenblum, M.D.
Arnold G. Blumberg, M.D.
Associate Physician
Jerome Weinstein, M.D.
Adjunct Physicians
Arnold L. Berger, M.D.
Wilbur B. Brett, M.D.
Associate Dermatologist
Joel Schweig, M.D.
Adjunct Dermatologists
Norman Goldfarb, M.D.
Eugene L. Bodian, M.D.
Neurology

Associate Neurologist
Kurt Adler, M.D.

MEMBERS

OFTHE

MEDICAL
BOARD

Gynecology

Visiting Gynecologist
Marie P. Warner, M.D.
Associate Gynecologists

Jack Cohen, M.D.
Bernard Greenblat, M.D.

Rodlology

Visiting Radiologist
Bernard Epstein, M.D.
Associate Radiologist
Paul Steinhorn, M.D.
Optometry
Staﬂ‘ Optometrists
Edward L. Steinberg, O.D.
Bernard Attinson, O.D.
Podiatry
Staﬁ’ Podiatrist

William Reider, Pod.O.

Surgery

Director
Sidney Hirsch, M.D.
Adjunct Surgeon
Stephen Deckoﬂ", M.D.
Visiting Neurosurgeon
Joseph Siris, M.D.
Visiting Urologist
Daniel Kaufman, M.D.
Adjunct Urologist
Albert Sutton, M.D.
Visiting Orthopedist
A. H. Lewert, M.D.
Associate Orthopedist
Julius Schneiderman, M.D.
Visiting Proctologist
Benjamin Warner, M.D.
Visiting Ophthalmologist
Edward Seretan, M.D.
Associate Ophthalmologist
Arthur Minsky, M.D.
Visiting Otolaryngologist
Sam Clayton, M.D.

Visiting Anesthesiologist
Georges Bean, M.D.
Dentistry

Director
Paul Scheman, D.D.S.
Associate Director

J. Gordon Rubin, D.D.S.

Associate Dentists
Benjamin Schwaid, D.D.S.
Bernard Lebow, D.D.S.
Adjunct Dentists
Henry Lewis, D.D.S.
Samuel Plotnick, D.D.S.
Elsa Friedman, D.D.S.
Martin Protell, D.D.S.
Leon Basson, D.D.S.
Herbert Forman, D.D.S.
*Executive Committee Member
f Deceased 1959
IAppointed in 1959

19

�The body of our Annual Report indicates that 1959 was a year
in which the Professional Development Program, introduced
by Dr. Lewis L. Robbins, was launched. The goals of the program have been outlined and the beginnings of its implementation have been described above. Additional personnel required
by this program were initially engaged as of July, 1959, and
were gradually added during the second half of the year, so
that the 1959 calendar year data does not show appreciable expenditures for the Professional Development Program as such.
COMPARISON OF COSTS

1958-1959
1958

— TOTAL OPERATION

1959

%

INCREASE
16.

Salaries
$1,241,350.
$1,442,458.
3.
Food
127,142.
131,083.
Maintenance
and Grounds
( 8.)
78,914.
72,408.
Administration
29.
Expenses
111,300.
143,860.
Medical Supplies
55,217.
49,289.
(11.)
Repairs and
Replacements
48,101.
41,727.
(13.)
13.
Total
$1,662,024.
$1,880,825.
This table shows that the total expenditures for all operations
increased by 13%; the percentage increase from 1957 to 1958
was 11%.
Salaries and wages increased by 16%. This is in keeping with
our experience of the past ten years in which this item rose by
ten to ﬁfteen percent per year. Almost the entire rise in this
ﬁgure was caused by increases in rates rather than by the addition of new positions. The chief factors in this increase were
the across-the-board increase of about 13% to all nonprofessional
employees and provision of time and one-half for overtime for
all employees. These actions were taken by the Board of Trustees
in accordance with the “Statement of Policy Regarding Personnel Practices” promulgated by the Greater New York Hospital Association and subscribed to by the Board of Trustees.
Increased salaries were also provided for all categories of the
professional staff. The impact of the Professional Development
Program as such was hardly felt in 1959 ; its further implementation will produce a more appreciable impact during 1960.
.

20

Food costs increased 3% in accordance with the rise in the
food price index.
Out-patient services expenses increased by only 6% as compared with 30% in 1957 and 21% in 1958. This reﬂects the stabilization of this operation after a period of constant growth
dating back to 1954 when the large Queens Out-Patient Service
was established.
The largest increase was in administration expenses which
rose by $32,000, or 29%. The following were the chief components of this increase:
INCREASE IN DOLLARS

ITEM
Ofﬁce Equipment

$3,500
Medical Care Prepayment for Employees 8,000
Social Security and Retirement
Contributions
9,300
Personnel Expenses
6,300,
Medical Care Prepayment for employees (Blue Cross and
Blue Shield coverage for the employees and their families) was
initiated in July, 1959 as part of our over-all improvement of
personnel practices. Social Security and retirement contributions rose both as to rate and volume. Personnel expenses rose
in accordance with liberalized policies as to travel and other
allowances for professional staff.
SERVICE DATA: IN-PATIENTS

Total number of
patients treated
Total patient days
Average income per
patient day
Average cost per
patient day
Average loss per patient
per day

1958

1959

%

INCREASE

—
——

536
70,691

537
70,219

$16.58

$18.83

+

13.5%

$18.73

$21.69

+

15.8%

$ 2.15

$ 2.86

+

33%

REPORT OF
THE ADMINISTRATOR
Maurice Bachrach

�With total number of patients treated and the number of
patient days virtually unchanged, average income per patient
day rose by 13.5% while average cost per patient day rose
by 15.8%. The average loss per patient day rose by 33%
over 1958. Thus, In-Patient Service developed a gross operating deﬁcit of $200,826 for the year in spite of an increase of
$4.00 in the per diem rate paid for indigent patients by the City of
New York as of July 1. Without this increase, this loss ﬁgure
would have been appreciably higher, since 75% of our In-Patient
Service (50,000 patient days) is assigned to indigent patients.
Most of our deﬁcit both for In-Patient and Out-Patient Services was met by a grant from the Federation of Jewish Philanthropies of New York, while an increasingly large deﬁcit is being
met by our own trustees. Our Board of Trustees meets the
operating deﬁcit for treatment and training programs as well
as for research, which is their sole responsibility. As we continue
to put more and more of the Professional Development Program
into action, our gross expenditures for the In-Patient Service
will continue to out-run foreseeable increase in operating
income. Closest integration of planning and effort between the
hospital administration, our Board of Trustees and the Federation of Jewish Philanthropies of New York can lead to construetive solutions of the support problems which lie ahead during
the next few years. The most potent ingredient of such integration is close agreement as to the hospital’s goals as they have
been expressed in the programs promulgated by Dr. Robbins
in 1958 and 1959. These goals promise the provision of the
highest attainable level of patient care and are so incontravertible, that they must stimulate all concerned to meet them in
spite of the difficulties to be encountered.
The growth of the professional programs must be accompanied
by parallel development of administrative services. Careful
application of sound administrative procedures to every phase
of all of our programs will tend to make these programs more
effective and to introduce elements of management that can
decrease cost without impairing service.
During 1959, Mr. Samuel Davis joined our staff as Assistant
Administrator. We willnow be able to plan for increased appli-

cation of administrative processes in the professional areas.
More time and effort will be available for improvement and
intensiﬁcation of personnel administration. An important function for administration during the next year will be to develop
major projects in conjunction with Dr. Robbins and the professional staff and appropriate board committees, a master plan
outlining the physical development of the hospital for at least
ﬁfteen years ahead, a survey of existing plant and buildings
and a comprehensive site plan leading to the development of a
research building and an activities therapy building.
The hospital’s administration will continue to maintain constructive relationships with community agencies such as the
Nassau County and New York City Community Mental Health
Boards and the various co-operating social agencies, as well as
Long Island Jewish Hospital. Efforts to intensify and improve
the areas of co-operation will continue. The board has already
authorized the creation of an effective public relations program
which will lead to wider and more productive community participation in the life of the Hospital and greater usefullness of
the hospital in the life of the community.
The task of administration during 1959 has been a great one.
None of our accomplishments and none of our plans for the
future would have been possible without the devoted and intelligent assistance of the department heads who worked so closely
with us. It is therefore more than appropriate to state that Mrs.
Angelina Canavan, Dietitian; Mrs. Dorothy Croghan, Accounting Supervisor; Mrs. Lillian Dailey, Ofﬁce Manager; Mr.
Thomas R. Lumley, Superintendent of Buildings and Grounds;
and Mrs. Sarah Travers, Executive Housekeeper supplied the
basic day-to-day services which provided an essential foundation
on which professional programs are built. They worked unceasingly with sometimes inadequate staff, to meet the challenge
presented by the growing Professional Development Program
of the hospital.

21

�The following professional

and nonprofessional employees
supported the treatment,
training and research goals of
the Hillside Hospital in 1959:
PROFESSIONAL

Biochemical Research
Dr. Vivian Goldenberg
Grace Kittel
Susan Rea
Dr. Bernard Searle
Daniel White
Creative Therapy
Edith Zierer
Dental Technician
Sheila Berger

Experimental Psychiatry
Romeo Cartolano
Dr. Robert Kahn
Eric Karp
Dr. Donald Klein
Jean Kolodny
Dr. George Krauthamer
Hanna Mosquera
Dr. Max Pollack
Dr. Nathaniel Siege]

Intramural Clinic
Laura Zaves
Laboratories
Theresa Midulla
Medical Librarian
Ellin Resnick

Nursing Service
Registered Nurses
Frances Anderson

Susie Mae Behlmer
Marie Caﬁero

Kathleen Cliggett
Mary Cressy
Mary Ann Dalton
Ann Dispensa

Jean Hendry
Nancy Jeff eries

Mary Jones
Sandra Kraner
Grace Lyons
Eleanor MacPhillips
Flora Mae McCartney
Catherine McCormick
Helen Murray
Yolande Paquet

Lorraine Schaeﬂ’er

Helen Schippicase
Rose Schulbaum
Suzanne Smith
Barbara Steinbach
Zurline Thornhill
Edith Titolo
Anna Urbach
Helen Ziegler
Licensed Practical Nurses
Alma Clinton
Mary Corrigan
Hope Fox
Theresa Howard
Alice McDonough

Isabell Pierce

Rosemary Stevenson
Gloria Swan

Catherine Wall
Delores Williams
Psychiatric Aides
Martha Adams
Olga Allen
Marion Bell
Patricia Bell
William Black, Jr.
Beatrice Blake
Annie J. Bond
Joseph Britt
Lawrence Burger
Frances Butler
Sylvester Campbell
Frederick Coley
May Conrad
Teresa Cooney
Naomi Cotter
Hugh Cracker

�Catherine Eames
Annie Ervin
James Faulkner
Janie Ferguson
Marion Flood
Irish Ford
William Godett
Margaret Griller
Katherine Hammel
Mabel Harper
Linda Hart
Pauline Hawkes
George Heller
Sandra Heller
Lawrence Hood
Alberta Hopkins
Ellen Kennedy
Joan Kelley
Asalle Kirby
Carole Kornfeld
Doris Kraemer
Josephine Lafayette
Ernest Lambert
Grace Lau
Leslie Lee
Miriam Lee
Alice Leliukevicz
Ella Mae Leonard
Lillian Leslie
Anna Lewin
Georgine Lohman
Ellen Long
James Merrill
Edith Minor
Bertha Monroe
Helen Olsen
Clemmie Palmer
Elizabeth Rodriguez
Barbara Sang
Lessie Mae Scott
Samuel Scott
Mildred Shaw
Nancy Smith
Virginia Smith
Marian Thomas
August Tosi
Martha Visalli
Catherine Williams
Thomas Wolf
Anna Wolfberg
Leon Wolfberg
Edgar Zephyrine

Occupational Therapy
Karen Beutlich
Joseph Chase
J udity Conrad
Laura Dunlop
Martha Ittelson
Mona Jones
Deanna Levine
Mary Marrone
Doris Metzger
Helene VViller
Pharmacist
Robert M. Frank
Psychology
Ira Rosenblatt
Dr. Allan Sapolsky
Dr. Stanley Schiff
Charles Silver
Dr. Felix Steiner
Leonette Vanderhost
Florence Volkman
Social Services
Case Work Division
Ida Baumstein
Anne Connery
Barbara Fishman
Robert Fishman
Beatrice Freeman
Evelyn Furman
Sally Gold
Regina Goldstein
Selma Hornstein
Sarah Klionsky
Sandra Match
Anita Mehr
Sylvia Riback
Esther Sanders
Lita Schmidt
Seymour Silverberg
Sylvia Solovey
Gisela Tauber
Lewis White
Group Work Division
Aaron Beckerman
Frieda Bradlow
Denis Dryden

Judith Duﬂy
Edward Fitzgerald
Geraldine Lauter

Eli Saul Levy

Evelyn Mason
Naomi Miller
Holmes Morrison
William Pressman

Frances Rubinstein
Philip Schwartz
Virginia Zaremba
NON PROFESSIONAL

Accounting Department
Arline Fleischmann
Lillian Ingber
Henrietta Lyons
Ethel Siegelman
Jeanette Silver
Dorothy Strier
Buildings &amp; Grounds
Erich Brau
Walter Foley

Frank Groene

William Hannigan
Robert Hill
George Loblein
Nero Moyd
Stanley Novak
Edward Reeder
Frank Reinlein
Walter Roland, Jr.
William Roland, Sr.
John J. Rose
Albert Schmid
Joseph Seagren
Albert Senese
Dietary Services
George Canavan
Francesco Cannetto
Emma Casamassima

Flozell Clarke

Hubert Cooke

Thomas Duncan
Arthur Dywer

Pardo Faro
Elaine Fields
George Fields

Alphonse Gross

Ella Jacobs
Fred LaBarbera
Alfred Lemaire
Gaetano Mandala
Arthur Martin
Ida Novick
Martin Novick
Gaspari Orlando
George Perreta

Arthur Pitts
Walter Rodney

Eva Schwartz
Broadie Taylor
Thomas Tucker
Ester Watkins
Leroy Watkins
Housekeeping
Cle Anderson
Betty Bruckman
James Cuozzo
George Czinczinger
Stanley Durant
William Garland
Fulgencio Gerena
Nathaniel Glover
Joseph Hope
William Hyman
Robert Jones
Harry Lewis
Charles McLeod
Richard Newton
Roosevelt Mitchell

PROFESSIONAL
AND
NON PROFESSIONAL

EMPLOYEES

Dorothy 0 ’Berry
Arturo Orengo
Booker Richardson
Rafael Salazar
Agnes Schuster
General Walker
Ray Warren
Blanche White
Oﬁice Services
Irene Attinson
Celia Bernstein
John Borgner

Janet Bowie

Diane Brafman
Manuel Brown
Irene Dinkin
Claire Dubin
Regina Freedman
Lillian Freifeld
Norma Friedman
Edward Golove
Frances Gullo
Adele Harris
Sylvia Hymowitz
Joan Kase
Edna Kappes

Yetta Levitt
Inge Mai

Sylvia Marcella
Fradele Marcus
Yetta Mintz
Catherine Muﬁ
Dorothy McClary
Margaret 0 ’Connor
Mary Pignoni
Gloria Podrid
Frances Roth
Joseph Ryan
Dorothy Saults
Charlotte Sinovoi
Miriam Slater

Jeanette Sobel

Edna Telesca.
Walter Theisen
Edna Weissman
Lotte Wollman
Blanche Zaitz

23

��HILLSIDE
HOSPITAL

is licensed by.

. . . .

The New York State
Department of Mental Hygiene.

is approved for

resident training by... . .
Council on Medical Education
of The American Medical
Association
The American Board of
Psychiatry and Neurology.

is accredited by .

....

The American Psychiatric
Association
The Joint Commission on
Accreditation of Hospitals

is a member

of.....

The American Hospital
Association
Hospital Association of

New York State
Greater New York Hospital

Association
Greater New York Fund
The United Hospital Fund
Welfare and Health Council of
New York City
The National Conference of

Jewish Communal Services

cooperates with. . . . .
Adelphi College
Altro Workshops

Federation Employment and
Guidance Service
Jewish Community Service
of Long Island
Jewish Family Service
of New York
Long Island Jewish Hospital
New York City Board of

Education

New York State Employment

Service

New York State Department of

Vocational Rehabilitation
Queens College of the
City of New York

is a participating

hospital

IWhIle no precnse form

.....

and Related Facilities for

essential for making a valid bequest to HIIISIde Hospital, the
following may be used: give to the Society of the Hillside Hospital, the sum of $

TheHospitaICounciIof
Gr t rN wY rk
HI::;DEeHO:PITAL

I

ISAMEMBER OF

.

.

.

IS

.

.

.

.

.

,

I

land or any specn‘uc property, such as bonds, stocks, etcetera, IS given, a brief descrlpH
tion of the property should be inserted instead .of the phrase "the sum of
If

.

.

.

.

.

.

$____.

THE FEDERATION or
JEWISH PHILANTHROP'ES'

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67294">
                <text>Progress and annual reports; research activities (folder title).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67295">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67296">
                <text>mfp-03-01-001-0-007</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67297">
                <text>1960-1963</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67298">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67299">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67300">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67301">
                <text>Hillside Hospital Annual Report (published copies), 29th, 30th, 31st, 32nd; Hillside Hospital A Report of Progress, 1960/61; Letter; </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67302">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67303">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80932">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87493">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94054">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100615">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6731" public="1" featured="0">
    <fileContainer>
      <file fileId="6555">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/e06d90c86c34900cbfbc862c755d6567.pdf</src>
        <authentication>15ada951bb078ffb8bea42b5be5e0745</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107160">
                    <text>IV:

10/113/60

Experieeutel Peyehietrie Presreue et niiieide neepitni
A

The

Review

veeieue prostate in the Department at Experineetei

W

Psychiatry have been devoted to en undereiending e: the node at

W‘iherepiu
“tie:
or

thrush undies or hreiu

taxation. the principal techniieel have been edepted tree deeoriptive
peyehieiry, uenrepeyehoiexy, electreeeeeyheiecrephy, linguietiee,
phereeeelour, end eeeielecy.
In

initial etudiee It

reaction were round

cenvuleive iterepy. ehenzee in brain

it reiete beth to

iepreveuent retinge end to

pro-treatment peyuhelecic variables. in our enderetendin; e:
ceevuieive therepy develeped, e centre: neerephyeieiezio-edeptive
view

e: eaeetie therepiee eeerted

(

). In this

Suuka»

view psychiatric

treeteente ereﬁtherepeutieeiir exteetive to the degree that brein
function in nee-trebly’eitered. While ehense in brein tenetien
neeeeeery

to: behavioral

change, the irpe

e: edeptetiee,

it

however,

veriee depending upon pre-treeinent peyoheleuiigend eeeieiecieag

charecterietiee er the subject. Thee, the node at eotien ie not eeen
ee

eiiher 'ercenic' er 'peyehelexie' bet tether ee the intereotion at

both eepeete in the individeel. further, while behevierei change in

�-2-

ralatad to chanson in brain function;

and the adaptiva

pattarn to

paynhologiéﬂoharaatariatic!t
praotraatnant
avalaationa at 'inprovaaant';
baing spacial typan at avalnatian or ahanga, ara darivativa Jadgnanta
baaad an

start

and

tanily anpaatatiana

and

talarannaa.

Thin hypothaaia was dovalapad and anatainad

in a aariaa at

atudiaa at onnvulaiva therapy. concurrant atndiaa of insulin tuna

indicatad that behavioral changa hora, too. van ralatnd to tha anaat
and dacraa o: prolancad cana

a: rapaatad aaiauraa - than. bainx tho

nanraphyaialogiélnhanaa
nanixantatiana
at
principal
prolansnd
in

thin thanany.
Tho node

at action of tha

nan paychetroyic asanta

anpraaaad within thin hypothaaia (

aganta would

III all.

). It ran anxgaatad that thaaa

b. attactiva to the dasraa that tho: indnaad paraiatant

chanxaa in brain

fanaticn'

and

that tha typa a: bahavioral raaponaa

vanld ha ralatad to tha type at brain nhanza, and to pranorbid

pnyehaloxigﬁ(para¢nality) pattarna. rho praaant proxrann in tha
Bogart-ant an. danisnnd to atndy than. ralatianahipa in datail.
Canvnlaiva Tharazz Prooana

or variaua anaanraa at brain tnnatian, tha anannt of slow

vat. activity in tho alantronncnphalacran

and cantabnlatory and

�-3H

dontal languago pottorno attor aaohorbital

(

)

oonottivo indiooo in oonvaloivo thorany oohaoeto.

voro tho aoot

In tho

firot

oxporioont, improvooont ratings ooro round to ho oorrolatod

dirootly with tho appoaranoo or high dogrooo o: ohango
indicoo (

).

1n thoao

rhooo oboorvationo woro tootod in a douhlo-hlind

study in which pationto rotorrod for olootroohock woro randoaly ao~
aignod to coorooo or oithor oonvuloivo or auboonvoloivo thorapy undo:

poutothal pronodioation. nigh dogrooo o: nourophyoiologie ohango
ooro oboorvod only in tho aonvoloivo group; improvonont ratoo

significantly highor in this group;

'02.

and than oubconvnloivo oohjooto

uoro ro-troatod by convuloivo appliaationo, tho improvoaont rota was

oinilar to tho original convaloivo group.
In tho oihconvnloivo troatod oahjoota, oonoidorahlo anonnto

o: oloetrieol corront paoaod hotwooh tho hitouporal oloetrodoo.

It woo

ooncludod, thorotoro, that tho thoropoutio agont

total oloctrioal curront,

or no, but an

all

woo

not tho

or nono quality

aahitootod by tho grand nal ooiouro. rho otgniticaneo or tho grand

nal ooiouro

was

turthor olahoratod

1n otudioo of tho

inhalant

convuloont, hoxatluorodtothylothor (Indoklon). 31-11ar dogrooo

o: olootrographio ohaugo, iayrovoaont ratoo, typo: o: bohavtoral

�‘hV,

change and ohanxee

in neuropeyohologio teak behavior were obaerved

in the inhalant and in electrically treated :ronpa.

It nae

anon apparent, however,

that not all anbjeote aaniteetin;

high decreea of physiologic ohanga were rated on 'inproved'.

In a

deeoriptive typelogio atndy, rive patterne were doeoribed,

eaperioally teraed ‘enphorio', 'hypoaanio', 'eoaatiaetien’,

’paraneid-Iithdraval',

and

'panio'.

While the

tirat

adaptive aedea were ratod ae 'nnoh inproved', the
aeen ae ‘uniapreved' or 'verae‘

(

two or

latter

theae

two were

).

In etndiee of peyoholegio variablea,

it nae

reported that

patiente rated ae 'anoh inproved' and ’reoevered' frequently
aanireeted peraenality patterne similar to that deeoribod by
Heinatein and

Kenn (

) an

the explicit verbal denial personality.

In language patterna, they expreeeed the language of denial,

when

dittnae brain change

denial,

was indnoed,

exhibiting anoh aepeote

an

niniaiaation, diaplaoenent, oliohee,|g§g. aere treqnontly than
unimproved enhaeote.

high

I Stale

eoore (

Other indioee related to favorable ontoeae were

),

and Rorschach deterninante or color,

abeent aoreaent and abaent torn-oeler (

).

alao, :avorable ontoeae nae aaaooiated

tith lea

In thin population,

educationalaohieveaont

�and

revels: birth

).

(

Antlehellner lea and Convalelve there
Seeking a way
EEG

slew wave

eae given

te eucaent the degree at peet-oeaveleive

activity,

an

inn-anneal: at

antlehelinercle cenpoand, diethaaine,
vex-1e“

“sea at

the eemalelve therapy

preeeee. Contrary to expectatlene, diethaaiae eaueed an iaaedlate
and entrained decreaee

in

EEG

alerting. Patleitl with dental

language patterae rellnxqalehed than; Instead of euphoria and well

being, the eibjeete were irritable, anxieue and expreeelve a:

nre-treateeet patterne. In eubjeete prior to cenvuleive or drug
therapy, elethaalne induced exciteaent, tenelen, anxiety and

lllaeery eeaeatlene.
Sabaeqeent etadlee with ether eentral antlohelinerglo
oeapeeade (VII-2299, JB-318,336, beeaetyaine) abated behavleral and

electrezraphle patterns alaalar te diethaelae. Stellar deeynohrenieatien
a! peet-eenvulelve

EEG

aleeing

wee

aleo noted with central

eynpathealaetie hallucinogene (euphetaaine, aeeoallne, LSD-25). and
baa been reported

re: antihietaainee (dephanlydraalne).

Theee

obeervatlene led to the eaageetlea that an increaee in central

ehellnergie activity eae a biocheaieal haste tor the eenvalelve

�therapy process

(

).

Pszshotrogic Drugs and
During

EEO

this period,the

drugs aroused

interest.

node of action of newer psychotropic

Following the concepts derived from

convulsive therapy, the neurophysiologis ohenges induced by drugs
were

tested within the

experi-ents in an

EEG

Ill.

experimental setting or acute

setting. It

was observed

that phenothiasines

(shlorprolasine, pronssine, triflnepronasine) induced

isation

and a

shitting o: the spectra: to the

ERG

synchron-

slow frequencies;

leprobanate and barbiturates , en increased synchronisation and a shift
of spectra: to

fast frequencies; reserpine,

an

inoreased slowing with

synchronisation at low dosages, and desynchronisatien at higher

levels. Inipraaine induced desynohrenisation with

a

shift of

frequencies to the slow bands.
Other experinental oonpounds tested included

phenyltoloxaline (Bristol), Deaner and

(liker),

wx-21h9 (Wyeth) and

its vsrions

BL-HlBB and

oongeners

trenquel (nerrill). For eaoh, no

consistent electrographis.patterns energed.

It
teens

use suggested that psychopharnaoelogio agents provide a

‘lr eliciting a variety

or nenrephysielogio patterns in

�.7contreet to the eingle pattern of induced oonvuleione. Furthermore,
the typo of neurophysiologie alteration, ee reflected in
synchrony and Iroquoooy

petterns,

or hehoviorel edoptetion.
elow :roqnonoieo

wee

Inoreoein;

EEG

related to epooirio types
EEG

eynohrony and e

shift to

or. oeeooieted with trenquillisetion, eedetion

deoreeeiog ogitotion; while deeynohronisetion and e

end

shift to test

frequencies in eeeooieted with oxoitenent, illusions, end delnlionol

idoetion. These observations orooeaeietont with hypotheeoo or
Hikler

(

).

The

merit of such teohaiqoeo for the eeeey or

psychotropic agents hoe been doeorihod

(

).

new

�-8Pszchcpharaacologz Evaluation Prograa
The

present pregraa, instituted in October 1959, is based

these studies and

is

on

designed to answer the following questions:

Is there s relation between aeasurable alteration in brain function
and behavioral change with

psychotropic drugs

on

chronic administra-

tion? Are there pre-treatasnt clusters of psychiatric, physiologic
and psychologic

variables related to the type of behavioral adanptation?

- to the type and degree of physiologic change?
Method:

is

an

initial approxiaation,

fixed

a double-blind,

dosage rendoa assignment drug study was undertaken.

Based on

clinical

experiences with various psychotropic coapounds, three classes were

selected

on

the basis of their patterns of :30 response.

‘The

selected agents were those eith predoainent desynchronicing patterns;
synchronising and slowing; or niniaal or no effect.

Patients

referred for drug therapy, after medical examination, and after

all other medications

have been discontinued are randoaly assigned

to one of three classes of compounds.

Patients are predoainantly middle class, urban, with high
educational attainment. Hillside Hospital is a non-profit,

philanthropic supported psychiatric institution, admitting voluntary

�.9patients for extensive psychotherapentic treatment.
of stay

is

seven months.

are prescribed by

Kean

duration

Convulsive and psychotropic drug therapies

star! psychiatrists

on

referral to the Department.

All treatment is adninistered by Departaental

start,

so

that the

experinentsl variables or drug dosage, route of administration,
assignsent to groups, 333. are readily controlled. All patients
in the hospital are available for study.

all patients receive

After a testing period,

ho cc of

medication daily tron individually labelled bottles.

increased in fixed weeﬂy etepe until a nsxiaua at

date,

1&amp;0

the study period.

Dosages are

After

weeks.

reotestinz occurs.

two weeks on maximum dosage,
To

h

liquid

subjects have been referred, and

110 have completed

Preliainary analyses of the data are

new

in

progress 0

avieral

Chan e5

In a survey or the behavioral adaptations of patients receiving

phenothiazines er iaipranine, various clusters at behaviors were
developed.

The typology was based on

the pre~treatasnt psychiatric

the treatnent reepenee and

profile. In the present study,

various measures of behavioral change are under study. Therapist

referral questionnaires

and

six

week

evaluatione; therapist and

�-10-

patient
two

Clyde Heed Scales; Lorr Scale evaluations in interview by

research psychiatrist, and Lorr ward scales; patient eelta

ratings including the Johns Hopkins synpten check

list

and the

Chicago Attitude Scalee are ancnget the neaenres being explored.

lenropezchelcgz: Paychelcgic tasks are viewed both as change

variables and predictive variablee. In convulaive therapy, changee

), tactile perception

in aencry tasks (

), crr

(

(

or figuree (

), rignre ground tasks
)

have been

(

), Recheler«3ellevne

(

and
tachietcecopic recogniﬂcn
,

)

related to the degree of induced neuro-

For each task, the degree or decrement in

physiologic change.

taek pertornance has been positively correlated with the amount of
EEG

slowing.

lollcwing treatnent completion, with the return of

physiologic indicee to pre-treatnent levels, performance in these
peychclcgic taaka also returns to prewtreatnent levels, or higher a

betternent of performance ascribed to practice eitect. Denial

scores

on

interview

(

), Rorechack deterninante

),

1

), auditory feedback

(

),and perception of the visual upright

(

)

have been viewed ae

predictive indices of the behavioral changes following nor.
various tasks are

new ﬁbeing

Scale scores

), language patterns after ancbarbital

(

(

(

Theee

asseeeed with paychctrcpic agents.

�.11.
In the convulsive therapy studies; the

lieetreencezhalogrsghzs
degree of

EEG

slowing was measured by counting the consecutive waves

in selected samples.
were

studied,

it was

When

the more subtle changes or druggeftects

necessary to apply less tediens techniques.

Electronic frequency analysis

was

introduced in August 1959.

By

asasurenent e! the pen deflection for various frequencies free
3

to

33 cps

in ten second epochs, rapid aeasnreaent of apparently

saall changes in total activity
and

and frequency

spectra are not obtained

applied.
Other physiologic variables include the response of £30 to

intravenous chlerprcnasine; blood pressure response to sechelyl;
EKG;

radioactive iodine uptake, and analyses or various blood and

urine element ordinarily conceived ac protective of the patient'e
welfare.

�Pnzghuliggualtion:

rollcving thy studios at syntgotio Iguanas. pattorns
(

)

in oonvnlntvo thnrspy, 0th.: anpoctu or Innguagc

cﬁndind for

worn

their ralatiou as 1361... st «hung. in intrnporlonll

with
nonltdurabln
nun:
.xplarctlou
attnr
bcinvior. attic,
(1T3)
thn‘
typewtokoa-rutio
augxoltod
11:;«1-t19 nounurOI,

or connoautivo 33-pin: a: dyldic apcoch

1.:

bu

A

useful lunar.

tppliud to writing toxta or tho

Hull. ran

had previously buon

hung.

nmlu ¢ individuals,

Jute intuit-d ﬂat

the two

index
(dyad)
at
a
ounnunieutioa
an:
sicniriuant
not.
portal

tho

ltttc

at tho intaraction than snnlytcn or

ltplrt‘.

Innplnn

or the participantl.

tpplytn; ‘htv technique to couralsivo tiara»: pntiunta,
august: in ran nonn and atnndnrd deviation worn rclntod both to

tn.

dogroo 0: induced use slow vuvo

nctivity

and to

lyutaatic

lan‘unxa puttorns obtained in indop-ndoat structurod iutcrvicvnc
Bpocch

boa...

new.

rupctttivc (lovarod nag:

223) and Iowa

vurttblc in connocutivo canplou (inoronnod standurd dovistion)

(

).

�In tnttrvidvt tutor.

&amp;nd

aft-r 8h. intravunoul administration

of coutrully .ctivo ngcnta, 11-11;: chtnguu rare obaorvtd.
Axtntu with a prcdauinnnt lynehronisatiou

ptttorn

tn.

on

EEG

uxhibttod n docroaao tn tutu 218 and inarcuao in Itnndtrd

deviation or soorcs,vh11n ataynchroniliag

compounds

olicitcd

grnttnr variability in apooch pa‘torus (lﬂOrOll. in
and

accrual:

13

varidbility at conntnntivo

133 noun)

neuron (doeronlo 1n

It;adnrd dcvistion).

0th.: 1:33:33. nasuuroo under study includu dintronln
r0110: quottontl, colt-rotoronco, tad

potion.

It

1- aucxoutod

are potont tuchaxquos to:
and poyuholusie

ultorttioa

1n

tuna. and

that than. paycholinsutstte nut-urns
ﬁho

operational unnlyiun a: phylialogta

crises: at payohopharnuoologic acunta

C

).

�aotiolg‘io Studio:
2h. cuncral prdbiun 0: tbs rolatiuu at

liaitl tautarl

to choico tad rocuitu o: parchiatrio troutucnt. and tho Ipoeitic
prdblun at tho rolnticn at

it... taatars

pittcrnn, within tun instieutioa.

and

to a cutie: at population

), uduoatiun, ago. place a: birth

In on: tinny (

utmdioa.

13d

ta in. rorcrrul

learn .3 tau California I nail. var. nixnitieuntly rciatod

to thc type .1 thnripr roe-iv'd ind tho utiliuntion o! ndaunctiv.

hoapittl nitric...
ndnantod hid

paiinntl uh. var. old-r, poorly

Than,

night: I

acorou und warn

tar.i;n-horn, pnrtieuinrly

Einicrn lnropo, utro ngat 11301: to be rotorrtd fur oloctro—
shook.

Thou.

rnlntianahipl were pro-nail: iudupondcut a:

diagnnlol. within tho crunp at cloctrolhock putiontl,

rottrrnl {or
In

rclltod to

36? vac .100

g cocond Iﬁuuy

at this

tin. tor

in... factora.

group (

). durstioa or

hospituliaation, dilohurxu ovuluutina and dincnoa¢n wars :0lniod to the can. 000111 taetcru. Fur «suspic, patiunta
hoapituliuod tar Sh. Ihnrtolt patina var. oidoat, had thi

icast oducution, war. nest likely to hivc
and had

in.

high

I

again

boon tornign born

scar... titular, nativoaborn, str-

�uduoatod, lunar 1

real. Ilﬁrl pttiontn v'ro hospltnllscd

tho

lnagost. Inn's rolttsonuhipl bald trnu within tronincnt
typo and
had thn

rithln

diutunaﬁao 31330.

On

allohurxo, .14.: pttttutu

not! tavurubli rttlngo. In not, valiant. rutad

ti

rooovcrod or IIOh luprovnd htd thq hlxhott F scarce, lunat
odnuuttou :ad

var. acct likaly to

ho rarclxn born.

In a study at patlont rtrulal a: 30!, 01:11.: ro-

lutlonlhtpu wort obncrvcd

(

). that. rolgtlounhlpi If.

no! undo: ntndr in tho out-pttlantxdopartnoat, sad in a trlw

hospital cunpnrattvc Itaay. In tn. lnttor Itudr. th- population!
or thrco hunptlalc in which :11

thrupltu are equally arullnbla

to all p¢tluata, - sonniugor roundatlau

lllplttl (Ippir-cltll,

Protoltant), nascaohau-ttn unnttl Xcslth

c ntnr (lavdroclnao

Catholla) and 3311314. noopltll (nlddln-clnnn Jalluh)

boin; alaoaacd.

It

but Etna postulntod that lhunc rcl:t1¢ulhlpl

rctlact tho tntlncncu at

.00131 bunksround on plynhologlcnl

pronoun, nah u hubltul
undo:

at axprcsslon.

tho putt-tn a: nontal

action

tr.

undo:

Ir.

”turn

or

Th. onutwibution

emulation

um

0: than. tactorc to

antaru
tho
tad
patsont-thtrnpttt
lllnsal,

atlﬁr.

�Exporinuutal Plyohiatrio Progr;ul nt Hillside ﬁespitnls
A

Max

Review

rink,

H.D.

the Depurtneut of Experimental Psychiatry, Kill-id.
Hospital, Glen Oaks, 1.1., l.I.

From

V:

11/60

�v: 11/22/50
Experimental Psychiatric Prograns at Hillside hospital:
A

Review

various programs in the Department of Experimental
Psychiatry have been devoted to an understanding or the node of
action or psychiatric therapies through studies or brain function.
The prin(ipnl techniques have been adapted tron descriptive
psychiatry, nenropeychelcgy, electroencephalography, linguistics,
pharaacology, and sociology.
In initial studies of convulsive therapy, changes in brain
function were found to relate both to evaluations of improvement
and to pro-treatment peyohologic variables. is our understanding
or convulsive therapy developed, a general neurophysiologicadaptive view of soaatic therapies emerged ( l ). In this view
psychiatric treataents are therapeutically effective to the degree
that brain tnnction in measurably altered. While change in brain
function is necessary for behavioral change, the type of adaptation,
however, varies depending upon pro-treatment psycholozic and
sociologic characteristics of the subject (2). Thus, the node of
action is not seen as either 'orgenic’ or "psychologic' but rather
as the interaction of diffuse neurophysiologic changes and
adaptive mechanisms. further, while behavioral change is related
to changes in brain function, and the adaptive pattern to
pre-treatnent psychologic characteristics, evaluations of
'inprovenent', being special types of evaluation of change, are
derivative Judgments based on start and {anily expectations and
tolerances (2).
The

�-2...

amine

series "or
studies of convulsive therapy. concurrent etudiee of ineulin ccna
indicated that behavioral change here, too, was related to the
onset and degree e: prolonged cone or repeated seizures - these
being the principal aanitestatiens or prolonged neurophysiologic
change in thie therapy (3,h).
The node of action or the new psychotropic agente was also
expressed within this hypothesis (5,6). It use suggested that
these agents weuld be effective to the degree that they induced
persistent changes in brain function and that the type or behavioral
response would be related to the type of brain change, and to
preeorhid peycholegic (personality) patterns. the present prograne
in the Department are designed to study these relationships in
"""""'m. hypS‘iEiSii‘ﬁ; a.‘+‘¢i3§.ia'gua‘
.. .. «'WIfahlr‘ehnebtn

”1.5";

detail.
GOHVVLSIvg IBERAP! PROCESS

or various neaeuree of brain function, the aecuut or slow
wave actiéity in the electroencephhlcgraa (7,8) and contahulatcry
and denial language

patterns atter anoberhital (9,10) were the
sensitive
nest
indices (11) in convulsive therapy subjects. In
one experieent, improvement ratings were correlated with the
appearance of high degrees or change in these indices (7,10).
These observations were thsted in a double-blind etudy in
which patients referred for electrcehcck were randomly assigned
te ceureee of either convulsive or subccnvuleive therapy under
pentothal prenedication. High degrees of neurophyeiclcgic change
were observed only in the cenvuleive group; improvement rates were
significantly higher in this grog); and when snbconvulsive subjects

�-3-

epplicetiene, the inprevcnent rete
wee sieiler tn the originel convulsive group (2).
In the enbccnvnleive treeted subjects, ceneiderehle emanate
er electric current pessed between the bitenperel electrodes.
It sppeered that the therepeutic egent use not the totel electrical
current, ger es, but en e11 or none quelity eenitested by the
grend eel seizure (8,12). the significsnce cf the grend eel
seizure wee exenined in studies of the inhalant ccnvnleent,
hexetlnorodiethylether (Indoklon). Sieiler degrees at electrogrephic cheese, iepreveeent retes, types at hehevicrel change
end cheeses in nenrepsychclegic tesk behevier were observed in
the inhelent end in electricelly treated groups (13).
It wee seen epperent thet net ell subjects lenitccting
high degrees 0: physielegic chenge were reted es 'iepreved'. In
e descriptive typelegic etndy, rive petterns were described,
eepirieelly tereed 'enphcric', 'hypeeenic', 'seeetieetien',
bereneidovithdreeel', end 'penic'. While the first tee of these
edeptive nodes were reted es 'nuch inpreved', the letter two were
seen es 'uniepreved' er 'ecrse' (It).
In stndiee of psychelcgic veriebles, it wee reported thet
peticnts reted es 'ench improved' end ’reccvered' frequently
menitested perecnelity petterns siniler to thet described by
Heinetsin end Kehn es the explicit verbel deniel personelity.
In lengnege petterns, petients expressed the 'lengnege or deniel',
when diffuse brein chenge wee induced, exhibiting such aspects es
explicit deniel, nininisetien, displeceeent, cliches, etc. eere
frequently then nniepreved subjects. Other indices releted to revereble
were

re-treeted

by convulsive

�4,ontooae were high 1 Scale ecore (15), and Rorechach deterrinante or

color, absent movement and abeent torn-color (16,17). In thie
population, also, favorable outcome wee aeeociated with low
educational echievenent and foreign birth (18).
ilfICXOLIEERGIO courovlnc one GGIVVLSIVE 2323‘?!

Seeking a way to augment the degree of poetoconvnleive

activity,

EEG

anticholinergic compound, diethasine, was
given intravenously at variene stages of the convulsive therapy
proceee (19). Contrary to expectations, dietharine caused an
innediate and sustained decrease in EEG slowing. Patiente with
denial language patterns relinquished then. Inetead of euphoria

nelow wave

and well being, tho

on

ethecte

irritable,

anxione and expreeeive
of pre-troataent patterne. In subjects prior to convulsive or
drug therapy, diethaoine induced excitement, tension, anxiety and
were

illusory sensations.
Snbeequeht etndiee with other central anticholinergic
coapounde (WIH-2299, JB-318,336, benactycinc) ehoued behavioral

electrographic patterne eiailar to dicthasine. Similar
deaynchrenination of poetaoonvuleive EEG cloning wee also noted with
central eyapathoniaetic hallucinogene (amphetamine, neecaline, LSD-2S),
been
and hae
reported for antihietaainoe (diphenylhydraaine).
These obeervatiene led to the suggeetion that an increaee in central
cholinergic activity wae a biochemical basic for the convulsive
therapy proccoe (20).
and

PSIOROERGPIG DRUGS AND EEG

this period, the node of action of newer psychotropic
aroused interest. Following the concept: derived from

During

drnge

convuleive therapy, the nenrephyeiologic changes induced by drnge

�-5-

tested within the sane acute experimental franework of the
EEG setting.
It was observed that phencthiacinee (chlcrpronazine,
proaasine, triftuopronanine) induced EEG synchronisation and a
shifting of the spectra: to the slow frequencies; neprebanate and
barbiturates, an increased synchronization and a shift of spectrum
to fast frequencies; reserpine, an increased slowing with synchrono
isatien at low dosages, and desynchronizaticn at higher levels (5,6).
Inipraaine induced desynchronisatien vith a shift of frequencies
to the slow bands (21).
Other experinental oerponnds tested included BL-H188 and
phenyltolexaaine (Bristol), Deaner and its various cengeners
(hiker), wr~21h9 (Wyeth) and frenqnel (Merrill). For each, no
consistent electrographic pattern was recorded.
It was suggested that psychepharnacclogic egents provide a
means for eliciting a variety of neorophysiclogic patterns in
contrast to the single pattern of induced convulsions. Furthernore, the type of neurophysiologic alteration, as reflected in
EEG synchrony and frequency
oatterns, was related to specified
types of behavioral adaptation. Increasing EEG synchrony and a shift
to slow frequencies were associated with tranquillisaticn, sedation
and decreasing agitation; while desynchronieation and a shift to
fast frequencies was associated with excitement, illusions, and
delusional ideaticn (6,20). These observations are consistent with
hypotheses of Wikler. The advantages of EEG techniques for the
assay of new psychotropic agents have already been reported (6).
were

V

�-6PSYCHOPHARHACOLOGI EVALUATION PROGRAM

besed on

present progree, instituted in October 1959, is
these studies end is designed to ensver the following questions:
Is there e reletion between eeesureble elteretien
in brsin function end behevierel chenge with psychotropic drugs on chronic edninistretion?
Are there pre-treetnent clusters of psychietric,
physiologic end psychologic veriehles releted to the
type of behevierel edsptetien?
And, ere such clusters related to the type end
degree of physiologic ohenge?Method: is en initiel epproxinetion, e double-blind, fixed
dosege rendon eseignnent drug study wes underteken. Besed on our
clinicel experiences with verious psychotropic coeponnds tree
195k to 1959, three clessss were selected on the besis of their
patterns of EEG response.' the egents selected were those with
either predoeinent desynohronising petterns, synchronising end
slowing, or mini-e1 or no effect. Petients referred for drug
therepy, etter nedicel exeeination, end etter ell other eedicetions
heve been discontinued ere rendonly essigned to e conpennd in one
of these three cleeses.
Petients ere predominently middle eless, urhen, with high
eduoetionel etteinnent. Hillside Hospitel is e nonnprﬂtit,
philenthropie supported psychietric institution, ednitting volantery
petients for extensive psychetherepentic treatment. The noen
duration or stey for petients is seven months. Convulsive end
psychotropic drug therepies ere prescribed by stetf psychietrists
The

�.7.
referral to the Departaent. All treatment is administered by
Departaental start, so that the experimental variables of drug
dosage, route of adainistration, assignment to groups, 232' are

on

readily controlled. All patients in the hospital are available
for study.
After a testing period, all patients receive he so of liquid
aediestion daily tron individually labelled bottles. Dosages are
increased in fixed weekly steps until a aaxiaua at h weeks. After
two weeks on maxiaua dosage, ro~testing oeeurs.
Io date, 1&amp;0 subjects have been referred, and 110 have eonpletod
the study period. Preliainary analyses of the data are new in
progress.
Behavioral Change: In a survey of the behavioral adaptations
of patients reeeiving phenothiasines or iaipraaine during 1958-59,
various clusters of behaviors were developed. The typologies were based
on the treataent response and on pre—treatnent psychiatric profiles.
In the present study, the typologies are being tested, and various
measures of behavioral change are being studied. These include
therapist referral questionnaires and six week evaluations, therapist
and patient Clyde Hood Scales; Lorr Scale evaluations in interview
by two research psychiatrists, and Lorr Ward Scales; and patient
sel£~ratings including the Johns Hopkins syaptoa check list and the
Chicago Attitude Scales.
lenrogszehelegx: Psycholozie tasks have been viewed both as
ehanze variables and predictive variables. In convulsive therapy,
changes in aenory tasks (22), tactile perception (23,2h), WeehslerBollevne (13), CF! (13), figureagronnd tasks (25): and taehistoseopie
recognition of figures (26) were related to the degree or induced

0%

�.8neurophyeiolegic change. for each task, the degree of decrement in
tank portornance was found to be positively correlated with the
enount of EEG cloning. Following treatnent completion, with the
return or phyeiologic indicee to pre-treatnent levelo, performance
in these paychologic tacks aloe returned to pro-treatment levels, or
higher - e hetternent of performance ascribed to prectice effect.
Denial ecoree on interview (27), Rorschach determinante (16,17),
I Scale coerce (15,17), language patterne after anoberhital (28),
auditory teedheck end perception of the vienal upright have been
viewed as predictive indicee of the behavioral chengee following
36!.
Thole veriene tasks are now being eeeeeeed with psychotropic
egente, for their capacity to chenge with verione agents, or their

capacity to predict change.
Electroencephelogrephze In the convnleive therepy etndiee,
the degree of RIG cloning nae neaenred by counting the consecutive
waves in selected eenplee (7). When the more subtle changes or
drug effect- are etndied, it ie neoeeeary to apply leee tedious
techniques. Electronic frequency enelyeie wee introduced in inguet
1959. By neaenrenent of the pen deflection for vaﬁione frequenciea
from 3 to 33 ope in ten eecond epoche, repid eeeenreeent of
apparently
enall chengee in total activity and frequency epectra are new obtained
and epplied.
Other phyeiologic variablee etndied in thie progren include the
reepenee er era to intravenous ohlorprenaeine; bleed preeeure reeponee
to neoholyl; the EKG, radioactive iodine npteke, end analyeee o:
varioue blood and urine elenente.

E 5

�PSIGROLIHGBISIIGS

series of studies in the Departnent have been devoted
to ternal lenguege patterns.
Following the etudies of syntactic lenguage petterns (28)
in convuleive therepy, other espects of lenguage were studied for
their relation es indicee or chenge in interpersonal behavior.
darts; otter considerable exploretion with verious linguistic
neesures, nuggested thet typeutoken-retioe (2!!) of consecutive
senplos or dyadic speech nay be e enetnl index (29,30). While
213 hed previously been applied to written texts or the language
senples of indiriduels, Jeffe indicated that the two pereon eonnunicetion (dyed) wee e acre significent index of the etete of
the interaction then enelysee or concrete eenples of the participants.
Ayplying this technique to convulsive therapy petionte,
changes in 21! neon end etenderd deviations were releted both to
the degree of induced ERG slow ueve ectivity end to syntactic
lenguege petterne obteined in independent structured interviews.
Speech heeene more repetitive (lowered nean 113) and nkre verieble
in consecutive eenplee (increesed etenderd devistion)§(31). In
Another

interviews hetero end otter the intrevenous edeinistretion or
centrelly ective egente, einiler chengee were observed. Agente
with e predominent synchronization pettern on the EEG exhibited e
decreese in mean or: and increase in standard deviation of scores,
while deeynchronieing conpounde elicited greater variability in
speech petterne (increase in TTR neon) end decreeee in veriehility
of consecutive eoorss (decreeee in etenderd devietion) (32).
Other lengnege neeeures studied included dietrese~relie£
quotients, self—reference, and elteretion in tense end person.

�«10-

It

was luggontod

that then. psycholingukatic nonsuroa

tr.

techniques for the opcrational annlyaoa or physidlagic and
psychologic ctr-eta of psychopharuteologic ugcnts (32).

potent

�.11 .3001030910 STUDIES

In the course or these psychiatric programs, considerable
interest wee engendered in the tenily organization to which patients

returning. Also, the general problem of the relation of social
factors to choice and results of psychiatric treatment, and the
specific problem of the relation of these factors to the referral
patterns led to a eeriee of pepnletion studies. In one study (33),
education, ego, place or birth and score on the California I scale
were significantly related to the type or therapy received and the
utilization of addonotive hospital services; Thus, patients who
were older, poorly educated, had higher P scores and were foreignhorn, particularly Eastern Europe, were most likely to he referred
for electroshock. These relationships were present independent of
diagnoses. Within the group o: electroshock patients, the tire for
referral for BC! was also related to these factors;
In a second study (18), duration of hospitalization, discharge
evaluation and diagnoses were related to the eaae social factors.
For example, patients hospitalized for the shortest period were
oldeet, had the least education, were most likely to have been foreign»
born and had the higher 1 Scale scores. Younger, native-born, more
educated, lower 1 Scale score patients were hospitalized the longest.
these relationships held true within treatment type and within
diagnostic close. On discharge, older patients had the nest favorable
ratings. In 30?, patients rated as recovered or much improved had the
highest 1 scores, least education and were most likely to he foresighorn. In another study or patient refusal of nor, similar relationships knee observed (3h).
were

�Theee

reletionehipe ere

new

under etudy in the Out-Petient

Depertnent, end in e tri—hoepitel conperetive study. In the letter
etudy, the population: or three hoepitele with preveiling differing
cliente, in which e11 therepiee ere equally eveileble to e11 petiente,
- Kenninger Peundetion Hoepitel (upper-ollee, Proteetent), Hheeeehueette lentel ﬂeelth Center (leverceleee, Getholio) end Hilleide
noepitel (niddle-eleee, Jewieh) ere being eeeeeeed. It hee been
postulated that theee reletionehipe reflect the influence of eociel
beckgrouud on peychologicel processes, such ee hebituel petterne
of eennunieetien and nodes of expreeeion. The contribution of these

factors to the pattern or mental illneee, end the petient-therepiet
interaction ere under etudy.

�-13SEHMAB!

.

on. Dopartnontal programs are a clustor of intsrrslatsd
studios toonssod about common population sonplos. Within Hillside
Hospital, rosoaroh laboratories in Bioohonistry, and in Hsdieino
are aotiro; and other laboratorios in psychodynanic psychiatry aro
boing dovolopod. In this Dopartaont, various disciplinos aro

participants,rsprssonting a gradual growth of six ysars. Furthsr
growth and tho dirsotions o: ensuing studios sro dopondsnt on tho
results of tho studios doscribod bars; as wall as tho growing
institutional avaronsss that roooaroh is an intogral part or the
hospital's operation and budgots - as such as troatnont and staff
training.

�”lh‘
Reterenaea
Authors at the {alleving references include the following
staff nenbere: Hex Pink, Hex Pollack, Robert L. Kuhn, Joseph Jette,
xertin 3. Green, Eric Kerp, Hyman Karin, Doneld F. Klein,
George Ireuthener, Arnold G. Blnnberg, Ittheniel S.
siegel,
Abrehen Keplen end Henry

1. J. Hillside Reap.
113, 19583

3.

J.

lééa 18h6, 1958)
A

Go., 325, 19593

J. Letkewite.

2. Die. Harv. 8:1. 12:
Eilleide Heepitel‘gt 13h, 1955) h. J.A.H.A.
Q}

197, 19571

5. Pszehozhernecolegz Frontiers, Little, Brown
6. Heuregazehozherneeologz, Eleerier, hhl, 1960;

7. A.H.A. Arch. Neural.

Psychiet. 1Q: 516, 19573 8. Die. Kerr.
5:3. 12: 227,19583 9. J. Hillside Heep. g. 3, 1955; 10. Arch.
lenrol &amp; Peychiet. 1g. 23, 1956.
11. First Int'l can . leurol. Sc1., Pergenon, 613, 1959:
12. Jeur. Herr. Kent. Die. $29: 117. 19603 13. A.H.A. Arch. Gen.Paychiet. (in press); lh. Unpublished nenneerﬁﬁtg 13. Jenr. Herr.
&amp;

'

Bent. Die. ggg: 187, 1960; 16. J. leurepeyehiet. 1: 2&amp;2, 19603
1?. Jour. lerv. Kent. Die. ggg. 2h3, 19593 18. A.H.A. Arch. Gen.
Psychiet. 1; S65, 1959: 19. A.H.A. Arch. laurel. &amp; Peychiet. ﬁg:
20. EEG Clin. Neurophyeiel. 15¢ 359, 1960.
380, 19583
21. Gened. Psych. Aeeee.

J.

A: 1668, 19591

22. Cent. Neural.

23. J. Hillside Hoep.‘§: 2&amp;1, 1957;
1g: 88, 19563
2k. Am. J.
Psychol. 13: 38h, 19593 25. A.H.A. Arch. Neural g: 5&amp;7, 19601
26. Free. 1?

Int.

Pezehel., lerth-Hellend, 238, 1959;
1%. J. Heuropeyohiet. 1} hS. 19593
28. Pezehezethelegz of
Guaranieetien, Grnne &amp; Stretton, 126, 19583 29. J. Hillside Heep.
g; 207, 1957; 30. Psyehiet. 3;. 2&amp;9, 1958.
Gong.

�.1531. Jour.

lorv. Hunt.

D13. 120: 235, 19603

Pazchiutric Drug Thorazz, 0.6. that‘s, 29, 19603
3b. Unpublished Hannueript.
Boap. g: 216, 195?)

32. ngnnieu at
33. J. Hillsid-

�lap-rtnaltal Fuyuhtutrac 2701:... at 3:11:14. luapitcls
A

title:

In: fink,

Fran tau ntpnrtuaut

”’F‘ul. 91“ “kl.

7!:
U

I,

1;!50

K.B.

a: sxpurtnuutnl Psychiatry, 1111.14.
10.1.;

'0’.

�/
[,

‘e

VI

//y

11/22/60

layoviunntal ruyuhtutrto Procrnnn u‘ [1113140 loapltnlu
A Icvtou

It. Virtoun

program: 1: an. nupartnant of xxpcrtnantal
Payoh‘airy 531‘ but: dcvutod to an underttnndtn: of tho sad. at
ﬂl‘itl at payuh1n$r1¢ thnruptta through studina at brtiu tunetiun.
rho principal inshnign¢¢ invo boon adapted {ran doneriptiv.

plyuilutry.vnanrapiyuhology, oloetronnotphnlocrnphy. lingututtcl,
phuruaaolﬂtyg and socinlocy.
1n
chungoa
brats
convululvu
thcrtpy,
at
initial attain:
functian nova round ta rtlatc both to ovuluution- o: inpruvaucnt

In

ptywholaciéﬁznrinblca.
Al 0‘? undarnttudtnu
and to pru~tr¢3tncut
or eonvulaivw thcrupy dovelupad, a genera: nouroyhynialozic1
(
usergnd
slanttw
). In this via:
thorapxos
a!
vita
udtpttvc
uiif‘i‘rxplnttonlly
thy
dogtoo
to
ottactivo
troutueutn
payihtntrtu
this brain function 13 uncuurahly nl‘nrnd. will. Chung. in brain
function 1- noatnsary tar bchuvtorul ch:u¢o, the twp. or nd:p$¢tton,
paywhologiédnna
hurtvnr, vnrtoo «avoiding upon pro-‘rontncnt
Itoiuloxliﬂcharactnrtutio: 02 sh. cuhdoot (2). Thus, tho use. or
uotlcn 1. not soon as ulthar 'oralnle' or *poynhologic' but rathcr
and
chaugua
of
nourophyaiologio
distant
tan
lattruaticn
a.
adnptivo 3008331.... turthcr, uh$lo bohtvtirtl chins. 1a rnluted
to ohnngns in brain ttnottaa,‘nnd the nanptivt patio!» t0
prt-triatuont psychologte thirtetcricttot, 07:1nat10nu a:
’1Iprovcunat', but»: npuottl $79.! or uvlzuntiou or chnnxo, arc
atrtvutivs stagnant. hated an :tatt and £1.11: oxpootutions and
inlcrtaonu (2).

�n2-

?hiu hypothuain Ill dovulopca and nuntstncd an a £021.! a!
ntuditl qt cunvulstvn thnrnpy. ctncurrcnt aﬁudios a: tuuulia can.
tnd1¢utod taut hohsvtor¢1 chant. horn. too, wua.r¢1ntod to tn.
lutot ind accrue or piniongut can: a: ropaatod stature. - that.
b.1uc tho prinaxpul manifestations at proloncod nonrcrhysioloctcaﬂ

an that»: (ink).

chm: in

It:

made

if

aoStoa of tho new pcyahotropio «goat; vac also

nithta thin hypothesis (5,6). It nan ouggontod that
ﬁhouo tgan%a would ho affectivc to tho 403:0. that ghoy induced
paratatant ch:ugau 1a brgtn fanatian and that the typo at bchaviur;l
rampaano Inuld to rolttud to tho typo or brain ohaagc, and to
prcaorbtd payohologit (paruunultﬁr) patturnt. Tho prisont pruxruan
in tin Btpartltat ‘20 4331¢u§d to study th.ue volitianuhipt in
unprosuud

_d¢tti1.
E

E

III

13‘ £88

a: turtou: nanutrnn at brain tunusiaa, thc alount a:

slaw

var. atttvity ta ta. cinctrcunoupphagzrin (1,8) tad contcbulutary
and 60.1.1 Inasmuch pattora: nttur unobarbital (9.10) not. thu
unit uoaca‘:vc that... (11) 1a .0I7‘101VD thorny: subjects. In
on. naportnont, tapruvclnnt ratings wire ctrruxttod with the
upponrnacc .1 itch dgcrooa or change in thou. inexact (7.10).
dtnbin-bltnd
1a
1n
abnorvntiana
tkntot
a
a‘udy
”‘2.
it...
Itiuh patiohta rotorrod for clootrguhock var. rand-n1: nustgncd
to court‘s o: otthor ocnvulutvu 0r aubconvulttvo therapy under
anurophytlologiénchaagt
pqntothnl prcnodtonttal. nigh dugrtul or
v!ra obuarvod only in tun convulitvn grnupg inprcvon-nt rutct varnixuitiouutly higher in this ﬁriﬁtj and vhaa subconvuluiv: nubjoeto

�U).

*

v.20 ru-trontad by couVIInivo upyliuutiona, ﬁlo tuprovcnnnt rut.
um: lintzsr to the orictual convtlaivt group (2).
In the anboouvulaivo treated Inhannta, uuuutdar;b1¢ Quaint.
or altntria «arrout yauaca hotuocu tho hitanporul cluotrodoc.
It Ipptﬂrtd that the thorupautic taunt wan not tho total cloatrle.1
currunt, aggugg, but an :11 or non. quality nan££.ctnd by thc
grand In: lotuuru (8,12). Th. algnittenuao at ﬁhc grand In!
I'liir. van~cxan1uod in etudiat of tho inhalant aouvnlsnnt,
insurlugrodtothylcth¢r (13692105). ﬁinilur 4.3!... of alsetro~
graphic ehsngc, ﬁngvovwnaut tutti, typos or bghgviortl ahtugo
and changes In nourvysyuholoxtiﬂgatk bahavivr nﬁro observcd in

tic tnhallnt

tn ulcatrieally treatud groups (13).
It at. anon npyaroat $hat act :11 tubjaats Ianiroatins
high tugraou or physiologxc chnngo warn rttod ts '1npravod'. Ia
a dcsaripttva typolngtn study, :31. ptttarna wire doacrihad,
impartcnlly turned 'ouphnrlu', 'hypounnio', 'sonlttnatiuu',
$0!!ﬂ.1£¢'1‘hdtlﬂl1'. and 'punlo‘. ﬁhtlo the ttrat tun of than.
udnpt11¢ .04.: nor: rttud I. 'nugh taprovod', ¢ho latter two were
noun as 'Iuinprovvd' or 'uoraa' (1%).
In station a: ysyuh01031£#VIrinb1on, it run vaportod that
pctxnnta rntcd as 'I‘ch improvud* and 'reaovurad' frequently
ltnituntcd puruonnltky puttcrut liuillr ta that diaeribod by
ﬁctuutnin and Ink: is ﬁhu laplacit vorbal 4.31.1 pornonality.
'In 1!:zunxo ynﬁtoras, patiantn capraastd thu 'lnazuugu a: doninl',
than ditthln brain ohnagc In: Indueca, txhiblttus anon napocﬁa an
txpltctt dintsl, Izaiuisataun, ditylne¢noat, cliches, g§g&amp;_uorc
traqu.ntly thug untuwravcd cubaoctu. Other 134130: taint-d to tnvorsblo
and

�.3.
hash I 5341. acct. (15), and Roruuhaeh dotarnintnts
«Olav, nbsaut novunaat and nbaont t-rn-calor (16,17). In thia
popu1&amp;tttn, also, :avurablo outatuu at. taaoctntod with 10v
uduaattgnnl uahxuvannnt tad {truism birth (18).

tutu... it?!

at

sitting a way to nuancat tun digit. of pentatonvulitvu :39
$1.! utvu nitzvity, ta anttahozanorciu coupltnd, «totEutzno, was
giro: tutrnvonoualy at various :tngos or tht ccavulutvc thor‘py
-

proutll (19). doa$r¢ry to oxyaetntiaal, ditthnlinc

eaunod In

lunadiatd and «attained ¢aer¢aan in EEG cloning. Patiunta with
donstl lagging. putt'ruu rulaaqntshad than. Inttcud or atphorin
aha wall hasng, thc lubjoota vat. irritqblc, anxious and prrO181V.
or pramtrnatnnnt patterns. In aubaastv prior ta eonvulaiva a:
drug thnrapy, diothantnu andueod uxaitanont, tan-ion, anxiety and
illusory nontatsunc.
ﬁuhaoqncht ntndica with 9th.: «antral antioholinurutc
ae-paunda (VII-8299. 33-318,336g hanaotyttno) aboucd behavioral
sad cloctrogruvhlc pattarau elitist to daoth‘xino. atnilnr
datynahrontnnttau o: postuconvulaivt 330 niacin; was ‘10. notod with
«Mt-'11 amnion-tutu: hunuinnuo (nphounno, «suntan, nan-as).
Ind ht: been rcpur‘od for tatihiatantnoa (diphunyihylrauinc).
that. thiarvaticnu 10d $a tut mugxultion thtt «a incrtano 1n coutrnl
ottltnargia activiiy VQI a btoahouscal haul: for thy convulaivc
ttorapr greats: (26).

rsmgonauo nma an no
During this parted, tho mod. 0: sctlaa cf ucv¢r psychotrepic
drug. trout-d intnrnst. rollcving tho caaouptc doravca tron
'

J2

otavulntvu ‘harupr, thu nc‘rophgwiologio outage: inanood by drug.

�.5...
f

tutti!

I1th1n tun 3.x. aautc oxpcrinautu1 trunnuork at th.
E39 usttinx. It It: thaurvod thtt phonothitslnos (ohlorpronasiac,

any.

prangnlnc, tritanaprolaaxna) :nduood axe ayauhrontauttou and a
oh£tt1ng of tho upcetrun to tho .10! frequaaotts; Improbaghtc cad
barbiturates, an incrouuud IyuchrnaxsatSOB and a shirt 0: spoctrnn
to inst (recitation; roanrpiuo, an Inorouood ulcvtns with Iyaohrouw

inattua at

.

dying... and douynchronisatioa at night! 10'010 (5,6).
2.133.313. tainted ﬁctynohrtnisnttua with a ah1:% ct :rcquauaicu
fa the a!” but: (21).
”‘ng
Gina: expirtnnatal annpounda tul‘cd inaludod nz~uxaa and
phtnyaioltlslino (ariatol), nectar tad its variant aoneaaors
(33:99), wtatlh9 (37"h) and trﬁnquol (lorrill). tor cash, an
I0|tiutcut olnctrucraphia putters it. recordta.
psyuhoyhnrtnollaciéwazoats
wgu
that
staccatod
It
pruvtd. u
nearaphyuiolotiéﬂpat§cran
u
for
of
1a
nasal
eliciting varicty
ctutraat t¢ tho sags}: psttura or induced scavalnionu. furthtrnouroyhyntolugidJtlttrttion,
sh.
a!
type
.02.,
I: rotlon$ad in
as: aynohrcny and IFC‘ICRGI ynttcrna, nun rolnt.‘ to apoottiud
typo: a: behavioral stuptntsdn. InorOtttuc nae aynchrony tad a shirt
GO aluu fvnqncactou aura nauoatttud with
trangutlltzn‘tua, notation
uni docrnﬁatng agitatious stilt angynohraatua£tua and a shirt tn
tu't tragucncloa It: antacxntta with excitouaut, tlluuionu. tad
dolnntcntl ilcatton (6.20). than: aha-trutionu are conclt‘aut with
hypothaloa o: Hitler. 2h. advantagon at are tuchntquco tn: the
300.7 or not payuhntropzc ugcntu haw. nlroady b¢0u reportcd (6).
low

�2h. presuut progrnn, instttnﬁod in Outabcr 1959. 1a banal an
sh... attitua and in 6.113304 £0 .3380? $8. I’llavinc quantlultu
In £3.90 t rolutlon hotutcn Innuurublo altovtttua
in 53:13 tunc‘ian and bohnvtoral «hung. with payuho-

airbus. unnaatatrttian?
120 that. proeﬁrtntnoatfqlua§oru gt paynhxatrao,
ptyctulcciéinnd ptyuhmlc¢1£&amp;variahzoa rolgtud to in.
tropic drugs

an

typa 0: hohnviornl adiptntttn?
And, art such cluntora rolntod to the typo and
403200 at phyutologle ohuuxo?#
‘gggaggs AI ua.1n1t1n1 ayproxinattcn, a doublnuhlind, sized
Gonna. random Isntgnncnt drug study

clinical

In. undertnktn. luccd

on our

varitu' piyuhctropto coup-sud; tron
195k to 1959, thrco clan... unto 0.100%04 an tho 5‘31! or that:
patﬁnrun or 310 ro‘ponao. tho slant. scloutnd wit. that. rich
oxpcrzoncoa with

caﬁhcr proloninan‘ dunynuhrouiutax pattcrnu, Irhahrontutng and

nlyvinc, or nintnal or no errant. Pattoutu r-rorrud in: drug
therapy, IItOf nudist: tun-auntaon. and art-r :11 other nodicntiouu
hay. boon diucoattuucd are randomly usutgacd to ‘ compound.1n an.
or that. ‘hrio «lacs...
Pa‘icnto are pvodonlnnuﬁly Ilddlo eluot, urban, utﬁh high
oiiontaonnl :t‘linlont. 1111.14. 80-pita1 1a a nou-pritit,
philanthtopie supported psychiatric tnutttutton, .duitttng voluntary
pattoutn {or txtonntvn puyuhothurcpoutie troitntut. fin loan
duration or its: fer patients in novon months. convuiaivc and
puychotropao drug thnrnpics It. pronortbud by star: payuhxntriota

�.1.
A11
thc
trlatnnut in aduluintorad by
to
naparﬁutu‘.
rottrrll
Da’artniatul stuff, no that the axpcraanutal vartthlta or drag
daoaco, rant. 0! adutaictrnttua, aaotguunut to groupu, 333, &amp;r¢
roadtly controllod. 111 patiantu in thc hoapttal arc «v.113blu
for titty.
Attor‘a tutti»: ptrtod, 111 puticnt: rocuivc he so or liquid
‘nndtogttoa daily tron 1nd:vtd:ally inhallcd bettlco. Dos;¢o: at:
incrcnscd in ttxnd tOIIII atop: tutti a u.x:uun at h ucnku. Artur
tun wank: on nixtnau 4.111., ro—tnatlnx ¢o¢ura.
to dn‘o, 1&amp;0 vuhjaoto but. hon: rtturtod, and 110 have outplatod
tn. study period. Proltniunry analyst: of tho data At. an: in

on

prozroau.
Ichuvigral GhlI‘Oi In a tutti: u: tho bnhnviorul adnptnstonu
of pt‘tuuta rcaoiviag pitucthiasiutl or inipruutua during 1958-59,
variauc clustorn at bchnvtora var. duvolopad. 1h. typalocton wore but-d
on tho trontatut rcapiaat and on pr0~trlntauut ptyuh1&amp;tr1c protilus.
In $3. pruncut sitar, tho typoloxint at. being tested, and variant
scalarot at behavtoral ahtug. at. being atudtod. It... inaluac

thorlyitt ritorrnl quortiouuairoc

I1:

cvaluntiono) therapiat
tad puts-at Glyn. Road s¢nlang burr aoglu .valuntiona 1n int¢rviov
by two rnutnrch psychiatrtnta. and Lorr Hard Scale.) and puttout
unit—ratings 15013413: ‘ho Johan toutinl symptul about lint and the
stints. Attstnda 50:10:.
boon
both
vtcvod
I‘Vl
tank.
as
Psycholnglc
lutrggangglogzg
thing: vsrtnhlou sud pradlcttvo variablou. In convulsivo thorgpy,
chingo¢ in Inner: tanks (22), tactile paraoption (23,2h), wcohnlcro
Bolltvu‘ (13). err (13). flatro‘3rocnd talk. (25). ‘nd tachlntQUQOptu
recognition a! figure: (26) war. relatcd to thy Court. or induocd
and

ﬂ‘Ok

am

�neurophyutczogaggihnngu.

In: 9.03 tack, tn. dcxroo at docruuont tn
rouui ta b. poatttvny ocrr'lutod with the

‘llk vortoruuncn nus
assist a! :36 closing. lollewaac trout-oat aonalation, with the
rotur: a: phybitloxialiaaauca t. prootroatnnnt lovnln, performing.

payahologidﬁkasku
in than:
also raturnud to pro-trontnont lcvuln, or
higher ~ a buttarntnt 02 purrornnnco ascribed to practi¢o afloat.
Donia: start. on interviﬁw (27), aoroohach dotorl1nuntn (16,17),

r 8.11. Idﬂvit (15,17),

ltngunzu pntﬁarns attnr tnobnrbttal (28),
andatary toodbuck and porcuption if the 11:ua1 Iyrscht have bcan
v10v0d a: prcdlattvu attains at tho hchavioral outages following
362.
fhauo vurinuo tank. are at: being Isa-anon with paychctropio

:.£?:1.1p
agon$s,
alpncxty

capacity to prudiot chaago.

t. cling.

wl‘h vurtona anout319igfﬁhotr

§;I¢§ronniqggg;o‘gughzg In tn. convulttvn therapy ntndlnt.
the intro. of as» slaving was latsurod by counting tho oonncauttv.
wave- 1» lolcotad :unpi:a (7). lab.» ta. not. nubtlchohuazoo at

uttoetl arc ltudiod, it in uooclaury to gyply lula'ttdionn
toohntquoa. Iltctroulc Iroqutncy nnnlrlia wt: introduacd 1h Angint
1959. 8y nauaurounat 0: th. pun doticetion for vaﬁﬂoal rrnquoneius
Iran 3 ta 33 8?! 1n ttn ataoaa epochs, rapid nanuurcnnat o: upptrintly
nlnll august. in total activity nnd troguoncy aptctrl arc new obtatnnd
drug

tad applied.
ethn- play-1.1.316"
in thin program include tha
rtlpautn I: :36 to iatrnvontua chlorpronnsinzj blood protauro reapnunu
to
the nut, pullout!" 1041” mute, and
a:
turtouv blo.d and urin. elegantl.

man" “at“

”any”

“an“

w:

9!

115‘

8

�tho
atadlco
in
napnrtuont hurt beta dovctoa
.:
to torn;1 1.33133: puﬁtcruu.
iylzoving it. stutits ct syntactic lung‘tgu pattern: (:8)
tn asavulitvo ihsrapy, uﬁhor capogts at 11:51:30 vuru Ituaxod for
tkcir r01:$£on an iudSQIa of change in intovpornonnl bohtvtor.
.Jattc, urtnr oonoiiertblc omnlorutian with Various linguistic
consecutivn
or
that
suggcitaa
typo~tokoa~rtttol
(I?!)
lilltrit,
ho t
1nd»: (19.30). man.
«mm: at and“ apneh
it! hid prtvionoly §ncn npplicd tn urittua $311: or en. 1:ngungo
nanplou of indivﬁdulil, 3.1!. indicated that the two pcrnou cou~
nuatcttton (47") was 1 nor. liznitignnt indox at tho itttn at
tho interacting than auulylou or i¢paratu snnpxoa of tho ptrtitiplutl.
tpplying than toohutque ﬁt convulltvu shtrnyy patients.
chanson 13‘!!! noun and atundnrd «aviation. var. r01¢tnd both to
in. deavco or induced 3:3 ulot wire aat1viti and to uyutnet1c
lunxttxo pattern. ob$ttnca 1n indopondtut atruatnral interviouu.
apauah 5.01:. no»: rupo‘tttvc (lowered noun If!) and nor. vartnhlo
in coautcutivu nunplon (in-ruaI04 utnndurd d¢v1at10n) (31). In
intarvtawl but-r. and alter tho mutrtvvaonu aduanlatrtttoa at
ecutrally activa astutu, 31:11:: Ihlngil Int. obnurvod. taint.
with n yrcdouinant lynchruatxgtion pnttorn on tn. £86 oxhibitcd a
4.120ntt in net: 191 cud inﬂfilti tn itandnrd duvxatioa o: necros,
viii. dotynchrouising ealputuda 01101106 groatcr variability in
tyccch pattcrus (1:090... in RI! Inna) tad dtcrunan in v.r1ub111%y
of coauoeutiva scorn. (duorouun 1n ntandnrd deviatian) (32).
6th.: languaga notnnrnl atudiod includod diatroccurolior
quttt¢ata, uclt-rutcruncc, and alttrntion 1n tunnu and paracn.
Antﬁhar 30:10.

m

tutu

�.19.

nu: sagsoaﬁcd that ﬁt... yuywhcltnxutstta Inaiurcs tgo pa‘cat
incantqutl for sh: operational unnlytns o: phyaiologig%und
yi:¢h¢1¢¢1€?£ttactn a: ycychopharanaolugse taunt: (32).

It

�aggggaggzc $233133

It ta. court. at

‘

thou. plyuhta%r1e protraaa, comaidartblo
InﬁnrOtt Ian unguudarcd in at. tantly organisation to which pttttnto
turn rcturntnc. Also, its ginornl problem at tho ralntiou or stein!
M chase. and
a: pnychutric treat-out, and the
Ipttifia prathn a! the rnlutiau of thtli factor. in tht rarogrul
puttarna lad to a aortic at papulatian studsus. In on: study (33).
ﬁduaattua. ﬂgi, plus: ct birth cud score on tho Galltarnia r Iallc
wort ticnttioaatly ralctad to the may. at therapy rocoivod und the
utilatniton at adainottva hotpttnl aortic... rhui, pgttont; aha
var. older, pearl! uduantcd, had hishar I neuron And aura tarnishhnru, ptrtiuularlyranstnrn invent. wart neat ltkuly to be 90:0rfﬂd
tar ¢ls¢trouhooh. that. rclationahlpl worn proaont indopiadont or
atlxntnoa. within tic sunny 3: cluo‘ronhack patiuntu, $3. tins for
rotttrnl for 3a: 3:: ulna rolntnd to ﬁhoau factora.
In t nocand ntud: (18), dnru‘ton a! harpitnliantion, discharge
uvnluattan and asucnoun: vova rolniod ta tho Ian. social flotara.
fur uxauplo, patient: harpitlltuna for it. uhortcnt ported EOE.
oldest, had in. lcaaﬁ education, v¢ro punt llkcly ta hnvc baou farcicaioru and had the hiahﬁr t ﬁnal. user‘s. Younger, uttivowborn, not.
nénuatod, lava: ! 89.10 a¢oro yuttonta worn hospit.11sod thu taunt-t.
I)... rnlntinanhipl htld trnc within troutlant typt and within
diagnoatic 0131!. on dinohargt, 014.: patients had tan unit tavorablc
ratings. In :61, patients rated as renovated or sunk improvod had tho
highoat r 3.0!... lasat aduantion and war. moat 113.1: ta b. rurattg*
born. In anoﬁhcr study or p;t1cat textual a: new, 01.11;: rolattun~
ships tutu obsorvad (3h).

an».

nun:

�.12“

‘

thc
under
antarctiout
in
study
not
volatiiauh1pa
If.
It...
Dtpnrtutnt, and in I triuhtnpttnl coupura‘tvo study. In tho 133%.:
utuﬂy, tho pcpn1n%1ona at ﬁbre. haupttclu uttk provatltac dittcvtng
$0
.11 pttaoutt,
:11
wits!
aquully
in
thoruptcs
arc
I'lillhlt
cltuutu,

- Ionian:- muauw Iowan (mu-«nu, run-mu, hunk»
nottn lontil ﬂunl‘h cantor (lowiroclnns, ctthnlta) ‘34 ltllllio

loaptt&amp;1 (naddzcvcliuu, icwioh)

It.

ﬁning tanouacd.

It ha.

bcon

thy
rotlooﬁ
antlntnco
.2 social
rolutiandhtpt
it...
ha011ruund on payth.lo¢1all prrcanuou, such ll habitual pnttnraa
or contagiouttun and gods: of «sproutioa. {ha cantrthlﬁton 0! than.
tnotara to tho patﬁorn o: ncaﬁal 111303., and thy ptticIt-thnrtpiot
intoruottou are undo: atnﬁy.

postultttd that

�.13-

may;
it. nipnr$uoat:1 99032.3:

are a oluutar a! interrolntod
studios tocuunod about cannon pnpulntauu annplcu. within ltllltdo
Iblpttnl, restart! ltboratoricu 1a niaehauiltry, and in nadtctno
if. aattVQ; and 0th.: inbnrntorina 1a puyuhodyulnto puynhtntry Ar.hmaac aqvolcpud. In tat; Dtpnrtnont, various diacipllnoo tr.
vartttayaats,roprtuoatzn: a gradual cravth a: :1: 33.3.. tartan:
grcuth and t8. ﬂirtation. a: tanning 31341.. tr. dapoudont .a tau
rostlta at tho attain. dotcrahtﬁ hart; no will a: th§ (rowing
£Il$1titt¢ll1.nilrin031 that ruaonrch in an tutogral part of thy
httpitul't opcrnttcu and budgu‘n . II that ll trcntnnat and otutt

training.

�~13:-

kahuna”

fauna: uni-cue“ that“ m £0.11.ng
rut: hum" m rink, ﬂu hunk. “but 1.. tum, Jinnah um,
Int-u I. Erna, 3”,. Km, In" mu, ma: 3'. £1.13.
Guru Imam, ”and a. auburn. “that“ 8. 33.301,
abun- Inn: at! nary J. Mint“...
Aim" at

tho

J. “11.1“ lap. 93 197, 1957;
.3. J. mun. Hospital at
1958;

2. Ms.

3..

.113.

In".

81..

3:2:

h. 4.1.11.1.
1.1m... Iron

131;. 1955;

h
5.
ms
h “mule 1min”,
a c... .325. 1339; 6.
¢h02m00§2u. naval". Mal, 19603
7. Add. not. loan)... a 1-31.31». ﬂ: $16, 1957: 0. Mn. In".
an. '33: ”7.19563 9. J. i111.“- llup. g: 3, 1955: 19. Arab.
18116,

1958;

”my;

1.956.
:3,
rennin.
t
ﬁt
11. nm In“). 3” In“ 1. Sci. , Penman, 613.
u. “an Em. that. 31!. 122' 117. 19691 13. 1.3.1:.

Int-.1

Mm“.

1959)

arch.

Gun.

pan);
ﬁnalist“ autumn 15. Jar. low.
but. ml. ms 15?, 1960: 16. a. lunpuehut. 3,: an, 1960;
1?. am. it". lat. M... m; 11:). 1959: 18. Mid. Arch. on.
”want. .13 555. 1959; 19. Add. Auk. Int-1. I: "youth £9:
no.

1958;

21.

g:

(in

1h.

can“.

8!, 1,563.

usual.

can Emlyn“. 9,3: 359.
uni. Anna. 3. A: 1668, 1959:

to. no

13. 3.

Hanna. luv. g:

1950.

2:.

21:1, 1957:

car. lmol.
2h.

a. J.

luau: g: Shh 1m;
8&amp;.
17.19%:
Gong.
238,
1959]
901350;”
law-mama,
m,
335.
4.
28.
19593
lmopoychiu.
u.
chhgzﬂhclaa at
y
«1-. 35.11.14. Buy.
5
1953;
126,
Gun
29.
Mutton,
cwuuia,
g: 207. 19573 30. urchin. 3.2») 2139, 1958.
1?} 381:. 19593

25. MILL. Arch.

�.

«150

‘1-..

O

3'1.

:"9:

‘.".¢ "”‘o ﬁt‘t

&gt;
‘

‘

hip.

g: 216, 195'!)

g

31:.

w!

”5’

1,69}

M',
uranium-a Mnuonph
3.6;

2’. 196°,

3!.

W

33. ‘¢ 31.11.14.

�Experimental Psychiatric Programs at Hillside Hospital:
A

Max

Review

Fink,

MnD.

the Department of Experimental Psychiatry, Hillside Hospital,
Glen Oaks, L.I., N.Y.
From

VI: 1/61

�Experimental Psychiatric Programs at Hillside Hospital
A

Review

various programs in the Department of EXperimental
Psychiatry have been devoted to an understanding of the mode of
action of psychiatric therapies through studies of brain function.
The

principal techniques have been adapted from descriptive
psychiatry, neuropsychology, electroencephalography, linguistics,
The

pharmacology, and sociology.
In initial studies of convulsive therapy, changes in brain
function were found to relate both to evaluations of improvement
and to pre~treatment

psychological variables. As our understanding
of convulsive therapy developed, a general neurophysiologicadaptive view of somatic therapies emerged (1). In this view
psychiatric treatments are seen as therapeutically effective to
the degree that brain function is measurably altered. While change
in brain function is necessary for behavioral change, the type of
adaptation, however, varies depending upon pre—treatment psychological and sociological characteristics of the subject (2). Thus,
the mode of action is not seen as either "organic" or "psychologic"
but rather as the interaction of diffuse neurophysiologic changes
and adaptive mechanisms. Further, while behavioral change is
related to changes in brain function, and the adaptive pattern to
pre-treatment psychologic characteristics, evaluations of
'improvement’, being special types of evaluation of change, are
derivative Judgements based on staff and family expectations and
tolerances (2).

�-2This hypothesis was developed and sustained in a series of
studies of convulsive therapy. Concurrent studies of insulin coma

indicated that behavioral change here, too, was related to the
onset and degree of prolonged coma or repeated seizures - these
being the principal manifestations of prolonged neurophysiological
change in this therapy (3,h).
The mode of action of the new
psychotropic agents was also
eXpressed within this hypothesis (5,6). It was suggested that
these agents would be effective to the degree that they induced

premorbid psychologic (personality) patterns. The present
programs
in the Department are designed to study these
relationships in

detail.

CONVULSIVE THERAPY PROCESS

0f various measures of brain function, the amount of slow

activity in the electroencephalogram (7,8) and confabulatory
and denial language patterns after amobarbital (9,10)
were the
most sensitive indices (11) in convulsive
therapy subjects. In
wave

one experiment, improvement

ratings

correlated with the
appearance of high degrees of change in these indices (7,10).
These observations were tested in a double-blind
study in
which patients referred for electroshock were
randomly assigned
to courses of either convulsive or subconvulsive therapy under
pentothal premedication. High degrees of neurophysiological change
were observed only in the convulsive group; improvement rates were
were

�-3-

significantly higher in this group; and when subconvulsive subjects
were rc-treated by convulsive applications, the improvement rate .was similar to the original convulsive group (2).
In the subconvulsive treated subjects, considerable amounts
of electric current passed between the bitemporal electrodes.
It appeared that the therapeutic agent was not the total electrical
current, per sez but an all or none quality manifested by the
grand mal seizure (8,12)o

significance of the grand mal
seizure was examined in studies of the inhalant convulsant,
hexafluorodiethylether (Indoklon). Similar degrees of electroThe

graphic change, improvement rates, types of behavioral change
and changes in neuropsychological task behavior were observed in
the inhalant and in electrically treated groups (13).

It

apparent that not all subjects manifesting
high degrees of physiologic change were rated as 'improved’. In
a descriptive typologic study, five patterns were described,
empirically termed 'euphoric', 'hypomanic', 'somatization',
'paranoid-withdrawal', and ‘panic'. While the first two of these
adaptive modes were rated as 'much improved', the latter two were
was soon

seen as *unimproved' or 'worse' (1h).

variables, it was reported that
patients rated as 'much improved' and 'recovered' frequently
manifested personality patterns similar to that described by
Weinstein and Kahn as the explicit verbal denial personality.
In language patterns, patients expressed the 'language of denial',
when diffuse brain change was induced, exhibiting such aspects as
In studies of psychological

�-h-

explicit denial, minimization, displacement, cliches, 222. more
frequently than unimproved subjects. Other indices related to
favorable outcome were high F Scale score (15), and Rorschach
determinants of color, absent movement and absent form-color (16,17).
In this population, also, favorable outcome was associated with low
educational achievement and foreign birth (18).
ANTICHOLINERGIC COMPOUNDS AND CONVULSIVE THERAPY

Seeking a way to augment the degree of post-convulsive
slow wave

activity,

an

anticholinergic

compound,

diethazine,

EEG

was

given intravenously at various stages of the convulsive therapy
process (19). Contrary to expectations, diethazine caused an
immediate and sustained decrease in EEG slowing. Patients with

denial language patterns relinquished them. Instead of euphoria
and well being, the subjects were irritable, anxious and expressive
of pre-treatment patterns. In subjects prior to convulsive or
drug therapy, diethazine induced excitement, tension, anxiety and
illusory sensations.
Subsequent studies with other central anticholinergic
compounds (WIN-2299, JB-318,336, benactyzine) showed behavioral
and electrographic patterns similar to diethazine. Similar
desynchronization of post-convulsive EEG slowing was also noted with
central sympathomimetic hallucinogens (amphetamine, mescaline,
LSD-25), and has been reported for antihistamines (diphenylhydraminc)
These observations led to the suggestion that an increase in central
cholinergic activity was a biochemical basis for the convulsive
therapy process (20).

�PSYCHOTROPIC DRUGS AND EEG

During

this period, the

drugs aroused

mode

of action of newer psychotropic

interest. Following the concepts derived

from

convulsive therapy, the neurophysiological changes induced by drugs
were tested within the same acute experimental framework of the
EEG setting.
It was observed that phenothiazines (chlorpromazine,
promazine, trifluopromazine) induced EEG synchronization and a
shifting of the spectrum to the slow frequencies; meprobamate and

barbiturates, an increased synchronization and a shift of spectrum
to fast frequencies; reserpine, an increased slowing with synchronization at low dosages, and desynchronization at higher levels
(5,6). Imipramine induced desynchronization with a shift of
frequencies to the slow bands (21).
Other experimental compounds tested included BL-M188 and
phenyltoloxamine (Bristol), Deaner and its various congeners
(Biker), WY-21h9 (Wyeth) and frenquel (Merrill). For each, no
consistent electrographic pattern was recorded.
It was suggested that psychopharmacological agents provide a
means for eliciting a variety of neurophysiological patterns in
contrast to the single pattern of induced convulsions. Furthermore, the type of neurophysiological alteration, as reflected in
EEG synchrony and frequency
patterns, was related to specified
types of behavioral adaptation. Increasing EEG synchrony and a
shift to slow frequencies were associated with tranquillization,
sedation and decreasing agitation; while desynchronization and a
shift to fast frequencies was associated with excitement, illusions,

�and

delusional ideation (6,20).

These observations are

consistent
with hypotheses of Wikler. The advantages of EEG techniques for
the assay of new psychotropic agents have already been reported
(6).

�97PSYCHOPHARMACOLOGY EVALUATION PROGRAM

_______an.._________.__u~m._______.

present program, instituted in October 1959, is based on
these studies and is designed to answer the following
questions:
Is there a relation between measurable
alteration in brain function and behavioral
change with psychotropic drugs on chronic
administration?
Are there pre-treatment clusters of
The

psychiatric, physiological and psychological
variables related to the type of behavioral
adaptation?
And,

Method:

As an

are such clusters related to the

initial

approximation, a double-blind, fixed
dosage random assignment drug study was undertaken. Based on
our
clinical experiences with various psychotropic compounds from
l9Sh to 1959, three classes were selected on the basis of
their
patterns of EEG response. The agents selected were those with

either predominant desynchronizing patterns, synchronizing and
slowing, or minimal or no effect. Patients referred for drug
therapy, after medical examination, and after all other medications

have been discontinued are randomly assigned to a
compound in one

of these three classes.

Patients are predominantly middle class, urban, with high
educational attainment. Hillside Hospital is a non-profit,

�-8-

philanthropic supported psychiatric institution, admitting voluntary
patients for extensive psychotherapeutic treatment. The mean
duration of stay for patients is seven months. Convulsive and
psychotropic drug therapies are prescribed by staff psychiatrists
on referral to the Department. All treatment is administered by
Departmental staff, so that the experimental variables of drug
dosage, route of administration, assignment to groups, 323. are
readily controlled. All patients in the hospital are available
for study.
After a testing period, all patients receive no cc of liquid
medication daily from individually labelled bottles. Dosages are
increased in fixed weekly steps until a maximum at h weeks. After
two weeks on maximum dosage, re-testing occurs.
To date, 1ho subjects have been
referred, and 110 have completed the study period. Preliminary analyses of the data are now
in progress.
Behavioral Change: In a survey of the behavioral adaptations
of patients receiving phenothiazines or imipramine during 1958-59,
various clusters of behaviors were developed. The typologies were
based on the treatment response and on pre-treatment psychiatric
profiles. In the present study, the typologies are being tested,
and various measures of behavioral change are being studied. These
include therapist referral questionnaires and six week evaluations;
therapist and patient Clyde Mood Scales; Lorr Scale evaluations in
interview by two research psychiatrists, and Lorr Ward Scales;
and patient self-retina including the Johns Hopkins symptom check

�-9-

list

the Chicago Attitude Scales.
Neuropsychology: Psychologic tasks have been viewed both as
change variables and predictive variables. In convulsive therapy,
changes in memory tasks (22), tactile perception (23,2h), WechslerBellevue (13), OFF (13), figure-ground tasks (25), and tachistoscopic recognition of figures (26) were related to the degree of
induced neurophysiological change. For each task, the degree of
decrement in task performance was found to be positively correlated
with the amount of EEG slowing. Following treatment completion,
with the return of physiologic indices to pre-treatment levels,
performance in these psychological tasks also returned to pretreatment levels, or higher - a betterment of performance ascribed
and

to practice effect.
Denial scores on interview (27), Rorschach determinants (16,17),
F Scale scores (15,17), language patterns after amobarbital (28),
auditory feedback and perception of the visual upright have been
viewed as predictive indices of the behavioral changes following
ECT.

These various tasks are now being assessed with psychotropic

agents, for both their capacity to change with various agents and
their capacity ts predict change.
Electroencephalography: In the convulsive therapy studies,
the degree of EEG slowing was measured by counting the consecutive
waves in selected samples (7). When the more subtle changes of
drug effects are studied, it is necessary to apply less tedious
techniques. Electronic frequency analysis was introduced in

�August 1959.

By

measurement of the pen deflection for various

frequencies from 3 to 33 cps in ten second epochs, rapid measurement of apparently small changes in total activity and frequency
spectra are now obtained and applied.
Other physiological variables studied in this program include
the response of EEG to intravenous chlorpromazine, blood pressure
reaponse to mecholyl, the EKG, radioactive iodine uptake, and
analyses of various blood and urine elements.

�-11PSYCHOLINGUISTICS

series of studies in the Department have been devoted
to formal language patterns.
Following the studies of syntactic language patterns (28)
Another

in convulsive therapy, other aspects of language were studied for
their relation as indices of change in interpersonal behavior}.
Jaffe, after considerable exploration with various linguistic
measures, suggested that type-token-ratios (TTR) of consecutive
samples of dyadic speech may be a useful index (29,30). While
TTR had previously been applied to written texts or the language

individuals, Jaffe indicated that the two person communication (dyad) was a more significant index of the state of
the interaction than analyses of separate samples of the
participants.
Applying this technique to convulsive therapy patients,
changes in TTR mean and standard deviations were related both to
the degree of induced EEG slow wave activity and to syntactic
language patterns obtained in independent struuctured interviews.
Speech became more repetitive (lowered mean TTR) and more variable
in consecutive samples (increased standard deviation) (31). In
interviews before and after the intravenous administration of
centrally active agents, similar changes were observed. Agents
with a predominant synchronization pattern on the EEG exhibited a
decrease in mean TTR and increase in standard deviation of scores,
while desynchronizing compounds elicited greater variability in
samples of

speech patterns (increase in

TTR

mean) and

decrease in variability

�-12-

of consecutive scores (decrease in standard deviation) (32).

other language measures studied included distress-relief
quotients, self-reference, and alteration in tense and person.
It was suggested that these psycholinguistic measures are potent
techniques for the operational analyses of physiological and
psychological effects of psychopharmacologic agents (32);

�SOCIOLOGIC STUDIEE

In the course of these psychiatric programs, considerable
interest was engendered in the family organization to which patients

returning. Also, the general Problem of the relation of social
factors to choice and results of psychiatric treatment, and the
specific prohlem of the relation of these factors to the referral
patterns led to a series of population studies. In one study (33),
education, age, place of birth and score on the California F scale
were significantly related to the type of therapy received and the
utilization of adjunctive hospital services. Thus, patients who
were older, poorly educated, had higher F scores and were foreignborn, particularly in Eastern Europe, were most likely to be referred for electroshock. These relationships were present independent of diagnoses. Within the group of electroshock patients, the
time for referral for ECT was also related to these factors.
In a second study (18), duration of heapitalization, discharge
evaluation and diagnoses were related to the same social factors.
For example, patients hospitalized for the shortest period were
oldest, had the least education, were most likely to have been
foreign-born and had the higher P Scale scores. Younger, nativeborn, more educated, lower F Scale score patients were hospitalized
the longest. These relationships held true within treatment type
and within diagnostic class. On discharge, older patients had the
most favorable ratings. In ECT, patients rated as recovered or
much improved had the highest F scores, least education and were
most likely to be foreign-born. In another study of patient
were

�refusal of

similar relationships were observed (3h).
These relationships are now under study in the Out-Patient
Department, and in a tri-hospital comparative study. In the
latter study, the populations of three hospitals with prevailing
differing clients, in which all therapies areenually available to
all patients, - Menninger Foundation Hospital (upper-class,
Protestant), Massachusetts Mental Health Center (lower-class,
Catholic) and Hillside Hospital (middle-class, Jewish) are being
assessed. It has been “postulated that these relationships reflect
the influence of social background on psychological processes,
such as habitual patterns of communication and modes of expression.
The contribution of these factors to the pattern of mental illness,
and the patient-therapist interaction are under study.
ECT,

�SUMMARY

Departmental programs are a cluster of interrelated
studies focussed about common population samples. Within Hillside
The

HOSpital, research laboratories in Biochemistry, and in Medicine
are active; and other laboratories in psychodynamic psychiatry are
being developed.

In

this Department, various disciplines are

participants, representing a gradual growth of six years. Further
growth and the directions of ensuing studies are dependent on the
results of the studies described here; as well as the growing
institutional awareness that research is an integral part of the
hospital's operation and budgets - as much as treatment and staff
training.

�~16-

References
Authors of the following references include the following
staff members: Max Fink, Max Pollack, Robert L. Kahn, Joseph Jaffe,
Martin A. Green, Eric Karp,

Korin, Donald F. Klein,
George Krauthamer, Arnold G. Blumberg, Nathaniel S. Siegel,
Abraham Kaplan and Henry

Hyman

J. Lefkowits.

1. J. Hillside Hosp. 6: 197, 1957;
2. Dis. Nerv. Sys. 12:
3. J. Hillside Hospital h: 13h, 1955;
113, 1958;
h. J.A.M.A.
166: 18h6, 1958;
5. Psychopharmacology Frontiers, Little, Brown
6. Neuropsychopharmacology, Elsevier, hhl, 1960;
7. A.M.A. Arch. Neurol. &amp; Psychiat. 18: 516, 1957;
8. Dis. Nerv.
Sys. 12: 227, 1958;
9. J. Hillside Hosp. A: 3, 1955;
10. Arch.
Neurol &amp; Psychiat. 16: 23, 1956.
&amp;

Co., 325, 19593

11.

First Int'l

Cong. Neurol.

Sci.,

Pergamon, 613, 1959;

12. Jour. Nerv. Ment. Dis. 129: 117, 1960;
13. A.M.A. Arch. Gen.
Psychiat. (in press); 1h. Unpublished manuscript; 15. Jour. Nerv.
Ment. Dis. 129: 187, 1960;

16.

J. Neuropsychiat.

l:

2h2, 1960;

17. Jour. Nerv. Ment. Dis. 128: 2h3, 1959;
18. A.M.A. Arch. Gen.
Psychiat. l: 565, 1959; 19. A.M.A. Arch. Neurol. &amp; Psychiat. 82:
20. EEG Clin. Neurophysiol. 13: 359, 1960.
380, 1958;

J. g: 1663, 1959; 22.
J. Hillside Hosp. 6: 2hl, 1957;

21. Canad. Psych. Assoc.

16: 88, 1956;

23.

Conf. Neurol.
2h.

Am.

J.

25. A.M.A. Arch. Neurol. g: 5&amp;7, 1960;
Psychol. 13: 38h, 1959;
26. Proc. XV Int. Cong. Psychol., North-Holland, 238, 1959;
27. J. Neuropsychiat. l: h5, 1959;
28. Psychopathologx of

�-17-

m
Communication, Grune

'

&amp;

Stratton, 126,

19583

29.

J. Hillside

Hosp.

6: 207, 1957;

30. Psychiat. g3: 2&amp;9, 1958.
31. Jour. Nerv. Ment. Dis. 130: 235, 1960;

Psychiatric

HOSp.

Drug Therapy, C.C. Thomas, 29, 1960;

6: 216, 1957;

3h. Unpublished Manuscript.

32. ngamics of
33. J. Hillside

�EXPERIMENTAL PSYCHIATRIC RESEARCH
AT HILLSIDE
Review and Prospect
MAX FINK, M.D.

Reprinted from
JOURNAL OF THE
HILLSIDE HOSPITAL
Volume X ' Nos. 3-4 ° July-Oct. 1961
.

�EXPERIMENTAL PSYCHIATRIC RESEARCH
AT HILLSIDE
Review and Prospect
MAX FINK,

MD.

The dedication of Hillside Hospital as a Research Institute
has been a dream of many of its students—a dream that may
achieve realization in this decade. Dr. Tarachow was an early
proponent of this view; and both in his sponsorship of the Journal, and in his encouragement of research studies, he presaged
this development. He was also the inadvertent sire of the research studies in experimental psychiatry. While I was a resident in psychiatry in 1952, we collaborated in a study of the
relation of the early separation of child from a parent to the
adult choice of neurosis. Reviewing the hospital records of ﬁve
previous years we concluded that there was, indeed, a relation—
neurotic patients with obsessional neuroses had a signiﬁcantly,
greater incidence of separation than patients with hysterical
neuroses (2). This report was the beginning of the patient population studies described here.
Since 1954 the various programs in experimental psychiatry have
been devoted to an understanding of the mode of action of the psy-

chiatric therapies of the hospital. The techniques have been adapted
from descriptive and dynamic psychiatry, neuropsychology, electro—
encephalography, linguistics, pharmacology, and sociology. This report reviews these studies and presents support for the creation of
a Research Institute at Hillside.
PAST STUDIES

In our early studies of convulsive therapy, instituted with the
1

From the Department of Experimental Psychiatry, Hillside Hospital, Glen

Oaks, N. Y.

The studies reported here have been aided by the Board of Directors Research

Fund; the National Institute of Mental Health (Grants M-927; MY-2092,-27l5,
~4798; MF-12,033); Foundations Fund for Research in Psychiatry (FFRP 56-151);
Kaufmann, and Dazian Foundations; and numerous pharmaceutical concerns including Geigy, Bristol, Wyeth and Smith, Kline 8: French Laboratories.
159

�160

MAX FINK

aid of a grant award of the National Institute of Mental Health,
evaluations of patient improvement were shown to be dependent
both on changes in brain function and on psychological factors. As
our understanding of convulsive therapy developed, a general neurophysiologic-adaptive view of somatic therapies emerged (6).
A change in brain function was seen as a necessary condition for
behavioral change, with the type of change varying, depending upon
psychological and sociological characteristics of the subject (22, 25).
Thus, the mode of action was not seen as either ”organic” or “psychological” but rather as the interaction of neurophysiological
changes and individual patterns of response and behavior.
This hypothesis was sustained in studies of convulsive and insulin coma therapies (21, 22); and the mode of action of the new
psychotropic agents was expressed within this hypothesis. It was suggested that psychotropic drugs would be effective to the extent that
persistent changes in brain function were induced; and that the type
of behavioral response would be related to the type of brain change,
and to individual premorbid psychologic (personality) patterns (6,
28, 40).

l. Convulsive Therapy Process: Seeking a measure of altered
neurophysiological change that was sensitive and suitable for repeated retests, various measures were studied including changes in
the face-hand test (1, 10, 13, 35), memory tests (17, 35), amount of
slow-wave activity in the EEG (16, 23) and confabulatory and denial
language patterns after amobarbital (3, 15). The latter two, EEG
and amobarbital tests, were the most sensitive indices of change in
convulsive therapy subjects. In one experiment, clinical ratings of
improvement were correlated with high degrees of change in these

indices (15, 16).
These observations were tested in a double-blind study in which
patients referred for electroshock were randomly assigned to either
convulsive or subconvulsive therapy. High degrees of electrographic
slow-wave activity and positive amobarbital tests were observed only
in the convulsive group; improvement rates were signiﬁcantly higher
in this group, and when subconvulsive subjects were retreated by
convulsive applications, the improvement rate was similar to the
convulsive group (22).
In subconvulsive applications, considerable electric current passes
between the electrodes. It was postulated that the therapeutic agent
was not the total electrical current per se, but the “all or none”
quality manifested by the grand-mal seizure (9, 23, 42). The signiﬁ-

�EXPERIMENTAL PSYCHIATRIC RESEARCH

161

cance of the grand-mal seizure was examined in a comparative study
of the inhalant convulsant, hexaﬂuorodiethylether (Indoklon), and
electrically induced seizures. Similar degrees of electrographic change,
improvement rates, types of behavioral adaptations, and changes in
neuropsychological task behavior were observed in both the inhalant
and in the electrically treated groups (49).
However, not all subjects manifesting high degrees of physiological change were evaluated as “improved.” In a descriptive typologic
study, ﬁve adaptive modes were described, empirically termed “euH H
phoric,” “hypomanic,” “somatization, paranoid-withdrawal,” and
“panic.” While the ﬁrst two patterns were rated as “much improved,”
the latter two were seen as “unimproved” or “worse” (50).
In studies of psychological variables, it was reported that patients
rated “much improved” and “recovered" frequently manifested
personality patterns akin to the explicit verbal denial personality type
(37). These patients expressed the “language of denial” more frequently than unimproved subjects, exhibiting such aspects as explicit
denial, minimization, displacement and clichés (27). Other psychological indices also related to favorable outcome included high F
Scale score (42), Rorschach determinants of color, absent movement
and absent form-color (30, 45), and low educational achievement and
foreign birth (31).
2. Anticholinergz'c Compounds and Convulsz've
Therapy: Seeking a way to augment the degree of postconvulsive EEG slow-wave
activity, an anticholinergic compound diethazine, was given intravenously at various stages of the convulsive therapy process (20, 24).
Unexpectedly, diethazine caused an immediate and sustained decrease in EEG slowing, which was associated with marked changes
in language and mood. In patients with denial language
patterns
(27), these could no longer be elicited. Instead of euphoria and wellbeing, the subjects became irritable, anxious, and complaining. In
subjects prior to convulsive or drug therapy, diethazine induced excitement, tension, anxiety, and illusory sensations.
Subsequent studies with other central anticholinergic compounds
and sympathomimetic hallucinogens showed behavior and electrographic patterns similar to diethazine. These observations led to the
suggestion that an increase in the cholinergic activity of the central
nervous system was the biochemical basis for the convulsive therapy
process (38).
3. Psychotropic Drugs and EEG: Following these studies, the
neurophysiological changes induced by drugs were tested within an

�162

MAX FINK

acute experimental EEG setting. It was observed that phenothiazines
induced EEG synchronization and a shifting of the frequency spectrum to the slow frequencies; meprobamate and barbiturates, an
increased synchronization and a shift of the spectrum to fast frequencies; reserpine, an increased slowing with synchronization at low
dosages, and desynchronization at higher levels (18, 26, 28, 40). Imipramine induced desynchronization with a shift of frequencies to
the slow bands (33, 34). Each active psychotropic compound was thus
shown to have a characteristic frequency pattern.
Various other experimental compounds were also tested, and for
these no consistent electrographic pattern was recorded. These compounds have since been shown to have either no or very limited clinical psychotropic activity. The absence of behavioral change with these
compounds lent further support to the assumption that brain change
is a necessary condition for the action of psychotropic drugs.
These observations suggested that psychopharmacological agents
provide a means for eliciting various types of altered brain function
in contrast to the single pattern following convulsive therapy. Furthermore, the type of neurophysiological alteration, as reﬂected in
EEG synchrony and frequency patterns, was found to be related to
speciﬁed types of behavioral adaptation. The advantage of EEG techniques for the assay of new psychotropic agents and the technical
merits of electronic frequency analysis were assayed and described
(47, 52).
4. Insulin Coma Therapy:

In our insulin coma studies we con-

firmed earlier observations that persistent alterations of brain function were related to prolonged coma and spontaneous seizures; and
saw in this relationship support for a neurophysiologic-adaptive hypothesis. With the availability of the new psychotropic agent chlorpromazine, a controlled chlorpromazine-insulin coma study was undertaken in September, 1955. As patients were referred for insulin coma
they were randomly assigned to courses of either oral chlorpromazine
for at least three months in doses adjusted to fall short of toxicity;
or insulin coma, induced by a standard technique at least ﬁfty times
in each patient. While a number of minor differences were noted
in comparing the two therapies, the results at time of discharge
showed no statistical difference in the effectiveness of both treatments.
Neither treatment seemed to affect the basic schizophrenic process,
but chlorpromazine had the advantage of being safer, easier to administer, and better suited to long-term management (21). Concurrently, following the suggestion by the Creedmoor workers that

�EXPERIMENTAL PSYCHIATRIC RESEARCH

163

divided insulin doses were superior to single insulin doses, Blumberg
and Laderman (39) essayed this problem and demonstrated no signiﬁcant merit to the multiple-dose technique. (In 1958, following the
general conﬁrmation of these observations, insulin coma therapy was
discontinued at Hillside).
5. Neuropsychology: Various psychophysical tests were adapted
from neuropsychology, where their signiﬁcance in brain-damaged
subjects had been demonstrated. The early studies assessed these tasks
as indices of altered brain function (35), and measured the range of
performances of psychiatric patients, who are generally assumed not
to be brain-damaged. Thus, memory function was assessed on immediate recall, after various interpolated learning tasks (17, 35),
as well as during convulsive therapy (17). Tactile perceptual tasks
were ﬁrst examined in the clinical population (1). Later, with more
sensitive electrical tactile stimuli, Korin (10) observed the range of
thresholds in different body parts, the changes with altered brain
function (10), and the inﬂuence of set (instruction) on performance
(36). We also studied the perception of embedded geometric ﬁgures
(43), tachistoscopic presentation of embedded color ﬁgures (55), perception of the visual upright (55), critical ﬂicker frequency (49), and
interference in reading time by delayed auditory feedback (55). For
each task, the degree of decrement in task performance was found to
be positively correlated with the amount of EEG slowing. Following
treatment completion, with the return of physiological indices to pretreatment levels, performance in these psychological tasks also returned to pretreatment levels, or higher—a betterment of performance ascribed to practice effect.
Concurrently, assessment of various psychological measures as
indices predictive of behavioral change during convulsive and drug
therapies led to studies of the Rorschach determinants (30, 45), California F Scale scores (30, 42), language patterns after amobarbital
(27), denial scores on interview (37), and the perception of the visual
upright and auditory feedback (55).
6. Psycholinguistics: Concurrent with the syntactic language
studies (27), analyses of other language patterns were undertaken,
both in a search for more objective indices of behavioral change and
to gain experience in the technical problems of tape analysis for psychotherapy research. An index of variability in the vocabulary of
speech, the type-token ratio (TTR) of consecutive samples of dyadic
speech, was extensively studied (7,41, 44, 46, 56, 57).
In convulsive therapy patients, signiﬁcant changes in TTR mean

�164

MAX FINK

and standard deviations were related both to the degree of induced
EEG slow-wave activity and to syntactic language patterns obtained
in independent structured interviews. It was noted that speech became more repetitive (lowered mean TTR) and more variable in
consecutive samples (41). In interviews before and after the intravenous administration of centrally active agents, similar changes were
observed. Agents which produced predominant synchronization patterns on the EEG were related to a decrease in mean TTR and an
increase in the standard deviation of scores, while desynchronizing
compounds elicited greater variability in speech patterns and decrease in variability of consecutive scores (44).
Other language measures studied included distress-relief quotients,
self-reference, and alterations in tense and person. It was suggested
that these psycholinguistic measures are useful techniques for the
operational analyses of physiological and psychological effects of
psychopharmacological agents (44, 46).
7. Brain Damage and Schizophrenia: Following his studies at
Ittleson Center, Pollack reviewed the relationship between age of
hospitalization, intellectual functioning and prognosis in schizophrenic children and adults. He noted that initial hospitalization in
childhood and adolescence was related to I. Q. scores in the subnor—
mal range, deviant performance on psychomotor tasks, and more frequent ratings of “unimproved” at hospital discharge than was initial
hospitalization as an adult. The early and insidious onset of the behavioral syndrome “schizophrenia” was thus related to brain dysfunction (54). Findings suggest that different subgroups of schizophrenia may be classiﬁed on the basis of neuropsychological deviancy.
8. Sociological Studies: Considerable interest in the family organization to which discharged patients were returning, the relation
of social factors to choice and results of psychiatric treatment, and the
specific problem of the relation of these factors to treatment referral
patterns led to a series of population studies. In one study (8), education, age, place of birth, and score on the California F Scale were
signiﬁcantly related to the type of therapy received and the utilization of adjunctive hospital services. In a second study (31), duration
of hospitalization, discharge evaluation, and diagnosis were related
to the same social factors, while in a study of patient refusal of ECT,
similar relationships were observed (51).
These observations suggested a comparative interinstitution study,
and among three hospitals the relationships between social class and
other demographic variables (age, sex, education) to the clinical

�EXPERIMENTAL PSYCHIATRIC RESEARCH

165

variables of patient classiﬁcation (diagnosis), duration of hospitalization, selection of therapy, and discharge evaluation have been assessed.
Three teaching institutions were selected in which all therapies are
equally available to all patients—Menninger Foundation Hospital
(upper-class, Protestant), Massachusetts Mental Health Center (lowerclass, Catholic), and Hillside Hospital (middle-class, Jewish). In such
a comparison we have found the differences in designations of treatment, diagnosis, and discharge evaluation so marked as to make comparisons difﬁcult. While many relationships between social variables
and clinical variables were observed in each hospital, no social variable was found related to the clinical variables in every hospital
(53).

In an outpatient department study, sex, age, and marital status
were found to be related to the acceptance and rejection of patients
and failure to complete the application process (55).
These observations in population samples led to concurrent
studies of staff attitudes in the selection of therapy (ll, 12). In a
series of ward observation studies, Kaplan and Lefkowits indicated
the signiﬁcant role of staff attitudes (especially nursing personnel)
in the referral for subjects for somatic therapies, and in the transfer
of patients from one ward to another. (To study the inﬂuence of
staﬂ attitude on patient selection for drug therapy, we requested one
ward be designated as a “no-movement” unit. This was adopted in
September, 1959 and shortly thereafter by the whole hospital.)
PRESENT STUDIES

During the period of the convulsive therapy studies, many new
psychotropic compounds were assessed clinically (5, 21), electrographically (34, 40, 48), and psychophysically (48). The present psychopharmacology evaluation program, based on these studies, was
designed to answer the following questions:
1.

Is there a relation between measurable alteration in brain

function and behavioral change with psychotropic drugs on
chronic administration?
2. Are there pretreatment clusters of psychiatric, physiological,
and psychological variables which are related to the type of
behavioral adaptation?
3. Are such clusters related to the type and degree of physiologi-

cal change?

As an initial approximation, a double-blind, ﬁxed dosage, ran-

�166

MAX FINK

dom assignment drug study was undertaken. Based on our clinical
experiences three types of compounds were selected on the basis of
their EEG patterns. In this study, 203 subjects were referred, and 149
have completed the testing program, from October, 1959 to July,
1961.

l. Behavioral Change: In a survey of the behavioral adaptations
of patients receiving various psychotropic compounds during 195859, a behavioral typology based on the treatment response and on
pretreatment psychiatric profiles was developed (55). In the present study, the typologies are being tested, and various measures of
behavioral change studied, including therapist ratings, self-ratings,
and various ward observation scales.
2. Neuropsychology: Psychological tasks have been viewed both
as indices of behavioral change and as predictive guides in convulsive
therapy. Each of these tasks and a selected group of motor tasks are
now being assessed for both their capacity to reveal change with
various drugs and their capacity to predict change with the drugs
in this program (48).
3. Electroencephalography: In the convulsive therapy studies,
the degree of EEG slowing was measured by counting the consecutive
waves in selected samples (16). When the more subtle changes of
drug effects are studied, it is necessary to apply less tedious techniques
(48), and electronic frequency analysis was introduced in August,
1959. By measurement of the pen deﬂection for various frequencies
from 3 to 33 cps in ten-second epochs, rapid measurement of apparently small changes in total activity and frequency spectra are
obtained (52).
Other physiological variables studied in this program include the
response of EEG to intravenous chlorpromazine, blood pressure response to mecholyl, the EKG, radioactive iodine uptake, and analyses
of various blood and urine elements.
4. Data Analysis: To analyze the data generated in this study,
we have sought the aid of complex statistical methods and computational facilities. Analyses of covariance, correlation matrices, factor
analyses, and discriminant function analyses are computations now
in progress with these data at the NIMH Psychopharmacology Service Center’s Biometric Laboratory in Washington.
THE NEXT STEPS

Favored by a national research climate and a cooperative hospital
staff, these studies have proceeded vigorously. The assets for research
in this setting have been great—a selected, intelligent patient popula-

�EXPERIMENTAL PSYCHIATRIC RESEARCH

167

tion resident from six to twelve months, without individual economic
limitation of hospital stay; a sophisticated administration tolerant of
controlled studies; and approval of a Board of Directors who desire
“research” as an institutional function.
As Dr. Lewis Robbins noted in his ﬁrst hospital
report in 1959,
a specialty hospital can make little impact on the mental illness
problems of the community by treatment alone. The successful treatment of 350 patients a year is but little comfort to the 40,000 resident
patients in the state hospitals of Long Island. Nor will the annual
training of twenty or thirty physicians in the arts of psychotherapy
do much to help these unfortunates or the
many thousands of ambulatory mentally ill resident in the nation. No, a therapeutic goal
alone is salutary but inadequate to our needs. As he proposed, the
answer may lie in the dedication of a “research hospital,” as it is
here that a specialty hospital can truly excel.
The charter has been written in the Board’s assertion of research
as a hospital goal. With the assets of an exemplary therapeutic facility,
such rededication can provide the stimulus for the continuous
study
of the cause of mental illness and of methods of therapy.
Such dedication would provide the stimulus for comparative and
controlled assessments of different therapeutic techniques. Continued
study is urgently required of the selection of patients for various therapies; the application and mode of action of the therapies; and the
role of social and milieu factors in supporting the effects of our therapies.
Assessments require a meaningful classiﬁcation of subjects. The
behavioral variables alone, which are the basis of our
present diagnostic schemata, are unsatisfactory. Study is urgently required of the
applicability of social and demographic variables; psychological task
performance proﬁles; typologies based on behavioral response to deﬁned stresses or drugs; and physiological reactivity measures. Such
classiﬁcations are also essential for any biochemical, physiological,
or evaluative study to provide homogeneous samples and comparable
controls.
Assessments also require meaningful indices of evaluating change.
Present global “improvement” ratings and socialization measures are
inadequate. Whether the intervening variable be milieu therapy,
psychotherapy, drug therapy, or time, the criteria of behavioral
change require deﬁnition. The applicability of rating scales, language
tasks, self~ratings, psychophysical change scores, family assessments,
etc., require study and evaluation.
Recent studies of psychotic subjects have provided the suggestion

�MAX FINK

168

that there is a neurologic factor in a group of the schizophrenias.
The high incidence of electrographic and neurologic dysfunction, the
lack of behavioral response to all therapies, and the relentless course
of the illness suggest an “organic” involvement in this cluster. Such
a substrate must be clearly sought by the application of biochemical,
neurophysiological, and epidemiological techniques to various clusters of young psychotic subjects.
These are broader views of some of the questions studied in the
programs in experimental psychiatry of the past seven years. These

programs, and the contemporary projects in biochemistry and in
medicine, provide models of bootstrap studies undertaken with
limited support. A dedication of Hillside Hospital as a Research
Institute will provide the needed focus and impetus for the scientiﬁc
and humanitarian forces of the community to join in a common endeavor to resolve the problems of the mentally ill.
Acknowledgment: Participants in these programs include the
present members of the Department of Experimental Psychiatry:
Ira Belmont, Martin A. Green, Abraham Kaplan, Eric Karp, Donald F. Klein, John C. Kramer, Max Pollack, and Arthur Willner.
Former associates included Karl Andermann, Joseph Jaffe, Robert
L. Kahn, Hyman Korin, George Krauthamer, Nathaniel Siegel;
and Research Fellows Barre Alan, Fred Coleman, Harold Esecover,
Stanley Friedman, Henry J. Lefkowits, and Robert Shaw. The
cooperation of Arnold G. Blumberg of the Department of Medicine in the present program is gratefully acknowledged. The reports listed here are the result of the collaboration of these workers
and the professional staffs of the hospital who gave unstintingly of
their time and their good-will.
REFERENCES
(1)

'

This Journal, 1:21, 1952; (2) ibid., 2:67, 1953; (3) ibid., 4:3, 1955; (4)
ibid., 4:134, 1955; (5) ibid., 5:67, 1956; (6) ibid., 6:197, 1957; (7) ibid.,
6:207, 1957; (8) ibid., 6:216, 1957; (9) ibid., 6:229, 1957; (10) ibid., 6:241,
1957.

(13) Neurology, 4:211,
(15) ibid., 76:23, 1956;
1956; (18) EEG Clin.
(20) ibid., 10:207, 1958.
(21) ]. Am. Med. Assn., 166:1846, 1958; (22) Dis. Nero. Sys., 192113, 1958; (23)
ibid., 19:227, 1958; (24) Arch. Neurol., Psychiat., 80:380, 1958; (25) ibid.,
80:73, 1958; (26) Neurology, 8:682, 1958; (27) Psychopathology of Communication, New York: Grune 8c Stratton, 126, 1958; (28) Psychopharmacology Frontiers, New York: Little, Brown, 325, 1959; (29) Proc. XV Int. Cong.
Psychol, North Holland Publ., 238, 1959; (30) J. Nero. Ment. Dis., 128:243,
1959.
(31) Arch. Gen. Psychiat., 1:565, 1959; (32) EEG Clin. Neurophysiol., 11:398,

(11)

This Journal, 10:84, 1961; (12) ibid., 10:97, 1961;
1954; (14) Arch. Neurol., Psychiat, 72:233, 1954;
(16) ibid., 78:516, 1957; (17) Conf. Neurol., 16:88,
Neurophysiol.,9:180,1957; (19) ibid., 10:162, 1958;

�EXPERIMENTAL PSYCHIATRIC RESEARCH

169

1959; (33) ibid., 12:243, 1960; (34) Canad. Psychiat. Assn. ]., 4:1668, 1959;
(35) Proc. Int. Cong. Neurol. Sci., Pergamon, 613, 1959; (36) Am. J. Psychol., 72:384, 1959; (37) J. Neuropsychiat., 1:45, 1959; (38) EEG Clin.
Neurophysiol., 12:359. 1960; (39) Am. ]. Psychiat., 116:839, 1960; (40)
Neuro-Psychopharmacol., 1:441, Elsevier, 1960.
(41) J. Nerv. Ment. Dis., 130:235, 1960; (42) ibid., 1302187, 1960; (43) Arch.
Neurol., 2:547, 1960; (44) Dynamics of Psychiatric Drug Therapy, Springﬁeld: Thomas, 29, 1960; (45) J. Neuropsychiat., 1:242, 1960; (46) Am. J.
Psychother., 15:46, 1961; (47) Neuro-Psychopharmacol., 2:30, Elsevier, 1961;
(48) ibid., 2:381, 1961; (49) Arch. Gen. Psychiat., 4:259, 1961; (50) ibid.,
5:30, 1961.
(51) ]. Nerv. Ment. Dis., 132:153, 1961; (52) Medicina Experimentalis (in press);
(53) VA Conf. Psychopharmacology (in press); (54) Arch. Gen. Psychiat.,
2:652, 1960;
(55) Unpublished manuscript; (56) Psychiatry, 21:249, 1958;
(57) Comparative Psycholinguistic Analysis of Two Psychotherapeutic Interviews. New York: Int. Univ. Press, 1961.
° Due to the length of this Bibliography, it is presented in an abbreviated form.

��IIIIIIII, IIII III IIIII,
IIIIII
I
mill‘iﬂﬁl
IIIIIIIIII
IIIII
3,963.4.
16"”1WI
m3
“It W “WI
IIII. III fIIIIIII It IIIIIIIIIII II IIIIIIIIIIII IIIII.
IIIIIIIIII II ‘Ippayg I“- I,.Iv ;W.%sf; IOIII. 196%.
IIII. III III IIIIIIIIII
II
I!
IIIII
IIIIIIIIIIII
IIIIII
NMQII” t‘ IVA”;
.X1‘
‘31:.
a. :5
II.
‘
v
II
a.“
an.
1,
:W
”"1!
"
A...“

“'5‘

7

’

I

:32“;

.1

i
“In“

‘:I,1.:..«..-

.AL.

«LIAIIIL

1““

I.

rink, II III IIII, IIIII IIIIIIIIII IIIIIIII II IIIIIIIIII
1951.
”~15.
1:
mu:
IIWI
3o’iII
ﬂaky ”II My
‘ﬁﬂI ‘1»; "mﬁkg
”I;
”I,
“up
IIIIIII GIIIIIIIIIII
~

m.
IIIIIIII
II III IIIIIIIIII IIIIIII

III IIIIIIIII.
III IIIIII
IIIIIIIIIIII
III
IIIIIIII gww J; iI
:IIIHvuqht I59~Iﬁ6, XIII.
IIII, III IIIIIIIIIIII IIIIIIIIIII IIIIIIII It IIIIIIIII
IW;I
IIIIII
ISI~II9I
IIIIIIIII
III
IQ:
I”
;.
,,
1’63.
rink. III IIIIIIIIII II IIIIIIIIII IIIIIII IIIIIIII II III»
IIIIIII IIIIIIIQ ,,,MII,,IIIII.,
a
I.
,3];
.II
"
i
RIIII

u".-*‘&gt;.;,....-vII

I

--‘

P

'

I

'

III QIIIIIIIIIII ﬁllﬁﬁtilﬂﬁipillﬁtrlrlf‘nﬂﬁ IIIII
IIII IIIIIIIIIIIIIIIIIII
III: IIIIIII

IIIIIIIIIj-m
MIIII III

IIIIII III IIIIIIIII
IIII
IIIIIIII»
III
II:
3.,
liar.
IIII
IIII I! IIIIIIIIIIIIIIIII IIIIIIIIIIII II IIIIIII IIIII
IIIIIIIII
ImIfhgﬁI g1; IGISII IIIII

RI

�43,-»

JIIII. III IIIIII IIIIIIII
3.41%.«55 EW‘IWQI

I*

f,

’

,

.

.

-.

IS
,

0

IIIIIIIIII
IIIIIIIIIIIIII
II:

't

“T“ "n ”-I I u
‘

-

IIIIIIIII IIIIII IIIIIIIIIII IIIIIIIII II
IIII. I.I.I IIIIIIIIIII
.IIJ
IIIIIIIII
IIIIIIIII
I91~IIII
II.II
,,
IIﬁl.
IIII,

1.x.e
III
I.
IIIIIII IIIIIII
IIIIIIII
III.
II IIIIIIIIII IIIIIIIIIII II IIIIII IIIIII It IIIIIIIw

’Hlilﬁit

363*;13I 39‘3I

HI
’iﬁk; ‘II '“t”!
3I5I§m1““§p‘w19’”11‘333
m;- II III IIXIIIIII I:
m
IIIIIIIII III IIIIIII»
PIIIIIIIIII
IIIIII IIII IIIIIII. II. \I ;;I¢II.. ggﬁt .‘IIIII. IIIII
IIIXIII III. III IIIIIIIII IIJII IIIIIIIII If Ital! IIIIIIIII
IIIIIIIIIIIII
IIIIIIIII
IIIIIIIIII
I
II
III
1M3”:
“‘3”:
m3
II;
M
IQI l
3.
’I
amt“:
in
ﬁtﬂumﬁ
Kma‘iIIIII$3“;
mnétigt
prﬂliﬂi Iﬂﬁmr Jahwi .
IIII
_.

III

1961.:
“‘0
“I
III” m3
IIIIIII I. III IIII III IIIIIIIn
IIIIIIIIIIIIIII
IIIIIIIII
IIIIIIIIII
£ﬂ§£&amp;“§££:I
IIIIII
III
IIIIIIII
It IIIIIIII L”! ”3*1’73 1m.
III
III
III.
IIIII.
IIII
PIIIIII. II. XIIia II IIIIIIIIII
IIIIIIII
I: IIII IIIIIIIIIIII*
IIIIIIII
IIII
~

I
.,

.

“t

“I;

_

.I

I.

"In”.
IIIIIII II

’

I

I

'

IIII

I
IIIIIIIIIIII

A

“I; IMIS, '1’

‘

I

mm
a“;
IIIII_IIIIIIIIII
II

‘4‘.
MI,
“I
IIIIIIIII

IIIIIII

',

gIIIL
L;_
’IIIIIIIé;,

”If!

I

tit

_..

�grnnnrnxnr 0! lggllillll&amp;L PBIBlItYI!
[I‘LSIDI SPIIA

ngoontattoso

1261

cornbrul tutoriality and the BIG in Iolntton
to Psynhtltry, lbtropolitan :no Socioty, Jan.
Audurnnan, [.3 89:. run ﬂhnugtu on twat. and chronic Janin1-trat10u of Pagwhatropie Aconts 1n ’ayahittrie Subaootl,
cont. on 136 3:! Hanan Payohapharnaaology, Ubrld 6:33:00.
92 Puyugintry, lentrtal, Juno.
1n
02
loo-grub
luturo Puyuhtntrio Plunntnc,
u.:
lolrink,
coat. on “Future trend: in Hospital and con-unity faith:lie-pun, April.
any“, nun-.1 1-11,.
rank, n.: Prciautton 01 Individual rataout Increas- to convulV; Baccarat cont. eta-tunati.
Annual
ct
'1
atvahrhorcpy.
unto .
Round
in
At‘ttudou
Pros-nu,
tbs
troutnont
Stat!
rink, 3.:
lab}. on lbnnnru; 1321:0300: on ’uynhophnrnnaologia
hut-wt, AH, ensue, my.
link, 3.: BilB‘lIiOl a: Ptythologicnl and ltoohcnietl Synthosou
Occurring Duran: 10907097 tron Parana-cl, by lagoon, 8.,

Andornnnn, K.:

It“.

ABA,

III.

rank, n.: laurophyuiologic«Adaptive 1:0! or canvulutvo rhorupy
Bound table on 'luarophyutological chin... with iloetroconvulsivo rhurapy', ARA, chioaao, ”by.
rank, u.a chn1runn, coat. on Ila tad Eula: Paychcpharnnaoloxy.
World CongrOII of Plyuhlutry, Houtrutl, Juno.
rink, u.: 336 troqnoucy tad rnynhotropio Bras Activity,
nautuchn Arbuitoaunoxnschttt tit luurnpnychopharnukolozio,
hub-r: , Supt.
rank, n.: In. convulsive thorapy Press-a, Itstoru nil-our:
Paynhtntrtc Sacioty, at. tonic, ectobar.
rink, 1.: Ila and lulnn rayohophlauaaolony, 2.1a notioutl
Ioaosrch contoronoo, lovonhor.
:14 lohuvtor,
link, n.2- Plyohotrtplc Brunt, train Function
ancona county 8.010%: a: Icurology 33¢ Puychintry,
Duct-bar.

�Q

.2“
5195.9’
and
:39
r11okcr
rruqnaaay
3.:
critical
x»rp 3911:511Sty
;
Study, Sulturl Payohaiuztcnl Lauoutu‘tul,
Pundnlphu , lurch.
11.13, 3.: rypolou at thnviorsl Gunman with Ph¢ngthtuuiao
ﬁndicntlan, Gout. nu auhtsophrcutn, at. Elisabeth' a
lcupztal, J;n., W‘shingtan.
Pollack, n.:' 3.1. a: ltur01&amp;¢tea1 Dyntunotlon 1n tho childhood schizophraninn, Lynx. arthapuyohiatric Auioc.,
8.3., Burah.
in
Pollack, n.: scatnl £Ipo¢ta of Paytltnirtc Ironinout
YA
V1
Aunnnl
Problcnn,
Hothtdologia
loupst‘la:
first
nsonareh can:., Bantinuaﬁt, Karen.
“

or Sinnlﬁantous StimulaPullnck, H.s attordcrcd Pgraopt1¢n
ttou a: rsoc-aad Hand: A Ravine and thaory, Sac. 3101.
Payohtnt., Atlantic Gity, Juan.
810301, 1.: Diagnosis and truatnon‘ 1n Thrao Pnywhtntrto
noapitala, An. Saelologtcal Lss¢o., 8%. Louis, Aug.

�\

PUBLICATIONS OF DR.

MAX

FINK

1950

1.
2a.

Subdural Hematoma Developing During Hospitalization, Amer. J.
M.
1950
Dr.
(With
Green).
107:
381-383,
Pszchiat.
Patterns in Perception of Simultaneous Tests of Face and
Hand, Trans. Amer. Neurol Assoc. 72: 250, 1950 (with Drs.

_'
Ereeni.
&amp;
Arch.
Neurol.
ibid,
Pszchiat. ﬁg: 355-362, 1951.

M.B. Bender and M.

....
3.

1952

Test as a Diagnostic Sign of Organic Mental
Syndrome, Neurologz, 2: h6-58, 1952 (with Drs. M.B. Bender
and M. Green}.
Tactile Perceptual Tests in the Differential Diagnosis of
1952
21-31,
Hillside
J.
Hosp.
1:
Disorders,
Psychiatric
(with Dr. M.B. Bender).
A Clinical Evaluation of Carotid Angiography, Conf. Neurol.
13: 181-195, 1952 (with Dr. J.M. Stein).
Exosomesthesia, or Displacement of Cutaneous Sensation into
1952
Amer.
Assoc.
1Q:
Neurol.
Trans.
Space,
Extra-personal
.B. Ben er .
(with Drs. M.F. Shapiro an
&amp;
1952.
h81-h90,
Neurol.
Arch.
éﬁ:
ibid,
Pszchiat.
....
Order of Dominance in Cutaneous Perception, Trans. Amer.
Neurol. Assoc. 7h: 238-2h0, 1952 (with Drs. M.B. Bender and
M. Green}.
Patterns of Perceptual Organization with Simultaneous Stimuli,
Arch. Neurol. &amp; Ps chiat. 13: 233-255, l95h (with Drs. M.B.
The Face-Hand

'-

Bender and

M.

areani.

1953

8.

9.

HeDeielopment of Perception of Simultaneous Tactile Stimuli in
1953 (with Dr. M.B.
27-3h,
3:
Neurologz
Normal)Chi1dren,
Bender .

Perception of Simultaneous Tactile Stimuli by Mentally
Retarded Adults, J. Nerv. Ment. Dis. 117: h3-h9, 1953
(with Drs. M.B. Bender and M. Green).

�-210.
11.

Spinal Fluid Findings Following Cerebral Angiography, Neurol—
(
1953
with Dr. J.M. Stein).
137,
ogz'g:
A Statistical Study of a Psychoanalytic Hypothesis:
Absence
of a Parent as a Specific Factor Determining Choice of
Neurosis J. Hillside Hosp. 3: 67-71, 1953 (with Dr. S.
Tarachows.

12.
13.

Effects of Barbiturates

on

Perception, Trans. Amer. Neurol.

Assoc. 15: 1953 (with Drs. M.B. Bender, P. Bergman and
M. Nathanson).

Homosexuality with Panic and Paranoid States (Case Report)
J. Hillside Hosp. 3: 16h-19o, 1953.
l95u

Standardization of the Face-Hand Test, Neurology, h: 211-217,
l95h (with Dr.

M.

Green).

1955

Test in Patients with Mental Illness, J. Hillside
Hosp. 3: 3-13, 1955 (with Drs. R.L. Kahn and E.A. Weinstein}.
Delusional Reduplication of Parts of Body after Insulin Coma
Therapy, J. Hillside Hosp. A: 13h-1h7, 1955 (with Drs.
R.L. Kahn and D. Graubert).
The Amytal

16.

195 O\

17.

18.
19.

Relation of Amobarbital Test to Clinical Improvement in
Electroshock, Arch. Neurol. &amp; Ps chiat. 16: 23—29, 1956
(with Drs. R.L. Kahn and E.A. Weinstein).
Evaluation of High-Dose Reserpine Therapy for the Relief of
Anxiety, J. Hillside Hos . g: 67-77 (April) 1956, (with Drs.
M. Wachspress, 1.5. Blumberg and J.S.A. Miller).
Relation of Changes in Memory and Learning to Improvement in
Electroshock, Conf. Neurol. lé’ 88-96, 1956 (with Drs.
H.

20.

Korin and S. Kwalwasser).

Denial of Blindness Following Cerebral Angiography, J. Hillside Hosp. 5: 238-2h5, 1956.

�-321a.

Quantitative Studies of Slow Wave Activity Following Electroshock, EEG. Clin. Neuro hysiol. 8: 158 (abst) web.) 1956
(with Dr. §.E. Kahn).
Relation of EEG Delta Activity to Behavioral Response in
Electroshock: Quantitative Serial Studies, A.M.A. Arch.
Neurol. &amp; Psychiat. 18: 516-525, 1957 (with Dr. 5.5. Kahn).
1957

22a.

Clinical Response to Megimide, EEG. Clin. Neurophysiol. 2: 180, 1957 (with Dr. M. Green).
Clinical and Electroencephalographic Effects of Megimide in
Patients without Cerebral Disease, Neurology 8: 682-685,
EEG

and

1958, (with Dr.

A

Green).

Unified Theory of the Action of Physiodynamic Therapies,

J. Hillside

26.

M.

Hosp.

é:

197-206, 1957.

Perception of Embedded Figures After Induced Altered Brain
Function, Amer. Psychol. lg: 361, 1957 (with Dr. R.L. Kahn).
Social Factors in Selection of Therapy in a Voluntary Mental
Hos . g: 216-228, 1957 (with Drs.
Hospital, J. Hillside
R.L. Kahn and M. Pollacﬁ}.
Role of Stimulus Intensity in Perception of Simultaneous
Cutaneous Electrical Stimuli, J. Hillside Hosp. é: 2h1-250,
1957 (with Dr. H. Korin).
1958

27.

Changes

atholo
grune
&amp;

28.

29a.

in Language During Electroshock Therapy, in Psycho-

of Communication, Ed. Hoch, P. and Zubin,
gtratton, 1958, {with Dr. R.L. Kahn).

J.,

Lateral Gaze Nystagmus as an Index of the Sedation Threshold,
EEG. Clin. Neurophysiol. 12: 162-163, 1958.
Effect of Diethazine on EEG and Significance for Theory of
EEG. Clin. Neurophysiol. 19: 207-208,
Therapy,
Coggulsive
19

.

Effect of Anticholinergic Agent, Diethazine, on EEG and
Behavior: Significance for Theory of Convulsive Therapy,
A.M.A. Arch. Neurol. &amp; Psychiat. 82: 380-387, 1958.

�-uidem, Biol. Psvchiatr
THE-195.

29c.

New

30.
31.

‘

32.

33a.

b.
Bha.

b.

YorE,

ed.
Masserman,
,

J.,

Grune

&amp;

Stratton,

Experimental Studies of the Electroshock Process, Dis. Nerv.
Sys.. 12: 113-118, 1958, (with Drs. Kahn and Green}.
Comparative Study of Chlorpromazine and Insulin Coma in the
Therapy of Psychosis, J. Amer. Med. Assoc. 166: 18h6-1850,1958
(with Drs. R. Shaw, G. Gross, and E.§. Coleman).

Electroencephalographic Correlates of the Electroshock
M.
1958
Green).
Dr.
Nerv.
(with
Dis.
227,
Bye. l2:
Process,
Experimental Studies of Convulsive and Drug Therapies in
Theoretical Implications, A.M.A. Arch. Neurol.
Psychiatry:
&amp;
1958 (ﬁEtE‘ﬁ?§T'§TE?'EEEE‘
80:
733-73h
(abst.),
PSﬁchiat.
an
. . reEK).

Alteration of Brain Function in Therapy, in Ps
&amp;
N.
Brown
Co.,
Ed.,
Frontiers, Kline,
Little,

cho harmacolo y
BosEon, 1958,

Pp. 325‘3320
Effect of Anticholinergic Compounds on Post-Convulsive

EEG

Behavior, EEG. Clin. Neurophysiol. lg: 776 (abst.).
Effect of Anticholinergic Compounds on Post-Convulsive EEG
and Behavior of Psychiatric Patients, EEG. Clin. Neurophysiol. 13: 359-369, 1960.
and

1959

35.
36.

37a.

b.

Effects of Diffuse Altered Brain Function on Perception, in
Proc. XV Int. Con . Psychol., North Holland Publ., Amsterdam,
[959, PP. 238-259 (with ﬁrs. R.L. Kahn and H. Kojéﬁ)..lk~u-Al
Diff rences in
Psychological Factors Affecting Individual Jwﬁfgvﬁt
Behavioral Response to Convulsive Therapy,
2h3-2h8, 1959 (with Drs. R.L. Kahn and M. Po ac

128:

Significance of EEG Pattern Changes in Psychopharmacology,
EEG. Clin. Neurophysiol. 11: 398 (abst.) 1959.
EEG and Behavioral Effects of Psychopharmacologic Agents,
Neuro-Ps cho harmacolo y, ed. Bradley, P., Elsevier,
REE-HES, T950.
Amsterdam,

38ayr

/

Electroencephalographic and Behavioral Effects of Tofranil:
Canad. Psych. Assoc. J. h: 1668-1713., 1959.

v.9w.

�-5;

(abst.),

38b.

Idem, EEG. Clin. Neurophysiol. 13: 2h3-hh

39.

Relation of Tests of Altered Brain Function to Behavioral
Change Following Induced Convulsions, The First International
Con ress of Neurolo ical Sciences (III: EEG, Clinical Neuro—
and EEIIepsyi, Pergamon,‘fondon, 1959, pp. STE-519
physiology
W
a n and H. Korin).
ran

1960.

.

a

of Set in the Perception of Simultaneous Tactile
Stimuli, Am. Jour. Psychol. 13: 38h-392, 1959 (with Dr. H.
The Role

Korin).

Personality Factors in Behavioral Reaponse to Electroshock

l:

J. Neuropsychiatrz

Therapy,
Kahn .

h5-h9, 1959 (with Dr. R.L.

Wm:

Sociopsychologic Aspects of Psychiatric Treatment in A
Voluntary Mental HOSpital: Duration of Hospitalization,
Discharge Ratings and Diagnosis, A.M.A. Arch. Gen. Ps chiat.
"""
_1_: 565-571., 1959 (with Drs. R.L.
and M. Pol ac .
1960

h3.

Efficacy of Divided and Single Dose Schedules in Insulin
Therapy,

Coma

J.

Am.

P8

Drs. A.G. BlumEerg and
hh.
h5.

h7.

h8.

1960 (with

Eaderman).

in Verbal Transactions with Induced Altered Brain
Function, JNMB-IBO: 235—239, 1960 (with Drs. J. Jaffe and
R.L. Kahn).: S;uw.UUub‘Jua'but
Drug Induced Changes in Intervi w Patterns: Linguistic and
Neurophysiologic Indices, in ‘__Dynamics of Psychiatric
Drug Therapy, ed. G.J. Sarwer-Foner, C.C. Thomas, Springfield
Changes

9“

pp.

h6.

116:
839-h0,
chiat.
%.

’

Jaffe

1960, (With Drs. Jo

Social Attitude (California

and R.L. Kahn).

Scale) and Convulsive Therapy
-JNMB 130: 187-192, 1960 (with Drs. R.L. Kahn and M. Pollack).
5.“,"wllua-Du‘
Figure-Ground Discrimination After Induced Altered Brain
Function, A.M.A. Arch. Neurol. 3: 5h7~551, 1960 (with Drs.
R.L. Kahn and M. PollacES.
F

Prognostic Value of Rorschach Criteria in Clinical Reaponse
to Convulsive Thera
1960
2h2-2h5,
J.
Neuropsychiatrz
y,
l:
Kahng.
(with Dr. R.L.
r

.2”
//£
.'V

'

'..

/

«n:
Ln

1

I

aré/a

/-&gt;"

-'-

f,

4'

_.”

‘.

a“

’34

45.114.”
7;”
gay” n)/m /
(j

"

6..

ff)
,1"?
'

"'4

K

p

(1

‘

H

y

,y
/"

m;

«1"

(rm

*4

I

3

.

,

w

V

if“.
r

51:3

‘

/7w,«

5mm... x

{5"

‘

‘*'

4'"

/‘ (a 3.1;,'

A A.'

g

”z

"

e, p/fivJ’J‘
“l
'

W.

“if

3

f/

a 3 (f ‘-

,

/

’5

K

£9

/

3%»

u

�-

1961

h9.

Modification of Psychotherapeutic Transactions by Altered
Brain Function, Amer. J. Psychother. 1E: hé-SS ( with

R.i. Kahn).
Neuropsychologic Response Patterns of Some Psychotropic
Drugs, Neuro-Psycho harmacology 3: 38l-38h, ed. E. Rothlin,
Elsevier, Amsterdam (with M. Pollack, E. Karp,
G.
J. Jaffe,

SO.

H.

Esecover and

Krauthamer and D.F. Klein).

51.

Problem of Antagonists to Psychotropic Drugs,
30-320

ibid,

Inhalant-Induced Convulsions, A.M.A. Arch. Gen.Psychiat.
h: 259-266, (with R.L. Kahn, E. Karp, M. Pollack,
M.A. Green, B. Alan and H.J. Lefkowits).
53. Behavioral Patterns in Convulsive Therapy, A.M.A. Arch.
Gen. Psychiat. E: 30-36, (with R.L. Kahn).
Sh. Sociopsychological Characteristics of Patients Who
132:
Refuse Convulsive Therapy, Jour. Nerv. Ment. Dis. —'
""""“"“""""""""
M.
153-157, (with
Pollack).
SS. EEG Techniques in Study of Psychotropic Drugs, Acta of
on Techniques for Study of Psychotro ic
Int'l Meeting
Drugs, Soc. Tipografica Modense, Modena, 1951.
Withdrawal Symptoms Following Discontinuation of Imipramine Therapy, Amer. J. Psychiat. 118: 5h9-SSO (with
J.C. Kramer and D.F. Klein}.
52.

Experimental Psychiatric Research at Hillside: Review
and Prospect, J. Hillside HOSEital 19: 159-169, 1961.
Prediction of Individual Patient Response to Convulsive
Therapy, VA Coo erative Chemothera y Studies in Psychiatry é: 317-325, 1951.

Social Aspects of Psychiatric Treatment in Three HospiVA
Coo erative Chemotals: Methodological Problems,
202-205, 1951 (with
Studies
in
thera
Psychiatry
é:
M. PoElack, N. Siegel and R.L. Kahn).
Quantitative Electroencephalography and Human Psychopharmacology: Frequency Spectra and Drug Action,
Medicina Experimentalis i: 36h-369, 1961.
'7

-.\,A.-r-w,

.

-ﬁm...

,

_.

,,

.1 .

um.»

. .4

m

A~

a

‘R
.1.”

�1961

c"

h9.

Modification of Psychotherapeutic Transactions by Altered
Brain Function, Amer. J. Psychother. 15: h6- SS ( with

J. Jaffe,

H.

Esecover and R. f. Kahn).“

Neuropsychologic Response Patterns of Some Psychotropic
Drugs, Neuro-Psycho harmacology 2: 381- 38h, ed. E. Rothlin,
Amsterdam (with M. Pollack, E. Karp,
Elsevier,
G. Krauthamer and D. F. Klein).
Problem of Antagonists to Psychotropic Drugs,

30'320

ibid,

Inhalant- Induced Convulsions, A. M. A. Arch. Gen.Psychiat.
h: 259- 266, (with R. L. Kahn, E. Karp, M. Pollack,
M. A. Green, B. Alan and H. J. Lefkowits).
53. Behavioral Patterns in Convulsive Therapy, A.M.A. Arch.
Gen. Psychiat. E: 30-36, (with R.L. Kahn).
5h. Sociopsychological Characteristics of Patients Who
Refuse Convulsive Therapy, Jour. Nerv. Ment. Dis. 132:
153-157, (with M. Pollack).
55.
56.

Techniques in Study of Psychotropic Drugs, Acta of
Int’l Meeting on Techniques for Study of Psychotro ic
Drugs, Soc. Tipografica Modense, Modena, 1951.
Withdrawal Symptoms Following Discontinuation of Imipramine Therapy, Amer. . Psychiat. 118: Sh9—SSO (with
JKlein}.
EEG

J. C. Kramer and D. F.
CriticalEEGFlicker Frequency and EEG Alpha: A Reliability
Clin. Neuro hysiol. (with E. Karp and
Study,
M.
Pollack}.

‘

Neurophysiologic-Adaptive View of Convulsive Therapy,
J. Neuropsychiat:
Disordered Perception of Simultaneous Stimulation of
Face and Hand: A Review and Theory, Biological PsychiaM.
IV:
(with
Pollack).
try,
Factors Associated with the Selection of Applicants for
Out- Patient Psychiatric Treatment, Social Issues. (with
The

N.

Siegel

and R. L. Kahn).

�1962

I..—
61.

62.

Critical rlicker Frequency

and

Alpha:

EEG

Olin. lenroghzeio1., __c

Study,

EEG

and x.

Pollack).

A

Reliability

1962
E.
Karp
(with
,

of Action of Convaleive Therapy: The Neurophysioe
logic-Adaptive View, J. Neurogezchiats, ;; 231-233, 1962.
The node

Disordered Perception of Simultaneous Stimulation of Pace
and Hand: A Review and Theory, Biolo icel Pe chiatr , IV
Ede Jo

6h.

Hortil,

Ch‘pe 31, (With

He

P011.Ck)e

Tachietoeoopic Perception After Induced Altered Brain Function: Influence of Hental Set, J.l.H.D., :
, 1962,
(with 1!. Pollack, 11.1.. Kahn and E. Kerp).

Psychiatric Reaction Petterne to Inipraline (Torranil),
1962
D.F.
Au. Jour. Pezchiat., __:
(with
Klein).
,
66.

Behavioral Reaction Patterns with Phenothiasinee, A.M.A.
1962
D.F.
Arch. Gen. Pczphiat., __:
(with
Klein).
,

Quantitative Electroencephalography and Hanan Peychopharaacology. II: Drug Patterns, in EEG Correlate of Behavior,
ed. 6. Glaser.
68.

Iniprenine an an Adjunct to Phenothianine Therapy, Cong.
Pezchiatrz, __c , 1962 (with J.c. Kramer end D.F. Klein).

�69.

Motivation in Psychotherapy,

(with
70.

H.

Co

. Po

ohintr ,

z

,

1962

Siogol).

Rating Sooloo as Bohoviorol cpango Hoaauroo in Payohophorna1962
cology, v.1. Coon. Chonothor. St. in Pozchiat., 1:
,

(with DJ. Klein) .

��1.

195“

~-

1

‘

.3)...

Standardlzatlm of the Faee=~Hand Test,

1H1

.

1.

.

.

~..‘-.~-:- 1-

_.

1.1,..1

"9:“ .1:

(mthM.

_Neumlog:’21'1=12'17*,~

if}

‘

-.1955
;

157°

1.'i That 1n Patlents w1th Mental Illness, J1
.axld
.

(With

.

R9

Ed A01m; 126111).

Kahn

Ly}

of

‘Deltslmal Redupllcatlm of Parts
Insuhn
after
«)1...’
R1
13911147
Kahn
L1
D1
and
(mth
H0321“;

i151

Coma

Therapy,
-

.

'

A

I
'

.

-

.3

.

of

'

Relatmn

E17 1

'

1

~

.

.

f;-';tal

____

19.1

mmlxla

201

.

Denlal

S1.

_

=

'

of Bhndness

Pollowmg Cerebral

Angh ,

cal

.2231

1””

'bo

‘

’

Response
'

;

to Meglmde, ﬁle

”j

1197:206

r

213-1

f;

'1'

;

1.

.

1... =1.

‘

3.

1

1

1

’

3

,

of Megumde in Patlents mthout
(mth M1 Greenl1

»"."I_phalog'aph1c Effects

Cerebral Insease, Neum'Ly 18;". 682-685,
A Umfled Theory of the Aenm of PhysL;

.

231
5.;

‘

1957?

-

.

«11

‘

.

1

111111111311,

..

J1
,~

»

1

.

.

;

.

1

1

1.
_

.

Percep'aen of Enbedded ﬁgures After Induced Altered Iram hmctlon, Arlen -_Ps
»12 361, (with R1 L1 Kahn)1
‘“‘ﬁf_=
_
.

,

1

.

E

'
'1

2511

i

1

261:

Soclal Factors 1n Selectman of

-

3

17'.“-

‘3

"

3

,

‘

Quantltauve Studlee 80f Slow Wave Act1v1ty Follcmno Electroshock,
158 (Feb1) Absmct (with R1; L1 Kahn)1

.

:,li
.‘7

'

Evaluatlcm Of High-Dose Fez-35':
Therapy for the Rehef of Annety, J1;;H:LlJ.81de_
M1.
A1
G1.B
(mth
(Apml),
Wadxspress,
.1
3057515 57.77,
'Relatlcn of Changes 1n
Learnmg to Improvement in Electroshodt,
and
("3.11.12 'arld '85:." K'
waSSer)
(mm
Hﬁ
88"96

'18”

-

5?

~1

Test to Chnlcal Improvement 1n Bleetmshock,‘ Arch New?“
Psichlat1; Chmagoﬂﬂe23-29, (w1th R1 L1 Kahn and E1 A1 Welnsteln)

1

.

1955

'

.”

‘

lay an

.

a Voluntary kntal Hospltal, J 1 H11151de:.

"i

3

�,

_

j,
.

,R-Pwmmgw;wwﬁssuu 955.3,umnm'»,
a.

.

.

,_

.

hock
'

fef'lheor‘y

sP:

Con

"

'-

4

,l

5x2

Therapy, Po Koch and Jo Zubin (Edltors),
{Gr-me s‘ Stmtton, New.
.p 125-139,

'1;

wt, methazme, on

EEG

and Behavmr- SIgmfIcance

unease

.

,

g3; 380-387

.
Q

Q

.

‘

:1:-

.
.

,s

\‘..:-

'-

1‘s

u.“

I,
ILJMMJI-L‘LL

.

,'

'

a

.

.

:

u

QL‘_=A-uzca-m‘:&amp;

:‘ﬁ'u

was

'.Q“
‘

,.Q.-

.ijhV‘.

19 227
'

,

.

‘

(w1‘th ’Ms

I

‘n)s,

.“v

Q

Bwemnental Studles 'o‘f Oonvuls1ve and Drug Theraples In Psyclua}
'Inphcanons, Arch Neurol“ Psychlato, meaty, 80 733-734Abstract, (mth

Alterauon

1:,

of Emu Functlon in Therapy,

Em
s C00,
mule,
:uezs

Effect

of ArrtIcholmec

No

pp‘325-332 1959.,

and BehaVIor of
19600
359=339.
"101ﬁ12

as an Post-Oonvu131ve

Psyehla' a'ilfie Panents , Electr-éeneeﬂ f:

,.

L

EEG

1959
I

‘

'

35-0)

I

as

"Effects

In Proc. ‘XV Into
Kalm
Ro
and
238-239
Austerdam),
L;
Holland,
pp
Amt}:
en Percepuon,

1:0
BehaVIoral
Response
IndIVIdual
DIfferenees
In Rio
Psyduologleal Factors Affectmg
Ls Ka‘r-m and
'Convulswe Therapy, J]° new mento msquzsjzuaszua (szth
Mo

was

of mffuse Altered Bram thctlm

Pode)

9

,

I.

\

SIgnIeranoe of EBG Pattern Changes In Psychhanralogy,

Neum 111.551010» 11k.

398

Abs

'

.

H
'

1:

��1951 (tmued)

'

M031”Kahn)e
1

is

Who Refuse Cmvulswe Therapy,
Somyeheloglcal maractemstlcs of Patlents
M, Pollackh
J3, mm n‘ento
(mth
153457
2132

Tea‘zmqmu 1:: Study of Psyebopm Draws,
3x3, £13.,”31103

EEC
360:

_;

7"

1

‘

5;;

'

‘EJS'EID

.

:

'-

Masque

‘

*

_,

one Pollemng mcontlnuauan
C46

51‘9‘9550 (With

-

159631:sta

.

insauz,

E

.

Ele

'

60;;

E

Jo

-

..-.

_

,.

.

:é'.

«

,1

I

’*
«

:1

E?

1629;

i.

/63

1

Eggs

ijhActlm

elol

wlswe
of
_N_:;3:3c::ruat13 23133233

The Mode

(21":

gist};

‘

.j.-_.

650
-

ilj.

1%.th
31,-- Mp 362-36

J

o

,

:
.

1
.

_

;~'

,

A

1:29

Fa Klemh

"

'

The NemphysmloglesAdaptlve View,
.

of Face and Hand:

A

;{~i‘;:"_‘"fw5at':0n‘
"

7'" :

“22"430, (Wlth Mo

Renew

"

Press, Inc;..,_

(Elenmn

"(-2

.

0n:
Pellack,
3

rehens

Inﬂuence Of

Ra Lo Kat-1n

~3PM1;]th4!a“.179-173 (szth

1
1"*0. Reactim Pattems 1:0. Im:.jjf;":;i‘::
2132:4138,
(mth

‘

Rehablllty Study, Electroence’ho
M‘. Pollack).
and
Karp

'Z‘iiMy:

-i;

_‘

_

3'4“
3...»...

i:

'7 -5'

.

’

,

1

.

2

:Tadustoscoplc Perception After Induced Altered Brain

Mental Set, :Lonerve
'65:)

KIM)9

"‘

'

Alter-o

'

80u63 (nth E0

and Theory} «Jo-worn"

3

~

3111-

'Dlsordered Perceptmn Of 51ml1‘1_‘{-Ifi;

E61!»

'

F0

sane-3690

"anneal Fucker Frequency and EG Alpha

New York)Chapta

E

Impnamme Therapy,

and 13-0

-»

:

-

1962
.

2*

dMe- «maﬁa

-Quant1tauve
Spectra and Drug Acum, Mada

.

g 61

off.

_,

Expemnental Psychlatmc Research at Hlllslde Renew and Prospect, Ja Hlllszlde

_

Ej’V

j:.at
£118
‘

r

;-;-

+2

{j

-

’“V

Nu

and

Slegel)‘,

��Publications -

1963

and Human Psychopharmacology, (Abstracts, 1961 Meeting, Mbntreal),
Electroenceph. clin. Neurophysiol. lg; 133-137.

7/~

EEG

72.

Multiple Item Factors as Change Measures in Psychopharmacology,
Psychopharnacologia M: #3-52, (with D. E. Klein).

13‘

Quantitative Electroencephalography in Human Psychopharmacology
II: Drug Patterns, In: G. Glaser (Editor) EEG Correlates of Behavior,
(Basic Books,

New

York), pp l77~197.

74;

Comparative Studies of Chlorpromazine and Imiprandne, I: Drug
Discriminating Patterns, In: P. B. Bradley (Editor), NeuroPs chopharnacolo , Vol. III, (Elsevier Publ. Co.), (With
KL—Pollack'rD-r—EizKlein, A. G. Blumberg, I. Belmont, E. Karp,
(In Press)
J. C. Kramer and A. Willner).

Vii

Comparative Studies of Chlorpromazine and Imipramine, II:
Psychological Perfornance Profiles, In: P. B. Bradley (Editor),
Neuropsychopharmacology, Vol. III, (Elsevier Publ. Co.), (with
M. Pollack, E. Karp, I. Belmont, and A. Willner).
(In Press)

wia’

and Human Psychopharmacology, III: Changes on Acute
and ChronicnAdministration of Chlorpromazine, Imipagmine and Placebo
(Saline), :W. P. Wilson and G. A. Ulett (Editors), Applications

Quantitative

76.

SS
(In
Electroence
ofHEEG‘andWHumaﬁ"Psychopharmacology,
h.
Bibliography
clin. Neurophysiol., Supplement 23, (in preparation), (With L.

77,

*

“ﬁg.

7"

..

EEG

w»

Bouthilet

E. Cromwell, and

M.

Brown).

and
Im1pram1ne
of
Chlorpromaz1ne on Perceptual Analytic
Effects
Ability, Perceptual Responsivity and Memory as Revealed in
Rorschach Responses, J. nerv. ment. Dis., (with I. Belmont,
M. Pollack and A. Willner).
(In Press)

�Nm~£xpcrim1ts1

B.

‘9.

1.

BookRevimdeattm

23m"

use, 33

W

W3

Diffcmtial Trcctmnt and
R. D. Win: and w. Simon, 1:. c.
sispringficld. Illinois); 1959."
121-122.

in Schizoplmmic.

m.

Revicwqé' Amh.

Experimental Studies of the Mode of Action of Electroccnvulsivs Therapy Jun-Otto. Ottosoon (Editor) . get;

pm
KIWI

c
("ET—MW, {swam
Scam. 6'39

PM

The

i

A

Symbol

Wo_

”

V“

..

3"me
m
1

clin.

.3.

Will

J. Hillside

(Bateugf’:
“'

R. 001m

1956.
111.7.
Home 8101. 1952,

Psychiatry

H.

Bruin (Editor),

Pittsbm‘gh‘ﬁ 1961.

ENG.

11093., 1962, 31;:

Review“? ..

W

Doomtraliutim of Psychiatric Services and Ccntinuity
Milbcnk
of
Md, 1961,
CmL3thliM
Pictorial Fund, Na York. 1982. Ravi“.

”of
mm
of. mm: cad m._ War, 1963, 3.:
Jm»
Intmticncl Dicticnm

'

’

in Clinical Medicine,

harm
KUniv. Pittsb‘n‘gh Press,
on

0

(Esmgfyﬂwkgaﬁi
1361. E: :52. MMMHMNWNL

'15.!)

Psychic

Graphs-M.

of

Pour

“yﬂxginsgiﬁwﬂmiﬂﬁ

V

78-79.

”W,

Us

1;)“,

C. C.

Homology and

WWW,
cog, .
a“

Wit:

for
Electra;
Indicgtdgrs
QumtiStctua
cmvulc wk 'Ihcmpy. latter to the
tar. {an};m.
of

ﬁg.

23: 292-293.

P

"

mm

Mt
m,
Emmi/1953.
in

of
Inubmctim to Physical
chiam,"w: Scrgcnt and E. Slctcr

”"W,
An»

4 ' a;

1983*;

and Wilkins new,
1mm“
(In mas)
Review-dahntcl Mitch.

'

,

Cap 42.:

!

”1/

@3234

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67304">
                <text>[Hillside] Hospital annual report (folder title). </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67305">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67306">
                <text>mfp-03-01-001-0-008</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67307">
                <text>1956-1960</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67308">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67309">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67310">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67311">
                <text>Experimental Psychiatric Programs at Hillside Hospital - A Review (several).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67312">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67313">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80933">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87494">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94055">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100616">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6732" public="1" featured="0">
    <fileContainer>
      <file fileId="3786">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/2f72d717289d05cb684207e823cb7f30.pdf</src>
        <authentication>566433f2c3abf4221015fe305a951903</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104412">
                    <text>Psychopharmacology
erVicc Center

ulletin
N IMH-Sponsored Collaborative Study of Phenothiazine
Treatment of Acute Schizophrenic Psychoses, p. 1

January 1961

NIMH Grant Support for Early Clinical Drug Evaluation
Units, p. 3
NIMH—PSC Outpatient Study of Drug-Set Interaction,
p. 4
Research Conference on Drugs and Community Care,
p. 7
Conference on Information Needs of Psychopharmacologists, p. 13
The Psychopharmacology Research Unit at the Downstate Medical Center, Brooklyn, N.Y., p. 15
Experimental Psychiatric Programs at Hillside Hospital,
'
p. 18
Coca-Leaf Chewing in the Andes, p. 22
Publications, p. 25

U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE

-

Public Health Service

�Inquiries about the Psychopharmacology Service Center’s program are invited.
Please write to:
Dr. Jonathan 0. Cole
Chief, Psychopharmacology Service Center
National Institute of Mental Health
Bethesda 14, Md.

Correspondence regarding the Psychopharmacology Service Center Bulletin
should be sent to:
Dr. Lorraine Bouthilet
Head, Scientiﬁc Information Unit
Psychopharmacology Service Center
National Institute of Mental Health
Bethesda 14-, Md.

The Psychopharmacology Service Center Bulletin is distributed at irregular intervals by the Psychopharmacology Service Center, National Institute of Mental Health, Bethesda l4, Md. It is issued for information purposes to investigators interested in psychopharmacology. It is requested that the Bulletin not be considered part of the scientiﬁc literature, and not be cited, abstracted, or reprinted.

�NIMH-Spemered

Collaborative Study of
P/eemtbz'drz'ne Treatment of Acute Se/ez'gopbrem'e Pylcboyef
The National Institute of Mental Health, through its
Psychopharmacology Service Center, is sponsoring a collaborative study of phenothiazine treatment of acute
schizophrenic psychoses. The comparative efﬁcacy of
thioridazine (Mellaril) , fluphenazine (Permitil, Prolixin), and chlorpromazine (Thorazine) in the treatment of a large group of hospitalized acute schizophrenic
patients will be evaluated at nine psychiatric institutions.
Investigators at the collaborating hospitals applied for,
and have now received, N IMH research grants which
will support their participation in the study, which is
expected to begin in February 1961 and to continue for
2 years. The grants were awarded to the
following investigators and institutions on the basis of their interest
and research experience, the availability of patients, and
the geographical location and type of hospital organization:
Principal Investigators
Edwin M. Davidson
Melvin M. Kayce

Institutions
Boston State Hospital Dorchester,
Mass.

Richard Steinbach
Bernard Levy

Georgetown University and D.C.
General Hospital, Washington,
D.C.

Robert R. Knowles
Edgar A. Moles

Kentucky State Hospital, Danville, Ky.

Kathleen Smith

Washington University and Malcolm Bliss Mental Health Center, St. Louis, Mo.

James H. Ewing
Harold H. Morris

University of Pennsylvania and
Mercy-Douglass Hospital, Philadelphia, Pa.

Frederic F. Flach
Charles I. Celian

Cornell University and Payne
Whitney Clinic, New York,
N.Y.

Guy M. Walters
Christopher F. Terrence

Rochester State Hospital, Rochester, N.Y.
Springﬁeld State Hospital, SykesVille, Md.

George A. Ulett

Martin Gross
Irene L. Hitchman
John Donnelly
Francis J. Braceland
Bernard C. Glueck, Jr.

The Institute of Living, Hartford,
Conn.

The study is under the overall supervision of Jonathan
O. Cole, Chief of the Psychopharmacology Service
Center. Gerald L. Klerrnan, PSC Research Psychiatrist,
*Prepared by Gerald L. Klerman, Research Psychiatrist, Psychopharmacology Service Center, National Institute of Mental
Health, Bethesda l4, Md.

will serve as project coordinator. Other members of the
PSC staff who are involved in the study are Eva Y.
Deykin, Research Social Worker, Martin M. Katz, Research Psychologist, and C. Jelleﬂ' Carr, Chief of PSC’s

Pharmacology Unit.
The Planning Committee, composed of the principal
investigators in the collaborating hospitals and the participating members of the PSC staff, provides for the coordination and execution of the speciﬁc projects. Because of the parallels with the Veterans Administration
Cooperative Studies of Chemotherapy in Psychiatry, the
committee maintains close liaison with the VA Central
Neuro-Psychiatric Research Laboratory at Perry Point,
Md.
The Committee on Clinical Psychopharmacology, a
group of outside consultants appointed by the NIMH,
serves as the advisory and consultative body to NIMH
on this project, as Well as on other aspects of the Center’s
clinical program. Members of this committee are Henry
Brill (Chairman), Deputy Commissioner of the New
York Department of Mental Hygiene, Albany, N .Y. ; Sol
L. Garﬁeld, Professor of Medical Psychology, Nebraska
Psychiatric Institute, Omaha, Nebr. ; Goldine Gleser, Associate Professor of Psychology, Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio; Leo E.
Hollister, Chief, Medical Service, Veterans Administration Hospital, Palo Alto, Calif.; and George D. Ulett,
Associate Professor, Department of Psychiatry, Washington University Medical School, St. Louis. Mo.

DEVELOPMENT AND DESIGN OF THE STUDY
The Committee on Clinical Psychopharmacology and
the PSC staﬂ' designed this research project during the
spring of 1960. Following general approval by the National Advisory Mental Health Council of the principles
of the study, the Center staff discussed it with a number
of clinical investigators who had previously expressed
interest in such a project. In June 1960, representatives
from more than a dozen institutions met to plan and
clarify the research methods and aims of the study. A
number of the investigators who attended the meeting
subsequently submitted applications for an NIMH research grant to support their participation in the study.
Thus the ﬁnal design and methodology of the study
resulted from the combined efforts of the Committee on
Clinical Psychopharmacology, members of the PSC staff,
1

�In psychiatry, cooperative research has been slower to

and the principal investigators. The staff of the Biometric Laboratory of George Washington University,
which operates under contract to the NIMH, will provide ongoing consultation on matters of research design
and statistical techniques and will analyze the data from
the study.
The primary aim of the project is to evaluate the
effects of two new phenothiazine derivatives, thioridazine
(Mellaril) and ﬂuphenazine (Permitil, Prolixin) on
schizophrenic symptoms and behavior by comparing them
with the effects of chlorpromazine (Thorazine). Each
of the 9 hospitals will study 40 patients (10 in each of
the 4 treatment groups) . Newly admitted schizophrenic
if
the
for
selected
will
be
16
study
40
to
aged
patients
they present two or more of the following types of symptoms or behavior: Thinking and speech disturbances,
catatonic motor behavior, paranoid ideation, hallucinations, delusional thinking, disturbed affect and emotion,
and disturbances of social behavior and interpersonal
relations.

The patients will be on the prescribed research treatment regimen for 6 weeks. A double-blind procedure
will be used throughout. Improvement during the hospitalization phase will be assessed by the Lorr Inpatient
Multidimensional Psychiatric Scale, the Burdock Ward
Behavior Rating Scale, the Clyde Mood Scale, and
clinical judgments.
In addition to the primary aim, evaluating the efﬁcacy
of the drugs, the study will also allow for the followup of
2
least
for
of
at
cohort
patients
schizophrenic
a large
made
will
be
assessments
6-month
At
intervals,
years.
of the patients’ discharge status, psychopathology, social
performance and adjustment, and treatment program.
Social workers will interview family members for their
perceptions of the patients’ progress, home conditions,
and attitudes toward treatment.
COLLABORATIVE AND COOPERATIVE
RESEARCH
Since World War II, collaborative and cooperative research, in which a number of institutions follow a common research design, has been successful in many areas
of medicine. The trials of antimalarial drugs during
World War II, the extensive studies of antituberculous
drugs now in their 17th year, and the British-United
States research on cortisone and aspirin in acute rheumatic fever are some examples. NIH experience with
cooperative research includes the current extensive cancer
chemotherapy program of the National Cancer Institute
and the Collaborative Study of Cerebral Palsy, Mental
Retardation, and Other Neurological and Sensory Disorders of Infancy and Childhood being conducted by
the National Institute of Neurological Diseases and
Blindness.
2

_

in
of
studies
extensive
penicillin
the
although
develop,
CNS syphilis during the 1940’s stands out as a notable
AdministraVeterans
the
effort.
In
recent
early
years
tion has developed its Cooperative Studies of Chemodemonhave
studies
VA
now
The
in
Psychiatry.
therapy
strated the value of cooperative studies as a means of
clarifying important issues in psychopharmacology.
From the scientiﬁc point of view, there are two major
reasons for collaborative studies of psychiatric drug
therapy. First, such studies allow one to increase the
generalizability of ﬁndings. If the only question being
asked is whether drug X is better than placebo, then the
40
of
20
with
to
obtained
be
often
pagroups
answer can
tients. However, much larger groups of patients are
discriminareﬁned
make
wishes
to
if
(a)
one
necessary
tions between compounds which are closely related chemically and pharmacologically, such as the phenothiazines;
(b) to increase knowledge of predictors of drug response;
whom
for
of
a
the
patients
deﬁne
speciﬁc
types
to
(c)
or
particular drug is best suited.
Multihospital studies allow for comparisons among
institutions. In the mental health ﬁeld there has been
much discussion of the possible differences in the effectiveness of drugs given in varying hospital and clinical
settings. A multihospital study provides both the number of hospitals and the number of patients needed to
clarify these complex drug-environment interactions.
The pros and cons of conducting large-scale, multihospital cooperative studies of psychopharmacological
its
and
NIMH
by
been
have
weighed
carefully
agents
advisory groups during the 4 years of the Institute’s proPSC.
the
administered
by
in
psychopharmacology,
gram
The NIMH ﬁrst developed a wide program of basic and
clinical studies in psychopharmacology, and has until now
centered its major efforts upon the stimulation and support of individual research projects. While this program
has resulted in a great deal of clinical drug research, it
has not met the need for large-scale evaluation of widely
prescribed psychiatric drugs.
The several Cooperative Studies of Chemotherapy
in Psychiatry which have been developed by the Veterans
Administration in recent years have provided a great
deal of useful information about some of the newer psychiatric drugs. The generalizability of these ﬁndings
has, however, been limited by the special characteristics
of the clinical material available to the Veterans Administration. The NIMH Collaborative Study of Phenothiazine Treatment of Acute Schizophrenic Psychoses has
been designed to provide information on the effectiveness
of new drugs in a population which will include female
patients. The patients will, in general, be more acutely
ill and will be treated in a wider range of hospital milieus
than could be the case within the Veterans Administration. In addition, the study is designed speciﬁcally to
explore possible interactions between hospital milieu and
has
than
in
systematic
manner
more
a
drug response

�been possible in the earlier studies conducted by the
Veterans Administration.

The success of the Collaborative Study, a complex research endeavor, will depend upon close and continuing
cooperation and collaboration between the research teams

in the participating hospitals, the staff of the Psychopharmacology Service Center, and the advisory bodies
of the National Institute of Mental Health. As this
project develops, it is hoped that the participating groups
will undertake a continuing series of investigations of the
treatment of acute schizophrenic psychoses.

NIMH Grant Support for Early Clinical
Evaluation
Unity
Drag
In November 1960, the National Institute of Mental
Health announced the establishment of special grants
for early clinical investigations of psychiatric drugs. The
primary purpose of the grants is to broaden the present

scope of early clinical trials of promising new compounds
and to make it possible to screen more new drugs for
effectiveness in the treatment of psychiatric disorders.
The grants will be awarded to a limited number of
carefully selected clinical units to support trials of promising compounds in patients to determine the safety, appropriate dose ranges, and side effects of the drugs, preliminary studies of their clinical effectiveness in the
treatment of particular symptoms or syndromes, and
small controlled comparisons of new drugs with known
standard drugs or placebo. Because of the need for
ﬂexibility in tailoring a clinical research design to ﬁt the
types of drugs and types of patients under study, an attempt will be made to achieve an adequate balance between careful observational studies and small-scale
comparative and controlled studies.

This particular area was chosen for expansion because
NIMH considered it to be more seriously in need of further support than either of the other two major stages
of new drug development; i.e., (a) preliminary screening of new drugs in animals to determine safety and
pharmacological activity, which is being adequately supported by the drug industry and by National Institutes of
Health grants for basic research, and (b) deﬁnitive clinical drug research (controlled clinical trials and hypothesis-oriented clinical investigations), which is amply provided for by the existing NIMH research grant program
in psychopharmacology.
Expansion of support for early clinical drug evaluation
was therefore recommended by the Advisory Committee
on Psychopharmacology and by the National Advisory
Mental Health Council, and the Congress subsequently
provided funds for the establishment of special grants
in this area. The program will be administered by the
Psychopharmacology Service Center.

�NIMH-PSC Outpatient Study
The National Institute of Mental Health has recently
awarded research grants to Karl Rickels, of the University of Pennsylvania, Philadelphia, Pa., and E. H.
Uhlenhuth, of the Johns Hopkins University, Baltimore,
Md., to support their participation in a special research
project initiated by the Psychopharmacology Service Center. The study is a double-blind, placebo-controlled
investigation of the effects of an active psychopharmacological agent (meprobamate) and physicians’ attitudes
on a carefully deﬁned sample of neurotic outpatients.
It is one of the ﬁrst known attempts to control experimentally the communication of differential attitudes
by physicians when administering medication. The project is to be conducted at three clinics simultaneously,
the Henry Phipps Psychiatric Clinic of the Johns Hopkins University, the Functional Clinic of the Hospital
of the University of Pennsylvania, and the Neuropsychiatric Clinic of the Philadelphia General Hospital.
The study was designed by the staff of PSC’s Special
Studies Unit in collaboration with the two principal
investigators, Drs. Rickels and Uhlenhuth, and was approved by the Committee on Clinical Psychopharmacology and the Advisory Committee on Psychopharmacology, both of which are appointed groups of consultants
who serve the National Institute of Mental Health in an
advisory capacity. The two principal investigators subsequently applied for and received, on recommendation of
the National Advisory Mental Health Council, research
grants to carry out the study. Coordination of the project will be handled by the Center’s Special Studies Unit,
whose members are Seymour Fisher, Seymour H. Baron,
Mitchell B. Balter, and Elizabeth Hackett. Under contract with the National Institute of Mental Health, the
Biometric Laboratory of George Washington University,
Washington, D.C., will assist in the analysis of the data.
RESEARCH DESIGN AND METHODS

The Outpatient Study of Drug-Set Interaction is part
of a larger special program which is concerned with the
effects of psychological set and social interaction upon
drug response in both patients and normal subjects. The
study has three main purposes:
*Prepared by Seymour Fisher, Chief, Special Studies Unit,
Psychopharmacology Service Center, National Institute of Mental Health, Bethesda 14, Md.

4

of Drug-Set Interaction“

To determine whether meprobamate, administered
for a 6-week period at a ﬁxed dosage, is more effective
than an inert placebo in the treatment of neurotic outpatients. (See Laties and Weiss, 1958.)
2. To determine whether patients’ expectations or set
(as induced by contrasting behavioral roles by the doctors
participating in the project) have a signiﬁcant effect
upon treatment course. Set will be varied by training one
group of doctors (the “T” group) to maintain a positive,
consistent, enthusiastic, “therapeutic” approach to their
patients; another group (the “E” group) will be trained
to manifest a more aloof, uncertain, “experimental” approach in relating to their patients. The “T” therapists
will attempt to convey the belief that they are treating
the patient with a known, efﬁcacious agent; the “E”
therapists will attempt to convey the belief that they are
evaluating the agent.
3. To determine whether a signiﬁcant drug-set interaction exists; i.e., to test the hypothesis that a “T” set
will potentiate response to the active drug.
Following a pilot study of 24- patients, a total of 200
patients will be treated for a 6-week period, 50 patients
being assigned to each of the following 4 treatments:
Meprobamate combined with “therapeutic” set; mepro—
bamate combined with “experimental” set; placebo combined with “therapeutic” set; and placebo combined with
“experimental” set. The basic research design is in the
form of a 2 x 2 factorial analysis, with each of the two
independent variables being varied in two ways. Table
1 shows the four-cell design, which permits
an exact
statistical test (by analysis of covariance) of the three
1.

hypotheses.

Patients will be seen biweekly for 6 weeks. In order
to rule out the effects of the personality characteristics
of the doctors in the study, a total of 12 physicians will
participate, 4 psychiatric residents at each of the 3 clinics.
Thus, interclinic‘ comparisons will be possible. An attempt will also be made to validate the role behaviors in
the doctors.
TABLE 1.—-Researc}z Design

Medication (N=200 patients)

Set

Meprobamate

.........
........

“Therapeutic”
“Experimental”

50 patients
50 patients

.......
.......

Placebo
50 patients.
50 patients.

�The dependent variables are ratings—patients’ selfratings as well as doctors’ ratings—on a symptom-distress
checklist, on the Clyde Mood Scale, and of overall change.
Dropout rate will also be considered.
BACKGROUND OF THE STUDY
The impetus for this study stems from the Psychopharmacology Service Center’s interest in various methodological
problems involved in the clinical evaluation of psychiatric drugs, in particular the problem of attitudinal variables and their effect upon drug response. The basic
thinking underlying this approach was presented in a
draft paper prepared some months ago (Fisher, 1960).
That paper also pointed out the kinds of speciﬁc research
designs which would test for any unique interactive effects between medication and set (i.e., attitudes and
expectations) .
A review of the literature has revealed much clinical
suspicion that patients’ expectations may interact with
medication to produce differential clinical effects, but
supporting evidence for such speculations is rather tenuous. Sabshin and Ramot (1956) note that: “Often the
patient may interpret a change in his internal milieu in
the context of being a change in the expected direction.
It is thus possible for a subtle type of communication to
take place . . . and this may potentiate the drug effects. Hence a relatively speciﬁc effect can be geometrically increased.” However, the investigators do not
present empirical evidence.
That a particular drug can have one effect under one
psychological condition and a quite different effect under
another psychological condition is well documented experimentally. This holds for animals (e.g., Brown, 1958;
Chance, 1946; Gunn and Gurd, 1940) and for humans.
In an elegantly designed experiment, Hill, Belleville, and
Wikler (1957) clearly demonstrated a signiﬁcant interaction between incentive conditions and drug response
in human subjects. Nowlis and Nowlis (1956) and
Starkweather (1959), in studies of normals, report complex interactions between drug response and the subject’s perception of other subjects’ behavior.
In the clinical setting, Feldman’s paper (1956) indicated that the physician’s attitude toward medication
is reﬂected in his report of degree of improvement in
psychiatric patients. However, that is not conclusive
evidence for an interaction effect, since placebos were
not employed for comparison, and evaluation of the patients was badly contaminated by the fact that each of
the participating physicians made his own overall estimate of change
The latter comment also applies to a clinical study
reported by Kast and Loesch (1959), who similarly
argue that the action of a psychopharrnacological agent
can be made disproportionately more effective than an

inactive placebo when the medication is administered
within the context of a positive set (i.e., a given set can
potentiate drug response). While their theoretical formulation is quite ingenious and heuristic, their experimental design does not afford a valid test of their
hypothesis.
A more dramatic study concerned with potentiation
was published by Uhlenhuth et al. (1959). In a doubleblind, cross-over design using meprobamate, phenobarbital, and placebo, two physicians obtained signiﬁcantly
different rates of drug-related improvement in their patients. One physician (who was “therapeutic” and enthusiastic) obtained signiﬁcant differences between the
active drugs and placebo, while the other physician (who
was more skeptical and “experimental”) found no signiﬁcant differences among the three agents. The results of this study are certainly suggestive, but they are
difﬁcult to interpret since one cannot state deﬁnitively
what the effective differentiating characteristic(s) between the two physicians was (i.e., in addition to “attitude,” they obviously differed in an inﬁnite number of
ways), and because of the complication introduced by
using a three-way cross-over of drugs.
In March 1960, Irvin S. Wolf, of Denison University,
and PSC’s Special Studies Unit tested the interaction‘
hypothesis on normal subjects who were given dextroamphetamine and placebo under three different attitudinal sets (consistent, uncertain, and inconsistent expectations). Analysis of covariance for a 3 x 2 factorial
design on subjective and psychomotor dependent variables revealed a number of signiﬁcant or near-signiﬁcant
trends (all in the anticipated direction) suggesting a
drug-set interaction.
The signiﬁcance of this research approach is perhaps
revealed in the following considerations. When reference is made to a “place-b0 response,” it is evident that
the concept is a complex one. In a placebo-controlled
experiment, not only is there a general set of expectations associated with the symbolic value of receiving
medication from a prestige authority, but there are also
undoubtedly speciﬁc expectations about the nature, purpose, and action of the medication. These different
kinds of expectations have been discussed elsewhere
(Fisher, 1960), but one important implication is worth
repeating here.
The most frequently used model in controlled evaluations of drugs assumes that the “placebo response” (i.e.,
the amount of change attributed to nonpharmacological factors) is a type of “error” involved in assessing
the pharmacological effects of the active drug: If one
can accurately measure the degree of placebo response,
that effect can be subtracted from the total effect, thus
giving the pharmacological component. This assumes
that the psychological (i.e., general and speciﬁc expectations) and the pharmacological components are additive
in nature. As shown in ﬁgure 1, speciﬁc expectations
5

�CLINICAL

IMPROVEMENT

SET A
FIGURE 1.

SET

B

Hypothetical Data Illustrating Additive Model.

(sets A and B) do affect the response, but essentially
equally for subjects who receive the active drug and for
those who receive placebo. Irrespective of the set under
which the drug is evaluated, the conclusion is the same——
the drug is X units more effective than placebo.

CLINICAL

IMPROVEMENT

PLACEBO\

SET A
FIGURE 2.

\\\

O

SET

B

Hypothetical Data Illustrating Interactive Model.

A quite different possible model, however, can be built
on the‘ assumption that the pharmacological and psychological components are interactive. As shown in
ﬁgure 2, the speciﬁc expectations in set A potentiate the

drug response, and one cannot generalize the effect of the
drug without taking into account the set under which
it was administered. Note in ﬁgure 2 that if the drug
were evaluated in an experiment in which only set B
was operative, one would conclude that the drug was no
more effective than placebo—a conclusion which, though
6

correct, would have to be limited to the conditions of the
experiment. Figure 2 also shows, however, that under
set A the drug was obviously superior to the placebo—
an equally correct conclusion for the given conditions.
Thus, if it were established that the interactive model is
more appropriate for certain kinds of clinical evaluation,
one would run the risk of rejecting as ineffective a
treatment which really does have an effect (type II error)
whenever the clinical trial is conducted under inappropriate conditions of set.
A great deal has been written about the need for controls in clinical research. It has often been noted that
new forms of therapy are enthusiastically received on the
basis of early uncontrolled clinical impressions, only to
be laid to rest by subsequent controlled evaluation (Cornell Conference, 1954) . Recent papers by Foulds
( 1958) and Astin and Ross (1960) show that a signiﬁcantly greater number of uncontrolled studies in psychopharmacology yield positive results than do controlled
experiments. Undoubtedly, this difference can be
partly attributed to such factors as lack of controls, faulty
or biased measurement, faulty design, etc., in the uncontrolled studies, or to insufﬁcient dosage or duration of
medication, or sampling bias, in the controlled experiments. On the other hand, it is possible that this difference is not all due to various kinds of “error.” If some
genuine interaction effect should exist between physicianmilieu and drug action, that would go a long way in
accounting for many of the apparent discrepancies between the ﬁndings of hardheaded researchers and those
of equally hardheaded clinicians. In uncontrolled clinical trials, the patients may be exposed to a quite different
“attitudinal” atmosphere: They more often see themselves as being “treated” rather than “researched,” and
that might provide a quite different setting for drug
action. In many controlled experiments, the patients
are deﬁnitely aware that they are participating in a research project (implying “Let’s see if the drugs will help
you”), and such a perception is probably reinforced
whenever patients ﬁnd themselves periodically being observed, tested, and probed.

The overall aim of the Outpatient Study of Drug-Set
Interaction is to attempt to create experimentally these
two contrasting attitudinal sets within the context of a
controlled clinical evaluation.
REFERENCES
Astin, A. W., and Ross, S. Glutamic acid and human intelligence. Psychological Bulletin, 1960, 57, 429—434.
Brown, B. Inﬂuence of inter-animal and environmental stimulation on action of central nervous system drugs. Proceedings of the Western Pharmacological Society, San Francisco,

January 27—28, 1958.
Chance, M. R. A. Aggregation as a factor inﬂuencing the
toxicity of sympathomimetic amines in mice. Journal of
Pharmacology and Experimental Therapeutics, 1946, 87,
214—219.

�Cornell Conference on Therapy. How to evaluate a new drug.
American Journal of Medicine, 1954-, 17, 722—727.
Feldman, P. E. The personal element in psychiatric research.
American Journal of Psychiatry, 1956, 113, 52—54.
Fisher, S. Milieu controls in psychopharmacology. Manuscript, 1960.
Foulds, G. A. Clinical research in psychiatry. Journal of
Mental Science, 1958, 104-, 259—265.
Gunn, J. A., and Gurd, M. R. The action of some amines related to adrenaline. Cyclohexylalkylamines. Journal of
Physiology, 1940, 97, 453—470.
Hill, H. E., Belleville, R. E., and Wilder, A. Motivational determinants in modiﬁcation of behavior by morphine and
pentobarbital. A.M.A. Archives of Neurology and Psychiatry,
1957, 77, 28—35.

Kast, E. C., and Loesch, J. A contribution to the methodology
of clinical appraisal of drug action. Psychosomatic Medicine,

1959, 21, 228—234.
Laties, V. G., and Weiss, B. A critical review of the efﬁcacy
of meprobamate (Miltown, Equanil) in the treatment of
anxiety. Journal of Chronic Diseases, 1958, 7, 500—519.
Nowlis, V., and Nowlis, Helen H. The description and analysis
of mood. Annals of the New York Academy of Sciences,
1956, 65, 345—355.

Sabshin, M., and Ramot, J. Pharrnacotherapeutic evaluation
and the psychiatric setting. A.M.A. Archives of Neurology
and Psychiatry, 1956, 75, 362—370.
Uhlenhuth, E. H., Canter, A., Neustadt, J. 0., and Payson,
H. E. The symptomatic relief of anxiety with meprobamate,
phenobarbital and placebo. American Journal of Psychiatry,
1959, 115, 905-910.

Research Conference on Drugs and Community Care“
In September, the Psychopharmacology Service Center
sponsored a “Research Conference on Drugs and Community Care” to bring a number of investigators together
to discuss problems of research on the use of drug therapy
in the care of psychiatric patients living in the community. The conference, held in Washington, D.C., dealt
with studies of both acute and chronic patients, evaluations of home-treatment or day-hospital care, maintenance therapy, treatment speciﬁcally designed to prevent
relapse in previously hospitalized patients or to treat relapsed patients in the community, and followup studies.
The primary objectives of the conference were (a) to
permit investigators whose research in this area is supported by NIMH to discuss problems and to exchange
ideas and experiences related to solutions to problems;
(b) to provide the Center, its consultants, and the participating research investigators with an overview of the
nature of the research now being supported; (c) to determine what has been learned from these studies about the
role of drugs in the community care of psychotics; and
(d) to assess progress in dealing with the technical
aspects of these kinds of research; e.g., the establishment
of criteria and the development of methods for classifying patients and for evaluating change and adjustment.
In addition to NIMH grantees conducting research
on drug therapy in the community, the participants included investigators whose interests and experience were
compatible with the aims of the conference and several
who are just entering research related to this general
ﬁeld.

The conference was organized by Martin M. Katz,
PSC research psychologist. The formal participants
*Prepared by Martin M. Katz, Research Psychologist, Psychopharmacology Service Center, National Institute of Mental
Health, Bethesda l4, Md.

were Dean J. Clyde, Washington, D.C.; Jonathan 0.
Cole, PSC; Joel J. Elkes, Bethesda, Md.; David M.
Engelhardt, Brooklyn, N.Y.; Leon Epstein, Sacramento,
Calif; Seymour Fisher, Houston, Tex.; Norbert F reedman, Brooklyn, N.Y.; Sol L. Garﬁeld, Omaha, Nebr.;
Goldine Gleser, Cincinnati, Ohio; Bernard Glueck, Hartford, Conn.; Milton Greenblatt, Boston, Mass.; Martin
Gross, Sykesville, Md.; Leo E. Hollister, Palo Alto, Calif. ;
Martin M. Katz, PSC; Else B. Kris, New York, N .Y.;
Jordan Lawrence, Sykesville, Md.; Mark Lefton, Columbus, Ohio; Samuel B. Lyerly, Washington, D.C.; David
Mann, Brooklyn, N.Y.; Richard D. Morgan, Sacramento, Calif.; Benjamin Pasamanick, Columbus, Ohio;
Leonard Pearlin, Bethesda, Md.; Seymour Perlin, New
York, N.Y. ; George A. Ulett, St. Louis, Mo. ; and Joseph
Zubin, New York, N.Y.
The ﬁrst half of the program was devoted to reports
on six research projects, each of which was related to
some aspect of drugs and community care. The papers
reporting the projects emphasized aims and general research design, methodological and operational problems,
and plans for future work. The second half of the conference was devoted to theoretical and practical problems
of methodology. In many cases, new methods and methodological problems mentioned brieﬂy in the research
reports were presented in greater detail and discussed
more fully during the second half of the meeting.
Some of the points made in each paper are summarized
in the following paragraphs. These summaries do not,
of course, cover all of the points covered by the speakers,
but it is hoped that they will provide at least enough
information to convey some impression of the overall
content of the meeting and of the major issues which
were considered.

�SIX RESEARCH PROJECTS
Home Versus Hospital Care for Schizophrenics. Presented by Benjamin Pasamanick, Department of Psychiatry, Ohio State University Medical School, Columbus, Ohio. This study is designed to test the hypothesis
that acute schizophrenic patients can be treated at home
when proper public health care is combined with appropriate drug therapy. All ﬁrst-admission schizophrenic
patients referred to the Columbus Psychiatric Institute
are to be considered for the study. Those who are suicidal, homicidal, or so violently disturbed that it would
be impossible to keep them in the home will be dropped
from further consideration. The remaining patients will
then be randomly assigned to one of the following three
treatment groups: (a) A group treated at home with
drugs plus frequent visits by a public health nurse; ( b)
a group treated at home with placebo plus frequent visits
by a public health nurse; and (c) a hospitalized group
treated with the usual methods of the hospital. The
three groups are to be evaluated before treatment, after
1
year, and after 2 years by psychiatric and psychological
examinations, and by reports and ratings from nurses
and social workers (including interview data from patients and their families). Quality of housing and general home environment of all three groups will also be
rated.
A public health nurse, working in consultation with
the psychiatrist and social worker, will frequently visit
each home-care patient to give nursing guidance and
counsel to the patient and his family. Patients in the
home-care groups will be hospitalized when that is recommended, on the basis of previously established criteria,
by a diagnostic council from the Institute.
The hospitalized group and the home-treatment groups
are to be compared for total length of hospitalization,
psychiatric condition, and family reaction and receptivity.
The two home-care groups—one on placebo, one on
drug—will be compared for rate of hospital admission.
Discussion of this study was devoted to such matters
as control of medication in the home-care groups, degree
of comparability of the hospitalized and home-treatment
groups, and problems related to hospitalization of patients
assigned to home treatment. Later in the conference,
Lefton, also from the Columbus Psychiatric Institute,
presented a detailed discussion of the interview schedules
which will be used in the study.
A Study of Ataractics in

Outpatient Schizophrenia. Presented by David M. Englehardt and Norbert Freedman,
State University of New York, Downstate Medical Center, Brooklyn, NY. This project was described as a longitudinal study of the effects of tranquilizers on the
community adaptation of schizophrenic outpatients.
Questions of interest in the study are whether continuation of medication after an initial gain will prevent
relapse, whether further improvement is noted when med8

ication is continued, and, when there has been no initial
gain, whether improvement will occur after prolonged
administration of drug. Changes in symptomatology and
in social behavior associated with drug therapy will be
assessed after a brief time and after sustained administration of drug. The following criteria of outpatient
adaptation are being used: Maintenance of outpatient
status (i.e., avoidance of hospitalization), reduction in
psychopathology, freedom from functional decrement,
reduction in social dysfunctioning, concordance between
social adaptation and psychopathological changes, and
stability of clinic course during a prolonged period (up
to 24 months) of continuous treatment with drug or
placebo.
Baseline psychiatric and psychological data are obtained during the ﬁrst week. The patient is then placed
on promazine, chlorpromazine, or placebo. Dosage levels are ﬂexible and medication is administered doubleblind. Supportive psychotherapy is given, but the
emphasis is on medication. Patients are seen in the clinic
at frequent intervals. Detailed re-evaluations are conducted after 3 months and at the end of 1 year.
Preliminary ﬁndings reported by Engelhardt show that
the rehospitalization rate is signiﬁcantly lower in the
drug groups than in the placebo group. Also, the number of patients showing clinical improvement at 6 months
is much higher in. the drug groups than in patients on
placebo, as is the rate of improvement of a group of
patients who demonstrate severe thought disturbance on
initial evaluation. Further, the amount of social dysfunctioning as reported by the relative has been found
to be greater in the placebo group than in the patients
on chlorpromazine.
A detailed report on the accumulation and analysis of
the data on social behavior was presented later in the
meeting by Mann and Freedman, participating investigators in the study.
Freedman also discussed the problem of dropout, which
has been one of the major difﬁculties thus far. Attempts
to distinguish clear-cut differences in personality or psychopathological features in the patients who drop out
have not been successful, though the speculation is that
there may be a complex interaction between the patient’s
expectation concerning treatment and what he actually
experiences in the clinic.
Discussion of this project centered around the speciﬁc
kinds of information obtained from the patient’s relatives, the handling of such data, problems of following
up patients who drop out of the study, possible reasons
for dropping out, side effects (which have not been a
problem), the ethics of using placebos, and the possible
relation between degree of social dysfunction and level
of drug dosage.

Drug Therapy in a Daycare Facility for Relapse Control.
Presented by Else B. Kris, Manhattan Aftercare Clinic,
New York, NY. The aims of this project are to evaluate

�day hospital care plus drug therapy as a means of controlling relapse and preventing rehospitalization of formerly hospitalized psychotics, primarily schizophrenics.
Acutely disturbed (relapsed) patients who would ordinarily be rehospitalized are randomly assigned to one of
two treatments: (a) Rehospitalization and usual hospital care, or (b) drug therapy in a special day hospital
afﬁliated with the Research Unit of the Manhattan Aftercare Clinic. At the time of assignment to a treatment
group, the psychotic condition of each patient is determined by use of the Wittenborn Psychiatric Rating Scales.
Patients assigned to the day hospital are immediately
started on intensive pharmacotherapy, with drug dosage
individualized according to patients’ needs.
Length of time between onset of relapse and subsequent remission in the two treatment groups, and community adaptation following remission, are being compared. After patients are released from either the hospital or the day hospital, the investigators will study the
patients further to determine whether remission achieved
in the day hospital is temporary or lasting.
Community adaptation is being measured by a set of
scales developed by Katz, who described them more fully
later in the conference.
Kris reported that the most remarkable ﬁnding thus
far has been the rapid achievement of remission in the
day hospital patients, who return to their jobs far sooner
than patients who were rehospitalized. She also noted
that treatment in the day hospital seems to promote better community adjustment and that patients seen in the
day hospital seem to have learned that they can discuss
recurrence of symptoms without fear of being rehospitalized.

Questions about the details of handling patients at the
day hospital were discussed, along with comments about
the liaison betwen the day hospital and employment
agencies or vocational rehabilitation centers, possibilities
of using the center as a training facility for physicians
and psychiatrists in private practice, criteria for admission to the study, and the stafﬁng and physical layout
of the day hospital.

Termination of Treatment With Ataractic Drugs. Presented by Martin Gross, Springﬁeld State Hospital,
Sykcsville, Md. This project, begun in 1958, investigated
the importance of continuing chronic psychotic patients
on medication after their release from the hospital. All
patients in the study were ﬁrst stabilized on one of six
drugs and then randomly assigned to either (a) a control
group which was continued on active medication, or (b)
an experimental group which was gradually transferred
from drug to placebo under double-blind conditions.
Patients who relapsed were removed from the study and
placed on medication if they had been receiving placebo
or were rehospitalized. The criterion for relapse was the
clinical judgment of the treating psychiatrist. A rating
scale developed to permit objective determination of the

'

psychiatric condition and social adjustment of the patients was described by Lawrence during the second half
of the conference.
During the preliminary phase of the study, and at
intervals thereafter, patients were evaluated by psychological tests, and their families or the people with whom
they were living were interviewed by the social workers.
Frequency of relapse while on active medication was
compared with that which occurred while patients were
on placebo.
Summarizing some of the ﬁndings from the study,
Gross reported that relapse occurred signiﬁcantly more
frequently during the withdrawal or placebo period, the
relapse rate being approximately three times as high
during the placebo period as during the period on medication. He also noted that three-fourths of the patients
who relapsed while on placebo did not require rehospitalization but were able to regain stability after medication was resumed.
Among the problems of methodology and design which
Gross enumerated were the difficulties experienced in
dealing with six different drugs rather than with a single
drug. He noted also that the generalizability of the
ﬁndings was limited in that patients in the project——
chronic psychotics who were free from alcoholism and
organic brain damage and who were able to attend the
clinic regularly—could not be considered representative
of the general outpatient clinic population.
In reply to a question, Gross stated that he felt the low
incidence of dropout was due to the personal contact between the patients and the social worker and physician.
Other points discussed were the difficulties of maintaining double-blind conditions and of objectively determining the point of relapse, procedures for determining
whether the patients took their medication, and techniques for switching patients from drug to placebo.
Drugs and Social Therapy in Chronic Schizophrenia.
Presented by Milton Greenblatt, Massachusetts Mental
Health Center, Boston, Mass. This study was initiated to
determine (a) how much of drug effectiveness is due to
the drug per se and how much to other causes, and (b)
whether there are signiﬁcant social and environmental
differences between hospitals which may account for the
differences between drug effects in one setting and
another.
Sixty chronic schizophrenics were transferred from a
State hospital to an intensive treatment center (the
Massachusetts Mental Health Center), where 33 received drug in addition to other therapy and 27 were not
given drug. Comparison groups were composed of 55
patients remaining at the State hospital, of whom 25
were assigned to drug treatment and 20 were not. In
neither setting were the patients assigned to “research
wards.” The criteria on which patients in the four
groups were compared were clinical improvement and
discharge rate.

�Findings reported by Greenblatt showed only slight
differences between the State hospital groups and the
MMHC groups after 6 months. At 18 months, however,
there were differences which suggested the possibility of
a beneﬁcial carryover of milieu effects in patients who
had originally been transferred to the MMHC.
In commenting on discharge rate, Greenblatt indicated that the State hospital criteria for discharge are
much more stringent than those of the MMHC. He
also noted that discharge rate was affected by the availability of a family or a transitional facility to which the
patients could be released. Among other special problems which he discussed were the difﬁculties of incorporating chronic schizophrenic patients into MMHC
treatment routines without changing the environment of
the Center, the reasons for having decided not to attempt
double-blind administration of drugs, and the possible
signiﬁcance of any effects of “transfer trauma” in patients
moved from one setting to another.

The Eﬂeet of Ataractie Drugs on Hospital Release Rates.
Presented by Richard D. Morgan and Leon Epstein,
California State Department of Mental Hygiene, Sacramento, Calif. This project is one aspect of a much
broader study of population movement in the California
State mental hospitals. Morgan’s paper was devoted to
the overall study, and Epstein’s to the parts of it which
are speciﬁcally concerned with drug therapy.
Morgan ﬁrst brieﬂy explained the system of cohort
followup analysis which is being used, noting that it is
essentially the application of individual followup analysis
techniques to a group of patients who have one or more
characteristics in common—cg, age, year of admission,
sex, diagnosis, etc. Having set July 1948 as the beginning point for the collection of data, the California State
Department of Mental Hygiene is now systematically
coding and punching onto IBM cards detailed information on all ﬁrst-admission patients in the State’s 11hospital system. The records are not restricted to the
period of ﬁrst admission, but cover residence during subsequent readmissions in the same hospital or in a different
one within the State system. A wealth of information is
collected for each patient: Vital statistics, diagnosis and
details of treatment, and data covering current hospital
entry, previous hospitalizations, leaves, etc. Thus, a
patient’s complete record of hospitalization can be examined in great detail at any point during the followup
period, and cohorts can be constructed on the basis of
any combination of a large number of descriptive
characteristics.
Morgan observed that this technique permits analysis
of the frequency or the likelihood of occurrence of
changes in status during any speciﬁed interval in the
followup. The status of a given cohort of patients can
be examined for any period of time. Data being collected in this study are proving valuable in studies of
current administrative policies and investigations of the
10

effectiveness of new or expanded programs. This system
is also valuable in providing retrospective control data
which may be used in lieu of a control group in evaluations of speciﬁc programs.
Following Morgan’s report, Epstein discussed a particular set of analyses of these data in which the aim is to
evaluate the role of tranquilizing drugs in the recent

decline in State mental hospital populations, a decline
which has occurred in California as well as in other
States.
For the period from July 1, 1955, through December
31, 1957, additional information (i.e., additional to that
routinely obtained for all patients) on details of drug
therapy was recorded for each patient in the State system
who had received treatment with drugs. Name of the
drug, total amount of drug administered, number of days
on drug, and the reason for stopping drug treatment were
among the additional data recorded. By looking at signiﬁcant subgroups—for example, ﬁrst-admission male
schizophrenics between the ages of 25 and 4-4—the investigators hope to be able to draw certain conclusions
about shortened periods of hospitalization and their association with drug therapy. Data concerning drug usage
during the period of the study are now being analyzed.
Epstein stated that investigators participating in this
study are “painfully aware” that the data involve a
variety of physicians, drugs, settings, and timings of drug
treatment in relation to admission, as well as a variety of
discharge policies among the 11 different hospitals. Despite such problems, the data do provide some reﬂection
of what may be associated with drugs as they are used in
a total system.
A number of the conference participants were particularly interested in certain speciﬁc applications of data
being recorded in the California studies or of cohort
analysis techniques generally. Others expressed concern
about the use of release rates as a criterion in studies such
as these, questioned the comparability of present-day
schizophrenics with those of a few decades ago, or asked
whether the current “decline” in certain hospital populations might not be in part a reﬂection of the decline
in birth rate which occurred during the depression.

RESEARCH METHODS

The section of the conference which dealt speciﬁcally
with methods was devoted to technical and theoretical
problems which arise in carrying out research on drugs
and community care. In accord with evidence that drugs
in combination with other psychiatric treatments are
contributing signiﬁcantly toward. maintaining formerly
hospitalized patients in the community, investigations
have been initiated which are aimed at specifying the nature of these treatments and their effects.
For purposes of the conference, the question of speciﬁcity was seen as having two major parts. The ﬁrst was
concerned with the problems of specifying the kinds of

�patients who are helped by a given treatment, identifying the clinical, personal, and social characteristics of
patients which are associated with response to treatment, and identifying the “types” of patients who are
most likely to respond to a given treatment. In addition
to the question of types of variables which merit study
with regard to this problem, the technical problems which
arise here, such as coding and the application of multivariate analysis procedures, were also considered in separate papers.
The second part of the section on methods was concerned with the problems of specifying the effects of a
given treatment, of measuring clinical change and the
various aspects of adjustment. Several approaches to
these problems were described.
Population Speciﬁcation
Three papers were concerned with the search for signiﬁcant variables in clinical history, sociological characteristics, or personality of the patients.
Clinical history was discussed by Bernard Glueck, of the
Institute of Living, Hartford, Conn. Although several
clinical and social variables have demonstrated some general predictive value in studies of response to treatment,
Glueck observed that the search for speciﬁc prognostic
factors in these areas has not been very successful. He
reviewed some of the clinical history variables which have
been linked to response to insulin therapy, electroshock,
and lobotomy, and commented to the scarcity of such information in relation to treatment with drugs. His
major criticism was aimed at the continuing lack of
a common language to describe psychiatric conditions.
Following a description of Q-sort techniques which he
and his associates are applying to this problem, Glueck
suggested that Q-sort methods provide a means of standardizing language and making comparable the ﬁndings
from different clinics or hospitals.
Sociological variables were covered by Leonard Pearlin,
of the National Institute of Mental Health, Bethesda,
Md. Arguing for greater speciﬁcity in this area, Pearlin
observed that generic variables such as social class, age,
and sex role are too global to be of much value in understanding the relations among variables. The need, he
maintained, is for greater emphasis on description of the
social context—i.e., the family, the community—and a
descriptive system in which the “social characteristic in
context” is the unit of analysis.

The role of personality in the prediction of response to
treatment was the topic of the paper by Seymour Fisher,
of Baylor Medical School, Houston, Tex. His review of
previous work in the personality area and his own experience led him to the opinion that the more simple personality variables have not been very helpful in the past
as predictors and are not likely to be too helpful in the
580375—61—2

future. Increased emphasis should, he felt, be placed on
theoretically derived conﬁgural measures of personality.
Several possible conceptual dimensions were described.
He acknowledeged, however, that the linking of personality variables to response to treatment is subject to
a number of pitfalls, some of which he enumerated.
The discussion which followed focused upon the issue
of the single variable versus the conﬁgural approaches
in attempts to relate personality and treatment response,
and resulted in some clariﬁcation of the roles of each.
The issue, however, was not resolved.
Methods for dealing with population variables were discussed by Samuel B. Lyerly, of the Society for Investigation of Human Ecology, Washington, D.C., and Dean
J. Clyde, of the Biometric Laboratory of George Washington University, Washington, DC.
Lyerly, in a paper entitled “Interview Data: Coding,
Scaling, and Selection of Potentially Useful Variables,”
emphasized the differences in hospital and community
situations which affect the collection and analysis of data,
the characteristics of information which are essential to
statistical analysis of data, and the importance of insuring that information collected is comparable from subject to subject. With regard to coding, he discussed
different types of data and classiﬁcation systems, the role
of the pilot study, ways of handling of “free responses,”
and the application of simple mathematical procedures
to patterning problems. Problems of weighting, suggestions for dealing with “does not apply” responses, and
the application of different types of validity models were
also considered.
Clyde’s paper, “Multivariate Problems: Clustering
Variables and Classifying Patients into Types,” focused
on the role of multivariate models in drug research. He
described the following three approaches and presented
examples of the application of each: (a) Analysis of
covariance, whose use was exempliﬁed in a study in
which control of the pretreatment level of severity of
illness was required; (b) factor analysis, which was used,
in the example presented, to reduce a large number of
items in a rating scale to two independent dimensions
and thus served to clarify the composition and meaning
of the instrument; and (c) discriminant function, which
was applied to a problem of separating out groups of
patients on the basis of their differential response to
drug treatment. The relevance of the latter procedure
to the problem of etiology was also considered.
In discussing these papers, Goldine Gleser, of the University of Cincinnati, Cincinnati, Ohio, elaborated upon
several approaches to separating subjects into meaningful groups. Three statistical models for accomplishing
this kind of separation were described. She stressed
that the state of knowledge in the ﬁeld is not sufﬁciently
advanced to permit the prediction beforehand of the
best way of separating groups, but pointed out that study
11

�of the outcome of such empirical separation can yield
hypotheses which can then be cross-validated in other
studies.

Methods for Measuring Improvement
Papers presented in this section of the conference described methods which are being used or developed to
evaluate the adjustment of the patient and to specify
ways in which improvement is manifested.
Norbert Freedman and David Mann, of the State
University of New York, Downstate Medical Center,
Brooklyn, N.Y., described the manner in which they are
attempting to measure psychopathology and social behavior. Emphasis within the clinic is on the psychiatric
rating scale approach, and in their community studies
emphasis is on a “naturalistic” approach. They have,
through preliminary analysis of their psychopathology
ratings, identiﬁed factors which improve with drug treatment and which predict drug response to treatment. In
the area of social behavior, development of an extensive
interview schedule covering such areas as family history,
work history, and social pathology was described by
Mann. He also discussed in some detail their coding
procedures, the progress of their approach to studying
the “typical day in the patient’s life,” and the dimensions
of classiﬁcation which have been derived from the social
data and which will contribute toward deﬁning “social
remission.” It was pointed out that the deﬁnition of
social remission is one of the central aims of the project.
The details of a rating scale for measuring the improvement of outpatient psychotics treated with drug and
placebo were discussed by Jordan Lawrence, formerly of
Springﬁeld State Hospital, Sykesville, Md. The scale,
which is completed by a psychiatrist or psychologist and
a social worker following an interview with the patient,
has three sections, one covering major psychopathology,
one describing neurotic symptoms, and one concerned
with social adjustment. Lawrence reported that the
more reliable items in the scale have been factored and
have yielded tentative dimensions of “schizophrenia” and
“depression.” He also indicated that the three subscores
and the total score have been found to discriminate well
between pre-relapse and relapse conditions, but noted
that further, better controlled validational studies need to
be carried out.
Progress on the development of a set of inventories
designed to assess clinical and social adjustment was reported by Martin M. Katz, of the Psychopharmacology
Service Center. He noted that the instruments are based
on the need to integrate two points of view, the patient’s
and the relative’s, in assessing the adjustment and per-

12

of the patient. The inventories represent atobtain objective estimates of (a) the amount
of home and free-time activity in which the
involved, and (b) the patient’s and the relative’s level of satisfaction with the patient’s functioning
in the clinical, work, social behavior, and free-timeactivity areas. A validity study was described in which
relatives were shown to be in very high agreement with
psychiatric assessment (based on intensive clinical study
of the patient) with regard to the level of psychopathology present and the extent of home, social, and free-time
activities of the patient. Several trends in the data were
noted: The relative is capable of providing accurate,
objective information in certain areas; the sheer quantity
of activity as reported by patient and relative reﬂects the
level of adjustment; and the relative’s level of expectations at the time of assessment correlate highly with
adjustment. More detailed study of the composition of
the instruments and their general applicability is in
progress.
Mark Lefton, of Ohio State University, Columbus,
Ohio, described his implementation of the interviewschedule approach, which had some similarity to others
with regard to the areas of functioning sampled. Separate schedules were designed for the patient and the
relative. The variables of prime interest in Lefton’s
assessment of community adjustment are social participation, work performance, psychological functioning as
measured by a relative’s ratings on a list of psychopathological indices, performance as a homemaker, and meas»
ures of the relative’s expectations and tolerance of deviation. He reported that several measures have been
found to discriminate between patients who were returned
to the hospital within 6 months and those who remained
in the community, as well as between patients who
function well and those who function poorly in the
community.
During the discussion of these papers, one participant
commented on the salutary effect that commitment to
a particular approach has in this area, but he cautioned against inﬂexibility at this early stage in the
development of the ﬁeld. The use of clinical judgment
as a criterion‘has its advantages, but it was noted that
areas of disagreement among raters can be just as important for understanding the nature of the problem.

formance
tempts to
and kind
patient is

In an area that has seen only scattered attention in
the past, the conference participants agreed that the
diversity and extent of efforts now being directed toward assessing the clinical and social effects of various
psychiatric treatments are very promising developments.

�Conference on Information

Needo

A conference on scientists’ need for information, sponsored by the Psychopharmacology Service Center under
contract wtih the Matrix Corp., of Arlington, Va., was
held on November 25 and 26 in Washington, DC. It
was a small, invitational conference of scientists active

in research in psychopharmacology, documentalists, and
other information storage and retrieval specialists. The
aims of the conference were several: To learn whether
the conference method of face-to-face interchange would
reveal more relevant data about scientists’ needs in the
ﬁeld of information and. communication than has hitherto been revealed in questionnaire and interview studies;
to learn whether bringing the generators and users of
information into direct contact with the experts in
documentation would yield information of value to both;
to obtain speciﬁc information about needs of scientists
working in psychopharmacology; and, as a byproduct, to
help the PSC’s Scientiﬁc Information Unit plan its
future activities.
The meeting was very informal. There was no prearranged agenda, nor was any attempt made to arrive
at speciﬁc recommendations. Under the chairmanship
of Roger W. Russell, of Indiana University, Bloomington, Ind., three speakers presented papers as starting
points for the discussion. Robert J. Hayes, of the Electrada Corp., Los Angeles, Calif., reviewed the whole ﬁeld
of information storage and retrieval, emphasing new
methods and machines. He brought out that there are
now machines that can be applied to almost any problem or situation in the ﬁeld of information storage and
retrieval. Emphasizing the team approach to the problem, the cooperative efforts of users, operators, and machine experts, he observed that the application of machine
methods to information problems is successful only when
the machine specialists and documentalists have a clear
understanding of the users’ requirements.
Daniel X. Freedman, of Yale University, New Haven,
Conn., discussed the use of information in his own research, reviewed the development of his research program
and the role of information in the program, and mentioned ways in which information could be more useful.
Murray E. Jarvik, of Yeshiva University, New York,
N.Y., also reviewed the sources of information that he
employs, including journals, monographs, books, reprints, review articles, conferences, the public press,
science writers, drug company literature, textbooks, and
other materials.
In addition to these three speakers, several other participants described their uses of information, covering

of Pyye/oop/onrmneologz'rtx

kinds of information used, how it is used, and ways in
which they would like to have it improved.
Interspersed among the papers was lively and varied
discussion from most of the participants. The following
summary attempts to convey some of the ideas presented
in the discussions, but it does not cover all the points
that were made.
Throughout the meeting one recurring theme was concern about the quality of scientiﬁc information. Commenting on the many problems of so-called scientiﬁc
writing, one participant observed that much scientiﬁc
writing occludes more than it illuminates. Most participants felt that many experiments were poor to begin
with and should never have been published. They
pointed to the need for editors of scientiﬁc journals to
evaluate work more carefully and more critically before
accepting it for publication. On the other side of the
question were emphatic comments that strong efforts in
this direction could lead to stultifying and untenable
orthodoxy in science.
One of the participants maintained that the problem
was too much information, and that steps should be taken
to cut it off at the source; i.e., to induce the scientist
himself to be more selective in reporting his work. Another took the opposite point of view, saying that, as with
farm surpluses, the real problem is not that of having too
much information but of distributing and using information more effectively.
A frequently recurring generalization was that scientists
do not make maximal, or even good use of the many
sources of information available to them. As each participant mentioned kinds of information he used, others
remarked that they did not know of those sources.
Similarly, when speciﬁc needs were mentioned, other
participants often retorted that such needs were now
being satisﬁed and the scientist had only to take advantage of available services.
One of the questions raised was whether centralized,
or even decentralized, information services could ever
serve all the needs of scientists. One participant suggested that much of the seeming dissatisfaction with present information and communication is due to the unrealistic expectations of scientists, who often want answers
to research questions that they themselves should submit
to research. Information at the forefront of knowledge
must be obtained by the scientist; readymade answers do
not exist. A related comment was that information needs
differ from one stage of research to another.
A point that could be generalized from the discussion
was that scientists perhaps do not know what they want
13

�in the way of information, and that it is, therefore, the
duty of specialists in the information area to provide
scientists with a wide variety of information presented
in many different forms. If that were done, the scientists
could then select what they need from what is offered
to them.
The usefulness of critical reviews of the literature was
discussed in some detail. Although all agreed that critical reviews are valuable, they noted that ﬁnding really
eminent scientists to write the reviews constitutes a major
problem.
Handbooks and other compilations of factual information that would be of particular value to the applied
scientist were also felt to be of great importance. Many
participants cited reprints, rather than journals, as one
of the most useful forms of information, and felt that
much could be done to make distribution of individual
articles more feasible and more effective.
In discussions of systems of handling information, it
was noted that a scientiﬁc discipline is itself an informational system, and that some disciplines are, at different
times, much more tightly organized systems than others.
Physics and chemistry, for example, are at present rela-

14

tively more “organized” than the biological sciences and,
therefore, in a sense, present fewer information and communication problems. This discussion, which occasionally bordered on excursions into the philosophy of
science, brought out the paradoxical observation that as
a body of knowledge or science develops and overthrows
old concepts and formulations, it is in a continuous cycle
of creating chaos out of order and then creating order
out of chaos.
In general, the conference participants agreed that
the most important and effective means of disseminating
and exchanging new information are by personal contacts
at scientiﬁc meetings, by the “ﬁrst” type of scientiﬁc communication—the letter—and by visits with other scientists. In discussing the value of this kind of direct,
personal interchange, it was suggested that tape recorders, which are now available in most laboratories and
university departments, might be used to simplify and
speed up the informal exchange of information. The
practical value of directories of scientists and of indexed
compilations of ﬁlms and other audiovisual aids was also
stressed.

�The Pylebep/aarmacolegy Rerearcb

Umt

State Unevem'ty of New Yer/e
Dowmtate Medical Center"
The Psychopharmacology Research and Treatment Unit
of the Department of Psychiatry, State University of New
York, Downstate Medical Center, Brooklyn, N.Y., was
established in October 1957. From its inception, the
Unit has been concerned with the study of the effects of
long-term psychopharmacological treatment on the community adaptation of schizophrenic outpatients. In the
selection of ambulatory schizophrenic patients as our
study population we were guided by the wide use to which
psychopharmacological treatment is put with such patients. By setting community adaptation as the criterion
of treatment outcome we hope to emphasize that change
in these patients must be deﬁned in terms of performance
at home, at work, and in the community, as well as in
terms of the usual criteria of psychological and psy—
chiatric functioning. By assessing the effects of longterm, sustained drug action (1 to 5 years of continuous
drug administration) we expect to determine to what extent such treatment may prevent relapse or lead to further improvement after an initial stabilization has been
attained.
The Unit thus focuses on the behavioral (i.e., psychological as well as social behavioral) correlates of drug
treatment and tries to apply the method of controlled
investigation to the clinical setting. Considerable effort
is also being extended to the methodology of outpatient
drug assessment and to the basic research task of developing objective assessment techniques which will allow
for the tracing of changes in the qualities of community
adaptation. These overall research objectives are discriminated into the seven speciﬁc studies outlined below.
The overall project is in part supported by Public Health
Service grant MY—1983. In addition to these long-term
studies of chronic schizophrenic outpatients, a section of
the Research Unit is speciﬁcally concerned with the
testing of new drugs. In the course of the short-term
studies we have an opportunity to test the validity of
some of the assessment techniques developed in the longterrn studies. Finally, the staff of the Research Unit
also engages in teaching psychopharmacology to undergraduate medical students and psychiatric residents. A
*Prepared on request by David M. Engelhardt and Norbert
Freedman, Psychopharmacology Research Unit, State University of New York, Downstate Medical Center, Brooklyn, N .Y.

research fellowship program is carried out by the Research Unit with second- and third-year medical students
who are expected to conduct their own experiments in
psychopharmacology.
The present staff of the Unit includes David M. Englehardt, Director, Norbert Freedman, Associate Director,
Leon D. Hankoff, Research Psychiatrist and Director of
the Treatment Unit, David Mann, Research Social Psychologist, and Reuben Margolis, Research Clinical Psychologist.

The research design of the principal (long-term) project has the following essential features: (a) A free-clinic
population of chronic schizophrenic patients is studied.
Some patients come with a history of prolonged hospitalization, some with a history of brief recurrent hospitalization, some without previous hospitalization. The population is ethnically heterogeneous, evenly divided between males and females, and draws upon the lower socioeconomic groups. (b) Patients are given one of three
commonly used agents, chlorpromazine, promazine, and
placebo, and are seen in a setting which emphasizes a
supportive doctor-patient relationship. The drugs are
given under double-blind conditions, and drug assignment is made randomly. (6) Assessment of treatment
effects is made by psychiatric ratings and psychological
tests, as well as by detailed social behavior interviews
administered to key relatives of the patient according to
a predetermined schedule. Psychopathology and social
behavior are thus independently evaluated, the former
in the clinic by a psychiatrist and psychologist and the
latter by the report of a relative. It is planned to assemble a cohort of 500 patients who have completed 3
months of treatment and a smaller number of patients
who have completed 1 to 2 years of treatment under
these relatively standard conditions.
Study 1: The Role of Ataractio Treatment in the
Maintenance of Community Status
Treatment may affect both incidence of hospitalization
and clinic dropout. Preliminary ﬁndings show that drug
treatment (chlorpromazine) is associated with lower incidence of hospitalization. Our next goal is to determine the role of drug treatment in preventing hospitalization by separately studying certain criterion groups.
15

�Thus, we hope to deﬁne incidence of hospitalization on
the basis of diagnosis, socioeconomic status, the relative’s
tolerance for the patient, and previous hospitalizations,
and to ascertain the probability of hospitalization for
each of these criterion groups separately, for drug andplacebo conditions.
Clinic attrition for reasons other than hospitalization
is also being studied systematically. Analysis of dropout
patients relative to patients remaining represents an important methodological task because of the potential bias
that early attrition may introduce in the interpretation
of results of change. Drug treatment does not appear
to affect dropout rate. Instead, dropout appears to be
affected by factors in the patient’s motivation toward
treatment and certain factors in the treatment situation. Social (group membership) determinants also appear to be implicated.
Study 2: The Measurement of Social Behavior
and Social Behavior Change
Emphasis is placed on the development of quantitative
and qualitative indices of community adaptation. The
instrument used is a detailed focused interview. This
interview elicits from a relative a reportorial description
of the patient’s activities at home and at work, covering
a speciﬁed timespan. These detailed reportorial accounts by the relatives provide measures predictive of
change as well as measures denoting changes per se over
the course of drug treatment.
Preliminary data have shown that the effects of drug
treatment can be discriminated by a relative reporting
on the patient’s behavior. This preliminary study has
involved the use of a simple checklist of social dysfunctioning ﬁlled out by the relative. Patients on drug
showed greater reductions in dysfunctional social behavior than did the patients receiving a placebo. Relatives having no awareness of the speciﬁc treatment the
patient was receiving were able to make this discrimination. The meaning of these differential changes must
await the detailed coding of qualitative behavioral
descriptions.
Study 3: Changes in Psychopathology and their Concordance with Social Behavior Changes
Changes in psychopathology are evaluated by the coding
of the doctors’ clinical judgments (progress notes), a
detailed psychiatric rating scale, and certain psychological test performances. Psychological tests are used primarily to elucidate the meaning of changes observed on
psychiatric and social behavior indices. A cluster
analysis of psychiatric ratings suggests that psychiatric
changes may be described in terms of two relatively independent dimensions of change, a cluster called thought
disorder and a cluster called change in anxiety and treatment contact. There is a trend for patients on chlor16

promazine to show greater reduction of thought disorder
than for patients on placebo.
Once the social behavior indices of change are sufficiently developed, we expect to determine the degree to
which psychiatric judgment and relatives’ observations
concur or diverge. Speciﬁcally, we expect to inquire
whether relatives and psychiatrists concur on speciﬁc
aspects of the patient’s behavior (i.e., belligerence) or
whether both concur that change has taken place but
are in fact referring to different areas of change. Preliminary data so far indicate greater concordance of
change on certain speciﬁc variables for patients on drug
than for patients on placebo. Basically, this study seeks
to attack the question of generality of the treatment effect.
Is the treatment effect limited to change observed in the
doctor’s office, or does it extend to the patient’s functioning in the community as this is perceived by a representative of the community? Implicitly, we are studying variations in the conceptions of mental health and illness
as these are held by different observers.
Study 4: Freedom from Functional Decrement

The possibility that sustained treatment with psychopharmacological agents may bring about a decrement in
the effectiveness of the patient’s functioning is especially
important for outpatients, on whom the demands for
effective performance in a community are greater than
for inpatients. Psychiatric ratings and relatives’ reports
on such variables as sluggishness, apathy, inertia, etc., are
especially relevant here. Equally cogent in determining
functional decrement are psychological test performances
on measures of inertia and perseveration* and the
Porteus Maze Test. Data on about 100 patients treated
with drug or placebo for a 3-month period have been
analyzed for changes in maze performance; so far we
have not been able to substantiate Porteus’ general
ﬁndings of a decrement with chlorpromazine treatment,
but we have observed a decrement in one speciﬁc subgroup. The subgroup was characterized by a “more
complex” level of cognitive organization. (See the following description of study 5.)
Study 5: Prediction of Clinical Course
Underlying our studies of the community adaptation
of a heterogeneous group of schizophrenic patients being
treated with drugs is the assumption that outcome is
modiﬁed by factors within the patient and within his
social mileu. Preliminary data suggest that several
parameters other than drug must be considered in predicting clinical outcome: (a) The patient’s motivation
toward treatment, (b) his cognitive organization, and
(c) the attitude of the family toward the patient’s illness.
The patient’s cognitive organization as gleaned from
*See Cattell, R. B. On the measurement of perseveration.
British Journal of Educational Psychology, 1935, 5, 76-92.

�Rorschach responses (based on a scoring derived from
Werner’s concepts) has been especially helpful in elucidating a “pattern of drug effects”: the direction of
change in response to a given medication depended upon
the patient’s cognitive organization.
Study 6: Incidental (Nondrug) Treatment Factors
In addition to the prognostic indices just enumerated, the
role of several nondrug factors within the treatment situation has been observed. We have explored the signiﬁcance of the initial response to placebo and the doctorpatient relationship as they may affect the patient’s clinic
attendance (dropout or hospitalization), as well as qualitative changes observed by the psychiatrist. Scoring
procedures for the assessment of both doctor-patient relationship during the initial interview and response to
placebo have been devised. These studies have emphasized the importance of nonverbal communication in the
psychopharmacological treatment of schizophrenic outpatients. They have also delineated the contributions of
the active agents to the treatment effect in some patients,
but have suggested that in other patient groups the nondrug factor was prepotent.
Study 7: Long-Term Drug Action
Patients remaining in treatment for 12 to 24- months
under drug and placebo conditions are observed at
monthly intervals and their progress is then graphically
charted. Our approach to long-term studies has been
to select one of the more reliable change indices (psychoticism) and trace the patient’s status at successive
intervals. In analyzing the time trends we have found
it useful to distinguish two baselines, one at intake and
a second after approximately 3 months of treatment.
This second baseline permits the comparison of any further improvement or worsening in the patient’s adaptation after allowance for the initial drug effect has been
made. It must be emphasized, however, that this study
is always limited to patients willing and able to remain
in treatment for such a long period of time. We are continually assessing differences between remainers and dropouts, so as to be in a position to detect bias introduced by
the selective attrition of the sample. These long-term
studies will also be corroborated by intensive case studies.
Study 8: New Drug Testing

The major efforts of the Unit are devoted to the study
of long-term drug responses of chronic schizophrenic
outpatients. Three relatively commonly used agents
are employed. However, one section of the Unit is concerned with exploring the suitability of newer psycho—
pharrnacological agents, speciﬁcally as they may be applicable to outpatients. Assessment methods which have

proved to be useful in the larger study are also employed
with the relatively brief trials of new drugs for outpatient
use. With the study of new drugs we also hope to extend
our information about the behavioral changes among outpatients in different diagnostic groups such as depressed
patients. Studies of the following compounds have been
completed or are in progress: fluphenazine (Prolixin),
isocarboxazid (Marplan), imipramine (Tofranil) , and
pyrbenzindole (IN—461, or 4-(1-benzyl-3-indolylethyl)
pyridine hydrochloride) .
In the course of conducting these studies we are accumulating a body of information about the methodology of outpatient drug testing; i.e., we are beginning
to delineate the relative advantages and limitations of
double-blind procedures in long-term assessment, the
merits of simultaneous appraisal of an agent by the multiple clinic-community-member criteria, the utility of at
least two baselines in the study of long-term trends, and
the advantages of a drug spectrum of chemically similar
agents which vary in presumed clinical intensity.

Future Plans

The ﬁndings so far support the view that the hospitalization rate tends to be lower for schizophrenic patients on
active medication than for those on placebo; that psychotic symptomatology among these patients tends to
be reduced by the drug; and that the adequacy of social
behavior as judged by the relative appears improved, although we are not able to specify the quality of behavioral changes implicated here. Preliminary data on
such variables as “psychotic thinking” also suggest that
with prolonged administration of medication there tends
to be less relapse with drug than with placebo. F urthermore, the data suggest that signiﬁcant variations in the
effectiveness of drugs depend on the patient’s cognitive
organization and his motivation toward treatment. In
certain criterion groups, incidence of remission tends to
be high regardless of drug treatment. In other criterion
groups whose improvement is lower, the remission rate
for patients on active drug exceeds the expectancy of
improvement attributable to nondrug factors.
Our next step in the project is to place these ﬁndings
on a more solid foundation: We expect to study a sample of 5-00 patients who have received 3 months of treatment; we expect to cross-validate some of the speciﬁc
predictions drawn from the initial sample; we expect to
specify the meaning of the qualities of treatment outcome, particularly in the area of community behavior,
through qualitative coding of behavioral descriptions by
the relative; we expect to conduct certain control studies
on the source of dropout, the patient’s condition after
separation from the clinic, and changes in a sample of
“isolated” schizophrenic patients, i.e., those not living
with relatives. Finally, we hope to describe changes in
subjective experiences among those patients judged by
17

�psychiatrists and relatives to be in remission. Thus, we
hope to describe improvement from three vantage points,
the community’s, the psychiatrist’s, and the patient’s.
In most general terms, it is hoped that our Unit can
contribute to the knowledge of the effectiveness of psy—
chopharmacological treatment of schizophrenic outpatients by developing and delineating criteria of treatment outcome, by specifying expectancies of clinical
change for speciﬁc patient groups, by indicating the
role of the drug and nondrug factors in outcome, and

by tracing the long-term consequences of treatment.
Once this information has been derived from a large
heterogeneous group of schizophrenic patients under relatively standard treatment conditions, it is hoped that
newer agents can be tested more effectively; i.e., that
the larger sample can be used as a reference group and
that inferences can be drawn from smaller patient groups
seen over briefer periods of observation.
Finally, we hope that the accumulated data will increase our knowledge of the schizophrenic outpatient.

Experimental Pay/chiatric Program: at
Hillside Hospital, located in Glen Oaks, Long Island,
N.Y., is a nonproﬁt, philanthropically supported psychiatric institution to which patients are admitted voluntarily for extensive psychotherapeutic treatment. Patients are from a predominantly middle-class, urban
population, and most have high educational attainment.
The programs of the Department of Experimental Psychiatry are a cluster of interrelated studies focused on
common population samples. Other research laboratories in biochemistry and in medicine are active, and
laboratories in psychodynamic psychiatry are being
developed.
The programs of the Department of Experimental
Psychiatry have developed over 6 years, and are devoted
to understanding of the mode of action of psychiatric
therapies through studies of brain function. The principal techniques have been adapted from descriptive psychiatry, neuropsychology, electroencephalography, linguistics, pharmacology, and sociology. Members of the
staff, representing various disciplines, are Max Fink,
Director, Karl Anderrnann, Ira Belmont, Martin A.
Green, Abraham A. Kaplan, Eric Karp, Donald F. Klein,
George Krauthamer, Joseph Jaffe, John C. Kramer,
Max Pollack, and Nathaniel Siegel. Former associates
who contributed to these programs are Harold Esecover,
Robert L. Kahn, Hyman Korin, and Henry J. Lefkowits.
In initial studies of convulsive therapy, changes in
brain function were found to relate both to evaluations
of improvement and to pretreatment psychological variables. As our understanding of convulsive therapy developed, a general neurophysiological-adaptive view of
somatic therapies emerged. In this view, psychiatric
treatments are therapeutically effective to the degree that
brain function is measurably altered. While change in
brain function is necessary for behavioral change, the
type of adaptation varies, depending upon pretreatment
psychological and sociological characteristics of the subject. Thus, the mode of action is not seen as either
“organic” or “psychological,” but rather as the inter18

Hz'ZZJz'de

HarpiMF

action of diffuse neurophysiological changes and adaptive mechanisms. Further, while behavioral change is
related to changes in brain function, and the adaptive
characteristics,
psychological
to
pretreatment
pattern
evaluations of “improvement”—being special types of
evaluation of change—are derivative judgments based
on staff and family expectations and tolerances.
This hypothesis was developed and sustained in a
series of studies of convulsive therapy. Concurrent
studies of insulin coma indicated that behavioral change
here, too, was related to the onset and degree of prolonged coma or repeated seizures, these being the prin—
cipal manifestations of prolonged neurophysiological
change in this therapy.
The mode of action of the new psychotropic agents
was also expressed within this hypothesis. It was suggested that these agents would be effective to the degree
that they induced persistent changes in brain function,
and that the type of behavioral response would be related to the type of brain change and to prernorbid psychological (personality) patterns. The present programs
in the Department are designed to study these relationships in detail.
Convulsive Therapy Process

Of various measures of brain function, the amount of
slow wave activity in the electroencephalogram and confabulatory and denial language patterns after amobarbital were the most sensitive indices in convulsive therapy subjects. In one experiment, improvement ratings
were correlated with the appearance of high degrees of
change in these indices.
These observations were tested in a double-blind study
in which patients referred for electroshock were randomly assigned to courses of either convulsive or sub'

*Prepared on request by Max Fink, Department of Experimental Psychiatry, Hillside Hospital, Glen Oaks, Long Island,

N.Y.

�»n-s,ww.-

.

.

E

convulsive therapy under thiopental (Pentothal) premedication. High degrees of neurophysiological change
were observed only in the convulsive group; improvement rates were signiﬁcantly higher in this group; and
when subconvulsive subjects were re-treated by convulsive applications, the improvement rate was similar to
the original convulsive group.
In the subjects given subconvulsive treatment considerable amounts of electric current passed between the
bitemporal electrodes. It appeared that the therapeutic
agent was not the total electrical current per se, but an
all-or—none quality manifested by the grand mal seizure.
The signiﬁcance of the grand mal seizure was examined
in studies of the inhalant convulsant hexaﬂuorodiethylether (Indoklon). Similar degrees of electrographic
change, improvement rates, types of behavioral change,
and changes in neuropsychological task behavior were
observed in the Indoklon group and in the electrically

treated group.-

It was soon apparent that not all subjects manifesting

high degrees of physiological change were rated as “improved.” In a descriptive typological study, ﬁve patterns were described, empirically termed “euphoric,”
“hypomanic,” “somatization,” “paranoid-withdrawal,”
and “panic.” While the ﬁrst two of these adaptive
modes were rated as “much improved,” the latter two
were seen as “unimproved” or “worse.”
In studies of psychological variables, it was reported
that patients rated as much improved and recovered
frequently manifested personality patterns similar to that
described by Weinstein and Kahn as the “explicit verbal
denial personality.” In language patterns, patients expressed the “language of denial” when diffuse brain
change was induced, exhibiting such aspects as explicit
denial, minimization, displacement, cliches, etc., more
frequently than unimproved subjects. Other indices
related to favorable outcome were high scores on the
California F Scale, and Rorschach determinants of pure
color, absent movement, and absent form-color. In this
population, also, favorable outcome was associated with
low educational achievement and foreign birth.
Anticholinergic Compounds and Convulsive Therapy
Seeking a way to augment the degree of postconvulsive
EEG slow wave activitiy, an anticholinergic compound,
diethazine, was given intravenously at various stages of
the convulsive therapy process. Contrary to expectations,
diethazine caused an immediate and sustained decrease
in EEG slowing. Patients with denial language patterns
relinquished them. Instead of feeling euphoric and experiencing a sense of well-being, the subjects became
irritable, anxious, and showed symptoms expressive of
pretreatment patterns. Prior to convulsive or drug
therapy, diethazine induced excitement, tension, anxiety,
and illusory sensations.
Subsequent studies with other central anticholinergic
compounds—WIN—2299 (2-diethylaminoethyl-a-cyclo-

pentyl-a-(Z-thienyl)-glycolate HCl), JB—318 ( l-ethyl3-piperidy1 benzilate HCl), JB—336 (N-methyl-3-piperidyl benzilate) , and benactyzine—showed behavioral and
electrographic patterns similar to those of diethazine.
Similar desynchronization of postconvulsive EEG slowing was also noted with central sympathomimetic hallucinogens (amphetamine, mescaline, LSD—25), and has
been reported for antihistamines (diphenylhydramine).
These observations led to the suggestion that an increase
in central cholinergic activity was a biochemical basis for
the convulsive therapy process.
Psychopharmacological Agents and EEG

During this period, the mode of action of newer psychopharmacological agents aroused interest. Following
the concepts derived from convulsive therapy, the neurophysiological changes induced by drugs were tested within
the same acute experimental framework of the EEG setting. It was observed that phenothiazines (chlorpromazine, promazine, triﬂupromazine) induced EEG synchronization and a shifting of the spectrum to the slow
frequencies; meprobamate and barbiturates induced an
increased synchronization and a shift of spectrum to fast
frequencies; reserpine induced an increased slowing with
synchronization at low dosages and desynchronization at
higher levels ; and imipramine induced desynchronization
with a shift of frequencies to the slow bands.
Other experimental compounds tested included BLM188 (which is 4-dimethylamino-3,4,5-trimethoxybenzanilide) and phenyltoloxamine, deanol and its various
congeners, WY—214-9 (which is tropin-4-chlorbenzhydryl
ether HCl), and azacyclonol. No consistent electrographic pattern was recorded for any of these compounds.
It was suggested that psychopharmacological agents
provide a means for eliciting a variety of neurophysiological patterns in contrast to the single pattern of induced convulsions. Furthermore, the type of neurophysiological alteration, as reﬂected in EEG synchrony
and frequency patterns, was related to speciﬁed types of
behavioral adaptation. Increasing EEG synchrony and
a shift to slow frequencies were associated with tranquilization, sedation, and decreasing agitation, while desynchronization and a shift to fast frequencies were
associated with excitement, illusions, and delusional ideation. These observations are consistent with hypotheses
of Wikler. The advantages of EEG techniques for the
assay of new psychiatric drugs have already been
reported.*
Psychopharmacology Evaluation Program

The present psychopharmacology program, instituted in
October 1959, was based on the studies described in the
*See Fink, M. EEG and behavioral effects of psychopharmacological agents. In P. B. Bradley, P. Deniker, and C. RadoucoThomas (Eds), Neuro-psychopharmacology. New York: Elsevier Publishing Co., 1959. Pp. 441—446.

19

�preceding paragraphs. It is designed to answer the following questions:
Is there a relation between measurable alteration in
brain function and behavioral change with psychotropic
drugs on chronic administration?
Are there pretreatment clusters of psychiatric physiological and psychological variables related to the type
of behavioral adaptation?
And, are such clusters related to the type and degree
of physiological change?
Method. As an initial approximation, a double-blind
drug study was undertaken in which subjects were randomly assigned to a ﬁxed-dosage schedule. On the basis
of our clinical experiences with various psychotropic
compounds from 1954 to 1959, we selected three classes
of drugs according to their patterns of EEG response.
The agents selected were those with either predominant
desynchronizing patterns, synchronizing and slowing, or
minimal or no effect. After medical examination and
after all other medications have been discontinued, patients referred for drug therapy are randomly assigned
to treatment with a compound in one of these three
classes.

Convulsive and drug therapies are prescribed by staff
psychiatrists on referral to the Department of Experimental Psychiatry. All treatment is administered by the
Department staff, so that the experimental variables of
drug dosage, route of administration, assignment to
groups, etc., are readily controlled. All patients in the
hospital are available for study. The mean duration of
stay for patients is 7 months.
After a testing period, all patients receive 40 cc. of
liquid medication daily from individually labeled bottles.
Dosages are increased in ﬁxed weekly steps until a maximum dosage is achieved at 4‘ weeks. After 2 weeks on
maximum dosage, retesting occurs.
To date, 140 subjects have been referred, and 110 have
completed the study period. Preliminary analyses of the
data are now in progress.

Behavioral Change. In a survey of the behavioral adaptations of patients receiving various agents during 1958—
59 a number of clusters of behaviors were developed.
The typologies were based on the treatment response and
on pretreatment psychiatric proﬁles. In the present
study, the typologies are being tested and various measures of behavioral change are being studied. These include therapist referral questionnaires and 6-week evaluations; therapist’s ratings of patients on the Clyde Mood
Scale; the Multidimensional Scale for Rating Psychiatric
Patients, used for evaluations in interview by two research psychiatrists; the Lorr Psychiatric Behavior Rating
Scales for ward behavior (AAMI: Level of Anxiety,
Level of Activity, Mental Disorganization and Interpersonal Relationships); and patients’ self-ratings on the
Johns Hopkins symptom checklist, the Chicago Attitude
20

Scales (self-perceptual scales devised to elicit attitudes of
dependency, ﬁght, ﬂight, and pairing), and the Clyde
Mood Scale.

Neuropsychology. Psychological tasks have been viewed
both as change variables and predictive variables. In
convulsive therapy, changes in memory tasks, tactile perception, Wechsler—Bellevue, critical ﬂicker frequency,
ﬁgure-ground tasks, and tachistoscopic recognition of
ﬁgures were related to the degree of induced neurophysiological change. For each task, the degree of decrement in task performance was found to be positiVely
correlated with the amount of EEG slowing. Following
treatment completion, with the return of physiological
indices to pretreatment levels, performance on these
psychological tasks also returned to pretreatment levels
or higher, a betterment of performance ascribed to
practice effect.
Denial scores on interview, Rorschach determinants,
F scale scores, language patterns after amobarbital, auditory feedback, and perception of the visual upright have
been viewed as predictive indices of the behavioral
changes following ECT.
Psychopharmacological agents are now being used to
assess these various tasks, their capacity to change with
various agents, or their capacity to predict change.
Electroencephalography. In the studies of convulsive
therapy, the degree of EEG slowing was measured by
counting the consecutive waves in selected samples.
When the more subtle changes of drug effects are studied,
it is necessary to apply less tedious techniques. Electronic frequency analysis was introduced in August 1959.
By measuring the pen deﬂection for various frequencies
from 3 to 33 c.p.s. in 10-second epochs, rapid measurement of apparently small changes in total activity and
frequency spectra are now obtained and applied.
Other physiological variables studied in this program
include the response of EEG to intravenous chlorpromazine, blood-pressure response to Mecholyl, the
EKG, radioactive iodine uptake, and analyses of various
blood and urine elements.
Psycholinguistics

Another series of studies in the Department has been
devoted to formal language patterns.
Following the studies of syntactic language patterns in
convulsive therapy, other aspects of language were
studied as indices of change in interpersonal behavior.
Jaffe, after considerable exploration with various linguistic measures, suggested that type-token-ratios (TTR)
of consecutive samples of dyadic speech might be a useful
index. While TTR had previously been applied to
written texts or to the language samples of individuals,
Jaffee indicated that the two-person communication
(dyad) was a more signiﬁcant index of the state of the

�interaction than were analyses of separate samples from
the participants.
Applying this technique to patients receiving convulsive therapy, changes in TTR mean and standard
deviations were related both to the degree of induced
EEG slow wave activity and to syntactic language patterns obtained in independent structured interviews.
Speech became more repetitive (lowered mean TTR)
and more variable in consecutive samples (increased
standard deviation). In interviews before and after
the intravenous administration of centrally active agents,
similar changes were observed. Agents with a predominant synchronization pattern on the EEG exhibited a
decrease in mean TTR and an increase in standard deviation of scores, while desynchronizing compounds
elicited greater variability in speech patterns (increase in
TTR mean) and a decrease in variability of consecutive
scores (decrease in standard deviation).
Other language measures studied included distressrelief quotients, self-reference, and alteration in tense
and person. It was suggested that these psycholinguistic
measures are potent techniques for the operational
analyses of physiological and psychological effects of
psychopharmacological agents.
Sociological Studies
In the course of these psychiatric programs, considerable
interest was engendered in the family organization to
which patients were returning. Also, the general problem of the relation of social factors to choice and results
of psychiatric treatment, and the speciﬁc problem of the
relation of these factors to the referral patterns, led to a
series of population studies. In one study, education,
age, place of birth, and score on the California F scale
were signiﬁcantly related to the type of therapy received
and the utilization of adjunctive hospital services. Thus,
patients who were older, poorly educated, had higher F
scores, and were foreign born, particularly those born
in Eastern Europe, were most likely to be referred for
electroshock. These relationships were independent of
diagnosis. Within the group of electroshock patients,
the time of referral for ECT was also related to these
factors.

In a second study, duration of hospitalization, discharge evaluation, and diagnosis were related to the
same social factors. For example, patients hospitalized
for the shortest period were oldest, had the least education, were most likely to have been foreign born, and had
the higher F scale scores. Younger, native-born, better
educated patients who had lower F scale scores were hospitalized the longest. These relationships held true
within treatment type and within diagnostic class. On
discharge, older patients had the most favorable ratings.
In ECT, patients rated as recovered or much improved
had the highest F scores, least education, and were most
likely to be foreign born. In another study of patient
refusal of ECT, similar relationships were observed.
These relationships are now under study in the Outpatient Department and in a trihospital comparative
study. This study is assessing the populations of three
hospitals, each of which has a prevailing patient population which differs from that of the other two. In each
of the three hospitals, all therapies are equally available
to all patients. The participating hospitals are the
Menninger Foundation Hospital, whose population is
primarily upper class and Protestant; the Massachusetts Mental Health Center, whose population is primarily lower class and Catholic; and the Hillside Hospital, whose population is predominantly middle class
and Jewish. It has been postulated that the relationships mentioned in the preceding paragraphs reﬂect the
inﬂuence of social background on psychological processes,
such as habitual patterns of communication and modes
of expression. The contribution of these factors to the
pattern of mental illness and to the patient-therapist
interaction are being investigated.
Plans for Future Work

Further growth and the direction of ensuing studies will
depend upon the results of the investigations described
here, as well as upon the growing institutional awareness
that research is as much an integral part of the hospital’s operation and budgets as are patient treatment
and staff training.

21

�Angler"
the
in
Com-Leaf Chewing
For many centuries, at least as far back as 1000 B.C.,
the inhabitants of the highlands in the Andean region
have been habituated to the consumption of the leaves
of Erythroxilon coca, a shrub growing in the Andean
mountainsides at an altitude between 1,500 and 6,000
feet above sea level. At present, the production of coca
leaves in Peru is estimated at 10 million kg. per year;
approximately 40,000 acres of cultivated land are used,
empIOying 25,000 workers (approximately 2 percent of
the population devoted to agricultural tasks).
The leaves of this shrub may be cropped on the second
or third life-year, and the plant continues to produce
for 20 years, yielding from three to six crops per year.
The leaves are dried in the sun for several hours and
then kept in cool, shadowed places until sold for human
consumption. Marketing is essentially free, being only
under the necessary controls for proper taxation and to
avoid illegal exportation. Coca leaves are sold all over
Peru, in any requested amount, from a few grams to
several th0usand kilograms. Human consumption of
the leaves, as such, is unrestricted. Industrial processing
for the production of cocaine is forbidden by law, although frequent disclosure of illegal factories and cocaine rings calls for improved. methods of ﬁscal control.
Coca leaves contain 0.60 to 1.80 percent of cocaine and
0.03 to 0.90 percent of ecgonine, according to calculations
from different laboratories and varying also with the
region and method of cultivation. Mention is also frequently made of the fact that coca leaves contain vitamin
B1 (6 to 8 mg. per kg), riboflavin (10 mg. per kg.) and
vitamin C (150 to 200 mg. per kg.).
The high content of cocaine in the coca leaves becomes
more meaningful if one realizes that the Peruvian people
consume an estimated 9 million kg. of coca leaves per
year, representing an average of 90,000 kg. of cocaine per
year. The legally approved medical requirements of all
the rest of the world amount only to 2,500 to 3,000 kg.
per year. (This does not include the legally approved
consumption in the United States. According to ofﬁcial
information from Peruvian sources, the Coca-Cola Co.
imports from Peru 140,000 kg. of coca leaves per year.
These coca leaves are decocainized and the decocainized
product is used in the manufacture of the Coca-Cola bevis
turned
obtained
cocaine
The
as
subproduct
a
erage.
over to the proper authorities for legally approved consumption, the surplus being incinerated. The United
States, thus, does not import or export cocaine.)
The 90,000 kg. of cocaine contained in the 9 million
kg. of coca leaves are consumed by approximately 2
million of the total 10 million inhabitants of Peru. These
22

million people represent 90 percent of all adult males
in the highlands, 20 percent of all adult women in the
highlands, and a large, but undetermined, percentage of
male children over 12 years of age in the highlands. Consumption of coca leaves at lower altitudes is exceptional.
The amount of coca leaf taken daily per individual
varies from 10 to 100 gm. The average adult man takes
approximately 30 gm. daily, but there are exceptional
chewers who will take as much as 200 to 300 gm. every
day. Although one speaks usually of “coca chewing,” the
act of consumption may not properly be called chewing,
at least in its complete process. The habitual chewer
usually takes a handful of coca leaves and carefully
cleans it from dirt, debris, and the main nerves of the
leaf. He puts the clean leaves into his mouth and chews
on them for 3 or 4 minutes until a bolus is well formed.
Then he takes the bolus in his ﬁngers and pricks it deeply
and repeatedly with a pointed stick which carries an
alkaline powder, to be described below. The bolus is
thereafter put back in the mouth and kept there, under
the cheek, without chewing, for about 1 or 2 hours, during
which the “chewer” sucks on it while he goes about
his business. Finally, the bolus is either discarded or
2

swallowed.
Usually, this process is repeated with 10 gm. of leaves
every 3 to 4 hours, with interruption of current activities
for about 45 minutes in order to prepare the bolus, in
what might be called a “coca break.” It is exceptional
to ﬁnd “chain chewing,” which brings up daily consumption to about 300 gm. per person.
The addition of an alkaline substance to the bolus is a
rather intriguing subject. The composition of this powder varies from region to region, ranging from plain quicklime to ground seashells or ashes of different plants. In
exceptional cases, chewers do not use the alkaline subshow
that
evidence
is
to
there
but
archeological
stance,
in one way or another it has been used for as long as coca

has been known to man.
One might speculate that this procedure increases
the yield of alkaloid in the mouth, but there is conﬂicting
evidence that this is a real fact. Gutierrez Noriega, one
of the authorities on this subject, claims that the yield
is increased by only 4 percent. Other explanations have
been offered—improvement of taste, breaking up of the
cellular membrane, etc.—but there is an obvious need
for further research in this direction.
*Prepared by Fernando Cabieses, Professor of Neurosurgery,
San Marcos University, Lima, Peru. Mailing address: Talara
655, Lima, Peru.

�It is generally accepted that cocaine is liberated in the

mouth, being extracted from the bolus. Actually, that
should not be a very difficult point to settle, but nonetheless different observers have reported very conflicting
data. The actual yield, which should result from subtracting the amount of cocaine in the discarded bolus
from the content of a similar amount of leaves, is difficult
to obtain because of the rather frequent spitting, the swallowing of part or all of the bolus, and the different
methods of titration. Published results vary from a
10- to a 90-percent yield. Also, whether the saliva contains free or bound alkaloid is not well known. At any
rate, some form of cocaine is swallowed and, again, not
much is known about its fate on reaching the stomach
and intestine. How much of it is destroyed or further
activated by the digestive juices is also in question. F urthermore, we have no information about how much is
absorbed into the bloodstream or about the behavior
of the gastric and intestinal mucosa exposed to bound
or free cocaine.
Cocaine absorbed into the bloodstream reaches the liver
through the portal system, but no one really knows much
about its metabolism at this level. There is some evidence
that liver tissue will detoxify cocaine in vitro, and this has
led to the thought that only a minimal amount of the
ingested alkaloid actually reaches the general circulation. Here, again, careful evaluation is needed, since
it seems that blood itself will partly destroy cocaine
added to it in vitro. And, to complicate matters further, the results of determinations of cocaine blood levels
in coca-leaf chewers are riddled with very difficult problems of interpretation, mainly because of the lack of appropriate methods of titration. Even if this information
were available, absolute ﬁgures on cocaine blood levels
would have but little meaning, owing to the lack of information on the level of neural toxicity of this substance.
How high a blood level of cocaine can be tolerated without nervous effects in a normal individual, in a cocaine
addict, and in a coca-leaf chewer is thus unknown.
In spite of all these important questions, it is quite
evident that some cocaine, or a cocainelike substance,
reaches the nervous system of the coca-leaf chewers. This
is easily concluded from clinical observation. Cocaine is
perhaps the best antifatigue substance known to man.
And it is a well proved fact that coca-leaf chewing is an
excellent means of combating fatigue, both in industrial
work and under experimental conditions.
The possible differences between the effects of parenterally or orally administered cocaine and those obtained
by chewing coca leaves, in normal as well as in habituated persons, and the action of cocaine and coca leaves
on different types of fatigue remain to be experimentally
evaluated.
Cocaine decreases hunger sensation, admittedly
through its central action. And this is also a very well
known effect of chewing coca leaves, brought about

either through a similar mechanism or, as commonly
assumed, through local anesthetic action on the digestive
tract. Whatever the mechanism is, coca-leaf chewing
kills hunger. And this effect has an obvious social implication. It is said, on the one hand, that because of
this action coca chewing leads to malnutrition. Other
groups of sociologists claim the opposite; that malnutrition leads to coca chewing. And a third factor is brought
into play when one is reminded that the coca leaves contain a fair amount of certain vitamins which are ordinarily lacking in other constituents of the usual diet of
the dwellers of the high Andes. A pharmacological
problem thus becomes a problem of socioeconomics and
of social anthropology. Malnutrition, poverty, low culture, and coca chewing all go together, and at times it
becomes almost impossible to disentangle one from the
other.
And if to this mixture we add high altitude, the problem becomes more and more intriguing and complicated.
One cannot but wonder why, if the coca tree is only
cultivated at altitudes lower than 6,000 feet, the habit
of chewing coca leaves is found mainly above that level.
Very few communities in the coastal area show the habit,
which is mainly concentrated in the high altitudes.
Futhermore, the habit of chewing coca leaves, a habit
carried on continuously for many years, is usually abandoned when the individual is permanently transferred to
lower geographical levels. And one cannot dismiss the
frequent claims of travelers and of cultured dwellers of
the highlands regarding the beneﬁcial effects of coca
tea or coca chewing against the acute symptoms of mountain sickness. Unfortunately, no experimental evaluation
has been made of these observations, which have been
subject to much literary discussion in years past. It is
true, of course, that high altitude is only one of the factors of a very complicated problem seen through the
narrow light of an off—habit, on-habit proposition. But
only a careful experimental approach will tell us what
the real importance of this factor is, especially in the
presence of a drug with as many unpredictable pharmacological actions as cocaine.
It is commonly accepted that cocaine has a deleterious
effect on the central nervous system when taken chronically. And it is only logical that this concept has been
used in the interpretation of the mental functions of the
coca-leaf chewers. This assumption, however, may not
be entirely justiﬁed, since most of the alleged “facts”
lack experimental veriﬁcation. The so-called effects of
chronic consumption of coca leaves are always related
to the other factors of the socioeconomic complex sur‘
rounding the coca habit; poverty, malnutrition, low culture, poor educational facilities, high altitude, etc. And
although coca may be an important determining cause,
the alleged low mental output of the Andean dweller
should not be blamed only on this factor, as it frequently
is. The appraisal of chronic coca-leaf consumption com23

�pletely separated from its socioeconomic constellation is,
however, very difﬁcult to achieve.
The acute action of coca-leaf chewing on mental
processes also lacks sound and thorough experimental
evaluation. A few experiments suggest that the effects
are quite different in habituated and nonhabituated individuals, as would logically be expected. The extent and
mechanism of these differences remain to be determined.
There is also some indication that muscular activity
during the process of coca chewing basically alters its
mental effects. It is said that if the individual is resting, daydreaming and pseudohallucinations ensue, but
that these mental effects can be prevented by physical
activity. These observations need further experimental
study, but this type of psychopharmacological study
would meet with great obstacles in the markedly introvert personality of the Peruvian Indian, his resistance
to participation in experimental studies of this type, the
frequent language difﬁculties, and the lack of basic
psychological and social anthropological studies in the
Andean milieu.
It is thus evident that there are many questions to be
answered concerning the pharmacology of coca leaves
and the socioanthropological aspects of this widespread
habit. Differences between the chronic or acute effects
of parenterally administered cocaine (a subject on which
much remains to be settled) and the chronic or acute
effects of coca-leaf chewing should be investigated. The

24

former leads to a rather well known condition: cocainism,
i.e., addiction to cocaine. The latter leads to a habit,
cocaism, which apparently does not follow the same psychopharmacological pattern, since a simple change in
socioeconomic status or a change in geographical milieu
leads to its spontaneous discontinuance; there is not a
clear tendency to increase the dosage, as there is in cocainism, nor are there any evident withdrawal symptoms.
Are these differences due only to the route of administration of cocaine? One certainly can provoke a
clear syndrome of cocaine addiction in experimental animals (dogs, monkeys) by chronically administering cocaine by the parenteral route. But so far it has not been
possible to obtain similar results by oral administration of
this drug.
Research Opportunities

There are many stimulating areas for research on cocaleaf chewing. Facilities for research in this ﬁeld are potentially available at the Brain Research Center of the
Armed Forces of Peru, of which I am director, and at the
American Hospital in Lima, which has a good neurological and neurosurgical service. Investigators who wish
to explore the possibility of conducting research related to
coca-leaf chewing, or who wish to obtain further information, are invited to write to me at the following address:
Dr. Fernando Cabieses, Talara 655, Lima, Peru.

�Publications
Tranquilizing and Anti-Depressant Drugs. Veterans
Administration Department of Medicine and Surgery
Medical Bulletin MB—6, September 12, 1960. Washington, D.C.: U.S. Government Printing Ofﬁce. This 19page bulletin is by Eugene M. Caffey, Jr., Leo E. Hollister, Alex D. Pokomy, and Jesse L. Bennett, all of
whom are members of the Executive Committee of the
Veterans Administration Cooperative Chemotherapy
Studies in Psychiatry. It presents a general summary of
current practices in the use of tranquilizers and antidepressives in psychiatry and in nonpsychiatn'c practice,
and includes tabulations of generic names, trade names,
and range of total daily dosage of drugs for outpatients
and for hospitalized patients. The price of the publication is $0.15. Copies should be ordered from the Superintendent of Documents, U.S. Government Printing
Ofﬁce, Washington 25, DC.
Agressologie, an International Review of Physio-Biology
and Pharmacology Applied to the Eﬁ‘ects of Agression,
is a recently established journal that should be of interest to psychopharmacologists. In the preface to the ﬁrst
issue, the title of the journal is explained: The commonly
understood meaning of the word aggression is applied to
the action of agents which harm the living organism by
attacking it abruptly (from the outside or from the inside), including cold, heat, lack of air, surgery, disease,

poisoning, and other causes of physiobiological disequilibrium which results in “more or less profound and
lasting disturbances” in cellular metabolism. The purpose of the journal is to synthesize and integrate contributions which many basic disciplines are making to the
study of the effects of “aggression” as previously deﬁned,
and to the prevention and treatment of such effects.
The journal is being published and edited by Henri
Laborit, of the H6pital Boucicaut, 78 rue de la Convention, Paris 15, France, and P. Huguenard, of the Hopital
de Vaugirard, Paris 15, France.

Metabolism of, and Analytical Methods for, Phenothiazine Derivatives Used in Psychopharmacology; A Selected Annotated Reference List, compiled by the Scientiﬁc Information Unit of the Psychopharmacology Service Center. This list of approximately 65 references is
made up primarily of articles concerned with analytical
methods for the detection of phenothiazine derivatives
used in psychopharrnacology, together with a few more
general articles on the metabolism of these agents. The
annotations are factual summaries of the articles, and
are not evaluative or critical. The list is arranged chronologically. Copies may be obtained by writing to: Dr.
Lorraine Bouthilet, Head, Scientiﬁc Information Unit,
Psychopharmacology Service Center, National Institute
of Mental Health, Bethesda 14, Md.

25
U. S. GOVERNMENT PRINTING OFFICE: 1961

0-

580375

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67314">
                <text>Experimental Psychiatric Programs at Hillside Hospital, Psychopharmacology Service Center Bulletin, January 1961 (U.S. Department of Health, Education, and Welfare)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67315">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67316">
                <text>mfp-03-01-001-0-009</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67317">
                <text>1961</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67318">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67319">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67320">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67321">
                <text>Article based on Hillside Hospital annual report. One of nine articles in the Psychopharmacology Service Center Bulletin: NIMH-sponsored collborative study of phenothiazine treatment of acute schizophrenic psychoses; NIMH grant support for early clinincal drug evaluation units; Research conference on drugs and community care; Confernce on informaiton needs of psychopharmacologists; The psychopharmacology research unit at the Downstate Medical Center, Brooklyn N.Y.; Experimental psychiatric programs at Hillside Hospital; Coca-leaf chewing in the Andes; Publications.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67322">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67323">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80934">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87495">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94056">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100617">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6733" public="1" featured="0">
    <fileContainer>
      <file fileId="6556">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/ec4afc36e7130461e6211b8cf229b80f.pdf</src>
        <authentication>15614c0aba92d94b8e5d0589849ccd08</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107161">
                    <text>$57”
4’13

/?é,/~(22
‘

may

JUN

HILLSIDE HOSPITAL

Glen Oaks

New

21

1961

York

June 12, 1961
MEMORANDUM

Victor Leventritt, Chairman, Medical Affairs Committee

TO

k

Mr. M.

FROM

:

Maurice Bachrach, Administrator

WWW”
SUBJECT:

Proposed Research Request Budget for

July'l,

1961

to June 30, 1962

income
and
the
of
proposed
expenses
Attached hereto is a presentation
been
has
carefully
Each
1961/62.
request
departmental
research
for
for
each
schedule
for
There
a
is
Robbins
well
myself.
as
reviewed by Dr.
as
Research Department. After the expenses are given for each department,
we have Shown applicable and potential income from various sources that
each
of
end
At
departmental
the
each
department.
for
have been designated
This
the
is
"net
deficit".
shown
the
have
department's
we
schedule,
income
that
for
designated
less
the
for
department,
expenditure
total

department.

will find the entire deficit picture which gives the
from
various
income
estimated
each
the
of
departments,
for
net deficit
research
the
total
to
which
Trustees
applicable
are
the
than
sources other
The
research
net
departments".
all
and
research
"net
deficit,
program
actual
$53,250;
our
at
was
projected
the
for
present
year
deficit
Budget
Research
1961/62
Request
The
$58,12h.
estimated
at
expenditure is
from
this
$h,250
of
decrease
net
$h9,000,
of
a
net
deficit
a
projects
actual
from
this
year‘s
decrease
and
$9,12h
a
Budget
year's Request
On

page h you

experience.

�-2-

June 12, 1961
HILLSIDE 1109131111,

M
wwnwm‘m
001. I
Col. II
- 1961/62

TENTATIVE REQEARCH BUDGET

1960/51
Budget

I.

001. III
1951752"

1950731

Request
Budget

Experience

est.)

(2 mos.

001. IV
Overage
001

III

over 001.

RE§EARCH IN EXPERIMENTAL
PSYCHIATRY

EXPEN§ES:

l2
3

.
.

.

1 .

Director

.

7 .
8 .
9 .

1o.
11.
12.
13.
11.
19.
16.
17.
18.
19.
20.
21.
22.

1,500
3,100
3,100

3,113
2,163

600

600

600

3,311
11,011

2,817
10,126

25,000
17,000

3r. Assoc. Exper. Psychology 13,000

10,920
7,500

13,000
10,667
7,500

9,500
8,500
1,110

9,500
8,597
1,105

2,172
3,360
2,890

2,251
3,127
2,356

Assoc. in Psychiatry
v

-

n

n

Assoc. EXPer- Psychology
6 . ‘Asst. Exper. Psychology

S

25,000
17,500
9,000
11,000
13,331
8,100
7,218
10,000
1,120
1,800
3,600
2,185
3,192
2,710
1,500
3,000
3,600
3,000

25,000
16,116

u

n

(NEW)

11

Assoc. in Social Psychology
Assoc. Exper. Psychology
E.E.G. Technician, Sr.
E.E.G. Technician Jr. (NEW)
Psycholinguistic Technician

Secretary
Clerk Typist
Technical Ass't.

Equipment

Travel
supplies

(office

(NEW)
&amp;

Medical)

Director's Professional

Expenses
Training Expenses

gocial security

Overhead

&amp;

Blue Cross

Research in
enses115351%§%151'9§23515177'7“'

Total

-

-

-

-

-

—

251

1,838
3,500
11,010

-

1,081
9,000
1,000
2,111

(A)
(B)

(0)

(B)
600 (C
7,218 (E)

500 (F)

(7,080)(G)
390 (c)
3,600 (H)

313 (C)
132 (C)

(150)
1,500 (I)
(1,500)
200

(100)

1,838 (J)
186

2,999

'

129,923

licable &amp; Potential Income
Researcﬁ in ExperimenEEI Psychiatry

122,839

7

159,797

29,871

A

23.'ﬁ?§7”565113 ﬁSEIEE‘EEFFTEE“"‘72,101
21. Drugs
25. Nassau County
26. Potential Income

Total Applicable
PotentiEI Income

-

3,120
11,102

&amp;

Net Deficit, Research in
EggerimenEEI PsycHIatry

78,000
1,800

-

111,708
5,089

-

.

12,307 (K)
5,089 (L)
(3,120)(M)
(11,102)(N)

89,923

82,800

119,797

29,871

10,000

10,039

10,000

0

I

�Memorandum

re: preposed Research Budget

June 12, 1961

ans-u.

II.

RESEARCH IN BIOCHEMISTRY

001.

EXPEN‘EES:

I

1960/61
Budget
27.
28.
29.
30.
31.
32.
33.
3h.
.35 .
36.
3?.
38.
39.
80.

Director
3r. Biochemist

3r. Biochemist
Biochemist
Biochemist
Jr. Biochemist
Jr. Biochemist

13,500
8,786

8,hlh

5,000
21, 500

8,168
h,000
gecretary (%)
1,680
Diener
1, 250
Laboratory Equipment
2,000
§upplies
7,000
Travel
1,000
3ocial Security &amp; Blue Cross 2,h80
Overhead
2,h75

Col. II
I96076I
Experience
(2 mos.

13,500
8,783
8,820
5,000
21,170

8,131;

3,972
1,692
1, 250
1,677
7,89h
1,000
1,776
h,2Bh

est.)

001.

III

I96I752
Request
Budget

13,500
9,883
1,816
5,300
8,600
8,868
h,h00
1,7h8

Col. IV
Everage
Col

III

over 001. I
697 (0)

(6,998)
300
100
308
800
68

(o)
(0)
(0)

5,800
6,200
1,000
2,000
3,200

3,800

(Q)

300

(950)

(800)
725

66,289

67,152

63,815

(2,83h)

Applicable &amp; Potential Income
Research in Biocﬁemist
MET—‘41::
13"".9.
Hea th service
ET
82. Potential Income

18,162
26,087

111,317

-

37,900
6,515

19,738

hh,2h9

h1,317

hh,815

22,000

25,835

19,000

7,000

2,066
1,000
3,000

PatentiaI

(19,572)

&amp;

Woe
Income

h3. Net Deficit- Research in

ems ry

III.

166

(3,000)(R)

MEDICAL DEPARTMENT RESEARCH

EXPENQEE:

88.
85.
86.
87.
88.

1:9.

Research Assoc in Medicine
Research Associate
Nurse-Technician

supplies
Travel &amp; Publications
3ocial 3ecurity &amp; Blue Cross

w

-

3,000

900
800

1160

-

h,000
3,108

(7,000)
8,000
108
100

139

1,000

245

I425

(200)
(35)

6,250

8,733

(3,027)

-

200

Total Expenses - Medical Dept

Research

(0)

(h80)

Total E enses - Research in
Biocﬁemlstry

Total Applicable

(O)

11,760

�Memorandum

-h-

re: proposed Research Budget
£31. I
1960/61
Budget

Applicable

,0.

&amp;

Potential

Income

June 12, 1961

Col.

II

I95575I"
Experience
(2 mos.

Est.)

Col.

III

I§5I752
Request
Budget

Col. IV
Overage

III

Col

over 001.

1,510
5,000

u,000

8,733

h,223
(5,000)

_2,510

h,000

8,733

(777)

2,250

2,250

-

Net Deficits Forwarded
§E§earc 1n
. syc iatry
Research in Biochemistry
Medical Dept. Research

h0,000
22,000
2,250

h0,039
25,835
2,250

h0,000
19,000

-

(3,000)
(2,250)

Total Deficits

6h,250

68,12h

59,000

(5,250)

1,000
2,000

1,000
2,000

1,000
1,000

8,000

7,000

8,000

10,000

10,000

(1,000)

58912::

Egauw

(E: 250)

51.

1c
Potential Income
. .

Total Applicable

PotentIaI Income

.ervzce

-

&amp;

52. Net Deficit Medical.
Dept. ﬁesearcﬁ

Unrestricted Research Income

Henry Kaﬁfmann MemoriaI Funa
scheuer Research Fund

Contributions - Other than
Trustees

Total Unrestricted Research Income 11,000
NET RESEARCH

-

I

DEFICIT;

III‘DEEERTMENT§"‘“‘

53, 250

(2,2SO)(31,_

-

-

(1,000)

-

_

�-Memorandum

- -

re: proposed Research Budget

ane

1

1961

BUDGET COMMENTS

I.

RESEARCH IN EXPERIMENTAL PQYCHEgTRY

EXPENSEB:

projects total expenditures of $159,797, an increase of
$29,87h over the approved budget for 1960/61. This increase is made up of the
The Request Budget

following items:
Note A:

Line 2-Associate in Psychiatry (Dr. Donald Klein)--Increase-----------—-—--$l,08h
This increase represents tﬁo factors:
a. Annual increment of $500 as of July 1, 1961 in accordance
with stated increment plan.
b. Salary adjustment made during the year in order to accurately

reflect

Dr.

Klein's actual qualifications and experience.

Note B:

Zine §--Associate in Psychiatry (Dr. John Kramer)--Increase—---------------$9,000
During the current budget year Dr. Kramer divided his time
between the research and clinical programs, being in charge
of the Electro Shock Therapy services on the clinical side.
He received part of his remuneration from the Operating
Budget and the remainder of his salary was made up by a
United 3tates Public Health Service Fellowship. His
Fellowship terminates geptember, 1961 so that $9,000 of his
total salary of $13,826 should be charged to the Research
Budget.
Note C:

Line 5-- Senior Associate in Experimental Ps hole

---------------------------

ncrease---~---------—-—-$1,000

Line 6--Assistant in Experimental Psychology (Eric Karp)—-Increase --------- $ 600
Line 10--EEG Technician Senior

....................

Increase

.................

$

390

£§§§_}2--PS cholinguistic Technician -------------- Increase ----------------- $

313

Line 13--‘Secretary-------------------------------- Increase----------—------$ 132
These repreEEnt regular increments for these positions.
Note

D:

fine 5--Associate in Experimental Psycholo (Dr. Ira Belmont)--Increase---$2,hlh
This increase represents two factors: Full year
employment for 1961/62 against part year employment
for 1960/61; increment from $12,500 to $13,500 as
of September 1, 1961.

�"Memorandum

-6-

re: prOposed Research

Note E:
Line 7--Assistant

Budget

June 12, 1961

erimental Psychology (NEW)--increase --------------- $7,2h8
personne? itEm grows out of two related factors

in

E

This new
in the program.
1. The volume of work in Experimental Psychology during
the current year has risen to a point where it places
a great strain on the two incumbents. In order to
complete the number of psychological tests and
experiments essential to the program it is necessary
to add personnel able to do this work. This however
would not require a full time worker.
2. This factor is related to the information given below in
Line 11 which states that we have made a definite policy
decision to make encephalographic studies of every
patient admitted to the Hoapital instead of a selected
sample of patients. This program of encephalography
for each patient necessitates a corresponding increase

in the number of associated psychological tests which
are made concurrently with each encephalograph in order
to complete the picture which we are seeking.

These two added work loads

qualified psychologist.

will

amply use the

full

time of a

Note F:

$
500
Kelman)----increase
(Dr.
8--Associate
-----------in roial Psycholo
Line
or y the fact that the
e 1 erence is accoun e
new incumbent has higher qualifications than the
present incumbent.

Note G:
Lin' e §--Associate in
ppo n ment en 3

erimental Psycholo

ugus

,

.

w

(Dr. Karl Anderman)-decrease--$7,080

Note H:

fine IluEEG Technician Junior (NEW) -------------- increase ----------------- $3,600
The purpose of this new position is to enable the department to
make complete encephalographic and associated psychological
examinations of every admitted patient.
At the present time we are making encephalograph studies on only
a portion of the population related to our drug investigations.
much
found
have
we
a
however,
these
of
studies,
In the course
been
have
we
than
abnormal
of
encephalograms
incidence
higher

It has

therefore
been decided that it would be valuable and informative to make
of
instead
each
on
patient
study
encephalographic
a full
selected patients in order to learn whether this high incidence
of abnormal encephalograms will hold for the total patient
population.
In order to achieve this, it is necessary to add this position
in
to
referred
services
additional
psychological
the
well
as
as
led to expect for our patient population.

Line

7

above.

�“memorandum

-7-

Note

re: proposed Research

Budget

June 12, 1961

I:

fine IS--Teohnical Assistant (NEW) ---------------- increase ----------------- $h,500
This positioﬁ‘is Being added in order to relieve higher paid
professionals, psychiatrists and psychologists from statistical
work and to provide a coordinating function in the department
in the development of more efficient methods. This will give
the top professionals more time and opportunity for the use
of their higher skills.
Note J:
Eine 50~~Training Expenses ------------------------ increase ----------------- $h,838

Cost for didactic psychoanalysis, special courses, etc., for
Dr. Donald Klein (Line 2 of budget); this expenditure is
covered in full by United gtates Public Health Service‘Grant.

Note K:

line

Income------ ------------~--~--a_~--increase—-------—--------$h2,307
Represents approximately $16,000 of additional funds for a con—
tinuation grant from the United States Public Health
3ervice and $26,000 from the same source for a Career
Investigation Grant to cover Lines 2 and 20 of the budget.
23--USEHS

Note L:

fine 25--Drugs ------------------------------------increase ----------------- $ 5,089
This {tam is for psychotropic drugs which the Hospital
receives free of charge due to our extensive research
studies. The cost of these drugs which the Hospital
would normally purchase are charged to the Operating
Budget and credited to the Experimental Psychiatry
.

Budget.

Note

M:

Line 2S—-Nassau County---------------------------- decrease----------------- $ 3,120
Research projects supported by Nassau County have been
completed and not renewed.
Note N:

Line 26--Potential Income ------------------------- decrease ----------------- $1h,h02
For I96I752 there are no pending grants or any other sources of
potential income to be noted.

II.

REiEARCH IN BIOCHEMISTRY

EXPENSES:

Note 0:

EIﬁes 58 and 30 through 3h------------------------ increase ----------------- $1,869
AII these increases totalling $1,869 are in accordance with the

stated increment policy of the Hospital.

the
Line

P:

29--§enior Biochemist------------------------decrease ----------------- $6,998

Kppointment ends August 31, 1961

�{Memorandum

-8-

Note

re: prOposed Researdh Budget

June 12, 1961

Q:

ITEE‘36--Laboratory Equipment ------------------ ---increase ----------------- $3, 800
This expenditure is Toor one item of equipment covered
Uhited States PUblic Health Service
in full by
Grant.

a

Note R:
TEEE-E3--Net

Deficit: Research in Biochemist ----decrease --------- - ------- $3,000
The decrease shown is the difference between the current year's
budget and the budget for 1961/62. It should be noted
that there is a decrease of $6,835 from our actual experience

III.

MEDICAL RESEARCH

Note 3:

Line §§--Net Deficit: Medical De
Research-~decrease ---------------- $2,250
ent
¥or
E?
accountéd
This decrease is
the fact that Dr. Arnold
Blumberg's full salary is carried in the Operating Budget
as Hospital Internist and Employee Physician. All other
expenses of this project are covered by a Federal Grant.

�Memorandum
OFFICE 01" 113E

Frm

The

Mlmm
June 30, 1961

Dr. Fink

To:

1961-62 Mdget

Re:

is

etateunt of the budget allowance for your
departnnt for 1961—62; this is sent to you for your guidance
The

attached

a

during the coming year.

If

you have any queationa whatsoever, please feel free to see me
about this femlation;
I do not hear
you I will assure
that all of the figures and procedures are accepted by you.

1133130

Mel.

if

Ira

�”7;” a
Q

ray—o“

meE
1961-62

WEARCH IN

WTAL

Salaries and
Director
Assoc.
"

nses

"

Sr. Assoc. Exper. Psycholoy
Assoc. Exper. Psycholoy
Asst. Exper. Psycholog
I
(new)
I
Assoc. in Social Psychology
Assoc. Exper. Psycholog

'

E.E.G. Technician, Sr.
15.3.0. Technician Jr. (new)

Psycholinguistic Technician
Secretary
Clerk Typist

1961-62
Reguest

(Kramer)

25,000.
17,500.
9,000.

25,000.
17,500.
9,000.

(Belmont)
(Karp)

13,33h.
8,100.

(Fink)
(Klein)

(Pollock)
"’

(Kellen)
(Andersen)

(Hosquera)

(Kolo

(Podrid

Director's Professional Expenses
Training Expenses
Social Security &amp; Blue Cross
Overhead

Research in
Total
nses
ZﬁﬁeriggnEEE

Egichiatii
Potential Income

licable &amp;
Research in EggngESEtal Pszghiatgz
3. Public Health Service

Drugs
Hess au County
Potential Income

Total

tent

Net

licable

Deficit Research in

ﬁrﬁntg

111,000.

114,000.

7,2148.

7:2h80

Psichiat'i

1

r

,Afyc ﬂy}.

‘3

..

jar

~M"
Deferred*

13, 33h.
8,100.

10,000.

10,000.

h,800.
3,600.
2, h85.
3,h92.

h,800.
3,600.
2,h85.
3,192.
2,710.

1,1120.

2,7110.
11,500.

1,1120.

11,500.

3,000.
3,600.
3,000.
600.

3,000.
3,600.
3,000.
600.
h,838.
3.500.
1h,0h0.

3.500.
1h,oho.

159.797.

159,797.

11h,708.

11h,708.

119.797.

119.797.

,

240,000.

110,000.

.

5,0890

&amp;

ncome

"?

\

Approved
1961-62
Budget

Technical Ass't (new)
Equipnent (office &amp; medical)
Travel
Supplies

U.

BUDGET

\\\

{Lu

[7/1,

PSICHIATRI

in" Psychiatry

A

HOSPITAL

/'

:1

11,838.

5,0890

cc: Dr. Fink
Dr. Robbins
Acctg. Dep .
*These items requested may be restored to the budget during 1961-62
additional funds become available.

if

�Duﬂelmh C1707

9L“!

v714x14

C

5.

/£j&gt;ur5r‘pf

~

"‘50 zaﬁ/
"‘.’U.'&gt;V'“
,I‘

June 12, 1961

HILLSIDE HOSPETAL
TENTATIVE REsEARCH BUDGET

Col.

I.

I

- 1961/62

C01. II
1960761

1960/61
Budget

Experience
(2 mos.

est.

Col. III
195I75§*
Request
Budget

)

Col. IV

Overage

7001

III

over Col.

I

RESEARCH IN EXPERDMENTAL
PSYCHIATRY

EXPENgES:

1 .
2 .

Director
Assoc. in Psychiatry

25,000
16,116

25,000
17,000

1 .

9r. Assoc. Exper. Psychology 13,000
7,500

13,000
10,667
7,500

9,500
8,500
1,110

9,500
8,597
1,105

n

.

3

5 .
6 .

7 .
8 .

u

Assoc. Exper. Psychology
“Asst. Exper. Psychology
"

(NEW)

Assoc. in aocial Psychology
Assoc. Exper. Psychology
1.13.0. Technician, Sr.
E.E.G. Technician Jr. (NEW)
Psycholinguistic Technician

9 .

10.
11.
12.
13.

9ecretary
Clerk Typist

'.
15.

Technical Ass't.

16.
17.
18.
19.

Equipment

Travel
supplies

(office

-

&amp;

Medical)

enses- Research in
Ezgerzmeniéz Psychiagry

licable

&amp;

Potential

2'3.
21. Drugs
25. Nassau County
26. Potential Income

Total Applicable

FofenEIaI Income

PS 0

rvice

3,113
2,163
600

600

-

1, 500
3,100
3,100

251

-

-

1,838
3,500
11,010

2,817
10,126

.

1,081
9,000
1,000
2,111

(0)

(D)
600 (C)
7,2118 (E)

500 (F)

(7,080)(G)
390 (c)
3,600 (H)
313 (C)
132 (C)

(150)

1,500 (I)
(1,500)
200

(100)

1,838 (J)
186

2,999

129,923

atry

72,101

-

122,839

78,000
1,800

-

159,797

111,708
5,089

29,871

12,307 (K)
5,089 (L)
(3,120)(M)
(11,102)(N)

-

-

89,923

82,800

119,797

29,871

10,000

10,039

10,000

0

3,120
11,102

&amp;

Net Deficit, Research in
EggsrimenfEI Psychiatry

(A)
(B)

'

“Fawn

.n
erimen
esearc
U:.:S:.::m%c§

Income

7,2113

10,000
1,120
1,800
3,600
2,185
3,192
2,710
1,500
3,000
3,600
3,000

2,251
3,127
2,356

600
Expenses
Training Expenses
30cia1 Security &amp; Blue Cross 3, 311
Overhead
11,011

Total

-

2,172
3,360
2,890

-

(NEW)

Director's Professional

20.
21.
22.

An

10 920

25,000
17,500
9,000
11,000
13,331
8,100

‘

�WWW
Memorandum

~S-

re: proposed Research

Budget

June 12, 1961

BUDGET COMMENTS

I.

RESEARCH IN EXPERIMENTAL PQYCHIATRY

EXPENSEB:

projects total expenditures of $159,797, an increase of
$29,87h over the approved budget for 1960/61. This increase is made up of the
The Request Budget

following items:
Note A:

Line 2-Assgciate in Psychiatry (Dr. Donald Klein)--Increase-~~---—---—-~---$l,08b
This‘fhcrease represen s we ac ors:
a. Annual increment of $500 as of July 1, 1961 in accordance
with stated increment plan.
b. Salary adjustment made during the year in order to accurately

reflect

Dr.

Klein's actual qualifications and experience,

Note B:

tine §--Associate in Psychiatry

(Dr. John Kramer)~-Increase----------------$9,000
During the current budget year Dr. Kramer divided his time
between the research and clinical programs, being in charge
of the Electra Shock Therapy services on the clinical side.
He received part of his remuneration from the Operating
Budget and the remainder of his salary was made up by a
Uhited States Public Health Service Fellowship. His
Fellowship terminates September, 1961 so that $9,000 of his
total salary of $13,826 should be charged to the Research
Budget.

Note 0:

Line ﬁ~~§enior Associate in Experimgital Psycholo
Drtéﬂax PoIIaCE--—-------------------—-::— ncrease ----------------- $1,000
Line 6--As§istant in;§§perimental Psychology (Eric Karp)--Increase
600
$
---------

Line lO--EEG Technician Senior-------------------- Increase ----------------- $ 390

Line 12--Psycholinguistic Technician -------------- Increase ----------------- $ 313

Eine 13--Secretagy -------------------------------- Increase--------~------~-$ 132
These repres§nt regular increments for these positions.
Note

D:

fine §--Associate in Experimental Psychology (Dr. Ira Belmont)--Increase---$2,hlh
This increase represents two factors: Full ytar
employment for 1961/62 against part year employment
for 1960/61; increment from $12,500 to $13,500 as
of 3eptember

l,

1961.

�Memorandum

-6-

re: proposed ?esearch

Budget

June 12, 1961
Un-

Note E:
Line 7--Assistant

erimental Psychology (NEw)--increase--------------- $7,2h8
personne§ item grows out of two related factors

in

E

This new
in the program.
1. The volume of work in Experimental Psychology during
the current year has risen to a point where it places
a great strain on the two incumbents. In order to
complete the number of psychological tests and
experiments essential to the program it is necessary
to add personnel able to do this work. This however
would not require a full time worker.
2. This factor is related to the information given below in
Line 11 which states that we have made a definite policy
decision to make encephalographic studies of every
patient admitted to the Hospital instead of a selected
sample of patients. This program of encephalography
for each patient necessitates a corresponding increase

in the number of associated psychological tests which
are made concurrently with each encephalograph in order
to complete the picture which we are seeking.

These two added work loads

qualified psychologist.

Note F:

will

Line 8-~Associate in gocial Psycholc
The difference is
new incumbent has

present incumbent.

amply use the

(Dr.

full

time of a

Kelman)----increase--------~---$
at the
iac

accounts or y e
higher qualifications than the

500

Note G:

fine §--Associate in §%perimental Psychology (Dr. Karl Andermagl—decrease--$7,080
Kppointment en s ugus
, /a .

the

H:
Line I1--EEG Technician Junior (NEW) -------------- increase ----------------- $3,600
The purpose of this new position is to enable the department to
make complete encephalographic and associated psychological

examinations of every admitted patient.

At the present time we are making encephalograph studies on only
a portion of the population related to our drug investigations.
In the course of these studies, however, we have found a much
higher incidence of abnormal encephalograms than we have been

led to expect for our patient population. It has therefore
been decided that it would be valuable and informative to make
a full encephalographic study on each patient instead of
selected patients in order to learn whether this high incidence
of abnormal encephalograms will hold for the total patient
population.

In order to achieve this, it is necessary to add this position
as well as the additional psychological services referred to in
Line

7

above.

�Memorandum

-7-

Note

re: proposed Research

Budget

June 12, 1961

I:

EEEE'I§--Technical Assistant (NEW) ---------------- increase ----------------- $h,500
This position is Being added in order to relieve higher paid

professionals, psychiatrists and psychologists from statistical
work and to provide a coordinating function in the department
in the development of more efficient methods. This will give
the top professionals more time and opportunity for the use
of their higher skills.

Note

J:

Tine 20--Training Expenses ------------------------- increase ----------------- $b,838
Cost for aiHEE'icfEEychoanalysis, special courses, etc., for
Dr. Donald Klein (Line 2 of budget); this expenditure is
covered in full by United §tates Fublic Health Service‘Grant.
Note K:

Line 23"‘USH‘I9 In00me-----n-m-'~~—--——---ou—-~-.._..-a-increase—-—---—-—--------$b2,30'?
Represents approximately $16,000 of additional funds for a continuation grant from the united States Public Health
3ervice and $26,000 from the same source for a Career
Investigation Grant to cover Lines 2 and 20 of the budget.
Note L:
Line §E--Drugs ------------------------------------ increase ----------------- 3 5,089
This item is for psychotropic drugs which the Hospital
receives free of charge due to our extensive research
studies. The cost of these drugs which the Hospital
would normally purchase are charged to the Operating
Budget and credited to the Experimental Psychiatry

Budget.

Note M:

Line §S--Nassau County---------------------------- decrease----------------- $ 3,120
Research projects supported by Nassau County have been
completed and not renewed.
Note N:

Line 26-—Potential Income ------------------------- decrease ----------------- $lh,h02
For I95I752 there are no pending grants or any other sources of
potential income to be noted.

�T’Heﬁo

ﬁranluh desk of

'L.ING.BE
‘

L

Jun 21, 1961

to: Dr. Fink:
of June 30, 1961, the
changes you requested will be
reflected in your net expenses.
As

will

net expenditure
of h0,000. at that time.

we

114%

show a

M

”(M

(L/ao/o/

6’35?

�Pg. 1

To:

I

Dr. Fink

Director, Research in Experimental Psychiatry

Fran:

Accounting Dept.

Re:

Report of Expenditures
1 60

-

H

31 1961

HOSPITAL 50331012110

”Lac

Fink
Siege],

Secretary

Podrid

Salaries 0

uses :

Assoc. in Social Psychology
Psycholinguistic Technician

maize}!

Kolodny

Medical Equipment

113.

Expense Account

Total Expenses
1333:

Income from Nassau County
'
Donat i on of Psych 0 room Dru g s

Net Expenses

cc: Mr. Bachrach

t

3,120.
2,172.
2,890.

1,500,

Office Equipment
Travel
Supplies
Social Security &amp; Blue Cross

Director's

25,000.

to Hospital
.

23,753'
$33.?-

:1
12, 3 .
18%.

ES.

3’1“».
3 , hog.
920.
600.

1,0 .
2 38 .

143,120,

37,109-

3,120.

3:35;9 .

{5%.
7

'

W,
0.

ho,ooo,

31,859.

�.1

Dr. Fink

Pg.

Director, Research in hcperhnental Psychiatry
GRANT

2

141-2715

1/1/61 to 12/31/61 Grant. approved for $65,886.
1/1/61 to 12/31/61 Supplemental Grant
16 2 0 .
approved for

with:

Amount

hl,058.*

1960.61
to
applicable

hperience

1960-61
Budget

.

To Date

,.

Grant. Balance 6/30/60

32,1105.

311,599-

Additions:
Amount applicable to 1960-61

1431053 -*

bl 053.

Starting Balance

Salaries

&amp;

ese

nses:
ssoc. n sychiatry

Sr. Assoc. in Exp. Psychology
Assoc. in Em. Psychology
Asst. in Exp. Psychology

Assoc.

in

73,u63.

Additions

&amp;

Exp. Psychology

Psycholinguistic Technician
E.E.G. Technician

Secretary
Secretary

16 ,h16.~- \

Klein
Pollock
(Gittehnan

675.

6’8?”
’ 9’

8,500.

7 ’ 890.

291.

luhlo.

3,360. mm»...

RM
V

.

h 028
9,8112.
" ’
7'93:

106.

'

Sspplies

2:5“).

Medical Equipment

Office Equipmnt

Social Security

9

.

7.500.

(Andermann
Kolodny
Mosquera

Castalano

’

10,920.-~r

(Krauthamer

%

15 583
6,1914.’

7,333.

(Belmont
Karp

v-1...

75 , 797 .

8:

Overhead

382.

1,928.

Blue Cross

9,681»

"

1-1519‘

,1 729.
3’ 259

1:100.

“Iravel

”933'

Total Expenses

Unexpended Balance

530'

-

is 3!“an

cc: Hr. Bachrach

"

Em

66,085.

9,672.

if)?

w,

a

5,

X“

I

3

41.3

6

7

3"?

�Pg. 1

W

m
Director, Research in Ehperimsntsl Psychiatry

To:

Dr.

From:

Accounting Dept.

Re:

Report of Menditures

J1EE}. HQ] .. 5323 39 mm

HOSPITAL SUBSDIZED RESEARCH

Experience
To Date

1961-62
Budget

SALARIES

Fink

Kramr

2%

6’25°

Equipment

Travel
supplies
3. S. &amp; Blue Cross
Director‘s Expert“ Accmmt

TOTAL EXPENSES

IESS

Donation of Psychotropic Drugs

NET EXPENSES

CC:

Hr. Baohroch

$313“

'
3
233‘
5 350

“65

5,089.

5 335

h0,000.

1

g

�Pg. 2
To:

Dr. Fink

Director, Research in hperinantal Psychiatry

cam 141—2715
Mariana
To
Date

Grant Balance 6-30-61

’

Addition:

Starting Balance and Additions
_S__ALARIES

Klein
Pollock

Belmont
Karp
Andermann
Kolodmr
Mosquera

Zoller &amp; Schniman

Cartolano

xrlmr

EXPENSES

Winner

Goldaclmidt

Supplies

Equipmant

Travel
S. S. 8: Blue Cross
Overhead

TOTAL EXPENSES

UNEZPENDED BALANCE

00: Hr. Bachrach

Sept. 30, 196;

6,810 .57
20 529,
2

72 ..

1,000.
3 ,500,
3,203,
2,025.
1, 771.
619.

1,133.
625.
ho.

2 ’2500

610.
263.
133,

1,01h.

301.

2 ,676,

21,168.
6,201,,

.,

..

__

..__..

._....

�av~

ﬂh

T6:

Dr. Fink

Director, Research in

Mammal Psychiatry

W

Experience
to Date

3.21;. 302 1961

Grant Balance 6-30-61

Additions

-’\

Starting Balance and Additions
SALARIES

Klein
Podrid

3,500,

861.

EIPENSES

8.8.

8:

Blue Cross

W

@1135
0

Supplies

row. Emmszs

mm

,.

8,166.

p.500.)

BALANCE

«

W
00: Hr. Bachrach

5"

64“

”‘5
27’?
6‘

ﬂex/4’"

ﬁb

(I

M

/
.

�d
To:

.

.‘Dr.

Fink

Director, Research in Experimental Psychiatry
(RANT

HI-hl98

to Date

Sept. 30, 1961

Grant Balance 6-30-61

Additions

___6.ééé..________.____..___

Starting Balance and Additions

M

Klein
Podrid

6.666.

3.500.
861.

EXPENSES

S.S. &amp; Blue Cross
Supplies

Overhead
TOTAL EXPENSES

UNEXPENDED BALANCE

CC:

Mr. Bachrach

78.

_______7_13‘_____________________

�"\

Pg. 1

x

To

W

Dr. Fink

Director, Research in Marianna]. Psychiatry

From: Accounting Dept.

Re:

Report of Expenditures

July

1

- October 31:

1961

HOSPITAL SUBSIDIZED RESEARCH

Ebcperience

'

To

Date

1961-62
Budget

SALARIES

Fink

Kramer

8.331..

EXPENSES

Equipment

Travel
Supplies

Blue Cross
Director's Expense Account

S. S.

&amp;

TOTAL EXPENSES

IESS

Donation of Psychotropic Drugs

NET EXPENSES

00: Hr. Bachrach

221;.

116.
13.

8,990.
1 “55

5,089.

I 525.

140,000.

�Pg. 2
To: Dr. Fink

Director, Research in hperimental Psychiatry
GRANT

141-2715

Experience
To Date Oct. 31, 1961
Grant. Balance 6-30-61

July

Oct.

Additions
. Starting Balance and Additions
§5_LARIES

""‘""""

Klein
Pollock
Belmnt
Karp

Andermann
Kolodny
Mosquera

Zoller- Schnirmn

Cartolano
Kramer

Winner

GOIdBChEidt

EXPENSES

6,810.57
20,529.
20,529.
147,901.57

1, 333.

14,666.

M333,
2,700.
1,771.
906.
1, 510.
879.

ho.
3,000.
1, 277 .
550.

Supplies

we“
3'“
S. S.

Blue Cross
Overhead
&amp;

'7

215.
6 .
l’iog.

3,568.

TOTAL EXPENSES

2Q

UNEXPENDI BALANCE

19.,hﬂs.._______________

00: we

mach

mg.

_...

�.M
W
Pg. 3

Dr. Fink

To:

Director, Research in Experimental Psychiatry

W

herience
to Date

-

Grant Balance 6-30-61

July

Additions

Oct.

Starting Balance and Additions

W

October 31, 1961

6 666.

6:66h.

13,330.

Klein
Pcdrid

h,667.
1,280.

Travel

111;.

EXPENSES

8.5.

&amp;

Blue Cross

Supplies

Overhead

TOTAL

WSES

UNEXPENDED BALANCE

CC:

Hr. Bachrach

10?.
15.
950.

7 ,133.

6,197.

_

��Pg. 1
‘

EEEQEEEEE!

To:

Dr. Fink

Director, Research in Emerimental Psychiatry

From:

Accounting Dept.

Re :

Report of Ehcpenditures

July

1

to

November 30: 1961

HOSPITAL SJBSIDIZED RESEARCH

Experience
To Date

1961-62
Budget

SALARIES

Fink

Kramer

10,u16.

EXPENSES

Equipment

Travel
Supplies

808.
205.
53.

Blue Cross
Director's Expense Account

S. S.

8:

TOTAL EXPENSES

LESS

Donation of Psychotropic Drugs

NET EXPHWSES

CC 3

“re BacmaCh

235

11,767 .

hég,

5,089.

10 302,

130,000.

1

__
,

�Pg.
To:

2

Dr. Fink

Director, Research in Khmerﬂwntal PSyChiatry
GRANT

141-2715

Merience
To

Grant Balance 6-30-61

July

Additions

Oct.

Starting Balance and Additions
SALARIES

Klein
Pollock

Belmont
Karp
Andermann
Kclodny
Mosquera
Zoller- Schnirman

Cartolano

Kramer

EXPENSES

Willner

Gold schmidt

6,816.57
20,529.
20,529.
h7,901.57

1,666.
5,333.
5,1633,375.

1 , 771 ,

1,117.
1 , 888 .
1,111.
ho,
2 ,250.

1 , 9&amp;3 .
83 7 .

Supplies

108.

Equipment

Travel
S. S. G: Blue Cross
Overhead

TOTAL EXPENSES

UNEXPENDED BALANCE

CC 3

Mr. Bacmactl

Date

1

.
’2?“

11,1160-

3h

0h]

13,352..

‘

___-.-

�To:

Dr. Fink

Director, Research in maximum Paychiotry
mum HI-h

98

Exporience
to Date
Grant

July
Oct.

Edam. 6-30-61

6 666.
61661;.

Additions

Starting Balmco and Additions

p.330.

SALARIES

Klein
Podrid

5,833.
1,575.

Travel

209.
138.

EXPENSES

5.3.

a:

Blue Gross

mm:
Overhead
MAL

MSES

mm

MCE

00: Mr. Bachrach

2?.
1,181.
8,969.

5361.

�Pg. 1

To:

Dr. Fink

Director, Research in Experimental Psychiatry

From:

Accmmting Dept.

Re:

Report of icpenditmrea

Jug:

1

to December 31I 1961

HOSPITAL SUBSIDIZED RESEARCH

Experience
To Date

--__

1961—62

Budget

SALARIES

Fink

12, 500.

Kramer

w

Equipment

Travel
Supplies

629.

318

Blue Cross
Director's Expense Account

S. S.

8:

2683,

13,797.

TOTAL EXPENSES

IESS

Donation of Psychotropic Drugs

NET EXPENSES

.

5,089.

2 ,295.

11,502.

ho,ooo
/

2K

CC:

Mr. Bachrach

;

1'

a.)

,7“.
‘
.1

"

..

�Pg. 2
To:

Dr. Fink

Director, Research in Experimental Psychiatry
GRANT

tax-2715

Experience
Tb Date
Grant Balance 6-30b61

July
Oct.

Additions

Starting Balance and Additions
SALARIES

Klein
Pollock

20 ,529 .

20,529.

WI

901.

2

, 000.

7,000.
6,583.

Belmont
Karp
Andermann
Kolodny
Mbsqnera
Zoller - Schnirman

1,771.
1, 327 .
2,255.
1, 310.

Kramer

3,000.

Cartolano

Willner
EXPENSES

6,8h3.57

Gold schmidt

Supplies

those.

hO.

2 ,652 .

1 , 1214 ,
1108 .

Equipment

Traﬂel
S. S. 8: Blue Cross
Overhead

1

.
’23;

5,352.

TOTAL EXPENSES

1 000

UNEXPENDED BALANCE

ﬁIQQ],

CC:

Mr. Bachrach

_

�To:

Dr. Fink

Director, Research in Experiments]. Psychiatry
GRANT

“1:5198

Meme
to Date
Grant Balance 6-30-61

July

Oct.

Additions

Starting Balance and Additions

W
MNSES

my)

BALANCE

cc: Mr. Bschrsch

13,330,

7,000.
1,870.

Travel

350.
171.

Overhead

“FUSES

6,6611.

Klein
Podrid
S.S. &amp; Blue Cross
Supplies

TOTAL

6,666.

.

ho.
____J_’),L2)J_.________________,__
102855.

2.2.15,

�Pg. 1

Dr. Fink

To:

Director, Research

Wu“).

1!:

From: Accounting Dept.

W62

Psychiatry

Report of Expemﬂtures

Re:
.

HOSPITAL

w

SUBSIDI-

RESEARCH

Experience
To Date

Fink

11bit”-

Kramer

750.
21h.
333.

Schnimn

W"

chin

Equipment

Travel
Supplies
S. S.

gig"
1
,1h9.

Blue Cross
Director's Ehpense Account
&amp;

359.

TOTAL EXPENSES

mss

Donation of Psychotropic Drugs

NET EXPENSES

CC:

Mr. Bachrach

1961-62
Budget

m
,

213

2 225

5,089.

15 213

1.0.000.

�Pg.
To:

Dr. Fink

Director, Research in Emperimental PsyChiatry
GRANT

MY-2715

Experience
Tb Date

W

6 ,8h3. 57

Grant Balance 6-30b61

Oct.

Additions

Starting Balance

Jan.
and Additions

68,906.

Klein
Pollock

2,000.
8 ,083.

SALARIES

Belmont
Karp
Andermann
Kolodny
Mosquera

Zoller

Cartolano
Kramer

EXPENSES

Uillnnr

Goldldhnidt
Supplies

Equipment

Travel
S. S. &amp; Blue Cross
Overhead

TOTAL EXPENSES

UNEXPENDED BALANCE

CC:

20,529.
20,32 3.

Mr. Bachrach

7, 628.

h:6730

1,771.
1,522.
2,633.
1’3h3.
3,000.
3. 3061,389.
938.

3,315.

1,h37o
839.

6,100.
50 0h}.

2

�Pg. 3
To:

Dr. Fink

Director, Research in Mex-mental Psychiatry
GRANT

DIX-£1798

Experience
to Date

Additions

July

6,666.

Jan.

6,66h.

Starting Balance and Additions

19

.

8

8.

SALARIES

EXPENSES

Klein
Podrid

21%;,

Travel

350.

Bur

SOS. &amp; Blue

Supplies

Overhead
TOTAL EXPENSES

UNEXPENDED BALANCE

CC :

Mr. Bachrach

60.
Cross

2%.
0.
1, 3,
12 555,

Lugs»,

�Pg. 1

To:

Dr. Fink

Director, Research in Experimental Psychiatry

From:

Accounting Dept.

Re:

Report of Ehcpenditures

July 1, 1961 to February 28, 1962

HOSPITAL NBSIDIZED RESEARCH

Experience
To Date

1961—62

Budget

SALARIES

Fink

Kramer

Schnimn

2%

Klein

Equipment

Travel
Supplies

Blue Cross
Director's Expense Account

S. S.

&amp;

TOTAL EXPENSES

LESS

Donation of Psychotropic Drugs

NET EXPENSES

CC :

Mr. Bachrach

15,371.
1,500.
1428.

666.

M0.
1,329.

232.
['22

21,858.
2 1225

5,039.

19 5§2°

h0,000.

_

_.

�Pg. 2
To:

Dr. Fink

Director, Research in Experimental Psychiatry
GRANT

141.2715

Merience
Date

To

Grant Balance 6-30-61

Additions

6,810.57

July - Jan.

62 ,062.

Starting Balance and Additions
SALARIES

"" '

68,906.

Klein
Pollock

2,000.
9,166.
8,673.
5,296.
1,771.
1,716.
3,000.
1,316.
66.
3,000.
1,694.

Belmont.

Karp

.

Andermann
Kolodny
Moequera
Schnirman

mm
Cartohno

Dramer

Goldachmidt

EXPENSES

Willner
Supplies
Trave1

s. s.

a.

Overhead

TOTAL EXPENSES

UNEXPENDED BALANCE

cc: Mr. Bachrach

3 , i460 .

h, 2 95 .

t

1

)

1:353’1‘..

Blue Cross

7,01h.
‘4

’

9.

13,},62.

�To:

Dr. Fink

Director, Research in Ewerimental Psychiatry
GRANT

DIX-M98

Mama
to Date
Grant Balance 6-30-61

Additions

July - Jan.

.

-—————l9-,991+.——-——————————————.

.___J.2;22L_.____.____.____..

Starting Balance and Additions
SALARIES

Klain
Podrid
EXPENSES

9 11 .
falls»

2

Baer

212 .

Travel

5.8.

&amp;

Blue Cross

Supplies

TOTAL EXPENSES

UNEXPENDED BALANCE

CC:

Mr. Bachrach

350-

319.
11h.

1h,h22.

__§,_S7_g_._________________

�Pg. 1
MEMORANDUM

To 3

Dr 0 Fink

Director, Research in Experimental Psychiatry

From: Accounting Dept.

Re:

Report of Expenditures

Jnl3Al..l£ﬁl.tn.laznh.31,—1262

HOSPITAL SUBSIDIZED RESEARCH

__

...____~_._.._w-.

__

Iii“
hramer
Schnirnan
Klein

Experience
To Date

1961-62
Budget

18,307.
2,250.
6h2.
1,000.

EXPENSES

Equipment

Travel
Supplies

Blue Cross
Director's Expense Account

S. S.

LESS

r

CC:

&amp;

Donation of Psychotropic Drugs

4...:

Mr. Bachrach

1 052.

1:971.

302.
509

‘__~.w_____

2'
““2

23 713.

5,0§3:~*WWM

.

513,960.

�Pg. 2
To

Dr. Fink

Director, Research in Experinental Psychiatry
GRANT

Mir-2715

Merience
To

6,813.57

Grant Balance 6-30-61

Additions

July - Jan.

§2 m2

Starting Balance and Additions
SALARIES

68 Qgé

Klein
Pollock

13:33:

gm“
A”?

ndermam

Kolodm'
Mosquera

w!
Krmr

Ichnirnn

Cartolano

Winner
EXPENSES

Goldachmidt

Supplies

Eq‘li

t

Travel
S. S. 8: Blue Cross
Overhead

TOTAL EXPENSES

UNEXPENDED BALANCE

CC 0

Mr. Bachrach

Date

9,718.
5,919.

1 771.

1:911.
3,353.
1,310.

66
000:
ﬁz6Sg.
1’36 .
h,326o ,

i’gﬁ’
,
0

7,927.

E]

555

‘

�PSe 3

To:

Dr. Fink

Director, Research in herimental Psychiatry
GRANT

MI-h798

aperience
to Date
Chant Balame 6-30-61

Additions

July to Jan.

Starting Balance and Additions

w
EIPENSES

1‘1““
Podrid
Baer

Travel
S.S. &amp; Blue Cross
Supplies

Overhead
TOTAL

MSES

UNEXPENDED BALANCE

CC:

Hr. Bachrach

__J.9..22lL.__.__._.—_______
:2

22!:

10,173.
2,686.
352.
I495.

397,
188.

_____2.135.______________.
16,136.

3

68.

�M
Pg. 1

To:

Dr. Fink

Director, Research in Ehcpermental Psychiatry

From:

Accounting Dept.

Re:

Report of Ebcperaditures

__EﬂaLJg—lﬁél_tn_hp=il_30,—1962

HOSPITAL

sussmxzm

RESEARCH

Experience
To Date

_.._...._.__.

1961—62

Budget

SHARES

Fink

20,2m4.

Kramer
Schnirman

3,000.

81h.

1, 308..

Klein

§§E§E§§§

Equipment

Travel

Supplies

S. S.

&amp;

Blue Cross

Director's Manse

i’éﬁi:
3%

Account

$99.

TOTAL EXPENSES

LESS

Donation of Psychotropic Drugs

NET EXPENSES

CC 3

29

Hr. Bacm‘aCh

‘

.

2

8]

2 295

22 186

5,089.

140,000.

__

_

�Pg. 2
To: Dr. Fink

Director, Research in Experimental Psychiatry
GRANT

Mir-2715

Emerience
To

Grant Balance 6-30-61

Additions

6,816.57

July - April

Starting Balance and Additions
SALARIES

Klein
P°11°°k

29%“
”P
Andaman
KOlOdW

Mosquera

MmSchnirman
Kramer

Willner

Gold schmidt

EXPENSES
-

Supplies

Egamt
8“].

So So &amp; Blue Cross

overhead

TOTAL EXPENSES

UNEXPENDED BALANCE

00: Mr. Bachrach

Date

8 3 , 065 .

_.__...__..__.

52 292

1%???
10,762.
6 , suz .
1 ’ 7 71 .
2 ’ 105 .
3 ’ 736 o

13%;:
3 , 000 .

S
.
3%;
2 o7 .

,

1 12 O

3,315.
2 1468
1,h23.
’

O

8 ’ 8h0 .

52 212
22

5

3?

.

�Pg. 3

Dr. Fink

'Mmqum—‘m
To:

Director, Research in Ebzperimental Psychiatry
GRANT

PIX-M98

Experience
to Date
Grant Balance 6-30-61

Addiu‘ms

July to April

‘

Starting Balance and Additions

—-4515S8~————————————26 658

SALARIES

K331“

1.
2:9g9.

11 2

PM?“

EXPENSES

Baer
T

371“
1

Sgt“;

Blue Cross

Supplies

Overhead
TOTAL EXPENSES

UNEXPENDED BALANCE

CC :

Mr. Bachrach

ﬂit
.

188 .
2 312

18,072.
8 ~86

�’

To:

Pg. 1

Dr. Fink

Director, Research in Experimental Psychiatry

From: Accounting Dept.

Re:

Report of Ebcpenditmrea
Jugs! 1I 1961

-

Max 2]“ 1262

HOSPITAL SIBSIDIZED RESEARCH

Emerience
To

-.....___

Date

1961-62
Budget

SALARIES

Fink

22,179.
3,750.

Kramer
Schnirman

W

1 , 028 .

Klein

1,558.

Equipment

Travel
supplies
8. S. &amp; Blue Cross

Director's

Ishcpense Account

TOTAL EXPENSES

IESS

Donation of Psychotropic Drugs

NET EXPENSES

U4872,032.
356.
519

22

262.

Mr. Bachrach

ho,ooo.

30.6%;

* Transfers from Grants MY 2715 and MY 1:798 as per your
to be entered on books as of June 30, 1962.

CC:

5,089.

2 225

memo

of 5/23/62

-

�Pg. 2
To:

Dr. Fink

Director, Research it:

Write;
GRANT

Psychiatry
rib-2755

Ehcperience
To

We

Grant

Additions

6-30-61
LPN-1;!

~

.

April

"""""

89,909 .

Klein
Pollock

2,000
12,h16.
11,808.

Behnont
Kerp

Andemm
Kolodny

Mos

ere

my:
Certoleno

Schnirman

ramer

1mm.

Travel
S. S. 8: Blue Cross

2,601.
1,600.
9,753.

Overhead

UNEXPDJDED BALANCE

00:

he

WW

92.

Supplies

Gold schmidt

EXPENS$

MOMS.
1,3}43 .

Willner

Equipment

TOTAL

7,165.
1,771.
2,330.

3 ’ 000 ,
6 , O36 .

K

EXPENSES

6,810.57
£33,063.

Starting Balance and Additions
SALARIES

Date

2 A1; ,

72 120,

11.112

.

�To:

Dr. Fink

Director, Research in Mex-mental Psychiatry
GRANT

PIE-M98

Emerience

to Data

Grant Balance

him

Additions

.

Starting Balance and Additions

_

26,658 .

26,658,

SALARIES

Klein
Podrid
EXPENSES

B8

er

12 ,36".

3,2h2_
37h .

Travel

h9h.

S.S. &amp; Blue Cross
Supplies

Overhead
TOTAL EXPENSES

UNEXPENDED BALANCE

00: Hr. Bachrach

2481;.

188.
g

692

12 256

g

202

�July 10, 1961

H830

re:

ﬁre. Groghan
Front Dr. Pollaak
nleaae aet aaide the annual increaent
approved for July 1, 1961 for retirement or other
annuity pnrpneee attentive Jnly 1, 1961. I understand
that the neniea withheld rill be nade available to me
at my raqneet.
Thank ynn.
Would ynn

Sincerely yours,

Hrszp

33E

FoIIacE, 55.5.

�July 10, 1961
HERO

To:

Mrs. Croghan

From:

Dr. Klein

please set aside tho annual increment
approved for July 1, 1961 for retirement or other
annuity purposes effective July 1, 1961. I understand
that the monies withhold will be made available to no
Would you

at

my

requoab.

Thank you.

Sincerely yours,

Drtgp

I

on

.

o

n,

.

�g

.I

Wm

[bur/m. a;

!‘

ll

L~O-h-b-C-* .0i

'

604’. a")

“wt
6

?

0

u-'
......... "

ﬁ
WW

4:~-5‘."4‘I-.0J.I«----'Q.OD.I'.II'.--.l“lC u-ov -....

n

_

)J’

4

I

I!

A

/

”

ll

,

I

,

1

”I.

II
i

II

II

‘

II

II

II

II

ll
‘

i

"W“
II

II

||
.

ll
ll

ll

r/.

03

nu».

a

A.

V

['2411/ /€/

-

�L\.‘\I-"-\

\y

Q.

�July 13,

1961

HERO

To:

Era. Dorothy Groghan

Front Dr.

rink

Max

Subject: Aaaignaout of salary Itaaa, 1961-62
Plaaao aaoign tho salary itaaa in tho Departaont of
Exporirontal Psychiatry aa tolloval
(a) lon-Govoroaant

1. Director
8. Social Psychologist
15. Toohnioal Aaaiatant
(b)

Dr.

Fink To ho appointad
To be appointod:
H.

NY-2115

2.
3.
h.
5.
7.
9.
10.

Payohiatriot (shooo)
Lazoc.
8r.
Expar. Psychology Aoaoo.
Aoaiataut_ '”
*
'
-

0.1. Kloih

John Kranar

Pollack
Dal-out
Ira
V
Eric Earp
Arthur Willnorﬁ
streettvum9f6t-w
Assoc. Expor.'Payoho1ogy
Karl Andoraanui
Ends 9/1/61
EEG Technician
Hrs. Haaaah-Hooquora
EEG
Taohnioian
ll.
- Hrl. Ilano Goldoohaidtr
Bagino 9/61
12. Poyoholinguiotio Toohoioian - Hrs. Joan Koloday
1h. Clark Typiat
- 32f. fygiawzollor
Max

‘

.

(o)

NI-h128

y

2. Payohiatriat
13. Soorotary
.

- D.F. Klltn
- Hrs. Gloria Podrid
Sinooroly youro,

ﬁtter

-

ﬂax FIBEI

3.5?“

�July 19, 1961

HERO

To:

Hre. Croghen

From:

Dr. Ire Beleont

pleeee set eeide the annual increment
approved for Sept. 1, 1961 for retirement or other
ennuity purposes effective July 1, 1961. I understand
that the monies withheld will be made available to me
Would you

at

my

toque-t.

Thank you.

Sincerely yours,

1331p

Ire

EeImonE,

55.5.

�Novenber 27, 1961
MEMO

To:

Mrs. Dorothy Groghan

From:

Dr.

Max

rink

Subject: Revision of Salary Assignments,
1961-1962 Budgot.

2nd

half,

Please assign tho following salary itoms in tho
Department of Exporinontal Psychiatry offectivo Jan. 1,
1962 to Juno 30, 1962 as follows:
(a) Nen-Govornmont
1. Director
- Dr. H. Pink
3. Psychiatrist
,- John Kronor (O$9000/annlb
8. Social Psychologist
- To be appointod
1h. clerk Typist
”Us Do schnirlm
'15. Technical Assistant
- To be appointed
(b) HI-2712
7

'

-21rPoychtatrist7**“‘““m“““‘””m““““”3“DTFT“ttetn“tO$kooo/annuo
8r. Assoc. lxper. Psychology - ﬂax Pollack
5. Assoc.
I
I
- Ira Bolnont

Assistant
I

'I

3

I
Assoc. Expor. Psychology
EEG Technician
EEG Technician
Psycholinguistic Technician

(c) HI-h798
C}. Psychiatrist
13. Socrotary

-

Eric tarp
Arthur Willner
To be appointed
Hrs. Hannah Hosquera
Hrs. Ilana Goldsohnidt
Hrs. Joan Kolodny

- D.F. Klein (Total loss
$h000)
- Hrs. Gloria Podrid

Sincerely yours,
Mllgp

HIE'TIEEI'HTET'

�MIMOIANDA
,“

�[13/

Memorandum From The
OFFICE OF THE ADMINISTRATOR

December 20, 1961

To:

Dr. Arnold Blumberg
v’Dr. Max Fink
Dr. Harry Goldenberg
1962-63 Budget

Re:

I

am

working on the budget

for the fiscal year -

July 1, 1962 to June 30, 1963.
Attached please find budget'forms with expense categories pertinent
to your department. The first column shows the budgetary allowance

for the current fiscal year; in the second column, kindly indicate
the appropriation you feel will be needed for the 1962-63 fiscal year.
You may append any data or schedules which you feel will be of assistance.
For each item of salary and expense contemplated for 1962-63, kindly
indicate in the appropriate column the source of support for the

expenditure.

Before you make your

please confer with
for next year.
Thank you

MB:DC

Enclosure

M:-

7254'

final determinations for purposes of this budget,

Dre Rebbins

for your cooperation.

as to your plans and budget prospectives

�~T0:

DEPARTWNT 0F MERIMENTAL PSYCHIATRY

HILLSIDE HOSPITAL

�L

F;

,

.
a

,

,3
,..

L:

....q.

a

a;

mg

3.

:m.‘
:2,‘ ,Fman
.3,

.35

n
1

a.»v.

GM

,r

I.

,

4

Ahrwwm.

a.

H..4.

H. ”a?”

mh. 4
.3.

. A».

Vt.

1

can

,

H
k

”21., ‘5‘.»

K

3.:

,

_,

L f.
L

H

‘

,

.

.

l

,

f.

:

.
,

hm

H

1+

..'I

{IIIII

i'l'l'll
«Inlgilillﬂllwll

it‘ll-Illlllllllllllll

«I'll'llll.wu,llllll"l

“EIIIIIIII!

.flllllllll

I'lllnlll

.,II|l|IIl|I:|-|lll|l.lll.

IIIII'III...,.Illlll'l.

Ill'lllll.

«IIIIIIII!

«ill-I'll!

,Illl'llllw

‘llllllllll

.Ill'l'llllll

ll!
‘

-

,
IlinllA

¢

A

x

.

, 1,

I

x

I.“

l

z. ,

M

I“ 1

.

/

,

i.

f

lI
&lt;

.

.

A

‘q

w

/

,

,

A.1 A. ..

. a.

.

‘

A

.

‘ t. 4

A

3/

$4,x

I

..

‘

‘
1

,

1

r.
WM.,IIIIIIIIIM‘IIHIIIHIIIIIII

A

4'.I

.

I

6.1"“

7

(

.

IIIIIIII'II‘I'

.In'!

, .

.l'm'l'ulllllll

r
‘E-E-E—mmmmm—E-E-E-EE—E-E-E—n__

ﬁll-I-lll-rlll-Ml-IIIIIIIIII-Il-I-lllll-l!
IllI'lllIIIIIII'IIIIIIIIII'III'IIII'IIII.

I

V

IIIII'IIIlllllll'l'lll'llll'll

ll:liWuI:laI.lul,||«llu||lWlllllllllllllulll4..

allllllwllilllllllllIlllllllllll'lllllI.

.llllllllllllllIIII'IIIIIIIIIIII
.lllllll'lIIIIIIIIIIIIIIIIIIIIII_
.llllll'llllIIIIIIIIIIIIIIIIIIII_

“InﬁllILIIIIIllll'lll'llllll'lll'l.

I...IIIIIIIIIIIII-I'lllllli'llI_

mmmw-III-Iun---------_
lulllillllllllllllllll‘ll'l'llllllllllllllI.

IIIllnl|II'IIIIIIII'IIIIIIIIII_
Illlllll'lllll'lllllllllI'll'.
a":lI-ﬂllIlll'l'llll'l'l'llllll_

gllvﬂ'lllllIlllllllllllllll'I.

III'IIIIIIII'II'II'I'I'l'll_

IIIII'I'III'IIII'IIIII'I'—

Hullllllll'lllll'llll'lllI_

llillllllllllilllllllllll.

J.

Y

5,.

“lllll'lll'l'l'll

IIIIIIIIIIIIIII

,

..

‘

,

\

I_

I

......

�ﬂFfBB’.
5%

WA:

I’wa

N

”/7

'

x
.

‘M.

”#7

11,1111;
’

”
47%?

6’7?

/
Wu”

6/

”F A203

/&amp;:W

-

���,

.

31-.

.

_

km.

Auoc.

he.

who
. rod-aha

up».

an.
.‘ kt"

A“

',
Pooh-log
,

7

m

.

Assoc.

uni-w
inn—-

~

rm

‘

roam

Sea-our;

mm.
Club-mm

.

(ml-Ad»
and

run).

nun-1)

mun

mat-01"! Put-utensil.

Train“ up»... (0:.

we;

W
W

3001.).

&amp;

nu.

an”

”7.”,—

4, an.

13.331»

moon.
5,100.

m7 :3:

.

A

7,50.
10.000.

"

1.1.20.

.

Wu

g b.000.
3.600.

'
'

.

4..

(W)

Us A

.m‘
m.
2:12.
n «a

2.1.65.

3,132.

2,1“.

£500.

.

3.000.
3,600.
3.000..

.

w

.
'

-

n4.)
Cron-

‘
~

.

3.500.

”MM.

7

'

0.3. Public

-.

.

a'
m

mm
Hula;

1.

M.

15,833.

it"s-nu

Tom lupus-a

muscu-

ram
mu
Scum-u

.

-

.

pun—L44

’

lquimt (arm.

.-

lug-n

'

2.3.0. Yeoman, Jr.

tholjnzuhuo

.

nrp

.

Auoc. 1n Soom’

V“

Bel-nut

mug
hpor.
mm
3.x.o. rochucim, 8r.'
.

.

We

i
'

1.13.100.

G

tea!

8'!“-

�81'. Anna. E190! Psychology Pollack
Assoc. Bqu‘r.
3.01%

Anya-.313)».
p

n

new. in

lung.
'E.E1.G.

metal":

thlby
I

a
m
W4
‘

_

30016.

m1!

.

_

~

Pmbloq

Exp". thploq

.7

Tahitian, Sr.

E.E. a. nemoimn,

Jr.

Hams

"

‘

~

1

mar-onngmtio technician
‘Stcutuy_

HINHW.

’

=j

smm
inert-Typist“

'

-

.

fwd/h‘wﬁﬁ
$92:me mun)
if Equip-Ont
w-mia
”PM”
'

.

’

‘

'

W

Wantor'a Prozac-10nd
ruining Enigma (hasnun)
"__Se¢1n
«Emu Gm

Wt!

1'
‘
m

'j:

2/1/11
"
.

.m
in
(/5:
WW3:
)7
*

_

‘

J47_-'

r5“

'

'
‘

�H1llside Hoqpitii
1962—63

Salaries
Director

&amp;

Budget

-

Research in Experimental Psychiatry

Assoc. Exper. Psychology
Asst. Exper. Psychology

.

Kramer

.

’Pollock

»

Belmont

'

Karp

Assoc. in Social Psychology
Assoc. Exper. Psychology
E.E10. Technician, 3r.
E.E.G. Technician,

4ﬁdhlﬂr
Moaquera

Jr.

,(L14‘.ALaQ»‘

(office

and Medical)

Training Expenses (Dr. Klein)
Social Security &amp; Blue Cross

thioaw

Total Expenses

Anglicable &amp; Potential Inca-o
U. 5. Public Health
Service
«Mr—“whoa”,

Ire.“

lions

7/4/4. a.

5».«~

"

ﬁfe"
.

Fﬂclv

1“ 7

4/0 3

Director's Professional Expenses

r. r-

lbowr

Scott/‘nual

(éI‘M)

7

?"',4]; : 3"”

47;: r: 417.

Supplies

W m-~.—

C)

agaao.

Podrid

1‘rawel

«-

v

5-»

[9‘100

,.r, n..

'
A/vi

Kolodny

.

mm.
Drugs

Request

Anderman

Psycholinguistic Technician
Sacretnry
Clerk-Typist
~Teohnioa1 Asst. gout/”‘4‘“

m...

Budget

.37

Klein

Nil/Mr

Overhead
$1.1¢¢1Lc.z

1962-63

Egggnees

Associate in Psychiatry
n.
I
Sr. Assoc. Exper. Psychology

Equipment

1961-62

F‘s-u ‘44.
7‘9
JI-A

?,h85.
3,h92.
2,7h0.
h,500.
3,000.
3,600.
3,000.

6)

&gt;640
J 70 /
39/4.
7~fec

—

,

/.(on

Juo,
300

"'

IOOo

h,838.
3,5001h,ouo.

V! 3!

.3'00

[76yj'h'

loco

153,797.

/?3/:9.

113,708.
5,059.

[4U

.43
2! as.

�”

V‘r/‘f/

f‘ﬁf/

�7-5-

H

”I

‘

I0“

V.

.4

.

ll

.

Mﬂzr
Th ﬂ

e,

[ll—Yr»

I

‘

.

ll
ll
I!

I

Corr/biz} o‘7

'

I

‘

*

-

.
‘

"
~

“W

ﬂﬂanoa‘

1

t

1.-

6110

Q Afﬂéeméudz"

,,

,

.V

7!!)

J’ﬂ /an~¥.-1IL .,

z?

;

.

�\.1———|

,/

/

/

APLJL20°.

5

.9

_.._-,.Iéo°

'

9

-

-

._

23“

1

30.0
H

ll
-

‘

~~.—.‘~“

-_,_

_.~‘-..____M

é~__~u-‘—#&lt;_.9 __

w

l,

Q:

are? v»

�.7:

We} f/'

ﬂap
71W?

jnMAzéxﬁi

_

.-

mlx/ 3.

/¥l

47‘
.5150

309.

LHM-

d.

'J’ao
4525

1

Joe

foo

/ la

6.

�0W»

"('

«auWLZLZEL—___Hiyoojm

______.__

-

6's!

aﬁfggmng

eggwg 3:
7740’”

6c. +90%!ou (1:)

,

I

r2

3(132.
.2”

{ﬂ _

%*
64»:

war»;

444/

a}

x5314)

ﬂaw/Mm'g)

”‘0

3

oo

3

3.3V

‘

flat

W6

33-»

3

lfasé

”Wm/Mm:

AWL“—
i/qh/

7:

€73.14”

Z
,

L

waGDi/n’xxaw»,

4’

.3,

M 010’

3&amp;4“; {Gay'aQ/I

d

,

,{ )4

“z

a.

"

7

x

(v

4,

A.

&gt;‘Mn-

~

,9;

'7
i/k

I

.r'ov

/f

.r’

��__

ﬂ“
,

4

,.’,A

"n.7,“

‘/

*

ﬂyca—

"ﬂnﬂ ‘M

Mambo

/

A

1‘1/

471,!

,

ﬁn—é

_

&gt;

“t,

I

,

TV

#

3,7.{54'

�ll

H
1

H

H

_,
ll

Ii
,

H

H

I!

H

.

�V.

5M»
MY47’4’

ﬂvwm/L

,k

A

vaCa-AM—c

W
‘I;
I

J,

.il’
1kl

/7‘+

3714‘
/; ’ 7’

L

"

.‘A

‘

"

foo

3 "

3 s‘?é-

C

!

M-

04M%9(.)

(Cato.

-

I

L

'44
")X’I—A

IN,

4

4 .34

I:

C:

"

L

"

4,700.

.._«:

,,__‘_ I

M.

6 f

‘ng‘glﬂ-ou

“Vi“
{t

",_
"

11‘03’

'

v

’

(Lu/L...

.

7

C u

3

.

-

457.

94

“M A'M
3» w

amm- 26/

:

H
I

,9]/

l

,

'

"

,

M

'

.

4,

4

L

cog!

‘

O

‘

Qro
37, ' 3 v

" 2my

ll

:

/

/4—2:»

,

ll

l

1:

'o

3

6'

/

_

ll

.."

050.

.1

“km—nn—m
ll“
|~,-

o

’7 ’

30..
’M‘
3o-o-v—

“.209

4-

‘4», o

W's-7"
'39, 332,

�M

W
in;
:24

%’:’7‘Z

.

7/1/22.

.

L°3lui’?°"

"

73‘4“”..1 may:

C

'

5M.
~

f/M/é»

'

‘

ﬁzz/Léu/zAJ/ﬁulamm

6M“ “j 17!!

Am

(2%”

/J’ I/o’
f’yoo?
.___L—\._.--.-

J‘Zv’f‘v
'

5%

5(ow MW”;
:I’ng

8:, 3c.

*

wind

I

a.

35/31.

(1:)

“W
WOO

I

3'.

(ﬂ

4a! anal/‘4‘». (I)
(liot‘)
(I,

3

...
f00

37 )JV
‘

£11
x

Mt‘ﬁ
7a ‘14.»

)4

-

rPCuumuIJI-m

H/«7ﬂ

(WA/”0;;

7%

’f/eM

lug/y '44
.31

[I

WdL;

.-

“75

«Ian:

%’ )4

I

”Ma:
'

20/»714'

'4344’

I300

O 4’33er 13...,

My”;
ﬂuWJ—«a‘fwl

WA];
?(

junk
7

’alljo

ﬂ {mac
/~

33v

37,

Jh‘yi

It‘

,0/57/4’

%",’/v.l~n

'

:H’n'.

W
/6 N13"

'
_

I/t/VJ’

W
.

739:",

��ﬂan-.1 Hx§l7/f.

A

A4
awn-wad,

xa/a'r/w

'CLo‘ol.

.‘

ﬁ/VOf

I,‘V

/

1'57

1-7.4

'

01“

"

Jud

J“,

4,7(5

,.

ﬂan-.4.

“.4

O

.

4;",j_
.

O

45",.

°

6/“,

$.54,

-

�\r

K’M
(“41.

13M

war“...
(Jot—7

Aofl/

roln/

10,41}

luoé'

671.06

J4

4674/

baddfg
.u 7.4/

IN“.

I’glylo

19J1J0

‘(a

4x.

4". -

‘9‘.“

(9-3.“

Ha.“

did.

‘1‘,

A0494

CJQ/‘A—o—O

’1‘}ka

WW“

‘I‘. ‘

JC—r Iii—##d'b
OMA-OL
7/1
‘

4744714

'

-

LvLol
I,

04.4.1;
44

1‘"

cub-o

'3‘.

’14

’I

{ll-I.“

O

‘

4:41.114

uni.

�’9."

‘

e'

’

s7wﬁv

'
~

.

a

,

a.

,4

/

.

HYa‘ro-J'
.

‘

K’CLA—Q)

.

‘

4

’

/

,

(,

.

t

M)

J

'

K

‘

l-

’14

L

n

(m)
*7”;-*~~

‘-

'

1

‘

I

1-,?!

7)!“

c

5 t

h

'3

L

3 1.3";

J.:Id-.

44!.

“I,"

.k‘44w9-Miww.”
.

.

"I"

I

d, can
I

0

/

1

I!

.

5

I

�9:3
.‘

79L; ,4, “a?” M/JaM/Muwﬁu
(1'0“)

/6:.‘

3M AW

6mg szwf

V

2 /’7Cv

J/ngg
gag/um»;
v%‘/&amp;"

ét’ﬂ’x

I

x;

V!

(I)

C)

2.

3’ no o
’,

.

foo

d4?5447 rPCuum/wm:

”/47”

7342/.“

A

4.“; «74

M7444

cdwwé.‘
/~ 17(3-éd
i6,
%
,4 KI/nu‘
O‘KM
7%
'

’

«

.2"

(j)

“MI/44m .(Z)

4‘4!

(/50

‘2’);007

‘

‘

raggxg

.4...
4/44,};

W Iiy/m
W
-¢.

I‘Avm‘.

'@

173,14’

A

A

’31:.
0
././wwa/«x..7
“'Mj/xm
?(
,0/L-7/f

{u/y

"A:

hrs in lawn,

/

gruWMAiw

7% 7//v

Jlnuﬁv’

{Mn‘

_

//.&gt;"

flu/no
.

‘__..._.._._._

��ﬂan—4‘ M/ 47/

610...,

11; v

J“.

.

K

39W

~

Chou.

"

,7?

,,

Mud
'

o

0

Waﬁoc
.

.,

�~24

Ioqu/

‘

but

and;
/, a «1.1.x

”1.114..

/,

347.41”

447-4?

”4,1.

p.441.

4%?

44' ’

4,-3.30

47.3.30

.1,_‘

all"

.

ago

.1“.
71-1.

W 3.

’

.4

0

.

.

�c

I 1&amp;4

6..
‘1‘”

I‘ve

:

4173.3v

�H.’ 23’ 1962

\.,

HERO

To:

Mr. H. Bachrach

Front

H.

Fink, H.D.

Subject: Adjustment of Expenditures HI

to

MY

2715 and

KY

h798

1.

Pleaao aeaeeign following expenditurae aaeigned
2715 to "non~government".

a. Salary of
lolodny, Jean

Jan. 1, 1962 - June 30, 1962
Goldechnidt, Ilene
Jan. 1, 1962-May 31, 1962
2. Pleaee reaeaign expenditures charged HY h798 by
transfer to "non-government” of the following items:
a. Gloria Podrid
Charge 2/5 to MY h793
7/1/51
‘
dtto
BIS/to
Ron-Govt.
'
b. Mrs. Gertrude Baer
Charge

o.

all salary to

Non-Govt.

Requiaitione dated:
11/61 ﬂax rink - expenaee
12/61 Max Fink - expenses
12/20/61 Max naailton
2/8/62 L.I. stenotape Co.
(Royal Typita)
2/8/62 Joint Purchasing (aupplies)

9.75
b0.61
50.00
53.20
h6.55

W.

."'

�oemnmtm or:

arm» mcmm
HﬂLﬂDEPKNFgﬂL

Gumcnﬂhl99'

May

23, 1962

MEMO

To:

Mr. M. ﬁachrach

From:

N.

Subject:

to

MY

Pink,

M.D.

Adjustment of Expenditures MY 2715 and
July 1, 1961 - June 30, 1962

MI L798

Please reassign following expenditures assigned
2715 to “non-government”.

1.

a.

Salary of

Jan. 1, 1962 - June 30, 1962
Jen. 1, 1962-Mey 31, 1962
Goldschmidt, Ilene
2. Please reassign expenditures charged HY h798 by
transfer to “non—government" of the following items:
a. Gloria Podrid
Charge 2/5 to MY h798
7/1/61 - data

lolodny, Jeen

"

3/S/to Non-Govt.

b. Mrs. Gertrude Beer
Charge

ell salary to

Non-Govt.

c. Requieitione dated:
Fink - expenses
Fink - expenses
12/20/61 Hex Hamilton

11/61
12/61

Mex
Max

9.75
h0.61
50.00
53.20

2/8/62 L.I. Stenotape Co.
(Royal Typite)
2/8/62 Joint Purchasing (supplies h6.55

Hex FInE, M.D.

�6/11/62
Brain Function and Bohavior Rososrch Progoct
Bud‘otagz Rocoonggggtiono

--

1262

~

62

- Rovisod 6/11/62

Following discussions or 5/22 and 23, a hudgst rooosnondation for oightoon months support was prosontod which
did not lost tho Radical Diroctor's approval. In ossonco,

it provided

for

an oxponditurs or $53.h10

for the

first

six months; $63,183 for tho next twolvo; and of those suns,
325.750 from Hillsido Hospital and $90,8h3 (including $9583
ovorhsod) from tho u.s.9.n.s. In lino with tho discussion
of 6/11/62, tho following rovissd budgot is prosontcd for
consideration.
1. It is tho intsntion of tho Director of tho Dopartnont
or Exporioontal Psychiatry to resign fro- hia prsaont pooition'
on July 1, 1962 to continue os Principal Invsstigator
(Consultant) of tho Brain Function and Bohavior Rosoarch
ProJoct (H! 2715) to Doc. 31, 1962.
For this poriod, to Doconhor 31, 1962 his ssrvicos
will ho conponsasod on a consultant stipond basis, tron
funds providod by tho Board of Directors of Hillsido Hospital.
2. It is roconnondod that Dr. Belmont, boginning 10/1/62,
bo continuod on a flat too stipond basic at an ostblishod
rats oqnivalont in ootivity to ono day pot wash.
3. It is roconnondsd that tho following adjustnonts ho
nadc in Dcpartnontal hudgsts to accomplish tho rsquostod
soparation of tho Dopartaont into constituont unite.

�-2-

s.

the expenses and activities of
Dr. Donald Klein he continued under the direct supervision
of Dr. Robbins, providing such secretarial and data processing services as his project may require.
b. in EEG technician salary be provided by the
hospital at a rate of $5,000/annuu for full tile. 1 would
suggest 2/5 tine; but this should be based on s reconaendation of tho hospital Neurologist. For the period that
Dr. Kramer is available, he will continue to read the
records; but provision should be node for others to do this.
0. Dr. Kroner to continue in the sane relationship
to end or 1962 continuing supervision or 30!, at Dr. Robbins'
K! h798 and

pleasure.
0.

Present budgets (to 6/30/62) he re-ellocated to show
estimated expenditure of approximately $30,000 in Board support,
allowing the following a
a) Estinsted balance 6/30/69 nr 2715
2000
Incone 2nd half 1962

h2001

stupoo
5.

Budgets for six nonths 1962 and 12 nonths 1963,

corrected for social security, blue cross and statistical
expenses are shown on next page. These provide, exclusive or
principal investigators
7/1/62 - 12/31/63
3h,260
Overhead

1/1/63 - 12/31/63

5,100
$38,960
50.500

�-36. Requeet 0.8.P.H.S.t
$hh,000
a. 196? Income
Expendituree 38.960
5.000 app. - carried forward

b. 1963

50,500

-._.£&amp;99_
hS.Soo

Overhead

6.8gg
$52,325

7.

With theee

adjust-cute, the budget ie reconnended

inclueingt
a. Continuation request or I! 2715 be aubaitted to
U.S.P.R.s., requeeting the aaount of 52,325 to retain at
Hillaide ﬁoapital for 1963 and the balance (app. 31.000) he
made available for application of continuation at the Mieeouri
Iuetitute or Paychiatry.
b. iproval for transfer of EEG analyser and tape
eyeten ee requeeted h/l/62 be approved.
6. Board of Directors approval tormfunde or 12,500
for period 7/1/62 - 12/31/62 aa continued aupport of Principal
Investigator (Coneultant) on baeis outlined above. In the
event coneultent tine 1- required in 1963, expenses and
ccnaultation teee are to be paid by Hilleide Hoopital through
{undo provided by the Board of Directore. A contingency fund
in the amount of 86000 ie eugteeted for thia activity.
a. U.3.P.H.s. be requested to approve Dr. Hex Pollack
ea oouinveetigator.

�7/1/62 - 12/31/62

1/63 - 12/63

1. Staff

Psychiatrist
I. Pollack, 8:. Res. Assoc.
taper. Peychol.

John Kroner,

3,956

-

I. Bel-out

7,500
3,582

15,000

'Earn,

Consultant

750

Res. Ass't.
Expor. Fsychol.
A. "illner, Res. Assoc.
Expos. Psychol.
B. Hosquereﬂ, EEO Technician

3.

b.350
h,700
1,000
1,700
1,h57
1,315

0. Podrid, secretary
Dr. schnirnanhe, secretsry
J. Xolodny, technician
351

BC

(OPP)

3,000
8,700
,

9,h00
2,000
3,800
~
2,600

950

Travel
Supplies
Conputaticn c Consultation

‘

Carried forward
Net

Overhead

u.s.r.n.s.

Total

'

Board support

Total Budgets: 18 nos.
uspns
Board

500

600
900
1;560&amp;

1,200
1,800
1,500

3h,260

50,500

3h,260

5,000
u5,500

5.100
38,960

6,822
$2,325

12,599

16,000)

$109,785

91,285
12,500 (¢ $6000 contingency).

Notes
0

H. Hosquere:

tins s 380 resesrch
i
and
as
ties
statistician,
clinicel
EEO services
recouaended by

Allows one

es Secretary-typistc Prograa

(it
sill

Neurologist).

not require second typist 1963.

�6/11/62

I!

Brain Function and Behavior Research Proaect
Budgetarz Reconnendetions

--

1962 - 63

- Revised 6/11/62

Following discussions or 5/22 and 23, a budget reconnendation for eighteen months support was presented which
did not nest the Medical Director's approval. In essence,

it provided

expenditure of $53,h10 for the first
six nonths; $63,183 for the next twelve; and of these suns,
$25,750 from Hillside hospital and $90,8b3 (including $9583
overhead) from the U.3.P.H.3. In line with the discussion
of 6/11/62, the following revised budget is presented for

for

an

consideration.
1. It is the intention of the Director of the Department
of Experimental Psychiatry to resign from his present position
on July 1, 1962 to continue as Principal lnvestigator
(Consultent) or the Brain function and Behavior Research
Project (M! 2715) to Dec. 31, 1962.
1962
December
to
31.
his services
period,
this
will be cenpensaeed on a consultant stipend basis, tron
funds provided by the Board of Directors or Hillside Hospital.
2. It is recon-ended that Dr. Belmont, beginning 10/1/62,
be continued on-e flat fee stipend basis at an estblished
rate equivalent in activity to one day per week.
3. It is recommended that the following adjustnente be
node in Departmental budgets to accomplish the requested
sepsraticn or the Departnent into constituent units.

For

�-2-

a.

activities of
Dr. Donald Klein he continued under the direct supervision
or Dr. Robbins, providing such secretarial and data processH! h798 and the expenses end

ing services as his project

require.
b. in EEG technician salary be provided by the
hospital at a rats of $5.000/annuu for full time. I would
suggest 2/5 time; but this should be based on a reconnendation of the hospital Neurologist. For the period that
Dr. Kramer is available, he will continue to read the
records; but provision should be made for others to do this.
c. Dr. Kramer to continue in the same relationship
to end of 1962 continuing supervision of ICT, at Dr. Rohbins'
pleasure.
h. Present budgets (to 6/30/62) he re-allocated to show
may

estimated expenditure of approximately $30,000 in Board support,
allowing the following:
a) Estimated balance 6/30/6? NY 2715
2000
Income 2nd

5.

half

1962

h2°?Z,
thhpoo

Budgets for six uonths 1962 and 12 months 1963,

corrected for social security, blue cross and statistical
expcnaes are shown on next page. These provide, exclusive of

principal investigator:
7/1/62 - 12/31/63
Overhead

1/1/63 - 12/31/63

3h,260
-

3.100
838,960
50.500

�-36.

Request U.S.P.H.s.s

s.

1962
-

Income

Expenditures

$bh,000
38.960

5,000 spp. - csrried forward

b. 1963

*

50,500
§IOOO

hS’SOO

Overhead

6:825
$52,325

7.

With

these sdJustsents, the budget is recossended

inelusing:

s. Continustion request of I!

2715 be submitted

to

J.S.P.H.S., requesting the ssount or 52,325 to rensin st
Hillside Hospitsl tor 1963 end the bslence (spp. 31,000) be
nsde evsilsble for spplicstion of continuation at the Missouri
Institute of Psychiatry.
b. Aprovsl for transfer of EEG snslyser end tspe
system so requested

h/l/é?

be approved.

0. Bosrd of Directors spprovsl forfﬂunds or 12,500
for period 7/1/62 - 12/31/62 ss continued support of Principal
luvsstigstor (Consultsnt) on basis outlined above. In the
event cousultsnt tine is required in 1963, expenses end

oonsultstion tees sre to be psid by Hillside Hospitel through
funds provided by the Bosrd of Directors. A contingency fund
in the slount or 36000 is suggested for this sotirity.
d. 0.8.9.3.8. be requested to spprove Dr. Hex Pollock
ss eo-investigstor.

�7/1/62 - 12/31/62
1.

1/63 - 12/63

Staff
John Kraser,

Psychiatrist

Pollack, Sr. Res. Assoc.
Bxper. Psychol.
1. Belmont
Consultant
I. tarp, Res. Ass't.
Exper. Psychol.
A. "illner, Ree. Assoc.
Bxper. Psychol.
H. Hosquerae, EEG Technician
0. Podrid, aecretary
at. Schnirneneﬁ, secretary
J. Kolodny, technician
as, no (app)
Travel
Supplies
Computation &amp; Consultation
H.

'

’

3,956

-

7.500
3.582

15,000

750

3.000

b.350

8,700

h.7oo
1,000
1,700
1,h57
1,315

9,hoo
2,000
3,800

950

1,500

600

1,200
1.800
1,200

11500?

Carried forward

,,

Net
'
.

Board Support

03935
Board

50,500.
5,000

_.,

3h,260

hS.Soo

h,zoo

6,825

38,960

52,325

12,500

$6,000)

51,h60

58,325

Overhead

Total Budgets: 18 nos.

9,600

900

3h,260

Total U.8.P.R.S.

-

$109,785

91.285

12,500 (+ $6000 contingency).

Notes

e

i

tine as

research
and i time as clinical
statistician,
EEG services (if reconaanded by Neurologist).
so Secretary-typist: Prograa will not require second typiet 1963.
H. Hosqueras

Allows one

EEG

�Juno 12, 1962
Dr. Lowis L. Robbins, Hodioal Diractor
Hr. Horbsrt Bookind, Prosidsnt, Board or Dirootors

ﬁillsido Hospital
Olon Oaks,

!.!.

Dsar Dr. Robbins and Hr. Bookind:

It is

with rogrst and with tondnsos for my
stimulating and exciting ysars at ﬂillsids that I
submit this lattsr of rosignation as Dirsotor of tho
Dopartssnt or Exporiasntal Psychiatry stractivo
Doooubor 31, 1962. I an aura you will ho ploaosd to
know that tho prograss hora havo lad to tho invitation
to ostahlish a rosoaroh and training program in a now
cantor, tho Missouri Instituto of Psychiatry at
St. Louis; as wsll as my appoint-ant as Rsssarch
Protoosor of Psychiatry at Washington Unirsrsity School
of Hodicino.

I look back at thoss ysara with ploasurs, for I
havo loarnod such and hats round snthusiastio and
dodioatod co-worksrs. I as aratotul to tho contidonoo
sxprosssd in my initial appointasnt by Dr. Israol strauss,
and to tho Board or Diroctor's support during thoso yoars.
During tho nsxt tow aonths, I should liko tho
opportunity to coaplots as such o: my progras as possiblo
hora, and for this roason hays askod to continua as
projaot dirsotor or ths USPH3 grant H12715. is soon as
tho studios hora psrait, I shall lsavs to ossuas my now
dutiss in St. Louis.
with my boot porsonal rogards, and assurancos of
loyalty, I roaain.
Rospoctfully yours,
Hrsgp

.

ﬂax

M

IInE, 5.5.

�HEHORAHDUH

June 12, 1962

to:

Dr. L. Robbins

FROM:

Hex

Pink,

M.D.

With the disapproval of the proposed 18 nonth budget
for the Brein Function and Behavior Project, and without a
to submit the
satisfactory alternative, I an conetreined
enclosed letter of reeignation, dated Deco-her 31, with a
recommended budget for the expenditures under HI-2715
during the renainder ot the grant period. I an dating
the roaignation as of this time to permit the oonpletion
of e major port or the progren. It in my intention to
continue thie program of studies or the relation of brain
function to behevior et the Hieaonri Institute of Poy‘
ehiatry, beginning early in September. For e treneition
period or e few nonthe, while aone onelyeeo end write-up
are in progress here, the continuation progrene will be

eetabliehed there. AI noon on my tine is predoninantly
in St. Louie, I will resign fully from the program here.
I truet this is satisfactory to you.
Roapeotfnlly yonre,

Krzdto
one.

or

M
n

,

. .

�June 12, 1962
Proposed Budget, Brain Function and Behavior Research Project
Jnly 1, 1962 - December 31, 1962

Estimated Balance, 6/30/62 MY2715
Income 6/30-12/31

12,000
h2,007
$Sh,000

Expenditures

l.2.

Prin. Investigator
Psychiatrist (Kramer)
3. Psychologist (Pollack)

h.
5.
6.

-7.

8.
9.
10.
11.
12.
13.

lb.

15.

”

EEG

12,500
3,956
7,500
3,582

(Belmont)

750

(Karp)
''
(Willner)
Technician (Moequara)

Secretary (Podrid)
(Schnirnan)
Technician (Kolodny)
Soc. Sec., Blue Cross
Travel
Supplies
Cowputation and Consultation

0,350
h,700
2,000
1,700
1, h57
1, 315K

'

Overhead

950
600
900

,

’

1,500
h,700

$52,h60
Balance carried forward 1963

$

1,5h0

�June 12, 1962
Proposed Budget, Brain Function and Behavior Research Project
July 1, 196? - December 31, 1962

Estimated Balance, 6/30/62 H12715
Income 6/30-12/31

12,000
h2,oo7
$5h,000

Expenditures

l.2.

Prin. Investigator
Psychiatrist (Kramer)
3. Psychologist (Pollack)

h.
So

6.
7.
a.
9.
10.
11.
12.
13.

lb.

15.

(Belnont)
'I
I
.
(Earp)
(willner)
'
£30 Technician (lacquers)
Secretary (Podrid)
(Schnirnan)
'
Technician (Kolodny)

Soc. Seo., Blue Cross

Travel
Supplies

12,500
3,956
7,500
3,582
750
13,350

‘

h,700
2,000
1,700
1.h57
1,3155
.

'

‘

Computation end Consultation
Overhead

950
600
900

1,500

ht7°°

3 2 h60

Balance carried forward 1963

'

3

1,5h0

�June 1?, 1962
Propoeed Budget, Brein Function end Behevior Reeeeroh Project
July 1, 196? - necenber 31, 196?
V

Settleted Belence, 6/30/62

HYZTIS

Income 6/30-12/31

.

12,000
g2.oov
$5h,000

Expenditures
1. Prin. Inveetigetor
2. Paychietriet (Ire-er)
3. Psychologist (Pelleok)
*
L.
(Beleont)
R
S.

6.

7.
8.
9.
10.
11.
12.

13.
1b.
15.

''

I
(Earp)

(willner)

Technicien (Hoequere)
Secretary (Podrid)
(Schnireen)
\
Technicien (Koladny)
Soc. Sec., Blue Cross
Trevel
Supplies
Coeputetion end Consultetion
EEG

'

Overheed

12,500
3.956
7.500
3.582
750

h,350
h.700
2,000
1,700
1.h57
1.315f
950
600
900

1,500

5&amp;12Q
2

Belence carried toruerd 1963

h60

a 1,5h0

�glidilibﬂl
Jan. 12,
To.

1962

Dr. In Robbins

---.~-- -----”.-.-.with tho disapproval at the prchIod 18 nouth budget
fur the Brain function and lohnvlnr Proaout, and without a
tntlntuatory altornativc, I am eenstrainod to submit the
with a
Isolated lattar at rculznatlon, datod noun-bowII~5115
Jl
roast-andod budgot for the Impoudlturuu and-r
during tho ronnlndor or the grist porlud. I :m attlng
rollcu:tlan In of ﬁhln #1:. to paralt the ounplo‘lon
of a IIJOr part at in. progral. It 1- Iy intanllon to
uoatlano tutubotavlor
proxruu of It‘dlou of tho ralatlon or brain
Pay—
I1UIOIF1
tho
or
functlun $0
InstitutIt
ohlntrr. bout-nan; early in Boptunhor. It: a truulttlou
902106 at I ran monthl, will. aqua analyacn and write-up
are in prograan bars, the oonﬁlnnntlou prouru-l will be
octablilhnd tiara. At noon an my tin. la produuiu:ntly
1a 3%. L§!1l. I will route: tall: from the progrum hcrc.
I ‘rlnt til: 1. natiltlctozr to you.
BprQoSShlly yours,

ti.

nmu
“.0

n

, .

.

�MEMORANDUM

DEPARTMENT OF EXPERIMENTAL PSYCHIATRY

June 1h, 1962

To:

Mr. Bechrsch

FROM:

Dr. Hex Fink

..‘.~.“‘..--.-.“enclosed budget dated June 12, 1962 for
6 months under project support by MY-2715 is contingent upon the adjustments euthorised in my
memorandum of 5/23/62, 3 copy or which is enclosed.
The estineted belence or $12,000 for 6/30/62 may
be in error by 10%, and if so, can be corrected by
using the belenoe, or adjusting expenditures to
conform with reality. Also, it is probable thst
lines 1, 2 ere overestimeted. I have also indented
this grent fully for Mrs. Mosquere (line 7).
After Hrs. Croghen hes made the adjustments of
5/23/62, if she will give me e true balance, I will
revise this budget statement.
The

Thenk you

HFsdts

for your cooperation.
Sincerely yours,

ﬁe: Fink, 5.5.

�MEMORANDUM

DEPARTMENT OF EXPERIMENTAL ?SYCHIATRY

June 1h, 1962

T0:

Mr. Bachrach

FROM:

Dr.

Max

Fink

enclosed budget dated June 12, 1962 for
6 months under project support by MY-2715 is con—
tingent upon the adjustments authorized in my
memorandum of 5/23/62, a copy of which is enclosed.
The estimated balance of $12,000 for 6/30/62 may
be in error by 10%, and if so, can be corrected by
using the balance, or adjusting expenditures to
conform with reality. .Also, it is probable that
lines 1, 2 are overestimated. I have also indented
this grant fully for Mrs. Mosquera (line 7).
After Mrs. Croghan has made the adjustments of
5/23/62, if she will give me a true balance, I will
revise this budget statement.
Thank you for your cooperation.
The

Sincerely yours,

ﬂaw
MF:dts

Max

Fink, M.D.'

�MEMORANDUM

DEPARTMENT OF EXPERIMENTAL PSYCHIATRY

July 20, 1962
Pollack
Co-Investigator
M. Fink, M.D.

T0:

Max

FROM:

MI-2715

Project

In answer to your question of 7/19, I plan to complete
my active participation at Hillside on September 15 and shall
request “vacation” time as terminal leave. For the past year
I have accrued 16 days as of 9/1/62, and have carried forward
15 days from 1960-61. If my calculations are correct, my
salary should be paid to October 26.

Effective on your return from Europe in September, I
believe you should assume full responsibility for the expenditures
and management of MY-27lS. Until I leave for Europe, and in
your absence, I shall continue to carry out these responsibities.
I shall notify NIMH as to the transfer of responsibility as of
September 15, and have notified Mr. Bachrach as attached memo
indicates.
In the event that you balieve my consultation will be of
service to you, I shall be pleased to come to N.Y. However,
reimbursement for expenses should be borne by the grant here.
Good

Hrtdts

luck!

Max

Fink,

M.D.

�do

’

MEMORANDUM

k

DEPARTMENT OF EXPERIMENTAL PSYCHIATRY

July 20, 1962
T0:

Mr. Bachrach

FROM:

Max

Fink, H.D.

Principal Investigator,
permit you to

MI-2715

Project

exact budget estimate for
MI-2715 for 1962-1963, I should like to bring the following
to your attention.
At the completion of my duties in Europe I shall return
to Hillside and complete such reports as may be necessary.
This should be done by September 15. I shall ask that I
complete my service on these programs as of that date, subject
to reimbursement for accrued leave. is of September 1, 1962
accumulated leave time will be 31 days, which will be requested
as terminal leave.
Until September 15 I shall continue to exercise responsibility for the project activities, but shall relinquish these
To

make a more

that date.
Parenthetically, I would suggest a prudent bookkeeping
measure for your consideration. is you know, the office of
Director of the Department has never been supported by
government funds. It is prudent to combine this course
until the final termination of the office. As a record

fully

as of

matter, if you exercise the prerogatives of your position
you could so reassign items in MI-2715, and non-government
for 1961-62 as to "carry forward” in non-government a sum
necessary for the position. In the revised budget estimate
you are planning to submit to NIMH, the item of principal
investigator need no longer appear.
Thank you for your cooperation.

HF:dts

ﬁax Fink, H.D.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67324">
                <text>[Hillside] hospital budgets. (2/2)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67325">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67326">
                <text>mfp-03-01-001-0-010</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67327">
                <text>1961-1962</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67328">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67329">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67330">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67331">
                <text>Proposed Research request budgets; letters; report of expenditures</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67332">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67333">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80935">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87496">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94057">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100618">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6734" public="1" featured="0">
    <fileContainer>
      <file fileId="3787">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/037717b3a94f66da3e9b2761caa9f3e2.pdf</src>
        <authentication>e23ad26e74d9d730dd0ebac94c7bdd05</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104413">
                    <text>January 8, 1960.
KIHORAIDUH

1803:

20:

SUBJECT:

Medical Director
DOpartnent of Experimental Psychiatry
Salary Scales for Professional Staff

Over the

past few years we have attenpted to establish
reasonable salary scales based upon the conception of full tine
work at the institution, without outside professional activity.
By adninistrative pressures, a policy of equating Job positions
both within the institution and between institutions has been
grafted onto the full tine concept. This latter has been nade
an integral part of the salary scales despite the awareness that

so-called equivalent workers within the institution were not
"full tine,’I and that institutional salaries are often different
because of the nador.fringo benefits.
Continuation of these fictions lakes further growth of
this unit extrenely difficult. we are severely handicapped
in recruitment; and the staff is restive, considering the
opportunities they have elsewhere. We cannot provide university
affiliation with graduate students as a source of new personnel;
nor have we established an identification for staff persons with
I

the

institution.

For these reasons, among others, the following revisions
of salary scale and work standards are reconnended for this Department, to be effective July 1, 1960.
A. General

Principles.

1. All appointments in Associate or Senior Associate
categories are to be node on a full tine basis.

�-22. All income tron ancillary eorvicee to accrue to
the aeeeoroh Fund of the Hillside Hospital.
3. For Aoaooioto and Senior iseociate stat: neoboro
‘

aro in apeoial training toward graduate degree or oertitioatee,
no
enae
to 83000 per anon: tor tour yoare lay bo approved by the
Hadioal Director on roooaaondation o: the Director or the Dopartwho

loot.

h.

aebbotioala Salary nay be paid up to .1: loathe
after (it. years service and up to one year after oight yearoerrioa in the Dopartnont for etudy at another laboratory or
ioatitotien. In the event that ouch eabbatioal in approved,

travel and relocation expeneaa up to 3 looo
nay be reqneetod.
5. Mentorohip in proteeaiooal eeoietiee and malpractice
insurance oorerago to to providod by the Departnont.
B. azeoifio Soolea
1e Pchhiﬂt’ye
o. For accredited Alerioan Board or
Peyohiatry, recent $13,000 - $20,000
with $1000 inoreaent, to 827,500;
b. For :raduetoe, eligible for exaninatiooe,
.16'000 ‘ .18,000a
o. tor lellove (hth or 5th year) $12,000 “
;

’1h3000

2.

Payohelegy.

a. Senior Reeearoh atatf ~ 31h,000 - $20,000
Ph.D. and ten or lore yoare orperienoe.
.b. Pazaoaroh Aeaoeiate - $10,000 - $15,000 .D.

o. Roeearoh iseietanae - $8,000
Phono

G‘ndid.t..o

~

$10,000

�ca.
4. Roooorch Follow - $5,000 - $7,000
a. Job Sgociticotioa.
1. For itou la, b, ond to, b, o, tho doooriptiono
in monotondun or ootobor 30. 1958, opply.
i

2. For itolo 1n ond 24:
ohoonto
In tho
or groduoto oohool otriliotion,
tho troininc or our oqn otorr 1o Iondotory. With tho potontiol
oupport of (routing ooonoioo oloo dooirono or providing troiaing
tundo, thooo rongoo oro onggootod,'ond itouo oiil bo roquootod
‘in tho noxt budgot.
10.

Poychiotriota Cooplotion or throo
yooro in psychiatric rooidoacy, ond dooirono or otndyiatdhring
hth ond 5th yoor.
2d. Ph.D. oondidoto or H.A. ooudidoto. Eorly
in coroor, without thooio, would roquoot tnndo to pornit ouch
oooiotont to oporoto within tho loborotorioo.
\

Roopoettully onbnittod,
IX

‘n, oo

�\

Departaent of Experimental Psychiatry

«

April It, 1950.

Director
SUBJECT: Salary Scales fer Pretessienal Start.
Correction of acne dated January 8, 1960.
Here stands except for specified revisiens receanended:

HEEORLIDUH

Page 1.

Page 2.

T0: Medical

General Princigles.
1. All appeiutsents er presetiens te senior
Research Associate are made en a 'full'~tell-tiae
basis. Appeintaents in ether categeriee are "fellotine"
according to established standards of the Hospital.
2. All inceae Irea ancillary services of "full"
full-tine start to accrue to the Research Fund of

A.

Eillsids Hospital.
3’ h, 5.
B.

'tCte

Sgecitic Scales
1. Psychiatry
(a) Sr. Research Asaeciate: en agreeaent
with the Medical Directer
(b) Research Associates for accredited
Aaerican Beard or Psychiatry, recent $18,000 . $20,000,
with $1,000 increaent, to $27,500; for greauates,
eligible for exasiuatiens, $16,000 - $18,000.
(0) tellers: (hth &amp; 5th year) - $12,000 - $1h,000
2.

Psychology
(a) Sr. Research Asseciate: stat.
(b) Research Associate: Ph.D. and esperinental ,»
experience $9,000 - $1h,000
(c) as. Research Assistant: x.i. or equivalent,
three years experience, and candidate for
Ph.D. at accredited university - $7,000 - 39,000
—

(d) Research Assistant er Pelbw: H.i. or one
year experience - $5,000 - $7,000

�Pug.

3

0.

Job Sgociticatiana:

while specificatians at 10/30/58 would apply,
following changes arc rnqnvatnd.
In original docignntion,
Rcuoarch Lsaociata in Psychology was limited to Ph.D. and thrus
ynnra or oxporicnec. this in hurdansonn, and :11 Ph.D. appointinbo designated 'Aaaociatc.' Assistant dasignation be subdividad
to Sonia: Rnaonreh tall-tint and Roacurch Aaaintaut, as abovo
pornittinx tho nmploynont or trainees 1nd aundidat-a, with

origiu;1 cpcoificutiona applying.

Roapodlully submitted,

‘EE§“FIEEI"HTET”~’"'

31:13

�����Pg. 1

Dr. Fink

To:

Director, Research in Emerimental Psychiatry

Prom:

Accounting Dept.

Re:

Report of Expenditures
.131; 1 - October 21: 1960

HOSPITAL SUBSIDIZED RESEARCH

1960-61

Ebcperience
To Date

25, We

8, 331e
3,167.
363.

Dudet

Salaries
BC

Assoc.

8c

arises:

Fink

in Social Psychology

Siegel

Psycholinguistic Technician
Secretary

Medical Equipment
Office Equipment
Travel

Supplies

Social Security

Director's

Kolodny

Podrid

118.

'

Blue Cross
Expense Account
&amp;

Income from Nassau County

Net Expenses

cc: Hr. Bachrach

h85.

1,500.

Total Expenses
Less:

3,120.
2 ,172.
2 , 890.

3,1t00o
3.1100.

(67.)

920.
600.

119.
161.
237.

10,120.

12,796.

3,120.

1214.

h0,000.

12 ,672.

�Dr. Fink

Director, Research in Experimental Psychiatry

Pg. 2

GRANT

biz-2115

5%

to 12/31/61 Grant approved for $65,886.
to 12/31/61 Supplemental Grant
16 2 O.
approved for

Amount

applicable to 1960-61

6

151%:
h1,058.*

1960-61
Budget

quaerience

Grant Balance 6/30/60

32,105-

3h,699.

Additions:
Amount applicable to 1960-61

1.12158 .*

m,

_

Starting Balance

Salaries

&amp;

Additions

8.

nses:

ese
ssoc. n sychiatry
Sr. Assoc. in Ehtp. Psychology
Assoc. in Exp. Psychology

Asst. in Exp. Psychology

Assoc.

in

Exp. Psychology

Psycholinguistic Technician
E.E.G. Technician

Secretary
Secretary

Klein
Pollock
(Gittelman
(Bel-"nut
Karp

(Krauthaner
(Andermnn
Kclodny
Mosquera
Bowie

Podrid

To Date

73,1463.

3h,699.

16,1416.

5,667.

10, 92°.
7,500.

2 ’ 500.
2 ,500.

8,500.

2,931.

h.l.10.

1,1426.

7,333.

3,360-

291.

1,123.

1.80.

MM
Supplies

Iviedical Equipment
Office Equipment

Social Security

8:

Overhead

Blue Cross

Travel

Total Eutpenses

Unexpended Balance

cc :

Mr. Bachrach

2,500.
382.
1,928.

101.

1196.

9,681..

2,7hh.
563.

72,9330

20,8270

13,372.

�1“
Director, Research in Experimm Psychiatry

Dre

mm

Pg. 3

181-2092

Great. terminates 12/31/60; expenditurepicked up by Great III—2715 Supplement.

mm

m0

Starting Behnce 5 Additions

We:PWIC"

Salaries &amp;
Sr. Assoc. in Me

Repairs to quipnent

800111 Security
Overhead

Tom

&amp;

Blue Crone

WW3

Wed

We

6,&amp;7e

7,h35e

To Date

0

Additions

Behave

cc! Hr. Mhrech

Wk

be

1960-61

Bidet
" 6/30/60

te

6,667.

7,h35.

5,667e

11,333.

130.
870.

1:3.

628.

6,667.

5,7080

0

7014.

1,727.

�Pg. 1

”MaDr. Fink

To:

Director, Research in kperimental Psychiatry

Fran:

Accounting Dept.

Re:

Report of Expenditures

.1an

3

.. 393mm; 30, 1260

HOSPITAL SUBSIDIZED RESEARCH

1960-61

W'Lec
Salaries

nses:

&amp;

Assoc. in Social Psychology

Psycholinguistic Technician
Secretary

Medical Equipment
Office Equipment
'l‘revel

Supplies

Social Security

Director's

Blue Cross
Expense Account
&amp;

Total Expenses
Less: Income from Nassau County
Net

muses

cc: Mr. Bachrach

Experience

Bidet

Fink
Siege).

Kolodny

Podrid

25,000.

3,120.
2 ,172.
2,890.

To Date

.

10, 338.

3,958.
5&amp;6.

730.

1,500.

118-

3,h00-

3,1400.

920.
600.

(55a)
173.
22h.
290.

10,120.

16,2014.

3,120,.

177.

130,000.

16,027.

gm

�M
Director, Research in Experimental Psychiatry

Dr.
(

'

GRANT

Pg. 2

111-27};

1/1/61 to 12/31/61 Grant approved for $65,886.
1/1/61 to 12/31/61 Supplemental Grant
approved for

Amount

applicable to 1960-61

W

Grant Balance 6/30/60

Additions:
Amount applicable to 1960-61

Starting Balance
Salaries

8:

ese

uses:

ssoc. n sychiatry

Sr. Assoc. in Eng). Psychology
Assoc. in up. Psychology
Asst. in

Assoc.

Psychology
Exp. Psychology

Ebcp.

in

Psycholingzistic Technician
E.E.G. Technician
Secretary
Secretary

Klein
Pollock
(Gittelman

Social Security

a:

Overhead

1960-61
Budget

Experience

32,1105.

3h,699.

311,699.

16 ,hlé.

7,083.

(Belmont
Karp
(Krauthamer

10,920.
7,500.

3,500,,

(Andaman

8.500.

3,6140.

Kolodny
Hosquera

h.h10.

1,783.
1,h06.

3 , 360.

Bowie

2.500.
382.
1,928.

Blue Cross

Total Expenses

Balance

5
d

.-

cc:

n

.n

ﬁ.w

,...,..—

I

I

Illll

291.

1:80.

165.
607.

3,130.

72,933.

26,185.

675:

-IIIM'
530.

,.
-Nv
“A.

3,125...

9.681;.

Travel

"I'fn'expended

To Date

73.h63.

7,333.

Podrid

Supplies
Medical Equipnent
Office Equipmnt

h1,058.*

1413958 .*

Additions

8.

l
"851%?
6 2 O.

8,51)»

�..o~’

Drcl'ink
Director, Research in

mm

Psychietry

mm

Pg. 3

III-2092

«when:

12/31/60; «podium» to be
picked up by Great 141-2715 Suppl-lent

Went

1960-61

Met
Great Balance

- 6/30/60

6.667.

Belem.

&amp;

mm»

W

Selene: I: Expense”
8r. Assoc. in Exp. Psychology
S plies
‘greee

Social Security
Overhead

Total

To

DI“

7,105,

0

Additions

mm

Experience

a Blue

heme

Wed

Behme

Pollock

6.661.

7,155,

5.567.

S,h17.

130-

SS.

725.

870.

785.

6,667.

6,982.

0

1:53.

�'

To:

Dr. Fink

Director, Research in
Prom

Accounting Dept.

Re:

Report of

119

Pg. 1

M

mm

herinentel Psychiatry

nditures

to

December 31, 1960.

A

-._A

-4tm

,.._

Assoc. in Social Psychol
Paycholinguietic Technician

Secretary

Medical Equipment

Office Equipment
Travel
Supplies

Social Security

ctor'e

Tom

Blue Croce
Expense Account
a:

mews

Less: Income from Nassau
County
Net Expenses

Pink

Siege].
Kolodnv
Podrid

25, 000.

3,120.
2,172.
2,890.

112.3335.

14,750.

739.

”5.

1 500.

,118.

(SS“ )

3 ,hOO.

3,hoo.

920.
600.

233°
290’

1‘3ng

”’566.

3.129..

265.

130,000.

'

‘

'

�Dr. Fink

Director, Research in Experimental Psychiatry
GRANT

Pg. 2

111-2715

approved for $65, 886.
1/1/61 to 12/31/61 Supplemental Grant
approved for

1/1/61 to 12/31/61 Grant

1’20.
ﬁg.

Amount

applicable to 1960-61
1960-61
Budget

quaerience

Grant Balance 6/30/60

32,105.

313,699.

Additions:
Amount applicable to 1960-61

1413958.!-

‘

Starting Balance
Salaries

&amp;

nses:

Asst. in Exp. Psychology

Assoc.

in

Exp. Psychology

Psycholinguistic Technician
E.E.G. Technician

Klein
Pollock

16,h16.
7,333.

8,500.

Karp

10,920.
7,500.

h,soo.

8,500.

31,3338.

h.h10.

2,”.0.

(61th
(Belmont
(Krauthaner
(Aniormann
Kolodny

Hosquera

3,350-

Podrid

Supplies
Medical Equipmnt
Office Equipmnt

Social Security

3h,699,

Bowie

Secretary
Secretary

8:

Overhead

2,500.
382.
1,928.

Blue Cross

Trml

Total kpenses

Unexpended Balance

_

I

cc :

Hr. Bachrach

To Date

73,h63.

Additions

&amp;

ese
ssoc. n sychiatry
Sr. Assoc. in Exp. Psychology
Assoc. in Exp. Psychology

_

hl,058.*

'

I

II.

3,750,.

291.

1,689.

EEO.

278.
697,

9,68,4-

31,116.

72.933.

31,1170.

631.

My
530-

3,229,

Mum

�Dr. Fink

Director, Roam): in Experimental Psychiatry

mm

Pg. 3

31-2092

mus

12/31/60;
Grunt
picked up by Grant 141—2715

Wt.

exp-Mite": to he

1960-61

that Balance - 6/30/60

'

6,667.

3mm. 6 Additions

W
Salute: &amp; Enema:

$‘o

To Date

71:35.

0

Additions

Starting

Met

We

“3°C. in

m. won-m
Supplies

Social Security

Overhead

&amp;

311:.

Total. Expenses

Unmanned Balance

cc: Hr. Bum-ad:

areas

Wk

6,667.

71:35.

5,6670

6

Q

a

130.
870.

63‘.
91-2.

6,667.

8,2138.

0

(813.)

�W
P80 1

W

Dr. Fink

To:

‘

Director, Research in Experimental Psychiatry

Fran:

Accmnting Dept.

Re:

Report of Menditures

1961

HOSPITAL SIBSIDIZED RESEARCH

Salaries

ec
Assoc.

&amp;

uses :

in Social Psychology

Psycholingulatic 'Dechnicien

Secretary

Medical Equipment

Office Equipmnt
Travel
Supplies
Social Security 8: Blue Cross

Director's Expense Account
Total Expenses
Leas:

Income from Nassau County

Fink

Siegel

Kolodny

Podrid

25,000.

3,120.
2,172.

2’890’

lb

181
5,5112.

l

'

’912'
D

220.0
_

1,500.

118.

3,)400o

3,h00.
920.

(SS )

2714'

600.

397‘
387:

10,120.

22,858.

34L

265.

.

l

__________________________________._____———-——--——--—Net Expenses

cc :

Mr. Bachrach

h0,000.

22,593

�Dr. Fink
‘

_..

.,

Director, Research in 'hcperimental Psychiatry
GRANT

Pg. 2

IKE-2715

1/1/61 to 12/31/61 Grant approved for $65 ,886.
1/1/61 to 12/31/61 Supplemental Grant
16 2 0.
approved for

‘B'iﬁi'ﬁ

Mount applicable to

Grant Balance 6/30/60

1960—61

.m

Additions:
Amount applicable to 1960-61

Starting Balance

Salaries

&amp;

Additions

nses:
ReseF-ch Issac. In Psychiatry
Sr. Assoc. in Exp. Psychology
Assoc. in Exp. Psychology

.

1960-61
Budggt

Experience

32,1105.

3h.699.

ulzostm

20,529.

73,h63.

55,228.

16,h16.
7,333.

9 ,917.

1,083.

10,920.
7:500-

5,500,
h,375.

8,500.

5,056.,
291.

To Date

8:

Asst. in Ebcp. Psychology
Assoc. in Exp. Psychology

Psycholinguistic Technician

W

E.E.G. Technician

Secretary
Secretary

Supplies
Medical Equipment
Office Equipment

Social Security a Blue Cross

Overhead

Klein
Pollock
(Gittelman

(Belmont
Karp
(Krauthamer

(Ardemenn
Kolodny
Hosquera

me
Podrid

14,1th3 9 360.
‘

Total Ehcpenses

Unexpended Balance

Mr. Bachrach

2 ,517.

1, 972 ¢
1:80.

Cartolano

13s

2 ,500.

382.
1.928-

99681“

Travel

cc :

b1,058 .*

281;.

920.

5,009.
979.

72:933-

38,396.

530-

16 ,832.

.

�Pg. 1

Dr. Fink

To:

Director, Research in Experimental Psychiatry

From

Accounting Dept.

Re:

Report of Ehcpenditures
1: 1260 - Februagz 28I 1961

ng

HOSPITAL SUBSIDIZED RESEARCH

Salaries

&amp;

80

menses:

Social Psychology
Psycholinguistic Technician
Secretary

Assoc.

111

Medical Equipment
Office Equipment
Travel

Supplies

Social Security

Director's

Blue Cross
Expense Account
8:

Total Memes

less:

Income from Nassau County

Net mpenses

cc: Mr. Bachrach

Fm

Siegel

Kolodny

Podrid

25, m0

3,120.
2,172.
2,890.

1 500.

,118.
3,h00.
3,h00.

12,33:
1’09;

,, J

£1455:

180'
13h.
61.
525.

920.
600.

1:17.

53:12“

26,238.

3,120.

“3,955.

10,000.

2 3 ,283.

"

;

4-;

A

3*)

7’

.

�\

Dre Fink

Director, Research in ﬁrperimental Psychiatry
GRANT

Pg.

2

PIX-273:5

1/1/61 to 12/31/61 Grant approved for $65,886.
1/1/61 to 12/31/61 Supplemental Grant
approved

Amount

Grant Balance 6/30/60

Salaries

&amp;

Eggnses:

ese
esoc.
sychiatry
Sr. Assoc. in Exp. Psychology
Assoc. in Earp. Psychology

Asst. in Ech. Psychology

Assoc.

in

Earp.

Psychology

Psycholinguistic Technician
E.E.G. Technician

Secretary
Secretary
Electronics Technician
Supplies
Medical Equipnent
Office Equipment

Social Security

8:

m

Overhead

Klein
Pollock
(Gittshnan
(Belmont

(Krauthamer
(Andermann
Kolodny
Mosquera

Podrid
Cartolano

Unexpended Balance

cc : Hr. Bachrach

Experience
To Date

3h,699.

M*

203529.

73,1163-

55,223.

16 hlbe
71333-

11

o

3:333.

10 920.

6 500.

3500-

5,765.

7:500-

5:000.

291.

hyhloe

2.895.
2,255.

3’36“

2480.

ho.

\a
’38:.
500.

295.

1,92 e\~\...1
9’68hN-h 5,3533..

Travel

Total Ebnpenses

111,058.?!-

32’h05-

2

Blue Cross

11:15:

1960-61
Budget

Additions

8:

16 230.

applicable to 1960-61

Additions:
Amount applicable to 1960-61

Starting Balance

for

15029.
72,9330

[6,852.

�Pg. 1

W

MEMORANWH

Dre Fink

To:

Director, Research in

Merinontal Psychiatry

From

Accounting Dept.

Re:

Report of Ebcpenditnres
195]
3]
12m
lamb
1.
3
Jul:

W

RESEARCH
SUBSIDIZED
HOSPITAL

Salaries
Assoc.

uses:

6:

in Social Psychology

Psycholinguiatic Technician

Siegel

m

Kolodny

Secretary

Medical Equipment
Office Equipment
Travel

Supplies

Blue Cross
Expense Account

Social Security

Director's

.

Total Expenses

less:

Net Expenses

7’125'

1 500.

180'

3,1400.

151:

1’ 335‘

1:681:

’118.
920.
600.

.

Income from Nassau County
Donation of Paychiatropic Drugs

3,120.
2,172.
2,890.

3,h00.

8:

Experience
To Date

1960-61
Budget

»»

~

x... ,,

.

110‘
626.

1117:

10,120.

2951.0.

3 ,120.

2,955.
2
:295:

h0,000.

21:390.

to Hospital

______________________________...——————————---

cc :

Hr. Bachrach

�Dre Fink

Director, Research in farperimental Psychiatry
GRANT

Pg. 2

m~271§

1/1/61 to 12/31/61 Grant. approved for $65,886.
1/1/61 to 12/31/61 Supplemental Grant
16 2 0.
approved for
T511137
Amount

applicable to 1960-61

1_‘_‘_____

Grant Balance 6/30/60

Additions:
Amount applicable to

Starting Balance

Salaries

Essen

1960—61

Additions

3.

nses:
Issac. In Psychiatry

Assoc.

hp.

in

Psychology

Exp. Psycholog

Psycholinguistic Technician
E.E.G. Technician

Bud eet

Experience
To Date

32,1105.

3h,699.

hl,058.*

20.5293

73,h63.

55,228.

16 ,h16.

12,750.
M327.

(Belmont
Karp
(Krauthamer

10, 920.
7,500.

7 , 5142 ..

(Amiermann

8,500.

6,1173,

Kolodny
Mosquera

,

7,333.

h,h10.
3,360.

&amp;

Overhead

Blue Cross

Travel
Total Expenses

Unexpended Balance

Hr. Bachrach

5,625.
291.
3,272,,

2,592.
1:80.

93.

Castolano

Supplies
Medical Emaipment
Office Equipment

Social Security

Klein
Pollock
(Gittelman

Em;
Podrid

Secretary
Secretary

cc :

1960-61

8c

Sr. Assoc. in Exp. Psychology
Assoc. in Exp. Psychology
Asst. in

h1,058.*

2,500.
382.
1,928.

9.968140"

3760

1,376.

6,1173n

14100"

72,933.

52,770.»

530.

2,158.

�P30 1

Dr. Fink

To:

Director, Research in Emoriuontd Psychiatry

W1

Fran:

Accmnting Dept.

Re:

Report. of Expenditures

w—WW
m
HOSPITAL

wnsmxzm

RESEARCH

M
Salaries

ac
Assoc.

&amp;

gases:

Fink

in Social Psychology

Siegel

Psycholinguistic Technician
Secretary

Kolodmr

Mics]. Equipusnt

1960-61

merience

25gme

19,7950

1,500.

180.

33’4me

5939

3,120.
2,172.
2,890.
118.

Office Equipmnt
bIVOI
Supplies
Social Security &amp; Blue Cross

7,917.
1,57h.
1,906.
711,

3shme
920.
600.

163689.

Total Expenses

1.3.120.

33, 308.

less: Incaus

3,120.

2 ,955.

Director's Expense Account

from Nassau County
Donation of Psychotropic Drugs to Hospital

Net

kpenses

~

41;]

cc: Hr. Backrest:

1417.

2: 295:

150,000.

28 ,058.

�Dre Fink

Pg. 2

Director, Research in "apex-mental Psychiatry
GRANT

'

a...

141-271;

.

$65,886.
for
Grant.
approved
12/31/61
1/1/61 to
1/1/61 to 12/31/61 Supplemental Grant
2
0
6
1
.
for
approved

121115:

Mat

applicable to

1960-61

1960-61
Budget

...

’41, 058 .*

Experience
To Date

Grant Balance 6/30/60

32,)405.

314,699

Additions:
Amount applicable to 1960-61

glIOSBJ

111,058s

73,1163.

75,757.

Klein
Pollock

16,2116.

lh,167.

(30130111:

10,920.
7,500.

8,583.
6,250.

8 ,500.

7 , 181.

Starting Balance

&amp;

Additions

Salaries &amp;ﬁsoc.uses:
In Psychiatry
Sr. Assoc. in Exp. Psychology

Hem

Assoc. in hp. Psychology
Asst. in Exp. Psychology
Assoc. in Exp. Psychology

Psycholinguistic Technician
EOEOG.

WWW

Secretary
Secretary

7,333.

(Gittelmn
Karp
(Krauthatner

(moment:
Kolodny

m
W

ughloe
3,360.

HOWE

5,1111.

291.
3,6509
2,353..
LBO.

93o

Oastslano

'

Supplies

pursuant
Office Equipnnt

2.500.
382.
1,928.

Medical

Social Security

8:

Overhead

Blue Cross

9.681;.

Travel

Total MEMOS

Unexpended Balance

cc: Mr. Bechrach

.

169.
1,5711.

7,366.

$139.91

72,9330

593,458:

530.

16 ,299.

'

�I

[1W

W

Iu' [44/

:

~--—;

I
C.

I

/

1/

/
’W
W

K4444”

'

LI“I

X

{

~//‘/.
/

I/L/
I I

/

1

I,

d
—

/

/
7’
'V e

-

‘1

.__

�2.7

f

444/

Ms/
,1.
r

a

M
dv

//'.

/
.4

—

’

M1

h.

1

a...

/
41%;»! /
’,

[14,.”

I If:/- (I t».

AI'VA‘;_727

44'

w

W
/

.4

/

/

4’15]

/

5;!

1%
’

/

{i
I

440/

a

a/

”M7142:

72ﬁ;4h.&amp;¢ igv

M

(A I»
r],

«Ac/47%

’

3

I

/
(5300

if

1’

C

II»

a»

W

ﬁwm)
72.

13/

/

one
53¢:

39 ace

�5—0

90¢

�1/3/61
Dopartnont or lxpsriaantal Psychiatry
1961-62 Bndgot, Propoood

I.

1960-61 Indgst (-ovsrhsad)

$118,882

a. Inorsasos in salariss, annual
inorsnsnts
b. Additions in prograns:
1. Psycholingnist - to ba aotivatsd
2. Sociologist to tho proxraa
3, £80 technician

Statistical
tsohnioian,
g.. Elootronio oqnipnsnt

é.
o.

s.

Status rslatinx to lndgst
John [razors Irt. tron fallowship
status to Rasaaroh Associats 9/1/61;
snbjoot to approval of g. or‘g.
Donald Klein: continnss as Isa. Assoc.
but is to ba grant (Kh798) supported.
that tho dittorsncs in
It is axpsctod
salary iton on grant and an lsvsl nay
ha up to $7500. Grant providss 85000
additional for sscrotaria1 and othar
sxpansss.
Sabbatieal ~ lax link: 9/15/61-8/1/62
Visiting Soiantist support is roqnsstad.
rhara is no salary ohangs during yaar.
Amount is $15,000 par annnn.
Expanss

III.

W
%,650
1 000

Changas in

0.

Souroas of Support (-ovsrhoad)
a. Approved:
1961-62
1. HI2715
.

ha P01161118:
2, nh798

rotal

0 12,000

170,732
12,000
182,732

72,231

-

(323,000) out.

3. Visiting Soiontist
c. To bs Raqnastads
h. Snpplonantary H12715

126,282

10,000
10,000
6'800

tins
tins

llaetronios spacialist,

II.

7.300

“17,000
13,500
30,000

r¢/~

gh,g§o

�$0,000
a. Board or Daroetorl
1. it would Ilk the Board to
apprevo I grant 0: $h0,000 to:
{var ytara; with an lpyortunity
to carry tarvnrd unoxpondod can:
far 2 yn;rs.
2. WI wanld also ask for a credit
tranltor tron operating budget
funds of value of psychotropic
drugs (to $10,000) roecivod in
the progran. In 1959. the
'

vulno was ontinntod as O11,000.
Inconn Eutinato: 182,731
Exponae

Estinatcs 182,732

��V

WWW—WM...‘

r
L

///~/

5

”A Z

3%”

'

IBKOO
&gt;3, W?

+

'
————-'_f"——'

I

23, We
’3 ’ (00

‘

2.00

..——

I

~

I

I

v

’

2“
3f?”
=

���May

5, 1961

Hrs. Croghan
Departnent of Experieental Psychiatry

Heme:

Iron:

Subject:

Budget

'1. In reviewing
find

budgetery expenses to date, I
the following in the Beapitelised Subsidized Research:
Expenditures 7/1/60 ¢ 3/31/61
$29,5h0
Less

my

credits (Nassau County)

5,250

(Drugs)

Estimated Expenses

nets
sonths

3

$2h,290
I

Salaries (3&amp;00 x 3)
Social Secutity
Travel
Other

10,200
300

1,000

_

200

net:
Less

credit for teeching

900

Research Associete in Psychiatry (Klein) app.

Secretary

I!

(Podrid) app.

hSOO

82g

$5,325
my

calculations are in error, please call as.

Thank yen.

a

Sincerely yours,
HTzOP

11,100
35,990

ax

n ,

.

�5. 1961

May
HOIO!

Mrs. Croghan

Irons Dapartaont of Expsriaantal Psychiatry
Subdaota

Budxat

1. In roviaviag a: budgstory oxpsusaa to data, I
find tho following in tho lospitalisad Subaidisad Rasaaroh:
nxpandituras 7/1/60 ~ 3/31/61
$29,5h0
Lass credits (lasoau county)
5,250
(Drug-v)

__.______

not:

$2h,290

lotiaatad xxoonsos 3 months
salarios (JhOO x 3)

10,200

Social secuoity
Traval
ethar

300

1,000
200

not:
Lass oradit for teaching
2.

11.100
35,990
200

I: this
is
iha

approxiaatsly
would you
oorraot,
ploasa assign
following sxpandituras to this account,
tron Grant l1-2715, attentiva April 1?
nosoaroh Associats in Psychiatry (Ilain) app. ASOO
Saoratary
(Podrid) app. “33:

I:

ay calculations aro in
Thank you.

85,325

error, ploaso call as.
Sinosraly yours,

IIsOP

ax

n ,

. .

�Prcptlod ltdgot 1961-6!
nevi-ad 5/22/61

Doparinont

.: tsp-rtnonttl Plyuhtltry

annuity:
Exponloo 1961-62

$156,hh0

Inoolo
warns

_

Eonpttal eruditl

108,870
1.510

116.;50

lot

Unuubcidisod

ltloarch

8

ko,ooo

�5/22/61

Bspcrt-sct ct lxpssissntsl Psychistry
Prcpcscd 1961-62 ludxst (lsvtssd 5/22/61)
Exp-uses:

1. Blrsctcr
2. Assoc. 1n rsychistry
.AQE‘o/B. Assoc. 1n Psychistry
h. is. Assoc. Expos. Psychology
5. Assoc. in lxpsr. Psychslcgy
6. Assist. in Expos. Psychslcgy
,rswo'7. Assist. in lxpsr. Psychc1cxy
8. Assoc. in Sosisl rsychclcgy

1960-61

1961-62

Apprsvsd

hsqusst

(3. link) 25,000

25.000

16,h16

17'500

Sllcta)
lrsnsr)

.

13.000
Pcllsck;
lslncnt 10.920
1.500
Ksrp)

.

Villas!)

2'004'

b‘;

1h,000
11,000
8.100

73200 (9)

9,500

10,000 (d)

I,$oo

1,h20 (s)

Elbsqusrs)
lss)

h:h10

k,aoo
3.600 (I)

)
12. rsychslingsistis rsshntc1sn élslcdn
Psdridg
13. soot-tar:
(Ibssclnsn)
1h. alcrkotyptst

1,172
3,360
2,890

2.300

-

2.700
3:500

16. [quip-cut (attics, nsdicsl
11. frsvsl
18. acrylics
19. nircctsr's Prstcsstscsl lxysnsss

b.5oo
3,h00
3,hoo

3.000
3,600
3.000

3,31h

3.500

9. Assoc. 1s lxpcr. Psychology 33:6)
Andsrssan)

8:.
”Eu/11. no lcchsicisn, Jr.
10. ans fschnicisn,

AﬂE‘VlSs

fcchnicsl Assistant

20. Social Bcccrisy/llns Gross

(lcs)

(sst.)

21. msrhssd

«-

600

11.01;].

20211

$129,923

33h80

(t)

600

11,200 kg
2,8h0 1
$156,hho

�-2.
Bopartnont

at lxporincutal Prychiatry

lxyoulon 1961~62
lacunae

0&amp;56ikk0‘

ﬂ?{5.3,qzelo

1. warns 31.2115
(62) - 1/1/61»12/61
(1/2)
Iroaght toﬁvurd (03%.)
(1/2)
(ca) - 1/1/62o12/62

h1,oso
k,oeo
32.000

w

87,059

2. warns x.h795

natinutod 8.1.2:

1k,26h
n.710

pr.
0701‘.

2.8!!6

21,820 (a)

3. 2cc¢htn¢ (But. he hrs. .181!!!)
h. Bra: rrnnlror (13%.)

'

1,000 (k)
3,570 (1)

4E=4HHhIHHap6Iadtﬁ-GIaI-é-otalG~9010htt§rttt+jhﬂﬁﬂy4hér

W

”3 Vs'ro

lot

lxpouaoa (Haunt-111104 lcncuroh) 3 ha,ooo

�lgtoot
Sagportod, in art, by l~h798, aa Garcon Iavoaticator,
otfoctivo 1/1 61. Bixtoroaoc in inooao will to
aooignod tron l1-27159
(b) loplncoo 3.). [loin in nx-avzs. In continuing onporvioion of la! prozroa would roqnoot continuation of
clinical onpyott a! l/h otat: poychiatriot iton.
low appointacnt, ottoctivo 9/1/61 at $8,500 for air
nontho, $9,000 thoroottor.
loo appointaont, to ho aado 9/1/61, at oatinatod
$12,600 pot annna.
ippointnont onco 9/1/61. Will not ho roplacod onlooBiroctor rocoivoa II! Vioiting acioatiat award.

(t)

(a)
(h)
(1)
(3)

(k)

(1)

Ion aypointnont to porait hoopital~uido onrvoyw
plannod attor 9/1/61.
low poaition to: ototiotioal ani onporviaory :nnotiono.
lollovo a roooanondatioa at Aaoiotont idniniotrator,
Hr. Bavio, tollowinc a Job convoy Icy 1961.
evorhoad allcvoaoo on l1-2715.
avorhood allowanoo on l-h798.
n~h198 allowo $18,!1h for oalary ani roooarch cooto;
$2,0h6 for ovorhood. rho-o'itoao aro applicablo to tho
prograa. It aloo allovo Oh.838 opooitiod oo training
cooto. Ihilo Dr. Kloin nay not ntilioo tho on: in tho
conin; yoar, it nay not to nood for othor pnrpoooa
without oxprooo provioion. It ia onticipatod that thio
on: will to rotnrnod to tho warns.
Incono ootinato boood on continuation of coarooo in
Biological Paychiotry and in noooarch lothcdology.
lininal oatiaato balod on 1959-60 and 1960.61
oxporionco.
loqnoot continuation ot clinical crodit-tor clinical
oorvicoo, followingll960-6l oxporionco.
‘

�5/!!I61

a.“

nupnrtuont at prorannatal Parnhtu‘vy
ttovonod 19§1~62 nudgit (3011804 5/22/61)
196o~61

lupus-0.:
1. Blrootor
H. fink)
2. assoc. 1a rnynhxntry
x1013)
J. Assoc. in Ptyuhtutvy
tranor)
Assoc.
8!.
8390!.
Psycholtcy
(Pollack)
g. A‘s... in super. Psyuhnlocy (not-oat)
.
6. Acoiut. 1n Savor. Puyehalogy Earp)
7. Alutlt. 1a
Payah01n¢7* Willa-r)
or.
8. Autos. 1: 3.0 :1 Payuholocy
luv;
9. Assoc. in Expor. Psyuholncy Ila

Ap’rovod

8:.

Inna

'

15.133131»,
m
330 ruahaictna,

Andlrllll)

on)

25.000
15.h16

-

13.000
10,9:0
7.500

-

.

8,500

10.
11.
1!.
13.
1h.
15.

47.
ll!
Pﬂytholtsgutattc rochniotna {301.43 )
50ar¢$ary
roarid
Clark. 10%
ftnuatlnan)
rlahnie Lnatutaat
30v)

.
2,112

16.
11.
18.
19.

Equtpuunt (otttc..n¢di¢n1)
traval
Suppltca
Dtruator‘c !rottultonnl lap-anon
800131 80¢n31$7llluo 0:03: (00‘)

h.500
3.h00
3,hoo

to.

no:

21. Ovarhoau

"f
ﬁg?!

{VFW
4‘

anf‘ &lt;\
\J,

a\.

iﬂﬂﬂt

3,360
2,890

-

$00

3.31h
11.0h1

$129,923

‘155 0500

�“531.1190

Inna-0i

1.

um

::::

um

'mzz-wzzx
.

_

W
,

01.059

I. um: MM

“mm am

“.000
10.850

3. latching (83%.)
h.
um.)
S.

m Wu-

clilttti crolit

(xerox/h

500

5.00.0 (a)

Itttr plyth$n3rtnt1;‘ggg

lit lliilill

(I)

(lhlniltltsod tinnitus)

(a)

\

W
W

‘

1505000

�(o)

(d)
(o)

(f)
(s)
(h)

sappurtod, in part, by u~h198. ll carter Invoc‘tcntcr.
ottaottvt 7/1/61. Dittoronco in incon- v111 be
assigned S!!! IY~2715.
Inpltaoa 5.1. Xi'an in ur~2715. In contanuzn; unparttnion a: no: progran would mounts: aonttnuttton at
tho 1/8 nt‘tt poynhxntrtlt.
lav appcxntunut. «rtagtavo 9/1/61 at :0.500 for at:
nontha, $9,000 ‘hnrunttur.
lav appatatnnnt, t- be and. 9/1/61, nﬁ outiuttad
$12,000 par gonna.
Appointncnt and. 9/1/61. 3111 not he rnplnood talus:
ntvactnr rﬁcctvbl III Vitittuc Scientiut award.
luv appointuant.to pcrult hoapxtllavado survey:
planatd utter 9/1/61.
New position for azntintloni and aupnrviaurr tunotlcnt.
Fallout 3 risen-audition of Assistant idlinistr¢‘ar.
pr. navio, (allowing a Job I‘TVII law 1961.
on continuation or court.- in
Inc... ontinnto bland and
non-arch nothodoloay.
Bioloctonl Payohtutry

(1) Kin1nnl catiunto based

anti-stat.

on 1959~60 and 1960~61

'

(3) noqscnt continuation or clinical credit for 01131301
suvvtauu. failurtuc 1960~61 o:pnr1¢n¢¢.

�HILLSIDE HOSEFRHL
WEGE &amp; SALARY SCALES

Scale
#

HIRING
RATE

SERVICE-MERIT INCREMENTS

"‘if""‘i?“”"“"§""

MERIT INCREMENTS

“ﬁf“"“‘3¢‘”"‘

l

185

193

201

209

217

225

2

205

21h

223

232

2&amp;1

250

3

225

235

225

255

265

275

,h

250

‘261

272

283‘

29h

305

5

275

2877

233'

311f

323‘

335

6

305

318

331'

324,

357

370

T

320

355

320

385

hoo

215

385

200

his

h30

nus

8

376

�9113 TITLES

ﬁrm

GRADES AND HOURLLRATES

F0 a JON-PROFESSIONAL PERSONNEE

#h

#5

$250-$305

$275-$33é

GRADE
MONTHLY RANGE

myTITLES ﬂed hr

A

JOB

- $l¢55hr

Accounting Clerk

Busboy

File Clerk
§_; $1.32 hr

Cook‘s Helper

Housekeeping

Dictaphone
Operator II

Asst. Gardener

Counter Aide

Leadman (days)

Dishwasher

'Linen
Asst.

DriYBr

[Store Keeper

Haniyman

Kitchen

Man

Maid

C

Room

" $1.032

:Cook IV

hr

Clerk Iypist

Mimeographer

Receptionist
Stenographer
Telephone

Operator
B

'Porter
Potwasher

- $l.h5 hr

Housekeeping
Leadman(Nights)

"Night Cook

Linen
Clerk

watchman

Painter

N.B, All hourlz

rates

Room

A

- $1.71 hr

Chief Telephone
Operator
Dictaphone
Operator
OPD

Receptionist
CaShier

Seoretary,IIj
Cashier
B "'

$1960 hI‘

Cook
C

III

- $1.50 hr

Licensed

Practical

Nurse

Psychiatric

Aide

Maintenance
Mechanic
include 1 me§l_p§rﬂggz_§t_the rate of $10.00 per month

I

A

- $1.8833

Jr.

Laboratory
Technician

�SUPERVISORY
&amp;
EWIEESSIONAL
PERSOBYlé
FOR
RATES
HOURLY
AND
GRALEE
WITHIN
TITLES
JOB

#6

GRADES

,

$37

$3110

-

$h15§

$370

MONTHLY RANGE

$05 -

JOB TITLES

A- $2.080

A- $2.31

Asst. Office Manager

Bookkeeper

Pay Master

B- $2.02

Assistant Bookkeeper

Registered Nurses

‘

hr
hr

A

-

Charge Nurse

Supervisor

$1.9h hr

Asst. Superintendent
Grounds

Asst. Dietitian
Gardener
Housekeeping Supervisor

0- $1.82 hr
Dental Hygienist
N.B.

All hourlz rates include

1 meal

per day

at the rate of $10.00 per

(Nursing)

Chef

.

Psycholinguistic Technician

8:

§h10 ~ $510

$2.h2 hr

Sr. Laboratory Technician

Bldgs

$1M

$2.19 hr

Executive Secretary

B"

#9

#8

#7

month

�JOB TITLES WITHIN GRADES

#2

#1

$15 -

$235

,

$1.20 hr.

HOURLY RATE

Ass't

AND HOURLY RATES FOR NON—PROFESSIONAL PERSONNFL

m

$215

1§g§g

Cook IV

Gardener

Busboy

Counter

Cleaner,

File Clerk

Housekeeping

Cook's Helper
Counter Aide

II

_

Man

I

Housekeeping
Leadman

Cashier

Clerk-Typist

Boiler

Dictaphone Operator

Chief Telephone
Operator

(days)

Ass't.

Leadman

(nights)

Maintenance Mechanic

Dishwasher

Linen

Driver

Psychiatric Aide II Painter

Handyman

Storekeeper

Receptionist

KitchenvMan

ward Clerk

Stenographer

Maid

Room

II

Mimeographer

linen

Attd‘t

Room

Room

Supervisor

Psychiatric Aide I
Secretary II
Cook

III

Dictaphone Operator

Senior

Telephone Operator

Night Cook

Porter
Poiwasher

*(Licensed Practical
Nurses at_one

incresent higher)

*Watchman

N.P. All rates include one meal per day at the rate of $10.00 per month.
* Not included in Schedule A
'

$235

-

$31.5

Assistant Chef

Accounting Clerk

Housekeeping

*Gateman

.

-,

BET??? :. 9‘19? .51 s- 39.5.}

Secretary I

Jr. Laboratory.

Technician

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67334">
                <text>[Hillside] hospital budgets. (1/2)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67335">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67336">
                <text>mfp-03-01-001-0-011</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67337">
                <text>1960-1961</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67338">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67339">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67340">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67341">
                <text>Proposed Research request budgets; letters; report of expenditures</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67342">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67343">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80936">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87497">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94058">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100619">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6735" public="1" featured="0">
    <fileContainer>
      <file fileId="3788">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/9060c539e20c3ba0581d3baa1fe2596c.pdf</src>
        <authentication>225bfe4d17bc385ee38289963bbb494a</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104414">
                    <text>l...“

I

3%

Protocol for Pilot Project. on Effect
of Drug on Corebrsl Emotion
‘

1. Object:
(a)
(b)

on
of dmgn

To

study the effect

To

observe the emotional responses to such ohangca

and

the perception of sensory stimuli;

in function.

first drug

selected is LSD-25 (Sandoa) - on erect preparation
which, in very minute doses, produces a time state with altered perceptions,
emotional reactions and occasionally hallucinatory phenomena.
Studies or
porcep’onol change-s in the visual, amnion", an! anaesthetic senses are planned.
Special enmhasis is to be placed on the more complex functions of spatial and
temporal orientation; discrimination of size and shape; body may; and the
perooption of multiple Simmons stimuli
.111.

(1)
(2)
(3)

(h)

In the emotional aphoro, the following questions are oonsidorud:
Are the emotional responses secondary to or simultanemm with the
perceptual changes?
Are the “spams: consistent in repeated exporinonta in each
In each class of oubjoabo?
subject?
Are the emotional moponooa related to personality structure in
Hal?
any predictable fashion?
In there any relation of the mouse to drug aotim and tho
ability of the subject to utilize the mohanisn of denial?

In addition, there are thornpoutio oonoidorations:
Dona 131) have org arrest on depressions?
fl;
2 Does 15]) have am- valun in eliciting pmhiatrio material in
bloom,- impressed subjects?

2. Subjects:

(a)

‘

The subjects are in
"Normal” controln~

at

three groups:
hospital yeraomol or hospitalized patients

a general hospital.

(b) Psychiatric subjects at Hillside

Hog)

(1 Depression a» psychotic anti
(2 Scbimphronin
(3 N9W1Co

ital:

“satin.

(o) Neurological subjects at Mt. Sinai Hospital:
(1) Cerebral (119%,me or diffuse.

cord
disease.
Spinal
£2)
3) Spinal root disease.

30

W05!

subject is to be heated in a similar fashion prior to drug
ingestion) during the period of drug activity; and after. Subjects
Each

tmatodhyESTandinsulinmtoboexanimddmingaxﬂaﬁortho

Repeated sessions with each subject
course of such treatments
As the drug action has a duration 0: 2 to 5 hours,
arc planned.
The testing new be divided
testing proceduren my be extensive.

into three mops:
Neurologcal.
a)
gb Modical.

c)

tholoacal.
‘\

�3a.. Neurological:

1. Routine neurological.-

2"

Visual.
Perception of color mixed and ambiguous figures taohistoscopi celly
exposed; and cation ion or relative size and distance.
.

,

‘

3. Tactile.
he

Double simultaneous stimulation or various

Amt”.
Perception

modalities.

of latrines” identification of sounds and estimation

of time intervals.
5. Special studies of bochr image.
Bbo

Medical:
Observation of the subjects by members of the Department of Medicine
has been ”quested (Dr. A. Blmberg) and is under consideration.
BiocheMcsl studios of hormonal studios secondary to drug activity
is under consideration, with emphasis on the possible role of
adrenal function in the reactions as measured to the pattern of
wxﬂtosteroid excretion.

3c. Psycholouoalt

Clinical psychological testing is considered an integral port 0
The cooperation of Dr. M. Ger-vita has been rethis survw.
An evaluation 0:: personality structure and habitual
quested,
methods of reaction to stress will be studied in each subject.
In addition, special testing procedures to study the mechanism
of denial are under stuck ha a. member of the psycholomstafrz:,-;LC
(lire Antinoph).

Specific testing procedures include the following tests:
a Rorschach.
b Bender Gestalt.
c
d

TvoTl
Special tests for denial.

he Supplies, Foods, Eton:
The drugs have been made available to me for experimental purposes;
Funds for the
at no charge kw Sundae Pharmaceutical Company.
equipmt moesssry for testing have been placed at my disposal
by the Neurological Research Fund of the Mt. Sinai Hospital.
The

following items are requested from Hillside Hospital:
(1) Office space and the use of one room in Treatment Dormitory
during experimental days.
(2) Availability of records and permission to request occasional
coowration of Homing Department and of the Record Room

staff.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67344">
                <text>Protocol for Pilot Project on Effect of Drugs on Cerebral Function, January 1953</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67345">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67346">
                <text>mfp-03-01-002-1-001</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67347">
                <text>1953</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67348">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67349">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67350">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67351">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67352">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67353">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80937">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87498">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94059">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100620">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6736" public="1" featured="0">
    <fileContainer>
      <file fileId="3789">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/d7a08df9cf0427fc8180966376064147.pdf</src>
        <authentication>df0afef232047bc6a8f732705fc32387</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="104415">
                    <text>USPHS M—927

Final Report

ALTERED BRAIN FUNCTION FOLLOWING ELECTROSHOCK

(Perceptual Changes Induced by Drugs and Electroshock)

the
Department of Experimental Psychiatry
Hillside Hospital
From

Glen Oaks,

L.I.,

N.Y.

September 1, 1959

�September 1, 1959

FINAL REPORT

weal
Department of Experimental Psychiatry
HILLSIDE HOSPETAL

1.,

Glen Oaks, L.

N. Y.
235$!

1

1.

Acknowledgment

2.

Summary

3.

Summary,Five Years, 195k

-

1959

27

h.

Publications,

195k

32

5.

Presentations

195k

-

1959
1959

37

195h

#h,

6.

Summary

#1,

September 1,

7.

Summary

3,52,

January 1, 1956

#3,

April

8.

Summary

-

February 1, 1958

1, 1957

September 1, 1959

-

2

January 1, 1956

hZA

- April 1, 1957

55A

- February 1, 1958

70A

Fink, M.D.

Principal Investigator

max

Research Associates (Experimental Psychology)

Robert L. Kahn, Ph.D.

Research Associates (Neurophysiology)
EEG

Technician

Secretary

Hyman

Karin, Ph.D.

Eric Karp,

M.A.

Martin A. Green,M.D.

195k 195h-1958
1958 1956 -

George Krauthamer,Ph.D.1959
Hanna Mosquera
Janet Bowie

'

Associates, supported through other grants:
Research
Research
Research
Research

Associate
Associate
Associate
Associate

(Experimental Psychol.)

(Psychiatry)
(Psychiatry)
(Sociology)

1956—1959
Joseph Jeffe, M.D.
Donald F. Klein, M.D. 1959 Nathaniel Siegel, Ph.D.l958 -

Max

Pollack, Ph.D.

1957

�Acknowledgment

These studies would not have been possible without the

of
Founder
of
Hillside Hospital,
and
the
support
interest
faith,
Dr. Israel Strauss, the Board of Directors, and the
Administrator, Mr. Maurice Bachrach, who sustained this program
during its early vicissitudes.

are also indebted to the Henry Kaufmann and the Dazian
Foundations of New York, the Foundations' Fund for Research in
and
the
Nassau
Board
County
of
Health
Mental
the
Psychiatry,
following pharmaceutical firms: Smith, Kline and French
and
Laboratories
Bristol
Geigy
Pharmaceuticals,
Laboratories,
We

Wyeth

Laboratories, whose support is gratefully acknowledged.

�September 1, 1959.

M-927

Altered Brain Function Following Electroshock
Progress Report #h
Max

Fink, M.D.,

February 1, 1958 - September 1, 1959

Director, Department of Experimental
Psychiatry

Hillside Hospital,

Glen Oaks,

L.I.,

N.Y.

Associates:
Robert L. Kahn, Ph.D.-Research Associate (Experimental Psychology.
y)
Psycholo
Eric Karp, M.A.-Research Assistant (Experimental
(Neurophysiology%
Martin A. Green, M.D.-Research Associate
Hanna Mosquera - Technician

Janet

Bowie -

Secretary

�-3ALTERED BRAIN FUNCTION FOLLOWING ELECTROSHOCK
SUMMARY:

In the past eighteen months, the various studies of the
convulsive therapy process were completed and extended, and
The
begun.
agents
of
psychopharmacologic
an investigation
framework for these investigations has been the neurophysiologicand
1955;
Kahn,
(Weinstein
view
convulsive
of
therapy
adaptive
Fink and Kahn, 1957) extended to insulin coma and drug therapies
in psychiatry (Fink, 1957).
The following aspects of the convulsive therapy process
were studied:

A
Convulsion:
comparative study
the
of
1. gignificance
of the neurophysIoIogic, psychologic and behavioral effects
of electrical and inhalant (Indoklon) induced convulsions.
2. S Eﬁe
a tic Basis of Neuro h siologic Change: Further
effects of acute administration of experimental
studies of
"normal"
the
both
on
and
agents
sympathomimetic
anticholinergic
and post—convulsive EEG.
s
There
As
Convulsive
of
ects
ic
3. Sociopszcholo

of
the
of
factors
Relation
age, education,
a.
F
Scale)
the
California
by
(measured
and
stereotypy
nativity
to the selection of therapy, duration of hospitalization,
diagnosis and discharge ratings.
b. Changes of F score with treatment, and relation
of these changes to EEG indices.
Thera : In supervisory
chothera and Convulsive
h. PsaIteratIons
psychotherapeuggc
in the
relationship
sessions,
with convulsive therapy were observed.
5. Perception: Both patterns of change and individual
differences on ac stoscopic figure-ground discrimination
tasks and perception of the upright with induced convulsions.
These studies were extended to drug therapies and the
following studies undertaken:
1. Neurophysiologic:
EEG
of
change on acute and chronic
Relation
a.
administration of various psychopharmaceuticals to clinical
behavioral change.

III:

8/59

�potency.

actiVityo

b.

EEG

as a screening device for psychopharmacologic

c. Relation of

EEG

changes to hallucinogenic

effects of megimide.
2. Communication Patterns: Relation of induced neurophysiologic change to dyadic diversification and syntactic
d.

EEG

language measures.
3. §pciopsychologic Studies: Aspects of the doctorpatient relationship affecting choice of somatic therapy.

studies have supported and expanded the neurophysiologic-adaptive view of convulsive therapy, and demonstrated
that such a hypothesis has applicability to our understanding
of the mode of action of psychopharmacologic agents.
These

�~5-

‘mm

PROGRESS REPORT

A.

THE CONVULSIVE THERAPY PROCESS;

1.

Significance of the Convulsion:
An earlier convulsive-subconvulsive control study
had demonstrated that significant behavioral changes occurred
almost exclusively in patients receiving grand mal convulsive
therapy. The present report is an assessment of the neurophysiologic,behavioml, and clinical effects of two different
methods of inducing convulsions - electrical and inhalant.
Twenty-five consecutive patients referred for convulsive
therapy were randomly classified into two groups with
seizures induced in thirteen patients by the standard Medcraft

alternating current instrument, and in twelve by the inhalation
of hexafluorodiethyl-ether (Indoklon). In both groups treatment was administered three times a week for a total of 10
to 2b applications, determined by clinical criteria by the
supervising psychiatrist.
All patients were tested one to two days prior to the

first

treatment, following the 10-12th treatment, and two
weeks following the last treatment. In addition to evaluations
of behavioral change, tests included measures of intellectual
function (five subtests from the Wechsler-Bellevue Intelligence
Scale), perception (figure-ground discrimination using embedded
geometric figures, the perception of pseudoisochromatic color
plates at high speeds of tachistoscopic exposure, and the
Street incomplete figures test), and social attitude (the
Levinson revision of the California F Scale). An electro-

�-6encephalogram was obtained during each of the testing periods,
and measured for the per cent time slow wave (6 cps or

slower) activity from a continuous 66 second sample.
The results failed to show any significant intergroup test
differences between the electroshock and Indoklon groups at
each of the three test periods.

Intragroup analysis, however, showed that during treatment
both groups made increased errors on the intellectual and
perceptual tests, and had higher scores on the F scale. By
two weeks after the termination of treatment both groups
returned to near pretreatment levels for most tests.
Both groups were comparable for the degree of induced
EEG slow wave activity after 10-12 treatments.v The per cent
time slow wave activity for the Indoklon group was 51% and
for the electroshock group h7.5%. Within each group individual
differences in behavioral change were related to the degree of
neurophysiologic change - those with the highest degree of
EEG change showing the greatest behavioral change.
Rank order
correlations between changes in test performance and the
degree of slow wave activity with treatment were positive for
all procedures, except the comprehension subtest of the
Wechsler-Bellevue, and reached a level of statistical significance
for digit span (+ .61, p &lt; .01), object assembly (+ .h6, pr&lt; .05),
F scale (+ .38, p (' .05), tachistoscopic perception
(+ .67: P &lt;: .01) and perception of embedded figures (+ .h3,
p &lt;

.05).

�-7Two

different convulsant agents thus produced similar

neurophysiologic and perceptual behavioral changes; and it
was concluded that the behavioral change in convulsive
therapy is related to the degree of altered brain function,
and is non-specific for the type of agent used to induce the
convulsion.
(Presented, in part, at the Eastern Psychological Association,
Atlantic City, April, 1959).
2. Biochemical“nu—On.“—
Aspects of the Convulsive«non-mu...Therapy Process:
The significance of high voltage EEG slow wave activity
in the convulsive therapy process (Roth §t_al, 1951, 1957;
Fink and Kahn, 19S?) and the report that this activity was
blocked by the administration of such anticholinergic agents
as atropine and scopolamine (Ulett and Johnson, 1957) provided
the basis for these studies. As there were attendant
unpleasant systemic effects with the administration of these
agents, reports describing diethazine as an anticholinergic
compound with potent neurologic but minimal systemic effects
(Jenkner and Lechner, 1955; Lechner, 1956) led to studies
similar to those of Ulett and Johnson using this compound
(Fink, 1958). These observations with diethazine further led
to the investigation of other experimental anticholinergic

agents.
Clinical and electroencephalographic responses to the
intravenous administration of diethazine, Win-2299, benactyzine,
JB-318, JB-336 and atropine in psychiatric patients at various

�-8.
stages of convulsive therapy were studied. Each is a potent
anticholinergic agent in vitro.
The subjects were ninety psychiatric patients referred for
convulsive therapy, ranging in age from 18 to 67, with a
A
of
diagnoses.
total of 107 observations were made,
variety
as some subjects were studied with more than one compound.
The observations were made in the EEG laboratory using a
standard 8 channel instrument and needle electrodes. In each
trial, the compound under study was administevhd intravenously
at a set rate per minute until clinical behavioral or electrographic changes were observed.
It was observed that administration of these anticholinergic
agents was associated with a) desynchronisation of EEG
rhythms with a blocking of post-convulsive delta activity;
b) alerting, excitatory behavioral response with illusory,
delusional and hallucinatory ideation, and c) systemic
effects of muscular weakness, dryness of the mouth, dry skin
and tachycardia. The electrographic, behavioral and systemic
effects were concurrent.
These observations are regarded as consistent with the
suggestion that the physiologic basis of convulsive therapy
lies in an increase in central nervous system cholinergic

activity.
Observations that

LSD,

amphetamine, mescaline and diphen-

hydramine - sympathomimetic and antihistaminic agents - also

induced

EEG

desynchronization, blocking of post convulsive delta

�-9-

activity and clinical excitatory activity support the suggestion
that the behavioral and electrographic patterns of these
compounds are also based on an alteration in synaptic activity.
Increased synaptic activity (cholinergic, sympatholytic effects)
is associated with EEG hypersynchronization, and clinical
sedation and euphoria; while decreased synaptic activity
(anticholinergic, sympathomimetic) is associated with EEG
desynchronization and clinical excitatory and.ha11ucinogenic
states, thus supporting a hypothesis initially described by
Wikler (195h). It was also suggested in these studies that
the discrepant observations of EEG slow wave activity after
the administration of atropine was related to significant
differences in dosage and to species specificity.
(Presented, in part, at the Society of Biological Psychiatry,
San Francisco, 1958 and awarded the first A.E. Bennett
Psychiatric Research Award of that Society; and, in part, at
American EEG Society, Atlantic City, 1958. Published, in part,
A.M.A. Arch. Neurol. &amp;
80:
and
380-387, 1957;
Psychiat.
accepted
for puﬁlication, EEG Clin. Neuropﬁisiol.)
3. Sociopsychologic Aspects of Psychiatric Treatmen :
a. Duration of Hospitalization, Diagnosis and
Discharge Evaluation.
In an earlier study of the Hillside Hospital
population (Kahn, Pollack and Fink, 1957), it was noted that
age, education, place of birth and social attitudes as measured
by the California F scale, were related to the selection of
therapy. Those patients who were older, had less education,
were foreign-born and with high stereotypy scores on the F Scale

�likely to receive convulsive therapy. In contrast,
who
and
who
native-born
better
were
educated,
younger,
patients

were more

obtained low scores on the F Scale, received psychotherapy as
their sole form of treatment.
This study was extended to determine the relations of
these sociopsychologic factors to l) the duration of hospitalization, 2) the clinical evaluations at time of discharge,
and
was

final diagnosis.
The entire in-patient adult population on March
studied. This consisted of 171 patients, 57 men
3) the

7, 1957
and 11h

68
16
from
to
in
women, ranging
age
years, with a median of
35 years.
Patients hospitalized for the shortest period (1-5 months)
were noted to be the oldest, have the least education, were
most likely to be foreign-born, and have the highest scores on
the F Scale. Younger, native-born, more educated, lower F
score patients were hospitalized the longest (10 or more months).
The same relationship of these factors to length of hospitalization was found when separate analyses were made according to
diagnosis and type of treatment (convulsive therapy or psychotherapy).
Discharge evaluations of improvement were significantly
related to age - the older patients having the most favorable
ratings. Analysis of the data by type of treatment, however,
demonstrated that among the convulsive therapy patients ratings
of recovered or much improved were given to those patients with

�the highest
born.

F

scores, least education

and who were

foreign-

Diagnoses of schizophrenia or psychoneurosis were
associated with lower F scores, younger ages, more education

native birth.

older, less educated, foreign-born,
high F score patients were more frequently classified as
involutional or manic-depressive psychosis.
It was postulated that these relationships reflect the
influence of social background and psychological processes,
such as the behavioral patterns of communication and mode of
expression; and that these relationships contribute not only
to the pattern of mental illness, but affect all aspects of
the patient—therapist interaction.
(Presented at the Eastern Psychological Association,
Atlantic City, and the Academy of Psychoanalysis, Philadelphia,
April, 1959. Accepted for publication, Archives of General
Psychiatry.)
b. Changes in Social Attitude with Convulsive
and

The

Treatment.

earlier observations that the California
F Scale is useful in understanding the reason for referral for
convulsive therapy and the evaluation of clinical response
Following

following such treatment, further studies were undertaken with
this scale in regard to the following questions: 1) What does
the F Scale measure in a psychiatric population? 2) Do F
scores change with convulsive therqay? 3) Are these changes
related to the degree of altered brain function?

�-12-

entire in-patient population of the hospital was
given the F Scale, and one month later, was retested with
The

a

"reverse" F Scale, in which each statement was changed to the
opposite of the original. The "reverse" scale was scored in
the same manner as the conventional scale, with high scores

reflecting greater agreement.
It was noted that those patients who made low scores
initially, indicating a predominant disagreement with the
statements, showed an increase on the "reverse" scale,
indicating a high degree of agreement. In contrast, patients
who made high scores initially showed little change on retesting,
agreeing with the statements to the same extent even though the
meaning was reversed. It is evident that low F score patients
are more critical and discriminating persons, while those
with high F scores are more undifferentiating and stereotyped
in their reactions.
This observation is related to the process of selection
of patients for convulsive therapy. A high degree of stereotypy of thinking and communication is incompatible with the

establishment of a conventional psychotherapeutic relationship,
thus inhibiting the psychoanalytically-oriented psychotherapy
stressed at this hospital. It follows that the high F score
patients will be unsuccessful in psychotherapy and most likely
referred for convulsive therapy.
In another study, sixty-nine patients were given the F
Scale before, during (at 10-12 treatment period) and after

�-13convulsive therapy.

Ten

patients, selected at

random,

constituted a control group and received subconvulsive electroF
in
score of +5.7
mean
There
increase
was
a
stimulation.
during treatment in the convulsive group - a difference
5%
the
level. In contrast, the control group
at
significant
showed an insignificant change during the same period (+0.5).
The extent of increase in the convulsive patients was related
to the degree of cerebral dysfunction as determined by slow
(more
The
with
EEG.
delta
high
the
on
patients
wave activity
+8.6.
of
had
mean
increase
a
record)
h0$
of
the
sample
than
Those patients with low delta indices, however, showed an
F
the
treatment
scores were
Following
+3.h.
of
increase
comparable to the pretreatment levels.
These findings support and elaborate previous observations
on the effects of convulsive therapy. Greater agreement with
show
conventional
treatment
during
statements
Scale
the
F
in
Changes
discrimination.
and
in
difficulty
stereotypy
of
changes
language
the
characteristic
thus
score
parallel
cliche;
and
of
use
increased denial, evasion, qualification,
and stereotyped expressions (Kahn and Fink, 1958). It is
also comparable to the increased difficulty in complex visual
F

and
1957)
figureKorin,
tactile
ground discrimination (Kahn and Fink, 1957).
(Presented at the Eastern Psychological Association, 1958;
and accepted for presentation at the Divisional Meeting of the
American Psychiatric Association, New York, November 1959).
and

perception (Fink,

Kahn and

�-1hh.

Psychotherapy and Physiodynamic Therapy:
Previous studies indicated that patients referred for
electroshock in this hospital are of two types. The larger

older age who have limited education
and are foreign born. They tend to be non-introspective
persons, stereotyped in their language and thinking, and
verbally uncommunicative. Symptoms of depression, agitation,
withdrawal and somatization are prominent. The second, and
smaller, group of patients are younger,native-born, bettereducated, and verbally communicative with a capacity for
introspection. They characteristically exhibit thinking
disorders and overactive behavior, with lesser degrees of
somatization and depression.
Four patients, two from each group described above were
studied to determine 1) reasons for referral, 2) whether
different attitudes were required in psychotherapeutic
3) the relation of the psychotherapeutic
management, and
approach to the patient's clinical response to convulsive
therapy.
It was concluded that these patients were referred for
convulsive therapy because of difficulty in communication in
the psychotherapeutic relationship. In two cases this was
a reflection of the patient's limited verbal and introspective
capacity related to educational and social factors. In two
instances, however, the impaired communication was reflected
in acting-out behavior.
group are

patients of

an

�-15Following treatment, the older, less educated patients
were able to sustain the behavioral change with a reassuring,
supportive technique, amplifying tendencies to minimization
‘In
the better
and denial developed during electroshock.

educated patients, the decreased acting-out behavior was
associated with increased interpretive psychotherapy.
It was suggested that the relationship of psychotherapy

to convulsive therapy various with the communication pattern
and adaptation shown by the individual patient.
Published in the Journal of Hillside Hospital, 1: 17-25,
19 58 ).
5.

Perception:

have
of
procedures
test
perceptual-cognitive
variety
been studied in patients receiving somatic therapies.
a. The Tachistoscopic Perception of Embedded
Colored Figures:
This task was studied in an experimental group
consisting of 35 consecutive referrals for convulsive therapy,
and "control“ groups of 20 patients treated with phenothiaains
medication (thorazine and promazine) and ten patients receiving
no somatic treatment, matched for age. All subjects were
tested prior to treatment, and after four weeks; the convulsive
weeks
two
time
a
following the
third
were
tested
patients
A

.

cessation of treatment.

�-15There was a

statistically significant increase in

mean

errors with convulsive therapy, and a significant
decrease from the pretreatment scores following treatment.
"Control" subjects made significantly fewer errors at each
succeeding period. There was a significant difference in
EEG
low
between
showing
changes
as
classified
errors
patients
(per cent time delta) when compared with high EEG changes.
There were high retest correlations for all groups.
There were marked individual differences in response
patterns prior to treatment. With brain changes there was a
reduction in perseveration, completion and confabulation in
some patients, and an increase in others, with no unions
Even
in those
to
cerebral
dysfunction.
attributed
patterns
EEG
with
high
changes, the "style” of his response
patients
pattern was maintained. Thus a patient showing completion
type errors prior to treatment would continue to make such
errors with convulsive therapy, although the threshold at

number of

which completion was shown might change.

(Presented, in part, at the Eastern Psychological
Association, Atlantic City, April 1959).
b. Rod and Frame Test (Withinz: This task was administered
to h? patients consecutively referred for somatic therapy.
Marked individual differences in performance were correlated
with age, education and score on the California F Scale.
Patients whose judgment of the vertical was strongly influenced
by the surrounding frame (field dependent) were more frequently

�referred for convulsive therapy than drug therapy. No
significant change was found with drug or convulsive treatment.
For both drug and convulsive groups retest correlations
were high (+.86 and +.88). It is considered that individual
differences on the Rod and Frame test reflect personality
factors that are of importance in psychiatric treatment.

�-18B.

PSIGHOPHARMACOLOGIC STUDIES;

1. Neurophysiologic Asgects:
According to the neurophysiologic~adaptive view of

the convulsive therapy process, the clinical efficacy of
repeated induced convulsions is dependent upon the induction
of a persistent alteration in central nervous function,

providing a milieu for changes in the subject's interaction
with the examiner and the environment. In these studies the
best index of neurophysiologic change has been those aspects
of cerebral function reflected by delta activity in the
electroencephalogram (Fink and Kahn, 1957). The efficacy of
newer psychopharmaceuticals in altering psychotic behavior
patterns has led to the suggestion of a similar hypothesis
for the mode of action of these agents, and to studies of the
relationship and specificity of altered behavioral patterns
to neurophysiologic change as reflected in electroencephalography.
Of the psychopharmaceuticals tested in acute experiments
an increase in synchrony with or without an increase in slow
wave activity has been observed for chlorpromazine, promazine
and triflupromazine. Behaviorally, these drugs were associated
with
a) increasing sedation, drowsiness, denial and euphoria;
b) decreasing agitation, panic, excitement and delusional and
hallucinatory activity; and c) minimization and displacement
of symptoms. Barbiturates regularly induced an increase in
fast activity with an increase in synchrony, with the associated
behavioral changes of sedation, euphoria, denial and minimization.

�-19Amphetamine and methamphetamine increased fast activity
without increased synchrony and behaviorally were associated
with alerting, hypomania, excitement and increased motor

activity. Decrease in voltage and per cent time of slow
wave activity in subjects with post-convulsive delta activity
with LSD-25, benactyzine, Win-2299, JB-318, JB-336
and diethazine. Of these drugs, benaotyzine produced increased
alerting, excitement, tension and panic; the other drugs also
produced illusory sensations and hallucinatory, delusional
and paranoid ideation.
was seen

electrographic patterns were consistently altered
concurrently with behavioral changes both in the acute and
chronic administration studies. Tranquilization, euphoria,
sedation and minimization of symptoms were associated with
increased EEG synchronization and shift of frequencies to the
delta range. Agitation, tension, panic, excitement, illusions
and hallucinations were associated with desynchronization of
frequencies.
Similar patterns were demonstrated in subjects with
prior delta activity. Agents that tended to synchronize
frequencies, as chlorpromazine and barbiturates, augmented the
per cent time delta activity and enhanced the clinical patterns;
agents that desynchronized frequencies, as diethazine, LSD-25
and benactyzine, minimized the clinical effects typically
ascribed to repeated convulsions.
The

�-20.
Various experimental psychopharmaceuticals were tested.
In addition to extensive studies of b-b methy].ethylg1utarimide

hexaflnarodiethylether (Indoklon) the following
agents were studied; phenyltoloxanine(PRN-Bristol), methonalide
(ELM-188, Bristol), tropin-h-chlorbenzhydryl ether (WY-21h9,
(Megimide) and

Wyeth), dimethylaminoethanel and

varieties, Riker),

its

congeners (Deaner and

JB-318, 329 and 336 (various

piperidyl-

benzilates, Lakeside) and imipramine (Tofranil, Geigy).
Because significant behavioral and electrographic
changes were observed, a more intensive investigation of
imipramine (TofrEnil) was undertaken.

In

28

acute experiments,

consecutive patients referred for physiodynamic therapies were
tested in the EEG laboratory at various stages of treatment.
TofrEnil solution (10 mg/cc) was administered intravenously at
a set rate (1 cc/ho sec) until electrographic or behavioral
changes became prominezit, for a total of h0-125 mg (0.5-2.5
Behavioral observation and electrographic recording
continued for one to three hours. In patients referred for
pharmacotherapy because of manifest depressive, withdrawn or
retarded behavior oral TofrEnil of 75-350 mg was administered.
In the acute studies there was initial restlessness,
associated with dizziness, dry mouth, "faintness," nausea,

mg/kg).

and on four occasions, vomiting.

These symptoms

persisted for

lassitude, heaviness
eventual drowsiness. Heart rate was

10-20 minutes, and were accompanied by

of the extremities and
unchanged or slowed.

Blood pressure dropped by 20-h0% in

�-21..

older (age &gt; 60) patients. Subsequently, subjects were
relaxed, quiet and disinclined to activity, even when
returned to their ward.
The electrographoc patterns accompanying these behavioral
changes were initiated by a gradual decrease in voltages
during the injection. By ten minutes, the per cent time
alpha had been halved. In patients with moderate amounts
of beta activity, such activity occasionally increased in
voltage and per cent time. By twenty minutes, in association
with behavioral lassitude, low voltage (to 50 microvolts)
random theta frequencies (5-? cps) appeared. In records with
post-convulsive delta activity, there was a marked decrease
in voltage and per cent time of slow wave activity. These
% to two hours.
for
electrographic patterns persisted
There was considerable individual variability in this
acute EEG response. In patients who received 100 mg or more
of TofrEnil, EEG and behavioral changes were observed in all
but three. In six patients, dosage of TofrEnil less than 50
mg were associated neither with EEG nor with behavioral
changes.
In chronic Tofrénil studies, behavioral changes generally
appeared during the second, and were maximal during the third,
week of treatment. The most prominent behavioral adaptation
was euphoric denial. Patients complained less of somatic

displaced their illness
became increasingly difficult to discuss

symptoms, and denied, minimized or
on

inquiry.

It

�-22In
six
patients
them.
with
significant life relationships
and
depressive
increased
and
restlessness
somatization

agitation,
restlessness,
affect persisted.
of
cessation
the
to
excitement, insomnia and vomiting, les
five
patients
in
noted
were
symptoms
No
in
change
therapy.
In three,

therapy.
showed
administration
chronic
on
studies
Electrographic
Low
modulation.
record
a decrease in voltages with poorer
Well
10%
appeared.
to
up
cps)
activity
(5-7
theta
voltage
few.
a
in
prominent
more
became
defined fast activity

after four

weeks of

NeuroInternationale
(Presented at the Collegium
the
1958;
at
September,
Psychopharmacologicum, Rome,
March,
Montreal,
Conference on Depression and Allied States,
in
Published,
1959.
EEG
Society, June,
1959; and American
harmacolo
chc
Ps
of
s
C.I.N.P.;
Proceedin
the
in
gamed.
part,
Ps
Ass.
cﬁiat.
1959;
32§~332,
N.
Kline,
ed.
19E8.
Frontiers,
682-685,
and
Neurology
__3. _E: 1653117159959;
_8_:

Relationship
Therapist-Patient
of
the
2. Aspects
Affecting Choice of Therapy.
than
other
aspects
involves
The selection of therapy
the
In
the
of
patient.
the manifest behavioral patterns
been
have
problem
this
further efforts to clarify

past year

therapist-patient
and
frustration
that
We
have hypothesized
relationship.
and
implicit
relationship
hostility in the therapist-patient
have
a
significant
environmental
pressures
or explicit

the
in
factors
emphasizing
undertaken,

influence in referral for somatic therapy.
residents
with
interviews
76
structured
In a pilot study
somatofor
requests
and supervisors were initiated following

�-23-

therapy. These interviews were designed to elicit the basis
of the referral. It was found that in only relatively few
cases was there a change in the patient's clinical status
which directly led to the referral. In most instances there
had been no change or progression in the presenting symptoms.
Factors contributing to the timing of the referral included
impending discharge, avoiding administrative discharge, and
pressure from the patient's family or ward personnel. .It was
also noted that patients with similar behavior patterns were
treated differently, some given somatotherapy and others none.
The reasons for this ranged from "whim" to quantitative
differences in symptomatology and individual preferences for
type of treatment.
It was concluded that factors other than clinical
indication played a role in the referral in a significant
number of cases. These same extraneous factors also influenced
the timing of the referrals.
As a result of these findings a "Somatic Treatment Referral
Sheet" was developed (see Appendix) to be completed by the
therapist whenever somatic therapy is requested. This study
is continuing.

�-2h.
3.

Language

Patterns as Measures of Behavioral and

Neurophysiologic Change with Drugs.
In previous studies of the convulsive therapy process,
it was demonstrated that two language measures, a syntactic
content analysis (Kahn and Fink, 1958) and dyadic diversifica‘
tion scores of unstructured interviews (Jaffe, Kahn and
Fink, 1958) provided objective indices of behavioral change,
and were related to the degree of altered brain function. In
a further test of these language measures as indices of

behavioral and neurophysiologic change, they were applied to
interviews on acute administration of various psychopharmacologic
agents.
Seventy-two interviews with patients at various stages
of drug therapy have been analyzed, using the following
agents: amobarbital, benactyzine, chlorpromazine, diethazine,
lysergic-acid diethylamide, and Win-2299.
Following a routine electrographic recording, an unstructured psychiatric interview, with short periods of
structured inquiry, was tape recorded. With EEG running, an
intravenous injection was then given at a slow rate. When
specific electrographic or clinical changes were induced, the
interview was repeated. Recording periods of EEG and verbal
behavior were alternated for the duration of the observation
period. The EEG was measured for changes in synchronization,
shifts in dominant frequencies, and per cent time of slow waves
(delta) and beta frequencies.

�.25tape recordings were transcribed and measured for the
diversification of consecutive 25 word samples of speech of
The

both participants (dyadic) and for syntactic changes. In
the dyadic analysis, the pooled verbal behavior of both
participants was transcribed, divided into 25 word samples,

for each sample the ratio of the number of different
words to the total number of words (a diversification score)
was calculated. The syntactic language analyses were based
on the response to standardized questions using a method
previously described (Kahn and Fink, 1958), scoring such
changes as syntactic use of person, alteration in tense,
evasion, qualification, displacement or verbal denial of
symptoms, use of stereotyped expression or cliches, cryptic
response, and withdrawal or silence.
Consistent changes were observed in both the dyadic
diversification and syntactic language measures in subjects
classified according to the neurophysiologic and behavioral
effects of the drugs applied.
Amberbital and chlorpromazine are neurophysiologic
synchronizing agents. Amobarbital regularly induces high
voltage well synchronized fast activity at 20-2h cps, while
chlorpromazine administration is followed by increased synchronization of the EEG record and a shift to slower frequencies
including occasional slow wave burst activity. Behaviorally
these drugs are associated with sedation and tranquilization.
On the language measures there was an increase in stereotypy
and

�-26~

repetitiveness associated with increasing use of
alterations in tense, displacement and evasion.
and

/
cliches,

Diethazine, benactyzine, LSD-25 and Win-2299 are neurophysiologic desynchronizing compounds. These drugs are
characteristically associated with decreased voltage and
per cent time of alpha activity and increased irregular low
voltage fast activity. Behaviorally hallucinatory, excitatory
or illusory activity are observed. 0n the language measures
there was decreasing repetitiveness, wide diversity of words,
less variability of diversification scores, and decreased
use of cliches and alterations in tense.
Further exploration of language measures are suggested
as a rational basis for the understanding of the psychologic
effects of the new therapies.
(Presented at the Conference on Psychodynamic, Psychoanalytic and Sociamgic Aspects of the Neuroleptic Drugs in
Psychiatry, Montreal, April, 1958, and at the American
Psychiatric Association, Philadelphia, April, 1959).

�-27.
SUMMARY

lgsh - 1959

out-“n”
laboratories of the Department of Experimental
Psychiatry were established at Hillside Hospital in September,
19Sh. During this five year period neurophysiologic,
and
and
perceptual),
linguistic
(personality
psychologic
sociologic aspects of "somatic" psychiatric therapies have
been the principal foci.
The

Convulsive Therapy:
The view of the convulsive therapy process as the induction of a non—specific state of altered brain function,
similar to craniocerebral trauma was supported and amplified

1.

cerebral
Within
subjects
altered
milieu,
this
21).
ll,
were seen to respond in various ways (26), of which the most
"successful" was explicit verbal denial (7, 31). This latter
(10,

adaptation was most prominent in characterologically disposed
individuals (36).
An alteration in brain function was pre-requisite to
behavioral change (7, 8, 11, 26). Grand mal seizures were
essential to this process (26) but electrical induction was
not (B-h2). The alterations in brain function were measured
in various ways including electroencephalography (6, ll, 12,
2h, 39), language patterns (b, 7, 1h, 31, h3; B-2h), perceptual tasks (2, 16, 17, 3?, h6; B-26, hl, h2) and tests of
Reference numbers are to publications or presentations (Blisted in the appendix.

)

�recall (8).

It

suggested that the neurophysiologic basis of
convulsive therapy may lie in an alteration in central synaptic
cholinergic - adrenergic relationships, with a predominant
shift to increased cholinergic activity as the operationally
significant pattern. Such interpretations were based on the
was

relationship of high voltage

EEG

slow wave

activity to

behavioral change (6, ll, 26) and the blocking of post-convulsive
electrographic and behavioral changes by central anticholinergic
agents (21, 3h, 35, bl, h2) and central sympathomimetic agents
(h2).
A variety of behavioral changes were seen during convulsive therapy (26; B-l7). Such patterns were viewed as
adaptations to altered brain function, and were believed
dependent upon characterologic and environmental factors (7,
25, 26, 36, ho). Clinical ratings of improvement were seen as
value judgments by the observer of
behavioral change in
the subject (26). Adaptations characterized by denial
mechanisms, both in behavior (B-17) and in language (7, 31)
were seen as most favorably rated by the psychiatric staff.
Such adaptations were related to habitual modes of conduct
(character, personality} (36; B-ll, 32).
The persistence of the altered behavioral nodes was noted
as dependent upon the degree and duration of altered brain
function, the environmental expectations, and the type and

�+29-

degree of family and medical support (26).

Different
varying types of

behavioral patterns were best supported by
psychotherapy (19).
Measures of linguistic behavior in structured (7, 31)
and unstructured (1h, 29; B-2h) interviews showed characteristic alterations towards increased denial, minimization,
displacement, stereotypy and repetitiveness related to the
degree of altered brain function (B-Zh). These changes were
blocked or reversed by anticholinergic hallucinogens (21,h3).
Various perceptual tasks provided indices of behavioral
change and were related to the degree of altered brain
function. These included the perception of simultaneous
tactile stimuli (17), embedded (Gottschaldt) figures (37; 8-16),
and tachistoscopically exposed words (37) and embedded color
figures (hl).
Sociopsychologic aspects of age, years of education,
nativity and degree of stereotypy and conventionality
(measured by California F Scale) were related to selection of
therapy, duration of hospitalization, diagnosis and treatment
response in hospitalized patients (15, 36, ho, hS).
2.
Neurophysiologic-Adaptive Hypothesis of Somatic Therapy.
Based on these studies, a hypothesis concerning the mode
of action of other therapies such as insulin coma, leucotomy
and psychotropic drugs, was expressed (10, 33, 38). This
view holds that the efficacy of these therapies depends upon
the induction of states of altered brain function, in which

�varying adaptive patterns may become prominent. The adaptive
pattern is related to the type, degree and duration of altered
brain function, the personality of the subject, and tolerances
and expectations of the environment.
Examination of
drug therapies
MY—2092

3.

is

this hypothesis as applied to psychotropic

now

in progress, supported by

USPHS

grants

and MY-2715.

Insulin

Coma

Therapy.

initial

case study showed the significance of denial
patterns and of persistent altered brain function for the
An

behavioral changes in insulin
In an insulin coma

therapy (3).
- chlorpromazine control study, no
coma

differences in hospital improvement ratings were observed in
the two treatment groups (27). Chlorpromazine was safer,
easier to administer, permitted continued administration and
allowed for greater degrees of concurrent relationship therapy
than insulin coma. These observations led to a replacement of
insulin some by psychotropic drugs in this institution.
h.

Pharmacotherapy.
The ongoing program in evaluating various psychopharma-

ceuticals is derived from these hypotheses. Electrographic
and linguistic analyses of effects of acute intravenous
administration and chronic clinical administration of various
new compounds are in progress. EEG patterns, along such
continua as synchronization-desynchronization and frequency
shift, and various perceptual, perceptual-motor and personality

�-31..
and
h2)
3h,
(21,
behavioral
bl,
to
related
being
tasks, are
linguistic changes (21, h3).
The neurophysiologic basis of experimentally induced

hallucinogenic states has been interpreted as an alteration
in synaptic chemical relations, such that the effective levels
of cholinergic activity is decreased (h2). Initial work on
this hypothesis (21, h2) is now being expanded.

�.132-"
PUBLICATIONS AND PRESENTATIONS

195k - 1959
A.

Publications.

195h

Patterns of Perceptual Organization with Simultaneous
Stimuli. Arch. Neurol. &amp; Psychiat., 72: 233- 255.
Bender, M.B ., Green, E. andFFinE, M.
2. Standardization of the Face-Hand Test. “”""§z
Neurolo , h:

1.

211-217.

Fink,

M.

and Green,

1955.

M.

'

Delusional Reduplication of Parts of Body after Insulin
Coma Therapy. J. Hillside Hos ital h: 13h-1h7.
Kahn, R. L., Fin , . an
rau er ,
h. The Amytal Test in Patients with Mental Illness. J.
Hillside Hospital, h: 3-13. Kahn, R.L., Fink,'M.
and Weinstein, .A.
3.

1956

Denial of Blindness Following Cerebral Angiography.
J. Hillside Hos ital, S: 238-2h5. Fink, M.
6. Quantitative Studies of Slow Wave Activity Following
Electroshock. EEG Clin. Neurophzsiol. Q: 158 (Abst)
Fink, M. and Ka n, R.L.
7. Relation of Amobarbital Test to Clinical Improvement in
Electroshock. Arch. Neurol. &amp; Ps chiat. 76: 23- 29.
E. A.
Kahn, R. L., Fink, M. and Weinstein,
8. Relation of Changes in Memory and Learning to Improvement
in Electroshock. Conf. Neurol. 16: 88- 96. Karin, H.,
Fink, M. and Kwalwasser, §.
5.

9.

Evaluation of High-Dose Reserpine Therapy for the Relief
of Anxiety.
Wachspress,
Hillside Hospital killer,
. 67- 77.
J. S .A.
M., Blumberg,'I'WG Fin E, ﬂ. and

�~33:.
PUBLICATIONS AND PRESENTATIONS

1957

Unified Theory of the Action of Physiodynamic
Therapies. J. Hillside Hos ital, 6: 197-206. Fink, M.
11. Relation of EEG Delta Activity to Behavioral Response
in Electroshock: Quantitative Serial Studies. A.M.A.
Arch. Neurol. &amp; Pszchiat..- 78: 516-525. Fink, M. and
10.

A

w

Itajin, ROE.

12. Significance of Individual Variability in the

to Electroshock. J. Hillside

Green, M.A.

13.

EEG

An

and

Response
Hospital, 6: 229-2h0.
EEG

Clinical Response to

Megimide. EEG. Clin.
Green, M. and Fink, M.

Neurophysiol. 2: 180.
Objective Study of Communication in Psychiatric
Interviews. J. Hillside Hospital, 6: 207-215.

J. Jaffe.

Social Factors in Selection of Therapy in a Voluntary
Mental Hospital. J. Hillside Hos ital, 6: 216-228.
Kahn, R.L., Pollack, M. and Fink, M.
16. Perception of Embedded Figures After Induced Altered
Brain Function. Amer. Psychol. 13: 361. Kahn, R.L.
and Fink,

M.

17. Role of Stimulus Intensity in Perception of Simultaneous
Cutaneous Electrical Stimuli. J. Hillside Hospital, 6:
2hl-2SO. Karin, H. and Fink, M.
18. Perception Experiments in a Study of Ambivalence. Arch.
Neurol. &amp; Psychiat. lg: 167-176. Karin, H., Tarachow, S.
and Friedman, S.
1958

with
Electroshock
19. Psychotherapeutic
Techniques
Patients.
"
‘J. Hillside Hospital, 1: 17-25. Esecover, 3.,
JaTTe, 3. and Kahn, R.L.
20.

Lateral

the Sedation
Clin. Neurophysiol. l2: 162-163.

Gaze Nystagmus as an Index of

Threshold.
Fink, Mo

EEG.

�PUBLICATIONS AND PRESENTATIONS

1958

21. Effect of Anticholinergic Agent, Diethazine, on EEG
and Behavior: Significance for Theory of Convulsive
Therapy. A.M.A. Arch. Neurol. &amp; Psychiat. ﬁg:
380.387. Fink, no
22. Effect of Diethazine on EEG and Significance for Theory
of Convulsive Therapy. EEG. Clin. Neurophysiol. l2:
207-208. Fink, M.

23. Effect of Anticholinergic Compounds on Post-Convuhive
EEG

776

and Behavior.

(abst). Fink,

EEG.

E.

Clin.

&amp;

Neuroph

siol. $2:

Electroencephalographic Correlates of the Electroshock
Process. Dis. Nerv. Sy . $2: 227. Fink, M. and Green,
EXperimental Studies of Convulsive and Drug Therapies in
Theoretical Implications. A.M.A. Arch.
Psychiatry:
Neurol. &amp; Psychiat. ﬁg: 733-73h (abet). Fink, M.,
a n, . . an
reen, M.A.
26. Experimental Studies of the Electroshock Process. Dis.
Nerv. Sys. l2: 113-118. Fink, M., Kahn, R.L. and
reen’ 0

M.

27. Comparative Study of Chlorpromazine and Insulin Coma
in the Therapy of Psychosis. J. Amer. Med. Assoc., 166:
18h6-1850. Fink, M., Shaw, R., Gross, G. and Coleman,

F.S.

28.

'

Clinical and Electroencephalographic Effects of Megimide
in Patients without Cerebral Disease. Neurology, 8:
‘
682-685.

Green,

M.

and Fink,

M.

Psychiatry, 3;: 2h9-258. Jaffe, J.
30. Communication Networks in Freud's Interview Technique.

29. Language of the Dyad.

Psych. Quart. 2g: hS6-h73. Jaffe, J.
31. Changes in Language During Electroshock Therapy.
and
Ed.
P.
of
Hoch,
Communication,
Psychopathology
Eratton. Kahn, R.Lo and Fink,
u n, ., rune

M.

�-35PUBLICATIONS AND PRESENTATIONS

1959

32. Effect of an Anticholinergic Agent, Diethazine, on
EEG and Behavior: Significance for Theory of
Convulsive Therapy. Biol. Psychiatry ed. Massrnan,

J.,

Grune

&amp;

Stratton,

N.Y. pp. 1

-l9

33. Alteration in Brain Function in Therapy.
N. ed.
Kline
harmacology
Frontiers,
E
Co., Boaton, pp. 325-332. Fink, M.
3h. Significance of

EEG

. Fink,
Psycho-

Eittle,

M.

Brown
‘

Pattern Changes in Psychopharmacology.

Clin. Neurophysiol. g: 398 (abst). Fink, M.
35. Electroencephalographic and Behavioral Effects of
TofrEnil. Canad. Psych. Assoc. J. A: 1665-1718.
Fink, M.
36. Psychological Factors Affecting Individual Differences
in Behavioral Response to Convulsive Therapy.
JoNoMoDo 128: 2h3‘2h8- Fink, Mo, Kahn, Roll. and
EEG.

PoIIacE, HT"

37. Effects of Diffuse Altered Brain Function on Perception.
Proc. XV . Int. Con . Psychol. Publ. North-Holland,
Amsterdam, pp. 238-239. Fink, M., Kahn, R.L. &amp; Karin, H.
38. Therapy of Schizophrenia: Role of Alteration of Brain
Function on Behavior. Congress Re orts II Int.
Cong. Psychiatry, I}: E9?-E§3
Kahn, R.L. and Korin, H.

labstS. Fink,

M.,

39. Relationship of Threshold and Duration of Seizures to
Degree of EEG Delta Activity Induced During Electroshock. EEG Clin. Neurophysiol. —2: 399 (abst).
Green, M.
ho. Prognostic Application of Psychological Techniques in
Convulsive Therapy. Dis. Nerv. Syg. 32: 180-18h.
Kahn, R.L. and Pollack, H.

In Press

bl.

Effects of Psychopharmacologic
Agents. szchotropic Drugs, 2: Ed. Bradley P. Fink,
b2. Effect of Anticholinergic Compounds on Post-Convulsive
EEG and Behavior of Psychiatric Patients. EEG Clin.
EEG

and Behavioral

Neurophysiol. Fink,

M.

M.

�PUBLICATIONS AND PRESENTATIONS

In Press

(contd)

Interview Patterns. The
D
amics of Psvchiatric Drug There , ed.-3T
arwer-Foner, C.C. nomas, Springfield, Ill.
Fink, M., Jaffe, J. and Kahn, R.L.
hh. Formal Language Patterns as Character Defenses:
Implications for Psychoanalytic Technique. Pszchologz
of Speech and Hearing Disorders, ed. Barbara, D. .,
Grune &amp; Stratton. Jeffe, 3.

h3-

Drug Induced Changes in

Sociopsychologic Aspects of Psychiatric Treatment in
a Voluntary Mental Hospital: Duration of Hospitalization, Discharge Ratings and Diagnosis. A.M.A.
Arch. Gen. Pszchiat. Kahn, R.L., Pollack, H.
an

h6.

n,

o

Set in the Perception of Simultaneous
Tactile Stimuli. Am. Jour. Psychol.Korin, H. and
Fink, M.

The Role of

�3.

Presentations.
1.

Relationship Between Altered Brain Function and Denial
in Electroshock Therapy. American Psychiatric
Association, Atlantic City.
Delusional Reduplication of Parts of the Body after
Insulin Coma Therapy. New York Neurological Society,
and the New York Society for Clinical Psychiatry,
New

York.

Relation of Changes in Memory and Learning to Improvement
in Electroshock. Electroshock Research Association,
Atlantic City.
h. Quantitative Study of Slow Wave Activity Following Electroshock. Eastern Association of Electroencephalographers,
Bethesda.
Newer Drugs in Psychiatry. Nassau Neuropsychiatric
Society, Long Island.
3.

1956

Changes in Language During Electroshock Therapy.
American Psychopathological Association, New York.

Electroencephalographic and Clinical Effects of Megimide.
Eastern Association of Electroencephalographers,
New

York.

1957

8.

Perception Experiments in a Study of Ambivalence. Section
of Neurology and Psychiatry of the New York Academy
of Medicine and the New York Neurological Society,
New

York.

Individual Differences in EEG Responsivity. Metropolitan
EEG Society, New York.
10. Criteria in Evaluation of Clinical Behavioral Change.
Round Table Discussion, American Psychiatric
Association, Chicago.
11. Personality Factors in Behavioral Response to Electroshock
Therapy. Electroshock Research.Association, Chicago.

�938PRESENTATIONS

1957

12.

EXperimental Studies of the Electroshock Process.
Society of Biological Psychiatry, Atlantic City.

Effects of Diffuse Altered Brain Function on Perception.
XV International Congress of Psychology, Brussels.
Therapy of Schizophrenia: Role of Alteration in Brain
Function in Behavior. International Congress of
Psychiatry, Zurich.
The Relation of Ambivalence to Aggression and Authority
in Psychoneurotic Patients. American Psychological
Association, New York.
16. Perception of Embedded Figures After Induced Altered
Brain Function. American Psychological Association,
New

13.

York.

17.

Behavioral Patterns in Induced States of Altered Brain
Function. New York Divisional Meeting, American

Psychiatric Association,

New

York.

Objective Study of Communication in Psychiatric
Interviews. New York Divisional Meeting, American
Psychiatric Association, New York.
Significance of EEG Frequency Shift for Psychiatry.
Metropolitan EEG Society, New York.
Effect of Diethazine on EEG and Significance for Theory
of Process of Convulsive Therapy. Eastern
Association of Electroencephalographers, New York.

An

1958

Correlates of the Electroshock Process. Eastern
Psychiatric Research Association, New York.
22. Significance of Individual Variability in EEG Changes
During Electroshock Therapy. Eastern Association
of Electroencephalographers, Montreal.
23. Experimental Studies of Convulsive and Drug Therapies
in Psychiatry: Theoretical Implications. New York
Neurological Society and the New York Society of
Clinical Psychiatry, New York.

21.

EEG

�-39.
PRESENTATIONS

1958

Patterns with Altered Brain Function.
Eastern Psychological Association, Philadelphia.
The Relation of F Score to Behavioral and Psychological
Response with Altered Brain Function. Eastern
Psychological Association, Philadelphia.
26. Intensity of Stimulation and Perception of Simultaneous
Stimuli in Cerebral Dysfunction. Eastern Psychological
Association, Philadelphia.
Communication

27.
28.

29.
30.

31.
32.
33.

3h.
35.

SociOoPsychological Aspects of Diagnosis and Treatment:
Theoretical Implications (Symposium). Eastern
Psychological Association, Philadelphia.
Drug Induced Changes in Interview Patterns. Conference
on Psychodynamic, Psychoanalytic, and Sociologic
Aspects of the Neuroleptic (Tranquilizing) Drugs
in Psychiatry, Montreal.

Psychological Factors Affecting Individual Differences
in Behavioral Response to Convulsive Therapy.
American Psychiatric Association, San Francisco.
Social Factors in Selection of Therapy in a Voluntary
Mental Hospital. American Psychiatric Association,
San Francisco.
A Critique of "Pre-Conscious" Perception and the "Poetzl
Phenomenon". American Psychiatric Association,
San Francisco.
Prognostic Value of Rorschach Criteria in Clinical Response
to Convulsive Therapy. Electroshock Research
Association, San Francisco.
Effects of Anticholinergic Agent, Diethazine, on EEG and
Behavior: Significance for Theory of Convulsive
Therapy. Society of Biological Psychiatry, San
Francisco.
Role of EEG Frequency Shift in Behavioral Effects of
Drugs. Section of Neurology and Psychiatry, Queens
County Medical Society, New York.
Effect of Anticholinergic Compounds on Post Convulsive
EEG and Behavior. American EEG Society, Atlantic
City.

�shoPRESENTATIONS

1958

Prognostic Application of Psychological Techniques in
Convulsive Therapy. Eastern Psychiatric Research
Association, New York.
37. EEG and Behavioral Effects of Psychopharmacologic Agents.
Collegium Internationale Neuro-Psycho Pharmacologicum,
Rome; and Eastern Association of Electroencephalographers, New York.
Relationship between Seizure Threshold and Duration of
Seizures to EEG Change During Electroshock. Eastern
Association of Electroencephalographers, New York.
1959

Effects of Tofranil. International
Conference on Depression and Allied States, Montreal.
Sociopsychologic Factors Affecting Therapist-Patient
Relationships. American Academy of Psychoanalysis,
Philadelphia.
Effect of Induced Cerebral Dysfunction in Man and on
Tachistoscopic Perception of Embedded Color Figures.
Eastern Psychological Association, Atlantic City.
Behavioral Changes with Different Methods of Induced
Cerebral Dysfunction. Eastern Psychological
Association, Atlantic City.
h3. Sociopsychologic Aspects of Psychiatric Treatment.
Eastern Psychological Association, Atlantic City.
hh. Language Patterns as Measures of Behavioral and Neurophysiologic Change. American Psychiatric
Association, Philadelphia.
EEG

and Behavioral

�C.

Reports in preparation:

1.
2.
3.

Experimental Studies of Convulsive Therapy - a
monographic review.
EEG Patterns and Synaptic Events in Experimental
Hallucinogenic States.
Comparative Study of Indoklon and Electrically
Induced Convulsive Therapies.
Studies of the Sedation Threshold.
Effect of Induced Cerebral Trauma in Man on the
Tachistoscopic Perception of Embedded Colored

Figures.
Individual Differences in the Perception of the
Upright in Hospitalized Psychiatric Patients.
Social Attitude (California F Scale) and Convulsive
Therapy.

Sociopsychologic Factors in Drug Therapy.
Modification of Psychotherapeutic and Supervisory
Relationships by Altered Brain Function.

�’os.

Relation Between Altered Brain Function and Denial in Electroshock Therapy
Robert L. Kahn, Ph. D.
Max

Fink, M.D.

Edwin A.

Read
,

at the

Weinstein,

M.D.

Annual Meeting American Psychiatric Association, May 1955.

the Research Service of the Hillside Hospital, and the Department of
Neurology of the Mount Sinai Hospital, New York.
From

This investigation was supported in part by the Medical Research and Development Board, office of the Surgeon General, Department of the Army under
Contract No. DA-h9-OO7 MD-3763 and grant M-927 from the National Institute
of Mental Health of the National Institutes of Health, Public Health Service.

�Although many

theories concerning the

mode

of action of electroshock

and
psycholphysiological
among
the
relationships
been
have
offered,
therapy
(3,h,5,6)
studies
In
previous
understood
(1,2).
remain
poor v
ogical factors

certain
function,
that
was
suggested
of
brain
it
of patients with alterations
of
effects
the
to
therapeutic
related
of the observed patterns of behavior were
electroshock.

dis(3,6),
anosognosia
of
or
illness
denial
included
patterns
in
and
language,
(8)
changes
time
and
(7),
reduplication
orientation for place
that
indicated
was
It
(9).
paraphasia
misnaming
or
particularly nonaphasic
These

than
rather
of
illness
the
stress
to
these phenomena were fonns of adaptation
neural
of
milieu
the
In
judgment.
Specific defects in memonv, perception or
motivations
his
the
expresses
damage,
patient
brain
reorganization provided by
the
with
modes
of
interaction
changed
of
in new s,rmbolic patterns indicative
of
forms
insuch
denies
the
delusion
patient
In
anosoynosic
the
environment.
of
an
the
and
operation,
fact
blindness,
of
a
limb,
loss
capacity as hemiplegia,
as well as other problems in livinﬁ.

In disorientation for place, the way in

the
symbolic
as
serves
hospital
which the patieit
be
need
to
the
often
traumatic
situation,
representation of some aspect of the
the
locates
or
of
familiar
place
a
name
the
he
uses
well and go home. Thus,
misnames and mislocates the

the
outside
hospital.
a
confabulates
journey
his
to
or
close
hospital
academy"
skating
"roller
a
as
the
to
hospital
'When a paraplegic patient refers
names
Mount
the
(Mount
Cyanide,
Sinai)
hos
the
ital
or a paranoid patient calls
home

symbolize the patient's feelings in dramatic fashion.

In paraphasia, the ob-

a
to
personal
related
usually
are
patient
jects
the
Thus,
patient
and
of
hospitalization.
illness
that
problem, particularly
and
and
objects
the
of
places
body,
selects aspects of the environment, parts

which are misnamed by the

in
of
his
a
feelings
the
exnression
for
them
language
his
in
uses
n

interaction.

new mode

of

�.3.
could be brought out by the administration of amytal sodium ("positive amytal

test").

'With a

return of the complaints of pain these changes in behavior

were no longer apparent

either clinically or under amytal. This

sequence of

events were repeated during two Subsequent courses of electroshock. While this

report supported the hypothesis regarding the therapeutic action of electro-

test" in investigating the probdid not represent the usual condition for

shock and showed the usefulness of the "amytal
lem,

it

concerned only one case and

is given.
The theory is further tested in the present study in which a group of
potients receiving electroshock for mental illness were given repeated amytal
tests before, during and after the course of treatment. The purpose of the
study was to determine the relationship between the clinical response to the

which electroshock

treatment and changes in behavior produced by the drug.

theses tested were that those patients
more

likely to

show: (1) evidence

The

particular hypo-

improved with electroshock would be

who

of brain dysfunction

on

the amytal

test

and

(2) behavior patterns indicative of denial.
METHGD

series of amytal tests. In this test, the patient is asked a standard group of questions pertaining to orientation and the
patient

Each

awareness of

was given a

illness.

The drug

ution at a rate of .05 grams (1

is then administered intravenously in a
cc) per minute until nystagmus, slurred

drowsiness and errors in counting backward are noted.
now

repeated.

The

The same

5%

sol-

speech,

questions are

following changes, when persistent, are called "positive" and

are deemed indicative of cerebral dysfunction.

1. Complete denial of illness.

2. Denial of major aspects of illness, such as attributing entry into
hospital to a trivial or past illness.
3. Misnaming the hospital, either
euphemism as

"rest

home."

its

proper name, or in terms of a

�ah. Displacement of the location of the hospital, such as to another city.
5. Confabulated journeyt
6.

Reduplication of the hospital, as stating that he is in another hos~
pital of the same or similar name.

7. Disorientation for time of day with confusion of day and night.

misidentification of the examiner such as calling
or an "entertainer".

8._ Gross

him a "lawyer"

9. Disorientation for year.
The

patient

was given

his

first test prior

to treatment, and re-tested

at weekly intervals. All patients in the series had negative amytal tests prior
to the initiation of therapy. Treatments were administered three times a week,
so that the patients were generally tested after every third treatment.

A

test

after a treatment. Testing was continued after the
termination of therapy until the result had become negative.
of
and
records
standard
tests
memory and learnElectroencephalographic
ing ability were also given, but will not be considered in detail in this paper,

was always given two days

POPULATION

Twentyufour patients

at Hillside Hospital receiving electroshock with the

Reiter Electrostimulator were studied. There
authors.

The

patients

were taken on the

was no

basis of consecutive referrals, and

the determination of the necessity for treatment was
Some

patients

were

selection of cases by the
made by

the clinical

necessarily excluded because their treatment

staff.

was terminated

or interrupted before they were adequateLy studied. Another was omitted because he had manifestations of brain disease and a positive amytal

to electroconvulsive therapy.

thirtyvthree. Patients
treatments.

Some

The number

who showed

test prior

of treatments varied from nine to

clinical

improvement tended

to receive fewer

of this variability could also be ascribed to differences in

the inclination of the resident psychiatrists to use this form of treatment.

�~5One

patient decided for himself that

he had enough treatment and eloped.

gnostically, the patients consisted of

1h with depressive

schizophrenia and one manic reaction. There were 15
and the ages ranged from 2h

series,

to

68

reactions,

women and 9 men

9

Dia-

with

in the

with a median of h7.

of response to E.S.T.
Evaluation.Wa—
M~~
All the patients were observed for at least eight weeks after completion
of treatment.
on

Determination of the patient's response to electroshock was made

staff opinion, the

the basis of the resident psychiatrist‘s impression,

nurses' notes and the clinical evaluation of one of us (M.F.)

who

supervised the

treatments but was not aware of the amytaltest results. In this way the pat-

ients

were

classified into three groups.

gﬁwwyarkedlv Improved; The 11 cases

in this group

were regarded as show-

ing recovery or marked improvement. These patients no longer showed the
ptoms which brought them

symp

into the hospital; their doctors felt they were better;

and the nurses' notes confirmed such aspects as being

able to sleep without

medication, better appetite, and improved capacity to get along with the other

patients and participate in hospital activities.
B.

Moderatelv Improvegz_

The

six patients in this group

showed some

improvement but continued to manifest

indications of mental illness. These

patients typically

relief, i;§:, acute depressive features

showed symptomatic

might be gone, but the dramatic change so evident in the

apparent. Each patient continued to

show some

first

group was not

noticeable disturbance such as

obsessional thinking, paranoid ideas, or somatic preoccupation,
C. Minimally or Unimnroved. In this group were placed seven patients

in

whom

change was not

ient improvement.
somewhat improved.

clearly noticable or

Some showed

But

who showed

only equivocal or trans-

fluctuations in behavior, at times appearing

the change was not sustained, so that by the end of

�9-6-

much
did
before.
as
they
appeared
treatment, they

are aware of the difficulties in evaluating improvement. Others might
In
by
these
any
case,
of
in
patients.
change
estimates
the
have differed in
and
the
between
first
the
differences
using this threefold classification,
We

third groups will

be

distincto
OBSERVATIONS

l.

ﬂggjggL

Test Results

of
The
number
tests
given
amytal
Reactions.
of
A. Distribution
Positive -um-W
from
to
three
thirteen,
ranged
electroshock
of
the
course
each
during
to
patient
shown
the
data
Table
is
In
maintained.
I,
depending on how long treatment was
.

for

the number of

and
number
and
percent posthe
treatment
tests given during

The
improved
patients
markedly
each
in
the
group.
patients
itive for all
moderthe
with
unimproved
the
group,
showed many more positive reactions than

between these groups.

Every markedly improved

ately improved patients in
On
other
the
treatment.
reaction
during
ient had at least one positive amytal
cases
unimproved
of
the
and
five
hand, one of the moderately improved patients
the
of
incaach
A
the
results
of
comparison
showed
result.
a
positive
never
the
than
better
at
significant
groups, using chi-square, is statistically
level of confidence.
TABLE I

pat—_

1%

WWW

DISTRIBUTION OF POSITIVE ANITAL TESTS DURING TREATMENT

”

No. of

tests given

durinc treatment

Markedly improved

(ll)

Moderately improved (6)
Unimproved (7)

Number

positive

%

Positive

50

38

76%

39

15

38%

hS

6

13%

the
In
groups
of
Fig.
treatment.
each
l
stase
at
B. Positive reactions
who
had
positive
each
in
of
group
the
patients
percentage
for
are compared
»

�treatment.
of
each
stage
at
results
after
reactions
had
positive
Almost half the markedly improved patients
nine
to
seven
after
reactions
had
positive
and.all
treatments,
three
only
treatments.

In the unimproved cases, on

of
number
positive
the
hand,
other
the

of
the
course
during
increase
consistent
no
was
and
there
small
reactions was
other
the
between
to
tends
fall
improved
group
moderately
the
Again,
treatment.
two.
Although some

than
more
received
patients

15

treatments the data is not

small
too
became
each
number
in
group
the
because
presented beyond this point
than
more
received
unimproved
patients
of
the
Four
of
comparison.
for purposes
mode
One
the
of
with consistently negative amytal test results.
20

treatments

occasionally
an
with
only
treatments
30
received
over
improved
patients
erately

positive reaction.
There were

variations in the per-

reactions.
positive
a .e-u'
two
consecleast
at
Using
week.
week
to
from
sistence of positive reactions
improved,
markedly
the
of
nine
of
persistence,
criterion
the
as
utive positives
showed
perunimproved
group
the
of
one
and
only
two of the moderately improved
C. Duration_3§
“-5

one
but
patients
treatment
all
of
termination
the
,After
sistent positives.
The
reconvulsion..
the
last
after
nine
days
had negative amytal reactions

treatment.
week
after
second
the
by
test
negative
a
developed
maining patient
improved
group
markedly
the
in
D. Factor of awe. Since the patients
conceivis
reactions,
it
from
depressive
suffering
be
older
tended to
persons
to
age
be
scley
related
might
results
test
able that the difference in amytal
assum—
the
is
this
Underlying
improvement.
clinical
to
coincidentally
and only
funbrain
altered
show
of
signs
to
more
s
likely
i
older
the
person
that
ption
|
shown.
each
is
2
for
group
mean
the
Table
age
In
electroshock.
when
given
ction

�-8.
TABLE 2

RELATIONSHIP OF CLIEICAL_IMPROVEMENT TO AGE

Than Age

Markedly Improved

(ll)

h7.6h

0'

Moderately Improved (6)

50.00

Unimproved (7)

35-29

It is apparent that the first
patients.

two groups were

older than the unimproved

Yet, while the mean age of the moderately improved cases

higher than the markedly improved group, theSe patients

still

show

is slightly
significantly

fewer positive reactions.

In Table

3

the

number of

positive reactions during treatment is

shown

of
he
over
to
age.
limited
years
patients
the
analysis is
for
In this table the relationship of positive reactions in the different groups
remains unchanged from that when the groups are considered as a whole.
each group when

TABLE 3
OVER hO
PATIENTS
IN
AMITAL'TESTS
DISTRIBUTION OF.EQ§EE;VE
a...

No. of

tests given

durine treatment_

Number

positive

%

fpsitizg

Markcdly Improved (1m)

h6

35

76

Mederately Improved (5)

3h

15

hS

Unimproved (3)

17

O

O

2. Other Aspects of Behavior.
were
there
and
disorientation
of
denial
illness
explicit
and
the
of
drug
influence
the
under
both
occurred
changes in behavior that
fashion
progressive
treatment
is
of
significantly
the
course
clinically during

Apart from

in those patients

who

improved.

These aspects may be divided

into verbal and

non-verbal communication.
A.
can:

Channes

in Verbal Language.

These consisted of

denial expressed in

�-99..

evasion and in the use of a syntactical pattern involving the third and second
When

person.

asked about

their

symptoms

patients

gave such answers as

"it's

hard to say" or “I forgot" or "I don't know; I‘ve been waiting for the doctors

tell
as "it's

to

me."

The change

what they

in syntactical person is illustrated by such remarks

call a depression," "I‘m afraid

answering the question "what

trouble."

Sometimes

In patients

patients

is

talk of a relative

would

there

One

to the start of treatment what

will get hurt" or

your main trouble" with "what

who improved

in the non-drug interviews.

somebody

was a

who was

is

3223 main

sick.

notable development of such patterns

patient, for example, whenzisked prior
his main trouble, said "I'm depressed."

such

was

After two treatments he answered the question with "I don't get along well
with

my

mother-in-law." After five treatments he said "I don't get what you

he
said
know."
After
ten
I
that‘s
"I
all
sick;
get
after eight,
what
11
"in
and
said
way
after
don't
my
see
wife,"
"right now, it‘s that I
do you mean" and "I don't know how to explain it." At the termination of
given
home"
an
followed
by
"I
to
want
main
get
was
as
trouble
his
tr atment,

mean," and

account of

how "good"

his wife was.

of
these
group,
increased
the
use
the
other
hand,
on
In the unimproved
language patterns did not occur. They were not present in some, minimally or

inconsistently noted in others.

In

some

of the unimproved patients there was

than
the
of
drug
the
under
effects
of
these
language
patterns
actually less use

there had been in the pre-amytal interview.
..B.

clinical
in

Changes

in

Non-Verbal Behavior.

and drug interviews most frequently

the moderately improved and

improved.

Euphoric reactions occurred both in

in the markedly improved, less

least in the group

which were considered un-

In the unimproved patient classed as manic, euphoric behavior was

present in his clinical behavior and was not changed by amytal.

�-10—‘

of
of
four
interviews
the
amytal
in
apneared
Changes in sexual behavior
other
the
of
each
in
one
in
only
but
patient
the markedly improved patients
makthe
examiner,
caress
hug
to
form
of
or
This took the
trying

categories.

ing remarks with sexual content or engaging in masturbatory

ient in the

unimproved group showed

activity.

this behavior both during are-drug

A

pat-

inter—

views and under the influence of amytal.

Withdrawal or "selective inattention" was shown by nine of the eleven
the
amytal
of
the
phase
drug
during
markedly improved patients particularly

about
the
questions
answer
to
of
failure
consisted
interview. This behavior
fashion.
and
cryptic
in
dysarthric
responding
and
hospitalization or
illness

the
other
each
of
groups.
in
once
occurred
only
the
drug
under
This reaction
who
appeared
the
category
unimproved
two
in
of
that
patients
It was interest
withdrawn before the

test

became more

responsive under the influence of the

drug.

ravage:

there
is
that
indicate
these
in
patients
tests
the
of
anwial
results
damage
or
brain
of
and
the
production
improvement
between
clinical
a relation
method
of
determined
this
by
particular
an altered state of brain function as
The

examination.

In patients

who improve,

the amytal test becomes consistently

treatment.
of
the
course
in
early
positive

In moderately improved or unimproved

does
not
increase
and
frequency
their
reactions
patients there are fewer positive
such
function
brain
methods
of
evaluating
with more treatments. With other
the
in
showed
abnormalities
All
not
patients
present.
close correlation was

found
frequently
as
was
and
*
learning
impaired
record
electroencephalographic
damage
The
brain
of
effects
who
did
not.
those
who
improved as in
in patients

are not unitary and

different

methods of study show varying

results.

more
analyzed_in
being
are
these
data
in
patients
a The electroencephalographic
the
show
that
The
findings
preliminary
be reported elsewhere.
detail, and.will
amytal
the
to
comparable
EEG
improvement,
to
related
abnormality is
Wegree of

test findings.

�.11 -

in
to
changes
function
brain
of
altered
In relating the various aspects
behavior after electroshock therapy

defects in the formation of
In the

of language.

first

symbol

it

has been helpful to distinguish between

patterns

and defects

in the adaptive uses

category one may include such

clinical

phenomena as

loss.
of
memory
and
certain
types
acalculia
aphasia, apraxia, finger agnosia,
cannot
select
he
but
wants
he
"know"
to
what
say
In aphasia, the patient may
and
movements
and
sounds
of
the appropriate elements from the entire category
of
elements
excannot
select
the
defects
With
patient
memory
integrate them.
them
temporal
pata
in
and
units
arrange
significant
perience, class
solving
of
problem
manifested
in
tests
commonly
also
tern. Such defects are
fre—
Such
are
patients
scale.
and in certain subtests of the Wechsler-Bellevue

them into

quently concerned with their

and
of
marked
anxiety
degrees
and
exhibit
defects

frustration.
Adaptive changes in

language, on

the other hand, relate to interaction

They
behavior.
of
motivational
aspects
the
with the environment and concern
The
besame
and
disorientation.
denial
of
are exemplified in the phenomena
and
other
in
defect
a
conditions
as
havioral element may appear under certain

cases as a

part of

an

be
may
example,
for
form of adaptation. Left~ri9ht disorientation,
impaired
and
is
of
right
which
the
left
concept
aphasic defect in

a
paralyzed
able
to
identify
seem
not
may
Other
however,
patients,
or lost.
or
and
ear
left
arm
their
(non-paralyzed)
Show
right
their
left arm, but can
relate
not
does
and
as
long
as
it
of
right
knowledge
left
similarly indicate a

the
not
in
electroshock
of
prois
action
therapeutic
to their illness.
milieu
neural
the
in
providing
rather
but
formation
duction of defects in symbol
The

in

which

altered forms of adaptation

may be

maintained.

outcome of

electroshock treatment by the

psychiatrists predict the
Other
point
treatments.
the
initial
amount of "confusion" that occurs after
The
test
amytal
Leprovement.
to
not
related
was
"confusion"
where
to cases
Many

�-12..
should be useful as a prognostic guide by defining the nature of these changes.

In

cases "confusion"

some

patients the amytal test

mainly a matter of memory defect and in these

may be

negative. On the other hand, some patients imp
such
Clinical
In
of
evidenae
few
without
treatments
"confusion."
a
after
prove
instances the amytal procedure may show an alteration in brain function. In
may be

this study almost half of the markedly

improved

patients had positive reactions

In another case, treated privately by one of us (E.A.W.),

within three treatments.

after only two
result prior to treat-

marked improvement of a severe depressed condition was noted

convulsions.

Yet

this patient,

who had

a negative amytal

ment, showed a markedly positive reaction one day
These

results

do

not

than patients

brain

damage

ectly

measure brain damage, but

rem

that

mean
who do

improved

not improve.

rather

after the second treatment.

patients

have a

The amytal

one deduces

test

greater degree of
does not

dir-

the presence of braincianage

the nature of the adaptive changes in communication. Thus patients with

brain

damaje who do not show such changes are considered to show a negative

re-

im~
methods
of
behavioral
demonstrating
other
that
sult. It is for this reason
paired brain function may not distinguish between improved and unimproved patpositive
do
and
not
others
amytal
a
Why
some
develop
test,
patients
ients.

despite

many more

convulsions

is unclear, but

factors and to the patient's habitual

mode

may be

related to personality

of adaptation to stress.

It is

be
so
function
brain
of
altered
state
treated
a
that
nevertheless,
necessary,
that these forms of adaptation or denial can be maintained. It is for these
which
electroshock
methods
of
administering
believed
that
reasons that it is
be
not
seizures
will
generally
unilateral
as
function
brain
minimally
alter

efficacious. Also

it

affords

some

explanation as to

why

electroshock often

has a beneficial short term effect while evaluation of long ternleffects

little

difference between treated and untreated cases.

show

�-13In considering what constitutes "improvement," it is likely that such
evaluations are dependent in considerable degree on the types of verbal and

patient denies that
imp
he
rated
and
is
and
uncomplaining,
affable
he has any problems,
appears
he
has
developed
he
that
has
or
does
mean
not
acquired
insight
that
It
proved.
non-verbal adaptation that the patient uses.

a more

realistic understanding

Thus, when a

of his interpersonal relations.

exemplified by the patient previously cited

who

said he

This

is well

was "depressed"

in

third person when asked about his illness. While his behavior is rated as improved, actual analysis of his language shows that he is using different forms of symbolic

the pre-treatment interview, but

later

used evasion and use of the

adaptation.
Recent
mechanisms of

studies have supported the findings concerning the development of
denial in the improved patients. Carter (12) confirmed Janis’

(13) findings of consistent evidence of circumscribed amnesias in patients
lowing electroshock.

He

that general memory impairment did not occur,
"selectivity" in forgetting of unpleasant material

concluded

but rather, that there was a
from the

fol-

patient's past life.

Komgold (11;) likewise reports

selective and

"mechanisms
of
observes
(15)
Teicher
similarly,
sensitized
forgetting.
highly

repression" for "emotional" stimuli after electroshock.
Another aSpect of the difference between the improved and unimproved
groups which may bear a

relation to the therapeutic

proved patients there were more changes in

all

not only in verbal patterns. Thus, a patient

mechanism was

that in in,

types of symbolic adaptation,
who

appeared withdrawn both in

the pre-drug and drug interviews had a poorer prognosis than the patient
became withdrawn only under the
who showed

who

effects of the drug, Similarly, the patient

altered sexual behavior under the effects of the drug had exhibited

this behavior during the prenamytal questioning as well, and did not improve
with treatment, while the four patients manifesting sexual behavior only under

�ﬁll!"

the effects of the drug, did improve.

The importance of

the change in symbolic

pattern is also illustrated by the fact that the unimproved manic patient showed
no changes in this aspect of his behavior during the amytal test. It is thus
likely that the facility of changing symbolic patterns in a situation of added

stress is

an important one

in determining response in all somatic therapies.

�SUMMARY AND CONCLUSIONS

ment

treatelectroshock
for
consecutively
referred
(l) Twenty-four patients
the
during
intervals
and
at
regular
during
were given amytal tests before,

courSe of treatment.

(2)

There proved to be a close relationship between the shorteterm

tests.

of
the
anwtal
results
treatment
and.the
to
sponse

patients

showed

early, persistent

re-

The much improved

positive reactions during
patients showed no positive reactions or

and increasingly

the course of treatment. Unimproved

intermediate group

who showed

infrequently and inconsistently.
unimproved
the
than
reactions
showed
more
positive
moderate clinical improvement
of
reincidence
positive
the
much
in
improved
the
of
short
group but fell far
An

showed them

actions.
(3) Changes in

behavior
forms
of
non-verbal
and
language

were most consistent and pronounced

related to denial

in the improved group, even in interviews

not employing drugs.
(h)

The

improvement
clinical
that
the
hypothesis
support
observations

function
in
of
altered.brain
milieu
of
a
in electroshockzmequires the creation
mainbe
may
of
those
denial,
Which new patterns of adaptation, particularly

tained.

�mmmmggzg

1.) Gordon,

Fifty

H. L. :

2.) Kalinowsky, L.

Shock Therapy Theories, Mil. Surg. $92: 397, l9h8.

B. and Hoch, P. H.

Shock Treatment, PBychosurgery and

:

Other Somatic Treatment in Psychiatry, (2nd ed.)

3.) ’Neinstein E.
&amp;

1..)

Psggrchiat.

A. and Kahn, R. L.
_6}_1_:

Syndrome

:

Ybrk, 1952.

of Anosocnosia, Arch. Neurol.

772-791, 1950.

'E‘Jcinstein, E. A., Kann, R. L., Sugannan, L. A., and Linn, L.
Use

of Amobarbital Sodium in Organic Brain Disease,

889-8911.,

Am.

:

Diagnostic

J. Psych., llg:

1953.

S.) weinstein, E. A., Kahn,

L., and Malitz, S.

R.

Its

the "Amytal Test" for Brain Disease:
A. M. A. Arch of

6)

New

weinstein, E.

Serial Administration of

:

Diagnostic and Prognostic Value,

“enrol. and Psychiatu 11: 217-226,

A. and Kahn, R. L. :

1951..

Denial of Illness: Symbolic and Physiol-

ogical Aspects, Springfield, 111., Charles C. Thomas, in press.
7.) Weinstein, E.

A. and Kahn, R. L.

Brain Disease, J. Neuropath.

8.)

&amp;

:

Patterns of Disorientation in Organic

Clin. Neurol.

l;

21h-226, 1951.

and
R.
A.
L.
E.
L.
A.:
Kahn,
Sugarman,
weinstein,
,
A. M. A. Arch. Neurol.

uplication,

9,) 'weinstein, E.
0rg-tanic Brain

Psychiat.

M. A.

Arch. Neurol.

10.) weinstein, E. A., Linn, L. and Kahn, R. L.:

Its Relation to the

Therapy:

{31:

808-8111, 1952.

L.: Non-aphasic Misnaming (paraphasia) in

A. and Kahn R.

Disease, A.

&amp;

Phenomenon of Red-

&amp;

Psychiat.,‘éz: 72-79,l952.

Psychosis during ﬁlectroshock

Theory of Shock Therapy,

Am.

J. Psych.,

$925

22-26, 1952.

11.)

Mcinstein, E. A. and Kahn,
A. M. A. Arch. Neurol.

ness,
12.) Carter J. T.:

Type

convulsive Therapy,

13.)

Janis,

I.

L.

:

R.
&amp;

L.: Personality Factors in Denial of
Psychiat.

Ill-

Q2; 355-367, 1953.

of Personal Life Hemories Forgotten Following ElectroAm.

Psychologist §; 330, 1953.

Psychologic Effects of Electric convulsive Treatments

Post-treatment Amnesias.) J. Nerv.

&amp;

Ment. Dis.

ill;

359, 1950.

(I.

�REFERENCESz

1h.) Korngold, M.:

An

Shock Treatment,

15.) Teicher, A.:

Investigation of

Am.

The

continued

Psychologist

Q;

Some

Psychological Effects of Electric

381-382, 1953.

Effect of Electroconvulsive Therapy

actions of Schizophrenic patients,

Am.

on

the Visual Re-

Psychologist, g, hhS, 1953.

�]
ONS

I
REACT.

90

._”

much Improved (11)

'*~

Mod. Improved

‘

80

” Unimproved

(6)

///

(7)

/

t// ‘\\\\\\_

//////////’
“~.

*

AMYTAL

POSITIVE

3o
PERCENTAGE

20

/

/
/
(“”

\

"
,
,/
.

" /

x,”
I
f

10
O

'

h-é

,__.._..7..___.-_....-_,_....__.-..;}..-.__
7-9

10.12

13.15

NUMBER OF TREATMENTS

occurring
reactions
test
amytal
of
positive
Fig. I.-—- Percentage
treatment.
of
stages
different
each
at
in
group

�{fw g;

,{1/,m»‘-‘

JUN

26

”12!. :c.

.M

Altered Brain Function Following Electroshock
H—927

Progress Report - February

1

1958 - September 1 1959

Summary:

In the past eighteen months various studies of the

convulsive therapy process were completed, a program for the

investigation of psychopharnacologic agents consistent with the
general hypothesis concerning the node of action of physiodynamic

therapies

was developed.

The

physiologic effects of nany

interrelationship of the neuro-

new compounds

with the psychodynanic,

perceptual, personality and sociologic aspects of patients'
behavior provided the framework for tnse investigations.
following areas of study were explained:

l)

of psychotherapy with physiodynanic therapy;

The

the interrelation
2)

the elucidation

of the synaptic chemical events which are the basis of the

convulsive therapy process by the acute administration or
experimental anticholinergic compounds at various stages of
convulsive therapy;
and behavioral

3)

studies of the acute and clinical

effects of

a

EEG

variety of psychopharnacologic agents;

h) the use or language indices, such as syntactic and dyadic~

1959

�-2-

diversification analyses, as measures of behavioral
neurophysiologic changes with drugs;

and

5) a comparative study

of indoklon and electrically-induced convulsions in psychiatric

therapy;

duration
of
6) sociopsychologic aspects related to

hospitalization, discharge ratings

and diagnosis in a voluntary

mental hospital; 7) the relation of social attitude to the

effects of convulsive therapy;

8) aspects of the

therapist-

patient relationship affecting aha: choice of therapy;

9)

studies of individual differences in the selection of, and
behavioral change with, convulsive therapy by perceptual aethods.
These

studies have supported and expanded the neuro~

physiologic-adapative view or convulsive therapy, and demonstrated

that such

a hypothesis has

applicability to our understanding of

the node of action of psychepharnacologic agents.

�Progress Report:
A;

Psychotherapy and Physiodyganic Therapy.

Previous observations have shown that two types of

patients are referred for electroshock in this hospital.

largest

number are

patients in the older

limited education and are foreign born,

age groups who have
They tend

to

introspective persons, stereotyped in their thinking
language and verbally unconmunicative.
symptoms
The

The

be non-

and

Their predominant

are depression, agitation, withdrawal and sonatisaticn.

second, and smaller, group of patients are younger, native-

born, better educated, and verbally ccnnunicativo with a

capacity for intropection. They characteristically exhibit
thinking disorders and overactive behavior states, with sonatisation
and depression occurring
An

to a lesser extent.

oratory
explanatory study

was

undertaken of four patients, two

for each group described above, for the purpose of determining
1) reasons for

referral for convulsive therapy,

2) whether

the differences in patients required different attitudes in

psychotherapeutic nanagenent with electroshock, and 3) the

�-1...

relation of the psychotherapsutic approach to the patient'e

clinical response to electroshock.

It

was found

that all of the patients studied

were

electroshock because of a failure of connunication
referred for
in the psychotherapeutic relationship. In
a

reflection of the limited verbal

and

cases this was

two

introspective capacity

social
factors. In the
of the patientdue to educational and
other two cases, however,-the inpaired communication

primarily

due

wee

to unmanageable acting out.

Following treatnent, the older, less educated patients
were able to

naintain this improvement with

a

reassuring

and
to
nininication
the
tendencies
denial
toohniqne,-supporting

during
developed
electroshock.

electroshock eeened to

make

In the

better educated patients,

the patients nore’anenable to an

psychotherapy.
torn
of
interpretive

It

or
psychotherapy
was concluded that the relationship

to electroshock varies with the particular_type of communication

pattern

and adaptation shown by the individual

patient. This

�-5.
the
and
been
Journal
written up
published in
material has
or Hillside Hospital, 7: 17-25, 1958.
B;

Biochemical Aspects of the Convulsive Iherapz Process.
The

significance or high voltage

the convulsive therapy process (Roth
and Kahn, 1957) and the

EEG

22.;l!

delta activity in
1951, 1957; Pink

report that this delta activity

was

'blocked hy the adninistration of ahtioholinergic'compounds;

atropine and scopolanine

(Ulett and Johnson, 1957) provided

the basis for these studies.

As

there were attendant unpleasant,

'systenio effects with the administration of these agents,

.reports describing diethasine

as an anticholinergio'conpound'

(Jenknerwith potent neurologic but minimal systemic effects
l956)
Lechner,
studies
19553
to.undertake
led
Lechner,
us
and

sinilar to those of Ulett
(Fink, 1958).

and Johnson neing this'conpound

These observations with diethasine led to the

agents.
of
other
antioholinergic
experimental
investigation

Clinical and electroencephalographic responses to the
intravenous administration of various anticholinergic agents

�-6in psychiatric patients at various stages of convulsive therapy
were

studied. These observations were related to hypothesis

covering the node of action of convulsive therapy and of

hallucinogens.
The

subjects were ninety psychiatric patients referred

for convulsive therapy, ranging in age tron

Ivariety of diagnoses.
since

some

The

total or

18

to 67, with a

107

observations were made,

subjects were studied with

more than one compound.

A

drugs were administered at various stages of the

treatment process.

The

observations were

laboratory using a standard

electrodes. In each
intravenously at

a

trial,

8

made

in the

EEG

channel instrument and needle

the compound under star was adninistered

until

set rate per minute with clinical behavior

or electrographic changes were observed.
The compounds

studied have been diethasine, Win-2299,

benactyaine, JB~318, JB~336, and atropine.

Each

is

a

potent

anticholinergic agent in vitro.

It

was observed

that diethasine,

Win-2299, benactysine,

�-7;
JB-318 or JB-336 administration

therapy were associated with

at various stages-of convulsive
a) desynchronisatien of

rhythms with a blocking of post-convulsive
b)

EEG

delta activity;

alerting, excitatory behavioral response with illusory, de-

lusional

and

hallucinhtory ideation, and c)_systenic effects

‘drynessof muscular veakness, degrees of the mouth, dry skin and tachycardia.
.

The

electrographic. behavioral and systemic effects were concurrent.
These observations are regarded as

consistent with the.

suggestion that the physiologic basis of convulsive therapy

lies in

an increase in

central nervous system cholinergic

activity.
Observations that

LSD,

amphetamine, nescaline and

diphenhydranine- synpathoninetic and antihistaminic agents

also induce

EEG

~

convulsive
of
desynchronisation, blocking
post

delta activity and clinical excitatory activity support the
suggestion that both the behavioral and electrographic patterns
are based on alteration in synaptic activity.

Increased

synaptic activity (cholinergio, synpatholytic effects) is

�-8.
associated with

336

hypersynchronisation, and clinical eedation

and euphoria; while decreased synaptic

synpathominetxic) is associated with

clinical excitatery

activity (anticholinergic,

EEG

and hallucinogenic

desynchronisation and

states.

Discrepant observations with the anticholinergic agents,

atropine, are considered to

be

related to significant differences

in dongs and structural chemistry.
This material was presented
EEG

at

a meeting of

Society in Atlantic City, June 1h, 1958.

the American

�-90.

Acute and Chronic

EEG

and Behavioral

Psychophersscologic Agents.

Iffects of

According to our neurophysiologic~adaptive view of the

clinical
the
convulsive therapy process,
efficacy of repeated
induced convulsions

is dependent

upon the induction of a

persistent alteration in central function, providing

a

nilieu

for changes in the subject's interaction with the exaniner. In
our studies the best index of neurophysiologic change has been

those aspects of cerebral function reflected by delta activity
in the electroencephalogram (Pink and Kahn, 1957).
The

efficacy of newer psychopharnaceuticals in altering

psychotic behavior patterns has led to the suggestion of a

similar hypothesis for the node of action of these agents, and
to studies of the relationship and specificity of altered

behavioral patterns to neurophysiologic change as reflected in
electroencephalography.
Of

the psychopharnaceuticals tested in acute experiments

an

in increase in synchrony with or without

activity has

an

increase in slow

been observed for chlorpronazine, pronazine and

triflupronasine.

Behaviorslly, these drugs were associated

wave

�-10with

a) increasing sedation, drowsiness, denial and eqhoria;

b) decreasing

agitation, panic, excitement

hallucinatory activity;
of synptons.

and

and delusional and

c) minimization and displacement

Barbituratee regularly induced an increase in

fast activity with

an increase in synchrony, with the

associated

behavioral changes of sedation, euphoria, denial and minimization.
Amphetamine and methamphetamine

increased fast activity without

increased synchrony; behaviorally they resulted in behavioral

alerting, hypcnania, excitement

activity.

and increased motor

Decrease in voltage and per cent time of slow wave

subjects with pcst~convulsive delta activity

activity in

was seen with

Lsnazs, benactysine, Win~2299, JB-BlB, JB-336 and diethasine.
Of

these drugs, benactysine produced increased alerting, excitenent,

tension and panic; the other drugs also produced illusory sensations
and

hallucinatory, delusional
The

and paranoid

ideation.

electrographic patterns were consistenthﬁltered

concurrently with behavioral changes both in the acute and
chronic administration studies.

Tranquilization, euphoria,

�.11sedation and minimisation of symptoms were conversely associated
with increased

EEG

the delta range.
and

hallucinations

synchronisation and shift of frequencies to

Agitation, tension, panic, excitement, illusions
were

associated with desynchronisation of

frequencies.
Similar patterns were demonstrated in subjects with prior

delta activity. Agents that tended to synchronize frequencies,
as chlorpronasine and

delta activity

barbiturates,

and enhanced

augmented the per cent

clinical pattern; agents that

chronised frequencies, as diethasine,
minimised the

LSD-25 and

tine
desyno

benactysine,

clinical effects typically ascribed to repeated.

convulsions.
Following these preliminary observations more intensive

undertaken.
was
of
an
(Totranil),
agent, inipranine
investigation
In

28

can3:§::::
acute experiments,
patients referred for physio-

dynamic

therapies

were

stages of treatment.

tested in the

EEG

laboratory at various

Tofranil solution (10 ng/cc)

was

adninistered

intravenously at a set rate(l'cc/h0 sec) until electroencephalographic

�total of

or behavioral changes became prominent, for a
mg

(.05«2.5 ng/kg).

hO-125

Behavioral observation and electrographic

recording continued for one to three hours.

A

second group of

ve, withdrawn
16 patients nanifesting depressienl or retarded bdnvior and
were

whp

referred for pharmacotherapy, received daily oral Torranil

of 75-250

mg

for four

weeks or

longer.

In the acute studies there was

initial restlessness,

associated with dissiness, dry mouth, 'faintness," nausea, and
on

tour occasions, vomiting.

These symptoms

10-20 minutes, and were accompanied by

lassitude, heaviness

of the extremities and eventual drowsiness.
unchanged or slowed.

persisted for

Heart rate was

Subsequently, subjects were relaxed,

quiet and disinclined to activity, even

when

returned to their

ward.
The

electrographic pattern accompanying these behavioral

changes were

initiated

the injection.

halved.
such

In {our

By

by a gradual decrease in voltages during

minutes,
the per cent tine alpha had been
ten

patients with noderateonnouniiof beta activity,

activity increased in voltage

and per cent time.

By

twenty

�-13minutes, in association with behavioral lassitude, low voltage
6

to

50

nicrovolts) randon theta frequencies (5-7 cps) appeared.

In six records with poet-convulsive delta
a marked decrease

activity.
two

in voltage and per cent time of slow

patterns persisted for

These electrographic

was

wave
5

to

hours.

variability in the

There was considerable individual

acute
of

activity, there

EEG

response. In patients

totranil,

but three.

who

received 100

mg

or more

angptehavioral changes were observed in all
In six patients, dosage of Tofranil less than 50
EEG

associatedéwith
were
either

EEG

mg

or behavioral changes.

In the chronic Tofranil studies behavioral changes

generally appeared during-the second, and were maximal during
the third, week of treatment.

The most

adaptation was euphoric denial which
They conplained

or displaced

prominent behaioral

noted in eight patients.

was

less of somatic synptois,

their illness

on

inquiry.

It

and

ed

ed

denial. mininisetien

became

increasingly

difficult to discuss significant lire relationships with then.

�'

~1h-

in three patients sonatiaation and restlessness increased and
depressive affect persisted.

In two of these, restlessness,

insomnia and vomiting led to cessation of therapy.
symptoms were noted

change in

in five patients after four weeks of therapy.

Electrographic studies
minimal changes.

No

on

chronic administration shoved

Voltages became lower and record modulation

poorer. Well defined fast activity became more prominent, and

in four subjects, low voltage theta (5-7 cps) activity

noted.

was

Details of these studies were presented at the Collegiun

Internationale Neuro«Psychopharmacologicum,

at the Conference

1958, and

Rone, September 12,

on Depression and

Allied States,

Montreal, March l9~2l, 1959.
D.

Patterns as Measures of Behavioral and

Language

Neurophsziolegic Change with Drugs.

In previous studies of the convulsive therapy process,
was demonstrated

analysis

(

)

that

two language measures,

and dyadic

syntactic content

diversification in interviews

(

)

provided objective indices of behavioral change, and were

related to the degree of altered brain function. In

a

further

it‘

�-15-

test

of language measures as indicea of behavioral and

neurophysiologic change, they were next applied to recordings
or interviews on acute administration of various psychopharnacologic

agents.
At the

present time

72

interviews with patients at

various stages of drug therapy have been analysed, using the
following agents:

anobarbital, benactysine, chibrpronazine,

diethasine, lysergic~acid diethylanide, and Vin-2299.
Following a routine electrographic recording, an

psychiatric

unstructured physiologic interview, with slow periods of

structured inquiry,

was

tape recorded. With

EEG

running, an

intaavenous injection was then given at a slow rate.

specific electrographic or clinical changes
interview was repeated.

When

were induced, the

Recording periods of

EEG

and verbal

behavior were alternated for the duration of the observation

period.
The EEG was

shirts in
(delta

measureg'tor changes in synchronisation,

dominant frequencies, and per cent

and beta

frequencies.

tins of

slow waves

�-16The

rthe

tape recordings were transcribed and measured for

diversification of consecutive

25 word

speech and for syntactical changes.‘

samples of dyadic

In the dyadid analysis,

participants
both
of
behavior
verbal
the pooled
divided into

total

i;g.,

the ratio of the number of different

number of words.
.

.

The

transcribed,

samples, and for each sample a diversification

25 word

score was calculated,
words to the

was

syntactic language

.
analysis

were based on response

to standardised questions using the nothod previously described
(

), scoring such changes as syntactical use of person,

alteration in tense, evasion, qualification, displacement or
verbal denial or symptoms, use of stereotyped expression or

clichzs, cryptic response,

and withdrawal or

silence.

Consistent changes were observed in both the dyadic

diversification

and

syntactic language measures in subjects

classified according to the neurophpiologic

and behavioral

effects of the drugs applied.
Anobarbital and chlorpronasinc are neurophysiologic
synchronising agents; anobmrbital regularly induced high voltage

�-17.
well synchronised

administration

fast activity, at

was followed by

20-2h cps, while chlorpronasine

increased synchronisiation of the

record and a shirt to ﬂower frequencies including occasional

EEG

slow wave

burst activity.

Behaviorally these drugs are associated

with sedation and tranquilisetion,

there

was an

On

the language measures

increase in stereotypy and repetitiveness associated

with increasing use or cliches, alterations in tense, displacement
and evasion.

Diethasine, benactysine,

LSD~25 and Win-2299

of the neurophysiologic deaynchronising.compounds.

characteristically induce decreased voltage
of alpha

activity

and increased

irregular

are examples
These drugs

and per cent

low voltage

tine

fast activity.

Behaviorally they are associated with hallucinatory, excitatory
or

illusory activity.

On

the language neasures they induced

'

decreasing repditiveness, wider diversity o: words, lesevariability
of

diversification scores,

and decreased use or

cliches and

alterations in tense.
neasures
Further exploration of language
are suggested
as a

rational basis for the understanding or the psychologic

�-13-

effects of the

new

therepies.

Details of these studies have been presented at the
Conference on Paychodynenic, Psychoanalytic and Sociologic

Aspects of the Neuroleptic Drugs in Psychiatry, Montreal, April
11—13, 1958, end

Aeeocietion,
American
the
Psychiatric
et

Philadelphia, April 27, 1959.
E.

Coupereble study or Indoklon and Electrica11y~
Induced Convaleiona in Pczchietric Therepz.

A

In our investigation or the-node of action of convulsive

therapy

we

have previouslymnnducted a convulsive-subconvnlsive

control study.

This study demonstrated

that

e

significant

behavioral change occurred almost exclusively in patients

receiving grand nel electroconvulsive therapy.

The

present

report in an assessment of the relative neurophysiological
behavioral and clinical effects of

two

different

methods of

and
convulsions
current)
(alternating
electrical
inducing

inhalent (indcklon).

�Twenty—five consecutive

patients referred for convulsive

therapywere studied. They were randomly divided into two groups,
13

patients receiving grand nal therapy induced

by the standard

while
convulsions were
Medcratt alternating current instrument,
induced in the renaining 12 by the inhalation of hexafluorodiethyl-

ether (indoklon). In both groups treatment
time a week for a
on the

total of

10

to

2h

wee

administered three

applications, determined

basis of clinical criteria by the supervising psychiatrist.
All patients were tested one to two days prior to the

first

treatment, following 10-12 treatnents, and

following the
of

lest treainent.

The

two weeks

tests given included

intellectual functioning (rive subtests

measures

'

from the Wechsler-

perception
(figure—ground
Bellevue Intelligence Scale),

figures,
the perception
discrimination using embedded.geonetric
of peeuoisochronatic color plates

at high speeds of tachistoscopic

exposure, and the Street incomplete figures

test),

and

social

attitude (the Levincon revision of the California I Scale).
An EEG was

given during each of the testing periods.

�-2066
from
continuum
slow
wave
cent
a
tine
activity
the per

second sanple was used as the index of neurophysiologic change.

results failed to

The

test differences

show any

between the electroshock and indcklon groups

at each of the three test periods.
showed

significant intergroup

Intragroup analysis, however,

that during treatment both groups

on

the intellectual and peripheral

on

the

F

scale.

By two weeks

tests,

made

increased errors

and had high scores

after the termination of treatment

both groups returned to near pretreatnent levels for most
Both groups were comparable

slow wave

activity in the

mean

EEG

after

tests.

for the degree of induced
10-12

treatnents.

The

s

user per cent tine delta for the indoklon group

was 51%, and

for the_electroshock group h7.5%. Within each group individual
the
of
behavioral
were
to
related
degree
change
in
differences

physiologic change, those with the highest per cent tine delta
showing the

greatest behavioral change. Bath

between change in

test

activity with treatment

and

correlation

performance and degree of slow wave
were

positive for all procedures, except

the comprehension subtest of the Wechsler-Bellevue)and reached
a

level of statistical significance for Digit

Span (e .61, p

&lt;-.Ol),

�p(

object Assembly (+.h6,

.05),

tachistoscopic perception (+.67,
embedded

figures (*.h3,

p

4&lt;

F

scale (+.38,

p &lt;

p

&lt;

.05),

.01) and perception of

.05).

This study has denonstrated that two very different

convulsant agents

may

produce similar neurophysiologic

behavioral change.

and

It is

concluded that behavioral changes

in convulsive therapy are related to the degree of altered

brain function, and are non-specific for the type of agent
used to induce the convulsion.

Details of this study were presented at the Eastern
Psychological Association in Atlantic City, April, 1959.
Sociopszchological Aspects of Psychiatric Treatment.

F.

In a previous study of the Hillside Hospital population,

it

was shown

tht the factors or age, education, place of birth

and

social attitudes as measured by the California I scale,

were

related to the selection of therapy. ‘Those patients

were

older, had less education, were foreign-born and with high

stereotpy scores

on

the

F

scales were

more

whp

likely to receive

�-22-

convulsive therapy.

'In

contrast, patients

who were

younger,

the
on
low
and
obtained
scores
native-born
educated,

better

as
psychotherapy
received
scale,

their sole

F

form of treatment.

study
the
relation
determine
to
was
Further
undertaken
of
duration
hospitalto
factors
of eociopsychological
1)_th°
2) the

isation,

The

Hospital
171
16

final diagnosis.

3) the

and

inspatient
of
Hillside
population
adult
entire

on March 7, 1957 was

patients.
to

68

57 nan and

llh

studied. This consisted of
from
in
age
ranging
wonen,

median
of
35-years.
with
a
years,

It
period

clinical

discharge,
of
time
evaluations at

was

(1—5

shortest
the
for
hospitalized
that
patients
found

the
least education, were
months) were oldest, had

foreign-born,
the
scores
andlad
highest
been
have
to
most likely
on

the

1

scale. Iounger,native-born,

more

educated, lower

r

'(10
more
or
the
longest
score patients were hospitalised
months).

The sane

hospitalisation

factors
of
of
length
to
these
rdationship

made
were
when
analyses
found
separate
was

�-23according to diagnosis and type of treatnent (convulsive

therapy or psychotherapy).
Discharge evaluations of improvement in the

population studied were

total

related
to age, the
significantly

older patients having the nest favorable ratings. Analysis
of the data by type of treatnent, however, demonstrated that

the convulsive therapy patients ratings of recovered or

among

much improved were
F

given to those patients with the highsst

scores, least education

and who were

foreign-born.

Diagnoses of schizophrenia or psychoneurosis were

associated with lower
and

high

native birth.
F

The

F

scores, younger ages,

more

education

older, less educated, foreign-born,

score patients were more frequently classified as

involutional or nanic-depressive psychosis.

It is

postulated that these relationships reflect the

ingluence of social background on psychological processes,
such as the behavioral

patterns of communication, nodes or

expression and symbolic values.

These not only contribute

to the pattern or mental illness, but affect

all aspects

of

�~2h-

the patient-therapist interaction.

Details of this study have been presented at the
Eastern Psychological Association in Atlantic City, Avril,
'1959, and at the Academy of Psychoanalysis in Philadelphia,

April 26, 1959, and has been accepted for publication in the
Archives of General Psychiatry.

0.

The

Relation of Social Attitude to the Effects

of Convuleive Therapz.
As

F

indicated in the previous section, the California

scale has been found ueeful in understanding factors related

to the referral for convulsive therapy and the evaluation of

clinical response following
have been undertaken with

questions:
population?

a

treatnent. Further studies

such

this scale in regard to the following

1) What does the

F

scale neasure in our psychiatric

2) What are the behavioral changes induced with

convulsive therapy?

3)

How

are theee changes related to the

degree of altered brain function?

�-25answer the

To

first

question, in part, the entire

in-patient population of the hospital was given the

later

One month

they were retested with a "reverse"

in which each statement

original.

The

was changed

"reverse" scale

was

F

scale.

F

scale,

to the opposite of the
scuzred in the same manner

as the conventional scale, with high scores

this procedure

reflecting greater
to determine

agreement.

The purpose of

whether the

to
the contents
related
patients' responses were

was

of the statements, or were a manifestation of a more general

personality aspect, such as acquiescence.

It

was found

that those patients

who made low

scores

originally, indicating predoninant disagreement with the
statenents,
indicating
who made

showed a

large increase

the "reverse" scale,

on

In contrast, patients

a high degree of agreement.

high scores

initially

showed

little

change on

retesting,

agreeing with the statements to the sane extent even though
the meaning was reversed.
low

I score patients are

while those with high

It is
more

evident that, in our population,

critical

I scores are

more

and

discriminating persons,

undifferentiating and

�.26..
and stereotyped in

their reactions.

is related to the process of selection

This observation
or

patients for convulsive therapy.

A

high degree of atereotypy

or thinking and communication is inconpatable with the establishment of a conventional psychotherapeutic

relationship, preventing

the psychoanalytically-oriented psychotherapy stressed at

Hillside Hospital. It follows that the high

sill

be

F

score patients

unsuccessful in psychotherapy and nest likely reterred

for convulsive therapy.
To

answer the second end

patients were given the
treatnent period)

and

F

third questions raised above,

69

scale before, during (at 10-12

after convulsive therapy.

Ten of

these

and
the
control
constituted
random,
group
at
selected
'patients,

received subconvulsive electrostinulation.

nean
There was a

increase of 05.7 during treatment in the convulsive group, a

difrerence significant at the
control group
(+0.5).

The

showed an

SS

level. In contrast, the

insignificant

change during the cane pertd

extent or increase in the convulsive patients

was

�-27-

related to the degree of cerebral dysfunction as

found to be

determined by delta

delta

(h0%

+8.6.

activity

on

the

EEG.

Those

F

patients with high

or more of the sanple record) had a nean increase of
low
with
delta indices, however, showed a
patients

statistically insignificant increase of
the

The

+3.h.

Following treatnent

scores were comparable to the pretreatnent levels.
These findings support and elborate previous observations

the effects of convulsive therapy.

on

the

F

Greater agreement with

seere scale statements during treatment

stereotypy and difficulty in discrimination.

show

conventional

The change

in

I

n

.

P

score thus seen part of the same process shown by the
z

characteristic language changes of increased denial, evasion,
qualification,

I

and use of cliches and stereotyped orpressions

It is also

comparable to the increased

visual

tactile perception

(

and

(

)

difficulty in

and figure-ground

(

).

complex

discninination

)-

Details of these findings were presented at the Eastern
Psychological Association in 1958 and will be elaborated at the

�forthcoming Divisional nesting of the American Psychiatric

Association in
H.

ﬂew

Zork.

Aspects of the TherapistaPatient Relationship Affecting
Choice of Therapz.
As

indicated previously the selection or therapy involves

other aspects than the actual behavioral pattern or the patient.
In the past year further efforts to
been undertaken, emphasizing

relationship.

clarify this

problem have

factors in the therapist-patient

he have hypotheSised

increased tension, frustration

and

that

such

factors as

hostility in the therapist~

patient relationship, as well as implicit

and

explicit pressures

present in the environment have a significant influence in

referral for sonatic therapy.
In a
and

pilot study

76

structured interviews with residents

supervisors were initiated following requests ﬁr sonatotherapy.

These interviews were designed to

referral. It
there

was found

a sudden change

elicit

the basis of the

that in only relatively

few cases was

in the patient's clinical status which

directly led to the referral.

most
In
instances there had been

�-29-

or progression

no change

the presenting eynptons.

in‘

Factors

of
impending
included
the
to
timing
contributing
the referral

diccherge, avoiding administration discharge, and pressure

tron the patient's family or

ward

personnel.

It res

also noted

were'treatod
that ptiients with ainilarhehcvior patterns
given senatotherapy and others none. The
4‘ renged
reasons for this raged from'"whin" to quantitative difference!

differently,

some

.

in synptonetelogy and individual preferences for type of
treatment.

initial

The

conclueien

wen

that in

a

significant

0; cases, factors other then clinical indication played

number

a

role

in the referral. These sane extraneous factors also influenced
the timing or the referrals

is

e

results of these findings

Referral Sheet"

to

was

completed by the

From

c ’Scnatic Treatment

developed‘(see form at end or report) to

therapist whenever somatic therapy is reqneeted.

this questionnaire

we

hope to obtain

further information

regarding indications for somatic treatment, more specific data

�-30.
concerning the therapist-patient interaction, and a more

definite idee of the therapist's expectations for such treatment.

I. Individual Differences in Selection of,
to Convnlsive.Theragz.

and Response

In the elucidation of individual differences related to

sonstic therapy, a variety of peripheral-cognitive procedureshave been used.

tachistoscopic perception of enbedded colored figures

The

has been given to 65
of 35 consecutive
were 20

patients.

experimental group consisted

The

convulsive
referrals for
therapy.

The

controls

patients treated with phenothiazine medication (thorazine

and pronasine) and ten

patients receiving

no somatic

treatment.

All subjects were tested prior to treatment, and after four weeks;
the convulairee were tested s third tine two weeks following the

cessation of treatment.

It

was found

increase in

that there

mean number

was a

statistically significant

of errors with convulsive therapy,

while following treetnent there was e significant decrease from

the pretreatment scores.

at

Controls

made

significantly fewer errors

�.31-

(practice effect).
errors between

patients classified

(per cent time delta)
were

significant difference in

There was a

when compared

as showing low

with high

high retest correlations for all groups.

EEG

changes

changes.

EEG

Marked

There

individual

ditferences in response patterns were noted prior to treatment.
With

brain changes there

was a

reduction in perseveration, conpletion

patients,

and contabulation in some

and and increase in

others,

with no unique patterns attributed to cerebral dysfunction.
Even

in those patients with high

his response pattern

was

showing completion type

to

make such

EEG

'stjh'

changes, the

ntein naintained.

Thus a

errors prior to treatment

ore

patient
would continue

errors with convulsive therapy, although the threshold

at which completion

was shown might change.

Details of this study

were_presented at the Eastern Psychological Association in

Atlantic city, April 1959.
The Red and

h?

Irene Test (after Witkin)

was

administered to

Harked
somatic
for
referred
therapy.
consecutively
patients

individual dirierencee in performance were correlated with age,

�w

_‘“

.v

.32-‘
education and score on the Calibrnia

vertical

Judgment of the

frame

(field dependent)

F

scale. Patients

whose

ﬁes strongly influenced by the sunnunding
were more

frequently referred for

convulsive therapy than drug therapy.

No

significant

change

‘

was found

with drug or.convulsive treatment.

convulsive groups

retest correlations

drug

For both/and

were high (.86 and
on

differences
in the
individual
considered
that
is
It
Frame

test reflect personality factors that are

in psychiatric treatment.

.88).

Rod and

of importance

�5

“J

a

,

:1: 7/16/59

L,

wig/r
1

_/

Function
Brain
Altered
Following Electroehcck
‘

24.927

Progress Report

-

Febmary 1. 1958

-

September 1, 1959

m:
L

previous
In our
studies

we have

demonstrated

that

an understanﬁng

of the convulsive therepy process required a nultifectoriel approach involving neurophysiologic, perceptual, personality, paychodynemic and

eocielogic eepecte cf behavior. Thus

is essential

it wee ehcwn that:

The

convuleim

to the therapeutic process (Fink, Green end Kuhn, 1958);

murcmeielegic

changes

reflective of altered brain function ere e

a Heinetein, 1956; Fink &amp; Kenn. 1957)
neceeeery prerequisite for behavioral change end ixproveemt‘ the
(Kuhn, Fink

biochemical beeie of the convulsive therapy preceee lay

level of cholinergic activity of the central nervous

is an

mm

increased

(Fink, 1958);

there are characteristic perceptual chengee with altered brain function
induced by convulsive therapy (Fink, Kuhn and Korin, 1957; Kehn and

Pink, 1957);

retina cf

improvement

after convulsive therapy are related

to personality characteristics defined by Rorschach
and

{mm

(Kahn and Fink, 1958).

interviews (Kuhn and Fink. 1957); end that evaluations of

�mm
(Kuhn

8.:

-2.
were

related to changes in syntactic aspects of language

Fink, 1958).

In the pest eighteen (18) months these statics wen completed and
extended, and an investigation of poychophamcologic agents begun. The

{mark
View

we
for these investigation:

of convulsive therapy (Veimtedn

Fink and Kahn, 1957) extended

mandarin patients (Pink,
The

been the nmxrophyeiologic adoptive
Kahn, 1955; Knhn

8c

at all,

1956;

to other physiodynenic treatmmta or

1957)

.

tho
convulsive therapy process were
relieving aspect- of

studied:

1. Siﬂficence or the Commune

Mologic,

A

cooperative study of neuro-

paychologic and bohemian). effects of

electrical

and

inhalant (Indoklnn) induced convuhicaa.

2. @2326 Basic of NeuroMiologg-c Chang: Further studies of
the effects of acute

wtmtric
3.

“notation

agents on both the

Mgwogo

AoEm of

of

marinentnl anticholinergic

'noml“

and

and pout-convulsive EH}.

Comm Thomas

3. Relation of the factors or age, education, nativity and

�n3.
mmotm

(mound w the California

max-aw, duration of
1:. Chang“

clung» to

EEG

hoapiuuuum,
of

F

1"

scale) with selection of

diagnosis and diochnrgo ratings.

scale with treatmnt, and relation of those

indiceo.

h. Mother-Lg and Conwlsivo

Tim-ram:

In aupervioory sessions, alterations in psychotherapy with
convulsive thorapy were studied.

W:

5-

Both patterns or change and individunl diffomnooo on

tuohistoocopio figumﬂ ground

ﬂicker immoy

domination tutu, critical

and perception of the upright with induced

‘

emulsions

were studied.

5093*ch are «tended to dmg therapies and the following studies
undertakom

1.

1010
:1.

c:

Relation of

EEG

charge on acute and ohmnic administration

of poychophamoouticals to clinical behavioral change.

b.

EEG

as a screening device for psychomrnceuuc potency.

�.. h .-

c. Elation of
6.

EEG

EEG

clause: to hallucinogenic activity.

effects at neginide.

2. Omnicstion Patterns:
Relation of induced neurophyeolcgie change to dyadic diversifi-

cation and syntactic language maeuree.

3. Aspects of the Therapist

..

Patient Relationship affecting

choice of somatic therapy.

metudiec
View

have supported and expanded the mumphyaiologxo-adapuu

of convulsive therapy, and dancnetrated that. such a

applicability to our understanding of the

mode

munch

has

of action of psycho-

phamacologic agents.

PROGRESS
A. tar:

l.

REPORT:

Gasman new?!

PROCESS

ﬁgniricance of the Convaleion:
A

cmmrable study of Indoklcn and electrically-induced convulsime

in psychiatric therapy was
control
eubccmuleive

completed.

An

mm demonstrated

changes occurred almost exclusively

electrocomruleive therapy.

The

earlier convulsive-

that.

uinIicant

behavioral

in patients receiving grand

mal

present report is an assessment at

�-5the relative neurophysiologic, behavioral and clinical effects of

hm different

of.
methods

inciting convulsions - electrical

cuxjreet)
and inhalant (indoklon) .
(eltemating

'consemtive
patients referred for convulsive therapy
Thaw-nave

classified
into
were tendonly

Won

/

3Wt,
/
.

,:./

patients
and

by

two groups

the steward

- «isms

Model-oft

mowed in

alternating current in.

in twelve by the inhalstion of heMlumdetlvl—ether

findeklon). In both groups treatment was ochinistered three times a

.5
{f}

[f book for a total of
IKE/o:
x!

I!
if

/

3'

10

to

21;

applications, determined on the basis

clinical criteris by the supervising psychiatrist.

,f‘.

\
A

All patients were tested one to two days prior to the
treatment, following 10.12 treatments, and

first

m weeks renewing the

lost tacatment. In addition to evaluations of

behavioral. change,

tests included nouns-es of intellectual function (five aubtests

In

the Kodachr-Bellme Intelligence Scale), perception (figure-groom!
discrimination using wedded geamtric figures, the perception of

pewdeochrcnstic color plates at high speeds of toohictoocopic
exposure, and the

Stmt moguls“ figure: test),

and

lucid

�.- 6

1e

etﬂtude (the Lennon revision of the California

1"

Scale).

An

testing
of
each
the
periods,
obtained
during
electroencephalogram was
on! mom-ed

for the per cent. time slow

we

(6 ope or slower)

activity

from a continuous 66 second sample.
The

to
failed
Insults

show any

significant inter-group teat

differences between the electroshock and indoklon groupe

at each of

the three test periods.
Inbregtoup
groupe made

onlyale,

that during treatment both

increased errors on the intellectual and perceptual taste,

end had higher

_

hmr,

showed

some

on

the

F

scale.

By two

weeks

otter the

terminal-g

for
tion of treatment both groupe returned to near pretreatment. levels

' moat mete.
Both groupe were comparable for the degree of indeeeed
wave

activity after

for the

10-12 treatments.

indokloa group was 51% and

The

EEG

slow

per cent time slow activity

for me electroshock group

It? 5%.

within each group individual differences in behavioral change were
the
with
thoee
change
of
neurophysiologic
the
degree
to
reload
behavioral
change.
the
greateet
sharing
delta
cent
tine
highest per

�-7mm: order correlations batman changes in

test

performance and

degree of slow wave activity with treatment. were positive

fer all

proeedwes, except the eomehension subtest of the Wechalar-Bellevm,

level of statistical significance for digit. span
1" scale (4* .33,
13
.05).
.01), object Assembly (hub,

and reached a

(+ 1,61, p

p

.05), ucmnoacopac perception (+.67, p

of embedded figures («13, p
This study demonstrated

.01) and perception

.05).

that up different

eonvulsant. agents

produce similar neurophysiologic and behavioral changes.

eencluded that. the behavioral change

It was

is related

in convulsive therapy/to the

degree of altered brain function, and

an

non-speciﬁc for the type

of agent. used to induce the eohvulsion.

(mud,

in part, at the Eastern Psychological Assecatien,

Atlantic City, April, 1959).

2. modicum ”mate of the Convulsive
The

significance of high voltage

There}?! l’ﬁt‘eceae2

m

delta activity in the

convulsive therapy process (Ruth 213.1) 1951, 1957; Fink and Wm,
1957) and the

report that this delta activity

ministration
(mate

was blocked by the

of the antteholinergic agents atropine and scepolamine

and Johnson, 1957) provided the

basis t‘or mane studies.

As

�-

8 a.

there Here attendant unpleuent systemic etfeote with the comm-tre-

tion of these agents, report: describing diethulne as an
entioholmcrglc

effects (Jenknor

compound

with potent neurologlc but

mm manic

and Loohner,19553 Lechner, 1956) 13+. us

studies similar to those of Ulett

and John-on

using

(Rink, 1956). These observations with diethacine

this

to mderteke
compound

lot to the investiga-

tion of other experimental antichollnerglc agents.
Clinical and electroencephalographic responses to the intravenou-

adninistration of dicthaxine
and atropine

in plychntrlc patients at

therapy were studied. Each
The

Win. 2299,

is

bemctyam,

JD

318,

dB

336

various: etegee of convulsion

a potent antiohollnergic agent

121

um.

eubjecte were ninety psychiatric patients referred for

convulsive therapy, ranging in age from 18 to 67, with

Wes.

A

total of

107 observations were rude,

a.

since

variety of
some

subjects

were studied with more than one compound.
The

observations were

8 channel

made

in the

EEG

laboratory ucing a standard

instrument and needle electrodes. In each

coupound under study was

tual,

the

mastered intravenously at a set rate

�-9

..

per minute until clinical behavioral

oz-

eleetrogrephic changes were

observed.

It was
was

observed that

salinistrstion of these sntichonnergic agents

associated with e) dosynchmmisstion of

bloom

of post-convulsive delta

activity;

EEG

1:)

rhythms with

s

alerting, excitstory

behavioral response with illusory, delusional end Mllucinatory

mention,

and c) systemic

effects of muscular weakness, dryness of

the south, dry skin and techycerdia.
end systemic

effects

The

electromﬂuc, behavioral

were concurrent.

These observations are regarded as consistent with the suggestion

that the physiologic basis

in central

of, convulsive therapy

nervous system cholmergic

Observations

that

LSD,

lies in

an increase

activity.

substantive, nasceline

sympathemnetic and
antihistaminic agents

-

and diphenhydmmns

also induced

convulsive
d‘
delta
desynchronisation, blocking
post

EEG

activity

clinical oucitstory scﬁviw support the suggestion that the

and

mvioral

md electrogrsphio patterns of these compounds are also based on

alteration in synoptic activity. Increased synaptic activity
(cholinergic, synpethclytic effects) is sssocieted with

-

EEG Immora-

synchreniseticn, and clinical sodation and euphoric; while decreased

�.. 1o

-

synapmc

activity (anticholimrgic, sympathmimtnc) is mandated

with

dosynchmniution and clinical excihtory and hallucinogmic

EEG

states, thus supporting the Wthesia mually

described mama

by Wilder (19514).
algont,
atropine,
Deacrepant observations with the anticholinergic

are considered to be related to significant differences in dosage.
(Presumed, in

put,

San
d‘
Biological
Paymatry,
the
Society
at

first

Francisco, 1958 and awarded tbs
Award of

that Society; and, in part, at

City, 1959. Published, in part,
380-387, 19573 and accepted

3. Socio

a.

A. E. Bennett

cal

01

A

A

1.

A

American

EEG

PsycIﬁItrio Research

Somty, Atlantic

Arch. Neural.

&amp;

cMat. g9.

for publiaation, ma Olin. Nemﬂmool.)
shiatric Treatment

ate of

Duration at Hoggtaluation.

Dawn

and

.'

Madam

Evaluation.

In an earlier study of the Hillside Hospital populationmahn,
Pollack

birth

:3:

and

Pink, 1957).

it

was noted

social attitudes

that age, causation, place of

F
California
measured
the
by
as

were related to the aelecﬁm of therapy. Those pation‘ua

older,

had

less education,

scores on the

F

scale,

who were

were foreign-born am with high stereotype

scales were

more

likely to waive convulsive therapy.

�- 11
In oontmt, petiente
I

‘

who were

..

younger, better eduoehdmetiveobem

end obtained it»: theeoree on the

1’"

scale, received peyoheﬂmerepy ee

their sole router treatment.
nutty
Another
wee undertaken to determine the relations of theee
eodepeyohologioal factore to 1) the duration of hospitalization,
2) the

Meal

evaluations at time of discharge, and 3) the final

diegxoaia.
The

entire impatient edalt population

studied. This oomieted

on!

maize in age from 16 to

171

68

patients,

years,

no:

on March

7,

1957 was

57 men and 11];

mo,

a median of 35 years.

Patients hospitalized for the shortcut period (1 - 5 months)
were noted

to

be the

oldest, have the least education, were

more

likely to be foreign-hem, and have the highest scores on the
“

scale. Younger, native-bum,

more educated,

loner

months).
(10
more
the
or
longest
each hoepitelieed

ship

of:

F

more patients
The same

these factors to length of hosmtelizetion was found

eepehte Ienelyeee

them

F

relation»
when

were made according to diagnosis and type of

(eomleive thempy or peyohotherepy).

�,'

12 u.

Discharge evaluations of improvemnt were significantly related

_

to age

-

the older patients having the most favorableratingm

Miami! of the date by type of treetnent,hovever, demonstrated that
among

the oeuvulsive therapy patients rating: of recovered or

much

inproved were
given to those patients with the highest F scores,

least education

and who were foreign-born.

Diagnoses of schizophrenia or peyohomuroeie were

undated

with lower F eeoree, younger ages, more education and native birth.
The

older, less educated, femignnborn, high

more

F

score patients were

frequently classified as involutionel or mic—depressive

psychosis.

It was

postulated that these relationships reﬂect the influence

of nodal background and psychological proceeoee, such as the
behavioral patterns of communication and modes of expression. These
Thane

not only oontﬂbute to the pattern of mental illness, but

affect all aspects

of the patientoﬂxerapiet

interactim.

(Pmeented at the Beaten: Psychological Association, Atlantic City g

April, 1959, and the Acedm of Psychoanalysis, Philadelphia, April,
1959. Accepted

for publication, Archives of General Psychiatg.)

�.. 13 ..
13.

Treatment.
Convuleive
with
Social
Attitude
in
Gwen:
Following the earlier observations that the California

is

1“

scale

useful in understanding mien-a1 for ccnvuleive therapy and the

evaluation of clinical reepcnee following such treatment, ﬁzz-ﬂier

studies were undertaken with thieeeale in regard to the {alluring
1) iihet deal the F scale measure in a psychiatric

question:
a

population? 2) Dc

1“

scores change with convulsive therapy? 3) Are

these changes related to the degree of altered brain function?

entire in-patient population of the heepital was given the

The

:16 one month

scale,

in

later,

was

retested with a "reverse“

ﬁnch each statement wee changed

The “reverse"

scale

as

to the opposite

or!

F

F

scale,

the original.

scored in the same manner as the ccnventicnal

scale, with high ecoree reflecting greater agreement.

It

was noted

that than patient:

who made low

scores

initially,

showed
an
with
the
statements,
disagreement
indicating a wedcninant

increase on the "reverse" scale, indicating a high degree of agreement. In contrast, patients the mde high scores

little

change on

initially

shaved

same
the
to
etatexunte
the
with
agreeing
reteeting,

�..

m ..

extent even thong: the nearing was reversed.

let:

P score

patients are

more

critical

and

It is

evident that

diesﬂmimting persons ,

while those with high F scores are more undifferentietihg and

stereotyped in their reactions.
This

aberration is related to the process or selection of

patients for convulsive thmpy.
thinking and commutation
on!

A

high degree or sterotwpy of

is incomtsble with the

a conventional psychotherapeuﬁc rehtionship,

psychoanalyticslly—oriented psychotherapy stressed

Hospital.

It

follows that the high

F

establishment

meeting the
at Hillside

score patients will be

unsuccessful in psychotherapy and most likely referred for con-

vulsive therapy.
In anotlmr study, sixtr-ndne patients were given the F scale

berm,

during

therapy.

Ten

(st

10-12

treatmnt period)

patients, selected at

group and received subconvulsive
mean

increase in

group

a.

F

random,

and

after convulsive

constituted a control

electrostimlsuon.

There was

s.

score of +5.7 during treatment in convulsive

a difference significant

at the

5%

level. In contrast, the

�- 15
In conﬁnes. the control group

..

showed an

insignificant change during

the echo period (+0.5). The extent of increase in me convulsive

petieﬁts was related to the degree of cerebral dysfunction es

&lt;1er

by

delta sctiﬂw

on the

m.

The

patients with my:

d6“? (1:010: 3955 of the mp1” 1‘3“”) had a

//
l'hebe patientsvith

mean

'

increase

e

a ’8’6”

f

low

delta indioes, however,

off 43.14,. Following treatment the

showed an

increase

3

2/

15’03&amp;8tashv

,f
1/

/

”(7/
-/'4,7,3?
,.

V

,2”

/
/

,.

/"5

scores were comparable to the

levels.

‘

,

‘

“these ,flndmgs support and eleborste previous observations on the

[5%.

,2)"

,

7752/

1"

cadets” e’f convulsive therapy. Greater agreement with the
,.

scale

‘f

std/Wes

/}

F

during treatment show conventional stereotypy and

3"

/r

(35“:ow

I
_

1n

discrimineuon.

Changes

in

F score thus

parallel the

fo’hehoteristio hnguege changes or increased denial, evasion,

///

"

,

,/,.L‘

,r

l7

//qdeiﬂicetlon,

'

/
/

and use of cliches and stereotyped expressions (Kuhn

‘

j"

&amp;

2

Fink, i953) .

It 1. .1“ ompmble to the

increased difficulty in

/

/

l

/

/

cochlea:

visual and tactile perception (Flak,

fairs-groom discrimination
j’(heseo1{;e§ at.

Knhn

(Karmic Fink, 1957).

/ﬂbyohletrlc Association,

at the Divisions].

Meeting of the American

3'

‘81

I

‘-

r

{'1' 4"

Karin, 1957) and

the Eastern Psychological Association, 1958; and

aeoepced for?" presentation

‘

8:

New

York, November 1959.)

�~16-

h.

Psychotherapy and thsicdzgamic Therapy:

Previous studies indicated that patients referred for
of
electroshock in this hospital are/two types. The largest
number are

patients in the older

education and are foreign born.

age groups who have
They tend

to

be

limited

non-introspective

persons, stereotyped in their language and thinking and verbally
unconnunicative. Their predominant symptoms are depression,

agitation, withdrawal

and somatisation.

The

second, and

smaller, group of patients are younger, native-born, bettereducated, and verbally communicative with a capacity for

introspection.

They

characteristically exhibit thinking

disorders and overactive behavior, with lesser degrees of

aonatisation and depression.
Four

patients,

two

for each group described above were

studied to determine 1) reasons for referral,

different attitudes
management, and

2) whether

were required in psychotherapeutic
3) the

relation of the psychotherapeutic

�-17.
approach to the

patient's clinical response to convulsive

therapy.

It

was

suggested that these patients were referred for

convulsive therapy because of a failure of communication in
the psychotherapeutic relationship.
a

In two cases this was

reflection of the patient's limited verbal

and

introspective

capacity related to educational and social factors.

instances, however, the impaired communication
by unmanageable

was

In two

manifested

acting out behavior.

Following treatment,

is older, less educated patients

were able to maintain a behavioral change with a

reassuring,

supportive technique, amplifying tendencies to minimization
and denial developed during electroshock.

In the better

educated patients, electroshock decreased acting out was

associated with increased use of interpretive forms of psychotherapy.

It

uas concluded

that the relationship of psychotherapy

to convulsive therapy varies with the communication pattern

�~18 -

and

adaptation

shown by

the individual patient. (Published

in the Journal of Hillside
S.

Hos

ital,

1: 17-25, 1958).

Perception:
A

variety of perceptual-cognitive test procedures have

been studied in

l.

patients receiving somatic therapies.

Tachistoscopic Perception of
Colored Figures:

The

Embedded

This task was studied in an experimental group

consisting of

35

consecutive referrals for convulsive therapy,

and "control" groups of 20

patients treated with phenothiazine

medication (thorazine and pronasine) and ten patients receiving
no somatic

treatment, matched for age. All subjects were tested

prior to treatment,
were

and

tested akhird time

after four
two weeks

weeks the convulsive

patients

following the cessation of

treatment.
There was a
number of

there

statistically significant increase in

errors with convulsive therapy,

was a

significant decrease

mean

and following treatment,

from the pretreatment scores.

"Control” subjects made significantly fewer errors (practice

�-19-

effect).

significant difference in errors between

There was a

patients classified as
delta)

when compared

showing low

with high

EEG

changes (per cent

changes.

EEG

tine

There were high

retest correlations for all groups.
There were marked individual differences in response

patterns prior to treatment.

With brain changes there was a

reduction in perseveration, completion and confabulation in
some

patients,

and an increase in

others, with

patterns attributed to cerebral dysfunction.

patients with high
pattern

was

EEG

no unique
3V0“

in

thOBO

changes, the ”style" of his response

maintained. Thus a patient showing completion

type errors prior to treatment would continue to make such

errors with convulsive therapy, although the threshold at
which completion was shown might change.
were

Details of this study

presented at the Eastern Psychological Association in

Atlantic City, April 1959.
2.

Rod and Frame

Test gWitkinzs

This task was administered

to h? patients consecutively referred for somatic therapy. Marked

�-

20

-

with
correlated
age,
were
in
performance
individual differences

education and score
judgment of the

frame

(field

on

vertical

was

dependento were more frequently referred for
No

significant

treatment.
found with drug or convulsive

convulsive groups

It

retest cerrelations

change

For both drug and

were high (*.86 and +.88).

is considered that individual differences

Frame

whose

influenced
by the surrounding
strongly

therapy.
than
drug
convulsive therapy
was

Patients

the California F.ecale.

on

the

Rod and

of
importance
are
that
factors
test reflect personality

in psychiatric treatment.
B. PSYCHOPHARHAOOLOGIO STUDIES

1. Neuroghzsiologic Studies:
view
the
of
neurophysiologic~adaptive
the
to
Acoprding

convulsive therapy process, the clinical efficacy of repeated
induced convulsions

is dependent

upon the

induction of

a

providing
function,
nervous
central
in
alteration
persistent
the
with
interaction
the
in
subject's
a milieu for changes
examiner and the environment.

In these studies the best

been
of
those
has
aspects
change
of
neurophysiologic
index

the
electnoin
by
delta
activity
reflected
function
cerebral

�enoephalogran (Fink and Kahp,1957).
The

efficacy of

newer psychopharnaceuticals in

altering

psychotic behavior patterns has led to the suggestion of aI/ﬂ
,1
1}

similar hypothesis for the node of action of these agents{ and
to studies of the relationship and specificity of altﬁred

behavioral patterns to neurophysiologic change as reflected
in electroencephalography.
Of

an

the psychophsrmaceuticals tested in acute experiments

increase in syhchrony with or without an increase in slow

wave

and

activity

has been observed for chlorpromasine, pronasine

triflupronasine. Behaviorally, these drugs

were

associated with a) increasing sedation,drowsiness, denial
and euphoria;

b) decreasing

agitation, panic, excitement

and

delusional and hallucinatory activity; and c) minimisation
and displacement or synptons.
an

Barbiturates regularly induced

increase in fast activity with an increase in synchrony,

with the associated behavorial changes of sedation, euphoria,

denial and minimization.

Amphetamine and methamphetamine

increased fast activity without increased synchrony and

behaviorally were associated with behavorial alerting, hyponania,

�-

-

22

excitement and increased motor activity.
and per cent time of slow wave

post-convulsive delta activity

Decrease in voltage

activity in subjects with
was seen

with LSD-2S,

bcnactyzine, Win-2299, JB~318, JB~336 and diethasine.

Of

these drugs, benactyzine produced increased alerting, excitement, tension and panic; the other drugs also produced

illusory

sensations and hallucinatory, delusional and paranoid ideation.
The

electrographic patterns were consistently altered

concurrently with behavioral changes both in the acute and
chronic administration studies.

Tranquilization, euphoria,

sedation and minimization of symptoms were concurrently

associated with increased

EEG

synchronization and shift of

frequencies to the delta range.

Agitation, tension, panic,

excitement, illusions and hallucinations were associated with

desynchronisaticn of frequencies.
Similar patterns were demonstrated in subjects with

prior delta activity. Agents that tended to synchronize
frequencies, as chlorprcnazine and barbiturates, augmented the
per cent tine delta activity and enhanced the clinical patterns;
agents that desynchronized frequencies, as diethasine, LSD-25

�-23and

benactyzine, minimized the clinical effects typically

ascribed to repeated convulsions.
Various experimental psychopharnaceutioala were tested.
In addition to extensive studies or 3-3 methylethylgiutarimide

(Heginide) and hexetluorodiethylether (Indoklon) the following

nhsnyltoloxanine
(PHD-Bristol), methenalide
agents were studied:

(BLH~lﬂl;lhristol), tropin-h-Ghlorhenzhydryl ether (WI-21h9,
Wyeth), dinethylaninsethanel and

verieties, Riker),

JB-3;;,

its

oongeners (Deaner and

329 and 336

(various piperidyl-

Geigy).
and
(Torrinil,
Lakeside)
inipranine
bensilatss,

significant behavioral

Because or 31:31

changes, a
was

and

electrogrephic

intestigation
of imipramine (Torrinil),
nere intensive

undertaken. In

28

acute experiﬂmenta, consecutive patients

referred for physiodynnmie therapies

were

tested in the

EEG

TofrEnil
solution
of
treatment.
various
stages
at
laboratory
(10 ng/oc) was administered intravenously

until electrographic or behavioral changes
a

total of

h0-12S

mg

at

a

set rate

(1 cc/ho sec)

became prominent,

(0.5-2.5 mg/kg). Behavioral observation

for

�«Zh-

and

In

electrcgraphic recording continued for one to three hours.

patients referred for pharmacotherapy because of manifest

depressive, withdrawn or retarded behavior oral Torranil of
75-350

mg

administered.

was

In the acute studies there was

initial restlessness,

associated with dissiness, dry mouth, “taintness,” nausea,
and on

tour occasions, voniting. These

symptoms

persisted for

t

10-20 minutes, and were accompanied by lasdtude, heaviness

of the extremities and eventual drowsiness.
unchanged or slowed.

Blood

Heart rate was

pressure dropped by

in older (age&gt;’ 60) patients.

20-ho%

Subsequently, subjects were

relaxed, quiet and disinclined to activity, even

when

returned

to their ward.
The

electrcgraphic patterns accompanying these behavioral

changes were

initiated

during the injection.
had been halved.

activity,

such

by a gradual
By

in decrease in voltages

ten minutes, the per cent tine alpha

In patients with moderate anounts of beta

activity occasionally increased in voltage

and

�-25per cent time.

twenty minutes, in association with

By

behavioral lassitude, low voltage (to

theta frequencies

(5—?

50

nicrovolts)

random

In records with post~

cps) appeared.

convulsive delta activity, there was a marked decrease in

voltage and per cent time of slow
graphic patterns persisted for

i

wave

to

two

There was considerable individual

acute

EEG

of Torrinil,

EEG

who

These

electro-

hours.

variability in this

received 100

mg

or more

all

and behavioral changes were observed in

In six patients, dosage of TorrEnil less than 50

but three.
were

In patients

response.

activity.

associated neither with

EEG

mg

nor with behavioral changes.

In chronic Torranil studies, behavioral changes generally
appeared during the second, and were maximal during the
week of
was

treatnent.

The most prominent

euphoric denial.

behavioral adaptation

Patients complained less of somatic

symptoms, and denied, minimized or displaced

inquiry.

It

became

lite relationships

third,

their illness

on

increasingly difficult to discuss significant
with then.

In six patients sonatisation and

�restlessness increased

and depressive

affect persisted. In

three, restlessness, agitation, excitement, insomnia and
vomiting, led to the cessation of therapy.

No

change in

sfgntons were noted in five patients after four weeks of

therapy.
Electrographio studies
a decrease

on

chronic administration showed

in voltages with poorer record modulation.

voltage theta (S~7 cps) activity up to
defined

fast activity

10%

r‘

became more p~ominent

appeared.

Low

Well

in a few.

(presented at the Collegian Interantionale Neuro-Psychopharmacologicum, Rome, September, 1958)

at the

Conference on

Depression and Allied States, Montreal, March, 1959] and
American

EEG

Society, June, 1959; Published, in part, in the

3

Proceedings of C;I.N.P. Psychopharnaoology Frontiers, ed. 3.
9

Kline, 325-332, 19593 Canad. J.
Neurologz, g} 682~685, 1958.

Pe

chiat.,

1959

(in prose);

�-272.

Language

Patterns as Resource of Behavioral and

Nauroghzsielogic Change with Drugs.

In previous studies of the convulsive therapy process,

it

was demonstrated

that

syntactic

two language measures, a

content analysis (Kahn and Fink, 1958) and dyadic diversification
a

scores or instructured interviews (Jaffe,

Kahn and

Pink, 1958)

provided objective indices of behavioral change, and were

related to the degree of altered brain function. "In a further

test of these

language measures as indices of behavioral and

neurophysiologic change, they were applied to interview

on

’

acute administration of various psychopharnacologic agents.
Seventy-two interviews with patients at various stages
of drug therapy have been analyzed, using the following agents:

emobarbital, benactyzine, ohlorpronazine, diethazine, lysergie—
acid diethylanide, and Win-2299.
unFollowing a routine electrographic recording, an

structured psychiatric interview, with short periods of
{\‘\

structured inquiry,
g

was tape

recorded. With

EEG

running,

intravenouq injection was then given at a slow rate.

When

on

�—28-

specific electrogrsphic or clinical changes were induced, the
interview

was

repeated.

Recording periods of

EEG

and verbal

behavior were alternated for the duration of the observation

period.

The

shifts in
(delta)
The

EEG

was measured

for changes in synchronization,

dominant frequencies, and per cent time of slow waves

and beta frequencies.

tape recordings were transcribed and measured for the

diversification of consecutive
participants (dyadic)

and for

25 word samples

of speech of both

syntactical changes. In the

dyadic analysis, the pooled verbal behavior of both participants
was

transcribed, divided into

25 word

samples, and for each sample

the ratio of the number of different words to the
words (a

diversification score)

was

calculated.

total
The

number of

syntactic

langw ge analyses were based on the response to standardized

questions using a method previously described (Kahn and rink,
1958), scoring such changes as syntactical use of person, alteration

in tense, evasion, qualification, displacement or verbal denial
of symptoms, use of stereotyped expression or cliches, cryptic

�-29withdrawal
and
or
response,

silence.

the
both
dyadic
observed
in
were
changes
Consistent

diversification
classified

and

syntactic language neasurss in subjects

behavioral
and
according to the neurophysiologic

effects of the drugs applied.
neurophysiologic
are
and
chlorpronasine
Ancbarbital
high
inducing
regularly
imobarbital
synchronising agents.

at
activity
fast
synchronised
voltage well
chlorpronasine administration

synchronisation of the

EEG

was

20¢2h cps, while

increased
folloudd by

record and a shift to slower

occasional
slow
including
frequencies

wave

burst activity.

sedation
and
with
associated
Behaviorally these drugs are

tranquilisation.
in stereotpy

and

On

increase
was
an
there
measures
the language

with
increasing
associated
repetitiveness

displacement
in
and-evasion.
cliches,
tense,
alterations
of
use

Diethasine, benactysine,

LSD—25

and Wine2299 areheuro»

compounds.
desynchronizing
physiologic

These drugs are

and
decreased
per
voltage
with
associated
characteristically

�-30-

cent tins of alpha activity and increased irregular low

voltage fast activity.
or

Behaviorally hallucinatory, exoitatory

illusory activity are observed.

there

was

On

the language measures

decreasing repetitiveness, wide diversity of words,

less variability of diversification scores, and decreased use
of cliches and

alterations in tense.

Further explaation of language neasures are suggested as
a

rational basis for the understanding of the psychologic effects

of the new therapies.

(Presented at the Conference

on Peychodynanio,

Psychoanalytic

and Sociologic Aspects of the Neuroleptic Drugs in Psychiatry,

Montreal, April, l958, and at the American Psychiatric

Association, Philadelphia, April, 1959.
3;

To

be

published).

Aspects of the Therapist-Patient Relationship Affed ting
”
Choice of Therapy.
The

selection of therapy involves aspects other than the

manifest behavioral patterns of the patient.

In the past year

further efforts to clarify this problem have been undertaken,
emphasising factors in the therapist-patient relationship.

We

�-31have hypothesized

that frustration

therapist-patient relationship

and

and

hostility in the

implicit or explicit

environmental pressures have a significant influence in referral

for somatic therapy.
In a
and

pilot

study

76

structured interviews with residents

supervisors were initiated following requests for sonato~

therapy.

these interviews were designed to

elicit

the basis of

the

referral. It

was

there a sudden change in the patient's clinical status

which

vas found that in only

directly led to the referral. In

relatively

few cases

most instances there

had been no change or progression in the presenting symptoms.

Factors contributing to the timing of the referral included
impending discharge, avoiding administrative discharge, and

pressure tron the patient's fanily or ward personnel.

It

was

also noted that patients with similar behavior patterns were

treated differently, sons given eonatctherapy and others none.
The

reasons for this ranged from ”thin" to quantitative

differences in syntonatology and individual preferences for
type of treatment.

�-32-

It

was concluded

that factors other than clinical

indication played a role in the referral in a significant
number of

cases. These

the timing of the
As

a

extraneous factors also influenced

referrals.

result of these findings

Referral Sheet"

was developed

be completed by the

requested.

same

From

a ”Sonatic Treeteent

(see for: at end of report) to

therapist ehenever somatic therapy is

this questionnaire

and continued

and ward personnel interviews we hope to obtain

therapist

further

infernation regarding indications for somatic treatment,
more

specific data concerning the therapist-patient interaction,

and a more

definite idea of the therapist's expectations for

such treatment.

�Soptonbor 1, 1959
A

an»-

«

FINAL REPORT

H~927*

’

Doportmont of Exporinontnl Psychiatry
HILLSIDE HOSPITAL

Glen Oaks, L.

1.,

N.

I.

Aoknowlodgnont
Summury, Five Yours, 195k

- 1959
Summary #h, Feb. 1, 1958 - Sept. 1, 1959
Publications, 195h - 1959

Prosontationl,

Initial studios

19Sh

~

1959

a.
b.
2S

30

bogun 1:11 1953, supportod by tho Board of

Diroctora' nooonroh Fund. Supported by Nationul Institute
of Mental Honlth Fund, Soptombor l, 195k - August 31, 1959.
Study continuing with support of grant MI-2715, United Statos
Public Health Sorvico (Jan. 1, 1959)

�Acknowledgment

studies reported here would not have been possible
without the faith and support or the Founder at Hillaide
Hospital, Dr. Iorael Strauss, the Board of Directors and tho
Administrator, Hr. Maurice Bachraoh, who auetained this
program during its early vicissitudes.
Financial Support was also given during this period by
the Kaufman Foundation, the Foundatione' Fund for Research in
Psychiatry, the Daaian Foundation of New fork; the following
pharmaceutical firms: Smith, Kline and French Laboratoriea,
Wyeth Laboratories, Geigy Pharmaceuticals, and Bristol
Laboratories; and the Mental Health Board of Nassau County.
The

�SUMMARY

14-927
19Sh - 1959

laboratories of the Departnent of Experimental Psychiatry
were established at hillside Hospital in September, 195k. During
this five year period neurophysiologic, psychologic (personality
and perceptual), lingustic, and socioloéic aspects of "somatic"
psychiatric therapies have been the principal foci.
The

1.

Convulsive Therapy:
The view of the convulsive therapy process as the induction
or a non-specific state or altered brain functbn, similar to.

craniocerebral trauma (10, ll, 21) was supported and amplified
with this altered cerebral milieu, subjects were seen to respond
in various ways (26) of which the most successful was explicitf
verbal denial (7, 31). This latter was most prominent in
characterologically disposed individuals (36).
in alteration in brain function was pro-requisite to
behavioral change (7, 8, 11, 26). Grand mal seizures were
this
to
essential
process (26) but electrical induction was not
(Boh2). Such alteration in brain function was measured by
various ways including electroencephalography (6, ll, 12, 2h, 39,
language patterns (h, 7, 1h, 31, h}, B-Zh), perceptual tasks
(2, 16, 17, 37, hé, 8-26, h1, h?) and tests of recall.
A variety of behavioral changes were seen during convulsive
therapy (26, 8—17). Such patterns were lbwed as adaptations to
altered brain function,wand were believed dependentlupon
Refcrbnce nunEers are to publications or presentations (5- I
listed in the appendix.

�characterologic and environmental factors (7, 25, 26, 36, ho).
Clinical ratings of improvement were seen as value Judgments by
the observer of the behavioral changes in the subject (26).
Adaptations characterised by denial mechanisms, both in behavior
(3—17) and in language a, 31) were assessed with the best rating
of improvement. Such adaptations were noted to be related to
habitual nodes of conduct (character, personality) (36, Bull,
‘

32).

durability of the altered behavioral nodes was seeh‘.
to be dependent upon such factors as the degree and duration of
altered brain function, the environnental expectations, and the
type and degree of family and medical support. Different
behavioral patterns were best supported by varyinc types of
The

psychotherapy (19).

It

also suggested that the neurophysiologicgbasis or
convulsive therapy nay lie in an alteration in central synaptic
cholinergic ~ adrenergic relationships, with a predominant
shirt to increased cholinergic activity as the operationally
significant pattern. Such interpretations were based on the
relationship of high voltage EEG slow wave activity to behavior!
change (6, ll, 26) and the blocking of the electrographic and
behavioral changes in central anticholinergic agents (21, 3h, 35
hl, ht) and by central synpathonimetics (ha).
Heasures of linguistic behavior in structured (7, 31) and
unstructured (1h, 29, B-2h) interviews showed characteristic
was

�-

3

-

alterations towards increased denial, minimisation, displacement,
stereotypy and repetitiveness, related to the degree of altered
brain function (B-Zh). These changes were blocked or reversed
by anticholinergic hallucinogens (21, h3).
Various perceptual tasks provided indices of behavioral
change and were related to the degree of altered brain function.
These included the perception of simultaneous tactile stimuli
(17), snbedded (Gottschaldt) figures (37, 8-16), and tachistoscopically
exposed words (37) and embedded color figures (hl).
Sociopsychologic aspects of age, years or education, nativity
and degree of stereotypy and sonventionality (measured by
California F Scale) were also studied and were related to selection
or therapy, duration of hospitalization, diagnosis and treatment
response/ in hospitalized patients (15, 36, ho, hS).
2.
Neurophysiolegic~Adaptive Hypothesis of Somatic Therapy.
Based on these studies, a hypothesis of the node of action
of other psychiatric therapies such as insulin coma, leucotony
and psychotropic drugs, was expressed (10, 33, 38). This view
holds that these therapies are also methods of inducing varying
states or altered brain function, in which varying adaptive
patterns may become prominent. The adaptive pattern is viewed
as dependent upon the type, degree and duration of altered brain
function, the personality of the subject, and tolerances and
expectations of the environment.
Examination of this hypothesis as applied to drug therapies
is now in progress, supported by USPRS grants HI-2092 and
HI-2715.

�Insulin Coma Therapz.
in initial case description (3) showed the significance of
denial patterns and persistent altered brain function to the
behavioral change in this form of therapy.
In an insulin cons - chlorpronazine control study (27),
no differences in hospital improvement ratings were observed in
the two treatment groups. Chlorpronazine was safer, easier to
administer, permitted continued adninistration and allowed for
greater degrees of concurrent relationship therapy than insulin
coma. These observations led to a replacement of insulin come
3.

by psychotropic drugs in

h.

this institution.

Pharmacotherapz.
Also derived from these hypotheses

is the

ongoing program

in evaluating various psychopharnaceuticals. Electrographic
and linguistic analyses of effects of acute intravenous
administration and chronic clinical administration of various

are in progress. EEG patterns, along such
continua as synchronisation~desynchronisstion, and frequency
shift are being related to behavioral (21, 3h, bl, ha) and
linguistic changes (21, h3);
The neurophysiologic basis of experimentally induced
hallucinogenic states have also been interpreted as an alteration in synaptic chemical relations, such that the effective
levels of cholinergic activity is decreased (h2). Initial work
on this hypothesis (
) is now being expanded.
new compounds

�.32..

In addition to these phenomena, other patterns of language and non-

verbal aspects of behavior have been observed which can also be understood as
symbolic forms of adaptation to illness. These include the syntactical use of
the second and third person, changes in mood, withdrawal and selective inatten-

tion, and alterations in sexual behavior (6).
in enduring fashion in patelectroencephalographic records indicated diffuse cere-

These types of behavior have been observed

ients

whose

lesions and

bral dysfunction; In patients with brain damage who did not Show delusional
denial and disorientation on ordinary clinical examination, the phenomena might
be

elicited in

sodium.

an interview following the intravenous administration of amytal

This observation furnished the basis for the ”amytal

test" for brain

disease in which the persistence of certain patterns of denial and disorient-

ation is considered an indication of cerebral dysfunction (h,5).
In considering further the relationship between brain damage and the
mechanism of denial

it

has been demonstrated

that the premorbid personality

important in determining what type of symbolic adaptation occurred.

Thus,

was

pat-

ients with the most striking and enduring manifestations of anosognosia were
those who had habitually used verbal denial and rationalization as a means of
coping with
On

their

problems (10).

the basis of these observations the hypothesis was developed that the

of
creation
the
convulsions
in
induced
lay
of
action
electrically
therapeutic
a milieu of brain function in which the patient might express his problems in
symbolic fashion, particularly in

the form of

explicitly

denying them.

A

case

reported in which a patient received electroshock treatment in an attempt
to relieve intractable pain associated with a Spinal cord tumor (11). After

was

a number of treatments, coincident with the appearance of disorientation for

state, the patient dennot clinically apparent they

a place and time, paraphasic misnaming and a euphoric

ied pain.

‘dhen

these associated.phenomena were

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67354">
                <text>Relation Between Altered Brain Function and Denial in Electroshock Therapy (research), 1955-1959</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67355">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67356">
                <text>mfp-03-01-002-2-002</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67357">
                <text>1955-1959</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67358">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67359">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67360">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67361">
                <text>Research papers, files, and related correspondence: research with Robert L. Kahn, and Edwin A. Weinstein</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67362">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67363">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80938">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87499">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94060">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100621">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6737" public="1" featured="0">
    <fileContainer>
      <file fileId="6537">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/4e44a5022aa24b8167f7810c1ba666eb.pdf</src>
        <authentication>6c8bb654be03cc6faa66ea6f3e6b84ab</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107142">
                    <text>��mm“mh«f.~«»-MM

���Patients with High Delta Activitv during Second, Third

Weeks of

ﬁeatmnt.

Clinical Katina
EEG

Delta

Both High
High

One

None

[ﬁramwr

-

high

Moderatelz Imgroved Unimproved

Much ImEroved

(18)

12

(67%)

h (22%)

2 (11%)

(16)

h

(25%)

8 (50%)

h (25%)

('20)

6

(30%)

7 (35%)

7

7mm]

-

(35¢

��Clinical

Ratings Cogpared to

EEG

and Amobarbital Test Results

much Improved

High

Delta and Positive

Amobarbital (29)

Either

High Delta or

Amobarbital (26)

Positive

Neither High Delta nor
Positive Amobarbital (36)

[arm

- x7414]

Moderately Improved

Uhimproved

25

3

1

10

ll

5

5

10

21

�and
Ruth.
Mt:
M
(29)

man:

or mum
Mu
('16)

mm
may am: at

num- Etc:

man Mm
mg:

(36)

�mm.
(29)
min:
mm: W mu a:- mum
-

Mus m!

“WW“!

(3%

�EEG

Delta - Amobarbital Test
Delta Activity; Records
Middle
Low
High
EEG

Amobarbital Test

Positive
Negative

[ﬁﬂ'ﬁ/

-

Ifxg'

(15)
(346)

29

8

8

10

16

20

�(cast
rbi
Positive (’35)
,

(M)

negative

,..
!

i

,‘

[I

\
.

I

A

’

H'
-,‘

I
x

‘\\|
x\.‘.
\

x

K

i
r
‘

1

(j.

‘\

;

1

I

z

E

10

16

20

��A.m..‘+l__-.A_MA;.“__

A...

&lt;

�;

a

M

���uhL—JCICHXU
m
I

Prepared by
“MS WEEK

IN CHICAGG

{DE—JD
C)

{SINH

“ﬁg“

“UL—:X‘Cl

A W «LE

.00

N

��MURRAY

11an 8-2077

S. F. KURZER

VICE-PRESIDENT IN CHARGE OF SALES

GRUNE 8: STRATTON
MEDICAL PUBLISHERS

381 FOURTH AVENUE
NEW YORK 16. N. Y.

���M
Merri/ébﬂ
M

HOTEL

WILLIAM HENNING RUBIN

PRESIDENT

FAMOUS FOR THE

"5""

OZMMMC

'

—

CHICAGO
JOHN B. GRANDE
GENERAL MANAGER

WHERE FAMOUS PEOPLE EAT

���ESRA No.

37

1957 Program

-1-

ELECTROSHOCK RESEARCH ASSOCIATION

SCIENTIFIC SESSION-

Thirteenth Annual Meeting
Sunday,

May

12, 1957

Hotel Morrison

Chicago,

Illinois

Chairman: Ernest B. Parsons, M.D., Pres.

Cotillion

Room

A.MJﬁ:
9:00

Registration

\v

9:30 A.M.'

1.

9:45
10:00

2.
3.

rNeurophysiology
Studies of EEG change with EST with or without Atropine
in Man and Rat. Tetsuo Fukuda, M.D., John A.
Stern, Ph.D., George A. Ulett, Ph.D., M.D.
Discussion opened by: Bernard L. Pacella, M.D.

.

A.M.

A.M.

.

15A
X/
MIL
u
10:
Mm"

“2?? 30
W1?

A. M.

Psychological Aspects
Personality Factors affecting Clinical Responses to
Electroshock Therapy. Robert L. Kahn, Ph.D., Max Fink, M. D.
An Evaluation of the Peculiar Selective Quality of Pos
Electrotherapy Amnesia. Aloysius S. Church, M.D., 5}t
Psychopathology of Electroshock Therapy.

W“
,,.

10:h5 A.M.

Bernard L. Pacella,
Discussion of 2, 3,

5.

11:15 A.M.

Technigues
Current Patterns in Cerebral Electro-Therapy.

6.

11:30 A.M.

l1:45

A.M.

M.D.
&amp;

4 opened by: Leo

Alexander,

M.D.

Gerhard

Hirschfeld, M.D.
Further Studies on the Analeptic Action of Peripheral
Electrical Stimulation in Hypoglycemic Coma.
Charles H. Jones, M.D.
Discussion of 5 and 6 opened by: William L. Holt, M.D.
R.

Embassy Room
P
12:30 to 2: 30 PM
105/”

Annual Luncheon and Business Meeting.

�'

-1-

EJJ
..

»

.u

...,

111'. .j,.
.

.

4

.

,.‘... ,,

-

.

v

7.
‘

6‘

r:

.

.

-.

-

....£x~
~

.

.“-

.

.."

'

‘

.

-.

‘

;-‘

.
'

.

,..

...

'

-.

: I

,

.-.

..‘

d.I

’

"x
-

s

1'
.-

.,

L

«i=2»

'_

"

.
.

f‘:

.1)-

1'!

1

~

I

\

WOV'.J“%£M{1A

..

‘

t

4.
'-

.'

.

:-

.-

.-

\‘J.'\
.r.
.

‘

:'

..:.'.-.3
.~...
.. .. ”-0.“.-.

:

.

'

.

n}.
I

.

.

-,-.L

z

.‘

'

.

1‘

'

.

‘

‘

.

5“ma...—
’

‘I

‘

-

--

‘

'

"
'

.

.

�ESRA No. 37

Cotillion

1957 Program

-2-

Room

7.

2:30 P.M.

8.

2:45 P.M.

9.

3:00 P.M.
3:30 P.M.
3:#5 P.M.

10.

4:00 P.M.

ll

#:15 P.M.
#:30 P.M.

Clinical Aspects
Clinical Applicationscﬁ'Nonconvulsive Electro-Cerebral
Stimulation. John D. Moriarty, M.D.
Indications for Electroconvulsive Treatment in Office
Psychiatric Practice. Paul H. Wilcox, M.D.
Discussion of 7 and 8 opened by: David J. Impastato, M.D.
The Use of Electra-Cerebral Stimulation in Mentally
Defective Patients. Harold H. Berman,M.D., Milton
’

Jacobs, M.D., and Joseph Spielman, M.D.
Discussion opened by: Charles Buckman, M.D.

Drugs and ECT
A Comparative Evaluation of the
Safety of the Use of
Chlorpromazine and Reserpine in Conjunction with Electroshock Therapy: A Review of the Literature and a Clinical
Report. David J. Impastato, M.D., Seymour Berg, M.D.,
Anthony R. Gabriel, M.D.
Electroconvulsive Therapy Combined with Chlorpromazine
and Reserpine. Frank J. Ayd, Jr., M.D.
Discussion of 10 and 11 opened by: Herman C. B. Denber,M.D.

����___.._——.————~—————-————-——————

_m,

—-———~———_.———..——————-————-——-———

�mm“.
Wm
-_

w—

_———~——————————_—
!

—-——-————-—————__—____.__.._.—

p.4—

““—.—

__.._._____.. ————————————___——-——____—._— _____
‘

. __

__

~

___.___ .____ ._..._ _ ...___.__._.

.—

���w v«w
1.

w

VW. .

,_

. . wv

ﬂ

.

9
«x;

M“
a?

s.

ks

\

x\

W”.

x

‘

\

tn

.\n.

as

.9:

���l

L.

.

x,

93‘1“”

nerT/‘wr'y

.

‘

V.

t

i

Mm,»
,‘(Z

R

�rwﬂ‘mrﬂ~“w~&amp;uwwé_é&lt; Wn:~'5~‘~".m
.

l

_

__-.

A—e

,...r‘_;..,1...

,

�PUBLISHED BY INFORMATION SERVICE

VOL. 9, NO. 10

OFFICE OF THE MEDICAL DIRECTOR

Available to non-members at 35.00 per year.

JUNE-AUGUST 1957
(SUMMER EDITION)

Dr. Alan Gregg Dies

APA Honorary Fellow Dr. Alan Gregg died at his
home in Big Sur, California on June 19 at the
age of 67.
He served as Vice-President, Division of Medical
Sciences, Rockefeller Foundation for two decades and
in this position of national leadership made
psychiatry
one of his major interests. Few men have had so profound an effect on the advancement of medical sciences
as he. He will be sorely missed by physicians the
world over and by psychiatrists most particularly.
NINTH MENTAL HOSPITAL INSTITUTE

For the ninth year over 400 staff people from all
types of mental hospital installations in Canada and
the U. S. will come together at the Hotel Cleveland,
Cleveland, Ohio, Sept. 30 Oct. 3 to consider common
problems and directions of progress. Major topics at
this year’s Institute will deal with the problems of the
open hospital, revision of commitment laws, management principles, role of private hospitals, mental
deficiency as a psychiatric problem and many others.
Prof. James L. Hayes, Department of Business Administration, St. Bonaventure University, will deliver the
Academic Lecture. The enrollment fee is $50. See
program and registration form in Mail Pouch.

-

All who plan to present papers at the 1958 Annual
Meeting in San Francisco please note Form for submitting proposals to the Program Committee in the Mail
Pouch this month.
NOTICES
1. THE ANNUAL APA DESK APPOINTMENT
BOOK FOR 1958 WILL BE OFF THE PRESS THIS
SUMMER. USE ORDER BLANK IN THE MAIL
POUCH. DEMAND EXCEEDED SUPPLY LAST
YEAR. SUGGEST ORDERING PROMPTLY. ($3.00
PER COPY).
2. WE HAVE A FEW HUNDRED COPIES LEFT
OF THE BOOK OF SUMMARIES OF SCIENTIFIC
PAPERS OF 1957 ANNUAL MEETING, BUT THEY
ARE GOING FAST. ($1.00 PER COPY).

THE

AMERICAN

—

GRADUATE TRAINING IN PSYCHIATRIC
HOSPITAL ADMINISTRATION
Two outstanding courses in psychiatric hospital
administration are now available and merit the attention
of all psychiatrists concerned with advancing professional standards in this area. One is at Columbia
University and the other at the Menninger School in

Topeka.
The Columbia University Course
This course, which leads to a Master of Science
Degree, is under the auspices of the School of Public
Health and Administrative Medicine and the Department
of Psychiatry of the Faculty of Medicine. It encompasses basic courses in administration, specialty
courses in the Department of Psychiatry, and supervised
field work.
Recognizing that mental hospitals are hard put to let
a staff doctor leave for prolonged periods, Columbia
has made every effort to tailor the course to meet candidates’ needs. It extends over 20 months, but
ei ht of these are in academic residence broken into
four quarters of 2 months each. The preferred plan is
for the candidate to spend four months in academic
residence, followed by 12 months in a supervised administrative residency or in a position already occupied by the candidate during which time he may carry
out a special project. This is followed by a final four
months in residence. For candidates who already
occupy key administrative posts and who cannot be
away for more than one quarter at a time, special
arrangements can be made.
As for costs, each candidate’s need is likewise
evaluated individually. The total tuition for the 8
months of academic residence is $900.00 and Public
Health Service stipends are available which will pay
this plus ordinary living costs. Frequently, state
funds in the state where the candidate works, are
available to pay travel costs.
There are some openings for the year starting in
Sept. Write for details to: Exec. Officer, School of
Public Health, Columbia University, 600 W. 168 St.,

M

PSYCHIATRIC

.

ASSOCIATION

Office of Medical Director, I785 Mass. Ave., N.W., Washington 6, D.C.
Canada Office, 2I6 W. St. Clair Ave., Toronto 5, Ontario
Office of Executive Assistant, I270 Avenue of the Americas, New York 20, N. Y.

PLEASE ADDRESS ALL NEWSLETTER COMMUNICATIONS TO OFFICE OF MEDICAL
DIRECTOR

�The Menninger School of Psychiatric
Hospital Administration
This School offers a one-year integrated course,
leading to a Certificate, which draws on the resources
of the Menninger Foundation, Winter V.A. Hosp., and
Topeka State Hosp., supplemented by other Kansas
state hosps. and schools, an industrial concern, a
general hospital, two universities, and several state
government agencies.
The curriculum consists of didactic instruction in
basic administration while clinical experience is provided by systematic rotation in the departments of participating institutions accompanied by seminars with
department heads and special projects.
With regard to costs, applicants may apply with state
sponsorship. The sponsoring state may pay the stipend
with the understanding that the applicant will remain in
the employ of the state after he completes training. A
limited number of stipends at $625 a month are available
to unsponsored applicants.
The next course starts in September. For full information write to the School, Menninger Foundation, Topeka,

necessary. (work on the new home is expected to start
this month. Hope is to have it finished by January 1). .
Approved setting up separate fund for receiving miscellaneous gifts (such as royalties from publication of
lecture series of North Shore Hospital) with proceeds to

.

be used to add to APA library. . . . Authorized and appointed Committee to work with planning group for the
Jamestown Festival this fall which will celebrate
Williamsburg State Hospital, the oldest in US. Drs. Zigmond Lebensohn, David Wilson, David Young, and R. Finley Gayle, Jr. are on the Com. with Robert L. Robinson of
this office as advisor. . . . Approved contribution of $50
to the National Society for Medical Research. . . . Continued APA membership in the World Congress of Psy-

chiatry. . . . Designated Francis J. Braceland as official
delegate to the General Assembly of the International
Society for the Organization of World Congresses of Psychiatry. . . . Approved in principle proposed constitutional
amendment prepared by the District Branch Assembly regarding election to membership in APA through the
Branches; and also another proposed amendment incorporating present practices regarding creation and operation of District Branches. . . . Approved recommendation
Kansas.
of Medical Director to consolidate all central office
APA Position
services for mental hospitals and to explore ways to
Our Association has always insisted that Supts. and
finance increased services in this area. . . . Suggested
Med. Dirs. of institutions for the mentally ill should be
appointments of APA representatives as follows: Dr.
Frank J. Curran to World Federation of Mental Health
psychiatrists. In doing so, however, it rec0gnizes the
need for special training in administration for those who meeting in Copenhagen; Herman C. B. Denber to Congres
de Medecins Alienistes et Neurologistes de France et
wish to qualify for these positions.
des Pays de Langue Francaise at Lyon, France; Rudolph
The courses described above have been established
with the encouragement and support of the Committee on C. Novick to Advisory Com. of National Congress of
Certification of Mental Hospital Administrators. Only a Parents and Teachers. (These appointments were made
handful of psychiatrists have completed them thus far.
by President Solomon). . . . Recommended to Council
The courses are expensive for the sponsoring agencies to reappointment of Dr. Henry Brosin to the American Board
of Psychiatry and Neurology. . . . Directed that problem
offer and experienced persons have put great effort into
of improving dental care in mental hospitals be explored at
curriculum development.
Commissioners, superintendents, and others in admin- next Mental Hospital Institute. . . . Received announceistrative positions, as well as those who aspire to these ment of retirement of Dr. Frederick L. McDaniel as CIB
positions, would do well to give serious thought to sign- inspector and expressed appreciation for his services over
five years. . . . Changed dates for fall Council meeting to
ing up for these courses. Available financial support
should be an encouraging factor.
November 23-24 (Sat.-Sun.) in Boston, Massachusetts. . . .
Selected Saturday, October 26, as date for next meeting of
NIMH GETS $4 MILLION INCREASE:

The US ConngS}.

has voted $39,217,000 for the Nat. Inst. of M. H. under/h"
Robert Felix’ direction. This is $4 million more than/
last year—remarkable in view of general economy dri e.
Testimony of Dr. Braceland for the APA and Mike Go
of National Committee Against Mental Illness played i portant part in explaining need for additional monies in
these areas to the Senate and House Committees. Senator Lister Hill and Representative John F ogarty, always
strong supporters of mental health, spearheaded the effort
to get the appropriations through Congress.
EXECUTIVE COMMITTEE ACTIONS

them

\

O A pilot training and research program stressing the
interrelations of biological and physical sciences as
key to better understanding of the nervous system and
human behavior has been set up at Albert Einstein Coll.
of Medicine, Yeshiva Univ., (Eastchester Rd. and Morris
Park Ave., N.Y.C. 61) with a $1,700,000 grant from the
Nat. Inst. of M.H. There is provision for 36 pre- and

st-doctoral fellowships. The grant covers a six-year
d. Write to Labe Scheinberg, M.D., Dept of Mediher details.
°

FALL COMMITTEE MEETINGS: Woodner Hotel, WashThe Exec. Com. met at the APA Central Offices June ington, D. C. The following Committees will meet all
29. (Unusual and pleasant feature was that most of the
day on Friday and Saturday, Oct. 25-26: Standing Coms.
APA staff members attended to become better acquainted on Technical and Community Aspects and Professional
with the Com. members and general affairs of the AssoStandards. Also Standing Coms. on Budget, Ethics,
ciation.) Among other things, the Com.: With regard to
Program and Nominations. Ad Hoc Coms. will meet only
financing remodeling of new home, delayed taking out any on request of the Chairmen and with clearance of the
mortgage unless and until expenditures appear to make it Coordinating Com. Chairman to whom they are assigned.

.

�~\

The Council this year will not meet to receive Committee
reports until November 23-24, but the Executive Com.
will meet with the other Coms. on Sat., Oct. 26.
Canadian Mental Hospital Institute
Plans for the first Canadian Institute are shaping up
nicely. It will be held at the King Edward-Sheraton
Hotel in Toronto, Jan. 20-24, under joint auspices of
APA and the Canadian Psychiatric Assn. This Institute
will be patterned after the U.S. meetings. Major theme
will be “The Mental Hospital and the Changing Community," Dr. Mary Jackson is Chm. of the Program Com.
with Drs. C. Buck, W. Boothroyd, J. Griffin, J. Hagan,
A. Miller, D. Lewis, and Drs. C. Roberts and J.Gilbert
of the M.H. Section, Dept. Nat. Health and Welfare as
advisors. Since it will have a clinical orientation, this
first Canadian Institute is planned for psychiatrists in
senior posts in all types of Canadian mental hospitals
and for the administrators of Federal and Provincial
mental hospital systems. More details in the fall.
New Printing of Glossary
With the first printing of 30,000 copies of A Psychi-

ASSEMBLY OF D,B, NOTES . . . .Met May 13-14 during
Annual Meeting. . . . Installed following officers for
1957-58: David C. Wilson, Speaker; Walter H. Obenauf,
Deputy Speaker; John R. Saunders, Recorder; Policy Com.,
(Area I) Albert M. Biele, Frank P. Pignataro (Alt.); (II)
Lester E. Shapiro, Ulysses SchutZer (Alt.); (III) J.G.N.
Cushing, Edward H. Williams (Alt.); (IV) James L. Sagebiel, G. Wilse Robinson (Alt.); (V) Alfred Auerback,
Edward G. Billings (Alt.). . . . Volunteered to assist Med.

Dir. in obtaining accurate information to publish obituary
notices in Newsletter. . . . Revised Procedural Code. . . .
Suggested Council action to seek extension of MEDICARE
program. . . . Commended Dr. Wilson for Assembly exhibit
at Annual Mtg. . . . Decided to study inspection of psychiatric facilities and depts. of psychiatry in gen. hosps.,
and facilities of public mental hosps. . . . Submitted two
proposed Constitutional amendments for consideration by
Council. . . . Will investigate planning of Divisional
Meetings. . . . Scheduled next mtg. for May 12-13, 1958
at St. Francis Hotel, San Francisco.

PERSONALS. . . S. Spafford Ackerly was honored by a
atric Glossary exhausted, a new printing of 22,000 copies Testimonial Dinner on June 19 in recognition of his 25is now available. A limited number of copies have been year contribution to psychiatric education and community
health in Louisville and Kentucky. . . . Paul V. Lemkau
made up with a hard-cover library binding for libraries
has
returned
to Johns Hopkins Univ. as Prof. of
and others who would like it in more durable format. The
Public
Health Admin. (mental health) at School of Hyhard-cover copies have no cover design—merely the
8:
Public Health following a 2-year leave of
giene
of
title the book. They sell for $2 per copy. The paperbound edition remains at $1 per copy. Order from Mental absence. . . . Baruch Silverman was presented a Canadian
Mental Health Award on Apr. 17 in recognition of “his
Health Materials Center, 1790 Broadway, N.Y. 19, N.Y.
outstanding contribution to the mental health of the CaDid you know that the following Isaac Ray Award
nadian people,” . . . Alan D. Miller, Dir. of MH Study
Lectures had been published and are available through
Center of Nat'l Institute of Mental Health, was transferred to England on June 18 for advanced study and reany bookstore? The Psychiatrist and the Law, byL
Overholser, 1953; Psychology of the Criminal Act and
search. Stanley F. Yolles has succeeded Dr.Miller as
Punishment, G. Zilboorg, 1954; The Guilty Mind: PsyDir. of the Center. . . . Major admin. appointments in N.Y.
chiatry and the Law of Homicide, by judge John Biggs
State on July 1 were: Arthur G. Rodgers (LF) as Dir.
of Syracuse State School; Ulysses SchutZer as Dir. of
Jr., 1955 (all these by Harcourt Brace 8: Co.); and The
Urge to Punish, H. Weihofen, 1956 by Farrar-Straus and
Binghamton 8. Hosp.; Charles Greenberg as Senior Dir.
Cudahy. The latter publisher will also publish the
of Rome State School; and William C. lohnston as Dir.
lectures by Dr. Philip 9. Roche given at the Univ. of
of Craig Colony. . . . Franz j. Kallmann received an
Michigan this year.
honorary medical degree as one of 6 scientists in differfields
honored
ent
Third
so
Int'l Congress of Medical
at
The
General Practitioner Education Project now operQ
Arts,
Turin,
Italy
during
1-9.
June
program,
. . .17;
from
the
Office
Central
E.
ating
(Charles
Goshen, Projand
Gantt
Harold
Horsley
Rosen
were Visiting Professors
would
information
about psychi- for
ect Director)
appreciate
2 weeks this spring at Univ. of Arkansas Dept. of
atric courses for GPs now in planning stage. It is sugDon
D.
Psychiatry.
.
.
.
Jackson appointed Asst. Clin.
gested that when a course is being planned effort should Prof. of
Stanford
Univ. Med. School and
Psychiatry
at
be made to have it approved for credit by the Amer.
elected
of
Pres.
Mid-Peninsula
Psychiatric Soc. . . .
of
Acad.
General Practice (through its local or state
William H. Kelly has accepted position of Asst. Dir. of
branches) as inducement to attendance. Dr. Goshen
of Mental Health and Head of Mental Hygiene Div.
Dept.
will be glad to assist in publicizing such courses.
for State of Michigan.
0 The Smith, Kline and French Foundation Fellowship NEW PRESIDENTS 8: SECRETARIES
. . . Ark. D. 8.:
Committee awarded 19 new Fellowships in May. 13 of
Robert
G. Carnahan &amp; Leroy D. Lamm. . . . Cent. Calif.
them will enable medical students to participate in reWilliam S. Fife &amp; Arnold Sheuerman, Jr. . . . N_o.
D.B.:
search and training programs this summer. Among other
Calif. P. Soc.: Thomas A. Gonda 8: Maleta Jo Boatman.
Fellowships announced, one doctor will study research
. . . .Kings County (N.Y.) D.B.: Morton H. Hand 8:
organization at Boston Psychopathic Hosp., another will Abbott
Lippman.
. . . Hawaii P. Soc.: Robert A. Kimtake a Master’s degree in public health, and two lecture- mich
8; Robert S. Spencer. . . . Md. D.B.: Leo Kanner &amp;
ship programs will be established. Applications for
Charles Ward. . . . No. Pacific D.B.: Herman A. Dickel
consideration in October this year should be submitted
8r D.E. Alcom. . . . Quebec D.B.: Graham
8;
Taylor
16.
and
Information
forms
by September
application
may Henry Kravitz.
. . NP Soc. of Va.: Thomas F. Coates,
.
be obtained from the Fellowship Committee, Box 7929,
&amp; W.D. Buxton. . . . Washington P. Soc.: Seymour
Jr.
J.
Philadelphia, Pa.
Rosenberg &amp; Marvin L. Adland. . . . Del. P. Soc.: George

I

�DeCherney 81 Walter Davis. . . . East Bay P. Assn.:
Louis B. Boyer &amp; Marion E. Roudebush. . . . Long
Island P. Soc.: Edgar D. Congdon 8: Harry H. Gonda. .
Milwaukee NP Soc.: David Cleveland 8: Edward C.
Schmidt. . . . No. Pacific Soc. of N&amp;P: D.E. Alcorn &amp;
Robert M. Rankin.

of P. at the Univ. of Miss. under Floyd Moore and Oscar
Hubbard. Also visited State Hosp. at Whitfield where
. Wm. L. Jaquith and John Head have built up a fine program since 1949. They have a high patient turnover now
and a new building for maximum security patients especially worth seeing. Also renewed acquaintance with
Beverly Smith and Willard Waldron in Jackson. . . . On
BRIEFS. . . . All who attend the World Congress in Sept.
June 21 went to NY to speak to Bd. of Directors of
will be glad to hear that Nat’l Committee Against
N.A.M.H. APA members present were Hon. Fellow Mrs.
Mental Illness, Inc. has (through APA) made funds availHenry Ittleson, Walter Baer, G.S. Stevenson, Jules
able for simultaneous translation of papers. . . . Herman Coleman, Marion Kenworthy and Paul Lemkau. Was
B. Snow, Supt. of St. Lawrence State Hosp. in NYS,
pleased by much support from the floor for closer ties
writes that 90% of his patients are in open wards exand strong Support for APA’s programs. . . . On June 28
cept at night. . . . Iago Galdston, Chm. of Com. on Int.
joined Ewen Cameron’s Com. in Boston on future planRels., has sent over 100 copies of the Summaries of
ning for the CIB in Pres. Solomon’s office. Drs. BarteAnnual Meeting Papers to colleagues abroad. . . . I have meier, Ewalt, Braceland, and Yerbury also there. . . .
prepared a little pamphlet about my favorite vacation
Flew back to Washington to meet with Joseph Barrett on
haunt called ”Day Sailing and Cruising in Mahone Bay,
planning for celebration of opening of Williamsburg
N.S.” and I’ll send you a copy if you write. . . . Chas.
State Hosp. (1773) in conjunction with Jamestown FestiBush and David Gaede are inspecting hosps. in Mich.,
val this October. . . . After the Exec. Com. mtg. Pres.
having just finished up in Mo. Hope to start in NYS in
Solomon and I flew to Nashville to participate in dedicaa few weeks. . . . Warren Johnson, my asst., recently
tion of magnificent new admission and treatment building
conferred with Cyril Ruilmann, F. Williams, and O. S.
at Central State Hospital named after the Supt. O. S.
Hauk in Nashville on psychology legislation in Tenn. . . Hauk. Wm. S. McCullagh, Pres. of the So. Psychiatric
Smith, Kline &amp; French Labs. have just granted $10,000
Assn. and Frank Luton also were among the speakers.
to the Nat. Acad. of Relig. and Psychiatry for fellowAsst. Supt. White presided and Cyril Ruilmann introships for clergymen who want to become mental hospital duced the speakers. Gov. Clement gave the main
chaplains (there are over 300,000 clergymen in the
address. The Tenn. program has improved remarkably in
country). . . . Sorry to hear of the death in June of Miss
the past two years. . . . Forgot to mention last month that
Dorothy Clark who rendered such valuable service as
in course of Mental Health Week speaking tour I particiAPA Nursing Consultant from 1949-1951. . . . Write to
pated in inspiring award ceremony for employees at St.
Dr. Leo Alexander for details about the fifth Annual
Louis State Hosp. where over 700 have served for 10-25
Institute of Psychiatric Treatment to be held in Philaof
Nurses
Dirs.
his
Kohler,
Supt.
Congratulated
years.
delphia Oct. 17-19. . . . A lady reporter at the Ann.Mtg.
and Volunteers who organized the program. . . . Mike
in Chicago was overheard to say, "Next to the White
Gorman and I had stimulating talk with Robert Felix and
House crowd this is the nicest group I’ve met.” . . . .
Seymour Vestermark recently concerning NIMH programs
Chas. Goshen and I attended meeting of APA Liaison
in coming year which will be expanded with increased
Com. with Amer. Acad. of General Practice in NYC to
appropriations. . . . Also attended meeting of Wyoming
discuss Gen. Practitioner Educ. Project. (R.Matthews,
Valley M.H. Soc. in Scranton, Pa. where I met APA
Chm., Frank Luton, Phineas Sparer, and Merritt Foster
members Robert C. Murphy and Emlyn T. Davies. . . .
were there for APA)....On June 6 spoke at Ann. Mtg. of
Received notice this month that NIMH Advisory Council
the M.H. Soc. in N.J. and on the 10th at the opening
had turned down our application for renewing M. H.
session of the M.H. Institute at Lansing, Mich. where
Architecture Study grant; but funds are available to
V. A. Stehman had brought in representatives of all Mich. continue it to end of
and in meantime effort will be
year
hospitals. It was an outstanding meeting well attended. made to find other ways of keeping it going. . . . Expect
. . . Went from Lansing to Battle Creek with E.F. Jones,
to be off to Mahone Bay, Nova Scotia by end of month for
Mgr. of VA Hosp. there, and showed his staff pictures of a few weeks of sailing and loitering. . . . Happy vacationforeign hospitals. . . . Did same thing for residents at
ing to you all. . . . The next Newsletter will be in Sept....
Ray Waggoner’s Institute in Ann Arbor a few days later
where also talked with Moses F rohlich who (as Chm. of
Com. on Nomenclature) is hard at work on system for recording case data on IBM cards. . . .With Robert L.
Robinson met in Toronto with Program Com. for Canadian Mental Hosp. Institute to finalize details on June 21
and was also able to visit Homewood Sanitarium at
Director
Medical
Guelph (A.L. MacKinnon, Dir.) where the Ontario Psychiatric Soc. was meeting on the 22nd. . . . Also recently
spent several days in Conn. with Chas. Bush where we
consulted with the Governor on the mental health prohas
Blasko
that
reJohn
there.
to
Sorry
report
gram
signed the Conn. Commissionership for another job; but P.S. Don’t forget to order
of
the
Desk
1958
copies
your
his efforts to have the law changed to give the Commisand
Book
of
Summaries
the
the
(33)
Appointment
have
been
successsioner more administrative authority
Scientific
before
the
(81)
Papers
supply runs out.
the
19
On
Dept.
visited
expanding
rapidly
ful. . . .
June

�����WV-..— -»——————.

———_,—_a—.__.._—_,-__ ._________, __._ —_________.___._. _

__

.__- .__.__._. _____... —*_

��October, 1956

vs

Age
EST # 1 &amp; 2

-

h

Below

115

us yrs.

over

Changes

- Reiter -

£9

pts.

6

7
H

L

M

5

S

8 (id—ﬂ)

7

3

10 (50%)

13

5

10 (35%)

6

h

19 (65%)

L

yrs

50

over

yrs

8:

Distribution

Age

—

H

M

8

h

16 (57%)

12

3

6 (28%)

5

3

13 (61%)

-

EST 1 &amp; 2

patients

h9

5

3

31

-

[10

yrs.

1

3

I41

-

SOyI‘S.

ll

yrs.
over

-

6

5

10

2

3

Reiter vs Medcraft -

.ii:;.L_
Reiter

(EST # 2)

H

12 (h8%)

yrs.

yrs

M

7

30

&amp;

L

6

-

61

H

7-2

20

51 " 60

9

M

h-6
Below 50

-

L

yrs.

&amp;

EEG

25

Medcraft (EST # 3) 16

ptS.

pts.

LWC

-

h

all

ages

6

_Z_:_2_

L

M

H

L

M

H

11

5

9

7

3

15

2

5

9

1

6

9

�Beiter vs Medcraft h

Reiter

(EST # 2) ‘17

Medcraft (EST # 3)

CONCLUSION:

9

M

pts.

8

3

Pts.

2

1

all

ages and

at

h—é

and

at 7-9,

xrs.

from

left to right. -

over

-

7

9

L

M

H

6

h

2

11

6

1

3

5

H

older group only)

whereas with Reiter

Medcraft produces maximal change early in treatment and

in changes

&amp;

6

L

Both groups (
same

-

MS

%

it

H

records with.Medcraft

increases. Therefore

later

changes consist only

���95

(I

M
hWé/Mv/ém

W
W/f
44’me
Wm"

PHI/M41; be

M 52/15

’4

gal/ﬁe):

MM)

686cm;

Mwwﬁﬁw

���\.
\
Séwrﬁ‘sax «wk?
'».,_

*Mﬁw'yr-Ea

”138:3?

‘

���4‘ .'

.ﬂu/W
aw

'

,

.

b;

Izaak?“

wumad,

W

’
147?
Xv

520’?

��Ti? V

1‘

s:
I.

7:.
V

Z

1

-

\_

rm
.

111374;?

:

7'“:

_

‘

"
-

.

&gt;

v,

‘ y;
’

*

Winn-n35
"W"
______
r
-

“22:!
‘
-

-——~‘——‘

.

‘

~

'

.

‘

’

'

‘

‘

(

‘

‘
.

I

J

‘

7

‘

I
v

'

-

'

V

n

I

l

' ¥

‘

‘-

����',

’03.

Alll‘llll

�. ,7

—

v
Q

,..

r. ‘

_ T TrK.

u
_

,..,

.

V,

9..

1

,

.

.,

a

‘

,_.

‘

w,

w

.
n
5

.

.

,

.

.

i

.A

.

:i.»

,.
...L.

I,

(

:4

.

,

,.

.

&lt;

5,: _.
.

.

.

.

z

.,.

"“

; .;

'n’hr

'

‘

1

V

13—,
.,

awh'A_

“,1
“1.“..«2

,

‘

n

.‘

r

r

1

.

.

.a .

_

_

‘
._

u...

,

a,

h

J _,

N
‘

'5
_,
‘

v

F :.
,

'v

h, .7

.

‘

4‘;-

_‘

,

.

x; x

,

.31..
,

u
.

.

.

,

.. ,2
..

_
"1

,

A

.

..a h .u

'.

A

...

. i

,

,

. N m.
u .

1

,

J

1-:
I

:. r.

,

,
‘

r

._

;
.

.

.

.

.ﬁ

.

.
,

rJ .

:.,

I
‘

V,

sv,._______-_._..:_:&gt;..7;_.;_T
t.« n—' n
a. r
r
,

:J:
I.

I;

»

.n .=

.

.

II\

'

'

J

any.

‘_.‘

,

2

Mr

.7

.

_

.

.3

‘l

,_

g»

..‘

I

.a‘

. ,~
L, m
.H

_
J

,V

,

--.,-_.'
r,

7

,

n

.T»
.
1

H
.

—

,

.

”37:-.."
\.L. \I

Z"
W“

‘

K

A

[“97 '.

.1:..."

,

.u:

._,

Nu
L

x;

'

,- ,

.

..

a

w

H

_

H _

_.

.,. .

.

.&gt;

.

7

wm

_,

.

.

.
.,

l , ,..

.,

,.

.

m

"W”.
5,2

,
,

' .3

1

.,
.

j

A

.

g

‘

.,
i.

..
.

‘

V.,,

Hutu”

ﬂ

A,

1

�����.g.W-

an},

,

3

‘

\——r

—-

--m

I-L
I

I

I

I

'

Mr
n/f

r?

l'

2,

7
6
1
‘.

é

'

/

./

o

-’

I

'

_»

’

//,,../

’

‘

,

*

Q

3
5*

�W
INDIVIDUAL PSYCHIATRIC TREATMENT INDICATIONS

Paul H. Wilcox, M.D.
Revised Nov. 21, 1953

Li

PREDOMINANTLY NEUROTIC

if

and

Org., B.P., F,

otherwise

IF

start

Nm,

Ag, 3, 0-0, G, HqA,

with Sequence

Ir,

Un, Of,

or Par,

start with

Sequence

I

III

PREDOMINANTLY SCHIZOPHRENIC

if

and

D

or Ag,

otherwise

I5

(Psychosomatic symptOms, anxiety or reactive depression)

start

start with

with Sequence

Sequence

I

PREDOMINANTLY ENDOGENOUS DEPRESSION

start with

Sequence

Sequence

Sequence

I

Sequence

E.S.nc.

II

III

Sequence IV

E.C.T.

COznc.

002

II

\/,
\
\
___,

4______e

93

MANIC

_,

COznc.

___,

E.C.T.

___,
___,

low E.C.T.

1:

Eu

if

Tr ______+ 602

\ifD

._____,

II

ifC
1:0
if c

__,

if t _____,
if 'r

_,
___,

(III)

(for termination of trance)

002m.

(II)

\&lt;:

(III)

high E.C.T.

C02

(IV)

E.S.nc.

(I)

E.S.nc. (I)
ifT
if t plus 0...? terminate
D
if _____, E.C.T. (II)

Note:

Appropriate psychotherapy should accompany all phases of treatment wherever indicated.
The goal of therapy is for the patient to have a mild 002 reaction (t) and be essentially symptom-free (O) for an observation period of at least two months.

£21

- anxiety increasing
Ag - agitation
B.P. - systolic B.P. over 170 mm.
Hg., systolic
c - brief confusion (e.g. only 5 min.)
C
- prolonged confusion (e.g. more than
AS min.)
Cf - clinical confusion
coznc. - non-coma 002 (whiffs)
C02 - coma 002
D
- persisting or increasing depression
E.S.nc. - non—convulsive electrostimulation
E.C.T. - electroconvulsive therapy
Eu - euphoria
F - marked fear and anxiety
A

H-A
G

Ir -

Nm

0

—

-

severe guilt feelings
- marked hate and aggressive
tendencies
marked

irritability

severe nightmares

symptompfree

-

for

2 mos.

or more

obsessive-compulsive features
Org. - organic changes
Par. - paranoid trends
O-C

s

- sleepless

tT - mild

tension
- mounting tension
Tr - prolonged trance state
Un - unreality feelings

���52

m

-

�MAX F'INK. M. D.
275 MIDDLE NECK ROAD
GREAT NECK. N. Y.
HUNTER

7-4542

\;
.

:\

\

\

.

w

.

.\\\

a

h
{zitgiisézirié

\
,5:11:15rfie1

v,

flhhugavwx.§.1

at»;

J.

3.11..

,

_

if
NDD‘

$5..

.

J

3.25.1.5

4.51

1.
$313

£511:er

“V

:2

1!

���a

M.“
.7

�-7

r.

v

my

.‘__r,\~. ‘_,_

an"

.7

”amt

,

0,

.7.—

..w

.

x

7

,

,...r,_

‘_— v-4

.

.

,_

w “K-

mﬂ.w~..—-~_‘nr—._;_i , _

7

_

7V

-_.-N,...~

.

1,-.. ~..~._.V..,.v .,_‘,.r_._h.,
V

.

if"?

��mw

""&gt;‘-

aw

ﬁn

’4_l4

I;

Ant“

.

����4...»...

”Mu-L"

����Ft:
£13

3"!

HM

(M)

��i
3

i
E

.1

i

��. _

a-‘v—{WWG’W’W‘tVF‘r‘Fw—ugfva
,

WNW—“W

“WW.
_

,

.

,

.

,

‘

W.

.

,

_.

,'
,
‘

A,.V,..

3m,

.zwu

-..m~w~

W

«RM-4mm

"F
v

:i‘\

@ﬁ
-

A»

\\\

'l

‘3“

l."

..,.

‘

“
\.§;‘.§g was. wig-33;;
__

‘

'

_

‘

A

Em

'

axis:

.3,

��(L ALLA 4

4T

��;;
i

�������For creative activity, as possibly, for problem solving, the hyperh

alert state must be avoided. In the alerted individual, discrimination
is more focused, acute, and differences are sharply maintained. Under such
conditions, old pathways are clearly maintained and the possibility of

new

associations is less.
For creative work, pathways must be connected

ected before. This can only be accomplished

were not con;

discrimination is diminished.

reverie; by fatigue (creativity late at night); by isolation;
by alcohol; etc. Perhaps in the EST situation, the cerebral state induced

This
?

is

if

that

done by

is similar to

drowsiness (Surely the

EEG

-

perceptual effects are similar)

patient is able to use ("create")
available before.

and thus the

new

defenses which were not

Also, in the tachistoscopic situation, the presentation

is

a

hyperalerting situation - but, the reverie state (or dream) afterwards, permits of greater elaboration of the memories (greater range of imagery -

greater creativity,).

I/e3ﬂd

�January 7, 1957

Role of Altered Cerebral

Motion in Behavioral

Change Following Induced

convulsions

m m,

14.9., Babe” In

M;

31.3.

m Hm

Karin, 31.1).

role of altered consciousness in the clinical behavior of
epileptioe, patients with mental disorders, and in the diagnosis: of dis-orders of the central nervous system is unclear. Recent studies of the
electroshook therapy process amonamtcd the crucial nature of persist.ent alteration in brain fxmction for the behavioral changes induced. In
the course of theee studies, an appreoietion was obtained of the types of
alteration in behevior induced 120' diffuse cerebral dysfunction; the role
of the pmoz‘bid personality in the behavioral pattern; and the smith.
1w of various tests on indiooe of altered brain function.
To define and measure the effeotc of alteration in consciousness
Pmblem
""""‘""'""
(manning rm diffuse control dysfunction) on clinical be.
havior patter-no.
The

Kethod: Subjects on a voluntary paychiatric hospital referred for electro—
shock therapy were studied concurrently by psychiatric, psychologic
and neuroplwciologic techniol.

Alteration in brain function (the demo of organic mental
I;
sycamo- was measured by four indicee:
(a) Eleotroenoophalogm, moored for per cent time delta
under nesting and activated conditions;
(1:)

Diaoriontetion, confabulatm-y responses one language

changes following intravenous mobarbital.

(c) Dininution in perceptual discrimination of simultaneous
tactile threshold stimulation touts.
(d) Interference with recall of 3 letter words after interpolated looming of nonsense syllables (”retroactive inhibition of recall") .

mound

by repeated psychiatric intent
and reports of therapists and hospital personnel timing

2) Behavioral ohengec were

views with subjects;
and after the period of therapy.

pmorbid percoaolity was eotimted by Cstructured interviews
with relatives and by Rorschach tests (scored for H o reopens”).
ROM“!
1) Modification of twavior is related to the dogma and persistence
of alteration in hrm function, as measured by the electroencephalogram,
amobarbital teats and perceptual discrimination teats.
3)

The

�in!

0'

J

c‘u

pattern at the induced behavioral change, manifested by
ahnnges in lmguags, mood, attitudes and symptom, is related to the preamorbid personality structure. Such behavioral patterns as euphoria,
donisl, withdrawal, severe wry loss and disorientation, paranoia,
WMrzitability and installed musty, have been obsemd.
3) Various indicss or altered cembrsl function have different
sensitivities to modification depending upon the extent and activity
(recent or old) at the dysfunction, and the personality of the subject.
2)

The

’

leusiem

1) Behaviors]. nodii‘icstian in canditims inducing altered brain
fanatics is ths adaptive response of tbs argmism under the conditian of
an aims-stint: in the state of camcioumss.
2)

has type of adaptive response

is

dependant upon tbs premorbid
pemomiity of tbs subject and the milieu in which the behavior occurs.

altered brain function mt be interpreted in tons
of thsir sensitivity; their time of application in the ongoing process;
and the pmrbid persmlity “the subject.
This significance of them observations in tha understanding of
epilepsy; the treatment. or mental illness; and in medsfinition 5f altered states of consciousness will be dissusssd.
3) Tests

01‘

Iron tbs Heumplwsiolom‘r Laboratory, Department of Fotperimental Psychiatry,
Hillside Hospital,
Gian Oaks, New Iork, U.8.A.

�January 7, 1957

Therapy of Schizophrenia:

Effect of Alteration of Brain Function

on

Behavior

In the course of experimental studies of the mechanism of actidn
of electroShock therapy in patients with psychiatric disorders, a hypothesis was elaborated regarding the mode of action of other therapies
in patients with schizophrenia. 1t has been demonstrated that the essenp
a
electroshock
is
in
therapy
behavioral
change
to
pre-requisite
tial
EEG
defined
by
function
as
of
brain
delta, loss
altered
sustained degree
of discriminatory ability on perceptual tests, and disorientation followThe
behavioral response
sodium.
amobarbital
of
administration
the
ing
under the conditions of an altered state of nervous system activity is
an adaptive response of the subject, dependent on the premorbid person,

ality

.

who

and the environment.

Similar factors have been demonstrated as operating in patients
Show sustained improvement following insulin coma therapy.

studies of drug therapies in schizophrenia demonstrate
that the therapeutic efficacy of the newer psychopharmacologic agents
demonmechanisms
which
brain
are
to
the
degree
to
related
is directly
strably altered.
Conclusion: The mode of action of the various physiodynamic therapies
(ICT, EST, Drug) is directly related to the degree of sustained alteration in brain function induced; such alteration being defined
by changes in the resting and activated electroencephalogram, disorientation tests, and perceptual discrimination tests.
,

Ongoing

��can

ﬁrsthand for the pemeption 01‘ words momma anti aubjem
were unable to Mantify m wows with increasing degrees at cerebral
3-)

Wmotim,

We:

in percoptim were highly sex-minted with other boo
Moral chug”, inﬂiaaﬁve of an alumni interaction with the omirmmt.
Minimum 1) Diffuse alter-nuns: in brain mum, as measured by
elactrmcaphalomﬁzm 631%: mad emanation tests after
mammal, results in altemtiw at pamytm pat-toms
by an
increase in threshold, impaired Metamucil: of stimuli, of which the
ability to diacriminato a rignre from a. comply: backgromxd in a 5min
h)

'

ma

We!

'

2) Alteration in pemepbim

mpmanu

sweet an
m
rather than a speciﬁc
as?

altered behavioral interaction with the envirmnt,
Maialogieal defect, This factor sham be considered in peroeptnal
112.20.00.21.
brain lemma as will.
nudist

{51%

Ion-k,
”.34:
m
W;

mar”?!

�December 17, 1956

Concept of Cerebral Localization vs Mass Action Effects

Certain functions ascribed to

1)

CNS

are "localizable", as vision,

motor power, motor aphasia; While others, as memory, judgment, insight, cal-

culation, figure—ground, are non-localizable.
(more

peripheral than central);

have marked

effects;

and

EEG

damage

The

is generally

first

group are

cortical

permanent; small lesions

is usually not pathological.

lesions are generally deep or basal; recovery of function is possible; small lesions have no effect (i.e. a mass action law is
applicable) and EEG effects are prominent.
The non—localizable

It

results in a non-localizable lesion - with diffuse dysfunction.
is the technic par excellence to study such mass action lesions.
2)

EST

3)

Psychological

measure mass

tests of "OMS” are positive to the degree that they
action effects rather than focal - except if focal dysfunction

interferes with performance as in lesions affecting vision, motor

power and

speech.
h)

Concept of Active vs

Static Lesions:

In studies of head injuries, lobotomy and post operative cases of six

or more months duration, the studies reflect localizable (cortical) defects
mainly: for the deeper

activities

nd
are
longer

active.

Any

defects in fun-

ction are expressions of specific cortical localizable damage.
In contrast, studies of brain tumors, immediate post-traumatic states, post-

(early) are studies of active dysfunction - a combination of
the focal and the diffuse defects. The degree of dysfunction depends on the mass

lobotomy, and

EST

effect, plus the localized defect.

m

away. ”cw-u

W7»:

6%

2.2

.-W

M-

���«M

m

a» mum at :1“er bum mum the dun»
Mariam mum
sum and chm a! me: aluminum; m vat-um a! the mmw‘mpu
and tho
«the submit

ammmmm
mammmmﬁg
mumammnwmmm.
Mmumafmw
mun
Winemwnuwm
at them mm“). mm 1»th mm mu with annWtupmhupmrbm
uwamwmmwwmm,
the Mine of
at
a act-Latin Wm m by th"W”,
WV.
the
an
dwaﬁmt
mm
mm»:
Mum
Mow,
m

W:
m

that

mum
and.

at

my

m Mum;

torﬁumohanin
WWMemlmm
meettheu

MWMWMWMNW¢

»

�(July 2, 1965)
Jan. 3, 1958

HOLE OF ACTION OF BIOCHEMICAL AGENTS

The

CNS

is

IN

BEHAVIOR

dependent upon a umber of enzyme systems

for

cholinestemseand
including
fmction,
mtabolisn
proper
acetylcholine, gluoose-pkwsphetase, etc.
CNS
function and, thereby,
affect
of
that
agents
variety
behavior- is large, since processes in equilibrim may be shifted

The

in either direction

by increasing

or decreasing the available

quantity of a metabolite .
A.

For drug action, therefore, the following are considerations

in potency:
(a)

Does

a drug affect an enzyme system in a

reliable

it

way?

to affect the system?
(c) What defenses does organism process to block
CNS?
in
action
once
limit
drug's
or

(b) Can

B.

Secondly,

get to

mile

(NS

an agent may

directly affect the metabolism

CNS
the
dependent upon the
is
extent
that
to
of a specific system,
system? Is the defect thw induced simificant for the netsbolism
of CNS underlying behavior? that defenses can body cell into play

when system

is affected to substitute other energy system?

Thus, the variation in drug effects in behavior depend upon:

(a)

Behavior

at onset;

and predisposition (personality)

to response;
(b) Drug dosage

- availability to

has on an enzyme system;

CNS

and the

effect

it

�(c) Dependence of organism on specific

enzyme

- and organismic defenses (i.e.,-~
substitution for affected system) .
Whether effect was gmdual (allowing for
system

((1)

defenses, i.-e . , alternate mtabolic system)

or acute (not allowing defense).
Imividual diffemnma in response may be due, thus, to differences
in:
(a) Dosage, mtio

S

mute of

Ministmtim

(b) dependence on the affected system

(c) adaptive ability to biochemical changes.
To

these clauses,

EEG

is a gross

approximation and indicator,

reflecting the homeostatic balmce in various enzym systems of
the

CNS.

������Personality-O.M.S.
Tests of O.M.S.
2-5-57

The

All our tests of changes in cerebral function tapas continuum.
degree of cerebral dysfunction at the time of examination will

determine which

tests will

The degree of

“

show changes

in patterns.

cerebral dysfunction is dependent

on numerous

variables including;
Rate of develogment of dysfunction

Premorbid

state of functioning

on

the tests employed

Stress of the examination- needs and motivation
of the subject
Localization of the cause of the dysfunction (local
vs. diffuse)
'

factor, the premorbid state of functioning, as characterized
the present evaluations of personality organization by the Rorschach
One

by

test

and by

interviels,

graphic fashion;

can be pictured as operating in the following

‘

�������������V

E

F

E

E

F
E

;‘

ﬁs‘;’*;)¢¢2\

_

a

'“ﬁ‘

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67364">
                <text>EEG (notes), 1955-1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67365">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67366">
                <text>mfp-03-01-002-3-003</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67367">
                <text>1955-1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67368">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67369">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67370">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67371">
                <text>Research papers, files, and related correspondence: EEG notes</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67372">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67373">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80939">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87500">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94061">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100622">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6738" public="1" featured="0">
    <fileContainer>
      <file fileId="6554">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/97daec70fcaf9223c3cc93bef9185f48.pdf</src>
        <authentication>ea0a277a541fba43d45012096746cae2</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107159">
                    <text>W,
;_
.

»

_

.

‘g
wA

.73.- ..g c 7...

._.‘

.v

—.—‘.n,

we“---

,

V

,_

m-

V

,7

, v.‘

-,v

V.

-

,

—

xv-

.r

f.»--,—-

,.v—.-“.....:v«u..w,amw

.

.mmng—W (tr/33‘; «waver—u... .Mwm—V w...
_

-

.

Electroshock
and
in
Improvement
Charges
of
Electroencephalographic
Relation
Therapy *
Max

Fink, M.D.

Robert L. Kahn, Ph. D.

This study was undertaken as part of an investigation of the relationship
between
V

”0.4",“

.,

altered brain function

to electroshock therapy.

Twentyb

prior to and at
weekly intervals duringanki following the course of treatment. The total of
four consecutive patients referred for

A.

awn-wmw

and response

160 records so obtained were

age percent time

time delta

at

EST

were given EEG'S

classified according to five criteria: the aver-

delta for three given lead combinations, the highest percent

any one lead combination, the slowest

delta frequency, the durb

ation of the longest bursts and the highest delta amplitude.

On

the basis

of the percentile scores obtained for each factor, the relative position of
each record was determined.

in the upper third of the distribution were

Those

considered to have high degree abnormality, while those on the lower third were
low degree abnormality.

By

this

method

found between improvement and the

EEG

showed a high degree abnormality

after

weeks and over 90%

after three

weeks.

of analysis a definite correlation was

rating.

Of

one week of

first three

had such a record by the fourth week of treatment.

for each of the

EEG

treatment,

80%

A

factors analyzed separately.
week

two

weeks and only one

similar relationship
The

was

findings were con-

firmed in a subsequent investigation of 30‘patients in which the

tained in the second and third

after

25%

In the unimproved patients, however,

none had a high abnormality record during the

found

the improved patients,

EEG

data ob-

of treatment were used to prognosticate

�nﬁi

m\

improvement.

It is

as determined by

concluded that early and persistent altered.brain function,

this

method,

is

a necessary

prerequisite for improvement after

electroshock therapy.

*

From

the Research Service, Hillside HoSpital, Glen Oaks,

New

York.

�sawmm
MMW§WM
w,

VJ'IWWVWMM-ﬂmmﬁmm
hula-«ﬁght
ﬁwﬁymgmrmwt
mm“
Wmmunmwm;
W
mmummawmmmwwmmm W
-

’3

mmmmmmmammmm
mummmmmmummm» "$01:me
‘-;:wamaf
w*:.mmuumwmm_
m
h

zwm .»,wmawmmmuwwwm

m
Eegmuﬂ)

,

W3¢MW.M:

��WMWWnMﬂmmemW-,'
W
mmmmwmummwt
tmmttnwWmhmhmz-Mnnmhmumtnmw
thatmatmm WM”
mmmmmt
Wanm
mummm
Mahatma:
Wmmmm
“

mmmm
mum
mammmmmm
manpmuummmmm,mmmmmm
mwmmhm
«mmmmmmm
mmmwmm ammumthlm
mm
Wrmmiarmm
Wthanntht
mmnmm%
my
were”
mmww
Mmgmhhu
hmwwmm
mwmmmmmmwmmmwm
WWWmtmrm-rammwww
Wag“
mm
hm
mamwmmmmmmmmmmwm
-

,

-

pa.

�Relatidn of Electroencephalographic Changes and Improvement in Electroshock Therapy

(

3

M
,

7' W41]

Fink M .D
Robert L: Kahn, Ph.D.

Max

fir/V
v,

,

.y

This' study was undertaken as part of an investigation of the relationship

41/4er
between altered brain function and reaponse to

I/mt—wju?

Twenty-four consecutive

’P—EII‘P

patients referred for

were given EEG-'5

EST

prior to

during and following the course of treatment. The

.«

and

at weekly intervals

total of

.

100 records‘ were

classified according to five criteria: the average percent If time delta for
'Mbmﬂavv
I
three given lead, the highest percent time delta at any one lead; the slowest

WM

frequency;

amplitude,

w“
H,

mm.

W

the tame- of the longest
On

the basis of

)‘n.

MAJ

bursts and the highest 601/9“—

percentile scores ob-

samba-med

'

tained for each factor, the relative position of each record was determineg
gose in the upper third of the destribution were considered to have 1 high degree

A

W MW
W“
correlation

tau/inc. Ml‘tW/‘au‘
abnormality, By this method of analysis

improvement and the FE .

after

‘

1gh’abnorma11ty

was found between

_

6f the

oniy‘one week of treatment, 80 a er two weeks and
over
'

g

.

,

A

weeks.

In the 'mimproved patients,

during the
A

w
a marked

first

c'atrately.

The

I

I

was found

I

I

I

I

loe-ether-kand,

g

three weeks and only one

similar relationship

313

‘

had. such a

each of the

$in
yw

EEG

90%

4’

improved

patients

after three

none had high abnormality

record b% the fourth

factors

as

.

.

30

‘

were

usedﬁ progn

altered

bain

EEG

data obtained in the second and third week of treatment
concluded that early and persistent

W1 W
im«Lu

function, as determined by this method, is a necessaryﬂfor
provement after electroshock therapy.

W

MM”-

week?”

analyzed

findings were confined in a subsequent investigation of

patients in which the

24’?

"

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67374">
                <text>Relation of Electroencephalographic Changes and Improvement in Electroshock Therapy (research)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67375">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67376">
                <text>mfp-03-01-002-4-004</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67377">
                <text>1955</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67378">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;; Kahn, Robert L.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67379">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67380">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67381">
                <text>Research papers, files, and related correspondence: research with Robert L. Kahn</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67382">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67383">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80940">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87501">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94062">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100623">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6739" public="1" featured="0">
    <fileContainer>
      <file fileId="6553">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/d01fea06dd83b521f86d15c567b14a69.pdf</src>
        <authentication>5db07271542a5e11cdde7c401a2c6afa</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107158">
                    <text>��s

[.9

227mb,

‘5)04

..:

L

M

~17!ou
'
m
,1

Z

0

is

,«

,

042454
“11“., m
«:4

’
‘

,J‘vmw&amp;

—!—.‘W_

��W

ﬁfw_“______‘______Wr
r

M

l)CZ¢/vw€u

M“
@WLE;
$54:

W

gm

.

KW

C

Z’W ‘TN’M

2r

3)

am!

Vn.

Fr‘e—L

WW’

Am);

Maﬂuﬂ/EW/

�INDEX TO ADVERTISERS
_

PAGE

AAAS ........................................................ 5, 394, 396, Inside Back Cover

American Tobacco Company _____________________________________________________ Back Cover
Columbia University Press _____________________________________________________________________

6

Ford Instrument Company ______________________________________________________________________ 391

International Equipment Company _____________________________________________________ 398
Johnson Research Corporation..--__________--_.____-________________-_.-____; ______________ 5
Macmillan Company _________________________________________________________________________________

8

Measurements Corporation _____________________________________________________________________ 6
Microcard Foundation _____________________________________________________________________________ 392
Oxford University Press, Inc ________________________________________________________________ 391

Rinehart &amp; Company, Inc ________________________________________________________________________ 394
Ronald Press Company ___________________________________________________________________________ 2
Schwarz Laboratories, Inc ______________________________________________________________________

4

Ivan Sorvall, Inc ______________________________________________________________________________________ 7
Taconic Farms, Inc __________________________________________________________________________________ 394

University of California Press _______________________________________________________________ 393
University of Chicago Press ___________________________________________________________________ 3
D. Van Nostrand Company, Inc _____________________________________________________________ 395
John Wiley

&amp; Sons,

Inc .......................................................................... 397

399

���������£32
»

.

x

:

‘
.

.

.

,

V

(

-

4

‘

V

‘

‘

'

.

,

\

.

,

-

'1'

”:5.

.9.

,2;

«E

a‘

,7;-

7-

\77

‘-

.

_

mtg if}
m:
34ifv; 5:32;:

;.

‘

,

er?”

is
VF»
‘ﬂh‘flaz:
”r:

91‘;._;.;..,.::_:.»’~~:_V
;‘;,».+~:-.éé
,5». ifp. ,, ..~- .393, - ,_-_».;,-,-«
r

.-

-

'
-

2

.
.

�DEW?

17; 1956

Gamept of Gamma]. Localisaﬁm to Hana Action Effects
1) Certain functionnascribod to

CNS

are "localiaable", as

motor power, motor aphasia; while others, an memory. Judgment,

Mm,

insight, m1-

culation, figure-ground, m nmlocaliuble. The first. greup am aortical
(mom pariphemi than antral); damage is generally permanent; will lenient!
have maimed

exam;

and

EEG

is usually

not pathological.

lam-vloodiubla lesions are generally deep or basal; mowezy at m:ctim is possible; null lesions have no effect (1w. at mass wtian 1am in
The

effects are pmﬁnmt.
2) m results in a nonuloealiuble lesion .. with diffuse Mfmcﬁwa
is the teahnic
gxgalleneo to study such mass whim lesiom‘

applieabla) and

It

3)

EEG

a;

Psychological

tests

’of ”OW”

am positive to the dogma that they
measure mass action affect»: ram” than focal - exaept it focal
interferes with pexfbmnoe as in lesions meating 75.31011, actor power and

mum

speech»
1;)

Concept of Active vs

sum Lesions!

In studies of head insulin, lobotom and post. apex-nun me! of an
or more mths duration, the atudiaa reflsct 100311111313 (cortical) Meats
mainly: for the deeper activities am no lager active“ Any defects in hm»
cticm am expresaima of speciﬁc certioal

laculinbla

W»

mtmst, studiee of brain tumors, immediate post-tnmtie statues, post-v
19mm, and EM (early) are stud-m or active dysfunction - a. cambinntim of
the focal and the diffuse defeats. m degmo of: dysmnction depends on the ma
In

offset, plus the localised defect.

�J.A.M.A., Dec. 13, 1958

PNEUMOTHORAX—MAURER ET AL.

2014

ination revealed adherence of the fundus and nodules
throughout the adnexa. A diagnosis of pelvic endometriosis
was made, and on Aug. 18, 1955, total hysterectomy with
bilateral salpingo-oophorectomy was performed. The patient’s postoperative recovery was again uneventful. In the
four and one-half years after the thoracotomy, the patient
has had no recurrent chest symptoms or pneumothorax.

Comment
Aberrant endometrial islands have been reported
in many locations, including the ovaries, uterine
ligaments, rectovaginal septum, sigmoid colon, urihernia
umbilicus,
bladder,
laparotomy
scars,
nary
sacs, appendix, vagina, vulva, cervix, lymph glands,
and small intestine, and in bizarre locations, such
as the upper and lower extremities, lungs, and
pleura.l Sampson’s2 original theory of transtubal
regurgitation of menstrual blood and endometrial
particles, published in his original paper in 1921,
could certainly explain the method of implantation
of endometrial growths on the pelvic and intraabdominal viscera, as well as on the inferior aspects
of either leaf of the diaphragm. The lymphatic and
hematogenous dissemination theory of Halban
would be necessary to explain distant endometrial
implants in the thigh, lung, and pleura.1a Distant
spread without passing through the pulmonary
capillaries could occur only by way of the vertebral
veins or “lung shunts” which have apparently been
demonstrated between the pulmonary arteries and
veins bypassing the lung capillaries.
In view of the concomitant ﬁnding of pelvic
endometriosis and the involvement of all layers of
the right leaf of the diaphragm, with perforation
and supradiaphragmatic seeding demonstrated by
thoracotomy, in the present case report, it would
seem logical to conclude that the endometrial
involvement of the diaphragm must of necessity
have occurred as the result of transtubal regurgitation and transperitoneal dissemination. Exact explanation of the method of development of the
pneumothorax on the right side is more difficult.
However, the clinical observation that all episodes
of pneumothorax occurred only during the time of
menstruation, and the inability to demonstrate any
source of lung leak or primary disorder in the lung
which could explain any possible leakage of air into

the pleural cavity, would suggest that the recurrent
pneumothoraces in the case reported here were the
result of erosion and perforation of the right diaphragmatic leaf by endometrial implant and the
fa]of
the
from
the
of
air
by
uterus
way
passage
lopian tubes into the peritoneal cavity and then by
way of the opening in the diaphragm into the
pleural cavity, with consequent pneumothorax. Although we are unable to ﬁnd any reports of spontaneous pneumoperitoneum occurring during the
menstrual cycle, the practical possibility of this is
suggested by the free anatomic communication between the cavity of the uterus with the peritoneal
space by way of the fallopian tubes. Practical application of this knowledge is regularly used in the
so-called Rubin test for patency of the tubes. During this procedure, carbon dioxide is passed into
the uterus and then by way of the tubes into the
peritoneal cavity. During the test, patients may
experience shoulder pain and present roentgenographic evidence of pneumoperitoneum.
Summary
Chronic recurring pneumothoraces resulting from
erosion of the diaphragm by endometrial implants
during periods of menstruation occurred in a young
woman. This was surgically corrected by excision
of the involved portion of the diaphragm. The un—
anticipated ﬁndings encountered at operation in this
patient present an additional indication for exploratory thoracotomy in all cases of unexplained, constantly recurring, spontaneous pneumothorax.
827 Union Central Bldg. (Dr. Maurer).

References
1.

(a) Novak, E., and Novak, E. R.: Textbook of Gyne-

cology, ed. 5, Baltimore, Williams &amp; Wilkins Co., 1956,
p. 546. (b) Nunn, L. L.: Endometrioma of Thigh, Northwest Med. 48:474—475 (July) 1949. (c) Hartz, P. H.: Occurrence of Decidua-Like Tissue in Lung: Report of Case,
Am. J. Clin. Path. 26:48-51 (Jan.) 1956. (d) Hobbs, J. E.,
and Bortnick, A. H.: Endometriosis of Lungs: Experimental
and Clinical Study, Am. J. Obst. &amp; Gynec. 4:832-843
(Nov.) 1940. (e) Nicholson, H.: Endometriosis of Pleura,
Thorax 6:75-81 (March) 1951.
2. Sampson, J. A.: Perforating Hemorrhagic (Chocolate)
Cysts of Ovary, Arch. Surg. 3:245—323 (Sept) 1921.

FUNCTION OF THE BRAIN.-—Any biological view of the function of the
brain leads us to an unavoidable conclusion: consciousness is not unique to man,
to the primates, or to the mammals: it goes back to the roots of vertebrate history and has been progressively elaborated in content, coloring and complexity roughly in proportion to the evolution of the neuromuscular system. It cannot even be
argued that consciousness is a unique vertebrate invention—the crab, the octopus, the
butterﬂy, the ant, all possess sensory devices imparting to them the awareness of their
world; all demonstrably engage in integrated time-binding, self-serving action, and it
must be presumed that all participate in some proportional measures in conscious
awareness of themselves and their environment—H. W. Smith, The Philosophic Limitations of Physiology, Perspectives in Physiology, Washington, D. 0, American

THE

Physiological Society, 1954.

�2013

Vol. 168, No. 15

TO
DUE
PNEUMOTHORAX
SPONTANEOUS
RECURRING
CHRONIC
ENDOMETRIOSIS OF THE DIAPHRAGM
Elmer R. Maurer, M.D., James A. Schaal, MD.
and

F. L. Mendez Jr., M.D., Cincinnati
Chronic recurring spontaneous pneumothorax is
results
which
disorder
usually
common
relatively
a
from rupture of subpleural blebs. Endometriosis of
the diaphragm, on the other hand, is an exceedingly
has
be
determined,
lesion
as
and,
nearly
can
as
rare
never been reported in association with, or as a
cause of, unilateral recurring pneumothorax.
The following case report is presented because
of the extreme rarity of the lesion involved and the
unusual association of pneumothorax with the menstrual cycle. It is the ﬁrst recorded instance of successful surgical treatment of chronic recurring pneumothorax by excision of a defect in the diaphragm
that has resulted from endometriosis.

communicated
This
diameter.
in
2
cm.
was an aperture

freely with the peritoneal cavity. The area of disease in the
diaphragm, along with the defect, was widely and completely excised. The consequent diaphragmatic opening was
0.
size
of
cotton,
sutures
mattress
with
interrupted
repaired
Examination of the specimen showed that the disease had
involved the complete thickness of the diaphragm. Final
inspection of the superior surface of the diaphragm revealed
which
1
in
diameter,
nodule,
cm.
purplish-red
a solitary
obviously represented a supradiaphragmatic endometrial
implant. This also was completely excised. Following reexpansion of the lung and the placement of an intrapleural
catheter for water seal drainage, the chest wall was closed
of
endometriosis
diagnosis
was
The
postoperative
in layers.
the right leaf of the diaphragm resulting in perforation and

Report of a Case
A 35-year-old woman was ﬁrst seen in consultation on
March 13, 1953, because of pain and dyspnea resulting

from a spontaneous pneumothorax on the right side. The
patient had had two previous spontaneous pneumothoraces
1952.
Nov.
14,
occurred
ﬁrst
on
the
having
the
right,
on
Findings on the general physical examination were negative
except for distant breath sounds over the upper right part
of the chest and hyperresonance of the percussion note due
revealed
chest
of
the
Roentgenograms
pneumothorax.
to a
a very minimal pneumothorax (15%) over the extreme apex
and the base of the right lung. No emphysematous blebs
were apparent in any portion of either lung. Because of the
small quantity of air in the chest and the absence of serious
thoratube
thoracentesis
or
of
air
the
by
removal
symptoms,
costomy was not thOught to be indicated. The patient was
discharged from the hospital for follow-up care by her attending physician. She was again seen in consultation on
March 20, 1954, approximately one year after the original
examination, because of 12 new episodes of recurrent pneumothorax on the right side. All pneumothoraces were associated with pain and mild dyspnea and had been veriﬁed
ﬁrst
the
chest.
For
of
the
examination
by roentgenographic
15
all
that
information
the
volunteered
the
patient
time,
episodes of spontaneous pneumothorax had come during
the period of menstruation. The important clinical signiﬁ—
time.
the
at
appreciated
not
observation
this
of
was
cance
Because of the chronicity of the lesion, open thoracotomy
with possible talc poudrage and excision of any blebs that
examinaroentgenographic
been
on
have
apparent
not
may
tion was recommended.
Right thoracotomy on March 31, 1954, revealed a persistent moderate pneumothorax on the right side. Careful
examination of all lobes of the right lung revealed no evidence of blebs. Testing of the lung with positive pressure,
while saline solution was dripped over the surface, disclosed
no points of air-leak. The lung parenchyma grossly presented a normal appearance and consistency. The most re—
markable ﬁnding involved the right diaphragm. Near the
point of emergence of the inferior vena cava and extending
radially and laterally in the central portion of the right leaf
of the diaphragm was a circumscribed, oval-shaped area of
attenuation which measured 4 by 3 cm. in diameter. Numersurface.
this
modulations
on
apparent
were
purplish-red
ous
In the central portion of the diseased area in the diaphragm

Photomicrograph of excised lesion, showing, endometrial
stroma and glands extending through ﬁbromuscular structure of diaphragm.
implant of endometrial nodules on the intrathoracic surface
of the diaphragm. Microscopic examination of the surgical
specimen showed extensive involvement of the ﬁbromuscular
stroma of the diaphragm by nests of endometrial stroma and
glands (see ﬁgure). The single nodule on the supradiaphragmatic surface was composed of endometrial tissue.
The postoperative course of the patient was entirely uneventful, and she was discharged from the hospital on her
ninth postoperative day, being afebrile and ambulant, and
with her right lung completely expanded.
Because of pain in the pelvis and dysmenorrhea, the patient was seen by a gynecologic consultant. Bimanual exam-

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67384">
                <text>Consciousness studies (notes), 1956-1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67385">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67386">
                <text>mfp-03-01-002-5-005</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67387">
                <text>1956-1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67388">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67389">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67390">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67391">
                <text>Research papers, files, and related correspondence: notes: consciousness studies</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67392">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67393">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80941">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87502">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94063">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100624">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6740" public="1" featured="0">
    <fileContainer>
      <file fileId="6552">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/866335cd8b6a0e848ec4f05bda1e57d7.pdf</src>
        <authentication>610411ecffe18c07ab2ae5b0c8adcc8c</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107157">
                    <text>ZJ’W
4r

9,

I;

/y’7'.rf

[E Wsﬁ%w‘&gt;

In a series of investigations of the role of neurophysiologic factors

in the changes in behavior induced by convulsive therapy,

that an alteration in brain function
prerequisite, for behavioral

it was

concluded

necessary, though not a sufficient

was a

change and "improvement"

(

).

Changes

in brain

function were measured by a variety of indices, of which alteration in the
waking

was

EEG

induces a

the most satisfactory

shift in the

EEG

(

). convulsive therapy consistently

Spectrum to slower frequencies, with the development

of runs and bursts of high voltage delta

activity.

m

frequencyI? per-cent ‘

The degree and

rate of development

frequ However, there is'uide variability in the
I‘

A

voltageandr‘degree
,t/
~e£-~h2rstr
time
treatment process

[lay

activity

different subjects.

With-equal—numbers—and

developed

’7

at various stages

of delta activity have been related to the age of the subject
of treatment
1

Yet, when

1’

), and

mode

), frequency

of induction (electrical, chemical, photo-chemical).

the
degree of delta
these factors are held constant, variability in

activity is
it”

(

(

of the

still

manifest (. ).

Previous experience has danonstrated that both the behavioral reSponse

Y

and

ratings of improvement to convulsive therapy

a
perceptualm processes as

may be

related to various

"

.

number and type of Rorschach responses (

),

�score on the California F scale
(

,

(

),

and

errors

on figure-ground

tasks

dud.

); and to such sociologic factors as age, education level, place of

fail.‘

W‘
M
treatment

m

to explain the degree of
the

EEG

the

variability, this

W

W“?
their perceptual-psychologic

aﬁﬁability

wt mm “a“

pie-treatment

ofA

W

subjects, Ma

‘

‘

EEG

M“

characteristics

WWWWMWW»
Was“
can—ad.
this
M. It is
the purpose of

j

study

m~--~m
to elate pre-treatment.

SUBJECTS AND METHOD :

W

Gonsecutive patients referred for convulsive therapy in a

voluntary psychiatric hospital were studied.
22

to so with a median of

149

c and

depressive, schizophreniﬁ

The

patients ranged in age from

years; and were diagnosed as suffering from psychotic
cyclothymic reactions.

While the range of conventionally applied diagnostic categories was

ML

5"
broad, the population exhibit} the cannon characteristics.

MAI.

(7414:444aA4;€7

a single ethnic

f“

�OBSERVATIONS:

l.

Quaint.

Variability of Induced-Beita—Activityt

In the patients receiving convulsive treatment and investigated
Mimi
Mm
,
a} 1 M/b/
by the methods outlined, the variability in the

Wed-Wotivity

is considerable.

We

have summarized the observations in

1146

patients in

Table

I0

While

the per-cent of records in the high degree category increases with

successive treatment given at three tines a week, half the population has
Aral“,
a; Z:/£
not achieved..:the’ degree of—éelta activit}; in the third week, and

in the fourth week.
in all subjects.

By

the fourth week, however,

5%

m
‘

y

140%“
is apparent

�TABLE

I

£24 4314/4.
Degree of Inducedﬁsihe Activity With Gonvalsive Therapy
gPerﬁzem of Groug, Name)
Treatment Period

W
~lHts-Aetjjri’ox
Mao—k

##

First
Rx

High Degree

Moderate Degree
Low

None

Degree

#

Week

Second Week ‘l‘hird Week Fourth Week

1-3

h-b

7-9

10-12

‘

14%

28%

he?!

60%

12%

21%

27%

2275

68%

h8%

25%

18%

16%

3%

2%

0%

HH

3/58

�-72.

BA «MM
Relation of Pre-Treatment Rorschach
to

3.4.3

*4

Variabili

”“2"
In the analyses of parable-meat 21:3... Rorschach
7%).

the number of responses andAqualitative aspects

*ann—Iimaw.._ ..

i’movement

Mbﬁuywa/‘iée'
related to the degree of induced tel-ta activity.
Wm—uummuw
z.»_..mM.m.w.w—m:"g:od Me

“mum—.9...

h re were

signiﬁcantly fewer cup-us

t

W

EEG

and color were

WWW

‘nv

mu»

magnum-u “a...“ m.» .own-ru‘m-v-u-m:

”4/. ML.

m mm.mm wulmw‘w.m mm,,.
‘

that

With

gh

"‘

were observed.

WW
We activity

\

manifesting moderate and low degrees of such activity.

degrees of

Be

W
133121911135

m

deem-96")
in patients with highNRgrees of

-.._-----_---_:.§
w
on those
activity t

,

3* - van.” w rv: .-mm—Nw-w,.bv,W M.

In patients

who

were observed)

avid;

taéeported signii‘'ican

significant differences in

Mw‘m.mmq_,m.m-.~=m~

failed to report
44». M ”iv!

movement

WK

ﬂy

fewer

EEG

Low

reactivity

"égher degrees of

7

”WW’ /

,

�...

-_’.. .ymrw—W‘w~——--

-w'r“""

~-

v-vwam-

/

W-

--»—',.w

erw w

�W-num
z 19*;
III
ff
;
“¢“-'—-h

nqh-II-uylL-"

'51?

A

expressed

y‘TAIB'I-E

------

similar relationship is noted for color responses. Patients

form-color“

in the

Rorschach developed lower degrees of

delta activity with treatment than those
l

or

a

,

greater degrees of
human movement

who

W4.
expressed color, coior-forxnll

.

olor responses.

Combining both

1W
My

who

&amp;

movement and

b color) 4“,

Wobserved in patients
w

who gave

nor form-color reSponses, than in those patients

who

neither

expressed

either or both these responses.
Analyses for number of whole responses (W), per-cent of good form

responses

(F‘s-$5),

significanttx

444%

populago)
and per-cent oi
responses, failed to demonstrate

Sawwuﬂ—v
M
relationships 1; the degree of induced an» activity.

�II

TABLE

Relation of

Number

of Rorschach ReSponses to Induced
wide-«4L

EEG

9*

Mean

Activity

$.13.

Diff.

Number

High Degree

Moderate,

am

Low

Degree

3m

114.2

7.2

20.8

15.0

High Degree

Moderate,

b...

Law

Degree

h.

of Resgonses

6.6

Number

2.9

3J4

5.0

5.].

’0

2.8

4L

SR2

(.01

of Movement Reagonse

2.1

2.3

wE305

gM+Fm+m2

�TABIE

Relation of

Movement and

To

A/

Induced

III
Rorschach
Responses
golor

EEG

M»
Activity

Ht

High Degr_ee

.—

9*

Moderatesz

Degree

h

Sign; .

Human Movement (M)

3?

20

(53%)

18

(147%)

Other Movement (FM-m)

2f

20

(71%)

8

(29%)

I?

16

(814%)

3

(15%)

33

17

(52%)

16

(h8%)

x2==

39

(75%)

13

(25%)

P

93

11

(148%)

12

(52%)

x2= 7.60

25‘

15

(60%)

10

(140%)

p L .05

37

3o

(81%)

7

(19%)

No

-

Movement

Form Color (FC)

Other Color (C,

or

None

Both

mm

Either

M

Neither

M

or

FC

nor

FC

CF

0-0)

52‘-

X2=

p

6.19

4 .05

3.88

4 .05

�.11..

3. Relation of Pro-Treatment Errors
§g§§gglo"1Variabilit
In a previous study

(

)

related to changes in the degree of
on

drug: is scored
bveo

Smx

to

q

errors on the hidden-figures test were
EEG

,1,
$.4va
eel-be activity and positive reaponses

the amobarbital test for cerebral dysfunction

physiologic responses into a

to

on Hidden—Figures Test

%

).

(

Combining the

index, a range of changes from zero

(Table Did)- The larger the pre-treatment error score,

the greater the degree of physiologic change with treatment.

The

triserial

ILL

correlation is +0.3h, significant atA .05 level.

TABLE IV

In a similar analysis of the pre-treatment errors to

/\

the difference just

fails of significance

Relation of Pre-Treatment

1;.

Considering the
Spectrum

made.

An

initial

some

EEG

Pattern to

amongst

EEG

(

Variability.

)

or these

and frequency

the subjects, an analysis of the

of these characteristics and the

study

variabilityﬁlm./

(Table Nb).

variability in modulation, voltage,

in the pro-treatment

relation between

EEG

EEG

patients

EEG

nesponsivity was

whose pre—treatment EEG

�TABLE IV

Relation of Pre-Treatment Errors in Hidden-Figures Test to Physiologic

Variabili 132

(a) Combined

EEG

- Amobarbital Index:

Miologic

Changes

Mean #

Errors

6+

(8)

13.3

3+, u+

(19)

11.2

0

(lb)

7.9

5+

)

,

1+, 2+

~=
p

+0.31;

4.05

34.» Mark

(b)

EEG

Ma Activity
nghﬂai‘ha
No

Highiﬁ:

5.13.

Diff.
3,2,

(31)

11.1;

7,7,

(13)

8.2

4.?

t

p

M, ms.

�.13...

manifested slow wave activity had demonstrated that high degrees of delta

activity appeared earlier
such

activity,
As

was

as per-cent

M
confirming
earlier report} of Kennard and W'illner
1"

Jawwnw
correlated with the degree of induced dean activity,
time/)del-ta- activity.*

MIX;

/

in patients without
(

).

13h;
pre—treatment per-cent time alpha
one approach to the problem,

activity

h

and were sustained longer than

measured

In 44 subjects, a correlation of +0.35)

‘05‘

week (10-12 treatment).
treatment
the
observed
fourth
during
level/was

DISCUSSION :

In these studies, the degreeof induced

EEG

delta activity during convulsive

therapy has beer- related to pre-treatment perceptual and
dwwations

ure,

patterns.

“i

limited
and
are
scope
in
\\ 2'

/

concluszwgarding
I
these\
and
d
bservati
theor
data
with
clini
of
s
th\consistencz

\\

explomtiglng;
,2; 1,7

further
warrants
constructs
"”” ‘"‘
””
"W“
‘

EEG

[While

{a

1m.“

reports the behavioral

patterns of euphoria, hypcmania and denial were shown to

be

consistently inter-

preted by the psychiatric observer or family as "improvement," While somatization,
).Improvement
"unimproved,"(
and
in
excitement
rated
were
as
paranoia
panic,

convulsive therapy has been related to such lire-treatment variables as high

*

Previously demonstrated as a correlation of +0.81; with degree of delta activity

(

).

�scores on

denial personality indices

anal-eerie the California

F

scale

)t
,

(

W
M

); absence of

(

cam-W
color,

human movement,

form-color responses, low number of responses, or high number of whole and

tests

good form responses on Rorschach

and

foreign birth

(

most highly esteemed,

educational

(

)

).

Thus,

(

); and low educational attainment

in an environment

where

verbal therapy is

patients least like the therapist in social

Mattributes

W

are referred for somatic

(or non-verbal) therapy. Under the conditions of induced altered brain

WM

function, those subjects with least ability

Wm
hypomania,

'\

WW
‘

"

,

she

I;

reapond with non-verbal behavioral mode; of euphoria,

denial, displacement

and minimization, and are

rated as

M

"W

”

"“76"“!

while Subjects with greater perceptual and linguistic discrimination respond
with the more verbal patterns of paranoid, panic, somatization and anxiety,
and are

I/

rated unimproved.

II

In the observations reported here, the pre-treatment perceptual

also related to the degree of physiologic response.
4

discrimmtion and verbal discrﬁptive ability
degree of induced

gum»

The

greater the

mode

is

M“!

on the Rorschach, the lower the

delta activity; the fewer the

Rorschach responses, the

less

.,

�.15discriminating and the less the ability to separate figure from ground,

W

the greater the physiologic responsivity to induced convulsions.

difficult to formulate

a causal relationship fer—the—eepeetc—e£

It is
clinical

behavior,(both pre and post-treatment) perceptual patterns and physiologic
response. But

M

M

behaviors

it

’L“’Z°
is operationally meaningful to interpret these various

W

of the subject

tainteraction with the

environment,

with each measure of behavior representing an abstract or sample of subjectexaminer relationship.

In this framework the problem of the relationdhip

between personality and physiologic measures

is transformed

"whether" to one of "how" and ”under What ccnditions."

from one or

In these series—aﬂ-

subjects, heightened perceptual discrimination appears related to low degrees

My»
W25
MW
Wluf
/
of alpha activity in routine, suite recording and decreased
delta-activity-

f06ﬂ””‘$

responssnity to convulsive therapy. In clinical behavior sudn subjects are
prone to

A

tutu: introspection, anxiety and ideastional disturbances;

and show

poor improvement ratings to convulsive therapy.
These observations are
and

EEG

consistent with previous studies relating personality

a5pects by Kennard, Ulett and Shagass. Kennard and Schwartzman

related resting

EEG

spectra of

low alpha index

(

to schizophrenic personality,

)

�~16-

psychotics ,

non-mm,

while high alpha index to

Ulett

gt_ a_l_. (

)

psychopaths and young individuals.

indicated anxiety prone7ness was ﬂying: correlated with

v

M
poor alpha activity, slow and fast activity in the resting record, and poor
response to photic stimulation

the sedation threshold
amplitude of beta
(

),

),

(

activity

and with poor

in the alpha range. In Shagass' studies of

low

was

responsivity to barbiturate as measured by

positively correlated with anxiety

clinical response to convulsive therapy

(

'

).

and

tension

Thus,

behavioral reaponsivity and interaction, reflected in personalitytheoay
ltheenyand

psychiatric nosology
by

EEG

may be

m

related to neurophysiologic reactivity as reflected

patterns, within the limits of the sensitivity of our measurements or

methods of experimentally

altering (activating) both behavior

Inherent in neurophysiologic responsivity are

all

and EG.

the aspects of the

internal milieu, as reflected in individual differences in biochemistry, and
in the pre-treatment
continuum as

EEG

record characteristics; the individual environment

reflected in perception, motor patterns, mood’ and verbalization;

but also the sociologic aspects of the individual's experience. In the series

of patients studied here, an ardysis of educational level with degree of
.

responsivity demonstrated a

I.‘

24.,q me $45 a:
D

.

3

EEG

V]

(

- p&lt; .02) relationvship. Subjects

�years of formal education had a lower percentage of high
6&amp;b’tgd7’a"
56w!
degree records than subjects with less than eight years or education.
\

with nine or

m

more

/CONCLUSI ON:
The

variability in the

degree of induced

5am)

mm

deb: activity manifest

during

convulsive therapy has been related to technical factors of the treatment.
Yet, when these are held constant,

(regs-365%;
' '
y has
studies,

been

patterns. Patients with fewer

variability is

still

manifest. In these

related to pretreatment perceptual

and EG

number of responses, fewer movement responses,

and absence of human movement, color and form-color responses on the Rorschach;

greater errors

on figure-ground discrimination

alpha activity

026m) 00'“ '
had higher degrees or induced eel-te- activity.

Physiologic reactivity,

measured

in

EEG

tasks; and higher per-cent time

interpersonabv
patterns;

behavior, manifest personality measures and d scriptions of clinical or

m
different
verbal behavior
aspects of the interaction of subjects
If
environment.

In mks framework,

EEG

and

and

personality variables are related

within the limits of the sensitivity of the measures used'

��#3:»

Mummmammmmtmmmmmmo

Mumthanmwmhmwuwuw
).
pmmummmtmaﬂommm(
mmthCAMomhi‘ﬂmh'f
(

.

handmmmnwmu

)yaaatomahmmctutountm,mumm,m

plau.a£b1rth(

).

mtmmmmumotuutmtmt

imammnmmmummmmmmwamo
and
thud:in
pmptu-luwyuholoﬂo
prim,
Wow
13mm
m WWW. m mam...

�swam:
3w

m
mm
mm m
cumm- ”that:

studio‘s.

for W110
3210

than” in a Wham

patients runs“! in ago

I'm 22

mwumandunorwmsaMnr-dhwumfm
psychotic: Wain, mhiaophmic and
W110
tho
mum mtm‘.
from

mm
minim
range of

uppnod

mm

sitcom: m

baud,

m

mm
(mum-mm:Maamcm(mhmmm
«and common Wmmmum.

-

m:

emu), mugmt

and

ﬁrst

Wm.

They

are primarily

m

group.

mum- mm m mm: m immfma used.

mycimm:

Mm

voluntarily

thwith
a
ported
first
(M
fa
tin.
Malina, pm};
M
was to in: yum) of paychuuic 11111333.
I

Him a uni: prior in mutant abject- wm mud Ink

mummm
WIW

m

new

Wmm

mmrmermofmmm mm W
crud
mamt 2W (Wm), in: nah»
mam-(0,
m)mdm1uubcr,ormponna(n).
Winn
113th
(M),

ma

or color

of
Winner:
Gamma mam mum
M,

a

(

). the mam»

�umuwnmmmmmzmummtw,
mmzeammmummmmuummm
mnwmmuwngummwommtwm.
Vassar-«u.

”WWI

mm
WWImathath.
m

obtainca prior to

mutant,

and at.

Pamumwmmt
mm mm mm mm «may mm mm rm tn. 1%.

“ﬁnmtcxinﬂmdﬂmmwwmﬂwwnmrdbymm

mmtmanmumanmmammmmcmm.
and
tho
highest. Mind: of claw
and
{mum
wtlviw,
m
W

Wmmnotmuwmiwmmmm. Emu-1mm”,

Wmclnuiﬂqdu'luﬁmworhuh'WﬁwM
”adv, wwmwcmmWWC

). Inﬁm

Whimuwmhn,mm1mm¢hishmeidwm
amuwm the mud and
autumn)

m

Wind

mm of tmhnnt (My

mod 1:: the tabulation.

7*?

mm

Patina who Gov-10nd him

�Wdummtmdtadmumrorw sump-nodsmn’
chased in

that high

m

map.

m

when

mm

am we damn-mu
‘

an: dm: at activity in “that wok mo alum in tho Manta-la

on“.

WW1“

tmtmt m

mm
mm
m:-

mm

that than u m,

malt-cum! or animating cam-mt ”mm.

Mm:

o£

mutants

from

m to

m,

mm» mm mm: to tum tram-mt»

run an:

the

pom mm

�W

Win “that
was» mam outlined, ﬁcvarmwm mmtofmnu
in th!

an
nab

activity in

mu

1::

puma MM

WI».

We

aw

ham sum-trim the

mucus in

m1. 1.-

“ﬁﬂﬂﬂﬂ
“QC“ﬂQ
1mm
munch-unto:
«and:
luau

high

dame cat-guy

umwiﬂz

tho
half
a
at
grim
wok,
pomuazm
8mm
m.um
m1”
MWammmtmtymommmmw-m mama
Bythofourtbmk,
rm“, 830%”me
“raw“.

Mm.

�Hum

mun

man Duane

Manta Dame

Whom.

a§§§

EH

3/58

�mmmammmmmmmamw

quuuwmmammtwmmmawhmagma

mawmum

‘Inpmuummamotm‘Mwmmum

mimwrmmn NW

and

thaw-m

farm was

(mama).

”HQQQO

”we

Mmmum mama“ tom Wotmntreama,

Wm
of

differ-um in m;

Many worn ohm-rod. mm dam

am saw activity tun obumd

maaent than in than with any

1n

philant-

mmnt,

oz-

who

mud

to apart

than with 2mm movement.

Oﬂd’“.

m3

ammmwumxmcm mm“.
WIWrmmWhMdemrmofdalm

humanize

«thug

with

tmuut

than them

who

”puma! color lad conﬁrm only

�gmaamAL
Ruth» at

m my

an

Be

a

'

7.2

nod-nu.

Low

my“

am

15.0

Mata,

Lu Dign-

5.0

5.1

393‘

6.6

R

2.3

(.01

�mun—movement, (:4)

‘

mm mm (m)

lo

mm

..

38

mm)

2a

2a

19

16 (ma)

a:

17

(m)

g

39

£7”)

23

u

as

15 {60%)

37

30 (31%)

1.8

(m)

(ms)

a (293)

'

3

lat-6.19
p g .05

(mg

I

as.
001°?
W”
or Hone

color (m)

m

((3., 0?,

mo
aim-H or m
MW" new 5‘0
’2’!

M)

'

as (W)
13

(253)

x2 .. 3.31:

P &lt;

.05

‘

(hﬁii)

n

(52%)

x’ .. 1.6a

w (W)

p &lt; .05

7

(19)

�4h
or

m

mm an
to

we
at
damn
mar
human

mt

mm

clawing were chance! in

mr’tmlar magma,

and

cow.

petunia we saw with»

than in

than put-nu

who

mm: or both that names.

Analyses

We:

Cm

rum-Ia.

boﬁh‘mmt.

for

(Mi).

m:-

and

of

than

pm

mm”

porn-am or good ram

(P)

man,

mud to

with

m m.-

of

at pomhr

Wane ummm autism

(W,

am

new

we 10121718:

mamwltudy(

immqu-tm

mmwwmmmc:
MW

mm

mum

m
mm

the physiologic

sun an activity andtopoﬂtiw

for uranium

We

(macro toaixpluammrad

Em

«swam

3.

into a single 1min. a range of

(Table

In).

The

chum

manhunt
11er

.mm,mmmmmﬁmwcwummam.
1:»

W

.05
at.
the
40.31;,
in
signiﬁcant.
correlation

M.

�0»)

W
WW
K0
MW

(31)

not}

702

(13)

3.3

has

3.2

1.5

Fast

�DIBOUSBIOII

In theee etudiee, the degree of induced

EEG

delta eetivity

during cenvuleive therapy hee been releted to pre-treeteeut

pereeptuel end

380

petterne. In eerlier reperte the

behevierel patterns at euphoria, hype-enie end deniel were
eheen he be

ceneietently interpreted by the peyehietrie

tenily
eheerver e!

ee

'ieprevenent', while eenetieetion,

penis, pereneie end excite-eat were reted ee Inniepreved(

). leprevenent in eenvuleive therepy

hee been

releted te each pre-treeteent veriehlee ee high eeeree
deniel pereeneiitw indicee (e
)3 eheence

Beele (

) end

an

the Geiiternie

r

or been: eeveeent, color, toreoeolor

whole
or
anther
high
nether
1e!
e!
er
reeveneee,
reepeneee,
end seed

for: reepeneee

on

lerecheeh teete

)3 end

(

lee edecetienel etteineent end tereign birth

(

).

Thus, in en environment where verhel therepy ie eeet highly

eetee-ed, petiente 1eeet like the therapist in eoeiel end
edncetienel

(

)

ettrihutee are referred for eeeetie

(er nonuverbel) therepy. Under the aenditiene of induced

�altered hrein reaction, thoee eanecte with leeet diearieineo
ve

tiee ehility reepend with

non—verbal hehevierel Iedee

o:

enphorie, hype-enie, deniel, diepleceeent end linieieetien,
end ere

reted ee 'eueh improved”, while enhjecte with

greeter peroepteel end linguietie dieerininetien reepend
with the mere verhel petterne or pereneid, penic, eoeetiee~

tiou end enxiety, end ere reted 'uniepreved.“
In the ebeervetione reparted here, the prentheeteent

perceptuel node ie elea releted to the degree of physiologic
reeponee. the xreeter the perceptnel diecrieinetion
end verhel

dieeriptive ehility

on

the Boreahech, the lower

the degree of induced elew were activity, the fever the
hereeheeh reepeneee, the ieee dieerieiheting end the 1eee

the

ehiiity to eeperete figure

In: ground,

the greeter

the phyeielosic reepeueivity te induaed aonvuleiene.

It

ie difficult to rereelete e eeeeel reletiehehip between

clinical hehevior (both pre

end peetetre%teent)

pereeptuel

�pottorno and phyoiologic rooponlo. But

it

in oporotionolly

looningtul to intorprot thou. various tasks to rolotod
behaviors of tho oubjoot in

hit intorootion with tho

onvironnont, with ouch nonsuro or bohovior roprouoating on

obstruct or Io-plo or oubaootuoxoninor rolotiouohip. In
thio tronowork the problon of tho rolotionship botvoon
poroonolity and physiologic noosuroo 1| transfornon tron
on. or 'whothor' to can of 'hov' and 'ondor what conditions."
In than. Jobs-eta, hoizhtouod porooptuol disoriuinotion
dogrooo
of alpha
oppooro rolotod to low

activity in routino,

waking rooordo and docroosod amount: of inducod slowing in

such
bohovior
In
oonvuloivo
clinical
to
thoropy.
coupons.
ond
idootionol
to
anxiety
introopootiou,
oro
subject:
pron.

dioturhouooo: and shot poop inprovolont voting: to oonvnloivo

thoropy.

an...
1/

oboorvotioao oro conoiotont with proviouo studio:

toloting personality

and

EEG

oopooto by Konnord, Ulott and

�shagaae. Kannard and subvertaaan
EEG

(

)

related reating

apectra of low alpha index to aehinophrenic pereouality,

while high alpha index to non-paycbetice, payebopatha and
young

indiviﬂuale. Ulett g§_5;,

anxiety ereneneea
and elow and

wee

(

indicated

)

correlated with peer alpha activity,

feet aetivity in the reating record,

and poor

reapenea to phetie atiaulatien in the alpha range.

abaxaae' atadiee at the aedatien threshold

(

In

), lav

reepenaivity to barbiturate aa aaaaurad by amplitude of
beta activity
teneien

wee

peaitively correlated with anxiety and
),

(

aonvulaire therapy
and

and with peer

clinical reepenee te

). Thee, behavioral reapenaivity

(

interaction, retleeted in personality concepta

psychiatric neaolexy nay

reactivity

ae

tetlected

be
by

and in

related to neurophysiolocio
BEG

patterna, within the liaita

at the aeneitivity at our aeaaureaente er aethoda at
experiaentally altering (activating) both behavior and

mac.

�Ink-rent in nonrophyliologic rcapensivity uro .11 the
tnpccta of tho inturuni

lilicu, a: rotlnotod

in individual

prootrostn§nt
and
336
ditterouccu in biochonistry,
in tho

rtcord entrnotorictiolg the individual onvirounont
continuum

I! rctloetcd in porccption, notor patterns,

need

lad varbdiiaation; but also tho oeeiologio 33poctn of th-

iudividnal'a .xparionec. In the scrioi at pati¢utc otudiud
hnro, an anulyuiu of cduentional lovol with dear-o of

rooponuivity danonatratud a aiguiricuut

(

-

p

EEG

(.02)

relationship. Subjects with nine or sore yunra of tarsal
cducttion had a lover parcentago at high degree slow unto
oleotronruphie rccords than aabjcct- with
yuurn or education.

lot. thin eight

�- 19

.

COICLUSIOII

The

veriebility in the degree of induced aloe

eotivity eeniteet during convuleive therepy
to technieel feature at the treeteent.
held cenetent,

etudiee,

BEG

fit,

were

hee been
when

releted

theee ee

veriehility is still eeniteet. In theee

slowing hee been releted to pretreeteent

pereeptuel end

EEG

petterne. Petieute with fewer

number

of reepeneee, fever reverent reepeneee, end ebeence of
hneen eaveeent, color end
Rorecheohg

greeter errore

for-acoler responses
on

on the

figure-ground diecriniwetiou

teeke; end higher percent tine elphe edtivity hed higher
decreee e: induced elee were

eetivity.

Phyeielegio reeetivity, eeeenred in

EEG

petterne;

interpereenel heherier, eeuireet pereenelity eeeeuree end
deeoriptiene of clinicel or verhel behevier ere different
eepecte er the interectien e: euhjeate end environment.
In thie treeeverk,

EEO

end

pereonelity verieblea ere

releted within the lieite or the eeaeitivity e! the eeeeuree
need.

�WWHWCW
“WWW
}

i

an: 111*, 11.0.,

W m.
A.

11.9.0 and

W

L. Kuhn,

31.9.“

�mmwfamuyumwmumo:
www.mmwotwmxarmm.
mmm.m.m,msaw.

mW
m

MM, In part. by
£41380 at tho

Kiwi”, rib-2715, Eli-072% and
mam. at mm. lit-1th.

�WWMmumﬁmmmmﬁmua

may, WMJmmmuisiu,fwmviml

mummmm
mmnw*
mwam-myammrmammm
(a).

Mwlwmumivity. W,mmfmqwmy

“Wolsmmmidtyvmmgmmin

wtmmjm. mmofdowlwtmmmtof

alumivitymbmmmmmofﬂnwbject,

fmmdw,mmofmwdm(m,
Meal. Wall) (6). Mmofmm.
m.m£mmicimtwupmnuummminm
mwmuudﬁtyiwmmt.

months
mmwdm‘mm
lid
Womb f leak
{ism-mam
(7, 19).

task: (23)
mm
and sad: “01051031 hector: u in, Mom). 11ml, and
(21!),

phat of birth

(22, 23).

on

�WWW:

W
Wupntimtsmhmdfor
til-WW.
Th- ut‘hocb

(3-4
lad-25)
Mob
stud“
mmr
tow

m
W
We
thmmmtawjeMMMt-ddth

minim

in

I volmtuy

Wm}.

atudiod.

WI

($.tm1ﬂmmtmpm (HOW). mums-bar
“court-39m, (mormmmmunmotmm
(R). Thu

ﬁgure-ma MWG: task was

W's

Mad-m

£13m“.

a nutritionist! of

�.m-me—v_

wmwvvv.wm-‘_ ....___~mv.m

V.-

ww..ww—

mm—pw'wlr‘

. u...” .m—

Wm
mwmmmmhmwvitym
Mmdudfioduﬁou,“
thmlm.
mm:
"mam"
“myimhmadnymmmt.
or "my." in

this

of slow wave activity,

WmWn-Wofmpamntﬁmoffnqmu

M7mw¢1m.ﬂnsmtmmmywhimtwlim
ofulwmmivity,md1awtamimothumtactivity

mmmm.
mmuwamdmrwmmummmm

Panama-«mammawotsm

attractant (8—8.7-Ommthmrun)mchmdin

ﬁahighdogntm.

mmmaamtamm

Wmotmiutymciﬂnrmkmwmm

mumm.

mmmmmaWMfmﬁmm
Maudmckmmamimmwmamt.

W

W
Manhunt-“(21).
WdWquWaﬂﬁw“
memmumdmm.
mmmmmmwanumﬁngmt
«thud-(6).

inorhntatim, oaxfmion.

and inmost!

mmormuvmmtxwmmm,

dmqummtnMMIwmfmun

W.

W

�-7“ _..__,., Mr". v- wwwmw “up...“ -- m wu—w'mWwvr-nmrvw‘

"mm mm
V

W___.

_

¢.‘WVI—m

WWW:
1.

vmngamdsmmmwg
mmdMBMMMﬂtyI-nom

(1.51.1).

mmwwmmmmmgm

Wynn-undid: umdwmm.,ha1fﬁn

mummammmmymm
www.mm‘mmtmm.
35!me

m.m,msmwmawmwin

�“wwmww—w—W.

.w.

.—V

.-

-mm

——--—-——u——~—v-—--

MI
with (Jamal-iv.

Baum of

mum-mug
RX 5

mm
Hist:

Dam:
Dam.

Lav

Ham

gm

mus)

W

MN MW

Hm“

Whit-k

1~3

I-G

an

m

m

12‘

11‘

27$

w:
1“

nu

25$

3t

2t

7-3

�mmmmm,mmormmmm

muunmwmwmmmmumw

tmmammmmmm

mum. mu

MWatmIMuwmiﬂtyMWsmiﬂmﬁy

mmef-mrmmn
.

WWII).

m

”WMMMMRMMWWWOf

mm...
munituhmmmofnaummivitymmlcubjm
Mnmnmdmmmm

WMwmmm(m

3).

m
WWMaW‘mmmip.

Purim

mwwmmmmwmm
nfmumdwdthmmﬂmmmwm
“Woulymfaﬂadmﬁnmlu'm.

Dubbing

mmmmm,mwormmmm

«mummwmmmmaw
m’mmmmmmuw
Wmthm
«techno-um»
‘

I

wamum'mu
Mum: “Wot W

M.Wafpod

rum,
mmmnummmwmmmotnmmnn
(PM).

’

activity.

(P)

mm

�mm'

HEB

slaw Hhmu.&amp;at1v1§:

M

8.13.

Diff.

“L

“.2”

Hunburraf ggggggggg (R)

Hodunutu, Law Dacron

13.2

7.2

20.0

15.0

Hu-hlr*o!‘nbwunnnt Egggggggg (Hoggggz
Hidh Dusruo

2;!

a.»
2.1

Hodumuun Lou

Dust-o

5.0

5.1

2.3 «.05

�WimmmAv-Wm—w—w‘mw

_——-..——

.3...

wmqumm'NWWﬁ—w

W111

Wormwmmmmm
m;
mug
to

W

£1.

M
cm m (m
M

Slow HIV.

W

‘Piodnnta 3 Low

20

(53”

18

28

20

(71‘)

19

1.6

33

ow

52

m

23

Hun:

(M)

No

Fan Color

(PC)

Color ((2, CF,
0-6) m ﬂan

”PC

mm

or re
a new PC

H

mm

mm!

ngm
I

(Wt

X1

B

(29%)

13¢ .05

(8%)

3.

(16‘)

17

(52‘)

16

(um

39

(75‘)

.13 (25%)

11

(um

12 (52%)

25

15

(60‘)

10 (“0%)

31

30

(an)

38

'

7

(19‘)

6.19

.

Y .

4,

�!
"4”"1

map-ammunmuumtmm-umm

mnwmmsmmmotmmmmivm

mmmtiwmmmmmmwmm
Wins.

Wmmmmnwmamn

W,umo£dmpuhwmmuixplmmm(mﬂn.

thym.mdﬂfmhﬂadcflwm

miner-th‘mmwmnnmm

mamas-«mm. mmmmunttm

MmmmmmMmmwm
mmwmwmuvanme-m

memmmtmmmm
mmmvnymmmmhmmatw

Mmmivity.mmdupmtmamhmivﬂy.

mmmjm:,.wmonommom

mm m

mW

nook (10-12?

mm“).

�.._._,f ‘

‘rﬂmww‘W‘m-m-

" " "‘"' ' ' '

"—"" '

my
burial of Pvt—W Ram in
Marian—gm ant to muggy» manning
(I)

W

wmvmtmms
'

(a)

m

a»

(19)

11.2

- '90.“

a. 10.

(1m

7.9

p c .05

555+
to.

(b)

2*

Mn

0

13.3

‘

‘

mama»: Acting:

MW
Noﬂi‘ﬁbugncua)
(31)

8.9. Diff.
'

11»

7.2

3.2

m

3.2

t
w

.2...

1.5 ms.

�W

ofmmmumiﬂtymwmiwme

mmdm
WWMMW.
mutiﬁtymmmndﬁmsuithmmwm
mmWmenymﬂ-th. m

WMMWwﬁtthn-u‘ww

mmwuumamwmmnmmjm.
(10-13).
3M1» hymn-gm (3145).
(mm).
(2523)
WWW; mm
mm. mm
1211

no)

(Mmuthwmgwmmm

(as-mm

m(a.1nmtmvammmnmamm..
than new». tho mudwor m Inw‘mim or
In

m.mmmwgmmm.w
WWWmWnMMb-mnwwm
.Whmdmmwmdcm. «Moan:
WWW
tint-hm magnum.
mewmnmmmmummm
Mviwcfﬂumathinﬂuudunfmmtﬂﬂtyofm

Wt.mmmmotthgmmw.uw
wmmuhwmmmaotum
muwmmmmmmmmarw
V

"

�Wigwam antennas: is a major
(30)
Welmmmlstudia Mom“). specificity
«cf 5:

subjoet any rennet

3W cmmmmmwmmumm

mm.

Witisopomimnymmingmlm

immeam
wwwmnmjoatinhia Wimwithm
mm

mdptmiolagioaltamu

of th- rolatimship

bum Wt)! and phyaiolodml

WhmlmfmmafW"tomof”W“md

Wmmm.“

MWmmmmﬂmmwm

mumm.

Fan-cobrmm,
Wormpams.mwnmormu m‘mmm
Gazer.

10w

(1953m1mmimlmmt
Wmhu‘mﬁuu

WWW
mmm
mmmm-m,
(22, 23).

mm inﬁrm-tad
sung-sting that 1mm mvimmm: um

.

�oohwj

"V'Ir r—v"-__

.wv

_

W. m—

.-

“muwﬁmw‘wm

a:

w

,_

~13.

WCwm—wmn therapy. mmmdwinmin
mum. tho subject- with the lust
ability

Win
wuwmmmmmuom,

mm. mm. «113th mainimiutian. mm
"Mammal“;muﬂmwbjomwithm
mummmmmmmmmmmm
mmmofmk.pmic.mtionm
wow.mdmntodoo"mmw.“

�€

1l

Wm___.,_‘i

4

i

4

“n...

Variability in the dam- of

1mm 01.0w um activity

mm‘nwmmmmmmrm
ofﬁnmt.
“MmMMtht.m.
Inmpmmswa,mc

thsﬂnmifut.

ummmmmmpmmmmpmmm
putt-m. Paintswimfmtotalm,fmw

mm,mdmefmw,mlorw’w10r

mpmmtbm,mmmﬁmw

«Wm..mmmmmmvm
hadhiﬁurdumofiuﬁndslmmmvity.
Wamutynmdiuﬁmmm,

www.mzyummmmm
«memmarzmmdm
mummWammmmwm.
www.mmpomutym-hmemhm‘dminﬁu
Mudmmiﬁvityofﬁumm.

��v.‘_,-..-...—, .w—~ .ku— __.—_.. 11__V.,~......——mr --

ym—‘W‘Fm__ -WV..-——.7—w...7Ww-....

[

m

,, w __ v—v _

W

u "—— v W— ‘v

«mm-m mmw.ww V‘mw.)-—_‘—m~ vm‘wm

I

!

E

17 .

W,
mwmmmmuapmmmmmmmh.
Jana,
Mu. J. PAM...

W
mm m

10. Kim, a.

to

19.

Canny.

K. 1-!"i

R. '1‘”

1965. 122:

E. and Layla. R. S.

_

3341.

L.wﬁnk,ﬂ. J.
Wityfminwmimlmpm
#548.
1959.
l:
Wyeth!”

W.
mmmm.

m.
chdmofmmaitmin
2u2~2N5.
1:
1960,
J.
1
to WV
umywm”
W;
R. 1... PM, H. ad Sisal. N. “mythological upsets of
m,
in than mammary hospitals. mm. M. mm"
Wt
m.
n.

W
m

W
m.
W.
aid

Kuhn. K. 1... Pink H.

w clinical
(cum), 195$, 18:

m,

Witll
in Wok. Auk. Mamet. 7391M.

“013313513,

23-29.

E. A.

W111} of

W

m

M. ma.
n.
n. 1...
in a wimtuy mm hospital. J.
‘22..

mm”949.,
1:!

or
«harm
1957,

W Palm,
mini:
We!
WeWinamem
rating
mm”
diam
$95,211:???
63 2

c.

3

ma diagnosis. Melt.

"“0

$

Win W.

2". Man. 3. I... Polladc.
souls and

Pom.

W,
,lmﬂl. Mo,
28.

I‘d Pink,

J.

H. and

m,

Gen.

Social limit-nan (Cnlifmia F
915.. 1960.. 130: 187-192.
ﬂow.
14.

H.

m.

Flam-gum diowinimtim

1‘ "'5 10

ILA.

27.

14.

W
W.

25. mm. 3.1...
23

Mop-yanlogm aspects of

H. and Fink. H.

23. Kuhn. R. L.,

'nn

1953, 15: ’5’1150

in paydmologtml

diam.

r

W,H.A.mw.s.
mmammmmwm.
1952. 115: “13423.
1. km. Beat.
in
9426..

W.
Wsmwmmmwmmammummmmm
can.
dim. WW. ummm"
in
a.
6mm
mm.
J.
ﬂuid“...
malts
fm
ahehomplulm
W.
ad
3..
m,inMuwywﬁa unrammotmmm
m,
J. mm"
We:Mt.«action
disarm.
far
«ﬂaming
mien
mm
W6.
W,
can. NW”...
in
Eummpk.
patina.
We
H.

A”

Mimitdu, 3.

ad rimmw.

The

m at 1mm

1955, 7: 29.38.

A.

19%,

30.

1.05:

and Winner, A. Significmaa of
which
shod:

“0-35.

H.

Grass, 3.

a... mamas. A.

1968.110: 651-661.

31 .

C. ‘1'!»

A

tho

th
M.

‘

195“, 6: 221-233.

�32.

33.
3'5.

mm.
W.
Pam“.
Win:
m.
Shun- c.
C. Sod-tin:

A

.W.
m.
mm
Awaits“
W

Ammumyamrmammmd
9: mass.
can. lawman”
A. L.
1!; 750
patient.

(3.

diam-13:1
11k: 100 0guns

-

.

.

,

“9

.

&lt;2.st

but prsyehiatric

mm”

1958.
'

.

WWmlwdvityinmdmic
Winn. Melt. madam" 1962, 6: 235432.
H.
Wmﬁatﬁuinpoymimc
macaw
Add.
5:34:12.
. Am. 3. v.
3%, mu, m:

3km:

3’ 0

z

ham. 1.

1957‘.

mmmmamowa

Sims,c.mdﬂdm,d.

37.

tool for
Wyniolncim
M... 1956, 18: #10419.

1988. 121:

‘

11.

may.

H.

«I.

A...

-

W.
Martian.
tam.
m1
0..

m
Vimmlmmm
Wm.

W
m,n.mdm,u. ”MMMW

madam:
Weird-tic.
shag-s

H.

J. Hmmyem”

J.

mam...

1962,

3

'

(mid:

tbs-58.

Uhtt 6.A.andm 3. mmmdwwimmlmwmn
thl Many mama we.
1952. 115: urn-sea.

3m,

“1.

mm.
mm
York. 1353.
Haw

s
Wihy
Sons.
Inc...
m
mm 1mm.
.

�February 21, 1957

Individual Differences in

EEG

Responsivity

Fink, MJD.
to present observations
Nbx

1)

Problem tonight

is

in the laboratory of Ex-

made

perimental Psychiatry at the Hillside Hospital and then try to discuss their

significance.

we have no

the clarification
The problem

explanation but wish to present this material for

it may bring.

is to account for the variability in

EEG

re3ponse to electroshock.

The Observations:
1)

Repeated

EST

induces

EEG

changes. These are of many kinds includ-

ing disorganization of frequency; decrease in beta frequency,
amplitude; increase in delta

%

%

time and amplitude; delta bursts; spike

charges; increased sensitivity to hyperventilation, amobarbital,
There

2)

is

a

direct relation in group data of (a)

with degree of induced

EEG

time and

dis-

-

# of treatments

changes (b) frequency of treatment (c) type of
'

treatment
Note

(gm

or pm).

that our analyses are devoted to

one

aspect of the

EEG

response

- i.e.,

delta.
quantitative measurements

The

and myself and included were

bursts; slowest frequency
3)

%

and

were described here

time delta, highest

1955 by Dr. Kahn

time delta, duration of

highest amplitude of delta.

But analysis of our records, so

classified as high, middle and

demonstrated a definite relation between the
ment"

%

in

EEG

response and the "improve-

in the behavioral\response.

Presented

at the Metropolitan

EEG

low

Society, February 21, 1957.

�In the

first

2h

table
the
was obtained:
following
patients,
%

High Abnormality

1-3

h—o

7-9

10-12

25

80

91

88

Moderately improved (6)

o

16

so

ho

Unimproved (7)

0

0

O

20

(ll)

Much improved

first

we were

struck by this correlation, and, devoted the subsequent year

to demonstrating the significance of this relationship.
our conclusion

- that,

improvement

You may know

of

in electroshock therapy requires the

induction of a state of altered brain fUnction, of which the EEG-delta
index

is

a cardinal sign.

recently,

More

notes that

3

we

at

the part of our table which

of 2h patients had high records within 1-3 treatments, and that

after

10-12 treatments 5

ord!

Why

Let

took a second look

patients

still

had not achieved a single high

rec-

this difference?
me

demonstrate some of our records to show the difference in

EEG

responsivity to electroshock.

It is
first series

all treatments were given in the
in the latest by Medcraft - three

important to note here that
by Reiter instrument; and

times a week.

That extraneous

ulus was eliminated,

all

factors as threshold or suprathreshold stim-

recent treatments have been given at threshold

stimulation, achieved by Dr. Green by repeated

PM

a seizure resulted.
1)
.

High

EEG

2) Moderate
3)

Low EEG

response.
EEG

- Lesnick

response. -

response.

Baum

- Silverwater

in increasing dosage until

�To

what can

we

ascribe the difference in response?

immediately come to mind, and

I will discuss each

one

A

number of

factors

briefly:

(a) .553:

is a factor in this varying responsivity, but not the sigIt is true that some younger patients achieve high EEG abnormal-

Age

nificant one.

ity early; as

first

two

patients over 60; but an analysis of the data of our
electroshock studies, for which I am indebted to Dr. Green, indicates
do some

age to play a small

role.

Analyzing the records of h9 patients, Dr. Green divided the results in-

to those above and below hS; above and below 50 - as significant cut-off points.
There was a tendency

for the older group to

have lower

EEG

ratings in the h-é

period; but by the 7-9 period, the differenCe was gone.
'

(b)

‘

§_egc_:

Clearly not a factor.
(c) Clinical diagnosis:

is difficult to assess. As you know, clinical diagnoses have no independent reliability. They are approximate descriptions of
experience,
clinical states and depend largely‘on the examiner's‘bias,
setting
This factor

[of the examination, purpose,etc; also on the patient's age; and only incident-

ally

on any

operationally defined observable pattern in the patient. For

these reasons, this analysis is deferred.
However, gross
more

inspection

shows

that patients with

low

reactivity

have

often been called schizophrenic and paranoid, than involutional depress-

ives and manic depressive- and that patients with high reactivity have more

often been called involutional depressives and manic depressives than schizophrenia-paranora.
-_-——-————————-———

of treatment:

�-h-

significant factors, and since we are describing the results
of individuals treated in groups in whom these factors were constant, we are
Both are

not going to explain this further than to say that

stances, to convert a low
a high

EEG

it is

possible, in

some

in-

response to three times per week electroshock to

response by going from Reiter to Medcraft; or by going from three

EEG

times per week to five times per week or twice a day. But these factors only
amplify further the variation in response. Egg. DeFede
We

have assumed

abnormality
We

is

have looked

appear

that the development of cerebral changes, of which delta

a prototype,

for

is

the logical outcome of repeated electroshock.

an explanation, therefore, of the

after adequate courses of

It

may be

may reSpond by

failure of delta to

shock.

that not all patients respond to brain trauma by delta, but

other changes (as increased beta voltages and frequency; or

increased disorganization; or increased responsivity to hyperventilation).
Regardless of the construction, a difference in responsivity exists, and

is

manifested in our series.
we have

The

factors

conceptualized the problem as one of "cerebral reactixdty."

we have

already outlined are important in such reactivity, as

have described, but we believe

that

more

is involved.

Out

studies are

we

new

in

the progress along the following lines:
1)

222 Factor

of Personality: In the course of our study of factors

which bare on the type of behavioral response

euphoria, paranoia, withdrawal

define personality

-),

we

to electroshock

(i.e., denial,

undertook a study of personality. To

is extremely difficult.

But Dr. Kahn

in our laboratory

has done so by the use of a variety of indices. The Rorschach; an interview

with relatives designed to

elicit

premorbid behavior, eSpecially denial;

figure-ground perception; tachistoscopic recognition of words, 32g.

�To

our surprise, significant correlations between the degree of delta

abnormality and two Rorschach factors

I

score were achieved.
63

and the

patients,

EEG

have

listed the table of

in the h-6

score reflects a low or middle

The

IS

as well as the denial interview
M &amp; C

initial
in
scores
our

responsivity.

The EEG's were done

CHART

(M &amp; C)

EEG

and 7-9 treatment

period.

The

negative

response; the plus, a high reSponse.

THEN REFERRED TO

significance of this chart is in the "apparent" diverse

phenomena

that it purports to relate. If borne out by future observations, it states,
that patients who'have no movement responses and either no color or color-form
responses have hh% chance of high EEG delta reSponse in the 2nd and 3rd week
of treatment; while patients with Form-color reSponses have only a

for

such a

16%

chance

result.

it be

that one's perception of the world is directly related to
one's cerebral respOnsivity? Or, do the conditions which permit delta to
appear, that is, those that require an ability to withdraw and assume a passive
Could

ree
Ostow
described
attitude as
by
for alpha index, also midify the patient's
sponse to the Rorschach?
we have become

increasingly interested in this problem of passive

choose to describe

attit-

it -

in the problem of "vigilance" - "alertness.“
In our laboratory, Drs. Pollack and Kahn are engaged in developing psychophysical

ude, or, as

we

measures of such "vigilanceg" while

we

have become increasingly aware of the

influence of the observer's activity on the ongoing
2)

A

second

factor

which

EEG.

interests us with regard to the

problem of

in-

dividual responsivity is the concept of physiologic reactivity. Electroshock

�EEG

(17)

ResRonsiviﬁz to

ECT

or

R

(58)

GM

00

2

OM

czyc

h (33)

h (33)

7

M

CE/C

3 (30)

u (no)

M

00

1 (25)

2 (50)

OM

M

m

FC

5%

level of conf.

S

(71)

9

(50)

h (22)

12

10

�is

a way of inducing certain diffuse chemical changes in the nervous system.

So

is metrazol - barbiturate -

activation technics

it

is

show

- hyperventilation.
significant variation in responsivity.
hypoglycemia

Each of these

For example,

that hyperventilation induced delta readily in some patients - eSpecially children - but in others, no such response is noted. Dr.
commonly known

Green of our

laboratory has hypothesized, and is

now

studying, the possibility

that a degree of physiologic responsivity - which is measurable - is an inherent characteristic'of organisms. To this end, he is carrying out pretreatment activation records in all our subjects; as well as measuring their threshold for

in

EEG

depend.

electrically induced convulsions.
I am confident that there are other "factors"

on which

responsivity to electroshock - and perhaps to

all activation -

we

the variation
may

the
ones described, namely personality, vigilance,
are excited by

and physiologic

responsivity.

tonight, not the common characteristic of the EEG
response to activation, but the individual variability and the factors on
we have emphasized

which

this depends.

'We

have

tried to exemplify our problem

by our data of

the variation in delta response to electroshock. Further study of each act-

ivation technic to relate the role of personality, vigilance and physiologic
reactivity to the variation in EEG responsivity.

�-3and
middle
(lower
socio-economic
upper lower
(Jewish)!
'

j
,

~

first

The

generation, group.
and

_

ideation‘

mood

, responses.

W;
in the first hospitalisation,
of Psychiatric
.

psychiatric

bellman”

«read-tune

class), immigrant

and

were

'

patterns we

114'

W.
They use voluntaﬂeﬁon‘ar predominantly
1,

with a short period (few months to few years)

illnesjzlectroconvulsive treatment

was administered

three

«W “M'-

_

times a week using

1hr

%
WM
mthods.

rﬂ
L3 r

.

suprathreshold unidirectional or alternating current

A“n*”"t ”WA

a

Jayne/1nd“!

11’

ﬂat

man

!0

ti

3.:

Wig Ml’" {M-dtun

ﬂit/“23‘

Within a week prior to treatment subjects were tested with Rorschach
and figure-ground discrimination

for presence or absence of

j
,x’”‘\_,
[I 2

responses
and

total

(H +

EM+

tasks.

The Rorschach

human movement

protocol was scored

responses (M),

total

m), type and number of color responses (0,

movement
CF

and F0)

In the figure-ground discrimination task, a,
()
modification of Gottschaldt's hidden figures, the subject

number of responses (R).

L

niacin-mam
is presented with
and below

it

a page containing two forms

a cmnplex figure

in which the

-

a simple geometric figure,

simple figure is embedded.

The

task is to outline the embedded figure in the complex figure.

I'

”A4€

"-

ad‘

Electroencephalograms were obtained prior to treatment, andweekly“
on a day following a

Mamie,

treatment. Patients whose pre-treatment records contained

�measurable delta activity were excluded from the study.
slow wave

activity

frequencies of
and

7

W
MW

was measured

04,

wave

actiﬁty,

Based on these

activity in the record.

of induced

by determining the per-cent time of

and—less
three
selected
in
cps,

highest amplitude of slow

The amount

and

leads; the slavest frequency

/

longest duration of burst

indices, records were classified as

pan/40M

"low,"

"moderate" or "high" degree delta-

W

previously described

of high degreesdeébba

(

activity, according to criteria

). In the observations reported here, the

activity in the

second and

third

development

weeks of treatment

treatment intervals) was used in the tabulation. Patients

who

M.

(We,

developed high

WWactivity during either or both these periods were classed in

3 of
delta
degree

the high degree group.

Those whose records did not demonstrate

activity in either ,week

were classed

in the moderate-low class.

7-9

tt%gree or"

�watt—baa

WI?

“H.“HQ

mammmuormmmummmwm

"mu

alum,

that

«warm ant m1: of “Mom

(W m).

In

Guide“ the “mummy in mum, vellum, m

rmwmmwmmmmmtm mm,“

Wsamunugmmwmmmmmumum
mﬂWNudl. MMM3M( )orthmputmtlm

mmzmwmnmcmutmwmammwmtw

mama
in

aetiﬁirapmﬁ muormdmmmalmthm

such
with“
«mum
mm

mmm&lt;

mm

an

«mu- apart at

W

).,

«mapmwmmmmpmmmm ”mtg-lam
muey m “rant-d nth tho

W

W ma
of

as pass-mm was at such wuvﬂyw In

mum

«1'

”3.“,

+0.35,
"

m1:

{'“4‘.

...,

am

“tax”; 44”..

a

l1" an activity.

tom-rm autism,

tho .05,

w

a

WW

2.3.2.1.“

Wmudu‘mumormduummwmu

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67394">
                <text>Individual Differences in EEG Responsivity</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67395">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67396">
                <text>mfp-03-01-002-6-006</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67397">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67398">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67399">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67400">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67401">
                <text>Research papers, files, and related correspondence. Drafts, one with Martin A. Green and Robert L. Kahn</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67402">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67403">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80942">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87503">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94064">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100625">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6741" public="1" featured="0">
    <fileContainer>
      <file fileId="6551">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/130db8be85bd0b48cc58aa475a58b045.pdf</src>
        <authentication>bc509f8c91b02a75587679edc6e65f4e</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107156">
                    <text>J4»

M

4‘

\
G: 3/22/57/

s '

Electroencephalogram in Electroshock: Role of

Delta Change in Behavioral

RBSponse

Following the original x observations that electroshock induces changes

in the electroencephalogram,

clinical

studies correlating snob changes with

numerous

In an exhaustive review of these

improvement were undertaken.

studies, Chusid and Pacella (1952) conclude their survey with "in our opinion,
the slow wave formations after electric shock treatment bear no direct relation-

ship to clinical improvement.

favorable therapeutic response depends

The

primarily upon the administration of a certain number of treatments in each

particular case,and since patients vary considerably in the degree of
abnormality noted with the

relationship between

changes and

EEG

it

of treatments,

same number

follows that any

clinical recovery is largely coincidentalai.
A};
A (. if‘kt" if:
I

/(/.fr

~”/

his/((9

F

,7
.6-

,

221

[ff &amp;
\

('1

F621,!”
if

,

CWA/Ll’ﬁi/I

{‘QJ/QJ { (44.1.
l

'41

[L

.6

o

’

f l!

if;

,0

a’,,.€"5.,‘

\ 2x
)4,er

1. '7

1‘

L-ﬁ
!

:13
&gt;

I"

Bdké’vttfi’

,

”1’

‘
‘

ﬂit)";
I

,

,

,

..

f,
\

Mix/4.x.

U

'

R.»

'4‘)

‘

1/6, , I.
1|

EEG

(MA

gr,“

I,

,

p.

in

7,1,, V”
‘

5

.9

4,,

(3.,

"M

/QM{

ﬂ’szf/lff’

,'

{.4
L

J“

\
(’2‘:

/

f’

:3 «m 1‘;

.-

in"

O

v’

w.»

1

,2”,

41

”
A

£146.11”

kg,”

(1

r14;

1

Q41 47‘4”! "4

1.0

7’

(nt/Z/ﬂ/f

'I"l.-',v rr

c

F

x9

if;

'A-b-

:t

{f
I

,

x

a

’,

A;

5’,

ﬂ

I”? (11"!

!

/‘)

"(Wk

,

/‘
(1..

1

f)

,-

$.44

,

a

,c

r

.,

,7

‘a

K

1

�‘

-'

J
’13]? .f‘ 5‘

V

In an early report, Hoagland

.

§§L§;;(l9h6) noted a correlation between changes in the per cent time of more

j
disturbed behavior
tr

I
/J"‘Z3’fa,t~x
V

than 13 cps activity and independent clinical ratings
became more

As

-.

T}

‘

manifest‘I, the fast activity increased. With treatment induced

behavioral improvement, this activity diminished; only to reappear with a
,_‘

if

'9‘!“ ‘AlerA

‘

1“

A

3:419:4{F’ﬁnf

reéitumu-ne of symptoms.

~35;

('1 I

a!

‘

I

.~

‘

"

v

I

f

A“

delta response an activated by intravenous

thiopentone, elicited characteristic

in the treatment course, there

EEG

was random

changes

in every subject. Early

irregular

slow wave

. A... "‘--"'-~—..

tre;;;;;E“‘EQE;eaee3¢%o
&lt;§¥¥§:nore
a highly rhythmic,
amplitude

f £41

"I,

clinical correlation.

Roth (1951), reporting the

high

I

.
/

Similar observationsﬁwere reported by Kennard

and Wilner (l9h8),without a

V

.v‘

1/1

4

runs and bursts.

These were

chiefly

activity whicht

bilaterally
2

up to 200-350 microvolts and continuous duration of 30

to
to

synchronous

cps, with voltages

3

80 seconds.

When

the resting record evinced rhythmic delta activity, thiopentone increased

voltage and duration, spread

its

area and decreased

its basic

its

frequency. Ebth

believed that these changes were related to the process of recovery, and concluded: "the development of a typical
10 of

the 36 patients

two weeks.

But

who

transient

EEG

change does not insure recovery and

obtained such change failed to remit for longer than
improvement

in clinical condition

seemed

to be related

l,‘.'

,

.

,

I

�to the
the

EEG

EEG

change even

in these patients. If

changes with the therapeutic

effect,

are correct in connecting

we

it would

seem.since most of

the patients developed typical changes, that the physiological basis for
improvement

is acquired

effective in promoting recovery."
«amen-«AW...

mzu/vx-W

it may or may not prove

by the majority of cases;

(

urn

)

y‘a—wnup-H‘QOMﬂh-MIAN-mwﬂmhﬁia m m

«WiniWW.iwm~mm

,

.,

7_

_, W_ni__u..aw»r

Iz=tsagillunily agreed'that electroshock induces diffuse slowing and
Meade,” (iég
increased voltages in the electroencephalogram. There is 1iII some inW dam/a w
dication that fast activity’, both in voltage and in per cent timel'aasae
dice!

dell-Ilia; enlistiées in nlxlxli; patients

2”

are intensively treated, -CL¢€-

who

a slowing of the persistent alpha frequencies.

degree, duration and

The

extent of the delta activity is directly related to the frequency and the
number of grand mal convulsions.

bInch

activity is usually symmetric,

and

with anterior placed electrodes, appears maximal in anterior electroenceph-

alographic leads. In patients

received twelve to twenty treatments

who have

d‘xuet
on a twice a week schedule, the electroencephalographic effects usually
“WNJw‘A

;

“ﬂmwui_w-i

«-

-‘

disappear in h -8 weeks following the last treatment.§ Studies of the prep

it»?

p

treatment

\

EEG

7

characteristics failed to demonstrate any relat’ ship with
"
_

po;t\seizure
the
electro cephalogram or clinical

\

onse.

Similarily, there

,2,.

tax: has been n report of
\
r
C/ﬂu 1 L/{L-"Ligﬂa :14 SM
K

rum—i

If
/“

.\

a relation betwe
K/

fat 6

Leg/2x,” ﬂu”?
K)

J

M.

f.”
(

thexpost treatment record
x”

A
v,

f

a [If

‘ ’

_

.-

V:

t

.

�Both of these. reports emphasize a.

W

relation between the degree of electro-

encpphalographic change and current behatioral response.

Mﬁﬂferent

aSpects are emphasized, namely delta response to barbiturate

activation and the beta response .2

m

—‘

m-...-‘.......—...7...—....-

Had other‘swlstematic

studies been done,

ha been that n correlation etween elec oencephalographic changes and
M
f:
”tax-:74“
5":
W”
Cu
X4,4!
.z/f,
behavioral response of electroshock exists. / Lack of such
if indeed

6W

.--,

‘

5

r

\‘p/‘

a relationship

arm
W
Wei
“)2”

40

/W

does

exist,

may

W

#

behavioral change,

,

-.’,

‘K"

A_Iff

measures of

I,

—

72:!

r.«L.1/€ALI':"

elm/7 ”r:

ﬂ-the relationship

between

EEG

"’-/

g

EEG Chaﬂ

geg

“(W:tﬂ/f

a”
kg";

I?!
or time
or c) methods/of evaluating behavioral response,

Whiéfux
elucidatgun
to

reflect

'

'

M/E‘C

{if

(vise/ZZ‘K;

response and

44.

.

"M

‘

���“NM

messwnaithink'

human”

change was not clearly noticable or who showed only equivocal or transient
improvement. Some showed fluctuations in behavior, at times appearing somewhat

whom

/

improved.

#1

But the changes were not sustained, so

they appeared

much

that

by the end of treatment,

as they did before.

are aware of the difficulties in evaluating improvement. Others might
have differed in the estimates of change in these patients. In any
case, by
We

MW.—

using this threefold classification, the differences between the
groups will

be

distinct.“

M‘ﬁe

‘i

first

.

,,

third

subjects.
these4“me
,w

mgﬂﬁﬁwgﬂhuﬁgyé‘wﬂewww“L»?«up,she?w

M.

and

WA“
s...,. 3......

suggestion of Dr. Hans Strauss (Clinical

;
cou‘oinﬂtidﬁb
three
lead
or
(fnontal.

'2’90' 0:"
*NWt‘M
*0-gis?¢ﬂm

av

.J,v

pgg‘gggja;“1%ngformléqﬁesmefEMMMSMAa‘EE.3.9“‘3'
'5"

lW-s‘i «#33253
AIWJrrrw-sv‘am .
'

‘

_

'

"‘c~"‘"“M:= 5.»...
,V

:4.

,

�.

V

.‘4

,2

C.

Minimallzfor Unimproved:

In this group were placed seven patients

was
not cleanLy noticable or who showed only equivocal or
change
transient improvement. Some showed fluctuations in
times appearing

in

whom

behavior, at

somewhat improved.

But the change was not sustained, so

of treatment, they appeared

much

as they did before.

,\‘\

that by the end

are aware of the difficulties in.evaluating improvement Others
J» might have differed in the estimates of change in these
patients. In any
case, by using this threefOld classification, the differences between the
we

1

first

and

third groups will

«*K‘EVALUATION OF EEG RECORDS:

C

)

be
A

distinct.” 1_”, 1.4 “MW, ”1,
total of 160 records were obtained in these

subjects. Fbllowing the suggestion

ofillluills

determined for three lead!
and

(frontal-parietal, anterior temporal;:vertex,
parietal-ear lobe) for 180 seconds of recording for each lead. The

delta index is defined as the per-cent time occupied by waves of 7 CpS
/°ebdéﬂbb
or
slew-n. The average delta-index for the three leads, and the highest delta
index in any lead were'éég'indices used in the final tabulation.
Simultaneously, the record was scanned for the slowest frequency
inn identified at least twice in any lead; the highest voltage of
any

delta wave; and the dhration of the longest
burst. Uther aSpects recorded, but not used in the final e/aluation, were the
regularity of burst act-

ivity, slowing of alpha activity; and.the degree frequencies d'amplitude
of fast act1v1t1es. These indices did not lend themselves to s
atistical

study; and were not identifiable in

all

the recordsp.’ Fast

activit'es

were

�.u-

7

j.

,2;

pézfzn Air. {in

//e 4/4;

xiv-sea

administered by the staff psychiatrists, using

electrostimulator. Treatment schedules were three times a
52/
As
9-to
showed
from
number
and
of
33.
varied
the
treatments
week;
patients
a Reiter

h?

C

greaémae’b

clinical

fewer
tended
the
to
give
treatments,
psychiatrist
,
spaced. There were 15 women and 9 men in the series, and

and more
__,_____.__

49/

the ages ranged from 2h to 68 with a median of h7.
EVALUATION

93

CLINICAL RESPONSE:

All the patients were observed for at

least eight weeks after termination of
ﬁiéemé;
the basis
therapy. The patient's response to electroshock was
of the resident psychiatrist's impression, staff opinion, the nurse's
notes and the clinical evaluation of the supervi§gaidxlcharge of electroshock.

The

patients were&lt;ilvided into three groups - markedly improved,

moderately improved and unimprovedJﬂaeduaa3lﬁ§EEEEEEZEEEEJEEEEiBnIhs)
response—tejeieetreshock:§

[3

A.

Markedly Improved:

The 11

cases in this group were regarded as

showing recovery or marked improvement.

These

patients

no longer showed

the symptoms which brought them into the hospital; their doctors
were

better;

felt

they

and the nurses' notes confirmed.such aSpects as being able

to sleep without medication, better appetite, and improved capacity to
get along with the other patients and participate in hOSpital activities.
B.

some improvement

These

six patients in this group showed
but continued to manifest indications of mental illness.

Moderately Improved:

patients typically

The

showed symptomatic

relief, 33;, acute depressive

features might be gone, but the dramatic change so evident in the
group was not apparent.

Each

patient continued to

show some

first

noticable

disturbance such as obsessional thinking, paranoid ideas, or somatic
preoccupation.

�medication could not be; controlled our evaluations of

fast activity follow-

1",

ing electroshe’cié are not satisfactory, and the results of Hoagland
W’“‘"‘“W
.m

M

~

v

7,;

,,._,_.,.r..:.:..-.eew.u

ttaal,

”Mina-x... ..

On

the basis of tho

the records were placed in a rank order from the greatest abnormality to
the lowest. The 160 records were then divided into

third

=

3

abnomality and lowest third

high degree

EEG

m

positive correlation

groups
= Low

- i__e."upper

degree abnormal-

ity .
,

,,,.

Wﬂm.wrmnp~4ohm»wz 1..“

cheek?

max
.. __I . __'

and improvement
“Wm h. ,.wu...—.mmM

'

om

muc

high

een early

ahno
eA

dc

of tre tment. Tlie reco ds of the
I

:psyThese

)

Mr"."W“,

BydtiliZing these quanfications of slow wave abnormality in\
\
such
EEG
we
be
electroshock,
abnormalitydnduc d
duced
conclude that
{

the
in first

3 weeks

,r'response.

2. What

M

fur“
of treatment is essential for t

ﬂea;

"3

e

short term” clinical

k

exist

between

the clinical reaponse»; and then amongeach

'1
1.

ach of the indices,
0

er?

fi\st with

ity

�//'

I,

-w

_‘

Quantitative Studies of Slow

Wave

Activity

Follgging Electroshock
Despite repeated attempts: correlations between slow wave activity induced
by electroshock and subsequent therapeutic outcome have been unsuccessful.

tain conclusions

from previous studies are warrented,.heue¥sih All

Cer-

patients sub-

electroencephalogra‘z;b
electroshock
the
therapy suffer alterations in
jected to

pliilllﬁ.

Three

patterns are generally described as 1) the slowing of the alpha

frequencies; 2) the appearance of random, symmetric SIOW'wave activity, generally
activitygcigiNB)
diminution of beta
which
of high voltage
progresses to burst
frequencies in rate and amplitude. There is a direct relation between the degree
of these changes, and the number and frequency of treatments.

saturation point of change is described, which can

is not increased.

ment, but which, seemingly,
changes are

reversible.

The

In

many

be maintained by

subjects a

further treat-

Also, such electroencephalographic

rate of return of the cerebral patterns to the pre-

treatment levels is generally 1 to h weeks, depending directly again on the number,
frequency and the type of treatment.
Another area of agreement among the cited authors

ship between degree of manifest
roencephalographic abnormality.
few treatments and without

memory

is the lack of direct relation-

loss and confusion and the degree of elect-

Mamba»
cited-of severe

Cases are

memory changes

significant electroencephalographic change; and

also of severe changes in cerebral rhythms without manifest clinical confusion or

laid

memory

on such

impairment.

O

Mam!

6f

5.

£257

In these reports, emphasis isfrequently

organic confusion also correlating poorly with clinical

results 0

,Euﬁada,

with

�studies, however,

Two

cited

may be

6L0

71t7¥éodf
which—noted a

correlation between

Electroencephalographic changes and clinical improvement.
amud, Kaufman and Péagcus

Hoagland, Mal-

+1924)»

in this

19h6 study of

involutional

in the electroencephalogram and in the excretion of

-(changes

women

ketosteroids

17

accomp

panying electroshock therapy of agitated depression, Psychosom. Med. 8'

2h6-251,19h6lg, reported a relation between changes in their clinical
me,
rating scale and the per cent timeJlB cps activity;AL the
bediszirbed
havior became more manifest, the 13 cps activity increasedi Sivtreatmeht

W

induced behavioural improvement, 13 cps

activity diminished.

of symptoms, there was an increase in the
More

recently, Roth (6hanges in the

%

time 13 cps

EEG

With recurrence

activity.

under Barbiturate Anesthesia

Produced by Electroconvulsive Treatment and Their Significance
Theory of

action,

ECT

EEG

for the

and Clin. Neurophys. 2: 261-280, 1951) described

ekseTies-e£.sindies_in_nhieh a relationship between thiopentone induced
EEG changes and the
recovery process. was—elicited. Roth noted that slow
Pod“ $12.94!.
wave activity as seen in a routinenrecord was irregular in
appearance,
and he confirmed the reports that it could not be satisfactorily related

to improvement.

;

By

administering an intravenous solution of‘;fbarbiturate

thdoperitone, Beth elicited characteristic changes in the
shock

in every subject. Early there

was random

EEG

irregular slow

after electro-

activity,
which, with more treatment, increased to a highly rhythmic, bilaterally
synchronous, high amplitude delta runs and bursts. These were chiefly
wave

2-3 cps, with voltages of 200-350 uv and continuous durations of 30-80

seconds.
pentone

th: resting record
increased its voltage and

its basic

When

W

duration, spread

activity, thén-

its area,

and decreased

frequency. Roth believed that these changes were related to the

process of recovery,‘§i$haagh,;the
a typical

evinced rhythmic delta

EEG

‘4”
concluded: “’Enuaner, the development of

change does not ensure recovery and 10 of the 36

attained such a change failed to remit for longer than

patients

two weeks.

But

who

�Similar analyses of the relation of each of the indices and clinical
result showed identical curves to the group curve shown before. Slide 2
shows

the

the relation of the delta index to improvement.

to

much improved group jumps

index in

by the 7-9 treatment; while the mod-

52%

erately improved and unimproved groups
10-20% by

The mean

show a

gradual, slow increase to

the 10-12 treatment.

similar set of curves is demonstrated in slide
highest percent time delta in one lead.
A

In the next slide the mean slowest frequency

3

for‘the

is recorded,

mean

and

this

too shows the same significant relationships. While the much improved

patients

show

delta

waves down

to

3

cps or

less

by the second week

of

treatment, the other two groups barely reach h cps by the fourth week of
treatment.
Slide

the

5 shows

correlations for the

same

The much improved group show

mean

higher voltages by the second

the fourth week the differences are perseatent for

Finally, slide

6 shows

highest amplitude

the

mean

all three

duration of bursts.

week and by

groups.

The

records

of the much improved patients show longer bursts, averaging more than 7_
seconds by the third week of treatment. Bursts are less frequent in the
unimproved and moderately improved groups and are

significantly shorter

here:€E:::¢::Mthe
in duration. Not noted
factor oﬁaregulgzgity of bursts.
In the lonéﬁbursts, wave forms frequently were more regular in frequency
and amplitude, than

in the other

two

groupsl

These studies may be

measures of slow wave

interpreted as demonstrating that each of these
activity arise from the same physiological process,

and assuﬂe the same significance

function induﬁed by electroshock.

in relation to the disturbances in cerebral

�3. Finally, can these alterations in the
aSpects of cerebral function which

may

EEG

have been

be correlated with other

altered by electroshock?

In these studies, three other indices of cerebral function were assayed!
the amytal test of Weinstein and Kahn) tests of double simultaneous tactile

g?)

Si)

stimulation/and tests of memory and recall. of these three indices, only
“gigpﬁﬁt'
V/
the amytal test showed a positive correlation withimprovement and with
A);
stoma; WW may.4, 41:2th Julia“ We 0’ is
this test, the subject is interViewedm uestions o
Ahbbld atdkhuus nae: alas/d
autbaeaawae
cafhﬂa
ation of int venou sodium amytal, the
stions are repeated errors in

thQ/I-vm

.

e

orientation, coniabulation, denial
as "POSitive" amytal

t:‘t,

and

illness

and

reduplicatioh are scored

are indicative of cerebral dysfunction.

“Ms”r
Ab

tal test.

9"”
,,
.1,

#ﬂwwf

yyyﬁr”

\

In the next,slide, #7, the pe centage positive amytalthSts are
if“
if“?
compared for edéh of the three groups,
«hf weeks of treat-

‘3

-

,

jge’difference between the much impror
-i the other two groups
is strfiing. While every patient in the mu_;‘; oved group had a positive
gonna
al by the third week of treatment,
the abno
\ity persistedgF

ment.

M
was

it

W#7

ation with improvement. In this
that there are various types of cerebralﬂgyeﬁ

function and that”g;:ﬂcannot speak in gross terms of a

”Absfgeeﬂ'thew
0“,.“ n .rvn w..,,«wm.~~m—we rm«Antw-12mm

gﬂMéorrelat1on
lath

and cerebral dysfunction or organighpsychoses.
muv maxim» we.

\\I
‘\

\

111;

{ZENWWf’IﬂWW

showed no

can be concl

EEG

‘\

‘15

um!

recall? These indices

respect,

\

\f

transient despite continue. treatment.
‘

WW“

Rh

“met”. WWW”,

‘ "New“ ewes V4799» “new“.y‘d

”fI

M

51““?

ﬂag“

”Why

�*

Semen, these ethe:ee pemttethe

�5M5?

Vt

m WWM in mamm: Relating at Induced Mu nativity to

WMum,
Roam

Dunno midonblo study and
shock

mom

Wind
ahcck

1:

menu.

the man at

Recent

tho

m

enema (9.6mm, at

wow-1cm

«that. In Mm own...

chanson

u

a,

the basin

no have: obnexwd n

mum at chasm

of

am.

And)

hm

tor tho 01mm-

rolnucn comm chum

inmaumdhmmncMmaadthamquRw. hmmmm
hum batman clinical

Wt

1'ch

emanation taunting

orientation and

olcctmahock nit-h changes in

Mam

whnrbi’cal (

mummmhngmgcf ).ondmxyandmu1(
“My in

1mm:

an

mluaticn of

”mm

mums

change:

function, and

behavioral

M,
'11: our

no

mama

1::th mm.

0mm

nan

and Panama (1952)

minim, up

direct

an an incur

W.

the observation b y various observers that clontrcmm

change: in the olentmencoptulogm,

with clinical

syn--

). Thoprcmt

in thc thmnnoophalnsx-nm,

a»

),

slow

alumni}: ta

Imma-

«mung

In an exhaustive

amm

their

may

W

mm c: than

nth-tho
sum

nan fez-mum arm clam-la shod:

mm Wmt.

such

a!

Watt

tmmt but

the favorable therapeutic

mmmmmmmommwnmmrﬁ

�tmm

in

tha dame of

tone» Wt

Maul”

each

m

can, we

we

abnormality noted with the

hem

my rahtionuhip

patient: vary comidenbly in

am number of hmmts, it

Em mango: and

is
War

anneal

largely wincidental or maul-11y mini-ad to othrrr factors.”
Yet, the alwtmcephalognphie chmgu

mmnt.
and

Most

new

Wen

wltagt

611:8.an that fast.

tin;

and

in tho

who

activity is dimuy mum

mnﬂsm (

Bach

L»

law.

ﬂuent:

wha have

intensively

In

View

electromock,

or the

it

dam,

),

The

to

than

{W

appears

than is a

duration and

mummy

m

W
ind»

in percent

slowing

at tho

meat of delta

Mar afar-and m1

and tho

and with

mtarlor

mind in anterior aleetmmeﬁmomphic

received twelve to wimpy

ramming

my be

1:: voltage and

W.

(

of wires treatments per wok, the

diuppear in us new

uWhock are con:-

The” in considerable

nativity in mud]: ”metric,

plum mutant. «hatred»,
In

dootrowophﬂm.

no

Imam.

by

mart that elactmshock Mm mm»

)

(
accrual»
), bath
wtivity

in paint“

persistent alpha

(

Maud

mutants

dammiognphic

a» last mama;
ctr tho

(

mum: am

mu bum max-meme

and

humeral

a.

schedub

effects usually

).

olcotmmephalumphic

to

an

weapons.

to

that a mktionahip dam
changes. Tia

swan

�.3...
do

”human.

indicate we}: a

Mod a relation human ﬂung» in
than :3 spa) and

WW
MW

MW“,

behavioral

Wm:

pentam, elicited characteristic
of tmﬁwmt tandem

thin xeuuiy

EEG

Vchanges

ungular

to

m

209—350

m!

mum,

”than

and. continua-nu

m

banana that thaw
eluded:

want-d by 113sz men

buﬁenlly

m
mum

its mm

changes were

(39th

of

and

to

3

which in»

Mm,

high

cps. with voltages up

30 $9 60

seem.

when

the

its

thiopsntono increased

«creased

mum ta

typical

a.

2

at

activity,
mu
We
spread

“ﬂy in the

”sunny appomd,

slam warm

harm. than. mm

unravel“

resting more!

mm

and

tmta

only to ran

in every subject.

continued
treatment.
with
to
Winnie,
cmsgd

«puma.

Whoa;

an.

‘

mapma

del‘hn'

Wang... A:

fem. nativity inerumdu with

W”

of

(3.91:6)

w ”want #130 tut activity (mu

9mm,

aw; (1951), reporting the

cm

apart.

Renal-ad 33 9;

Momdont clinical mung; atbomionl

behavior beam

man: with 3

m

Iﬁ an

m

its bum tummy...

the games: at

Waxy,

and cam

m change does not insure mmzy

mmﬂmﬁpmtnmoewmmfailadtaréxd‘bfwlongw
h
* i’mﬁ
and 1mm

G
(1'9

H

u
”I
)

won-m
“a
“mm the behaviaml comﬁtim.
‘

‘

"

:51,

9"

L‘lig

Yr

'

II":

.,,i‘3l’

‘

V

�4‘.

he

than

tmiunf.

wants; ﬁat

ulaudtothcmmnge
1:33

the

EEG

mm

militia“ patient»

clung“ with ﬂat therapeutic effect,

tin patianta dueloped typical dung”,

pmt

in 0.1mm audition sound

is

W

by tho lager-1w

cf

1.9

b-

«mammotof
«on, we

Ifmara

it

most»

10111:!

that. the physiological

hula far in.

W311: any or my not pm affective

in mixing waver-y."
Bow thee»

mmmogmphie
are

Mixed,

”pom «pm-m

1 solution batman the

dams of elect“?

change Ind cement-mt behavioral suspense. Different aspect:
namely

delta

mm

to barbiturate activation and beta. not.

ivity. In tho present impetigation, quantitative aerial studio! of the dart:
anyone. were undertaken to timer the following quuuonls
(1.)

What.

in tho "lama! of the elomcophalqmphie

mama to be-

havioral responu 1n electroshock?
(2)

I: a "hummus: «mm,

:1an
aubgocta 931;

what signification my

W’

at

prior ta

a) In the

tmtmt,

8 chums). ﬁnder-It.

bipolar,

hm tor an under.

of tho process of electromoek therapy?

1mm semi, tmnty-four Maw wa-

ianta referred for chetmhoek were studied.
do!»

11-.

mammalogrm an

tad at. weekly intervals during and after treatment. wing

destromcwphnlognph and noodle

and hyperventilation

chem.

bonding in

mmum m mum emu each molding.

�'

mm

Commuting, the

at least

.6.

was scanned

for the slowest frequency identified

twice in any land; the highest voltage of any delta wave;

and.

,

the dur-

atian of the longest period or delta bum activity.

mm basis or these five indicate! eleven” nativiwma

racom were

phoeduinnnkordar,tmthomtmmto£dauwmﬂtytotho
lowest.

recordanudividod into

The 160

3

mu

m-

m

thirdm

classiﬁed as “high degree deli: a records"; the middle third, as fmdemto
dag-no

Fignm

delta a records”;

I, II,

and

and than lowest

min! as now degree delta

III portray pin-mm

mama.-

and treatment records taken

am-

inguwlwtmatmntpomodtoemlitythethm rangeaofdel’aamtiuty
indwed‘hy electmahock.
b) In a second
shock

some at raw-tour

mun,

patients, ehctmncopmlogmpluc moon!-

lent. ,Mﬂng tin
treatment.

second and third

531133

records, the

wore obtained

mks of try-stunt,

initial

observations were tested in

weeks

x

after

«comm

W m:

mum

on

A11

of max-aw.

after

first eerie:

of 160

I predictive haw ofthemu

patients were

The

prior to treat--

and two ween

the named of analysis developed in the

pantie response.

mmmxg

unselected electro-

W

m- at 1am «at.

patient“ mupomo to

the bani: at the resident “psychiatrist’u

15leth m

mm,

the

nut:

&gt;

�.7...

opinion, the

man's not»

apex-visa in

and the 61111130. evaluation of tho

charge of elwbroahock. The pntients were dived-d into three groups a mob

academia]: uprated and

mama,
A.

WM!

mama
which

«an aim:

themaa‘lmtu

«coming to the following criteria;

:3,an
These punts no longer shmd the
mm

Th. 11

or Inn-had immanent.

hmgIt than into

mm

..

group were mended

the 116mm; their doctors

folt they warn mum

and

ﬁleepuithoutmdscant-ad mkupactaasbomgamn to

nation, better appetite, an!

capmw to gut along with others

improved

and

‘

participate in
B.

mm

Mimi

pmmnt

but cmtimed to

try'picany shared

gm,
Each

activities.

but the

The

units” mm

mun

amt!» 01111130

K.

idea, or

We: m

when than; a

,

m

less 111.

The

a»

haunt!

teatum night he

evident in tho first. group val not apparent .

no

m

noticablo disturbance such an obsession).

somatic pmccupauon.

raved:

mum

not clearly noticablo, mo

or who beam worse. may

showed tons

é! loam illness. mane

1.1191, 3&amp;2.” mute dopresiive

patinnt conﬂwd to thaw

thinking, paranoid

lb: patients in thisgmp

showed

change: were not

mmn

placed

showed equivocal

new patient-in

or transient changes,

ﬂuctuations in bshnvior, at

sum,

treatment, they appeared Inch as before;

however, no

that

times- appearing

by the and of

�Mesa

the

analyses of the mlatian batman the

delta activity and clinical ratings, denominated
between the

proved"

early appunnce of high @3290 delta nativity and the

classified

861 were

in the third week
in patients

and 88$

who were

or third

in

m

who

”lunch

won rated

13.

u nah

high degree 691%! in the second week;

91%

mutant. 0: the raced:

fourth week of

rated as migrated, none wan high degree delta in the

weeks

at tmtmnt,

aim
‘1:
The

and 20%

tare high degree delta

21 the

mnsudin mu 1, ma graphical; in ﬂgun h.

can

fourth week.

a

induced

significant relationship

clinical rating» 0! the meow in mucus.

mmved,

second

1

acme or

m a i m 99am Delta mom

m
Indian
W
(7)
Wed
Imam-d

85:113.:-

measured

Mam: k}

(u)
6.

(

analyses mm

indies:

91‘

of bursts, highest

Men

M

25

an

91

as

o

3.6

50

M

o

o

a

an

for the rolation hem-n each of

mm (avenge S-Mm delta,

mm,

M.

133

and slowest

highest 5mm

an...

they

duration

frequmy.) me the clinical rating!-

In each instance, the relationship or degree or induced delta index and the

clinical rating

was

sustained. This data will be

pramud in detail in a

�submmt ”port.

taunIndaxotnu-

2. Em

mmﬂmtaﬁm, contubulation

art!

dmial

ion:

1'

B

of. 11111033

in a ”matured latex-via

after the: administration or intravenous mobsrbital in patients ﬁrm brain lacuna
have ham sum-mm as signs of

13mm

arm

noted such patterns to ba

illness, unless than.

was evidence

«and probable, themfora, that
persistently
tum

mum

or new” cerebral

11'

mot

subjects,

).

(

We

had

m- m putientl hospitaliud with mm.

mum

elsutmahock indmed

patina nmbarbim tam Wild

«ﬁbril

be produced.

mmmmmu

(

). It

dysfunction,

This was indeed

mp0M&lt; ).

1n

ma,
mm
(58%)
and
10-42
fourteen
an
7-9
the
m
period,
an
am
mum
that

um; report, nu

mm

cerebral dysfunction

(671')

at the

2h

subjects, had positive

period.

In than Maw—four subjeotl, than new ninety-one to". sessions during
the

mac

ital tests

of therapy for which smear-rem;

chumphalogrm and ambush-

are availnble. Pro and poet mutant. records are not. mcludod.

mmmmnmuummummamdmmmumuw
sham a high relationship, both

ratings of

immt

delta wﬁviw

a

for the tests to each other,

during therapy. In Tabla

W

II, as.

and

to clinical

degree of induced

with the results a: the concurrent

mbarbihl

mu.

�W

TABLE
KEG

II

22m .. An___%mm

W

rat.

at

Hicidle

313x

Low

Positive

(25)

29

a

8

Negative

(us)

10

15

20

Watan

relation between the test data and clinical ntings of
am also simiﬁmt. In Tabla II, the ma and uobubital tout. results
The

me'dingtothoevomnl
mmmmedgmp
27%,(5 m
had n
umber of with. gamma test mctm; sad” that tho
cluster at with. nomad, high Em delta activity and mummy in»
clinical rating.

W

Vi M

proved rating 3.: 3

negative

mm

Wits).

mung a:

om. Email: alluifieant in the cluster at

test, 19' 1nd Mo me an: activity and clued.

Wand.
Rat

/m m\
rod

ma

Hunk

High Dam and roman
Amebazbital (29)

Either
Positive

33'

Dam or

obaz‘bital (26)

hither High Dalta not

Positive Amobarbital (35)

Iv

Immed

r.

M

W

Result! an

Moderately Impmvcd

25

3

10

11

s

S

1.0

21

3.

Thedatain'kbluEmmnhumtommorotabmmtimdum

n

Simiicant by elm-aqua

:t hotter than 2! 1m). of conﬁdence.

�the course of therapy in the

any

are rater}

uriy m the
It and

at

We

initial

twenty-atom

petimte.

ra’cdsrxzvttl who

me): improved tend to develop high degree

a: treatmnt,

Table 1) similar

and sustain

ohnmtionl,

it throughout

mde for the

are gnphically portrayed in figure 5.

A

EEG

delta. activity

the period. (ﬁgure

murbitel test result”

Waite

of figures it and 5

presented in figme 6, which chm e mmrkable eongmm of the two

3. am

to

0n»

‘
»

Following the observation:

event?

is
test date.

2

in this group, that the mch

:1de

patients had developed a high degree delta neurity earl: end had untamed
such

activity, electroememalogrm were obtained during the

week: of

treat-ant in

undertaken

Sh

second and

lelectmdxock
consecutive
patients. This study

to detenine whether or net the demo «at-delta response in

third

in

pro—

dictive of the wort-eta“ thermontic outcome
The

recent: were sound

hand during both,

one

a

to whether

h1g1 degree

delte activity was who

or neither of the h~6 and 7-9 treatment periods, and

the data was related to the clinical

«elation

TABLE

I?

(Table IV).

�Ono

"W,
um (16)
20

um High (1:)

h (25$)

a (50%)

h (25$)

6 (30%)

7 (35$)

7 (35$)

.

Total (9‘)
"' '

m 31mm

22

at the

2%

19

level of confidence;

13

�«42:»

or the 131518!” the

Mint

111$

delta ”tawny during tho ”00nd and third

mksoftmtnant, éﬂmmuduuwhimmd,mhmly3motp:mu
diluent high delta are so mud.

The

sum inﬂation and

dome delta activity in rebut! to the Short ton
The

arbitrary solution of ma second

based upon an
12.15

6100ka

trauma.

mtotmm

Further

sax-ion

and

in which the

W

delta beauty,

persistence of

6113100.

mlmtim.

third week: of

tmmnt was

mags tmtaont

of this data

Wul

1&amp;1“th

m

course

m

that the div-lop»

1211le fort.

at

mm:- of weeks, in round to mum: at of immanent regardlesa of tho
tine in the course of thump: II
continua: treatment in

after 15-20

am

trauma,

m delta mhngea no first. manifest.

subjects resulting in high

is associated with 9. MM

this later period. Patients given

many

m dolta activity

Won]. msponm at

mama n

the

at.

per weak, without the mention of high dogma delta activity,
a United behavioral responu

an

- one that is

M mwm
mt

5.10

placebo responu (

Diﬁuaaig g

of three tines

Wm“

significantly different than

). Intansiw uranium. at

a.

fmqmoy of

relultant induction or high dogma dam act-

was: per

ivity, will damn-cu

not.

Thu,

:1

aignifimnt behavioral

name.

mesa studies duonstmte a consistent missionship batman the

degree and duration or induced uhctrooneephalognphie

delta utivity and clinical

�‘13-

enlmtim at behavioral change. 3ymetr1o
1m been
and

automated»

We

at tho

evidence of dysfunction

(mama;

centers

and dyerhythuo delta

system)

mam

(own

nativity

WW

Strata»)...
and

Such

indioative
of an alteration in the state of consciousness,
also
activity is

new alteration bang unouy related to the aunt-10h, mum

with more

and frequency

and
(Strauss
slow
Bid]
wane
June,
et
the
:1,
of
aotivity

Brit).

and
behavioral
between
Muted
one.
rolationohip
county
We
m

the
further
electroshock
permit:
after
aspen”
on.

mmepmm mm no:

attendmt

pluliologio basis of tho electroshock
shock process thus

physiologic

“mat

We

conclusion that ohangee in

aunties:

prom.

in consciousness an 1L

o No upset: of the electro-

elaboration: the mention of the

to the behavioral response

mm neuro-

..

and the eigniﬂoanoe of these

observations for a theory of the node, of action of electroshock

tangy.

(a) Role

Won].
cerebral

2mm.

change

Changes

and
perception,
prone”,

whatever cause, ore

In this
dependent

9%.

\mieteot
1: a
moo-pennant
in mm,

Mt

extmively

mm,

I

of alteratim in

ltti‘budl, judgent,thooght

attending changes in cerebral Motion,

documented

rm

liter-store.
in the noumlogic

electmahook has hem mum to consistently

teat emanation, in a {whim Mob we

alter

two

in-

have con- to associate with

�431).

i

has

biochmm substrate or this

mu-

away.
mm
mm

has hem placed an tho noctylchonm—ohonmstomso changes

a

(ﬁnest-in,

KeEwhun), tho “Iteration 1n blood-brain burner (Aird), chug»

Tower and

in ionic

prance” has

and

promnqunbm

[9’99 “/fsrué
/'(ﬂ’
I‘M?

7

,r‘

L.

j

44“!

[Z

(3916301 and 31113391
x

w

A“? 5 1:34:

;

I;

' ‘

3

g

a

f

ff

V

M

v

1

.-‘

- mm),
L;

z

r

g» ﬁggéfiten/

�orient-p
with
extensive
In
impatience
an
function.
cerebral
of
altered
states

am

after wherbitel,

tests”

mama (

Wemauin and his

)

(

J

( o

be” dmnetmted the pmdictiw mm of this test for arsenic cerebral

Winn.

Davie
workers
by
ee
extensive
met-cue
experience
likewise,

Oawendom(
)and-ng
).( ), Oatmmdstnnae( ).

mum“

()huefﬂmdthe
altered

in e

hm Matias.

W

‘smu

signiﬁcancecfdiffuee
other tests of

unbral

mm

been applied

seriel reunion, it. is anticipated that than, too, mule! dum-

mum

sponse, within the

in cerebral

30.6

delhectivityueninduet

chengee

W

tmtmt

salmon to vacuum re-

and e

units a! the sensitivity of the test. to reflect

change!

mum.

lame mam, elmmwbeuidtcbeenthcdormmge

muctﬂundMiantoerMMOmrwachime
behevicral respcnae.

«diam

The

mac

of belmvioral patterns induced under these

is wide. 'Inprcvemnt'

being a subjective evaluation

On

1e 3 special

one at behavionl

the part. cf the

name,

charter that the patient

1: ‘bottor.’ Electrcehcck due not induce “immanent“;

diffemt than

it indwcs a mum

of

cmbml activity in men behavicr

To

the extent that. the induced behavior in deprecaed permeate is perceived as

lose

whining,

depressed,

mane

18

or

move,

before electroshock.

or in achnophrenic patients,

�.1;-

1m maximal,
proved".

behavior,

Wham

complaining, or
typo 9!

“an.
evaluated
to.
as
is
patient
mm,
wmmry
or

harm,

am,

1+.

1..

in pamuivod a:

mom, mum,

«ammo a; 'milprovld.‘

The

paranoid,

woman-

Warm. pattern induced by electroshock, is «pendent on a

m

mm, «mammumauyam-mmtt )ummotpmm.
lumbar cramp]: o! the relation
be
to
is
laﬂw

dolt(

) (

Meow

m

on

the

of. electroencephalographic

mural mom

me:

to be-

of epileptic patients. ban»

)deaeribuoymgapﬂspucmm ordinarilypleaant,

and cooperative

for his clinic visits.

consistently dyarhytmc.
drnm, and his

1336

0:: on. occasion he

12.

than.

no: cum},

an ‘1th delta activity.

on the

that,

records

m

unable and 31th-

mbaoqmt visit, tho

m was again dynamo-ac and o a behavioral 'zhtpromnt' nu ma.

51:11::-

obumtionawm roporwdbyﬂntt( )mdnnnndor( ).
(b) Theo
Our

,

of Electron

a

.
7

_

studies of the electroshock procesn have demonstrated tho

ing. ntemtion in brain function in induced only
in

whom

the greatest degrees of behavioral change

max deem delta. activity in the

taste as indiceu or altered
indioea

and sustained

as

noted.

Wannalogm

and

follow—

in patimtl

is have mailed

positive mobarbitll

«:0an function, with the knowledge that other

at altered brain Motion, applied in the

m

sex-1&amp;1

fashion, my

�‘16-'-

alee

show
We

3mm

alteration

and a

relation to behavioral change.

have been mmeeed that the rating: pf impmvemt are value Judg-

ment- of the behavioral response. L11 patient-e

induced by electroshock

in when cerebral

wrest changes in behavior.

changes are

My certain patterns

ere evaluated ee immved, believer. while other! are regerded

u "unmoved”

Immutiaeeenuespeemeeeeefthebehaviorﬂ. mammoftheeuba
of
the
conditions
brain
altered
function.
We
Jest

recent etudiee have netted a relation of the indueed botanical

Our Home

was

to epeeific peremlity aspecteC ).. Patten“ the neat close]:

apprm-mte the “explicit verbal denial" personality

greater degrees of denial,

dieplem,

mu

),

(

euphoria and Indie beim'ior (tuning

electrosheck therapy. and: edeptetime are frequently rated

alarmed",
and

no

clinical

my

mum

at!

”m

that the reletieaehip between nationality, behavioral response

mm

is met clear.

to the behavioral reepenee

The

mutton of other upeete of

an new ﬁnder investigation.

bother new in the nun: of taproment
to the induced

W103.

1a the environmental

w
new

endeegativill
ledificetim
Tb
of inﬁll, withdmel

to excitement, overactivitw and irritebility my be considered e positive
movement by

may.

The

the met-cps.“ but a disorganization by the and

maiden or

goals of the therapist and the family, and their

meantime

�4.7 bSnoh

phyeiologic
milieu for an ultomtion
the
altered cerebral tmotion provides

of the organin‘e edeptive interpersmol behavior. Changes are induced in percep-

tion, language, mod. recall, and Judaism mick ponit

adaptive intonation:

new

with the omirmmont to unfold. the type of adaptive behavior induced under these

conditions
which the

is

dependent upon the pereondity of the subject; the environment in

intonation occurs;

and the duration or the

state or altered cerebral

Man.
i similar view of the electroshock process m initially expressed by Weinstun,

Kuhn (
Linn and

chungoe and behavioral

).

who

mailed the interrelationship or neurOphyeiologic

room”.

These etudies amplify

clude anothar index or oltered broil: function
and

«e

their obeorvotione to in-

the eiootrooneuphlograme delte

also broaden their initiol empheeie on the denial pmcoeo

fol edeptative response, to include

no

the only cameo.

0.

wide

variety of indtcod behavioro under the

conditions of altered brain

faction.

The

description of the electroshock procese

is also comietent with the

observations of more

335;( ),

Roth ( .) and Lire

59,5 ).

This neurophysiologc-edeptive interpretation of electroshock pronides on

operational definilan o! the process which has procaine or further elaboration and

obeemtiono. Such an hypothesis also hoe application to an understanding of therapeutic process in insulin com. therapy

(

), lobotav

and

tronquillieing agents

(

)e

�.3transient

in clinical condition

improvement

seemed

to be related to the

in these patients. If we are correct in connecting the
EEG changes with the therapeutic effect
it would seem, since most of the
patients develop typical changes, that the physiological basis for imp

EEG

change even

provement

is acquired

by the

it may or

majority of cases;

may

not prove

I

effective in promotingxrecovery."
In the course of studies

of‘g§:ered

function
brain
induced by electro-

at the Hillside Hospital\in New York, further data on the relationships between EEG changes and clinical effects of electroshock were collected.
The general results of previous investigations on the alterations in the
shock

EEG

with electroshock were confirmed, but

between EEu

effects

and the

ailgs‘ca,~

clinical result

a

demonstrated.

was

\

I

are presented today:

(l)

The

definite relationship

.

Three foci

\\

Engpatterns following electroshock and thein\re1ation to
K

improvement.

(2) yThe intercorrelations of different quantifications of delta

activity.
(3) The relation of these observations to
/////X

”WM
SUBJECTS

aﬁcijLQn.1

"ﬁ-"MW‘

_
i.-..mwm_w~w
T /{1 Ionic
ﬂ

_

merm”wwww‘wmmm,._V.-c.-»...«——v—~~-"'”

aim,”
Twenty-four consecutive patients
U”

§§2_MEEHOD:Z§

_ -m “ﬁlm“-..—

a theory of electroshock

shock were studi d.

"“‘m'w-"MW

referred for electro-

m4

Electroencephalo rams were done
"511* few}
1/4?!
Lot/W
a“:
channel Medcraft instrument , needle electrodes,

prior to_treatment? “Ki 8
and bipolar recording was used. Hyperventilation wea-the-ealy-activation 6034’
(L. WLALF
Q44. a,
‘
technic
g treatment, records were taken earths day'aitasrar?;ézﬁé'"v*ﬁ‘
gurum
fitter
treatment.
generally 25 to 31 hours

MLWe

0%,

3»

1'9 CL

�this point I should like to summarize our findings and express
some thoughts as to their significance for a theory of electroshock action.
There is little doubt that electroshock induces delta abnormality in the
EEG. It is symmetric, chiefly frontal, but with increasingrtreatment,
the'gequencies
With
became
treatment
leads.
to
spreads
increasing
all
At

slower, the amplitudes higher, the burst activity longer and more regular.
While delta abnormality is present in every repord after electroshock, its
degree

is variable. Roth's experiment's inducing increasing delta abnormality
with barbiturate are significant in predﬁting the later changes induced by
further electroshock. In
mality

some

subjects however, a high degree delta abnor-

is not induced despite extensive treatment.
Our

correlations of degree of delta abnonuality with improvement are

fgggziéam:ch
ism of electroshock.therapy.
significant

An

alterationm cerebral“function

and also by the

'

as measured by the

magma
as,
amytal test,* ,t'necessary pre-requisite for improvement.
EEG,

zaﬂkﬂ

early, sustained
Where such

232::::
(and in the amytal test),
chan es fail to occur in the
a significant clinical improvement will fail to occur in the patient's behavior.
not4ﬁghent
The fact that the correlations were
with memory loss, points
to the possibility that this is not a significant factor in improvement.
EEG

In conclusion, these studies lend lapport tp a theory of

EST

enumerated
action recently
by Weinstein and one of us (Kahn). These

authors postulated that improvement following electroshock

is the result

of the creation in the patient of a milieu of altered brain function in

patterns of adaptation, particularly those of denial, may be maintained. Theib EEG studies demonstrate that an altered milieu of cerebral

which new

function as measured by delta abnormality is a pre-requisite for improvement.

To

supported.

this extent the first part of the Heinstein-Kahn hypothesis is

4M.-.

.1

�~5During the

tram

generally 25 be 31
11611113131381an

(

the

) was

period. words not.

noun

lam. Emu-mm,

We...

may“!

Wu on a» ﬂy, following a trauma,

all

Wit”.

test

101'

at many intervals, berm, during

”mat “him the Wmtnont WI.

manly

been mported

pntieats

organic brain
and

study

mm

hi"

).

(

thaw-ml electromook tharapy m manicured w the

mt: manhunt“,
tins

using a Bauer 0 h? eleabmatdnulator. Treatment schedules. war. three

a week; and the number of

,,

Won

arm- thorapy,

reﬁll“ at this

The

all!!!

wore studied by

matmnu

varied from

to 33.

9

As

patients

show-d

a clinical response, the psychiatrist tended to give fiver and more widely
spaced treatments. Thorn

are

15 women and 9 man

in the

can“,

and the ages

authaudiuoth'h
mezhto
EVALUATIOE 93‘.

ject...

33

3'0nt

for three lead

“natal-ear

W:

total at

3.60

records were obtained in muse sub-

Stmﬁss
( ) the delta index was
the suggestion of

minnow

10210)

A

69%:de

(frontal-parietal, anteriar “moral .. vertex,

for 180 seconds of recording for each lead.

1: defined as the per-cont tine occupied by waves at

7 0:16

The

delta

or SWCI'.

and

1W

The

&lt;36;th
and
load
the highsat kit:
for,
three
the
combinations,
average
1mm in any om lead combination mm the

indim

used in ma fin-1 inasmuch.

�«17end

tolermm', are significant factors in the behavioral nepense of the

petieet to therapy, am also, in the rating! a!
mane

effect.

sue teeters an signiﬁcant in the

The induced changes

improvement.

duration of the electroshock

in cerebral function persist for 24: weeks only

following even intensive courses of ti‘xerepy. In
respenee

‘

W

eases, the behavioral

tenatedtemepeﬂodotalmmmmniologyo

patterns of behavior we not adaptive in the

mum

Thackunged

of the patient, and the

behavior 'regreeees' to pun-treatise“ patterns. In other

instance, the

induced behavior in adaptive to the envirement. end, we assume, sustained

therett‘ter not by the initial change in brain

Noam,

developedintencﬁenof subjectuithenﬂmmt.

is

seen by the

milieu

is

may

embd.

linen in which

13

cheereetm

have

doctor,

have, and peanut.

stem

a

1:1in or many.

led to the conclusion that electroshock

a non-specific induction or pernietent

discharge

mptive (pemnlihy)

utilize devices not otherwise available ta

- the

mm

when

Altered cerebral fmetion

the subaeeb’e

different interaction with the envimmenﬁ
These

matmiswm

only to have a mazrrence of

disgusted or discharge in

prelude: the pbyeiologic
preceesea

the newly

fmeent mememl adaptation of the patient to the hospital

after electroshock,

planning

but. b y

of altered cerebral

than”

mm.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67404">
                <text>Relation of Electroencephalographic Changes and Improvement in Electroshock Therapy (research)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67405">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67406">
                <text>mfp-03-01-002-7-007</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67407">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67408">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;; Kahn, Robert L.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67409">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67410">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67411">
                <text>Research papers, files, and related correspondence: research with Robert L. Kahn</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67412">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67413">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80943">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87504">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94065">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100626">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6742" public="1" featured="0">
    <fileContainer>
      <file fileId="6550">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/371617534179d54e66d61621a46020c8.pdf</src>
        <authentication>6e55d00563bbed3481f9a9906c445b08</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107155">
                    <text>therapy,

we

hue

ahead-red

at

individul

wide

response. Subjects duomtrete sue

to

equivalent number: or induced

veriebﬂjkgy 1n

digress of

minim.

EEG

the

EEG

delta ee’dvity

In the observations

observed
the
to
teeters
of
to be reported, the reletien webologic

variability is amend.

mam Ed

Hethod:

referred
patients
consecutive
heapi’oelized
malty-dive

slammed.“

M

with
wire
tested
Subjects
studied.
therapy were
‘
im’TA‘MVvV «Ov1

M

W

the

tor

Bottleneck end ~

~

within a

week

prior to treatment. ﬂeetreemphllo—

wmdompriortotreemnt,endetweek1yintemledunng
treatment.

The

records were

wt!

for the degree of induced

deeoribed&lt;
previously
indieee
£5}
activity using quentitetive
Bad; petienh wee

or

imml’bbq

Medea-eff.

5?

Gem flaw.

Reﬂexeither
using
week,
times
a
three
trotted

instruments.

I «M—-W-nuzwm: .4-

HH'

an.

-\'.

[UK/W
Clo.)

f‘ru’f

a?)

�heults:
1. Subjects with
1!

and

FC

human

moment (H), fem-color

Rorschach responses showed

induced delta

(PC)

signiﬁcantly lesser

activity than subjects

who had no such

or bath

amounts of

responses.

2. Subjects with fewer Rorschach responses (R) and fewer

total moment (Home) teaponses
of delta activity.

m
3.

.

The

..

higher the

malted

simificantly greater degmee

Wmmt

«L
test, the greater the

«rot-beers

on the

degree of induced delta activity.

gnawing:

These studies describe a consistent

tram

perceptual responses and

041v

w

relationship between

pre—

obeemd degree of phtsiologic

alteration following repeated induced cerebral trams.

While

factors

of current, skull resistance, inherent responsivity of brain, 239.
may

affect the manifest physiologic alteration,

that the subject's usual

test eeores) affect the
the

EEG

nodes of adaptation

(reflected in his pemptnal

physiologic response to

cannot be viewed as

it is also probable
tram.

In this context,

in isolated physiologic index but is seen

�Conclusion:

Individual differences in the ma activity are related to
have
Insurer
as
latter
the”
differences in perceptual petteme.

been shown to

reflect pereomlity differencee,

we would

the individual'e node of adaptation ('persomliW')

ﬂ“

Wﬁest chengef mtg; Physiologic

‘76
5359::

(me).

suggest thet

Wed—be

We

EFFE‘ ’1
\

would conclude

that those aspects of experience and edaptetion that effect perceptual
trauma.
me
the
to
at
affect
also
responsivity
tests

�It't'f7

7-..“.

Psychologic Factors in

EEG

Reactivity to Induced

Cerebral Dysfunction
In the course of an investigation of the role of alteration in

cerebral function in the changes in behavior induced by convulsive
therapy,

we

have observed a wide

individual variability in the

wide
denonstrate
degrees of
Subjects
response.

EEG

EEG

delta activity

to equivalent numbers of induced convu1310ns. In the observations
to

be

reported, the relation of pSychologic factors to the Observed

variability is assessed.
Subjects and Method:

Eightyafive consecutive hospitalized patients referred for
electroconvulsive therapy were studied. Subjects wire tested with

the Rorschach and the Gottschaldt embedded figure
Sinai Modification) within a

week

test (Battersby

—

prior to treatment. Electroencephaloat weekly intervals during

grams were done

prior to treatment,

treatment.

records were measured for the degree of induced delta

The

and

activity using quantitative indices previously described.
Each

patient

was

treated three times a

or Medcraft instruments.

week, using

either Reiter

�Results:

1. Subjects with
H

and

FC

human movement (M),

Rorschach responses showed

induced delta

form-color (F0) or both

significantly lesser

activity than subjects

who

amounts of

had no such responses.

2. Subjects with fewer Rorschach responses (R) and fewer

total

movement

(MWFM+m)

responses

Showed

significantly greater degrees

of delta activity.

3.

The

higher the nambeehefepre-treatment error.score on the

Gottschaldt test, the greater the degree of induced delta activity.
Discussion:
These studies describe a consistent

relationship between pre-

trauma perceptual responses and the observed degree of phisiologic

alteration folloWing repeated induced cerebral trauma.

While

of current, skull resistance, inherent responsivity of brain,
may

affect the manifest physiologic alteration,

that the subject's usual

modes

EEG

etc.

also probable

of adaptation (reflected in his perceptual

test scores) affect the physiologic
the

it is

factors

reSponse to trauma.

In this context,

cannot be viewed as an isolated physiologic index but

is seen

�activity
interpersonal
in
the
setting
by
influenced
as one that is
of the

test situation.

Conclusion:

to
related
are
EEezeactivity
the
Individual differences in
have
these
latter
as
Insofar
differences in perceptual patterns.
been shown

to reflect personality differences,

the individual's

mode

we would

of adaptation ("perSOnality") is related to

(EEG).
index
the
physiologic
in
manifest changes

that

those aspects of experience and adaptation

tests

suggest that

also affect responsivity of the

EEG

‘We

would conclude

that affect perceptual

to trauma.

���_..,,,

WWw-w

,,

.w ”m.“

"Wm“. ‘WW..‘M_

.

,,

’w m—w"'1"‘mr-' W'sw-m-v-ni

w

ar—

w..,._r..._.c

‘11ij

���EE

4»

mm
0%; MW

I'quw.

”a Mme-(W

“,de
'. d2. M + F6.
Eneu.

MwFt

0“

2°

(FMm)

2o

"

H.

M

‘37)

H’

(1.9.)

e

(:42)

6’40.

3

(I57.

($71

“-—

.1

E4“

O'C)

H

I§

«2.)

I2

Suﬁ.)

(4°74

lo

(“74)

‘—

oS'

-

Esr' 0-4

.154;

-3":

�W

M

l4.

2

,2,

mm“
'

”W
3‘!!-

4.6

”M
-?.I

2-!

c.

2. 3

.0!

non-I-

”*Fm-Ihs

(a:

EJfI-‘Il .(«y-h

�������//

7%2.4“;

M»!

é

4,4...»

r9

x‘W

W.

J

,

w
’

.,

{a

2:

%

__

A

J 7

l:‘&amp;%ﬁw

¥£a¢v

Mcwa

”

WM
iawzbz
%/

A

MLW:

/

WWW/rm!

:2,

J4

”Mug:

�3.053.567”

�/

4/WUO‘
7

#-

A

1'

011W

4f

r

-

Wu.m

7

,z,

[,5h

7:

-

r

r-

Mlv4"

‘

Aw!—

7

7

/

7
A «4.1.

/

,

IJ

7 ‘/
‘

7/

M

M”
by“
W '

Atatu— “

I;

AD
M144:

ﬂ,

" 4/

/

M:

��Aug/L4.

4»

ﬂ

AM

'

’4”)

.

4,5.

(-&lt;.o‘&gt;

�A9921

r'

”a“

A/

A/.

l‘

“L

‘L;

57””

13.15”
/

//. ("/1

.

'
.2. w»

‘5:

'_

‘

s

M.

�'rr'

�”921'.“

M

We.

’91

/

W
I

~

~23;
/

('2.

10.
U", 2,,

�APR

V ;

q

«1

/U

9

I...

’

,3

/

{-91

I

“A;

"4/4

'2

7

5"7‘ 3’

01.5,

2

‘y

‘65

�A98

1.1 ‘ f“

d|

-,

.

/‘~'

M, /

21 '5.

����“”92

w
2

M

�I

--I‘_,4‘L&lt;.Jnu

�||

’7.“

_H

I!

ll

.2./

2.33

&lt; or

�II

II

II

3;)!“ch "37)
II

II

II

II

ll
II
‘

II

‘I

ll

ll
.
1|

II

II

I!

H
ll

II

II

II

�II
.

0!! PC

3
‘ii

W

(

II

II

II

II

II

II

II

-

II
.

II

II

II

II

II

II

I
I

II
II

II

II

II

II

II

II

2.

���IS.

Mpc.

had”

II”

!!

9

7 A?)

(33')

I‘ll,
(0M :9»—

“n
“I
.

+
a?

(I
’

anr9

II

II

II

II

II

II

II

II

I
ll

/0

(«a

(a)

f‘Jo
2

II

r;

7

I)

m“

/.2

+

W1
7.3“,

—»

�93

71$

if

’4'“

I!‘
(L
..

_

4!!

f 26“,)"
‘2

ll

”L

‘

ll

’i:

__

,7Or)“

__(z,?)"
AI
mm"

H
+»a‘l
!!

j:

(p’ll

"
“41'

2.9/

{7/

[(2
/‘/£

"2.6

4,527

3.5/3

I???

45143

57’”

1/4 7

IL/Hs

6 7- 7’-

H‘ér

”62.24

49'0L/

3732,
(€42,

27771...

47.31’

(31.54"

64 7)

I36

7”

W
9

V”

°

2.24

//

I42.

s39

9 2.
-

_2_J_'#_.L3_3__

[cor

v“

4""

3

'

‘

4. //

.2./“’

6/70

"22'

‘

I

1

/°:,‘

-

‘

n_ﬂ

”J

�f};
7})“;
‘

..

44»

L

.’

6’
5"

z

’0

,

aw
,M

p9

,

PL;

o

/

ll

/!g

cll’
I

L

r

/S"'

-

’—

W
a u.
/

(367»)

‘l

I!

{ﬁlﬁ
(’9’;

L

(Cara)

/

{d

3

AL” 6?

./o

ﬂd

3°

/

C

/ “ 3

‘5'

4'

’L/

f

3

3

�Ill

W

W

#H-

m
If

I
.

’Il

4+»

u

‘H++-

,

IIII

+H~I~

~+H+-

[III

I

II

I

'

Ill

‘
‘

Nu.
m

m:

#H-

m

III

ink-

m

.

'

II

M
I

H

II

III

"1/

HH-

’I

_l

I
I

-1-H+

IN!

'

ﬂﬁ—
III
I

.

'

,I

clam

##4- u

#44-

"

1-m-

#+H-

l7 Fc.
l'7

\‘l
cm

DC.

m:

,,I

I

I

£4

III

,ll

+H+
I

an ac

'ﬂ-l-L I
'

’

up”

II

6172:

1+“

14H~

4”.
”II

'

II

m:

N!

rm.

II
4+"I

II

III

\'

'

u {I

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67414">
                <text>Psychological Factors in EEG Reactivity to Induced Cerebral Dysfunction (research), 1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67415">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67416">
                <text>mfp-03-01-002-9-008</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67417">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67418">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67419">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67420">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67421">
                <text>Research papers, files, and related correspondence: research with Robert L. Kahn</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67422">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67423">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80944">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87505">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94066">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100627">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6743" public="1" featured="0">
    <fileContainer>
      <file fileId="6549">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/8ad71ef7a3c44154da4264a3d36d2625.pdf</src>
        <authentication>d939faed36329ffba731bbff9e10004f</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107154">
                    <text>An

Objective Study of Communication in Psychiatric Interviews

Joseph

Jeffe,

H.D.

From

the Department of Experimental Psychiatry, Hillside Hospital, Glen Oaks,

Read

at the

New

York

N.Y.

Divisional MBeting, A.P.A. November, 1957.

Supported by Grant 565561 of the Foundations' Fund for Research in Psychiatry.
14’!

10-1h-S7

�The

clinical interview is the psychiatrist's primary tool for the

diagnosis of psychopathology, the modification of behavior, and the

collection of research data.

Only

in recent years, however,

have the

actual transactions which comprise the interview been studied objectively.
Investigators of the interview have usually employed systems of
content analysis (1), which are based upon various theories of psychodynamics.

Currently, there

is increasing

emphasis upon formal aspects

of interaction such as temporal patterns of speech (1h) drastic change
of subject (3), PHYSiological relationships of the participants (2),

grammatical patterns of language (S, 6, 9), and speech disturbances and

silences (10). These aspects, in contrast to content categories, are

relatively independent of theoretical preconceptions,

and are more

readily

quantified and studied statistically.
In many investigations of these formal variables, however, the

total context of the
interview. These approaches neglect the fact that the psychiatrist is a
participant observer, i.e., a significant variable in the interaction
(11). Others have attempted to control this variable by means of
structured interviews in.which the doctor's contribution is standardized
patient's

communications are abstracted from the

according to a predetermined experimental design (6, 7, 1h). These

structured situations delete the very quality of living relationship that

is the ultimate

concern of the psychotherapist (7).

methods of verbal

We

are in need of

interaction analysis that neither preclude nor

prescribe the doctor's clinical responses.
The

this paper is to present a method of interview
a) is objective and quantitative, b) preserves the

purpose of

analysis which

�.2...

natural patient-therapist relationship,

and

c)

treats the interview

as an integrated system of interpersonal communication. This

is

accom-

plished by including the doctor's usual clinical behavior in the data
to be studied.
the

The raw

material is not the patient's speech, but rather

total verbal output of the

"two person" or "dyadic" group.

�Method:

tape recorded interview

The

is precisely transcribed,

without regard

to the speaker of the words. Careful attention is given to subtle

repetitions such as "I - I mean," "well as - as I say,"
polated expressions such as "you know,"

The

inter"so to speak," "as I said," etc.
and to

transcript is then arbitrarily divided into consecutive units of

100, 50 or 25 words depending on the discreteness of the phenomena to
be investigated. Thus a unit contains contributions of words from either

doctor or patient alone, or from both in varying proportions.
The measurement

applied to these units of dyadic Speech is the typetoken-ratio (TTR). This is an index of the balance between repetition

variety of words (12). The TTR is the ratio of the number of
different words (types), to the total number of words (tokensL in a
sample of language. For example, in a 100 word sample the repetition
of the identical word 100 times in succession would produce the lowest
and

possible ratio of .01
of 1.0 would

different

result

if

(l

type/100 tokens). The highest possible

every one of the 100 successive words were

(100 types/100

tokens). These extremes of stereotypy and

diversity are rarely encountered,
situations (8).
The

i.e.

"word-type,"

ratio

and then only

the numerator of the

in grossly pathological

TTR,

is arbitrarily

defined. All words are different which are pronounced or spelled

differently. Thus, ive, gives, gave, given and gizipgﬂ are considered
different types, as are "know" and "no." Vocalizations not clearly
"

�.u-‘
identifiable as
which

is

words are omitted, with the major exception of

"mmhmm"

a frequent utterance of the interviewer in our records.

Contractions are retained as single words, but vulgarisms such as "I
dunno" are

edited to read "I don't know."

The TTR

scores

is calculated for

is graphically plotted,

additional precision, the units
may be advanced 25 words

the

last half

at

unit

each

as

and the

illustrated in Figures

may be

first half

unit. This often smoothes the resultant curve.
is illustrated in Figure 3.
TTR

have

in a single person's language (12).

1 and

2. For

overlapped, e.g. 50 word units

a time, so that each unit

of the preceding and the

Previous studies of the

pattern of consecutive

is

composed

of

of the subsequent

The

overlapping technique

dealt with the overall average
The

sequential pattern in dyadic language.

present method studies the

�Observations:
In the

last eighteen

months approximately

sixty recorded interviews

this method.

The

material includes forty

patients in all diagnostic categories.

The

dyadic

have been inveStigated by

found to be sensitive

to a variety of clinical

TTR

patterns have been

phenomena

(8). This

report illustrates the changes in language interaction occurring during
the course of hospitalization and therapy, as well as changes in rapport

in individual interviews.

and defensive operations
A

- andic

TTR

Pattern in Clinical Change.

first

Figure 1 shows the pattern of the

three separate

1500 words of

interviews during the clinical course of one patient. The doctor is the

in each. This case

same

was

selected as an unequivocal example of gross

clinical change. In the first interview the patient

was

agitated and

depressed. She refused to be seated and paced about the room, reiterating
stereotyped self-recriminations, crying hysterically, with marked

pressure of speech. At the time of the second interview, following a
course of grand mal electroshock, the clinical picture was grossly altered.
She was

less agitated and

complaining of a memory
appeared

more

deficit.

cooperative, although withdrawn and
On

alert, poised, conversational

insightful.

She had been

The TTR of

later,

discharge two months
and,

she

at times, surprisingly

rated clinically as "recovered."

consecutive 25 word units of interaction, for each of

the three periods described, is graphically represented in Fig. 1.
Consecutive points are connected by lines so that the fluctuations in the
graph

reflect the difference

between successive scores.

The mean TTR

for

�~6-

the complete interview from which these samples were taken is represented

line through each graph.

by a horizontal

strates
The

a

The

fluctuating equilibrium about the

pattern of scores

mean.

interviews of these three successive stages

changes.

The mean

demon-

show a sequence

of

level of the interaction is seen to increase as the

clinical status changes from psychosis to "recovery." There is a concomitant restriction in the amplitude of the pattern, i.e. a decrease in
variation about the mean.
Comment:

The sequence of change

in the

TTR

pattern parallels the progressive

in interpersonal communication that

improvement

clinically.

was apparent

This suggests an approach to the quantification of

clinical

change, defined

as an altered pattern of verbal interaction in the interview.
B

-

in Communication‘within the Interview:

Changes

Figure
shown

2

is

an enlargement of the

in Figure 1.

first

of the three interactions

Here the sequence of changes

within a.single interview

are examined rather than comparing the patterns of successive interviews.
As

described before, the patient was speaking continuously in a disorgan-

ized affective outburst.
mﬂrich

The lower

line indicates the

the interviewer participated. Following

remarks, units

3

-

12

ﬁne

25 word

units in

doctor's introductory

represent the patient's uninterrupted speech.

Wide

oscillations of the pattern are prominent. From samples 13 onwards the
doctor made repeated efforts to communicate with the patient. Two independent judges reviewed the transcribed protocol, and both identified
three areas in which there seemed to be an understandable, rational

�-7interchange between the participants. These periods are labelled
"rapport" in the upper

line.

tions of the pattern are

much

During these three periods the

constricted.

Compare

oscilla-

other non-rapport

periods such as 23-2h and 39-hl, in which the doctor's participation
amplified the oscillations.
Cmmmnh

This

illustrates

a method of quantifying

interpersonal phenomena,

such as the degree of "contact" with a severely disturbed

patient.

The

affective pattern in this patient represents the psychotic integration,

for this reason, the occasional occurnnces of conventional,rational
conversation are described as periods of "rapport." The restriction in

and

the amplitude which characterizes these periods

is similar to the

overall pattern at the time of "recovery."
0

- Analysis
Figure

3

of a Complete Interview.

initial

demonstrates the

dvadic

TTR

analysis of a complete

interview. This interview is the discharge evaluation of a patient
had been hospitalized following a
months of

hospitalization, she

who

bizarre suicide attempt. After seven

had "improved"

clinically. This took the

form of a hypomanic mood and a gross denial of her severe emotional

conflicts.
word

The

interview

units advancing by

is

scored by the method of successive 50

ZS word

steps.

The mean TTR

for the interview

is shown by the horizontal line drawn through the graph. The pattern
falls into several natural segments. There are two areas in which ten
consecutive points fall below the mean (areas h and 7). These are
unusual in this interview. There are also areas of gross deviation

�~8from the mean (such as area

determine our

criteria for

2).

Thus we allow the

phenomena

for persistent changes in the

TTR

to be studied. In general,

we

look

level, gross trends or sudden shifts.

Several of the deviant areas are described to
The

objective pattern to

illustrate the

method.

interview begins with a hypomanic monologue in which the patient

visit

describes her successful

home,

her euphoric outlook and plans for

a rosy future.
Area 2 has been delineated because of gross deviation from the mean.
The

beginning of

this period coincides with

a change of topic to her plans

is interrupted
by a period of confusion as she tries, with some difficulty, to recall
one of the details of the job. The end of the gross fluctuation coincides
with the rationalization "I don't think I'll have too much trouble."
Area h was delineated as one of the two sections in which 10 consecutive
for going back to her job

scores

fall

two days hence.

Her optimism

Its beginning coincides with

below the mean.

about her depression on admission to the hOSpital.

a statement

This area ends with

the lowest score of the interview which,precedes by only a few words a
spontaneous reference to her suicide attempt. This large deviation

at

the end of area h embodies the main characteristics of the following area.
Area 5
The

is characterized

by large

content of this area

attempts to prove

at the

is

how much

fluctuations

above and below the mean.

completely on the theme of suicide. She

live. The doctor's queries
with increasing resistance. In the begin-

she now wants to

end of the period meet

ning of the next segment (area 6) she stubbornly refuses to discuss the

subject of suicide further, at which point she changes the subject
abruptly.

�-9Area

7 was

delineated

on

precipitous drop in the

the basis of
TTR,

criteria. It begins with

”two

a

followed by 10 consecutive scores below

rise. Its

the mean, and ends with an equally abrupt

beginning coincides

with a change of subject by the doctor in the form of a question about
her feelings at that

the "you-me" relationship,
period ends
Area

9

when she

in the interview. This content area, 1.6.

moment

is

at

a very

It

The

of an extremely low score enclosed by two

coincides with a brief mention of a meeting with

a young man who told her how well she looked.

remark and her statement
These examples

repetitive level.

abruptly changes the subject.

is delineated because

large deviations.

pursued

"I decided to get

illustrate areas

him

It

ends with an embarrassed

off the topic."

of disturbance or disequilibrium in

the verbal interaction pattern. In contrast, areas

I

3, 6,,23 and 10 are

areas of relative stability or equilibrium in the record. These stable
areas are marked by a different quality of communication. They consist

either of a euphoric,

hypomanic monologue which avoids

all stressful areas.

or of evasion of the doctor's probing questions by superficial rational-

ization and conventional cliches.
Comment:

Recent reports of objective interview studies using other techniques

(10), have noted that the interaction goes through a series of definable
phases, which

may

and successful defense
and the events
The

stressful disorganization

correspond to periods of

respectively.

The

phases demonstrated here,

that delineate them, suggest

an analogous fonmulation.

content areas that disturbed the pattern in this final interview

�also did so

the

initial

interview seven months earlier. we
anticipate that the discussion of a subject that had resulted in disequilibrium but now no longer does so, may constitute an operational
on

definition of "resolution of an area of conflict."

�Discussion and Conclusions:
Diverse and highly personal interpretations of interview data limit

the growth of psychiatry as a science. Systematic study of the actual

transactions

may

lead to operational definitions of hitherto subjective

it is

likely that the patterns of verbal
diversification presented here constitute part of the subliminal cues to

phenomena.

For example,

therapists
affect, etc.

which

reSpond when.making

clinical

judgments of anxiety,

Objective investigations of the interview must encompass the behavior
of both participants since the events observed are interpersonal processes.

Gill,

Heuman &amp;

Redlich (h) define even the

initial interview

as "the

diagnostic evaluation of an interpersonal relationship." Reusch (13)
has recently stated
have the

that “observations

made

in social situations

characteristics of a scientific procedure in which

do

not

one aSpect

is studied in detail while all other variables are held constant."
The method presented here is an attempt to convert these concepts
into practical research methodology.

It

permits a quantitative statement

of various clinical phenomena occurring either within single interviews
or in the course of therapy. Disturbances of verbal interaction are

defined operationally in terms of the configuration of the

Applications to the definition of clinical change and

pattern.
transactions
TTR

within the interview have been presented.
The TTR

is

only one of many quantifiable aspects of dyadic speech.

interaction, time reference, and relative amounts of participation
doctor and patient may also be measured. Further applications of these

Pace of
by

techniques are under investigation.

�REFERENCES

1. Auld, F.

and Murray,

E.J. (1955): Content-Analysis Studies of

Psychotherapy, Pslchol. Bull. 2a: 377-395.

2. Coleman, R., Greenblatt,

and Solomon, H.C. (1956): Physiological

M.

Evidence of Rapport During Psychotherapeutic Interviews,
Dis . Nerv.

3. Eldred, S.H.,

sttem,

ll:

2-8.
E.R., Salzman, L., Meyersburg,

Hamburg, D.A., IHWOOd,

(l95h):

H.A. and Goodrich, G.

A

Procedure for the Systematic

Analysis of Psychotherapeutic Interviews, §§zchiatry, l1:
337-3h5.

h. Gill,

M., Néwman, R. and Redlich, F.C. (l95b): The

in szchiatric Practice.
Press.
5. Goldman-Eisler, F. (195h):

A

New

York:

Study of Individual Differences and of

Interaction in the Behavior of
Interviews, Jour.. Rent. Sci.
6.

Initial_1ntervigg
International Universities

Some

Aspects of Language in

lQQ: 177-197.

Gottschalk, L.A., Gleser, G.C. and Hambidge,
Behavior Analysis, Arch. Neur. and

G.

(1957): Verbal

ngchiat.,

21; 300-311.

7. Grinker, R.R., Sabshin, M., HaMburg, D.A., Board, F.A., Basowitz, H.,
Korchin,
Use

m?

S.J.,

Persky, H. and Chevalier, J.A. (1957): The

an Anxiety-Producing Interview and

Its

Meaning to the

Subject, Arch. Neur. and Psvchiat., 11: hO6-hl9.
8.

daffe, J.: Language of the Dyad:

A

Method of

Interaction Analysis

in PBychiatric Interviews, Psvchiat , (in press).
9. Lorenz, M. and Cobb, S. (195h): Language Patterns in PBychotic

and

Psychoneurotic Subjects, Arch. Neur. and Pszchiat., 1g: 665-673.

�REFEREEIJCES

lO. Mahl, G.F., (1956): Disturbances and Silences in the Patient's
Speech in Psychotherapy, Jour. Abnorm. Soc. Psxcholu

§_3__:

1-15.

11. Handler,

G. and

Kaplan,

:‘J.K.

(1956): Subjective Evaluation and Re-

enforcing Effect of a Verbal Stimulus, Science,

l2.

Mowrer, O.H. (1953): Verbal Behavior

(Ed.) szchotheragz:

T1139

1.2143

in Paychotherapy. In

582-583.
Mowrer

and Research, New York: Ronald

Press.
13. Ruesch, J. (1957): Disturbed Commnication,

New

York:

11.14".

Norton.

1h. Saslow, G., Matarozzo, J.D. and Guze, S.B. (1955): The Stability of

Interaction Chronograph Patterns in Psychiatric Interviews,
Jour. Consult. P§Xcholu

1.2: 14174430.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67424">
                <text>Joseph Jaffe: An Object Study of Communication in Psychiatric Interviews, 1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67425">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67426">
                <text>mfp-03-01-002-8-009</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67427">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67428">
                <text>Jaffe, Joseph</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67429">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67430">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67431">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67432">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67433">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80945">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87506">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94067">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100628">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6744" public="1" featured="0">
    <fileContainer>
      <file fileId="6548">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/c779b264e0ba3e779d39ff5db1a0879e.pdf</src>
        <authentication>d5ea2d1f830983dbe61a4c62d8e73b61</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107153">
                    <text>Significance of Individual Variability in
EEG

Response

to Electroshock

Martin A. Green,

From

M. D.

the Department of ExPerimental Psychiatry, Hillside Hospital,

Glen Oaks, N.

10-11-57

"r
.50

�Significance of Individual Variability in
EEG

The assumption

Response

to Electroshock

is often tacitly

made

in studies of nervous system

function that the capacity for neurophysiological change is similar for animals
or humans in the groups under study. Differences in response are ascribed to

different parameters of the stimulus or to differences in the location and extent of lesions, either spontaneous or experimentally produced.
tion

may

Such an assump»

Perhaps another factor in the

not be warranted, however.

variability

of response under these conditions is an individual variability in neurophysio—

logical reactivity or responsiveness.

The

initial "base-line"

may

not be similar

in all individuals.
The

possibility of different inherent patterns of reactivity has

suggested by the studies of the alterations in the
have been impressed by the high degree of

EEG

been

during electroshock.

variability in

such

We

alterations both

in their quantitative and qualitative aspects. Although this variability has
been described by previous

investigators,

it

has not been stressed sufficiently;

nor have possible explanations been advanced or systematically investigated.

present report concerns a description of the changes in the EEG
Hillside Hospital
during electroshock in the/' material. The concept of neurophysiological
The

reactivity is presented

and studies

that

may

clarify this

problem are suggested.

�MATERIAL AND METHODS:

Eighty-nine patients
were

studied.

The

patients

who

received electroshock for psychiatric illness

Hillside Hospital and

were voluntary admissions to

the majority had not received electroshock previously.

The

diagnostic groups

and
schizophrenia.
psychosis
manic~depressive
included psychotic depression,
The

largest group

was

patients with depression.

Agesranged from 20

to

68 years,

with a median of #7 years.
Treatments were given three times weekly, each patient receiving at

least

12

treatments.

The Medcraft

instrument (alternating current) was used

61
for
current)
for 28 patients and the Reiter instrument (unidirectional

patients.

Electroencephalograms were taken prior to,

and two weeks following the course of treatment.
EEG

was abnormal were

to

36

weekly

Patients

specifically excluded from study.

2h
(from
day
non-treatment
a
an

at

whose

intervals during,
pre-treatment

Tracings were done on

hours following the previous treatment) with

eight channel Medcraft machine using needle electrodes.

Frontal, motor,

and
earlobe
vertex
temporal,
posterior
temporal,
anterior
parietal, occipital,

placements were employed with scalp

to scalp

and scalp

to earlobe combinations.

�RESULTS :

I. Delta Activity.
A.

Quantitative Differences:

delta activity

The

to the method described by Fink and

(8).

Kahn

The

was analyzed

according

duration of burst activity,

the lowest frequency, the average delta index in several leads, the highest
measured.
were
lead
one
in
time
delta
and
the
percent
highest
amplitude,

Re—

cords were classified as showing a low, middle or high degree of delta activity

(Fig. 1) according to

criteria previously described (8).

All patients developed delta activity during the course of
but differences in the amount of the slow activity and
were very apparent (Table

I).

Some

early in treatment whereas other
even

after

serial

12

EEG's.

not develop in

treatments.
As

treatments

of development

patients developed "high delta activity"

patients

showed only "low" or "middle" changes

latter patients

were followed

further with

treatment was continued, a high degree of delta activity did

some

of these patients

until

on

a daily basis.

This individual

variability in

treatments were given
change.

These

its rate

12

20 or more

They were
EEG

treatments, or until

resistant to neurophysiologic

response was independent of the type

of electroshock current employed, being present both with

unidirecticnal current applications.

alternating and with

�- h TABLE

Degree of Delta

I

Activity in Serial Electroencephalograms

during Electroshock
(2-n records were taken for each patient)
No.

Activity

EEG

No

change

delta activity

Low

Middle
High

B.
may be

ity.

-

EST 1

delta activity

delta activity

of Records in Each Treatment Period

u

L:..§

3

l

37

21

7

3

20

22

10

1

28

#5

25

1

16

amount
of
delta
the
activity
Although
total
Differences:
Qualitative

activ~
and
of
delta
voltage
to
frequency
records
as
differ
type,
similar,
One

prominent qualitative difference

during a course of 12 treatments.

is in the form of bursts which
as treatments are continued.

is the ratio of irregular delta

In some patients the

become more

The

show

burst activity

initial delta

change

frequent, slower and of higher voltage

irregular delta activity in such records is

less prominent and usually occurs at faster frequencies. In other patients

the reverse occurs.
form.

12

0

5

activity to bursts of slow activity. Nearly all records

much

-

10

Although burst

Delta activity appears chiefly in an irregular and scattered

activity is also present,

third group of patients the

amounts of

it is

not conspicuous.

irregular delta

and

In a

bursts are approx-

imately equal (Fig. 2).
These differences in the form

that the delta activity

assumes

is usually

constant during the course of treatment. At times, however, burst activity will

�.
become more prominent

-

5

than the irregular delta only during the

latter part

of

the course of treatment; or burst activity which appears prominent early in

treatment

may be overshadowed and

obscured in

later records

by a large amount

of continuous irregular delta activity.
The slow

activity is

maximal

electrodes and less pronounced at the

at the anterior temporal
more

frontal

and

posterior electrodes. Often

asymmetric, being of higher voltage, slower, and in greater amounts

anterior temporal
Only

and

frontal electrodes as

asymmetry occurs during treatment both with

is

at the left

to the right (Fig. 2).

compared

rarely is the reverse true, i.e. accentuation

it

on

the right side. This

alternating

and with

unidirectional

currents.
Another type of abnormality, though an infrequent one,

of rhythmic runs of delta activity which

(Fig. 2).

The

may

continue for

10

is the

to 20 seconds

regularity of the frequency and voltage of the slow

these runs is very striking.

appearance

waves in

These runs are usually infrequent, but may be

the most prominent alteration in the record.
In many records the amount of delta activity fluctuates during the

tracing. At times,

some

in other parts of the
This variation

II.

is

portions of a record

same

may

appear nearly normal, while

record the delta activity

may be

quite pronounced.

independent of the electrode combinations employed.

Spike or Spike-Wave Activity:
A

large number of records

or high voltage.

Most

show

single spike activity of low, moderate

often such spikes are slower and not as prominent as

�- 6 -

those present in patients with seizure disorders.
show spikenwave

A

small number of records

activity. This is usually at irregular,

mixed frequencies

and, again, does not resemble the regular rhythmic bursts commonly seen in

patients with seizure disorders (Fig. 2).

III.

Alpha Activity:
The

alpha activity

shows changes both

in

amount and frequency.

As

the amount of delta activity increases the amount of alpha activity usually

decreases. Changes in frequency occur but are not pronounced.

will

be slowed by 1-2 cps but

tracing. In a small

number

at times will remain the

same

The

frequency

as in the pre-ECT

of patients the amount and voltage of alpha activity

increases during treatment. This change persists during the post-treatment
period after the slow-wave activity subsides (Fig. 3).
IV.

Beta Activity:
The

fact that

activity in the

EEG

many

and the

induce
fast
barbiturates,
particularly
sedatives,

of
administration
the
in
controlling
difficulty

these drugs in this population studied makes
during the course of treatment.

are minimal.

activity.

The most

it difficult

to evaluate changes

In most instances changes in fast activity

frequent change,

when

present, is a decrease in the

�Discussion:

is that of the individual variability in the
As
EEG
described,
electroshock
therapy.
and
of
during
alteration
degree
type
and
of
rate
slow-wave
amount
of
its
the
activity
manifested
in: l)
this is
(amount
slow-wave
the
in
activity
differences
2)
development;
qualitative
The problem

being raised

of burst activity vs irregular delta activity, symmetry, fluctuating appearof
3)
slow
activity);
of
presence
rhythmic
slow
of
runs
ance
activity,
Spike or

spike-z-rave

activity;

and

LL)

changes in alpha and beta

Previous investigations (2, h, 5, 10,
have

ll,

activity.

12, 1h, 17, 18, 19, 20, 25)

stressed possible correlations with age , sex, frequency of treatment,

and
clinical change.
diagnosis,
employed,
of
current
psychiatric
type

Increasin" the frequency of treatment, for example, will increase the degree

of similar sex, age and
the
with
same
the
frequency
treatments
at
given
are
psychiatric diagnosis
same type of electroshock current, variability in the rate of development
of alteration in the

EEG.

However, when "ratients

their type anc‘. degree are still very prominent.
One explanation for this variability might be the distribution of the
electroshock current in the brain. Perhaps minor differences in the resistance

of changes in the

EEG

and

and
blooc‘
vessels
of
the
distribution
of the skull, in

their penneability or

taken
the
pathways
in
differences
create
of
tracts
nerve
in the arrangement
the
of
brain
portions
different
such
Unler
circmnstances,
the
current.
by
may

receive more or less current in

one

patient as

compared

to another.

variously
these
by
generated
of
the
electrical
activity
Differences in
type

affected areas might account for variability in the

EEG.

Available studies employing direct intracerebral measurements indicate

considerable diffusion of current throughout the brain (6, 9, 16, 21).

�However, a

concentration of current anteriorly and along: large neuronal

pathways, such as the corpus callosmn, has been demonstrated.

No

further

infon'ration is available as to amounts of current received. by more Specific

cerebral areas.
Due

to the high resistance of the skull only a small portion of the

applied. current actually reaches the brain.

The amount of

current entering

different portions of the brain is said to be determined by the resistance
of the skull overlying these areas; the anterior concentration of current
being; the result of the thinness of the temporal bone with its consequent
lower resistance as compared to other parts of the skull (9, 21).
Several considerations, however, indicate that individual differences

in these factors of resistance

and amount of

areas of the brain are of minor,
during-g

electroshock.

It is

if

current reaching,- different

any, importance in the

ELG

response

the occurrence of the generalized seizure

291'.

§_e_,

rather than the passage of electricity, which is the primary factor. During
a course of grand-mall therapy induced by non-electrical means such as
metrazol,

EEG

changes occur which are similar,

with electroshock (13, 1h). Diffuse slow-wave

in general, to those seen

activity, accentuated

of
The
amount
described.
are
activity
anteriorly,
slow—wave activity increases during treatment but shows individual variability
unrelated; to the n unber of treatments. Another observation is that electroand 81‘.de

or spike-wave

shock therapy nhich induces

petit-mal (7, 18) or focal (3) seizures rather

than grand-mal, does not produce the characteristic build-up of slow-wave

activity. In addition, there is no increase in the degree of delta activity
in our patients in whom grand-mal tae rapy is given with high suprathreshold
stimuli as compared to those in whom threaiold stimuli are used.

�-9-

.

Factors of current cannot be entirely dismissed, however. Even with
grand mal therapy, the type of current employed may influence the
we haVe

EEG

change.

confirmed a previous study (20) showing that the rate of increase

of delta activity

is

slower in therapy with unidirectional current than in

that with alternating current. Similarly, brief stimulus therapy is said to
produce smaller degrees of

alteration in the

EEG

as compared to alternating

current therapy (15).
The
EEG

other theory to

be

considered in explaining the variability in

re5ponsiveness, and the one which

is

probably more determinant, involves

inherent differences in neurophysiological reactivity.

By

this is

meant

both the quantitative and qualitative aspects of the inherent capacity of

the nervous system to respond to stimuli or injury. Not only the degree of

response, but also the type of response,
type and degree of

EEG

may have

these determinants.

The

abnormalities developed during electroshock therapy

appear to be the reflection of such inherent individual differences in

neurophysiological reactivity.

Several types of investigation
Methods

other than electroshock

may

known

serve to

to produce

test this hypothesis.
EEG

alterations could

be

applied prior to treatment. These might include lowering the blood sugar
by

parenteral insulin, intravenous administration of convulsants such as

metrazol or Hegimide, photic stimulation, or the intravenous administration
of drugs such as barbiturate.

In addition, perhaps the actual electroshock

seizure ﬂzreshold or the pattern 0: severity of the seizures
measure of nervous system responsiveness.

Data from such

could be correlated with the degree an? types of

shock.

In this manner

it might be

ELG

may be a

investigations

change during

electro-

possible to demonstrate different patterns

�410-

classify individuals accordingly.
not only help in understanding the variability in

reactivity

of neurophysiological
Such

studies

may

and

alterations during electroshock but would have wider application
to other problems in clinical electroencephalography and neurology. For
example, tie basis for the development of Spontaneous seizures secondary
the

EEG

to traumatic, vascular, or neoplastic lesions of the nervous system
known. Patients with lesions comparable in type, size and location
or

may

not develop seizures.

As

previously described,

spike or Spike-wave activity during electroshock.

difference in

not

may

subjects

some

show

This suggests an inherent

clinical seizures or

he capacity to develop

is

EEG

seizure

is
reflected in

the
whether
the
to
injury
nervous
system,
"injury"
following
activity
spontaneous or induced. Differences in this capacity may be

varying patterns of neurophysiological reactivity.

Differences in neurophysiological reactivity

in the pre-troatment
abnormal

(ll),

EEG.

Patients in

whom

"instabile" (22), or axons

may

also

be

manifested

the pre-treatment record is

a predominant alpha rhythm (S)

LEG
the
in
during electroshock.
the
alteration
to
said
develop
greatest
are
Other investigators have not confirmed these observations (2, 23). Actually,

such

correlations

depend on the method of

analysis of the pre-treatment

criteria used for "abnormality." Further investigation of this relationship is necessary.
Suggesting that neurophysiological reactivity is an inherent process
does not imply that a physiological basis does not exist or cannot be in-

record employed and the

vestigated. This

may

reside in the central nervous system

itself, consisting

of individual differences in neurochemical systems or in the permeability of

cells-or blood vessels; or

it

may be

outside the nervous system. Individual

�‘11-

differences in hormonal or other humeral substances produced during the

stress of electrosho

k may

serve to "sensitize" or "desensitize" the

cerebrum with regard to developing

ical activity. That such factors
following studies.

Trypan red

different

may be

amounts and types of

electr-

operative is suggested by the

injected intraperitoneally in cats before

a course of electroshock decreased the permeability of the blood~brain

barrier

and reduced the degree of

EEG

changes as compared to control

animals (1). Atropine and scopolamine adminstered during a course of

electnodiock in

man

blocked the development of the usual slowawave activity

(2h).
Electroshock therapy affords an excellent opportunity for the experimental investigation of the problem of an inherent neurophysiological

reactivity.
animals.

The

One

is able to

apply studies directly to man, rather than

stimulus to the central nervous system can be standardized

and the degree of neurophysiological change

changing different parameters.

controlled, within limits, by

Tests of 336 responsivity can be given before

such dianges are induced as well as during and

after treahnent.

Re-study of

patients is often possible then subsequent courses of treatment are necessary.

�.12..

marl:
l. Indiviéual

EEG
the
in
qualitative,
changes during a course of electroshock treatment in 89 patients are

éifferences, both quantitative

and

described.

2. These differences are pronounced

and

are not explainable by age, sex,

type of shock current, frequency of treatment, psychiatric diagnosis,

or clinical change.
3.

An

inherent capacity for neurophysiological change that has both quan-

titative

and

qualitative aSpects

may be

the primary determinant of these

differences.
h. Variation in skull resistance and in the amount of current reaching
the brain aspear to be minor factors.

5. Investigations that might serve to

described. Such studies

may

test

the hypothesis presented are

lead eventually to a classification of

individuals as to different patterns of neurophysiological reactivity
and

clarify other problems in clinical neurology

and electroencephalography.

�é 13 -

REFERENCES

l.

Aird, R.B.,

Strait,

(1956):

S.C.
and
Bowditch,
M.K.,
Hrenoff,
L.A., Pace, J.w.,

Current Pathway and Neurophysiological Effects of Electri-

J.

cally Induced Convulsions.

Nerv.

Ment.

&amp;

Dis., igg:

Bagchi, B.K., Howell, R.W. and Schmale, H.T. (l9h5):

alographic and

The

J. Pszchiat., lgg: h9-61.

Am.

R.
(1953):
and
S.
Feinstein,
Berg,
Impastato,
D.J.,
P.S.,

Bergman,

Electroencephalographic Changes Following
Focal Seizures, Conf. Neurol.hl§:

Electroshock,

EEG.

Chusid, J.G. and Pacella, B.L. (1952):

Electric

271-277.

Clin. Neurgghxs., g:

Shock Therapies,

J.

Electrically Induced

Slow Wave Phenomena

Callaway, E. and Boucher, F. (1950):

157~162.

Neuro. Ment.
H.

Dis., llé‘

(1953):

shock on the Cortical and Intracerebral

shock Process,
M.

J. Nerv.

and Kahn, B.L.:

&amp;

Response in Electroshock:

Arch. Neurol.
Hayes, K.J. (1950):

Arch. Neurol.

&amp;

The
&amp;

95—107.

Electroactivity of the

l3:

287-29h.

Experimental Studies of the Electro-

Ment. Dis.

Relation of

in

Effects of Electrou

Brain in Schizophrenic Patients, Conf. Neurol.,
M., Kabn, B.L. and Green, MLA.:

in Intensive

The Electroencephalogram

Delgado, J.M.R., Alexander, L. and Hamlin,

Fink,

Electroenceph-

Clinical Effects of Electrically Induced Convulsions

in the Treatment of Mental Disorders.

Fink,

505-512.

EEG

(in press).

Delta Activity to Behavioral

Quantitative Serial Studies, A.M.A.,

Pszphiat. (in press).
Current Path in Electric Convulsion Shock,

Psxchiat., §§: 102-109.

�-1hREFERENCES

10.

LC. and Pincus,

Hoagland, IL, Malamud, w., Kaufman,

G.

(19%):

in the Electroencephalogram and in the Excretion of

17

Changes

Ketosteroids

Accompanying Electroshock Therapy of Agitated Depression, Psychosom.
Med. , 8:

11.

216-251.

Kennard, M.A. and Willner, MD (1908):

Electroencephalogram

M.

lg:
13.

Serial

(1955):

Results from Shock Therapy,

4AM

ho-hs.

P83111835” £02:

Igtz,

Which

Significance of Changes in the

Changes Due

to Electrotherapy, Dis. Nerv. $35.,

120-122.

Knott, G.R., Gottlieb,

J.S.,

Leet, Hull and Hadley, H.D.

Jr.,

(1943):

Changes in Electroencephalograph Following Metrazol Shock Therapy:
A

1h.

Quantitative Study, Arch. Neurol.

8c

Psychiat., 29: 529-53h.

Levy, N.A., Serota, mm and Grinker, R.R. (19142):

Disturbance in Brain

Function Following Convulsive Shock Therapy, Arch.Neurol.

PsEhiat.,

ﬂ:

Liberson, wur. (1951):

1009-1027.

Current Evaluation of Electric Convulsive Therapy,

Mento
ASS.
Nerv.
PUbl.
R93.
D180,
0... nun-U.

Lorimer, F.M., Segal,

&amp;

M.M.

and

Stein, S.A.

2:

199-2310

(19149):

Path of Current

Distribution in Brain During Electroconvulsive Therapy,
EEG.

17.

Clin. Neurophysiol.,

3;:

318-3148.

Moriarity, J .D. and Siemens, J .0. (19M): Electroencephalographic Study
of Electric

Shock Therapy, Arch. Neurol.

&amp;

Psychiat., 21: 712-718.

�- 15 REFERENCES

18.

Pacella, B.L., Barrera,

S.W. and Kalinowsky, L.

(l9h2): Variations in

of
Shock
Therapy
with
Electric
Electrocephalogram.Associated
the

Patients with Mental Disorders, Arch. Neurol.

&amp;

Pszchiat., 51:

367—381l-

19.

Proctor,

J.E. (l9h5): Clinical and Electra-physiological

L.D. and Goodwin,

Observations Following Electroshock, Amer. J. Pszghiat., 39;:
707-800.

20.

Proctor,

L.D. and Goodwin,

J.E. (l9h3): Comparative Electroencephalographic

Observations Following Electroshock Therapy using

Alternating and Unidirectional Fluctuating Current,
22:
21.

Raw 60
Am.

Cycle

J. Pszghiat.,

525-530.

Smith, J.w. and Wegener, C.F. (19hh):

On

Electric Convulsive Therapy with

Control???
Electrodes
of
Application
Parietal
to
a
Particular Regard

Neurol.,
et
Acta
Measurements,
Pszchiat.
Voltage
Intracerebral
by

lg:

529-5h9.

Sulzbach, W., Tillotson, K.J., Guillemin,

(l9h3):

A

Consideration of

Some

V.

Jr.

and Sutherland, G.F.

Experience with Electric Shock

Various
to
Regard
with
Special
Mental
Diseases,
Treatment in
Psychosomatic Phenomena and to Certain Electro~technical Factors,

23.

Taylor,

R.M. and

Pacella, B.L. (19h8):

The

Significance of Abnormal

Electroencephalograms Prior to Electroconvulsive Therapy,

J.

Nerv.

&amp;

Ment.

Dis., 291: 220-227.

�.

16

-

REFERENCES

2h.

Ulett,

G.A. and Johnson, M.W. (1957):
Upon

Electroencephalographic Changes Induced by Electro-convulsive

Therapy,
25.

W911, A.A. and

EEG.

Olin. Negggghxsiol.,.2: 217-22h.

Brinegar, wgc. (19h7):

Following Electric
21:

Effect of Atropine and Scopolamine

719-729.

Electroencephalographic Studies

Shock Therapy, Arch. Naurol.

&amp;

Pszghiat.,

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67434">
                <text>Martin A. Green: Significance of Individual Variability in EEG Response to Electroshock, 1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67435">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67436">
                <text>mfp-03-01-002-10-010</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67437">
                <text>1957</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67438">
                <text>Green, Martin A.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67439">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67440">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67441">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67442">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67443">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80946">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87507">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94068">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100629">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6745" public="1" featured="0">
    <fileContainer>
      <file fileId="6547">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/547dda87f02e63e10815bbd8bd8b58a3.pdf</src>
        <authentication>2de3623b012b67ce51e9e637220d0b84</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107152">
                    <text>Role of EEG Frequency

Shift in Behavioral Effects of

Drugs

mmmm.*
During the past few years

we

have been

interested in the interrelation-

ship of changes in various measures of brain function and the behavioral
response of psychiatric patients to somatic therapies.
were devoted

Our

initial

studies

to the changes in tactile perceptual tasks in patients with

organic psychoses. This study, carried out at Bellevue Psychiatric Hospital,
demonstrated that patients with active organic psychotic reactions made

repeated errors in the simple task of reporting two simultaneously applied
cutaneous stimuli.

The

persistence of such‘errors

was

interpreted as an

index to the presence of an "organic mental syndrome."

In the

initial studies at Hillside

Heepital in 1952, the

same

patterns of errors were observed in patients receiving convulsive therapy.
we then became interested in the role of altered brain function in the
"improvement" induced by convulsive therapy.
we

In our

first

group of

patients

followed consecutive electroshock referrals with weekly measures of

changes

in brain function

of brain function:

and

memory

clinical interviews.

tests,

simultaneous

we

used four indices

tactile tests, the amobarbital

test for organic brain disease described by Weinstein and Kahn, and the
degree of induced delta activity in the EEG. It was soon apparent that
neither the memory scales nor the tactile tests were sufficiently sensitive
indicators of alteration in brain function to be satisfactory for our
purposes. The amobarbital

test,

however, was a

sensitive indicator. In

this test, the subject is asked a series of questions regarding his illness
the Department of Experimental Psychiatry, Hillside Hospital, Glen Oaks,
Island, N.Y.
Read at the Section of Neurology and Psychiatry, Queens County Medical
Society, June 3, 1958.

Frcm
Long

‘

�.2and

orientation for place, date, time

and

person. Following the

administration of intravenous amobarbital until the patient has nystagmns,
the questions are repeated. Errors of confabulation and disorientation

are scored as "positive" tests, and have been found almost exclusively in
subjects with active cerebral dysfunction. In the patients in the
electroshock series, a significant relationship was observed between
changes

in this test and impmvement ratings in convulsive therapy.

Amobarbitﬂ Test
EST

-

Improvement

#1

“----‘--- u..---.--—----—--——-we

in the

also measured the changes in
EEG.

ﬁne degree

of induced delta activity

Examination of a series of preliminary records, as well as

the description in the literature, demonstrated the early development and
‘persistence of Slow wave activity in the

EEG

during convulsive therapy.

this preliminary information, we obtained weekly records during and
‘We measured
of
treatment.
a
after course
specified leads for the per-cent
time delta, the slowest frequency, highest voltage of delta and the duration

With

of burst activity. Using these quantitative indices
180 records

activity.

in
The

we

ranked the

initial

patients according to the extent of the induced delta
upper third were classed as ”high degree delta records,"

2h

the middle third as "middle or'moderate degree delta" and the lowest third
as "low degree delta

activity."

High, Middle and

Low

Delta

-

EST

#1

�.3 When we

related the development of high degree delta activity to

improvement

rating, a signiﬁicant relationship
Fig.
EEE

was

again demonstrated.

5

Delta - Improvement -

EST

#1

---—-—------ -—------ yo--— --—‘-..- ~-

In subsequent months

development of high degrees of

third

to

EEG

delta activity during the second and

ratings. In the next table,
these observations in the next Sh patients.

weeks of treatment

have summarized

a predictive study, relating the

we embarked on

improvement

F1

.

we

6

Table: Patients High Delta 2nd, 3rd weeks of Treatment
EST

2’ 3’

’4

-_------- ----—----‘u-n-—---------_-----m-‘-----—----By

this time

we

believed that

EEG

delta activity

was

related to the

behavioral changes in convulsive therapy, and

its significance

in a control convulsive-subconvulsive study.

Of

was

tested

consecutive convulsive

therapy referrals, randomly selected patients were subjected to a course
of subconvulsive therapy instead of the convulsive therapy. This

to the patients or their therapists. 0f the

substitution

was unknown

subjects

received convulsive therapy in this series, high degree delta

who

activity records

were observed

in

of treatment. Of the 27 Subjects

3h during the second
who

to the fourth

h?

weeks

received subconvulsive therapy,

however, none demonstrated either-high or middle degree

delta activity

�.u.
EEG
.

records during any week of treatment. In concurrent behavioral

evaluations,

of the h? subjects in the convulsive group

h2

behavioral change, while only
showed such

3

showed marked

of the 27 in the subconvulsive group

a change. In clinical improvement ratings, 2h of h? were

rated "recovered" and

"much improved;" 15

"unimproved or worse."

But

as "improved" and

8

as

of the subconvulsive group,only

3

were

"recovered" and "much improved," 5 as "improved" and

19

rated

as "unimproved

cr'worse."
we were now

convinced

that high degree of

EEG

delta activity reflected

the physiologic changes essential to the behavioral change in convulsive

therapy.

An

alteration in brain function, sufficient

induce considerable

-

and of

the kind to

activity appeared to be the prerequisite,
not sufficient factor - in the convulsive therapy

EEG

a necessary, ﬂaough

slow wave

process. Perhaps a similar relationship was observable in other somatic

therapies?
we

next examined insulin

activity is induced,
hours after gavage.
receiving deep
or prolonged

which
Not

coma

therapy. During each coma,

EEG

delta

usually persists for a few minutes to a few

infrequently - in approximately 1/3 of patients

insulin therapy in our hospital, seizures, aphasia
result. After such events, EEG changes of delta activity

coma

coma

persist for days,
The relation

'

and

in cases of prolonged

between prolonged coma,

coma,

for

weeks and months.

altered brain function and

behavioral response has been discussed by numerous authors. Revitch
reported eight cases and concluded that improvement was related to the
induction of organic brain damage, similar to lobotomy. Yaeger et a1

�-5.
noted a correlation between length of coma, degree of organic confusion,
remission of mental symptoms and degree of
of prolonged coma.

EEG

In reviewing our insulin

abnormality in 12 cases

coma

experiences,

noted

we

that our best clinical results have been observed in prolonged coma cases.
As a result, it has been the intention of our staff to induce such a state.
Persistent
coma

EEG

delta activity has been observed in a small

subjects, and only in those with prolonged

neurologic signs. Thus, in insulin

coma

number of our

or persistent

also, a relation between
delta change and behavioral response is indicated.
Concurrent with these investigations, We had begun clinical

EEG

coma

investigations with the newer tranquilhers. Initial study of Raudixin

in

1953

He were

failed to indicate

any

clinical efficacy.

able to administer large doses - up to 10

With
mgm.

reserpine, however,
At these

levels,

behavioral change become prominent but so also did neurologic complications.
Parkinsonism was readily induced, and seizure induction and increased

clinical depression became prominent. The EEG changes on chronic administration were small. With our doses, desynchronization was apparent, but at
higher dosage hyperSynchrony was also noted.
With chlorpromazine, however, we were more

fortunate.

we had undertaken

a control insulin coma-chlorpromazine study, in'which the experimental
dosage called

for levels sufficient to induce clinical parkinsonism. In

three of the thirty patients grand mal seizures were induced. In

all

patients significant changes were observed in serial EEGs. These consisted
of increased modulation, increase in per-cent time alpha, and in twenty
patients lOW'voltage theta and delta activity.

On

hyperventilation, delta

�burst activity was observed.
In reviewing the experiences of others,

noted numerous reports
of chlorpremazine inducing seizures; exaggerating seizure activity in

epileptics; and activating seizure
available for reserpine.

EEG

we

records. Similar reports are

review of the electroencephalographic effects of various phreno-

A

tropics demonstrated that not all newer agents induced
Meprobamate,

in clinical doses, induces

an increase

in

activity.

slow wave
EEG

fast activity,

with increased voltage and Spindling. The records are most similar to

barbiturate records.
Benactyzine (or suavitil) induced neither slow nor

fast

activity
but desynchronized the record, with flattening of voltages and loss of
wave

whatever rhythmicity was present.

clinical experience we were impressed that chlorprcmazine
and reserpine were the most effective modifiers of psychotic behavior,
with benactyzine and meprobamate as relatively inefficient agents. It
From our

seemed

appropriate therefore to extend the neurophysiologic adaptive

hypothesis of the

it was

mode

of action of convulsive and insulin
EEG

frequencies to the delta range would

active in modifying psychotic behavior; while those that induce a

shift to the beta range, or
As a

corollary

it was

desynchronize the record would be less effective.

suggested that agents that induce no change in brain

function or changes so small as not to be reflected in serial
have

therapies;

suggested therefore, that agents that induce a change in brain

function reflected by a shift in
be most

coma

little

EEGs

would

behavioral effect. Thus, a classification of newer phrenotropic

�-7drugs based on

their

EEG

effects

was suggested:

(3) Increased slow wave activity with hypersynchrony
(b) Desynchronization with voltage and frequency irregularity,
.and
(0)

irregular theta

Increased high voltage

fast activity

In reviewing the available literature reports of promazine and perphenazine
would indicate

delta range.

that these agents induce a shift in the
Mepazine has minimal

EEG

effects,

EEG

spectrum to the

and these are

largely

desynchronization. Information regarding other newer agents was not

available.
we
EEG

have undertaken two studies based on

changes to behavior.

One

is serial

EEG

this hypothesis relating
studies of patients

receiving chronic tranquilizer medication at the hospital.
a study of the

relation

acute administration:

between the

EEG

and

A

now

second

is

the behavioral effects on

the data of our chronic administration studies

are not yet available, but the acute studies have progressed sufficiently
to danonstrate the applicability of the hypothesis.
Fbllowing the observations by Denber

derivatives, diethazine,

elicit
some
EEG

when

that

one of

the phenothiazine

administered with chlorpromazine, would

activity similar to convulsive therapy, we undertook
explorations of this compound. In the EEG laboratory with continuous
31 w wave

recording, varying amounts of diethazine from 100 to 250 mg. were

administered intravenously over a 10 minute period in psychiatric patients

at various stages of the convulsive therapy process. Instead of hyperynchrony, patients who were pretreatment and without EEG delta activity,
demonstrated significant desynchronization of the record.

�-8Fig. 7,
EEG

- Diethazine - Pretreatment

interesting, however,

Most

8

was

the effect of diethasine in patients with

increased slow wave activity during convulsive therapy. Here, too,
desynchronization became manifest, and there was a decrease in the voltage
and per-cent time

of the induced delta activity.

EEG

- Diethazine - Delta Activity

effects, we observed distinctive
behavioral changes. Patients became more irritable and restless; they
Concurrent with these

complained of sensations of

extremities. In

some,

EEG

unreality,

visual illusory

and of dysesthesias of the
phenomena and

delusional thoughts

their illness, the setting of the test procedures or our identity.
There were changes in their language patterns opposite to that previously

about

described for amobarbital, so that denial, minimization, cliches, third
person

mode and

past tense were less prominent.

The

duration of these

behavioral and language changes was from one to five hours.
changes were of similar duration

administration and disappearing

The EEG

- appearing during the period of

when

drug

the behavior had apparently reverted

to the pretreatment state.
The

ability of diethazine to

activity led to

an evaluation of

induce

other

illusory

known

and

hallucinatory

hallucinogens. In checking

�-9the literature

we

noted

that

that mescaline reversed the

Denber and Merlis had previously described
EEG

changes induced by electroshock,

in a

fashion identical with diethazine. Pennes had observed hallucinogenic

activity for another experimental compound Win 2299. We obtained some
of this material, and repeated our diethazine studies. Here, too,
Win 2299 induced EEG desynchronization associated with clinical patterns
of restlessness, excitement, hallucinatory and illusory activity.

Fig. 11,
Win 2299

We

repeated these studies with

was a

-

12
EEG

LSD, and

again the same patterns. There

difference in the time constant, but concurrent with the behavioral

effects

we

observed

EEG

changes.

Recalling the ability of benactyzine to desynchronize records,

this

compound

intravenously, and again,

we

observed the same

we

EEG

administered

pattern of

desynchronization, associated with restlessness and excitement. While

not observe the illusory and hallucinatory patterns,
kinds of language changes in these patients that

we

we

did note the

we

did

same

observed with diethazine.

�Fig. 16, 17
Benactyzine

The

chemistry of these compounds

Thus, from each of these agents,

-

EEG

is noted in the next figure:

EEG

desynchronization was induced, and

hallucinogenic or excitatory activity was observed.
we can.now

amplify our

initial

hypothesis to encompass hallucinogens.

like to refer first to conclusions described in
l9Sh by Wikler in a study of the effects of mescaline, n-allylnormorphine
In-this regard, I

and morphine

in

would

man,

in

which he

stated:

"....

regardless of the drug

administered, shifts in the pattern of electroencephalogram in the direction
of desynchronization occurred in association with anxiety, hallucinations,

fantasies, illusions or tremors, and in the direction of synchronbation.with
euphoria, relaxation or drowsiness." ‘We would now generalize our observations
of

EEG

changes and behavior to note

shift to the delta
behavior. Agents that

and

that agents that induce

EEG

synchronization

range are potent agents in the control of psychotic

induce synchronization in the beta range are relaxant,

euphoriant and sedative, while agents that desynohronize the record tend to
be

hallucinogenic.
This hypothesis lends

itself to

a variety of applications.

It provides

a bases for the understanding of the mode of action of various organic

�-11-

therapies in psychiatry.

EEG

analysis

may

also provide a basis for the

assay of new drugs and therapy procedures. Finally, these observations

permit a more rational management of the somatic therapies.

to explore each application in

summary

I would like

fashion.

application of the neurophysiologic adaptive hypothesis - for
that is the rubric under which we subsume the relationship between the
The

in brain function, reflected by the EEG, and the changes in
behavior - to insulin coma therapy has already been described. we have
changes

applied this concept to our studies of phrenotropic agents, and have
been able, both

It is

predictively

and

retrospectively, to assess

new

agents.

possible to understand lobotomy therapy, and sleep therapy,

within this framework.
As

is

for the assay of

drugs, our explorations into hallucinogens

that each of the potent hallucinogens
a biochemical similarity in a common tertiary amine radical connected

one example.

have

new

we

have recently noted

by an ethyl linkage to a large nucleus.
compounds

with this linkage.

One

On

this basis,

we

sought

for

group are known anti-parkinson agents

with anti-cholinergic properties as parsidol, artane, kemadrin, panparnit
and benadryl.

we have

not yet tested these compounds for their

EEG

or

clinical effects. Recently, Pfeiffer reported at the Academy of Neurology
that these compounds, in trained subjects, were identified most with LSD.
In 1956, Gottlieb reported that benadryl desynchronized the

patients, much as we saw this evening.
available in the literature.
shock

EEG

of electro-

Thus, some confinnation

is

�.12With regard to the

third

therapies - this hypothesis

ammﬂication

may

- the

management of somatic

be of considerable help.

In convulsive

therapy and in drug therapies, the patient'who responds in a favorable

fashion is‘no problem. But what of the patients

who

responds poorly,

or not at all? Could the failure of response be related to inadequate
dosage?

In electroshock,

when a

patient manifests paranoid or withdrawal

behavior, or no significant change, an

If

the record

we may assume

fails to

EEG

provides a guide to management.

demonstrate high voltage slow wave

that treatment has been inadequate,

activity, then

and continue the

treatnent course or increase the frequency or alter the convulsant
method.

If

EEG

changes are present, then we would assume

that other

factors - personality, sociologic or interpersonal - are not conducive
to "improvement" by electroshock, and other remedies sought. Similar
applications are possible for phrenotropic agents.
In summary,

we

believe that somatic therapies in psychiatry exert

their effects primarily by altering brain function. Changes in the
EEG Spectrum are one reflection of sudatalteration and are useful as
a guide to the mode of action, effectiveness and application of somatic

therapies.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67444">
                <text>Role of EEG Frequency Shift in Behavioral Effects of Drugs, 1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67445">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67446">
                <text>mfp-03-01-002-12-011</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67447">
                <text>1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67448">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67449">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67450">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67451">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67452">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67453">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80947">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87508">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94069">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100630">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6746" public="1" featured="0">
    <fileContainer>
      <file fileId="6546">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/10dd96ea03d444a3545ca7a104bdf5fe.pdf</src>
        <authentication>a67bc54ff65c228d90099b2591e160d9</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107151">
                    <text>SOCIAL FACTORS AND COMMUNICATION IN PSYCHIATRIC PATIENTS

I:
11:

III:

From

Pollack Ph.D.

Choice and Results of Therapy

-

Duration of Hospitalization and Diagnosis

- Robert

Observations in an Interview Setting

- Joseph Jaffe

Max

L. Kahn Ph.D.

.

M.D.

the Department or Murmantal Psychiatry, Hillside Hospital, Glen Oaks,

L.I. , NJ.

Presented October 19, 1958,

at Hillside Hospital.

�III:

9-29-58

Social Factors and Commmication in Psychiatric Patients
1: Choice and Results of Therapy
Recent investigations by Hollingshead, Redlich, Frank, Levinson
and others have indicated a

relation

between

social class and

psychiatric disorder with respect to type and incidence of mental

illness, selection

be present

and maintenance of treatment and therapeutic outcome.

report is concerned with the role of social factors in the

.

selection and efﬁcacy of therapy in Hillside Hospital.
me most intensive analysis of the relationship of social class to
mental

illness has

been recently reported by Hollingshead, Redlich and

their coworkers. In their studies the population of New Haven was
divided into five social classes on the basis of weighted criteria or
education, occupation and place of residence. or the residents who were
under psychiatric care, those from the upper social classes were more

frequently treated with psychotherapy, while organic treatment or

custodial care

was more

comm among the lower classes. Of the

psychotherapies, psychoanalysis was entirely restricted to the We upper
groups. Social class was the predominant determinant of the type of

treatment selected even when the diagnosis was held constant. They
summarize

their observations as follows: I'....

it

is found that

and
does
treatment
not depend on psychological
medical determinants

alone, but on the status position of the patient as well. Psychotherapeuﬁc

in disproportionately high degree to the upper social
data of this study would seem to indicate that most

methods are, applied

levels.

The

�in a setting where the background of the
patient is similar to that of the therapist."
It is possible, however, to relate the results obtained from these
commity studies to such selective factors as the patient's financial
psychotherapy takes place

resources or the extent and type of treatment
more

critical test of the

facilities available.

A

importance of social factors affecting choice

of treatment would be in a setting where the same therapeutic tecrmiques
and services are

available to

all patients, regardless

of their ability

to pay.

is

at Hillside Hospital. the of the main
criteria for accepting patients is their “ability to participate
profitably in psychotherapy." Individual psychoanalytically oriented
psychotherapy is regarded as the primary method of treatment with
organic therapies available when needed. Thus a patient is seen in
This requirement

met

regular therapeutic sessions throughout his hospital stay even

when

undergoing a course of caustic therapy. The average length of hospital

stay

is six

months, with some

The purpose

patients remaining from

of the present report

is

12

to 16 months.

to smnmarize the relation

factors of age, education, place of birth, and social
attitude (as measured by the California F scale) to the selection or
between the

treatment and the ratings of improvement at time of discharge in this
environment.

muons
1957 was

The

entire in-patient adult population of

studied. This consisted of

171

patients,

March 7,

57 men and 111; women ,

ranging in age from 16 to 68 years, with a mean of 35 years.

�Procedure: The patients were tested with a ten-item modification

of the California F scale suggested by Levinson. The

F

scale is a

questionnaire which has been related to such factors as authoritarianism,
acquiescence, ethnocentrism and

rigidity.

The

patient reads ten

statements and indicates whether he agrees or disagrees with each
statement and to what extent.
from one to seven and the

The

score given for each item ranges

total score range is

10

to 70.

The

greater

the agreement the higher the score obtained. The statements themselves

are extreme, uncritical or stereotyped expressions. For example, one
of the statements
would be

is: "If

people would talk less and work more, everybody

better off."

Choice of Therapy:

will first take up the relation of these social and psychological
factors to selection for treatment. During the period of this study,
(Table I) approximately one-third of the patients received convulsive
The
small
with
and
two-thirds
treated
psychotherapy
were
only.
therapy
group of patients who received insulin coma and drug therapies are not
We

represented on the slide.

When compared

to psychotherapy patients, the

convulsive group were older, had fewer years of education

not completed grade school

also had a higher

F

-

-

many had

and were frequently foreign born.

They

score, which indicates that these patients tended

to agree with social stereotypes.
At this time, the psychiatric residents and their supervisors
were also tested. Their average F score was 21.8 with a mean age of
thus more closely approximating the psychotherapy group than the

33 .9.

�electroshock group.
This figure has dealt with group averages for each of the factors
mentioned. There was however marked

at
the patients is

variability within each of the

groups, with patients

each end of a wide range.

grouping

shown

group with reSpect to length of

convulsive therapy.

As

One method

in the analysis of the electroshock
hospitalization prior to receiving

illustrated in the next table

electroshock patients were divided into three groups:
were
and

(Table

II),

the

1) those who

after admission, 2) between three
after six months. There is a definite correlation

treated within three
six months, and 3)

of sub-

months

prior to convulsive therapy and F score, age,
education and birthplace. It is of interest that there is a gradient
for each of the social factors. As a group the patients referred for
between length of stay

convulsive therapy

after six

months of

hospitalization are most similar

to the psychotherapy patients with respect to each of the factors.
Che

set of data not

shown

in the slide is the ratio of male to

female patients referred for somatic therapy during each of these

hospitalization periods. Although the ratio of females to males in
the hospital population is two to one, hh per cent of the patients in
the group treated within three months were male.

In the group

hospitalized for six months prior to convulsive therapy, however, only
7

per cent are males. Thus, male patients are referred for electroshock

earlier in their hospital stay than
As

patients.
expected, a larger proportion of depressed patients
female

~ 52

cent - received electroshock than did those with other diagnoses.

per
To

�-5.
control for the factor of diagnosis in choice of treatment, the psychotic
depression patients were subdivided into those

who

received electroshock

and those who were given psychotherapy alone.

The

results are

the next slide (Table

III).

While the two groups are comparable

age and education, the electroshock
mean F

shown

in

for

patients had a significantly higher

score and a higher percentage were foreign born. Thus,

it may

that persons classified as having a psychotic depression are not
necessarily referred for electroshock because they are older or less
educated, but rather that they come from cultural backgrounds that are
be

more commonly

associated with psychologic processes that

make

successful

in the psychoanalytically oriented psychotherapeutic
relationship less likely. These findings are consistent with previous
studies which have shown that patient-therapist differences in systems
communication

of values

may hamper

Redlich note:

"We

therapeutic relationship.

As

Hollingshead and

are not sure what attributes a good patient must have,

but they include sensitivity, intelligence, Social and intellectual
standards similar to the psychiatrist‘s, a will to

do

desire to improve one's personality and status in

life,

attractiveness and charm. Rarely will such standards

one's best, a
youth,

be admitted by

psychiatrists. On the contrary, psychiatrists claim that the selection
for treatment is based on purely psychiatric criteria....."
Results of Therapy:

Social factors are as significantly related to treatment result
as they are to treatment selection.

hospital treatment

on

To

the 171 patients,

analyze the effects of the
we

selected the discharge

�evaluation as the criterion of improvement. At time of discharge a

patient is classified in

one of four

categories: recovered,

much

improved, improved or unimproved.

relation of social factors to the discharge evaluations is
presented in the next slide (Table IV). There is a definite, almost
The

linear relationship, between the improvement rating and these four
social factors. The recovered group of patients had the highest F
scores, were oldest, least educated and
of foreign

birth. In contrast,

showed the

highest incidence

the unimproved group had the lowest F

scores, were younger and better educated - almost all having gone to
college - and were primarily native~born.

for patients treated with convulsive therapy
the improvement ratings parallel those for the total population.

Analyzing the data

(Table V)

Again, the recovered group had the highest mean F scores, was the oldest,
most poorly educated with the highest incidence of foreign

birth.

The

illustrates the relation of these observations

next slide (Table VI)

to time of referral for treatment. Within the electroshock group
67

per cent of those

who were

treated early in the course of

hoSpitalization were rated as recovered or
those treated

after six

these two groups.
were more

much improved, whereas

months only 30 per cent were

As was

noted

earlier, patients in this latter

similar to the psychotherapy group

It is

classified in

WEUh

respect to these

not surprising, therefore, that they were
treated with somatotheragy only after an extensive course of

social factors.

psychotherapy.

group

�.7In summary, the observations that social factors are related to
type of therapy received as well as therapeutic outcome are consistent

with the studies of Hollingshead, Redlich and their coaworkers.

their findings in demonstrating
that these factors are also significant in a hospital setting where
where
and
selection
of
not
therapeutic
criterion
to
a
is
pay
ability
all forms of therapy are equally available to the entire population.

Furthermore, the present studies extenii

While

the relation between social factors and treatment selection

are clear, and are consistent with previous findings, the relation of
these factors to improvement ratings appears paradoxical.
observations that those patients with high
and

less educated,

more

F

scores,

The

who were

older

often received convulsive therapy and were

discharged more frequently as recovered are consistent with the results

reported in 1956 in a follow-up study of Hillside Hospital patients
conducted by Rachlin, Goldman, Lurie, Gurvitz and Rachlin.

It is

possible that the differences in communication between therapist
patient that result in referral for convulsive therapy may also
influence the discharge rating. Thus,

Kahn and

and

Fink have previously

to denial, evasion,
and
benefit
most
receive
to
and
of
cliches
use
are
likely
stereotypy
from electroshock. Such language patterns appear more frequent in
shown

that verbally

uncommunicative persons, prone

persons in the lower socioeconomic groups. Because of the differences

therapist and patient, the therapist may set different criteria
for improvement for the older less educated patients than he does for

between

the young, sophisticated ones,

�class patient

The lower

may

also set goals for himself that are

The
from
class
patient's
the
different
patient.
upper
qualitatively
aspirations for himself and the therapist's expectancy for the patient
of
time
of
hospital
improvement
at
Ratings
an
interactive
are
process.

discharge are relative in that they refer to a baseline of premorbid
functioning. Thus the rating of recovered is defined as, "the reasonable

expectation that the patient will be able to return to his community
and function as

well, or better, than

he did before he became

ill."

therapist's perception of the patient's premorbid functioning may
be influenced by the distance between his value system and that of
the patient and both influenced by their social class. ‘The greater
the social distance between therapist and patient the less rigorous
the requirements for behavioral change. Fer example, for older, lower
class patients, ability to resume work may loom as the major criterion
The

of improvement. For the upper class patient work adjustment
only one of a

may be

host of criteria, including such intangibles as work

gratification, ease of sociability, etc..
This presentation has dealt with a few of the relationships
between social factors and psychiatric treatment in a voluntary,
psychotherapeutically-oriented hospital. The other speakers will
deal with

many

of the questions

left

unanswered

in this report.

�THERAPY SELECTION

F

Score

Yrs. of
Education

Foreign

gMeanz

Age
{Mean}

Electroshock
(Ii-57)

14306

’40.3

11-2

26%

Psychotherapy

36.1;

32.6

11.8

9%

Groggs

(Na102)

SMean)

%

Born

�.10TABLE

II

LENGTH OF HOSPITALIZATION PRIOR TO
ADMINISTRATION OF ELEBTROSHOCK

F Score
gMeanz

Groygs

Less than

3

{N-Bh)
3

mos.

to 6 mos.

(N-IO)

More

than 6 mos.

(N~13)

Age
(Mean!

Yrs. of
Education
Ween!

%

ForeignBorn

148.3

M45

10.1

1:173

he. 7

39.8

11.7

30%

32.9

29.5

13.14

�-11TABLE

III

SELECTION OF THERAPY IN PATIENTS
WITH PSYCHOTIC DEPRESSION

Yrs. of
Education

Foreign—
Born

F Score
SMean!

Age
SMean)

Electroahock
(N'Bl)

50.3

h8.6

10.6

1:253

Psychotherapy

h1.0

h7.6

10.0

2h%

GrouEs

(n-29)

SMean)___

%

�-12TABLE

:1

SOCIAL FACTORS AND DISCHARGE EVALUATION

F Score
SMean)

Age
gMean)

Yrs. of
Education
gMeanz

1 ForeignBonn

h2.9

Mus

10.7

Much Improved

39.0

35.6

11.2

22%

Improved

36.1

31.2

11.2

16%

31.2

13.2

11%

Recovered

h1%

(N-17 )

(n-82)

(N'63)

Uhimproved

(n-9)

31.1

�-13TABLE V

DISCHARGE EVKLUATION IN CONVULSIVE THERAPY

Yrs.‘of

F Score
sMeanz

Age
SMeanz

Education

%

Foreign-

SMeanz

Born

53.1

51.6

9.u

50%

(N-26)

h2.0

h3.8

10.6

35%

Improved and
unimproved
(Ni23)

39.7

32.3

12.3

12%

Recovered
(N-B)

Much Improved

�-m-

M
TABLE VI

LENGTH OF HOSPITALIZATION PRIOR TO ELECTROSHOCK
AND DISCHARGE EVALUATION

Recovered

Much

8:

Iﬂroved

Improved
U

raved

Groggs

Less than

32%

6 mos.

70%

30%

than 6 mos.

31%

59%

(n-Bh)
3

to

ms.

68%

3

(N-lO)

More

(N-13)

&amp;

�III:

9-29-58

-15-

Social Factors and Communication in Psychiatric Patients

II: Duration of Hospitalization

and Diagnosis

Just heard a presentation of factors associated with the
selection and results of treatments. I will next conéider the relation
You have

of these factors to length of hospitalization and to diagnosis.

It is

obvious that the length of time a patient stays in a mental

hospital is related to the particular function and philosophy of the
institution. In an institution such as Hillside Hospital which admits
only voluntary patients and emphasizes psychoanalytically oriented psychothe
In
limited.
particular
of
is
the
hospitalization
length
therapy,
montthin
16
from
complete
to
one
was
the
studied
the
population
range
L

months.
of
six
over
with
an
stay
slightly
average
hospital,

Several factors can.be postulated which might be related to the
duration of hospitalization. Since

it commonly takes less

time to produce

behavioral change with convulsive therapy than with psychotherapy, one
would expect to

find that the consulsive therapy patients are kept in the

hospital for the shortest period while the psychotherapy patients are here
longer. The data, as presented in Table VII, shows no significant difference
between the two groups.

If

anything, there

is a slight

tendency for

psychotherapy patients at Hillside to be institutionalized for the shorter

period.
A

second possible factor

is the severity of the patient's illness.

be
who
will
necessarily
more
intractable
those
are
that
patients
It
maintained in the hospital further to receive additional treatment.
Examination
demonstrates
shown
Table
in
VIII,
the
however,
as
data,
of
those
that while
patients hospitalized for the shortest period do have
may

be

�Much
and
Improved,
Recovered
of
of
ratings
incidence
discharge
a higher
and
chance
are not significant.
variation
within
a
differences
are
the

In the Hillside followhup study of Rachlin
there was no relationship

EELEE'

it

was

also found that

between discharge evaluation and length of time

in the hospital.
On the basis of the data and discussion presented by Dr. Pollack,
be
should
a relationship
there
that
hypothesis
advance
the
further
can

we

of
and
duration
hospitalization.
the
background
social
patient's
we
oriented
psychotherapy
psychoanalytically
With Hillside's stress on
would expect that those patients who are most like the therapists with regard
between a

to these factors.would be kept

The
the
period.
for
longest
the
in
hospital

data is presented in Table IX. Patients

shortest

who were

period had the highest F scores, were

hospitalized for the

oldest, had the fewest

Conversely,
born.
of
native
and
smallest
the
percentage
education
of
years
F
the
lowest
had
the
scores,
the
who
longest
the
in
hospital
were
those
of
and
smallest
the
percentage
education
of
most
years
youngest ages, the

foreign born. These differences are statistically significant.
In Table X a similar analysis is shown for only those patients
receiving electroshock.

Again, each of these factors

is related to duration

of hospitalization.
The same

results are obtained

psychotherapy only

is

when

the data of those patients receiving

While
XI.
shown
Table
in
as
analyzed separately,

F
low
have
Pollack
Dr.
scores, are
indicated,
as
these patients as a group,

electroshock
the
than
born
and
native
more
education
have
more
younger,

patients, there is

still

a significant difference within the group in the

the
time
in
hospital.
of
the
to
length
according
direction
predicted

�These same relationships of

social factors to hospitalization are

found even when the patients were subdivided according to

diagnosis. In Table XII the data is shown for the

in the hospital for each diagnostic group.

F

their final

score and months

The diagnoses were subdivided

into four major groups and include all but three patients in the population
studied. For each group there is a significant difference between those

in the hospital for the shortest and the longest periods, with those in
the longest having the lowest scores. Similar results are shown when the
data

is

analyzed

It is also

shown

for

each diagnostic group with respect to age (Table XIII).

for education (Table

schizophrenic patients

stay.

It

who were

who

XIV), with the exception of the

had about the same education

for each length of

should be noted, though, that many of the schizophrenic patients

here for ten months or more were quite young - around 16 or 17,

and so did not have the opportunity to receive education beyond the middle

of high school.
Analysis of place of

hospitalization is

shown

is associated with a

birth for
in Table

each diagnostic group and length of

XV.

marked decrease

Increase in length of hospitalization

in the

with the exception of the schizophrenics,

number

who

of foreign born, again

as a group, had very few such

persons.
The

previous tables have indicated that not only

is there

a significant

relation between each of the social factors studied and length of
hospitalization, but that there are large differences between the diagnostic
groups themselves, even when comparing patients with the same period of

hospitalization.
in Table

XVI.

The summary

It is

data comparing the diagnostic groups

is

shown

clear that patients diagnosed as involutional psychosis

�have the highest F scores, the

oldest ages, the least years of education,

highest incidence of foreign born. In contrast, the schizophrenics
have the lowest F scores, were the youngest, had the most education and the
and the

of foreign born. The manic-depressive and psychoneurotic
involutionals
the
to
closer
with
the
manic-depressive
between,
in
patients fell

least

number

like the schizophrenics.
relationship between these social factors

and the psychoneurotics most

This marked

and diagnosis

is not surprising. Certainly the relationship of age and diagnosis is an
established concept in clinical psychiatry. In the involutional disorders
and
What

names themselves have a chronological conndstion.

in dementia praecox the

is

unexpected, however,

is that

age should also be

related to the

and
that the
and
disorders,
psychoneurotic
of
manic-depressive
diagnosis
other social factors of education, place of birth and F score should

in
this hospital.
the
diagnostic
major
groups
differentiate
all
significantly
we have postulated two hypotheses to account for these relationships.
The first is based on the fact that persons from different social backgrounds
acquire different habitual
and expression.

modes

of adaptation and patterns of communication

Accordingly, under conditions of stress, damaged brain

function, or other etiological conditions associated with the onset of
mental illness, a person will show those behavior patterns or symptoms

his habitual patterns. Thus, a person from
background
communicate
in nonsverbal,
to
more
lower
apt
social
class
is
a
do
so in
to
more
while
class
people
likely
are
physical terms,
upper

which are of the same type as

ideational and verbal terms. Thus, anger

may be shown by

lower class

people by physical violence, while those from upper classes are more
and
Redlich
Hollingshead
exhortation
argument.
to
to
or
resort
likely

�-19-

have noted

that these differences

among

people of different classes lead

to different psychodynamic patterns in psychoanalytic terms. Thus, aggressive
and sexual behavior

behavior

variation

is

is restricted
among

more acceptable
among

to lower class parents, while such

the upper classes, lending to considerable

the different social classes in superego development.

Irish

Italian patients who were diagnosed
as schizophrenic in a V.A. Hospital, found significant differences in their
types of symptoms related to cultural differences in their family backgrounds.
Patients coming from Irish families in which active expression of emotions
Marvin Opler, studying

and

were frowned upon and with dominant over-protective mothers, were

passive,

compliant and withdrawn, and fearful of anything which might separate them
from the protection of the

hospital. Patients with Italian family backgrounds

that encouraged free expression of
showed

were

assaultive

and

emotion and were ruled by a dominant

destructive behavior, were difficult to

father,

manage and

rebellious against authority.
In a comparable study Miller and Swanson have also noted that

hospitalized schizophrenics exhibit significant social class difference

in symptomatology - lower class patients showing "motoric themes," while
middle class patients exhibit "conceptual or ruminative themes."
According to our hypothesis, then, we would expect

lower social levels would show symptoms

sensory or motor patterns.

Among

that persons

from

that are non-verbal, expressed in

such types of symptoms would be psychomotor

retardation, anorexia, catatonic stupor, muteness, hysterical blindness or
paralysis. In this connection

it is noteworthy that hysterical

symptoms

have
been reported as
the army

far

men

more

frequent

among

enlisted

in

than

officers. In addition hysteria which was apparently so common in‘world.war
I was not nearly so notable in wbrld'war II, and, in fact, has been reported

�in the general population. This decrease, in our view, is
related to the general increase in educational level of the country as a
whole. If one finds a classical case of hysteria in New'York today, I

on the wane

Rican
be
immigrant
Puerto
the
in
likely
it
population who have the poorest socio-cultural background. (One cannot,
of course, ascribe the decrease in hysteria to a greater freedom in sexual

will

understand that

matters;

has

it is

shown,

most

most

common

in

more

poorly educated people who, as Kinsey

are least inhibited sexually).

In the laboratories at Hillside Hospital the investigations of persons
with depressive psychoses have been more intensive.

we have

noted a

common

of
lack
characterized
hy
these
behavior
of
in
people,
premorbid
pattern
imagination, creativity and introspective capacity, and by conventionality
and general rigidity. Similar patterns have been noted in a series of

studies of such patients by other authors.
background, such as

that involving

little

we

or

believe that a poor cultural

no

education, spending early

and
cultural
is
environment,
meager
resources,
in
a
illiterate
largely
years
conducive to the development of such a personality pattern. When mentally
disordered, such persons tend to react with a repertoire of behavior patterns

consistent with their background which
A

we

second hypothesis concerning the

term depression.

relation of social factors to

and
between
do
the
with
has
interaction
patient
to
diagnosis
psychiatrist.

this hypothesis a diagnosis may not be based on an actual
how
of
the
reflection
extent
a
to
but
behavior
great
is
a
pattern,
objective
psychiatrist perceives or identifies the patient. It has been noted frequently
that patients with similar symptoms will be differently diagnosed and treated
depending on their social class. For example, we recently studied three

According to

patients

who were

admitted with similar symptoms of depression, anorexia and

�insomnia.
who was

All three were referred for convulsive therapy.

One woman,

62, born in Russia, of limited education with an F score of 70,

was diagnosed as

involutional melancholia.

this country, with

The second, aged hS, born

in

an F score of 53 and a high school education, was termed

manic-depressive, depressed. The third, aged hh, also born in this country,
with an F score of 33 and a college education, was diagnosed as psychoneurosis,

reactive depression.
In conclusion, in the Hillside Hospital population social factors of
age, education, birthplace and F score are significantly related to the

selection and results of treatment, length of hospitalization and diagnosis.
These findings

illustrate the

importance of social factors in affecting

language and communication patterns and the nature of the interaction

patient and therapist. Current data, both from our own laboratory
and as reported in the work of others, indicates that psychotherapy is most
likely to take place with those persons who most closely resemble the therapists

between

in terms of cultural background and communication pattern. In Hillside, with
its emphasis on psychotherapy, it is clear that patients who best meet this

criteria are also keptthe longest. This is true for either patients
receiving convulsive or psychotherapies alone, and for all diagnostic groups.
In the evaluation of clinical improvement there may well be different
expectancies towards patients in terms of these social factors.
with
may

little

In a person

education and different modes of expression than ourselves,

we

regard, for example, the manifestation of denial as improvement. But

in a patient

much

like ourselves in cultural background, the

denial will be regarded as a defense and the patient

is

showing of

considered unimproved.

patient,himself, may have different expectancies not only in terms of
the type of psychiatric treatment, but for what constitutes improvement as well.

The

�believe also that the attitude of the patient's family may be crucial
in both the patient's and therapist's conception of what constitutes

we

improvement.

relation between social factors and diagnosis was interpreted in
affects
background
cultural
one's
that
indicated
was
First
ways.
it
The

two

the type and

and
accordingly
and
communication,
of
expression
symbolic
pattern

the possible type of

symptoms

a diagnostic statement

behavior pattern.

patient

and

is not

Rather,

it

that will be

shown.

Secondly,

we

believe that

simply an objective evaluation of a given

is

a reflection of the interaction of the

psychiatrist in relation to their respective cultural backgrounds

and modes of communication.

It is

between
mind
the
while
relationship
that
in
to
keep
important

social factors and the psychiatric aspects described is probably applicable
as a generalized principle, the specific findings may vary in different
For example, in a study using the F score at the

settings or institutions.

Boston Psychopathic Hospital, the same relationship to type of treatment
was noted as

in our report,

i.e.,

the electroshock patients had higher

scores than those receiving psychotherapy.

patients there, however,
patients

is

was higher than

Since the average score of the

at Hillside, their psychotherapy

had the same mean score as our electroshock cases.

Another example

the finding of Hollingshead and Redlich that schizophrenia

common

diagnosis proportionately

among

F

was a more

lower than upper classes, while at

Hillside the schizophrenics had the highest education. This discrepancy
two
of
the
in
composition
the
variation
be
accounted
by
for
can probably
middle
from
drawn
the
largely
being
the
Hillside
patients
populations,
lower
classes.
social
few
from
the
or
with
upper
relatively
groups

�-23-

In Hillside the diagnosis of schizophrenia

may

indicate an "interesting"

same
diagnosis
the
population
while
State
Hospital
in
a
patient,

may

represent a "hopeless" patient.

It

be
tested
to
studies
these
by
raised
remains for the hypotheses

In
involved.
the
psychological
of
processes
studies
and for further
interaction.
communicative
of
studies
on
been
working
have
particular we
Some

Dr.

of the details

Jaffe.

and findings of

this

work

will next be presented by

�DURATION OF HOSPITALIZATION AND TYPE OF TREATMENT

in Ho§ita1

Months

Treatment Grog-pa

1

-

5

6

-

9

10 or more

Electroshock (S?)

26%

30%

M453

Psychotherapy (102)

32%

he}!

25%

" 5.73
df " 2

(3112

p

-

N.S.

�-25TABLE

VIII

DURATION OF HOSPITALIZATION AND DISCHARGE EVALUATION

Discharge Evaluation
Months

in

Hoggital

Recovered or
Much Iggroved

Improved or

raved
EM

1-5 (h9)

69%

31%

6-9

55%

15%

52%

148%

(624)

10 or

more (58)

Chi2

df

p

-

3-83
2

N.S.

�- 26..
TABLE IX

DURATION OF HOSPITALIZATION AND F SCORE, AGE, EDUCATION
AND PLACE OF BIRTH

in Hogi‘bal

Months

91-192

-

9
{bl-6h}

10 or more

133.9

10.5

31.0

Mean
Age

145-5

32-5

27 .9

Years
Education

10.0

11.9

12.8

W

19%

10%

1

ean
F Score

M

Mean

5 Foreign Born

-

5

6

ski-582

�-27TABLE X

DURATION OF HDSPITALIZATION AND

F SCORE, AGE, EDUCATION

AND

PLACE OF BIRTH IN PATIENTS RECEIVING ELECTROSHOCK

Months

in Hogaital

-5
pm 52

6

Mean
F Score

58.2

h5.6

3h.9

Mean
Age

51.7

h2.2

32.1

6.5

12.3

13.2

67%

2h%

16%

1

Mean.Years

Education

%

Foreign

Born

-

9
551-172

10 or more
531-25 2

�DURATION OF HOSPITALIZATION AND F SCORE, AGE, EDUCATION
AND PLACE OF BIRTH IN PATIENTS RECEIVING PSYCHOTHERAPY ONLY

in HogEital

Months
1

-

S

6

-

10 or more
gN-262

SN‘BB}

9
SN-hB!

Mean
F Score

h0.2

38.6

27.8

Mean
Age

[‘3 c 2

29 o 1

2,4 0 8

11.1;

11.7

12.1:

Mean Years

Education

%

Foreign

Born

30%

16%

8%

�W
TABLE

MEAN

F

XII

OF
DURATION
TO
ACCORDING
GROUPS
DIAGNOSTIC
SCORES FOR

HOSPITALIZATION

Months

Diagnostic

in Hoggital

3;;

L2;

58.2

50.9

35.0

Manic Depressive

h0.02

h6.1

33.1

Psychoneuroses

h0.05

36.6

36.1

Schizophrenia

36.3

38.5

27.6

Greg
Involutional Depression

10 or more

K

�-30TABLE

MEAN AGES FOR

XIII

DIAGNOSTIC GROUPS ACCORDING TO DURATION OF HOSPITALIZATION

10 or more

Diggggstic Gregg

3L;§L

£1;;2_

Involutional Depression

58. 8

5h. 5

52. 3

Manic Depressive

h6.8

39.1

35.5

Psychoneuroses

141.0

27 .1

27.1

Schizophrenia

27.8

27.8

214. 1

�.31TABLE XIV

W

OF
DURATION
TO
ACCORDING
GROUPS
DIAGNOSTIC
FOR
EDUCATION
MEAN YEARS OF

HOSPITALIZATION

Months

in Hogaital
10 or more

1;;;§

51:113

7.1

9.6

16.0

11.0

11.7

12.3

Psychoneuroses

8.7

12.5

12.5

Schizophrenia

13.3

12.3

12.9

giggnostic Groggs

Involutional Dapression

Manic Depressive

�-3 2..
TABLE Lv

OF
DURATION
TO
ACCORDING
GROUPS
DIAGNOSTIC
BORN
FOR
FOREIGN
PERCENTAGE
HOSPITALIZATION

in Hogital

Months

Digestic

Grougs

_1__-_§

6

-

9

10

or more
0

Involutional Depression

57$

113%

Manic Depressive

39%

23%

0

Psychoneuroses

50%

19%

13%

Schizophrenia

10%

8%

12%

�TABLE XVI

DIAGNOSIS AND F SCORE. AGE: EDUCATION AND PLACE OF BIRTH

Dialysis
Involutional
Depression

Mean
F Score

'

Mean
Age

Mean Years

Education

%

Foreign

Born

{NI-21:2

Manic Depressive
(NI-322

Psycho-

' neuroses

Schizophrenia

(Iv-372

$31-68)

52.3

140.8

36.9

32.8

56.7

1:1.9

29.1;

26.1

8.9

11. 5

11. 9

12. 7

146%

26%

22%

10%

�-313-

Relationship:
Patient-Doctor
the
on
Effects of Social.Factors
Setting
Interview
Observations in an

illustrate
will
I
In this report

how

discussed
factors
the social

hypothesis
Our
interview.
clinical
the
in
ommunication
c
affect
morning
this
and
mmunicate,
can co

that this is

why

treatment.
results of psychiatric

and
choice
the
to
relevant
they are

One way

to test

would
hypothesis
such a

actual
an
in
events,
important
psychodynamically
that
he to demonstrate
such
as
age,
factors
to
related
significantly
are
setting,
interview

of
a
study
the
be
might
A
step
first
and.F
score.
education, nativity
communication
of
kind
the
of
representative
which
is
event,
defined
clearly
psychotherapy.
to
relevant
that is

The phenomenon

pattern.
communication
such
one
with
deals
This report
e—recording
tap
the
mentioned
explicitly
the
patient
no
whether
or
studied is
may bear upon
transaction
spontaneous
This
interview.
during an experimental
and
interviews
rimental
in
expe
develops
which
transference situation

t

the

well.
as
in psychotherapy
METHOD:

The

clinical

setting in

which the observations

we re made was an

initial

of
patients
edure
proc
screening
the
of
interview. This was part

interviews
All
hospital.
this
in
therapies
sive
convul
and
referred for drug
the
during
Psychiatry,
imental
Exper
of
Department
the
in
were performed
was
It
tests.
psychological
and
physiological
of
battery
week as a
to
asked
was
The
patient
and
patient.
doctor
the
of
the first meeting
was
procedure
unstructured
generally
and
a
about his difficulties,

tell

�.35followed. The purpose was to get an impression of the patient's communication

patterns,

and

to secure a tape recording of the interaction.

Several months ago,

that the interview

it was

noted that some patients mentioned the fact

was being tape—recorded, whereas

nothing about the procedure. Since that time,

recorded

this data at the conclusion of

I

other patients said

have

each session.

systematically
In addition, the

following experimental structure was purposely introduced.
A

Tanberg tape-recorder was prominently placed beside the desk

which the interview took place.

This instrument was turned on Just before

the patient entered the room, and was clearly in his line of vision.
was about

at

It

the level of the desk, at a distance of about seven feet from

the patient's chair. The red neon glow bulb, the revolving reels of tape,
and the operating noise of the machine could all be observed. An unconcealed
mire ran directly from the instrument, across the desk, to a microphone which
-

lay in clear view between doctor and patient. However, the interviewer
no mention of

by the

made

the recording set-up unless the subject was introduced verbally

patient.

OBSERV£IION33

Since

this experimental structure

have been recorded.
17

was

introduced, 31

initial

interviews

The

tape-recording was mentioned by 1h patients, while
others made no such observation. They will henceforth be referred to as

the "Mention" and

No

Mention" groups respectively.

a) Qualitative: The patients

variety of attitudes.

who

mentioned the recording expressed a

The most common was

curiosity, with inquiry as to the

purpose of the interview, and the use to which the recordings might be put.

�-36A

minority expressed overt suspicion, either refusing to proceed with the

interview for several minutes, or voicing their fears of humiliating or
incriminating uses which might be

did'nt

know

the room was bugged."

made
A

of the recordings.

One

patient said, "I

physician in this group of patients

requested that the recorder be turned off for a

moment so

that

he could ask a

question as a colleague, "off the record." After a spontaneous mention of the

to explore the attitude underlying the remark.

recording, an attempt was

made

This varied from definite

hostility

and suspicion, through mild objection and

uneasiness, to passive acceptance of the procedure. Only one patient expressed

delight, saying, "I'm glad this is being recorded,
In addition to these subjects

who

it's

like a confession."

explicitly mentioned the recording,

patient is included in the "Mention" group.
to the microphone, shook her head as

if

She

one mute

pointed to the recorder, then

to say "no," and covered her mouth

with her hand.

In the

"No

Mention" group, non-verbal recognition of the recording was

often apparent. Most of the patients looked repeatedly at the recorder and
microphone , sometimes
up

furtively. Several of

them

actually touched or picked

the microphone while speaking. I accompanied one patient back to the ward

following the interview, and while chatting in a lighter vein she asked
way, was

that all recorded?"

that the

ﬂNo-mention" group was aware of the recording.

"By

the

Thus there was considerable non-verbal evidence

Quantitative:
Quantitative data for the "Mention" and
Table-XVILIt

is apparent that the

group

"No—mention" groups

is seen in

explicitly remarked about the reabout 20 years. They were also better

who

cording were younger, on the average, by

educated, and with only a single exception were native born.

They had a lower

score on the F scale and I tended to spend more time with them. All the

differences between the groups are statistically significant;

�.37-

TABLE

MENTION

XVII

NO MENTION

53121:).

N=17)

26.7

h5.2

1h.1

p&lt;

.002

10.9

P&lt;:

~02

93

53

I&gt;&lt;:

.05

F SCORE

3h.1

11702

DURATION OF
INTERVIEW (minutes)

39.6

2900

AGE

(years)

EDUCATION
%

(years)

NATIVE BORN

p‘&lt;:’ .05

�DISCUSSION:

Using a

single objective index, 3:2. an overt statement about an

unexpected experimental procedure, two patterns emerge from

patients.

The group of

this

group of

subjects mentioning the recording have the

same

sociological characteristics as those patients from the total Hillside
Hospital population

are treated by psychotherapy alone. They are

who

less

younger, have some college education, are native born, and are

stereotyped in their attitudes. They mention the experimental procedure

in a challenging

way.

Gill,

Newman

and Redlich have described the anxiety-

producing effects of tape-recording psychiatric interviews. This group of

patients meet the stress by verbalization of their subjective reactions.
talk about it, ask questions, object, 222.
The group who do

not mention the recording have the

same

They

sociological

wharacteristics as those patients in the total Hillside Hospital population
who

are typically referred for electroshock

(i;g.

non-venaal therapy) or are

hospitalized for the shortest period. They are older, have at most a high
school education, are more likely to be foreign born, and are stereotyped

in their attitudes as measured by the

F

scale. These patients

the procedure overtly, although they notice
the doctor, whatever you

do

is justified

their compliance

and

what to say, but

I'll be glad to

it.

Their attitude

do

not question

is

"You

are

and should not be questioned."

In

vauiescence they resemble surgical patients who submit
themselves passively to treatment, neither resisting nor actively participating.
When asked to tell about themselves their attitude often is, "I don't know
The "Mention" group

They do

answer any questions you may ask."

display a different attitude toward the therapist.

not treat the physician's procedures as completely outside their

�-39-

verbalize their resistance, and express their negative
feelings directly to the interviewer. The "mention" reaction indicates

jurisdiction.

They

curiosity and the skepticism that Freud felt

was

required of the analytic

patient. In discussing this point, Fenichel notes, that if the patient
"is not skeptical at all, the suspicion is warranted that he is repressing
negative transferences."

It is

not surprising that the interviewer, with

a psychoanalytic orientation, spent about 10 minutes longer with the "mention"
group.

This study demonstrates, then, that these sociological factors

may

be

related to actual differences in the quality of patient-doctor relationship.
In this one limited aspect of the communication pattern, the sociological
background allows us to predict whether the

patient will verbalize his reactions

or not. If this single stress situation is representative of the general
behavior in psychotherapy,

we

can get some notion of why these

related to choice or length of treatment.

'we

factors are

expect that patients

who

decline to mention such an obvious situation as a microphone and tape-recorder,

will be equally loathe to express the variety of feelings about the therapist
which are crucial for analysis of transference.
Further studies of the data are in progress which may increase our
understanding of the observations reported. For example, a detailed content
analysis of the

way

in which the recording

deviant cases.

Two

of these have already been described.

patient, with high

F

score,

who

was mentioned sheds

light

upon the

One was an

older

in contrast to the usual pattern of such

persons, did mention the recording. Hewever, he differed from the other

older patients in having a medical education.

His way of mentioning the

�-h0

-

recording was to suggest a change in the interview from that of doctorpatient to that of colleagues speaking "off the record." One is tempted
to predict the form of his therapeutic resistances from this event. Another
patient mentioned the recording,but in an unusual way. She was delighted
with the "confessional" aspects. In her sociological characteristics, she
too did not fit a clear pattern, being in her 20's, but with a high F
score.

It is

to be noted that she was an ex-Catholic.

Other studies of the psychiatric interview, using experimental stresses
more characteristic of psychotherapy, furnish additional evidence of the
importance of sociological factors. For example, Saslow and Matarozzo

research on psychotherapeutic communication.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67454">
                <text>Max Pollack, Robert Kahn, and Joseph Jaffe: Social Factors and Communication in Psychiatric Patients (research), 1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67455">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67456">
                <text>mfp-03-01-002-11-012</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67457">
                <text>1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67458">
                <text>Pollack, Max; Kahn, Robert L.; Jaffe, Joseph</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67459">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67460">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67461">
                <text>Research papers, files, and related correspondence: research with Joseph Jaffe, Robert L. Kahn, and Max Pollack</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67462">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67463">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80948">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87509">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94070">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100631">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6747" public="1" featured="0">
    <fileContainer>
      <file fileId="6545">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/c8041bb911b27dd176a67a53d9ba080c.pdf</src>
        <authentication>51e8ec2d2ba520c72d5afb41bd417d27</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107150">
                    <text>Prognostic Application of Psychological Techniques in
Convulsive Therapy

Robert L. Kahn Ph.D. and

From

Max

Pollack Ph.D.

the Department of Experimental Psychiatry, Hillside Hospital,

L.I., N.Y.
Aided, in part, by grants M-927 and MY-2092 of the National
Institute of Mental Health, National Institutes of Health, U.S.
Glen Oaks,

Public Health Service.
Read at the Eastern Psychiatric Research Association,
October 25, 1958.
IV: 10-2h-58

New

York,

�Prognostic Application of Psychological Techniques in
Convulsive Therapy
One

of the more important

clinical applications of

psychological testing techniques is the prediction of the
has
there
In
treatment.
in
particular,
results
psychiatric
been a considerable effort to determine valid psychological
The
to
results
somatic
the
for
therapies.
criteria
prognostic
date, however, have not found clinical acceptance.
Using the Rorschach, for example, Rabin (1) has stated
that ”single Rorschach factors cannot serve as indices or as
has
Piotrowski
In
contrast
of
improvement."
predictors
published a number of papers on the prognostic use of the
Rorschach in insulin coma and convulsive therapy (2, 3, h, S, 6).
Unfortunately, his criteria, as reported in successive papers,
are vague and contradictory. In l9h1 he reported six explicit
prognostic signs which were applied in predicting clinical
months
the
termination
of
several
after
a
over
period
response
of treatment. But Rees and Jones (7), in a study of schizophrenic
found
somatic
that
of
a
therapies,
receiving
variety
patients
Piotrowski's signs were related to the results on a chance basis
only.
The differences in the studns of various investigators
can be accounted for by methodological variables. These
variables include factors of population, number of patients
observed, the method of analyzing data, the kind of somatic
therapy utilized, and the criteria for evaluating improvement,

�-2made
in
evaluation
is
which
the
clinical
time
the
at
including
incon—
Another
for
basis
treatment.
of
relation to the course
sistent results may be the lack of an adequate theretical
framework.

in
been
have
we
engaged
several
years
past
These
were
studies
convulsive
of
therapy
the
process.
studies
mode
action
of
the
concerning
a
to
hypothesis
test
initiated
of convulsive therapy which was derived from observations on a
hypothesis
of
the
to
brain-damaged pepulation. According
Weinstein and Kahn (8, 9) the therapeutic effect of convulsive
function
brain
of
altered
the
induction
to
therapy was related
of
symbolic
a
new
type
for
conditions
the
creating
necessary
adaptation, mainly denial, in characterologically disposed
shown
altered
that
have
Our
already
studies
previous
persons.
change
behavioral
for
condition
a
function
is
brain
necessary
(10, 11) and that the manifestation of denial language patterns
with treatment is related to the evaluation of improvement (12).
The purpose of the present report is
l) to summarize the
the
and
demonstrate
2)
to
on
personality factors,
findings
application of these findings as prognostic criteria for
convulsive therapy.
For the

�Method:

studies were conducted at Hillside Hospital, a
non-profit, voluntary, mental hospital, admitting patients
who are considered as having early and curable illnesses.
Psychotherapy is the principal treatment employed, with
somatic therapies available when needed. The material presented was collected in a series of studies during a period of
three and a half years. While a total of 180 patients have been
investigated, varying numbers were tested with each of the
techniques of personality evaluation. The patients ranged in
age from 20 to 66, with a median of hS, and included twice as
These

many women as men.

All patients received convulsive therapy administered
three times a week, using either a Medcraft alternating current
instrument or a Reiter C-h? electrostimulator. A minimum of
12 treatments was given, with the total course determined by
the supervising psychiatrist in charge of the convulsive therapy
unit. All psychological procedures were adminstered in the
week prior to the start of treatment.
The determination of the patient's response to treatment
was based on the medical director's evaluation at the time of
discharge, usually within six to eight weeks following treatment.

�Procedures and Results:
1.

Family Interviews.

According to the original

theory, it was considered that persons showing characteristics
of the "explicit verbal denial" personality, as described by
Weinstein and Kahn (13) would be most likely to show a behavioral change rated as improvement following treatment. This
was tested in a standardized interview with members of the
patient's family, eliciting information on the patient's
attitudes, mode of communication and reactions to stress.
Fifteen areas of behavior considered to be related to denial
tendencies were scored from the interview material. A score
of O, 1 and 2 was given for each item, depending on whether
the designated behavior was minimally, moderately or markedly
shown. The sum of the scores thus obtained was used as the
denial score.
The relatives of h? patients were interviewed, and
denial personality scores ranged from O to 25, with a median
of 11. The patients were divided into two groups: those with
scores from 11 to 25 were classed as "high denial," and those
from 0 to 10 as the ”low denial" group.

results of this analysis were significant, showing
that of the patients with high denial scores, 58% were in the
much improved group and only one patient was unimproved. Of
the patients with low denial scores, on the other hand, only
The

30%

were much improved and an equal number were unimproved (1h).

�-5-

results based on family interviews
felt that our conceptions of prognostic

Although these
were promising,

we

personality factors could be extended and made more amenable
to practical application by the use of standardized psycholog-

ical procedures.
For this purpose the Rorschach test
2.

The

Rorschach Test:

We

used.
have obtained Rorschach
was

protocols in 87 patients receiving convulsive therapy. The
&amp;
of
the
to
records were scored according
Klopfer
criteria
Kelley (15). Only those components were analyzed which were
considered related to the personality aspects under study.
It was found (16) that the much improved patients had

significantly fewer total number of responses, and a significantly
greater per cent of whole and form responses than did those
The
who
rated
as
unimproved.
were
stereotypy and
patients
limited imaginative capacity of the much improved patients
was also shown by their giving a greater percentage of popular
responses, with little diversification of content categories.
They were less likely to have any kind of shading response.
Those patients who had human movement (M) responses had the
poorest clinical responses, while those with no movement of
any kind had the best results. With respect to color, an F6
response was associated with a poor clinical result, while those
with no color at all did very well.
Combining some of these factors tended to sharpen the
differentiation in terms of outcome. Thus, of those who had

�.6.
In
much
improved.
as
rated
both
M
much
66%
improved
FC,
were
with
nor
neither
those
of
contrast,
and only one patient was unimproved.
We have converted these results into prognostic criteria,
M

and FC, only

as shown

in Table

I.

17%

In one column are

listed those

Rorschach

closely related to a favorable
In the other column are those factors which are

factors which have been
prognosis.

were

most

For
example,
outcome.
unfavorable
clinical
of
an
prognostic
67%
much
were
of those patients with ten or less responses
16
more
with
or
those
of
28%,
responses
however,
Only
improved.
had a good

result.

�TABLE

I

Prognostic Rorschach Indices of ImErovement
Favorable Prognosis
%

Unfavorable Prognosis

Much

%

Ingroved

Improved

of Responses

Number

Movement

Color
F

and

FC

less

(67%)

16 or more

(28%)

present
present

(28%)

None

(63%)

M

No FC

(60%)

FC

-

75

a:

Shading
M

10 or

~

100

None

Much

(21%)

(59%)

o - 59

(27%)

(58%)

Present

(33%)

Neither Present

(66%)

Both Present(17%)

�’8-

It

should also be noted that comparison of post treatment

Rorschach records with those obtained prior to treatment failed
to show any significant change. This confirms similar observa-

tions by others (6, 17, 18, 19) and indicates that the Rorschach
pattern is probably a reflection of the basic personality rather
than transient aspects of the disease process.
3. Social Attitudes: The F Scale. While these Rorschach
results amply confirm the concept of the relation of personality
factors and results of treatment, further data was obtained in
application of measures of social attitude such as the California
F Scale.
This scale, originally developed in studies of ethnOa
centrism and authoritarianism (20) has been increasingly used
in the study of more central psychological processes. In our
laboratory the F Scale has been regarded primarily as a reflection
of stereotyped thinking and communication. It has been observed
that patients who receive convulsive therapy at Hillside Hospital
P
scores than those given psychotherapy
higher
significantly
alone (21).
In these studﬂs a ten-item modification of the F Scale
(22) has been used. The test is rapidly administered, taking no
longer than 10 minutes in most cases. The subject reads 10
ambiguous statements and indicates whether he agrees or disagrees
with each statement, and to what extent. The score given for
each item ranges from one to seven and the range of total scores
is 10 to 70. The greater the agreement, the higher the score

have

�-9-

statements themselves are extreme, conventional
or stereotyped expressions. For example, one of the statements
is: "If people would talk less and work more, everybody would
obtained.

be

The

better off."
This

test

patients prior to
score of ho as a cut-off point,we

has been given to 96

convulsive therapy. Using a
found that of those patients with scores of ho or more 71% were
rated as recovered or much improved. In contrast, only 36% of
those with scores below ho were so rated. In general, the

higher the score, the better the clinical result.
We have also tested an additional 13 patients, referred
for convulsive therapy, but who either refused treatment or
terminated it of their own accord prior to completion. Of
these, eleven had F scores below ho, an observation consistent
with the general expectation that such persons haVB a poor
response to convulsive therapy.

�-10-

Discussion:
These observations have shown

that in the course of the

investigation of theoretical problems of convulsive therapy,
certain standard psychological procedures have provided data
which is significantly related to the therapeutic outcome. This
data can now be applied to the practical problem of clinical
prognosis.

that

favorable improvement rating is given
to those patients who develop euphoric, hypomanic or denial modes
of adaptation following treatment (23). Such behavioral change
is most likely to occur in persons whose premorbid personalities
may be characterized as non-empathic, non-introspective, nonverbally communicative and highly conventional and stereotyped
with little imaginative or creative capacity (1h). On the
Rorschach prior to treatment these patients give few reaponses,
fail to show human movement, shading or integrated color responses
(F0) and have little variety of content. 0n the F Scale, their
scores were apt to be over b0, showing a high degree of stereotypy in their communication.
In contrast to such patients, others are either unchanged
by convulsive therapy or develop such modes of reaction as panic,
paranoid behavior, or increased somatic concern, such as
We

have found

a

complaints about their memory. These patients are rated as
unimproved. While this latter group of patients showed diverse
patterns in their premorbid personality characteristics, they
were more apt to be imaginative, introspective and less stereotxnd
in their communications. On the Rorschach they gave human

�-11movement, integrated color and shading responses, and were more
On
good
than
the
prognosis patients.
diversified in their content
the F Scale their scores were most likely to be under ho.

finding that meaningful prognostic criteria can be
derived on the basis of personality constellation rather than in
terms of nosological entities has important implications. For
one thing, this conception leads to the use of further psychologSuch
application is
for
prognostic
ical techniques
purposes.
laboratory
Secondat
Hillside
under
in
Hospital.
our
way
currently
mental
of
increased
an
understanding
derive
to
is
possible
ly, it
disorders, their management and prevention. Thus, we have previously noted (1h) that the same personality factors which are
related to a good prognosis with convulsive therapy, are etiologof
of
psychiathe
certain
types
development
in
important
ically
tric disorder. Studies of patients with psychiatric depression,
for example, demonstrated a prominence of premorbid personality
patterns characterized by the inability to communicate verbally
(2b), and rigidity and lack of imagination (25). Such persons
and
verbal
conventional
to
techniques
are generally refractory
require non-verbal therapeutic techniques. It seems that the
same personality factors which make a person responsdve to nonverbal forms of therapy are involved in his susceptibility to a
depressive reaction. The same stereotypy and conventionality
which lead to a catastrophic response in the individual faced by
the sudden loss of a job or close relative, permit the develop-. t
ment of denial, minimization and displacement under the conditions
of altered brain function and are considered "improved" by the
family and the therapist.
The

�-12-

that in the course of investigation of
theoretical problems of convulsive therapy, certain standard
psychological procedures have provided data which is
significantly related to the therapeutic outcome. This data
can now be applied to the practical problem of clinical
We

have shown

prognosis.
On the Rorschach test, those patients without human
movement, shading or integrated color (FC) responses, few

total responses,

and with

little originality

or variety of

content have the best prognosis. On the F Scale, a score of
less than no is prognostic of a poor clinical reaponse.
The theoretical conception developed in these studies
leads to the application of additional psychological techniques
for prognostic purposes, and to an increasing understanding of
the etiology of psychiatric syndromes with its implications
for management and prevention of such disorders.

�-13-

W
REFERENCES

1.

Rabin, A.I.: Effects of Electric Shock Treatment Upon
Some Aspects of Personality and Intellect, Am. Psychol.
23 28,4,

19b7o

5'1

Rorschach
the
of
Possibilities
Z.:
Prognostic
Piotrowski,
Method in Insulin Treatment, Psychiat. Quart. $3:
679, 1938.

3.

Piotrowski, Z.: Rorschach Manifestations of Improvement
Med.
Psychosom.
in Insulin Treated Schizophrenics,
508’ 1939.

6.

l:

A
the
Device
for
Experimental
Z.:
Single
Piotrowski,
in
Prediction of Outcome of Insulin Treatment19h0
Schizophrenia, Psychiat. Quart. lg: 26?,
Aid
in
Method
a
Prognostic
Rorschach
as
2.:
Piotrowski,
the Insulin Shock Treatment of Schizophrenics,
19h1.
807,
Quart.
lg:
Psychiat.
Effects
N.D.C.:
Z.
and
Lewis,
Piotrowski,
B.L.,
Pacella,
of Electric Convulsive Therapy on Certain Personality
10h:
Am.J.
in
Psychiat.
Traits
Psychiatric Patients,

83, 19h7.

An
Rorschach
of
the
A.M.:
Evaluation
Jones,
Test as aPrognostic Aid in the Treatment of
Coma
Therapy, Electronarcosia
Insulin
by
Schizophrenics
&amp;
Leucotomy, J. Ment. Sci.
Therapy
Electroconvulsive

Rees, W.L. and

21:681, 1951.
Weinstein, E.A., Linn, L. and Kahn, R.L.: Psychosis During
Electroshock Therapy: Its Relation to the Theory of
Shock Therapy, Am. J. Psychiat. 109: 22, 1952.
Weinstein, E.A. and Kahn, R.L.: Denual of Illness:
Symbolic and Physiological Aspects, Springfield, Ill.
C.C. Thomas, 1955.

10.
11.

12.

of
M.
E.A.:
Relation
and
Weinstein,
Fink,
R.L.,
Amobarbital Test to Clinical Improvement in Electro&amp;
1956.
23,
Neurol.
Arch.
shock,
lg:
Psychiat.
EEG
M.
of
Delta Activity
and
Relation
R.L.:
Kahn,
Fink,
to Behavioral Responses in Electroshock: Quantitative
&amp;
1957.
516,
Neurol.
Arch.
Psychiat.1§:
Serial Studies,

Kahn,

Kahn, R.L. and Fink, M.: Changes in Language During

Electro-

shock Therapy. In Psychopathology of Communication,
&amp;
New
Grune
York,
Roch, P. and Zubin, J. Eds.,
Stratton, 1958.

�~1h—

13.

Factors in
Weinstein, E.A. and Kahn, R.L.: Personality
&amp;
Neurol.
Arch.
Denial of Illness,
Psychiat. Q2:
355, 1953.

Personality Factors in Behavioral
Response to Electroshock Therapy, Conf. Neurol. (in
press).

Kahn, R.L. and Fink, M.;

New
The
Rorschach
D.:
Technique.
Kelley,
Klopfer,
York, World Book Co., 1§E§.
Kahn, R.L. and Fink, M.: Prognostic Value of Rorschach
Criteria in Clinical Response to Convulsive Therapy.
Paper read at Electroshock Research Association
meeting, San Francisco, 1958.
Beck, S.J.: Effects of Shock Therapy on Personality as
Shown by the Rorschach Test, Arch. Neurol. &amp; Psychiat.
ﬁg: h83, 19h3.
Kelley, D., Margolis, H. and Barrera, S.E.: Stability of
the Rorschach Method as Demonstrated in Electric
Convulsive Therapy Cases, Rorsch.Res.Exch. 5: 35, 19b1.

B. and

16.

17.

18.
19.
20.

21.
22.
23.

Kisker, G.W.:

A

Projective Approach to Personality Patterns

During InsulinéShock and Metrazol-Convulsive Therapy,
&amp;
Soc. Psych. 21: 120, 19h2.
Abn.
J.
Adorno, T.W., Frenkel-Brunswick, E., Levinson, D.J. and
New
The
York,
Authoritarian
R.N.:
Personality,
Sanford,
Harper, 1950.

R.L., Pollack, M. and Fink, M.: Social Factors in
the Selection of Therapy in a Voluntary Mental
HOSpital, J. Hillside Hosp. g: 216, 1957.
Levinson, D.: Personal communication.
Fink, M. and Kahn, R.L.: Behavioral Patterns in Induced
States of Altered Brain Function. Paper read at
Divisional meeting, American Psychiatric Association,
Kahn,

New

York, 1957.

.
A

a

A.

N

a__.....

..-

Cohen, M.B., Baker, R.G., Cohen, R.A., Fromm-Reichmann, F.
and Weigart, E.V.: An Intensive Study of Twelve Cases
of Manic-Depressive Psychosis, Ps chiatr , 11: 103,

195h.

.A-aL.......;.—..M.u

~.~

,
i

Hamilton,

D.M. and Mann, W.A.:

Hospital Treatment of
In Depression, Hoch, P. and
&amp;

Involutional Psychoses.
Zubin, J. Eds., New York, Grune

pp. 199-209-

Stratton, 1952,

j
5

E

t

i
2

1

s

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67464">
                <text>Robert L. Kahn and Max Pollack: Prognostic Application of Psychological Techniques in Convulsive Therapy, 1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67465">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67466">
                <text>mfp-03-01-002-14-013</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67467">
                <text>1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67468">
                <text>Kahn, Robert L.; Pollack, Max</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67469">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67470">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67471">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67472">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67473">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80949">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87510">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94071">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100632">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6748" public="1" featured="0">
    <fileContainer>
      <file fileId="6544">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/e7dc2fcb5fc19380588fec1c1d7b8cf6.pdf</src>
        <authentication>e4bf0125cc9cc7fe7c750dbacfa00dd7</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107149">
                    <text>�SOME EFFECTS OF A NEW PSYCHQTOQEN

IN BEFRESSIVE STATES

J. Mednna
Univereity of Illinoie College of
L. G. Ahood

A

and

L.

Hedioine

group of 3~R~snhetitnted piperidyl beneiletee have been

recently denonetreted to poseees peychotceieetic propertiee(l.2).
The N-nethyl-snpiperidyl beneilete, in doeegee of 5-10 mg
orally,
produced distinct auditory and visual hellucinatione in every
nor-e1 individual teeted. The hallucinations lasted for many
bears, and were accompanied by green distortion of visual perand by e confosionel etete corresponding to delirium.
ception
A nnnber of
subjects exhibited paranoid ideotion and ideee of
grandeur, while others suffered a conplete loee of contact with
the environ-eat, end frequently reacted to their hallocinetione.
When the toxic symptoee disappeared, the
experienced
ethecte
e
earked physical eeekneee for 10—24 honre, after which period they
regained their pro-experimental statue.
It see noticed, however, that some of the normal volunteer subJects developed a change in their heeic mood and drive. This
change usually appeared 24 to 48 hours after the phyeicel weakness
disappeared. The newly energies modulation of need can be characterized es slightly hypenenic end of increeeed drive. This
leet observation indicated that the drug night he naefnl in the
treatment of peychietric states in which the ontetending eyepton
ie a depressed need.
In the course of exonining the structureoaotivity relationships
of various congenere of the piperidyl beneiletee (3), it wee
found that substitution or e cyclopentyl for one of the phenyl
groups in beneilic acid considerably enhanced peychotogenie
potency end greatly prolonged the duration of action. The colu
pound, deeigneted JB-329', has the following structure:

Q
*-

{’

I

“2‘5

0

Ell/Q
- g

361

‘0

N-ethyl-B-piperidyl cyclopentylphenyl glycolate hydrochloride
This derivative also eeened to produce considerably more hyperend central etieeletion than did its beneilate congener.
ectivity
The present comnunicotion concerns the nee of J8~339 on psychi-

etric patients.

DB, one a 60-year-old eon, e
first
patient,
§5g3_ﬁgt_*:
ormer r cklayer, who had been hospitalized for the last ten
years. Exeeinetion revealed his caee to be one of eevere depres»
eion iith suicidal tendencies, ceoeed apparently by the necrotic

The

�.

7

.., .

t

V...

".7“ .........4. ,g-vvwmh . ”a...“

.

man.

w.- ...,..r.....,.......

r.” ..u._,..,,.,.—Y “any,” p,..r.._....~.w.....F—,

.»...

wwv.-.» an...“

...~.,v»,.,

.

"ﬁn y”...

wr—u-nrl’nu _,.,

V...

..W;.,..I.:.v...._.._..r*‘ 7..

reaction of his burned~out body to the insoluble probles of his
wife’s gsychotio illness. The patient eas given 12 as of 33-329,
and sit in an hour showed signs of confusion, drowsiness, ataxia,
and hypereflexia. A few hours later he began
hallucina~
having
tions, saa disoriented, extreaely restless, and beg nning to lose
contact with the environaent. Autonosic syaptoas were present
throughout, such as aydriasis, tachycardia, dryness of the south,
and muscular weakness. At the end of 24 hours, he seeaed con~_
siderahly less depressed, sailed, laughed, and was such sore
talkative, although he professed to be Just as depressed as he
was before the treat-ant. Psychological re-exaaination with the
Eduardo and Rorschach tests indicated a definite iaproveaent in
seed and general outlook, and although the depression still
existed, it seessd realistically based, and was considerably less
overehelding. The patient, hosever,.rofased to go back to his
psychotic wife, and was returned to a state hospital.
EP,
a
an
33~year-eld unaarried shite aan, coaplained
he,
0%..
o
extreee apathy, and a chronic spastic colitis.
spression,
He had quit his job over a year ago because of an increasing
depression, accompanied by feelings of inadequacy and lack of
desire to work. Psychological tests revealed his to be iasature,
with little or no effect, no signs of anxiety, and no insight
into his condition. He reacted to 10 ag of JB~329 in such the
seas manner as the previous patient, covering a tine-span of 18
hours. At the and of this period, he appeared very cheerful, and
of the depressed, haunted features of his face had disappeared.
all
He gave the iapression of a nan sell on the way to
after
recovery
a long illness. That ease day he indulged in a rather vigorous
gene of baseball, nixed, and talked freely with the other patients.
He adsitted feeling sore aggressive and exuberant, and expressed
a desire to go back to sort as soon as he was discharged. Psychological re~exaaination showed his to be sore responsive, less
inhibited, and his outlook less liaited. The patient was discharged two days after receiving the drug, and two days later
be procured a position, which he still retains after three aonths.
c
a
had
lea,
47-yearweld'aarried.aan,
a history
§%;f_§g‘_%l
0
ntera ttent depressions since 1953. He had been unable to
work during the past year because of the depression. at the ties
of his admission, he showed syaptoas of restlessness and extreae
agitation; he ens harassed by self-accusations and feelin of
guilt. Pro-therapy tests revealed an inadequate personal ty with
en extreaely passive dependence.on other people. The existent
anxiety and depressive features sore overlaid upon a longostanding
character disorder. The patient's response to 12 ng of JB~329
differed fro: the previous patients only insofar as the halluci»
natory episodes sere far aore vivid and of longer duration.
After 36 hours, the patient exhibited aarked increase in actor
activity and a draaatic iaproveaent in need. Psychological reexasination revealed that he was now able to express hopeful and
resolute attitudes toward the future, although he still had
little confidence in his ability to achieve the goals he envisioned.

�after being discharged,
which

he spontaneously erote a letter
were taken the following statements:
free
For your infor~
nation, ay progress has been good. I as working about [all tine
have gained-about ten pounds. ﬂy appetite is very good not.
as extremely grateful to you for what you have done.‘
Two weeks

...I
...I

who
a
54*yearuold
earried
sea
shite
eoaan
ap»
gagg_§g‘_3z each
older, and had been in a very severe depree~
pears very
sion for the last ten years. She had phobic paranoid reactions,
suicidal ideas, and hysterical attacks accoepenied by screening.
excessive crying, and other indications of desire {or attention.
Psychological exaninetion indicated an unsound personality strse~
tnre which scene to have been infantile even before the onset of
the present illness. The effects produced by 12 a; of JB~329 were
to those in the other patients. and lasted for 24 hours.
eiailer
The following day, she appeared more vivacious and nest of the
outward signs of her illness had disappeared. 0n the succeeding
day, she socialised for the first time with other patients, and
participated in occupational therapy activities. She seeaed‘sur~
prisingly cheerful, enjoyed her food, and appeared outgoing.
After three days, when her husband case to take her hose, she
reacted violently and relapsed into her previous condition. Her'
condition was apparently developing into a full—bloen psychosis.
Electroshock therapy was adninistered during the next week, and
although the patient showed improvement at first, she again relapsed into the previousaagiteted depressive condition.
No 5: KB, a 46—year-old shite-nnaerried resale with
Ca
paranoia delusions. was depressed and apathetic. She was
extra-sly
tense and anxious. and her grasp on reality was tenuous. Her
reaction to 10 a; of JB~329 see similar to that of the other
except that the hallucinations and disorientation lasted
patients,
up to 36 hours. Two days later, she appeared definitely anieated.
cheerful. and coegosed. When questioned about her past condition,
she replied, "I feel such more alert and don’t toel.depressed.
Strangely enough, this was one of the first things I noticed.
I feel new as it before the treat-ant I had been living in a [let
tee-dimensional eorld and I had sort of retreated into ayseli.
and nee, after this treatment, I feel I as out in the noraal
three-dioensional world. I feel such sore alive...I have lore
energy and enthusiasm.“ The patient resneed her work on the day
following.her discharge. She continued to shoe improve-ant during B
the next few weeks, although after one south-she appears to be
relapstng into her former state. She reported. however, that a
symptoms, which she referred to as a ”catatonic nightnere." a
condition during which sheeeeeaed to be conscious but was unable
to sore and which had existed for eany years before the treat—
aent, had coapletely disappeared and had not yet returned.
LCCT

'

DISCUSSION

Five cases have been presented which serve as pilot experiaents
in the application of the piperidyl bensilatee to patients
manifesting psychopathology. Of the five cases, the first and

�“-vv—l‘vrr‘vr‘n-I—vw—v'wvwbvu'

.V

‘1"N"x'-w-*,—-

meg-w,v—u—m- . mun—aw wr—
.

Wmuw‘aw—r

_..

wenhvvrv-"v'

Wham-1 rap. &gt;mvr-.-.—_—,WVgrnww.-m.n WK‘J'W‘ wm

~

wane—v -

.w u-‘nnw

-4the fourth can be considered eo experieentel ouccooeee but
therepeutic failures. These two particular ceeee have never
reepondod‘eell to any other for: of therapy, including electron
check and drugs.
In three case: (Noe. 2, 3, end 3) the single application of the
oxperiaentol dru; proved to he of therepeutic value. Cece: No.
2 and 3, who were unable to work for over e
before the oxyear
porieent, were able to do oo. Case No. 5, which is the neat
interesting of our small oxporieental group, wee working prior
to the experiment; but that petiont'e state-onto end our objective
observation are both indicative of the therapeutic effectivonoee
of the drug. Cece No. 4 proved to be a therapeutic failure with
reepect to the drug. but the patient aloe failed to recover
after electric convulsive trootnonte.,
All five canoe treated hed only one synptoa in cannon-~ooee
degree of doproeeion. The other most remarkable con-on feature
of cases No. 3, 3, 4, and 5 one an extreme infantile personality
which could not be expected to change after a eingle treatment
of whatever eort. If it were not for the fifth coco, where the
loot remarkable ohengee were produced, this drug, 38-329 and ite
con¢enere could be earmarked for the treatment of depreoeive
otateo only. In the fifth case, however, beneath the light
dopreeeion were deeper disturbances of thinking end perception
eluding superficial observation. In effect, ehe eee psychotic.
lhethor her perticular paranoid state ehoold be diegnoeod ae
latent eohieophrenie, effeltivo paychooie, or achieophroniforio beside the point. The ieportance of this case io that it
indicates some usefulness of the piperidyl benziletee in e
patient eith lurked perceptual and cognitive dieturbenooo.
There are a great nu-ber of questions uneneeered by thie proliainary experiment. Both the extent and duration of leproveaent
have not been fully aeeoeeod. It reneino to be detereinod
1) whether repelted adainietretion of the drug in hallucinogenic
doeeo would have produced a greater degree of improvement in the
eueceeefei canoe and total or partial leproveaont in the unseen
ooeeful fourth cone; or 2) whether the production of the poychotogonic etete ie necoeeery et oil to produce ieprovenent; or
3) if deily repeated small doses of the drug for an extended
time would have produced the care but clover iiproveoent. Both
the effect end proper doeege ochedule of e aeintonenco ascent
of JB-329 have yet to be determined. Finally, the proper field
of application of this drug in peychiatry ie in doubt. do for
co the cxporieentol results on nornel and pathologic etheoto
permit any conclueion, the drug would be epglicable to depree~
eive etetee. Our fifth case. however, reieee some slight hope
that JB-329 or related derivetivee night be useful in treating
the grove personality dieordere cocoonly diagnosed an albino.

,

-

a

phrenil.

L

of enticholinergic egonte in the treetaont of eohieophroeie
ie not nee. Forror and eo~eorkere (4) odainieterod very large

The nee

'10.!"me

�W

“u—wmumw—HWM‘ w ,

y:-

m ;«m«

mu, 7-"
v

mlm“

wﬂwnm—u‘u—w“ Imam. m... .. -.

. .r t i . a r n . -

_

_

i n. --'—-'-v&gt;-vv_uru'v

»

'I‘uﬂv-"vWO4‘m‘ &lt;‘AmevN’--ww z-ew11IUI'm—rl—I-

.5doses (up to 200 mg) of atropine intramuscnlerly to schizophrenics
seniteetinc eose degree of anxiety. [Such doses of atropine produced core; but nest of tho psychotogonic and stisuleting notions
achieved with JB—329 were absent. It remains to be seen whether
the besic eeoheniss ot-thooe tvo nodes of therapy is sisiler,
although our findings suggest that atropine is devoid of the
exceesive stimulating properties of JB~329. LSD—38,_enother
hellnoinogen, has been used therapeutically in treating psychotics,
lsrsely es en edJunct to psychotherapy or electroshock convul—

sions (5, 6).
With regard to the code of sction hardly more can be said than
that the substance has definite enticholinorgic properties, but
evidence thet the central ettect itself involved cholisergic
blocksde is locking (1, 3). The piperidyl bensiletes in smaller
doses produce facilitation of sotor neurons (Renshee cells) in
the lesbsr region of the cat‘s spinal cord, while larger doses
produced couplete inhibition (7). Acetylcholine is presumed
to be a mediator in Renshew cells which are believed to exercise
a generalized sup reesion in motor neurons innervating okeletel
soocle.v Kiseich ‘8) hes demonstrated en inhibition of electricel
activity in the reticular bulber forention of the rabbit with
2.5 eg/kg of JB~329. in contradictincticn to LSD, which in exci~
tetory. Such neurophysiologicel studies are merely prelisinsry
end. although they say oxplsin certain effects of the drug, such
es hyporrcrlexie. considerably more work of this sort releins to

be done.

clinical results with the drug are even more obscure, perticnlerly since the therepentic effects become apparent long
after the hellucinatione and autonomic sysgtoss have disappeared. Furthersoro, otudieo on animals indicate that the drug
is rcedilg hydrolyzed in the body, and is completely elisineted
in 24-48 ours.. One can only conclude, therefore, that therapeutic effects are related to the drug in a secondary manner.
The piperidyl beneilntos probably serve es a trigger necheniss
for e long series of neuroohysiologicol effects resulting in the
inprevelent in the pstient s psychopathslogicel etstns. Sub~
sequent clinioel work ie oiled at working out proper dosage
schedules, on well no the indications for the use of this and
other related drugs.
The

SUMMARY

entioholinergic psychotonimetic agent, Noethyl-3~piperidyl
cyclopentylphenyl glycolote (JR-329), has been used in the treat~
sent of e snail author of depreeeed patients. The drug induces
e drive of eotivity eccosponied by sons sood elevation. This
sceningly desirable effect tron s therapist's viewpoint occurs
after e period in which there are psychopathologicel effects or
s definitely psychotic nature. The post~psychotic effects which
sees desirable are of a prolonged duretion (days to reeks possibly).
There is st least all ht evidence in two casee or e continuing
stete of isprovenent n inte3retion of the mental functioning and
A

new

behavior.

'

�.

,w... E.

n‘vw-“m-w~'mwwm‘w‘m‘—Iw

—

,.,

-—-

--——-

q"r.xr)r.«,"l‘w

wine—uw.w

m_m

,

.v

.

w-..-....w w. m—u—wnm .c

up... (“mu—r
.

.- "le-

REFERENCES

l.

6., Oetfeld,

N., and Biol, J. A new group
of peychotceieetic egente. Proc. Soc. Exp. Biol. end ﬂed.,
Ahead, L.

A.

97: 433, 1958.

2.

Oetteld. A. l., Ahead, L. 6., end Hercne, D. A. Studies
with cerulopleeein end e nee hellucinogea. A.M.A. Arch.
Neurol. and Peychiet.. 79: 317, 1958.
Abuod. L. 6., 03:5.1a. A. u., and 31.1, a. Structure~
activity roletionehipe of Supiperidyl heneiletee with
peychotcgenic propertiee. Arch. Int. Phereecody. ct
Thor. (in prose, 1958).
Forrer, G. R. AtrOplne toxicity there_y in the treatment
of aental dieeese. AI. J. Paychiet., 08: 107, 1951.
Just, F., and Penal, ﬂ. Proepective peychietry. Inch. Mod.
ﬁche-chr.. 99: 889, 1957.
Sandlson, R. A., end Whitelae, J. D. A. Further etudiee
in the therapeutic velue of LSD in eentel(illnees. J.
»

3.

4.
5.

6.
7.
8.

Heat. Sci., 103: 332, 1957.
Ueki, 8., hiehi, 8., end chcteu, K.
Hieeich. K. Persoael coneunicetion.

Personal communication.

Foorxowas
‘

Syntheeieed bf Dr. John Biel, Lekeeide Leboretoriee,
Hilveukee, Wieceeein.

authors ere deeply lndebteﬂ to Dr. F. J. Gerty for hie eeny
invaluable suggeetione, end to Dr. Alec K. Roeeneeld for the
plydhalogicel teete.
Aiéed by greute free the Mental Health Fund, Stete at Illincie.
end the Teegle Foundation.
The

�Institute of Human Nutrition, Praha,
(J. Mast-k)
A

PSYCHOSIS CAUSED BY BENACTYZIN INTOXICATION
Minis VoJ'i‘cmuovsm"

The dimethylaminoethyl ester of benzylic acid is known in the literature by the following names: Benaetyzin, Suavitil, Parasan. It was
synthesized in 1936 in the CIBA Laboratories in Switzerland as a spasmolytic agent, but it was not until 1955 that it first came to be used in
psychiatry by Munkuad &amp; Jacobsen, where it proved to be a useful
tool for decreasing anxiety and psychic tension, without having any
hypnotic side effect. During the following two years it was roughly
investigated for both its clinical and pharmacological qualities and was
applied to many patients in various institutions. The specific action
of this drug upon the central nervous system placed it, together with the
tranquilizers, on the level of the leading modern psychopharmacological agents. For its composition and central nervous action it was called
an “antiphobic” agent, while its chemical structure ranged it among the
diphcnylmethanes having a central nervous effect (together with e.g.
Meratran. Frenquel, or Atarax). 'I‘herapeutically it is used more commonly in cases of neurosis than in psychotic cases. Its pharmacological
and clinical attributes have been described thoroughly in other publications. This substance was also synthesized in Czechoslovakia, in
the Laboratories of the Institute for Research in Pharmacology and
Biochemistry and has been tested since May 1956 in several clinical
institutions (Dr. Hanzlic‘ek, Dr. Vina‘r’, Dr. Vojté’chovsk‘y). The results
of these tests have been published elsewhere. At the clinical department
of the Institute of Human Nutrition we administer Benactyzin in the
therapy of some gastrointestinal diseases.
Thus we had an opportunity to observe the course of an acute intoxication, which we refer to in the following case history. It was the enormous size of the dose used, fifteen times greater than described in the
literature (Jacobsen (1955)— 90 mg). as well as the fact that to our
knowledge it is the only case where psychotic symptoms appeared,
which stimulated the communication.

.43, .

i

�A

PSYCHOSIS CAUSED BY BENACTYZIN INTOXICATION
MILos

\’o.1'r1'«:1;11ovs1\'\"

The dimethylaminocthyl ester of benzylic acid is known in the literature by the following names: Benactyzin, Suavitil, Parasan. It was
synthesized in 1936 in the CIBA Laboratories in Switzerland as a spasmolytic agent, but it was not until 1955 that it first came to be used in
psychiatry by Munkvad &amp; Jacobsen, where it proved to be a useful
tool for decreasing anxiety and psychic tension, without having any
hypnotic side effect. During the following two years it was roughly
investigated for both its clinical and pharmacological qualities and was
applied to many patients in various institutions. The specific action
of this drug upon the central nervous system placed it, together with the
tranquilizers, on the level of the leading modern psychopharmacological agents. For its composition and central nervous action it was called
an “antiphobic” agent, while its chemical structure ranged it among the
diphenylmcthanes having a central nervous effect (together with e.g.
Meratran, Frenquel, or Atarax). Therapeutically it is used more commonlyin cases of neurosis than1n psychotic cases. Its pharmacological
and clinical attributes have been described thoroughly in other publications. This substance was also synthesized in Czechoslovakia, in
the Laboratories of the Institute for Research in Pharmacology and
Biochemistry and has been tested since May 1956 in several clinical
institutions (Dr. Hanzlié’ek, Dr. Vina‘r’, Dr. Vojféchovsk'y). The results
of these tests have been published elsewhere. At the clinical department
of the Institute of Human Nutrition we administer Benactyzin in the
therapy of some gastrointestinal diseases.
Thus we had an opportunity to observe the course of an acute intoxication, which we refer to in the following case history. It was the enormous size of the dose used. fifteen times greater than described in the
literature (Jacobsen (1955)— 90 mg), as well as the fact that to our
knowledge it is the only case where psychotic symptoms appeared,
which stimulated the communication.

�515
CASE HISTORY
L.B., a 29 year old married female, a physician by profession,

with a sensitivepersonality, but without previous psychiatric symptoms, during a short period of
emotional excitement following some misunderstanding with her husband, consumed almost a teaspoonful of pure Benactyzin. (During the reconstruction of the
case it was ascertained by weighing approximately the same amount of the drug,
that the patient had consumed about 1300—1400 mg of Benactyzin). It was used
solely for its soothing effect without any intention of committing suicide. The course
taken by the intoxication, as described by the patient herself and corroborated by
her husband and the physician summoned to the case, was as follows: About ten
to fifteen minutes after taking the drug the patient became confused, she felt as
if she were looking at herself and her surroundings from a distance is; as if everything was running away from her. She expected to faint, but remained seated
quietly on the sofa. After about twenty minutes she became agitated and leaving
her seat walked in a very unstable manner to the bathroom to take a shower.
There she noticed in the semi-darkness a pile of laundry lying on the floor, and on
top of it she suddenly saw her six months old son. Let us continue in the patient’s
own words. “I was unable to realize at the time that this could not be true since
the baby was actually at home with his grandmother. As I kept looking the baby
suddenly turned pale, then yellow, his eye-balls deviated to one side and he appeared to be on the verge of dying. Finally, before my very eyes, he started fading
away and disappeared. In a wild attempt to find him I searched among the laundry
and then, feeling completely desperate, I ran out to seek an injection for him. My
husband prevented me from going out. I accused him of being the cause of our
baby's possible death.” According to the husband there followed a short struggle
and the patient was compelled to remain in the room. What occurred in the next
period is covered by amnesia (that is between the twentieth and the fiftieth minute),
and it is the husband alone who continues the description of the case as follows.
“She showed signs of anxiety and her face held a terrified expression. Her orientation in space was altered, when she tried to seize an object she would miss it
by about 20 cm, she would also miss the chair when trying to sit down. She became
more.and more agitated and repeatedly tried to run into the corridor, even though
she was only partly dressed, with the persistent idea of obtaining the injection for
saving her child. A short time later, having managed to escape, she was found on
another floor, in vain seeking an opening into a wardrobe and talking confusedly
about the death of her baby. She was brought back into the room, where she became
slightly calmer." The patient is able to continue the description of the events which
followed (that is about an hour after the consumption of the drug), as the amnesia was lifted for this period. “I tried to understand that I could not really have
seen the baby, since he was not there, but whenever I thought about him the whole
situation appeared again very clearly before my eyes and I felt a terrible anxiety.
At this time I partly realized that I had only suffered from a hallucination. I tried
to focus my mind on my surroundings and the conversation, but my thinking was
disrupted and l was unable to integrate individual notions into a logical whole,
even though I did partly realize the inadequacy and incoordination of the words I
used. I believe I even repeated certain phrases stereotypically.”
At this time, that is between the first and second hour of 'the intoxication, the
physician, who had been summoned, noted considerable psychomotor excitation,
agitation, inadequate behaviour and inadequate answers to questions and diagnosed
33

ac-ra rarcu.

rr NIUIOL. scan, 33, 4

�516
psychotic state. The patient confessed having taken a large dose of Benactyzin,
but resolutely denied any suicidal intention. Her face was flushed and showed signs
of crying, her pupils were dilated and she looked terrified, her pulse was 921 min.,
her blood pressure was not recorded. Caffeine and coramine Were applied hypodermically. The patient violently protested against taking the injection saying,
“Do not give it to me, but to my son, who is dying.” Two hours later, when the
physician saw the patient once more, there were still slight signs of psychomotor
agitation and emotional instability, but the patient had just experienced a critical
attitude towards the hallucination and psychotic state.
In her story the patient describes her feelings during the period between the
second and fourth hour after consumption as follows: “After the injection I felt
roughly normal. I realized the impossibility of what I had seen, but I still remembered it with a feeling of terror.” Her husband observed that she became calmer
after the injection, but her speech was still inadequate.
Four hours after taking the drug she became normal, but was very tired and
sleeply. An hour later, that is five hours after taking Benactyzin, she was able to
ride home on the bus. Then she spent a quiet night, and the following day she was
without symptoms.
a

EPICRISIS

Ten to twenty minutes after consumption of 1300—1400 mg of pure
Benactyzin a 29 year old married and mentally healthy female, a physician by profession, showed signs of indisposition, ataxia and derealisation, later there appeared psychomotor excitation and a temporary true
optical hallucination showing the horrible image of the death of the
patient’s baby. This experience led to great anxiety and psychomotor
excitation and the whole behaviour was centered on saving the baby. In
the period between the twentieth and fiftieth minute of the intoxication the patient passed into a delirious state, wih confused consciousness and followed by amnesia. This stage was characterized
by the appearance of a secondary delusion about the death of the
child and accompanied by aggressive behaviour motivated by the wish
to save him. Thinking was incoherent, there was a feeling of blocking
of the thoughts with a strong accentuation on anxiety, agitation and
ataxia. The physician who examined the patient some time between the
first and second hour after the intoxication, noted a psychotic state
with signs of agitation, inadequate answers to questions, and the delusion about the death of her baby. Upon physical examination a flushed
face, dilated pupils, and tachycardia were observed. The psychomotor
agitation decreased after the application of coramine and coffeine and
there arose a critical attitude towards the hallucination and delusion
experienced, but the emotional bond to their memory remained. Disorders in thinking stood out foremost (blocking of the thoughts). These
were apparent in the form of incoherence and perseveration. Three or
four hours later the psychotic state had definitely ceased and was re9

�517

placed by tiredness and sleepiness. After this phase there were no further complications.
DISCUSSION

The toxic dose of Benactyzin has not been ascertained for man. Experiments on the human subject were made impossible by the marked
effect of even small doses of the drug upon the central nervous system,
as may be observed both clinically and on the electroencephalogram
(Coady &amp; Jewesbury 1956). After a dose of four to six mg of Benactyzin, the following unfavourable side effects were described: dizziness,
apathy, relaxation of the muscles, a dull feeling of the extremities, as
if they were not connected with the body, sluggish thinking and lowered
attention, decreased reactivity to external stimuli, blocking of the
thoughts, derealisation, ataxia. Among the symptoms of disturbance
of the vegetative nervous system, it was especially dryness of the mouth
and palpations which stood out. The side effects described above occur
in about 40 per cent. of the patients treated, causing a marked decrease in the therapeutic value of Benactyzin. The dose used to date
never surpassed 90 mg (per single dose) and were never accompanied
by qualitative disturbances in thinking or hallucinations or. confusion
(Jacobsen 1955).
The Benactyzin intoxication described above (about 1300 mg) was
characterized by a delirious psychotic episode with a brief optical hallucination, followed by a secondary delusion, confusion, and psychotic
behaviour. Before and after the delirious state in our case, there were
the other side effects commonly described in the literature, namely
ataxia, derealisation, and blocking of the thoughts. The atropine-like
visceral effects which could be expected after such a large dose of the
drug were not felt by the patient herself even though they could be
observed to a small extent (tachycardia, flushed face, dilated pupils).
The psychotic course of the intoxication could be explained by the specific and quantitative action of Benactyzin upon the central nervous
system. While the theme of the psychotic episode might well be understood psychodynamically: a sensitive mother whose main problem of
life is the health of her six months old child, the optical hallucination
may be the realisation of her fears.
The relatively benign course and short duration of this intoxication
and the negligible visceral symptoms which accompanied it, even
though the dose taken surpassed therapeutic dosages more than a
thousandfold, denote a relatively low toxicity of Benactyzin. On the
other hand this case only accentuates the predominative action of this
drug on the central nervous system.
33‘

�518
SUMMARY

The clinical course of an intoxication by about 1300 mg of Benactyzin characterized by a short benign delirious psychotic state is
described.
REFERENCES

GeseIIscha/l f. chem. Iniluslrie, Basel, Schw. Pat. No. 183065, 187825, 1936.
(.‘oady, A., &amp; E. C. 0.1ewesbury (1956): A clinical trial of benactyzine hydrochloride
(“Suavitil”) as a physical relaxant. Brit. med. J. 1, 485—87.
Davies, If. B. (1956): A new drug to relieve anxiety. Brit. Med. J. 1, 480—84.
Jaeobsen, E. (1955): A new drug efective on the central nervous system. Dan. Med.
Bull. 2, 159-160.
Jacobsen, E., A. Kehler, V. Larsen, I. Munkvad &amp; K. Skinhaj (1955): Investigations
into autonomic responses during emotion. Acta psychiat. (Kbh.) 30, 607—25.
Jensen, 0. ”slergaard (1955): Suavitil in the treatment of psychoneuroses. Dan.
Med. Bull. 2, 14043.
Munkvad, I. (1955): Treatment of psychoses and psychoneuroses with a new sedative (Suavitil). Acta psychiat. (Kbh.) 30, 729—39.
Vinar, D., M. Vojté'chovskﬁ &amp; Vinarova’ (1958) : Cas. lik. Ees. (Prague), in press.
,

Received April 4, 1958.

Milo} Vojtéchovsk)", M.D.,
Praha XIV, Budéjovika 800,
Czechoslovakia.

�Reprinted from Psychotropic Drugs

THE COMPARISON OF THE PSYCHOTIC EFFECT OF
TRYPTAMINE DERIVATIVES WITH THE EFFECTS OF MESCALINE
AND LSD-25 IN SELF—EXPERIMENTS
S. SZARA

Central State Institute for Nervous and Mental Diseases, Budapest (Hungary);
Forsehungsabteilung, Psychiatrisehe und Nervenklinik der Freien Universitat, Berlin (Germany)

INTRODUCTION

\

Indolealkylamines have been considered for a long time as a group of active substances
of rather slight pharmacological and almost no psychiatric interest. Renewed attention
has been focused on them since the discovery of the presence of 5-hydroxytryptamine
in blood, in the enterochromafﬁn cell system, spleen, kidney, and the central and
peripheral nervous tissue. An excellent review on the pharmacology of indolealkylamines by ERSPAMER appeared in 1954, and many other reviews have appeared on
5-hydroxytryptamine or serotonin (AMIN et al.1; FREYBERGER et al.11; GADDUM
et al.12; HIMWICH13; LANGEMANN17 ; PAGE2"; ROTHLIN). The tryptamine derivatives
have been of interest only in connection with their effect on blood pressure. Data on
their effect on the central nervous system can be found only sporadically (NIEUWENHUIZENlS; SPEETER AND ANTHONY“). Our attention towards their possible psychotic
action was attracted by the works of FISH, JOHNSON, AND HORNING9 on Ptptaa’enta
alkaloids among which they found bufotenine, N,N-dimethyltryptamine, and their
N -oxides. In experiments on animal they found these drugs to have psychotic effects,
but experiments on humans were made only with bufotenin by FABING. We therefore
decided to make self-experiments and experiments on normal volunteers with N,Ndimethyltryptamine and with the N,N-diethyl compound also (Fig. I).
Bufotenine

HG

I

/\ANH/
l

I

l

CH2CH2 N(CH3)2
C

(WCHZCHz-N(CH3)2

DMT

“

T—g

l

\ANH

/\j—j—
\NH

CH 2 CH 2 -NCH
(2 5)2

Fig. I. The chemical constitution
of bufotenine. DMT and T—9.
References

1).

466.

�PSYCHOTIC EFFECTS

or

DMT,

r-g,

461

MESCALINE, AND LSD-25

METHODS AND MATERIALS

The N,N—dimethyltryptamine (DMT) and the N,N-diethyltryptamine (T-g) were
obtained synthetically by the method of SPEETER AND ANTHONY.
For the purpose of puriﬁcation the amines were distilled in high vacuum. For the
experiments, sterile aqueous solutions of the hydrochloric salts were prepared and
used in a concentration of 30 mg per ml. The lethal doses estimated in white mice by
the usual method were 135 mg/kg in the case of DMT, and I20 mg/kg in the case
of T-9.

'

Although the substances have been not very toxic in mice, we were very cautious
in the self-experiments.
In the peroral experiments, starting from 14 mg and increasing the dose up to
150 mg no observable psychic or vegetative effects were found. After the unsuccessful
peroral experiments, intramuscular experiments were made. In this titration series
other physicians of the Institute of Budapest took part. The doses administered were
IO mg, increasing to 150 mg (zle. 2 mg/kg body weight). Psychotic effects were observed from 30 mg, Le. 0.2 mg/kg body weight; they reached their optimum in doses
about 0.7—1.0 mg/kg body weight. On further increasing the doses the psychotic
symptoms were suppressed by the vegetative and organic symptoms. Therefore the
further experiments on normal volunteers were made with the above-mentioned
optimal dose. A detailed paper on the results obtained with normal volunteers, is
to appear in Psychiatria at N eurologica (SAI—HALASZ et al.22).
THE SELF-EXPERIMENTS

The purpose of this report is to compare the psychotic effect of tryptamine derivatives
with the well-known effect of mescaline and lysergic acid diethylamide in self—
experiments. I believe that this method of experimentation is one of the best ways
of obtaining direct information on subtle psychopathological phenomena, which are
of great importance in understanding the schizophrenic syndrome.
TABLE I
THE DATA OF SELF-EXPERIMENTS
Dose

Substance

I.

Mescaline
II. LSD-25
III. DMT
DMT
DMT
DMT
IV. T-9

0.35 g

IOO lug

0.25 mg—I 50 mg
75 mg
75

mg

60 .mg
60 mg

A dmin.

Date

per 05
per 05
per os
i.m.

Dec. 1955
Dec. 1956

i.m.
i.m.
i.m.

March—April 19 56
April 1956
June 1956
March 1957
Nov. 1956

Place

Budapest
Vienna
Budapest
Budapest
Debrecen
Berlin
Budapest

The experiments were carried out over a period of 16 months. I took mescaline
at Christmas—time 1955, and the LSD—25 was tested in Vienna at the Psychiatric Clinic
of the University, by courtesy of Prof. Dr. HOFF and Docent Dr. ARNOLD, in De—
cember 1956. The ﬁrst intramuscular administration of DMT occurred at the end of
April 1956, and was followed by the experiments on normal volunteers. We reported
References

1).

466.

'

�s. szARA

462

the results at the Annual Meeting of the Hungarian Physiological Society in Debrecen.
During this meeting I made the second intramuscular experiment in order to get an
electroencephalographic recording. A third DMT—experiment and some biochemical
investigations were made in Berlin at the Research Department of the Psychiatric
and Neurologic Clinic of the Free University, by the courtesy of Prof. Dr. SELBACH.
The T—g—experiment was made intramuscularly in November 1956 in Budapest.
I shall not go into details about the effects of mescaline and LSD-25 becauseI
am not able to add any new aspects to that well—known picture. Nevertheless, the
chief features of these experiments will be mentioned later. At present I shall only
describe in more detail the symptoms of DMT and T—g model psychoses, in View of
the lack of such reports in the literature up to now.
(a) The BAIT—experiments

As mentioned above, DMT ingested per as has no observable effect. But an intramuscular injection of 30 mg could already produce some mydriasis and subjectively
some perceptiOn disturbances. The larger the dose, the more striking are the symptoms.
About the self—experiment made with 1.0 mg/kg, Le. 75 mg DMT in total, I can report

the following:
In the third or fourth minute after the injection vegetative symptoms appeared,
such as tingling sensation, trembling, slight nausea, mydriasis, elevation of the blood
pressure and increase of the pulse rate. At the same time eidetic phenomena, optical
illusions, pseudo—hallucinations, and later real hallucinations, appeared. The halluci—
nations consisted of moving, brilliantly coloured oriental motifs, and later I saw
wonderful scenes altering very rapidly. The faces of the people seemed to be masks.
My emotional state was elevated sometimes up to euphoria. At the highest point I had
compulsive athetoid movements in my left hand. My consciousness was completely
ﬁlled by hallucinations, and my attention was ﬁrmly bound to them; therefore I
could not give an account of the events happening around me. After %—I hour the
symptoms disappeared, and I was able to describe What had happened.
In the second intramuscular DMT-experiment, the duration in time and the
symptoms were mamiy the same.
At the third DMT-experiment, the dose was somewhat smaller (60 mg); the
symptoms were thus milder, but qualitatively the same.
(b)

The T—g—exyberimem

The symptoms of the T-g—experiment are brieﬂy as follows. About 15 minutes after
the injection of 60 mg of T-g came the same vegetative symptoms as described for
DMT. The illusions, hallucinations, and the athetoid compulsive movements in the
left hand were the same as for DMT. But the alteration of the surrounding world
and the emotional reaction to them were strong and impressive. The mask-like faces
of the' persons, the dream-like mysteriousness of the objects and the room gave me
the feelnig that I had arrived in another world, entirely different and queer and full
of secrecy and mystery. This wonderful but strange world attracted me at one
moment, but the next moment I did not want to accept it. I became perplexed; I did
not know what I ought to do. I began to walk anxiously up and down, and said:
”I ought to do something, I must!” There was a peculiar double orientation in space
References p. 466.

�463

PSYCHOTIC EFFECTS OF DMT, T-9, MESCALINE, AND LSD-25

and time: I knew where I was, but I was inclined to accept this strange world as a
reality, too. The dusk of the room was lightened for some minutes, and again the
light was switched off, and that seemed to me as if this period might be an entire
epoch, ﬁlled with events and happenings, but at same time I knew that only several
minutes had passed.
(6)

The comparison of the results

I should like to compare the effects of the two tryptamine derivatives outlined above
with the effect of mescaline and LSD-25. The most outstanding differences can be
established in their time of duration.
Intensity
of symptoms
T-9

DMT

LSD-25

Mescalin

Flg. 2. Schematic course of the self-experiments.

_

In Fig. 2 it can be seen that the duration of the DMT-induced model psychosis
is about one hour, that of T—g is about three hours, while the LSD— and mescaline
symptoms lasted for 8—10 hours. The onset of the symptoms in the case of tryptamine
derivatives is wsentially quicker than the onset of the others. The elevation of the dose
of DMT did not produce a longer state of intoxication, but the symptoms were more
organic. It is remarkable that in all the four model psychoses the symptoms developed
and passed away in wave form.
The specialsymptoms are demonstrated in Table II.
TABLE II
THE MAIN SYMPTOMS OBSERVED IN SELF-EXPERIMENTS
Symptoms

I. Vegetative symptoms
2. Athetoid movements
3- IIIUSiODS

4. Hallucinations
5. Disturbances of

a. spatial perception
b. time perception
6. Bodily sensations
7. Depersonalisation

Emotional reaction
a. euphory
b. anxiety
9. Autism
10. Language changes
8.

References

1).

466.

Mescaline

DM T

LSD-2 5

T- 9

Preceded the other symptoms Coincided with the other symptoms
—
+
+

++

++
—

_

I

+++
+
+
++

+++
+
++
+ ++

+

—_

—
-—
~——

+++
++

—|—

++

_+

'

,

+++
+

+++
+
+
+

+++
++ +
+
+++

++

+++
+
+++

___

+++

_+

�464

s.

SZA'RA

As can be seen, the different symptoms were not
equally apparent in every case.
(I) The vegetative symptoms in mescaline and LSD-25 preceded the
other symptoms, while in the case of the tryptamine derivatives the
disturbances

sensory

appeared

as early as the vegetative symptoms began.
(2) An interesting phenomenon observed only in the
tryptamine derivatives was
the appearance Of athetoid, choreiform compulsive movements. As
far as I know,
these symptoms have not yet been described in the
case of other hallucinogenic

substancesf
(3) The perceptional disturbances are
qualitatively the same for all the substances;
only quantitative differences could be observed.
(4) The emotional reactions, however, were
qualitatively different, viz. my
reaction to mescaline and DMT was euphoric, to the LSD—25
anxious, but in the case
of T-9 euphoria and anxiety alternated. These
phenomena, together with the severe
autism and the above-mentioned ambivalency were observed
only in T-g. However,
it is well—known from the literature that it can occur in the
case of mescalnie and
‘

LSD-25 also (HUXLEY14, SOLM523).
The comparison shows that the structure of a model
psychosis, which can be
considered as a form of the acute exogen reaction
type (BONHOEFFER), depends on
the chemical structure of the causative agent,
apart from the fact that absorption,
metabolic and excretion processes may determine the course in time.
BIOCHEMICAL INVESTIGATIONS

v

‘

The rapid onset and the short duration of the symptoms in the DMT—induced
state is
very interesting from a biochemical point of View, and it is probably connected with
the rapid metabolism of DMT (FISH ct LIL).
We know from the investigation of ERSPAMER6 that in rats the
main breakdown
product of DMT is 3—indolylacetic acid (3-IAA) which is excreted in the urine
partly
in free form, but largely bound to glycocol as indolaceturic acid. We
investigated the
excreted indole derivatives in the human volunteers chromatographically
and photo—
metrically, and obtained the same results as ERSPAMER (SZARA25). In addition,
an
interesting phenomenon was observed (Table III). We found in the urine after
a
larger
dose of DMT more 5-hydroxyindolylacetic acid (5-HIAA) excreted
than was normally
present. Unchanged DMT was not estimated in the urine extracts. These data
suggested
TABLE III
TOTAL 5-HIAA EXCRETED

THE APPROXIMATE AMOUNT OF
AND AFTER THE
N 0.

I

2M

3‘”
4
*

Dose of DM T

150 mg

I50 mg
75 mg
60 mg

IN A 6

DMT EXPERIMENT

h PERIOD BEFORE

Amount of 5-HIAA*

alter expt.

1.0 mg
1.2 mg
1.5 mg

2.0 mg

before expt.

3.0 mg
3.0 mg
1.2 mg
L5 mg

Estimated by two-dimensional chromatography, developed with
p-dimethylaminO-benzalde‘and
the
hyde,
eluted spots measured colorimetrically.
**
Self-experiments.

References p. 466.

�PSYCHOTIC EFFECTS OF DMT, T-g, MESCALINE, AND LSD-25

465

that the DMT is very rapidly metabolized, and perhaps displays its effects by means
of serotonin. In order to obtain more information about the relationship in the blood,
I made an experiment with 60 mg DMT. The extracts of I5 ml blood taken before,
and IO, 30 and 90 minutes after the experiment, were chromatographically investigated,
and I found qualitatively only two indol derivatives, namely tryptophan and 3—IAA,
but no serotonin 5—HIAA or unchanged DMT could be demonstrated. The 3—IAA
level of the blood was elevated in the 10th and 30th minute (Fig. 3).
3- 1AA

lug p.c.
100

50

10
_

30

._+.&gt;
90
minutes

Time in
after injection of DMT
_

.

Fig. 3. The 3-IAA level of blood during the DMT experiment.

This ﬁnding did not support the presumption that serotonin plays a role in the
psychotic effect of tryptamine derivatives. The evidence, however, is not sufﬁcient
to allow one to draw deﬁnite conclusions in this respect.
DISCUSSION

In discussing the mechanism of action of tryptamine derivatives, it must be admitted
that at present there is no deﬁnite knowledge about the biochemical mechanism of
action. The clinical picture, however, taking the other experiments on normal
volunteers also into consideration, enables us to give some information concerning
this mechanism.
The rapid onset of the psychotic symptoms makes it seem probable that DMT
affects directly those brain structures that are affected indirectly by LSD and mescaline (BLOCKZ). The appearance of choreiform athetoid movements is possibly due
to an effect on structures other than those affected by LSD or mescaline. The tryp—
tamine derivatives seem to be the ﬁrst hallucinogenic substances to cause athetoid
movements, and should therefore provide a new tool for investigating experimentally
the exact mechanism of this phenomenon.
Unfortunately, I have not enough time to develop in detail the very interesting
psychopathological symptoms of T—g, which reminded me of the conception of the
“schizophrene Grundstimmung”, described by WYRSCH27.
It is, however, very remarkable that tryptamine derivatives without the OHgroup in the 5-position are able to produce mental phenomena. As UDENFRIEND at al.
demonstrated in animal tissues, there is no enzyme that could decarboxylate trypto—
phan to produce tryptamine; it is assumed therefore that only the enteral bacteria
can produce this substance.
‘

References p. 466.

�s. szARA

466

There is a possibility that from this tryptamine the schizophrenic organism may
is
It
noteworthy
in
the
enzymically.
substances
way
hallucinogenic
wrong
produce
in
of
disturbance
evidence
team4
a
his
BUSCAINO
presented
and
recently
Prof.
that
be
desirable.
would
ﬁeld
in
this
work
Further
in
schizophrenia.
metabolism
indole
the
SUMMARY
The psychotic effects of N,N-dimethyltryptamine (DMT) and N,N-diethy1tryptamine (T—9) have
been compared with the effects of mescaline and LSD-2 5.
The most outstanding features of DMT model psychosis are the rapid onset and the short
duration Of the symptoms. This may indicate a different mechanism of action from that of LSD
and mescaline.
New symptoms appearing with both tryptamine derivatives are the choreiform athetoid
movements. This phenomon could be a new tool for investigating experimentally the mechanism of
the extrapyramidal compulsive movements.
of
indole
and
aminotoxic
the
theory
Of
derivatives
supports
effects
tryptamine
The psychotic
schizophrenia.

REFERENCES

].

Physiol. (London), 126, (1954) 596.
A. H. AMIN, T. B. B. CRAWFORD AND I. H. GADDUM,
2 W. BLOCK, Z. physiol. Chem.,
294 (1953) 1; lbid., 294 (1953) 49; ibid., 296 (1954) 1; ibid., 296
(I954) 1083
V. M. BUSCAINO, Quaderni aeta neural, (1953).
4 V. M. BUSCAINO, D. KEMALI, R. BAGNULO, Aeta Neural. (Naples), 10 (1955) 547.
5
V. ERSPAMER, Pharmacol. Rev., 6 (1954) 425.
6 V. ERSPAMER,
118.
(1955)
(London),
127
Physiol.
].
7
H. D. FABING, Am. ]. Psychiat, 113 (1956) 409.
8
H. D. FABING AND J. R. HAWKINS, Science, 123 (1956) 886.
9 M. S.
FISH, N. M. JOHNSON AND E. C. HORNING, ]. Am. Chem. 500., 77 (1955) 5892.
10 M. S. FISH, N. M. JOHNSON, E. P. LAWRENCE, E. C. HORNING, Blaehim. Biophys. Aeta., 18
(1955) 56411 W. A. FREYBURGER, B. E. GRAHAM, M. M. RAPPORT, P. H. SEAY, W. M. GOVIER,O. F. SWOAP
AND M. J. VANDER BROOK, ]. Pharmacol. Exptl. Therap., 105 (1952) 80.
12 I. H. GADDUM AND A. HAMEED KHAN, Brit. ]. Pharmacol., 9 (1954) 240.
13 H. E. HIMWICH,
Nervous Mental Disease, 127 (1955) 413.
].
14 A. HUXLEY, The Doors of Perception, London, 1954.
15 D. KEMALI, V. M. BUSCAINO AND R. BALBI, Aeta Neural. (Naples), 11 (1956) 209.
16 D. KEMALI AND G. ROMANO, Aeta Neural. (Naples), 11 (1956) 959.
17 H. LANGEMANN, Sehwelz. med. Waehsehr., 85 (1957) 957.
(9).
(1936)
18 F.
Amsterdam,
Akad.
Koninkl.
Wetensehap,
39
Proc.
NIEUWENHUYZEN,
J.
19 I. H. PAGE,
Pharmaeal. Exptl. Therap., 105 (1952) 58.
].
20 I. H. PAGE, Physlal. Revs, 34 (1954) 563.
21 E. ROTHLIN, A. CERLETTI, A. KONZETT, W. R. SCHALCH AND M. TAESCHLER, Experientia, 12
(1956) 15422 A. SAI-HALASZ, GY. BRUNECKER AND S. SzARA, Psychiat. et Neurol., (in press).
23 H. SOLMs, Praxis,
45 (1956) 746.
24 M. E. SPEETER AND W. C. ANTHONY,
Am. Chem. 500., 76 (1954) 6208.
25 S. SzARA,
Experientia, 12 (1956) 441.
23 S. UDENFRIEND, C. T. CLARK AND E. TITUS, ]. Am. Chem. 500., 75 (1953) 501.
Daseinwer’se. Paul
27
Psychologie.
Klinlk,
Studlen
des
zur
Die
Person
Sehlzophrenen.
WYRSCH,
J.
Haupt, Bern, 1949.
1

j.

'

DISCUSSION
A. SAI—HALAsz, I stltuto Centrale per le malattie Nervose e M entali, Budapest (Ungheria)

Il collega SzARA ha avutO occasione stamane di parlare in dettaglio sugli esperimenti fatti con me
Or—a vorrei richiamare l’attenzione soltanto su un
normali.
in
soggetti
la
dimetiltriptamina
con
fenomeno, che mi sembra assai interessante dal punto di vista clinico. Su 30 persone esaminate 22,
schema
dello
i
disturbi
1e
le
allucinazioni,
illusioni
e
semilateralizzati:
i1
sintomi
cioé 73% avevano
i segni di lesioni piramidali prevalevano a
anche
ed
atetosici
i
movimenti
dello
spaziO,
e
corporeo

�PSYCHOTIC EFFECTS OF DMT, T-9, MESCALINE, AND LSD-25

467

sinistra. Questa differenza era netta. Per esempio un soggetto sperimentale guardando la mano
sinistra diceva che essa non gli apparteneva pil‘l, aveva cambiato forma ed era divenuta luminosa e
bellissima; guardando invece la mano destra, diceva. che non presentava nulla di straordinario.
Abbiamo sperimentato su tre persone mancine, e in questa i fenorneni prevalevano alla parte
destra. Si dovrebbe concludere che 1a dimetiltriptamina produce una Iesione semilateralizzata
dell’emisfero non dominante del cervello.
Questo fenomeno ﬁnora. non segnalato dalla letteratura. per gli altri farmaci psicotropi ci
propone due questioni:
(1) La prima sarebbe la seguente: come si pub immaginare, che una sostanza chimica abbia
un effetto nocivo molto pi1‘1 forte sull'emisfero cerebrale non dominante? Sappiamo a1 contrario,
che é appunto l’emisfero dominante i1 ph‘l sensibile, specialmente se danneggiato nel sistema
vascolare.
(2) La. seconda domanda é di carattere psicopat'ologico. Si tratta cioé di sapere se questa
semilateralizzazione ci pub dire qualcosa sugli aspetti delle psicosi sperimentali. HOFF e PéTZL
hanno gia‘L/dimostrato collo “Zeitrafferphéinomen”, che lesioni organiche dell'emisfero non dominante possono produrre fenomeni psicopatologici molto strani. Lo “Zeitrafferphéinomen” é stato
descritto gié da BERINGER nel corso di psicosi sperimentali mescaliniche. Secondo 1a nostra. opi—
nione sarebbe di grande interesse studiare ancora. 1e psicosi sperimentali gié conosciute, a1 ﬁne di
evidenziare se ci sono diﬂerenze fra. 1e due parti del corpo. Ci pare probabile, che questo fenomeno
non sia un eﬂetto solo della dimetiltriptamina. Ad ogni modo, conoscendo i fatti suddetti, noi
possediamo ora una. nuova. sostanza per aiutarci a conoscere meglio i problemi dell’emisfero cerebrale non dominante.
‘

�Reprinted from
Psychotropic Drugs
SHORT COMMUNICATIONS

283

Effects of psychomimetic drugs on cerebral synapses
The psychomimetic drugs allow us to elicit at will a limited, reversible, mental derangement in
man and a related distorted behavioral pattern in animals. They can therefore be highly potent
tools equally for the physiologist, the behaviorist, and the experimental psychiatrist. The tremendous versatility of the brain is nonetheless the manifestation of activity in a ﬁnite number of
structures and of mechanisms relating them. It follows, therefore, that the multiple patterns that
add up to biological behavior must share in part the available mechanisms. It is by virtue of this
probability, rather than because of any exact or fancied resemblance to the clinical conditions, that
the study of chemical or so-called model psychoses and the agents producing them can be expected
to be fruitful.
To the physiologist this suggests the need for identiﬁcation of the underlying unitary processes
involved; to the behaviorist, the identiﬁcation of the combinations constituting known behavior
patterns; and to the experimental psychiatrist, the comparison of natural and induced psychoses.
All can proﬁtably use drugs as tools for analysis. The clinician, furthermore, can convert these
ﬁndings into tools for diagnosis and the means for therapy.
The high vulnerability of synapses to chemical inﬂuences makes them a natural focus of
inquiry. We have utilized the synapses of the optic cortex of the cat (lightly anesthetized with
sodium pentobarbital) activated by transcallosal impulses initiated in one cortex and evoking
post-synaptic impulses recorded at the symmetrical point in the opposite cortex. This has proved a
very convenient preparation and the data are representative of a variety of cerebral synapses,
including cortical, subcortical and medullary synapsesl. By intracarotid injection we achieve an
active concentration of the drug or chemical in the ipsilateral hemisphere with sufﬁcient dilution on
entry into the systemic blood stream to obviate peripheral effects. The ipsilateral recording elec—
trode simultaneously monitors the input and output of the terminal synapses in the system, which
is submaximally activated every two seconds.
In this way we have established that synaptic transmission is under the control of a delicate
chemical equilibrium between cholinergic excitation reciprocating with adrenergic inhibition. It is
then evident that a disturbance of this equilibrium would lead to abnormal synaptic transmission,
resulting in disturbed cerebral and mental function.
Among the synaptic inhibitors naturally found in the mammalian brain are adrenaline, nor—
adrenaline, and serotonin. The last is by far the most powerfu13. Substances with a chemical
similarity to these become candidates for the role of psychomimetic drugs. Such is indeed the case
with mescaline, adrenochrome, adrenolutin, lysergic acid diethylamide (LSD-2 5) and bufotenine.
Mescaline is closely related chemically to adrenaline, which on oxidation is converted initially to
the indole, adrenochrome. Adrenolutin is a minor modiﬁcation of adrenochrome. Serotonin and
dimethyl-serotonin, or bufotenine, are indoles, and LSD-2 5 can be regarded as built on an indole
nucleus. It strengthens the argument, therefore, that we ﬁnd all of these to be synaptic inhibitors3 4.
Furthermore, their ranking as synaptic inhibitors parallels the ranking as to psychomimetic
potency in man.
The agreement between data from the anesthetized cat and the human encouraged us to
believe and test that tranquilizers, reported to be clinically effective in partially offsetting mental
disturbance, would have a predictable action on synaptic inhibition by psychomimetic agents. If
the synaptic inhibition so produced were truly instrumental in bringing about psychotic behavior,
then the improvement of such behavior that is observed clinically might be due to antagonizing of
an endogenous chemical corresponding to the exogenous psychomimetic drugs.
This, indeed, turns out to be the case. The prophylactic administration of chlorpromazine,
promazine, reserpine, and azacyclonol, in doses having no effect per 33 on synaptic transmission,
prevents or reduces the synaptic inhibitory action of the psychomimetic drugsz.
Overdoses of tranquilizers clinically produce toxic phenomena, some of them taking the form
of depression, and even psychosis. Likewise, large doses of the tranquilizers produce a depression of
synaptic transmission indistinguishable from synaptic inhibition. Characteristically, the tranquilizers exercise their clinical effect without a corresponding degree of depression. This is reﬂected in
the ratio of depressant to prophylactic dose, or “synaptic safety margin”. This safety margin is nonexistent for phenobarbital, equals 2 for reserpine, IO for promazine and 20 for chlorpromazine and
DEPARTMENT OF
EXPERIMENTAL PSYCH'IIRY
‘

s

“

APR

wetHyTAL

30

40.59

�284

SHORT COMMUNICATIONS

azacyclonol. The above data suggest the hypothesis that synaptic inhibition is one of the mechanisms responsible for some forms of mental disturbance. A perversion of metabolism resulting
either in an excess of endogenous inhibitory substance or an excess susceptibility of the neurons
upon which it acts, would result in abnormal patterns of activity whose variety would be determin—
ed by varying thresholds and, in particular, by abnormal inhibition interrupting normal control,
and thereby releasing more primitive and less adaptive —perhaps subcortical—t—patterns of activity.
Such conceptions emphasize the role of naturally occurring inhibitory indoles in mammalian
brain. Of these, serotonin is highly active, dimethyl—serotonin or bufotenine is twice as active as
serotonin, while adrenaline and adrenolutin are relatively weak inhibitors. Psychotic manifestations
have been clearly described for all but serotonin, whose powerful peripheral disturbing actions
seriously obscure the picture when it is introduced by the usual routes. For this reason we are
testing the effects of intracarotid serotonin injections in man.
The importance of serotonin has caused us to extend our original observations of its cerebral
synaptic inhibitory action with experiments designed to record the action of “in situ serotonin”.
This is accomplished by the use of iproniazid, the inhibitor of monoamine oxidase (MAO), the
enzyme responsible for the destruction of serotonin. With intracarotid injections of iproniazid we
can reproduce the cortical action of serotonin and show that, at the height of the synaptic inhibi—
tion, the MAO titer on the inhibited side is, in fact, lower than on the control side; as would be
expected if iproniazid is exercising its action by inhibiting MAO and, consequently, accumulating
natural serotonin at the synapses.
Following the reasoning already outlined, we again assessed the pertinence of the data
to possible clinical signiﬁcance by testing the action of tranquilizers against serotonin. We ﬁnd
that the tranquilizers exercise a prophylactic or preventive action against the inhibitory effects of
serotonin in the same way that they antagonize psychomimetic drugs.
A comparison of the cerebral synaptic action of psychomimetic drugs with that of naturally
occurring cerebral synaptic inhibitors and their modiﬁcation by tranquilizers produces data consistent with the hypothesis that a disturbance of synaptic equilibrium—in this case, by a preponderance of inhibitory effectiveness—is a potential mechanism for some kinds of mental disturbance, and that therapeutic results could be anticipated by various means of preventing or annulling
this eﬂect. The opposite kind of disturbance or a preponderance of excitatory effectiveness seems
also plausible. The prevention or annulling of this deviation in synaptic equilibrium would require
different measures. The effectiveness of different tranquilizers and varying therapeutic measures
might be expected to become diagnostic criteria.
Veterans Administration Research Laboratories in Neuropsychiatry,
V. A. Hospital, Pittsburgh, Pa. U SA.
1

2
3

4

A.
A.
A.
A.

AMEDEO S. MARRAZZI

S. MARRAZZI, Science, 118 (1953) 367.
S. MARRAZZI, Ann. N. Y. Acad. Sci, 66 (1957) 496.
S. MARRAZZI AND E. R. HART, Science, 12I (1955) 365.
S. MARRAZZI AND E. R. HART, ]. Nervous Mental Diseases, 122 (1955) 354.

APR

,7

3 ‘0"!!!

DEPARTMENT OF
EXPERIMENTAL PEVOH‘AIRY

HILLSIDE HOSPITAL
GLEN OAKS, N. Y.

�a
hemical aspects of Psilocgpin
p39
0......” “-4
cum

-c£—¢h—-g-M-

by A;Hofmannj

Eagle

psychotropic act1ve principle of Psilocybe mexic!
Helm has been isolated in crystalline form. This fungus
6ne
is
of the so- called magic or s.a¢red Mexican mushrooms used since
orecolumbian times by the indians of Mexico- dur1ng religeous
ceremonies and also by soothsayers to acquire clairvoyence.
The

inawater, but practically unsoluble

organicmost
in

solvents._r
Analysis, Spectra and colour react10ns indicated that 1t 13 a

\\
tryptamine.
The spec1al structural features of psilocybin are dis~.
.

�to central autonomic stimulation, the study of Psilocybin on

1solated
variety of
organsshows Only
on peripheral structures
¢

littleactivity ofshe
‘

adrug

5

‘

��8 MARCH 1958

.
‘

PSYCHOSIS AND TREMDR DUE TO
'
\L
MECAMYLAMINE
.

_

M.

HARINGTON

M.B. Cantab., M.R.C.P.
SENIOR REGISTRAR AND MEDICAL TUTOR

PRISCILLA KINCAID—SMITH
M.B. W’srand, M.R.C.P., D.C.P.
REGISTRAR

DEPARTMENT OF MEDICINE, POSTGRADUATE MEDICAL SCHOOL OF
LONDON

ganglion-blocking agent for treat—
ing hypertension was introduced two years ago (Freis
1955, Ford et a1. 1955), and since then it has been widely
used in clinical practice, its chief advantage being that it
is fully and regularly absorbed when given by mouth. It
produces the same side-effects, due to blockade of the
parasympathetic system, as do other ganglion-blocking
drugs, but in addition reports have been published in
America indicating that mecamylamine may also have a
toxic action on the central nervous system (Schneckloth
et al, 1956, Deming et al. 1957).
We describe here four patients in whom tremor and
mental disturbance, with confusion and hallucinations,
developed while they were receiving mecamylamine, and
we suggest that this may be a not uncommon complica—
tion of treatment with mecamylamine given in large dosage.
MECAMYLAMINE as a

\

Case-reports
Case l.—A man, aged 55, was ﬁrst seen in July, 1955, com—
plaining of headaches. He had two years’ history of high
blood-pressure and ﬁfteen years’ history of gout. Although

intelligent, he was unstable and did not follow any regular
occupation.
On examination his blood~pressure was 230/140 mm. Hg;
he had numerous retinal haemorrhages and exudates; his urine
contained a trace of albumin and could be concentrated to
1.020; and his blood-urea level was 30 mg. per 100 ml.
Treatment.—-—Benign essential hypertension having been
diagnosed, he was treated with subcutaneous pentolinium, to
which reserpine 0-1 mg. thrice daily was later added. This
regime reduced his blood—pressure, and his fundi considerably
improved.
Mecamylamine therapy—In July, 1956, mecamylamine was
substituted for the pentolinium, 20 mg. thrice daily being
necessary to keep the blood—pressure down to 140/80 mm. Hg,
with the patient in the erect position, for the greater part of the
day. This dosage, however, caused troublesome side-effects,
at ﬁrst principally constipation, but later difﬁculty in micturition associated with frequency.
DR . HOBSLEY

BaraEtlaésCZIS

499

ORIGINAL ARTICLES

REFERENCES
M. (1952) Rev. Sanid. Polie., Lima, 12, 198, cited by Ferris et al.
2

Bernstein, C., Klotz, S. D. (1952) Ann. Allergy, 10, 479.
Dameshek, W., Neber, J. (1950) Blood, 5, 129.
Dobson, A. M., Ikin, E. W7. (1946) 3'. Path. Bact. 58, 221.
Ferris, H. B., Alpert, S., Coakley, C. S. (1952) Amer. Praetit. 3, 177.
Frankel, D. B., Weidner, N. (1953) Ann. Allergy, 11, 204.
Hoffmann, C. R. (1957) Surgery, 41, 491.
Loew, E. R. (1950) Med. Clin. N. Amer. 34, 351.
Maunsell, K. (1944) Brit. med. _7. ii, 236.
Mollison, P. L. (1951) Blood Transfusion in Clinical .Medieine, p. 317.
Oxford.
F. M., Margolin, S., Jackson, D. (1953) 3‘. med. Soc. N. i. 50,
Offegkgantz,
3 .
Simon, S. W., Eckman, W. G., Jr. (1954) Ann. Allergy, 12, 182.
Stephen, C. R., Martin, R. C., Bourgeois—Gavardin, M. (1955) 7. Amer. med.

Ass. 158, 525.
Wilhelm, R. B., Nutting, H. M., Devlin, H. B., Jennings, E. R.,
0. A. (1955) ibi‘d. p.’ 529.
W’inter, C. C., Taplin, G. V. (1954) Ann. Allergy, 12, 717.
Wright, W. A. (1950) .Med. Times, N.Y. 78, 466.

Brines,

Readmission.—In February, 1957, retention of urine developed and the patient was readmitted to hospital. His bloodurea level was now 60 mg. per 100 ml., rising after ten days to
72 mg. per 100 ml., he had a urinary infection, which was
treated with tetracycline. Soon after admission his requirement
for mecamylamine fell: the dosage was reduced from 60 to
30 mg. daily, and his blood-pressure was maintained at 110/70
mm. Hg with the patient in the upright position.
Mental and nervous symptoms.——On Feb. 19, 1957, he had a
tremor of the hands. All hypotensive treatment was stopped,
but next day the .tremor had increased and he became mentally
confused. Two days later his condition had deteriorated
further: he had a coarse generalised shaking affecting his whole
body, present at rest, and accentuated on attempting any
voluntary movement. His speech was slurred and jerky.
There was a general increase in muscular tone and in the deep
reﬂexes; the plantar responses remained ﬂexor. He was completely disoriented in both space and time and had vivid
frightening hallucinations. His extreme restlessness and
picking at the bedclothes suggested alcoholic delirium tremens.
From time to time he had lucid intervals during which he had
considerable insight into his condition. Repeated large oral
doses (10-15 m1.) of paraldehyde subdued the tremor and
relieved the hallucinatibns for three to four hours at a time.
This striking clinical picture persisted for a week and then
gradually subsided. By March, twelve days after the mecamylamine treatment had been stopped, the hallucinations had
disappeared and the patient’s mental state had returned to
normal. He could now remember in detail what had happened
during his delirium. Slight tremor persisted for a further two
days before ﬁnally clearing. During this period he had been
treated with subcutaneous pentolinium because his blood—
pressure had risen after the cessation of hypotensive therapy;
but it was difﬁcult to keep his blood-pressure down, because
he was conﬁned to bed. He was discharged from hospital on
March 14, 1957, taking two injections of pentolinium daily;
his blood-urea level had fallen to 38 mg. per 100 ml.
Readmission.——Four months later he was readmitted with
uraamia and left ventricular failure and died in ﬁve days.
Necropsy

There was atheroma of the blood-vessels at the base of the
brain, the gyri were ﬂattened, but no localised abnormality was
found on section of the brain. The kidneys showed lesions
of malignant nephrosclerosis.
Case 2.—A woman, aged 65, was admitted to hospital in
July, 1956, with left ventricular failure. She had eight weeks’
history of exertional dyspnoea. Her blood-pressure was
300/160 mm. Hg, and she had hmmorrhages and soft exudates
in her fundi. Her blood-urea level was 30 mg. per 100 ml.
She was treated with digitalis, mersalyl, and hypotensives—
at ﬁrst subcutaneous pentolinium and later oral mecamylamine.
When ﬁrst seen at Hammersmith Hospital in September, 1956,
she was very much improved symptomatically, but her bloodpressure was 200/130 mm. Hg, and the dosage of mecamyla—
mine was increased from 12-5 to 20 mg. twice daily. In
October the dosage was further increased to 45 mg. daily; but,
although this dosage did not control the hypertension, urinary
retention developed and she was admitted to hospital on
Oct. 29, 1956.
On admission she was cooperative and well oriented but somewhat apprehensive and overexcitable. Her blood-pressure was
290/140 mm. Hg, and soft exudates but no papilloedema were
noted in her fundi. There was no sign of heart-failure. Her
urine contained albumin, and her blood—urea level was 66 mg.
per 100 ml. Mecamylamine therapy was continued, the
dosage being slowly increased until on Nov. 6, 1956, she was
having 65 mg. daily. Her systolic blood-pressure remained
about 200 mm. Hg.
.Mental and nervous symptoms.—ln the early hours of NOV. 11,
1956, she became agitated and confused, having hallucinations
of voices and complaining of noises in the head. Her bloodpressure was 170/90 mm. Hg. She had general hyperreﬂexia.
K2

�M
500

ORIGINAL ARTICLES

During the succeeding days her confusion increased, and she
was disoriented for most of the time but had intervals of insight
and cooperation. Mecamylamine therapy was stopped on
Nov. 13. On Nov. 17 she was grossly confused and hallucinated, with paranoid delusions. She also had a coarse tremor of
arms and legs. Her blood-urea level had risen to 97 mg. per
100 m1. on Nov. 17 and to 140 mg. per 100 ml. on Nov. 20.
She became more agitated and violent and was completely
inaccessible. On Nov. 21 her condition made it necessary to
transfer her to a mental observation ward. She went progressively downhill, her blood-urea level rose to 296 mg. per
100 ml., and she died on Nov. 30, 1956, without any improvement in her mental state.

mid-poms. The kidneys were typical of malignant nephrosclerosis.

Case 4.—An electrician’s mate, aged 46, presented in January,
1956, with four months’ history of blurring of vision and

dyspnoea. His blood-pressure was 250/150 mm. Hg and he had
bilateral papilltedema with scattered retinal haemorrhages. His
urine contained albumin, granular casts, and occasional leuco—
cytes; his blood—urea level was 155 mg. per 100 ml. There
was no history to suggest previous renal disease. In view of
his visual symptoms hypotensive therapy was considered
advisable, in spite of the severe renal failure, and treatment
was started with subcutaneous pentolinium. At the end of
February his blood-urea level was 222 mg. per 100 m1.
Mecamylamine therapy—At this stage he was given oral
mecamylamine. He was not very sensitive to it, 60 mg. in
divided doses daily being needed to keep his blood—pressure
down to 160/100 mm. Hg. On April 14, 1956, six weeks after
mecamylamine therapy had been started, he was readmitted
to hospital with increasing trembling of his arms and legs for
the previous three days. On admission his blood—pressure was
160/90 mm. Hg. He still had bilateral papilloedema. He was
dyspnmic, and his jugular venous pressure was raised.
Mental and nervous symptoms.—He was drowsy and mentally!
confused. He had occasional spontaneous quivering of his
lips and a coarse irregular tremor of his limbs. His muscular
tone was increased; his lower limbs showed almost cogwheel

Necropsy

The left kidney was small (55 g.) with generalised ischazmic
atrophy suggesting occlusion of the renal artery. The right
kidney weighed 110 g., and its histology was that of ﬂorid
malignant nephrosclerosis. The brain showed a small area of
softening in the right internal capsule, and the cerebral arteries
were considerably affected by atheroma.

Case 3.—An electrical engineer, aged 53, was found in
January, 1956, to have a blood—pressure of 240/140 mm. Hg,
bilateral papilltedema, heavy albuminuria, and a blood—urea
level of 40 mg. per 100 ml. Malignant essential hypertension
was diagnosed, and he was treated with subcutaneous pentolinium and with rauwolﬁa alkaloids; but his“ blood—pressure
was difﬁcult to control, and during the next six months further
deterioration in the fundi and increasing cardiac enlargement

were noted.
On admission to Hammersmith Hospital in July, 1956, he
had heart-failure, blood—pressure 260/140 mm. Hg, bilateral
papilloedema, haemorrhages and exudates in his fundi, and
albuminuria. His blood-urea level was 139 mg. per 100 m1.
Treatment with subcutaneous pentolinium was continued,
a dosage of 30—40 mg. twice daily being necessary to control
his blood-pressure. Rauwolﬁa was not given. Chlorpromazine
50 mg. thrice daily was given because of vomiting. After a
month the heart-failure had cleared and the blood-urea level
fallen to 60 mg. per 100 ml.
Mecamylamine therapy—On Sept. 10, 1956, mecamylamine
therapy was started, and pentolinium was withdrawn gradually
during the next few days. The blood—pressure was not satisfactorily controlled during the period of transfer, but by Sept. 17
it was down to 140/80 mm. Hg, with the patient in the erect
position, for most of the day. This was achieved with a dosage
of 20 mg. mecamylamine thrice daily. By now the blood-urea
level had risen again to 100 mg. per 100 ml. The fundi still
showed papilloedema, but there were no fresh exudates or
haemorrhages.

Mental and nervous symptoms.—On Sept. 24, 1956, shaking
of the limbs and trunk was ﬁrst noted. This tremor also
affected the face and tongue; it was coarse and present at rest
but exaggerated on voluntary movement. The speech was
jerky and difﬁcult to understand. There was a general increase
in muscular tone; the tendon—reﬂexes were exaggerated, and
knee and ankle clonus could be elicited; the plantar responses
were ﬂexor. Mecamylamine was withheld after it had been
taken for fourteen days, and pentolinium therapy was restarted;
but the tremor increased, and four days later the patient
became drowsy and confused. He was now disoriented and
hallucinated, speaking to imaginary people and seeing snakes
and insects crawling across his bedclothes. His body shook so
violently as to rock the whole bed. Paraldehyde reduced the
tremor somewhat, but he remained confused and steadily
deteriorated. His blood-urea level rose to 170 mg. per 100 ml. ,
his urinary output fell, and he died, after repeated attacks of
left ventricular failure, on Oct. 7, 1956.
Necropsy

The brain was overweight (1490 g.) and oedematous, with
a small area of recent softening at the posterior end of the
putamen on each side and a recent small haemorrhage in the

THE LANCET

rigidity. His tendon-reﬂexes were uniformly increased, and
he had bilateral ankle clonus. His plantar responses were
ﬂexor. Hypotensive therapy was stopped, and he was treated
only with digoxin, but the confusion and tremor persisted,
and he died on April 16, 1956.

Necropsy

'

The kidneys showed the changes of malignant nephrosclerosis. The brain showed cerebral oedema, but no localised
lesion or other abnormality.

Discussion
The clinical picture was similar in each of these four
patients. In three the ﬁrst neurological abnormality to be
noted was a coarse tremor which affected the trunk and
head as well as the limbs and caused difﬁculty with speech.
It was variable in the early stages, perhaps hardly noticeable when a limb was at rest, but brought out when voluntary movement was attempted. The shaking of the trunk
made it look as if the patient was shivering. The tremor
was equally present on both sides of the body. At its
height it was so violent in two patients as to shake the
whole bed. Mental symptoms were observed before the
tremor in one patient, but in the others a few days after
the tremor. They consisted of a clouding of consciousness with confusion and disorientation, together, in three
cases, with hallucinations which were usually visual but
sometimes also of hearing or of touch. The mental state
ﬂuctuated, and there were lucid intervals, with some
insight, between periods of extreme delirium. Both tremor and mental symptoms were alleviated temporarily by
administration of paraldehyde, in case 1 strikingly so. In
this patient, who recovered from the episode, the mental
abnormalities disappeared ﬁrst, the tremor persisting for
a few days before ﬁnally clearing.
Examination of the nervous system in these patients
revealed a general increase in muscle tone, symmetrically
exaggerated tendon-reﬂexes with clonus, and ﬂexor
plantar responses. In no case were any lateralising signs
found. Electroencephalography in three cases gave
records which were difﬁcult to interpret because of arte—
fact due to muscle tremor; there was complete absence of
alpha rhythm, but in no case was positive evidence found

�8 MARCH 1958

501

ORIGINAL ARTICLES

either of a general metabolic disturbance or of a localised

lesion.

The patients all had severe hypertension. In two this
was frankly malignant, with papillaedema; in the other
two the presence of active retinitis and progressive renal
failure indicated that the hypertension was in a premal—
ignant phase, and at necropsy lesions of malignant nephro—
sclerosis were found in the kidneys. Renal function was
impaired in all. In three there was gross renal failure
with a raised blood-urea level which continued to rise until
death in case 1, who already had some renal impairment,
shown by a failure of concentrating power, but who had
a normal blood-urea level, there was a further deterioration in renal function and a temporary rise in the bloodurea level coincident with a urinary infection. This
patient’s blood-urea level had returned to normal by the
time that his neurological symptoms had cleared, but it
rose again later, and uraemia was present at his death four
months afterwards.
All four patients were receiving large dosages of meca5

mylamine (60—65 mg. daily) because smaller amounts had

not reduced the blood—pressure. The duration of admin—
istration of mecamylamine before neurological symptoms
developed varied from seven months in case 1 to fourteen
days in case 3. Case 1 had the least impairment of renal
function.
Since cerebral arterial disease is common in hypertensive patients, the question arises whether organic brain
damage due to haemorrhage or to infarction could have
caused the symptoms observed. Evidence of local cerebral lesions was found at necropsy in two cases: in the
right internal capsule in one case; and in both basal
ganglia and the pons in the other. The whole clinical
picture, however, was more like a toxic confusional
reaction, bearing in its fully developed state a striking
resemblance to alcoholic delirium tremens. The symmetry of the tremor, the absence of any lateralising signs
in the central nervous system, and particularly the complete disappearance of symptoms in case 1 after mecamylamine had been withheld suggest strongly that this drug
was to blame. In the patients who did not recover,
uraemia and death supervened probably before sufﬁcient
time had elapsed to allow the mecamylamine to be
cleared from the body.
Mecamylamine is a secondary amine and freely diffusible across cell membranes. There is evidence that
this drug is concentrated within the cell (Milne et al.
1957). It is therefore likely that its mode of action differs
from that of ganglion-blocking agents such as hexamethonium and pentolinium, which are quaternary ammonium compounds and are distributed only in the extracellu—
lar ﬂuid. That mecamylamine has a different, and previously unrecognised, mode of action at the neuromuscular
junction has been shown by Bennett et al. (1957). From
this it might also be expected that mecamylamine, apart
from producing the same side—effects due to parasympathetic blockade as other ganglion—blocking drugs,
might also have toxic actions from which methon—
ium compounds are strikingly free. There is some experimental evidence of a direct toxic action on the central
nervous system. Rats given mecamylamine in large
doses develop a tremor and have generalised convulsions
before death (Milne et al. 1957).
The frequency of this complication of treatment is not
certain. Doyle et al. (1956), Smirk and McQueen (1957)
and Kitchin et al. (1957), in their accounts of clinical

experience with mecamylamine, do not mention any
neurological symptoms related to its administration.
The four cases described here occurred among ninety
patients treated with mecamylamine at this hospital
(twenty of them with malignant hypertension). The
average daily dosage of mecamylamine in the whole
series, however, was only 35 mg. , and only sixteen patients
received more than 50 mg. daily. Moreover, this is a
selected group of patients, including some with severe
hypertension who were speciallyreferred.
In addition to the cases described in detail above,
three other patients treated with mecamylamine developed
a tremor without mental symptoms: a woman, aged 31,
with malignant hypertension and systemic lupus erythematosus and a woman, aged 51, with malignant hypertension and renal-vein thrombosis, both with moderate
impairment of renal function (blood-urea level 40—70 mg.
per 100 ml); and a man, aged 51, with malignant essen—
tial hypertension and urxmia (blood-urea level 114 mg.
per 100 ml.). The daily dosage of mecamylamine in these
patients was 25, 50, and 30 mg. respectively. In the two
women the tremor disappeared when the dosage of
mecamylamine was reduced and pentolinium was partly
or wholly substituted. It certainly seems that patients
with severely impaired renal function are much more
likely to develop symptoms of neurotoxicity while taking
mecamylamine: of ﬁve patients in whom the blood—urea
level was 100 mg. per 100 ml. or higher at the start of
treatment four developed tremor and three of these mental symptoms. This complication is presumably related
to the retention of mecamylamine in the body, its urinary
excretion being reduced in renal failure (Milne et al.
1957).

Summary
Four cases are described in which a syndrome of
tremor, mental confusion, and delirium developed under
treatment with mecamylamine. Tremor developed in
three other patients.
This complication of mecamylamine treatment
occurred in patients receiving large dosages thereof
(60—65 mg. daily); all these patients had or subsequently
developed malignant hypertension and in all renal func—
tion was impaired.
We thank Prof. J. McMichael and Dr. M. D. Milne for their
help and advice; and Dr. I. F. Goodwin for permission to report
a patient under his care.
REFERENCES

Bennett, G., Tyler, C., Zaimis, E. (1957) Lancet, ii, 218.
Deming, . B., Hodes,M . E., Edreira, J. G., Baltazar, A. (1957) New
Eng]. E.Med. 256, 739.
Doyle,A ,y,Murph E A. Neilson, G. H. (1956) Brit. med. ff. ii, 1209.
Mo yer,]. H. (1955)]. Lab. clm. Med. 46, 815
Ford, R. Dennis,E.,
Freis, E. D. (1955) Lancet, ii, 977.
Kitchin, A. Lowther, C. P. Turner, R. W D. (1957) 1'b1'd. p. 605.
Milne,M. D., Rowe, G. G., Somers,K., Muehrcke,R. C., Crawford,M. A.
(1957) Clin. SE1. 16, 599.
Schneckloth, R.E ,Corcoran, A. C. Dustan, H. P., Page, I.
3'. Amer. med. Ass. 162, 868.
Smirk, F. H., McQueen,E G. (1957) Brit. med. 3‘.1, 422.

H

(1956)

“ How then does a good physician help a patient to face
death and, accepting the ways of nature, to meet it? It is not
done by all the busy paraphernalia of scientiﬁc medicine,
keeping a vague shadow of life ﬂickering when all hope is
gone. . . . If man lives as a stranger in a lonely crowd, he dies
utterly alone. Whereas his entry into the world is the ﬁrst
stage of the dissolution of an intimate partnership with his
mother, his ﬁnal departure is the ultimate in solitary procedures.”——WILLIAM B. BEAN, Arch. intern. Med. 1958,
101, 201.

�W

502

ORIGINAL ARTICLES

ESSENTIAL FATTY ACIDS AND IDIOPATHIC
HYPERCALCIEMIA OF INFANCY
A. T. JAMES
J. WEBB
Ph.D. Lond.

and then after roller drying of this concentrated milk.
No loss of these two acids was found, although the same
experiment was repeated several times.
Table I also shows the linoleic-acid + linolenic-acid
contents of the same sample of milk after storage under
various conditions. After three months at room temperature
or at 37°C the “ essential ” fatty-acid content had fallen
to two-thirds of the original value 5 after six months’
storage under similar conditions the “ essential”
fatty acids had dropped to less than half their previous

B.Sc. Lond.

THE NATIONAL INSTITUTE FOR MEDICAL RESEARCH, MILL HILL, LONDON

T.

STAPLETON

W. B.

MACDONALD

D.M. Oxon., M.R.C.P.

M.D. Melb., M.R.A.C.P.

ASSISTANT DIRECTOR

LECTURER

PEDIATRIC UNIT, ST. MARY’S HOSPITAL MEDICAL SCHOOL, LONDON

ATTENTION has been‘drawn
deﬁciency Of “ essential ” fatty

to the possible role of a
acids (linoleic and arachi—
donic acids) in the genesis of idiopathic hypercalcaemia
Of infancy (Lancet 1957). It has been suggested (Sinclair
1956a) that in the preparation of evaporated milks there
is some loss of essential fatty acids and an even greater
loss in the production of National Dried Milk made by
passage over hot rollers; thus infants fed on dried milk
preparations might receive a diet deﬁcient in essential
fatty acids. This suggestion could have provided an
additional explanation of the frequency with' which
hypercalcaemia of infancy has been recognised in the
United Kingdom, where dried milks are widely used,
although one established factor to explain this frequency
has been the extent of fortiﬁcation of infant foods with
vitamin D (British Medical journal 1956).
We have studied the fatty-acid composition of samples
of human milk, cows’ milk before and after drying by a
variety of commercial techniques, stored dried milk, and
evaporated milk. Similar analytical studies of whole blood
from three healthy infants have been made, as well as
from three infants with idiopathic hypercalcaemia; the
latter were studied both before and after treatment with
cotton-seed oil (a rich source of linoleic acid). The fattyacid analyses were made with the gas-liquid Chromatogram (James and Martin 1956).

value.

Comparative Analyses of Various Milk Preparations used in
'
Infant Feeding
Table II shows comparisons of the fatty-acid composition (major components only) of two samples of human
milk, fresh cows’ milk, roller-dried milk, National Dried
Nlilk, and ‘ Carnation ’ evaporated cows’-milk.
The
difference in the levels of linoleic + linolenic acids in

TABLE I—LINOLEIC-ACID CONTENT OF cows’ MILK DURING PROCESSING
AND STORAGE (As PERCENTAGE OF ACIDS IN THE RANGE C3-C20)

Milk

Under the conditions used for the fatty-acid analyses the
gas chromatogram does not differentiate between the cis-cis,
cis-trans, and trans—trans forms of linoleic acid. In addition
linoleic and linolenic acids (the C18 di- and tri-unsaturated
acids) are not separated; so‘ the ﬁgures reported refer to the
sum of these two acids. However, the linolenic-acid content
of all the fats studied is likely to be low.
Studies in collaboration with other laboratories have shown
excellent agreement between the gas chromatographic and
spectrophotometric techniques for determining (1) a combined
value for linoleic and linolenic acids and (2) arachidonic acid.
The linoleic acid isolated from cows’ milk by the gas chromato—
gram has been shown to be 9 : lZ-octadecadienoic acid by the
micro degradation procedure described by James and Webb
(1957).

Results
Changes in Fat-composition of Milk on Processing to Dried
Milk and on Storage
In Table I are listed the linoleic-acid + linolenic-acid
contents of fresh milk, the same milk after concentration,

Powder Powder
stored stored Powder
3 mos. 6 mos. stored
at room at room 3 mos.
8 temp- temp- at 37°
erature erature

Fresh concen-.
milk trated After
before roller
120/
t ota(l drym dryin

_

solids

(21%

Kincaid)

so

Linoleic acid +
linolenic acid

3-2

s

1

3-0

3-4

2-3

1-4

2-4

Powder
stored
6 mos.
at 37°

1-1

human milk and cows’ milk was less than has sometimes
been supposed; but the effect of diet on these levels has
yet to be determined.
“ Essential Fatty-acid ” Levels in Blood of Infants with

Methods
Each sample Of milk was extracted exhaustively with ether-ethanol
overnight to remove the lipids. Samples of whole blood were
similarly extracted. The lipid extracts were saponiﬁed with methanolic potassium hydroxide, and the non-saponiﬁable material was
extracted with petroleum ether. The alkaline solution was acidiﬁed
with 5N sulphuric acid, and the fatty acids were extracted with
petroleum ether. The extract was dried over anhydrous sodium
sulphate, and the acids were converted to methyl esters by reﬂuxing
with anhydrous methanolic hydrochloric acid. Samples were stored
in high dilution in petroleum-ether solution at +2°C, and the
solvent was removed by evaporation before applying the sample to
the gas-liquid chromatogram.

THE LANCET

.

Hypercalcaemia
Case 1.—A male infant, born on Feb. 21, 1956, who had
well-established hypercalcaemia, was studied at the age of
9 months. He was fed cotton-seed oil containing 500/0 w/w
of linoleic acid for twenty days. During the ﬁrst ﬁve days he
received about 5 ml. of cotton-seed Oil a day; during the next
twelve days about 8 ml. a day; and during the last three days
about 20 ml. a day. The serum—calcium (table III and ﬁg. 1)
had been high for so long that it seemed improbable that the
fall from 15-8 mg. per 100 ml. to 9-9 mg. per 100 ml. in ten
days was due to a chance variation in its level, although such
variations are known to occur. Analyses were made of the fatty
acids of whole blood taken from this child before, while, and
after he was given cotton-seed Oil. NO signiﬁcant change
TABLE II—MAJOR COMPONENTS OF MILK FATS FROM VARIOUS SOURCES
EXPRESSED AS PERCENTAGE OF FATTY ACIDS IN RANGE C3-C20

Human milk
Sample
1, ten
days
after
start of
lactation

Acid

Myristic
. .
Branched C15. .

nC15

..
Palmitoleic

..

Palmitic
Branched
unsat. C17

nC17

. .

.

Linoleic
Oleic . .
. .
Isomers of oleig
acx

Stearic
. .
Poly-unsat. C20
(not arachidonic)

Cows’ milk

Sample
2, three
mos.
Fresh
after
start of
lactation

5-7
0-5
0-8
3-9
26-5
1-5

9-0
0-2
0-4
2-6
20-0

0-7
5-1
38-6

Trace
4-4
46-0

0-7
3-2
23-3

12-1
1-8

7-7

10-6
1-6
1-2
2-0
16-6
2-0

1-1

36

3-5
26-1
3-1

0-6
4-1
30-4
10-0

0-8
4-4
26-0
5-1

10-3

12-0

10-5
1-0

13-8
2-0

.

0-8
1-0
2-2
26-4
1-5

Not measured
Not
measured

National ‘
Cama—
OsterDried
’
milk
Milk
tion ’
roller- bought tinned
dried
from a
milk
clinic
10-7
1-3
1-3
2-2
29-7
1-5

.

0-

‘

Dill";

.

.

. i

. .

.

EXPERIMEI‘EIAI.

r.

.5

.....;-.‘a' {II

HILLSIDE HOSPITAL

“24.53

GLEN OAKS, N. Y.

9-4
1-8
1-4

2-4
21-8
1-5

�Effects of Pitressin Hydration on the
Electroencephalogram
Paroxysmal Slow Activity in Nonepileptic Patients with Previous Drug Addiction

ABRAHAM WIKLER, M.D.
Surgeon (R), United States Public Health Service
LEXINGTON, KY.

0. s. MPMTWHT or

HEALTH,

tenement... MD

rustic mum:

sum!

ﬁEPRiN‘lED WITH PERMISSION FROM

“in"!!!

A. M. A. ARCHIVES OF NEUROLOGY ANi} P‘S‘IQHIATRY
VOL. 57-JAN. 194')"

HEV-J-L’EI" KV'.

�EFFECTS

PITRESSIN HYDRATION
ELECTROENCEPHALOGRAM

OF

ON

THE

Paroxysmal Slow Activity in Nonepileptic Patients with Previous Drug Addiction
ABRAHAM WIKLER, M.D.
Surgeon (R), United States Public Health Service
LEXINGTON, KY.

LTHOUGH hydration by forcing of ﬂuids and the use of pitressin

has long been employed to precipitate epileptic seizures for diagnostic purposes in persons suspected of having idiopathic epilepsy,1
no study has been made of the electroencephalographic changes produced by this procedure, either in normal or in epileptic subjects. 'A
single injection of pitressin has been reported to have no effect on the
electroencephalogram,” but no data have been found on the effects of
water intoxication except for the statement by Allen 3 that some experiments of this type on dogs had been attempted.
The present study was undertaken in an attempt to solve a clinical
problem. A patient at the United States Public Health Service Hospital was referred for electroencephalographic study because he exhibited
periodic episodes of antisocial behavior. A diagnosis of psychopathic
personality had been made, but it was desired to rule out epilepsy. A
routine electroencephalogram was essentially normal. A pitressin hydration test was then made with a view to provoking a ﬁt, antisocial
behavior or “epileptiform” changes in the electroencephalogram. Neither
a ﬁt nor antisocial behavior occurred during this procedure, but paroxysmal slow activity did appear in the electroencephalogram. This was
difﬁcult to interpret because of the lack of control data in the literature,
and therefore further investigations were made.
MATERIALS AND METHODS

The subjects for these experiments were 14 male patients at the United States
Public Health Service Hospital who were undergoing trearment for addiction
From the United States Public Health Service Hospital.
1. McQuarrie, I., and Peeler, D. B.: The Effects of Sustained Pituitary antidiuresis and Forced Water Drinking in Epileptic Children: A Diagnostic and
Etiologic Study, J. Clin. Investigation 10:915. 1931. Hilger, D. W.; Mueller,
A. R., and Freed, A. E.: The Pitressin Hydration Test in the Diagnosis of
Idiopathic Epilepsy, Mil. Surgeon 91:309, 1942.
2. Gibbs, F. A.; Gibbs, E. L., and Lennox, W. G.: Effect on the Electroencephalogram of Certain Drugs Which Inﬂuence Nervous .Xctivity, Arch. Int.
Med. 60:154 (July) 1937.
3. Allen, F. F.: Spontaneous and induced Epilegtifo: 1n Attacks in Dogs, in
"tr-rel iat. 102:67, 1945.
Relation to Fluid Balance and Kidney Function, f= m.
5

�to opiates while serving sentences for violation of the Harrison Narcotic Act and
who volunteered for this test. All these subjects had been in the institution six
months or more and had not used opiates habitually for at least that length of
time. Their ages varied from 32 to 46, with an average of 37.1. None gave a
history of epilepsy, and in no case had a seizure been recorded since the patient’s
admission to the institution. All were in good health. For 7 patients a diagnosis
of psychopathic personality was made on admission.
Electroencephalograms were made before and after pitressin hydration. Silversilver chloride cup electrodes were applied to the scalp, and bipolar recordings
were made from the frontal, precentral, parietal and occipital regions. The electroencephalograph was a four channel, capacity—coupled, ampliﬁer and oscillographic
apparatus with photographic recording on bromide paper. During the recording
the patient lay quietly on a comfortable bed in an electrically shielded, sound—
proofed, air-cooled room. An observer was always present to note movement
and to make sure the patient was not asleep. Records were taken before, during
and after hyperventilation.
Each record was analyzed as follows: A representative thirty second sample
was selected, and all waves over 5 microvolts in amplitude were measured and
counted. Paroxysmal activity was not included in the strip. The mean alpha
frequency was calculated by averaging all frequencies from 8 to 13 per second,
and the percentage of alpha activity was determined by calculating the time
occupied by such frequencies during a thirty second recording. A frequency spectrum was then plotted. The limits of individual variation from day to day were
determined on several records, and, with this method of analysis, the variation
in alpha frequency was found to be not more than 0.5 cycle per second, and that
in percentage of alpha activity, 12 per cent.
The method of hydration varied to a considerable extent because of differences in the ability of the. subjects to tolerate this procedure. In the ﬁrst few
experiments, pitressin was injected hypodermically every hour for seven hours
(in doses of 0.3, 0.4, 0.5, 0.5, 0.5, 0.5, 0.5 cc.), and the patient drank 500 cc. of
water every hour for eleven hours. Some patients were able to tolerate this,
but others suffered from vomiting and abdominal cramps. The procedure was
then altered by giving smaller doses of pitressin hourly for eight hours (0.2, 0.3,
0.3, 0.3, 0.3, 0.3, 0.3, 0.3 cc.) and administering 1,000 cc. of 5 per cent dextrose
in distilled water intravenously every two hours until a total of 5,000 cc. had
been given during the eight hour test period. Some minor modiﬁcations
were
made in the dosage in individual cases.
The patients were admitted to the research ward in the morning, and preliminary physical examinations and records of pulse, temperature, blood pressure,
respiration and weight were made. An electroencephalogram was made in the
afternoon. Pitressin hydration was begun early the next morning, and the patient
was weighed at frequent intervals. Another electroencephalogram was; made the
same afternoon, after maximum ’hydration had been achieved. The patients
were closely observed, and records of blood pressure, pulse, respiration and
temperature were made every four hours during the period of hydration. A regular'
diet was prescribed, but coffee, tea and soup were excluded.
RESULTS

Clinical Observations—Some of the patients were fairly comfortable
during these procedures, but most of them had some degree of discomfort, chieﬂy nausea, abdominal cramps and occasional vomiting.

�Considerable puﬂiness of the face appeared in a few patients. In none
did alarming reactions of circulatory nature appear, and there were no
signiﬁcant changes in pulse rate 'or blood pressure. No epileptic seizures
of any kind were precipitated. It was found that the smaller doses
of pitressin (0.3 cc.) were just as effective in inhibiting diuresis as
larger amounts and produced less discomfort. On the morning fol—
lowing pitressin hydration voluminous diuresis took place, and the
patient’s weight returned rapidly to or slightly below the control level.
Electroencephalographic Observatiom.—The data are summarized
in the table. The average gain in weight at the end of hydration was
Eﬂects of Pitressin Hydration on

the;

Electroencephalogram

r—A—‘M—q

Total Per Cent Alpha Frequency

Alpha Percentage

Snb- Pitres- Gain in
ject sin.
Body
Differ
No. Cc. Weight Before After ence Before After

Difference

1

3.4

5.3

9.9

10.1

+0.2

71.0

73.7

+

2

3.4
3.2
3.2

5.0
4.5
2.7

10.2
11.1
10.7

9.8
10.6

—0.4

10.5

——0.2

83.5
47.3
42.3

82.1
40.0
63.3

— 1.4
— 7.3

2.6
5.1

11.5
11.6

10.9
11.4

~0.6

42.7
57.4

42.2
67.8

— 0.5

3
4

5
6

3.0
3.0

4

—-0.5

—0.2

8

3.2
2.6

1.8
3.2

9.9
10.3

10.0
10.0

+0.1

—-0.3

87.1
76.2

90.8
67.7

9

2.5

7.3

10.3

9.7

—0.6

74.3

58.9

10

1.3

4.3

11.5

11.5

0.0

22.6

22.9

11

1.3

5.3

11.1

10.5

—0.6

42.9

63.9

12

1.3

4.4

10.9

10.7

—o.2

63.3

41.2

13
14

1.7
1.0

5.3
3.9

10.4
11.1

10.4
10.6

0.0

67.0
60.8

61.2
46.9

7

——0.5

2.7

Comment

Shift to slow side and paroxysmal delta activity after
hydration

721.0 Shift to slow side after

hydration

+10.4 Shift

to slow

side and parox~

ysmal delta activity after

+

3.7
— 8.5

hydration

"

Shift to slow lid-e after
hydration
—15.4 Shift to slow side and paroxysmal delta activity after
hydration
+ 0.3 Paroxysmal delta activity
after hydration
+21.0 Shift to slow side and paroxysmal delta activity after
hydration
-—-92.1 Paroxysmal delta activity
after hydration

5.8
—13.9
—-

Shift to slow side and paroxysmal delta activity after
hydration

’_—“__——-—-———————
3
4.1

or
per cent of body weight. In 3 of the subjects the mean
alpha frequency was lowered 0.6 cycle per second, but in the remainder
the changes in alpha frequency, although mostly in the direction of
slowing, were within the range of daily variation. In half the patients
the frequency spectrum showed a deﬁnite shift toward the slow side
(ﬁg. 1). In the remainder no deﬁnite shift could be observed. In no
case was there an unequivocal shift toward the fast side of the spectrum.
The most striking change, however, was the appearance of bursts of
slow activity (6 cycles per second) of moderately high amplitude in
7 of the 14 records after hydration (ﬁg. 2). All but 1 of the control
recoyds were essentially normal and contained no paroxysmal slow
activity, either before or after hyperventilation. In the one record
Kg.,.

�a scant amount; of paroxysmal 6 per second rhythm was
present, and

this activity was greatly increased after hydration. In those records
which showed paroxysmal :3 per second rhythms, such activity appeared
in short bursts of 8 to 15 waves two to six times during the entire
run,
which was usually about three or four minutes. The incidence of
paroxysmal slow activity was not entirely the same as that of shift in the
frequency spectrum to the slow side. In 2 records there was a shift
but no paroxysmal slow activity. and in 2 the latter was
present but
there was no shift in the spectrum. There was no correlation between
the incidence of paroxysmal slow activity and the degree of hydration
or the total amount of pitressin injected. Nor was there a correlation
between the admission diagnosis of psychopathic personality and shift
in frequency spectrum or incidence of slow activity. Such changes
in the electroencephalogram after pitressin hydration were
present in
50 per cent of patients with diagnoses of psychopathic
personality and
in 50 per cent of the others. Consciousness was not grossly disturbed

5 6-7 89

IOII

l2!) l4 '5'l6 I?

2| M27 30
Fig. 1 (case 1).-——Eﬂ'ects of pitressin hydration on the frequency spectrum of
the electroencephalogram. The solid bars indicate values before, and the outline
bars values after, pitressin hydration. On the abscissa are plotted frequencies in
terms of cycles per second; on the Ordinate, the number of such frequencies in a
thirty second record. Note the shift to the slow side after hydration.
IS

during the electroencephalographic recording so far as could be determined by the observer in. the electroencephalographic chamber.
COMMENT

Although none of the patients gave a history or showed clinical
evidence of epilepsy, the electroencephalograms obtained on‘ half the
subjects after pitressin hydration could be termed “epileptoid” because
of the presence of paroxysmal slow activity. Furthermore, it is noted
that this change occurred in only half the subjects and was independent
of’the degree of hydration. This suggests that the appearance of “epileptoid” changes in the electroencephalogram depends on individual susceptibility. It should be emphasized here that the persons subjected to
this test were not truly representative of a “normal” group, since all

�had previously been drug addicts and recent studies at this institution
have shown that the great majority of the drug addicts fall into either
the psychopathic or the psychoneurotic group.‘
The ﬁndings provide a partial answer to the clinical problem which
gave rise to this study. It is evident that the appearance of paroxysmal slow activity in the electroencephalogram after pitressin hydration
cannot be considered indicative of epilepsy in the clinical sense of the

W.
wwmwww.WWwwmwwwwMaW
A

l

2
3

4

.

”NM.“.V“Mm”,rwyﬂ-MMMW‘MWﬁ«MV"V’AM'W‘W(VM/MVW‘v’w..”’V"'V’”‘tM/“ﬁ'“MP“v
.

WW WW",MM:A

2
3

A'

ﬂ

,1

,
35‘3“”

'W

”Ki—mﬁmmwmwwm
IVWWWWWM

mm

.

A

“A

I

.5.

1

v

n________r_______,____

vwmsxwlMMWWmswwm
.

4

.—

.

g.

.l

W.NWMNWJWW¢MW{MINWMMMWW

N‘MMWEMWMWMMMWWwmwwwvwﬂwawwWW
-

2
3

ii

“WW
MW
M;WWWMWIW{V\I‘JNWW
”Wm-WWW
h___________n_________n

B

I

'

‘JWMWN
MMWWi‘Wlw

5‘

WWW“V““M/“V’WMWMWWW-wWWW"
t

5-

H

2
3
4

“W

.
hW‘Wmm»

‘

,

n

n

,-

[-1

4 M'._M"‘wfw”.“f{‘wﬂgﬂ/ﬁfﬁAewMﬂWWNVI‘ﬁM'JWI/l {\VWK‘WAWMV

l

W“

W.’x{AMA}.A!W‘My/WWJfNUWWWW'WIl/V”NWAAfv’KVM/MM'y‘M‘fMﬁWV’V/‘N‘
F“

'

WVNVWMmtwAvW‘fPMdWWM
.

,

M

B

-

-

'1

2-.

a

a

I

r‘v‘wAMN/WwwwwwwwMMNMWx/vvwvvwv

.WW“.[it~ww’hwtwmwmmwniM”"¢"MWWWW‘MW
n

P

Wﬁ__u—rh———nn-_
of pitressin hydration
the

“W-

Fig. 2 (case 6_‘i.«—~-Effects
on
electroencephalograg:
(bipolar recording from the frontal (1), pretentral (2), parietal (3) and
occipital (4) leads; calibration 50 microvnlts; time in seconds). A and B
are control records made before and after hyperventilation, respectively; A' and 8’,
records obtained before and after hyperventilation after pitresszin hydration. Note
the paroxysmal 6 per second activity
gr hydration.
4. Aldrich, C. K., and Ruble, D.

Addicts, to be publishsd.

x."

:

Studizs

w“

the Pe sonalities of Drug

�term. However, it does suggest the possibility that the physiologic
mechanism which underlies the production of clinical seizures by this
method is also operant in certain susceptible nonepileptic persons and
that, essentially, quantitative threshold differences determine whether
or not, in any given case, clinical seizures will be precipitated. It
would be illuminating, in this connection, to compare the group observed
in this investigation with “normal” subjects and with persons known
to have epilepsy with special reference to the incidence of paroxysmal
slow activity. in the electroencephalogram after pitressin hydration.
However, such studies have not yet been made.
SUMMARY AND CONCLUSIONS

The electroencephalograms of 14 nonepileptic men with previous
drug addiction were studied before and after pitressin hydration. No
clinical seizures were induced by this procedure.
The alpha frequency showed a tendency to slowing after hydration,
but in only 3 instances was the degree of change greater than that
which could be expected from day to day variation. There was no
signiﬁcant change in the percentage of alpha activity.
In half the records there was shift to the slow side of the frequency
spectrum.
In half the records paroxysmal slow activity of moderately high
amplitude appeared after hydration.
There was some correlation between the appearance of paroxysmal
slow activity and the shift of the frequency spectrum to the slow side,
but no correlation with the degree of hydration or the amount of pitressin
'
administered.
The possible signiﬁcance of these observations in their relation to
idiopathic epilepsy is discussed.
United States Public Health Service Hospital.

�Reprinted from THE

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Vol. 98, No. 4, April, 1950

EFFECTS OF METHADONE AND MORPHINE ON THE
ELECTROENCEPHALOGRAM OF THE DOG
ABRAHAM WIKLER

AND

SOL ALTSCHUL‘

U. S. Public Health Service Hospital, Lexington, Kentucky

Received for publication January 26, 1950

|

J-.
.4.

‘v...

The present study was made as part of a comprehensive investigation of the
comparative actions of methadone and morphine on the central nervous system
(1, 2). The dog has been utilized in these studies because the effects of small
doses of methadone and morphine on this species are analogous to those in man
(3—5). In particular, however, we wished to compare the effects of large doses
of methadone and morphine on the electroencephalogram since such studies cannot be made with safety in man. Some of the observations made in the course
of these investigations are also of interest with reference to the pharmaco—physiologic aspects of convulsive seizures.
Electroencephalographic studies were made on eleven dogs. In eight of these
animals the effects of methadone and morphine were observed without previous anaesthesia or curare. This was accomplished by the insertion of wire or “mercury cup” electrodes
which made contact with the dura over the desired cortical area. The mercury cup electrode (ﬁgure 1) was inserted under aseptic conditions and permitted the recording of electroencephalograms without muscle artifacts in the same dog as often as desired over a
period of several months. In one experiment a bipolar wire electrode insulated except for
the tip (interelectrode distance about 1.0 mm.) waslinserted into the left anterior lateral
hypothalamic area and ﬁxed in place by cementing its upper end to a metal cylinder which
was screwed into the calvarium along with other screw leads which served as cortical electrodes. In these eight dogs the electrodes were inserted under sodium pentobarbital (Nembutal) anaesthesia but experiments were not made until one or more days later after full
recovery from the anaesthetic. In the three remaining dogs screw electrodes were inserted
into the calvarium and in the midline plane of the sphenoid bone (Via the oropharynx to a
depth of 1.0 to 2.0 mm. below the ﬂoor of the sella turcica). This was done under ether
anaesthesia and the animal was then curarized (“Intocostrin” 1.5 cc. I.V. initially and 0.5
cc. I.V. at about 40-minute intervals thereafter) and artiﬁcial respiration was maintained
through a tracheal cannula. Experiments were not begun until the ether effects had worn
off as indicated by a return of the electroencephalogram to a normal pattern. In all dogs,
silver disc electrodes were also ﬁxed on the ears to serve as reference leads. In most experi—
ments, a 3-channel Grass resistance-capacity coupled inkwriting electroencephalograph
was used; in some, a four channel resistance-capacity coupled ampliﬁer-oscillograph was
used with photographic recording. Shielding of the animal was accomplished by a wire
screen grounded cage.
The motor patterns of convulsive seizures produced by large doses of methadone or
morphine were studied in six other dogs. After one or more seizures they were terminated
by intravenous injection of Nembutal. Moving picture records were made for subsequent
analysis of the convulsive patterns.
The dose range for methadone was 2.0 to 75.0 mgm./kgm. and that for morphine, 5.0 to
METHODS.

1

Now Resident Psychiatrist, Illinois Neuropsychiatric Institute, Chicago,
437

9

(as.

is

‘

it

111.

�438

ABRAHAM WIKLER AND

son

ALTSCHUL

initial doses were given subcutaneously while subsequent doses were given subcutaneously or intravenously.

350.0 mgm./kgm. In all experiments

The pre-medication resting electroencephalograms of the dogs varied considerably from dog to dog and on different days in the same dog (ﬁgure
2, control records). However, the changes produced by methadone or morphine
were quite different from spontaneous variations in electroencephalographic pattern. After small doses of methadone (2.0 mgm./kgm.) or morphine (5.0 to 10.0
mgm./kgm.) irregular high voltage random slow waves appeared in cortical tracings although fast activity present in the control records persisted (ﬁgure 2).
After larger doses of methadone (about 75.0 mgm./kgm.) or morphine (about
RESULTS.

LUGITE CUP

RUBBER DAM
MERCURY

,4 SILVER

m:
_%/

WIRE

\

mLT‘T"

\
,//ﬂ\\\\\\\m&amp;\‘

////

Hm

'

.

.

,l y }

2

-'

,,

,

J
‘

._

_—

SCALP

———MUSCLE
SKULL
DURA

—r---CORTEX

FIG. 1. Mercury cup electrode for recording E.E.G. from dura in unanesthetized and

uncurarized animals. Under Nembutal anesthesia, the scalp and muscles are incised and a
threaded trephine opening is made in the skull. The mercury cup is screwed in place and
the scalp sutured over it. After recovery from anesthesia and healing of scalp wound, recording of EEG. is made by inserting a sharp-pointed, ﬁne but rigid needle, insulated exis
The
latter
conthe
into
dam
rubber
and
the
mercury.
scalp
for
cap
the
through
tip,
cept
nected by the stout silver wire to the underlying dura. After completion of record, the
needle is removed. Mercury is rescaled in cup by rubber darn. Procedure may be repeated
indeﬁnitely over a period of several months.

200.0 mgm./kgm.) the earliest change (about one to three minutes after sub—
cutaneous injection) was the appearance of bursts of high voltage moderately
fast activity (ﬁgures 3B and 4B) in the cortical tracings. Later, high voltage
slow waves appeared in the cortical tracings (ﬁgures 30 and 4C). In several exof
of
bursts
high voltage
the
another
change
was
striking
appearance
periments
less
and
(ﬁgure
4D)
after
dome
morphine
mal”—like
and
spike
sequences
“petit
frequently and less typically after methadone (ﬁgure 3D). These complexes apassociated
not
but
both
were
from
hemispheres
in
cortical
or
one
tracings
peared
with any signiﬁcant change in tracings from sphenoid leads (ﬁgures 3D, 4D, and
4F). In some experiments bilaterally synchronous spike and dome activity in
the cortical tracings could be induced by sudden loud noises (clapping hands—ﬁgure 4D). Relatively early (twenty to thirty minutes) after methadone
seizure
discharges
spike
voltage
after
high
four
morphine
to
hours)
later
(two
or
appeared synchronously in the cortical tracings (ﬁgures 3E and 4G). In one of

.-.

f?
n

r

�438

ABRAHAM WIKLER AND SOL ALTSCHUL

In all experiments initial doses were given subcutaneously while subsequent doses were given subcutaneously or intravenously.

350.0 mgm./kgm.

The pre-medication resting electroencephalograms of the dogs varied considerably from dog to dog and on different days in the same dog (ﬁgure
2, control records). However, the changes produced by methadone or morphine
were quite diﬁerent from spontaneous variations in electroencephalographic pattern. After small doses of methadone (2.0 mgm./kgm.) or morphine (5.0 to 10.0
mgm./kgm.) irregular high voltage random slow waves appeared in cortical tracings although fast activity present in the control records persisted (ﬁgure 2).
After larger doses of methadone (about 75.0 mgm./kgm.) or morphine (about
RESULTS.

W
/// '

LUCITE CUP

RUBBER DAM

/

MERCURY

SILVER wnRE

\m+.—'

\
//ﬂ\\\\\\\\\\\‘
3W
,1
.
..,\//l
0/” V

x////

W,

,

..

5

‘.,-

'_'

23932,,

"ww/

,

..

y

i

.

'
“‘8-//////////%m,m

.

J

\N
1

1

2

_

SKULL
DURA

-————coarsx

FIG. 1. Mercury cup electrode for recording E.E.G. from dura in unanesthetized and

uncurarized animals. Under Nembutal anesthesia, the scalp and muscles are incised and a
threaded trephine opening is made in the skull. The mercury cup is screwed in place and
the scalp sutured over it. After recovery from anesthesia and healing of scalp wound, recording of EEG. is made by inserting a sharp-pointed, ﬁne but rigid needle, insulated exis
con—
The
latter
the
into
dam
rubber
and
the
mercury.
scalp
for
the
cap
through
tip,
cept
nected by the stout silver wire to the underlying dura. After completion of record, the
needle is removed. Mercury is rescaled in cup by rubber dam. Procedure may be repeated
indeﬁnitely over a period of several months.

200.0 mgm./kgm.) the earliest change (about one to three minutes after sub—
cutaneous injection) was the appearance of bursts of high voltage moderately
fast activity (ﬁgures 3B and 4B) in the cortical tracings. Later, high voltage
slow waves appeared in the cortical tracings (ﬁgures 30 and 4C). In several exof
of
bursts
high voltage
the
another
change
was
striking
appearance
periments
“petit mal”-like spike and dome sequences after morphine (ﬁgure 4D) and less
frequently and less typically after methadone (ﬁgure 3D). These complexes apassociated
not
but
both
were
from
hemispheres
cortical
in
or
one
tracings
peared
with any Signiﬁcant change in tracings from sphenoid leads (figures 3D, 4D, and
4F). In some experiments bilaterally synchronous spike and dome activity in
the cortical tracings could be induced by sudden loud noises (clapping hands—
methadone
after
minutes)
to
thirty
(twenty
early
Relatively
4D).
ﬁgure
seizure
discharges
spike
voltage
after
four
high
morphine
hours)
later
to
(two
or
appeared synchronously in the cortical tracings (ﬁgures 3E and 4G).-Irr gnepf

W-."
:
"em
4"

,

‘

.1]

—

*Since the publication of“ 95. paper we -nvo substitutged
fdi'ﬁi's
an
the
since
Wire
latter
for
*"z’rplatinum
Silva.
a Fer-i 0d of time and permits
amalgam with mercury a
mercury to leak throughw

rel

~.

_

‘

.4

,

.

‘

‘

‘5:
3.:

�439

METHADONE AND MORPHINE ON EEG

three experiments with sphenoid leads, such spike seizure discharges appeared
in the basal lead as well (ﬁgure 3E) and were followed by a steady 25 per second
rhythm in the latter while the cortical tracings were isoelectric or showed only

l
N~VAVE

K..~u,,V‘.~
-.

v

I".

fl ,'
.w.”w“: ‘w‘ﬂxﬁﬂl‘ﬁ,'\"

I}

c

V

——.—-—_—.~.

.’

1

\

.-*.*'
-

9'

N\W’WW§;""MJ a?
u

:~'

.I.

$15”

A

,5

'—-

_

FIG. 2. Dog #70. Mercury cup electrodes in left fronto-parietal and right parieto-occipital regions. No anesthesia or curare. All tracings bipolar transcortical. Time in seconds.
Gain same throughout. A—control. Note predominantly fast activity. B—two and onehalf hours after methadone 2.0 mgm./kgm. subcutaneously. Note general increase in voltage
and admixture of irregular slow waves. C—control, two days later. Note irregular rhythms,

varying from 10—30 per second (large “spikes” are probably EKG artifacts). D—two and
one-half hours after morphine 10 mgm./kgm. subcutaneously. Note changes similar to
those in B.

slow activity (ﬁgures 3G and 3H). In another experiment the spike seizure discharge from the cortex followed immediately after a typical spike and dome paroxysm (ﬁgure 3G). In the single experiment with hypothalamic bipolar leads,
typical spike and dome discharges after morphine 20.0 mgm./kgm. (subcutane-

�440

ABRAHAM WIKLER AND SOL ALTSCHUL

WWW
WWWW
WWW/«WAN
EFFECTS OF METHADON 75 MG/KG. ON E.E.G. OF DOG

”AI—um...

axe

SMMA’“

A

”“1

smVI

WWW
WWWMMW
WWW
.

..

l

\

FIG. 3. Dog #102. Curarized. Artificial respiration. Screw electrodes in left anterior-

parietal, right posterior-occipital and basi-sphenoid regions. In all records, upper tracing
is right occipital to right ear, middle tracing is left parietal to left ear and lower tracing is
sphenoid to left ear. Calibrations on “A” apply to all records except “F” where gain was
reduced as indicated. A—control. Note mixture of fast and slow frequencies of moderate
voltage in cortical tracings and periodic 4 per sec. waves of moderate voltage on a back‘
ground of low voltage fast activity in basal tracing. EKG is shown to point out slow activity
in basal tracing is of approximately the same frequency as heart rate. B—three minutes
after methadone 75 mgm./kgm. subcutaneously. Note bursts of high voltage spikes in
cortical tracings and little change in basal tracing. C—ﬁfteen minutes after methadone.
Note admixture of high voltage slow waves in cortical tracing; occasional random spike
in basal tracing. D—nineteen minutes after methadone. Note burst of 2 per sec. dome

ously) appeared in the cortical tracing from one hemisphere; later the
spike components increased progressively in voltage and the pattern assumed

�441

METHADONE AND MORPHINE ON EEG

EFFECTS OF METHADON 75 MG/KG. ON E.E.G. OF
(CONTINUED)

006

WMWMMWWWWh
MUM/MtllttﬂtttttttttttltWWW

MNWWWMMWMWWW

WWWMWWMWMWWWWWWWMWWW

WWWWWWWWWWWMIWW
[WV

wwwwmwwmwwtwwmwwwwmwm
I
“0}N

FIG. 3 (Continued)

and spike discharges from left- parietal region alone. E—twenty-two minutes after metha-I
done. Note very high voltage seizure discharges synchronous1n all tracings, consisting of
repetitive spikes of about 8 pe1 sec. frequency, gradually becoming faster. F—twenty-eight
minutes after methadone during a second seizure discharge, shown at 1educed gain. Frequency 15 per sec. G—end of seizure Note steady low voltage 25 per sec. terminal discharge
in basal tracing while cortical tracings are practically isoelectric at ﬁrst, then show only
irregular slow activity. H~thirty- seven minutes after methadone. EKG and basal tracings
showing cardiac slowing and abrupt end of another seizure discharge followed by steady
25 per sec. low voltage activity.

that of a sustained high voltage spike discharge. The tracings from the contra-

lateral cortex and from the hypothalamus showed no signiﬁcant changes during
this period. In all instances, after subsidence of the seizure discharges the cor-

�442

ABRAHAM WIKLER AND SOL ALTSCHUL

EFFECTS OF MORPHINE 238 MG/KG. ON EEG. OF

006

M'L’NMWNWNWWW

WWWWW
7

lhll

I

fl

wwMMJ‘tWJlsl .«qulllllll 'uln kW] \liiWW”"AMMWMAN'"MW,“AA
.

:

:4

ii

D

respiration. Screw leads in right parieto-occipital,
left fronto-parietal and basi-sphenoid regions. In all records, upper tracing is right parietois
lower
and
tracing
left
to
is
fronto—parietal
left
ear
middle
tracing
to
right
occipital
ear,
record
middle
Note
records.
all
on
gain
refer
“A”
to
Calibrations
left
on
to
ear.
sphenoid
is almost twice that on the others. A—control. Note mixture of moderately high voltage
slow and low voltage fast activity. B—one minute after morphine 200 mgm./kgm. subcutaneously. Note increase in moderately high voltage fast activity in cortical tracings; there
is little change in basal tracing. C—twenty-seven minutes after morphine. Note admixture
of high voltage slow waves in all tracings. D—one-half hour after total of 238 mgm./kgm.
FIG. 4. Dog

7%

93. Curarized. Artiﬁcial

tical tracings were isoelectric for a few seconds and then high voltage slow activity appeared. In most experiments this sequence of events was repeated
several times after the last injection of either methadone or morphine.
The motor patterns of the seizures were similar after either drug except that

�443

METHADONE AND MORPHINE ON EEG

EFFECTS OF MORPHINE 238 MG/KG. ON E.E.G. OF
(CONTINUED)

006

mll‘léllllijlW-“meww
WSMI

,

FIG. 4 (Continued)

of morphine (24 mgm./kgm. I.V. 3% hours, and 14 mgm./kgrn. I.V. 4 hours after ﬁrst dose).
Note burst of high voltage spike and dome complexes from right parieto—occipital region

alone; irregular high voltage slow activity in basal tracing. E—seven minutes after D.
Burst of spike and dome complexes from right parieto-occipital region with synchronous
activity in left fronto-parietal tracing, elicited by clapping hands loudly. F—eight minutes
after E. Similar synchronous cortical discharges occurring spontaneously. G—continued
from F. Note burst of spike and dome complexes from cortical leads followed immediately
by seizure discharge of very high voltage spikes. No change in basal tracing. H—end of
seizure. No change in basal tracing.

they appeared sooner after large doses of methadone (ten to thirty minutes)
than after large doses of morphine (two to four hours). Clonic movements were
more prominent in the seizures produced by methadone. The morphine seizures
were predominantly tonic.

�444

ABRAHAM WIKLER AND SOL ALTSCHUL

between the effects of methadone and morphine on
the electroencephalogram have been reported in the cat (6). In this species small
doses of methadone produced diphasic spikes with admixture of slow waves while
larger doses produced seizure—like sustained spike activity. Small doses of morphine caused an increase in frequency while larger doses produced slow waves
and subsequent disappearance of electrical activity. These differences appear to
be peculiar to the cat for in our experiments with dogs, small doses of
either drug produced admixtures of slow waves while larger doses produced seizure-like discharges. The bursts of moderately high voltage spike discharges seen
early after methadone or morphine were very similar to the changes produced
ab~
in
of
this
the
species
cortical
in
the
electroencephalogram
rat;
morphine
by
olition of cortical electrical activity seemed to be due to anoxia since
brain waves reappeared after tracheal insuﬂiation of oxygen (7). In man also,
the effects of single and repeated doses of methadone and morphine on the electroencephalogram are comparable (5, 8). Likewise in chronic spinal and
in chronic decorticated dogs single and repeated doses of methadone and mor—
phine produce similar effects (1, 2). However, in our present studies, some quantitative differences between the effects of these drugs were noted. Convulsions
appeared much sooner after subcutaneous injection of methadone than after
morphine. Also “petit mal”-like spike and dome activity in the electroencephalogram were much more prominent after large doses of morphine than
after methadone. Electrical seizure discharges from subcortical basal structures
of
the
in
of
in
but
dose
methadone
none
experiment
one
after
large
a
were seen
experiments with morphine. However, this difference may not be a consistent
one since a sphenoid lead was used in only three experiments. Nevertheless, some
differences in the actions of methadone and morphine may be expected since
these drugs appear to exert different actions on enzyme systems concerned in
brain metabolism (9).
Our observations are also of interest with reference to the origin of the electrical signs of convulsive activity, particularly the spike and dome pattern.
Hursch (10) found that section of the corpus callosum did not alter the pattern
of bilaterally synchronous “petit-mal” discharges in the cortex. Jasper and
Drooglever-Fortuyn (11) and Hunter and Jasper (12) were able to produce spike
and dome and sustained spike activity in both cortex and thalamus by electrical
stimulation of medial thalamic structures. These observations suggest a subcor—
tical origin of “petit-ma ” complexes. On the other hand, Hayne, Belinson and
Gibbs (13) as a result of studies in man, concluded that “. . . The present ﬁndings do not suggest a subcortical but a cortical origin for the three per second
wave and spike of petit mal, because (a) the spike registers on the cortex as neg—
ative when referred to a relatively inactive area, (b) it can appear as an isolated
and purely focal discharge in one cortical area and (0) no evidence was found
that it is causatively related to thalamic or other subcortical activity.”
Our ﬁndings are strikingly analogous to those of the latter group since
after large doses of morphine electrical seizure patterns could, and most often
did appear in cortical tracings without concomitant signiﬁcant changes in tracDISCUSSION. Differences

�METHADONE AND MORPHINE 0N EEG

445

ings from sphenoid or hypothalamic leads, and spike and dome discharges were
frequently observed in cortical tracings from one hemisphere only. However,
while suggestive, our evidence is not conclusive with regard to the origin
of spike and dome activity since in our experiments the two cortical electrodes
were not in strictly homologous areas and our basal electrodes (sphenoid lead
and bipolar hypothalamic leads) could not be relied on to pick up electrical activity in the dorsal thalamus. Our records also indicate that the spike and dome
discharge and sustained spike activity are closely related since in several
instances after large doses of morphine a spike and dome pattern was followed
by prolonged sustained spike activity without interruption. Except for the question of the thalamic origin of these seizure discharges, these observations are
analagous to those of Hunter and Jasper (12).
It is also of interest to note that when a seizure discharge was recorded from
the sphenoid lead, this was followed by a sustained low amplitude 25 per second
discharge apparently originating in subcortical basal structures. This resembled
strongly the “after seizure” discharge seen in chronic decorticated cats following
electroshock (14). In the latter study, morphine appeared to alter the electroshock seizure pattern so that fast and slow sequences resembling “petit mal”
discharges were seen in some records. In our present investigation, this 25 per
second discharge appeared in the sphenoid lead tracings while cortical activity
was absent or of a different character. Such independent activity of subcortical
structures and cerebral cortex has also been noted after ﬂuoroacetate (15).
SUMMARY

The effects of small and large doses of methadone and morphine on the
electroencephalogram were studied in unanesthetized and uncurarized dogs and
in curarized dogs. The motor pattern of the convulsive seizures induced by large
doses of these drugs was also observed in different dogs.
2. A “mercury cup” electrode is described which facilitates the repeated recording of electroencephalograms from the dura over the cerebral cortex in unanesthetized and uncurarized animals, without interference due to artifacts from
the scalp and temporal muscles.
3. Small doses of methadone or morphine produce an admixture of fast and
high voltage slow activity in cortical tracings. Large doses of either drug produce seizure discharges which may appear synchronously in cortical and basal
tracings or in cortical tracings alone. The seizure discharges from cortical tracings were both of the spike and dome and sustained spike patterns. At times
the former passed over into the latter Without interruption. An “after-seizure”
25 per second low voltage discharge in the tracings from the sphenoid lead was
not associated with activity in the cortical leads.
4. The motor pattern of seizures induced in dogs by large doses of methadone
or morphine were essentially the same, although clonic movements were more
prominent in the methadone convulsions. These seizures appeared much sooner
after subcutaneous injection of methadone than after morphine.
1.

�446

'

ABRAHAM WIKLER AND SOL ALTSCHUL

REFERENCES
99°F!"

S"

WIKLER, A.: Am. J. Psychiat., 105: 329, 1948.
WIKLER, A., AND FRANK, K.: THIS JOURNAL, 94: 382, 1948.
SCOTT, C. C., AND CHEN, K. K.: THIS JOURNAL, 87: 63, 1946.
SCOTT, C. C., CHEN, K. K., KOHLSTAEDT, K. G., ROBBINS, E. B., AND ISRAEL, F. W.:
THIS JOURNAL, 91: 147, 1947.
ISBELL, H., WIKLER, A., EISENMAN, A. J ., DAINGERFIELD, M. A., AND FRANK, K.:
Arch. Int. Med., 82: 362, 1948.
LEIMDORFER, A.: Arch. Internat. Pharmacodyn. et de Therap., 76: 153, 1948.
CAHEN, R. L., AND WIKLER, A.: Yale J. Biol. Med., 16: 239, 1944.
ANDREWS, H. L.: Psychosom. Med., 6: 143, 1943.
GREIG, M. E., AND HOWELL, R. 8.: Arch. Biochem., 19: 441, 1948.
HURSH, J. B.: Arch. Neurol. Psychiat., 63: 272, 1945.
JASPER, H. H., AND DROOGLEVER-FORTUYN, J .: Res. Publ. Assn. Nerv. Ment. Dis., 26:
272, 1947.
HUNTER, M. B., AND JASPER, H. H.: J. Electroencephalog. Clin. Neurophysiol., 1: 305,
1949.
HAYNE, R. A., BELINSON, L., AND GIBBS, F. A.: J. Electroencephalog. Clin. Neurophysiol., 1: 437, 1949.
WIKLER, A., AND FRANK, K.: Proc. Soc. Exper. Biol. and Med., 67: 464, 1948.
WARD, A. A.: J. Neurophysiol., 10: 105, 1947.
»

E‘PSDSDF'?’

Hg...

12.

~

13.
14.
15.

�EXPERIMENTAL SCHIZOPHRENIA—LIKE SYMPTOMS

MAX RINKEL, M. D., H. JACKSON DESHON, M. D., ROBERT W. HYDE, M. D.,
AND

HARRY C. SOLOMON, M. D.
Boston, Mass.

Reprinted from
AMERICAN JOURNAL OF PSYCHIATRY
Vol. 108, No. 8, February, 1952

Printed in U. S. A.

�[Reprinted from THE

AMERICAN JOURNAL OF PSYCHIATRY,

Vol. 108, No. 8, February, 1952]

EXPERIMENTAL SCHIZOPHRENIA—LIKE SYMPTOMS
MAX RINKEL, M. D., H. JACKSON DESHON, M.D., ROBERT W. HYDE, M.D.,
AND

HARRY C. SOLOMON, M. D.
Boston, Mass.

Printed in U. S. A.

�EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS

‘

MAX RINKEL, M. D., H. JACKSON DESHON, M.D., ROBERT W. HYDE, M. D.,
AND

HARRY C. SOLOMON, M. D.
Boston, Mass.

-

The nature and cause of the major psychoses are still unknown. Repeated attempts
have been made to reproduce experimentally
psychotic symptoms in the hope to uncover
their psycho—physiological relationship. In
1886, Schmiedeberg succeeded in producing
cataleptic phenomena in rabbits by the use
of ethyl-urethan. In 1904, Peters(II) discovered the cataleptic action of bulbocapnine; Baruk and de Jong(1, 9, Io) investi—
gated this, as well as many related chemicals,
more extensively and demonstrated the catatonic elfect upon man and animals. With the
discovery of new chemicals and chemical
compounds, new tools are made available to
the psychiatrist to investigate psychoses experimentally, and a new branch, experimental psychiatry, is emerging. The experimental
psychiatrist has the advantage of knowing
the one factor, in the causation of psychotic
symptoms, the chemical that was administered to the patient and started the chain of
reactions. The psychopathological genesis,
however, of the psychotic phenomena will
best be investigated by methods of the inter—
Read at the 107th annual meeting of The Ameri—
can Psychiatric Association, Cincinnati, Ohio, May
1

7-11, 1951.

From the Department of Psychiatry, Harvard
Medical School, and the Boston Psychopathic Hos—
pital; Dr. Harry C. Solomon, Director.
Aided by a grant from the McCurdy Company,
Rochester, New York.

H

C

/8
HC

\‘/

CH.

\C/
/\{twin/
\/ \/
C‘

CH

572

H

/ */\
C

_,
CH.

8

&gt;

CH.

\f”?
/\if”?!/
\/ \/

HC

N~CH;;

CH_

NH

\r/

HOOC

..

GET—CE
5

HC

Chemistry and Plu'zrmacology
L.S.D., which stands for the German Ly—
.vergsdure Didthylamid, is the abbreviation
used for the diethylamid tartrate of lysergic
acid which, according to A. Stoll, A. Hofmann, and F. Troxler(I7), is diastereomer
but not structurally isomeric with isolysergic
acid as seen in the accompanying formula.

coon

\*/

Hi

pretative analytical branch of psychiatry. Of
the chemicals used experimentally at present
2 are outstanding: mescaline, an alkaloid
known in its crude form as peyote for hundreds of years, though only in the past few
years chemically synthetized, and d—lysergic
acid diethylamide tartrate (L.S.D.), a member of the ergot group. Although these chem—
icals are quite different in their chemical
structure, in their effect upon normal subjects
and psychotic patients they show great simi—
larities with regard to the production of psychotic symptoms. The schizogenic effect of
mescaline has been reported in a number of
articles, most recently in a brilliant experimental and psychopathological publication by
Paul H. Hoch(8). Our paper is concerned
essentially with the description of the effect
of d-lysergic acid diethylamide tartrate
(L.S.D.) upon male and female individuals
who, subsequent to the administration of this
chemical, responded with the production of
psychotic-schizophrenic-like phenomena.

+—

C

Hi

HC

CH

C

CH

NH

N—CH.

CH.

�-

I952]

M. RINKEL, H.

J.

DESHON, R. W. HYDE AND H. C. SOLOMON

It is water soluble and administered orally.

Pharmacologically L.S.D. belongs in the
group of the ergonovine substances. It has
a deﬁnite“ effect upon the in situ uterus of the
rabbit, and causes peculiar states of motor
rigidity similar to the catatonic phenomena
in the dog and cat as' seen with bulbocapnine
(19). In our own experiments we noted an
especially strong physiological reaction in a
29-year-old very sensitive white girl who was
menstruating at the time. She complained of
most violent abdominal constrictions, which
may have been caused by vehement uterine
contractions. The peculiar psychological effect, seen as excitation in experimental ani—
mals, was ﬁrst observed and described by the
chemist, A. Hofmann. In his laboratory
notes of April 4, 1943, he remarked that,
while working with L.S.D., he noticed in
himself a peculiar restlessness associated
with slight dizziness. He had to interrupt
his work and went home to rest. While at
home, he felt as if intoxicated, a condition
characterized by an extremely stimulated
phantasy. After darkening his room, for the
daylight bothered him very much, he had a
most wonderful experience. Phantastic images of most extraordinary plasticity and intensive kaleidoscopic coloring passed before
him. This state of intoxication lasted about
2 hours.

Literature
Following this discovery a number of au—
thors investigated the effect of L.S.D. in
self-experiments, on normal subjects, and on
psychotics. W. A. Stoll(18), who ﬁrst systematically investigated the psychological phenomena of LSD, conﬁrmed Hofmann’s experiences and reported as the most striking
psychological ﬁndings disturbances in perception that led to hallucinations, acceleration
of thinking, slight dimming of consciousness,
but maintenance of judgment. He regarded
the psychotic condition as an acute exogenous
reaction type and pathologically as diencephalosis. Condreau(4) conﬁrmed most of
Stoll’s ﬁndings, but reported that in his experiments the subjects’ consciousness was not
disturbed aside from the feeling of intoxication. He added that the subjects maintained
their capacity of self-criticism, but showed
increased distractibility andiwere less able

573

to concentrate. The basic theme of thought
remained unchanged, and the changes in feeling tone he felt to be merely an intensiﬁca—
tion of the previous underlying mood. He
added as a new observation forced laughing
and one instance of athetoid movements as
suggestive of involvement of the diencepha—
lon, thus contributing to W. A. Stoll’s origi—
nal conception. A. M. Becker(2) essentially
conﬁrmed the observations of Stoll and Hofmann and emphasized the astounding production of psychosis—like syndromes following the administration of mere “traces” of a
chemical substance. He believes the psycho—
logical manifestations are the result of two
different basic disturbances: affectivity and
impulsivity on the one hand, and intention—
ality on the other. The most striking contrasts among his observations were manic—
hyperkinetic and inhibited depersonalized
manifestations. In contrast to Stoll, who
termed L.S.D. a “Phantasticum,” Becker
suggested the designation of “Psychoticum”
for L.S.D. Umberto de Giacomo(6, 7), of
Italy, in his experiments with rather large
amounts of LSD. (300 to 500 gamma) ob—
served in his patients catatonic-like phenomena, which were similar to those produced
by bulbocapnine. M. Rinkel(12) and Victor
H. Vogel(18) reported their experiences
with diethylamide of lysergic acid, adding
as new observations paranoic trends and, in
contrast to previous publications, slowing of
thinking and poverty of thought. Bush and
Johnson( 3) used L.S.D. as an aid in psy—
chotherapy, and reported that their psychotic
patients responded with an increase in activity and greater verbalization of psychopathology. They noted occasional short periods
of confusion and disorientation, and occasional transitory visual hallucinations. Most
of their patients showed some degree of eu-

phoria.

Method and Procedure
In our own experiments, L.S.D. was given
I 7 times to 15 normal adult volunteers, students, nurses, and doctors, in the 19—48 age
range, and, as freshly prepared solution, to
some psychotics: dementia praecox and
manic-depressive, depressive type. The observations on the psychotic patients are still
in progress and will be published later. The

�574

EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS

normal subjects, who were kept without
breakfast, received LSD. in doses ranging
from 20 to 90 gamma p. 0., in most cases
one gamma per kilogram body weight, while
the psychotics were given 3 gamma per kilogram body weight. This increased dosage for
psychotics was chosen on the basis of the
unanimous reports in the literature that psychotic patients were particularly resistant to
the effect of LSD. The subjects were kept
under continuous observation by at least one
of the authors for the ﬁrst 5 hours and, on
occasions, tape recordings of the subject’s
productions were made. The subjects remained under observation the same day at
the hospital, and were seen again the following day. The main emphasis in our observations was on the clinical psychiatric picture.
Routine neurological and circulatory system
examinations were not done, but signs occurring in these areas were noted, if observed. In 9 of the experiments, electroencephalograms at or near 2 hours after L.S.D.
were taken, and Rorschach tests were given
to 5 normal subjects and concrete-abstract
thinking tests to 2 subjects during the height
of the L.S.D. reaction. Controls of EEGS
and psychological tests were done while the
subjects were in their normal mental state.

Results
I. Disturbances of Thought and Speech.—
The most prominent psychological changes
observed were those in thinking and speech.
They were present in all our experiments.
There was no cloudiness of consciousness,
no intellectual weakness, but most frequently
we observed difﬁculty in the power of expression. The subjects became more and
more slowed down, poverty of thought became apparent, and the ﬂow of speech became increasingly diminished and blocked.
One subject, a middle-aged depressed pa—
tient, went into a complete stupor. In another
instance occurred unwillingness to speak, a
symptom similar to the negativism of the
schizophrenic. Hesitancy, indecision, and impairment of abstract thinking were frequently present; also looseness of thought
and actual disconnection with increased dis—
tractibility were common observations. As
in schizophrenic patients, some of the sub—

[Feb

jects exhibited such phenomena as lack of
spontaneity, irrelevance, pedantic imitation,
and subjectively automatic speech. In one instance, we had the impression of the formation of a neologism. Acceleration of thought
with ﬂight of ideas associated with rhyming
and punning; garrulity and loquacity of the
hypomanic type were seen in a cyclothymic
medical student within 45 minutes after the
administration of LSD. In general, the effects appeared within 30-45 minutes after
the oral administration of L.S.D., and disappeared gradually after 3-4 hours.
II. Affect and M ood.—-Clear-cut blunting
of affect and suspiciousness, as often seen
in schizophrenic patients, were outstanding.
These symptoms frequently led to feelings
of indifference and unreality with disturb—
ances in body image. The subjects experienced hostility and resentment, and on rare
occasions ambivalence. The phenomena occurred about 15' minutes after the administration of LSD; feelings of indifference
and blunting tended to be protracted; suspiciousness, hostility, and resentment were
always more transient. Changes in mood
were twofold: euphoria and depression,
which occurred in about equal number. Euphoria was either of the shallow elation type
with silliness, as seen in the hebephrenic, or,
in a cyclothymic subject, of the jovial and
infectious type, as found in hypomanic and
manic states. Depression was combined with
dependency, indecision, insecurity, passivity,
and feelings of being “lost.” In no instance
did we observe the happy and dreamy feeling
of ecstasy as it has been described by other
authors who experimented with L.S.D., mescaline, and other similar chemicals.
III. Perceptiou.—Usually within 40 minutes after the intake of LSD. disturbances of perception were observed. Those of
visual perception were most common and
mainly of the illusional type. The subjects
would see rippling or wavy lines on the wall
that might evolve into geometrical pattern,
or be associated with color such as yellow,
orange, or pink. In some instances, subjects
saw a thermostat on the wall as a cruciﬁx
but fully realized that the experience was an
illusion. None of the subjects, however, had
the feeling of seeing something of extraor—
dinary beauty, as it was stated in early re-

�I952]

M. RINKEL, H.

J.

DESHON, R. W. HYDE AND H. C. SOLOMON

ports on L.S.D., or as it may occur under
the inﬂuence of mescaline.
Gustatory disturbances occurred frequently; the subjects experiencing a metallic
or “funny” taste or heavy tongue.
Auditory perception was changed only in
a few instances. The subject would hear a
sound that was either near or distant, and in
one instance of a depressed patient, the noise
of a typewriter in an adjoining room was perceived as music, seemingly beautiful music.
The sense of time was disturbed in II out
of 17 experiments. It was characterized by
the feeling of time accelerated or retarded.
IV. Hallucinations and Delusions—Disturbances in perception, in a complex way,
often lead to hallucinations and delusions.
A vivid phantasy, a pseudohallucination or
illusion, in the process of mental dissociation,
may ultimately appear as a real object outside the subject and thus constitute a real
hallucination. By a similar process, changes
in auditory perception, combined with exist—
ing suspiciousness, may lead to ideas of reference and delusions of persecution. It may
be stated that hallucinations, predominant
under the inﬂuence of most phantastica, sub—
sequent to the injection of LSD. were
rather meager and never showed the quality
of an extraordinarily beautiful or threatening experience. The occasional visual hallucinations consisted mainly of formed images,
which occasionally were preceded by crude
ﬂashes of light. Perhaps the above—men—
tioned disturbances of taste perception should
be mentioned here as gustatory hallucina—
tions. In only one instance we noticed an
auditory hallucination, which consisted in
hearing bells, although there were none anywhere around. Haptic hallucinations were
experienced by two subjects. One male sub~
ject had the rather vivid feeling of his trousers being wet from urine, and one female
schizoid patient was convinced that she lost
urine and wet her slacks and the bed. She
actually, later on, did wet the bed, and it may
be possible that her hallucination was stimulated by autonomic excitation of the bladder
mechanism. Morbid ideas were common;
they included ideas of reference and ideas
of inﬂuence. One female volunteer became
quite paranoic and was Still disturbed the following day. Major delusions, ideas of gran—

575

deur or persecution, as seen in the delusional
states of the paranoic or paraphrenic, were
not observed. That may be due, perhaps, to
the fact that in our experiments on normal
volunteers we used only relatively small
amounts of L.S.D.
V. Depersonalization.—Alteration of personality occurred rather frequently. Those
changes consisted mainly in the subject’s feeling that his legs were either extraordinarily
long or heavy; in one psychotic patient the
feeling was that the leg between ankle and
hip had disappeared entirely. Most common
was the feeling of unreality as regard to the
subject, himself, and the outer world. Though
these phenomena were of minor magnitude,
they, too, indicate symptoms particularly ob—
served in the schizophrenic patient. In no
instance were we able to elicit experiences,
of synaesthesias, as frequently seen in mescaline intoxications.
VI. Behavior.—The most and striking
change consisted in underactivity, associated
with lack of spontaneity and initiative. One
schizoid-depressed patient went into a state
of catatonia; another one became stuporous.
A female schizophrenic patient, who had received 3 gamma/kg. body weight of L.S.D.,
became agitated; after an initial state of inertia, she suddenly stood up and went through
many and various motions. She knelt down,
kissing the wall, the ﬂoor, the examining
table, and progressively became more and
more excited. She tore off her clothes and
became noisy to such an extent that the ex—
periment had to be terminated by the intravenous injection of 0.5 g. of sodium amytal.
In our normal subjects, overactivity or in—
appropriate behavior was rarely noted, but
psychomotor manifestations, such as smiling,
giggling, and laughing, more often appropriate than inappropriate, were frequently observed. This was particularly so in a student
of cyclothymic personality make-up.
VII. Intellect—In our normal subjects,
intellectual functions were never disturbed.
The subjects were aware of what they were
doing at every moment of the experiment.
Their memory also never became disturbed;
each one was able to give, in a written report, a description of all the experiences he
went through. Also, the psychotic patients
did not show any particular memory defect.
.

�576

EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOM S

Patients Whose verbal expression became
slowed down and ﬁnally completely ceased,
as in the case of stupor or catatonia, were
able the following morning, under sodium
amytal or d—desoxy-ephedrine, to recall their
thoughts or personal experiences of the day
before under the inﬂuence of L.S.D.
VIII. Autonomic Nervous System.—All
normal subjects and also the psychotic patients had numerous subjective complaints
and symptoms. Since they mostly belong in
the group of disturbances of the autonomic
nervous system, they are best described here.
The most common symptom was change in
appetite, which more often was decreased,
and associated with nausea, than increased.
Complaints of headiness, giddiness, faintfre—
and
tremulousness,
shaking
were
ness,
The subjects complained
, quently expressed.
of chilliness and coolness of whole or part of
the body, lump and “funny” feelings in ab—
domen, constriction with oppression in chest
and precordial discomfort, violent cramps
and constriction in the abdomen in a pa—
tient who just happened to menstruate. Objectively observed were ﬂushing, sweating,
shivering, and shivering with goosepimples.
Tachypnoea, salivation, pallor, sighing, and
obscattered
micturation
of
were
urgency
servations. Changes in pulse rate and blood
pressure were of minor magnitude and observed only occasiOnally. Involuntary smiling, giggling, or laughing were considered in
the nature of “risus sardonicus” where the
subject described these phenomena as occurring Without or against his will. One subject
stated that in a smile he felt as if his facial
muscles were like plastic wax being moved
by some inexorable force. Pupils were often
maximally dilated.
Gross disturbances of the cerebrospinal
nervous system were not observed, except in
some instances “dysarthria,” which consisted
of a transient stumbling over words and was
never marked.
IX. Electroencephalogram.—EEGS were
taken in 9 experiments at about the height
of L.S.D. reaction, and compared with the
EEG of the same subject in his normal state.
In general, the EEG changes were only
slight. Principal changes occurred in the
alpha rhythm, which was characteristically
increased in rate from 1-3 cycles per second.

[Feb.

In one case, an individual who was very relaxed, a slowing of about 2 cycles per second
was observed. Hyperventilation showed a
diminished responsiveness and may be due
to the subject’s reduced cooperation.
X. Psychological Tests.
A. Rorschach—Controlled Rorschach tests
were given to 5' subjects at the height ofL.S.D. reaction. All tests given during
L.S.D. reaction showed abnormalities principally of the schizophrenic or paranoic
type. There was noticed autistic thinking
with decreased organization, contamination
responses, and lack of logical thinking, also
negativism and diminished emotional inhibition indicating anxiety, depression, and aggression. One Rorschach test revealed a
moderately schizophrenic picture with autistic thinking and withdrawal.
B. C oncrete-Abstract Thinking—The tests
consisted in employing proverbs and aphorisms and recording the subject’s reaction. On
the whole, the results, especially the wide
range of responses in abstraction and overgeneralized and tangential thinking, were
similar to those obtained in schizophrenic
patients.
DISCUSSION

The common denominator in all our experiments with L.S.D. on normal subjects is
a profound transformation and alteration of
the psychic state of the individual, as it is
a common factor in all psychotic states. The
various mental phenomena that we have reported were brought about by mere traces
(I:I,000,000g/kg. weight) of a chemical,
d—lysergic acid diethylamide tartrate. The
mental phenomena show similarities to symptoms that occur in actual psychoses. We
noticed, predominantly, changes similar to
those seen in schizophrenic patients. The
subjects exhibited preeminently difﬁculties
in thinking, which became retarded, blocked,
autistic, and disconnected. The affect was
shallow or there was clear-cut blunting.
Feelings of indifference and unreality with
suspiciousness, hostility, and resentment also
approximated schizophrenic phenomena.
Hallucinations and delusional disturbances
though present were much less prominent or
striking, but together with the manifestation

'

�‘

3952]

M. RINKEL, H.

J.

DESI-ION, R. W. HYDE AND H. C. SOLOMON

of depersonalization were most reminiscent
of schizophrenic dissociation.
To a much lesser degree were there similarities to the confusional states. Gross clouding of consciousness was absent in our experiments, but illusional misinterpretations
were not infrequently observed.
A few cases showed similarities to the
manic-depressive states, with changes in
mood of euphoria or depression. However,
only in one cyclothymic-pyknic subject the
intensity was of a hypomanic or manic state.
Delusions of grandiose or persecutory nature, familiar in the paranoic psychoses, were
not seen.
We mention the similarities of the experimental phenomena to actual psychotic
states in order to caution against fallacies
that may occur in the interpretation of experimental psychotic disturbances. The same
caution that is warranted in the application
of an animal experiment to a pathological
condition in man is needed in the application
of the psychiatric experiment to natural psychosis. Our experiments have brought to
light the fact that, in a short space of time,
under the inﬂuence of a mere trace of a
chemical agent in normal subjects, a variety
of mental symptoms occur that are similar
to natural psychoses, and that in psychotic
patients an accentuation of existing, or elicitation of latent, schizophrenic phenomena
takes place. It may be possible to assume that
fundamentally the mechanism of origin of
natural and experimental psychotic phenomena is a similar one: a chemical agent that
pathologically stimulates selectively various
higher, especially perceptive, brain centers
with the result of hallucinatory and delusional experiences. H. J. DeShon, M. Rinkel,
and H. C. Solomon( 5) have already pointed
out that the clinical effects of LSD. imply
such an involvement of the higher and highest
centers of the central nervous system, and
perhaps of lower levels of the nervous system

as well.

Many authors assume that chemical endogenous substances are the cause of schizophrenic psychosis. We must bear in mind
that, in addition to d—lysergic acid, a great
variety of seemingly unrelated chemical
substances are capable of producing transi-

577

tory psychotic-like symptoms. Although observations are still too few to allow the for—
mulation of a well-founded scientiﬁc theory
as to the chemical origination of psychotic
symptoms, we strongly believe that this
branch of experimental psychiatry is progressing in the right direction, and may
some day provide an answer to the most perplexing problems in psychiatry.
SUMMARY

The effects of minute amounts of dlysergic acid diethylamide tartrate (L.S.D.)
on normal subjects, with an age range of
19—48 years, and some psychotic patients of
the schizophrenic, depressive, and paranoic
type are reported.
2. Psychotic phenomena and alterations
of the autonomic nervous system were observed. The psychotic phenomena were pre—
dominantly schizophrenia-like symptoms that
were manifested in disturbances of thought
and speech; changes in affect and mood;
perception; production of hallucinations and
delusions; depersonalization and changes in
behavior. The basic intelligence was not
reduced.
3. Electroencephalographic examinations
at the height of the L.S.D. reaction revealed
only slight changes, principally increased
alpha rhythm, except in one case where there
occurred a slowing of about 2 cycles per
'
second.
4. Rorschach tests showed abnormalities
principally of the schizophrenic or paranoic
type. Concrete—abstract thinking tests also,
on the whole, showed responses similar to
those obtained in schizophrenic patients.
5. N 0 scientiﬁc theory for the origination
of the natural psychotic phenomena or psychoses is being advanced, but the belief is
expressed that experimental psychiatry progresses in the right direction.
1.

Credits

Our preparation of LSD. was supplied,

in ampules containing I mg. substance, by
courtesy of Professor E. Rothlin, Director
of the Pharmacological Laboratories of Sandoz Chemical Company, Inc., Basel, Switzerland.

�EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS

578

BIBLIOGRAPHY
I. Baruk, H. Psychiatric. Medicale, Physiologique et Experimental. Masson et Cie. Paris (VI),
1938.
2. Becker, A. M.

Zﬁr Psychopathologie der Lysergsaure-Diathylamid-wirkung (On the psychopathology of the effect of lysergic acid diethyla—
mide). Wien. Ztschr. Nervenh. 2:402, 1949.
3. Bush, Anthony K., and Johnson, Warren C.
L.S.D. 25 as an aid in psychotherapy. Dis. Nerv.
Syst. 11 : 241, Aug. 1950.
4. Condrau, Gion. Klinishche Erfahrungen an
Geisteskranken mit Lysergsaure-Diiithylamid (Clinical experiences in mental patients with lysergic
acid-diethylamide). Ejnar Munksgaard, Copenhagen, 24: 9, 1949.
5. DeShon, H. J., et 31. Mental changes experimentally produced by L.S.D. Unpublished article.
6. Giacomo de, U. Données biologiques sur l’ac—
tion psychopharmacologique de la diéthylamide de
l’acide lysergique (Biological data on the psycho—
pathological action of Lysergic acid diethylamide).
Paper read at the Symposium on “Chimie cerebrale”
of the International Congress of Psychiatry, Paris,
Sept. 18-27, 1950.
7. Giacomo de, U. La catatonia sperimentale.
Schizofrenie, 4: 195, 1934-1935.
8. Hoch, Paul H. Experimentally produced psy—
choses. Am. J. Psychiat., 107:607, Feb. 1951.
9. Jong de, H. Die experimentelle Katatonie als
vielfach vorkommende Reaktionsform des Zentralnervensystems (Experimental catatonia, as a frequent reaction type of the central nervous system).
Ztschr, ges, Neur. Psychiat., 139 : 468, 1932.
10. Jong dc, H., et Baruk, H. La catonie experimentale par la Bulbocapnine. Paris: Masson et
Cie, 1930.

Pharmacologische Untersuchungen iiber Corydalisalkaloide (Pharmacological in-

II. Peters, F.

[Feb.

vestigation of Corydalisalkaloids). Arch f. Experi—
ment, PathoLogie, 51:130, May 1904.
12. Rinkel, M.
(I) Discussional remark on
L.S.D.—Clinic of the American Psychiatric Asso—
ciation, held at the Annual Meeting of the A.P.A.
May 1, 1950, in Detroit. J. Clin. Experiment. Psy—
chopathol., Jan. 1951 (Van Ophuijsen Memorial

Issue).
(2) Discussion at symposium on “Chimie cere—
brale” of Ist World Congress of Psychiatry, Paris,
Sept. 18-27, 1950. Printed in “Les comptes-rendus

du Congrés.”
13. Schmiedeberg, O. Uber die pharmacologischen
Wirkungen und die therapeutische Anwendung einiger Carbamin Séiure-Ester. (On the pharmacological effect and therapeutic application of some of
the esters of the Carbamin acid). Arch. f. Experiment. Pathologie und Pharmakologie, 20: 203, 1886.
J. E. Psychopathologie der
14. Staehelin,
Zwischen-und Mittelhirnerkrankungen (Psychopathology of the diseases of the diencephalon).
Schweiz. Arch. Neurol. und Psychiat. 53 : 374, 1944.
15. Stoll, A. Les Alcaloidés de L’Ergot (The
alkaloids of ergot). Experientia 1:250, 1945.
I6. Stoll, A., and Hofmann, A. Partialsynthese
von Alkaloiden vom Typus des Ergobasins (Partial synthesis of alkaloids of the type of the ergo—
basins). Helv. Chim. Acta, 26:944, 1943.
17. Stoll, A., et a1. Ueber die Isomerie von Ly—
sergsaure und Isolysergsaure (On the isomery of
lysergic acid and isolysergic acid). Helv. Chim.
Acta, 32 (No. 2) : 506, 1949.
I8. Stoll, W. A. Lysergsaure-diithylamid, ein
Phantasticum aus der Mutter-korngruppe. (Lysergic acid diethylamide, a phantasticon of the ergot
group). Schweizer Arch. Neurol. und Psychiat.,
60: I, 1947.
19. Vogel, H. Victor. Discussional remark to
Hoch’s paper (ref. 8).

‘

��ILQMH
‘_

.1”.
'_

.,

z::y1;,;m.ynom

32/

[7

_

kHLLQJ-»
'2 2rd,
GLEN QAKS N. L

CLINICAL EFFECTS OF A “STIMULANT”
BARBITURATE
(Sodium I :3—dimethylbutyl ethyl barbiturate) in Schizophrenics

BY HARRY

[Reprinted from

H.

PENNES,

MD.

T8: JounNAL or Nnnvous AND MENTAL DISEASE, Vol.

119, No. 3, Mar. 1954]

�[Reprinted from THE JOURNAL

OF NERVOUS AND MENTAL DISEASE,

Vol. 119, No. 3, Mar. 1954]

CLINICAL EFFECTS OF A “STIMULANT”
BARBITURATE
(Sodium 1:3-dimethylbutyl ethyl barbiturate) in Schizophrenics
HARRY H. PENNES,

M.D.‘x‘

central
the
nervous
than
rather
depress
stimulate
barbiturates
Many
of these drugs
evaluation
clinical
but
animals
in
experimental
system
barbitu—
of
central—depressant
Administration
a
limited
been
has
(15).
of
amelioration
transient
often
sodium
produces
such
amytal
as
rate
different symptoms' in schizophrenics (6, Io, 3). These symptom
changes are usually attended by a variable degree of hynotic (sleep—
producing) eﬂect which may proceed to actual sleep as the dosage
is increased. In the drug therapy of schizophrenics the excessive narcosis
produced by the central-depressant action of the barbiturates in common
administered.
be
which
conveniently
total
the
limits
dosage
may
usage
It was considered possible that a central—stimulant barbiturate might
of
the
desirable
ordinary depressant
the
activity
therapeutic
possess
barbiturates without the disadvantage of excessive narcosis.
The stimulant barbiturate utilized to test this hypothesis was 1,3—
dimethylbutyl ethyl barbiturate, sodium salt (15), (hereafter designated
as DMBEB) which is similar structurally to sodium amytal (14). A
small number of observations has also been included on another stimu—
lant barbiturate, namely, 3,3—dimethyl allyl ethyl barbiturate, sodium
salt, (supplied for research purposes by Eli Lilly and Company, Indianapolis) (16). According to reports, DMBEB produces a period of
increased alertness and restlessnes in unanesthetized dogs, followed by
convulsions; the seizures, which occur only in warm-blooded animals,
are Violently tonic in type and the locus is probably the spinal cord; no
hypnotic or anesthetic effects are noted in sublethal doses (13, 14,).
The reﬂex contraction of m. tibialis anticus is augmented in spinal and
barbital—anesthetized dogs; in this regard it is I/250th as active as
strychnine, one—fourth as active as picrotoxin, and more active than caf—
feine, cocaine, or ephedrine (9). The crossed—extension reﬂex in m. gas—
trocnemicus and respiration are also augmented (8). The convulsant
activity of DMBEB may be antagonized by administration of sodium
amytal (14). The sodium salt of 3,3—dimethyl allyl ethyl barbiturate
produces a restless, frightened, or boldly vicious animal in which con—
‘From the Department of Experimental Psychiatry (Paul H. Hoch, M.D.), New

York State Psychiatric Institute.

[25I]

�252

Harry H. Penna:

vulsions ﬁnally ensue; blood pressure and body temperature rise while
respiration is stimulated (I6).
Gottlieb has previously observed that DMBEB produces a euphoric
effect in depressed patients after oral administration in subconvulsant
doses (4). The drug was likewise maintained at a subconvulsant level
in the present study in order to rule out the possible therapeutic effect
of a generalized seizure.
PROCEDURE

schizo—
administered
hospitalized
20
to
Patient5.—DMBEB was
duraMean
mean
females.
8
males
and
was
32.5
12
years;
age
phrenics,
tion of illness, 13.4 years; mean duration of hospitalization, 2.2 years.
The diagnostic categories were as follows: pseudoneurotic, 6; catatonic,
The
pseudo—
unclassiﬁed
schizophrenic,
mixed
1
II.
;
or
hebephrenic,
2;
neurotics presented diffusely neurotic symptomatology in a basically
of
criteria
the
and
to
according
diagnosed
were
schizophrenic setting
schizo—
unclassiﬁed
and
mixed
of
The
Polatin
Hoch and
(7).
group
phrenics presented admixtures of catatonic, hebephrenic, and paranoid
cata—
Gross
disease.
of
the
features
the
well
as
primary
as
components
tonic stupors or excitements and diagnostic categories other than schizo—
phrenia were not included. Most of the patients were quite well pre—
served. Sixteen of the 20 cases had either no or slight deterioration
(6 pseudoneurotics, 2 catatonics, I hebephrenic, and 7 mixed or un—
classiﬁed schizophrenics); these patients were chieﬂy short-term, volun—
tary hospital admissions. The remaining 4 subjects displayed an
advanced degree of schizophrenic deterioration and were long—term,
state hospital patients. All but 2 patients had received at least one
course of electric convulsive and/ or insulin coma therapy at some time
during the course of the illness.
Dru gun—DMBEB was dry—sterilized in an electric oven at I50—I60° C.
for one to two hours. Immediately prior to intravenous injection the
drug was dissolved in 20.0 cc. of sterile distilled water at a concentration of 5.0 mg. per cc. A colorless solution was quickly formed. The
the
in
administered
20
of
that
dose
63.5
DMBEB
was
was
mg.
average
subjects. An injection rate of about 5.0 mg. per minute was used in all
subjects. The same procedure was followed in the administration of
3,3—dimethyl allyl ethyl barbiturate, sodium salt, to 2 patients both of
whom also received DMBEB on another occasion. Each patient also
independently received intravenous injection of sodium amytal (Amobarbital sodium, Eli Lilly and Company, Indianapolis), 250-500 mg. dis—
solved in 10.0 cc. of sterile distilled water at a rate of about 50 mg.
per minute, as well as 20.0 or 40.0 mg. of pervitin hydrochloride (Smith,

�Eﬁect: of a "Stimulant” Barbiturate

253

Kline and French Company, Philadelphia) in 2.0—4.0 cc. of solution in
one minute. Six patients also received intravenous sodium amytal in the
same dosage and rate of administration as that of DMBEB. The drugs
were administered in random orders to the various subjects. Injections
were performed between 8:00 A.M. and 4:00 P.M. without limitation of
food or the subject’s usual ward activities. Changes in the patient’s baseline clinical status were recorded in protocol form for a period of at
least 48 hours following injection.
RESULTS

I. Mental Reactions.——DMBEB reduced clinical symptoms in II
(55.0 per cent) of the series. Three patients (15.0 per cent) showed only
increase of symptomatology and 6 (30.0 per cent) had no reactions
except for side-effects to be described in section II.
A. Symptom-reducing reﬂect—The therapeutic action was most pro—
nounced in the pseudoneurotic group. Four out of 6 patients in this
group experienced complete or almost complete relief of anxiety and
tension, phobic concerns, irritability and hostility, and depressive manifestations. All 3 obsessive—compulsive patients in this group experi—
enced amelioration of the disabling symptomatology, slight in I and
quite complete in 2. The usual duration of relief was two to eight hours,
but in 2 subjects the improvement lasted 16 to 24 hours. The symptomatic
improvement began during the injection, usually concurrently with
cephalic sensations described variously as “light—headed” or a “subtle
feeling of relaxation.” In the 14 overt schizophrenics (hebephrenics,
catatonic, mixed, and unclassiﬁed), 7 patients showed slight to mod—
erate therapeutic responses which were in general less complete than
those of the pseudoneurotics. The effects in the overt schoziphrenic
group consisted principally of signs of personality reintegration with
more normal emotional feeling and display, less self—concern and self—
preoccupation, an increased tendency to contact the environment, and
a somewhat higher verbal productivity. The most deteriorated cases
responded least to the drug in a therapeutic sense; these patients also
responded least to sodium amytal and pervitin.
These therapeutic responses to DMBEB were qualitatively identical
with those often produced by central—depressant barbiturates. How—
ever, the therapeutic response to DMBEB was more complete than to
sodium amytal administered in the same low dosage to 6 patients (30,
50, 65, 89, 100, and 100 mg.); this was particularly true in the pseudoneurotic group. Moreover, clinical signs of hypnosis with DMBEB
occurred in only 4 patients in the series and consisted of transient drowsi-

�254

Harry H. Pennes

excessive
slurred
speech,
and
nystagmus,
a sleepy expression;
ness
euphoria, and other signs of acute barbiturate intoxication were not
feel—
relieved
reported
no
subjects
present. Some of the most completely
after
such
of
signs
and
objective
of
drowsiness
displayed
no
ings
DMBEB. In addition, DMBEB produced none of the signs of psychic
“stimulation” that usually occurred after pervitin, a cephalotropic sym—
pathomimetic amine. Administration of pervitin was almost invariably
attended by a positive “stimulation” aspect consisting of increased alert—
ness and energy, feelings of optimism, and heightened psychomotor acaction
the
DMBEB,
to
therapeutically
In
responding
patients
tivity.
elimina—
neutralization
or
summarized
be
therefore
a
as
symptom
may
tion without concomitant “stimulation” and, as described above, with
occasionally a minor degree of sedation.
B. Symptom—increasing eﬂects.—Symptom intensiﬁcation occurred in
him—
for
felt
copiously,
follows:
sorry
one subject wept
3 patients as
self, and complained bitterly of mistreatment by doctors; a second

identi—
of
seizure
origin
hysterical
subject had a brief, opisthotonic
cal with the type occurring in the drug—free state; the third subject
felt more perplexed, confused, and depressed. These reactions were all
exacerbations of pre—existent manifestations which had also previously
increased spontaneously or in response to amytal and/or pervitin.
These excessive reactions appeared to be precipitated “psychologically”
as a secondary reaction to the unusual side effects produced by DMBEB
barbituof
showed
acute
of
these
signs
None
subjects
Section
11).
(see
resemble
did
the
reactions
entirely
not
In
subnarcosis.
addition,
rate
the exaggerated emotional discharges so often produced after pervitin,
since none of the primary “stimulation” effects of pervitin on psycho—
motor processes was present.

C. Absent mental reactions.—Six patients (30.0 per cent) had no reac—
tions to the drug in terms of pre—existent symptomatology. In 3 of these,
the side-reactions to the drug were so intense that the patients were
preoccupied with little else. In the 3 other subjects, there were no mental
side-effects.
considerable
of
absence
the
of
despite
signiﬁcance
changes

II. Side Reactions.—Practically all (18 out of 20) patients experi—
enced side—reactions. The toxic effects appeared during the injection and
the sequence of events was approximately the same in the majority of
subjects. Tingling sensations or other paresthesias began in any part of
the body, and rapidly became pruritic in nature; this was followed by
or associated with hot and cold sensations and a mottled erythema in
face, chest, and trunk. Pilomotor reactions often appeared on arms

�Eﬁect: of a "Stimulant” Barbiturate

255

and back; less frequently there were feelings of vague abdominal dis—
comfort or slight nausea; repeated, forceful sneezing; and occasionally
burning of the eyes. Cephalic sensations previously referred to (Section
IA) usually began early in the injection in a small minority of sub—
jects; on assuming the erect position some patients complained of a
vague vertigo of nonspeciﬁc nature and minimal degrees of ataxia
were observed.
The maximum dosage of DMBEB that could be comfortably tol—
erated by the subjects was limited by the pruritis, which was the most
frequent side-reaction (18 out of 20 patients). The itching usually
began in scalp, face, eyes, soles of feet, or genital areas. Spread was rapid
and in some cases the pruritis became generalized; some subjects rubbed
and scratched vigorously and became extremely distressed, tending to
disregard the other actions. All the side-reactions enumerated above
were of relatively short duration, usually subsiding in IO to 30 minutes. In some cases, the pruritis persisted for several hours, although
distress was always minimal after the ﬁrst 10 to 30 minutes.
In 17 cases, the injection was discontinued when the above reaction
deﬁnitely appeared, particularly the pruritis. The average dosage administered to these subjects was 64.4 mg. total or 1.01 mg. per Kg. of body
weight. The threshold dosage for the appearance of any effect, mental
or toxic, was in the neighborhood of 30.0 mg. The range of effective
therapeutic dosage without toxicity was therefore quite narrow. Two
patients received full dosage of 97.0 and 101.0 mg. total without side—
effects and a marked symptomatic improvement in one.
Two subjects displayed seizures at dosages of 59.0 mg. (0.65 mg. per
Kg.) and 68.0 mg. (1.04 mg. per Kg.), although other subjects receiv—
ing equal or larger dosages did not display seizures. The involuntary
movements were of a jerky, nonrhythmic myoclonic type; in one subject
the movements were more or less generalized and in the other limited to the right arm. The movements occurred in cycles of about 15-20
seconds duration for a period of about 10 minutes. Consciousness was
not impaired during the seizures; deep reflexes were normal in the inter—
seizure phases; there were no facial weakness, pupillary changes, nys—
tagmus, Hoffman or Babinski reﬂexes. The seizures appeared in these
two subjects after the itching had become severe and generalized. Continued experience with the drug showed that no patient developed a
seizure if the injection was discontinued at or shortly after the appear—
ance of the pruritis.
None of the side—effects of DMBEB occurred after sodium amytal
with the exception of its quite minor hypnotic action. Pervitin sideeffects were totally distinct, consisting usually of mouth and throat

�256

Harry H. Penna:

dryness, peripheral numbness and lightness, chest pressure, and cephalic

tightness or aching.
Sodium 1,3-Dimet/zyl Allyl Ethyl Barbituratc.—This stimulant bar—
biturate was administered in doses of 1.26 and 1.37 mg. per Kg. to
2 subjects. The same side-effects were produced as with DMBEB and
with the same apparent intensity. One subject experienced generalized
myoclonic—like twitchings. No therapeutic effect on mental symptoma—
tology was observed.
DISCUSSION

DMBEB has been classiﬁed as a “stimulant” barbiturate in animals
in the experimental pharmacologic literature because of its convulsion—
producing property and augmentation of spinal reﬂexes (13, I4, 8). The
epileptogenic action was conﬁrmed in this clinical assay of the drug
inasmuch as 2 subjects had seizures under the drug, the dosage being
maintained at the subconvulsant level in the other patients. The seizures
occurring in these 2 subjects were of myoclonic type, whereas Swanson
and Chen reported that the drug produced severe convulsions of tonic
convul—
of
difference
This
animals
to
as
in
(14).
type
laboratory
type
sion may be a species difference or reﬂect the limitation of dosage in
man. The median convulsant dosage after intravenous administration
to guinea pigs, rabbits, cats, dogs, and monkeys ranged from 2.0—3.0 mg.
with
brief
the
whereas
episodes
myoclonic
(14),
weight
body
Kg.
per
DMBEB in this series occurred with dosages of 0.65 and 1.04 mg.
per Kg.
The numerous side—reactions observed in man have not been reported
in animals; some of these side—reactions are purely subjective and there—
fore not observable in animals. Knoefel found that DMBEB produced
a stage of increased alertness and restlessness prior to the seizures (8);
dogs under sodium 1,3—dimethyl allyl ethyl barbiturate became restless
and also appeared frightened or boldly vicious prior to the onset of
convulsions (16). These apparent changes in emotion and behavior in
animals could have been secondary to a highly distressing action such
as occurred in man, mainly the severe paresthetic and pruritic response.
Either a peripheral or central locus of action might underlie the typical
constellation of tingling, burning or cold, pruritis, pilomotor contrac—
tions, erythema and sneezing. The sneezing in man may be analogous
to the respiratory augmentation observed in animals (16). Gottlieb
noted that the toxic reactions to DMBEB in man were not signiﬁcantly
affected by administration of antihistaminic drugs (4).
Despite the motor Stimulation caused by DMBEB in man and
reported in animals, there was little or no evidence that the drug acted

�Eﬁects of a “Stimulant" Barbiturate

257

in
stimulation”
The
“psychic
in
stimulant”
term
patients.
as a “psychic
behavioral
and
emotional
the
is
exaggerated
to
applied
generally
man
the
to
sodium
amytal,
or
with
intravenous
of
subnarcosis
as
phenomena
with
as
mood
of
psychomotor
processes,
or
“primary” heightening
of
these
of
Neither
amines.
types
the cephalotropic sympathomimetic
be
the
this
drug
In
may
DMBEB.
after
respect
reactions occurred
which
and
are
potent
metrazol
strychnine
such
with
as
grouped
agents
of
absence
The
stimulants.”
weak
“psychic
convulsants but relatively
be
in
DMBEB
with
man
stimulation”
may
of
obvious signs
“psychic
associated with the fact that the seizure locus in animals is apparently
the spinal cord (14).
have
been
no hypnotic or
has
to
reported
DMBEB
Although
observed
effect
weak
was
hypnotic
animals
effects
a
in
(14),
anesthetic
difference
This
series.
of
the
may
of
the
present
in the minority
patients
reﬂect species variation or technical limitations in animal experimenta—
tion inasmuch as a slight degree of narcosis is often purely subjective.
From the therapeutic point of view, DMBEB produced symptom
effects
the
of
the
series;
of
cent
20 or 55.0 per
amelioration in II out
ob—
Gottlieb
were most complete in pseudoneurotic schizophrenics.
60.0
i.e.,
material,
different
in
results
patient
the
tained almost
same
of
series
IO
in
administration
a
oral
after
per cent improvement,
schizo—
of
a
whom
as
diagnosed
was
only
one
severely depressed patients,
establish
advisable
deemed
therapeutic
been
to
has
It
not
(4).
phrenic
value on more than the present preliminary tentative basis because of
the high toxicity of the drug which would preclude therapeutic appli—
cation. The same conclusion was reached by Gottlieb (4).
The observed therapeutic activity of DMBEB cannot be explained
allevia—
because
action
weak
symptom
hypnotic—narcotic
in terms of its
tion (particularly in pseudoneurotic schizophrenics) occurred without
obvious
of
absence
and
the
fact
this
of
view
In
action.
such
appreciable
the
of
action
the
that
is
therapeutic
it
stimulation,”
apparent
“psychic
drug requires another explanation. Two hypothetical explanations are
the following:
and
stimulation”
properties
does
“psychic
DMBEB
really
possess
I.
in addition the hypnotic action of the ordinary barbiturates; the balance
between these two actions is such that a net weak hypnosis is occasionally
the resultant in man. In this case it would have to be assumed that the
complete
almost
the
theoretically
retained
is
despite
action
therapeutic
of
level
far
effects
in
stimulant
as
and
so
narcotic
of
cancelling-out
consciousness is concerned. In support of such a possibility is the clinical
observation that in simultaneous administration of amytal and benzedrine to mental patients, considerable therapeutic activity may ensue

�258

.

Harry H. Penna:

despite a fairly complete mutual neutralization of the narcotic and
stimulant actions of the two drugs (11). In this connection it may be
observed that Gottlieb interpreted the euphorizing action of DMBEB
in mental depression as a consequence of its “stimulant” properties and
from this concluded that amytal may exert its euphorizing action in the
same condition by a stimulant rather than a narcotic action (4). Gottlieb did not report any hypnotic action of DMBEB in his series such
as was observed in the present study; the difference may possibly be a
function of the oral route of administration in his study as compared
with the intravenous route in this report. His data could also be inter—
preted in terms of a narcotic rather than a stimulant action of DMBEB
and the beneﬁcial effect of amytal in depression still explained in
terms of a narcotic action rather than a stimulant one.
2. The second hypothetical mechanism for the therapeutic action
of DMBEB would be that the drug exerts this effect by a mechanism
other than central depression or stimulation. Direct evidence for this
interpretation is lacking. However, there are several sets of data which
suggest that the ordinary central-depressant barbiturates exert their
therapeutic action on mental symptomatology independently of their
hypnotic-narcotic actions. These data are the following: (a) a few
subjects display almost complete relief of symptomatology after intra—
venous injection of small amounts of sodium amytal before any or
much intoxication is apparent in the form of drowsiness, slurred speech,
or nystagmus. Conversely, a few subjects show little change in the
mental status even though the central-depressant action may be carried
to the point of sleep (10, 5). (b) The ﬁrst effect of the barbiturates on
the human electroencephalogram is the appearance of relatively rapid
(20-25 sec.), medium—high voltage activity, particularly in the frontal
leads (II, I, 12). The appearance of this activity coincides temporally
with reduction of anxiety and tension in some patients and the appearance of a more or less euphoric state (11, 12). The physiologic signiﬁcance of this rapid activity has not been fully determined as yet but in
any event it is distinct from the EEG charges which are usually accepted
as manifestations of depressed consciousness, i.e., high voltage, slow
activity (2).
In view of these considerations, it is possible that both DMBEB
and the ordinary barbiturates owe their therapeutic effect on mental
symptomatology to some hitherto undisclosed feature of their action.
The pharmacologic literature contains reference to a large number of
motor stimulant barbiturates which have never received clinical assay.
These compounds show no underlying uniformity of chemical structure
and many are in the thiobarbiturate series. The possibility exists that

�Eﬁ‘ects of a “Stimulant” Barbiturate

259

without
these
of
drugs
with
obtainable
some
therapeutic action may be
the excessive toxicity of DMBEB.
SUMMARY
bar—
ethyl
The “stimulant” barbiturate, sodium 1,3—dimethylbutyl
various
with
20
patients
biturate, was administered intravenously to
value.
of
its
therapeutic
forms of schizophrenia in a preliminary assay
effect
therapeutic
occurring
I. The drug exerted an irregularly
in
pseudoneurotic
degree
of
complete
which
most
was
(55.0 per cent)
further
establish
advisable
to
deemed
been
schizophrenics. It has not
which
toxicity
the
high
of
relatively
because
the therapeutic efficacy
would preclude therapeutic application.
in
convulsant
is
the
a
that
drug
literature
the
2. In accord with
remainthe
in
seizures;
had
series
myoclonic
this
animals, 2 patients in
level.
A
subconvulsant
maintained
a
at
ing subjects the dosage was
small minority of subjects showed weak signs of central nervous system
central—depressant
the
drowsiness;
of
form
the
slight
in
depression
action has not been reported in animals.
occurred
independently
the
of
usually
effect
drug
The
therapeutic
3.
evidence
was
No
action.
central—depressant
and
of its weak
infrequent
of
the
in
sense
stimulant”
acted
“psychic
as a
obtained that the drug
heightening of mood and psycho-motor processes.
action
the
of
therapeutic
mechanism
the
of
4. Several explanations
of the stimufurther
of
investigation
the
desirability
and
offered
were
lant barbiturate series indicated.

BIBLIOGRAPHY

the Cerebral CorBarbiturates
of
Action
on
E.:
and
I.
Finesinger,
A.
M.
B.,
(1) Brazier,
tex. Arch. Neural. 6r Frye/liar” 53: 51-58, 1945.
Brain.
the
of
Activity
Electrical
the
Underlying
Mechanisms
: Physiological
(2)
I. Neural, Neurosurg, 6* Psych, 11: 118-133, 1948.
Sodium Amytal
of
Intravenous
Value
M.:
Prognostic
and
I.
Hope,
S.,
(3) Gottlieb, I.
in Cases of Schizophrenia. Arc/z. Neural. 6' Prychiat., 46: 86-100, 1941.
Acid. Arch.
Barbituric
5-(1,3-Dirnethylbuty1)-5—Ethyl
of
Action
Antidepressive
(4)
Neurol. 6r P5yc/ziat., 66: 318—328, 1951.
and
Sodium
Amytal
of
Administration
of
Effect
S.
B:
(5) Harris, M. H., and Katz,
Sodium Rhodonate on Mental Patients. Am. I. P:yc/ziwt., 12: 1065-1083, 1933.
NERVOUS &amp;
JOURNAL
and
Therapy.
of
Narcodiagnosis
Status
Present
(6) Hoch, P. H.:
MENTAL DISEASE, 103: 248-259, 1946.
Psychiat.
of
Schizophrenia.
Form
Pseudoneurotic
P.:
Polatin,
and
(7) Hoch, P. H.,
Quart., 23: 248—276, 1949.
by
Nervous
Central
System
the
of
and
Depression
Stimulation
K.:
(8) Knoefel, P.
Therap.,
6'
Pharm.
Exper.
Acids.
I.
Thiobarbituric
and
Barbituric
of
Derivatives
84: 26-33. I945&lt;9 Exper. Therap., 57:
Pharm.
Barbiturate.
I.
Convulsant
of
Action
a
: The
(9)
130, 1936 (Proc.).
Sodium Amytal, Pervitin
to
of
Schizophrenics
Reactions
Clinical
H.:
H.
(10) Pennes,
'

—:

�260

(11)
(12)

(I3)
(I4)
(15)
(16)

Harry H. Penna:
Hydrochloride, Mescaline Sulfate and D-lysergic Acid Diethylamide (LSD25).
(To be published.)
: Personal Observation.
Rubin, M. A., Malamud, W., and Hope, 1.: EEG and Psychopathological Manirestations in Schizophrenia as Inﬂuenced by Drugs. Psychosom. Med., 4: 355-361,
1942.
Shonle, H. A., et 31.: Relation of the Structure of Dialkyl Barbituric Acids to the
Length of Their Action. I. Am. Chem. Soc., 58: 585—587, 1936.
Swanson, E. E., and Chen, K. K.: The Aberrant Action of Sodium I :3—dimethylbutyl
Ethyl Barbiturate. Quart. I. Pharm. é‘r Pharmacol., 12: 657-660, 1939.
Tatum, A. L.: Present Status of the Barbituratc Problem. Physiol. Rem, 19: 472502, 1939Taylor, N. B. G., and Noble, R. L.: Some Pharmacological Properties of Sodium
Ethyl, 3:3 Dimethylallyl Barbiturate. Nature, 163: 447, 1949.

��W
Ruth.

t

,
mm
mm.bail. Ion-r “I!“

i

mammcsmmcm

mmmnuﬂ.‘
iv

P.hmulJ.I.lIOou
,_

«2:!

"WWW“

'thﬁ-WMW-lmw
mun-nuns;
MM,”

mug-v.4

pawn

1...,”

.»,t

Proof. to: Dr.J.D.lcCou

it. nonu- Ltd.
but
lo: 959

“on“, “a

m

�gnu-gotta
or
ﬂu
«unnoand
at
up
nun-um
at»),
mum».

Ann; tho

mm,
(mm,
mauuorummwgpu'wubom
attache-amid.

”haul-Watt!”

muunuu,nwu,mumwwu1uu
vlllult. m,ud¢mlduquuonofﬁom¢nub
Mr
uticomamnleutboc-W

mummwu,muuaoomump
mm,1umovd1h-u(cmsuand,19533 Inn-r,
M1955,
mam,
1955. 1957;

1956;

-.‘-a.-1--

ran

195‘).

mmmuxtuwmtmsmtzu

“mummmwmumm
Min-lull. Itmmuthttumotm
«rutnammuummwwmd

Wan-«An

m

.u-..

Hum.»

a.‘

“.“.".‘m'

.-

‘

�4-1-1-

We

CN nice weighing between

1.8

and 20 gram were used;

all

0.2
of
:1.
value
a
m
in
intraparitoneany
inJected
were
8201'.
80
of
.experilenta were carried out at a root tcperatnre
The clonio convuleion (produced ”I nicotine, pentylenetet—
was taken ae tho end

point and the

resale, etrychnino or picrotoxinﬂ
obeerved
date.
the
frocalculated
van
613,. in tern of “Jim.
(LIICEI’IIID

I HMO!

The

1949).

Imaof
phenobarbital
duration
nor-a1
the
increase in

noeie (neaeured by the

ion

of rightinc reﬂex) produced by

the”

of
the
of
potutiation
intensity
couponnde we investigated.
eeriee
by
a
the
Iowa
in
ooapared
van
phenobarbital by these agents
the
dose
the
in
presence
obtained
by
varying
of doeo-ruponee aux-roe
The

(30
of
phenobarbital
don
constant
of a

Prolininary

”en-eats

were

I‘m/in.)
carried out to eetahlieh the

latentperiodof thepbonobarbitalandtoeneurothattbedoeoeot
15
The
iajooted
were
latter
the ataractioe need were euboonvnlaant.

atar—
neefnl
were
those
clinically
nopnoba-ato were teeted. Five of
of
etmtaral
their
became
selected
were
othere
while
aotice

(Table
I).
to
bemtynine
relationlhip
0

obtained
were
and
pierotoxin
Pentylenetetrasole

nicotine 95$

Laboratoriee;

ellfate fro.

1'.

l

H.

ﬁlth,

fro- laatnen
Ltd.

fret

in

Organic Chemical-g

Meat“
etryebnine

�w.

‘TSE'

rm-Nr‘mn

'.5w-7-

‘,-v

T:
.viq

m

fouroonnlmtlbytho
mutmumottbocnnoftho

Mucupmatutdmm-nnndinhhlon.

mow

q»:

u;
1“v

"

Input-uhthouinqunu-hcﬂihtmottbﬂgg

�9i

was.“

43-3:

:2
.'.w

-.....&lt;

.

entegonised the convulsions ea did ediphenine.
end

80 525A eholished the tonic
The

“upload,

piprsdol

phase.

effect of ease of the etereotios

of phenoherhitel is shun in rehle

III.

The

on the

ties of

fieently shortened with eech eta-pound used while the
motion ves signifieestly prolonged .
Further iﬂicetioe of the

menus

station

onset use sini—

antics of

W
'

of
intuitw of this
phenobdbdtslestienoenheseenieml. Thesedese-reqeeu

“1;" de-oeetrete the relstive effectiveness Iillitrsl for sillin.

oftheseeaepeueds. Ghleqreeesinenetheeestpetent,vhileheaee-

tylilee-dﬁistolsppeeredsoneuhetsinilsrteeeohethc. Assenlonoludeepreh-eteverethelessteffeetive. heelepeofthe
dose—response serve

those of the other

W

for syn-chaste ves eon-idem}; different

Ms.

ft.

Ietea-pretstienoftheseusultseetethesieilerityes
difference of the site of eetien oh the cents-.1 eel-m get. is

dqndent upon our knowledge of the feces of «tier: of the oomlsellt
scents. lhile this leeelieetion of oesttel ooenlsent entice is not
definitely known, it is geeenlly shoddged tht
estspredoninenthontheoerehreloortez, whiletheledllhryull
pontine regions ere less sensitive. Pia-atom hes its pads-insist
eetion on hulher structures ehile stryehine sets st e lever level ef
the oerehroepdml uis. Iieotine is believed to
its outrel

We

convulssnt sotion

We

st the level of the dimephlel.
Itnstheeeknovledgedthsttheoonvueentsestsinltueasly

st different

1evels of th- centre]. nervous

mun.

Onr

results suggest

�4—H-

tht

the coupon!!- which inﬂuence the clone

combat ”turn of on.

ormoftboonmﬂwdnaﬂwtcmlnumottbm
'

norm mun.
equal-on of attraction by

uni

unta do“ not mac-urn: in); tint than
sive sci-urn m tux-notion, or can

of that: «foot

any

We

modify

;_

ﬂu

comma

and

pt you.“ little

which

for

or

”Nectar-1mm

a

India

southconvul-

anal norm

n

".0111. action

mnu(1955)hndumbdthamotﬂ52ﬂ
out
pound
Mott-alternation.
h"
a
mutant
M
u muting

«wwwtwomwmumsmum
pro-um. HtmjutmmmhmMmM
road“;
:- mated
We W
Mona-don
of

with chlorine-I130, a

12

”5&amp;10mootdnmhcttogtuohurnd.

moxnmwwmamumadnmmw
roar.

MIMummtm-QOWMhnuW

Mun-t0.

“1pm, t p.“

_

Anti-p.110,

walla him“.-

mnwtomﬂnuuou
mumthmmmwm1956). noun a» £1955)
all
or mum.- (noun a: mm

“WWn-imﬂnnnwmmw

�-5-5-§-

want.

nativity, team-r with

m «not on .11 four «mum,

mmiupwmuummumm

ﬂththoomtimudduhmwm
utionotthownuminumtmumha
b..tumuutiou
mm,
tyxino,
dentin-W We”.
Moon-ow.
Marmara-sin,
murmur“.

0!.thqu

and mute]. on

Wuumlmmwwmmmmm.

u«.mmmmuuatunmmmﬂﬁo
Pavia”mmmuamwunuuu.
nub-WWmenth-pnmottm

I:

Wd‘O/UO.

mnummwwwmummﬁm

innaundtmmutthMp-éﬂyw

,.

"a

I.
(Wingw,
WW
(1957)

In many Mdmtuuuu u cm.
do.)

an

udulM-(uquu-mwaaumaw
mum-g mmummwormm.“

mmamumumutuwmd
Wu.utuqaumutbunuuwuunua
of'utomdow.

.;

mmmamwwwmwmm
«www.m-mwwmwmum
mthmuopotuqupcumuthuuuuu. Wanna
uh
mm‘mrmmumuugmcm

mm... nulmmmmu-mmzu- MM
mumumm(m,uumm19ﬂ).

�”IL-*-

1

:1.
u“-

1‘

a

A

.

.

:\

1

:

1

~=‘-&lt;‘Wlﬂ-me~4

a“

airﬁai’iw"

..

MmmtnottmoIWNLWn-(I)
(l)uluuy¢loao1(l)ondlnuuctw
m1“),

mu
umcwwaomphmmul.

.1

�m

Wu,morp1nn,uprobmto,uuqmm1,
nova-.1 «Ml-cum. any-um proau. utma;
of
Ion
clouo
to
thMM.”
tumult” nth c unpai1.

Wm

mun-mu,
1311.00.

manual,

am

or

3100“...th-

w

‘

2.

mule-91d
um,
Mnmnu,m1u,

wuwmulot,hnuonndiﬁ~ityofm

awmumnmtmdammuw.
ummammuaummm
3.

“Wham-WMuRMtme-Mdm
umumd,n-¢om,mw,wmorm
“ulna-mm
ammotu-Wtyuw-n
munu1ummnmmmwm.m1m
'

A.

W
muamudmpoumu.
to

«mm.
3M0
)uuu

n
V

«

,

~

;,
s.

z
.
1,,
..

(.9;

A

a.»

you.
man
mm
I

Mm¢ha3a11vaé2r$imH

lMMﬁAxtﬁ-m¥*-"‘m&amp;héw«gu

\

�.74).?—

W

in with to ﬂunk

thou orpniutiom for

tonal-3
tolu-

"11111310 tho
wm":

~WW»II"M

~

..--M-

.....,...

n...

..

9..

.

Ml!....;

that cart“! in nun.
,

“I‘M“
Ia Met, IJ.

m1.“

E11100
0000.

8" 525A

0000.

W

Pipndol

m.
m

mm
man

ad

to

mu,m.

0.0..

“10mm

3x

,:;"'-.

55.1.6

at“ -.
.iﬁmi-ﬂiaﬁ.“

.0

‘ “a

.3...

W.
“an,”

oo;oo

'5

1

W,
m

M

.1“. n1” ‘Pun.

.'

4.52.

-

�Box-pr,

r.n.. J.

m1.

Borg-r, LIL. Ann.

M,
mu,

0.,
0.,

1.x. And.

11m”.

Int.

India, 3.,Sloro,

1954.

m.

“1.

301.

J. nan-«1.

m... mm,

413

1957, 91, 685

1955.19,?”
1956.
0.1..

n. an

an Pllvu, 1..

“maxim, am,
’0, ”3‘"
8..
m.
Win,nun-t.W,

1956.13.14:
IO,
‘0'

3..

M m1.

1953, 23: 305

Arch.

ad mun.

mm,

0.11.,

1:19..

0.11., and

5m

1., Apt: Pint-001. ct renal.
1955.
tended.
at
not:

“J,‘.,

git
?

m.

1133

m MOD», '0'
1956,

run-«1.
a.
r..,:.
at
my...
mama,
320
1957,
tron.
MI.
1.
and
lb
:.n.
sun,
Wall,
In
1957,
and
pro“.
3001.1,
1.3.,
aura, 9., ll», IJ.
3.3.

1955.

1949,

99

n.
we
n.

3&amp;6

��‘

.........,.,

4

8n»

AU 8.
_

Ian-av.

8m.

o8

08

so

an»

8.

on.

a...

8. a.

a.

:

an»?

u n

,5
9.5.

.3.an

.

“at.

LED-

..,..y

�CV

A3

ot'oﬂg

gwgong

p.»

aw.a.p.uv

pro

Acto.9.wv

.

a.»

Au.~.w..v

u.w

or»

Aarqnarov

a o

~u...u.nv

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67474">
                <text>Files and reprints: hallucinogens and EEG, 1958 (folder title 1/2).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67475">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67476">
                <text>mfp-03-01-002-13-014</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67477">
                <text>1958</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67478">
                <text>Various authors</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67479">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67480">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67481">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67482">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67483">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80950">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87511">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94072">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100633">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6749" public="1" featured="0">
    <fileContainer>
      <file fileId="6543">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/c577bc7f069484c31c474ab088079b96.pdf</src>
        <authentication>ecc528f0eb233cc9aa9e8503f0092d28</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107148">
                    <text>OF'
THE EFFECTS
CERTAIN DRUGS ON
CEREBRAL SYNAPSES
By

Amedeo S. Marrazzi

Reprinted from

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
APR 3 0 1qt§9
‘ ‘
Volume 66, Article 3, Pages 496—507
March 14, 1957
DEPARTMENTOF
.

EXPERIMENT”

PSYBH‘HRY

SIDE HOSPlTN-

Hug-LEN OAKS. N- Y-

�THE EFFECTS OF CERTAIN DRUGS ON CEREBRAL SYNAPSES
By Amedeo S. Marrazzi
Velerans Administration Research Laboratories in Neuropsye/ziatry,
Veterans Administration II ospital, Pittsburgh, Pa.
As Edward Evarts has so clearly indicated in his contribution to this volume,
we are all interested in determining the neurophysiological correlates of mental
disturbance in the hope of thereby gaining an inkling of its underlying mech—

anisms and developing a rational therapy for it. Humphry Osmond has
drawn a dramatic picture of the opportunity presented by the situation made
possible by the psychotomimetic drugs, which afford us the means of inducing
at will a reversible model psychosis. This model psychosis, even though it
bears only a fragmentary resemblance to schizophrenia, nevertheless simulates
certain aspects of mental disturbance by perhaps similar mechanisms. Furthermore, the so-called model psychosis also can be shortened and terminated
is
in
effectiveness
clinical
which
for
schizophrenia
will
the
tranquilizers
at
by
claimed. The use of drugs as tools thus creates favorable conditions for studies of mental illness.
Our efforts, as investigators, are directed more toward an intelligent applica—
tion of the hypotheses of mechanism rather than toward simple clinical evaluation. The conditions that we wish to interpret are fully and truly exhibited in
man but, before we can take full advantage of controlled conditions induced in
humans, it is necessary to perform some prototype experiments in animals
since, in such experiments, more procedures are permissible and in them those
experiments intended for man can be constructed and rehearsed. This pur—
is
be
humans
with
work
before
done,
needed
can
the
my
groundwork
pose,
justiﬁcation for presenting some data on animals and making comparisons
with clinical conditions and experimentally induced conditions in man.
FIGURE 1 summarizes the data that led my co—workers and me to a hypothesis that served as the point of departure for studies in this ﬁeld.1 It
shows that in our survey of a variety of sites in the nervous system we ﬁnd, as
far as we have gone, that a consistent reciprocal relationship exists between
excitation or enhancement by acetylcholine and acetylcholinelike substances,
including anticholinesterases, on synaptic-transmission phenomena and inhibition by epinephrine, norepinephrine, all sympathomimetic amines in varying degrees, and related substances.2 It seemed plausible that any perversion
of metabolism that would distort the balance of endogenous chemical or
neurohumoral control of synaptic-transmission processes could lead to abnormal cerebral performance or mental disturbance, and that chemicals or drugs
could alter the equilibrium of transmission and thereby alter cerebral and
mental function in the direction of health or disease.
The limitations of communication with animals make it exceedingly difﬁcult,
though not impossible, to relate the behavioral disturbances that can be produced in them with mental disturbance in man. Since our basic premise, however, is that all cerebral function, including both behavior and mental proc—
in
series
and
in
accumulated
parallel
of
units
is
functional
made
esses,
up
496

�Marrazzi: Effects of Certain Drugs on (‘erebrztl Synapses 497
SIMILARITY

OF

CHOLINERGIC

EXCITATION

AND

ADRENERGIC

INHIBITION

AT

VARIOUS

SYNAPSES

ACETYLCHOLINE

ATROPINE

0R

CURAFIE

ANTICHOLINESTERASE

TEA

EPINEPHRIQJE

mnzpmepuamz
AMPNETAMINE

Epnsonms

(-)

CORTEX

‘MIDBRAIN

(—)

~n£spmnoav

(_)

CENTER

PARASYMPATNETIC
GANGLIA

(-)

svunmznc
GANGLIA

(_)

”c/

(-I

6.23536: *

-----------

553%?

(

-

4 ENHANCEMENT

3' BLOCK
‘I HONOLOGUE OF SVMPATHETIC

mcounzn
OF

**

GANGLION

FIGURE

an. , _______

(-)

INHIBITION
CNOLINERGIC

EXPERIMENTS

2‘ DEPRESSION

EFFECTS
IN

PROGRESS

1

combinations to form patterns, I believe it of value to study such units,
that is, the synapses.
The transparent model of the brain of the cat (FIGURE 2) illustrates a relatively simple synaptic* preparation that we have found convenient for study.
I must emphasize, at the outset, that we consider the experiment pertinent to
the extent that it deals with visual pathways, since the powerful psychotomi—
metic drugs exhibit an important Visual component in the hallucinations,
dramatically so with mescaline. More important than that, our ﬁndings im—
press us with the similarities rather than the differences between synaptic per—
formance and susceptibility to chemicals, either endogenous or exogenous
(drugs). Therefore, we are really using the transcallosally activated cerebral
synapses in the visual area of the cat merely as representative of cerebral
synapses in general, all of these synapses having qualitative similarities and
varying principally by differences of threshold. We do not intend to suggest
that an alteration in this speciﬁc pathway is necessarily responsible for mental
disturbanceT A little later I shall outline a general working hypothesis based
‘ “Synapse” is used throughout in the sense of designating the total complex involved
the functional arat
ticulation of 2 neurons, that is, presynaptic nerve ends, transmission process, postsynaptic dendrites, and soma.
’r Chronic
interruption in a system such as the transcallosal. as mentioned by Edward Evarts, should not necessarily be expected to produce the same changes as an acute interruption by drugs unaccompanied by surgical

trauma and subsequent degenerative processes.

�498

Annals New York Academy of Sciences
93
.5“

.Qaﬁda

05
mm

399%

@003

.3235

029533

33.

Saginaw

Qumozaumqnbv

18:38.35

gobs—Tm

wagon?

£35

2:
we

1:58

“223359

.12.—

.

.N

35c

5:...

~
A

688.:

.

�Marrazzi: Effects of Certain Drugs on Cerebral Synapses 499
patterns that results from alteration in amounts of
synaptic regulators or in the thresholds of the neurons upon which they act.
Since Edward Evarts has already outlined our technique I can be very brief
in pointing out certain features. Because the brain is a communication system
it seems most appropriate to measure function by recording the handling of a
test message. The test message is supplied in the form of a submaximal elec—
trical stimulus applied to 1 optic cortex in a cat that has received a. light dosage
of pentobarbital sodium. This stimulus initiates a conducted response in the
association or transcallosal tract that connects the stimulated point to a sym—
metrical point in the contralateral cortex where, after synaptic. transmission,
the stimulation evokes a cortical potential, as first described by Curtis and
Bard.3 To help distinguish between peripheral effects that would contribute
to the afferent drive constituting the background against which the impulses
are elicited and the strictly central effects, we take advantage of the fact. that
an intracarotid injection will achieve a transient, higher concentration of drug
on the ipsilateral or recording side but, when diluted by the blood in the general
circulation, the concentration of the drug is brought down to levels that are
below the threshold for the peripheral effects. Under the conditions of our
experiment, the amounts of the drug passing through the circle of Willis to the
other cortex are unimportant.
In this way it becomes possible to demonstrate (FIGURE 3) that epinephrine,
a chemical natural to the body, one known to produce anxiety when accumu—
lated in sufﬁcient amounts, either endogenously or exogenously, also produces
cerebral synaptic inhibition, as indicated by the reduction in the signal (surface

on a disruption of normal

negative wave) corresponding to outflow, while the inﬂow (surface positive
wave) is essentially unaltered. The same type of synaptic inhibition is shown
for another cerebral neurohumor, norepinephrine, in the next line of the same

IOO
LIV.

IOO ”\4

The cerebral synaptic action of epinephrine and norepinephrine in a 2-neuron intercortical (transcallosal) system. Potentials are evoked in the optic cortex by the electrical stimulation of a symmetrical point
m the contralateral cortex. Epinephrine (10 lag/kg.) was injected into the i silateral carotid artery after A.
and norepmephrine (150 lug/kg.) was injected after D. A and D are centre 5, B and E represent inhibition,
and C and F show recovery.
FIGURE 3.

�500

Annals New York Academy of Sciences

0-9-?
H
I

HO

H0

H
I

OH H

I

H

-N\
CH3

EPINEPHRINE (dihydroxy-phenyl—ethonol methyl amine)

h‘h‘,“

”'9?"
HCH3H
AMPHETAMINE (phmyl-isopropyl amine)

_*.+

H

__'.+
H

CHSO

MESCALINE (trimethoxy-phenyl-ethyl om'ne)
FIGURE 4.

Types of phenyLethyl amines producing mental effects.

ﬁgure, but this action is evidently weaker than the other, requiring a larger
dose to produce approximately the same degree of inhibition.
In FIGURES 4 and 5 are shown some structural chemical similarities of compounds with which other contributors to this volume have already dealt.
Attention is called to the close structural similarity (FIGURE 4) of epinephrine
to amphetamine, which is also capable of producing anxiety, and mescaline,
which does so regularly and with dramatic intensity, producing a full-blown
“model psychosis.” These drugs in turn are related to the group shown in
FIGURE 5, in which epinephrine15 once more presented alongside a ﬁrst— oxida—
tion product, adrenochrome, which is an indole. Below these are pictured
d- lysergic acid diethylamide (LSD- 25), the very highly potent psychotogen
which can be considered to be built on an indole nucleus, and 5- hydroxy—
tryptamine, or serotonin The epinephrinelike psychotogens thus can be
chemically related to the indolelike ones, including established drugs such as
LSD— 25, reputed drugs such as adrenochrome, described at the beginning of
this monograph by Humphry Osmond, and by myself elsewhere,2 and the
b which is
4“
in
the
postulated by Woolbrain,
naturally occurring indole found
ley and Shaw5 to be sufﬁciently related to LSD- 25 possibly either to compete
with or to add to its action. We now looked to see whether there was any functional parallelism or neurophysiological correlate of this relationship by using
the objective test of cerebral performance afforded by the evoked- potential
ac—
IS
FIGUR126
the
that
data
there
an
showing
the
c.at
presents
in
technique
tual correspondence111 structure, and that all the compounds produce synaptic

�Marrazzi: Effects of ("ertain Drugs on Cerebral Synapses

- EH-c-("6"3

no

no

on

0
——&gt;

0

501

N

has
EPINEPHRINE

H

CON

ADRENOCHROME

/\

Cat's
C2H5

N-CH3

-c-c-NH2

HO

N

N

SEROTONIN

D-LYSERGIC ACID
DIETHYLAMIDE (LSD-25)

FIGURE. 5.

inhibition identical in kind to that produced by epinephrine, but vary in degree
of effectiveness, so that for the approximately equivalent effects shown it re—
quired milligram amounts of mescaline, but only microgram quantities of
LSD-25, which duplicates the relative potency of these compounds as found in
clinical experience. The dosages used throughout our experiments are inten—
tionally of a size selected to produce incomplete actions, so that recovery back‘
to the control level can be secured more readily.
Very interesting is the ﬁnding with serotonin, which turns out to be the most
effective cerebral synaptic inhibitor of all, being effective in as little as l—ug.
doses. Accordingly, rather than being an antagonist, this indole, or something
like it, may represent the type of endogenous substance that is instrumental in
bringing about some forms of spontaneously occurring mental disturbance.
b and is
brain48h
is
in
the
serotonin
since
so
naturally present
Furthermore,
highly potent (about 20 to 25 times as potent as epinephrine in the same experiment), serotonin becomes, as we pointed out over a year ago,2 an even better candidate than either epinephrine or norepinephrine, which are also found
6
1"
for the role of inhibitory neurohumor.* This ﬁnding would
in the brainﬁ‘“
must penetrate the blood-brain barrier at least in the small amounts required to exercise the cerebral action described.
’ Serotonin

�Annals New York Academy of Sciences

502

IOO

MESCALlNE

IOO
UV.

IOO ’D

100‘:
UV.

/

4"
A

A

A

A

'°°”

A

A

SEROTONIN
CONTROL

MAXIMUM

EFFECT

RECOVERY

FIGURE 6.

point even more closely to a derangement of neurohumoral balance at synapses
as a potential mechanism of cerebral or mental derangement.
Unfortunately, except for the intraventricular injections described by Sherwood,7 there have been, thus far, no documented reports of serotonin—induced
mental disturbance* in man that are clearly separable from the natural anxiety
initiated by the profound peripheral effects such as circulatory disturbance,
other autonomic effects, and emesis. There are, however, such reports for a
close analogue of serotonin, dimethyl-serotonin, or bufotenin, which is used
for its mental eﬁects by some primitive peoples and has been observed by
Fabing8 to produce such disturbances in man experimentally. These 2 subof
metabolite
epinephrine that
well
presumed
adrenochrome,
a
as
as
stances,
‘ The fact that patients with carcinoid have large amounts of circulating serotonin without showing marked
has develsym toms of mental derangement could represent an adaptation to very high levels of serotoninofthat
such patients
ope and accumulated gradually. This suggestion would account for the relative immunity
to the possible central effects of high doses of serotonin injected intravenously.

�Marrazzi: Effects of Certain Drugs on Cerebral Synapses 503
CONTROL

MAXIMUM

EFFECT

SEROTONIN

IO pg

RECOVERY

nomcwcnmn,
N

H0

/hCH-

/kg.

CH 3

CHEN'CH’

./\N

H

BUFOTENIN
0=

0:

5 pg /kg

MON
/

N
H

ADRENOCHROME 2000 pg/kg.
FIGURE 7. (‘erebral synaptic inhibition by indoles in a _2-neuron intercortical (transcallosal) system. The
potentials evoked in‘the cerebral cortex of the cat by electrical stimulation of the contralateral cortex every 2
seconds. The injections were given in the 1psxlateral common carotid artery.

Hoffer, Osmond, and Smythies9 report as reproducing some aspects of the clini—
cal syndrome of schizophrenia when injected intravenously in man, are com—
pared in the cat in FIGURE 7. Again, all these compounds have the identical
qualitative effect, namely, synaptic inhibition, but bufotenin, tested in the same
animal, exhibits twice as much effectiveness as does serotonin, which required
10 pg. for its effect on this occasion. Adrenochrome, though it does induce
synaptic inhibition, requires so large a dose, 2 mg, that it seems an unlikely
candidate for the role of endogenous psychotogen responsible for a form of
mental illness, although a substance somewhat like it might be responsible.
The great effectiveness of serotonin not only suggests that this is the type
of chemical structure implicated, with the reservations already noted, but that
it constitutes 1 link, another being its natural occurrence in the brain, in the
chain of evidence identifying it as a cerebral neurohumor. A required piece
of information to round out this evidence would be the measurement of the
actual liberation of serotonin during, or prior to, the recorded synaptic activity.
This is a tedious and difficult type of experiment, and it is attended by special
handicaps in work on the brain. Another approach leading to a similar conclusion, however, is quite readily followed. This approach is the accumulation
of what must be naturally occurring serotonin, strategically located at the
synapses, by the poisoning of the enzymes that normally lead to the destruction
of serotonin and account for the ready reversibility and short duration of the
action of serotonin. This is the technique that has been used so successfully
in the study of the function of acetylcholine in the brain, and it is in this manner,
by the use of a powerful anticholinesterase, that we demonstrated the presence
and operation of acetylcholine at cerebral synapses.1 Serotonin is known to
be very susceptible to destruction by monoamine oxidase, which is abundantly

�504

Annals New York Academy of Sciences

CONTROL

EFFECT
RECOVERY
FIQURE 8. The cerebralsynaptic action of iproniazidin a 2-ncuron intercortical ttranscallosal) system.
potentials evoked in the optic cortex of the cat by electrical stimulation of the contralatcral cortex every
onds. The iproniazid (S mg./lu;.) was injected into the ipsilateral carotid artery.
MAXIMUM

The
2

sec-

present in the brain.10 We therefore attempted to inhibit. this enzyme by
iproniazid (Marsilid). FIGURE 8 shows the result of a preliminary experiment
in which we injected iproniazid into the common carotid artery of the cat. in
the same way that we had done previously with serotonin. The effect produced duplicated the serotonin effect as if, indeed, the serotonin at the synapse
had been preserved by the inhibition of monoamine oxidase by the iproniazid.
I believe this ﬁnding offers another piece of important evidence that serotonin
is present naturally, not only in the brain, but at strategic sites where it is capable
of inﬂuencing synaptic transmission. We have not as yet measured, as we
need to do, how much this dose of iproniazid, given in this way, inhibits cerebral
monoamine oxidase in the cat.
We believe that the somewhat discouraging attitude of some investigators
toward basing clinical prediction on animal experimentation is not, entirely
justiﬁed, since this procedure is a natural result of the comparison of objective
criteria such as we have just described with clinical evaluation based upon
questionnaires and much undoubtedly shrewd clinical observation, both of
these types of data being very difficult, indeed impossible, to quantitate. Ac—
cordingly, we are more impressed by the degree of correspondence obtainable
rather than by the discrepancies that are to be found. Thus our evoked-potential experiments in the cat rank the psychotogens and psychotomimetic substances studied so far, in general, in the order of clinical effectiveness, and they
suggest that at least part of the mechanism responsible for mental disturbance
is to be found in an imbalance in the regulation of synaptic transmission.
One such imbalance we have already described.
If this hypothesis is truly useful, and if the animal preparation used bears
other than a merely empirical relation to the clinical data, we should expect
that. the various tranquilizers for which varying degrees of clinical success have
been claimed would have some action here also. “'e proceeded to test this
extension of our thinking, and we found that all of the several types of tranquilizers are capable, when administered prophylactically to cats, of partially
preventing, in the doses used, the cerebral synaptic inhibition of a test dose of

mescaline.

this reaction, using chlorpromazine ('l‘horazine). 'l‘he figures now read from top to bottom instead of from left to right, as in the previous
FIGURE 9 shows

�Marrazzi: Effects of Certain Drugs on Cerebral Synapses 505
MESCALNE

2.5mg/kg

MESCALINE AFTER CHLORPROMAZINE

CHLORPROMAZNE

0.05mg./kq.

CONTROL

MAﬂMUM

EFFECT

RECOVERY

60’\.

200

UV.

The_prevention of the mescaline effect by chlorpromazine in a 2-neuron_intercortical (transcallosal)
system. The potentials evoked in the cerebral cortex ofthe cat by electrlcal stimulation of the contralateral cortex every 2 seconds. The injections were made in the 1psrlateral common carotid artery.
FIGURE 9.

The ﬁrst column shows the control, the mescaline inhibition at B,
and the recovery at C. After this, chlorpromazine is given in doses which,
per se, have no apparent effect on synaptic transmission, as shown by the new
control D in the second column, but now when mescaline is given again, the
synaptic inhibition E is much reduced when compared to B. Without the
tranquilizers, the same degree of inhibition of mescaline can be repeated several
times in succession, provided that complete recovery is allowed between in—
jections. Records G and II show again that this dose of chlorpromazine did
not impede synaptic transmission despite the ability of the drug to protect
against mescaline. If the dose is increased twentyfold it does have a depressant

ﬁgures.

MESCALINE
A

2.5 mg./kq.

MESCALINE

AFTER RESERPINE

D

CONTROL

B
MAXIMUM

EFFECT

C

RECOVERY

n
E

RESERPINE

0.lmg./kg.

G

m
I

The prevention of the mescaline effect by reserpine in a 2-neuron intercortical (transcallosal)
system. The potentials evoked in.tlie cerebral cortex of the cat by electrical stimulation of the contralateral
cortex every 2 seconds. The anCCtlonS were given in the ipsilateral common carotid artery.
FIGURE 10.

�506

Annals New York .‘Xcademy of Sciences
MESCALINE

CONTROL

MAXIMUM

2.5m/llq.

MESCALINE

AFTER

FRENOUEL

FRENOUEL

tqu/kq.

m

The prevention-of the mescaline effect by It‘renquel in a Z-rieuron intercortical (transcallosal)
system. The potentials evoked In the cerebral cortex of the cat by the electrical stimulation of the contralateral
cortex every 2 seconds. The unections were given in the ipsilateral common carotid artery.
FIGURE 11.

action on synaptic transmission. The same prophylactic action is obtained
with reserpine (Serpasil), as shown in FIGURE 10, and with azacyclonol (\lt‘renquel), as shown in FIGURE 11. Another point of correspondence with clinical
findings is that the margin of safety, in this case the range between the prophy—
lactic and the synaptic-depressant, dose, is large, the depressant dose being 15
to 20 times the prophylactic. dose with both chlorpromazine and azacyclonol,
but the factor is only 2 with reserpine. The latter drug approximates the
action of the barbiturates, which can reduce the degree of demonstrable inhibition from mescaline by reducing synaptic transmission in the ﬁrst place.
I feel justiﬁed in saying, then, that the preparation described is pertinent to
the clinical situation in that it ranks the psychotomimetic substances in the
order of their clinical eli'ectiveness, and that the action of mescaline, the only
drug that we have tried so far, is prevented by the tranquilizers.
By use of the evoked—potential technique, we have demonstrated that:
(1) There exists an equilibrium of neurohumoral control of transmission at
cerebral synapses and throughout the nervous system, as far as I have surveyed
it, that is susceptible to distortion and imbalance by disturbance in the amounts
of chemical regulator or the susceptibility of neurons.
(2*) The psychotogens and psychotomimetic substances discussed. structurally and functionally resemble the actions of the fairly well-established inhibitory synaptic neurohumors, epinephrine and norepinephrine, and of sero—
tonin, the new one that we have described.
(.3) Serotonin or its dimethyl derivative, bufotenin, comes close, even closer
than does LSD-25, to representing the type of endogenous psychotogen that
might be a natural cause of some forms of mental disturbance.
We speculate that such disturbance can be produced by direct perversion of
normal patterns of neuronal activity by the undue inﬂuence of synaptic inhibitors or, indirectly, by such inhibitors impeding the ﬂow of impulses from
higher controlling centers and releasing the more 1,)rimitive, simpler, and less
well—adapted patterns of activity that we call abnormal.

�Marrazzi: Effects of Certain Drugs on Cerebral Synapses 507
References
1. MARRAzzr,

118: 367.

A. S.

1953.

Some indications of cerebral humoral mechanisms.

Science.

E. R. HART. 1955. Relationship of hallucinogens to adrenergic
cerebral neurohumors. Science. 121: 365.
3. CURTIS, H. J. &amp; P. HARD. 1939. lntercortical connection of the corpus callosum. 126:
2. MARRAZZI, A. S. &amp;

473.

B. B. CRA\\'F()RD &amp; J. H. GADDUM. 1954. The distribution of substance P and 5—hydroxytryptamine in the central nervous system of the dog. J.
Physiol. 126: 596.
4}). PAGE, I. H.
1954. Serotonin (5—hydroxytryptamine). Physiol. Revs. 34: 563.
5. WOOLLEY, D. W. &amp; E. SHAW. 1954. A biochemical and pharmacological suggestion
about certain mental disorders. Science. 119: 587.
6. VOGT, M. 1954. The concentration of sympathin in different parts of the central
nervous system under normal conditions and after the administration of drugs. J.
Physiol. 123: 451.
7. SHERWOOD, S. L. 1955. The responses of psychotic patients to intraventricular injections. Proc. Roy. Soc. Med. 48: 855.
FABING, H. D. 1955. Personal communication.
99°
HOFFER, A., H. OSMOND &amp; J. SMYTHIES. 1954. Schizophrenia: a new approach. II.
Result of a year’s research. J. Mental Sci. 100: 29.
10. KOELLE, G. B. &amp; A. DE T. VALK, JR. 1954. Physiological implications of the histochemical localization of monoamine oxidase. J. Physiol. 126: 434.

4a. AMIN, A. H. T.,

'1‘.

�APR

23

‘959

DEPARTMENT OF
EXPERIMENTAL PSYBHMIRY

HILLSIDE HOSPITAL
GLEN OAKS, N. Y.

�PSYCHOTOMIMETICS, CLINICAL AND THEORETICAL
CONSIDERATIONS: HARMINE, WIN-2299 AND NALLINE

17%;»4”

M :9

HARRY H. PENNES, M. D.,

PHILADELPHIA, PA., AND

PAUL H. HOCH, M. D., NEW

Reprinted from

AMERICAN JOURNAL OF PSYCHIATRY
Vol. 113, No. 10, April, 1957

YORK CITY

�PSYCHOTOMIMETICS, CLINICAL AND THEORETICAL
1
WIN-2299
AND
CONSIDERATIONS: HARMINE,
NALLINE
HARRY H. PENNES, M.D.,2

PHILADELPHIA, PA., AND

This report describes the clinical effects
of 3 psychotomimetics in mental patients.
The results will be related to nosological and
certain biological aspects of the “model psychoses” in general. The agents are (I) harmine, an alkaloid present in plant prepara—
tions ingested by some South American
tribes(1) ; (2) Win-2299, a synthetic
cholinolytic(2) and (3) N-allylnormorphine
(Nalline), a synthetic morphine antagonist
(3, 4, 5).
MATERIAL AND METHODS

Single dosages of the drugs were given
to 32 voluntary, physically normal mental
patients, at the New York State Psychiatric
Institute; 29 were in the 18-35 year age
range; 19 were males and I 3 females.
Twenty-two were schizophrenics of the
pseudoneurotic and other nondeteriorated
types, with only the primary symptoms of
the disorder. Five additional schizophrenics
had auditory hallucinations or delusions be—
fore the drugs. The remaining 5 subjects
had severe psychoneuroses or recurrent depressions. No patient had clouding of consciousness. Each drug was given about 9: 00
and
breakfast
after
a 48-hour
light
a
am,
medication-free period. Examination by the
authors and nurses were made for the remainder of the day in a shaded private room
and also in the succeeding 72 hours. No
patients were informed of the probable effects of the procedures. Most subjects
showed excellent cooperation in reporting
drug effects. In most cases, each patient received one drug of the 3 tested, but some
received different doses of harmine on differRead at the 112th annual meeting of The American Psychiatric Association, Chicago, Ill., April 30May 4, 1956.
2 Director of Clinical Research, Eastern Pennsylvania Psychiatric Institute, Philadelphia, Pa.
3 Commissioner of Mental Hygiene, New York
State.
The actual study was performed at the New York
Psychiatric Institute, New York, Department of
Experimental Psychiatry.
1

PAUL H. HOCH, M. D.,3 NEW

YORK CITY

ent days. Each drug was given in salt form
but for brevity will be referred to as the
base.
RESULTS
GENERAL

Since the new manifestations under the
drugs were not present in the pre-administration period, they were clearly distinguishable from the patients’ baseline symptoms. At low dosage, each drug produced
slight drowsiness, either with or without
other symptoms. With medium or high
dosage, the reactions qualitatively resembled
those in a former series of similar subjects
who received mescaline or LSD(6, 7, 8).
Thus, diffuse alterations usually occurred
in many realms—autonomic, motor, perceptual, emotional, intellectual, and be—
havioral. Unlike mescaline or LSD (cf.
Discussion for dosages), the present drugs
regularly elicited some degree of clouding of
consciousness in addition to the preceding
changes. The characteristic reaction at
medium or high dosage was a semidelirioid
or confusional state with intermittent drowsiness or sleep. The confusional periods
were cyclic. Their intensity and time of
occurrence correlated only partly with drowsiness or sleep. Major symptoms were
impairment of contact, attention, grasp, responsiveness, and concentration, with general “dreamy” or twilight quality. Full delirioid reactions occurred in 2 subjects at
the highest dosages of 2 drugs (Win-2299,
Nalline). Most subjects had intermittent
amnesia during the reaction itself but were
able to provide adequate descriptions of the
major events. A spotty defect in recall was
usually present in the 72-hour follow-up
period.
Visual hallucinations (cf. Discussion for
alternative terminology) occurred at medium
or high dosage with all 3 drugs. Subjects
were easily roused after the onset of drowsiness or sleep and reported some of the hallucinations that had occurred in the “dream887

�888

CONSIDERATIONS OF PSYCHOTOMIMETICS

ing” state. In all cases, the hallucinations
occurred only with eyes closed and disappeared promptly when the eyes were opened.
Hallucinations other than visual were infre—
quent. Perceptual distortions of body and
environment were moderately frequent.
Neurological changes included varying degrees of subjective vertigo, light—headedness,
subjective and objective ataxia, and sluggish
speech. Like mescaline and LSD, these
drugs produce a variable degree of intensiﬁcation of different types of baseline symptoms. Harmine also occasionally produced
a shallow euphoria. Nalline often produced
relaxation of rather marked degree. After
a few initial hours of peak intensity, reac—
tions usually subsided gradually between the
fourth to eighth hours, often with ﬂuctuations in degree before complete remission.
No subject reported effects after 24 hours
except for minor, nonspeciﬁc “hangover”
feelings.
INDIVIDUAL DRUGS

Harmine.——Turner, Merlis, and Carl have

recently pointed out that the alleged hallucinogenic activity of pure harmine is a complicated issue on the basis of the previous
literature on crude plant extracts(9). The
threshold hallucinogenic dose of the pure
drug in the present study ranged from I 50.0—
200.0 mgm. intravenously. With this route,
5 of 11 subjects reported visual hallucinations of varying degrees of complexity and
organization. Bradycardia and hypotension
occurred with all doses of intravenous harmine despite a 20- to 30-minute injection
time, thereby limiting maximum dosage to
300.0 mgm. Average maximum changes
were a pulse rate of 18 beats per minute and
systolic blood pressure fall of 16 mm. mertermi—
in
was
one
subject
Injection
cury.
nated at 210.0 mgm. because pulse rate
dropped from 82 to 48 per minute and blood
pressure from 118/78 to 88/60. Recovery
occurred in about 30 minutes. The drug was
not hallucinogenic by the oral or subcuta—
neous routes. However, ingestion of crude
plant extracts by natives does produce visual
hallucinations according to ﬁeld observations(10, 11, 12). In an experimental study
by Cardenas(13), normal subjects also reported visual hallucinations and other effects

[Apr.

noted here, after ingestion of an aqueous
solution of yahé (Banisteria caapi, a source
of harmine). Visual hallucinations might
have occurred in the present study with
higher oral (loses, the maximum oral amount
(960.0 mgm.) being 4.8-6.4 times greater
than the intravenous threshold hallucinogenic
amount (150.0-200.o mgm.). The amounts
of harmine taken orally under ﬁeld conditions and in Cardenas’ study are unknown,
precluding comparison with the present
study. Further analysis of the hallucinogenic
activity of harmine is complicated by nu—
merous botanical and chemical considerations(1, 10, 11, 14).
Additional reactions to harmine which
occurred frequently were: nausea and vomit—
ing; slow, coarse, spontaneous tremor of the
extremities of an “extrapyramidal” appear—
ance; humming and buzzing noises (no
voices); “waviness” of the environment;
“sinking” sensations of the body; subjective
sense of body vibration; and subject numb—
ness, accompanied by objective evidence of
reduced sensitivity to light touch and pinprick. These reactions, plus all the preceding, occurred in almost every patient with
the intravenous route; and (except for hallucinations) some occurred with oral dosages
higher than the threshold of 3000-4000
mgm. The reactions were generally more
intense by the former route.
Win-2299.—The mental effects of Win2299 in man have apparently not been described previously. The 2 subjects receiving
2.0 mgm. had the sedative effect. One of
these subjects in addition became “hypersensitive” to light and sound, and spots on
the wall moved and changed form. At the
6.0 mgm. level, all 4 subjects had severe
mescaline- or LSD-like reactions plus a confusional state of moderate degree. These
mescaline-like effects included bizarre perceptual distortions of soma and environment,
unreality feelings, and synesthesias in one
case. The single subject at 10.0 mgm. had
a full delirioid episode with complete loss of
contact, disorientation for time, place, and
person, and responses to complex, organized
visual and auditory hallucinations. This reaction occurred in brief but cyclic episodes;
partial contact and lucidity were restored
after persistent comments and questions.

�I957]

HARRY H. PENNES AND PAUL H. HOCH

Most subjects had a moderate degree of
mydriasis; blood pressure and pulse rate
changes were insigniﬁcant.
Nall-ine.—The results with Nalline in the
main conﬁrmed previous observations of
others in different types of subjects, includ—
ing normals( 3, 4, 5). Past and present
ﬁndings included varying degrees of relaxation or euphoria, anxiety and dysphoria,
miosis, nausea, drowsiness and sleep, thought
disturbances, feelings of heaviness or lightness of limbs, and visual hallucinations. In
the present series, visual hallucinations occurred in the single subject receiving 10.0
mgm., in 7 of 8 at 20.0 mgm., and in 2 of
3 at 30.0 mgm. In 4 cases (and in 2 with
harmine) the hallucinations were Lilliputian
in type, a not infrequent feature of acute
toxic psychoses in general. So far as can
be judged from the literature, a possible
major difference from previous observations
consisted in the occurrence of frank mescaline-like or delirioid reactions. At 20.0 mgm,
3 subjects had typical diffuse, bizarre per—
ceptual disturbances, severe unreality feelings, and other signs of psychic disorganization. At 30.0 mgm., a similar reaction
occurred including auditory hallucinations
and synesthesias. In another subject at this
dose the effect was overtly delirioid, with a
strong resemblance to the Win—2299 toxic
psychosis previously described. The intravenous route probably accounts in part for
the appearance of these reactions, since previous reporters of the mental effects of
Nalline have used the subcutaneous route,
usually at dosages of 10.0-15.0 mgm. and
sometimes higher( 3, 4, 5).
DISCUSSION

Relatively high doses of harmine by the
intravenous route were required to produce
the full psychotomimetic effect with visual
hallucinations. The same was probably true
of Nalline. It is conventionally stated that
acute toxic psychoses occur in apparently
normal individuals after high dosages of
various other drugs, for example, atropine
and cocaine(I5). There is a dearth of precise data on the number of such drugs, dosages required, and regularity of effects.
However, not all drugs in relatively high
dosage produce the diffusely abnormal men-

889

tal changes which are the criteria of psychotomimetic action. For example, clinical
differentiation may be made between a confusional-hallucinatory state and a simple,
progressive depression of level of consciousness elicited by narcotics and other agents.
High dosage alone would therefore not preclude the classiﬁcation of the present or
other drugs as psychotomimetic in a selective or speciﬁc sense. Transient cerebral
anoxia could have resulted from the hypo—
tension and bradycardia with intravenous
harmine or a respiratory depressant action
of Nalline, which has been reported at dosages used in this study(3, 5). The ﬂorid
and diffuse reactions elicited by these 2 drugs
would certainly not appear to be characteristic of those in cerebral anoxia. In addition,
the circulatory effects of harmine usually
disappeared about 20 minutes after termination of injection, whereas the mental re—
actions lasted at least several hours at peak
intensity.
Harmine, Win—2299, and Nalline fundamentally produced an acute organic reaction
type, because of the basic mental clouding
and confusional effects. Harmine and Nal—
line each produced mental clouding together
with systemic toxicity (cf. above) ; on the
other hand LSD and mescaline elicit neither
clouding or toxicity in major form within a
certain dosage range. However, Win-2299
did not display this association of the 2 effects, since severe mental clouding occurred
without obvious systemic toxicity. It is possible that confusional aspects may be more
prominent for a given agent whose threshold
psychotomimetic dosage is high relative to
threshold dosage for any effect. Quantitative data relevant to this proposition are
lacking for any psychotomimetic but are obtainable in principle. It is very probable,
however, that absolute dosage thresholds for
psychotomimetic activity correlate poorly
with mental clouding. In ascending order,
these dosages are very approximately: LSD
(oral or intravenous) under 100 micrograms; Win—2299 (oral) and Nalline (subcutaneous or intravenous) 55.0-20.0 mgm.;
harmine (intravenous) and mescaline (oral
or intravenous) over 100.0 mgm. LSD and
mescaline are at opposite extremes of an
enormous absolute dosage range, and produce

�89o

CONSIDERATIONS OF PSYCHOTOMIMETICS

practcially no clouding whereas the 3 intermediate agents elicit frank clouding at near
threshold.
There is evidence, however, that LSD and
mescaline may produce clouding of consciousness at dosages well above threshold.
Pennes has previously reported a sedative
effect of LSD in 26.0% of a series of schizophrenics(8). The drug less occasionally
(about 10.0% of cases) produced a confusional state(7). MacDonald and Galvin
more recently reported a 58.0% incidence of
mental clouding and confusion after LSD in
50 subjects. The psychotic subjects in their
series apparently received the drug in dosages (per kilogram of body weight) up to
6.0 micrograms as compared with 1.0-2.0
micrograms orally in Pennes’ series(16).
Mescaline sulfate (4oo.o—6oo.o mgm., intravenously) often produces slight drowsiness
throughout the entire reaction and occasional
confusional states(7).
There may be an underlying similarity for
all the drugs under discussion in the relationship of the visual hallucinogenic response
to visual restriction and hypnagogic mechanisms. First, it will be recalled that visual
hallucinations with the present drugs always
disappeared when the eyes were opened.
Wikler noted the same in post-addicts under
mescaline(4). The authors have not noted
this effect in frank form with either mescaline or LSD but have occasionally observed
that hallucinations are reported as less distinct and vivid when the eyes are opened.
Darkening of the room does initiate or intensify visual hallucinations with eyes open
under mescaline or LSD. If eye closure and
reduction of intensity of external light affect drug-induced hallucinations by the same
mechanism, then the difference with respect
to this mechanism may therefore be negligible between the present drugs and LSD.
Such a mechanism may be related to that
presumably operative in hallucinations and
other mental disturbances recently reported
as occurring with generalized restriction of
sensory input(17).
Secondly, the abnormal visual phenomena
with the present drugs are probably best
categorized as hypnagogic hallucinations or
even more broadly as hypnagogic imagery
or visions. This term is used because of the

[Apr.

invariable drowsiness (cf. Results, General) ; disappearance on eye opening is also
consistent with the hypnagogic quality of the
response. According to Ardis and McKellar,
spontaneous visual hypnagogic images in
normals are usually experienced in the
drowsy state and with eyes closed. These
authors also found strong resemblances in
detail between mescaline visual hallucinations and normal visual hypnagogic imagery
(18). Previous workers with Nalline have
variously used the terms visual hallucinations, day-dreaming, vivid visual fantasies in
a dreamy state, or nightmares.
The apparent differences between the
present drugs and mescaline or LSD may
therefore be quantitative rather than qualitative. The conclusion would be that mescaline and LSD may also basically produce an
organic reaction type. It is a familiar ob—
servation that the visual hallucinations which
are so characteristic of the drugs under consideration are relatively infrequent in
chronic schizophrenia. These considerations
obviously do not preclude various possible
relationships between psychotomimetics and
a possible endogeneous “toxic factor” or
metabolic disturbance in the “functional”
psychoses. Hoch and Wikler have recently
and independently summarized the other implications of the drugs and the “model” psychoses for experimental psychiatry(19, 20).
The indole nucleus, alleged to be speciﬁc
for psychotomimetic activity(2I), is absent
in mescaline, Win-2299, and Nalline. How—
ever, with the exception of mescaline, the
remaining 4 psychotomimetics contain a tertiary nitrogen grouping (2 in LSD). Since
these compounds are otherwise grossly dissimilar in molecular conﬁguration (ﬁg. I),
the entire structure undoubtedly has to be
taken into account. Despite this well-known
factor and the very small series of drugs,
there are certain indications that the tertiary
nitrogen grouping may contribute to psychotomimetic activity. In brief, some of the evidence relates to effects of apparently minor
changes in the LSD molecule, effects of
quaternization of VVin-2299 on its CNS potency(2), and comparison of the actions of
serotonin with those of its tertiary amine
derivative, bufotenine(22). However, in ad—
dition to mescaline, the literature reports

�HARRY H. PENNES AND PAUL H. HOCH

I957]

891

other psychotomimetics without the tertiary
nitrogen groupings: marijhuana, which is
n0n-nitr0geneous(9) and 3,4,5-trimethoxy—
amphetamine, a mescaline derivative(23).
9 W: "5
Some types of centrally acting drugs other
OCH3
\ c2 “5
than psychotomimetics also possess the terFuther
of
OCH:
analysis
grouping.
tiary
nitrogen
IE SCALINE
on,
these relationships will be presented elsewhere(24).
There is no apparent common neurophar—
macological basis for the psychotomimetic
action in general and for harmine, Win—2299,
and Nalline in particular(2, 5, 25). Win2299 is qualitatively similar to atropine in
animals by virtue of its peripheral cholinolytic and central actions(2). The mechanism
of production of abnormal mental effects
‘HCL
HO- 0" C- 0' CH2. CH2- /
similar
be
both
for
N\
drugs, Win—2299 apmay
\°2"5
parently having a lower threshold dosage.
2299
(2
2
to recent speculations, some psy—
According
—-—
chotomimetics may produce their effects as
antagonists of cerebral serotonin(26, 27').
N-CH20H=CM2
The mental effects of oral LSD and intravenous harmine (both indoles and peripheral
antiserotonins) differ in many respects (Results, General and Harmine) . The difference
in route of administration is not a factor in
0n
View of the ﬁnding of Hoch that oral and
0
"CL
'
intravenous LSD have the same qualitative
effects(28). However, differences in relative
Structures of Some Psychotomimetics.
levels
contribute
the
to
dosage
apparent
may
FIG. I.—Harmine was supplied in 2 forms: as the
base isolated from Banisteria caapi(I) and as the dissimilarities between the 2 drugs.
c—N

CH35

\

\

HARMINE

NH

LYSERGIC ACID DIETHVLAMDE

C2 H5

6-

D5

WIN-

DIETHYLAMINOETHYL
GLYCOLATE

CH

N

CYCLOPENTYL

THI‘ENVL)

HYDROCHLORIDE

G“
CH2

H

ALLYLNOHMCRPHINE

synthetically-prepared HCl-zHaO. The following
dosages refer to hydrochloride form in each case.
Harmine: oral, II patients, zoo-960.0 mgm.; subcutaneous, 6 subjects, 40.0-70.0 mgm.; and intravenous, II patients, 100.0-3oo.0 mgm. Win-2299
tablets: 7 patients, 2.0-I0.0 mgm. Nalline: intravenous, 12 subjects, 10.0-30.0 mgm. Intravenous
harmine and Nalline were injected over a 20-30
minute period.
Mescaline and lysergic acid diethylamide (LSD)
were not given in this study. LSD and harmine
contain the indole nucleus whereas the remainder do
not. The tertiary nitrogen grouping is present in
LSD (both in aliphatic chain and cyclic constituent), harmine (non-indole member), Win-2299
(aliphatic side chain), and Nalline (linking allyl
side chain with ring member). Cf. Discussion.
Both forms of harmine were supplied as the dry
compound by Dr. K. K. Chen, Eli Lilly Laboratories, Indianapolis, Indiana. For parenteral administration, solutions in pyrogen-free distilled water,
20 cms.,3 were used several hours after autoclaving.
Win-2299 was supplied by Sterling-Winthrop Research Institute, Rensselaer, N. Y., as the racemic
mixture of the hydrochloride salt. Nalline was supplied by Merck and Co., Rahway, New Jersey, N-

SUMMARY

Harmine, Win-2299, and Nalline in single
dosage produce many new mental effects in
schizophrenics grossly similar to those elicited by mescaline and LSD. Many of the
same effects are reported in normals after
harmine and Nalline (other workers). Unlike mescaline and LSD at usual dosage
levels, the present psychotomimetics regularly produce drowsiness and sleep along
with the aberrant mental effects. The resultant state is partly that of “hypnagogic”
visual hallucinations or imagery. The results
with increased dosage suggest that the basic
Allylnormorphine HC1= Nalline HCI; ampoules of
distilled, pyrogen-free water containing sodium bisulfate, 0.2% and sodium citrate, dihydrate 1.5%.
For intravenous administration, ampoule contents
were diluted up to 20.0 cms.3 with pyrogen-free distilled water.

�892

CONSIDERATIONS OF PSYCHOTOMIMETICS

effect of these agents is to produce an acute

toxic reaction type. The difference between
them and mescaline or LSD with respect to
clouding of consciousness and certain aspects
of the hallucinogenic response may be quantitative rather than qualitative. The indole
nucleus is not necessary in the structure of
psychotomimetics since Win-2299 and Nalline are non-indoles. The tertiary nitrogen
grouping may contribute to certain aspects
of psychotomimetic action.
BIBLIOGRAPHY
1.

Chen, A. L., and Chen, K. K.

Quart. J.

Pharm. Pharmacol., 12:30, 1939.
2. Luduena, F. P., and Lands, A. M. J. Pharm.
Exper. Therap., 110:282, 1954.
3. Wikler, A., Fraser, H. F., and Isbell, H.
J. Pharm. Exper. Therap., 109: 8, 1953.
4. Wikler, A. J. Nerv. Ment. Dis., 120: 157-175,
I954.

Lasagna, L., and Beecher, H. K. The Analgesic Effectiveness of Nalorphine and NalorphineMorphine Combinations in Man. J. Pharm. Exper.
Therap., 112: 3 56-363, 1954.
6. Hoch, P. H., Cattell, J. P., and Pennes, H. H.
Am. J. Psychiat., 108: 579, 1952.
7. Hoch, P. H., Pennes, H., and Cattell, J. P.
Proc. Assn. Res. Nerv. Ment. Dis., 32: 287, 1952.
8. Pennes, H. H. J. Nerv. Ment. Dis., 119:95,
5.

1954-

9. Turner, W. J., Merlis, S., and Carl A. Am. J.
Psychiat., 112:466, 1955.

Perrot, Em, Raymond-Hammett. Bull. Sci.
Pharmacol., 34: 337; 417; 500, 1927.
10.

11.

1941.
12.
195513.

[Apr.

Iberico, C. C. Bol. mus. Hist. Nat., 5:313,
Schultes, R. E. Natural History, 64: 120,

Cardenas, G. F. Estudio Sobre el Principio
Activo del Yagé. Thesis, Universidad Nacional,
Facultuaa de Medicina y Ciencias Naturales,
Bogota, 1923.
14. Albarracin, L. Contribucion al estudio de los
Alcaloides de Yagé. Thesis, Bogota, 1925.
15. Goodman, L., and Gilman, A. Pharmacological Basis of Therapeutics. 2d Ed. New York:
MacMillan, 1955.
16. MacDonald, J. M., and Galvin, J. A. V. Am.
J. Psychiat., 112:970, 1956.
17. Bexton, W. H., Heron, W., and Scott, T. H.
Canad. J. Psychol., 8:70, 1954.
18. Ardis, J. A., and McKellar, P. J. Ment. Sci.,

102:22, 1956.
19. Hoch, P. H. Am. J. Psychiat., 111:787,

I95520. Wikler, A. Am. J. Psychiat., 112 : 961, 1956.
21. Hoffer, A., Osmond, H., and Smythies, J.
J. Ment. Sci., 100: 29, 1954.
22. Fabing, H. D., and Hawkins, J. R. Science,
123: 886, 1956.
23. Peretz, D. I., Smythies, J. R., and Gibson, W.
J. Ment. Sci., 101 : 317, 1955.
24. Pennes, H. H. In preparation.
25. Gunn, J. A. Arch. Internat. de Pharmacodynam.. 50 : 379, 1935.
26. Gaddum, J. H. Drugs Antagonistic to 5-

Hydroxytryptamine. Ciba Foundation Symposium:
Hypertension. pp. 75-77, London, 1953.
27. Wooley, D. W., and Shaw, E. Proc. Natl.
Acad. Sci., U. 5., 40: 228, 1954.
28. Hoch, P. H. Studies in Routes of Adminis—
tration and Counteracting Drugs. Lysergic Acid
Diethylamide and Mescaline in Experimental Psy—
chiatry. New York: Grune &amp; Stratton, 1956.

��Psychiatria et Neurologia

Internationale Monatssehrltt tiir Psychiatrie und Neurologie
Revue Internationale Mensuelle de Psychiatrie et de Neurologie
International Monthly Review at Psychiatry and Neurology

Editor: J. KLAESI, SchloB Knonau

Redactor: E. GRUNTHAL, Bern

S. KARGER

Basel (Schweiz)

New York
Printed in Switzerland

Vol. 135. No. 4/5, 1958

Separatum

Sal-Hulda, 11.; Brunecker,

G. 11nd Szdra, SL:

Psychiat. Neurol., Basel 135:

285—301 (1958)

Aus dem Staatl. Zentralen Neurologisch-Psychiatrischen Institut in Budapest
(Frau Dr. M. Gimes)

Dimethyltryptamin: ein neues Psychotieum
Von A. SAI-HALASZ, G. BRUNECKER und ST. SZARA

Einleitung
Die ohere Stufe des Entwicklungsprozesses der Fachwissenschaften, die sogenannte experimentelle Stufe, beginnt die Psychiatrie fast als letzte der medizinjschen Féicher nur neuerdings zu

erreichen. Den wirklichen Anfang bedeutet Beringers Monographie
ﬁber Meskalin [1927], mit welcher zu gleicher Zeit die HaschischBeobachtungen von Frdnkel und Joel erschienen. Den zweiten
groBen Fortschritt auf diesem Gebiet bildete die Entdeckung der
Lysergséiurediéithylamid (LSD 25) durch Stall und Hoﬁmann [1943].
Der erste ausfiihrh'che Bericht Stalls [1947] bedeutete den Anfang
einer groBen Anzahl von Publikationen. Das Ziel dieses Artikels ist
die Bekanntgabe eines neuen Psychotikums bzw. dessen Wirkung
auf normale Personen.
Die Bewohner Haitis benutzten schon seit

J ahrhunderten bei

religiﬁsen Festen ein narkotisch wirkendes Schnupfpulver, das «Cohoba» genannt wurde. Mit Hilfe dieses Mittels konnten sie angeblich
mit ihren «helfenden Geistern» in Verbindung treten, sogar auch
von diesen Ratschlﬁgen erhalten. Das «Cohoba» wurde aus der
Frucht der Piptadenia Peregrina gewonnen und enthjelt unter anderen Alkaloiden auch verhéiltnisméiﬁig groBe Mengen Bufotenin und
N-N-Dimethyltryptamin (DMT), wie dies auch von Stromberg und
Fish et al. bewiesen wurde. Bufotenin und DMT sind beide Indolamine und in naher Verwandtschaft mit dem biologisch hﬁchst
aktiven Serotonin:

�Sai-Halész, Brunecker und Széra

286

{\/\NH)

/\——-—-—CH2—CH2—NH2
0H
II

|'

OH

A—
1
n

—CH2—CH2—N/CH3
:1

\/\NH/

\cm.

Bufotenin

Serotonin

/CH3
/\————CH2—CH2—N
\CH3

b“
J
\ \NH

N-N-Dimethyltryptamin

Bufotenin ist daher ein N-Dimethyl-Derivat des Serotonins,
beim DMT fehlt jedoch vorigem gegenﬁber eine 5-OH-Wurzel. Das
Bufotenin isolierte Handovski aus der Haut von Kroten [1920],
Wieland hat es synthetisch hergestellt. Raymond Hamet gab Hunden
intravenos Bufotenin und stellte voriibergehende BlutdrucksteigeAﬂ'en
intravenos
fest.
gréBere
Evarts,
Tachypnoe
Apnoe,
spiter
rung,
Dosen Bufotenin und LSD-25 verabreichend, stellte bei jenen eine
beinahe identische Wirkung der zwei Chemikalien fest: voriibergehende Erblindung, Ataxie und ein Zahmwerden. Er erklﬁrte dies
alles durch eine Hemmung der sensiblen Reiziibertragung. Evarts
nahm die Wirkung des Bufotenins und LSD-25 als Analog des
Serotonins an.
Nach Fabing ist Bufotenin ein in der Natur weitverbreitet vorkommendes halluzinogenes Indolderivat, dessen eine Hauptquelle
die sogenannten Amanita-Pilzarten bilden. Fabing experimentierte
an jungen, intelligenten Verurteilten: er injizierte intravent‘is wéihrend 3 Minuten Bufotenin. Es traten Erroten, Gesichtsperspiration
und Kribbelgefiihl im ganzen Korper sowie Oppression in der Brust
auf. Die Versuchspersonen sahen einige Minuten lang purpurne
Flecke, die Storung der Raumwahrnehmung und Konzentration,
daneben Depersonalisationsgefiihl und psychomotorische Unruhe
dauerten fort. Bei groﬁeren Dosen war Erbrechen, Nystagmus und
Mydriasis zu beobachten, deshalb hielt Fabing das Mittelhirn zum
Teil als Angriﬂ'spunkt des Bufotenins. Die kardiovaskulﬁre Wirkung
des Mittels war verhiiltnisméiBig gering. Die Versuchspersonen berichteten wéihrend 6 Stunden nach der Injektion iiber angenehmes
Relaxationsgefiihl.

�Dimethyltryptamin: ein neues Psychoticum

287

Material und Methode
Unseres Wissens nach wurde die Wirkung des DMT am Menschen zuerst durch uns gepriift. Das DMT wurde von uns selbst
synthetisiert nach der von Speeter und Anthony angegebenen Methode. Die salzsﬁurige Losung wurde als Injektion angewandt: die
wirksame Dose war 0,7—1,0 mg/kg intramuskuléir, meistens gebrauchten Wir 0,8 mg/kg.
DMT wurde an 30 normalen Personen, meistens Arzten, gepriift (I7 Manner, 13 Frauen; Alter zwischen 20 und 42 J ahren).
Jede Versuchsperson wurde vorerst somatisch untersucht, und nur
jene erhielten DMT, die vollkommen gesund waren und keine starkere vegetative Labilitéit zeigten. Auf den Blutdruck wurde sehr
geachtet, da das DMT leicht starke Hypertonie erzeugen kann. I6
Versuchspersonen wurden vor und wéihrend des Versuches mit
Rorschach untersucht. (Auf dessen Ergebnisse gehen wir hier nicht
ein, da einer von uns1 auf dem III. Internationalen RorschachkongreB in Rom 1956 iiber diese berichtete.) Wﬁhrend dem Versuch
wurden parallel zwei Protokolle aufgenommen und die Versuchs2—3 Tagen die subjektiven Erlebnisse
nach
aufgefordert,
personen
aufzuzeichnen; die Protokolle wurden dann durch diese Aufzeich5
Fallen wurde wiihrend des Experimentes EEG
In
ergéinzt.
nungen
durchgefiihrt. (Bisher noch nicht veroﬂ'entlicht.)
Ergebnisse
Schon nach 3—5 Minuten nach der Injizierung fﬁngt das DMT
zu wirken an, und innerhalb einer Stunde léiuft die ganze experimentelle Psychose ab. Die Wirkung ist plotzlich und intensiv, mehrere Versuchspersonen berichten anfangs V011 einem weltuntergangsé‘thnlichen Erlebnis mit Starker Todesangst. In einigen Fillen
war jedoch die Angst nicht so ausgepréigt, und die éiuBerst intensiven
Illusionen und Halluzinationen fesselten die Aufmerksamkeit. Die
Angstperioden wechselten mit solchen Starker Euphoric ab. Wéihrend des ganzen Versuches war das wellenartige Auftreten bzw. die
Intensitﬁtsschwankung der gesamten pathologischen Phéinomene
sehr charakteristisch. Wahrnehmungsstﬁrungen bzw. solche des

Korperschemas, Depersonalisationserscheinungen, extrapyramidale
Hyperkynesien, objektive Reﬂex- und Sensibilitﬁtsstﬁrungen fﬁrbten oft das Bild. Natiirlich waren bei den Versuchen auch die kultu1

A. S.-H.

�288

Sai-Halész, Brunecker und Széra

rellen und Pers6nlichkeitsunterschiede bemerkbar. Bevor wir die
einzelnen Symptome naher betrachten, geben wir hier einige typische
Protokolle wﬁrtlich wieder:
Dr. J.N., Arzt, 28 Jahre. 10. 5. 1956. 50 mg DMT i.m. P.: 78/Min., RR 130/100
Hgmm.
3! Starker Schwindel und Kribbeln im ganzen Kiirper; hauptsiichlich sind die
Lippen gefﬁhllos-eingeschlafen.
4/ «Alles ist glﬁnzender, die ganze Welt ist bedeutend heller.»
5/ «Als ob meine Stimme aus einer tieferen Kehle kﬁme. Das Zimmer ist gespensterhaft. Mir schwindelt. Ich amﬁsiere mich darﬁber, wie Ihr mich belauert.»
«Ach, wie herrlich sind die Far-hen!» Er lacht und spricht andauernd. (Zwangslachen, Logorrhoea.)
Maximal erweiterte Pupillen. RR: 160/120 Hgmm, P: 88/Min. Rhythmische
Bewegung des linken FuBes.
«Ach, neue Welle! Die Bilder kommen in solchen Mengen, daB ich gar nicht
weiB, was ich mit ihnen anfangen soll! Zuvor waren sie noch angenehm, doch
jetzt ist es schon zu viel!»
Er lacht wiederum auf. «Alles ist so komisch. Die Farben leuchten ganz fantastisch. Die Gesichter sind auch ganz anders. Warum beobachtet Ihr mich so

verdachtig ? »

10' «Ich sehe eine Farbenorgie, doch in mehreren Schichten nacheinander. Die Welt

bewegt sich immer mehr.»
11' Er schmunzelt, spricht inkohéirent, bewegt sich viel und gestikuliert lebhaft.
RR: 165/120 Hgmm. P: 88/Min. Er klagt ﬁber Dyspnoe.
12' «Ich fiihle in meinem Bauch Leere und trotzdem Fﬁlle, dorthin hat sich alles
Schlechte verzogen.»
«Hoﬂ'entlich kommt es nicht wieder.»
«Man sieht seltsame Sachen, und trotzdem ist alles schnell vorﬁber, so wie auf
der Wellenbahn.»
«Die Wand bewegt sich auch, marchenﬁlmhaft. Ich fﬁhle mich ganz so, als ob
ich geﬂogen ware.» RR: 155/120 Hgmm. P: 88/Min.
Assoziationen aufgelockert, sucht nach Ausdriicken. Keine Dyspnoe.
«Das Zimmer beginnt seine normale Form wieder zurﬁckzugewinnen! Nein,
doch nicht . . . »
Er setzt sich auf und sieht zum Fenster hinaus. «Nur wenn ich hinausschaue,
fﬁhle ich, daB ich auf der Erde bin. Mir ist, als oh wir bis jetzt geﬂogen wﬁren! »
«Ich habe das Gefﬁhl, daB dies ﬁber allem ist, ﬁber der Erde. Es ist beruhigend,
zu wissen, daB ich wieder auf der Erde bin.»
Pupillen noch maximal erweitert. RR: 145/110 Hgmm, P: 84/Min. Bewegt sich
andauernd, gestikuliert viel. Sprache ist ﬁfters inkoh'arent, kaum verfolgbar.
«Ich habe inneres Zittern, meine Gefﬁhle kann ich nicht gut ausdrﬁcken. Ich
fﬁhle mich so, als ob ich hetrunken ware.»
Er zittert. «Dieses Zittern ist gar nicht so unangenehm, es bedeutet, daB die
Reise zu Ende ist, aber alles ist noch nicht vorﬁber.»
Rhythmische Zuckungen des linken FuBes. «Jeder Anwesende hat gleichmiiBig
gelbe Zﬁhne.»

�Dimethyltryptamin: ein neues Psychoticum

289

28' «Alles hat einen ﬁberirdischen Stich und ist doch so real. Schade, daB alles in
einem geschlossenen Zimmer geschieht. Mir scheint, daB ich zusammen mit
dem Zimmer ﬂiege. Erlebnis der Reise. . .»
Pupillen miiBig erweitert. RR: 140/100 Hgmm, P: 80/Min. «J etzt habe ich schon
das Gefiihl, daB alles vorbei ist.»
Ziindet sich eine Zigarette an. Die ZigaIette sieht er grﬁBer und umfangreicher.
«Ich habe das Gefiihl, als oh ich lande. Die gehobene Stimmung léiBt nach.»
Assoziationen noch immer gelockert. Hort in der Mitte angefangener Séitze auf,
vergiBt was er sagen wollte, spricht iiber anderes.
«Alles scheint gelb zu sein, hauptsﬁchlich die Schatten. Ich weiB, daB dieser
Zustand aufhéirt, und doch. fiirchte ich mich, daB er weiterbesteht.»
«Ich bin so nervos, als ob ich ﬁebrig wire. Es ist beruhigend, daB ich dauernd
bei BewuBtsein war.»
Klagt ﬁber Miidigkeit. «Alles ist voriiber, nur meine Gedanken schwirren durcheinander.»
«Alles ist grau und farblos. Die Welt ist jetzt ganz ode.»
AuBer leichter Miidigkeit beschwerdenfrei. Assoziation schon normal. «Ich hatte
stets das Gefiihl, daB sich nur die AuBenwelt und nicht ich selhst mich verwandelte.»
Dr. Z.J., Arzt, 30 Jahre. 1. 6. 1956. 60 mg DMT i.m. P: 72/Min., RR: 110/70 Hgmm
(linkshﬁndig).
5' Er fiihlt sich ein wenig schwach. «Kollapsartiges Gefiihl.»
6' Ausgesprochenes Schwindelgefiihl.
7' RR: 130/90 Hgmm, P: 84/Min. Pupillen etwas erweitert.
8' Schwache Dyspnoe. «Das ganze ist eher angenehm.»
9' «Die Farben sind unveréindert. Mir schwindelt sehr. Leider geht es mir auch so
mit dem Alkohol: mir schwindelt, ohne daB ich mich wohl fiihle.»
10' «Ich habe einen beklemmenden Druck auf der Brust, aber es kommt mir
vor,
daB ich auch ohne Luft existieren konne.»
11’ «Das silherne Muster der rechten Wand des Zimmers ist
ganz reliefartig. Das
Beklemmungsgefiihl nimmt ab.»
12' RR: 135/80, P: 88/Min. Rechter Patellarreﬂex verstﬁrkt, rechtsseitig Babinski13'
14’
15’

16'

17'
18'
19'

Tendenz.
«Die Gesichter haben sich veréindert, sind ganz mephistoéihnlich geworden.»
«Uberall dominiert die silberne Farbe! Die Gesichter sind auch aus Silber und
teuflisch. Die silberne Farbe ist schon, nur ein wenig furchterregend.»
«Der eine Gummischlauch des Blutdruck-MeBapparates ist violett, der andere
silbern.» (In Wirklichkeit schwarz.)
«Die Gesichter sind asymmetrisch wie im Kino. Alles verandert sich im Raum,
auch die Gesichter und Gegenstéinde.»
RR 130/85 Hgmm, P: 88/Min. Reﬂexdiﬁerem der unteren Extremitiiten ist
auch weiterhin vorhanden.
«1111' schwebt alle im Raum. Bis J'etzt habe ich noch nicht die Rﬁumlichkeit der
Dinge bemerkt. Die Anschauung des Menschen veréindert sich vollkommen.»
«V01: ungefiihr einer halben Stunde konnte ich die Injektion bekommen haben.
Mir kommt es vor, als ob diese Minuten viel reicher wﬁren, deshalb erscheinen
sie mir linger.»

�Sai-Halész,Brunecker und Széra

290

20' «Mein Uhelsein verstﬁrkt sich wieder, ich fiihle mich sehr schwach. Mir ist,
als ob ich keinen Atemreﬂex hﬁtte; wenn ich nicht daran denke, wiirde ich zu
atmen vergessen. »
21’ «Alles ist statuenhaft. Die Gesichter sind teuflisch.»
22' RR: 130/80 Hgmm, P: 84/Min. Pupillen mﬁBig erweitert.
23' «Mir fallen solche Details auf, die ich bis jetzt noch nicht bemerkt babe.»
24' «Ich fiihle mich vollkommen gewichtslos, gar nicht, als ob ich 75 kg wiege.»
25' «Es ist merkwiirdig, daB mir meine Hinde vollkommen fremd sind, als ob sie
gar nicht mir gehorten.»
26' «Ich kann die Réiumlichkeit der Dinge besser beobachten; ich glaube, die
Kiinstler sehen sie immer so. Wenn es so bliebe, wﬁrde ich Maler werden.»
27' RR: 130/85 Hgmm, P: 80/Min. Rechtsseitge Babinski-Tendenz besteht weiter.
28' «Die Gegenstéinde haben gar kein Gewicht. Ich glaube, ich konnte viel grijBere
Gewichte heben als zuvor.»
29' «Die Gesichter sind noch immer statuenhaft.»
30' Er verlangt schwere Gegenstéinde und versucht, sie aufzuheben. «Die haben
alle kein Gewicht.»
331' Er hort Musik mit geschlossenen Augen und lichelt.
32' RR 125/85 Hgmm, P: 80/Min. Keine Reﬂexdiﬂ‘erenz. Pupillen mﬁBig erweitert.
33’ «Die Musik ist schon und fesselnd. Als ich diese (Abendsternarie aus Tannhéiuser) letztes Mal horte, schwebte die Musik ﬁber mir, ich war jedoch auf der
Erde. J etzt schwebe ich zusammen mit der Musik.»
34’ «Die Nebengerﬁusche storen mich sehr, schade, daB es Grammophonmusik ist.»
35' «Alles wird schon natiirlicher. Das ganze ist sehr angenehm.»
37' RR: 125/75 Hgmm, P: 76/Min. Pupillen méiBig erweitert.
40' «Ich fiihle mich schon halbwegs in Ordnung. Meine Hand gehort wieder mir.»
45' RR: 120/70 Hgmm, P: 80/Min.
50' «Ich bin ein wenig miide, sonst ist alles voriiber. Das Gewicht der Gegenstéinde
kam auch zurﬁck. Es war merkwiirdig, daB sich am Anfang Angenehmes und
Unangenehmes vermischte, in der zweiten Halfte jedoch war alles schon und
I

gut.»

Von den retrospektiven Erinnerungen ist folgende ihres
lyrischen und subjektiven Charakters halber von Interesse:
Dr. E.Ch., Arztin, 27 Jahre. 50 mg DMT i.m., 27. 8. 1956.
Teils fiirchte ich mich, teils bin ich sehr gespannt, was eigentlich auf mich
wartet. Mein SelbstbewuBtsein mochte ich gem durchwegs behalten. Was werde
ich wohl erfahren? Mit 16 Jahren hitte ich gerne Gott gesichtet — wird das jetzt
kommen? Oder wird sich eine andere Zeit meiner Vergangenheit verlebendigen?
«Guten Tag, Ihr Versuchskaninchen ist angekommen», begrﬁBte ich die zwei

jungen Minner.
«Ich messe IhIen Blutdruck, dann gehen wir ins andere Zimmer hiniiber.
Der Blutdruck 120/90. Sie fﬁrchtet sich gar nicht», sagt der eine. Ich fiihle einen
Stich, jetzt gibt es schon kein Zurﬁck mehr. «Sehen Sie sich gut im Zimmer um»,
hore ich, «sehen Sie auch aus dem Fenster.» Fliichtig schaue ich auf den Schreibtisch, die Stiihle und die monotone Wand. Alles ist kahl. Ich schaue durch das
eisenvergitterte Fenster und sehe die groBen alten Baume. Ich sehe den déimmerigen
Himmel, und auf einmal ﬁng es an...

�Dimethyltryptamin: ein neues Psychoticum

291

Mir schwindelt entsetzlich, es trommelt in meinen Obren, mit meiner rechten
Hand greife ich zum Hals, da ich dort einen ziehenden Schmerz fiihle. Mir schwindelt. — In diesem Augenblick bedauere ich, mich in dieses Experiment eingelassen
zu haben. Ich sehe auf meine Uhr, es sind noch kaum einige Minuten vergangen.
GroBer Gott, wann wird dieser Versuch ein Ende nehmen?
Der Kopf des einen Kollegen zieht sich in die Lange, er bekommt Schlitzaugen. Das Gesicht des anderen wird ﬂacher und vierkantiger. Dieses eigenartige
Licht, als ob der Schein einer Quarzlampe dammere. Meine Hand ist ganz zyanotisch.
Ist sie wirklich so ? Ich ho're Sausen. Ich bin irgendwohin unterwegs, aber wohin?
«Blutdruck 160», hﬁre ich, «Puls 100.»
Das ist jetzt der Tod. Wie einfach alles ist.
Das Sausen hat aufgehort, ich bin angekommen. Vor mir zwei stille, sonnenbeschienene Gﬁtzen. Freundlich nickend beobachten sie mich. Ich glaube, sie begriiBen mich in dieser neuen Welt. Es herrscht dumpfe Stille, wie in der Wﬁste.
Ich wage nicht, sie anzusprechen. Das ist doch Agypten, diese die Siihne der Sonne,
und ich bin endlich zu Hause. Zu Hause in jener wirklichen und schonen Welt,
wo binter den zwei Gotzen sich heitere Menschen zwischen den hohen, gelben
Sﬁulen und Statuen bewegen. Wie vornehm und einfach sie sind. Ihre sonnengebraunten Gesichter sind verklart, ihre Bewegungen frei und grazios. Weiter drinnen singen die Priester mit brausenden Stimmen. Der eine Gotze — nur seine Augen

leben

spricht mich an:
«Geht es Ihnen besser?»
«Es wird mir sehr gefallen, wenn das Ubelsein, welches der hohe Blutdruck
verursacht, aufhiirt», antworte ich.
Ich sehe mir meine Hand an, ein von mir ganz unabhéingiges, selbstandiges
Wesen und dazu sehr schon. Die Form ist so wie zuvor, doch als ob sie mit einem
goldbraunen Staub gepudert ware. Und die N age] sind rosa Muscheln.
«SchlieBen Sie die Augen. Was sehen Sie ?» Ich gehorche.
Aus der Dunkelheit sehe ich durch schwarze Eisengitter in den hellen Tempe].
Griiner Ranch qualmt darin und der Gong tont. China! Ich kann meine Augen
nicht geschlossen halten, da mir schwindelt. J etzt zeigt man mir die RorschachTafeln. Ich kann mich so schwer darauf konzentrieren, es ist so langweilig. Jetzt
erheben sich die hellen, metallschimmernden Wande, dann sinken sie wieder nieder.
Es ist, als 0b das Zimmer atme. Auf der ganzen Flache kreisen vielfarbige — gelbe,
hellgriine, rosa und blaue — Fischschuppen. Die glanzende Kugel der Lampe beugt
sich kreisend naher. Ich sehe wiederum das Gitter, doch ist jetzt dahinter kein
Ranch, sondern nur glatte runde grﬁne Steine.
Auf meinem linken FuB kriecht etwas, doch sehe ich dort gar nichts. Alles
bewegt sich und wogt. Im F ensterglas kreisen farbige Kranze und Fackeln mit ungeheurer Schnelligkeit. Ich mochte gerne erklaren, was ich sehe, doch .. .
An den Wanden sehe ich das zischende, weiBgekronte, wogende Meer. Einige
Wellen erreichen mit gedﬁmpftem Brausen den Strand.
—

«Debussy» — sage ich.
Ich bin ein ganz kleiner Punkt, wie eine Bliite auf dem Wasser von den
Wellen geschaukelt. Doch ich weiB, daB mir kein Leid geschehen kann. «Pupillen
sind verengt, Blutdruck sinkt», bore ich.
J etzt ist es schon still, die Schuppen kreisen immer langsamer, endlich bleiben
sie stehen und verschwinden. Nur die seltsame Beleuchtung wéihrt fort. Das WeiB

�292

Sai-Halasz, Brunecker und Szara

ist noch auffallend weiB, alle Linien scharfe schwarze Konturen. Die Dimensionen
sind sonderbar. Die ganze Welt ist furchterregend realistisch. Das ist die wahre
Farbe und Form der Dinge. Geféihrliches Spiel, es ware so leicht, nicht zurﬁckzukehren. Ich bin mir dunkel bewuBt, daB ich Arzt bin, das ist aber gar nicht
wichtig; Familienbeziehungen, Studien, Plane und Erinnerungen sind von mir sehr
weit entfernt. Nur diese wirkliche Welt ist wichtig, ich bin frei und ganz allein.
Zuriick, zuriick, drange ich mich. Ich muB den Weg zur realen Welt zuriickﬁnden.
Auf dem Weg nach Hause treﬂ'e ich einen Bekannten im Bus. Ich beginne
mjt ihm zu plaudern, damit ich die Realitéit der Beziehungen zu spiiren bekomme.
Die am Wege stehenden Baume erscheinen grau und verblichen. Das Leben ist
stumpf, unfreundlich und gleichgﬁltig.
Ich bin ein anderer Mensch geworden, erfahrener und freier. J etzt verstehe
ich schon viel mehr.

Wenn wir die einzelnen Symptome der DMT-Psychose betreﬂ's
Hauﬁgkeit untersuchen, finden Wir folgendes:
1. Vegetative Symptome wurden in allen 30 Fallen beobachtet.
Das bestandigste Symptom war die Steigerung des Blutdruckes, die
im allgemeinen 20—40 Quecksilber-mm erreichte, manohmal sogar
noch mehr. Die hochste von uns beobacbtete Blutdruckerhohung
betrug 70 mm, in einem Falle, wo der systolische Druck vor dem
Versuch 140 mm zeigte und sich wéihrend des Experimentes bis auf
210 mm steigerte. Der diastolische Druck erhohte sich regelméiBig,
doch in kleinerem MaBe als der systolische (meistens 10—20 mm, in
einem Falle sogar 40 mm).
Fast regelmaBig war die Pupillenerweiterung. Die Mydriase
schien parallel mit den farbigen Halluzinationen zu erscheinen. Ob
jedoch zwischen diesen ein kausaler Zusammenhang bestand, ist
kaum wahrscheinlich. Eine Pulsbeschleunigung geringeren MaBes
war auch in fast allen Fallen festzustellen.
Objektive Atmungsstorungen fanden wir nicht, doch wurden
von 23 Versuchspersonen (76 0/0) ﬁber Atemnot berichtet; diese
wurde von einem Oppressionsgefiihl des Herzens begleitet. Dieses
klinische Bild erinnert stark an das durch Serotonin hervorgerufene;
es konnte vermutet werden, daB die molekuliire Ahnlichkeit der
zwei Substanzen diese Erscheinung erkléirt: DMT verursacht auch
wie Serotonin einen Krampf der pulmonalen Arteriolen. Die sympathicomjmetische Wirkung des DMT unterstiitzt diese Vermutung.
Zur volligen Klarung dieses Mechanismus miiBten natiirlioh weitere
Tierexperimente durchgefiihrt werden.
Die sympathicomimetische Wirkung des DMT konnte nicht an
allen Organen nachgewiesen werden. So fanden wir z.B. keine be-

�Dimethyltryptamin: ein neues Psychoticum

293

deutende Hyperglykéimie und Tachypnoe. Die ganze vegetative Wirkung des DMT iihnelt mehr derjenigen des Serotonins als der des
Adrenalins.
2. Sinnestiiuschungen wurden in 27 F ﬁllen (90%) beobaohtet.
Diese waren in der Mehrheit optischen Charakters: helleuchtende,
farbige Illusionen und Halluzinationen, die sich stets im schnellen
Wechsel befanden. Bei geschlossenen Augen vermehrten sich die
Halluzinationen und nahmen szenenhaften Charakter an. Eine
unserer Versuchspersonen erzéihlte mit geschlossenen Augen:
«Ich sehe F elsen, Téiler, méirchenhafte Gegenden, mit kaum
einem Schein von Rot als belebende Farbe. Watteau-artige Bilder,
dort sind jedoch die Gestalten griiBer. Diejenigen, die ich sehe, sind
ganz winzig und verlieren sich in den Felsenrissen, kleine Anhiinger
der furchterregenden Umgebung.» Oder spéiter: «Orthodox-griechische Einsiedler, die in F elsen gehauenen dunklen Hﬁhlen leben. An
den Wéinden leuchten Ikone. Man spiirt, daB ihr ganzes Leben auf
diese Heiligenbilder zentriert ist.»
AuBer den optischen fanden wir auch — wenn auch seltener —
akustische und haptische Halluzinationen ﬂiichtigen Charakters, die
ebenso plﬁtzlich verschwanden, wie sie erschienen.
3. Stb'rungen der Raumwahrnehmung wurden in 22 Féillen (73 %)
beobachtet. Die Dimensionen des Zimmers ﬁnderten sich am auffallendsten. Nahes und F ernes verschmolz ineinander. Die Form des
Zimmers wurde ganz neu: oval oder vielkantig. Es konnte festgestellt werden, daB sich eben jene Dimensionen ﬁnderten, auf
welche die Aufmerksamkeit gerichtet wurde. Wie auch in Meskalinund LSD-25-Psychose veréinderte stets jene Mauer die Lage, die
eben angeschaut wurde. In einigen Fallen, in denen die Versuchspsychose Starker ausgeprﬁgt war, gingen die Raumdimensionen vallig
verloren. Es stellte sich dann immer ein subjektives Erleichterungsgefiihl ein, sobald die richtige Riumlichkeit der Dinge wieder wahrnehmbar wurde.
4. Stb‘rungen des Kb'rperschemas erschienen fast immer gleichzeitig mit denen des Raumes. Es handelte sich um Symptome, die
an den parietalen Symptomenkomplex erinnerten: die Versuchsperson bemerkte z.B., daB ihre Hand schon nicht ihr gehiire; oder
wenn auch die GewiBheit bestand, daB es doch ihre eigene Hand
sei, hatte diese doch etwas Selbstéindiges und Seltsames an sich.
0ft waren die St6rungen des Kérperschemas halbseitig; in 4 F ﬁllen
dehnte sich die St6rung auf die ganze linke Kiirperhﬁlfte aus.

�294

Sai-Halész, Brunecker und Széra
5. Zeitstc'irung war in geringerem MaBe in allen Fallen vorhan-

den, erreichte aber nie eine grijﬂere Intensitéit. Solche Erscheinun— wie beim Meskalin-Versuch berichtet —
daB
Zeitsinn
der
ganz
gen,
verlorengegangen ware, haben wir nicht bemerkt. Die Dauer des
Versuches wurde immer etwas ﬁberschﬁtzt. Eine Versuchsperson
fiihrte das «auf die reichere Fiille der Minuten» zuriick.
6. Denkstb'rung. In 21 Fallen (70 0/0) fanden Wir eine ausgesprochene Auflockerung der Assoziationen. Die Sprache wurde inkohéirent, angefangene Siitze konnten nicht beendigt werden, da schon
der néichste Gedanke im Vordergrund stand. Diese Inkohéirenz verursachte auch beim Protokollfiihren Schwierigkeiten. 0ft schwiegen
die Versuchspersonen fiir einige Minuten, antworteten auch nicht
auf Fragen; sie erkléirten spéiter, daB sie ihre Gedanken nicht genug
beherrschen konnten, um etWas Verstéindiges zu antworten.
In 5 Fallen hatten wir es mit paranoiden bzw. wahnéihnlichen
Gedanken zu tun. Diese Versuchspersonen berichteten erst 1—2 Tage
spater, daB sie wéihrend des Versuches ﬁberzeugt waren, man wolle
sie tﬁten bzw. vergiften. DMT war das Gift, die Versuchsleiter die
Mﬁrder. Eine Versuchsperson wurde Wéihrend des Experimentes
sehr unruhig und muBte mit Gewalt niedergehalten werden. Sie erkléirte am néichsten Tage folgendes: «Ich fiihlte, daB ich vergiftet
wurde und sterben werde und schon nichts dagegen tun konnte.
Trotzdem kéimpfte ich einen seelischen Kampf, ob ich bis zum letzten Moment am Leben hé’mgen Oder ruhig sterben soll; das letztere
war sehr verlockend, da ich mich sehr wohl fiihlte. Dieser seelische
Kampf éiuBerte sich in meinem Motorium als Unruhe; ich spiirte
und wuBte alles.»
In anderen Fillen waren die Beziehungsideen nicht so ausgeprﬁgt, doch berichteten die Versuchspersonen nach einigen Tagen,
daB sie betreﬁ's der Aufrichtigkeit und Zuverléissigkeit der Versuchsleiter ein wenig unsicher waren. Am nichsten Tage war dieses Gefiihl mit den eventuellen aggressiven Einstellungen zusammen verschwunden.
7. Aﬁ'ektive Verdnderungen. Euphorie ist eine verhﬁltnismﬁﬁig
0ft zu beobachtende Erscheinung der DMT-Psychose. In 8 Féillen
(27 0/0) war sie stark ausgeprﬁgt, in 12 Fallen (40%) milderen Grades
Oder nur auf kiirzere Zeit bemerkbar. 0ft trat sie zusammen mit
Zwangslachen auf, in anderen Féiﬂen war sie mit Introversion verbunden; letztere wurde durch ein «verkléirtes» Lﬁcheln begleitet,
das manchmal fast wéihrend dem ganzen Versuche dauerte. Die

�Dimethyltryptamin: ein neues Psychoticum

295

Versuchsperson lag mehrere Minuten lang wortlos mit geschlossenen
Augen und léichelte; manchmal jedoch weinte sie vor Seligkeit und
seufzte: «Oh, wie wunderbar ist doch alles!»
Wie schon bemerkt, ist die Angst eine der héiuﬁgsten Erscheinungen der DMT-Psychose. Am stéirksten ist sie einige Minuten nach
Verabreichung der Injektion bemerkbar, wenn sich die Umwelt so
plﬁtzlich und intensiv veréindert, daB die Versuchsperson die feste
Umgebung verliert. Nur 4 Personen berichteten, keine Angst gehabt
zu haben. In der zweiten Héilfte der Psychose tritt Angst Viel seltener auf. Nur eine Versuchsperson klagte wﬁhrend des ganzen
Versuches iiber Angst und sagte: «DaB es nur nicht zuriickkomme ! »
Was nicht zurﬁckkommen sol], konnte sie nicht erkléiren; sie antwortete: «Na ja, das Ganze!»
8. Bewuﬁtseinstb’rungen. Nur in 7 Fallen (23 0/0) haben wir eine
BewuBtseinstriibung beobachtet. Sie war stets am Anfang des Experimentes bemerkhar, d.h. 8—15 Minuten nach Verabreichung der
Injektion und dauerte nicht léinger als 2—5 Minuten. Wéihrend dieser
Periode sprechen die Versuchspersonen nichts, und auch spéiter
bestand eine Amnesie der Ereignisse, die inzwischen geschahen. Es
blieb ihnen nur das Gefiihl, daB etwas Schreckliches vorging.
9. Neurologische Verc‘inderungen. Die Reﬂexe waren wéihrend
des Versuches 0ft (63 %) erhtiht oder lebhaft. Voriibergehende pathologische Reﬂexe (Babinski usw.) fanden wir nur in 3 Fallen (10%).
Im Motorium zeigten sich ausgepréigte Veréinderungen. Fast
alle Versuchspersonen hatten eine hyperkynetische Zeitspanne, in
der sich unwillkiirlich-extrapyramidale und Willkiirliche Bewegungen mischten. Nur einmal war die Hyperkynesie so stark, daB Gewalt angewandt werden muBte, um einen Unfall zu verhiiten.
Sensibilitéitsstﬁrungen gesellten sich oft zur Stﬁrung des K6rperschemas. Meistens waren die Fehlleistungen seitens der Tiefensensibilitéit, Gewichtsschﬁtzung, Kﬁrperlage usw. zu beobachten.
Die Oberﬂﬁchensensibilitéit war relativ viel besser erhalten. Sensibilitéitsstﬁrungen fanden wir in 18 Féillen (6000).
10. Halbseitigkeit der Symptome. Eine der interessantesten Beobachtungen beziiglich der DMT-Psychosen war, daB in Mehrzahl
der F ﬁlle die Symptome halbseitig ausgepréigter waren. Dies war
ebenso bei den neurologischen Symptomen wie bei den Halluzinationen und Kﬁrperschemastﬁrungen bemerkbar. Die linke Seite
war stets die stéirker betroﬂene. Wir hatten Gelegenheit, 3 Linkshéindige unserem Experiment zu unterziehen; bei diesen dominierten

�Sai-Halész, Brunecker und Széra
___—____—_——_—————————————-—-———~
296

Abb.

100 %

1

80%

40%
20%

s-aaa°a°-Eaa°a:a°§-Eé°-EE
g
be
:1
:5

a;
s:
&gt;.,

a
"-4
0
'8

A:

H

m

"‘

{-11

o

I:

cu
3'3

E,”

H

o9-1

&gt;5

no
3::

g:

.H

.0

gcu

8
0
.=:
:2
53

Q
'8

au

:5

uo
.5.”
0

aa

o
0
m

C121

:o

‘53

a:3
(I)

1

:1
'-'
:5

an
....

f:O
m

ﬂw

m

a

a)”

‘

M

o

CIT-I

o

a:
‘9

'8

w

""

ho”

s

2":
cc

94

aH

:o
2;

4.:

'-'

ﬂ

tan
5::

5
4::
0
m

F
‘3

w

Q

5

E75

b;

&lt;‘.

:1

H

:o

E
E

:1

«a

p:

'5cs

o
:1

g
3

g

....

&lt;

g

v-c

an
E

o
A4
v
“-1

=

4

Q.

m

:1

I-

:o

gm

4-»

' 53
rd

a
a

E

:3

.ao

_.
g
m
o
"=1

°

[—1

an

g
g
c:
""
‘9

*8
6)

u
m

g

cc

a

5.0

c:

.2

s

m

die Symptome rechtsseitig. (Auf diese Erscheinung kommen wir in
der Besprechung noch zuriick.)
11. Nachwirkungen. Alle Versuchspersonen klagten am Experiment folgenden Tage iiber Miidigkeit. Diese dauerte manchma] nur
einige Stunden, bei einigen jedoch 1—2 Tage. Wéihrend dieser Periode
2
Nach
ein
7
Tagen
depressiv.
%)
(23
wenig
Versuchspersonen
waren
Die
in
betreﬂ's
alle
30
Ordnung.
Personen
vﬁllig
Stimmung
waren
1
der
in
wir
Abbildung
einzelnen
der
gehen
Symptome
Hﬁuﬁgkeit
wieder.
Besprechung
Durch die DMT-Versuche ergeben sich 3 Tatsachen, die fiir das
weitere Verstéindnis der sogenannten Modell-Psychosen éiuBerst

interessant sind:

und kurze Dauer der DMT-Psychose.
2. Halbseitigkeit gewisser Symptome.
3. Nahe chemische Verwandtschaft zwischen DMT und
Serotonin.
1. Pliitzlicher Anfang

�297

Dimethyltryptamin: ein neues Psychoticum

Wirkung des DMT ist etwas ganz Neues unter
der Psychotica. Meskalin fingt nach fast einer Stunde zu wirken an,
Haschisch und LSD-25 wirkt noch langsamer. Aber auch die Dauer
der Psychose ist beim DMT auffallend kurz, und zwar 40~60 Minuten. Um diesem Problem nﬁherzukommen, haben wir — wie
schon berichtet - die Ausscheidung von DMT und 3-Indolessigséiure
wéihrend und nach dem Versuch untersucht. Wir fanden, daB nach
Verabreichung von DMT die Quantitéit der 3-Indolessigséiure im
Harn stark zunjmmt und in den ersten 6 Stunden schon ungeféihr
das Zehnfache der normalen Ausscheidung erreicht; ebenso erhﬁht
sich — jedoch nur in geringerem MaBe — die Ausscheidung der
5-hydroxy-3-Indolessigséiure, was auf einen Zusammenhang mit dem
Serotonin-Stoffwechsel hinweist. Im Harn fanden wir jedoch kein
unveréindertes DMT, was bezeugt, daB das DMT im Korper sehr
schnell und vollig abgebaut wird. Dies kann uns erkléiren, warum
die Wirkung so schnell abléiuft und auch das DMT peroral unwirksam ist: wahrscheinlich wird es in der Leber abgebaut, bevor es die
psychische Wirkung ausiiben konnte. Es bleibt aber noch immer die
Frage oﬂ'en, warum das DMT so schnell wirken kann. Nach der
Theorie von Rothlin und Patzig veréindert sich das Meskalin und
LSD-25 im Organismus, bevor es eine Wirkung ausiiben konnte; es
wéire eigentlich ein Umbauprodukt dieser Substanzen, das die psychotische Wirkung habe. Beim DMT kann kaum von so einer Transformation die Bede sein; das plotzliche Auftreten der Symptome
unterstiitzt die Vermutung, daB das DMT selbst die psychotische
Wirkung ausiibt. DMT wéire demgemﬁB das erste Psychotikum
auBer Bufotenin — das selbst ohne Abbau oder Umbau die experimentelle Psychose verursacht.
2. Die Halbseitigkeit einiger Symptome ist eine der interessantesten Erscheinungen der DMT-Psychose. Es treten gleich zwei
Fragen auf:
a) wie ist es moglich, daB eine chemische Substanz auf eine
Hemisphﬁre stéirkere Wirkung ausiibt als auf die andere, und warum
stets auf die nichtdominante Hemisphéire ?
b) hat die nichtdominante Hemisphéire eine wichtige Rolle im
Auftreten der experimentellen Psychose oder wenigstens einiger
Symptome ?
Diese Fragen kann man heute noch kaum beantworten. Es wﬁre
zu oberﬂéichlich, sich auf die erste Frage mit der Antwort zu begniigen, daB die nichtdominante Hemisphéire chemischen Intoxi1. Die rasche

-—

Psychiat. New-0]., Basel. Vol. 135, No.

4—5

(1958)

20

�298

Sai-Halész, Brunecker und Széra

kationen gegeniiber mehr «verwundbar» wire; dies sollte sich doch
dann auch bei anderen Vergiftungen zeigen. Oder aber ist der Kreislauf der dominanten Hemisphéire im Notfall zu besserer Regulation

fﬁhig ?

Die zweite Frage, 0b néimlich die rechte Hemisphﬁre im Auf—
treten psychopathologischer Syndrome eine wichtige Rolle habe,
wurde schon in anderen Zusammenhéingen beriicksichtigt. Hoﬁ und
Pﬁtzl fanden, daB das Zeitraﬁ'er-Phéinomen nur bei rechtsseitiger
Lﬁsion zu beobachten war and meistens bei parieto-okzipitalen
Schﬁdigungen. In der DMT-Psychose zeigt sich ein groBer Tei] der
Erscheinungen eben als parieto-okzipitale F unktionsstﬁrungen (visuale Halluzinationen, Kﬁrperschemastﬁrungen, Raumwahrnehmungs-Stﬁrungen usw.). Es scheint, daB die Halbseitigkeit bei der
DMT-Psychose uns einen weiteren Beweis bietet, die Theorie von
Hoﬂ und Pb’tzl zu unterstiitzen: eine rechtsseitige Gehjrnschéidigung
iibt eine «bahnende» Wirkung beim Auftreten gewisser psychopathologischer Phﬁnomene ans.
3. In den letzten J ahren héiufen sich die Publikationen, die eine
zentrale Rolle des Serotonins in der Funktion des zentralen Nervensystems annehmen (Brodie et al.). Es wurde auch angenommen
(Woolley), daB der Serotonin-Stoffwechsel in der Genese der Psychosen, hauptséichlich der Schizophrenic, einen wichtigen Anteil
habe. Wie schon erwéihnt, fanden wir im Harn der Versuchspersonne
ungeféihr 4—5mal mehr 5-hydroxy-3-Indolessigséiure als bei Normalen; diese Substanz ist, wie bekannt, das Hauptabbauprodukt
des Serotonins. Es gibt wiederum zwei Mﬁglichkeiten: entweder wird
die 3-Indolessigséiure, also das Abbauprodukt des DMT, sekundﬁr
oxydiert, oder aber mobilisiert das verabreichte DMT eine bedeutende Menge des gebundenen Serotonins. Im letzteren Falle ware
die experimentelle DMT-Psychose im strengsten Zusammenhang mit
dem Serotonin-Stoﬂ'wechsel verbunden. Hier k6nnte man nach gewissen Analogien einen in den zentralen Synapsen abspielenden
kompetitiven Antagonismus der zwei Aminen vorstellen. Es miissen
noch weitere mit radioaktiven Isotopen gezeichnete DMT-Experimente vorgenommen werden, um diese Fragen zu lﬁsen und auch
damit einen Wichtigen Schritt zum biochemischen Verstéindnis der
psychotischen Zustéinde im allgemeinen zu tun.
Durch unsere ohigen Beobachtungen kﬁnnen wir auch feststellen, daB auBer dem Bufotenin das DMT auch eine bedeutende R0116
in der Gesamtwirkung der Piptadenia-Extrakte zu spielen habe.

�M“—
Dimenthyltryptamin: ein neues Psychoticum

299

Insofern unsere Ergebnisse mit den spﬁrlichen an Menschen
gewonnenen Bufotenin-Beobachtungen zu vergleichen sind (diese
sind wegen der intravenosen Anwendung des Bufotenins kaum moglich), ist es auffallend, daB das DMT eine periphere-vaskulﬁre, serotoninartige Wirkung in geringerem MaBe als das Bufotenin ausiibt.
Dies kann vielleicht der strukturelle Unterschied, d. h. die beim
Bufotenin vorhandene 5-OH-Wurzel erkléiren. Diese und die iibrigen
Detailfragen konnten bloB weitere, an denselben Personen und unter
gleicher Anwendung der 2 Indolamine durchgefiihrte Versuche kliiren.
Z usammenfassung

Dimethyltryptamin wurde synthetisiert, und dessen psychotische Wirkung untersucht. Nach intramuskuléirer Verabreichung
von 0,7—1mg/kg Dimethyltryptamin tritt schon nach 3~5 Minuten
ein psychotischer Zustand auf, der in vielen Erscheinungen denen
ahnelt, die durch Meskalin und LSD-25 verursacht wurden. Die
Dimethyltryptamjn-Psychose lauft innerhalb einer Stunde ab. AuBer
der Beschreibung der Symptome werden 3 Probleme nﬁher untersucht:
1. Was kann die Ursache des plotzlichen Auftretens und schnellen Ablaufes der Dimethyltryptamin-Psychose sein.
2. Welche Rolle spielt die Halbseitigkeit der Symptome, also
die stiirkere Schiidigung der rechten nichtdominanten Hemisphéire beim Auftreten der psychopathologischen Erscheinungen.
3. Welche F olgerungen konnen beziiglich der Bedeutung des
Serotonin-Stoﬂ'wechsels im zentralen Nervensystem betreﬂ's
der nahen cliemischen Verwandtschaft zwischen Dimethyltryptamin und Serotonin gezogen werden.
Die Ahnlichkeiten und Unterschiede zwischen den Bufoteninund Dimethyltryptamin-Psychosen sollen weitere Experimente klarstellen.

Re’sumé

On a synthétisé la diméthyltryptamine et étudié son action

psychotique.
Aprés une administration intra-musculaire de 0,7—1 mg/kg de
djméthyltryptamine, un état psychotique est apparu aprés 3 a 5
minutes déja. Il ressemhlait par beaucoup d’aspects a ceux qui sont

�300

Sai-Halasz, Brunecker und Széra

provoqués par la mescaline et le LSD 25. La psychose a la diméthyltryptamine dure une heure. A part la description des symptﬁmes on
a étudié de plus pres 3 problémes:
1. Quelle peut étre la raison du début brusque et de la ﬁn rapide
de la psychose a la diméthyltryptamine.
2. Quel role joue la latéralisation des symptémes ainsi que
l’atteinte prépondérante de l’hémisphére droit, non dominant, lors
de l’apparition des symptomes psychopathologiques.
3. Quelles conclusions on peut tirer de la proche parenté
chimique entre la diméthyltryptamine et la sérotonine pour la
signiﬁcation du métabolisme de la sérotonine dans le systeme
nerveux central.
D’autres expériences montreront les ressemblances et diﬂ'érences entre les psychoses a la Bufotenine et a la diméthyltryptamine.
Summary
Dimethyltryptamin was synthesized and its eﬁ'ect on psychosis
investigated. An intramuscular injection of 0.7—1 mg/kg Dimethyl3—5 minutes a psychotic condition
after
and
was
given
tryptamin
was induced which in many respects resembled those phenomena
induced by mescalin and LSD 25. This Dimethyltryptamin psychosis
lasted less than an hour. Besides a description of the symptoms we
have investigated three problems:
1. The reason for the swift start and rapid departure of the
psychosis.
2. What is the signiﬁcance of the one-sided nature of the
in
of
the
disturbance
the
right
degree
is,
that
greater
symptoms,
non-dominant hemisphere when the psychopathological phenomena
begin to show.
3. Having regard to the close chemical afﬁnity between Dimethyltryptamin and Serotonin, what conclusions could be drawn
as to the import of serotonin metabolism in the C.N.S. Further
experiments should clarify the similarities and differences between
psychoses induced by Bufotenin and those by Dimethyltryptamin.
LITERATUR
Beringer, K.: Der Meskalim'ausch, Springer, Berlin 1927. — Brodie, B. B. et al.:
Science 122, 968, 1955. — Erspamer, V.: Pharmacol. Rev. 6, 425, 1954. — Evarts,
E. V.: Arch. Neurol. Psychiat. 75., 49, 1956. — Fabing, H.D.: Amer. J. Psychiat.
113, 409, 1956. — Fabing, H.D. and Hawkins: Science 123, 886, 1956. — Fish, M. S.,

�m
Dimethyltryptamin: ein neues Psychoticum

301.

N. M. Johnson and D. C. Homing: J. amer. chem. Soc. p. 77, 1955. — Fraenkel, F.
und E. Joel: Z. ges. Neurol. Psychiat. 111, 84, 1927. — Hoﬁ, H. und 0. Po'tzl:
Z. Neurol. 151, 599, 1934. — Page, I.H.: Physiol. Rev. 34, 563, 1954. —
RaymondHamet: Compt. rend. Soc. biol. 135, 1414, 1941. — Rothlin, E.: Experientia 12, 154,
1956. — Speeter, M.E. and W. C. Anthony: J. amer. chem. Soc. 76, 6208, 1954. —
Stall, A. und A. Hoﬂmann: Helv. chim. Acta 26, 944, 1943. - Stromberg, V.L.:
J. amer. chem. Soc. 76, 1707, 1954. — Stoll, A.: Schweiz. Arch. Neurol. Psychiat.
60, 1, 1947. — Szdra, SL: Experientia 12, 441, 1956. — Wieland, H. und H. Mittasch:
Ann. Chem. 513, 1, 1934. — Woolley, D. W.: Brit. med. J. 1954, 122.
Adresse der Autoren: Dr. A. Sai-Halész, Dr. G. anecker, Zentrales Neurologisch-Psychiatrisches
Institut,
Budapest-Lipétmezb‘ (Ungarn). Dr. St. Széra, 113 Hesketh Street, Chavy Chase 15, Md.
(USA).

�,

u

'1‘

�Copyright, 1958, by the Society 'for'Experimental Biology and Medicine.
Reprinted from PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE,
1958, v97, 4837486

A New Group of Psychotomimetic
L. G.

ABOOD, A.

M. OSTFELD

Agents.ale

AND

(23782)

JOHN BIEL

Divisions of Psychiatry and Preventive Medicine, University of Illinois College of Medicine
and Lakeside Laboratories, Milwaukee

During the past few years, much interest
has developed in psychotomimetic agents, particularly with regard to LSD 25 and mescaline. At the same time, considerable emphasis has been placed on the possible role of
adrenalin and serotonin in psychoses, particularly because they are structurally related
to the psychotomimetic agents and are pharThe, role Of
macologically antagonistic.
acetylcholine and acetylcholine- like sub'stances, on the other hand, has received relatively little attention.
Knowledge of the hallucinogenic properties
Of cholinergic blocking agents,,such. as atroh
pine and hyoscine, dates back to thetime of
the ancient Hindus. Recently, a group of
piperidyl benzilates possessing anticholinergic properties were synthesized by Biel and
associates(l) as possible antispasmodics in
the treatment Of duodenal ulcer(2). In the
course of therapeutic trials, it was found that
the tertiary amine hydrochlorides of the benzilate esters, although active anticholinergics,
produced undesirable side effects, particu-

larly hallucinations. The quaternary ammonium salts, on the other hand, were entirely devoid of such effects. We have recently, Obtained a series of such substances
and examined their psychotomimetic effects
on animals and human subjects(3).
Methods. The psychotogenic effects of the
N—methyl-3-piperidyl benzilate and related
congeners were tested on over 40 human volunteers who were either normal or patients
complaining of minor disorders. Although
some of the patients had limited knowledge of
the psychotogenic action of the drugs, the
majority of subjects were completely unaware
Of their nature.
Ceruloplasmin determinations were made on many subjects, employing
a method described previously(4). All of
the agents were tested for their behavioral effects in animals, including some 30 Siamese
ﬁghting ﬁsh, 50 rodents, and 5 cats. The action of these agents on the Siamese ﬁghting
ﬁsh is comparable to those described 'for LSD
by Abramson(5). In rodents there were
marked behavioral changes, such as initial excitement and marked' hyperactivity, spon* Supported by grants from Mental Health Fund,
taneous squealing, lack Of ”responsiveness to
State Of Illinois, and Teagle Fn.
stimuli, muscular weakness, (and lethargy.
,

_

4

_

�NEW PSYCHOTOMIMETIC AGENTS

The anticholinergic effect of the agents was
determined on isolated smooth muscle preparations and the rectus abdominus according
to the method of Chang and Gaddum(6).
Results. Experimental ﬁndings have indicated that the compounds are extremely powerful hallucinogens, in many respects more interesting than LSD and mescaline. When
administered in 5-15 mg doses, orally, to human volunteers, distinct auditory and visual
hallucinations occurred within one hour in
for
recurred
and
periodically
individual
every
periods up to 10 hours after administration of
the drug. Hallucinations were accompanied
by gross distortions of visual images and severe alterations in feeling state. A number of
subjects exhibited paranoid and megalomanic
delusions, while the affective states ranged
from a feeling of unpleasantness to extreme
terror. Some of the subjects actually carried on conversations with imaginary individuals involving situations dating back 10-20
years. The following are almost exact quotations from different subjects: “People from
India are standing outside a tent. They have
turbans and those are camels.” “I see six
people sitting around a table playing cards
. a monkey is over the table hanging by
his tail.” “I am walking down a narrow corridor and suddenly stop and cannot move
is beating
. . . a band is playing . . . a drum
3/4 rhythm.”
The subjects receiving 10 mg (orally) of
N-methyl-3-piperidyl benzilate were in complete loss of contact with the environment for
vis—
dramatic
While
hours
experiencing
many
ual and auditory hallucinations. In many respects these anticholinergic agents come
closer to simulating clinical psychoses than
do mescaline and LSD.
Thus far, a number of congeners have been
tested for both hallucinogenic properties and
anticholinergic effect on the isolated colon
(Table I). Of all the compounds tested for
hallucinogenic properties, N-methyl-3-piperidyl benzilate is the most potent, with the Nethyl derivative being somewhat less effective. The tetramethyl derivative is considerably less effective than the N—ethyl derivative. The quaternary derivative is devoid of

,

psychotogenic effects. As for the antispasmodic potency, although the 3 substances
possessing psychotogenic properties are perhaps the most potent, the remaining compounds are still quite effective.
Ceruloplasmin determinations were made
on all subjects, since this enzyme was shown
to be increased in the serum of acute schizophrenics(4,7). The method used has been
described previously(4).
Preliminary observations have indicated that as much as a
50-75% elevation in the blood ceruloplasmin
accompanies the hallucinatory episode produced by these agents. The enzyme increased
only when marked psychogenic disturbances
were apparent, returning to normal shortly
after the psychogenic effects disappeared and
while peripheral autonomic effects, such as
mydriasis, muscular weakness, and dryness of
the mouth, still persisted. A rise in ceruloplasmin has been shown to accompany
changes in affective or feeling states, regardless of the mechanism by which the effects are
produced (3 ) .
Discussion. A discussion of the relative
antispasmodic properties of this group of
compounds appears elsewhere(1). It is apparent from the present study that in this
series of compounds there is no direct relationship between the anticholinergic effect on
smooth muscle and psychotogenic potency.
The presence of the hydroxyl group in the
acid moiety to yield the diphenylacetate ester
is undoubtedly essential for hallucinogenic
effect, while only slightly enhancing the anticholinergic effect. Since both the diphenylacetate and the benzilate derivatives penetrate
the blood brain barrier, it would appear that
the hydroxyl group is an absolute require—
ment. The presence of a quaternary nitrogen
in the piperidine ring only slightly inﬂuences
the anticholinergic effect, but apparently pre—
vents the compound from penetrating the
blood—brain barrier. As a rule, quaternary
ammonium compounds are not able to enter
the central nervous system through the blood
stream. Preliminary observations have shown
that intrathecal injections of the quaternary
compound into rats produce much the same
kind of neurological and behavioral disturb-

�_,,'

_

a

\

4
l

NEW PSYCHOTOMIMETIC AGENTS

TABLE I. Structure-Activity Relationships of. Some Piperidyl Benzilate Congeners. Anticholinergic effect was determined on isolated rat colon with concentrations of about 10“ M.

\
/
Ill/Q

ox
R—O—C—C

\
\/\O
—

Relative
Relative halantilucinogenic cholinergic
potency
potency

Name

R

X

N—methyl-3-piperidy1-benzilate

m

0H

++++

++++

OH

+++

+++

OH

—

+

+++

I

\N/
CHs

N -ethyl-3-piperidyl—benzilate

\/

N
02115

1,2,2,6 tetramethyl-4-piperidyl benzilate
CH3

\N/(CHS) 2

CH3

N-ethyl-3-piperidyl-diphenylacetate

\/

H

0

+++

OH

0

+++

N

02H5

m
\/
/\

N-dimethyl—3-piperidyl benzilate

N+

CH3

ances observed with the tertiary benzilates.
At present, numerous other congeners are
being examined for their hallucinogenic properties. Future synthetic work is contemplated in an effort to explore other structureactivity relationships from the point of view
of hallucinogenic effect. In view of the work
of others on anticholinergic substances, it
may be predicted that the distance between
the hydroxyl group and the piperidyl nitrogen
is critical( 8,9). Introduction of alkyl groups
into the molecule would, therefore, presumably diminish the anticholinergic potency, and
it will be of interest to determine the relationship of such a change to hallucinogenic
effectiveness.
Summary. A series of synthetic anticholin-

C'H3

ergic agents have been shown to possess potent psychotomimetic properties. Chemically,
the agents are esters of piperidine and benzilic acid. Among the effects produced are
megalomanic and paranoid delusions, visual
and auditory hallucinations, and a partial loss
of contact with the environment. A number of
congeners of the compounds have been examined with regard to structure-activity relationships.
J. H., Sprengler, E. P., Leiser, H. A., Horner, 1., Drukker, A., Friedman, H. L., J. Am. Chem.
1. Biel,

Soc., 1955, v77, 2250.

2. Ewing, P. L., Seager, L. D., Keller, G., Dodson,

D.,

J. Pharmacol. Exp. Therap.,

1954, v110, l7.

3. Ostfeld, A. M., Abood, L. G., Marcus, D. A.,

�NEW PSYCHOIOMIME’TIC AGENTS
Arch. Neurol. Psych. in press.
4. Abood, L. G, Gibbs, F. A, Gibbs,E ., ibid.,
1957, v77, 643.
5. Abramson, H. A., Evans, L. T., Science. 1954.
V120: 9906. Chang,

v79, 255.

H. C., Gaddum, J. H., J. Physiol., 1933,
.

t

'

'

7‘Akerfeldt,
M., J. Pharmacol. Exp. Therap.,
Lands,
8.

S., Science, 1957, v125, 117.

A.

1951,

v102, 219.
9. Goodman, L., Gilman, A., The Pharmacological
Basis of Therapeutics, ed. Macmillan Co., N. Y., 1955.

Received December 23, 1957. P.S.E.B.M., 1958, v97.

DEPARTMENT OF
EXPERIMENTAL

rsvcumm

HlLLSlDE HOSPITAL
GLEN OAKS. N. v.
MAY1

4'53

'-

�Reprinted from the A. M. A. Archives of Neurology (5“ Psychiatry
March 1958, Vol. 79, pp. 317-322
Copyright 1958, by American Medical Association

Studies with Ceruloplasmin and a New Hallucinogen
ADRIAN M. OS'I'FELD, M.D.; LEO G. ABOOD, Ph.D.,

and

Knowledge of the hallucinogenic prop—erties of atropine—like compounds is cer—
tainly as old as that concerning the effects
of mescal and marihuana. It has been pos—
tulated that the oracle at Delphi induced her
prophetic vision with belladonna. Hughes
and Clark1 quote a lively description of a
17th century American epidemic of atro—
pine poisoning. Readers of English detec—
tive novels or American Western stories
are familiar with the deadly nightshade and
Jimson weed, respectively.
The recent synthesis of N-ethyl-3-piper—
idyl benzilate hydrochloride, JB 318*,2
an agent chemically related to atropine
(Figure), led to the present studies. Originally intended as an autonomic—blocking
agent in the treatment of peptic ulcer, the
drug exhibited hallucinogenic properties, so
prominent as to merit further investigation.3
At the close of the conference of the
Brain Research Foundation on blood tests
in mental illness in 1957,4 several unan—
swered or partly answered questions were
raised or implied. What are the serum
ceruloplasmin levels in disturbed behavior
not of psychotic proportion? Does the con—
centration of this protein vary with the severity of the mental disorder? Is its
concentration in the blood increased during
Submitted for publication Sept. 16, 1957.
Department of Preventive Medicine and Division
of Psychiatry, University of Illinois College of
Medicine.
Now at the Institute for Psychosomatic and
Psychiatric Research and Training, Michael Reese
Hospital (Dr. Marcus).
This research was supported in part by the
Mental Health Fund, State of Illinois; the Brain
Research Foundation, and the Dan Crego Fund.
*The material was supplied by Drs. John Biel
and H. L. Daiell, of Lakeside Laboratories. Dr.
John Biel cooperated in the study and made helpful
suggestions.

DAVID A. MARCUS, M.D.,

Chicago

N—ETHYL—B-PIPERIDYLBENZILATE (JB 3l8)

CHz—7CH—CH2\
N—CH:

\

CHz——- CH——-CH2

/

CHzOH
l

CH—O-C
H

ATROPINE

drug—induced psychoses? And, ﬁnally, since

ceruloplasmin attacks certain pyrocatechol
(catechol) amines in vitro, what effect does
an increase in these pyrocatechol amines in
the blood have on ceruloplasmin?
The present study, then, had the dual
purpose of examining the psychotomimetic
properties of ]B 318 and assaying the effects on serum ceruloplasmin of (1) JB
318—induced “psychoses,” (2) intravenous
infusion of some pyrocatechol amines, and
'(3) naturally occurring behavior disturb—
ances of moderate severity.

Experimental Methods and Results
Studies with J B 318.—In all, 45 volunteer
nonpsychotic subjects were studied. JD 318
was administered orally to nine subjects in
doses of 10 or 15 mg. Three who took the
agent were professional persons employed
in the hospital; six were medical ward patients, selected only because their general
state of health was satisfactory. The three
317

�A. M. A. ARCHIVES OF NEUROLOGY AND PSYCHIATRY

professional persons had prior knowledge of anxious to repeat the experience. Seven
the effects of the drug, whereas none of experienced visual hallucinations, and four
the patients were told what to expect. Blood of these also described auditory hallucina—
was drawn for serum ceruloplasmin deter— tions, which were especially prominent in
mination before and at the peak of the three.
The visual hallucinations usually consisted
hallucinatory phase. Ceruloplasmin was
measured by the method of Abood5 in of amorphous colored forms, whereas
eight of the nine subjects.
brightly colored, elaborate images were inThe determination was done as follows: frequent. In the ﬁve cases in which animal
One-tenth milliliter of fresh serum was and human forms were reported the images
incubated with 0.1 ml. of 0.1% p-phenylene— were usually related to speciﬁc events in the
diamine and 1.0 ml. of 0.2 M tris(hydroxy— recent past experience of the subject. Most
methyl)ethanolamine buffer (pH 6.8) for hallucinations lasted only a few seconds, al—
a period of one hour at 37 C. After the though one subject reported images persist—
addition of 2 ml. of distilled water the mix- ing for many minutes. Generally, but not
ture was read at 490m“ on the spectro- always, the maximum hallucinatory effect
photometer. An optical density reading of was attained when subject was kept alone
0.100 corresponds to an activity of IOMM in a darkened, quiet room.
The auditory hallucinations consisted
of substrate (p—phenylenediamine) oxidized
of
musical
such
mainly
sounds,
stand—
0.1
as whistling,
hour
ml.
The
of
one
serum.
per
ard curve was determined by oxidizing the singing, and band playing. A few reported
substrate with puriﬁed human cerulo~ noises, such as sirens and hammering or
banging radiators. Emotional disturbances,
plasminrt
such
fear
and
as
bewilderment, seem to acReactions related to the autonomic activ—
visual
whereas
hallucinations,
the
company
the
30
of
about
minutes
ity
drug began
after oral administration and consisted of auditory experiences were not usually disthe following: dry mouth, blurred vision in turbing.
Two
be
subjects
to
appeared
paranoid
all cases, usually tachycardia, facial ﬂushing,
hallu—
the
during
or
immediately
following
and disappearance of the carotid sinus re—
ef—
While
the
cinatory
central
responses.
ﬂex. There was no appreciable effect on
fects
ofthe drug persisted, the subjects
blood pressure. Nausea occurred in two pa—
showed
reduction
of
intellectual
a
capacity,
tients, vomiting in one. The autonomic recharacterized
rela—
short
attention
by
span,
actions began 15 to 60 minutes before the
tive
and
anomia,
inaccurate
time
grossly
hallu—
and
outlasted
the
psychic phenomena
All
remained
in
judgment.
contact with
cinations by l to 24 hours. The peak auto—
the actual environment, but the presence of
nomic effects preceded the peak psychic
familiar
a
person or object was required to
effects in every case.
enhance orientation and allay apprehen—
Perceptual responses were characterized sions.
by distortion of Visual images, visual and
The following are taken essentially verauditory hallucinations, and alterations in batim from the comments of
dur—
a
patient
feeling state. All nine subjects reported dis— ing the
period of hallucinogenic effect:
tortion of visual images and an initial change
“My arms are heavy and everything feels far
in mood, characterized by apprehension and away. My head feels light. I’m
very weak. . . .”
“Lots of people are talking incoherently. I think
lethargy. The general feeling tone was re—
it’s
Spanish.”
ported as unpleasant by eight of the nine
“The room feels distant. I wish I could lift my
subjects, and none of the subjects were left
is
arm but I can’t. The
and
Dr. G. D. Cummings, of the Michigan Department of Health, supplied the puriﬁed human cerulo—
plasmin.
1'

318

room
a
narrow,
band is playing. The rhythm is M. . . .”
“The room is a long corridor, and I’m in it and
I’m 8 or 9 years old. I wonder how I’ll get out. I

Vol. 79, March, 1958

�I

CERULOPLASMIN AND NEW HALLUCINOGEN
of .18 318 on Serum
Ceruloplasmin’l‘ of Normal Volunteers
TABLE l.——Eﬂect

Before

JB

Ceruloplasmln Approximately Two Hours
After J B 318
Subjects Who
Hallucinated

318

230
242
304
224

188

230
241

2l 1

115
120
155
315
*

160
170

Subjects Who Did
Not Hallucinate
_

«——~

-

_ _

-_

.

__

-_

143

296

The values are expressed as optical density X10 8.

know I’m in bed and also in that other place. There
must be more than one of me, and one is a little
girl.”
“People from India are standing outside a tent.
They have turbans, and those are camels.”

An electroencephalogram taken on one
subject revealed no abnormality, even dur—
ing a series of vivid hallucinations.
Ceruloplasmin levels uniformly increased
in the six subjects who experienced hallucinations and decreased slightly in the two
who did not (Table 1). The parallelism of
ceruloplasmin levels in schizophrenic psy—
choses and those induced by JB 318 is
evident. There was, however, no propor—
tionality between the per cent increase in
ceruloplasmin and the severity of the psy—
choses. Nor were the ceruloplasmin levels
during the drug psychoses as high as commonly occurs in acute schizophrenics?6
Studies with Pyrocatechol Amines and
Human Subjects.—Pyrocatechol amines and
their breakdown products have been increas—
ingly implicated in schizophrenic psychoses.
Since ceruloplasmin has been shown to at—
tack epinephrine and serotonin in vitro,7 it
was deemed worth while to infuse certain
pyrocatechol amines intravenously and to
gauge their effects on behavior and serum
ceruloplasmin. There was a uniform slight
decrease in serum ceruloplasmin with each
agent, as well as with control dextrose in—
fusion.
The subjects were general medical patients who were either convalescing or not
seriously ill. None had rheumatoid arthri—
tis, liver disease, acute infections, or known
carcinoma, conditions sometimes associated
Oxtfeld at

(11.

with high cerulopla51nin.4'6 The infusions
were all administered by an unfamiliar
physician in a new setting. Apprehension
was initially evident in the behavior and
Speech of each subject. Common were such
comments as “We’re on the same side,
aren’t we, Doc. . .you won’t hurt me”; or
“lf the test comes out bad, will I have to
stay here [in the hospital] longer?”
With a single exception, the subjects
were relaxed, beginning about 15 minutes
after perfusion was started. About half
slept, and nearly all commented on how comfortable and tranquil they felt. None of the
subjects on levarterenol, serotonin, or dex—
trose reported any unusual sensation. The
subject on isoproterenol U. S. P. and the
two who received epinephrine experienced
a rapid heart rate but no emotional disturb—
ances. One subject who received epinephrine grimaced, tossed about, and was
agitated during the infusion.
Since the effects of the infusion on ceruloplasmin were identical regardless of the
agent administered, the parallel decline in
anxiety and in ceruloplasmin attracted our
attention. It was postulated that if there
were a parallelism between feeling state
and ceruloplasmin, then both would be ex—
pected to undergo an increase during peri—
ods of disturbed behavior.
2.—E[fect of Various Agents“ onSerum
Creruloplasmin of Normal Human Subjects

TABLE

Agent
Levarterenol

Epinephrine

Dosage
10 jug/min.
10 jig/min.
20 jig/min.
5 pg/min.
10 ug/min.
10 ug/min.
15

Isoproterenol
Serotonin
Iproniazid
5% dextrose
with water

jig/min.
pg/min.
ng/min.

15
15
5 ug/m‘m.

mg/min.
mg/ min.
100 mg. orally

0.25
0.50

Ceruloplasmin
Control
186
213
292
228
350
144
235
220
188
211
222
196

During Drug
Eﬂect
140

232
225
191

347
102
205
200
214
189
224

1'

177

230

225

240
278
182

228
236
160

187
170

__-

141
150

TThis subject alone was markedly agitated during the infusion. N onpsychotic at present, he had been previously hospitalized six times for acute schizophrenic episodes.
319

�A. M. A. ARCHIVES OF NEUROLOGY AND PSYCHIATRY

Ccruloplasmin* of Disturbed
and Tranquil Subjects Who Were Not
Psychotic

TABLE 3.——Serum

Disturbed

Tranquil

262
250
220
222

136
157

154
272
240

lVlean
*

S. l).

348
230
282
410
263

202
170

181
118
186
156

230
170
120
166

The values are expressed in terms of optical density X10 5.

This thesis was tested in 26 consecutively
referred clinic patients. Previously, one pa—
tient who could not speak English and
three whose psychological states were not
clearly discernible to the observer were not
included, leaving a group of 22 patients.
Each subject was interviewed in order to
determine his general psychological state.
Eleven exhibited disturbed behavior, such
as weeping, pacing the ﬂoor, sweating, and
tachycardia and/0r admitted to prominent
feelings of anxiety and depression. An
equal number whose illnesses were not
viewed by them as unduly threatening were
calm in the clinic setting. Ceruloplasmin
levels for the two groups are shown in
Table 3.
No attempt was made to determine a pre—
cise psychiatric diagnosis, but the behavior
disturbances in the one group were of neurotic proportions. Increased ceruloplasmin
levels in the disturbed group are evident and
are signiﬁcant at the 0.001 level of probabil—
ity.

Comment
The correlation of elevated ceruloplasmin
with particular types of behavioral disturb~
ances apparently involving an alteration in
“feeling state” raises the problem of the
mechanism of ceruloplasmin production. In-

asmuch as hallucinogenic agents, such as the
present one (see also Alkerfeldtﬁ Abood“)
seem to stimulate ceruloplasmin production
only during the hallucinatory or psychogen—
ically disturbed phase, a central mechanism
would appear to be involved. It is of par—
320

ticular signiﬁcance that the onset of the
enzyme elevation is within minutes after
the occurrence of hallucinations or anxiety,
suggesting a rather unique mechanism for
enzyme production. Contrary to our origi—
nal expectations, an elevation in blood
pyrocatechol amines, which are apparently
endogenous substrates for ceruloplasmin,
was not, in itself, a stimulus for increased
production of ceruloplasmin, but, rather,
caused a decrease in many instances. What
increases were noted in the infusion studies
were apparently related to anxiety reactions
to the manipulative procedures involved’in
handling the subjects. Since, in the present
studies, no noticeable alterations in feeling
state resulted directly from the pyrocatechol
amines, it remains to be seen whether in
those instances in which such reactions
have been attributable to infused epineph—
rine8 an elevation in ceruloplasmin does
occur. Future studies are aimed at the
clariﬁcation of many of these points.
The suggestion that changes in cerulo—
plasmin may reﬂect alterations in emotional
state has been proposed by others. Leach
and associates9 have postulated that many
environmental factors, including stress, can
alter the enzyme level. Meduna4 described
a patient who exhibited a high serum cerulo—
plasmin &gt;during an acute schizophrenic
psychosis and a normal value during a lucid
interval. Hoffer10 has noted an increase
in a serum pyrocatechol oxidase (presum—
ably not ceruloplasmin) during the acute
phase of a schizophrenic attack. Schizophrenia is a genetic limitation involving par—
ticular enzymes within the brain or
elsewhere in the organism. In the face of
environmental stress, such limitations be—
come prominent, and metabolic products
with psychotomimetic properties accumu—
late." The psychosis itself is ushered in
by the sensory distortions, altered feeling
state, and hallucinations so induced. Sub—
sequently, when the patient attempts to
reconcile his present state with his past ex—
perience, the disorganization of cortical
function begins.
Vol. 79,‘ March, 1958

�CERULOPLASMIN AND NEW HALLUCINOGEN

Numerous reports”12 are available on
the psychogenic properties of the bella—
donna alkaloids, but the effects were quite
variable and difﬁcult to interpret because
of the many peripheral side-effects, particularly with atropine. JR 318 possessed about
one—third of the cholineric—blocking effect of
atropine on smooth muscle,‘3 and at the
doses used in the present study produced
a slight, if any, effect on blood pressure,
heart rate, or gastrointestinal tract. Even
the more superﬁcial peripheral effects ob—
servable with atropine, such as mydriasis
and dryness of the mouth, were occasion—
ally absent with the doses of JB 318 used.
With regard to the possible mechanism
of JR 318 and other cholinergic—blocking
agents on the central nervous system, very
little'can be said. Although the evidence in
support of the role of acetylcholine as a
chemical transmitter in the central nervous
system is not convincing“:15 disturbances
in its concentration or action within the
central nervous system result in a wide
variety of psychic and neurological symp—
toms.
Many cholinergic agents, such as isoﬂuro—
phatef“,17 produce central nervous system
disturbances which are apparently associated
with the accumulation of acetylcholine in
the brain. The observations of Pfeiffer et
al.18 that the “muscarinic” component of
acetylcholine—like agents, such as arecoline
and physostigmine, are of value in the treat—
ment of catatonic schizophrenia, suggest a
role of acetylcholine in mental disease.
There would appear to be a conﬂict between
the argument that a cholinergic agent is
beneﬁcial in schizophrenia, while a choliner—
gic—blocking agent is psychotomimetic; but
the neural mechanisms involved in psycho—
genic phenomena are much too obscure to
justify the comment on this apparent dis—
crepancy. What is signiﬁcant is the fact
that acetylcholine does seem to inﬂuence
psychogenic phenomena and may be of im—
portance in the study of mental disease.
Ostfeld at al.

Summary
A recently synthesized atropine—like
compound, N-ethyl—3—piperidyl benzilate,
induced altered feeling states, visual and
auditory hallucinations, and increased se—
rum ceruloplasmin in seven of nine patients.
Infusion of four pyrocatechol amines—
epinephrine, levarterenol, isoproterenol, and
serotonin—appeared to have no effect per
se on serum ceruloplasmin. Iproniazid, an
amine—oxidase inhibitor, was likewise inef—
fective.
Serum ceruloplasmin undergoes small, but
signiﬁcant, increases during psychiatric disturbances of neurotic type and proportions,
and decreases by a similar amount during
periods of tranquility.
Department of Preventive Medicine, University
of Illinois College of Medicine (Dr. Ostfeld).

REFERENCES
Hughes, J. D., and Clark, J. H., Jr. Strontium
Poisoning: A Report of 2 Cases, J. A. M. A. 112:
1.

:

2500, 1939.

J. H.; Sprengeler, E. P.; Leiser, H. A.;
Homer, J.; Drukker, A., and Friedman, H. L.:
Antispasmodics: II. Derivatives of N—Substituted—
3-Piperidols, J. Am. Chem. Soc. 77:2250, 1955.
3. Biel, J. H.: Personal communication to the
authors.
4. Brain Research Foundation, papers read at
Medical Conference, Chicago, Jan. 12—13, 1957,
by Akerfeldt,5 Abood,8 and Meduna.
5. Akerfeldt, S.: Oxidation of N,N-Dimethyl—p'
plienylenediamine by Serum from Patients with
Mental Disease, Science 1252117, 1957.
6. Abood, L. G.; Gibbs, F. A., and Gibbs, E.:
Comparative Study of Blood Ceruloplasmin in
Schizophrenia and Other Disorders, A. M. A.
Arch. Neurol. &amp; Psychiat. 772643, 1957.
7. Holmberg, C. G., and Laurell, C. B.: Investigations in Serum Copper: IlI. Ceruloplasmin
as an Enzyme, 'Acta chem. scandinav. 5:476, 1951.
8. Hoffer, A.: Epinephrine Derivatives as Potential Schizophrenic Factors, Quart. Rev. Psychiat.
&amp; Neurol. 18:27, 1957.
9. Leach, B. E.; Cohen, M.; Heath, R. G., and
Martens, 8.: Studies of the Role of Ceruloplasmin
and Albumin in Adrenaline Metabolism, A. M.A.
Arch. Neurol. &amp; Psychiat. 762635, 1956.
10. Hoffer, A.: Conference on Biochemistry and
Mental Disease, University of British Columbia,
Vancouver, B. C., Canada, June, 1957.
2. Biel,

321

�A. M. A. ARCHIVES OF NEUROLOGY AND
11.

Quigley, J. P.: Mental Disturbances from

Atropine or Novatropine to Subjects Under the
Inﬂuence of Insulin, J. A. M. A. 10921363, 1937.
12. Wangeman, C. P., and Hawk, M. H.: The
Effects of Morphine, Atropine and Scopolamine on
Human Subjects, Anesthesiology 3:24, 1942.
13. Ewing, P. L.; Seager, L. D.; Keller, G.,
and Dodson, D.: Cardiovascular Effects of Some
Derivatives,
J.
Diphenylacetate
3-Piperdy1
Pharmacol. &amp; Exper. Therap. 110217, 1954.
14. Eccles, J. C.: The Physiology of Nerve
Cells, Baltimore, Johns Hopkins Press, 1956.
15. Feldberg, W. S.: Central and Sensory Trans—
mission, Pharmacol. Rev. 6285, 1954.

322

PSYCHIATRY

Koelle, G. B., and Gilman, A.: The Chronic
Toxicity of Di—Isopropylﬂuorophosphate (DFP)
in Dogs, Monkeys and Rats, J. Pharmacol. &amp;
16.

,

Exper. Therap. 872435, 1946.
17. Rowntree, D. W.; Nevin, S., and Wilson, A.:
The Effects of Diisopropylﬂuorophosphonate in
Schizophrenia and Manic Depressive Psychosis, J.
Neurol. Neurosurg. &amp; Psychiat. 13:47, 1950.
18. Pfeiffer, C. C., and Jenney, E. H.: The 111-

hibition of the Conditioned Response and the
Counteraction of Schizophrenia by Muscarinic
Stimulation of the Brain, Ann. Nevv York Acad.
Sc. 662753, 1957.

'-

Printed and Published in the United States of America

�DEPARTMENT OF
PSYCHIATTY
EXPERIMENTAL

HILLSIDE HOSPITAL
GLE.

CAKS.

MAY-1

4's;

N

Y.

�Vol. 167, No.

l

MEDICAL LITERATURE ABSTRACTS

neuralgic pain from herpes zoster, and in patients
with tabetic crisis. R 875 was then given to 8 patients with psychalgia in whom a diagnosis of cenesthopathia associated with depression had been
made. In these patients the drug proved to be
ineffective; it was tolerated badly and the cenesthopathia frequently was increased. Thus, the effectiveness of the drug in patients with organic
syndromes contrasted with its complete ineffectiveness in those with psychalgia.
R 875 may be administered orally or subcutaneously; the intravenous route of administration is
contraindicated because of the risk of respiratory
accidents. Certain undesirable side-effects of the
drug, such as malaise, nausea, vomiting, and oc—
casionally drowsiness, require care in administering
it; rest in bed is advisable, at least for the initial
phase of the treatment.
the Hearing Level Following Severe
Poliomyelitis. R. Batson and F. McConnell. A. M. A.
J. Dis. Child. 95:139-145 (Feb.) 1958 [Chicago].
A Study of

The authors report on 87 selected, extensively
paralyzed patients, between the ages of 5 and 37
years, with poliomyelitis who underwent detailed
audiological assessment in order to determine the
precise status of auditory acuity. The audiograms
obtained from these patients were compared with
those obtained during the same period from 2
groups of young adults without poliomyelitis. Near—
ly all the pure-tone thresholds in the patients with
poliomyelitis departed from the zero decibel reference level by more than 10 db., indicating some
depression of hearing acuity as compared with the
levels in the control subjects, which adhered ex—
tremely closely to the zero decibel reference level,
denoting normal threshold of audibility. Inspection
of the pure-tone and speech thresholds in the
patients with poliomyelitis revealed that more than
75% (28 patients) showed at least a slight depression
of acuity which would be considered deviant from
the norm. Numerous factors were considered in an
effort to clarify the causative signiﬁcance of the reduction in sensitivity to auditory stimuli in the patients with poliomyelitis. Factors such as age, sex,
and possible drug therapy were not thought to
inﬂuence these results. It was believed that depressed hearing responses could not be attributed
to emotional disturbances or lethargy accompanying serious illness, since the patients gave oral responses to speech-hearing tests which required
more physical energy than the effort required for
signaling in response to pure-tone stimuli. It was
found that the duration of disability did not correlate well with the extent of hearing loss. Several
patients who were ambulatory and others who were
in a wheelchair throughout the day demonstrated
the same defect. A signiﬁcant correlation, however,
was observed between loss in hearing and loss in

117

vital capacity, in that patients with marked decrease
in vital capacity were apt to show signiﬁcantly
greater hearing loss. The signiﬁcance of this is not
clear, and it may be only a reﬂection of the severity
of the disease in a particular patient. Because there
are many other clinical symptoms more distressing
to the patient and the physician, and since communication with such patients is usually at close
range, reduction in sensitivity to auditory stimuli
can be easily overlooked even when it reaches moderate proportions of severity. The causative signiﬁcance of this ﬁnding is not clear.
New Group of Psychotomimetic Agents. L. C.
Abood, A. M. Ostfeld and J. Biel. Proc. Soc. Exper.
Biol. 8: Med. 97:483-486 (Feb.) 1958 [Utica, N. Y.].
A

group of piperidyl benzilates possessing anticholinergic properties were recently synthesized as
possible antispasmodics in the treatment of duodenal ulcer. In the course of therapeutic trials, it was
found that the tertiary amine hydrochlorides of the
benzilate esters, although active anticholinergics,
produced undesirable side-effects, particulary hallucinations. The quaternary ammonium salts, on
the other hand, were entirely devoid of such effects.
The authors recently obtained a series of such substances and examined their psychotomimetic effects
on animals and human subjects. The psychotogenic
effects of the N-methyl-S-piperidyl benzilate and
related congeners were tested on more than 40
human volunteers. Although some of the patients
had limited knowledge of the psychotogenic action
of the drugs, the majority of the subjects were completely unaware of their nature. All the agents were
tested for their behavioral effects on animals, including some 30 Siamese ﬁghting ﬁsh, 50 rodents,
and 5 cats. The action of these agents on the Siamese ﬁghting ﬁsh is comparable to the action described for lysergic acid diethyl amide (LSD) by
Abramson. In rodents there were marked behavioral
changes, such as initial excitement and marked
hyperactivity, spontaneous squealing, lack of responsiveness to stimuli, muscular weakness, and
lethargy.
The compounds proved to be extremely powerful
hallucinogens, in many respects more interesting
than LSD and mescaline. When administered in
oral doses of 5 to 15 mg. to human volunteers, distinct auditory and visual hallucinations occurred
within 1 hour in every individual and recurred
periodically for periods up to 10 hours after administration of the drug. Hallucinations were accompanied by gross distortions of visual images
and severe alterations in feeling state. A number of
subjects exhibited paranoid and megalomanic delusions, while the affective states ranged from a
feeling of unpleasantness to extreme terror. Some
of the subjects actually carried on conversations
with imaginary individuals involving situations datA

_

�118

MEDICAL LITERATURE ABSTRACTS

ing back 10 to 20 years. The subjects receiving 10
mg. (orally) of N-methyl-S—piperidyl benzilate were
in complete loss of contact with the environment for
many hours while experiencing dramatic visual and
auditory hallucinations. In many respects these
anticholinergic agents come closer to simulating
clinical psychoses than do mescaline and LSD. Of
all the compounds tested for hallucinogenic properties, N-Methyl-S-piperidyl benzilate is the most
potent, with the N-ethyl derivative being somewhat
less effective. The tetramethyl derivative is considerably less effective than the N-ethyl derivative.
The quaternary derivative is devoid of psychotogenic effects. As for the antispasmodic potency, although the 3 substances possessing psychotogenic
properties are perhaps the most potent, the remaining compounds are still quite effective.

Recurrence of Glioma of Cerebral Hemispheres:
Histological Features and Therapeutic Possibilities.
I. Papo and R. Tritapepe. Minerva chir. 12:144-31446 (Nov. 30) 1957 (In Italian) [Turin, Italy].
A second surgical procedure was performed on
34 patients with a recurrent supratentorial glioma.
At the ﬁrst operation this tumor appeared to be an
astrocytoma in 7 patients, an oligodendroglioma in
7, a glioblastoma in 16, and a changing type of tumor in 4. Histopathological changes from astrocytoma to glioblastoma were observed in 1 patient 11
months after the ﬁrst operation. It is possible, however, that areas of glioblastoma were originally
present. Atypical areas were found in sections of
the oligodendroglioma in 4 patients, who were
operated on, from 35 to 103 months after the ﬁrst
operation. This phenomenon could justify the differentiation of the oligodendroglioma. The immature and atypical features of glioblastoma became
more evident at the second operation. A type
of glioma, which originally appeared to be oligodendroglioma with atypical areas, changed into
glioblastoma in 1 patient 25 months after the ﬁrst
operation.
The longest postoperative survival period in patients with astrocytoma was 19 months, in those
with oligodendroglioma 21 month, in those with
glioblastoma 26 months, and in those with a
changing type of glioma 6 months. The authors
point out that in most instances there is reappearance of the symptoms of glioma rather than its recurrence. Astrocytoma and oligodendroglioma often
change into glioblastoma. There is no evidence to
show whether this is due to the intrinsic character—
istics of the tumor, to the surgical intervention, or
to the x-ray therapy. A gradual higher degree of
malignancy seems to develop even in those gliomas
which did not originally present a neoplastic structure. Surgical therapy, with rare exceptions, affords
no beneﬁt to patients with recurrent glioblastoma
but may be considered in patients with recurrent
astrocytoma and oligodendroglioma.

].A.M.A., May 3, 1958

GYNECOLOGY &amp; OBSTETRICS

Induction of Ovulation in the Human: Therapeutic
and Diagnostic Importance. H. S. Kupperman,
J. A. Epstein, M. H. G. Blatt and A. Stone. Am. ].
Obst. 8: Gynec. 75:801-309 (Feb.) 1958 [St. Louis].
The authors explain on the basis of a diagram
the current status of knowledge of the normal
cyclic functioning of the pituitary-ovarian axis. A
defect or alteration in any one of this normally
sequential series of interactions can result in menstrual irregularities, ovulatory failure, and/0r amenorrhea. It was felt that speciﬁc hormone therapy
in properly selected cases of failure of ovulation
might artiﬁcially trigger the defective ovulatory
mechanism. Since the proposed therapy theoreti—
cally was to be speciﬁc for an isolated defect in
ovulation, patients with other hormonal imbalances
that secondarily inﬂuence the pituitary-ovarian axis
were not included in the series. The patients who
were euthyroid with normal adrenal function and
who menstruated fairly regularly or who menstruated after therapy with progesterone and
showed an absence of pregnanediol with a ﬂat
basal body temperature were judged as having
ovulatory failure and fulﬁlled the criteria established for the “potentially responsive” cases. Those
whose only endocrinopathy was failure of ovulation
received 20 mg. of conjugated estrogens (equine),
administered intravenously as a single dose, not
sooner than the 18th day of the menstrual cycle. Of
the 40 patients treated, 31 were barren, and 9 were
either single women with menstrual irregularities
or married women practicing contraception.
Nine pregnancies resulted among the 17 infertile
patients in whom ovulation was induced after no
more than 2 injections of estrogens given intrave—
nously at intervals determined by the patients’ own
basal body temperature charts. The history of infertility in the 9 women in whom treatment resulted
in pregnancy ranged from 2 to 7 years. One of the
nonpregnant patients had her ﬁrst spontaneous
ovulatory menses in 3 years in the cycle subsequent
to the menses induced by estrogens given intra—
venously. Three other patients with a history of
only infrequently occurring spontaneous ovulatory
menses also had normal 28-day cycles for 1 period
after that induced by estrogen. Moreover, 4 of the
9 pregnancies occurred during the cycle subsequent
to the estrogen-induced ovulatory response. The
negative responses were due to mechanical inability of the ovaries to respond to pituitary stimulation, i. e., polycystic ovaries of the Stein-Leventhallike syndrome, where the thickened ﬁbrous tuniCa
presents a mechanical barrier to ovulation. Surgical
exploration with bilateral ovarian wedge resection
was advised in 8 of 12 infertile patients who were
negative responders. In each of the 8 patients op-

�COUNCIL ON DRUGS

1634

Orphenadrine Hydrochloride.—N,N-Dimethyl-2(o-methyl-a-phenylbenzyloxy) ethylamine hydrochloride—The structural formula of orphenadrine
hydrochloride may be represented as follows:
[CH3

CH

Cy

0 CH2CH2N\

CH3

'

HCI

CH3

~

Actions and Uses.—Orphenadrine hydrochloride,
the o-methyl analogue of the antihistamine, diphenhydramine hydrochloride, produces a reduction of
voluntary muscle spasm. The effect is central, presumably by an inhibitory action on cerebral motor
areas, and resembles the central effects of atropine.
Orphenadrine exerts only weak antihistaminic and
sedative eHects. It is not primarily a peripherally
acting anticholinergic agent since, in therapeutic
doses, it produces few of the typical effects on
smooth muscle, the eye, or secretory glands which
characterize atropine and other peripheral para—
sympathetic blocking agents. The skeletal muscle
relaxation is not of the type produced by mephenesin or zoxazolamine, since there is no evidence that
it interrupts transmission through peripheral neuromuscular pathways. Nor is there any indication that
it acts at the myoneural junction in the manner of
the curariform drugs; it does not cause ganglionic
blockade.
Orphenadrine has been used for the symptomatic
management of paralysis agitans (Parkinson’s disease). Subjective observations seem to indicate
that the drug may bring about beneﬁcial effects in
approximately half of the patients so treated.
Rigidity is apparently relieved much more readily
than is tremor; in occasional patients with severe
spasticity, tremor may even be accentuated as the
spasticity is relieved. Other salutary effects ascribed to the action of the drug include relief of
oculogyria, sialorrhea, diaphoresis, blepharospasm,
and disturbances in gait and balance. The drug
also exerts a euphoriant effect which is useful in
combating the depression and fatigue that frequently accompany this syndrome. In common with
other antiparkinsonian drugs, the therapeutic effectiveness of orphenadrine diminishes with prolonged
use. For this reason, and because it is considered
somewhat less active than other antiparkinsonian
drugs, orphenadrine is probably best employed as
an adjunct to such other agents as procyclidine,
trihexyphenidyl, cycrimine, or benztropine for the
treatment of paralysis agitans. It may, however,
be tried alone for patients who have become refractory to the other antiparkinsonian drugs.
Because of its antispastic effect on voluntary
muscle, orphenadrine has been proposed for use
in a variety of clinical conditions which may be
unrelated in etiology but in which pain due to

J.A.M.A., July 26, 1958

skeletal muscle spasm is present. These have been
described as sprains, strains, ﬁbrositis, whiplash injuries, noninﬂammatory rheumatic and arthritic
states, and torticollis. Although such use might be
considered a logical clinical application of the
drug’s pharmacological action, the evidence available to date is not adequate to permit a sound
conclusion as to the ultimate effectiveness of such
therapy. Further studies are also needed to conﬁrm
the possible usefulness of orphenadrine in the
treatment of the extrapyramidal involvement associated with high doses of reserpine or phenothiazine-type tranquilizing agents.
The clinical toxicity of orphenadrine hydrochloride appears to be low, at least with therapeutic
doses. Thus far, side-effects have been limited to
nausea, dryness of the mouth, dizziness, mild excitation, and occasional hallucinations. Most of these
effects tend to subside or disappear with a reduction in dosage. Because of its anticholinergic classiﬁcation, orphenadrine should be administered cautiously to patients with glaucoma, tachycardia, or
urinary retention.
Dosage—Orphenadrine hydrochloride is administered orally. The usual initial dose is 50 mg. given
three times a day. This dosage should then be ad—
justed according to the clinical response of the
individual patient and the appearance of sideeffects.
Preparations: tablets 50 mg.
Applicable commercial name: Disipal.
Biker Laboratories, Inc., cooperated by furnishing scientiﬁc data to aid in the evaluation of orphenadrine hydrochloride.

Pancreatic Dornase.—A stabilized preparation of
the enzyme, deoxyribonuclease, prepared by fractional precipitation of aqueous acid extracts of beef
pancreas followed by dialysis, sterilization by ﬁltration, and lyophilization. The activity of pancreatic
dornase is determined by measuring the rate at
which it reduces the viscosity of thymus deoxyribonucleic acid, potency being expressed in terms of
units. One unit is an amount of enzyme which
causes a drop of one viscosity unit in 10 minutes at
30 C, where the flow-time of water is taken as one
viscosity unit.
Actions and Uses—Pancreatic dornase is derived
from beef pancreas, and, in contrast to the deoxyribonucleases produced by hemolytic streptococci
(streptodornase), it is a single nuclease. Like
streptodornase, it acts directly upon a substrate
of deoxyribonucleoprotein (and deoxyribonucleic
acid). The action of pancreatic dornase has been
characterized as one of rapid depolymerization,
with a resulting decrease in viscosity of purulent
material. Pancreatic dornase degrades deoxyribonucleoprotein to relatively large-sized fragments,
thus differing from streptodornase, which continues

�Vol. 167, No. 13

COUNCIL ON DRUGS

Mepazine Hydrochloride. — 10—[(1-Methyl-3—piperidyl ) methyl] phenothiazine hydrochloride—The
structural formula of mepazine hydrochloride may
be represented as follows:
N-CH;

&lt;

CH2

(II)
.3

-

HCI

Actions and Uses—Mepazine hydrochloride is a
phenothiazine derivative with actions and uses
similar to, but not identical with, those of chlorpromazine. Although less potent, mepazine is not
merely a weak chlorpromazine. Pharmacological
studies indicate that it differs from chlorpromazine
in that it does not lower the body temperature in
rats as does chlorpromazine; it does not antagonize
the waltzing syndrome in mice as does chlorpromazine; and it augments carotid sinus reﬂexes in
cats whereas chlorpromazine inhibits them. The
signiﬁcance of these differences with respect to its
clinical usefulness is, at present, unclear. The drug
is used principally for its calming or tranquilizing
action in the management of neuroses and psychoses in which anxiety, tension, agitation, and
increased psychomotor activity are predominant; it
is said to exert a selective action to normalize the
thinking process of mentally or emotionally disturbed patients. Because mepazine is less potent
than chlorpromazine, it does not produce the excessive sedation, drowsiness, and depression which
frequently accompany therapy with the latter drug.
On the other hand, the diminished potency of
mepazine makes it less effective than chlorpromazine for the long—term control of the most severe
forms of agitation and tension; it has little or no
immediate effect on acute psychotic disturbances.
In terms of over-all psychotherapeutic effectiveness, mepazine might be considered to be intermediate between the most potent agents such as
chlorpromazine and the milder agents such as
meprobamate.
Like chlorpromazine and other phenothiazine derivatives, mepazine hydrochloride exerts an antiemetic effect and may be used for the control of
nausea and vomiting from a variety of causes. The
drug has also been used for its calming effects in
surgery, in obstetrics, and in anesthesia. Other reported clinical applications include use in narcotic
withdrawal to control restlessness and agitation, in
chronic alcoholism to lessen anxiety and tensions,
and in advanced neoplastic states to reduce the

1633

quantity of narcotics needed for control of pain.
However, sufﬁcient evidence is not available to
establish its usefulness for the latter purposes.
The acute toxicity of mepazine hydrochloride in
experimental animals is less than that of chlorpromazine hydrochloride, and, in general, its clinical
use is followed by a somewhat lower incidence of
side-effects and untoward reactions. As already indicated, the usual doses produce a calming effect,
with little sedation and drowsiness. Although jaundice has not as yet been observed with administration of mepazine, physicians should be alert to its
possible occurrence. The drug should not be given
to patients with a history of jaundice or liver damage. The most frequent side-effects of mepazine are
atropine-like in nature and include blurring of
vision, dryness of the mouth, and constipation.
Since constipation can lead to more serious forms
of intestinal obstruction, it should not be neglected;
if necessary, laxatives should be prescribed. Less
frequent side-effects include occasional dizziness,
tremor, urinary retention, and transient hypoten—
sion. The most serious toxic reaction to mepazine
is referable to hematopoietic depression. As with
chlorpromazine, the drug can produce leukopenia
and granulocytopenia. It should, therefore, be used
with discretion; peripheral blood cell counts are
indicated at frequent intervals during therapy, and
patients should be advised to report to the physician immediately upon the onset of fever, sore
throat, or marked weakness. Because it potentiates
the action of other central nervous system depressants, mepazine is contraindicated in patients under
the inﬂuence of large doses of narcotics, barbiturates, or unknown large quantities of alcohol.
Dosage.—Mepazine hydrochloride is administered orally. For the treatment of ambulatory
neurotic patients, the usual initial dose is 25 mg.
three or four times daily. This dosage can be increased every week by increments of 25 mg. per
day until the desired effect has been attained. For
those psychiatric conditions which are severe
enough to require hospitalization of the patient,
the initial dose is 100 mg. per day; this may be
increased by 50 mg. every ﬁve to seven days. Maintenance dosage for such patients is usually 400 mg.
per day or more.
For the treatment of nausea and vomiting, the
dosage ranges from 50 to 100 mg. per day. Dosage
for use in surgical and obstetric patients has not
been ﬁrmly established; single doses ranging from
50 to 200 mg. or more have been employed.
Preparations: tablets 25, 50, and 100 mg.
Applicable commercial name: Pacatal Hydrochloride.

’

�COUNCIL ON DRUGS

1632

the bacteria, as such, responded to the antibiotics,
i. e., a transformation of the original bacterial
arthritis into a chemical arthritis occurred. If the
nodules were originally situated only in the skin
(as clinically described) and only later appeared
in the subcutaneous fat tissue (as described in the
biopsy specimen and at autopsy), one could postulate that originally circulating trypsin caused
vascular alterations in the deeper layer of the
corium, with resultant skin nodules, and later the
circulating lipase resulted in subcutaneous fat
necrosis and subcutaneous nodules.
Summary
A chronic alcoholic patient had episodes of
abdominal pain for two years, on the basis of a
relapsing pancreatitis. Four weeks prior to his
death, he developed swelling and tenderness of the
various joints, with chills and fever. This could
have been due to a bacterial polyarthritis associated
with an acute pulmonary lesion such as pneumonia.
The bacterial infection could have precipitated an
acute pancreatic fat necrosis, on the basis of a
Schwartzman phenomenon. Excessive amounts of
circulating enzymes (trypsin and lipase) caused a
striking involvement of the extrapancreatic fat tissue, cutaneous and subcutaneous nodules of fat
necrosis, and necrosis of the periarticular fat tissue,
initiating a chemical polyarthritis. The abdominal
symptoms that appeared later were due to extensive

J.A.M.A., July 26, 1958

mesenteric fat necrosis. The terminal jaundice was
due to hepatocellular damage (toxic hepatitis)
secondary to the pancreatic and extrapancreatic fat
necrosis. The depression of blood calcium level was
characteristic for extensive pancreatic fat necrosis
and was due to saponification of the fatty acids
liberated from neutral fat by the enzymatic action
of pancreatic lipase.
References
1. Roberts, N. J.; Baggenstoss, A. H.; and Comfort, M. W.:
Acute Pancreatic Necrosis: Clinicopathologic Study, Am. J.
Clin. Path. 20:742-764 (Aug) 1950.
2. Balser, W.: Ueber Fettnekrose, eine zuweilen todtliche
Krankheit des Menschen, Virchows Arch. f. path. Anat.,

90:520-535, 1882.

3. Hansemann, D.: Discussion in Verhandlungen arzt-

licher Gesellschaften, Berl. klin. Wchnschr. 26:1115, 1889.
Blauvelt, H.: Case of Acute Pancreatitis with Subcutaneous
Fat Necrosis, Brit. J. Surg. 34:207-208 (Oct.) 1946.
4. Ponﬁck, E.: Ueber die sympathischen Erkrankungen
des Knochenmarkes bei inneren Krankheiten, Virchows Arch.
f. path. Anat. 56:534-556, 1872. Scarpelli, D. 0.: Fat Necrosis of Bone Marrow in Acute Pancreatitis, Am. J. Path. 32:
1077-1087 (Sept-Oct.) 1956.
5. Vogel, F. S.: Cerebral Demyelination and Focal Visceral
Lesions in Case of Acute Hemorrhagic Pancreatitis, with
Consideration of Possible Role of Circulating Enzymes in
Causations of Lesions, A. M. A. Arch. Path. 52:355-362

(Oct)

1951.

and Brakney, E. L.: Acute Hemorrhagic Pancreatic Necrosis Produced by Local Schwartzman Reaction:
Experimental Study on Pancreatitis, J. A. M. A. 1553569574 (June 5) 1954.
7. Richman, A.: Acute Pancreatitis, Am. J. Med. 21:2466. Thal, A.,

274

(Aug)

1956.

COUNCIL ON DRUGS
NEW AND NONOFFICIAL DRUGS
Monographs and supplemental statements on drugs described here and in subsequent editions of New and Nonofﬁcial Drugs are based on the evaluation of available scientiﬁc data
and reports of investigations.
H. D. KAUTZ, M.D., Secretary.
Mepazine Acetate.—10-[ ( l-Methyl-S-piperidyl)
methyl]phenothiazine acetate—The structural formula of mepazine acetate may be represented as
follows :
N " CH3

&lt;

0

CH2
‘

u

CH3C OH

Actions and Uses.—Mepazine acetate has the
same actions and uses as mepazine hydrochloride,
except that it is administered parenterally. (See
the monograph on mepazine hydrochloride.)
Dosage—Mepazine acetate is administered by
intramuscular or intravenous injection. For severely

agitated psychotic patients, the dose by either route
is 50 mg. three or four times daily. For the treatment of severe nausea and vomiting, daily doses of
25 to 75 mg. are injected intramuscularly. Dosage
for use in surgical and obstetric patients has not
been ﬁrmly established, but single intramuscular or
intravenous doses ranging from 50 to 200 mg. or
more have been employed.
Mepazine acetate may be injected parenterally
either as the full-strength solution or as a diluted
solution. Chloride or alkaline solutions should not
be used as diluents since they cause precipitation
of mepazine acetate. Oral therapy with the hydrochloride salt should be substituted for parenteral
injection as soon as possible.
Preparations: solution (injection) 50 mg. in 2 cc.
Applicable commercial name: Pacatal Acetate.

�1631

DIAGNOSTIC PROBLEMS

Vol. 167, No. 13

with antigenic properties may cause a Schwartzman
reaction, and antigenic speciﬁcity is not involved,
i. e., the provocative antigen need not be identical
with the sensitizing antigen.
It may be recalled that, in the case under discussion, the joint involvement was conspicuous
early in the course of the disease. There was no
deﬁnite evidence of rheumatoid arthritis, either
clinically or pathologically. Bacterial polyarthritis,
speciﬁcally of gonorrheal origin, should be considered, although a most careful search failed to
reveal any evidence for a gonorrheal infection of
the genital organs. Gonorrhea] polyarthritis in the
early stages shows a serous type of synovitis, and
cultures of synovial fluid may be negative.
The association of polyarthritis with periarticular
fat necrosis and pancreatic fat necrosis raises the
following possibilities: 1. There may have been a
rheumatoid
of
coincidence
polyarthritis
a
pure
with pancreatic fat necrosis, whereby the peri-

The interesting feature of this case was the onset,
with polyarthritis followed by the appearance of
disseminated subcutaneous nodules, while the
abdominal symptoms appeared later. The involvement of the pancreas proper, revealed at autopsy,

TABLE 3.—Etiology of

Acute Pancreatitis“

I. The common channel theory: reﬂux of bile into pancreatic duct
secondary to obstruction of ampulla of Vater
a. Calculus at ampulla of Vater
b. Spasrn of the sphincter of Oddi
c. Edema
II. Obstruction of pancreatic ducts by
1. Stone
2. Spasrn of sphincter of ampulla of Vater
3.
4.
5.
6.

Fig. 5.—Relatively well-preserved body and tail of pancreas. Large hemorrhagic, chalky, mesenteric mass extends downward from pancreas.

III. Alcohol
A. Acute
B. Nutritional
IV. Metabolic disturbances
1. Malnutrition (as it has been produced
experimentally by ethionine)

was not too extensive; it is possible that extrapancreatic involvement occurred early and was
limited to the retroperitoneal space, enabling the
escape of pancreatic lipase into the circulation by
way of the lymphatics, circumventing the enterohepatic circulation. The resultant high lipase levels
may account for the extensive involvement of the
joints and skin.
The various theories about the etiology and

2.

Site

Trauma
VI. Vascular changes

(Necrotizing arteriolitis; periarteritis nodosa)
VII. Infection
(e. g. mumps, scpticemic, acute cholecystitis?)
VIII. Allergic
a. Schwart7m3.n phenomenon
*

Extrapancreatic Fat Necrosis
In Literature In Our Case

+
+
.......................
Retroperitoneal fat tissue ..................
+
+
Mediastinal tat tissue ......................
+
—
Subepicardial fat tissue ....................
+
Subcutaneous fat tissue ...................
+
+
—
Bone marrow ...............................
+
Central nervous system
+
(perivascular demyelinization) ...........
+
—
Periarticular fat tissue .....................
+
necrosis at the site of the original intradermal
Mesenteric fat tissue

Hyperlipemia

V.

pathogenesis of acute pancreatitis are summarized
in table 3. An interesting recent theory6 relates
acute pancreatitis to the Schwartzman phenomenon, whereby intradermal injection of a cell-free
ﬁltrate of Salmonella, followed by intravenous injection of the same ﬁltrate, results in hemorrhagic
TABLE 2.—-Sites of

Edema of papilla of Vater
Tumor of pancreas
Squamous metaplasia of the epithelium in the ducts
Surgical ligature

——

V

injection. Using this principle, injection of a bacterial endotoxin in sublethal doses into a pancreatic
duct, with a subsequent provocative intravenous
injection of the same endotoxin, has produced a
fulminating pancreatitis in rabbits. Any substance

Richman" (modiﬁed).

articular fat necrosis occurred in a site of decreased
resistance; but, despite the high incidence of
rheumatoid arthritis and the relative frequency of
pancreatitis, such a coincidence of these with periarticular fat necrosis has never been reported.
2. The pancreatic fat necrosis in the early clinically
latent phase of the disease, with liberation of lipase
into the circulating blood, may have led to a chemical polyarthritis due to extensive periarticular fat
necrosis. 3. A bacterial (gonorrheal?) polyarthritis
preceding pancreatitis cannot be excluded, despite
the negative bacteriologic ﬁndings.
One might speculate, on the basis of morphologic
evidence of a chronic pancreatitis, that the pancreas
was already sensitized. A bacterial polyarthritis
could then have provided an antigenic provocation
for a Schwartzman phenomenon, which led to an
acute pancreatic fat necrosis, in the course of which
large amounts of circulating trypsin and lipase were
liberated. The circulating lipase caused a peri—
articular fat necrosis, which in turn caused a proression of the polyarthritis, despite the fact that

DEPAR MENT OF

EXPERIMENIAL PSYCHIATRY

HILLSIDE HOSPITAL
GLEN OAKS, N. Y.

JUL3

1

‘5.

�elements.

3. The rhythm of

4

-6 cycle/sec in the

sub-

cortical area disappears completely following
administration of chlorpromazine in the dosage
of 7.5—10 mg per kg, and does not appear even
in response to painful stimulation with electric
current; which undoubtedly indicates an inhibitory effect of chlorpromazine on adrenergic
elements of these structures.
4. Administration of epinephrine against a
background of a pronounced chlorpromazine
effect produces a temporary decrease in symptoms of the chlorpromaaine effect on the organism. Accompanying this, there is a tendency
to activation of electrical activity in all parts
of the brain.

5. Comparison of our data with those in the
literature leads us to the conclusion that the
adrenergic substrate of the reticular formation exerts a complex inﬂuence on individual
structures within the reticular formation as
well as on the cerebral cortex. This action is
apparently associated with metabolism of
adrenergic substances, and for this reason it
changes in a reciprocal manner as a result of
the action of epinephrine and chlorpromazine.
RE FERENCES
1.

2.

AGAFONOV,

V.G., Zhurn. nevropatolog.

ipsikhiatr., 56,
ANOKHIN, P.K.,

No. 2, 94, 1956.

XX Mezhdunarodnyi kon—
v Briussele (Collected

gress fiziologov
papers, 20th International Congress of
Physiologists in Brussels), 151, M. ,

3.

4.
5.

6.
’

7.
8.

1956; Fiziolog. zhurn. USSR, 43, No. 11,
1072, 1957; Zhurn. vyssh. nervn. deiat..
9, No. 4, 489, 1959.
ANOKHINA, I.P., Zhurn. nevropatologi
psikhiatr., 56, No. 6, 478, 1956.
BAN'I‘SEKINA, M.M., Biull. eksper.
biolog. i med., No. 8, 3, 1959.
VERSHININ, N.V., Farmakologiiamchobnik) 137, M., 1952.
GAVLICHEK, V., Fiziolog. Zhurn. USSR,
44, No. 4, 305, 1958.
DOBRZHANSKAIA, A.K., Zhurn. vyld.
nervn. deiat.. 9, No. 1, 22, 1959.
POPOV, E.A. and T.A. NEVZOROVA,

Zhurn. nevropatolog.

No. 7, 559, 1956.

9. SHUMILLNA,

11.
12.
13.
14.
15.

56.

A.I., Zhurn. nevropatolog.

ipsikhiatr, 56,

10.

ipsikhiatr..

No. 2, 118, 1956; Kinf.

po vopr. elektrofiziolog. ts. n. s..
Tez. dokl. (Abstracts of Confsnnes on
Problems of Electrophysiology of the
C.N.S.), 144, M., 1958.
BRADLEY, P.B. and A.I. HAUCE, EIG
clin. Neurophysiol., 9, 2, 191, 1957.
DELL, P., M. BONVALLET and A.
HUGELIN, Journ. Physiol., 48, 403,
1956.
GANGLOF‘F, H. and M. MONNIER, Physiol. et Pharmacol., acta, 15, l, 83,
1957.
RINALDI, F. and H. HIMWICH, Dis.
Nerv. System, 16, 5, 1955.
ROTHBALLER, A.B., EEG clin. Neurophysiol., 8, 603, 1956.
VOGT, M., Journ. Physiol.. 123, 451,
1954.

THE ANTAGONISTIC ACTION OF CHOLINOMIMECTIC

AND CENTRAL CHOLINOLYTIC AGENTS ON
THE EEG OF THE RABBIT

P.P.

DENISENKO, Division of Pharmacology, Institute of Experimental Medicine, Um}! Academy
of Medical Sciences, Leningrad (Received January 21, 1959)

Today the presence of cholinerglc synapses
in the central nervous system, particularly in
the cerebral cortex, is considered an estab—
lished fact. The cerebral cortex can be stimulated with acetylcholine (Markosian, 1937;

Feldberg, 1950) and various "cholinopositive"
substances — cholinomimetics (nicotine, arecoline) and anticholinesterases (physostigmine
and diethyl p-nitrophenyl phosphate, or phos-

phacol) — which, like acetylcholine, are
capable of causing excitation of choline-roactive systems (Rizzolo, 1929; Miller, 1037;
Stewart, 1952; Michaells, Finesinger, Ver—

ster, Erickson, 1954). The rate of proﬁle-

tion of acetylcholine in the cortex depends on
the functional state of the cortex (Macintosh
and Oborin, 1953).
The establishment of the role and significance

�of aeetylcholine in the activity of the cortex and
other parts of the brain has aided in the under—
standing and the correct evaluation and interpretation of the inﬂuence of cholinolytic drugs such
as atropine, scopolamine, etc. upon psychic
activity. ()1 the other hand, it has given rise
to the synthesis and investigation of new sub-

stances with cholinolytic action, inasmuch as
this opens up an opportunity for entirely new
methods in drug therapy of psychic and nervous
diseases and increases the armamentarium of
sedative and anticonvulsive drugs, as well as
antidotes for poisoning with anticholinesterases.
Among the cholinolytics known today there
are a considerable number of substances capable
of exerting a blocking inﬂuence chiefly on cholinergic structures in the central nervous system. Owing to the obvious predominance of
central cholinolytic action over peripheral,
substances of this type have, at the suggestion
of S.V. Anichkov, been classed in a separate
group — central cholinolytic agents.1
In chemical structure, central cholinolytic
agents in most cases are complex esters of
amino alcohols and aromatic acids, such 'as
diethylaminoethanol and diphenylacetic acid.
Pharmacologic studies of central cholinolytic
agents are conducted by various methods, especially the methods of conditioned reﬂexes and
electroencephalography; among others are experiments with convulsions produced by nicotine, arecoline, pentylenetetrazol, and other
'

drugs. As

research, electroencephalography is being increasingly widely
used. However, out of the large group of cen—
tral cholinolytic agents, this method has been
used only for partial investigation of caramiphen (Pentaphen, Parpanit), benactyzine (IEMa method of

22, Diazil), and Z—diethylaminoethyl diphenylacetate (Diphacil, Trasentine) (Schallek and
Smith, 1952; Paskov, 1958).
In the current study an electrophysiological
investigation was made of five new substances
synthetized by S. F. Torf in the chemical lab—
oratory of the Division of Pharmacology, In—

stitute

Fxperimental Medicine, USSR Acad—
emy of Medical Sciences: Preparation IBM263 (benzene sulfonate 0f l—diethylaniinoisopropyl methoxyd l pheny lacetate . Preparation
IEM-265, or Methyldiphacil (racemic
l—diethylaminoisop ropyl diphenylacetate hydrochloride), Preparation [EM—268 (racemic
1-dimethyl aminoisopropyl diphenylacetate
hydrochloride), Preparation [EM—273 (benzene—
sulfonate of 2-methylcholine diphenylacetate),
Preparation IBM—275, or Methyldiazil (racemic
l
«timethylaminoisopropyl benzilate hydrochloride». We also made a comparative study
of the influence of certain other central cholino1

‘The term "central cholinolytic agent" was
approved and accepted at the 9th All-Union
Conference of Physiologists, Biochemists,
and Pharmacologists in 1959.
125

olytic agents, namely Diphacil, Diazil, Pentaphen, Aprophen (ﬂ-diethylaminoethyl diphenylpropionate hydrochloride), Diprophen w—di-Npropyl thiodiphenylacetate hydrochloride), and
Tropacin (tropine diphenylacetate hydrochloride)
upon the bioelectrical activity of the brain.
METHOD

Experiments were conducted on rabbits
weighing 3 —4 kg with implanted nichrome or
platinum electrodes. Potentials from the cortex (temporal and occipital areas), thalamus,
and hypothalamus were recorded unipolarly.
Experimental equipment consisted of a differential amplifier from the Moscow experimental
shop and either an ink-writing or a type MPO—2
oscillograph. The amplitude—frequency characteristic of the ink-writing apparatus in the O —
70 cycle/sec range was flat to within 20%.
The inﬂuence of the central cholinolytics,
as well as of acetylcholine and cholinomimetics
(nicotine and arecoline), on the spontaneous
electrical activity of various parts of the brain
was investigated. In addition, electroencephalography was used to show the existence of
antagonism between these two groups of substances. No substance was administered to

the same animal more than once a week.
EXPERIME NT A l. RESULTS

Before proceeding with the study of the in—
ﬂuence of central cholinolytic agents on the
electrical activity of various parts of the brain,
we considered it necessary to determine how
it changes under the influence of acetylvholine
and cholinomimetics (nicotine and arecoline).
This was essential because one of the tests in
the study of substances of central cholinolytic
action involves a determination of their anticonvulsive activity in nicotine and arecoline
convulsions (Bovet and Longo, 1951; Kharauzov. 1954; Artem'ev, 1955. 1957; Zeimal',
1955, 1957; Golikov, 1956; Liberman, 1956;
Sokolova, 1957; Smirnov, 1957; Fedorchuk,
1958; Jacobson, 1958).
Intravenous injection of nicotine and arecoline (0.4 mg/kg) produces tremor and convulsions in the animal due to the stimulating effect
of these substances on the choline—reactive
systems of the brain. For further evaluation
and analysis of the influence of central cholinolytic agents on the bioelectrical activity of
the brain it was important to compare the picture of general excitation of the animal with the
changes in the electrical potentials of the brain.
Normally, the electrocorticogram of the
rabbit was made up chieﬂy of waves of medium
amplitude (30 -60 uv) and a rate of 4 —9 per
second. Superimposed on these we re fast
small waves with an amplitude of up to 15 av.
Occasionally single high-amplitude waves
appeared (5 —8 per min). As a rule, potentials

�large doses (0.4 -0.5 mg/kugi. 1.9. .dosos
which usually cause a convulsive seizure is
animal. In the last case we recorded simultaneously the champs in brain potentials and

of the thalamus and hypothalamus, were faster
than those of the cortex but of considerably
smaller amplitude (Fig. 1. 1-3; Fig. 2, 1-3;
l-‘ig. 3).

.l

FIG. 1. Influence of nicotine and Diphacil on the RH;

-

-

-

somatosensory cortex; B hypothalamus. l normal
EEG; 2 — 3 min after intravenous administration of nicotine
in a dose of 0.43 mg/kg; 3 — prior to administration
of Diphacil (6 days after the initial application of nicotine);
4 — 5 min after intravenous administration of Diphacil in a
dose of 5 rug/kg; 5 — absence of stimulating action of nicotine
(0.43 mg/kg) administered after Diphacil; 6 — 4 hours after
administration of the preparations.
A

Cholinomimetics (nicotine and arecoline)
were used in small doses (0.25 mg/kg) and

the contractions in the hind limb.
After the administration of choiinomimstios
126

�no

FIG. 2. Antagonism of cholinomimetic arecoline and choline—
lytic Methyldiazil displayed in the rabbit EEG.
A —

-

somatosensory cortex, B thalamus. 1 — normal EEG;
2 — 3 min after administration of
arecoline
in a dose of 0.45
mg/kg; 3
restoration of original state; 4 — 5 min after intravenous- administration of Methyldiazil (0.5 mg/kg); 5 —
absence
of stimulating influence of are coline in the
same dose after
Methyldiazil; 6 — 8 hours after administration
of the preparations.

-

the animal's behavior changed abruptly, espe—
cially if administration occurred against a background of general depression which was usually
observed after the rabbit had temporarily been
in a darkened room. Whereas prior to the ad—
ministration of the preparations the rabbit lay
quietly in its stand with its head between its
paws and at times even semi-asleep, following
administration of nicotine or arecoline it

exhibited unrest, turned its head, jerked,
pricked up its ears and reacted keenly to any
external stimulation. Mter epinephrine was

given intravenously in the dose of 0.4 mg/kg,
severe convulsive movements were observed
lasting, with interruptions, for several min—

utes.

Along with the changes in the behavior of

the animals already mentioned, there were
also marked changes in the spontaneous elec—
trical activity of the brain (Figs. 1 and 2).
These changes took the form of an increase in
amplitude and number of the high—frequency
potentials and quantitative diminution, to and
including complete disappearance, of high-

�FIG. 3. EEGs in various parts of the rabbit brain before
(upper oscillograms) and
5 min after (lower
oscillograms) intravenous administration of central cholinolytic
agents in the following doses: Diazil 0.5 mg/kg (A), Diphacil 5 mg/kg (B),
Aprophen 2 mg/kg (C).

Left, cortex; right, subcortical structures.
amplitude slow waves.
Changes in the EEG appearing after administration of nicotine evidently are not the result
of induction of muscle currents but reflect
changes in the electrical activity of the brain.
inasmuch as they precede motor excitation of
the animal. Such a supposition appears to be
even more probable because 10 — 15 min after
the strongest general excitation produced by
administration of nicotine, the rabbit calms
down (muscle tone becomes normal, movements decrease or disappear, and the animal
reposes quietly in its stand) . Simultaneously
with this, lowering of general EEG activity is
observed, with an increase in the number of
abrupt high waves and a diminution of the high-—
frequency discharges.
Comparison of changes in the EEGs of different parts of the brain discloses that follow—
ing administration of nicotine cortical potentials
show the first and strongest changes. Changes
in the EEGs of the hypothalamus, thalamus,
and other subcortical structures are less pronounced and appear later than the cortical
changes.
The other cholinomimetic, arecoline, in
doses of 0.4-0.5 mg/kg also had a stimulating
action: it caused unrest. convulsions, and
tremor, which, as is generally recognized,
are the result of the stimulating action of are—
coline on the choline-reactive systems of the
brain. The stimulating action of arecoline on
~

128

the brain is reﬂected in the EEG to the same
extent as is that of nicotine. As shown in
Fig. 2, the amplitude of the fast oscillations,
especially in the subcortex, rises sharply
and the number of oscillations increases

appreciably.

Typical changes characteristic of excitation
appeared in the EEG following intravenous injection of acetylcholine in doses of 0. l - 0. 8
‘y/kg. In doses of 1 ~50 'y/kg acetylchouno
produced such changes only du ring the first,
very brief timevinterval after the injection;
this was followed by a pronounced depression
of electrical activity.
Thus, in experiments with cholinomimetics
(nicotine and arecoline) and acetylcholine. a
characteristic picture of EEG changes a»
crease in amplitude and number of fut rhythms
and a decrease in slow waves) was produced
which in combination with changes in the
general condition and behavior of the rabbits
(excitation, tremor, convulsions) permits us to
regard, with a high degree of probability, the
observed picture of EEG changes as a roll..tion of cerebral excitation.
In addition, a clear—cut distinction was observed between the action of nicotine and arecoline on the cholinergic systems of the brain:
the first and most marked changes uder the
inﬂuence of nicotine are in the cortical EEG,
but under the inﬂuence of arecoline, in the subcortical structures. The changes produced by

�arecoline and nicotine are not identical in
duration. The intensification of activity prochiced by administration of nicotine lasts a
maximum of 10—15 min and is often succeeded
by a general dqreesion of electrical activity.
Potentials of normal magnitude and rhythm
appear in l - 1 1/2 hours, but the sensitivity of
the cholinsrgie systems to nicotine and mani—
festation of the corresponding reaction to nicotine are not restored for 4 -—5 days. Arecoline
a more lasting excitation which is succeeded by the normal EEG picture. 0n repeated
one hour after the first injection,
one may observe complete restoration of sensitivity b arecoline.
Ahinistration of central cholinolytic agents
gave opposite results. General calming of the
animal was observed following administration
of cholinolytic agents. This was manifested
especially prominently when central cholinolytic
agents were administered to animals which had
not yet become accustomed to the stand and the
experimental conditions, or when the prepara—
tions were administered at the very beginning
of the experiment when the rabbit remained
somewhat excited. In such instances the ad—
ministration of a cholinolytic agent caused
jerking of the paw, attempts to escape the stand,
head movement, and reactions to external stimuli (noise, light, and sound) to disappear immediately. Two to five minutes following admin—
istration of Diphacil, Diasil, Pentaphen, Aprophen, and other substances in the group under
investigation, the state of unrest was succeeded
by general depression. of an intensity which
depended on the dose of the cholinolytic agent.
The rabbit lay quietly in the stand and reacted
feebly to external stimulation.
Simultaneously with the change in the state
and behavior of the animal, characteristic
changes were also observed in the electrical
activity of the brain: slow waves (1 - 2 per sec)
lg) to ”0 v predominated in the EEG. High—
a potentials disappeared entirely or
marke‘y decreased in number (Figs. 1, 2, 3).
These cheapo in electrical activity following
the injection of central cholinolytic agents
could be registered in all portions of the brain
which were under study. The intensity and
duration of theee
depended on the dosage
of the agents admhistened as well as on their
properties. This. similar changes could be
observed following intravenous administration

pm

Motion

frwy

We

of Diphacil. 5 mar/ks.

Wen,

Mammal-oil.

2

mar/ks;

mg/kg; Diaail, 0.6 mg/kg; Methyl—
easu. 0.1 mg/kg; and Diprophen, 15 mg/kg.
other hand, intravenous administration
cholinolytic agents in identical
heee redted in dissimilar changes in the
thalamus. and hypothalad cortex, such
as Diazil and Methylmus. Motions
dis-ll
greater changes in the potentials
of the
structures than of the cortex.
whereas administration of Methyldiphacil and
Diﬂlacil renlted in greater changes in the
cortex. Under the influence of Pentaphen.
1

it.eeet
~
‘

I” h

a“
Meal

129

131’

Aprophen, and to some extent Methyldiphacil,
changes in the EEGs cf the cortex and subcortex were approximately identical (Fig. 3).
Duration of the action of the preparations
under study varied between 2 and 30 hours
depending, apparently, on the dosage and their
physico-chemical properties. The strongest
and most lasting effect was observed after the
administration of Diazil and Methyldiazil, and
the weakest and shortest after administration
of [EM-268 and Diprophen.
Thus, experiments with central cholinolytic
agents showed that they cause general depres—
sion of the animal, a decrease in reﬂex activity
and characteristic changes in the EEG (predominance of slow, high-amplitude potentials).
Comparison of changes, following administra—
tion of central cholinolytic agents, in behavior,
general condition, and EEG, which were oppo—
site to those seen after administration of
cholinomimetics (nicotine and arecoline), per—
mits the conclusion that the EEG changes produced by central cholinolytic agents reﬂect a
state of cerebral depression due to blocking
of the cholinergic systems of the brain.
From our own and published data we knew of
the antagonistic relationships between cholino—
lytic and cholinomimetic agents that have been
demonstrated on peripheral structures as well
as in experiments with conditioned reﬂexes
and with nicotine and arecoline convulsions.
It was of interest to find out whether these
antagonistic relationships are exhibited in the
EEG. A special series of experiments were
therefore carried out for the purpose of investigating the influences of central cholinolytic
agents on the EEG already altered by the administration of cholinomimetics, and vice versa.
It was found that central cholinolytic agents in
definite doses prevent and cancel the action of
cholinomimetics. As shown in Fig. 1, Di—
phacil prevented the action of nicotine administered in a dose which usually produced a pro—
nounced rise in electrical activity. Convulsions
were the external manifestation of the stimulating inﬂuence of nicotine on the brain. Nicotine administered after Diphacil, Methyldiphacil,
Pentaphen. and other preparations never pro—
duced convulsions. Similar results were obtained wiﬂi arecoline: preliminary administra—
tion of Methyldiazil prevented the effect of a
convulsive dose of arecoline (Fig. 2).
Figs. 1 and 2 show that normally both of
these cholinomimetics exerted a pronounced
inﬂuence on the EEG. Their administration
in the same doses against a background of
action by central cholinolytic agents was without effect; the EEG remained the same as after
administration of central cholinolytic agents
Diphacil and Methyldianil.
In these experiments there were also data
indicating a certain preferential antagonism
batman arecoline and Diazil or Methyldiazil
and between nicotine and Diphacil or Methyldiphsoil. Preparations such as Pentaphen and
Aprophen prevent and cancel the action of

-

�arecoline and nicotine equally effectively.

as
application
clinical
for
agents
tion of these
cholinolytics and tranquilizers.

DISC U$ION

REFERENCES

experi—
the
of
the
course
in
clear
It became
experito
an
administration
following
ments that
(Diphacil,
preparations
older
of
animal
mental
as
and
others)
Aprophen.
Pentaphen,
Diazil,

S.V.. In the book: Novye
i
eksperimente
v
sredstva
lekarstvennye

1. ANICHKOV.

and
in
experiments
klinike (New drugs
clinic), 5. L.. 1958.
protivosudo—
Izyskanie
V.S.,
ARTEM'EV,
2.
rozhnykh sredstv metodom eksperimental'anticonvulsive
for
search
(A
noi terapii
agents by the method of experimental
1955;
L.
Dissertation.
,
therapy).
i
atsetilkholina
rol'
Fiziologicheskaia
izyskanie novykh lekarstvennykh of
role
physiological
(The
veshchestv
new
for
search
the
and
acetylcholine
drugs), 1. L.. 1.957.
soveshch.
dokl.
Tez.
GOLIKOV,
S.N.,
3.
i claim.
strukt.
mezhdu
sviazi
p0 probl.
the
of
(Abstracts
veshchestv
lekarstv.
between
Connection
the
on
Conference
13,
of
Drugs),
Action
and
Structure
Tarw, 1956.
dokl.
Tez.
iref.
4. DENISENKO, P.P.,
deiat.
nervn.
vyssh.
probl.
soveshch. p0
Problems
on
Conference
the
of
(Abstracts
of Higher Nervous Activity). No. 1, ‘6,
1... 1958.
1
mom.
5. ZEIMAL‘, E.V., Biuli. eksper.book:
the
in
1955.
42,
1,
39,
med.,
Fiziologicheskaia roi' atsetilkholinai
izyskanie novykh 106m rstvennykh of
veshchestv (The physiological role
new
for
search
the
and
acetylcholine
drugs), 79, 1... 1957.
itoksiFarmakolog.
LIBERMAN,
5.8.,
6.
kolog.. 6, 10, 1956.
bioBiull.
eksper.
A.A.,
MARHEIAN,
7.
1937.
4
119,
(2),
med.,
log.
Farmakoiogicholtm
D.S.,
PASKOV',
8.

GEM-275),
Methyldiazil
—
agents
well as newer
— sigIBM-268
and
(IBM-265),
Methyldiphacil
slow
EEG:
large
the
in
develop
nificant changes
be—
waves
medium
and
waves appear and small
be
may
changes
These
come less numerous.
of cere—
state
of
a
manifestations
regarded as
confirmed
interpretation
an
bral depression,
the
of
experibehavior
and
condition
the
by
mental animals.
The depressant effect of central cholinolytic
nature,
cholinolytic
of
a
is
brain
the
agents on
action
the
cancel
and
prevent
inasmuch as they
(nicotine,
cholinomimetics
and
of acetylcholine
stimu—
a
exert
themselves
which
by
arecoline),
some
is
There
brain.
the
on
influence
lating
already
which
was
antagonism,
preferential

discussed earlier.
more
one
as
serve
hand,
one
on
These data,
synapses
cholinergic
of
existence
the
of
proof
other
the
on
system;
nervous
in the central
the
that
proof
convincing
hand, they provide
not
characteristic
is
central cholinolytic effect

of
an
but
agents,
cholinolytic
individual
only of
of
esters
(complex
entire class of compounds acids) which have
amino alcohols and aromatic
been called "central cholinolytic agents."
and
new
that
hope
to
Our data permit us
found
be
posmay
agents
cholinolytic
powerful
Two
action.
central
sessing a predominantly —- [EM-265 (Methyl—
of the preparations studied
— are
(Methyldiazil)
IBM-275
and
diphacil)
and
tranquilizers
as
trials
undergoing clinical
cholinolytic drugs.

1

CONC LU SION'S

to
used
was
Electroencephalography
1.
of
properties
cholinolytic
establish the central
complex
representing
of
substances
a number
and aromatic
diethylaminoethanol
of
esters

acids.

in
manifested
2. A pronounced antagonism,
central
between
exists
EEG,
their action on the
agents.
cholinomimetic
and
cholinolytic
be—
interdependence
3. There is a definite
of
action
the
and
tween the chemical structure to the degree
cholinolytic agents. According
study
under
the
preparations
of vigor of action,
of diminorder
following
the
in
may be arranged
ishing strength:
Methyldiphacil,
and
Aprophen
phen,
Diprophen.
and
IBM—268,
Preparation
chocentral
the
4. The EEG data regarding
esters
complex
of
series
of
this
ytic action
recommenda—
the
which
permits
investigations

u

kharakteristika alkaloids Mann
antikholinesteraznogv sredstva (Pharma—
alkaloid
of
the
characterizatmn
cological
Disantichoiinesterase),
an
nivaline as
sertation, L.. 1958.
rol'
Fiziologicheskaia
9. SOKOLOVA, LA. .
atsetilkholina i izyskanie novyldl
vennykh veshchestv (The phydol“
role of acetylcholine and the
1957.
122,
L.,
drugs),
new
1
Parmakolog.
10. FEDORCHUK, IU. G..

130

imh
m
'

toksil&lt;olog., 4, 52, 1953.

11. KHARAUZOV,
giperkine zov

N.A., Farmakoterapﬂl
tsentral'nogo proiskhoal-

hyper“

deniia (Pharmacotherapy of
of central origin). Dissertation. L..
1954; Izbiratel'noe vliianie lekar
not.”
tsentral'nuiu
na
veshchestv
nykh
of
influence
(Selective
nuiu sistemy
-_.,
L..
system).
nervous
central
the
on
'

‘

�13. FELDBERG, W., Brit. Med. Bull., 6,
11, 312, 1950.
14. JACOEON, E... Antibiot. Med. a. Clin.
Therapy, 5, 2, 89, 1958.
15. MACINTOSH, F. and P. OBORIN, Abstr.
Comm. XIX Intern. Physiol. Congr.
580, Montreal, 1953.
16. MICHAELIS, M., J.E. FINESINGER,
F. VERSTER and R.W. ERICKSON,
Journ. Pharmacol., III, 2, 169,

THE EFFECTS OF

17.
18.
19.
'

20.

1954.
MILLER, F.R.. Journ. Physiol., 91, 2,
212, 1937.
RIZZOLO, A., Arch. Farmacol., sper.,50, 16, 1929. Tsit. p0: Chem. Abstr.,
24, 1158, 1930.
SCHALLEK, W. and 1LT. SMITH, Journ.
Pharmacol., 104, 3, 291, 1952.
STEWART, W., Brit. Journ. Pharmacol.,
7, 2, 270, 1952.

HYPOCAPNIA ON

THE FUNCTIONAL STATE OF

THE RESPIRATORY CENTER

G.L. FEL’DMAN, Department of Human and Animal Physiology, State University, Rostov-on-Don
(Received January 8, 1960)
METHODS

The question of the physiological mechanism
and biological function of sleep has long interested investigators (Legendre and Pierron,
1913; von Eoonomo, 1925; Hess, 1949; and
others) and has also been the subject of syste—
matic study in experiments conducted at the
Pavlov Laboratory (Pavlov, 1911, 1923, 1935;
Krasnogorskii, 1911; Rozhanskji, 1913;
Petrova, 1941; Asratian, 1953; Anokhin, 1958).
Ole method adopted for exploring the nature of
sleep inhibition and its effect on normal behav—
ior of the brain is that of artificial sleep depri—
vation. Thus, as early as 1891, M.I. Manasseina demonstrated that keeping puppies awake
for a period of 4 to 5 days will lead to death by
degeneration of the nervous tissue of the brain
Legendre and Pierron (1913) described histo—
logical changes of the neurons in the region of
the motor analyzer in the cerebral cortex of
adult dogs deprived of sleep for 7 days. Prolonged sleep deprivation produces severe
derangement of brain function, manifested in a
derangement of the processes regulating biochemical activity (Fedorov and Sikolskaia,
1M1), nervous breakdown (Ukolova, 1959),
and so on. Reports by N. Kleitman (1923),
N. Kleitman and M. Li (1923), Tyler (1955),
Bredlend (1955), and others, describe changes
during experiments in sleep deprivation in

The present study was conducted on 34 ani—
mals (10 kittens between 18 and 30 days old,
13 kittens between 35 and 55 days old, 6 adult
cats, and 5 puppies between 25 and 40 days
old), with electrodes chronically implanted
according to the method described by A. B.
Kogan (1952). The electrodes were implanted
in the region of the motor and visual analyzers
of the cortex and in the subcortical sections of
the brain. Potentials were recorded bipolarly
with an interval between the electrodes of 3 mm
for the surface electrodes, 1.5 mm for the
depth electrodes. Recording was done with a
two—channel electroencephalograph with optical
recording or a four—channel ink-writing electro—
encephalograph. Physiological tests were made
of the effects of a sound stimulus (intermittent
siren twice per second) and a tactile stimulus
(an air current). Parallel with this, and with
the same chronically implanted electrodes,
determinations were made of the thresholds for
direct electrical stimulation of the correspond—
ing points in the brain.
For purposes of comparison, we studied the
intensity relationships for the motor components
of the natural conditioned food reflex (Varukha,
1954) and coordination tests in which we analyzed
the placement of the footprints made by the
animals in walking. Throughout the period of
wakefulness the animals were permitted to move
about without restraint and were constantly
observed under natural light by day and bright
elect‘ric illumination at night. We kept the

humans.

Thus a study of the effects extended wake—
fulness has upon brain function as revealed in
the EEG and other indicators of. the functional
state of the brain is a matter of definite

interest.

131

�may be somewhat wider than the actual
distribution, due to analytical errors and
biological variation in the ratio of single
bone to whole skeleton. It is predicted
that in 1966 the average young child in
the world will have a skeletal concentration of strontium-90 of about 4 MIC of
strontium-90 per gram of calcium; that
10 percent may have a concentration of
8 one; that 1 percent may have a level
of 20 uuc; and that none will have a
level exceeding 80 one of strontium-90
per gram of calcium.
References and Notes
1.

Lamont Geological Observatory Contribution
No. 347. This research is being supported by
the Division of Biology and Medicine of the
U.S. Atomic Energy Commission. Many individuals have contributed valuable suggestions
and criticism. These include E. C. Anderson,
C. L. Dunham, M. Eisenbud, H. Hollister.
W. H. Langham, W. F. Libby, J. F. Loutit,
L. Machta, W. G. Marley, N. G. Stewart, H.
L. Volchok, and H. Q. Woodard. We also express our gratitude to the many medical doctors around the world who have assisted in
essential sample procurement. Rieta Slakter is
in charge of the Lamont analytical laboratory.
R. Alley, W. Blake, T. Bott, J. Brokaw, D.

IO

:55»

5.

6.
7.

8.

9.
10.
11.
12.

Harlin, M. Mandel,.._G. Markle, J. Rippey, J.
Sonderburg, and R. lWoehr assisted in various
aspects of the techniCal and secretarial work.
J. L. Kulp, W. R. Eckelmann, A. R. Schulert,
Science 125, 219 (1957).
W. R. Eckelmann, J. L. Kulp, A. R. Schulert,
ibid. 127, 266 (1958).
The two commercial laboratories were Isotopes, Inc., Westwotid, N.J., and Nuclear Sci—
ence and Engineering Corp., Pittsburgh, Pa.
H. L. Volchok, J. L. Kulp, W. R. Eckelmann,
J. Gaetjen, Ann. N;.Y. Acad. Sci. 71, l, 293
(1957); H. L. Volchok and J. L. Kulp, Nucleonicr 13, 49 (1955).
D. L. Thurber, J. L. Kulp, E. J. Hodges, P.
W. Gast, M. Warhpler, Science 128, 256
'
(1958).
A. R. Schulert, E. A. Peets, D. Laszlo, H.
Spencer, M. Charles, J. Samachson, Intern.
]. Appl. Radiation and Isotopes 4, 144 (1959).
A. R. Schulert, E. J. Hodges, E. S. Lenhoff,
J. L. Kulp, Health Phys., in press.
J. L. Kulp and R. Slakter, in preparation.
F. J. Bryant, A. C. Chamberlain, G. S. Spicer,
M. S. W. Webb, Brit. Med. ]. l, 1371 (1958).
Health and Safety Lab. U.S. Atomic Energy
Comm. Publ. No. HASL—42 (16 June 1958).
J. L. Kulp and R. Slakter, Science 128, 86
(1958).
D. V. Booker, F. J. Bryant, A. C. Chamberlain, A. Morgan, G. S. Spicer, Atomic Energy
Research Establ. (G. Brit.) Publ. No. HP/R
2182 (1957); F. J. Bryant, A. C. Chamberlain, A. Morgan, G. S. Spicer, Atomic Energy
Research Establ. (G. Brit.) Publ. No. HP/R
2056 (1957).
H. H. Mitchell, T. S. Hamilton, F. R. Steg~

13.

14.

Isosterism and Competitive
Phenomena in Drugs
q_

A study of structure-activity relationships
in agents acting upon autonomic effector cells
Daniel Bovet

Making use of the considerable means
offered by organic synthesis, many investigators have directed their efforts to
the ﬁeld of therapeutics and have sought
to lay the groundwork for a pharmaceutical chemistry or, better, for a chemical
pharmacology. If such an ambitious program has not yet been fully realized,
nevertheless, during the last ﬁve decades,
one can notice the emergence of a few
basic concepts whose usefulness continues to be conﬁrmed. This is particularly true of the concepts of isosterism
and of competition.
Numerous drugs were ﬁrst derived
from products of biological origin, par-

ticularly the alkaloids. The elucidation
of their structure helped chemists to embark on syntheses of analogous compounds. In this respect cocaine, atropine,

8 MAY 1959

and morphine are good illustrative
examples. The molecules synthesized according to their models exhibited clinically useful anesthetic properties, spasmolytic activity, or pronounced analgesic
effects. In each case, chemical similarity
produces in-some-way-related physiological properties.

Analogous observations have subsequently been gathered in many other
ﬁelds, but it has also become evident
that sometimes very different, even antagonistic, pharmacological properties
may be found in chemically similar
molecules.
Despite the fact that the concept of
“antimetabolite” is based on rather old
experiments, it was deﬁned essentially
in the ﬁeld of “antivitamins”; the work
of Woods (1940) and Fildes (1940) on

15.

16.
17.
18.

gerda, H. W. Bean, J. Biol. Chem. 158, 625
(1945).
H. Spencer, D. Laszlo, M. Brothers, ]. Clin.
Invest. 36, 680 (1957); “Deposition and Retention of Ingested Strontium-90 in the Skeleton" (Washington, D.C., 23 Apr. 1957), committee report (ofﬁcial use only).
C. L. Comar, R. H. Wasserman, M. M. Nold,
Proc. Soc. Exptl. Biol. Med. 92, 859 (1956).
C. L. Comar, I. B. Whitney, F. W. Lengeman, ibid. 88, 232 (1955).
Consumer: Repts. 24, No. 3, 102 (March

1959).
19. J. L. Kulp, A. N. Kaufman, R. S. Slakter,
W. R. Eckelmann, in preparation.
20. Health and Safety Lab. U.S. Atomic Energy
Comm. Publ. No. HASL-5I (10 Nov. 1958).
21. L. Machta and R. J. List, “Stratospheric data
and meteorological interpretations,” paper
presented at a meeting on “ABC—sponsored
Research and Development Related to the
Collection and Classiﬁcation of Atmospheric
Particulates,” held in Minneapolis, Minn.,

Oct. 1958.
22. W. F. Libby, Proceedings symposium on Noxious Eﬂects of Low Level Radiation, Schweizerischen Akadcmie der Medizinischen Witsenschaften 27-29 Mar. 1958, p. 309.
23. R. S. Russell, Nature 182, 834 (1958).
24. Unpublished data from the Lamont Geologi8—9

25.
26.
27.
28.

cal Observatory, Palisades, N.Y.
A. M. Brues, Science 128, 693 (1958).
M. P. Finkel, ibid. 128, 637 (1958).
E. B. Lewis, ibid. 125, 969 (1597).
F. J. Bryant, E. H. Henderson, G. S. Spicer,
M. S. W. Webb, Atomic Energy Research
Establ. (G. Brit.) Rept. No. C/R 2583 (May
1958).

the antisulfonamide component of yeast
and its identiﬁcation as p-aminobenzoic
acid found a large acceptance. The idea
that a compound structurally similar to
one normally present in the organism is
able to interfere with the function of
this metabolite could be applied in many
ways. Its success, especially in enzymology [where, for the ﬁrst time, it was
clearly formulated by Quastel (1925—
1928)], in chemotherapy, in vitaminology, and in endocrinology, obviates a detailed discussion of the underlying physi-L
cochemical and biological principles. Instead, I would like to draw your attention to the importance of studies of
competitive phenomena in pharmacodynamics, especially in the pharmacology
of drugs of the autonomic nervous system. I would like to show how a very
large part of therapeutical chemistry
depends on the relations between many
alkaloids or synthetic compounds and a
few hormones, chemical transmitters,
and products of tissue metabolism of
rather simple chemical structure: epinephrine and norepinephrine, acetylcholine and propionylcholine, histamine, and 5-hydroxytryptamine (Table
1).
Dr. Bovet is head of the department of therapeutic chemistry at the Istituto Superiore di Sanita, Rome, Italy. This article is a translation of his
Nobel lecture, presented 11 December 1957, when
he was awarded the Nobel prize for medicine and
physiology for 1957. It is reproduced here with the
permission of the Nobel Foundation. We are indebted to Dr. Ernest Schoffeniels of the department of neurology. College of Physicians and Surgeons, Columbia University, for the translation.
1255

�Drugs of the Autonomic Nervous System

The history of the research in this
ﬁeld is one of the most spectacular and
successful chapters in the chemistry and
physiology of the alkaloids and hormones. As far as transmitters of the

sympathetic system are concerned, one
may recall that the isolation of epineph—
rine by Takamine (1901) was preceded
both by empiric application of ephedrine-rich mahuang by the Chinese, and
by the fortuitous discovery of the properties of tetrahydronaphthylamine by
Bamberger (1888). The exact signiﬁcance of norepinephrine has been established only recently, by von Euler
(1946).
In the ﬁeld of parasympathomimetic
agents, the observation of the properties
of muscarine (1811) and the synthesis
of acetylcholine (1866) preceded, by a
century and a half century, respectively,
the discovery of acetylcholine of Loewi
(1921) and its isolation from tissues
(1931). Histamine was synthesized
(1907) shortly before its identiﬁcation
in the products of animal and plant
origin and before Dale and Dudley
(1910) began their well-known studies
of its pharmacological properties.
The recent discovery of 5-hydroxytryptamine (Rapport, 1949) is the culmination of the work of Erspamer on
enteramine isolated from enterochromaﬂin cells (1937—1952) and the work
of Rapport, Green, and Page (1947—
1948) on the vasoconstrictor factor of
serum, serotonin.
The relationship between epinephrine,

(CH2)

/COO.CH2.CH2.N(CH3)31

“\COO.CH2CH2N(CH3)3

1

£5
E
I34
8

0- 3

7

a%

2
w
.=‘
-

3
g

.

0
Fig.

n=12345
Curarizing effect of choline esters
8

1.

and dicarboxylic aliphate acids with normal chains. Curarizing activity was established in rabbits by measuring the “head
dro P ” dose of the various compounds
given intravenously. Curarizing activity
reaches a maximum with succinylcholine
and decreases with higher homologues of
the series. [Bovet, Bovet-Nitti, Guarino,
Longo, and Marotta, 1939]
1256

Table 1. Drugs with a competitive action with respect to epinephrine, acetylcholine,
histamine, and 5-hydroxytryptamine.
Adrenaline
(noradrenaline)
H

\

CH0H.CH2rN/

,

CH

0H

Hydroxytrypt amine

.
.
Histamine

Acetylcholine
CH

3

K
CH3.COO.CH2.GH2.N\

6213

CH/

H

H

\\N—c

CH3

’H

NH-CH
.

OH

CH

2.

CH

2.

H-

cHz.CHz.N\H

N/

\H

H

Sympatholytic
Antihistaminics :
Parasympatholytic
Antihydroxytryptaagents :
agents :
.mines
”
Ergotamine
929 F
Atropine (spasmolytic
Yohimbine
2339 R.P. (Antergen)
agents )
Benzodioxane Curares:
Pyrilamine
d-Tubocurarine
(933 F)
Diphenhydramine
Dibenamine
Gallamine
Antazoline
Phentolamine
Decamethonium
Promethazine
Succinylcholine
Ganglioplegic agent:
Hexamethonium
Central ganglioplegic
agents:
Antiparkinson agents
Antiphobic agents
_

,

tissue acetylcholine, and the nervous
system was recognized early. In 1904,
Elliot, struck by the similarity existing
between the pharmacological action of
epinephrine and the effect of stimulating
the sympathetic system, proposed the
hypothesis according to which epineph-

rine is released from sympathetic nerve
endings and transmits the impulse from
nerve cell to smooth muscle ﬁber.
Wieland in 1912 and Le Heux in 1919
tried to demonstrate that choline and
acetylcholine were local hormones. Their
hypothesis, we know, was successfully
developed by Loewi, Dale, Cannon, and
Bacq, whose experiments established the
concept of chemical transmitters. The
hypothesis of chemical transmission by
acetylcholine ﬁrst proposed for viscera
innervated by the parasympathetic system was later extended by Dale, Feldberg, and Vogt (1936) to the neuromuscular junction. Recent investigations on
the physiology of the end plate have, in
sum, conﬁrmed this mechanism. The reaction between acetylcholine and its receptor located at the postsynaptic mem—
brane can now be integrated within the
framework of electrophysiological ﬁndings, particularly those demonstrating
electrical nonexcitability of this membrane and its great sensitivity to the
transmitter (Kuﬂler, 1948; Castillo and
Katz, 1956).
To turn now to substances antagonizing these various hormones and transmitters, models for the synthesis of
adrenergic and cholinergic blocking
agents were furnished by compounds of
biological origin, such as ergotoxine,

atropine, and curare. The antihistaminics were studied later and represent syn- '
thetic products of completely original
design.

In practice, these drugs have been

widely used in the symptomatic treatment of dysfunction of organs which are
dependent on the activity of the autonomic nervous system: heart, blood vessels, bronchi, gastrointestinal tract, and
uterus. The antagonists of epinephrine
found their major application in the
treatment of vascular disorders and hypertension. The antagonists of acetylcholine are used primarily as spasmolytic, mydriatic, and muscle-relaxing
Table 2. Structural relations between
and
sympathomimetic
Sympatholytic
agents. [Raymond-Hamet, 1937; Bovet
and Simon, 1936; Druey, 1936; Bovet,
de Lestrange, and Fourneau, 1942; de
Beer and Fassett, 1938; Hartmann and
Isler, 1939; Gross, Tripod, and Meier,
1951]

SYMPA'HOMIMEIIC
AGEN’S

/’
H0
\0H

SYMPAYNOlVYIC
AGENYS

CHOHCHZNHCHg

ACHECHENHE

CH2CH2N(C2H5)2

V
AC CH2CH2NHCH3
\v

OCHZCH2N(C2H5)2

OH

ANHCHECHzNH:

N&lt;

V

CH 2

mm
L

c
(2115).?

93*”

HUM

HOMNH
CH3

NCH3

o/\I~1chzc{r\m-&lt;':H2

CHJDV
OCH3

\N—CH;

N

CH2 C&lt;NH—(IIH2

\N—CHg

CH3

0H

SCIENCE, VOL.

129

�agents. The antihistaminics are most
useful in the treatment of urticaria, rhinitis, asthma, and other allergic diseases.
For speciﬁc illustrations, I shall use
examples from three different pharmacological groups. For the epinephrine
group, I will consider ergotamine; for
the antiacetylcholine group, curare; and
for histamine, I will consider the syn—

thetic antihistaminics.

“ifssﬁm "
,

'"

CH?
C3

Synthetic Sympatholytic and
Ergotamine-Like Compounds
Sympatholytic drugs form a group
characterized by common pharmacological properties. They act as competitors—or blocking agents, in AngloSaxon terminology—by opposing the
effects of epinephrine and norepinephrine. Most characteristically, they block
the hypertension and vasoconstriction
produced by epinephrine.
As is often the case, various drugs of
this class were introduced empirically
into therapeutics long before their pharmacological actions were established. As
long ago as 1909, Froelich noticed that
animals pretreated with small doses of
the dextrorotatory isomer of epinephrine
became resistant to the effects of the
natural isomer. Today we explain this
observation as resulting from a partial
block of the receptors by a pharmacologically much less active enantiomorph
of the compound. Later Loewe (1927),
Kiilz (1936), and Raymond-Hamet
(1937) described N-alkyl derivatives of
phenylethylamine with sympatholytic
properties; analogous properties were
described in the phenoxyethylamine
series (Anan, 1930; Levy and Ditz, 1933;
Bovet and Maderni, 1933; Bovet, Simon
and Druey, 1937), the phenylethylenediamine series (Bovet, de Lestrange,
and J. P. Fourneau, 1942), the isoquinoline series (Hjort, de Beer and Fassett,
1938), and the phenylaminoethylimidazoline series (Meier and M'Liller, 1939;
Hartmann and Isler, 1939). In each of
these groups the structural similarities
between the antagonistic molecules with
either sympathomimetic or sympatholytic properties are evident (Table 2);
the degree of substitution on the amine,
the suppression or displacement of the
phenolic function, the closing of a ring,
are sufficient to reverse the pharmacological action. It is very important to
notice that while the distance betWeen
the amine function and the aromatic
ring remains constant in both sympathomimetic and sympatholytic agents, the
inhibitory 'molecule has always, in con:
8 MAY 1959

{gags seems i} {We casing mag,
Fig. 2. Pachycurares. (Left) d-Tubocura-

rine; (above) gallamine.

Table 3. Classiﬁcation of the main groups of sympathomimetic and sympatholytic agents.

©-c-c—N

©—o-c—c—N

©mc-c-n

Phenylethylamines

Phenoxyethylamines

Phenylethylene diamines

Tiiii

r

i

Sympathomimetic agents
Phenolic derivatives of
Phenylethylenediamine and
Epinephrine
its phenolic derivatives
Phenylethylamines and their phenoxyethylamine
phenolic derivatives
Sympatholytic agents (aromatic series)
N-Diethyl-N’-propyl-N’N-Diethylphenylethylamine N-Diethylphenoxyethylamine
phenylethylenediamine
Dibenamine
Dibenzyline
Tetrahydronaphthylamines,
N-substituted
Sympat/tolytic agents (heterocyclic series)
N -MethyltetrahydroBenzodioxane:
Phenylpiperazine
Phentolamine
isoquinoline
Prosympal
Benzylimidazoline
Piperoxan
Sympatholytic alkaloids
Yohimbine
Ergot alkaloids

Table 4. Structural relations between sympathomimetic and sympatholytic agents: from
epinephrine to ergotamine. [Marini-Bettolo, Chiavarelli and Landi, Vittory, 1950—1953;
Bovet, Bovet-Nitti, Virno, Longo, Marotta, and Sollero, 1953]
[NH _ CH3

CHOH-CHZ

NH 2

,NH2

/
(31+2&lt;:H2

NH2

GHz'ct'
0H3

OH
OH

Adrenaline

Phenylethylamine

Amphetamine

Tetrahydronaphtylamine
CH30H‘I3H2

IcorchH5

CH3 _

843 LS

alibi-c

co

C H2 -0H
\Nz—CH

2 H 5-»

3

9|

6 1.5.

_

CIH2

CH\ N/CHZ
c,o\lI
NH—

N\
COG
N‘

X30

ERGOTAMINE
1257

�The most active natural and synthetic

tradistinction to the excitatory one, an
amino group substituted by more, and
heavier, radicals. Generally the inhibitory molecules also have a more stable
structure and a higher molecular weight.

sympatholytic compounds, whose effectiveness is sufﬁcient to permit their use
in the clinic, are generally polycyclic or
heterocyclic, with structures analogous

Table 5. Investigations of synthetic oxytocic agents, derived from phenylglycinamide.
[Bovet-Nitti, 1952, 1954]
CH

CH

3

3

NH- CH- CHZOH
co-

CONH-CIZHCHZOH

CH2' CH2
N—

CH3
CZ H5
NHCOCH2N&lt;

c2*‘5

8331.8.

Ergometrine

62'

"
s

CZ H5

NHCOCH2 N

1048

I

€sz

1.3.

,6sz
NHCOCHZN.

H
0sz‘N- co- CHz-N c
’2 5

|062

|058I.S.

1.5.

Table 6. Natural and synthetic curares: d-tubocurarine (King, 1935; Wintersteiner and
Dutcher, 1943); 3381 RF. (Bovet, Courvoisier, Duclos, and Horclois, 1946) ; gallamine
(Bovet, Depierre, and de Lestrange, 1947) ; succinylcholine (Bovet, Bovet-Nitti, Longo,
and Marotta, 1949; Fusco, Palazzo, Chiavarelli, and Kniisli, 1949).

“3‘0
&lt;300 H 3

‘

E"?

06H;
on

/

;..
C2H5

\

/"x

I

1‘

————©—o

O—(CH2)5-—-0

I °2H5

3381 R.P.

d-Tubocurarine

'

O‘CHZ-CHZ'N(CZH5)3I '

on 2coocnzc H2N(CH3)BC! -

,

.

o-cwcwmcm-I'
2
2. 253
or 0 Hz- CH2*N(CZH5)3'I

]

_

.

CHz-COOCHZCH2N(CH3)3C!‘

Succinylcholine

Gallamine

Table
Subject
Mammals
Birds
Amphibians
(rectus
abdominis)
1258

7.

Pharmacodynamic properties of synthetic curares.

Pachycurares
(competing agents) :
tubocurarine, gallamine

Curarization
Curarization
Antagonism to acetylcholine

Leptocurares
(depolarizing agents) :
succinylcholine, decamethonium

Curarization (muscular ﬁbrillation)
Contracture followed by curarization
Acetylcholinic contracture

to the above-mentioned compounds despite their complexity. Benzylimidazoline
(Meier and Miiller, 1939) and dibenamine (Nickerson and Goodman, 1947)
are related to the phenylethylamines;

the aminomethyl-benzodioxanes (Fourneau and Bovet, 1933), to the phenoxyethylamines; and phentolamine (Gross,
Tripod, and Meier, 1951) to phenylethylenediamine derivatives (Table 3).
Studies conducted at the Istituto Superiore di Sanita by Marini-Bettolo and
Chiavarelli, on the chemical aspects, and
by F. Bovet-Nitti, Longo, Marotta, and
Guarino on the pharmacological aspects,
illustrate the usefulness of the concepts
of isosterism and of competition in this
kind of investigation.
When the isolation and structural determination of the ergot alkaloids was
achievedwresearches for which we are
largely indebted to Stoll and Jacobs——
much work was done to prepare derivatives by partial or total synthesis; thus,
dehydrogenated derivatives (Rothlin,
1947) and oxytocic derivatives closely
related to ergometrine (Rothlin, 1947)
were prepared, and the diethylamide of
lysergic acid with hallucinogenic properties was discovered (Stoll). Since we
proposed to investigate the structureactivity relationships of ergotamine, we
used as our working hypothesis the con—
cept relating structure to antagonistic
action.
At ﬁrst sight, the structure of the
ergot alkaloids seems to be very different from that of epinephrine or of sympathomimetic derivatives of the phenylethylamine series. Nevertheless, since
the skeleton of B-tetrahydronaphthylamine (2-aminotetralin) can be recognized in'the structure of lysergic acid,
we decided to study compounds of this
group (Table 4).
Pharmacological tests with derivatives
of relatively simple structure demonstrated the sympatholytic activity of
2-diethylaminotetralin (843 1.5.). Studies with more complex molecules, in
particular the amide and amine derivatives of 2-tetralin, are a new step in the
attempt to reproduce the essential portion of the lysergic acid skeleton. Using
molecules of increasing complexity, one
may go by successive stages from phenylethylamine to tetrahydronaphthylamine
or to N-(2-tetra1yl) -N-methyl-N’-ethylB-alaninamide (916 LS.) and the ergot
alkaloids, with a resulting progressive
diminution at each stage of sympathomimetic properties and the appearance
of sympatholytic properties.
Oxytocic activity was observed in a
large number of synthetic derivatives,
SCIENCE, VOL. 129

�and this class of compounds seems very
broad compared to that of adrenolytic
substances (Table 5). In the course of
experiments performed on rabbit uterus,
isolated or in situ, several derivatives of
aminotetralin and of aniline and even
some aliphatic compounds showed strong
activity. We may single out such examples as N,N-diethyl-N’- ( 2-tetralyl ) glycinamide (621 I.S.); N,N-diethyl-N’-3( 1048
4-dimethylphenylglycinamide
LS.) ; and N,N,N’,N’tetraethylglycinamide (1062 LS.) (Bovet-Nitti, 1953).
The main difﬁculty, apparently encountered also by other investigators,
was the lack of parallelism between effects observed in laboratory animals
and in man. Generally speaking, a satisfactory solution to the problem of syn—
thetic oxytocies has not yet been reached,
and the question is still under study.
Antagonists of Acetylcholine:
Synthetic Curares

The problem of competitive agents
that antagonize acetylcholine activity is
rather complex, due to the multiple
functions of this transmitter. Acetylcholine is the chemical transmitter in viscera innervated by the parasympathetic
system; it has a role at the neuromuscu—
lar junction, and it is liberated in ganglia

during the passage of a nerve impulse.
A surprising fact, which has been proﬁtably exploited in pharmacological investigations of competitive agents, is that
compounds antagonizing acetylcholine
differ according to the site of action of
the local hormone. Thus, atropine and
benzoylcholine neutralize the muscarinic effects of acetylcholine on cardiac
receptors, on the intestine, or on secretions; tetraethylammonium iodide or hexamethonium block the nicotinic action of
acetylcholine on sympathetic and parasympathetic ganglia. Finally, curares are
speciﬁc antagonists of acetylcholine in
striated muscle. With respect to the
structure of antagonists, synthetic curares
furnish us with a succession of examples
comparable to those we have reviewed in
the sympatholyticgroup. These investigations were begun in 1946, after King’s
elucidation, in 1935, of the structure of
one of the physiologically active constituents of Amazonian curares, and
after the introduction by Grifﬁth and
Cullen in 1942 of the chemically pure
alkaloid as an adjuvant in anethesia.
d-Tubocurarine, which is extracted
from a menispermum, Chondodendron
tomentosum, is found in curares prepared by the natives of the Upper Ama8 MAY 1959

,

emcageugcagcagefcam

Mammengmécm

{1:39}

CHQCG B Ci‘iéci‘ig

‘
’

R;C8313

(CH333NCHgCRgu C0 CHg

Fig. 3. Leptocurares. (Left) Decamethonium; (right) succinylcholine.
zon. It is an alkaloid of the group
bis ( benzyltetrahydroisoquinoline) , whose
molecule has two quaternary ammonium

ity, and this was also true for polyphenol
ethers and aromatic esters. The latest
investigations on the path to ultimate
simpliﬁcation are concerned’ with the
activity of aliphatic derivatives.
In England, Barlow and Ing and
Paton and Zaimis (1948) reported extremely interesting observations on the
curare-like effect of decamethylene—w-

functions.
In research done with our colleagues,
Viaud, Horclois, and de Lestrange, we
ﬁrst looked for molecules structurally
close to the selected model. By successive
transformations, we were able to synthesize relatively simple derivatives with
analogous properties (Table 6). From
a series of new compounds with two
quinolinic rings bearing quaternary ammonium functions, we ﬁrst selected the
diiodoethylate of 8’ ,8’ ’ -diquinolyloxy1,5-pentane (3381 R.P.). This was the
ﬁrst synthetic compound with curarelike action in mammals showing a speciﬁcity comparable to that of natural
alkaloids isolated from curare (1946).
It was then found that aminophenol
derivatives which have neither quinoline
nor isoquinoline rings had similar activ-

bis-trimethylammonium hydrate (decamethonium). In our Laboratory of
Therapeutical Chemistry at the Istituto
Superiore di Sanita, the curare-like action of succinylcholine was ﬁrst recognized. This compound was synthesized
by Hunt in 1911.
The number and variety of compounds with curare-like action, the relative simplicity of their mode of action,
and the possibility of precise pharmacological assay permitted a careful study
of structure-activity relationships of synthetic curares.

Solveni front

D

Iodine

Carboxylic reagent
Bromothymol blue

0
000

@%s
+

60

O

Enzymic hydrolysis

(5%)

01

cm.{

R;

1

o

O

o

@

@s....,...ho....

@
@
@
®
+

a

2

§ §

Choline

Succinylmonocholine
Succinate

3
20

Control

Non-enzymic
hydrolysis (96)

Fig. 4. Chromatograms of (a to e) succinlycholine at various stages of enzymic hydrolysis;
(f) a mixture of succinylcholine and its products of hydrolysis; (g) 0.1 mg of succinylcholine after nonenzymic hydrolysis. [Whittaker and Wijesundera, 1952]
1259

�Fig. 5. Comparison between curarizing effects of d-tubocurarine (left) and of succinylcholine (right) given intravenously as a single
fol—
muscle
of
the
Contraction
anesthesia.
gastrocnemius
chloralose
under
(First
line)
the
dog,
continuous
perfusion on
injection or by
lowing the.rhythmic stimulation of the sciatic nerve; (second line) control of the speed of injection; (third line) blood pressure. The
record shows clearly the difference between the duration of neuromuscular paralysis following a single injection of succinylcholine
(370 1.8., 0.05 mg/kg) and of d-tubocurarine (0.1 mg/kg). Also, on comparing the effect of a single injection of d—tubocurarine with
continuous perfusion of succinylcholine (initial injection of 0.05 mg followed by repeated injection of 0.0062 mg at each signal), one
sees that, for the duration of subtotal and reasonably uniform eurarization (about 80 percent, for 20 minutes), the reversibility of the
effect is quick (about 10 minutes) after infusion of succinylcholine while it is slowly progressive (about 50 minutes) after injection of
d-tubocurarine. [Reuse, 1953]

I will mention only two important
factors which inﬂuence the activity of
bis-quaternary derivatives: the distance
between the quaternary ammonium
groups and the massiveness of the molecule.
The ﬁrst factor is illustrated by comparison of polymethylene-bis-trimethylammonium derivatives (Barlow and Ing;
Paton and Zaimis, 1948) as well as of
aliphatic diesters of choline (Bovet,
Bovet-Nitti, Guarino, Longo and Marotta, 1949) (Fig. 1).
Careful pharmacological study showed
that the action of new synthetic derivatives was sometimes quite different from
that of the natural alkaloids.
The differences between the action of
decamethonium iodide and succinylcholine iodide on the one hand and the

action of d-tubocurarine and of the tri—
iodethylate of gallamine on the other
were carefully studied by Paton and
Zaimis, Brown and Dias and in our own
laboratory. The British authors have proposed calling these two groups depolarizing agents and competitive curares. We
proposed designating decamethonium
and succinylcholine as leptocurares, and
tubocurarine and gallamine as pachycurares (Figs. 2 and 3; Table 7). The
advantage of our nomenclature lies in
the fact that it does not presume the
mechanism of action. The main differ—
ence between the pharmacodynamic effects produced by the two types of
curares is determined by the responses of
amphibian and bird muscles. In birds,
the pachycurares are typical curarizing
agents, while leptoeurares induce con-

ESHWEH
H
.

CH,

C“Cf~iLCHNH

};

fag;

\g‘fsfmwx
‘

as?
N
1260

y
2‘

ecu,
'2

CHECHEMCHM

Fig. 6. (Left, top) Histamine; (left, bottom) pyridylethylamine; (above) pyrilamine.

tracture that is followed by eurarization.
In mammals the differences between
the two groups are less sharp. The responses of muscle from different species
or of different muscles from a single
species are not always comparable. Also,
intermediary steps seem to exist between
depolarization and curare competition.
The distinction between the groups,
though relative with respect to the
mechanism of action and the type of
preparation used, are, nevertheless, useful if we want to compare relations between chemical structure and pharmacological activity.
Clinically, the most important factor
in classiﬁcation of curares is duration of
effect. In this respect, the introduction
of a short-acting curare, particularly succinylcholine, is an important step forward. The relative ease with which suc—
cinylcholine is hydrolyzed by pseudocholinesterase and the very low toxicity
of the products choline and succinic acid
account for the brevity of action and the
remarkable tolerance of the organism for
this curare (Fig. 4; Table 8).
The ﬁrst clinical observations concerning short-acting curares were published
by Valdoni (1949) and Scurr (1951)
and deal with suxethonium. The introduction of succinylcholine into anesthesiology was ﬁrst proposed in Sweden, by
Thesleff (1951), Holmberg and Thesleff
( 1951), Tammelin and Low (1951 ) , and
von Dardel (1951), and in Austria, by
Briicke et al. (1951), Mayrhofer and
Hassfurther (1951), and Holzer (1951).
In the light of these various investigations, one may today recognize two
methods of using succinylcholine: single
injection when very short action is required (as for endoscopy or electroSCIENCE, VOL.

129

�Table 8. Hydrolytic products of succinylcholine.

(CHgaN‘CiECi-izococ Hacib c OOCHZC HZN ’(c 1493.1’

-Succiny|choline
1'.

(CH3)?

CHZCHZOCOCHZCI‘ECOOH + OHCHZCHZN (cl-1‘3)3

I

Choline

Succinylmonoct‘oline

l
lrl(.7H3)3N CH2 CH 2OH+ HOOCCHZCHZCOOH

Succinic acid

Choline

shock) or continuous infusion in surgical procedures of long duration.
Two recordings from a study in our
laboratory demonstrate results obtained
with the two types of application. They
show the superiority of continuous infusion of short-acting curares over the
classical technique (Fig. 5).

Antihistamines

The last example I will use to illus—
trate the concept of competition is concerned with compounds that antagonize
the third local hormone, histamine. This

particularly rich ﬁeld since the usefulness of these compounds has stimulated a great many investigations within
a very few years. In 1937, in Fourneau’s
laboratory, we began—A. M. Staub and
I—to look for compounds antagonistic
to histamine. Considering the number of
features that histamine, acetylcholine,
and epinephrine have in common, we
looked for antagonism comparable to
that exhibited by sympatholytic compounds toward epinephrine and by parasympatholytic compounds toward acetylcholine. We obtained the ﬁrst positive
results in 1939 with thymoxyethyldiethylamine (929 F). Our experimental work
was then directed toward deﬁning criteria for antihistaminic activity. Staub
(1939) extended her observations to
phenylethylenediamine derivatives. In
1942, the syntheses by Mosnier, the
pharmacodynamic studies of Halpern,
and the ﬁrst therapeutic results of Cuilleret, Thiers, Gaté, Celice, Perrault,
Decourt, and Durel with dimethylaminoethylbenzylaniline, or Antergan,
deﬁnitively established interest in compounds of this group. The role played
by histamine in many allergic affections
assures a broad area of clinical application of these compounds. After the pio—
neers (Maderni, de Lestrange, and
Benoit in Fourneau’s laboratory in Paris;
is a

Table 9. Principal groups of synthetic antihistaminics: 929 F (Bovet and Staub, 1937) ;
Antergan (Halpern, 1942); antazoline (Meier and Bucher, 1946); diphenhydramine
(Loew, Kaiser, and Moore, 1945); promethazine (Halpern and Ducrot, 1946); chlorphenamine (Tislow, La Belle, et al., 1949) ; pyrilamine (Bovet, Horclois, Walther, and
Fournel, 1944); tripelennamine (Mayer, Huttrer, and Scholz, 1945) ; thonzylamine
(Reinhard and Scudi, 1947).
Antihistaminics related to:
Sympatholytic agents
onQ

[OHS

CH

ocnac H2N(62H5)2
CH3

929F

”Q
CH

‘0H 2 0H 2 Maria)

2

Antergon

Q

Spasmolytic agents

0

\ZCH CH

Diphanhydramine

O

cuzcnmcusiz

N

\ N-CH2
_

Antozoiine
8

MAY 1959

:EH GHZCH2N(CH3)2

Chlorphenamino

2N(CH3)

Pyrilamine

N‘cnacnzmchu

3

CH—

@001

ECHocH ZCHZNKSH 3’2

Promethazine

\C

Histamine

Tripulennominc

ﬂZOOCHS
N/

\ZCHZCHZNCHa)

Thonzylamino

Table 10. Structural relations between
histamine and antihistamines. [Walter,
Hunt, and F osbinder, 1941; Nieman and
Hays, 1942; Bovet and Walthert, 1943]
NH

/\
/

/

’I

CH2 CH2 NHZ
,

I,

HISTAMINE
Histamine action

2.

N

I

Antihistamine action

HQ":

CH2 CHZN:

(/\n-CH2.GH2.NHZO
KEV)

/J

Nona

\

,/&lt;CH 2 .0H 2 .NH 2

\

"[0142

A"

(7N1ii
KN

6H2

ii;

N’0
2 ‘01::

CH

0

o

\N

~

/-CH2CH2. NH2

“3

+

K

I

R

N:
N

[CH3
CH2.CH .N\

*

CH%

Viaud, Horclois, Mosnier, and Charpentier in French industry; Hartman
and Hofman in Switzerland; Rieveschl,
Scholz, Huttrer, and Roblin in the
United States; Cavallini in Italy), about
500 chemists synthesized, in less than
ten years, more than 5000 compounds in
the antihistaminic group.
Pharmacologists were easily able to
recognize the competitive nature of the
antagonism exerted by these antihistaminics toward histamine. Chemists, however, could not perceive any relation
between the structure of antihistaminics
and histamine which logically might
explain such activity, nor could they ﬁnd
a relationship among the various active
compounds. It was therefore impossible
to escape the conclusion that most of the
results were rather empirical.
From the pharmacological viewpoint,
it was possible to distinguish three groups
of substances (see Table 9) with antihistaminic action and relate them to (i) the
sympatholytic group; (ii) the parasympatholytic-sympatholytic group; and (iii)
histamine itself.
To the ﬁrst group belong the phenolic
esters (929 F) and the phenylethylene—
diamine derivatives (1571 F) studied at
the Pasteur Institute, Halpern’s Antergan, and the antazoline of Meier and
Bucher. The compounds of the second
group, from a chemical point of view,
have more homogeneous structures, in
1261

�common with atropine-like drugs and
other spasmolytics; some of these are, in
fact, spasmolytic as well as antihistaminic (diphenhydramine). In derivatives of a-aminopyridine, which form
the third group, the antihistaminic action
is more speciﬁc and almost free of secondary effects. It is interesting to note
in this group the isosteric reactions which
account for the pharmacological activity. Walter et al. (1941) and Niemann
and Hays (1942) have shown that
a-pyridylethylamine derivatives have histamine-like activity, and that a fundamental difference exists between a-, [3-,
and y-substituted pyridines in this
respect. In this case, the analogy of
structure which is not evident between
histamine and pyrilamine (Neo-Antergan) may be seen between the groups
a-pyridylethylamine and (it-pyridine ethylenediamine (Table 10, Fig. 6). A
typical compound from this group is
pyrilamine (see Fig. 7), but many other
synthetic compounds of similar design
have also proved to be active.

Central Action of Transmitters
The compounds considered so far do
not exhaust the ranks of competitive
agents. Pharmacologists are to some extent les enfants terrible: of physiology.
They did not wait for the battle of the
neuromuscular junction to be won before
engaging in a more difﬁcult encounter.
They proposed that the available evidence suggested the action of a chemical
transmitter in the central nervous system, exactly as in the autonomic nervous
system.
Analyzing the collective results from
various laboratories, Feldberg (1950)
concluded that the theory ascribing a
transmitter role to acetylcholine in the
central nervous system was the only one
able to offer convincing and satisfactory
interpretations. Even if intervention of

noncholinergic chemical transmitters in
the central nervous system is not excluded, we must admit that our knowledge about the probable roles of norepinephrine, epinephrine, histamine, and
5-hydroxytryptamine is still quite incomplete.
The physiological role of the reticular
formation in the brain stem has been
clearly deﬁned by Moruzzi and Magoun
(1949). In the last few years, a considerable number of investigations have
shown that compounds affecting the autonomic nervous system also affected this
formation.
Paradoxically enough, cholinergic as
1262

HISTAMINE

0.001

cm/H 0
20

.mm/Hg
200
100

0

15

PYRILAMINE

HISTAMINE

1.0

0.001

“

j

1

V.

10

5

0

0

‘_3lOsec

Fig. 7. Antagonistic action of pyrilamine with respect to the vasodilating effects of histamine in cerebral circulation. The subject was a dog under chloralose anesthesia. (A)
Blood pressure, femoral artery (mm-Hg); (V1) pressure recorded through a catheter
introduced in a centrifugal direction into the external maxillary vein (mm-H20) ; (V2)
pressure in the internal maxillary vein (mm-H20). Injection was made into the saphenous vein; dosages are given in milligrams per kilogram. [Virno, Gertner and Bovet, 1956]

well as adrenergic substances affect the
electrical activity of the cortex in the
same way that direct electrical stimulation of the reticular formation does.
Under well-deﬁned experimental conditions, acetylcholine (Bonnet and Bremcr,
1937) and epinephrine itself (Bonvallet,
Dell, and Hietzel, 1954) provoke a
transient activation in the electroencephalogram. The administration of either
an anticholinesterase (eserine, diisopropyl ﬂuorophosphate) or of amphetamine
(Bradley and Elkcs, 1953) produces an
intense and prolonged desynchronization.
From a strictly pharmacological viewpoint, the major interest in this type of
investigation stems from the similarity
in observed antagonisms between various
groups of drugs in the central nervous
system and in viscera innervated by the
autonomic nervous system.

As early as 1947 we suggested that in

extrapyramidal syndromes some relation
might exist between the central, “antiparkinson,” effect of certain tertiary
amines and their ganglioplegic properties in peripheral ganglia (Sigwald and
Bovet; Dumont; 1947).
“Antiparkinson” drugs form a relatively homogeneous group comprising
diethazine (Diparcol), isothazine (Parsidol), caramiphen (Parpanit), and trihexyphenidyl (Artane), as well as some
antihistaminics (diphenliydramine and
promethazine).
Electroencephalographic studies (Fig.
8) have shown that three groups of compounds produce an electroencephalogram similar to that recorded during
sleep: the parasympatholytics (scopolamine and atropine), the central ganglio—
plegic or “antiparkinson” drugs (Table
11), and the neuroleptics (chlorproma-

w;

mwgwmmwww

W
MWMvM

51mm

‘

.

-..,: p‘,

51%; g‘ﬁ‘kﬁﬁg‘ﬁ’?‘ “if“?'9““(high ‘) K

$3.)wa

ai’zfiig'f$6,133?3.25%

“

if:

(3:1‘331“

ii

4,
,.

“‘

;.§l(¢t

{brave-112m}?

Fig. 8. Antagonistic action of diethazine against convulsive patterns caused by nicotine
on the electroencephalogram of curarized rabbit. (A) Blocking reaction after acoustic
stimulation (black line). (B) Convulsive seizure by nicotine (2 mg/kg) in normal animal. (C) After injection of diethazine (5 mg/kg) a second injection of nicotine no longer
produced the electrical changes observed previously. and the acoustic stimulus fails to
produce the blocking reaction. [Longo and Bovet, 1952]
SCIENCE, VOL. 129

�zine, reserpine). These also antagonize
the cortical reaction elicited by external
stimuli (stress) or by desynchronizing
agents (eserine and amphetamine) (Bovet and Longo, 1956). The effect of
such synchronizing agents may, as a ﬁrst
approximation, be localized in the reticular formation and thus be comparable to the importance of chemical
transmitters at this level.
Many observations suggest that speciﬁc receptors fOr epinephrine, acetyl-

choline, and histamine are speciﬁc proteins with a structural conﬁguration
complementary to that of the transmitter. This concept was ﬁrst proposed
by Fischer, who illustrated it with the
now famous model of key and lock.
his mechanism has been invoked to
explain observations in physiological and
chemical studies of taste and smell. Recently, Landsteiner and Pauling applied
this idea of “complementary conﬁguration” in the ﬁeld of immunological reactions.
At this point it would not be possible
to consider the various aspects of reactions between chemical transmitters, inhibitors, and receptor proteins without
taking more space than is available.
The particularly simple case of binding acetylcholine with cholinesterase has
been studied by Nachmansohn (1953—
1954) and Wilson (1954). They consider acetylcholine to be attached at two
points, one electronegative and the other
elcctropositive, and have drawn valid
conclusions with respect not only to
various anticholinesterases but also to a
new group of drugs that reactivate the
phosphorylated enzyme.
If I cared to develop the extensive
areas covered in this article I could include other topics and point out that
different groups of compounds affect the
metabolism of mediators because they
are precursors or because they inhibit
synthesis, slow down or accelerate liberation, or interfere with destruction. In
every phase, investigations have been
successful and the results appear to be
very promising.

Conclusion

The composite picture I have tried to
present, at the risk of relating many al—
ready well-known facts, appears, despite
inevitable gaps, very certain. If, in concluding, we rapidly retrace our path, we
will see that in covering the vast ﬁeld
of pharmacology, the structures of a
small group of remarkably simple biogenic amines have led us, like the thread
8 MAY 1959

Table 11. Central ganglioplegic agents: diphenhydramine (Loew, Kaiser, and Moore,
1945) ; diethazine (Sigwald, Bovet, and Dumont, 1946; Bovet, Fournel, and Charpentier,
1947); caramiphen (Domenjoz, 1946; Griinthal, 1946); trihexyphenidyl (Doshay and
Constable, 1949).

/ \

/ \
CH-O-CHz-CH2~N(GH3)2

Diphenhydramine (Benadryl)

-GO'O‘ OHZ'GHZ'N(02H5)2

Caramiphen

&lt;// \\&gt;
S

N'CH2'CH2N(02H5)2

:COH'CHZCHZN

&gt;

Diethazine

Trihexyphenidyl

of Ariadne, through the labyrinth of very

a name always well-known and sometimes very close to us.
The future of pharmacodynamics is,
nevertheless, so rich and promising, and

diverse physiological actions and chemical structures.
It has been said that the art of the
orator is to speak about what he knows
and to hide his ignorance. I do not feel
any need to resort to such an artiﬁce in
presenting the current picture of the
chemical pharmacology, because it is, in
ﬁnal analysis, only a kind of “natural
history” and classiﬁcation of organic
molecules.
I would say that the results obtained
so far give rise to optimism because they
let us catch a glimpse of the pharmacology to come as a well-ordered and
well-deﬁned science in which foods,
drugs, and poisons will be integrated in
the metabolism of the simplest constituents of living matter.
Finally, in recalling the great names
associated with studies of the pharmacological agents that made it possible
for us to reach our present level, I can
only speak with emotion of all those
who preceded me, particularly of my
teacher, Ernest Fourneau, who wrote
such a great and glorious chapter of
therapeutic chemistry and whose name
will forever be written in the history
of this science.
My feelings are sincerely divided between the immense pleasure I feel at
the honor which is bestowed on me and
my sense of inadequacy at being unable
to repay my teachers and colleagues all
that I owe them. This feeling is the more
vivid because therapeutic chemistry is a
very young science that has developed
amazingly during the past half century;
perhaps in no other domain does the
part played by each individual appear
so clearly and with such continuity as in
our studies, where every formula bears

it bears so many theoretical and prac—
tical possibilities, that I cherish the hope
that my future work will justify not
only the marvellous distinction I have
received today but also the conﬁdence
and the friendship of my teachers and
colleagues, whose works cannot be separated from those I pursue with confidence, enthusiasm, and love.
Bibliography
The following bibliography includes mainly general reviews; concerning studies published prior to
1948, the reader is referred to the work published
in collaboration with Mme. F. Bovet-Nitti.
Z. M. Bacq, “La pharmacologie du systeme nerveux autonome, et particuliérement du sympathique, d’apres la théorie neurohumorale,” Arm.
physio]. physicochim. biol. 10, 467 (1934).
D. Bovet, “Introduzione allo studio ﬁsiologico e
farmacologico del curaro,” Boll. soc. ital. bio].
sper. 25, 539 (1949).
, “Introduction to antihistamine agents and
Antergan derivatives,” Arm. N.Y. Acad. Sci. 50,
1089 (1950).
, “Some aspects of the relationship between
chemical constitution and curare-like activity,”
ibid. 54, 407 (1951).
and F. Bovet-Nitti, Structure et Activite’
pharmacodynamique des Médicaments du syrtéme nerveux vége’tatif (Basle, 1948).
“Curare,” Experientia 4, 325 (1949).
,
“Rapports de structure entre sympathomimétiques et sympatholytiques. De l’adrénaline a
l’ergotamine,” Actualités pharmacol. N0. 6
(1953), p. 21.
, “Le chlorure de succinylcholine, agent
curarisant a breve durée d’action,” Sci. Med.
Ital. 3, 509 (1955).
, S. Guarino, V. G. Longo, R. Fusco,
“Recherches sur les curarisants de synthése. III,
Succinylcholine et dérivés aliphatiques,” Arch.
intern. pharmacodynamie 88, 1 (1951).
D. Bovet and V. G. Longo, “Pharmacologie de
la formation réticulée du tronc cerebral,”
Oomph-rend. 20éme Congr. intern. physiol.
Bruxeller (1956), pp. 306—329.
D. Bovet and P. Viaud, “Curares synthése: Chimie
et pharmacologie,” Aneslhésie et analgésie 8,
328 (1951).
F. Bovet-Nitti and D. Bovet, “Recherches sur les
ocytociques de synthése: dérivés de la phenylglycinamide,” Arch. intern. pharmacodynamic
6, 327 (1954).
F. Briicke, “Dicholinesters of -dicarboxylic acids

‘

1263

�and related substances,” Pharmacol. Revs. 8,
265 (1956).
W. B. Cannon and A. Rosenblueth, Autonomic
Neuroeﬂector System (New York, 1937).
J. Castilljo and B. Katz, “Biophysical aspects of
neuro—muscular transmission,” Progr. in Biophys.
and Biophys. Chem. 6, 122 (1956).
H. H. Dale, “Transmission of nervous effects by
acetylcholine,” Harvey Lecture Ser. 32, 229
(1937).
L. Donatelli and U. Seraﬁni, Gli antistaminici di
sintesi (Naples, 1951).
J. C. Eccles, “The electrophysiological properties
of the motoneurone,” Cold Spring Harbor Symposia Quant. Biol. 17, 175 (1952).
V. Erspamer, “Pharmacology of indolealkylam~
mines,” Pharmacol. Revs. 6, 425 (1954).
U. S. von Euler, “The nature of adrenergic nerve
mediators,” ibid. 3, 247 (1951).
S. M. Feinberg, S. Malkiel, A. R. Feinberg, The
Antihistamines (Chicago, 111., 1950).
W. Feldberg, “The role of acetylcholine in the
central nervous system, Brit. Med. Bull. 6, 312
(1950).
R. Fusco, G. Palazzo, S. Chiavarelli, D. Bovet,
“Ricerche sui curari di sintesi, IV,” Gazz. chim.
ital. 79, 836 (1949).
L. S. Goodman and M. Nickerson, “Clinical ap-

plication of adrenergic blockade,” Med. Clin.
N. Am. 34, 379 (1950).
H. R. Grifﬁth and G. E. Johnson, “The use of
curare in general anesthesia,” Anesthesiology 3,
418 (1942).
B. N. Halpern, “Les antihistaminiques de synthese,
essais de chimiothérapie des états allergiques,”
Arch. intern. pharmacodynamie 68, 339 (1942).
, “Sur le mécanisme d’action des antihistaminiques de synthése,” Presse Med. 57, 949
(1949).
H. R. Ing, “The curariform action of onium
salts,” Physiol. Revs. 16, 527 (1936).
S. W. Kuﬂler, “Physiology of neuro-muscular
junctions: electrical aspects,” Federation Proc.
7, 437 (1948).
O. Loewi, “Problems connected with the principle
of humoral transmission of nerve impulses,”
Proc. Roy. Soc. (London) 1188, 299 (1936).
G. B. Marini~Bettolo, “Contribution a l’étude
des alcaloides des Strychnos du Brésil,” Festschr.
Arthur Stoll (Basel, 1957), pp. 257—280.
, S. Chiavarelli, D. Bovet, “Ricerche sui
simpatolitici di sintesi della serie dell’ergotammina,” Gazz. chim. ital. 80, 281 (1950).
A. R. McIntyre, Curare. Its history and clinical
use (Chicago, 111., 1947).
D. Nachmansohn, “Metabolism and function of

Manuel Luz Roxas,
Agricultural Chemist
Manuel Luz Roxas was one of the foremost scientists in the Philippines. His
valuable services to the University of the
Philippines as a teacher of chemistry in
the College of Agriculture and the important role he played in the creation
and organization of the National Research Council of the Philippines will
be long remembered.
Almost immediately after Dr. Roxas’
graduation from the University of the
Philippines in 1911, with a BS. degree

Hg?
‘

\

._

Manogmmm OF

in Agriculture, his ﬁrst research work
appeared in the Philippine Agriculturist
and Forester under the title “The pandan industry in Majayjay.” This was
soon followed by three other articles in
the same journal: “The cultivation of
coconut,” “The effect of some stimulant
upon rice,” and “The coffee industry in
the island of Luzon.” Dr. Roxas pursued
further studies in his chosen ﬁeld and in
1913 obtained his MS. degree at the
University of the Philippines, where he
then served as instructor in chemistry
until he was appointed a university fellow to the United States. Evidently this
appointment was in recognition of his
unusual endowment with the “divine
spark” to perform research. He enrolled
in the University of Wisconsin and received his Ph.D. there in 1916.
On his return to the Philippines, Dr.
Roxas resumed his position in the Col-'
lege of Agriculture in the University of
the Philippines, where he was later appointed assistant professor, then professor of chemistry, and ultimately, professor emeritus of agricultural organic
chemistry. He was also named Distinguished Alumnus of the University of the
Philippines in 1932 for achievement in
scientiﬁc research. All these deserved

11111111111111 131111111111

HILLSIDE HOSPITAL
QLEN omsm. v.

'

recognitions were due to his active labor
in the ﬁeld of research, especially in
agricultural chemistry and food technology; his 95 scientiﬁc papers were
published in various journals, including
the Philippine Agriculturist and Forester, the [ournal of Biological Chemis—
try, Sugar News, and the Journal of the
Philippine Islands Medical Association.
The National Research Council of the
Philippines owes its origin to the leadership of Dr. Roxas. He headed a committee that worked continuously in
preparing the draft of the bill for its creation which was introduced in the House
of Representatives. With the support of
Manuel L. Quezon as Senate President
and other leaders of the Philippine Legislature, and the cooperation of the then
Governor General Frank Murphy, Act
4120 creating a National Research
Council for the promotion of research
along scientiﬁc lines was approved on
8 December 1933. Elected as ﬁrst chairman of the National Research Council,
Dr. Roxas did a great deal in the organization of the different divisions integrating the Executive Committee of the
council. For his distinguished and outstanding contributions in scientiﬁc research in the Philippines, Dr. Roxas
may well be considered the “father of
the National Research Council of the
Philippines.”
Manuel Luz Roxas was a man of
sterling character, a good Filipino and
patriot, simple and humble; all these
qualities enhanced his merit as a true
man of science. Our country can never
repay what it owes him for his scientiﬁc
labor and devotion to research.
ANTONIO G. SISON

National Research Council of the
Philippines, Quezon City
SCIENCE, VOL. 129

_

3.1u1111959

the nerve cell,” Harvey Lecture Ser. 49, 57
(1956).
W. D. M. Paton and E. J. Zaimis, “The methonium compounds,” Pharmacol. Revs. 4, 219
(1952).
M. Protiva. “Chemie antihistaminovych latek a
histaminové skupiny,” Nakladatelstvi L'eskolovenske’ Akademie véd (Prague, 1955).
M. M. Rapport, “Serum vasoconstrictor (serotonin) : IV,” ]. Biol. Chem. 180, 961 (1949).
Raymond-Hamet, “Sur un nouveau cas d’inversion
des eﬂets adrénaliniques,” Compt. rend. acad.
sci. 180, 2074 (1925).
Rend. ist. super. sanita‘ 12, 1-264 (1949) (numero
speciale sui curari di sintesi).
Ibid. 15, 723—1040 (1952) (numero speciale sugli
ergotamminici di sintesi).
E. R. Rothlin, “The pharmacology of the natural
and dihydrogenated alkaloids of ergot,” Bull.
schweiz. Akad. med. Wiss. 2, 249 (1947).
A. M. Staub, “Recherches sur quelques bases
synthétiques antagonistes de l’histamine,” Ann.
inst. Pasteur 63, 400 (1939).
S. Thesleﬂ', “Succinylcholine iodide. Studies on its
pharmacological properties and chemical use,”
Acta Physiol. Scand. Suppl. 99, 1 (1952).
D. W. Woolley, A Study of Antimetabolites (New
York, 1952).

�Cultural Determinants of Response to Hallucinatory

Experience

ANTHONY F. C. WALLACE. Ph.D.
PHILADELPHIA

�Reprinted from the A. M. A. Archives of General Psychiatry
July 1959, Vol. 1, pp. 58-69
Copyright 1959, by American Medical Association

Cultural Determinants of Response to Hallucinatory
Experience
ANTHONY F. C. WALLACE, Ph.D.,

Philadelphia

Hallucination attracts the attention of the
anthropologist for several reasons: First,
because, as one of the most ancient and
most widely distributed of the modes of
human experience, most, if not all, human
cultures provide deﬁnitions of and responses
to it which are of interest to the descriptive
ethnographer; second, because a vast quan—
tity of content has been introduced into the
cultural repertoire of mankind by halluci—
natory ideation in dreams, visions, and
hypnogogic imagery, and hallucination must
therefore be considered in relation to culture
change; and, third, because hallucination is
often deﬁned in Western societies as a
symptom of mental and/or physical disease,
and anthropologists play a role in medical
research in these societies. It is in the last
context, particularly in the area of mental
health research, that the present inquiry is
undertaken.
Cross—cultural materials on hallucination
may be of interest in a mental health re—
search context in at least two ways. First,
and rather obviously, both psychiatrist and
anthropologist will expect the manifest con—
tent of hallucination to vary, as does the
content of other behavior, to some degree
with cultural setting, and they may be
interested in the range, frequencies, and
associations of various types of manifest
content. Differences of opinion exist in
Submitted for publication Sept. 3, 1958.
This study was in part supported by Grant
M-1106 from the National Institute of Mental
Health, U. S. Public Health Service.
Research assistants were Fred Adelman, Josephine Dixon, Joan K055, and Robert J. Smith.
The writer has beneﬁted from discussion of
methodological problems in psychopharmacology
with Dr. Harry Pennes and Dr. Harold Rashkis,
of the Eastern Pennsylvania Psychiatric Institute.

74/58

regard to the supposed variability of latent
content: Lincoln, in his study of dreams in
primitive cultures, and other psychoanalyti—
cally oriented scholars have emphasized the
universal presence in dreams of Oedipal
themes and the classic “Freudian” sym—
bols 13; less strictly psychoanalytic ethnolo—
gists have not emphasized the presence of
these themes so much as culturally and
personally idiographic onesﬁ2'3 In any case,
however, we shall not be primarily concerned with the content per se of hallucina—
tions. Rather, we shall deal with the
problem of the deﬁnition of and response
to the experience, by the society, by the
scientiﬁc observer, and by the hallucinator
himself. The rationale for such an approach, in a mental health context, is twofold: First, knowledge of the range of
deﬁnitions and response, and their cultural
associations, may help in diagnosis and in
communication with patients; and, second,
it is likely that in some cultural subgroups
in our society the nature of deﬁnition and
response to hallucination entertained by
hallucinator and his associates may aggra—
vate or precipitate other mental disabilities
in the hallucinating person. Indeed, the
mental patient may suffer from added anx—
iety precisely because of the nature of the
deﬁnition of hallucinatory experience which
he entertained prior to experiencing it him—
self. Certainly among hospitalized patients
in our society, the attempt to conceal halluci—
natory experiences from the staff is both
chronic and, in one sense, realistic: Staff
members frequently take a negative View of
hallucinations, and hallucinating patients are
subject to measures which, from the pa—
tient’s standpoint, may be punishments (de-

�RESPONSE TO HALLUCINATORY EXPERIENCE
lay in discharge, restriction of privileges,
questioning on sensitive issues, subtle contempt, and even ridicule, from both staff

and other patients) .23

Problems of Deﬁnition
Uncertainties of deﬁnition impede re—
search in the area of hallucinatory experi—
ence. Although hallucination is commonly
treated by psychiatrists as a symptom of
mental disorder, its occurrence is neither a
necessary nor a sufﬁcient condition for such
a diagnosis. Most psychiatrists, furtherword
the
restrictions
two
on
impose
more,
“hallucination,” excluding from its exten—
sion those ideational experiences which oc—
cur during sleep and assigning to it a
generally negative valence. These restric—
tions are useful in psychiatry in our own
cultural setting, but they are not helpful in
establishing a cross—culturally applicable
deﬁnition (nor need they be, for a Western
psychiatrist’s deﬁnition is to be regarded
as only one cultural variant), since in some
societies dreams and waking visions may
be for many purposes treated as equivalent.
For the purposes of this study, “hallucina—
tion” will be deﬁned, very broadly, as pseu—
doperception, without relevant stimulation
of external or internal sensory receptors,
but with subjective vividness equal to that
aroused by such stimulation. Included in
its extension, therefore, are dreams, the
ter—
of
“hallucinations”
psychiatric
waking
minology, and hypnogogic imagery; excluded is the fainter audiovisual imagery of
reﬂective thought. There remains a some—
what dubious category, occasionally referred
to as hallucinations in the psychiatric lite-ra—
ture, of perceptions whose subject matter
is unambiguously provided by external stim—
ulation but whose form displays subtle or
gross distortion. The most familiar exam—
ples are the undulating ﬂoors, stretched
perspectives, echoing sounds, and other dis—
tortions experienced by some subjects on
administration of the so—called hallucino—
genic or psychotomimetic drugs, and by
normal subjects who have consumed nar—
Wallace

or alcohol, have been breathing
anesthetics, or are in process of losing
consciousness (fainting). We shall leave
these phenomena out of the range of our
deﬁnition, on the ground that a “hallucina—
tory” dimension already exists, of vividness
of subjective imagery in the absence of
sensory stimulation, at all points of which
the pseudoperception may be equally undis—
torted, and relate these dubious cases,
rather, to a logically independent dimension
of perceptual distortion. The relationship
between the two dimensions may, of course.
be investigated empirically.
A second major problem, in addition to
the concept of hallucination itself, is that
perennial ﬂower of confusion, the word
“possession.” Casual observers and many
anthropologists alike use this word in two
very different senses: as a label for some
person’s overtly observable behavior, and as
a label for a native theory to explain this be—
havior. These two uses are, unhappily, often
confused. It may be best to state ﬂatly, at the
outset, that I shall use the word “possession” to denote any native theory which
explains some event of human behavior as
being the result of the physical presence,
in a human body, of an alien spirit which
takes over certain or all of the host’s executive functions, most frequently speech and
control of the skeletal musculature. A phe—
nomenon of possession does not, therefore,
for me exist; the word merely labels a
theory.
Now the possession theory happens to be
frequently applied, in folk beliefs, to three
very different classes of phenomena, for
each of which other terms exist. One of
these is hallucination; the second is hysteri—
cal dissociation (including multiple personality, fugues, somnambulism, conversion
hysterias, and hypnotic states); the third is
obsessive ideation and compulsive action.
Clinically, these are distinguishable phenom—
ena. But any one, or group, of them can
be, in folk theory, explained by the mecha—
nism of possession. Unfortunately, some
observers have, in their eagerness to empa—
thize with their subjects, used the word
cotics,

75/59

�A. M. A.

possession to denote not only a type of folk
theory but also whatever phenomenon their
folk happen to use the theory to explain.
In other words, if a people use the concept
of “possession” to explain certain hysterical
dissociations (such as the stereotyped
fugues which are so commonly induced in
many religious rituals), the anthropologist
tends to say that the dancers in the ritual
are “possessed”; similarly, if a people use
the theory to explain hallucination (which
is, incidentally, a less common use of the
concept), the anthropologist may refer to
hallucinators as “possessed” persons. Even
more confusingly, the ethnographer may use
the word to denote any person who is
thought to be persistently inﬂuenced by a
supernatural being, whether located inside
or outside the person’s body.
A third problem of conceptual ambiguity
is the notion of trance. There would seem
to be at least two major uses of this term:
(1) to denote physiological collapse with
coma or the occasionally concomitant delirious hallucinations; and (2) to denote
(again) states of dissociation. The possi—
bilities of semantic confusion are manifest.

Problems of Methodology
At ﬁrst, it was hoped that the Human
Relations Area Files (HRAF), including
the old Cross—Cultural Survey Files at New
Haven and the completed portions of
HRAF at New Haven and Philadelphia,
would provide a sample of societies various
of whose cultural features could be sta—
tistically related to the phenomena of
hallucination. The data contained in HRAF,
however, even when supplemented by mate—
rial from sources not tapped by HRAF,
and by data on societies not included in
HRAF, proved to be not amenable to
statistical treatment, for three reasons: A
sample which included representative cul—
tures from all major culture areas was not
available; the data were not comparable
from society to society, because of the
extreme unevenness of the reporting (rang—
ing from no report at all to careful, exten—
76/60

ARCHIVES OF GENERAL PSYCHIATRY

sive, and psychiatrically informed study),
and the data provided were usually too
crude to permit the discriminations which
I regarded as signiﬁcant for statistical cate-

gories. N0 quantity of time or money spent
in HRAF and other library compilations
can remedy all of these defects of the eth—
nographic literature, and only a vast expenditure of funds in ﬁeld work could amass
new and adequate data on a sufﬁcient num—
ber of societies. The inference to be made
is, rather, that the ethnographic literature
available for areal or world samples, of
the sort envisioned by Murdock 14 and
others in connection with HRAF, is not
suitable for statistical analysis with respect
to all dimensions of anthropological interest,
but is suitable only with respect to certain
highly formalized and conventionally re—
ported dimensions, such as kinship and
subsistence activities. The cultures on
which data were collected from HRAF in
the abortive statistical phase of the study
are the following:
Abipone
Achewa
Ainu
Andamanese
Apiaca
Apinage

Aranda
Arikara

Assiniboin
Balinese
Bena
Blackfoot
Buka
Bushman—Hottentot
Canella
Chuckchee
Creek

Crow
Cuna
Dahoman
Easter Island
Gros Ventres
Hopi

Ifugao

Indian Yoga
Kamilaroi
Kwakiutl
Lamba
Maori
Marshallese
Plateau area (North
America)
Sherente

Since nontrivial and signiﬁcant statistics
appeared to be unachievable, the obvious
next step was to consider what prestatistical
manipulations of the data were possible
and whether any of these might yield formulations of interest. Experimentation
along these lines brought me to construct
a rather tedious list of “existence theorems,”
which I shall not reproduce here, but which
proved later to be valuable in setting up the
matrix of concepts. Existence theorems are
Vol. 1, July, 1959

�RESPONSE TO HALLUCINATORY EXPERIENCE

eminently prestatistical, but they are neces—
statistical
of
description,
sort
to
any
sary
since they deﬁne the relevant and nontrivial
categories. An existence theorem is merely
a statement that of the class A: there is at
least one member concerning which the
statement [9 in true; thus, for instance, the
theorem
where

“there exists at least one (x) such
that . . .”

(3x)=df

and

(x):df

“society”

and

A

ber of the society as meaningless concatenations of visual and/or a u d i to r y
pseudo-perceptions.”

The whole of the theorem would read:
“There exists at least one society such that
hallucinations are deﬁned by some members
of the society as meaningless concatenations
of visual and/or auditory pseudopercep—
tions.” From the existence theorems,
derived from the HRAF cross—cultural ma—
terials and from my ethnographic knowledge, the dimensions of hallucinatory
experience shown in Table l were con—
structed. These dimensions are offered as
a formal frame of reference within which
to observe cultural deﬁnitions of hallucina—
tory experience, and as a rough statement of
the range of cultural variability evident in
the ethnographic record.
With the foregoing semantic and methodological considerations in mind, we may
proceed to discuss, informally and nonstatistically, certain implications of the ethno—
graphic data.

Conditions of Hallucination

If one were to design an electronic brain

which behaved in all respects like a normal
human brain, one would have to include in its
speciﬁcations both a capacity for hallucina—
tion and a capacity to distinguish halluci—
nation from sensory perception. Most
human beings hallucinate (in the broad
sense of the term which is employed in
Wallace

Communication

Contains no information but is a meaningless pattern of auditory or visual images
(:2 Contains information in the form of observation of phenomena that really exist somewhere (but are not messages)
(1. Contains message from a supernatural being (ghost, soul,
demon, divinity, etc.) located outside Ego’s body
a . Contains message from, or is the experience of, a supernatural
being (ghost, soul, demon, divinity, etc.) located inside
Ego’s body
((5 Contains message from one part of self (e. g., own soul, conscience, memory, Id, subconscious, etc.) to another (6. g.,
consciousness, ego, etc.) or to other person
as Contains message from a natural being communicating by
means of radio, telepathy, or other means of telecommunication

(1

1

B

p12“hallucinations are deﬁned by some mem-

1.—Dimensiom of Hallucinatory Experience

TABLE

Mechanism of control

Can be controlled by hallucinator and/or hallucinator’s
fellows by manipulating physical condition and/or foreign biochemical factors
()2 Can be controlled by hallucinator and/or hallucinator's
fellows by nonphysical means (such as will, prayer, ritual,
worry, suggestion, autosuggestion, psychotherapy, etc.)
I). Can be controlled by will of alien supernatural or natum
being

b

I)

1

t

b5
b.
b1
b3

b

1A0 2

0 [Ab 3
b 2N) a
I) 1A0 2A1)
.

Other (ﬁll) [Vb

sz

3])

0 Induction
c. Hallucinator seeks to induce or repeat experience
C 2

/—"C

1

D Concealment
d1

Hallucinator conceals experience from group or denies

oc-

currence

d 2 ,—/d

1

Punishment

E

e. Group institutes punishment and/or social extrusion
e

2

He

1

Therapy

1“

Group or individual institutes therapeutic and/or prophy—
lactic measures

f1

fz Hf!
G

Role assignment
g1 Experience qualiﬁes individual for valued social role (adult
hood, shaman, healer, diviner, priest, etc.)
g2

My

1

H Behavior guidance
hi Content of experience may be taken as guide for individual
and/or group action (other than therapeutic) irrespective
of social role of hallucinator
h: Content of experience taken as guide for individual and/or
group action (other than therapeutic) only when hallucinator already ﬁlls certain social roles (e. g. shaman, prophet)

h

, Content of experience not taken as guide for individual and/
or group action (other than therapeutic)

77/61

�A. M. A.

this paper), in one way or another, quite
frequently; and there is no society, to my
knowledge, in which hallucinatory experience is unknown. Hallucination is, in fact,
one of the most widely distributed of the
modes of human experience. Explicit re—
ports of dreams, visions, and the hearing of
voices are found in the sacred literature of
the pre—Christian Near East; if mythology,
ritual, and other religious behavior be re—
garded as in part the legacy of such experi—
ences passed on by oral or written tradition,
we may suspect an antiquity measured in
tens or hundreds of millenia.
Under the general rubric of hallucination,
however, there can be assembled a wide
range of types of experience, from the Vivid
and realistic supplanting of reality in ec—
static visions and auditory revelations, to
a relatively pallid verbal or visual imagery
which blends imperceptibly into ordinary
“thought.” These experiences are known
from Western clinical observations to be
prompted by the most various circum—
stances: sleep, anoxia, pharmacologic agents,
brain tumors, psychological stress, fatigue,
sensory restriction, and others. Relatively
little seems to have been done to relate the
conditions precipitating and surrounding an
event of hallucination to the content of the
experience; ethnographic investigation may
offer a few clues here.
The speciﬁc conditions under which hal—
lucinations have been reported in the ethno—
graphic literature may be divided into the
following categories :
Sleep

Fatigue
Hunger and thirst
Prolonged physical
pain

Extreme physical

illness
Social isolation

Special exercises
(breath control,
posture, sensory

restriction)
Drugs
Emotional stress in
normal persons
Mental illness

It should be noted that these conditions are

not logically independent, and that frequent—
ly (and especially in voluntarily induced
hallucination) two or more of the conditions
are realized at the same time.
Three observations are pertinent. First,
in many societies relatively little signiﬁcance
78/62

ARCHIVES OF GENERAL PSYCHIATRY

is attached to differences in the conditions

under which hallucination occurs. In par—
ticular, dreams during sleep, spontaneous
waking visions, and induced hallucinations
under drugs or stress may be given equal
status and comparable evaluation. Western
society is remarkable for the importance it
assigns to differences in the precipitating
conditions of hallucination; the most strik—
ing example, of course, is afforded by the
profound distinctions we draw among
dreams (in sleep), delirium (in illness or
intoxication), and “hallucination” in the
restricted sense (in the waking state). Second, we must take note that, although not
all hallucinatory experiences are regarded as
desirable in any society, in primitive socie—
ties it is very common for hallucinations
with desirable content to be not only ac—
cepted with pleasure but deliberately sought
with the aid of such devices as hallucino—
genic substances (e. g., some American
Indians ingest parts of the cactus peyote
and Paleo—Siberians, the mushroom ﬂy
agaric) and various sorts of personal disciplines, ranging from breathing and posture
exercises, through hunger, thirst, and isola—
tion, to prolonged physical self—torture. The
tendency to minimize discrimination among
hallucinations on a criterion of precipitating
condition of course does not imply any
inability to discriminate between hallucina—
tion and sensory perception; the preferential
status of hallucinatory experiences is possible only when it is clearly differentiable
from normal experience. Third, it appears
that both the subjective feeling tone and the
speciﬁc content of the hallucination are
heavily inﬂuenced by a still more pervasive
condition: the cultural milieu in which the
hallucination, and particularly the voluntary
hallucination, takes place.
The latter point is worth elaborating here,
although it anticipates some of the material
to follow, because it is relevant to the
methodology and evaluation of clinical research with hallucinogenic compounds under
varying experimental conditions. Typically
in such research the clinician administers
Vol. 1, July, 1959

�RESPONSE TO HALLUCINATORY EXPERIENCE
to a group of healthy urban adults, often

medi—
the
with
identiﬁed
themselves
persons
cal or an auxiliary—medical profession, a
substance which induces various instrumentally measurable physiological changes and
observable alterations in behavior. The subjects are asked also to report verbally on
their subjective experience. These verbal
reports reveal a considerable variety of
experience: Some subjects are euphoric;
some are entranced by the intensity of
esthetic pleasure they achieve in the contemplation of color, form, and movement
divorced from meaning; many complain of
anxiety, physical discomfort, various un—
welcome perceptual distortions, and attitu—
dinal changes; some hallucinate and some
do not. These various reports and observa—
tions are taken to indicate the psychological
actions of the drug. Similarly variable re—
sults, but usually with transient intensiﬁcation of chronic symptomatology, are given
by mental patients from roughly comparable
cultural backgrounds (but, of course, by
virtue of illness occupying a very different
social status). But no cultural controls are
employed; and it is possible that to an
unknown degree the subjective experience,
and hence even the physiological measures,
is inﬂuenced by the negative attitude toward
any distortion of normal sensory and cognitive experience which many members of
our society share, at least those people who
do not customarily seek such special experi—
ences as are afforded by narcotics and
alcohol or by mystical or esthetic preoccu—
pations.
Some indication of the quality and mag—
nitude of the possible effect of differing

cultural attitudes toward hallucinatory ex—
perience under differing conditions of drug
administration is given by the differences
in the experiences reported by normal white
subjects after administration of mescaline
and by American Indians after consumption
0d of introduction, and of intragroup per—
sonality differences: ﬁrst, the inﬂuence of
tains mescaline).
The literature on the mescaline experi—
ences of normal subjects is rather scattered,
Wallace

and some of it, particularly if it has an early
date of publication, is unsatisfying because
of the inadequacy of sample description and
the disjointed and anecdotal style of presen—
tation conventional at the time. Neverthe—
less, the consultation of several prime
sources “'25 reveals a reasonably consistent
pattern of described phenomena, which con—
trasts with the pattern described (also,
unfortunately, sometimes in undeﬁned sam—
ples) by anthropologists’ American Indian
informants.”12'1“"!24 The fact of major
contrast has been brieﬂy remarked in print
by one of the—foremost anthropological stu—
dents of peyotism, Slotkin,21 who observed
in the course of discussion of attempts of
white persons to suppress peyotism that
“the responses described in clinical experi—
ments on Whites are so different from the
responses described by Indian Peyotists .
as to fall into completely different catego—
2.—Contrasts in Prevailing Character of the
Responses 0f_Climcally “Normal” White and
Indian Subjects of M escaline Intoxication

TABLE

White

Indian

Variable and extreme mood
shifts (agitated depression,
anxiety, euphoria, depend—
ing on stage of intoxication
and personal characteristics)

Initial relative stability of
mood, followed by religious
anxiety and enthusiasm,
with tendency toward feel—

Frequent breakdown of social
inhibitions and display of

Maintenance of orderly and
“proper” behavior (“revivalistic" enthusiasm is socially proper in context)
No report of suspiciousness

“shameless” sexual, aggressive, etc., behavior
Suspiciousness of others present in environment (reported to be uniformly present
by Guttmann and noted in
self by Kliiver)
Unwelcome feelings of loss of
contact with reality, depersonalization, meaningless“split-personality,"
ness,
etc.
Hallucinations largely idiosyncratic in content
No therapeutic beneﬁts or permanent behavioral changes

ings of religious reverence
and personal satisfaction
when vision achieved, and
often, also, expectation of
“cure” of physical illness

Welcome feelings of contact
with a new, more meaningful, higher order of reality,
but a reality preﬁgured in
doctrinal knowledge and
implying more, rather than
less social participation

Hallucinations often strongly
patterned after doctrinal
model
Marked therapeutic beneﬁts
and behavioral changes (reduction of chronic anxiety
level, increased sense of personal worth, more satisfac»
tion in community life)

79/63

�A. M. A.

ries; they do not seem to be talking about
the same thing.” The salient differences in
the reports are displayed in Table 2; the
reader should note that a meaningful statis—
tical presentation of frequencies of response
types, while desirable, is precluded by the
nature of the data available.
These marked differences would seem to
be plausibly explained by two related fac—
tors which are independent of possible
differences in racial physiology, of chemical
action of the drug owing to variations in
dosage, mixture with other agents, of meth—
od of introduction, and 0f intragroup person—
ality differences: ﬁrst, the inﬂuence of the
setting in which the drug is taken (the
white subject’s experiences occur usually
in a hospital or university research setting;
the Indian experiences, in a ceremonial
lodge during a solemn religious ritual); and,
second, differences in the psychological
meaning of the primary drug effects when
experienced. Certainly, gross enough situ—
ational and semantic differences exist:
White normal subjects generally take mes—
caline once or twice, in a clinical research
setting, with deﬁnite knowledge of an ex—
perimental or a clinical purpose in the
investigation, and without any commitment
to or interest in peyote, or to mescaline
in any form, as a personal religion; Indian
peyote users take mescaline repeatedly,
in a solemn religious setting to the
accompaniment of serious ritual, with
deﬁnite knowledge of a religious purpose
in the usage and, often, with hope for per—
sonal salvation, of which the vision is the
evidence. The former factor—the setting—
5
been
has
reported by Fernberger to yield
differences in content, which can to some
degree be affected both by suggestion by the
experimenter and by autosuggestion. The
latter, the semantic, factor would seem to
be signiﬁcant at the present stage of theory
concerning the action of the hallucinogens,
since it is recognized that both personal
character and, perhaps, personally or cul—
turally determined values concerning the
“homeostasis of subjective—experience” may
80/64

ARCHIVES OF GENERAL PSYCHIATRY

affect response to experimentally induced
changes in sensation and perception.19 We
quote the work of Hoch, Cattell, and
Pennes 8 in this connection.
We have pointed out that the alterations in the
vegetative nervous system appear ﬁrst under the
influence of mescaline, lysergic acid, pervitin, etc.
This is usually followed by alterations of per—

ception, bodily sensations, and changes in body
image. In many patients it would appear that the
perceptual alterations are conducive in producing
anxiety, uncertainty, and, at times, rage. Seemingly, the perceptual alterations lead to a lowering
of reality control, thence to tension and anxiety,
which in turn lead to depressive, aggressive, and
paranoid manifestations. Schizophrenic patients
whose reality contact is already impaired are
seemingly more vulnerable to drugs that have a
disorganizing effect on reality perception. As yet
it is unclear whether the emotional alterations seen
in these patients are due to a physiological action
of the drug per se or due to the experiencing of
an alteration of reality and other changes on a psy—
chic level.

Interpretation of Content
In most primitive societies, even if (on
other grounds) the hallucinator is regarded
as being ill, or the hallucination itself is
unpleasurable, the content will not be re—
garded as a meaningless concatenation of
pseudoperceptions. The content of hallucination is sometimes interpreted as a message
introduced directly into the subject’s consciousness by a supernatural being, directed
either to the hallucinator himself or to the
community through him as an intermediary.
More frequently, hallucination will be in—
terpreted as a real perceptual experience by
the soul, which has wandered from the body
and is seeing and hearing events involving
real or supernatural persons which are occurring in another place, or which is able
to see and hear events and supernatural
beings present but imperceptible to others.
The message—intrusion theory tends to blend
into primitive theories of possession; in our
society, it is expressed in the conventional
telepathy, radio, radar, brain—washing, and
electrical—current delusions and is classed as
a paranoid mechanism, while the spiritual—
perception theory is associated with extreme
Vol. 1, July, 1959

�RESPONSE TO HALLUCINATORY EXPERIENCE

religious enthusiasm. But in both theories,
the content of hallucination is interpreted
as signiﬁcant information.
In at least two culture areas, that of the
17th—century Iroquois Indians of what is
now New York State,26 and of Western
society after the advent of psychoanalysis,
a third theory also has existed as an alterna—
tive explanation for hallucination. In this
theory, the hallucination conveys an emo—
tion—laden message from the soul, or some
unconscious part of the mind, to the conscious self, and thus is a process of thought.
This view, like the others, regards the content of hallucination as a message containing
information. It appears to be a rare idea
that the content of hallucination is mean—
ingless, and one may hazard the guess that
this notion is largely conﬁned to psychiatri—
cally unsophisticated, nonparanoid, and
tepidly religious, or nonreligious, members
of Western society.
If a hallucination is regarded as a mes—
sage, there are evidently two approaches to
its interpretation: to take the manifest con—
tent literally, and to regard the manifest con—
tent as a symbolic expression of signiﬁcant
underlying ideas. The latter approach may
entail various techniques, such as guessing
and devices of free association, the consul—
tation of a formal list of symbols and their
meanings, and the more or less standardized
derivation of meaning from the context of
circumstances (such as ritual, illness, situ—
ational stresses, and the like) in which the
hallucination occurred. It is not important
here whether or not there are, in truth,
universal themes and symbols expressed in
dreams and other hallucinatory experiences,
as psychoanalytic theory and data suggest.
The important point is that most human
beings, in most societies, outside Western
civilization, regard hallucinatory content as
communication bearing signiﬁcant informa—
tion which can be understood either directly
or by the use of special methods of interpretation.
Now this belief in hallucinatory content
as communication, particularly when it is
Wallace

coupled with the conviction that the com—
munication is not merely intrapsychic, seems
to have an effect both on the content of
hallucination and on the hallucinator’s, and
his community’s, response to it. Halluci—
nation in itself is not frightening, either
to hallucinator or to his community, al—
though the content may be; but even if the
content is frightening, it is valuable knowl—
edge. Hence the overt response to halluci—
nation will very likely be markedly affected
by its classiﬁcation as communication.
It is to the topic of response to hallucina—
tion that we now turn.

Response to Hallucination
The difference in response between Eng—
lish white and Australian black to a course
of hallucinations in a mourning woman is
vividly illustrated in the following anecdote,
reported by Parker,15 the author of a study
of the Euahlayi tribe of Australia.

Our witch woman was rather a remarkable 01d
person. When she was, I suppose considerably
over sixty, her favourite granddaughter (lied.
Old Bootha was in a terrible state of grief, and
chopped herself in a most merciless manner at the

burial, especially about the head. She would speak
to no one, used to spend her time about the grave,
round which she ﬁxed upright posts which she
painted white, red, and black. All round the grave
she used to sweep continually.
More and more she isolated herself, and at last
discarded all her clothes and roamed the bush 5.
la Eve . . . as she had probably done as a young
girl.
She dug herself an underground camp, roofed
it over, and painted enormous posts which she
erected in front of her “Muddy wine,” as she called
her camp. She never came near the house, though
we had been great friends before.
She used to prowl around the outhouses and pick
up all sorts of things, rubbish for the most part,
but often good utensils too; all used to be secreted
in the underground camp. She never talked to
anyone, but used to mutter continually to herself
and her dogs in an unknown tongue which only her
dogs seemed to understand.
We thought she was quite mad.
One day, while we were playing tennis, she sud—
denly, muttering her strange language and dancing
new corroboree steps, clad only in her black skin,
came up. Matah told her to go away, but she only
corroboreed round him and said she wanted to see

81/65

�A. M. A.

She danced round me for a little time,
then sidled up to me and said:
“\Nahl [negative or “no”] you frightened, wahl
me hurt you. I only womba—mad—all yowee—
spirits—in me tell me gubbah— good—I lib ‘long
a youee: bimeby I come back big feller wirreenun
[as a medicine woman] wahl you frightened? I
not hurt you.”
And after crooning an accompaniment to her
steps, off she went, a strange enough figure, dancing and crooning as she went towards her camp;
and not until the spirits gave up possession of her
did she come near the house again.
I used to tell the other blacks to see that Bootha
had plenty of food. They said she was all right,
the spirits were looking after her. Lunatics, from
their point of view, are only persons spirit-possessed.
Gradually old Bootha, clothed as usual, came
back about the place.
Strange stories came through the house back
to me of old Bootha. She was very ill for a long
time, then suddenly she recovered, not only recovered but seemed rejuvenated. We heard of
wonderful cures she made; how she always consulted the spirits about any illness; how there were
said to be spirits in some of her dogs; how she was
now a rainmaker, and, in fact, a fully ﬂedged
witch.
me.

.

.

.

The reader will note a typical Western
attitude toward the “lunatic,” a blend of
amused contempt, pity, and anxiety, and
also the native woman’s awareness of the
attitude, and her effort to clarify the white
man’s misunderstanding by explaining that
her hallucinatory experiences were “good.”
Noteworthy also is the satisfactory (both
to the woman and to her associates) social
remission, which was achieved in the course
of becoming a shaman: a remission which,
I suggest, was facilitated by her anxiety—
free acceptance of hallucinatory experience.
This anxiety—free acceptance of, and willing—
ness to describe, hallucinatory experience
contrasts vividly with the common shamed,
fearful, self—doubting attitude of Western
patients, who frequently try to conceal the
fact that they “see things” or “hear voices,”
and sometimes “confess” (as the psychi—
atrist puts it) to hallucinations only under
very careful questioning.
Response to hallucination may be considered both as a matter of the hallucinator’s
response to the experience and as a matter
of the response of his group (and the two,
82/66

ARCHIVES OF GENERAL PSYCHIATRY

of course, may be equivalent). As I have
indicated, in primitive societies the fact of
hallucination per se is seldom disturbing;
but the content itself may be disturbing or
not, depending on the nature of the socially
appropriate response. Dreamers or vision—
aries may resist strenuously the hallucinated
suggestion that they undergo an arduous
process of becoming a shaman, or that they
accept the role of berdache (an institutional—
ized inversion of sexual role among the
Plains Indians), or that they commit some
act, like murder or incest, which violates
social norms; they may be stricken with
panic at learning of approaching community
disaster, or that they have been bewitched,
or that they will be captured, tortured, and
killed in a future war. Similarly, the hallu—
cinator’s associates may respond with dismay, or with enthusiasm, to the wishes of
his soul, and may institute protective meas—
ures to avert harm from him or from them—
selves, may induct him into the special social
relationships indicated by his vision, may
conduct the indicated medical treatment, or
may take his revelation as a code for social
reform. The signiﬁcant point is that it is
the content of the communication which is
the focus of interest and the fulcrum of
action rather than the fact of hallucination
itself.
Let us now consider, by contrast, the
responses to hallucination typical in
Western societies. In some social groups,
particularly religious sects, hallucinatory
experience with supernatural ﬁgures ap—
parent in the manifest content is interpreted
as divine, 0r Satanic, revelation, and is
responded to either by acceptance of in—
junctions discovered in the content or by
repression, or even punishment designed to
drive out “possessing” devils. In psycho—
analytically inﬂuenced groups (which prob—
ably include a considerable proportion of
the urban population of Western countries),
dreams are interpreted and used as a basis
for psychotherapeutic action, but waking
hallucinations are regarded as symptoms of
serious psychic illness. And in the rest of
Vol. 1, July, 1959

�RESPONSE TO HALLUCINATORY EXPERIENCE

the population at large, waking hallucina—
tions are probably regarded primarily as
indications of “nervous breakdown,” or
even “insanity.’ The latter unfavorable
social diagnosis is very commonly followed
by the social extrusion of the hallucinator,
with or without prior medical advice, into
a mental hospital or some other socially
restricted environment, or at the very least
into a quasiostracism at home or in lodgings.
Police force is available and not uncom—
monly used to sanction and to effect this
extrusion. In medical circles, despite recog—
nition that hallucination in many conditions
is a secondary symptom, and despite the
insistence of workers like Boisen that “what
the voices say is the important thing, not
1 hallucina—
the mere fact of hearing voices,”
tion is commonly taken to be a grave sign.
In some of the research literature, indeed,
hallucination is treated as if it were the
essential feature of psychosis.
Now it is reasonable to suppose that most
persons, when they hallucinate for the ﬁrst
time (certainly when the ﬁrst waking hallu—
cination occurs), are aware of the culturally
standard interpretation of and response to
hallucination in their society. Even if they
do not accept this interpretation and re—
sponse as wise or proper, they will be aware
of its probable evocation in others. If this
is the case, then it is likely that the person’s
interpretation of, and response to, the fact
of his own hallucination in a given context
(as well as its content) will be a function
of the way in which the fact (and content)
of hallucination is deﬁned by his culture.
The function should determine in part his
’

emotional experience both during and after
the event, and possibly (by cultural suggestion) its perceived content as well.
'We may ask, at this point, how much
anxiety, self—depreciation, and cognitive dis—
tortion are added to the miseries of mental
patients by the circumstance that they have
learned to fear waking hallucination in the
course of living in a society in which waking hallucinatory experience is almost uni—
formly negatively valued? (The scientiﬁc
validity of the valuation is irrelevant.)
Furthermore, we must question the completeness of any research into the psychophysiological action of the so—called
psychomimetic drugs, of sensory restriction,
and of other hallucinogenic procedures
which fails to weigh not only the magnitude
but also the direction of the probably mas—
sive contaminating effect of cultural sug—
gestion upon the subjects. For what is
measured is not just the action of a drug
or other procedure, but the action of the
procedure plus the subject’s interpretation
of and response to this action, plus the feedback effect on the continuing action itself
(Figure); and all of these actions, inter—
pretations, responses, and effects are factors
with direction, as well as magnitude.
There may be much that the therapist can
do to alter the internalized cultural deﬁni—
tions of hallucinatory experience in his
patients, if he wishes. But it is research
problems that chieﬂy concern us here. It
would be possible in clinical research to con—
trol for the direction of cultural effects by
employing as control subjects persons whose
subculture differs sharply from that of the

Hallucinatory

pseudo—

perception
SPECIFIC

HALLUCINOGENIC
STIMULUS
CONDITION

cognition
of Situation

-””'“°'°‘
,

.

-39. “—3).
_____ Musculofure
1’

Vaugned'gme"

"em”s

'

.

WWW

/

‘
.

personal-3y

.

2‘

..

dynamics

,

Internalized
cultural
15"
definition
of situation
9

MOTOR

vEggAL
*{ RESPONSE

Mediation of response
,
,
to hallucmOgenic stimulus
by facets 0m; subjectlve
experience.
_

-

-

9

NERV°
Wallace

83/67

�A. M. A.

experimental subjects in its deﬁnition of the
expected experience, and by ensuring that
the experimental conditions for the controls
were sufﬁciently close to culturally normal
conditions for them to permit generalization
from past learning. Furthermore, it would
be possible to select subjects systematically
on criteria of personality, of past experi—
ence, and of attitude toward the expected
events; and it would be possible to vary
deliberately the general situational structure
with other variables held constant, both by
physical manipulation and by deliberate in—
struction and suggestion to the subjects.
Such procedures, incidentally, should also be
considered in relation to other than halluci—
nogenic compounds; they evidently would
apply to such drugs as tranquilizers, sedatives, and energizers, which on other evidence also depend in part for their effects
on relatively unexplored interactions with
personal dynamics and sociocultural milieu.18
Methodologically, such manipulations are the
reverse images of the controls imposed by
the placebo—and—blind (or double—blind)
techniques and of analysis—of—variance tech—
niques involving multiple pharmacologic
agents; whereas the placebo-plus—blind, or
variance—analysis, design varies the chemical
agent and holds situation constant either by
randomization or by laboratory control, the
method of cultural and situational controls
would hold the drug constant and vary such
aspects of situation as the physical experi—
mental conditions, instructions to personnel,
and character and background of subjects.
Drug and cultural controls should ideally
be combined in one design.

Summary
The paper brieﬂy examines the range of
cultural variation in conditions inducing,
interpretations of, and responses to, hallu—
cinatory experience. The published data
suggest strongly that internalized cultural
deﬁnitions of hallucinatory experience have
a profound effect on the responses both of
mentally ill and of normal persons. Meth—
odological controls for cultural differences
84/68

ARCHIVES OF GENERAL PSYCHIATRY

are indicated in research with hallucinogenic
substances.
Eastern Pennsylvania Psychiatric Institute.

REFERENCES
Boisen, A. T.: The Exploration of the Inner
World, New York, Harper &amp; Brothers, 1936.
1.

Eggan, D.: The Manifest Content of Dreams:
A Challenge to Social Science, Am. Anthropologist
2.

54 :469, 1952.

Eggan, D.: The Personal Use of Myth in
Dreams, J. Am. Folklore 68 :445, 1955.
4. Fernberger, S. W.: Observations on Taking
Peyote (Anhalonium lewinii), Am. J. Psychol.
3.

34 :267, 1923.

Fernberger, S. W.: Further Observations on
Peyote Intoxication, J. Abnorm. &amp; Social Psychol.
5.

26:367, 1932.

Guttmann, E.: Artiﬁcial Psychoses Produced
by Mescaline, J. Ment. Sc. 82 2203, 1936.
6.

Hoch, P. H.: Experimental Induction of
Psychoses, in The Biology of Mental Health and
Disease, 27th Annual Conference of Milbank
Memorial Fund, New York, Paul B. Hoeber, Inc.
(Medical Book Department of Harper &amp;
7.

Brothers),

1952.

Hoch, P. H.; Cattell, J. P., and Pennes,
H. H.; Effect of Drugs: Theoretical Considera—
tions from a Psychological Viewpoint, Am. J.
Psychiat. 1082585, 1952.
8.

Huxley, A.: The Doors of Perception, New
York, Harper &amp; Brothers, 1954.
10. Klﬁver, H.; Mescal Visions and Eidetic
Visions, Am. J. Psychol. 371502, 1926.
11. La Barre, W.: The Peyote Cult, in Native
American Culture, Yale University Publications
in Anthropology, No. 19, New Haven, Conn, Yale
University Press, 1938.
12. La Barre, W.: Primitive Psychotherapy:
Peyotism and Confession, J. Abnorm. &amp; Social
Psychol. 42:294, 1947.
13. Lincoln, J. S.: The Dream in Primitive Cul—
tures, Baltimore, Williams &amp; Wilkins Company,
9.

1935.

Murdock, G. R: World Ethnographic Sample, Am. Anthropologist 592664, 1957.
14.

15.

Parker, K. L.: The Euahlayi Tribe, London,

Archibald Constable

&amp; C0., 1905.

Petrullo, V.: The Diabolic Root: A Study
of Peyotism, the New Indian Religion, Among the
Delawares, Philadelphia, University of Pennsyl—
vania Press, 1934.
16.

Vol. 1, July, 1959

�RESPONSE TO HALLUCINATORY EXPERIENCE
Radin, P.: The Winnebago Tribe, Washington, D. C., Bureau of American Ethnology, 37th
Annual Report to Secretary of Smithsonian In—
stitute, 1915-1916, 1923.
17.

Rashkis, H. A., and Smarr, E. R.: A Method
for the Control and Evaluation of Sociopsychological Factors in Pharmacological Research,
Psychiat. Res. Rep. 9:121, 1958.
18.

Rubin, L. S.: The Psychopharmacology of
Lysergic Acid Diethylamide (LSD—25), Psychol.
19.

Bull. 54:479, 1957.

20. Slotkin, J. S.: Menomini
Philos. Soc., n. 5. 42:4, 1952.

Peyotism, Tr. Am.

J. S.: The Peyote Religion: A
Study in Indian—White Relations, Glencoe, 111.,
Free Press, 1956.
21. Slotkin,

Wallace

22. Smythies, J.

R.: The Mescaline Phenomena,

Brit. J. Philos. Sc. 3:339, 1953.
23. Smythies, J. R.: A Logical and Cultural
Analysis of Hallucinatory Sense—Experience, J.
Ment. Sc. 102:336, 1956.

D.: Personality and Peyotism
in Menomini Indian Acculturation, Psychiatry 15:
24. Spindler, G.

151, 1952.

25. Stockings, G.

T.: A Clinical Study of the

Mescaline Psychosis, with Special Reference to the
Mechanism of the Genesis of Schizophrenia and
Other Psychotic States, J. Ment. Sc. 86:29, 1946.
26. Wallace, A. F. C.: Dreams and the Wishes

of the Soul: A Type of Psychoanalytic Theory
Among the 17th Century Iroquois, Am. Anthropologist 602234, 1958.

Printed and Published in the United States of America

85/69

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67484">
                <text>Files and reprints: hallucinogens and EEG, 1959 (folder title 2/2).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67485">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67486">
                <text>mfp-03-01-002-15-015</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67487">
                <text>1959</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67488">
                <text>Various authors</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67489">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67490">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67491">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67492">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67493">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80951">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87512">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94073">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100634">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6750" public="1" featured="0">
    <fileContainer>
      <file fileId="6542">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/18207735ad5546b08aac89618232e7bc.pdf</src>
        <authentication>66f756c9dd21d0500a4b4e9773773d3e</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107147">
                    <text>�������Wm

«

.
.

”1%! W3

l/W

W

"79"!
-

duh [cow

~

4444...;

n—

wlamaZu-ﬂ

nag

‘3

073

/3
W
_———_—_é¢%0u_LL__p_J_
1w...

mug:

.

j”

/ 3

H4

Ito

:98

��'VfJii

MMud‘vue
I7M¢2+ ?
la

Mal.

.max
Q

,4”;
.
9:19

M00

4/73
,“
K

We;

/a¢/If
,,
(14.2...e‘23m,“

L

DF/Wdﬁ

ﬂan"

714

-

“7‘ 44.4.5

44W

r

M

,

%W(“ W77

27/56:.) xéa/av-p 2/3“;

413»;

Ma... 7w,»

#1W
1‘
I;
a.“

me:

‘M‘M w
4‘

7‘

WWW/3,1:I/7
w»!

AWL—«awe;

CK’S")

mm)

M

�7

7

4%?

%

,4» 014/.-

a‘,‘”
__n
”ViV

W ,,

(A.

2‘

MW

"5

11M;

r

W

��‘

WMA

(“Av/Jaw AJa—lnw.m.5¢nﬁ¢

�������M

Wf

-

I7

‘70

[Lav/2.».

5’52

31

,9: d3:

���������ﬁbrw
Dr?
'

D.-

£44415" Iv
~43

VP-’YV

MED-thaw

Masha“.

-6”
'DFP-

m

51am

JV

1

‘

��\ \-_'

&lt;f/

e4 AM (3

�����73/4 r 4/»!

/ 4?

��"

,;

.

“A;

7

m

7V

����Ph.

i74800

MECHOIYI® CHLORIDE
(METHACHOLINE CHLORIDE
U.S.P., MERCK)
a SHARP

DOHME

MECHOLYL* Chloride produces the same physiologic response as does acetylcholine, which,

when released at nerve endings, produces parasympathetic stimulation. In therapeutic doses,
MECHOLYL slows the heart rate, lowers blood
pressure, constricts the bronchioles, dilates the
peripheral blood vessels, constricts the pupils,
Increases intestinal tone and peristalsis, causes
salivation and ﬂushing, and stimulates the detrusor muscle of the bladder. In general its eﬁects
are the opposite of those produced by epinephrine. Its action is much more prolonged than
that of acetylcholine and it is, moreover, devoid
of the nicotine-like effect of that substance.

METHODS OF
ADMINISTRATION
MECHOLYL Chloride is a potent substance

and careful consideration should be given to
Its dosage and method of administration. For

*MECHOLYL is the registered trade-mark of
MERCK &amp; CO., Inc., for its brand of methacholine.

[i]

stopping an attack of paroxysmal auricular
tachycardia it should be given by subcutaneous
iniection (never by intravenous or intramuscular
injection), and the same method of administration
may be used in treating scleroderma, chronic
ulcers, Raynaud's disease and other vasospastic
states, although in the latter conditions better
and more prolonged eﬁects are obtained when
it is administered by the method of ion transfer
For administration by mouth
(iontophoresis).
the less hygroscopic MECHOLYL Bromide is
supplied in tablet form.

Atropine intravenously immediately terminates
the action of MECHOLYL. A syringe containing
a suitable dose of atropine sulfate [0.6 milligram
(l/iOO grainI] should be available for immediate intravenous iniection if the dose of
MECHOLYL Chloride causes undesirable symp-

MECHOLYL Chloride is supplied in ampuls

Since MECHOLYL constricts the bronchioles

containing 25 milligrams (0.025 gram) of the
powder. Solutions for subcutaneous iniection
are prepared by dissolving the drug in sufﬁcient
sterile distilled water to make it possible to
measure accurately and administer easily the
dosage desired.

WARNING
Injections of MECHOLYL Chloride
should be given subcutaneously only.
lniections should never be given in-

travenously or intramuscularly.
PRECAUTIONS
The patient should

be lying down during the

administration of MECHOLYL Chloride to minimize the effects of lowered blood pressure.

[2]

toms.

Overdosage of MECHOLYL may produce
momentary cardiac arrest. The Trendelenburg
position, to give the cardiac center the beneﬁt
of any circulation present, is sometimes beneﬁcial

in such an emergency.

and may produce an asthmatic attack in those
subiect to this condition, it should be used with
extreme caution, if at all, in cases where there
is a history of asthma or hypersensitivity.
Substernal pain following the administration
of MECHOLYL is said to be rare. However, the
use of this drug in patients subiect to angina
pectoris is not recommended.

USE IN PAROXYSMAL AURICULAR
TACHYCARDIA
One of the most efﬁcacious uses of MECHOLYL
Chloride is in terminating attacks of paroxysmal
auricular tachycardia. It is, however, not effective for prophylaxis or for continued treatment
in cases of frequent recurrence of the arrhythmia.

[3]

�not recommended for the treatment of
auricular fibrillation, auricular ﬂutter, or paroxysmal ventricular tachycardia.

It is

DOSAGE
The initial subcutaneous dose of MECHOLYL

Chloride should be limited to IO milligrams (0.01
gram) to test the patient's tolerance. Careful
preliminary testing of the patient with a small
dose will not nullify the effect of a subsequent
dose, and is advisable if there is any doubt of
the patient's ability to tolerate the drug.

treating paroxysmal auricular tachycardia
in patients under twenty years of age, IO milligrams given subcutaneously usually terminates
an attack. In older patients, 20 to 40 milligrams
may be required; obese patients sometimes
require more.
In

Slow absorption of the drug due to inadequate local circulation may interfere with the

therapeutic response. If the attack is not terminated in two minutes, compression of the vagi,
together with gentle massage at the site of
iniection to promote absorption, is suggested.
Conversely, if absorption is found to be too
rapid, further absorption may be retarded by
applying a tourniquet above the site of iniection.
The eﬁects of MECHOLYL may be terminated
immediately by atropine.

[4]

and larger dose (if that given ﬁrst
fails to interrupt the attack) may be given 20 to
30 minutes later, providing no severe reaction
has occurred following the ﬁrst dose.
Quinidine in moderate doses (not more than
0.2 gram four times a day) usually does not
impair the MECHOLYL effect. Larger doses
tend to inhibit its action, although MECHOLYL
has been known to “break through" the depresr
slon of quinidine.

174800
For oral administration or administration by
the method of ion transfer (iontophoresls)—Ph.

A second

I

Gm. bottles.

10 Gm. bottles.
MECHOLYL BROMIDE (for

oral administration

only) is supplied in
Boxes of 24—200 mg. (0.2 Gm.) tablets
Bottles of 500—200 mg. (0.2 Gm.) tablets

OTHER USES OF
MECHOLYL CHLORIDE
been used (by suba number of other condi-

MECHOLYL Chloride has

cutaneous iniection) in
tions, particularly in certain vasospastic diseases,
such as Raynaud’s disease, in chronic ulcers, and
in scleroderma. If a test dose of IO milligrams
of MECHOLYL Chloride has been well tolerated,
the subsequent dose may be increased cautiously
up to 25 milligrams (0.025 gram). In these
conditions, however, the much more prolonged
eﬁect produced by MECHOLYL Chloride administration by the method of Iontophoresis (ion
transfer) or by the oral administration of
MECHOLYL Bromide Tablets is preferred.
MECHOLYL CHLORIDE is supplied

,snm
DOHME

SHARP 8: DOHME

as follows:

Philadelphia, U. S. A.

For subcutaneous iniection—

DIVISION OF MERCK a: CO. Inc.

Boxes of 6 ampuls each containing 25 mg.

(0.025 Gm.) of the dry powder.
I 5 I

P-

IB-413

[6]

Printed in U.S.A.

�For the Medical Profession
only

‘ANECTINE’®
CHLO RIDE

BRAND

SUCCINYLCHOLINE CHLORIDE

INJECTION
20 mg. in each cc.

Multiple-dose vials of

IO

cc.

(for intravenous use)

; n’l
' ix, use
'v 6’ ‘ "

' e .,'alysis.

While respiratory depression is
usually
a
r
single
dose
of
the
drug,
or
following
’M‘uV-r-mtous administration,
cessamore prolonged respiratory
there
may on occasion be
depresoion
requiring adequate respiratory exgen by the administration
of supplemental or controlled
.

-

-.

.

‘ANECTIN E’ Chloride brand Succinylcholine
Chloride Injection is an ultra-shortactmg skeletal muscle relaxant;
that is, following intravenous injection of small
procedures. The quick
return of spontaneous respiration is a deﬁnite
For more prolonged relaxation
advantage.
‘ANECTINE’
may be given by continuous intravenous drip; tachyphylaxis does
occur and cumulative action is not
seen. The degree of relaxation not be
ordinarily
may
controlled
by
the solution. Upon
stopping the intravenous drip, adjusting the rate of ﬂow of
narily resumes within a minute and
spontaneous respiration ordirecovery is complete within 5 minutes.

CHEMICAL PROPERTIES
Succinylcholine chloride, also
to as diacetylcholine chloride, is
odorless, crystalline substance referred
a white,
which'is
readily
soluble
in
succmic acid bis (ﬂ-dimethyl—aminoe‘thyl)
water. Chemically it is
ester dimethochloride, and its formula
is as follows:
i
'

'

’

Cl
CH2COOCH2CH2iV(CHa)3

CH2COOCH2€H2N(CH3)3
:I'he ester linkage is rapidly
hydrolyzed in alkaline solutions but is
in acrd solutions. In order to
relatively stable
promote
stability, solutions should be
refrigeration. It appears that
succinylcholme is rapidly hydrolyzed kept-under
followmg its

PHARMACOLOGICAL ACTION

‘ANECTINE’ causes muscular
transmission at the myoneural paralysis by producing a blockage of nervous
junction.This action was ﬁrst reported
et al.1 Independent studies
by Bovet
The
at
Wellcome
Research Laboratories have been
conducted on the synthesis2 and
pharmacology“7 of the drug. de Beer and his
associates3-7 have found that doses
as low as 0.05 mg./Kg. given
cats are effective in producing
intravenously to
muscular
relaxation, and that intravenous doses of
0.1 mg./Kg. or more
produce
and complete muscular
characterized by short durationprompt
paralysis which is
of
and
action
extremely rapid recovery. Repeated
injections produce reproducible and
phylaxls nor signiﬁcant cumulative predictable muscular paralysis, neither tachyeffects being seen.
When given by intravenous drip,
a predetermined degree
(scratic
of relaxation in a cat
nerve-gastrocnemius muscle) could be closely
approxrmated by adjusting

�The administration of doses of ‘ANECTINE’ sufﬁcient to produce complete
neuromuscular blockade has not caused any signiﬁcant. ghange in blood pressure
(except for the typical asphyxial pressor response in the absence of adequate
respiration). No,evidence of any histamine-like depressor action has been found,
thus differing from observations with d-tubocurarine. The ECG of the caﬁ was
unchanged during a 2-hour infusion maintaining complete paralysis.
'

‘

‘

Acute toxicity studies in albino mice showed the intravenous L.D.5o to be 0.55
to 0.59 mg./Kg. Complete paralysis resulted, with marked dySpnea and anoxia;
death was apparently due to respiratory failure. Those mice which survived the
initial symptoms exhibited disappearance of anoxia and dyspnea in 2 minutes and
had completely recovered within 30. minutes. Chronic toxicity studies on albino
rats showed that the intraperitoneal injection of -1' mg./Kg. or less, twice daily
over a period of 4 weeks, produced no evidence of toxicity.
important.diﬂ‘erence‘between ‘ANECTINE” and d-tubocurarine is that the
former is not antagonized by anticholineste'rases. On the comrhlti’, 5.14.911 drugs as
physostigmine, lThis
rostigmine (neostigmine) and procaineaapnoli‘asgmthg 5;th 1:8 :11
would support the theory that syuccinylcholine'is hydrogze
succinylcholine.
by cholinesterases and that interference with this enzyme actiOn results in per- -.
sistence of activity of the drug. Edrophonium (Tensilon) also prolongs the action of
succinylchohne.
An-

'

,.

'

CLINICAL INDICATIONSUKNI) DOSAGE

‘

1

Short Duration: ‘ANECTINE'

Chloride brand Succinylcholine Chloride Injection is indicated for the production of muscle relaxation during surgical procedures,
3,9,13il5-17 and in conjunction with electroshock therapy.13,14,16 In view of its
very
short duration of action (usually about 3 minutes following a single intravenous
injection) succinylcholine is ideally suited for procedures ;requiring 'only brief
relaxation, .such as endotracheal intubation, endoscopic examinations, orthopedic
manipulations, short surgicalvprocedures such as tonsillectomies, and electroshock
therapy. As described previously, intravenous administration of the drug produces
relaxation within a minute, which lasts about 3 minutes and is quickly followed by
recovery of spontaneous respiration in those cases where apnea hasoccurred.
Dosage for. Short Procedures: The average dose for’relaxation of short duration
is 20 mg. (1"cc.) ‘ANECTI‘NE’ Injection given intravenously (Foldess)... The
optimum'doSe will vary among individuals and may vary from =10 to 30 mg." for
adults (0.5 to 1.5 cc.). Following administration of doses in this range, relaxation
develops in about 1 minute; maximum muscular paralysis may persist for about 2
minutes, after which recovery rapidly takes place within the next few minutes.
However, very large doses may result in more prolonged apnea. ”-21
Obviously, facilities for supplemental or controlled respiration with ,adequate
exchangeoi oXygen should be available at all times. In order. to'avoid carbon
dioxide accumulation and hypoxia, supplemental or controlled respirationgshould
b? provided during respiratory depression without waiting for the development
0 apnea..
,

Prolonged Relaxation: Although ‘ANECTINE’

isfshort—acting, prolonged relaxation may be obtained by repeated injections or, preferably, by maintaininga
continuous intravenous drip.8,3o By adjusting. the rate of ﬂow, the desired
degree of relaxation may be obtained and maint‘air‘ie'd‘, and the degree of relaxation
can be changed within 30 seconds by changing the rate of ﬂow. Upon stopping the
ﬂow of the intravenous drip solution, relaxation. quickly disappears. In those
cases where respiration has been depressed it usually returns to normal_within a.
few minutes upon stopping the intravenous drip,
V.

Dosage for Long Procedures: The-'aVerage dose for continuous intravenous infui‘

sion is 2.5 mg. per minute for adult patients. For convenience'in preparingsolutions
for intravenous drip there are available ‘Anectine’ Chloride Solution, 50 mg.
per cc.,
10 cc. ampuls and 100 mg. per cc., 10 cc. ampuls. The, contents of one 500
in
mg.
10 cc. ampul may be added to SOD-ecstetileiisotonic saline solution to
an
prepare
(1
0.1%
mg. per cc.) ‘Anectine’ Chloride Solution; the contents of one 1 Gm. in
’0 cc. ainpul‘maybe added to 1,000
cc. to prepare an 0.1% ‘Anectine" Chloride
Solution. This concentration is suitable for continuous intravenous infusion, See
literature accompanying ‘A‘u‘ectine' Chloride Solution,’5_0fn‘1g./cc., 10 cc. ampuls, and
100 mg:‘]cc.,«10 c‘c‘. animals for details regarding use of'r'this‘product for obtaining
' '
r‘elaxatiOn.
Solutions
for
prolonged
intravenous drip jay also be‘ prepared. for a
dilution of‘An‘e’ctine’ Injection, 20 mg./cc. in appioprrate proportions.
‘

NOTE: Succinylcholine is rapidly hydrolyzed by alkaline'solutions and therefore
loses potency rapidly. it mixed with thiopental sodium (pentot‘hal sddium). Such
mixtures, if used at all, must be used within a few minutes ofvprepatationq however,
separate injection of ‘ANECTINE’ is preferable. Succinylcholine chloride is quite
stable when storedqunder refrigeration. 0n long standing at room temperature
potency gradually decreases; however; solutions may be kept as long as 3 months
at room, temperature without signiﬁcant loss of potency as determined by
biological assay.
,

,

'

!~-

‘

�.m

.

.

CONTRAINDICATIONS AND PRECAUTIONS

The drug should be used only by those skilled in‘ the administration of
sppplemental *oecontrolled. respiration and facilities for this procedure, including
adequate respiratory exchange with oxygen, should always be immediately
..
available. “'V
'

'ANECTINE’lis not an anesthetic agent and should not be regarded as a substitute for anesthesia; 'its‘Ause“ does not take the place of givmg an adequate
amount of anesthetic agent.
Some anesthesiologists believe that rapid injection is responsible for the muscular
twitching that is seen just prior to relaxation. These fascrculations may be due to
the‘rate’of injection of the drug, and may be minimized or avoided ‘by giving the
injection more slowly/,8,”8
While respiratory depression is usually of very short duration following a 'single
dose of the drug, d" following cessation of continuous intravenous administration,
‘LiiCl‘C may‘e..-.§ribcc{i.iongespeaially with excessive
doses, more prolonged respiratory
depression 1.9-2]- requiririg controlled respiration and the administration of oxygen.

The duration of the effect of ‘ANECTINE’ may depend on plasma-cholinesterase
activity.94,2°,27 Patients’with severe'liver disease, severe anemia, severe malnutrition, and possibly those suffering from' polyphosphate insecticide poisoning may
have a decreased plasma-cholinesterase activity which may intensify and prolong
the action of ‘ANECTINE’, especially if large'doses are used.23,29 In such cases,
in addition to the usual measures of controlled respiration and administration of
oxygen, it may be desirable to administer plasma or whole blood for the purpose of
restoring cholinesterase activity,”
Neostigmine and other anticholine’sterases, as well as edrophonium (Tensilon),
do not antagonize the action ,of~‘ANECTINE’, but on the
prolong its
contrary
eﬁ'ect. They are therefore contraindicated as antidotes for ‘ANECTINE’.
Intravenous injections of proCaiiie likewise may prolong and intensify the action
of ‘ANECTINE’.

There is evidence that intraocular pressure is increased slightly following injection of ‘Anectineflﬂ “This effect is seen immediately after the injection and
during the fasciculatory phase; it' subsides as complete paralysis supervenes; it
appears to be the result of brief contraction of the extraocular muscles. This
suggests that ‘Anectine’ should ’be usedl‘with caution, if at all, in intraocular
surgery. The opinion is expressed that the effect is probably not sufﬁcient to contraindicate the drug in general, surgery or electroshock therapy for patients with
"'
glaucoma.
‘

r‘

.- .KBIBIZIOGRAPHY
1.

2.

Bovet, D., Bovet—Nittl, F., Guarino, 3., Longo, V.G., and Marotta, M.: Pharmacodynamical
property of certain derivatives of suc’cin'ylcholine with curate-like action: esters of trialkylethanolamine of dicarboxylie aliphatic acids. Rendieonti Istituto Superiore di Sanita 12:106, 1949.
Phillips, A.P.: Synthetic curate substitutes from aliphatic dicarboxylic acid aminoethyl esters.
J. Am. Chem. Soc. 71:3264, 1949.
Castillo, J.C., and de Beer, E.J.: Poteii‘tiationbl' curarizing action of diacetylcholine (succin lcholine) by aliphatic dicarboxylic acid aminoethyl amides. Federation Proceedings 9:262, 19 0.
Castillo, J.C. and de Beer, E.J.:_The neuromuscular blocking action of succinylcholine (diacetylcholine). J. Pharmacol. 6: Exper. Therap. 99:458, 1950;
de Beer, E.J., Castillo, J.C.,1.Phillips, A.P.,3Fanelli, R.V., Wnuck, A.L., and Norton, S.: Synthetic
drugs inﬂuencing neuromuscular activity. Ann. New York Acad. Sci. 541362, 1951.
Wnuck, A.L., Norton, 5., Ellis, C.H;, and- de Beer, E.J.: Production of controlled neuromuscular
block by infusion of diacetylcholine. Federation Proceedings 11:403, 1952.
Ellis, C.H., Norton, 3., and Morgan, W.V.: Central depression by drugs which block neuromuscular
transmission. Federation Proceedings “11:42, 1952.
Foldes, F.F., and McNall, P.G.: Succinylchélinei A new’a‘ppréach to muscular relaxation in anesthesiology. New England J. Med. 247596, 1952.
Brucke, H., Ginzel, K.H., Klupp, H., Piaffenschlager, F., andWerner, 6.: Muscle relaxing effect:
of bis'echoline e'sterof dicarboxylic‘acid in narcosis. Wien. klin. Wchnschi‘. 63 :464, 1951.
Ginaiel, K.H., .Klupp,.H.,; and Werner, G.: Pharmacology of
”bis—quaternary Yammonium
a,
compounds. Comparative tests withisome aliphatic dicarboxylic acid esters. Arch. int. Pharmacodyn. and Therapy. 87:79, 1951.
7Gi'7nzzei,9§(l‘.H, Klupp, H., and Werner, G.: A‘dicholine ester with greater curare effect. Experentia
.
a.
Arnold,‘0.H., Bock-Greissau, W., and Ginzel, K.H.: Wien. med. Wchnschr. 101:492, 1951.
Thesleﬁ‘, S.; Pharmacological and clinical tests with LT 1. (0.0—succinylcholine iodide). Nordiak
’
Med. 46:1045, 1951.
Holmberg, G., and Thesleff, S.: Succinylcholine iodide as a muscle relaxant in electro—shock treatment. Nordisk Med. 4621567, 19SL‘Abst. in J.A.M.A. 14821064, 1952.
Dardel, 0.37., and Thesleﬁ, 8.: Clinical results with succinylcholine iodide, a new muscle relaxant.
Nordisk Med.‘46:1308. 1951.
Thesleﬁ‘, 5., and Dardel, O.V.:'Clinical report on succinylcholine iodide. Presented at 26th International Congress of Anaesthetists, London, September 3—7, 1951. Abstracted in J. Am. MJWom. Assn. 7:58, 1952.
"

3.
4.
5.
6.
7.
8.

9.'
10.
11.

:

12.
13.

.

-

,

‘

14.
15.

‘

16.
~

'

�I7. Mayrhofer, 0., and Hassfurter, M.: Surgical risks in patients with cardiac and vascular disorder.
Wien. klin. Wchnschr. 63:88.5, 1951.
18. Holzer, 1-1.: Wien. med. Wchnschr. 102:112, 1952.
19.
{IggerfgIséKd Prolonged respiratory paralysis after succinylcholine. Correspondence. Brit. MJ.
20. Love, S.H.S.: Prolonged apnea following scoline. Correspondence. Anesthesia (London) 7:113, 1952.
21. Gould, R.B.: Succinylcholine. Correspondence. Brit. MJ. 1:440, 1952.
22. Bovet, D., Bovet—Nitti, E, Guarino, S., Longo, V.G., and Fusco, R.: Investigations on synthetic

23.
24.
25.
26.
27.
28.
29.
30.

31.

curarizing drugs. III. Succinylcholine and its aliphatic derivatives. Arch. int. Pharmacodyn.
and Therapy 88:1, 1951.
Poulsen, H. and Hougs, W.: Letters to the Editor, Lancet 2:199, 1952.
Foldes, F.F.: Letters to the Editor, Lancet 2:245, 1952.
Kay, H.T.: Letters to the Editor, Lancet 2:200, 1952.
Evans, F.T., Gray, P.W.S., Lehmann, 1-1., and Silk, E.: Sensitivity to Succinylcholine in Relation
to Serum-cholinesterase, Lancet 1:17.29, 1952.
Bourne, J.G., Collier, H.O.J., and Somers, G.E-:ASuccinyIchoIine (Succinoylcholine)—MuscIe
»S[«
Relaxant of Short Action, Lancet 1'§2.£5, 1952.
Lehmann, 1-1.: Letters to the Editor, Lancet 2:199, 1952.
Hampton, L.J.: Personal communication.
.L .
,r .:l
Diacétiyilchdlihe
I"
and
Little.
M., Jr , Hampton, L.].,
Grosskreutz, D.C.'.
(Succin’yIcIroIine): A
Controllable Mu'scIe Rel’axant. Presented before the Twenty-seventh Annual Cpnzress of Anes‘ ”
‘h
thetistSyVirginia Beach, Virginia, Septemher 22-15,..1952. " " ‘1 '
Lincoff, H.A., Ellis, C.H., DeVoe, A.G., de Beer, E.J., Impastato, D._I., Berg, 5., Orkin, L., and
Magda, 1-1.: The EEect of Succinylcholine on Intraocular Pressure. Am. J. Opth. 40:501,1955.
—

PREPARATION
FOR IMMEDIATE INJECTION OF SINGLE DOSES FOR SHORT PROCEDURES

‘ANECTINE’

CH LORIDE mo
SUCCINYLCHOLINE CHLORIDE

INJECTION
20 mg. in each cc.

multiple-dose vial: of IO cc.
For intravenous i'nieetion
V

Also available:

FOR PREPARATION OF INTRAVENOUS DRIP SOLUTIONS ONLY

‘ANE

CTINE ’

C H LO R I D

E

m

SUCCINYLCHOLINE CHLORIDE

STERILE SOLUTION
50 mg. in each cc.
IO cc. ampuls

(Total contents 500 mg. Succinylcholine Chlorlde)
To be diluted before using
FOR PREPARATION OF INTRAVENOUS DRIP SOLUTIONS ONLY

HIGH POTENCY
‘A N E C T I N E

’0

CHLORIDE

SUCCINYLCHOLINE CHLORIDE

STERILE SOLUTION
100 mg. in each cc.

10 cc. ampuls
(Total contents I Gm. SuccinyIchoIine Chloride)
To

be diluted before using

‘Aneetine’ Injection is supplied in the form of a sterile isotonic
aqueous .rolution. ImtoniCity 15' achieved by the addition of a :uitable
quantity of sodium chloride.

\\

.”
p,“

BURROUGHS WELLCOME

&amp;

CO.

(U.S.A.) INC.,TUCKAHOE, N.Y.
Associated Houses:
LONDON
BOMBAY

by 731

MONTREAL

BUENOS AIRES

Printed in u.s.A.

SYDNEY

CAIRO

JOHANNESBURG
DUBLIN

AUCKLAND
41 I o o 6

�Poloni, A.: L'Acetilcolina nel liquor dei malati di mente. Hancenze di effetto
curarosimile del liquor di echizophrenici sul mnecolo
acetilcolina e en
dorsale dell:
saga, I1 Gervello g1: 81-1oh, 1951.

Translation of

EEEEEEE‘

author, using the method of Tower for the conservation of acetylcholine
in spinal fluid, and the dorsal muscle of the leech for the test, has made the fol»
lowing observations in several trials, making use of the spinal fluid of 10 normal
subjects and 110 mental patients, of whom 50 were schizophrenics, 10 progressive
paralytica and 50 subjects with other forms of mental disease:
The

(1) That the spinal fluid of normalaubjects cistains acetylcholine in a
to 1:1G'
concentration varying from

1:1

(2) That the spinal fluid or schiaophrenice in 9h$ of the case: does not
contain ecetyloholine bet a substance which produces an action antagoMstic to acetglgholine, 7; weble to that of ”curare", in a concentration of 1:1 to 1:1'
....

(3) In the spinal fluid‘of the progressive paralytic: one encounters the
some curare-like subetance nut in a lower concentration than in that
of schizophrenics.
(h) The spinal fluid of persons affected with other forms of mental sick—
ness, as well as that of normal subjects, did not contain the curerelike substance in a discernible quantity, but only acetylchcline, which
was found in greater concentration in the hystericale and epileptice, in
lower concentration in senile psychotics and alcoholics.
This emphasizes the pathologic vale of the report obtained from the spinal
fluid of schizophrenics and progressive parelytics and suggests the hypothesis
that the curare-like substance is trimethylamine, product of the excessive catabol~
ion of choline, of which the author has found an abnormal urinary excretion in

schizophrenics;

(In the

some

paper, in a footnote, the author eliminates trimethylamine, since

does not have aurora-like

properties.)

it

�CHOLINERGIC ASPECTS OF CONVULSIVE THERAPY

Max

Fink,

M'.D.

�\

From
‘

the Department of Psychiatry, Washington University School
of Medicine and the Department of Psychiatry at the
Missouri Institute of Psychiatry, University of Missouri
School of Medicine, SUOO Arsenal St., St. Louis, Missouri 63139.
MH-072u9
and
MH—2715,
MH—927,
grants
part,
IVE-11380; and the Psychiatric Research Fomdation of Missouri.

Aided, in

IX:

65-8

2-25-66

by

USPHS

Revised for the Jowmal. 06 vaouA and Manta! Disease.

�CHOLINERGIC ASPECTS OF CONVULSIVE THERAPY

While

the

mode

of action of convulsive therapies remains

enigmatic, one theory holds that the early development and
persistence of changes in brain function are requisite to changes

in behavior.“3’21,22

useful index of neurophysiological change
is the appearance of high voltage electroencephalographic slow
wave activity.22 '23 While the biochemistry of this
activity is
A

poorly understood, demonstrations that it is inhibited by anticholinergic corrxpoundsl9920’3""56 suggest that cholinergic systems
may

play an active part.
The EEG

patterns and the response to anticholinergic drugs
in convulsive therapy are similar to experimental and clinical
head trauma and to a

lesser extent, to spontaneous seizures.

impulses has been extensively studied since the early
descriptions
by Dale12 and Loewi.38 A constituent of nervous tissue in
a

acetylcroline is liberated during the excitation
process. It is rapidly hydrolyzed through the mediation of
aoetylcholinesterase and is rapidly reconstituted by the
bound form,

�choline—acetylase system.‘+5

Free acetylcholine has not been

measurable in normal cerebrospinal

fluid despite the rapid

breakdom of bound acetylcholine during periods of activity
and excitement.63

But the normal

have measurable cholinesterase

cerebrospinal fluid does

activity.“1

ChoLéneILgic Mme/ta 06 CILanLoce/Lebm

mena.

Free

acetylcholine was found in the cerebrospinal fluid of cats
within a few minutes after experimental head trauma and

persisted for varying periods up to 1+8 hours. The quantity
of free acetylcholine varied between 2.7 and 9.0 gamma/ 100cc
and the amount was

related to the degree of induced trauma.6

Concurrent electroencephalogram

first

demonstrated high

voltage fast activity, interpreted as evidence of an intense
neuronal discharge, which was succeeded by-a short period

of flattening of all recorded electrical activity. These
phases were followed by prolonged periods of high amplitude

sharp waves in the delta frequencies.
The

behavioral changes related to the degree of induced

trauma and to the amount of measured free acetylcholine.

With

higher levels of acetylcholine, Bornstein reported greater
degrees of EEG abnormality and greater changes in consciousness.
Spontaneous post-traumatic seizures were also
amount

related to the

of free acetylcholine measured in the cerebrospinal fluid.

�Bornstein applied acetylcholine to exposed cat cerebral

cortex.

When

the concentration of acetylcholine was

or less, high amplitude sharp
the electroencephalogram.

to

2

waves

When

of low frequency appeared in

the concentration

gamma/100cc, the electroencephalogram

parallel to the post-traumatic records.
Investigations in neurological patients
McEachern demonstrated

1 gamma/10000

was

increased

flattened in a fashion
by Tower and

free acetylcholine in the cerebro-

spinal fluid only in patients with recent head trauma, recent
grand—Hal

seizures or after electroconvulsive therapy.63 Free

acetylcholine varied from 0.2 to

100 gamma/ 100cc.

In assaying

spinal fluid cholinesterase activity, they noted a sharp rise

in the butyrylcholinesterase fraction and a fall in the

acetylcholinesterase fraction in patients with head trauma
and following convulsive therapy.

however, the cerebrospinal

although

it

'

After spontaneous seizures,

fluid did not exhibit such inversion

contained free acetylcholine. They concluded that

the level of free acetylcholine varied directly with the
degree of cerebral damage and that reversal of cholinesterase

fractions

was a more

sensitive indicator of cerebral

damage.

Electroencephalograms taken at varying intervals following
trauma also indicated a

relation

between the degree

of

EEG

abnormality and the appearance of free acetylcholine in the

cerebrospinal fluid.

�Increased acetylcholine in rat brain after traumatic shock
was also reported by Kbvach, at a£.35 This acetylcholine

activity
vitae.

was

inhibited

by

the administration of atropine tn

electrographic, behavioral and neurologic signs of
head trauma were blocked by the parenteral administration of
The

atropine, as were similar clinical changes
occurring after the intracisternal addition of acetylcholine.6
0.5—1.0 mg/kg

applied these observations to the treatnent of closed
head injuries. In 20 patients with varying degrees of trauma,
he administered atropine subcutaneously in doses of 0 .1 mg/kg,
Ward

noting clinical improvement in

some and

electrographic effects in others.67

a reversal of the

The same changes

in the'
.*-‘_

post-traumatic electroencephalogram were reported by Jenkner
and Lechner in a study of diethazine, another anticholinergic
single intravenous dose in forty patients resulted
in nornalizing the abnormal electroencephalogram in twenty—two
drug.

A

and marked improvement in

six others.33

Similarly, in experiments of post—traumatic shock and
cerebral edema in animals, Denisenko reported a blocking of
the clinical changes by such anticholinergic compounds as
methylbenactyzine and adiphenine (Trasentin).13
ThuA,

the amount

06 Mae

acetytchloune

may tamed/52

éptnat ﬂuid 60110“)th cmtnocuebaat mama and the

tn

the,

amount 06

-

‘

-A,‘r

�ghee acety£cho£ine,

the degnee and type

05

e£ecthoencepha£nghaphie

in carded/C behavion

abnolzmablty, and changed

phenomena, which may be deduced by

appear/L aA

the adminibtnation

Lute/mutated

anti-

06

chounugie daugb.
Bluuln

acetylchoﬂéne and antéehounugic dhugb.

The

effects

of the direct application of acetylcholine to the central nervous
system

may

also

be blocked by

anticholinergic drugs.

The

administration of the cholinesterase inhibitor di—isopropyl
fluorophysphate

(DFP)

elicited high amplitude rapid frequency

patterns similar to

status epilepticus and some posttraumatic states.2'*’31a32a68 These EEG effects were blocked
by small doses of parenteral atropine and scopolamine. The'
EEG

geat increase in acetylcholine after tetraethyl
(TEPP) was measured and

pyrophosphate

related to the toxic effects

and the

induced convulsions .29 ’59

Chatfield and

Dempsey

prepared exposed animal cortex with

prestigmine and evoked electroencephalographic spike activity.

prior administration of atropine blocked the appearance of
spiking, or if present, this electrical activity could be

The

eliminated by atropine.9
In contrast to these findings, Brenner and Merritt applied

topical acetylcholine in concentrations of

2—1/2

to

1096

to the

exposed cortex of cats and noted no effect. on the electro—

encephalographic changes

after intravenous atropine

(1 mg/kg) .7

�The

concentrations of acetylcholine in these experdnents, however,

were higher than the

topical applications

(1-H gamma/1000c) and

the intracisternal (0.2-10 gamma/10000) injections of Bornstein.6
Brenner and Merritt also noted electroencephalographic effects

similar to acetylcholine after methacholine (Mecholyl) and
carbamylcholine (Doryl) in concentrations much lower than the

acetylcholine concentrations. They ascribed the increased

effectiveness of these cholinergic drugs to their lack of
sensitivity to cerebral cholinesterases.

6mm Atady a

necuAa/Lg

Ceaebao¢pina£ Fluid Acetyﬁchoﬁine and Seizuneb.

One view

Thug data

M9,

conﬁuwxg and

to quaiiﬁy thié iAAue.

of acetylcholine metabolism finds

it

in nervous tissues in an

inactive and bound form. During periods of activity, acetylcholine
is liberated at the cell membrane where it is rapidly deactivated
by cholinesterases. The amount of bound acetylcholine is the

resultant of the continuous processes of synthesis, liberation
'u

and breakdown.15

It

has been postulated that the level rises

falls during waking activity.15’29’“5’6°
at al. reported increased free and total acetylcholine

during sleep and
Tbbias

after chlorofornland pentobarbital anesthesia in rat and frog
brain but no changes after strychnine or picrotoxin convulsions.5°

�(microacetylcholine
of
level
the
neasured
Richter and Crossland
in
and
rat
sleep
anesthesia
during
tissue)
brain
gamma per mg.

brain to be

300%

The
difference
levels.
post—seizure
than
higher

rate
resynthesis
the
as
however,
transient,
in tissue levels is
gamma/gm/minute).“5
(7
high
is
brain
in
rat
for acetylcholine
Crossland
a£.16
and
at
Elliott
confirmed
by
These observations were
and Merrick.11

Giarman and Pepeu

reported the increase in

be
roughly
to
various
depressants
following
acetylcholine
nervous
central
the
of
of
depression
the
degree
proportional to
Buck,
and
Maynert
activity.29
motor
in
system and the reduction
sedation
during
levels
acetylcholine
brain
however, studying
elevated
with
associated
were
sedatives
concluded that some

existed.39
relationships
rigorous

brain acetylcholine but that no
of.
observations
In part, this may be related to the earlier
in
measured
synthesis
acetylcholine
McLennan and Elliott that
narcotic
of
low
dosages
by
accelerated
rat brain slices is
dosages.”°
by-high
inhibited
but
drugs,
in
fluid
the
in
spinal
Free acetylcholine was reported
an
patients,
epileptic
patients with epilepsy.1°’63
5.0
0.02
to
of
in
quantities
demonstrated free acetylcholine
Of 56

Acetylcholine
gamma/100cc.
1.0
of
with
an average
gamma/100cc
extent
the
seizures,
of
the
frequency
to
related
levels were

since
time
the
and
to
abnormality,
of electroencephalographic

�the last seizure but bore no relation to medication, type of
epilepsy or level of cholinesterase activity. Elliott at al.

also noted free acetylcholine in the spinal fluid in concentrations up to 3 gamma/100cc after pentylenetetrazol (Metrazol)
convulsions.16
Tower and McEachern viewed

the increased acetylcholine

as a by—product of the seizure and not causal.63 Studying

the hypothesis that seizures were induced by the accumulation
of acetylcholine, Tbrda neasured the level of acetylcholine

in brain tissue after pentylenetetrazol convulsions. She noted
a rise in the acetylcholine content of brain before and a fall
during the convulsion.

Below

certain levels of acetylcholine,

convulsions failed to occur. She suggested that the

fall in

.

tissue acetylcholine during a convulsion was due to the
inhibition of acetylcholine synthesis by increased concentra-’
tions of metabolites such as annenium ions.51:62
Giarnen and Pepeu also measured changes in central nervous

system acetylcholine following various stimulants.29 Only

after

nethacholine and 3, 5—dimethylbutylethyl-barbiturate was there
a significant change in the acetylcholine level. They noted a
decrease in association with induced convulsions. With other
drugs which they classified as stimulants (LSD, iproniazid,

iproniazid

+

hydroxytryptophan, and iproniazid

were no changes in the acetylcholine

level.

+ DOPA)

there

They concluded

that

�despite intense excitation produced by these compounds, there
were no changes in acetylcholine levels unless these were
accompanied by convulsions.

(The

between these observers and Cone
may be

differences in observations

at at.

related to the differences in

measurenents, fOr the

latter

and Tower and McEachern

methods

measured changes

of biochemical

reflecting free

acetylcholine only, while Giarman and Pepeu measured total
acetylcholine including bound and free forns of acetylcholine.“°).
Thane btudieb Auggebt

that

aae accompanied by an tncteaee

tibeaated

6aom

tté

Apontaneoub on tnduced 4etzune¢

tn tnteaeettutaa

ﬁnee

aeetytchottne

bound ﬁonm whtch may be aeﬁteeted

tn the Aptnat

staid. Ceaebnat activity and eetzuneé enhance aeetytehottne
deatAuction, toweatng txnbue teveZA 06 aeetytehottne, white eteep
and anebthebta augment aeetytehatine paoduetion ineaeaetng ttbbue

tavetb.
'

Centaat

Menuoue SyAtem

Cholineeteaaeee.

Tower and McBachern

also measured spinal fluid cholinesterase activity.63’5“’65

By

reporting cholinesterase activity as a ratio of the rate of
hydrolysis with two substrates compared to an acetylcholine

substrate, acetylcholinesterase/acetylcholine and butyrylcholinesterase/
acetylcholine ratios are derived. Normal cerebrospinal fluid
contains these esterases in the ratio of 33:17.

�-10In patients with head trauma, Tower and

MCEachern

reported

an inversion of the cholinesterases with an increase in the

butyrylcholinesterase of the spinal fluid and a decrease in
acetylcholinesterase activity. The extent of the cholinesterase

related to the severity of trauma and to the degree
abnormality. A similar reversal was observed in patients

reversal
of

EEG

was

undergoing convulsive therapy.

In patients with elevated spinal fluid acetylcholine
spontaneous seizures, however, no change in the

after

ratio of

cholinesterases or total cholinesterase activity was found.
Changes in cholinesterase activity may be related to changes

in cell

membrane

permeability. Acetylcholinesterase is found in

highest concentration in the central nervous system while
butyrylcholinesterase predominates in other tissues, especially
blood serum. With increased cerebral acetylcholine, vasodilation

predicted, with
vascular fluid transudation varying with the extent and duration
of the vasodilation.35 Spiegel, Spiegel—Adolf, and their
and increased

cellular perneability

may be

co-workers demonstrated such perneability changes and increased

conductivity of the tissues associated with the appearance of
various ions (as potassium and phosphate) in the spinal fluid
following electrically induced convulsions.5"'58

electrolytes as nucleic-acid splitting

enzymes

Such non-

also increased.

�-11-

Changes

in cellular permeability

may

be the basis

for the high

concentrations of acetylcholine and increased concentrations
of butyrylcholinesterase after

induced seizures or head trauma.65

That changes in cholinesterases may be large and measurable

is suggested

tte recent demonstrations that neural stimulation

by

and learning produces changes in brain weight and acetylcholinesterase

reports, Pryor and Otis studied
the effects of repeated induced seizures in Wistar rats.“3 After
Following these

activity.37’“9
as

little

as

u

weeks they observed

increases in brain weight and

in acetylcholinesterase activity which

was

related to decrements

in behavioral perfornance.
persistance of acetylcholine in spinal fluid after
head trauma and after seizures despite increased cholinesterase
The

activity

may be

acetylcholine—
the
of
the
related to
sensitivity

acetylcholinesterase system to concentration relationships.8’“1’55
At "physiologic" concentrations, hydrolysis of acetylcholine is
rapid

(3—H

ndcmoseconds) but

at higher

and lower concentrations,

the activity falls off quickly. In contrast, the
butyryldholinesterase~acetylcholine relationship is non—specific

rate of hydrolysis increases with increased concentration.
These relationships relate to theories of the induction of
seizures. While the usual concentrations of acetylcholine at

and the

cell

membranes

are destroyed by the specific activity of

acetylcholinesterase in a

few microseconds, an excessive

concentration following excitation

may

exceed

its rate of

�-12-

hydrolysis.

The

seizure threshold

induced, with the seizure

itself

may be

reached and a seizure

adding to the amount of free

acetylcholine. Increased acetylcholine affects vascular and

cellular perneability altering the concentrations of various
ions, including butyrylcholinesterase in tissues and in the
cerebrospinal fluid. Through the activity of this esterase,
though of low efficiency and depending on concentration

acetylcholine is reduced in tissues to levels for the
action of acetylcholinesterase.
ChoZanAzcnaAeA appcanb

in the Apina£ 6£uid

kinetics.

more

direct

a4

a ncﬁﬂcction

06

theta incncaAc in inzcnchZuzan gluidb ac6u£xing

diam changcb

in

cc££ mcmbnanc pcnmcabizity accompanying incncabcd

EEG

Hypcnbynchnony and Induced Convu£5ion4.

of high voltage

EEG

slow wave

The

acctchhoanc.
significance

activity for the convulsive therapy

process has been repeatedly described."’?-’23’50,51 In the usual
course of convulsive therapy, interhtreatment electroencephalograms

record progressive increases in amplitude and in theta activity
and a reduction in beta activity. As treatment continues, delta

activity appears in bursts and eventually is the dominant activity
in all leads. These changes are directly related to the number
and rate of induced convulsions, and is not specific for a method
of induction. While

some

relationships to type of electrical

current has been observed, all seizure inducing methods —- electrical,
intravenous chemical or inhalant -— exhibit the same type of EEG

pattern changes.21’22a23:3°

�-13The

early appearance of high degree hypersynchrony and

its

persistence throughout a treatment course has been found to be

prerequisite to improvement.

Both

the electrographic and the

behavioral changes of induced convulsions are transiently
reversed by the acute administration of experimental anticholinergic
compounds.19’2° The intravenoue

injection of diethazine,
bonactvzine, the piperidylbenzilates JB—318, JB—336 and JB—329
(Ditren), and

subjects.

WIN-2299 induced EEG

These

EEG

desynchronization in psychiatric

changes were associated with behavioral

alerting, anxiety, tremors, illusions and hallucinations. In
patients who had recently received electroconvulsive therapy
there

was

a reduction in slow wave activity and a reversal of

euphoria, denial and confusion. Atropine, in low doses, was

also associated with

EEG

desynchronization accompanied by

tachycardia, nervousness and tension. At higher dosages,
hypersynchronous slow waves followed by lower voltage, poorly

organized delta activity with superimposed beta activity was
accompanied by progressive confusion and

disorientation.

effect of anticholinergic drugs on the slow wave
activity of convulsive therapy was also assessed by the chronic
administration of atropine (5 mgm per day) and scopolamine (1-3
The

during the weeks of treatment. The amount of

EEG

slowing was

significantly less than in a control group.66 The samples were
too small for a clinical correlation but the data is consistent

mg)

�-1uwith blocking of the clinical effects of electroconvulsive

therapy. Marked improvement was reported in

treated,

none

of

scopolamine-treated and in

5

controls receiving unmodified

replicated

ECT.

of

2
1+

7

atropine—

of the

6

This study was not

by the authors who suggest

or population changes may have
results in a second study.“

that dosage factors
contributed to the different

-

AA

tn cueblcat

tJLauma,

the demographic changes

induced convuutoms may be modiﬁed by the
06

antichounugtc

dlLugb

Auggebting

06

Want/cation

that tncneeued

amounts

acetytchoune on tncneated chounugtc aecepttvity ts
amounted with the htgh voltage Atow wave activity.
06

Acetytchoune and Induced Convutbtont . Despite a constant

application of treatments, however, there is great variability
in the time of appearance, the duration, anount, and sensitivity
to modification by alerting, hyperventilation and barbiturates

of the electrographic slow

activity in psychiatric
populations.30 These differences relate to differences in
central cholinergic activity. The failure of certain patients
to develop hypersynchrony may be associated with the absence of
free acetylcholine and with minimal changes in cerebral function,
wave

�-15thus precluding a clinical response to induced convulsions.
Tower and McEachern

in their study of craniocerebral trauma,

included observations of six psychiatric patients undergoing
convulsive therapy.63 Studying the patients
ments they reported free spinal

after

3-7

fluid acetylcholine in

treattwo

patients; and an increase in butyrylcholinesterase and a
decrease in acetylcholinesterase with a reversal of the ratio
of cholinesterases in five of the six patients. Concerning
the one patient in the series

who

failed to

show

either free

acetylcholine or a cholinesterase ratio reversal in the spinal

fluid, the authors stated; "It is interesting that this patient
was the only one of the six to show no response to treatment."
From

these observations they concluded that the spinal fluid'

&lt;3;

changes in induced convulsions were more

like those of

4

‘4‘

craniocerebral trauma than those of spontaneous epilepsy.

«3-.3‘

Other evidence of alterations in the perneability barrier
may be

seen in the demonstrations of an increaSed concentration

of cocaine in brain tissues three days after a series of
induced convulsions.1

The change

12

in concentration of this

large molecule, ordinarily absent in brain tissue, was associated
with the appearance of hypersynclu'ony (delta bursts) in the
electroencephalogram,

�1
-.,,-_..._.

-15Fhom

theae oboehvationb

we would

conclude

that induced

convuibioni, like chaniocehebhai thauma and Apontaneoui Aeizuheb,
ane aAAociated with an incheaie

in

ghee

acetyichoiine in inten-

cebtuiah 6iuidA, attuing cuebhai pumeabifity and enhancing

the appeahance

is maintained
Lb

.

one

05 cholinebteJLaAeA.

The Level 06 ghee

by hepeated induced Aeizunei .

heﬁiection

ieveu

06 aLCULed

aitehed pehmeabiiity

06

06

EEG

acetyichoiine

hypmynchlwny

acetyichoiine and the

eiecthoiyteb and otheh Aubitanceé,

inciuding choiineAtULaAeAs.

The changeé

in intuceuuiah elect/w-

.oi.m_m_._._..

_

..l.__a

u.-

iyteé, inciuding aeetuichoiine phovide the biochendcai AubAthate
601:. the pelwibtent behaviouai changed and EEG hypwynchnony
ﬁoaowing induced convuibianb.
An

ww...-._.~__.-m~

06

application

the phedietion

o6

06

these conciuiioni is been in the btudieb

the convuiAive thehapy heéponbe and the

ctaiiisication as psychoaei.
~--....-_

Choiineétehabei and the Ciaibiﬂicatian 06 PAychOAeb.

._‘

4»
..

V

Punkenstein

at at. reported a relationship

between the blood

pressure response to methacholine and the clinical response
to convulsive therepy.25'27 Immediately after the injection

the blood pressure falls, usually returning to
the baseline within 5-20 minutes. A return within 5 minutes

Of methacholine

places the patients in Groups
after-

20 minutes

\‘ \e

I, II or III;

places'the patient in

while a return

Groups VI and VII.

�-17Group

I and

Group

II-III

respectively, while
and

97%

have a

9%

and a

35%

Gkoup VI and Group VII

recovery

rate,

subjects have

89%

recovery rates to induced convulsions.27 Group I

to III reactors

may be

looked upon as patients in

whom

is rapidly hydrolyzed; while Groups VI and VII
have a slow hydrolysis rate. (The response to injected
epinephrine was suggested as a second criteria in the
classification, but is of limited discriminating value.”8)
methacholine

While we have no biochemical explanation

fbr the differences

in the metabolism of methacholine in these psychiatric groups,
it is possible that the blood and tissue cholinesterase
activity levels of Groups I—III is high while that of Groups
VI-VII

is

The

low compared

to general psychiatric populations.

differences in blood cholinesterase levels in normal

and mentally

ill

subjects have been extensively studied.
Despite differences in nethods,“’5 elevated cholinesterase

levels

compared

to normal populations have been reported for

depressive subjects,"""’5"‘7952 schizophrenic subjectslh’28’53
and a mixed

psychiatric populations .“2 Alpern reported lowered
cholinesterase levels in schizophrenic subjects.2 While these
studies appear inconclusive, they provide data that the
variations in blood cholinesterase levels are generally greater
and frequently elevated in the mentally ill. Negative
reports
include the failure by Ellman and Callaway” to confirm
Rubin's study; and Altschule's review of the data suggesting

�-13no abnornality
'

of cholinesterase levels in the mentally

ill.3

that cholineAth

play

These Atudteb AuggeAt

meaAuAeA may

a signiﬁcant note. in the thuapeutéc aupome to canvutatve
the/mpg and in the pathoggnebta 06 paychobu.

�-19;

CONCLUSIONS

This review summarizes some of the available data suggesting

that cholinergic

mechanisms may be

central to the convulsive

therapy process. Induced convulsions are associated with
cerebral vasodilaticn and increased cellular permeability,
followed by the appearance of increased amounts of enzymes
and

electrolytes in intercellular and cerebrospinal fluids .

The

increase in acetylcholine, vasodilation and increased

permeability appear as interrelated phenomena associated with
'

trauma, seizures and induced convulsions.
These biochemical changes acconpany increased

hypersynchrony which

is recorded

as

EEG

slow wave

electrical

activity in

scalp electrodes and which can be nodified by the acute and

'

chronic administration of anticholinergic drugs as atropine,
benactyzine, diethazine, procyclidine and various piperidyl—

benzilates .
In these regards, induced convulsions are more similar to

cerebral trauma than to spontaneous seizures.

in cerebral biochemistry alter cellular activity
sufficiently to affect consciousness and the behavior of subjects .
Failure to induce persistent biochemical changes, including the
The changes

concentration of acetylcholine, results in failure to produce
behavioral change.

�-20There

is,

as yet, no consistent evidence for differences in

the sensitivity or dependence of populations on cholinergic
mechanisms.

Differences in the rate of development of cerebral

changes to the sane number and frequency of induced convulsions

classifications of the nentally ill based on the blood
pressure response to methacholine suggest, however, that such
differences may be significant in the pathogenesis of different
and

.._..__...V

___,‘~,‘....____...

'

«uAW—‘wﬂﬂw

,1“

psychoses .

�REFERENCES

1.

Aim,

B., Strait,

R.

L.

A., Pace,

J.

W., Hnenoff,

M.

K. and

Neumphysiological effects of electrically

Bowditch, S. C.

indnced convulsions. Arch. Neurol. Psychiat., 75: 371-378, 1956.
2.

Alpern,

D. O.

i kholinergicheskaya

Aktivnost kholinesterasy

reaktsiya kmvi pri shizofrenii. [Cholinesterase activity and
cholinergic reaction of the blood in schizophrenia.] Fiziol. Zh. ,
4: 87-90 , 1956 .

3.

Altschule,

Vitamins, enzyme systems, and trace elements.

M. D.

Bodily Physiology
Grune
'+.

Stratton,

8

in

Mental; and Emotional.

New

Augustinsson, K.-B.

.

04143on, pp. 169-172.

York, 1953.
The normal

variation of

human blood

cholinestenase activity. ‘Acta Physiol. Scand., 35: ‘40-52, 1955.
5.

Augustinsson, K.-B..

Glick, ed., Method.

Assay methods

Bernstein,

M. D.

New

Brenner,

‘C.

and

York, 1957.

Presence and action of acetylcholine in

experimental brain trauma.
7.

D.

vol. 5, pp. 1-63.

05 Biochemical mug/6416,

Interscience Publishers,
6.

for cholinesterase. In

Merritt,

J. Neurophysiol.,

H. H.

9: 3&amp;9-366, 19146.

Effect of certain choline

derivatives on electrical activity of the cortex. Arch.
Neuml. Psychiat., 48: 382-395,
8.

19‘62.

Burgen, A. S. V. and MacIntosh, F. C.

significance of acetylcholine.
and

J.

H.

In

The

K. A. C.

physiological

Elliot, I.

H. Page

Quastel, eds.. Numchomw, pp. avu-375. Thomas,

Springfield, Illinois, 1955.

�9.

Chatfield, P. 0. and

Dempsey, E.

W.

Effects of prostigmine and

acetylcholine on cortical potentials.

Amer.

J. Physiol.,

135: 633-940,

19142.

10.

mne’

W.

Va,

and neuronal
11.

and MCEaChem,

D. B.

&gt;125:

A.

J.

73: 59-63, 19%.

effect of anaesthesia

The

acetylcholine content of the brain. J. Physiol. ,

56-66, 195a.
The

Dale, H. H.
and

AcetYIChOlele

Do

activity in epilepsy. J.A.M.A.,

Crossland, J. and Merrick,
on the

1.2.

mer,

action of certain esters and ethers of choline,

their relation to nmscarine. J.

Pharmacol. Exp. Ther.,

6: 1u7. 191a.
13.

Phamacological blocking of central cholinoreactive

Denisenko, P. P.
systems and the

possibilities of its therapeutic application.

In

G. B.

05

Chounugic and Addenugic Tamwiuion. Vol.

Koelle,

W. W.

Douglas and A. Carlsson,

general ed. , leceedéngb
Meeting, pp. 1u7-152.

l“.

05 «the. Second

Macmillan,

New

eds.,
3

Phanmacalagy

of

Intunatéand

H. Rascova,

Phamnacologicat

York, 1965.

F., Hemphill, R. E., Reiss, M. and Brunmel, E.
Investigations into cholinesterase levels in serum and
cerebroepinal fluid of psychotic patients. Biochem. J. ,

Early,

D.

45: 552-556, 19u9.

15.

Bccles, J. C. The Phyuozogy 06 Synapbu,

Press,

New

York, 196“.

316

pp-

Academic

�16.

Elliott,

K. A.

C., Swank,

R. L. and Henderson, N.

Effects of

anesthetics and convulsants on acetylcholine content of brain.
Amer. J. Physiol., .162: neg-um, 1950.
17.

Ellman,

G. L.

and Callaway, E.

Erythrocyte cholinesterase—levels

in mental patients. Nature (London),
18.

Pink,

M.

A

J. Hillside
19.

192: 1216, 1961.

unified theory of the action of physiodynamic therapies.
Hosp. (Glen Oaks), 6: 197-206, 1957.

Effect of anticholinergic agent, diethazine, on EEG
and behavior: significance for theory of convulsiVe therapy.
Pink,

M.

Arch. Neurol. Psychiat., 80: 380-387, 1958.
20.

Pink,

M.

Effect of anticholinergic

compounds on

post convulsive

electroencephalogram and behavior of psychiatric patients.
Electroenceph. Clin. Neurophysiol.,
21.

22.

12

(2): 359-369, 1960.

of action of convulsive therapy: the
neurophysiologicadaptive view. J. Neumpsyclﬁat. , 3: 231-233,
Pink,

Pink,-

M.

M.

The mode

1962.

and Kahn, R. L. Quantitative studies of slow wave

activity following electroshock. Electroenceph. Clin. Neurophysiol. ,
s: 153, 1956.
23.

Alan,

B, and

beﬂcowits, H.

J. Inhalant-induced convulsions.

Arch. Gen. Psychiat. (Chicago), 4: 259-266, 1961.

�2“.

Freedman, A. M., Bales, P. D.,

Experimental production of
Amer.

25.

J. Physiol.,

mstem’

Do Ho

Willis,

electrical major convulsiVe patterns.

156: 117-1214, 19%.
.

Gr‘eenblatt,

J. New. mnto Dis. , [08:
mnkenstein,
changes

J.
27.

D.

Rmkenstein,

D.

nervous system

Autonomc

shock treatment.

M.

and Solomon, H. C.

in mentally

Autonomic

ill patients.

114: 1-18, 1951.

H., Greenblatt,

M.

and Solomon, H. C.

Autonomic

test of prognostic significance in relation to

electroshocktreatment.
28.

electric

psyChOIOgic changes

Dis.,

Nerv. Ment.

301011011, H. C.

HOQ-HZZ, 19.48.

H., Greenblatt,

paralleling

and

Mn

nervous system changes following

26.

A. and Hinwich, H. E.

Psychosom. Med., 14: 3147-362, 1952.

Cholinesterase activity of whole blood from healthy
and schizophrenic individuals. Nature (London), 198: 1118-1119,
Gal, E.

M.

.

1963.
29.

Giannan,

M.

J.

acetylcholine.
30.

and Pepeu, G.

Drug-induced changes

Brit. J. Pharmacol.,

in brain

19: 226-2314, 1962.

Significance of individual variability in EEG
response to electroshock. J. Hillside Hosp. (Glen Oaks),
Green,

M.

A.

6: 229-2H0, 1957.
31.

Hampson,

J. L., Essig,

C.

F.,

McCauley, A. and Himwich, H. E.

Effects of di-isopropyl flnomphosphate (DFP) on electroencephalogram
and cholinesterase activity. Electroenceph. Clin. Neurophysiol.
,
2: ui-us, 1950.

�32.

E., Essig,

Hinwich, H.
Freedman, A.

M.

F.,

C.

Hampson,

J. L., Bales,

P. D. and

Effect of trimethadione (Tridione) and other

drugs on convulsions caused by di-isopropyl fluorophosphate (DFPj .
Amer.

33.

J. Psychiat.,

106: 816-820, 1950.

effect of Diparool on the
electroencephalogram in the normal subject and in those with

Jenkner, F. L. and Lechner,

H.

The

cerebral trauma. Eleotroenoeph. Clin. Neurophysiol., 7: 303-305,
1955.
3M.

Johnson, L.

c., Ulett,

A., Johnson, M., Smith,

G.

K. and

Sines, J. o.

ElectroconvulsiVe therapy (with and without atropine); effect on

electronically analyzed electroencephalogram. Arch.
(Chicago), 2:
35.

Gen.

Psychiat.

32u—336, 1960.

Kabat, E. A. , Glusman,

of the albumin and

and Knaub, V.

M.

ganma

Quantitative estimation

globulin in normal and pathologic

cerebmspinal fluid by inmunochemioal methods.

Amer.

J.

Med. ,

4: 653—662, 1948.
36.

Kovach, A. G.

3.,

Fonyo, A. and Halmagyi,

M.

Acetylcholine

content of the brain in tratmatic shock. Acta Physiol. Acad.
SCio Hung.,

37.

'3: 1-“,

1957.

Krech, D., Rosenzweig,

M.

R. and

Bennett, E. L. Effects of

envirormental complexity and training on brain chemistry.

J.
38.

Carp. Physiol. Psychol., 53: 509-519, 1960.

Loewi, 0.

ﬁber hmmrale Ubertragbarkeit der Hemmemdirkxmg.

Arch. Ges. Physiol., 1898 239-2‘J2, 1921.

�39.

Maynert, E.
on

H0.

W.

Effects of C.N.S. depressants

and Buck, E. G.

brain acetylcholine. Phamtacologist, 6: 191,

McLennan, H. and

Elliott,

196M.

Effects of convulsant and

K. A. C.

narcotic drugs on acetylcholine synthesis. J. Pharmacol.
Exp.

“1.

Ther.,

103: 35-u3, 1951.

Nachmansohn, D. and Rothenberg,

on

Specificity of

enzymes

M.

A.

Studies on cholinesterase:

in nerve tissue. J. Biol.

Chem.,

158: 653-666, lSHS.
M2.

Plum, C.

M.

Study of cholinesterase

mental disorders.
#3.

Pryor,

T. and

G.

nervous
and
in
activity

Clin. Chem” 6: 332-3H0, 1960.

Otis,

Effects of chronic administration

L. S.

of electroconvulsive shock on behavior, brain weight and brain
Presented

chemistry.

at the

American Association

for the

Advanoenent of Science, Berkeley, 1965.

an.

Ravin, H. A. and Altschule,

M. D.

Serum

cholinesterase activity

in mental disease. Arch. Neurol. Psychiat.,
M5.

Richter,

D. and

58: 6‘45-650, 1952.

Grassland, J. Variation in acetylcholine

content of the brain with physiological state. Amer. J.

Physiol.,
M6.

159: 2u7-255, 19u9.

Richter,

D.

J.

Sci... 88: I‘28-‘43“,

Ment.

and Lee,

M.

Serum

choline esterase and anxiety.

19M2.

�H7.

“8.

#9.

Richter,

D.

J.

Sci.,

Ment.

and Lee,

M.

Serum

88: 1135-439, 19H2.

Rose,

J.

Acta

Psychiat. Scand., 38:

T.

Rosenzweig,

The Funkenstein

M.

choline esterase and depression.

test - a

review of the

literature.

12H—153, 1962.

R., Krech, D., Bennett, E. L. and Diamond,

M.

C.

Effects of environmental complexity and training on brain
chemistry and anatomy: a replication and extension.

J.

Comp.

Physiol. Psychol., 55: l4294437, 1962.
50.

Roth,

M.

Changes

in the

EEG

under barbiturate anaesthesia

produced by electro-convulsive treatment and

for the theory of

ECI‘

their significance

action. Electroenceph. Clin. Neurophysiol. ,

3: 261—280, 1951.

51.

Roth, M., Kay,

D. W.

K., Shaw,

J.

and Green,

J.

Prognosis

and Pentothal induced electroencephalographic changes

in

electro-convulsive treatment. Electroenceph. Clin. Neurophysiol. ,
9: 225—237, 1957.

52.

Rowntree, D. W., Nevin, S. and Wilson, A.

The

effects of

diisopropylflmrophosphonate in schizophrenia and manic depressive
psychosis. J. Neurol. Neurosurg. Psychiat., 13:
53.

167-62, 1950.

Rubin, L. S. Acetylcholine hydrolysis in psychiatric patients.

Science, 128: 2510-255, 1958.

.

-1

�5Q.

Spiegel,

E. A. and

Spiegel-Adolf,

Permeability changes in

M.

the brain induced by Metrazol and insulin convulsions. J. New.
Ment.

55.

Dis., 93: 750-755,

Spiegel, E.

A.

191*1.

and Spiegel—Adolf,

Physicochemical effects

M.

of electrically induced convulsions (cerebrospinal fluid studies).

W5.
56.

A880, 70: 130-132, 19“”.

AHEI‘. NeUI‘Ol.

Spiegel, E.

A. and

SpiegeléAdolf,

Physiological and

M.

physicochemical mechanisms in electroshock treatment.
COnfin. Neum1., 13: 38-63, 1953.

57.

58.

Spiegel,

A., Spiegel—Adolf,

E.

and Henry, G.

.M.

Physicochemical

changes in the brain accompanying

electrically induced convulsive

discharges. Trans.

Ass., 68:

Amer. Neurol.

Spiegel-Adolf, M., Wilcox, P.

H. and

171+, 19'42.

Spiegel, E.

A.

Cerebrospinal ﬂuid changes in electroshock treatment of

59.

psychoses. Amer.

J. Psychiat.,

Stone,

role of acetylcholine in brain metabolism

W.

E.

The

and function.
60.

Amer.

J.

'IbbiaS, Jo Ml. Lipton,

104: 697-705, 19%.

Phys. Med., 36: 222-255, 1957.
Mo

A. and

Iepinat,

A. A.

Effect Of

anesthetics and convulsants on brain acetylcholine content.
Proc- $Co Exp.
61.

Torda, C.

B11010

Mdo,

6': 51'5“,

19145.

Effect of convulsion inducing agents on the

acetylcholine content of the brain.
173: 179-183, 1953.

Amer.

J. Physiol. ,

�62.

Torda,

Effects of single injection of corticotropin

C.

on ammonium ion and acetylcholine content

63.

Tower,

D. B.

and McEachern, D.

of brain.

(ACTH)

Amer.

J.

Acetylcholine and neuronal

activity. I. Cholinesterase patterns and acetylcholine in
the cerebrcspinal fluids of patients with craniocerebral

tram.
616.

Canad. Jo Researdl, Sect. E, 27: 105-119, lgugo
\

Tower, D. B. and McBachern, D.

of cholinesterases in

human

The content and

characterization

cerebrospinal fluids. Canad. J.

Research, Sect. E, 27: 132-145. 1949.
65.

Tower, D. B. and McEachern, D.

II.

Acetylcholine and neuronal activity.

Acetylcholine and cholinesterase activity in the

cerebmspinal fluids of patients with epilepsy. Canad.

J. Research, Sect.
66.

Ulett,

G. A.

E, 27: 120—131, 19u9.

and Johnson,

M. W.

Effect of atropine and

sc0polamine upon electroencephalographic changes induced
by electro—convulsive therapy.

Electmenceph. Clin.

Neurophysiol., 9: 217-22u, 1957.
67.

Ward, A. A... Jr.

Atropine in the treatment of closed head

injury. J. Neurosurg.,
68.

Wescoe, w.
The

0.,

7: 398-402, 1950.

Green, R. E., McNamara, B. P. and Krop, S.

influence of atropine and scopolamine on the central

effects of

DFP.

J.

Pharmacol. Exp. Then, 92: 63-72, 191.8.

�for Ihe Bio Sciences
Informgﬁon Exchange.
.
.
.
.
NoI' for publlgnhon
pubhcahon
or

Prepared

j

DEPARTMENT OF
HEALTH, EDUCATION. AND WELFARE

——1

m”:

PUBLIC HEALTH SERVICE
NATIONAL INSTITUTES OF HEALTH

"one: or

;

.

s

SUBMITTED TO! ‘Public Hoalth Service. NeIionaI lnr+i+u+es of

'n-r

OF

Paganini

“mmame

‘

and

Give names. department. and ofﬁcial

Win
‘l'ifles

RESEARCH
Hulfh.

'

‘

'

rnoJEcIr;”.-\

Div. of Research Grants. Bofhesda l4. Md.
'

,

in Spinal Fluid
§

7

a—sm. (022

,

'
,

PROJECT NO. (Do no? use this space)

and.

U

lemme}
l

Read"

Injuries“

'

,

I

of PRINCIPAL INVESTIGATORS and ALL OTHER PROFESSIONAL PERSONNEL engaged on the
proiecf.

11.9., Rmsurgem, mums: Gluing Instructor in NeuroIn.
surgery. Dartmouth Radical School

Smutﬁadgs.

i.

.

John P. Wilson, Ph.D., Assistant meensor 1n the Physiological
Sciences,
Dartmouth Medical School

I

NAME AND ADDRESS OF APPLICANT INSTITUTION:

'

Hitchcock Fomdation
Hanover , New Hampshire

SUMMARY OF PROPOSED WORK — (200 words or less —- Omlf Conﬁdential data.)
In In Bio Sciences lnforrnaﬁon Exchange summer!“ of work In progrcss are exchanged wlﬂn qovernmonf and privan agencies supporﬁng research
In modiul and rant-d ﬁelds and an forward“ to invosﬂqaton
such informnﬁon. Your summary Is to be usod for rhese purposes.

vbnqm

study of in. neq'tylnholine MW: of spinal fluid
mama“
in hudinjxaﬁu, utilizing the biéh'nsa'y author! am! Young; Mariana, has
A,

bun

Wt“

tale .mn. In! study Indiana the presence
put
of «cannon», smtonin.‘ and one. unidentified
in the period
following head injury. mezpmponod “any: is an extension of this
Mainly
ml: u.m1n tissue as will as tpifail fluid. and ~11; aging. in addition
chain: 'analysis for these one 3mm” (spectrephntnnuomter).

during tha

We“

f.‘

Silbmitted
beginning

SIGNATURE OF
PRINCIPA
INVESTIGATOR

for periOd

I.

September 1956

A

,

ldenfify fhe Professional SchooI (medical, dental; public healfh. graduafe. or
ofher) wifh which this proiecf should b idenfiﬁed:

mm,

INVESTIGATOR

——

mm

Romanian ..

Do NOT um:- Ti—u: :nnn'n-

I

11

ed.

�12/17/56

smmc

comm wanes
WW3
rwml
:5an
or

~

may

mam

Acrmr!

IN BLOOD

ml mm...

m)

mma:

)5.“th

for
the
at
mum of t papa-1m
mutation
mod
for):
Gil-13:1
mm
th
Mien,
in
Matt“,
Mm
mum
Samar, Brooklyn, «.2... Pom-my 15, 1957.
A

with. m mom-mm nth-ad in ”portal for tho «5mm; a!

W My W

m

W

tar um» 91' m
«mu-cm» Minty. Though
of W31. “14 «mm-nan (2.39) and
on m thalliutan» in min-.1 fluid. the mum. in nanny applaud. to the may.“ of
and
and
«11:,
um
mm, m. on» biological num. Only 0.3
um,

:1. of

13311:].

fluid at 0.001 I1. at

m

mu
«um:

knyltuooblno 10 why-d a
lmdng incubation,

m um

is nquirod for a
in

dnmtion.

W but”, pa 8.

1! “Situated by

am“

51

tol-

trickle”—

mm into a calorimeter tube.
notummm¢1smwwnmmrm~wmmm «.1331.
uotio acid, cum-1mm, ind daunting

m thus Whom.

Thu

than

that map

mu :m

an: m mt: with ”Miami” to product
Absorption

mm

a.

510

tho

a.

ma

to format ton,
color with an

New”.
want,
m
m
M.

or
new
in.
y.

an be

both may.»
mum the cam in not
by Adding *Mn 1397"
u in spin]. ﬂuid, um sham-mu 1:
n
«1mm Wu:
mum-m),
(lawnmmmwmmm

dot-ruin“

0!

W

“machinist-mu.

mm of mm in various Mansion. fluids at. amounts-nod
and coup-rd to tho ﬁndings in pun-nu with mm dim».
Th. nor-:1

W
“01ka

Yb

Ind!!!

W10»).

alto mu .ployd to “My «batman. that
action, no): u LSD, which is a mum inhibitar of
10

�WW.
Wham” mtahmtortothnmnmwwwcm
hr this mu the awyummm - hm“: -

WOJn1¢romoerquythu¢ummmmmtof

tm»mmlibcatdhyumc

lauwrkmwamwmawmmmnmm
mum at m mm, 9.3. mm mu m...
3

601m, 3.,

m4 Gold-abut,

m, a.

3mm.

My», 1,

21.6

(1956).

�we
«mwmman.

m:
31.3mm,
wmmmc
cmmms,
m

1'3ch

W W, W W.
'm

.m
no Magnum - Lon; Inland

for

of a

n.‘.,

3661“,,

1)

m ”may,

not

M1» on an.

”WW-

mm»

harm),

and

for tho

Illa; than 111:“

mu

u

spam.

mum

mum“
of

and

and

”both“!—

mum.» 1mm in fan

madman. a: aninitiou 1:
Mm
a.
"mm

m
mm

and tin-Sr

to u»

»

W

in

mu W. W]!
ma

‘

wat
u
Wtimﬂu York Mm,
11.0%ch
cm
15, 19,7!

“W
nautical mm: m
mm.
mu

that:

m
s:

muons; mm;
(nmalm, mom. mm

of atypical alkaloid-

m-

mm»,

mthmuumbounafmuc mp: mkummcut
1n thiamine,
and Wow. I'm: sum in :
Mia «fat
mm,
2)

awn-s

in

”WM 111le

20mm
rm-

the

91‘

m

from

macros!

M
Marina. municidanﬂmdtmmdwmﬁkh

wish

alkaloid!

W

I”

be

much. duration at diam-ranting nut-win 1:: tbs who

«Wu.
to

We

03:10:13.1"

I couple“ uh“ for henna;

m6.

mutating

than
and
hack
«mm
ma
mum-1a,
«man.
um,
mad
tmtm
into a. null value at cthylm mum“. Tho aim a truncated m

M
Wu

to dryness, thin upon-d out on mt» pupa. Separates: of tho
1: want either by handing cur-anaemia an; Mme).-

1anmmppmu1n
mmmnarmmuostmtmamm
mum. at
mun, ms. mu. am.» 3min.

m

�“
cam mum

«an an a!

mt

thomh
with H»

(521:1), or by

in

1n 1::

m3.

m- petition

:5me“ W (m bola).

At

oommdm mum m «a «a: 1m puma). um ﬂax-1p: ,
the.
club“ with 1106M, tht «ma
by mpontm in «11ﬁlth ﬂaking.
mud tub», than mm. arms. and Wm mama. m
this point

than

W

WI

m
MinnaﬁyotwlwtomdbthnMaunm«maintain-momma

mummuawxomumqmmutmmmu

W.
M

Mal-Inﬂux com-mm; 1m

«mum at out amen my be gland

mm,
thmhthMmWw5uw,
mat. mad ”imam, mmtmu, WWI»

W
mama.
W
W
bah

structural

{mm

at

th-

'13.,

and

to!

16 drug:

tar in pasture

m

dam-trusting the

with

ml:

w.

metric

Rub dag

mhmtmthmmmoﬁhmcamwath WWIMtMO.
Amioutm of tin mm to ﬂu arm. a! “Mum“ prior to m {allowing
4mg

than” will I» mean“.

�(Effect a!

In a

Was
Mona

an 3%

Theory of convulsion
for
amriigmﬂme

report to this society we noted the relational” between

the degree of induced delta

eetidw

during the course or therapy and the

behavioral response to electroshock. Thane patients, in when big: éegreee of

delta nativity were induced early, and were sustained, miteeted the greatest.
degree: at helmvieral change, as well as a significantly greater percentage
of inprovemrt. and recovery than these patients in when only law degree:

a: delta activity were

We

(Fm: m:

m.

1957).

In the past few years, a variety of reports relating changes in £me( 1‘)

leetylchoum and oholineeternae in the spiral fluids of patients (Subs,
Herd) 1rd

minis

0

(Bernstein, Teller and HeEnohern) following head

the obsem’cime that cholixm'wbic agents may
by trauma

(32mm, Bard,

Jemmr)

alter the

EEG

m;

putterne induced

and by electreeheck

(Inuit),

led us to investigate the role of autylcholine-eholinestemee metabolism
in acctroeheck therapy.

In

1956

Ulett reported that atropine or schpclmne,

when

administered

row! the clock schedule blocked the appurme of the delta activity

on

a.

we

hm

com to mandate with electroshock therapy. meet. noted, however,

�that his patients nurtured numerous madcaiubla aide effecta during these

mutations.
(19%) had

Previously, mm (1950 ramming the suggestion of Bernstein

new that atmpine mama bath the

EEG

patterns and the

mumlogm signs induced in an by head trauma. Here, too, the side

effects wen marked. In 1953.

W:-

md Lechmr ropertad that

mum-a1 effects similar to atropine mm
intend in patients with

610W
11-.

in

tram,

head

on

also reported the effect at

normal subjects.

the

EEG

hypothesis of the

we

of nation

lanthanum is a soluble

We: Wr
“was:
dry

with.

at“

comlaiva

mama»

aethnsm

the bmdyoardia,

«11m:

moment neumplvuiolagicnqdapﬂva

than”.

coupow with

Wologic

to atropine. In maximum animals. hymns 335;

Media 1.1m.

and

111mm:

of patients ﬂaring electroshock Warsaw; and to

relate than them findings to the

ham

and

whim by Maine min-

we
purpose of this repwt to describe the effects of
is

dicthuine

um;

Thcy

EEG

blocks

slowing of the heart;

Wasp-m, «ﬂatten.

induced by ucatylcholme,

main

ugal

uni hypotenaion.

m

ma fasciculation
e

and pilocarpmﬁ and induces

�~3-

m:
shock

ﬁreﬂy-two paymttric patients, in-vurioua stages of electron-

treatmnt in an

studied.
the

EEG

these

351

upon-ward. voltm’ury purchiatric hospital have been

WW
Follow

laboratory.

Wtemd intmmny
at

a routino

amtration,

4mm”
both
the

were

25 mm

the habtwioral

m

per minute, for a total

errata. Prior
and a

to the

W

Mahatma,

period were upeonaordad. Running 'dmg

record again

tested in

recording, diamante

unstmtured historical intervicw

regarding, and meordeﬁ

EEG

EEG

an

BEG

at the rate or

290 to 250 nan, depending upcn

drug

maximum, aubjoots

Imam periods were mntinued until

mummm Wanna patterns on visual
\.

inspe ction.

m

m:

(a)

Neal:

follwed by
n fooling of

Q.

11!.

subject; manifested spontaneous gouging initially;

dryness of the mouth and, a thickmsa of speech. They nohd

heaimde

and

makneu of the

increased mathsmou and difficulty in

W

were

Psychiatnc/cleaﬂy mnifoctad in
between 13 and 30

mm

attaining

mm

am

noon

rammed by

eyelid closure.

subjects. In the not. pound

titer drug mutation, ax

subjects spontan-

�.3.
0011333”

med fouling: of

«mm mums

mm

amnion

illusions,

about than" 111mm, the setting of the

«auras or our icientity.
by the

um:

and Myrtle

Such

and

m: pm-

patterns were transient and had diaappuamd‘

of the expat-meat, usually vitiun three hours. In

um subjects, mesing august-loan and panic led to, a «mum at
an wrung.

amt

Hero, too,

mummm at minimisation War was

mum: tune hours.

(b) In previous studies,

we had

noted the intimate rolaﬁommP

hem ehangan in syntactic language 1:3th with
mmm induced by allotmm.
changes
diothaaino inﬂamed

In

In subjects

alteration in

mm prior to abatmshook,

in syntactic pattern at

an

“lurking” musty.

3&amp;3er with tielta activity, We}: clinical amnesia

{anthems

of an ”alteration in cerebral function, diathaninu induced a
appearance or

animation of

amt: languaga

ambnl

patterns.

indicative

tmient. dis-

The pct-5.06 01'

ohms”

in language in mum-rent with 63mm in eloetmmephalom.
(a)

Patterns: In

all words, than

dosymhmiaaum or fmqmneics. Them

m.
M

15

in

3.

MW in wltage and

a decrease in pruinamo at

In patients without. delta activity

(magmas),

�.5.

me

«mum

‘ppannoa or small

by the
T123543

5.-

W8

of 198 voltage 6-? cps uctivity.

are Monstmtcé in Slidoa 1,

not. appear

slower

to be alterad.

0131.2.

The

basic alpha rate does

Mishap in voltags and appaamnoe of

The

fmuweies with mwmtmtion in blockad.

In patients with vu'ying

”thaw waiting
voltages:

W

1m voltage

m

and

burst

«halite.

in

3

is

a decrease

ntdxitw diuppoun; and

31m and am Wotan hem

This change

It wants

times

{bits
or Maud high voltage dean

from convulsive urea-am, them

are now: in Sudan

ham.

«W

«mm Manny

and voltage

1m,

15mm. mm Ghana's

Ind h.

mm: is West in all 6100mm imam.

during drag

mumum,

and

persists far

one

Concurrent with electroencephalogram changes,

uillon}. and language patterns

at the pm-dnjoatioa
language

in

313%

m putter”,

Nauru: awn uppured.

ciascxﬁbed. With the

to three

as the ho-

mum

the para-injection behavioral and

�as w:
ﬁtness

obaorntions confirm the report of Jeanne: and Manner of tho

affects af diethaaim

altars

moot-d:

subjects.

in’*uonm1"

we

also note that

diam

II‘ with mammal: induced delta activity in a fuhion
dearth“

similar ta atropine and ocopolnmine, l5

ty-

Ulett.

Memo".

Shea patterns are similar to the affect of these anti-showman conpaw-ads

in records

1'0le

head

tram.

In the» subjects,

intmvma

ammo caused immediate changes bath in the we and in behavior. It
is appsrmt, Wafers,
and

that. it;

its: duration of activity is most mum). for

the

@0an mm.

mutual: aim audits by mmus obumra at new man

attracts of head

ﬁrm point to an inﬂate

of muralagie dyst‘motion, the

:2» mwlohonm 1n the
the

madly affects the centre). nervous when,

basis fer the

owned

EEG

alteration;

and the

1m). at

spinal fluid. the effmt at ttmpine both an

mm a» continuum

tin-tho: support to ﬂu

chm: of

relationship batman the dome

an

mm» m wbjoets with heaé mm mm

Wim
Em putt-rams.

of

mmm.
In those studies of Wain. and
u

the

patterns

and

has nutylcholmo

chatmahook, the intimate relationship 13¢qu

EEG

bonnie:

�.7.

m

trauma...

m
ﬂuid
m

mama.

beam

On

We

the bases

note the parallel to we observations» in head

of,

these observatim, as wall as studies at spinal

chanmmmu lavela,

would magi-st

that

[the

(Tower and

mwem,

Mammal substrate

in similar to that. of head

tram.

Fink and

W22),

of the electmshack promos:

Electroshock my be Ionized upon as a

continua-d mothod of inducing cerebral dysfwc’oian for

its

bazaviaml

“Tact.

Purim
pmidas

13m

atudiaa have

(1th

that. alteration in cerebral

mm:

pbyuiologic basis for the behavioral changes in electmahock

(Fink and Kahn, 1957). Such altamtion in

embm

mum pmidol m

milieu for a change in the eat-mum's adaptation to his environment.
aspects a? behavior, in pemaptim,

mum

lama,

mood,

recall,

memory,

m
affect,

the basis for the therapist's ovalmtim

ate. Margo mange,

and

of immanent.

studies of ﬁiathudm amplify this neumplvnolegia

mm“

The

hypothesis of electroshock by suggesting the type of

Minute

mat.

Marlins

both the

Wuhan

biennium

and the beluvioral

chm.

�m:
Dicbhaam, a patent mﬁwohcainergic unwound,

1:1th

was

upemmntnny

intuwnmsly in wyuhiatric subjects in various sages at

commlaive thanpy.

mectmmcephalogma minimum

theme in voltggs,

a.

and observatmm or

éeaynchronixatim of fmquencioa,

hyperventilation Manson in

mean}: mmmt print dnlta activity. accords with delta activity sham!

ammu- changes with mama‘s-anus of delta burst activity.

Gmmt
pat-amass

with the ahetrogmﬁxic effects, behavioral and language

indicative of a reversal of the electroshock affoct. were charred.

It is

maelndod

that:

(a) Disthuine is a patent anti—cholimrgia amount! that readily
enters the

antral

not—mus

system upon

intmmm ministration.

(b) The Modalities}. butts ras- Fm changes in electroshock is

to this of head trams; and

(s)
therapy

The
may

biocheniml

lie in

buis of

the

mode

of action or

m

cmﬂsive

the acetylchounoocholmatemu system.

��(glum‘ﬁrzr

Wﬂ

«/¢V7/‘

“W“W
WMWW—
#MZ
;

_WMQ!4¢W

MM

‘

é;

7%

WM/

64331”

.461

ha—

@fﬁ/If/y EEQaQ/JW

gag/M1114.
ﬂ
64x7

���14.3.,“

,

/

-4I/

.

..

M...

�é“; sessé c

W

ﬁg?

ngz/
&amp;

W‘Za-

MWX

m

’55

2

“a!

gégil Mara.
461/

4.

.4“)

¢

MM:
Wu
W
Jeni

#M“
K/m

1»

14:44::____

��/Z¢,

Aﬁfﬁgg L££A4AIZI~

mWMmQ

("43
2%
2

.

@a

M

3"

���/
/
'v-—-9:'
wpw'.”
v
-'
MIG/’4
4trsmg+¢zi9
-

._

~‘

~

.

"
.

Dr

������10/

M‘

£77.

~———-—-—-————-——__

/

1

w
W?
WW M tr
M WM mu 5 m;
Mar

fir
WM
ltra

in

x1“!

EEQ.

32
'

#2

Cf;

.-

.20

_

Wa
MAX—«l

4.4.!”

.

#34“...

4'“

‘7

AIM
xcreq

cwé‘.’
:4.

('3)

M44.
Min-A-

��“0011/

/;4a+

a”

._—————-9

,4¢,,‘“‘“':_:=,

l/aw M

#u/t.

410/
ﬁ’é‘fu’”

S“

v

MM

��[f7

x,

W/

r{

/¢C//

A"!

wax
/

(31)

I)

2

%%l

-———-&gt;

MIL.

”cw

/ )

��ﬂew-

�O

EST

—_WU. ”WXW
IK.

Bag

11“»

“~

f

‘
4W
Iy

.NQ

W

.CW

‘e’

Iaéas/uue'

‘

MM?

c)
jivfeaﬂﬁuﬁp

041..

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67494">
                <text>Files: Acetylcholine and Cholinesterase, 1956-1966 (folder title 1/4).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67495">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67496">
                <text>mfp-03-01-003-0-001</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67497">
                <text>1956-1966</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67498">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67499">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67500">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67501">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67502">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67503">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80952">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87513">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94074">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100635">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6751" public="1" featured="0">
    <fileContainer>
      <file fileId="6541">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/9528d68ea90232ebce57ade28fbef74f.pdf</src>
        <authentication>93461c25c5f8ae971bd4c1aadc2a1278</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107146">
                    <text>I;
I

Mnémc

.

'

Recent studies
changes

in the

7&amp;4

’demonstrated that a necessary

change

in behaviort was the development of early

mg

sistent signs of altered cerebral function of

slomgga

”a

was a

“f7

in these laboratories re-evaluating the role of cerebral

mechanism of electroshock

pie-requisite for

?. [ours

Wt

(Fm/IL

indeay

and

per-

which electroencep/alographic

and/(ah , r:f.:'6)

any.

mes may

of this observation remained unclear until the recent reports of Ulett

describing the ability of premedication with high doses of atropine to pre-

We wt};
(WMI‘Collowing
5

vent the appearance of the

EEG

suggestion of this report,

we

delta abnormality

a

.

nth

the

investigated the roles of acetylcholine and

cholinesterase in electroshock therapy.

The

data amply demonstrates a close

relationship between the degree? and persistence of the ele ctroencephalographt‘cr
abnomality and the appearance of measurable quantities of free acetylcholine

in the
m

‘

mm“ as“
as well

{:5mm

of.

to ﬁcholyl-cholinesterase,
The

I

q

”'2

('7’de

}

Loewi

u

W?
normal ratios of” cholinesterase

WW
of the
‘

p
$.00»

.

1

f .—
p.

role of acetylcholine in the transmission of nervous impulses has

been a subject

Edi}

W

x

072/)

Q).

for study since the first description of
The arguments as

«If

theWeﬁ‘ects
4

(ﬁes

r’

to whether actylcholine is the main or only

�agent in the transmission of the nervous impulse are not of primary concern

It is sufficient to

here.

of nervous tissue; that

note that acetylcholine

it

excitation process; that

exists in a

it

is

bound form and

a normal constituent

is librated during the

a

is rapidly hydrﬁlyzed through the specific action
S

of cholinesterase; and as rapidly reconstituted by the choline-acetyléueg

fluid

iﬁ:

Richter

Crossland

-

1916). Furthemore, normal cerebrospinal
I‘M? Mariam ”‘?¢‘94)
4.94mi
m‘t‘uﬁv
contains no free acetylcholine
deSpite the rapid breakdown of

system

(

&amp;

a,

bound acetylcholine during periods of

activity

and excitement.

The

cerebra-

spinal fluid normally has a definite level of cholinesterase activity, which

is principally of the "true" or mecholyl hydrolyzing type{ IVMﬂM/“V 4“}
"Romsuetkg. any).
.111

the absence of free acetylcholineﬁand under the ”normal" conditions

described! ﬁe electroencephalograms

fail to

(a) Effect of Cranlocerebral Trauma:

variables

was

lationship of

described by

show any
.

The

consistent abnormality.

earliest

changes in these

0
glmstein (l9h6) in a classical study of the re-

changes, degree of experimental head trauma, and levels of
cad/w»?!grew
oft!
cats
free acetylcholine in the 09!.
stu
subjected to varying degrees
EEG

0

a

of head trauma, B/mstein

first

showed

that free acetylcholine appeared in

{Yaszwm

the

CSF

‘

céE.
within a few minutes; and persisted for varying periods up to M hours.

There was a positive

relation between the degree of 17am and the quantity

�-3gamma

9
per cent. cu-

electroencephalograms demonstrated patterned changes.

Initially, the

of free acet’lcholtne which

w

Eg-rwﬁﬁal

varied-khan

2.7 and 9.0

Ocn

Com-raw

records were

filled with

high voltage .fast activity,

516

int'preted

as an intense

neuronal discharge; only to be followed by a short period of flattening of

all

#01

recorded electrical activity. These periods were "followed by prolonged

periods of high amplitude sharp waves in the delta frequencies.

Mt

0

Ulth thes/e'zlectroencephalographic changes, Bﬁrnstein fur-

ther noted that behavioral manifestations

w{

he werencorrelated with degree of

the
of
as
as
free
level
well
acetylcholine
traumal/

”in; highest levels

of acetyleholine; he noted the greatest degree of

abnormality as well as the greater severity

””77? M

u/ the
of

WW

t'anges a the appearance ofAseizures.
_

W,

diva

EEG

alteration in consciousness,

7393!. rnnumnrm

further substantiate these observations, B/grnstein applied acetylE Y 105553
choline to the
cat cerebral cortex. When the concentration of acetylTo

and

choline was 1

gamma

per cent or less, he observed high amplitude \sharp waves

of low frequency in the electroencephalogram.
creased to

.7lmaém WAC/c!

the concentration was in-

he
~Wana Mada

per-cent, the electroencephalogram
we. fad-w

2 gamma
74:

When

Tower and McEachern (1919 a)

flattened,‘

m

repeated thﬁe studies in human cases:

w

�cere‘rospinal
in the
fluid only in patients following head trauma, recent grandmal seizures and electroshock therapy.

to 100

gamma

In
cent.
addition,
per

terase activity of

the.

ific cholinesterase

spinal fluid.

(benzoylcholine

Specific cholinesterase

(

mecholyl

The

free acetylcholine varied from 0.2

Tower and

Mc

Eachem assayed the choles-

They noted a sharp

- splitting)fraction

rise in the nonspecand a drop

in the

- splitting) fraction in the patients

head trauma and those following electroshock therapy.

No

with

such inversion was

demonstrated in the fluids containing free acetylcholine following spontaneous

seizures. These authors also conclude that the level of free acety-

lcholine varies directly with the degree of cerebral damage; adding, however,

that the degree of reversal of the cholinesterase fraction is an even
sensitive indicatbr of cerebral

more

damage.

In most of these subjects electroencepéhlograms were taken at varying

intervals following trauma. Here, too, as in Bernstein's experimental study,
there

Was

a

direct correlation of the extent of

EEG

abnormality and the

appearance of free acetylcholine in the cerebrospinal
Thus,

we may

conclude

that craniocerebral

fluid.

trauma

results in the appear»

�-5.
in the spinal fluid; and that a

ance of increased amounts of acetylcholine

direct

{KN rJ
relation “between the amount of

acetylcholine, the degree and type of

electroencep‘llographic abnomality and clinical behavior.
(b) Effect of Atropine on post-tramuatic

EEG

and Behavior:

In his studies, Bernstein, administering 0.5
0

atropine, demonstrated a reversal or a blféking of the

EEG

-

1.0 mg/kg.

effects of trauma,

depending on the relation of the dose to the trauma. Atropine also modified

W

the behavioral and neurologic signs of trauma. In the experimental condition
of

[Mrﬁﬁc/UEPNM

acetylcholine, which induced

EEG

and

clinical ﬂanges similar

+1.14

to head trauma, Bornstein also demonstrated the blocking and reversing effect
of atropine.
Ward ( 1950)

applied these ideas to the treatment of

human

cases of

closed head injury. In 20 patients with varying degree‘ of trauma, he admin-

istered atropine subcutaneously in doses of 0.1 mg/kg.. In selected cases he
noted dramatic clinical improvement which

action.

He

\

.traum.we.

also noted,

alographic effects of

IA)

lg.

m

M

ATTRI Ben-5;}

to

he

atropine

selected instances, reversal of the electroenceph.

In the study of another anti-

�To“)

f

\DIW
I
cholinergé'

drug,

"DIPARCOL"

‘6'

(diethazine), Jelkner and Lechner( 1955) re-

port significant alterations in the post-traumatic electroencepbdogramio

A

single intravenous dose in no instances of abnormal electroencephalogram re-

sulted in nomalizing in
More

22

instances and marked improvement in six others,

recently, Ulett and Johnson (1956) demonstrated the

of peripheral atropine

IL’

.0

to block the

same

effect

occurrence of slow wave activity follow-

ing electroshock therapy. This study suggests the possibility that the same
biochemical condition underlies the electroencephalographic abnormalities in
head trauma and
One

in electroshock.

report stands out in contrast to these findings.

the§5
In
ex-

periments Brenner and Merritt (19h2), applying topical acetylcholine in con-

centrations of

to

232‘

intravenous atropine

to the exposed cortex of cats, noted no effect of

10%

ng/kg)

on

the electroencepahalographic changes.

It is

important to note however, that the concentrations of acetylcholine in these
experiments was significantly higher than the topical applications

“a,

0.:

ML

andnmtra-steruc (0.2
Merritt, however,

make

-

10 gamma)

(1-34 g7ama%)

injections of Bomstein (19h6). Brenner aha-4.1L

note of electroencephalographic effects similar to ace-

0
tycholine from mecholyl (acetylbetamethylcholine) and d’iryl (carbamylcholine) ,
‘

each in concentrations much lower than the acetylcholine concentrations.

�-7.
They ascribed the increased

effectiveness of these cholinergic drugs to their

lack of sensitivity to cerebral cholinesterases.
A

-

variety of experiments utilizing

DFP

(di-isopropyl fluorophosphate)

a compound with irreversible anti-cholinesterase effects

-

demonstrate‘ the

developnent of high amplitude rapid frequency waves similar to status epileptic“;s

as well as lesser degrees of abnormality noted in post-tramnatic states
_

wich

et a1,

1950; Frefdman

_e_t_

a}, 1929; and

Hampson

gt a},

1950.)

A!

..
(Hit

In these

studies, too, the electroencepahalographic effects were blocked by small doses
of atropine.

In another laboratory study, Qhatfield and
posed animal cortex with

activity.

The

Me
PR0 ST!

Dempsey

(l9h2) prepared ex-

NW

and evoked electroencephalographic Spike

admestratgﬁof
prior
atropine blocked this spiking, or

if

present, the alnormality could be eliminated by atropine.
Thus, from a

clude

variety of experimental and clinical studies,

that electroencephalographic activity

as a result of trauma,

To PM; AL

‘5“

we may

con-

induced by acetylcholine, either

application or interference with normal cerebral

metabolism, can be blocked or eliminated by atropine.

�-8(c) Role of CembraSpinal Fluid Acetylcholine in Seizures

Acetylcholine

is

normally present in nervous tissue in a bound, in-

active form. During periods of activity, the free acetylcholine is liberated

at the cell

”I;

The

membrane, where

it is

rapidly deactivated by cholinesterasmﬁ-

level of central nervous system

a
acetylcholine is this

ant of the processes of synthesis, liberation and breakdown.

It

the result-

may be

post-

ulated, there/jars, that the level will rise during sleep and fall during act-

ivity.

this hypothesis is tge

That

(1949) and

Elliott,
,

was demonstrated by

Swank and Henderson (1950)

liquid air quick-freezing methods,

Etc.“

ter

ANIM

in “8.1 experments.

was 300% higher than
'

micrograxmna

the post seizure level.

tissue levels is transoi'ent, however, as the

7
in rat brain is high (1 gr:

.

and Crossland demonstrated

anesthesia and sleep level of acetylcholine (measured as

brain tissue)

Richter and Grassland

’R’tSW

”thesis

The

By

using

that the
per

mg

'

difference in

rate for acetylcholine

J
Elliott 33 a; confirmed thez'e
(I950)

gaxmna/gm/minute).

observations. In addition, they noted that after metrﬂzole convulsions Jﬁi FK’EE

acetylcholine was always demonstrable in the spinal fluid in concentrations
up

to

3 gamma

per cent.

In spinal fluid studies in
Tower and

Me

man, Cone, Tower and Me Eachern (19h8) and

Eachern (19h9 B) also demonstrated significant quantities of free

�.9acetylcholine in patients with epilepsy. 0f 56 epileptic patients,
meaSurable

demonstrated/free acetylcholine in quantities of 0.92 to 5.0
with an average of 1.0

gamma

per cent.

gamma

“¢¢

‘7.)
()7

per cent,

acetylcholine level was directly

The

related to the frequency of seizuresf/ the extent of electroencephalographic
abnormality, and the relation of time of

/

n01

.,

M
sampling
l

14¢,

tonlast seiZure.

It bore

I

relation to medication, type of epilepsy or level of cholinesterase act-

ivity.
As

to whether the acetylcholine appeared in the spinal fluid is a by-

product of the

a M V“ ' s I o n

/
conclusion; or whether

C

the increase in acetylocholine was a

is problematical.
a,
increased

cause of the seizure,

lieve that the

Tower and

[{cetylcholine liberation

itself but related

Me

Eachem (19h9 B) be-

is not

due

to the seizure

to the basic process causing the seizure.
I

In a study of thfhypothesis that the accmuulation of acetylcholine

is basic to

the seizure process, Torda (1953), induced convulsions in animals

by met zole. She determined the level of acetylcholine in brain

fore and during convulsions.

She

W
tissue be1' '

.

noted that convulsions are preceded by a

rise in the acetylcholine content of tissue; that the content gradually $118
during the convulsion; and that

*

5423..)

occur. Furthermore, she postulated
convulsions

u

WAS

8.

certain levels, convulsions failed to
can?»

send 3 factor} which in physostigmine

probably acetylcholine, but in electroshock seizures was not.

�Shendllu concluded
was due

that the fall in tissue acetylcholine during a convulsion

to inhibition of acetylcholine synthesis by increased concentration?-

Sec”
of metabolitesnas ammonium ions.
While considerable argﬁihent waxes about the significance of acety-

lécholine in the mechanism of seizures,

it is apparent that free

acetylcholine

appears in the Spinal fluid following seizures; that activity and seizures

enhanceﬁiacetylcholine; dfstruction/lowering tissue levels of acetylcholine;
while sleep and anesthesia Aﬁgment acetylcholine production increasing tissue

levels.

�W!"—

"

WM—w-"ﬁ '

TNT

&lt;-

Mm;
E

Aest‘
I.

/

I

w-

.

,

»

urr

u

'
,

M

0'

-

,,._

-m—~

I
4,4

"

6Z7

v

-

,1

5

M

1,;“414,

m. -w—.‘

—V&lt;.._—.

.Avv»/—

up

~~r

.-———:v

mm”
M:

.

~

.

w.,--

”v7

/’

W“, .. -v.

..

.

.

.

wﬂnm .,,_.V,r,

_.._ .&lt;‘._,._r_.__.=_,,m,_qw

'

-.

‘

EE
&lt;

,.

’

I
I: l
-7'
['4imzzm4m-‘ean-,g-gﬁc
‘

~

—

‘

,
/

-~—...:.;_.-f.._

Mg;

((244.4'4/pv

A

,

,

,..

/
/'
l
.

’

/

3

‘

j

Z

e"

.

�����-«

”tum-35$:

434..

\2

as:

{525%

mthhw
‘3‘

M

.

{3%.

«3%.

Ma

g.

7

\i‘xw
_.

,

n

ﬁwkﬁkxﬁhﬁ

\.m§\.
5n
Q“

W;
‘53
h}.
41“;

7

53.3%

_

x

w

x

”‘1;

(“VM
,

«$ka

��the level of free acetylcholine and should follow a decay rate equal to

the
EEG

WWI-£6
rate of in desthtion.

Since previous studies demonstrated that

Ron

hypersynchuy was a necessary pre-requisite to clinical response to

electroshock therapy,

it may be stated that the

absence of free acetyl-

choline precludes changes in cerebral function and thus precludes a

ical response to electroshock.
Certain assumptions

61M

(1/ .WQS

in \mﬁxam

em

.

may be made

regarding

M‘

W£%,ML 4W;

Cholinesterase I is found in

clin-

WM“;

all
4 {a ;ﬁb€,¢.¢£ £0»£u64*

'

'

highest concentration in the central

W,
W
nervous system; while cholinesterase II is predominant inAblood serum.
With the increase

W!

M/mx.dv£[7

in acetylcholine levels, in the intercellular fluids M

Wftoaow M 6i mm

‘5‘”;

vs odilation and increased cellular permeability
degree of transudation of vascular fluids

may be

I: into the

dependent on the extent and duration of the
/

predicted, with a

intercellular spaces

tasodilation, (Kabat gt 3;.) 19118);

ration changesggﬁztlt high

ncentrations of

15?;
,

enzymet, th

4/

rate of hydrolysis idndecreased,

'

achnﬁnson and Rothenberg,

�@
Tit/4M

ﬁgﬂﬂﬁ

W05!
M. r
'

”1“."
I
(m0 4» w- ar
A

»

W
M L’

M.%u

7

.

WW1

’53),

do

W
MW;
-

’

.

-

W
I44"!

%_

/o¢

/ZM"‘

�2% Mwaﬂ.‘

éﬁ

7M/Cc

42

d

a

&gt;/~7‘$[

6a
56)

iwwwh‘
4M
444W
'

'wZ/zé
9“.

ﬂ

A—ﬁr7:9%__~_

��__ _%j%i%%

__M
__~__

Meg/Eran!»

,

,

M
W/

8&amp;9-

afﬂt

‘9

_4€§./_""f.

'

1%

ﬁﬂwjg;

W M;

___-#__

�����F:+r§¥¥33~%¢;*‘

'77
,

"“37
'

\.

*Q W~~
-~’ vM—w7ﬂx-«7A

77.7.«7-«7 .

.ﬁW-M

1'}

f

MW~
§'
\»M
‘
\

ﬂ

r

\-

j

"39%

\~§\-&amp;3~

.uxawk

,

7

-

7

«.77;

7

777

,

77.7—7— ...-&lt;

w...

7-

W
-

7

7

7

7

77

77.3,

777

a

Q7
M353;
--:-..___7—a.7..7
'

77.7.7

1377-3 ~&amp;\ 71;;7.}7c§?§37\7:s7

sw
C\

hﬂa§»3~§~3~
77-.. 7.7.77

‘

7-

7.,

7

x

77

5g

.v‘wz\
if»;

~

\

f

��I: she/ﬂ

ammunummmmmmmmemw

at our.Mating
um
'mmsmmmmaozmmmmmmumu

Meat

11:

than Inherited“

ﬂu

1-01.

mmpn—mquuiuformmhmurnammtot
mhwpmtsim ddﬁndocobulmuondmam

Wcummawmmm(mmmv$6h

topmtmawotthamdalhtmutw(mttmdm
1956). rationing the

Inseam at this report, In investigated the
,

of acetylcholm Ind cholinoatome in

diam-tutu

n clone

of

w’

My.

«f ﬁfe? ":9-

‘

therapy. as. data amply

the dean. and persistm of the
ham
1".th

010W
113109

mm

75:,

role:

“humility math-

I'm acetﬂdwlim in

:ppm

of measurable quat-

the cerebmpinal fluid as wall as an

in-

moralenrucetvlchdjnohthotmumornemmpnmm

Mamamrormsmmtmtmumotmwxm
affects by Dale

M1
(1911s) Ind/(1921).

'

rho

W:

n

to another

«1th

4

'

�“wwwmmmtu‘mdmammmm
of

M

0mm hon. It in affluent to who

that mtyldmnm 1|

nmmlmtitmtofmmmmy mtnmmmabmtmaaa
is liberated

as.

an

mum

normal cut-Ironing].
1.913%)

than“ th-

or activity and

that

m

ﬂuid contains

an hm

saga-mt.

no true

of bdund

1?.

iallnpidly

mtylchoum (faster

and McEachorn

new

periods

The comma-121ml

dummy;

nomliy
has
ﬂuid

lenl of Munster-nae activity, Men is principally of the

mM

W

was;
a: Manning and .- mam mmtitutod
mun (mm-a 6mm - 19M). Funk-awn,

«citation

W

through

by

during thy

W

(W

n

“two"

deﬁnitm-

and Rothanborg: 1935).

hmmdfmmtylchonmmdwwrthc'mml"condium
(a)

fact.

:10

mmbrd Tm: th- mliast chug» in than

Wmaomumwaommmwmuauummdm
vngaumpdEmm,mdoxpommhudtm,mdm
otrmumymwminthoembmpamnm. human-numbMtedtonqingdogmluthomtrm,homu1nnruahamdthattm

�v

r

A—w—

WWW—«WW.

W-_-m_w..__quw$

mtmmmwnmcsruuunarummmmm
per-1m for varying poriodl up to Mm. that m a. pain»

mum

‘mmmmammmmwnttnomwmma
mamaandsammmh
human;

mum,

W

was

rm activity{ inmlytohtoﬁmdbyawm

tbs records won filled with high voltam

urpntodalunmﬁeuo neuranldiachatgoy
period of

mtumd We.

{humus

of :11

room-dud Glacial-191

activity. Thou period:

~mwwwmm—n

-M."

mthntoﬂmndbypnlowmothighwnwbshammmh

fw.
summogmmc
.

tbs delta.

than

With

that behavioral
as wen

u

.

i

changel,

-

Barnum 11mm:- new

Nautical! an duo 00th with dogma of tum,

with the 15931 of tree mtylclmline. with highest levels

a:

mmmmwmmuudagmotmmnmwumuum
the
in
alteratim in
seventy
gm‘bar

ma the
1'0

Wmu.»

o: apontanam

farms:-

ahounotothnupoud

mam,

change!

Wanna: animus.

those chain-mum,

in

m.

Bantam applied acetyl-

«teen-balsam. Unauthomntntimot

amylmmlgmporom.arm,hooblemdhighmpntudu

�Mmsdloufnqumyintheauctmmoplhlom. manommutation an increased to

2

gun

pen-cont, the

ﬂattened; in a tnhiun pal-Inn}. to the

Tatar,“

kaW

mammpmlogm

pout-twat“

a) repeated mm.

§

rum.

mm mum-um

otnxwingtmofwmandoﬂm»wm¢nsordem.

13112

mmmmmmmrmmmmmnmwm

mummmwzm,mmiummmm
therapy.

murmmtyloholimuxﬁsdhuOJwMgmmrmt.

In

muQMrmm-aemmdmmmmmiuwatmm
ﬂuid.

Mm:MmmmmpMcmmmM(m

wmmntm)
-

(tn-chem

fondling

dug: in the lpociric

chainsaw

emitting) fraction in the pntiantl with head trams

mm W.

tho fluids outlining
mean

faction m a

lo

s'ugh

hint-310nm

and

We

Wadi:

rm antyloholim tanning mutations mum.

more also conclude ﬂat the Laval a: nu agctymm uric.

Wummmotumbmmgm,mr.

than:

Mmdnﬁmldmmnmmmtnmummmw
sitiw indiutor of

mm m.

�Inn-tatuaumjomwmrmunmnmh—
iamla tanning.

m.

Hun, too, an in Bernstein's

W

cm,

Mmammwmumamumtdmmwwum

adenwmmmaﬁWMd.

mmmmmludnmtmmnmmnmunthaw

”ammuarmmmmmmnudgmum

adfmtrahﬁondmhomﬂnmtofmwlm,ﬂum

mmdwogmowwmmhémmﬁ
Banners
gm Am 9&amp;th
of

(12)

In u.-

on

BEG

and

mms, Barnum, maturing 0.5 - 1.0 lag/kg.

um,

mumudamdor&amp;umdmm¢hm¢tmb
Mam'unumorunmmmm; Atmpimdsomdm
tho

Word

and

usablogic

aim

of

tum.

In tho maximum

eon-.-

.wmgm
mmmwmm,mmaumnwmm
dmm of mmcistam

induced Km and

clinical

m: rmrsing arrest. or «3mm.

m&lt;m&gt;mmmmmmmathmm¢
WWW. mmpumummmotmhmintend atropin- aubomunly in data «(0.1

W0.

In

about! an!

�.__..

_“_«,

_._.__,,....&lt;.,.___,.

W7.

w

_.

mmwmmummmmmmnmwam
actim.

”waww",

..

__._

7

bmmnmmma,mrmafﬂualectw

'exmpmpmpmo effaahl

.w

M”

wwwmmwv—WWWWWV.W_

0239113301110

«um. hmsmammu-

am, Inn-mm

(mm). mwmuﬁﬂ

mmamwmmwmmnm.”
AWWMHMMWOIWW

mmmmmmammwwmmomn:
IMW,Mtandemm(1956)Wthume£fm

-A——.~-T.v

_

ofpoﬁpheglatnﬁminﬂocﬂngthemmotdmmwacﬁuw
following unattached:

the

sm Wen].

mm.

00:811th

mm

saw mggom tbs Minty any

mm.

the

mmmmmmum

WWW

mu-

MWMdsmmnmmnmmgﬂndi-nga. Inmates-

3m:

W

mmmm in
Wmmdzimloﬂwtmmedmnaotmu,wbudmdfm

parjnants

and

Hewitt (1913);

topical

.ofinWatnﬂmﬂM/kﬂmthooloatmmmm
xtumrwmmmhmr, thatthecmnmumofmamwm

mmmnmamswmwmmmmmmappuuuéu
(Mm$)mmmmmm(o.2emm)mmatnom

�thin (W).

3m:

and

”.11“.
of
hm“, mar,
WW]:-

ognplun affects 81:11” to noetycholino

(WW),

chonu)

and duty].

than th-

mmm mmm.

1mm at that. cholinorgic drugs

mums.
IA

-

n

van-Low

ma

at expert-ants

nah in commutation! Inch lover

my mum ﬂu 1mm attach

thou-lack.“
to

um

with incur-11:10

2m mmm (awwmﬂ-

DFP

muutytomhnl

(div-1W}.

Imam“)

cumin-stoma. strum - mum-

thadaubmtnthighmpnmdonmdfuqmymvelmumm

mnpueusuuuumm dugmoxabmmutymmnmt-W
mm

919;.
(Es-non.

museum,

too,

1950;

mag,

192m and Ema-ca

mmmmmnphicoftoctImnWby

Inn dot» at am.
In

W

as.

1950).

mama-y mm, tantrum and 3-way (191:!)

pm

mud dwtmmphdomplﬁc
m1
mmuw. ﬁnpriarWtimotnmpimelm,

expand

cox-u: with procugdno md

ovum, mmmntyoomuonmmmbyatm.
m.rmanneworupommae1mmam.mmm
and. tint

datum-MW

activity induced

by

mtyldzoune,

um

�tuna,
uI
combs-alum unbeblocbdoralmmmbyatmm.

topical tpplmuen or interference with

mum. of

am

run.
may.
mummpnmtmnemuamuam,

mmmotacuuty.mrmmmunhenuumw
maxi-,1Ihonit1lnpiﬂym1nudbycholmmnu. thunder

Wmmauwlm ilyﬁnnﬂaruulhntd’ﬁbpmm
at

manna,

ulnar-1510:: and

mmmuuuu
-

this

mm

is true

um

It N ha

mm, Wm.

dudngnlupmdhﬂdnﬂngmiﬂw. nut

m Maud

by aches:- and 02-083de (1919)

NW§.mmﬂdeM'(19SO)mmupemu.
11mm:

on quash-trauma methods,

Riches: and

cm

wining

dam-mad um

(many-dam
mwmmmxamwm

prn.mmm)ulwmmmmtmm

an

wmmmmnmymnummm
rats. for

Micheline

1n

nth-11:1

18 high (1

gulp/mu).

Elliott

ggmmjmmunu'obsemum. 111mm, thqmtndthat
snot-mm mmmrmmwmmmmmn

�_...—_——___w

wv—wwrvnvr—ﬁwwv—wvw

th‘smmnmmmtmﬂmuptoJEtmmm
Intpdmlﬂuidotﬂiuinnn,“m,Tmrundﬂon(19hﬂ)md

mwhmmm
alumnae-ad mimt managed
rmmmmupumuumomm. 0t56wihpthpt1mﬂ.hh
(1919 B)

(Wmmmnmmmwmnm'mmuuudoawa
mmoem,umqmndeJMWM. magnetism:-

mmmnmpdmmmotmymmot
WWw,wmnuumor‘motmm¢
“Whitman“. Itbonmnhﬂmtomdicgﬁm,typadepﬂsply
armaehammnuacuuv.

hummumtymwmmmamuam

mammumrmmmmamwmma

_munofthaac1mn,1apobmm rmrlhdmmm (19193)»

mmmwmmnumumtmuwm
iwmmnudhthohsdcmumth-mum.

ht’ahwdmlwmmmdmdmw

lib-intact): «13m process, rm (1953).1ndnoodoauvu1d.min

mwmtruoh.

Sheatoxudmdtholmlofmtyldxolim

13an

-

�”memcm.

mmmtommmmm,addbytmommmmmmmmtdusmj anthem”

Mfmsdumgwmmgwdmtmmmmh,m

Wmn,mmudtmtm,
.MhWWumpmmyaummm,bﬂh
mmmmtmrmnmm
WWWM.
maimhiladtoopw.

Wmammmmmummumotmtymmm
that: by increased mam-cums ﬂ ”tam“. such a min in.
M13

mm

nrgunent

mm

the significance of newb-

‘Wmﬂnmcmdms, niaappumtﬂmttmmwh

mwmmmmdrmmm; thitmvityuﬂ
mummammamum,

«mm;

mm

sloop

mug-mm,

M

W

mammal-19701.net

tum

@tyldzonm product“

mm

with than
muse:
80m
omimumdchmgummmm,2mrmdncm(mwhw

(a)

,

Walnut! ”1:413:de

«shun-ammo activity.

«Wmaammmrmmmmmm

Twin.-

Minster».

�"w

——_&lt;__~___..——ww—m_mw—.wrw

“—vwr

,

wwwv

I (”ta-m“, .. ”apedtic',: for Mahlﬂgdw mid: he a ma: Spain-o{r

21w for

WW;

and

«shaman-a II

('psendo", ﬁes-Specific,“ a!"

WW

Warsaw-MW). m
have 6133mm ram
«Wrormmawmmmoum.
differential

a..—vnv—_——-_

nu

cholimteme activity an

mm
he»
083

Bach/Ann and

mm

1133a,

This

qualitative dintlnctim. W Rpm-ting the

138111158

substratu’to

mtylchonnc, but

a ratio of the activity

mtylcholm mum-nu,

an

Wm

(mu Wm - me).

autumnal m the

zonal as: consist:

a;

mm

necholyl and haul-

m nuns are found:

In mch

ntiol non-1

of 33:17 for lack/10h to sub/Ash.

manor “pawn"

amt-Suez- with a

mi].

‘

non-speciﬁc

eaten“

emporium.

In patients with hand

.‘IZ

chainsaw” activity.

tram,

I'm and kitchen report a sweat

may, manu-

mum.
the county of mammmm

eorrdnﬁm between ﬂu extent at tho
th- dagm of

Wu.

tuna and

usert. that. there in a definit-

mend both with

�r,_._W__,__.___._...

Inpuumvith

mmmmammuvmru:

unatotopmmuiznm,hmr,mm1nthonuodobd139mm or total audits-Item activity“: round.

Imrandlhmm

(191:?

g), in than study

érudounbnl
at
tram, n-

W‘mmmtmmtmmmw.

3m»

&amp;pm
WW,
zuwnzmmmnmmmgmmmmmw
ﬁmw
decram
c‘Wmﬂthnmerulofth
Wotan“,
amr 3-?

am

Mupomd rm mtylchanm m..1?

ratio at abolition-M7411 ﬁve pt tho :1: patient.“ Fro-than ohm»

nmmwmmtmmtmwmmmmm
nor:

1113

than. of crunooerehnl

um

than

that:

found

in opium.

kmtmmpmmmmmmmmmwum
Momtmwaweamna ratio reversal,- fb-ymwﬂn
ummmmtmnpcmntmaaamlymotmmumwm
to want."

W

�mrmmyaahmmmu.

Alia,

fmmcwdmrmﬂ

pungent
m
ot’l'mrmdgcﬁcehcémb),
mtthctcguths
fwdtoMspimlncid WWW thalamus tomcat-ant,
penuts us to considor the

yummy

basic to the anaemia of the

um:-

that

such

hm

9:.th pmceu.

Ghana‘s:

.g.

.

ocmlusians
Certain further deauctiom and

agaafalectric

m

mmmgmmma
mum.

The pmscuce

intcmnnhr ﬂuids Mean alcctmcn

Maximum;

The

pen--

mduccaachangeinccn—

ﬂax-activitywith‘anmmu when acetylcholina
induce;
to
gradual

pastime.

tom: “trim

ofﬁo mtylchaum inﬁll

WW,

nﬂwted in tb

nudomeofhwanmmncmtelymﬂm

�»;y-

mmarmmwmmmwwrmamnuoqmmw
an at

new

destruction. 31m.

pm”

IMO?

Mutated tint

lmonnnnmmmnmausaxnmumuypnhunmxuwintnhumnxmqmmnijhmbmahock thonpy,

it my be stated that the absence a! {mo acetylchcnne pm-

cludu chmgu 1n eczema]. {motion and thus pracludu

n

clinical aspen-e to

electroshock.

‘hﬁhhnummmummsnybomwbrqpnnmgdumpainaﬂluuwmmepmb
usability

at!

explaining the increald 1n Ghanaian-Ame activiw.

I is round in highaat cannuntrttian in the central narvoun
estemse

Quintet-rue

aystaum while

n is pram in other games, especially blood serum.

choline-

With the

increase in mtylchoum levels in the inter-cellular ﬂuid: as a result. of

stimulation and convulsion,

“sodium and increased cellular pemeability may

bawm¢mum,muhacbgmouttnmmmmmaaatwumnurﬂmuh1Mmibuhﬂmm

celluhr

spaces dependent on the extent and duration of the

ﬂuctuation,

(but

�r_"__.

m,_m

into tbs spin-1 fluid; and that thus the electrolytes increased, than

siwmsnt increase in
changes
.

mm

in permsbmty of calls

may

ﬂms

such

u

nusledc‘soid Splitting

was

s

amps“.

pmids the basis for the sppomncs

of high concentrations of scstylchouns and for increase concentrations of

Cholinutsrus II, (Tatar sad
With the increase

HcEschom 19h?

in cholinss’oerssa activity, should not the free sooty.

lchouns be rapidly destroysd?

ﬂuid after trams

a).

To what

melanin

cam

it's persistence

and seizure be «embed? An explanation

is available in the

for this discrepancy

observations 0: Hush-am and Rothsabsrg (191:5). continue!

by Tower and Ks ﬁschsm (191396) and Burgaa and the Intosh (1955),

tylchouas

-

shonnsstersse

I

system

“humanips.

At ”physiologic”

extremely rapid

(3-4.1

1vity

in spinal

is

cmcsntrations, mdrolysis

microseconds) but

falls of! very ﬂuidly

extremely sensitive to

(Haldane

at higher

and lower

of,

ill-t the sea-

montrstion
acetylchonne is

consentmtims, set.-

tbs
Cholinesusrass II
cum). In contrast,

acetylchonns uhtionship 1s non-specific, and the rats at hy€re1ysis incmsss
with concentrsum.
0011

mums,

insstarase

this

I, in the

11:53

acetyai‘shonm
functional
with nouns].
st.
1m_ls o:

soatylsholins is dsstmysd by the specific.
oMsr 0! milliseconds.

Where

wvity of

chol-

the excitaﬂea is such as to

-

�1nd. to an
of

“casein

mm

by

concentration of sootyloholino in nervous tissue, the rots

momma. ‘aooodoo.

choline mounts, the ssisuro threshold

dissociation in sootyloholino

-

unt vaaouur

ad

As

is ruched

the oonoontntion o: oootyiand c soisuro occurs. 1h.

_

cholinostorsse I motionﬂzip vaults in s per-

sistonoe of acetylcholine. rho «ism-o,

In. acotylchouns.

‘

itself,

perhaps adds to the Ian].

at

inc'mmd mtylaholino airing.” rapidly. with result-

1'1»

permeability
connineffects and the appearance of increased

names») mmoimnuooohomonom II. Itumoouvuyorwo
onlym, though of

lot sfﬂciomy,

roduoos tho sootyicholins
~«mum of

cholinostonso

and

69th

on concentration

aworim,

1on1, InAhours to

kinetics that

-

to levels for the plvsiologic

I.

Altontionintlnbloodbnin pewbmty humorbyths cantimingsutim

omo observed in pout-electroshock oioctmooophnogrm.
1: evident in the mount apart no Aird 33

g

(1956)

Such

s possibility-

«annotating a significant

increase in tho concentration or odd-inc in bmin tissuo 3-day: utter s ashes
of 12

elects-om. an on. shows

#olooulo, ordinarily obsent in brain

tho clung.

tism,

in omcantntion of this

mg.

to b. con-eluted with the spposmoo

�,

w— _,

N‘erm—.
#179

WW

ducal

unu,

however,

the

1::

mt subjects.

the

ma

1tuntoa

311

com

awumum of trout-

«‘WW

AM»
7
ms
extent;
miuuw to
«-

Despite a

Maﬁa:

nry may

in the

of high dogs-ea hypersymhmy,

m:

by Alerting,

mule

the

duratiamdﬁ'

hypnrvmtmum

populating. me

and

wly appearance

m persist-mo Wont the tmtamt cont-u,

has been described In a neceﬁnry pu-requinita for imprwmmt following

shook( nuke: Kuhn. 1956).

Batman

certain patients to dovdop

137”“an

aholine Ind

Manama:

Assuming

my be

um mechanism
Perhaps

and

gloom-

of.macs-mug the failure

them staring of acetyl-

nﬁud.

is.
that a gnnd m1 leisure indicative of the developmnt of tissue

1min or free acetylchonm in mass at the
I;

hub-

at. at hydrolysis by Mae-unl-

that the electroencephalographic Wrenchrany in a reflection of tbs

persistence of this almond. concentration of acatylcholineg than tho diffemnco

in

paint: who maintain hypermchrm and those in when it

rapidly (tumour-O

Ida]

disappem, 15 a nﬂactim of the theta.“ of the wonmatemmcetyldmum
hydrolysi- Byataa. Persistent.

Mommy "cults non decreased "to of

�rw‘“.

a“

+

V

‘.

,

“m---“vmw

hydrolysis of acetylcholim.

.Ismbmmmmmdm'oomct, dWrmorbothof
the following postulates

m

opantin

an

patient: with persist-mt hyper”:—

chm.
1)

Western”

spread batman the

the

tiam.

opt“

ammunition, so that than in a great

Imam.- substrate concentration and those present in

with high gootylchaline) Ind/[Y

2) Gunmetal-nu

m

I~1a in 108

1113.1”, lo that the cmntntian kenotion a: this mm

opemtim, thong) at a slow decay rate. Conversely, in patients with short

ed

lampemymhm, cholineatomaelandnintismandspimlﬂuidm
Anthem,

at”

the appunnce of high oomentratiom of acetylcholine stuns!»

the production or tissue cholinestemse

I in the central

Frau tho lucid studies of ”am-noun (195$), a

stated in depnasive psych”
induced

mtylchonne my

pncnorbid

m1.

(1

nervous system.

dim rahtionahip batman cm—

Mutton of tum cholinestcmse‘ I and level
.

/)

luv-750..

of nervous nativity can be

mmpnuul depression) , than the

choc:4 .

g.»

alumni“

I
to
production
a
maul.
Waters”
amt.
m

�g;

hmmmmmwmmumummm

_atummuv1ty. Wuﬂaweiwtnmwmmmd

WWNWPGW. Itilmww

mmmxmmbymmmxx.

rhpbhodpmmnotnb

mrmcmwmohdmmumbéomuam

matm.g.g.nntommzomm. hummus-Wm”
mmumuimmsmwmmmducmx,n,mmm

Mgmwmmsmuﬁamwmm tomato:
Wumumdmmum. mmxnﬁmmaﬁw
mtnuuummmmmamnumw;sssmnm

�4t).

awn-mwmm.
the
l

«tutor cautnlnorvm

”Input

Immuoimumm” 1, human tn:

of our): and sustained ma

levels of :cotylnhouno m
Khan, the

Wencﬂlhareaaidhrpndicumnm

data

Wmnohm

and

910nm spinal ﬂuid

mum to a slow 1nd of chainsaw” activiw.

at peripheral “mat-.1431 w chained: neat: 1|

thn hypotheti- roaming central nervous syntax

nictivity to

“rte

elect—reducer.

�thmmphmdem,
1)

mammmamnmmmnud. It'snhuato

3)

Whmdduudbwhmcuaoﬂurmmﬂmﬁxm

ﬁn"

memm—Wrww.

«swim 1nd...

W

tht
‘3)

a)

shamans activity and patterns ethical norm all

at

up

blame

mm
a m”
a)

‘)
1’)

at. of

W

at M
“1 frequency at emu-mu
(patina-1) mung;

Momummy.
mm

1

.7

�NEW»

J?

I

i

.

,

\J

Danae ReleefAeetylchenne

/
bu].

'

E

”Km

m

Mm

at

i

E

Wvulsulﬂ

45%

(”&lt;—

thenpyﬁdmtnted thet/

Gen-change in behevie

6
wee the development or

slowing

up

he"?

as f Wheat

oheervetion

W

-

we.

index (Finkw
and ﬁlm,

mined unclear until

the

«out report!

J’
the than; at Mention with high deeee of atropine
s f1.

E

«‘1

E

{E

""1?

ijmtmg
Week
WWM”)

ﬁcdw-

View. describing

"‘"

hum-tomemﬁemmenw

E)W” “M" “

W131-

'7:

the role of care-

Wrelrequeite

,

?:-

Conan/.hve

in the melanin o:

WW0

E

F

amazes

-

7'3""‘

early and persistent eight of altered cerebral Mention

2

E

15:7

umrmwwww22".

'W‘m~"

"M"

m-dbe’prevent the appeennce of the

EEG

delta abnormality (meet um John-on,
name“) 1d;
1956). Following the mggomm at this report, we
role/
Convu' | £09
of eeetylchame and cholineetereee in
therepy. The data up]:-

m

E

W
”‘35“:

e

m

clue relationship

ehetreeneephalogrephic

S‘ounvxﬁ

ities of free eeetylchonne

1n

Wane
~&gt;

between the degree and persistence of the

led the appeuenee of measurable quant-

the eerebreepinel fluid as wall as an inn.

vereim of the annual ratios of bensoycholmemlinemme to monomehenmetereee .

W
he

role. of ecetylehenne 1n the

bum

tea!

study since the

Loud

tnnuﬁdan

first

eﬂeﬁe—by m1. (1911:) and/(1921). the

3

description of

We.

W

of nervous impel-ea he:

as to whether

gmmm

"’

�lawmanaalyﬁgentmthomaiuionofmuwmmmmmt
cf

pm", man: here. It in mnmnt

a normal constituent of nervous

is liberated

m
it

mm in n baund torn and

tiuuo; that

during the excitation process; that

through the specific notion of

that mtyldzonm 1:

Minute”

11'.

in rapidly hydrolysed

aid as rapidly raconttitutod

by tho

Wtyhu‘ Bysm (Righter h mainland -

new].

«3&amp;0;me ﬂuid

191m)

damn

W
W

contain- no

1910)..

in» mtylcholim

(Tower and 1493116th

mo rapid breakdown o: bound acetylcholine during periods

of activiﬁy and excitement.

cerebroapiml fluid manually has

The

chain-stance activity,

principauy

”ohm hydrolysing typo (Warm and

of the

ducribed, eloobmemelﬁdlogma
Effect.

:3

crab

fail to

'tm‘

or

w

condition-

Wm

Show

Tram:

W

Bothenborg. 1915).

In tbs shame of fmo «Mammalia- and under the

(3.)

Fummm,

any conailtant abnormality.

506-)

ﬁﬁMU
Jeotad to varying degree: of had tram, Bomtainﬂﬁut abated that
(I

4

In.

�‘1'.

acetylchmne uppeu'ed in the 08? within a
_

few

aw”
minutee etterhtnme and

Wm
up“:
Wﬂoeitiwhnktm

persisted for verying periods up to he hams.
hw_¢,_e./
”MK“
at tame/:1 ﬁe quantity of tree
W... W”-~Nu
'{L
versed heaven 2.? and 9.0 pm per cent, Mi

'Wgne
7__

‘

,

“MM

.

Wu} Mm

amount-m. electroencepﬂlogrm
1111:1113, the Vracorde were

mud

filled with

all

patterned changes.

high voltage

recorded electrical

fut Witty.

1n:1

short

mm in

immune.

my!»
mum
F.

-

activity. mane periods

then Inﬂated by prolonged perloﬁe a! high amplitude sharp

the delta

“V,

z.-

terpreted as an intense neuron-J. discharge; only to he followed by

m

“I.

were 0.190

correlated with degree of

tame,

WW
mtylcmhemthegmteetdegneotmmmntylmthe
M
seventy-M
WM.

as well

all with the

level of tree mtylcholine. with highest levels

W

MA.

5(-

in containment-change- in

greatef

and

'20

J

gamma“-/'

‘

period of ﬂattening of

Iﬁ‘J‘

eponteneoue

of.

name,

poet~tremt1c eeimree/ 0/1/24.

Wow

furtmr substantiate these abstention, Bemetein applied ecet

choline to the apoeed cat oerehrel cortex.

acetylcholine use 1

gm

When

the concentration of

per cent or lose, he observed high

mutude

�W“

sharp

ms

at

low frequency

castration m immune! to

mum

.

m

(£2, patimto
therapy.

gm

pan-09111.;

Eu

mount

"(19349 a.)

:1me

mpeutud

was found

Wham

the can.

the electmcaphalogm

in a fashion pummel to the poototnmtic

Tower and

@

2

in the electroencepmom.

”com.

by};
WI

W

”arm.
thou studios in

in up «rebroapiml ﬂuid only 13'

'7 adtmm,moentgmm«1uuure3}nd’m
that :m neotylchguna varied IMOA to .100 gm per ant. In
”1

addition. Inner and Mencken-n assayed the cholkutenu activity at the spinal

“Maternal
M
(W ﬂatwf/ m.
W
W

fluid.

They noted a sharp

rise in the mamaiﬂc oholinesterase (berm.

Molina-splitting)

.WW”

with”.

taunting

thanpy._

Ho

such inversion

m

dmmstrated 1n

the fluids containing tree acatylohonm following Spontaneous seizures.

than: authors

oL

‘

do. concludcﬁt the m1 of tree acetyloholm varies

directly with the degree of cerebral

W

P. .._ ‘

3%
dam;
Mr,

rover-:1 of tho ohalinenterue

slum inﬂate:- nt con-bra dunno.

adding,

tau a,

that the

traction/tram non m

�W
-5-

want-)Ww an m at

(g m of those

i
P

5

tervala

tanning

MA

mm,

direct cox-“hum of the

_of Em

Mommy m

appearance of true uoo‘ylgaolmo in the nnbmspzlml
Tf
(-l [I
m. I'
that. eminent-b211, traum-

WM
ﬂ”
W/
m

I

1"

m?!

mes-d
a

in-

the

ﬂuid.

.

min-11mm-

ofﬂaoctyldmnno in tho Imus]. ﬂuid;

and,

that

the”
bemoan
mum
the
dim:
degree
pthmtylcholiﬁ,
aim
wt

at

and type
()3)

{“49—

.

‘

varying

1

.

lA~

mammognphic nbnomlity/ an!" clinical War.

am Am g. mtg-swan
at

EEG

and Behaiorz

ﬁw‘x mu Mud- W
u“ /w
mama-d {munching at mam attests/Mb—
.

W

j—h‘

“1.31m °£

3th.

6‘“

W

”ﬁshnet-n1

a

and neurolcgic {.1336 of

W

*h tum.
trams.

4;;

W
”1.574;

Mn“
2

“:86

awn/9
Men of 'mtncistorml acetylchoune, which induaod Em and clinical
.

W

effect of utmpdm.

closed head

In 20

clung” 11:11:: to had

Ward (1950)

tum, Bgmatoin

applied axons

1331117.

1m:

06 31.10414.

_

Water! ibis—W

to the

trentmt

of

0...

human

pttienuuith varying agree of

iatarad atropine subcutaneously in dam o: 0.1

when

In

cues 9f

m,

,

be achin-

M

can!

�r
WWWmmmm—W’mmww
E

aux.

mmmmmmlmm'mmm

rmml at tho electro-

,_

.W.

.
A

E.

enceprmlognphclc

effects

.

W

~vm1Wv—wr

E

m.

cholinergic drug,
a!
alterations in the
report

31mm

Inﬁm study of author anuJaguar and Loom

(1955)

915::th
We

Ammumtmnmmhommammmmm
E

E

«(At

a_

833”“me

r

A-..“

‘

m

.

__V

W

tu: 9.11.4447

M
W

mudmmmnmgmzzmmmmmdwmmcmm
of

atropino in blocking the

following

the

010% and Johnna (1956)

WW

w

W

and
I

in

m

Wm

of that wave activiw

therapy. this study suggest;

an biodmictl

in head mm.-

Mutated the smith“
ﬂat

uﬁdeﬂ; th- chctmnoepkﬂommic
\

I

\\

E

I

‘
_

manpoz'tstandaoutinconmsttothuennmngarlnﬁwhm_
'

\

pennants Brenner and Merritt. (19M), applying topical aoéﬁyldzoline

1n

concentratiomctﬁtomitoWWcomdmu,Wmdfm
i

or intmenma atropin- (1

E

E

It is

important to not.

the

r

‘

1r

E

nag/lag) on

hmr,

oloctraomphnlom

that the concentrations of

“Mabel!”

in thésa expemnta ma signiﬂmﬂy higher than the topim¥ upplioationl
.

r

E

.

L

E

«hang».

(1-1; game. S) and than

intncistamn1(o.2
.

-

10

N

,

Born.of
gum)1njecti%a
1

.:/\_

.\

�mm

Banner and

(19115).

ognphic affect:
01101130) and

than tbs

imu

hunt,

annu- to

doryl

hunter,

m

not. of

0100th

:cetyuholina from mecholyl (nootylhetmthylo

(Micheline),

not: in mneontrations

193$).de concentration.

mh 1m:-

Thq ascribed the manned effect-

at those abolinergic drug: to their lack of maitivity to cerebral

mums.

mm

high

«11
u
n
epileptic”,

mm
In

(W,

ﬂan

at

913;,

am.

In author

1950;

degrees a!

abnomlity noted in mhtmmtie

boom 339,,

1919; and

Emma 23$.19So).

m1

if present,
ﬂu»,

mentor}

The

tho

in:

warn

W

by

‘

study, Ghntﬂald and

aorta with prosuwm

39m activity.
or

1075531;

studios, too, the olectmneoﬂnlognphie effects

.1111 date!

exposed

W

«puma. npid fnquencykw

similar, to status

Dempsey (19152)

and «oh-d

pnpmd

eloctmemoptnlomma

prior aduiniatntim of ntropinn blocked this spiking,

Ibnomlity

could be

15leth by atropine.

a variety of upexdmntul and clinical

elude that eloctroenuphnlogmphic nativity induced by

studiu, u- my

con-

uctyldmuno, nth»!

�w .—-——\W-

W..

'WM

as e result at

Btu-Lug

tram,

topical application or interference with nee-all

period! of aetiviﬁy, 3% free acetylcholhe in liberated

W,

mm,

when

it in rapidly Mum by 01103111081283”.
{mu—ML

WAammchmne
115M101:
at
ma
We,
hm.
that the

than the

Th9 10701

mint,

of

remnant of the processes

It may be

postulated. therefore,

m1 mm rise during aleep and run mmiﬂw.

this methane is true
and

is

at the cell

That

we: denountrehd by Richter and Cree-land (19h?)

Swank and Render-eon (1950)

in animal uporlmntn. m using

liquid air quick-freezing methods, Edema: and Greenland denomtrated that.

mm

the anesthesia and sleep 1M1 at wetylehonne (manned ea

per

a.

brain tissue)

was 300%

difference in ﬂame level:

rate for acetyleholme in

21g

f”

(1950)

Maw, “

_ Vﬂ

'

*~-~r-—.._

(ﬁtter mtmole camﬂei

brain

is

however, an the meynﬂxeeia

high (7

W‘“

observation»

The

game/alum“). Elliott

W‘mey
H“

,

0,94»

A

noted that

”W «J'N'n‘ﬁ'
a free mtylohnline was always demmatrabh

WW”,
x.

is tme’imt,

at

6611th these

higher than the poet eeiaure level.

in

-

�-7 w»

mmmwmm_—-—

'“ " ' -

:

qumm

unmadﬂﬁdmmcmquptoBmwmt.
m,

In ’lpin-J. ﬂuid audio. in

fear and Kahuna!!!

(191:9 B)

Illa

Geno, Tan:- and He Enohem (191:8) and

mmm

woman!) in patients with opuspay.

free
(77%)

mud

lignuieant quantum: at
Of 56 OpilOPtic

W

mammal.-

rm miyloholine

directly ranted to the

momma
to the last minute.

W

‘in

quantities of 0.02 to 5.0

at cultures, the extent

It hon no

mention to

mansion,

cm

emulsion, orwhetharthe

«nun,

that. the

3pm ﬂuidisabyb

mummammoamumd-s

is prom-untied. Tm:

and

When:

hem-ad mtylchoum liberation in not

itself m‘mntod to the mic

is buie to

the

scum

process

due

mung ﬂu ”inure.”

process, Torch (1953)/ induced»

animals by metruole. She dctomined

mm;

type of epilepsy

mm.“

line

ot‘

I

“ﬂammumymmmauzymm
or the

mo-ammm

af-f;m
abnormality, ml the mung»:
of

or lavai of choljnaatemne activiw.

product of the

M;
J

gum per cent, with In may at 1.0 gum per cent.
16791

ﬂuent“,

tin level

01'

(191:9- B)

to up

be.

“ism

§

mm

Won:

1::

mammalian in bran

�Mam berm nadduring

W

Wm.

mm¢me

convulsions

rise in mintymmum Mutant of tissue; that tho

by a

my»
mum

Mfﬂndudngﬂwcmnlﬁm3umﬂutbomcemm15,m
whim failed to occur, )hrﬁzem/de
a

-

\\\_~_,_.H_.

than”

K.’

as

during u convulsion

We»;
H111»

duo

V‘;

to inhibition at aoetylchenno

mama;

martial. argument” about. the

MWWM’ZMMM
choline
the

W
Mum mﬁummum

Inch 3:

ram-m;

'

mtylchaum;

while sleep and

W

.

mtautivity

tum 1m].- nf

and
-

15min.

WW
magma:

mem-

mum 0.th mtylchoum produnﬁan

abut-ration: of change: in mtylchonm, armor and

of

of

W»!

Gmtlnt
War/wed...“

03m.

Mun 1m.

W
Mb...

in
clam ﬂuid
Jan-L,
dostmcum, lowering

mowing

J.»

—_‘_..~... . ,‘_‘

manned concentration- at

by

tum,

/" prob-Lb
acatylohouna, but in
m
msm"ﬁot¢&amp;nmumtthofmmmmw

in

mm

poetuhud

/,:v’

.
‘

whim:

z”

with

When:

(1916),..—

min-1 fluid cholinemmu activity.

are normally

fwd

1n the spinal

fluid:

than

Two

W

Minuteman-I

�\

} 0m”, -

~apec1nc',§ or

ity for wetylcholine;

and

hm

mxéming)mm

Bath

W

W

Wyn

for Mom

and

differential rite pend” qualitative distinction...
cholirmstame activity

a,

memo.

has a high

cholimtarwo 'II (.“psaﬁdo', 'nm—apecitio,' or

Mam-manning).
dittemnt. rates a!

madam—1

1

.éetymxoam, but

Mandamus.
By

Thin

‘

”porting the

M
ratio of the activity ”errand

and

prf
W(mﬂ1M/Aah Wk”:

bent.

oylcholiué swam—ates to an aoetylcholim substrate, m_ meio- are round:

WMw-‘C/WLW M

osr contains antenna in an

_

Thus, normal 68! consists

ntio

-

/1,u?l’zjdua.2

mo)‘ In such

0133:17 for

n“

non-specific ester-nae component.

In institute with hand

tram, Tour and Warn

report

‘5

dwinzfTr

W

the dog-reset

mmtyg

ﬁzz-J2

65.x;

tram and‘tho “Av-o:

””

mu

it"
,g
3

nAsimﬂmt

correlation batman the extent of the chalkenamc reversal “in with
'

1

WW
a)”;
M

minly of imposing" octane“ with a
.

no

I

,

the oWncomalogmphin

33

3

Jr”?

�In patients with

130de mu ﬂuid hétylcholm activity a I

result of Ipcntenoouc seizures, hammer, no change in the ratio of chol-

inestemea or total cholineeternae activity an

Wm
Manx:-

Tower and

a

their study of creaioocrehral

(19w 3), in

‘:A

six
portede psychiatric phtienta mapping

in:

*

ﬁle

rm.

W);

W

patients utter 3.7 troatmntc, theymported

{1;

m
M
decrease

cholimntame,

a “I.

tram, re-

therapy.

ﬁtm-

rm ioetylohonne act-

a:
cholinectemco with a

revered of the
5

W
We:
W

ratio of chcnneetoru? in five of the six patiente. Fro: tho/e oblont

“time
more

(V

they concludejthnt the apinﬂ. ﬂuid

Wax:
are- “Du—4

'

in

lib those of cmniooemhrel tum than then found in opucpcy.
haul-ding the one patient in the series

who

{tiled to

show

either

1“ﬁeyW“
tat "It

{mnwetylcholim or a cholincaterace ntio reversal,

0

u mum-ting that this patient was the only om o: the six to chow no
recponce to treatment

.'

�Ducunm

m
,

but than variant obnomtiom, In my comma that
therapy induces spinal ﬂuid changes mm

otrmrandwchem

(191:9

rum to maps»). ﬂuid

b), ﬂu

W

111m

cerebral

tram

amt. that onlytho gamma,

railed ta

show

a response to

peanuts us to consider the pwnibmty that such biochemical

“t,

basic to the machinist o: the

W

at alas-uric current through brain

ular activity with

an .inemaae

to inﬂuee a grand mal'acisun.

in

m.

Thu

tmtnant,

We m

process.

cnmlusiom
certain further deduction: and

‘ago

than than.

an

mamas

poasibla. the pun--

manna: a change in cell-

mtylnhnuno to level: uranium.

presence at! free

:1lech

in tho

�enema—II in

Mt

in other

tam,

W

blood

anew

man.

With

a.

1mm in acetylcholino levels in the inter-canning fluids an a result of
.

mum
amm'umnmdtmundmmmmmmmm
annular ms dupendantm ma ottoman duration or themuon, (mm.
ngm)vltmwpmwmwmbmmsmmmmw
81:6.me in mm mom (19M. "s2. W» M. '53). Thu
I!!! convulsion,

3111:9301

and

modihﬁna and nomad annular pemahility my

�throws
mumm;mmtmbmehmmud,
luxuriant

mmmmmmumw-m

splitting

m.

4

mummramtydmmmmmﬁomtormtw

_

wwmumamwmmwtermmmtma
ﬂmmm ’n. (rmr w mm
1916 B).

mammmincholmMmae activity. mummfmmwb

1mm

replay

be

ﬂuid nth-r

m

doatroyud?

and

re whet

We.

”ism I» «edited?

:1:

can

.

.

it’- pal-datum in

in amplmtim for this (1180mm

ammuntheobumtmormmmmm.mm"
tyrower

and He Enchun (1919c) and Bax-gen me

monoun-

At ”physiologic“

mantmtione,

m «2% (m
rapid

(3-15

dam)

mtnﬂm.

mm:

but at. higher and

fans

acetylnhoum nation-hip 1:
with

(195$). thet the

33.6w
sensitive
- chonmteme-I cyst. is

mtienehipe.

1v1ty

he Intonh

cm).

Wu,

mg. with hem-1

ne-

to concentrationor.

acetymhenne 1s

Mr concentmtiona, set-

In contrast. the [hasten-e411

and the

mm

rd: of hydrants 11mm

levels of acetylohnnna et

eettutyoreheaamteytheepune
«name-nu, theseemohenne

inseam-I,

1n the order or

nimucom.

.

more 3% annotation

W

-

�loaf» In main menu-luau or mwlaxolm in mm tissue,
at hydrolysis

Mascara-2‘1:
by

ehouneumtn,

my

As

tha

rah

an mutation at acetyl-

thaimnthrydzouu mammalian”. occurs. In.

dissociation inpootylcboum

- Ghanaian-a I whammy results in a par--

mm,1tu1f,par}upalddstothtlmlof
unﬁt-#61:. with munnu mom-ea

untmoeofaoetylchonne.

nu ﬁtym.

mm

gym: pemmuw grim

.W

1mm
muesnmnummmmnmumﬂ.'1t1umauuwottua

ant. vascular and

0mm,

aid the

or

mummcm,mmmmnmmmmmt,
ypuulbi

uduoeathnm‘ylcholmm,
action at

'

mmudm,umrermmo1agu

muons-I

mm,muhasentumm,ubccomnmummw

�all?»
.

!

I

W

dwwm{mubm)nmmmmm
hmumnamwaotmmmmmmuu

Wuhnecmﬂmdmmpnvmmmmtmmm
due”

mu,

)2pr
m,

extent)

its

in lost abducts. Ila-pelt. n

m up at uppunnoa

mum:

m

vuy greatly in

of mg: dogma

WW.

nut.-

daumua: m

2171

to modiﬁcation by ﬂex-ting,

ituntosa-

has bean

W

applicatiu: of

b

mmmﬁan and hub--

w

psyuhntzic popﬁhtion. me

and

1t!

any appearance

courts,
trait“:
Want
yum
the

63mm u n uncanny pn-mquuiu for

Mt

following 01.0m—

m(
ampmumwmm'z Pcmmiomudwm.

M&amp;Km,1956). ButmtutbcmhmiumucﬂnngtheMnno!

dialing and

Mentor-Ion m be nut-d.

Assuming

that a grand

Ill

is.
seizure
indicative of the

MW

of

tism

le'nlloffmo

mmmnm-«mnudwwwmm-I/

’md

ehctmphdognmc hyperqnchmil a reflection at u:

um. the

per-31m

of thin abnoml commutation a! Micheline; than the difference

upmummnmmmmmmmman W(Mhouni

Wm,

13 a

nﬂactian of tho

mm m

W
«we.

d tho dammsuwtymm

Persimt types-3mm units m-

M

nt- of

�.vp—v—vW—yw—qw—nw

«

W
‘13mzmmmmmmm.dummorwd
WWW.

of

!

ﬁn {ma-mg postulates are opontiiu

k

£3

menu

with pom-tons

E

chm;

l
E

W

.

Westerns-i 18 in low cWﬁﬁ;u tint 12W in a great

1)

.

spread

tho

hm

tho amigo].

mum- aubatmh Mutation
and

at

Wanna-II 131m. no that tho concentration 135mm. of chum

on oporatiw,
[and

hi.

W1:

a lion docq

nu.

Camel-loin in patients with short

hypersy'mhm, Whoomrnae-I and-II in tissue

mm

and spinal

a. ”7

fluid

am

we produotion of tissua cholimsteaé-a-ao-I 1n the oentml nervous syntax.

W mm
WW ame-I my“ aim-rm tho lucid studio! o:

(1955’),

mutation of Mam? cholimateroao-J
ﬂ
‘

35

4‘—

high.

\Purmemon, the appeal-once or nigh concentration of
acetyldxouno

am

in

I

new with high mummy
2)

and those pmsent

and

a direct

mum}: between on»

level of

aetiuty can

deMa’o
be
‘

do...

91»th
1M Manon» my stunts chainsaw-1 pmduotion to o m zoom.
stated 1:: Massive psycho-3 (fungus-.1

60pm).

than tho

Wu! mu.

Eﬁofji 1

�‘

.53.-

In moth-r cutout, those studies
of outcome reactivity. “Eadie:
_

In

have opplioation

imp-W

by

to the woman

Watch an!

other: havo damn-tram a mhtiomhip between the blood pressure reopen-o
of patients to inject“! mohohl and
ahock. Namely].

Ward“,

is

ﬂair mama). naponaivity to alcoho-

a potent oholinugio agent which induces

sweating; and

vuadﬂation,

momod peristalsis. It is rapidly

cholimutoma-I and slowly by cholinostam-ﬂ.

Tho

W

15'de w

pressure of sub-

mu an: arm- mused menoml and Muml to the baguun. 1n n variablo
length of

tin, 3.3. the to

natal-unto

'

20.119112“.
more than
Patients whoa- blood pressure

“mummswmmomieduaroupl, II, QMIII no

notions; those whose blood pressure “has 20 or more 11mm

to rotum to o

MWImotonhwooﬁm
WM M”!
mt ntouitthdthonupII-vmructomaﬁimute.
hmmmmnmtonmoMmmmwpﬂIn9ﬁmmxy
buoﬂmueroupvlmdmmcum.
,

g"
Wilt-v

rats. (momma at,

1952.)
'

hmmmzummuummupumumm-mmA

Wmédmlylio
a lion

npiﬂyhydmlyudy than the

W81. nu.

V. may

Gmumm potiontahan

m»
predict. Hanson, that tho tholinoutenu

‘

uuuwmnmdwxammuldbohighyuhuoﬂmmuvﬁy
\va x

�a.
dwnamwum. Homnhnrcaamrpnmnm
mmurwmmmmdemM4,mumuu

mammmmwmmmnmmmm
mammmmﬁarhmammmmmum

mmaudpwmmwmmmumpmu
mwnmmuammmmuwumm.

�Wmmamnﬁanummotmm-oraammmm
W
emmwmuummamyummtmwmm
l

quire
#11:

veriﬂmtim.

1mm

For

this purpose

mutionahipo

ho

WM
Wash-at
1)

it in

anaemia.

'

murmumaammmmmnm.
typo,

OllQWﬂogrlI patterns.

m

and

magnum at

suggest-d that an

mam.

1‘4an

A1», the

“mum

2)Rohumdmchmty1choumuvohtothomnicalmd
patina“.
3) mung» 1::

indie” or mama brain nmcuon othorthnn mama:

such

mtylrhmao 10701:.
h)

mums; of cholinoatenae actimy

and patterns or blood

spinal ﬂuid to:

41)le
b)

We!“

a) ram otdwoloznant of 3m
,

d) amber and frequency of

tmtnentl
a) antennae (perimnl) mativity
f) 60mm]. meti‘rityo

14
.&amp; 7’

5.

Wm

n...

WWWM?
éIJMW~

4*
,

um

and

�111: 7-3-6A

(I:
on rue

ROLE

or AcsrrtCHOLrue

'

'

'vh .d)

AND CHOLINESTERASE

'IN'OONVULSIVE THERAPY

-«

IStudies evaluating the role
of cerebral changes in the
mechanism of cenvulsive therapy have demonstrsted that the

develogpent of early and persistent signs of altered cerebral.
function are prerequisite to changes in behavior (Pink and

»

t

A

~A.

. at

':

n
.

'

.c.

‘

I:

‘c

.'
V

A

s ',
&lt;:-~t

‘

Kahn,‘l956),

In these studies, electroencephalographic slowing

was the nest significant.index This ohzrvation remained un-v
clear until the reports of Ulett describing the effects of pre-

medication with high doses of
appearance
in
the
atropine
preventing
of the EEG delta abnonnslity (Ulett and
Johnson, 1956). Following
reniewed
the suggestion of
the
we
report.
role dt acetylthis

cholinestersse in-‘convulsiva' therapy.
‘he data
suggests a close relationship between the degree and persis
of the electroencephalographic slowing end the appea ence of
and
choline

measurable quantities of free acetylchnline in theygnrebrnspinal
/

influid as well as an inVersian of the aerial ratios of benenycholine.

.

'cholinesterase to lecholylcholinesterase.
that:
The role of acetylcholine in
transmission
of nervous
the
impulses has been studied since the first descriptions of Dale
(1915) ..snd Loewi (1921). The srgunenta as to whether actylcholine'

is the main or only agent in the trans-ﬁssion of the
nervous,
impulse are not of primary concern here. .It is sufficient that
acetylcholine is a normal constituent of nervous tissue; that it
exists in a bound torn and is liberated during
the excitation
is
that
process;
it rapidly hydrolyzed through the specific'action~

-

A

‘
"

.

A

.1

F
.v
«an

‘

-&lt;

_-

:

.V.

l

antes-.3

var-I‘m.-

,,

.

“be”:
wMYJ/I'"

44::

gauges-5mm

�.

.1

of cholineeteraae and as rapidly reconstituted by the choline-

I

'

acetylaee system (Richter &amp;.Crossland, 1969). Furthermore,
normal cerebrospinal

fluid containe

_

free acetylcholine

despite the rapid breakdown of

(Tower and HcEechern, l9b9a)

bound

no

acetylcholine during periods of activity and excitement.

'The cerebrospinal

fluid normally has measureeble cholin-

esterase activity, principally of the "true" or mecholyl

’

hydrolyzin3 type (Nachmeneon and Rothenberg, 1965);
'

In the absence of free acetylcholine and under the conditions

described, electroencephalograme_fail to

consistent

show any

‘

I

abnormality;

..

‘

i

(a)

Effect of gregiggerghggl

.

3

Exagggz

.1n n

study of cats

subjected to varying degrees of head trauma, Borenetein (1946)
reported that free ecetyltholine appeared in the

CSF

within a few

udnutes after experimental head trauma and persisted for varying
houret
acetylcholine
quantity
of
periods up to £8
free
_The

varied between 2.7 and.9.0

gamma

percent, and-the

amount weeV

poeitively related to degree of trauma...‘

Conconntant electroencephalo3raes demonatrated patterned
chan3ee. Initially, the records were
high
,

filled with

n

fast activity, interpreted as

voltage

intenee neuronal discharge;

only to be followed by a short period of

flattenin3 of ell

recorded dectrical activity. These periods were then followed
by prolonged periods of. hi3h amplitude sharp waves in the

delta frequencies.
The

.

behavioral chan3es were also correlated with degree of

trauma, as well as with the level of tree acetylcholine, with

,higheet levels of-acetylcholine. Bernstein reported the greatest

_‘-_...

�_,

‘

1

,
_

,. .3

w.

a

yawn-mun?”

lift!“

.1»?

.

..

my vmr

in?!

0...“,

yr,“

y». my -1,“ 'V'W'FM' cream-ls“.

.

_

.

.~

&gt;

I

-3degree

of m abhor-slit” the greatest.

and

thence; in

consumes

'

furthermre. spontaneous post-Ftrat-oticseisures livers also
related to the
of tree aco'tylcholino- appearing iii the
apical fluid.

1

“t

l..,‘_.‘.__..

l...

V
A

t

‘

’

further substation ,theae‘ohsarvations, Bonstsin applied
.acetylcholine to the eiposed cat cerebral cortex.' "h. the
concentration of sutylcholine use
percent or less. he
To

,

‘

.

.

'

EI

-

.

line

‘

observed high amlituda sharp waves of low froqmncy in tho electroencephalogram.

When/the concentration ‘ves increased
to 2

3—:

perceot,’ the electroencephalogr- flattened in. afashion parallel
l

to the post-trematic records.

‘

.

Tower and HcIIchem(l9lo9a)'-Iropa_ated

neurological pstients.

thssa studies in

Irse acotylcholins ass

112

foond in the

cerebrospinal fluid only in the patients with. rocoot hood trams,
~recent grand-ml seizures or convulsive therapy.- The free acetylcholine varied from 0.2 to

lOO'

3‘s

perceot. lnladdition,

Tower

end lichchern assayed the cholinesterasa activity of the spinal
fluid; They noted ashsrp rite in the “nonspecific cholinesters'se

‘

fraction '(hensc'ﬁiholine-splittiog) and a drug in the
specific
choliioesterasefractiou (escholyl-splittioc); in the patients
‘

with head trams and

those'follwiu
in

Mlsive

thereby. no

~
-

such inversion was ’d-oustrstod it: the

fluids containing tree
acetylcholins fondling spontuooos soisores; These authors
concluded that the level of tree acetyleholino varies directly}

the
degree
of cerebral dance; «nesting, haever. that
with.
the reversal of the oholinostersse' frantic: cos ‘a sore sensitive

indicator ot-esrshral donate-V ,'

I.

'

_

'

’

�7-1-2
intorvalo
following
varying
at
cm
in loot of theoe anhjeeto. .‘lhe nthore reported a direct

Electroencephalocrnooere

trano

-

m

and the appearnce
of
the
of
ahnorn'lity
degree
correlation
oerobroopinal
fluid.
in
the
of free acetylcholine
_

two
Theoe
'

increeoe the

etudiea indicate. that crnioeerehral tron-a nay

nomt

of free acetylcholino

in

the opinal fluid;

’wt

of froo
that a direct relation eniota between tho
acetylcholine, the degree and type of eioctroondphalouraphic

and

abnormality. and changeo

in clinical behavior.

'

Bornotein adainiot'ered O.5-l.0 tog/its atropine after hood traumawae

tho
induced anddennatrated blocking of

mifeot no effecto.

Following
the
experitrana.~
induced
intreciotornal
which
ecotyldlouno.
addition of

jof
and
neurologi'c eigno
behavioral

nntal

2

clinical change. oililar to head trouno.'lornatoinohoerved 1 blocking effect or atropino.
zoo and

,

Vardf1950) applied theoe idoaa to tho treatnont
caeeo.

..
of hulah

'

of closed head injury. .In 20 patiento with varying degree

of trau'oa.‘ he adminioterod atropine

outmoly

dooea
of
in

0.1 tog/kg. In one eaoao'henot'ed'clini'éel ignorant. and in
tho
of
electroencephalographic
of
the
1
othero, revoroal
effocto

am:

ntioholinargic
of
'otndy
a
another
dm.
tragna. In
Lechnar (1955) reported oinificant altoretiona in the poet-

and

»

tranatic electroencephalogrn.
inota‘nceo
'

in

22

of

A.

oingle iatrovonooo dooe in

abnornal electroenoeph'aloorno reoulted in

inatoncea and unto-a iaprovooont 1. eix othoro.

‘

1.0

nor-dieing
!
o

,

�.

3

Iv.

.

.

p 5 u

'

..

'

‘

,

.

V“

U
-

'F

‘

‘

'

r

‘‘

Ulctt and Johnson (1956) donoootntd tho I... ’oﬂoct'ot Antroptno
1n blocung tho oppnronco of no:
111601”
couwlo1n.
oct1v1ty

vi.

than". an'

mood: tho

study

oouuto

tho
that

0.- Motbdcal .chauo.

oloctMuphoch on...

13 hood

;

m...

cod 1:

,.-

i
.

“owl-1o...1::
oootrut t6 thou 11.11:. In an:
out
undo
noon
0.
mod-onto Broom: .d Hordtt _(1m).__m1y1og top1c‘11'ocoty1f161111.11

,'

-

1

’

thou.

of

tom!

1o concoctrouooo o1-2-1l2

«to;

noted no offoct of

clocttooocoohologuohu

that tho

mtntw.

no “unfunny

atom

an...

11:

to tho

otrop1.

of oootylohou. 1o
than
tho tinted
lad-or

tho

.rooot)

,m

:5
~

'

I

m2.

W

at

onoophalogtophic otfocto won

Modal

by

.
‘_-

A

#ﬁ.1w-_

‘

moot“.

.
-V

.

in

ﬁ...___‘..-%

1.,mr-4gmv4._.ﬂ

41V

W

to 6.1;.an about:-

‘Wq

1950)

11.. 1950).. Inothou

3

.

1

«duty of 1.011qu nth
choumtoruo'
1nh1b1tor on (614.9:ny (Imam-photo) Mutton 1113b
qutodo 1‘.“ (Money
pot... “-11“ to out.
1n
opuoptmoo. u -11 u 1.3.: «lop-o. of
no.6

.' 1969; and

v

_

tho potont

post-truth:

.

_'

.

ototuﬂlltnttcmuot 11.,

-

on tho

h

w

‘

motion. to.

thutlod o1 logo1t1v1ty

A

.

_

.

tut1oom1hoyucﬂbold01Wdfott1Mﬂthou-

at"...

‘

1"...“

§

(mutants).

I

_.

'34;

(oatylutuothylcho1bl
a“ by:
-chol'yl
111 commutati.oh 1.» ti.” on. .otylobu. concou“ch
ennui-31c. drugs to

w...h-

hM-—mbvwmmr

wWe... am

(OJ-IQ

‘

A

quuuuu'u (1-1 3-1

oloctroooooohologrqluc oflocto 011111: to

4

ﬁlls)

to ooto.

'-

‘

(1

1-.....

earth:

Mt
tho. Wu

1;

atria-tuna
'o’z Wain (1946). mm: .11
smut.
potent) at]

ow

w.

m

new”.

at .1...

too, tho

“cotto-

0.11 dam of otrop1oo.

�- 6.In another_laboretpry study, Chetfleld and Dempsey (1942)

'ptepered exposed animal cortex with proatlgnlne and evoked electroedcephalographic spike actlvlty.

The

prier.edu1nlstratlon of

V

.

_
‘

'atroplne blqcked’thls spiking, er if present, the abnormality
could be elimlnated-by ettopineuv
Thus. from a

_

variety of experimental

end

cllnlcnl studles;

__

we
A

may

conclude that.eletttoencephaldgtaphic aetlvlty_1nduced by

‘

acetylchallne. either as a result of trauma, topical applleation qr
[ntefitxcnce with cerebral metabolism, can be blocked gr ellmﬁnated
5y atrnpxne

(a) ‘Role of Cerebtnaplnal Fluid
W...‘

" Acetyicholtne

normally appears to be present-1n nervbus tissue in

bound. inactive farm.

'chollne

15

activated
thus the

During periods of

liberated at the cell
by

Ac

cholinesterese.

activity, free acetyl-

membrane, where

The

it is rapidly de-

level of-bqund acetylchcllne ls

resultant of the processes of sinthesis. liberation

breekdpunw

It

may be

and

postulated, therefore, that-the level wlll

rise during sleep and fall daring ectlvity. ‘That this hypothesis
'15 true was demonstrated by thhtet and Crosslend (19a9) and

Elllatt.

Swank-and Henderson (1950) in anlmal experiments.

By

using ltquld-alr‘qule-freezlug methods. Rlcﬁter_and‘Croaslapd
demonstteted that the anesthesia and sleep level of acetylchollne
{measuted as microgtemﬁe per mg:

brain tiesue)

was

JCCZ

higher-

poet
thaﬁ the
seizure level“ ‘The d1£fetence_1n tissee levels is

trapslent. however. as the tesyntheels rete for acetylchollhe 1p
rat brain is high (7 gimme/gm/mlnute). lﬁlllett‘et a1. (19$0l;

a

�-

7

_

AIter metrezole convulsions,
confirmed these observations [they also noted that free acetyl~
was

choline

ttatione

always demonstrable

in the spinal fluid in concen.

up

to

3

V

.

l

genus per cent.&gt;

ln spinsl.£luid studies in
and
and
Tower
(1948)

Cone,
Tower
and Menschern
men,

Mcéechern.(l949h)-slso denonstrsted significsnt

of
free eoetylcholine in pstients with
quantititCe
56

enileptic patients.

49

epilepsyl"0f

(77X)'demonstrsted’messursble free acetyl—

chuline in Quantities of 0;02'to 5;O genus oer cent. with an average

per.cent. lhe acetylcholine level was directly reletedl
extent
eelzures;
of electraencephslogrephic
the
to the frequency of
ebnormslity..snd the telation.of the time of coupling to the last

of.l.0

gamma

seizure.

It

hare no relation'to indication, type of epilepsy or“

.Ievel of cholinestetese

sctivity.ll

'

.

,

Whether the acetylcholine appesttng in the

~

'.

A

3

g.

spinal fluid is a

by-broduct of the convulsion, or whether the incress} in acetyl-

I]choline is'n cause of the seisure, is problematitel.
McEachern (l949b)

Tower and

believe that the increased scetylcholine libetstion'

ls not due to the seizure itself but related to the basic procees'
causing the seizure; In a s“dy of the hypothesih that the accumulation
of scetylcholine is basic to the seizure process, Terds'(1§53)
induced Canvaeions'in animals by nettezoles She_determined the

level of scetylcholine in brsin tissue before and during convulsions.
.She noted that convulsions ere preceded by s

"

rise in the scetylcholine
content of tissue; that the coucanc‘grueuaiiy fells'durins the
convulsion; and that below certain levels, convulsions failed to

‘occur.v She suggesteﬂ that the

fell in tissue scetylcholine during

convulsion use due to inhibition of see.tyleholine synthesis by
concentrstious
of metabolites such so smunnium ions.
increased
a

'

�While

ebout
erguneut
the role of acetylthere.ls considerable

choline in the mechanism of seizures.

it is

probable the: free

acetylcholine ie increased during seizure. and appears in the
cerebral
spinal fluid; that
activity and eeizures enhance acetylcholine destruction; lowering tissue level. of acetylcholine;‘

WW

while sleep and enestheeie.eugmeot acetylcholine production,
.

increasing tissoe levels.

7

l.

.

rd)
Concomitant with
their observations of changes in acetycﬁbline. Toqer and Mczechern (1949)
oeaeured spinal fluid cholineetereee activity. ‘rwb types of cholinii
lesteresea are normally found in too ebinel fluid: .cholioeeteraee-I
("c-me".

"specific"

or-necholy'l hydrolyzinﬁ), which has a high:

'

nod

specificity far eeetylcholioe;
cholineeterdIo-II ("peeudo"."
epecific". or beozoylcholine-hydrolyzine). -Both coupounds hydrolyze'
-

‘

ecetylchollne, but have different rates of hydrolyeie ftr mecholyl
"and beoZOylcholine. -Thioldifferehtiel rate permit! duelitetive'

distinctionse
of the

.By

repertins the cholioeetereoe ectivityJee e ratio.

activity with uncholyl

and benroylcholine

substrates to

on

retidio ere found: cholinesterene-l/
choline-tereue-II[acetylchbline.(with Ash/Ash - 100).

acetylcholioe substrate,

acetylcholine and
ln-such ratios normal

CS?

two

contain: eatereeee in the ratio of 33:17

‘ior choliuentereee-I to cholioeetereee-II. Thus; noruel CS? consistedllllllli
with
of
"epe¢i£ic”
utterance
a euell non~apecific eetereoe component.
mainly
'

i

In patients udth heed tron-I. Toner end Holechern reportm
m
inverting of the eniupte of dbollniptirg‘le with d lignIIiCInt

meg.

mime

unionist-nan meme

decreaue in choline-cerebe-I

ectivity.-

betweenthe current or the cltolihbotereee

of

mm

fluid

and e

They eleogreQOrted a

Mﬂel

correlation

with the severity

�of cm...

W
the
of
electroencepheloirmhic

and with the degree
I

II

I

abnormality;
'-

.

,I"

In patients with increeeed

result of spanteneoue eeieurne.
of.

1

e 395-1221:

r"

,

eoihel'tluid ,ecetylchoiine

howewet. no

cerebral

ad

Tower

tum,

ee e

thmge'ingthe ratio.

cholineste'raseslor total" cholineetereee ectivity‘

w

_

wee found.

nonethern (194090. in their etudy of

crazie-

reported obeervetione in eix peythietrit petiente

undergoing convulsive

there",

\Studyiegthe patients otter 3-?

treatments; they. reported tree ecetylcholtne activity in the
Iepinel fluid in two petiente; end en increeee in
cholineetereee-II
and e decreeee' in aoli‘neeteree'e-I with e revel-eel of
the retio
of cholineetereeee in five 6! the eie petiente. In:
the,”
Nobeervetione,

they

-

like thoee

of ctmiooen‘hrel tron-e

epilepe'y.

petient in the Veeriee who foiled to ehow.
free
eoetyltholine or e cholineetereee retio
either
Mani-in
_

Regarding

the

one

the eoihel fluid. they

Petient

wee

wtou:_"1t.ieinteteetlnsthet thie
no"
one-of.
theeie
tee-me. to
only.
to a...

the

tree'tneut".

..

.

I

1

'

I

DISCU§§ION
.

Fran theee verioue met-yetioneQwe hey contlode thet canvuleive therepy iodueee epiunl fluid
like
cerebrel
sore
ehmgee

emtw

thn than of
maintained. we chpredtet
trans”

,

epilehey. If the perhllel ie‘
ot
the
degree
ehhtitn

new

electroencephalogrmhic ebnouelity, the

acetylcholine,

end

e—

,

thaaee
the
thetfluid
epinel
in
cootlmd

induced céwuleione were sure

thihkthoee found in

.

“arena

of free

revered of cholineetereee ectivity retioe

�-.10

_

the splnal field and the nunber and frequency of lnduced cone
vtlslons., Also, item the observntlans of Tower end McEachern
1n

(1949b), the cemment thst

ohly the

patient

who

failed to

shew.

-§pinal fluid changes-talled'to show a response to treatment,

ptrmits us tu consider the possibility that such biochemical
bas1c
therapy
of
the
the
chmges are
to
ccnvulelve
medical“
process.
cpnClualonsiare
pnsslhls'.
ad
The hasssge of
electric current: through breln sw‘stencesilnduces
in
change
sctlvlcy with an increase 121 free
a

deductions
Certain further

mm“

.

acetyl-.

choline to levela'suffictenti‘to1nduce a grand nsl seizure.
The

.

presence of

'

'

free acetylchollne 1n the intercellulsr fluids

electrical hyperaynchronyr‘renscted lathe .386 as delta?
slwlng-r The degree of hyperaynchrow sc'mrate-ly reflect} the,
decay
acetylchollne
of
should
fonds!
free
a
ad
rate equal
level
S1nce
studiesthe
purines
of
deatrhctlon.
acetylchollne
rate
to
demonstrated. that EEG hypersﬁchtony use: a, necessary ﬁrvrequlsite
induces.

'

.

'

'

to the

cllnlcsl respome

1n

central‘slvsthﬁapy.

it

my be stated

.mu'mm chances

that the dunes of free aestylchollne
in cerebral fulcrum ad thus prilud'es s clinical

rem

the 1ndueed convulsions.

tn

Certain eat-muons nay be ends regardles changes In cell
embrace permeability as emlal’nlng the incresse in theme-:-

.estetasd activity; Chollnesterase-l ls feud m htgheat concen-

'

tratlran

.

15

~-

1n the

centre} nervms system;

predominant in other tlesues. especihlly

the increase in eoetylchollne

‘

anus chounfcsmrsse-II

Innis

blid serum

With

1h the 1ntercel§lulsr

cerebral fluids as a result of stlmletlon and cmwlslhn,
vasodilation and increased cellular permshillty
be
Pradicted’;’
my
'

D

E

.MLr-JM:

4‘

.

‘
.

M.

-.

.

t

a

‘-

.

�~11}
thﬁ

inch:vasculdglfluids'tnto
with a degree of ggancudatian of
dnrittan
of
thg'.
and
ch.
on
dlpcndcnt
spaces
nxtcnt
cellulnr
vnddtlptlio-n
_do

occur

numétous

wag

(um

0:11., 19m,

anpiy.dcnonstrstcd

‘Ihnt ouch

”manna chm

'

SﬁlejiIFAdolf
8910331
1n
and
by

répofti (1961; '62, 'bb,"£§;.'53)é

-

.

.

denunstrat§d
They

cdnductivity
cbhvulsldnn
e1.c:r1c.11y_iuaucgd
tacguased.che
that
Idikqgo
pot-saint
as
ﬁargous
of
ions.
1n
n
cf the clouue; resultud
thh
lldid§
el§ctgolyths
the
while
phbiphatQ,
that
and
ipingl
into
and

nan-cltcirolytés
nngsnittcant
1n
.tncraalcd.
incrpaso
1h
Gunﬁght
prﬁibiliﬁy
nucleic-acid abutting 'enzyus.
of £011; may'thtu prﬁvida thé basil for-thudappoarahco of high

‘w-u

'contgntrati§u§ of a¢§tylch611ns and for lqcrcnand cancantgattons'
of cholineaterasefll (Tower 1nd1HcBIéhern.19b9c)."
_

.

within. 1n;glil%;1n‘ch011héytct‘ne‘acglgitz;

free act-tylﬁtoiiné

_rnp1d1y&gt;
b0

dutioyoih?

T.“

wit

ohoﬁﬂd not tﬂe

$phdnsn

can

ind
uéttbed?
agitate-ht.
sbtml'
fluid. arm: ugh;
m panache-e. in.
1‘
qbuertitiann.
EB.
thin‘diactcpcdcf
nvnillbla
in
An éxplanattqn.for
'
Sy
:kuurgxl
(19.005).
Nachuntoh
of
Mun-ad
and__loth¢nber3

.

McEdchcm (1969c) .ind poison and

HuprtoIh (1955),.{thaf the
acetylcholinc-cholthél'brabe-I'uyatﬁu is vary aanptttvi~co:¢on¢aq4
itdtibn relpttonshlpq; At "physiqlogic" éoncentrdtlons, hydtolysis

,

-

and,
buc'd:
1i
higher
of ncntylcholigi
tdpid‘(3—6’nucranecoudn)
qu1c¥1§itiL}dqno
off
cutv,).
activity
£111:
lower cqngcptrgtionl.
rtiatiénﬁhip
to
chbltneutaraac-Il-acutylchollno
In conraac. the
rafd
with
egocenttaiian.
hydrolyita-tncfgases
of
the
and
non-specific.
i

.

'um.
nor-.1
um.

{mama mu-

n:

«manna. a cell

'

Qéttvity'
chi
geocylchbltnn
ipqctftc
by
thidgntioﬁjd
npnbr-neny tho
f

;_1
‘jt

�.i.

V-“ wry...”

m.“

r'rr'l

r

.

v:

_,

r“'\7ﬁ"x.:r'7m¢rm.,

_

’0";
3

Of

cholineaterase4l ithhe order of niliiseconds.

.

_Where

-

.

.

'l

excitation

3
A

a

,

lead%

to an'excesaive‘concentration of acetylcholine in nervous

tissua

the

:nté othydtnlysia

I

by cholinesterase-I is

F
4A

A

'A’Q":

exec-eded.

thu con:enrration of acetylcholine mounts, the seizure threshold
is reached and a seirure cccurs. The dissociation in ncetyichoiine-

A3

m}!

1

“+4—ow

cholinestern5u—Z zclationahip

chnlinn

The

neiznrej

liree acetylcholineul

itself,

The

results in

a perniatcnce of acetyl—

pernapa adds to the level of

“gt“..i.

increased acetylcholine diffuses rapidly,»

with resultant vascular-and cellular_permeability effects and the
iPPEﬁvahcé cf inzréaaed ions in CéF; ﬁnd also

etficiencf,

increased cholin-

r

LAM;

astsrawemii.

4

Aﬂnmnmm.

It

15

the activity of this enzyme}.th0ugh'cf

lqw-

3

and dependent on concentration kinetics that rdduceﬁ’

the acetylcholine

leval;yaperiod

I

.

j

'
,

of houra to days.

tb levels

-

.__\._-xw-:‘.mz...'

for the p‘Eaiologic action of cholinesterase-I

1“

Alteratian in the blood brain permeability barrier by the f
~continuing action of acety-lchoiin e may be the biochemical aub'5trntc {or the hvpcrsynchrony so often obServed in past~electro~

«nu—“\me'mut

maﬁw—«A

.hnck-electraencephalogramst Such a possibility is evident in the'
I

'i

'

'

report by.Aird et all (1956) demondtrating a significant increasn
in the concentration of cocaine in brain tissue 3 days after a'

'seriea'of

12

induced convulsions.

‘

g

of
concentration

tiisued to

he

His data about the change in

i,

.

1M

.

'
-

'

In

..—.u..‘,~«.r.n.v.—

9-1.4.L

—

.1.

“F...

thi a large molecule, ordinarily absent in brain

torrelatcd with the appearance of bypersynchrony

’

I

(delta.bursta) in the elecnroencapnalogran.
In our studiea of thc appearanca cf clactroencepnalographic
he, have confirmed tire many
changes with

acmvulaimi

.previous reports tnat convulsive thctapy induces hyparsynchrony
in most subjectst

Despite a constant application of treatments,

‘

a

�«.13-‘
electro-

however. the time-of'appeatancé. duration and extent of the

graphic slow

'

1'

A

.

'ventiiation

it;

its sensitivity
barbiturates - all

QAV$f

and

populations.
and

-

The

to wodification by aierting,'hypervary greatly in psychiatric

appearance
degree
of
hypersynchrony,
high
early

beeﬁ
has
the
course;
tieatmeﬁt
persistencv throughoﬁt

described as a necessagy prerequisite for improvement following
Electroshock(Pink and Kahﬁ..1956).

But what

is thé~mec§anism"

"undcrlying the failure of certain patients_to deielcb hyperaynahrony?_
Perhaps-thgse studies of aceryléhollne and cholinEstﬁraﬁes

may be

rélated.
‘Assumiug

that

a grand mal seizure

is indicative of the

at‘ttssue levels 9f free acetylchnline In eicess of "'
ﬁhu fate of ﬁydzoiysis by cholinesterase~I;-and_thét the electroencephalographiC.hypatéyuchrony.13 a reflection of the'peraiatenCe,
development

'

of this.abncrmél concentration of acetylcholihe; than the differencé
1h pugzehts who

maintain.hyperaynchrony"ind those lh'vhom

it

‘rnpidly (fgv hears) disappears. is a reflection 0f the kinetics
of the ch01tngsterase-acegylnhollne h§dtofysis systeﬁg

Persistént..

hypersynchrbnj Insult; from dccteiqéd rate of hydrdlyeﬁs of

’cboline.v

¢

‘arahstn-nﬂ

acttyl-

,.
_If the hypothclla~prevtouely'deducgd are cattact; nithér-ane»

‘

.

.

V

'

.

,

f

u-ww-xa..yrmwméw.w}v-JH‘

or both bf the felLowlng postﬁlateg‘are operative in patients with
99 tslsteﬁnt hypersy nebr‘ony:

(1)

is

a

‘

.

Chaitaeﬁteraseél is in

low

great.spread betweén the apt!

thosé
preéent
'_and

1n

cancentratton,

an

that théte'

trace concentration
the ttésue with high acctyicﬁolxne;vandlor'

'(2) Chalinesregage-Ii is

a1 enzym¢~aub

low, so

that the concentration

Ltwetzks cf chis‘system are opcratxve, though at a slow decay

..

.13...-

...,.__..J

rate“

�‘

_

fonversoiy. :u patientc with short-lived hyper:yuchruny. Cholin-

cetetaee-I

and

-II in tissue

and

spinal fiuid

may be

unusually

-

Furthermore, the‘appeatﬁnce at high concentrations of acetyl-~

Ichcline stimulates the production of tissue chclinesterdse-i in the(antral nerVDus.system.- From the lucid studies of Nechmanaon (1955).
a

direct relatzonship bétwéen concentration of“tiesue cholin--

estethee~1 and level of nervous activity can be deduced. It 109'
ievels of cholinestereaeél can be dull- demonstrated in depressive
'psythoseé (? menonaueal deptession), then the electrcshock_induced

_acetylcholine

may

stimulate cholineetetaee-I production to

a mare

normal. pre~morbid leverm
,

cantext,
these studies
1n_enqrher

problem of autonomic

reactivity.

may

have application to the.

‘Rncent qtndies by Funkenltein and

others have demonstrated a relationship between the blood presents
of patients
.respbhsefto injected mecholyl and their event-n1 reopensiyity to
'

:i'
”

'

-

'Hecholyl
which
a
induces“
cholinetgic
potent
is
agent
electsaShack.

'

“

~2i:

tachycatdia,
ic?‘
perietaISist
sweating.
incteaeed
and
vagadilation.
chnlin~e
hy
hydraitzed
cholinestetaseél
and slowly by
ls rapidly
estetaee—II.

5;..

atter
injected
fails
vatinb'le length of time,

blood pressure of subjects

return. to the baseline in a
five to more than 20ninutee. Patients

rthalyi
i

The

and

presiﬁre'l

whose blood

5
the
minutes are classified as Group I.
baseline
in
to
returns
those
whose blood pressure takes 20 or more
'21!
':an
reactions;

minutes

II

to return to‘a baselineg‘es Group

The Gtoup 1

reactors have a

92 improvement
'

VI and

VII reactions.

'IlllI-I-I

-

rate with canvuisive

{1-

-

H;

i

~

therapy. and the Group

II,

II-III reectorl :

352 rueovery

rate

In

a

i

contrast, the

Gto up VI

reactors have a

892 and

the Group

US;da~9§1~agent-uzeaauuzyq:ate.£runktntto&amp;n-otqe3~y¥$953--

I

;

1

�“

VII a 97! recovery

as patients in

2W4"??-:'£€i§:?fjw*ja

15 _

Groupu_ I

to

may

llI

may

be looked ubon

the injedted mecholyl is
hydrolyzed;
rapidly

while the Group V! and VII patients have
We

a

slow

hydrolysis rate.

predict, therefore, that the blood cholinestereee ectivlty.-'

levels of Grouce

l-III

would be high; while the

activity of
Groups Vl-Vll would be low we recall here a similar prediction
cholinthe
date
central
for
of
nervous
levels
item
Iy
regarding
esterese~l, in which the develovuent df early and sustained EEG
hypersyhchrony and elevated epinel fluid levels of acetylchdline

related to low level of cholineeterase activity. _Thus,
the date of peripherelystlmulatiou by cholinergic agents is
A

,was

congruent to the hypothesiq regerding central nervous‘system‘reP

activity to electrcahock.
cammsmus:
This survey of the

literature of the roles of acetylchollne

of

cholinesterase in convulsive therapy hue led to a number
speculetione which require yeriflcetlan. 'For this purboee, it
and

3

is

‘

suggested that en-investigetion of the following relationships,

'be undertaken.
(1) Level of free_ecetylchollne iu the epiqal

fluid. 1‘3.

type;
cbnvulalye
frequeucy.
to
number
and
therapy
relation
Also. the essociated electroencephalogram'patterns;
Reletidn
of such ecctylcholine levels to the clinicel
(2)
behavior of patients.
(3)

than

z‘

3;“:Ww’gwwm‘us

rate (Funkenetein $5321" 1952);

;Patients in Funkeaetein
whom

.24;

EEG

in indicec of altered brein function other
with such ecetylcholine levels.
Changes

’

, .7

.,

_

�{4); Reiéttoh

chalineate'fﬁe
gétivify
of
blpbd scrim andpspinu fluid to:

(I)

ﬁattémﬁ of

and

‘

age,
,

(b)

alméta

(c)

rate bf

deveiwopt'zent of‘ EEG

(d). numbg: ,md fréqqencyof
.

f

‘

treamhts

.

(e) ,aﬁtbn'omc (heriphgnli reactivity

-(.f)',cerébu1 reacthﬂty‘

‘
‘

,

3

.

gpexfsonauty
Run: ofatroptne“. physos‘tiglnlne'admini‘attatian on
(’8‘)

(5)

hypersyhchrony

‘qliﬁical behavtdr.

,

_-

‘

~‘

E36,“,

j

4

�III:

7-3-6A

‘r

(1:, ﬂab-(i)

‘

ON THE ROLE OF ACETYLCHOLINE AND CHOLINESTERASE

IN CONVULSIVE THERAPY

Studies evaluating the role of cerebral changes in the
mechanism of convulsive therapy have demonstrated that the
development of early and

tunct

persistent signs of altered cerebral

are prerequisite to changes in behavior (Pink and

on

Kain, 1956)
-

was the most

In these

studies, electroencephalographic slowing
s
significant index. This obhrvation remained un-

clear until the reports of Ulett describing the effects of pre~
meo11ation with high doses of atropine in preventing the
appearance
of the EEC delta abnormalitv (Ulect and Johnson,
1956). ’Followlng
the suggestion of this report.
-

we

Eg

5:

reniewed the role of
acetyl—

choline and cholinesterase in convulsive therapy”

{é

to

data

The

lg;
ve

x

close relationship between the degree and
persistence?
of the electroencephalographic slowing and the appearance
of
Suggests

a

T:
.¥

measurable quantities of free acetylcholine in the cerebrospinal

{g

fluid

E;

as well as an inversion of the normal

ratios of benzoycholine-

cholinesterase to mncholylcholinestersse.

I

h:§

.
.

Ihe role of acetylcholine in the transudssion of nervous
impulses has been studied since the
(1914) and Loevi (1921).

first descriptions

The arguments as

d

of Dale

to whether actylcholine

is the main or only agent in the transmission of the nervous
impulse are not of primary concern here. .It is sufficient that
acetylcholine is

a normal

constituent of nervous tissue; thst
exists in a bound form and is liberated during the excitation
process; that

it is rapidly

it

hydrolyzed through the specific action

g)

�oi cholinesterase and as rapidly reconstituted by the choline—

acetylase system (Richter
normal cerebrospinal

a

Crossland, 1949). Furthermore,

fluid contains

(Tower and McEachern, 1949a)

no

free acetylcholine

despite the rapid breakdown of

bound
The

acetylcholine during periods of activity and excitement,
cerebrcspinal fluid normally has measureable cholin-

esterase activity, principally of the "true" or mecholyl
hydrolyzing type (Nachmanson and Rothenberg, 1945);
In the absence of free acetylcholine and
the
conditions
under
described, electroencephalograms fail to show any consistent
.

abnormality.

Effect of Craniocerebral Trauma: .In a study of
cats
subjected to varying degrees of head trauma, Borenatein (1946)
(al

reported that free acetlehcline appeared in the CSF within a few
minutes after experimental head trauma and
persisted for varying
periods up to 48 hours. The quantity of free acetylcholine
varied between 2.7 and.9.0 gamma
and
the amount wasl
percent,

positively related to degree of trauma.
Concommtant

changes.

electroencephalograms demonstrated patterned
Initially, the records were filled with high voltage

fast activity, interpreted

as an intense neuronal discharge;

only to be followed by a short period of

flattening of all

recordedeaectrical activity. These periods were then followed

delta frequencies.
behavioral changes were also correlated with
degree of‘
trauma, as well as with the level of free acetylcholine.
with
highest levels of acetylcholine, Bornstein
reported the greatest
The

m

�consciousness
in
change
the
greatest
degree of EEG abnormality,
also
seizures
uere
and furthermore, spontaneous post-traunatic
the
in
appearing
related to the amount of free acatylcholine

spinal fluid.

applied'
Bernstein
observations.
these
To further substantiate
when
the
cortex.
cerebral
exposed
cat
scetylcholine to the
he
gamma
1
less.
or
acetylcholine
percent
was
concentration of
waves of low frequency in the electrosharp
observed high amplitude

encephalogram.

When

the concentration'vas increased to

2 gamma

parallel
fashion
in-a
flattened
percent, the electroencephalogram
to the post-traumatic records.

A

112
in
studies
these
Tower and McEachern(l969a) repeated
the
found
in
was
Free
acetylcholine
patients.
pneurological
head
trauma,
with
recent
the
in
patients
only
cerebrospinal fluid
The
free
acetyltherapy.
convulsive
‘recent grand--nal seizures or

from 0.2 to
varied
choline

lGO

gamma

percent. In addition,

Tower

spinal
the
of
and HcEachern assayed the cholinesterase activity
cholinesterase
the
nonspecific
in
rise
fluid; They noted a sharp
fraction (benzcyhholine-splitting) and a drop in the specific
the
in
patients
(mecholyl-splitting),
fraction
cholinesterase

therapy.
No
those
convulsive
following
with head trauma and in
free
containing
the
in
demonstrated
fluids
such inversion was

acetylcholine follouing spontaneous seizures. These authors
directly
acetylcholine
varies
concluded that the level of free

that
however,
damage;
cerebral
of
with the degree
suggesting,
sensitive
more
a
was
fraction
cholinesterase
of
the
the reversal
indicator of cerebral

damage._

-'

�- 4-following
intervals
varying
taken
at
were
Electroencephalograma
direct
a
reported
The
authors
most of these subjects.

trauma in

of
the
of
degree
correlation

EEG

abnormality and the appearance

cerebrospinal
fluid.
the
in
of free acetylcholine
trauma
craniocerebral
indicate
that
These two studies

may

fluid;
spinal
in
acatylcholine
the
of
free
amount
the
increase
free
of
the
between
amount
and that a direct relation exists
electroencephalographic
of
type
and
acetylcholine, the degree
behavior.
and changes in clinical
abnormality,
(b)

Effect of Atropine

on

Bernstein administered 0.5-1.0

pggt-grggggtig
mg/kg

EEG 5&amp;4

thgviog;

atropine after head trauma-

EEG effects,
manifest
of
the
blocking
demonstrated
and
induced
was
the
experiFollowing
of
trauma.
behavioral and neurologic signs

mental addition of

intracisternal

induced
which
acetylcholine,

trauma,“Bornstein'
head
to
similar
EEG and clinical changes
observed a blocking effect of atropine.
human
of
treatment
the
Wardflgﬁo) applied these ideas to
degree
with
varying
20
In
patients
head
injury.
closed
of
cases
of
doses
in
subcutaneously
of trauma, he administered atropine

and
in
improvement,
clinical
noted
he
some
cases
In
mg/kg.
0.1
the
of
effects
electroencephalographic
the
of
others, a reversal

Jenkner
anticholinergic
drug,
trauma. In a study of another
the
in
putreported.simificantl'alterations
(1955)
Lechner

and

40
in
dose
intravenous
traumatic electroencephalogram. Asingle
normalizing‘
in
instances of abnormal electroencephalograms resulted
others.
in 22 instances and marked improvement in six

_

�-

5

-

atropine
effectwof
Ulett and Johnson (1956) demonstrated the sane
conVulsive‘v
illoﬁing
slow
wave
of
activity
the
in blocking
appearance
biochemical‘nechanisnl
same
the
therapy. This_stndy suggests that
’

.

V

'

under£:5the electroencephalographic changes in head cranes and in

.

*-',._—s

Mov

~...,_..-—~

in contrast to these findings}: In their

i

_.

M.
.

experiments Brenner and.Herritt (1962), applying topical scetyle

in
concentrations of 2-1/2 to
choline

102

‘

to the exposed cortex

of cats, noted no effect of intravenous atropine

(l

nglkg) on the

electroencephalographic changes. lt_is iaportant to note, however,

that the concentrations of acetylcholine in these experiments
than
significantly
the topical applicetions (1-4.
was
higher

3“.

I

percent) and the intracistsrnal (0.2-10 galls percent) injections
Bornsteind(1946).
Brenner and Merritt. houever5'slks_note of
of
electroencephalographic effects similar to acetycholine free
mecholyl (acstylbetanethylcholine) and doryl (carbanylcholine),
each in concentrations Inch lover than the acetylcholine concen-

effectiveness
of these
incteessd
the
ascribed
trstions.
lack
drugs
cholincerebral
of
to
sensitivity
to
cholinergic
their
They

‘

estereses.
A

I

variety of experiments with the potent cholinestarsse'

inhibitor

DFP

.

.31.

induced convulsions.
due report stands out

a.m-

fluorophosphate)
demonstrated high
(di-isopropyl

amplitude rapid frequency 885 patterns similar to status

epilepticus, as well as lesser degrees of abnormality noted in
post-traumatic stete!!(ainnich, et el., 1950) Freedman et a1.,
electrohempson
the
1949; and
et al.. 1950). In these studies, too,
encephalogrephic effects were blocked

by

snail doses of atropine.

-——.‘

Cs-

�In

rustle? labcratbry study. Chétfield

and Dempsey (1942)

evoked
and
anxmai
prestigmlne
:ortcx
expasud
ytch
prepared
r9103hdlU.YJDF1C Spiﬂe autlwtzy.

electro-

prior.admznzs:ration of

The

'uzrcane biotk\d this 5:1 1:5. a: if present, the abnormality
v?u.d be viim‘:1th by atrepir~
7C

1

trtn

'hu..

a

variety of experimental

clznlcal scudzcs,

and

'har eie-ttnuvcethIographic acti;1cr

._:ti;:hrr;:¢. irhc:

-T;t'!‘!". ‘th

as

3

wﬁ

tnd¢¢¢d bv

reswlt of trauma. topical appl;astict or

:rrvzral m;:a‘clzﬁn,

can be blscked ur elzmztated

ltz'tln|k‘
-.
(r) ‘3}.: 'x '.;re:.cwg:n31
~

a:e:yL.n;1;1¢ ﬁcrtully appnars :;

“Jqu, ;v¢;ttae iczm.

It

trcaxd;un
{L58

Ln

4

The

level of spund acetyichclinc is
v

c: the pro: I! 3325 cf synLEcsig. liberation an;

may be

Lcscuiat

is true :45 npmanstratpd
1W:

-.
nex.{;3;.

pr-Sen: 1: vezvous 11554t

a

I

u

.

therefore, that the level bill

during «lead and fall duslng activity

{111352. 9v'xn

a“

‘T

ac:1;i:;, r:ce acatvicell membrane. where it is rapidl; de-

Activated ty challnestarase.

c::.:an;

bv

.

Du::n3 pazxud$ of

:hu;in# is liberated at the
;h;. the

.,‘.‘.:l
Au€£.luld.;‘£-

"‘
r.u.J

2

by

thhte:

Pyzdur$;n (1950?

and
La

That

this hypothesis

Crosaiand {19u9b and
aagzyz uxanrimun;s

Sy

Richter
and Grassland
qu1ck-freézing
methods.
asxrg liquid air
deﬁoﬂSLYdtzd

that the anesthesia ard sleep level of acetylchoiin‘

.Lgustcd

mi:ragra:13 per

25

:Fdn fn» Ln»? uvi;urc lcvc;

Itdnxieﬁt

..

?.

.5

(D N

mg.

The

brain fiSbUd}

was 3092

hich?

difteteECe in tinauc levels

13

.5 the resynthesis rate for azetyluhclihe in
m

rat braxn is high (7 gammaigm/clnute). 'Elliott er a1. (1930}

:.

par--

�After metraeole convulsions,
free
noted
that
also
XIhey
acetylobservaticne,
these
“K
;3r?ic~‘i
n
;
chul;ne :ws always demunstzable in the spinal fluid in concen-

tratians

to

up

In spinal

3

gamma

per cent.
man, Cone, Tower and HtEechern

fleid studies in

ahd
Thuer
and McEathern (1949b)
‘1348)

ti
quantititls
86

also demonstrated significant

free acetylcholine in patients with epilepsy‘ 'Of

patiehts.
epileptic

Lhuiine in quanti'iea

49 (7723 demonstrated

0:02
tc
of

SP0 gamma

naeeurable free acetyl-

per cent.

ith

an

average

was
related
level
directly
acetylcholine
pu:.cent. Ih:
(L the frequeﬁcy cf seizures; the extent of electroencephalzgraphic
t6
the last
of
relation
of
time
the
sampling
and
the
abnormality,

cf

2

O

gamma

It bore

seizure.

no

relation ta medication. type of epilepsy or

level at cholinestetase activity.
Whether the

',

a

.

a
the
in
fluid
is
spinal
appearing
acetylcholihe

ty—prcdcct of the canvulsion. or whether the increase in
9

-

catae of the Seizure, is

prshlenlticela

acetyl-

Tower and

chachern (1949b) believ that the increased e;e:ylchcline liberation
(T;

itself but related

is not due to the seizure
caaeing the seizure.
A“

In

a

to the basic preceee

s“dy ef the hypOthesls that the accumulation

acetyleheline is basic to the seizure process. Torda (1953?

indured convdsxcrs in animals by metzazcle

She determined the

level of acetylcholine in brain tissee before and during convulsions.»
convulsichs
byla
She noted that
preceded
are
rise in the acetyicholine
content of t:ssue; the: the content gradually

falls during

the

convulsion; and that below certain levels, convulsions failed to
occur.
3

She

ccnvulsioc

suggesteﬂ that the
was due

fell in tissue acetylcholine during

to inhibitien of acetylcholine synthesis by

incrcdeed reagentratiacs of mezabclites such as

ammonium

ions.

�While there

is considerable

orgumcnt about the role of

the
machanism of seizures.
choline in

it is

acetyl-

probable thot free

atetyltholice is increased during seizures and appears in the
spinal fluid; that cerebral activity and seizures enhance acetyl:hcline destruction. lowering tissue levels of_acetylcholine;while sleep and anesthesia augment acetylcholine production,
V

inLrGaSXSg

(d)

tissue levels.
Svstoo
Nervous
Centrai
Cholinestegase: Concomitant with

their observations of changes in acetycholine,
measured spinal fluid choliuesteraee activity.

Tower and Hcﬁachern
Two

(l9é9)

types of cholinii

esterases are normally found in the spinal fluid: cholihesteraso-I

i"true". "specific". or metholyl hydrolyzing),

-

which has a high

specificity for acetylcholioe; and cholinesteraBe-II ("pseudo","nonspecific”, or beozoylaholine—hydrclyzine). Both compounds hydrolyze
acetylchcline. but have different ratio of hydrolysis for mecholyl
and

beozoylcholite.

distinctions
of the

.By

This diffexehtial rate permits

qualitative
reporting the cholioesteraso activity as 5 ratio

activaty with mecholyl

acetyicholine substrate,

two

and benioyloholine

rati$

are found:

substtates to

an

cholinesterasevl/

acetylcholine and cholinesteraoe-II/acetylcholine (with Ash/Ash - 100).
in such ratios manual

CSF

contains esterasea in tho ratio of 33:17

for cholinasterase-I to cholineateraee-Il. Thus, normal
‘

CSF

consists-

inly of "specific" eaterases with a small nonhSpeciiic esterane component.

traoma,
with
head
Toner and Kcﬁachotn report an
patients
inversion of the amounts of cholineoteraies with a significant
In

increoae in the cholinei‘trase-II fractiOn of spinal fluid and a
decrease in cholineatorase-l activity. They also reported a correlation
between

[la extent of the cholinesterasc rcvérsal with the senority

�the
electroencephalographic
of trauma and with the degree of

‘

abnormality.

scetylcholine
a
as
patients
With
spinal‘fluid
increesed
.In
however,
the
ratio
in
change
no
sponteneous
of
seizures,
result
found.
actitity
was
cf :holinesterases or total cholinestereee

(e)

Effect of ﬁle trnehock

on

at

A

Tower and McEachern’(l9493),

esterases:

it

oline

and Ch

in-

in their study of cranio-

psychiatric
trauma.
in
patients
six
reported observations
cerebral
Studying
3-7
after
the
patients
convulsive
therapy.
undergoing
the
they.reported
in
activity
free
acetylcholine
treatments,
.

’spinsl fluid in

increase in cholinsstersse-II

patients;
and a decreaee in cholinestarase-I vith a reversal of the rstio
llron'thess
Of
the six patients.
of cholinestersees in five
and an

two

in
changes
fluid
the
concluded
spinal
that
they
observations,
cdnvuleions
trauma
craniocerebral
those
like
more
were
at
induced
than those found in

*

epilepsy.

Regarding the one patient in the

series

who

failed to

show

cholinestsraee
in
ratio
reversal
or
s
free
scetylcholine
either
the spinal fluid, they wrote: "It is interesting that this
response
shun
to
no
of
to
the
six
one
the
was
only
patient

treataen.." .
DISCUSSION

From

these various observations,

vnlsive therapy induces spinal fluid

we may

conclude

changes more

that con-

like cerebral

is.
'trauma than those of spontaneous epilepsy. If the parhllel
of.
the
degree
maintained. we can predict a relation between
of
abnormality,
the appearance
free
electroencephalographic
qcetylcholi1e.

3nd

;

ra"97331 of cholinestcrane

activity ratios

'

�‘“
the
L-L

Fpl'd: fizid

and the number and frequency of induced-con;

xtisisrs. Alsu. irsm the Observatians of raver
(1959b), 1hr ccmnent that cnly the patient
suing? ELUiJ ;hangua
us in

ptrmits

:hnngcs are

filled

who

and McEacharn

failed to

Show

to show a response to treatment,

cozsider the pcssibility that such biochemical

basi: to the :cchanism of the achuleive therapy

process.

Certain further deductions and conclusions are possible.
rhé
brnin
subrtances
of
induces
through
electric current
passage
change
a
in

cellular activity with an increase in free acetylchclinc to levels sufficient‘to induce a grand mal seizure.i
The

preaence 3f free acetyltholinc_in the intercellhlnr fluids

electrical hypersynchrony.ref1ecced in the

induces
,

slaving

The

degree of hyperaynchroqracturately reflecth the

level of free acetylcholine and should follow
to the rate of acctylcholine destruction.
demonstrated that
1c

the

as delta

EEG

a decay

rate equal

Since previous studies

hypersynchtony was n_neccssary pre-requisitc

EEG

clinical responsc in coavulsive thcrapy, it

may be

stated

that the absence of free acetylcholine suggests minimal changes
in cerebral function and thus pracludes a clinical reapanse to
the induced convulsions,
bc
made regarding changes in
Certain assumption: may
membrane

cell

permeability as explaining the increase in cholinf

esterasd activity“ Cholinesterase-I is found'in highest concen-

trarian in the :entral

nerQOus system; while

cholinﬂesteruse-li

is predominant in other tissues, especially bloba sdrum. ~With
the increase in acctylcholine levels in the intercellulur

terebral ilwids as

a

‘

xesult'of stimulation

.-J.-;'..L ..i ;w::tjs;;

and

convnleibn,‘

:uliuau: gartelhllzty

may be

predicted,

�..

11..

interthe
fluids
into
of
vascular
with a degree of transudstion
of
and
the
duration
the
on
extent
dependent
cellular spaces
vssodilstisn (Rabat et all. 1948). 'Ihst
_do

such permeability changes

in
and
Spiegel-Adolf
by
Spiegal
demonstrated
amply
occur was

;

.

demonstrated
They
'53).
'é8,
'6h,
'42,
(lQél,
numercus reports
cenductivity
the
increased
that electrically induced convulsions
cf the tissue; resulted in a leakage of various ions, as potassium
and phosphate, into the spinal fluid; md that while the electrolytes

iignificsnt increase in non-electrolytes
permeebility
in
Charges
nucleic-acid splitting enzymes.

i .creased. there was a

Wes

of cells

may

this provide the basis for the appearance of high

:ﬁccentrations of acetylchdline and for increased concentrations
-

oi chalinesterase-Il
wt ch~he

(T owe: and Mczachern

l9h9c)

incevihy in cholinesterase activity, shculd not the

free acetylcholine be rapidly destroyed?

To

what Mechanism can

seizure be ascribed}

its persistenze in spinal fluid after
An explanaticn for this descrepancy is available id the ebsersetidns
trauma and

cf Nachmsnson and Rothenberg (l9é5),

hy
confirmed

McEachetn (1949c) end Bergen and Macintosh

lever and

'

(l955),lthet the

scary!:hcline-chclineglerssc-I system is very sensitive to concen-

tration relaticnships.
of acetylcholine

At

is rapid

"physiologic" concentrations, hydrolysis
(3~4 microseconds) but

at higher and

quichly_(hsldene
off
curve).
lower concentrations, activity falls
relationship
is
In conrast. the chdlinesterase-Il-acetylcholine
nGt'EpCCllli, and the rate of hydrolysis increases with csncentration.
Thus, with normal functional levels of scetylcholine
membranes, the

scetylcholine is destroyed

by the

at cell

specific activity

�where'exzxtJZLcn

-:41 in the Urdu: of "111;3dC9ﬂdi
'!;U&amp;uLVc

'1..‘q;. :rL:.:1"-"wf

cchaevtratton of acatylcholisu in “Bfiohs
is

Hytirwﬁxw

‘; ‘b: ‘*::e:tr3:icn

f

:lr311rﬁ:ster.19a—I t.s ex;cc:J¢d_

Ev:

{Htéskrld
the
seizure
uf acatvlzholivc mount:,
The

:2

I

tree acetylahoiine

t"r‘1";

-~'.'

*1

I:

~~II

.r‘;c1nn;y.

The

“erhaps adds to the

level of

rapkdly,«
diffuses
ucstylcholtne
increased

a;

the actlvtzi cf thia enzyae.

Jun LCgﬁﬁduﬁt
ad

Lu CUCLUDCYaCXCn

A

‘Lc

acetylcholice level’

f):

fke

shwcx

persistence of azwtyl-

a

the
and
pctmrubility
effects
vaatulax-ind cellular
£53;
cholxn~
Inzteased
413:
and
.v‘retued inn. 1n

1" t.~':t"’
'¢

’.vnshiv rzeults in

nex:;ra. itself.

The

Etna

'W'

disscnlation in acet/isholtné~

a

tﬁOugh c1 low

klnolizs that

lchls

period of heurs to days. to

p

cholineatetaRP-I.
of
action
/w;alcgic

(lottrtcnvcphgiagraMs

Suuh a

posstblllty

xs

ev.5c:t in the'

I

Tcpﬂ$2 by Axrd e:
1n

1n-.e;ae
a
democdttating
(1936)
sxgniticact
1;.

erin

gdcszte
in
of
cuvuent::;103
the
‘ 12

L9LC€RTT¢L10a

itisund

Cedutuw

’v‘

tiesue

is data

induced convulsionq.

3

da,; af e'

shows the change in

brain
in
absent
tﬁis
ordinarily
nnlecule.
large
ct

of
wﬁtﬁ
hypersynchrvnv
the
;nTT91aLcJ
Appearance
ta be

eleCtroancephaiogram‘
the
in
(deitu bursts}

electroencephalographi:
of
of
the
appearance
In 0d: stLdica
nuwbuni'
the
many
confirmed
have
we
changes nuth
hypersynchtony
induces
therapy
convulsive
previoug reparas that
of
treataents.
application
constant
a
Deepitc
in maqt Suh‘c~(w
'

#cmwnlsiozs,

_

�FLHCLICof
the
Jnd
54r3:1cn
extra:
ILmv of Appearance,

(it

“VlﬁVﬁf,

‘rT'XXATXOH 315

*"ri‘::w“"

.

‘

{v
hyperaler21u1.
c;d1‘i:1L1‘"
tc
senaazxvzty

its

Qaca

graph;; 5ch

I

herb:tgrates

all

cgrly appearrnce

TLQ

vary greatly in géyzhiatric

of?.igh

degree hvpe: vnchrany.

bwaa
has
tzcatmunt
the
::.r:‘~‘
1:* ::§ 33:1IHEE'CV (Lfvgghiji

31¢;Yihﬁﬂ as a nuccaaary

E'sctrgﬁﬁ”( t-tr':

'quh:iwlrr

2H:

and Kihn. 1956).

Bu: what 1: ch; meghanism'

imitate of caftain pﬂttents_zo deveiop n3persy1.Lrauy
be
and
acccyléhriine
may
chottneqterases
of
&lt;tgiiee
-

L%ewﬁ

9:;L4y3

greraqgtsira to: inprrvcmeu: folluwing

\s-uﬂ.' .la
"Z¢piwﬁx

seizuze ls :ndznattnc o: thy

*EA: 4 armnd m;.
;

{13:uc

KQIHL;

2f

{tee

a»:'{2.chv'LHv in

‘HH

and
ghnlznugcaraae-i;
by
,"
-«;c
*nd~a;;z‘s

n.

erlag'-.5;;

hypetsyncnrcnv

La

1

iKSQ$E a!

that the alertrc—

ref\r\::LLn cf the pvrstazunce

the
ditfctence
then
3f
acetylcholinu;
c~rven‘:¢;2cn
Phﬁ”':d1
‘32:

9‘

u. :rﬂ-tr:: -in ra:a;¢1r ry;c:e,n :n:;r.v in-

at in

whom

it

Persistent

.frizzc=2-r3we-QLPn;l;bol{we hydrolysln system.

{La

3

Lh

of
ace:"Lhvnral
of
atu
I
decreased
fr3a
rate
I
h5“a7annchtnn", resulcs
K

.

.

V

s-prrvlousiy deduced are correct, ezther one
'J

9"

0'

LI

V
1

rv-

in

.A

0‘

t

r9

n

’ I‘
‘1

,—

P"

patients with

(a
as
are
operatlva
pcstula:
suing

.cr'xst.uz hyﬁvrzy nebrbny:

("
1%

:‘i

attrast-I

IS in law

s: rte er: in LF: tisSue

t2)
h‘

Yh&lt;‘

2

Cb'litugrpzata—II is

:oﬁc=n£r3££nu ,

«12L h1gh
Kev, so

%:

that thc:e

a;¢:ylchclzne; and/3r

that the noncancraziou

at
though
are
02e241122.
g; 5.
suqtyt
'h:..-

1

slaw decay rash
o

�I

‘,

f)‘:W-‘rvrs. t“:

"

st: gfztzl Ira

in»

‘.-*

“2:-

1"

2

~

3

::

"ca

proqz tlcn

&lt;th
.L

.

Fran

Chv

a:v:yl-

nzgh cgnawnLratiors or

:"l':us:eraae—I

stuchn

suuid

.

attivit"

cad be

(;Q55!.
.

of Wacnmunsan

ill-n

If

can be deduzcd“

13w

demorstracad in dapre:?£ve

yzr~xe5 g‘ acnopausal depr¢sszct), then the electroshock induced

'

$:L:V1-‘QIIUL 1¢v-:rimula:2 ;%;l;ne {grasp-I graduation to a more

usn“ku:

Eu
,4

-\

\

v

1‘!

:g:

-

-

cgﬁu"'crac#3
c r .t “.CE

Ha4.3:

xu“

«

chhriy.

2

z:

‘“"gi;ia:: r, tzarv122d;3,

an

r31):
l

éﬁn

y‘;rra

L)

txue to more than

-;‘.c;-

upnli:ation

cm

Rucent szudius by Funkeaatein and.

rglarlcsshlp Fatwaer the blond p:e&gt;3ure
a

"aren* L!(11FP:51~ ‘gegt whicb iﬂduces

swancpag, and in;:¢n.cd

peristalris.

20

minutes.
5

minutés are :lauSLfied as Gtaup 1. .1,
20 or were

c

‘JYI

.3.

'daczsrs have

h.'..~¢‘ax:u.-,

ax

a 92 Improvemant

C’W‘Tiht, the Group
‘,~..
,

.._..-

V1

sir-.1

GK'C‘J-P

charapv, and the Group II—III reactors a

'IIIII-III

I:

Patients whcsa bleed preséﬁre

'na.r1:#e: zhcsa vF‘ue blaod presecrc zukej
92:13:: 2:.

(ha

:1: b43313: in.a varlnc;e {ength of time.

t;ﬁh.ﬁ$ to [J3 baseline in
xrd .L‘

:1J11e3_may hive

untrrgvi: [EdQLIUity

‘Ezm 01

'\

Iiﬁ.~it. tigsc

4

if tiaaué ;nclltester85&amp;—E in the

ogzuac‘ ctaLentrat on 0‘ chxuu 'hcixn—

aid snvgi cf rer"ccs

3t

_

_‘

c..".

x‘

_

"\c_r..e—
‘

’P?‘

é

ratu with Louvulsive

35%

recovery rate

reactor: have

MW.

-......»n.a.cac

textzmw

a 892 and

the Group

I‘*'Hal-*mHO‘vw-Iy9ﬁ-’
'

In

,-

�ﬁll

a: 31., 1952).
:e:c"crﬂ rate (Funkensteln 9—“
-Pa7;ean in Fuzkensteln Grcups l to Ill may be looked
972

a

;: Ew;l;ui- :1 "him
ET

n 'J' m

C‘.

'1

de

Ch: 1716

and VI;

V1

upon

tad weuhalyl is r2p;dly hYJrolyzed;

patients

have a-slow hydrolysis

rate.

predict, therefore, that the blood cholinesterase activity.
levels of Grorps I~III w0uld be high; while the activity of

Je may

Grazps Vl-Vll would be low

We

recall here

a

siuular prediction

rega:ding the ds:a fur central nervous system levels of cholin-A
11 which

u‘rergse~l,

the development of early and sustained

EEC

hyperaynchran) and elevated spinal fluid levels of acetylchclinc

relatvd to

was

a law

level of cholinestarase activity,

1. 43"¢ cf 9:11pﬁnral
‘u:

V

\

u

\

.

azngtuast

0y

8

cbslincrgic agcntz is

the hypotheeib'regarding central nervous sysrvm re?

:5

aztivitv :2

:zzm‘;atl&gt;n

Thus.

a

., ”w“

“a

~c:r.shuix.
a

A,~‘

,.-."..(
'c-~
:AJ'L
H—-—.- as...

ThLG

survey of the

litarature

of the rJlos

acetylzholin (f

"V
.o.

:hclinestarase in ccnvﬁlslve therapy has led to a

aﬁd

speculations which require verification.

For

number of

this purbose. ‘t
L

Rdgglilhd that an-investlgarion of the ftlivwing relationships

:elztlon :c :3Evulslve therapy - type,
,0

J

I

v

o

9

L."

I

in

14"

number and

fttquency.

.ociated oleczrcencephalogram'partarns.

h

Relsclcn of such a;eryl:hollne levels to the clinical
behavior oi patients.
(2)

(3)
Llaé

BE“

Changes in lndices of

altered braih function other

with Such acetylchcline levels

�(L)

'Relaciou of :holinesherase accivity

1:03 serum and splnal

and

patterns of

fluid to:

(a)

age

(b)

diagncsis

(c)

rate at development cf

(d)

number and frequency of

EEG

hypersynzhrocy

t:eatmehts

reactivity
(e) autcacmlc (peripheral)
reactiﬁity
[csrebral
(i)
if»)

«g;

_pe:sona11ty

Rut

at"

:nLrIL Eshxvic:

atropine. 'physcgstigmine adrainistmticn

on
’

EC,“

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67504">
                <text>Files: Acetylcholine and Cholinesterase, 1956-1966 (folder title 2/4).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67505">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67506">
                <text>mfp-03-01-003-0-002</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67507">
                <text>1956-1967</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67508">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67509">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67510">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67511">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67512">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67513">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80953">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87514">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94075">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100636">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6752" public="1" featured="0">
    <fileContainer>
      <file fileId="6540">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/22ce0e2ce2b39aba2aae8d5d1394cc60.pdf</src>
        <authentication>2c9db7ac17279fda4146fb703f39bab1</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107145">
                    <text>'

""" "r

'

"

WWO WW WW3.
IN

Max

Rink,

-*-'

'"I’W

v“ ”kw "FWHWOMV'.’ v.3.

"m

qr min...“

.7...

W

14.1).

mthofPoydmiatry
of
School
Missouri
Meir» ,
of
MRI-nit};
Psychiatry,

at the Nissan Institute of

63139.
Macaw}.
St.
Innis,
Annual Street,
and
Vii—072w,
bin—927,
m—zns,
usms
in part, by
gums
Missouri.
of
Formation
:3
Iii-11380; ltd the Psychiatri
5WD

W.
VII:

7—25—65

Ram

��Wm,

lQNQe) . The
activity md emitement (Tracer and
oembmepiml fluid does have measurable cholinestemse activity,
however, principally of the ”true” or maholyl hydrolyzing type

(Madmen

and Rothenberg, 19%).

In the absence of free

acetyldroline and mder the cmditims described, electmenoephalogrm

fail to
(e)

Show

almorulity.

mummy: Meta

of Crmiooembml

Trauma: Free

mtylcholim was found in the cembmepiml fluid within a few
minutes after experismntel head trauma in cats and persisted for
varying periods up to #8

m9

(Bernstein, 19%). The quantity

of free mtyldmline varied between 2.7 and 9.0 gamma percent,
and the
was related to the degree of induced trauma.

wt electmemeptulogmm demstmted patterned

Carma-rent

charges. The records were

first filled with high

voltage fest

activity, interpreted as evidence of an intense neuronal discharge,
com to he succeeded by a short period of ﬂattening of all
recorded electrical activity. These phases were then followed
by prolonged periods of high amplitude sharp waves in the delta
.

freqmncies.
The

behavioral changes related both to the degree of trauma

wt
of mtylcholine,
md the

of measured free acetyleholim.

With higher

Bernstein reported greater degrees of

abnormality and greater charges in omecioumess.

poet-tnunetic seizures

were

levels

EEG

Spmtmeoue

also related to the ammt of free

mtylcholine warring in the spinal fluid.

�Bernstein applied amtylcholine to exposed cat cerebral

cortex. men the concentration of acetyldroline was

or less, high wlitude shup
the electromoephalogrm.

waves

When

of

1

gm

percent

low frequency appeared

in

the concentration was increased

tOngmepemnt, theelectmencephalogmflattmdina
fashim parallel to the post—tramtic records.
Investigatims in neurological patients by Tower and
HcEadrem (1909a) damnatmted free acetylclwline in the
cerebmepinal fluid only in patients with recent head
recem grind-mu seizures or after

electmvulaive

Free acetyldxolhe varied from 0.2 to 100

gm

tram,

therapy.

percent. In

assaying spinal fluid dnlineetemae activity, they noted a
sharp rise in the nonspecific dmlimsterase fraction

(bmwyldwlineaplitting) sad a drop in the specific
dwlinesteraee fraction (mdmlyl-eplitting) in patients with
head trauma and following convulsive therapy.

The

cerebmapinal

fluid did not exhibit such inversion, although it contained free
acetylcholine, after spontmeous seizures. They cmcluded that
the level of free aoetylcholine varied directly with the degree
of cerebral dmage and that reversal of the cholimvterase

W

was

a

m

sensitive indicator of cerebral (image.

Electroencephalogrm, taken at varying intervals following
EEG
of
between
the
degree
relation
indicated
a
tram, also
abnormality and the appeamce of free acetylcholine in the

cerehmeﬁinal fluid.

�. r

-; o-Tn-

"W

wu-rm- V“

7

~

MNIWWF‘.

«wwwnmw' . ”3-.— :Nr‘ ‘mw— l‘.«nmw~.—WMM v-y

»".\—-

(max .9 w— , r‘ "murmur 1 Wm" q‘

4;.
These observations were recently

oonfimd

by Kovaoh,

wounded increased aoetjldxoline in

o: 1.1;.

rat brain after traumatic
shock, and an inhibiﬁn of this activity by the ministration
of atropine to the muscle preparation.
Tim the «want 05 {no aootgtchoune may ammo in tho

who

Aptaol staid {cunning

WWW

mum

and the. mount 05

(no acugwwune, the dean.“ and typo cg mmmcapmogwuc
«bloom/aim and «Maya in clinical bohavion appeal: cu

Wound phenomena.
(b) Antioholinegﬂo

m

and

tram:

oleotmgr'aphic,

The

bohavioml and neurologio signs of head trauma were blocked by

the parenteral achinistmtion of 0.5~1.0 m/kg atropine (Bomtein,
19%), as were similar clinical changes: oomrring after the

intmciutornal addition of acetylcrnlino.

Ward (1950)

applied

these observations to tho treatmm: of closed head injuries.

In

20

pttiants with varying dogmas of tram,

he amtiniotomd

atropine subcutanowsly in doses of O .1 mg/kg, noting clinical

in soon and a reversal of the oleotmgraphic effects
in others. Similar alterations in the poat-trmnnatic electroimprovement

encephalogram were reported by Jenkner and Igdmer (1955) in a

rtudy of diethaxino; amthor antidxolinergic drug.

A

single

introvomm dose in forty patients maultod in normalizing the
'

abnormal electroencephalogram

in six othom.

in twentyi-tm and

marked

ingrovemt

.mr—‘xv

�T-W‘vw 'h'mivu‘

-.-. ~.w—w.y‘~ WVMMW'Wn-uvw‘w—W 1."'"q'(

v

-—

m7

"In“?

-

"mmwuﬁwuwmw‘vu “m""vw -WW’-xm -~ wr: TW'f..‘-|‘.Yr 1m

Sinilar oboewatiam have been reported with mthylbezuctyzine
md
in minal exporimnts of post-trumutic shock and

man
03mm}.

Odom:

(mm,

affect of atropine

Thu

1&amp;5).
assessed in the convulsive therapy

was

process by Ulott and Johnson (1957). With the administration of

mnpordaydvmtngmwoeksthepatimts
moeivnd oleotxoshodc therapy, the
of slow wave activity

atropinewto

mt

oigxificmtly lass than in a omtrol grow who had not
monivod tho atropine adhinistmtion. (In a later study these

was

authors failed to replicate this study, suggesting that dosage

factors or popllatim ohms-m

multo

[Johnson 93;

&amp;,

may

haw contributed to diffemnt

1960]).

Similar affects mm obacmd with experimental antioholixnrgio

was
diothaxim, banaotyiim, the pipaddylbenzilates

(Pink, 1958, 1960). The intruvonms injection of

and JB-329

(Ditm), lid

WIN-2299

JB-318. JB~336

111de ES damchrmizatim

in psychiatric subjects. Those EEG ohmgos were associated with
bahaviml alerting, anxiety, tram, illusions, and hallucina—

tions. In patients the

than

had recently received eloctmomvulsive

a reductim in slow wave activity md a
manual of euphoria, denial md oonmsim. Atropine in low

thumpy,

dam,

was

was

associated with

tadnvoardia,

mass

E88

desyndumization acoarpmiod

and Maxim.

by

At higher dosages,

hypcnyndum slow wows, followad by lower voltage , poorly
omitted delta activity with super-imposed beta activity wm
associated with progressive confusion and disorientation.

”I..- —w m hwy”.--

�.erw—spmﬂlwtvnvamnw."

w—

r..«wwruun-x...—..,«».w..i.

in combat

Both

Wguphtc

mm"._., w-uvw-m .7..-7._~.-—v-—wwww..—

um

~—

._.‘...,W wan

rvw—Hw.

;W.——»—.- w—u w "r
-

, -—

wwv—ku.“

and induced convulsions, the.

ehahgu my be modiﬁed by the.

WWMOR

antichottuugte MA, Auggutbig that tamed manta
96 acetytehaane on.
chawvigtc unpuvttg 4'4
undated with the. high vauaga Alon) wave activity.
05

Wed

(0) Brain

Similar

EEG

mﬂlcholim

and mtfahnlimggzc

ahmgaa and similar blocking by

my

mticblinergic

drugs has been obserwd following the direct application of

amtyldmoline to the central nervous cystem. The achinistmtim

of a cholimtemse inhibitor

Df'P

(di-isagpmpyl fluoroplvsphate)

elicited high unplitudn rapid frequency EEG patterns similar to
of poststatus epileptiws, as wall as changes similar to

M

stma (Madam £314, 19‘69, Samson gt 9;” 1950,
mid Hindi-m 333b, 1950, and Weasel 93.31;, 19%). These EEG

traumatic

effects were blodmd by small. dose: of parenteral atropine and
in amtylcholim after
awpolmim. The mat
tetmthyl pyrophosphate (TEPP) was masumd and related to
the toxic misfostatims and cmwlsims induced (Sim and

inm

Pepcu, 1952; Stone, 1957).

Chatfield and

W

(1M2) prepared exposed

miml cortex

with pmstiminn and cvdcud oluhmnoephalogmphic spike

activity.

Thu

spiking, or

prior

mismtim of atmpim blocked this

if present,

thc «mutuality could be eliminated by

atropine.
In contrast to that: findings, Bmmor and Merritt (19%)
applied tepical acetylduolim in concentrations of 2~1/ 2 to

to the exposed cortex of cats,

and noted no

effect

on the

10%

w- «ﬂu-xwa—VVlwu-

��“mun-ny- rw-WV‘VKwnZw'w—w

"1W:wmwvtwwav 1W”'_&lt;1&gt;vwnv.&lt;_wum,vwwv ]- ‘_

VFW, .. .- w

n - ~-....Vr.ﬂ.--“ “W,- ..‘,_.,‘......_,.,.‘ -.v—--Y‘. ,-.

-3-

Elliot gt. 5}; (1950) md Crosslmd lid Herridc (195“). 61mm and
Popou (1962) fomd the increm in aoetyldnlm following various
dapmssants to bc
proportional to the degree of
depmssim of the central nervous system and the mduction in motor
md Buck (196:4), turnover, studying 13min
activity.

My

W

lavas

and sedation omeludod

that some ”dating agents
are associated with devoted brain aoetylomline, but that no
dawns mlatimxshipo existed. In part, this may be mlated
acetyld'xolina

to the earlier obsorvatims of

Wu:

Elliott (1951) that
acetylcholine synthesis unsound in mt brain slices, is
accelerated by low dosages of mootic drugs, but inhibited by
and

him dosages.
Pme

autylcholim

patimts with epilepsy

was

mported in the spinal fluid in

(Cone, Tower and

Wm,

19%; Tower

an
(7‘3
epileptic
patients,
Mom,
domtmted free aoetylcholine in qumtities of 0.02 to 5.0
percent with an average of 1.0 gm percent. Acetylcholine

and

191mb).

0f

56

gm

lawla Hem related to the fmquonoﬁ of seizures, the extent
of electmmplulogmphio abnomality, and to the time since
the lam: soizum, but bore no relation to mdication, type of
epilepsy or lawl of cholinesteme activity. Elliott at al.
also noted that :1: fm acetyldmoline was dennnstmble in the
spinal fluid in cmoentmtims up to 3 gm permnt after

mmzoln convulsions.

7

.w .. "urn“...

�.7.~w.. V.

-

V

,,

“my",w

1...,"—

4~.vn,w—._._.m~,m raw-w": '— 0.. ”75v.. .— _‘
.

‘wwm‘ ,van... ..__.,.Wry.~.~ m-Zwm-V'I—r‘wn W.W ”-mw-w.w.mwr~m
-

n—r.~~—.

&gt;¢r:'l.irmv --"‘v-w-V‘MVSWVP

-9Tower and McEachem (19'4933) viewed

mm

the increased acetylcholine

of the seizure, and not causal. Studying the
hypothesis that the acmlatim of acetylcholixm induced seizures,
Tom (1953) masumd the level of acetyldxoline in brain tissue
after mtmnolc convulsions. She noted a rise in the
as a

aoetyloholim content of bmin, before a soizum and a fall
during the convulsion. Below certain levela of acetylcholine,
cotwulsiona failed to occmr.

that the fall in
tissue aoctyldaolim during a convulsion was due to inhibition
She suggested

of aoatylcholim synthesis by increased concentmtims of
metabolites such as mimn ions.
Gianna!) and Pepeu

also measured chmges in cantml nervous

system acetylcholine follwing various stinmlanta.

moholyl and 3, S—dimthylbutylcthylobarbiturate

Chly

was

after

them a

significant chmgc in the amtylmolim level. may noted a
decmase in association with induced convulsions. With other
drug: which they classified as stimlmts

iprmiazid

1:

(LSD,

hydroxytmyptophan and iprmiaxid a

ipmniazid,
DOPA)

tum

war: no changes in acetylcholine level. may omcluded that

despite intense excitatim produced

an

by

these coupomds, them

in acetylomline levels unless trace mm
by convulsims. (The differences in obscrvatims

no changes

Wand

between these

MomdemcgggléandTmranndEaduem

muted to the differences in mthoda of biochemical
monuments, for the latter measured chmges in spinal fluid
my

be

mflocting the free acetyloholim. while Gimmn and

Pepeu

«way—.-

—-—.\.

�T-

-

w;—----w~~~.~

.7

um

.

r -

xu

‘

r

v,m__.mwa,mﬂmuwwr~pw m~'mvv'v—rﬂr vav-u—w.

---—w

~

,~

.ﬁﬁr'A—HIwmmrrw‘(Wr-1Inr’mwmr"W'mv-w’

total acetyloholim reflecting band and free fame
and Elliott, 1951]).
of amtyloholim.
The“ mom augguz that Apart/tango“ an. induced su'zwtu
by
moanpmécd
in intercom 6n: mag/Maine
an
m
abound 6m La bound {own which my be inﬂected in the
(Laid. Cmbm activity and Auzwtu enhance magma”
«lawman, awaiting wine Levels 05 Mots/Moan, Mule “up
and muthuia my augment acetytchoune paoduotéan inc/away
about mm.
measured the

[mm

We

W

’

(:3)

Central Nervous sttem Cholinostemes: Tower and

Worn

(19%) also measured spinal fluid molinesterase activity. The

typos of cholimatemnos are nomally found in the spinal fluid:

mimestemoe-I (“tm,“ "opecifio," or macholyl—hydrolyzing),
whim haaaa high specificity for aoetyldaoline; and cholinestemse—II
("psexido," "non-Specific," or banzoyloholine~hydrolyzing) .

momds

Both

hydrolyze aoetyloholim but have different rates of

hydrolysis for monolyl and benzoyldzoline . 'mis differential

rate permits qualitative distinctions. By reporting the cholinestemsc
activity as a ratio of the activity with a moholyl substrate and
with a benzoyldioline substrate compared to a substrate of

acetylcholim; two mtios are found: crolinestemse-L/aoetyldlolim
and clnlimntemoolllaoetyldiolim. In such mtios normal
oembmspinal fluid contains astemsea in the ratio of 33:17
for molimstome—I to dialinestcme‘ll .

_

In patimts with head trauma, Twer and Mcanhom reported
an inversion of tho cholinestemsea with an increase in the

VHF-"147

�».———w

~. r...

&gt;qu

.

'v—vv—W n»

“W...“

mm

xwwu-w_~ WY— .

“-7 mrmm wnwW—u—mr- w...” maum—w—w—y
w

«W

.

unv'r“!

"31A“ man-.wvvmw "w” w~:-

-11..

dtolimtum—II fraction of the spinal fluid

and a decrease

in cholinesteme-I activity. Tho extent of the dualinssterass
reversal was related to the severity of trauma and to the
dogma of the electrocnccphalogmphic abnormality.
In patients with elevated spinal fluid acetylchclins after

$1)th

seizures, however,

no change

in the

ckmlimstomscs or total armlinestemse activty

woof
was found.

in cholinestcms activity may be undamtood
in relatim to ohmgcs in cell neutron: permsability.
C'holixnsteme—I is fmmd in highest cmmntratim in the
The charge

cmtral mmus system whilc d'xolinsstemse-II pmdaninatss
in othcr tissues, especially blood serum. With an incmm
in acetylcmnnc levels in cerebral intcmellular fluids,
vasodilatim md incmased cellular permeability may be
predicted, with a dsgme of tmsudaticn of vascular fluids into
the intemsllular spaces varying with the extent and duration
of the vasodilatim
and

their

(W g,
31:.

19%). Spiegsl, Spiegel-Adolf,

oo-woﬂcem (19“1, 19M, 19““, 19148, 1953) demonstrated

and: pemeability changes and inmassd conductivity of the

titauos associated with the appearance of various ions (as
pctassim and phosphate) in the Spinal fluid following
electrically induced convulsims . Such nm~clcctrolytes as
nucleic-acid splitting

cellular psmability

enzymes

may

also increased.

in

Changes

thus provide the basis for the high

concentrations of metylchclim and the increased concentmtims

of duclinesteme-II in induced seizures or head trmma (Tcww
V

4nd HcEcchem 19n9c).

.

persistence of acetylcmlim in spinal fluid after head
dmlimstencsc
dcspdte
and
trauma
«fur seizma
The

imam

.

vmr

Var"

.muw

��rw

~—.r&lt;

—-._..'—v-w__ ‘-

,m Am

w—w—

WW

7- v

nan—1"“ w—u-n w
v

mm

mug;

'- wmn—uw—v W
v

mm

--

,mmmm‘u—n

w

a"...

mm

-13-

«mum m mm
5M nuvocu Mama

0‘

mbmu
nmuimy
«a
WWW
at

«may.

(a) Aceﬂldaolino,

EEG

13mmmd‘wmy and Induced Oonvulsims:

Alteration in the blood—brain permeability barrier by the
cmtinuing action of acatylcholine

may

be a biochemical substrate

for the postwlectmshoa hypemynchrmy of the electroencephalogram
Sud: a possibility is evident in the damnation of an inmm
in the mmtmtim of cocaine in brain tissues thme days after
a series of

12

induced cmwlsims (Aird

We

g:

.1332.,

1956). The

in emcentmtim of this large molecule, ordinarily
absent in brain tissue, was associated with the appearance of
syndimny delta bursts) in the electroencephalogm.
We

hove

oonfimd the

many

hyper—

pmvious reports that convulsive

therapy induces electrogmphio hypersynchrmy (Pink and Karin,

g

53;, 1961) . Despite a constant applicatim of
treatments them is a great Variability in the time of appeanmce,
1956:, Pink

the duration and the extent of the electrcgraphic slow

wave

activity as well as the sensitivity to modificatim by alerting,
hyperventilation and barbiturates in pcytidaﬂxic populations.
The

early appearancn of

dagroo
hypersynchrony and
high

persistence thmugzout a

prerequisite to

mamnt cause has

its

been described as

improvement following electmshodc (Roth, 1951;

Roth, §£_g£;, 1957; Pink and Kahn, 1958).

the differences in the dogma of induced

It is
EEG

possible that

hypersyndurmy

mlated to differences in central clmlimrgic activity.
The failure of certain patients to develop hypersynchrony may be
associated with the absmce of fame aoetyldroline being related

may be

to

him).

changes in cumbml function and thus producing .a

»

“V.lvf"——Iw vu.- "a'v

�WW.

_.

7: .my- "“ .~..v.,W ”"
.

,

.

“V

WW

7*MW--—- ‘-u :u wr—u ‘V-U-lw‘-um- WWWW‘,”._¢.~K—.wvﬂﬂ m”. ~"m--'~w
,

e

~

*

.7

_,.,.

,

v ,7,

,

(lawn), in their study at” cmniocambml tmmna, included
observations of six psychiatric patients undergoing cmvulsive
trumpy. Studying the patients aftar 3~7 tmatmnts they
reported free spinal fluid acetyldmline in two patients; and
an increase in cholimstemse-II and a decrease in dwlinestemsesl
with a reversal of the ratio of dialinestemses in five of the

six patients. hm those obscrvatims they concluded that the
spinal fluid changes in induced convulsions were more like
those of amniocembml trump. than those of spmtmeous epilepsy.
described the one patient in the series

failed to
show either fme mtylcmline or a dmlixnsterase ratio reversal
in the. spinal fluid as: "It is interesting that this patient
was the only one of the six to shrew no response to treatment."
They

If olectrogmphie

hypersynchmny

who

is a mflectim of increased

fme mtyldxolim, subjects who maintain hypersynchmny and
those in whom it disappears rapidly may be exhibiting diffemnaes

in the kinetics of the dwlinestamsawoatyldmoline hydrolysis
systcns . Persistent hypemyndumy may result from a decreased
rate of hyd‘olysis of wetylcholine , associated with low
mntmtims of either- cholinestarase-I or cholinestemse—II .
(Conversely, in patients with short-lived hypemymdurony,
dmlimstnmse-I md -II in tissue md spinal fluid

may be

unusually high) .

Fm thug

chuwacéoM

we would

conclude

demon; m mediated M an Mme in

in

W,
mm

enhancing 2th:

MW“

that induczd
{we acetyichouue

Mg
Momma.

naming mutual
06

The

and

Lava as ﬁne

1:;

.

ru- » m.

“mmvw-w'

-

,

v-

�"w

aw-"m, wrrwnw“—5—

mmrwmwm._
.

mallow

426

Wad

m

wm—w—w w.

"mm-v

m-u—v—v—

nw—wuw-

gwmy"w_mw u- m.

-55..
by

muted induud autumn.

EEG

hwynchlwny a one. Reﬂection 05 abtmed {even 05 Managua
and muted
05 01h“ momtym. It 11A pubabtz
that that chaugu in
movide the

mam

mngw
mm“
pwibtwt
4mm:

Mochwécaﬁ

50mm

56!:

{nomad

the

bohemian“ changes

mm“ .

(f) malimstezm md the Classification of Psychoses:
mesa studies have application to tho problem of autonomic
reactivity and tho classificatim of the psychoses . Manstein,
91:.

31;. (19%, 1951, 1952) have

demtmted a relationship

betwaon

the blood pmaaum maponse to injected mthacmoline (Macholyl) and
the clinioal response of spydtiatric patients to convulsive therapy.

is a potent cholimrgic agent which induces vasodilation,
tamycardia, mating; and increased peristalsis . 11:53 rapidly
Phﬂmacholinc

hydmlyled by ermlimstemse-I and slowly by duelinesterase-II .
mo blood pronouns of subjects falls after injected macholyl and

returns to the baseline within five to
whose blood pressure

20

Grow VI and VII
have a

9

and a

am

recovery

and Group VII mactom

1133;” 1952).

patients in

20

89%

to

nﬁnutes. Patients
5

those whose blood

Wine,

Group II—III

rate, respectively, while

and

97%

minutes have

recovery mtes

as

reactors
Group VI

(Wotan

GmupItoIII mactommybelohkeduponas

whom

while Grows v1

I, II, or III reactors;

ormm minutes to
motors. Group I and

35%

than

returns to the baseline within

how classified as Gmup

pronoun takes

more

the injected mdwlyl is rapidly hydrolyzed;

‘and

VII have a slow hydrolysis

rate. It is

probable, themfom, that the blood and tissue oholimstemse

activity levels of Grows I-III is high; while that of

Groups

-

unr

�.- n.

.— .

VI

.wr-. .,m-w.w-,,.

..-

-

VII in low.

A

mwkwmr

“or a mum: mviow,

similar analysis

systom levels of

"'"ww—ﬁi-m

may

in

mud:

r—nmﬁm.mn-‘mrmrp.’ "nu—mu“wl'r-_'In.

m Rose,

1962.]

mgarding central nervous

dwlimammo-I in the dcvelqmnt of

EEG

hypmyndnmy and spinal fluid levels of acetyldxoline,
providing the built for a
hypoﬂuais mgarding
contra}. nervous cyst-m

periptnral

mt

Inactivity to induocd convulsions and to

momma agate.

Arm

�.

”V7“

:vn-r—

www- 7.". New“- mu..~

“Av ‘:~vv-'me~'v xwmm~m.__en.sw—_.

mm

_.m immv—rmc "cw. .ww-‘rwwm-u-ﬁ—Wrw—_ml

-17-

see significant in the convulsive therapy ptccess. The published

data indicates

thlt

induced convulsions ame.associated with an

inczease in intercollulsr scetylcholinc to levels greater than can
be destroyed by cholinsstensse—I

activity. Vascdilstion

and

increased cellular permeability are fblloued by increased amounts

cf cholineetersse—II

electrolytes in inter»

and other enzymes and

cellular fluids.
These changes are
hypersynchwcny which

reflected in the increased electrical

is recorded as

EEG

slow wave

activity in

scalp electrodes, and which can be modified by a wide variety of

enticholinerzic drugs.
In these reasrds, induced convulsions are more similar to

cerebral trance, than to spontaneous seizures.
The changes in the onrebmel biochemical milieu alter

cellular activities sufficiently to be associated with altered
behavior of subjects. Failure to induce high and persistent
concentrations of ecotylcholine and Illiuwe to induce concomitant
fbilume
to produce behavioral
electrolyte changes results in a
‘

change.

Difﬁerences in the rate of development of cerebral changes

reflect differences in the dependence of subjects on cholinergic
mechanisms or in their sensitivity to changes in acetylcholine
1mm. mm differences provide the basic for the classification
of the mentally
The

the

mode

ill by Funkenstein and by Pink and Kahn

(1961).

observations provide a rational biochemical basis for

of action of induced convulsions in altering the

�m"

'A

"VI-v

Ww—vv—n—u—m—«rrm

mum-mam
mm

with tho mm

«truer

mmmmwrmawm

-13..

of

pomtie subjactn. 'nnu

mm

view

mwopmsiologie—adapﬂm

(Fink, 1957, 1962).

an mistmt

wavy expressed

�_.,. m...“ ... .4. .. .ﬁ-a

v “3-..."- w..——_ww «av—m... ”VWFI-WquwLH-‘M‘AW‘K' w-v'lw . . "m." Inn—www-Iw‘m
v.

"uvw

-wu

v

rays-y‘—

:—.-

me‘n—I'“m

32mm
Aird, R. B... Strait, L. A., Pact, J. 91., muncff, H. K. and Witch, 8. C.
Neurophysiologic effects of electrically indwed convulsims. M’ch. Newt.

rum.

scum,

1956, 75: 371-373.

Pram

and actim cf acatylchclinch experimntal
Bomstuin, NJ).
trauma. 1. Nuanpkyuatu 19166, 9: sue-355.

min

Horritt, H. B. Effect of certain choline dcrivatim
clactrionl activity of the cortex. Auk. “want.
(6%.).

on

Runner,

C. and

mm.

Human, A. S. V. and NacIntosh, P. C. The physiOIOgical significant of
acctylcholim. In K. A. C. Elliot, I. H. Page and J. H. Qustcl
C. C. Thoma, Springficld, 111., 1955: 37I4~375.
(Editors),

uwmmuw.

mtfield,

on

Dewy,
cortical potentials. Mu.

Cam,

W.

“Viv

P. O. and

Tm,
in epil’psy.

V.,

Worn,
Jo‘oquo. 1&amp;3, 73:

D. B.

Grassland,

J.

1950, 162:

“SQ—MW.

E. w. Effects of prostimine md acetylcholine
J. Pkg/«20L, 19142, 135: 633~6u0.

and

D.

I.

Acotylchcline and mammal

59.639

effect of anaesthesia on the
matylchclim commit of the brain. J. Phydob, 195%, 125: 56~66.
Dale, R. H. Th action of certain «tau and ether: of choline. and
their relation to maxim, J. Plummet. Exp. Thu., 1913, 6: 1'47.
Elliott, R. A. (3., Swank, R. L. and Henchman, N. Effects of mﬂmtics
and cmvuhmts on acctylcholixn content of brain. W. J. Phgual...
Pink, H.

A

and Merrick, A.

Tm

unified meaty of the cctim of psychodynmic therapies.

Pink, H. Effect of anticholimrgic agent, diethazine, cn EEG and behavior:
Iimificm for theory of convulsiva therapy. Mch. Newt.
(cued,
1958, 80: 380-4587.

was

“ch.

Fink, H. Effect of mticholinomic
on pcat—cmvulsiw electromccplaogm md behavior of psychiatric patients.
can.
Humming 1%0, 12 (2): 359—369.

Emeh.
’

Pink,
view.

m.

of action of cmvulaivu therapy: the mm'ophysiolosic-adaptivc
J. Nwaoplgcuazu 3: 231-233.

M.

Pbdo

Pink, H. and Kahn, R. L.

thtintive

studies of slow wave activity following

cloctmstnck. Bactuzuccph. can. "wuphyuotn 1956,

8: 158.

Pink, 14., mm, R. I... Karp, 2., Pollack, M., Gm, H. A., Alan, B. and
Lafkcwita, H. J. Inhalantuinducad convulsions. ma. Gen. mama, 1961, In 259-356.

mm,

A. PL, Bales, P. D.,

Willis,

md Himwich, H. 8. Experimental
pmdwtim of electrical major convulsive patterns. Amen. J. PhyuloL,
1&amp;9, 1H6: 117—1218.

Mkenstuin,

D.

H., Gmmblatt,

H. and

A.

new
Mutt. 0.3.,

801mm, H. C. Autmmdc

chins“ ramming electric shock Mutant.
mm
19%, 108: #094122.

J. New.

�.-

“

'E'mr u-men...

Mountain,

wumW,mu“... 1~w‘mww.w“~-mmmern“—"~—IJ...-

mm,
amnesia

H.,
paralleling peyoholoﬁo
1951, 11”: 1‘18.
D.

qvp-

—..,.

WW

me‘w

”Va-WV“..—

mwmmwmvmuww

W3
mantally ill paﬂlnts. 1. How. m. 01.6.,

H. and Solomon, H. C.

Autonoiuio

Menuhin, D. it, emenbhtt, M. and 301m, H. C. Autammio nervous
system out of prognostic simfioanoe in mlation to alactmskndc treatment.
P‘ymm. Mo, 1952. 1“: 3“?“3620
Gianna, N. J. and Pepeu, G. Drug-induced charm in bmin aoetylcholim.
W. J. Fitment” 1962, 1% W233.
A. and Hiwich, H. E. Effects of
Mam, J., 33313, C. P., Manley,
di-iaopmpyl flmmptmplmto (DEF) on alectmanoephalogm and cholinastarase
activity. ,Eumamcph. can. “Mphysutu 1950, 2: Mil—ha.
Basis, C. F... C. F. Hampson, J. L. Balsa, P. D. and
Effect of trimthadima (Tridima) and other drugs on
Madam,
oonwlaions caused by di-isqwmpyl flmmplmphata (OFF). Ame-A. J. mum.
Himioh, H.

23.,
A. H.

1950, 106: 816-820.

Jonkner, P. 1.. no ladmer, H. The effect of Dipamol on the olectmmoopmlogrm
in tho normal subject and in time with canme tmuna. EWmuph. can.

”meto'

1955,

73

303’3050

6., Ulett, G. A., Johnson, H., Sﬂth, K. and Sines, J. 0.
Eleotmomwlsive thrapy (with and without atmpim); affect on
Johnsm,

I...

analyzed ahctmanoophalogmm.
chemically
2: 32u-336.
1960,

Melt. Gan. Paychiot”

alum,

M. and Knaub, V. Quantitative estimatim of the
Kabat, E. A.,
albmin and gamma globulin in actual and paﬂmlogic oembmspinal fluid by
nomads. MM. 1. Mad" 193:8, *3 (5): 653-662.

Wm

Kovada, A. G.

3., meo,

A. and Halmagyi, M.

hm
Hamid"Wit

Aoetyldiolina‘omtmt of the

brain in traumatic smdc. Aotc Phyaiozaglca (HungJ, 13:
fiber

Lou-vi, 0.

Meir. £. 4. gas.

14.

our Hemmnwﬁkmg.

1921, 189: 239-»2u2.

Haymrt, E. W. and Buck, E. 6. Effects of C.N.S. Dapmsmts on Brain
Aoatyloholim.
19M, 6: 191.

Wtagut,

Heisman, H. and Elliott, K. A. C. Effects on omvulsmt and narcotic drug
on aootyldxolim aynﬂnus. 1. PM. I Expat. Thump" 19513103: 35.

mam.
Wm,
specificity of We in mm
D. and

Studies on cholimtama: on
tissue. 1. Biol. (than, 191:5, 158: 653—666.
M.

A.

Ridxtor, 1). mad Crossland, J. Variation in acetyloholim’oontmt of the
brain with physiological stata.
J. Phyatolu 19%, 159: 2h7-255.

W.

Rosa,

J.

'1'.

'me

We;

Menuhin hat
in the

~ A

mview of the

literature. Add

mdor barhitmte anaesthesia produced by
twain-mt mad their simificmoa for the theory of M
clam-awake
actim. Enougmuph. can. Managua" 1951, 3: 261480.
Roth,

)4.

EEG

�Both, 15., Kay, D. W. K., Show, J. end (keen, J. Prognosis and
pentothel induced electmnmplulogmphic changes in electm—omvuleive
treatment. summaph. can. Nemphy‘iol” 1951, 9: 225-237.

Spiegel, E.

A. and

Spiegel-Adolf, H. Permebility chmgee in the brain
induced by tamed and insulin cannﬂaions. J. Nuv. Max. 91.5.,
19‘31, 93: 750—3755.

Spiegel, E. A. and Spiegel~AwlL H. mysiooodieuionl effects of
electrimlly inclined cmvulsime (mmbmepinal fluid studies).

Tum. Mu.

mm.

1455.,

19%,

'70:

130-132.

Spieaal, E. A. and Spinal-Adolf, H. Physiological and phyuicodwmicel
mechanism in electroshock treatment. Conan. Newt” 1953, 13: 38-53.

Spieael, E. A., Spinal-Adolf, H. and Hem'y, G. mysiooodxdical changes
in the brain
electrically induced convulsive discharges.

marina
Tm. m. Newt. Au"

19M, 68: 17h.

Spinal-Adolf, M., Wilcox. P. H. and Spiegal, E.
in
electrmhodc
treatment of psydxoees.
Mae
19.48, 10“: 697-406.

Stem,

We

Tom,

H. E.

1. Pk”.

The mole

Me,

A.

Cerebmspiml fluid

m. J. mama,

of acetyldwbline in brain mtebolism and fmctim

1957, 36: 222'255.

Effect of omwlsion inducing agents in the amtylcholine
content of the brain.
J. Phyeutn 1953, 173: 179—183.
(2.

m.

Effects of single injection of corticotmpin (ACTH) on
We, ion
and emtyldxolim ambmt of bmin. Ana. 1. Miguel”
mnim
1953, 173: 1764.78.
C.

Wm,
and
patterns
wetyldmline in the oemhmspinal fluich
0011th

a. Aoetylclmline ma neumml activity. I.

ﬂower, D. B. and

of patients with

maimmbml mm. CW. 1. Quench,

Tatar,

Wehem,

27

lQuQa,

(Seat. E): 105-119.
D. B. and

dnlimstemes in hm
1949b, 27 (Seat.

13):

mutant and characterization of
mmbmspiml fluids. Canad. J. Rum,
D.

'Ihe

132-1'45.

Acetyleholine and neuronal activity.
Worn,
II . Acetylmolim and dwlima‘hmsa activity in the

Tuner, D. B. and

D.

fluids of patient: with epilepsy. szm'. J.

(Sm.

E): 120‘1310

Ulett,

G. A. and

mbmspiml
RPAWA’?,
27
1mm,

datum, M. W. Effect of atropine and soopolanﬁne upon
eleetmenceplulogmphic charges induced by electm-oonvulsive therapy.
Euwameph. can. Namaphguot" 1957, I: 2174224.
Ward. A. A. Atropine

in the treatment of closed head injury. J. Newsag”

1950, '7: 398-402.
Ueeeoe, H. C., Green, R.

Wm,
of atropm md aoopolauim on the
3.,

B. P... and Kmp, S.
central effects of DFP.

Wt.

The

J.

inﬂuence

�DEPARTMENTAL CORRESPONDENCE
DATE

Julx 29z I965

SUBJECT

Cholinergic Mechanisms in Convulsive Therapy

To.“

Max Fink

FROM

George A, Ulettz

MODo

A most interesting

paper, well put together and documented and with

which

I

MoDo

DEP'T
DEP'T

am in the main in agreemento

There is one minor typographical error on page l2.

GAUzlz

�CFDLINBMC

W315 WV!)
IN

Max

W

Fink, PM).

mmmpmmotpmmnmmsmmmma
Paydaiatzy, (immunity of Iii-semi. Sdml of Medicine
SHOO

Arsenal Street, St. Innis, Missouri. 63139.

,

Aided, in part, by usms grants ”44.921, 114-2715, ail-mus, md
Iii-11380; ad the Psydiiatric March Fomdntion of Missouri.

�VI: 7-17-65

WCWHWIVEW
Despite

mm

application and study, the nod: of action

ofﬂnccnwhivethmpmmnminsuﬁmic. Matudy
mmmdtomumphysiological(
paydwlogical(
social

). clinical

(

),

(

and

aspects, elucidating me pmaent nam—

)

phyaiological-«laptiw

).

View

of the process

).

(

'lha amply dnvalcpmnt and persimmon of signs of altered cerebral

fmctiun mm mpomd to

be requisite to

(Pink md Kahn, 1956), with

mess

in behavior

0100*:ch

slow wave

activity as the mat significant index of altered brain function.
Thu

this

Mien
slow

um

that pmddcatim with ampina inhibited

‘Jormcn,
1957) and the report
activity (Ulett and

that antidxolimrgic

a

mm

nursed these clinical

ahatmgmphic alarms (Fink,

1958)

311mm that .me

biodmnical basis for the convulsive therapy process
the clnlimraic

m

as wall

may

be

in

of the central nervous system. This

raviaw discusses the available data agarding acatylcholim

ﬂ

�and the

dwlimstemes in the convulsive therapy process.

Acetylcmline has been extermively studied m an active
agent in the transmission of

dowdptiom of Dale

mm

impulses since the

It is

(191A) and Loewi (1921).

first

a

comtitmmt of mmm tissue, existing in a bound form which

is liberated

during the excitation process.

It is

rapidly

hydmlyud thrwgh the specific action of duclinestarase and
in rapidly momstituted

by

the ohcline~aoety1ase system

(Rid'ater and Crosslmd, 19W) . In

noml cembmspinal fluid,

free acotylchclim is not present despite the mpid
bound

and

breakdown

of

acetylomline during periom of activity and excitement (Tower

Wm,

19u9a). The cambmspinal fluid does have measurable

dwlinesteme activity, havever, principally of the "two" or
mdwlyl hytvlyzing type (Madam

and

mm,

19%). In

the absence of free aoetyldxomle and mdar the conditions described,

electroencephalom fail to

show

abnormality.

�(a)

Grahame ﬂats of

sootylcholim

was found

Crmiooembml Tram: Prue

in the osmbrospinal fluid within a

few

minim after sxpsrimtsl Mad trauma in cats md persisted for
varying periods up to “8 hours (Bomstein, 19%). The quantity of

ﬂu
the

amtyldmlim varied

W1:

was

(:th

between 2.7 and 9.0

gm

pennant, and

related to the degree of induced mum.
shotmsnoephalogmms

amazes. me mooxds were

demtmted pattmd

first filled with

activity, immuted as svidsnoo of

high voltage fast

an intense neuronal

distant-3e. soon to be sumedsd by a short period of flattening

of

all

recorded electrical activity. These phases wen then

followed by pmlongod periods of high

mlitude

sharp waves- in

ttwdcltafmqusnciss.
'msbehaviomlohmgsswsmmlatsdboﬂitothsdsgmsof

mmmd

to tho

want of mmd fme amtyld‘nline.

Vth

highcr lovels of amtyldlolim, Bomstsin reported greater dogmas

of

EEG

Why

and

water changes in

consciousness.

�31&gt;th

wt

post-traumatic seizures ware also related to the

of fme acetyldwlim appearing in the Spinal fluid.

Bomstein applied amtylctnline to exposod cat cambml

cortex.

When

the concentration of amtyldxolim

percent or lass, higx amplitude slurp

waves

appomd in the electxmmaphalom.

When

was

W6

t0

2

gm

percent.

was 1

gm

of low frequency
the concentration

01.0meth

the

1000160
fashion
the
patetzmnatic
flatumed in a
parallal to

Parallel investigatima in neurological patients by
and

Wm

(mm dumtmtad free

Tower

acetylcholine in the

cerebmspiml fluid only in patients with meant head tmuna,
meant wand-ml seizures or after alectmcmvulsiye therapy.

M0 amtychlim varied
fluid
spinal
assaying

from 0.2

to

0310111103001”:

100

gm

peasant. In

activity, they noted a

sharp rise in the nonspecific dwlinesteme fraction

(Mmoylcholim-splitting) and a dmp in the specific cholinesteme

fzmtian (mohaiyl—eplitting) in patients with had tmma and
sanguine convulsiva therapy.

The

cambmspinal fluid did not

�exhibit such invemion, although

after

it

contained free acetyldxolim,

spontaneous seizums . They concluded

fr“ mtyldzoline varied directly with the
damage and

that the level of
degree of cerebral

that reversal of the dualimeteraae fmetims

was

a mm sensitive indicator of cerebral dmgc. Electmencephalogrmna,
taken at arming intervals fellowing

minim

between the dagme of

tram,

also indicated a

EEG-Wt); md the

appoamm of free amtylcmline in the cerebmspiml fluid.

mm
Wkwwm
Tim

«the,

4;me We!

mm 0‘ due magma-u. may tame in the
(cumming

{m autgtchouu,
abnombbty, and

WW

«the.

Mg“

W“ W.

«tam and the want

chalk.“ and type 0‘
4'.»

05

demomuphalogmpuc

dialed mm); «ppm «6

�Antietam}

(b)

bahavioml and

mutual

m

and trauma:

mmlogio signs of mum

The

m

electrogmphic,

blocked by tbs

awninistmtion of 0.5-1.0 Wkg ntmpim (Bernstein.

I

1986). as was similar

inmcistml

clinical

change”

mowing after the

additim of aestylchcline.

Ward (1950)

applied

injtmida.
those oboemtima to tbs tmatmnt of closed head

In

20

of
patients with varying dean-e3
trauma, ha administamd

mopim

WW1);

immt

in

some and

in doses of 0.1 m/kg, noting clinidal
a

mml

effects in others. In a study of
diethnxine. Jonkner and

the

W

at the

W

forty patients with

anticholimgic drug,

altemtiaw in

(1955) mportad

post-mmtic aloctmcmophnlnm.

dose in

electroencephalographic

W

A

sinﬂe intmvamus

electroencepmlogrmm

resulted in normalizing in twanty-tm and

marked

inpromnt

in six otham.
Similar observations have been Imported by Denisamco (1965)
using mthyl‘bamctyzim and

poat-atrmmtic

mmtin

in animal

that and 03li em.

ewinmta

of

�Truss

obssmtims

were assasssd

in the convulsive therapy

process by Ulstt and Jornsm (1957). These workers administersd
dosages of atropine

w to

the patients waived

that the

mt:

mm

slsctmsm

of slow

wave

per day during the weeks
therapy. They downstmtsd

activity prodmsd in those patisnts

ms significantly less than tbs control group

who had

not received

the atropine ministration.
(In a 141th study these authors

fdlsd to mplicats this

study, suggssting that dosage factors or population changes
have contributed

to different msults [Jormsm

These observations provided the basis

g}. 31., 1960]).

for studies with

othsr imam anticholinsrgic mounds (Fink. 1958, 1960).

hummus

JB—336 arid

Wins.

the pipsridylbsnxilntss

JB-329 (131mm). and WIN-.2299 induced

dssmhrmiutim in psychiatric subjscts. These
Hum

The

injection of smrimntally active anticmlinsrgic

camels as disthssim.
JB-ala,

may

EEG

EEG

changes

associated with barnvioml darting, anxiety, tramm,

illusions and hallucinatima. In patients

also had

mently

-

�mind

elootmoonvcnsivs

the achsinistmtion of

throw,

these Imomds was associated with a mduotion in slow

awn, mm

wave

and 'eonnnion.

activity

and

reversal of

Aunpim

was

also examined in low doses, and in these administmtims,

EEG

dosynctumizstion ms obsomd

nervousness

sod

tension. At highnr dosages, hypersynchrmous

slow waves, followod by lower

activity with

menisci by tachycardia.

mimosa

wings.

poorly organized delta

bots activity

melamine:

by

pmmssivo

confusion and disorientation.
Both

in

oleotrogmphic

annual

tum

and indwed convulsions, the

0W8

may be

mdified

by

the commont

(hogs,
administratioh of mticholinargio
thus suggcoting that

immaud smarts of aootylohlim or inorusod oholimrgic
receptivity is sssoointod with the high voltage

slow wave

activity.
(a)

min

and
iomlino
anticholimm
gm

m:

SimilanEGorangesandtublookingthmmnobumd
following the

dinct application of

mm systm.

sootyloholixu to the

mm].

�The

aministmtim of a omlineeteme inhibitor-

DP?

(di-isopmpyl fluoroxmospheta) elicited high amplitude rapid
frequency

We
19mm,

EEG

patterns similar to status epileptious, as well as

similm to those of post—hmtio states (Freeman 33 11.,

Hanson

Egg,

effects were blod&lt;ed

1959; and Himioh
by small doses

339;,

1950). These

EEG

of parenteral atropine. 'me

great increase in aoetylcmoline after tetmtthyl pyrophosphete
was

(TBPP)

manned and related to the toxic misfestetims and omvulaims

induced

(mm and

u:

thfield and Dempsey

1952; Stone, 1957;)

(19%) prepared exposed animal cortex

with pmstigmim md evoked electroencephalographic spike activity.
The

prior

mistmtion of atropine blocked thio spiking,

the
almomality oould be eliminated
present,

by

or

if

atropine.

In contrast to those finding, Emma!" and Merritt (19%)
applied topical aoetyldxolim in concentrutima of 2-412 to

to the exposed cortex of cats,

and noted no

effect

on

10%

the

electroencephalographic changes after intmwnous atropine
(1 mg/kg.) 'lhe concentrations of acetyldtoline in these experiments,

�10

however, were higher than the
and the

gm

topical applications (l-‘t

intrusistemal (0.2-10

gm

percent)

percent) injections of

Bernstein (19%).. Burner and Merritt also

made

note of

elem-

encephalogmphic effects similar to acetylcholine from motion/1

(emtylhetmthylcmline)
much

lower than the

and cloud (oerbanyldlolinﬂin

mtyloholim concentrations.

They

cmoentmtims
ascribed

the increased effectivems of these diolinergic drugs to their
lack of sensitivity to cerebral almlimstemses.
These data are

conflicting and further study is museum

to qualify this issue .
(c) Oembxnsgiml fluid Amtxlcholine and Seizures:

of aoetyldiolim metabolism indicates that

it is

One View

fomd in nervous

tissues in an inactive band fem. hiring periods of activity,
amtylcholim is liberated at the cell
dsectivated
rapidly

by

mm,

dwlinestemse.

The

where

wt

it

is

of bum

asetyldmolim is the resultmt of the continuous processes of

synthesis, liberation and bredcdmm.

It

has been postulated that

the level rises during sleep and falls during activity. (Richter
and Cmssland, 19%;

Elliott,

Swank and

Hendersm, 1950; Giaruun

�Pepeu. 1962).

By

using liquid

air quick freezing

methods.

Richter and Grassland measured the level of acetylcholine (micro-

gem per

brain tissue) during anaesthesia and sleep to be

mg.

300‘ higher than

post-“12m levels.

The

difference in

tissue levels is tnansient. however, as the resynthesis rate for
acetylcmline in net brain in high
(1950) confirmed

m1.

the” owemtiom, also

Pepeu (1962) fomd an increase

3

noting that after

gm

per cent. Gimmn md

in wetylcholine named by a

central nervous mum depressants to

be roughly

reduction in

and no

mm activity.

acetyloholim we reported in the spinal fluid in

patients withepllepey (Cone,
and PbEeahem.

19149 1)).

0f

55

'Ibwer and

mascara, 19%;

epileptic patients.

demetmted free acetylcholim in quantities of
5.0

M

proportiml

to the degree of depression of the central nervous system

m

:3in

convulaims free wetylcholine me demustmble in the

spinal fluid in concentrations w to

1;!

gm/gm/minute). Elliot

(7

with
1.0
of
an
cent
average
per
gem

gamma

Tower

an (77%)

0.02

to

per cent.

�12

Acetylchclim levels were related to the frequency of seizures,

ﬂnextentofelectnnncemelogmphicmmlity,mdtothe
the since the

lat

seizum, but bore no relation to medication,

type of epilepsy or level of clnlinestense eotivity.
Tower and Maﬁa-hem (1904912)

vimd the increased

acetyldwlim a by‘prodmt of the seiem,
Studying the hypothesis

that the

and not

camel .

emetim of ecstylchcline

indmed minutes, 'l‘orde (1953) measured the level of ecstylclwline

in brain tissue netmmle convulsims.

.‘

She noted

a rise in the

,_

V

V

ecetylcholine content of brain, before a seizure and a

the cmvuleion.

Below

fall (bring

certain levels of ecstylcholine, convulsims

failed to comm. Stu suggested that the fall in tissue
acetylmolim during a oonvulsim

was due

to imibition of

ecstylcholine synthesis by increased concentrations of metabolites
such as

mnium ions.

Wmmmmumdohmgesmmmmm
system acetyldmolim following various stimulmts . Only

after

�13

unholy]. and 3, S-dimthylbutylcthyl-barbitmte

significant chmge in the acetylcholim level.

damn.

was

They noted a

in associatim with induced convulsions.

drugs which

ﬁrearm as stimlants

Md
mmmdumainmtyldmlim
+

other

With

133mm,

(LSD,

hymoxytmyptaphm and iEprmiazid

level.

there a

+ DOPA)

them

WWW

daspito inﬂame excitation produced by these commie. them

wan no dung» in mtylcholim level unless than were
accompanied by convulsions.

(The

differences in observations

botmmmuwerkmmdmggglmdmmrmdﬂcﬁadmm
my be

in
diffemnaas
the
to
related

mummnts, for thc latter

methods

of biochemical

wand changes in spinal fluid

w

61m

and Pepeu
mﬂecting the fun acctyldxolim,‘while
12;
bound and
reflecting
acetyldwlim
mumdntatal

true form of aoetyldzoline.)

Thu: Atuau wages: that
on:

Wed

by an

sputum

Lame. in

an.

induced

1mm

law

5n: awtytchaunc

�”mm—“hr“

V» 3-

‘

v

w»

.

m

w

1-:

“r.

0...

~

W "n

,

nr-r-w, ..-.p:..u&lt;ﬂv.»rrw-¢.M “av—w.

.

.,. 4. ....“.,_.

w...

,, 'zs-sznr-W"“air‘quvww'ﬁ'qmti'd‘u.

w.

»

,‘rv

—.».‘

wm‘

,

w

-

1n

abound 4m in

bound

(on which my

wind. (Laid. Cmbm nativity

Micheline dalmatian,

manna.

Lemming

mum

15qu

in #1:

enhauu

tame (cum

9‘

Me blew and Mama auguwut mallow:

madam“ 42mm aunt
(d) Comm]. Nervous

Wm

and

be

mm .

Sgt”

('holinostemes:

(19%) also uncured spinal

Tower and

ﬂuid cholimsturase

activity. No types of dnlimstemes are normally

found

in

the spinal fluid: dwolimstemad ”true," "Specific," or

Molyl-hydmlyzing) . whim has a high specificity for
acetylcholim; and dxolimtemacu-II ("pseudo,"

or bonmyld'uolim-hydmlyzing) .

"mpacificﬂ

Both oompomds hydrolyze

acetylcholim but have diffmnt rates of hydrolysis for
mcholyl and bonzoyloholine . 'mis differmtial mta permits

qualitative diatimtiom.

By

reporting the cholinostemse

activity as a ratio of the activity with a

mocholyl substrate and

with a homoyldmoline substrate compared to a substrate of

acetyldmlim,

two

ratios are fomd: dzolimsteme-I/wetyldzoline

. ---

v

r

v

,

--

‘

~-

a"; .

��rmw,

16

vasodilation

and increased

with a degree of

cellular permeability

may

be pmdicted.

amudetion of vascular fluids into the inter.

the
of
duration
md
with
extent
the
varying
cellular spaces

g:

vaaodilxtutim (Rabat
mad

their comma
pomability

such

51;, 19%) .

Spiegel, Spiegel-Arblf,

(19%, 19W, 19%, 19%, 1953)

chm

demtmted

and increased oonchwtivity of the

ions
(as
various
of
with
the
associated
appearance
tissues
potassium and phosphate) in the spinal ﬂuid following

electrically indwed convulsions .

Such

non-electrolytes , as

nucleic-edit: splitting mama , also increased. Ganges in

cellular permeability

@6011th

may

thus provide the basis for the high

of aoetyldzoline and the increased concentratiom

of aholimstemse-II in induced animus or head
and

We!“
The

head

1989c.) .

persistence of acetyldxolim in spinal fluid after

tram

activity

tram

(Taver-

and

may be

after seizm'es despite increased cholinesteme
related to the sensitivity of the acetyldxoline-

dxolimsteme-I system to meantmim relationships (Nadmm

W. , ~1— ~- A” .—,.-

�17

and

Wu,

1935; Tower and

Wm,

muse; Burger: and

McIntosh, 1955) . At "physiologic" comantmticrns, hydrolysis

of mtylcmlim is rapid (3-4
lunar

com—um,

MW)

but at higher and

the activity falls off quickly . In

contrast, the dialinastemaun acutylchclim relatimship is

map-cite

and the

rats of hydrolysis incimma with increased:

ammunition.
0m view of these

mktimhips

suggests that while the

usual concentrations of mtyldmolim a cell
dostmyod by the specific activity of
few

Wounds,

my

«and

the seizum

are

dnlimstomeJ in a

m excessive concentration following excitation

the mate of hydrolysis by

coir-m Mahala

mnbms

may be

itself

cholimstcmeJ.

m

reached and a seizure inclined, with

adding to the mum: of free amtylcholim.

The

immune! acctylcholine diffuses rapidly, affecting vascular

and

annular pumability

and

imam; the mntmticns of

various iom and dmlinentemmn in the

of molimateme-II , though of

low

031".

The

activity

efficiency and depending

on

��in brain tissue,

associated with the appearmoo of hyper-

(delta bursts) in tho electroencephalogram.

syndmrony
We

was

have

oonﬂmd the

many

pmvim reports that convulsive

thumps: induces elootmgmphio hypomyndarony (Pink and Kahn,

m

1956;

93. 93;, 1981) .

mutants than is

mom.
slow
by

m

Despite a constmt application of

a great variability in the

the W103! and the exam of the alcotmgmphio

mitivity

activity as well as the

alerting. hypeantilatim

synchrony and

in psychiatric

dew hyper-

its persistence thmmlmt a treatmt

has boon described as pmmquiaite to

It is

to mdifioatim

and barbitumtes

populations . 'lhe early appearance of high

Week

tins of

(Roth, 1951; Both 93.2%,

mm
19531;th

possible that the £15.fome in

EEG-hypemynduw my be

of central oholimrgio

following

and

@,1956) .

induood
the dogma of

muted to differences in the activity

”Wm

.

patients to develop hypomyndmmy
pnoluding a clinical

me

name

me failure of certain
may

thus be associated

to Wood convulsions.

Tower

�.. 7.7. wrunvx—u—

20

and

Will“

(lauea), in

ﬂair study

of

mommbml tram,

included obaawations of six paydziatrio patients mdergoing

convulsive therapy. Studying the patimts aftor 3.7 momenta

aootyldaoline
in two patients;
may mpootod free spinal fluid
and an

imam

in

(momma—II

mumstomod with

and a

demase in

a reversal of tho mti-o of mono-stoma:

in five of the six patients. hm those observations they

minded that

the spinal ﬂuid dmges in induced convulsions

mmmliketmmofcmimmbmltrmmanﬂmoof
spontaneous epilepsy.

Boarding the one pttient in the series

failed to

who

show

either true wotyldmlim or a duolimoocmse ratio reversal in
the spinal fluid, they wrote:

patimt

was

Mt."

"It is interesting that this

the only one of the six to

show no rospouso

If electmgmphio hypemyndxrmy is

of inommd {me acetylcholim , subjects
whammy and those in

whom

it

who

to

a reﬂection

maintain hyperh

disappears rapidly

may be

exhibiting diffemnoes in the kinetics of the d1011nestemse~

wm. w,-

Nx‘vrpl

.1

�-\

“

--~w an» .7

r'v-vww-‘ 1".

-.r

Ti'prp"-ﬂ-=Au‘n “-6.“..-

~-‘

‘31 .

W

W

.

,
“‘7.dvzw‘".

V... mu.

metw'w—mwmlv‘lu":.e.vrlvn—“Atm-‘mWW

w-xm

“m.-

Y‘a""'

21

acutylctwlim hydrolysis system. 'Fhmistant hypemyndumy

result

dsmd

{mm a

may

rate of hydrolysis of acetylemline,

associated with low mnemtmtions of either molimatemsea-I
with
shortin
patients
'(Oonwmly,
dlolimutcmc-II
.
or

lived hypemynduw, dxommteme—I md -II in tissue and
spinal fluid
PM:

be mmually him) .

may

that:

anomalous

was

0&amp;0:va

«wanted

“W‘m,
«shaming the

We.

an: WWW a
EEG

51prwa

1.5

a;

Lgtu

at

WWW

paovtde

We

in We mwmum.‘

wumtuuu.

Mad
one

WW W
pubable that

saw! an

that induced

Wag embmcpweabuétym

and

It a

on would coucmde

aw

by

The Level. 05

upcmd Mad .5qu .

mama

of

pmabuéty

Mud Law
05 exhale.

ﬂzuc changes in

05

«anaemia.

mm

deem-

m mama: 4mm (an m pmumx

chugu foaming induced

0.0qu .

w

..—-.w-w~.-w...

�K.

i

[

‘

v.

,7

W

.. f m

.l

.

V, ».

V,

,,,,_V

-.

.o

“:2 ....V ﬂu, ”w...“

- w-wﬂl’m'."

”no”.

.7

..n “w... amp-“mm- "...v'vmm. ._,

f.v-w—«-—v~—— v0?" m—v‘

wkumu.

,

3‘“

.7

a

run

,.

.

--

22

(6)

Gaolimtemes

Thus studies

may

and the

Classifimtim of

Paw:

also have applicatim to the problem of

‘

automic Inactivity

mum

and the

clansiﬁcatim of the psychoses .

and athora (

a «Miami-nip between

)

true blood

haw

”castrated

pmssum response to injected

madmlyl an! the clinical mponae of psychiatric patients to

ammlsiw
whim

ﬁlmy.

lel

is a potent cholimrgio agent

mm,

mama vasodilation, tadxyoardia,

peristalsis. It is rapidly hydrolysed

by

and

W6

diolinesteme-el and

:11me by dzolimstemse-II . Tbs blood pronoun of subjects

fall: after injected mohalyl
within five to more than

20

md mtums to the basolina

minutes. Patients whose blood

E

l
I

i

plum

returns to the baseline within

classified as

Group

panama takes

20

Group VI and VII

5

minutes have boon

I. II, or III mentors;

those whose blood

armors minutes to mtum to baseline, as

rumors.

Group

I md

Grow;

IIoIII motors

�23

have a

9

and a

35%

recovery rota, respectively, while Group

and Group VII

reactors

9:92;, 1952).

Group

patients in

whom

89%

and

97%

recovery rates

I to III reactors

may be

VI

(Menorah

looked upon as

the injected morolyl is rapidly hydrolyzed;

while Groups VI and VII have a slow hydrolysis

rate.

We

may

predict, therefore, that the blood cholinestamsa activity
levels of Groups I-III would be high; while the activity of
Groups VI
A

-

VII would be low.

similar analysis

may be made

mgarding central nervous

uysten levels of cholineatemmel in the development of Em
hypersynolumy and spinal fluid levels of acetyloholim, providing

a basis for a oongment hypothesis mgarding central nervous
system

reactivity to induced convulsions

dmolimngio agents.

and

to peripheral

�.

..—

.—\..‘

..

.—Vw-~'.

7......

"any.” “.7

lmr.r"vv,~

..

...~

y..

.

_,_,‘

,

~~,.. m. .WWV

mm. rm.

~

v-y

‘

WV

W

H

.wa-ﬂq

2'4

CONCLUSION :

Central oholinergic Insomniac: appear nah-

W

in!» in the convulsive therapy process.

‘ significant

The published

data

[that
induced convulsions are
indicate

associated with an increase: in interoelluler acetyloholme to

levels greater thm can be destroyed

activity.“ Veeodiletim

and increased

are followed by increased

other

enzymes and

by

cholinestemse-I

cellular permeability

wants of cholinesterese—II

and

electrolytes in intercellulsr ﬂuids.

These chmges are reflected in the increased

hypereynchrmy which
can be modified by

is

electrical

recorded in scalp electrodes, and which

mticrnlimrgc

drugs as atropine, benactyzine,

and diethazine.
The changes

in the cerebral biochemical milieu alter cellular

activities sufficiently to

be associated with

altered behavior

of subjects. Failure to induce high and persistent cmcentrttions

of acetylcholim and failure to induce concomitant electrolyte
changes

results in a failure to produce behavioral change.

4'u-L...»

1.x.

—~-

--

7

�2S

Diffcmnoos in the mates of development of

reflect diffemnoea in

mbml

that ‘0me of subjects

on

ohangas

cholinergic

ruthenium or in their sensitivity to changos in aoetyloholixm

levels. Then diffemoes provide the basis for the classifica‘

tion of the mntally
“most:

the

mode

ill by Pmkonstein

and by Fink and Kahn (1961).

observations pmvidu a rational biodnmical basis for

of action of induced mnvulsicns in altering the

buhavior of psychotic subjects. These views are consistent with

the mom general neurophysiologio—adaptive theory expressed

earlier

(Fink , 1957) .

�REFERENCES

M,

R. Bo, Stmit’ L. A0, PM, do We, “muff, Mo K. ma
Bowditch, S . C. Nemphysiologic effects of electrically induced
ccnvuleicm. Melt.
Peyehiet.
1956, 75: 371-378.

”Wt.

(cum,

Bomstein, M.D. Presence and action of acetylcholine in experimental
brain trauma. 1. Nwophyeutn 19%, 9: 3%«366.
Bummer, C. md Merritt, H. H. Effect of certain choline derivatives
on electrical activity of the cortex. Mch. Munoz. Psychmt. (cum,
19ﬂ2, H8: 382~395.

Wu,
of ecctylcholine.
A.

s.

V. and

Macintosh,

1-“.

C.

In K. A. C. Elliot,

The

I.

physiological sigiificancc

J. H.
Springfield, Ill...
H. Page and

Queetel

1955: 37u-375.
(Editors), Numchmmg. C. C Thomas,
Omtfield, P. 0. and Way, E. W. Effects of proatigmine md
acetylchcline on cortical potentials. Mu. J. P11544201... 1m,

135: 633~6H0.
Cone,

W.

V., Toner,

activity in

Wm,

D. Acetylcholine and neuronal
and
epilcpey. J.A.M.A., 19%, 73: 59-63.
D. B.

Dale, H. H. The action of certain esters and others of choline, and
their relation to marine. J. thueol. Exp. Thu... lSlu, 6:1»7.

Elliott, R. A. C., Snark, R. L. and Hmdemcn, N. Effects of
mathetics end ccnvulsmts on acetyldmline content of brain.
W. J. "15161.0(" 1950. 162: ass-hm.
PM. M. A unified theory of the action of paydzodynmic therapies.
J. Hill‘idl H06p., 1957, 6: 197-206.
Pink, M. Effect of mtichclinergic agent, diethezine , on
behavior: simﬂcance for theory of convulsive therapy.
Adah. Mental. Paychiat. {Ch£c.). 1958, 80: 380‘387.

EEG

and

Fink, H. Effect of mticholinergic compom$ on poet—convulsive
olectmencephelogxm and berminr of psychiatric patients.
Eummuph. cu... Nauphyuot" 1960, 12 (2): 359-369.
Pink, H. and Kuhn, R. L. Qumtitati-ve studies of slow wave activity
following electroshock. Eucmemph. can. ”canophyaiat” 1956, 8:158.

Fisk, M... Kahn, R. 1..., Ken), 2., Pollack, H., Green, M. A.. Alan,
and Iefhowits, H. J. Inhalmtoinduc-d convulsions. Mch. Gen.
1961, “:259-266.

mm,

'

m, Bales, P. p., Willis, A. md Hinwich, H. B.
Experimtel production of electrical major convulsive patterns .

W.

A.

J. ”twin-L"

1%9. 1%: 117.12“-

B.

hymn

��an'V-WI'

-3Spicgol, E. A. and Spinal—Adolf, M. Physicochemical effects of
electrically inclined convulsims (cambmspinal fluid studias) .
Tm. MM. Newt. AAA” 19%, 70: 130-132.

Spicgel, E. A. and Spinal-Adolf, H. Physiological and mysicochomical
Marxism in
tmatmnt. Conga. NewwL, 1953, 13: 38-63.

013::th

Spiegol, E. A.,

Wm

Spicgclmlf,

changes in the brain

H. and Benny, G.

Physiococl'xcmical

electrically induced convulsive

discharges. Tum. ML. Haunt. MA... 19%, 68: 17a.

Spinal—Adolf, 14., Wilcox, P. H. and Spiegel, E. A. Cembmspinal
fluid menses in electroshock treatmnt of paydzoces. Mu. J.

mm”

Stone, H. E. The role of acatyldmolim in brain metabolism and

“mm.

Tom,

m.

J. M0 M9,

Effect of convulsim
content of the brain. Man. J.
C.

1957, 36: 222“255c

inning agents

much,

on the acetylcholim
1953, 173: 179.183.

Tonia, C. Effects of single injection of corticotmpin (ACIH)
on manium ion and acetylcholine (intent of bmin. MM. 1 . Myuol"
1953, 173: 176-178.

Acctylcmline and murmal activity. I.
Warm,
Gnumtomso pattcrm and acutyldwlim in the cembmpinal fluids

Tower, D. B. and

D.

of pationts with armiommbml trauma.
27

(seat. E):

105“].190

I

cm. 1.

Rucauh, 19u9a,

cmtent and dmmcteriatim of
cambmspiml fluids. Canad. J. Rumch,

Tow-r. D. B. and McEachcm, D. The

hm
27 (Sect. E): 132-1u5.

dwiimatcmes in
Rush,

w

Tower, D. B. and HcEaclnm, D. Amtylcholino and neurmal activity.
II . Acetylcholim and cholinestcme activity in the
cembmspinal
fluids of patients with cpilnpay. Can“. J.
Image,
27 (Seat. E): 120~131.

Mum.
“We

Ulott,

upon

Rum,

Effect of atropine md scopolminc
changes indumd by electm—conwlsive

G. A. and Johnson, H. w.

can. MthyAioL.,

therapy.

Ward, A. A.

1957, 9: 217-22u.

Atropine in the treatment of closed head injuzy,

J. Nwww.,

1950, 7: 3984402.

�cmLINElEIC

WIﬂiS,
AND BEHAVIOR

CONWLSIVE TIERAPY

Max

hm tha

Pink,

M.D.

Wt
m1

of Psychiatry at the Miami. Institute of
Psychiatry, University of Hisawm'. School of Hedicim,
suoo
Stmet, St. Louis, Missouri. 63139.
Aided, in part, by USHiS grunts $1.009”, I‘m-2715, ”ii-07239, and
Mil-11380; and thc Psychiatric Recent-h Poundaticn of Missmri.

'mismportispartofﬂnstudypmmminhmctimand
Behavior" undertaken
New York.
Hillside
at

Hospital in

�n

-.v-..ww.nmipv~.. NJ, mi

V:
CHOLINERGIC MECHANISMS, CONVULSIVE THERAPY,
AND BEHAVIOR

Studies of induced convulsions have

m

that the early

develommt and persistence of aims of altered colonel function
are prerequisite to chmgee in behavior (Pink and Kenn, 1956).

Electmemptmlogmphic slow new activity

was found

to

be a

significant index of altered bmin ftmction, and the dmnonetm-

ticn that premdiceticn with atropine inhibited this slow

activity (Ulett

and Johnem, 195$) suggested a

wave

relation to

cholimmio melamine. In the following review the mle of
acetylcl'olixn and the axolineetemeee in convulsive therapy is

diamond.
Aoetylcholine he: been extensively studied as an active
agent in the transmission of nervous iwulses since the

descriptions of Dale

(1911;) and

loud. (1921).

It is

first

a

constituent of nervous tissue, existing in a bomd form mich

is liberated during the excitation process. It is rapidly
hydrolyzed through the specific ectim o

rapidly reconstituted

by

gelimetemee

and

is

the cholimﬂeoetyleee system (Richter s

V

6~28~65

,

�Croeslmd, 1909). In normal cerebroepinal fluid {me eoetylcholim

is not present despite the rapid breekdom of

bound ecetylcholine

during periods of activity and excitement (Tour and HoEecMm,

lease).

The

cerebrospinal fluid does have neasmble ctnlineetemee

activity, beaver, principally of the "true" or mctwlyl hydrolyzing
type

(New

and ibthenberg,

m5).

In the absence of free

acetylcholine and under the conditions described, electroencephalogram

fail to

show

abnormality.

(e) Effect of ﬁrmiocerebral
was

Item:

Free eoetylclnline

fomd in the cembroepinal fluid within a few minutes after-

experimntal heed
periods up to

'58

tram

in cats and persisted for varying

hours (Bernstein,

19“).

The

quantity of free

ecetylcholim varied between 2.7 and 9.0 game percent, and the
mount me related to the degree of induced
Concurrent electmmoephelogrm
The

records were

first filled

he followed by e

demetreted patterned changes.

with high voltage fest

interpreted as evidence of an intense

to

tram.

nemel

activity,

discharge, only

short period of flattening of

all

recorded

�alactriaal activity.
periods of high
'Iha

These phases were than followed by prolonged

mlituda

sharp wam in the delta fmqmncies.

behaviml chmgea wan nlatad both to the dame of

amt

of masmd

trams

and

higher

haul: of acatylcholine,

of

amornality and

EEG

to tha

addition, spmtmaous

to ﬂu

matar

With

Bernstein uportad snatcr degrees
(mange:

poet-Me

aunt of free

fm aoatylcholim.

in consciomnass. In

aaixums «am also ralatad

amtyldlolina app-axing in tha spinal

ﬂuid.
Bomatain also applied acatyld'zolim to exposed oat cambml

cortex.

”Mt

When

01‘

tho omeantmtion of mtg/lanolin.

1808.

fraqmncy in the
was

inmasad to

ht

EX:

vaporized high amplitude sharp waves

electmphalogm.

“man

’7

2

was 1

gm pamt,
wam

by Towar- and HoEaeham

of law

the oonoantratim

the alactmonoaphalogrm

flattened in a fashion parallel to the

Pamllal studies

'

post-Mic ram.

can'iad out in

mlogioal patients

(19%”. Pm: acatylcholina

was

fomd in

7

1

{wéli
14?”!
[6cm

�«1—.

.

;_....

7,. rm.

.

‘

4‘1"“.7

..

run--

«m

w, raw-"aw ~~.w.:-v-w—.--lam—www—nv-rwww
-

the cambmopinal fluid only in patients withmoent Mad

wv

.r'.

r

tram

mount pond-m1 seizures or aftor convulsive trunpy. Free
...;—--°-"“' "

aootyldioline varied from 0.2 to

100

gm
__

~

peroent.

_,,./
Tour

~

v. m3...»

Mom also assayed spinal fluid oholimtome activity,
rating a sharp rise in the nonspecific cholinestemse fmctim
(benzoylclwlimqmitting) and a drop in the specific oholinestemse

the oeubmopiml fluid did not exhibit such invasion, although

it “dined fm mtyloholim.
of

They concluded

fm mtylcl'nlim varied directly with the

damage

huge.

taken at varying intervals following

Kantian batman the dome of

{m

EEG

was

a

mo

Electmmoephuomm,

tram,

also indicated a

abnormlity and the appeazmoa

aootylcholine in the umbmspinal fluid.

Thu, ﬂu

spinal

dogma of oombml

andhat reversal of the dwlinesteme fraction

sensitive indicator of cerebral

of

that the level

want as

549.:

Micheline. my {mug in the

(Mdéaltmiugmuocmbwmmmdmmuntaé

Wt

/
W“

_4___._.._..-'

follavdng oonvulaivo mommy. Pollovim spontaneous soizums

01W, 4a.:

\

and

fraction (mohalyl-splitting) in patients with had 12mm and

,

�.5and
the
degue
acotylchoune,
(no

Wenuphdogmﬁic

«type 06

abnambbty, and changu in clinical bellow»! my be

{Wad

phenom.
(b)

antioholm

Am1m,

o

behavioral and neurologic aims of

pamtenl

m

mm

and

The EEG

were blocked by the

Mimic»: of 0.5.1.0 lag/kg atropine (Bomtein,

as were similar clinical charges counting

addition of mtyloholim .

to the

tram:

W1:

Ward (1950)

after the intmistenul

applied these observations

of closed head injuries. In

varying dogmas of

tame,

he

20

patients

’with

ministered atropine subcutmly

indousof0.lnglkg,notingclinioelimrovmntinsommda

Md

reversal of the eloctxmoephalogmphic effects in others, In a
study

09m,

mower uﬁtmolinergio

Inchner (1955) reported altemticns in the

moephalogm.

W

A

p‘tvtremtio electro-

single intravenous dose in forty patients with

aleotmpmlom resulted in normalizing in twenty-

),

�F

i

H4

~37».

.V

v

.

“WW.

awn"

V

l -.—.p..r \':v';"'r~~

gw~-_.....—m .— ...r

1"" “v: n

n‘

, ,

,

m.

,-

two and marked

,

. ,

.-

,,_

_

,

,

__.,,_3._.7,,_,._ “,1”, ‘4‘._,V

,

an- a www-ruymumrm-e ,, ., .F ‘7...arm'Hﬂ ,_ ya,V. a“W. .. ﬁauawﬂl.‘ .w-qﬂw’ uvwwwrvw-1': -r~)\w‘nw
.

.

.

I

5.1119th in six others.

In subjects following convulsive therapy the (feet of atropine

inblockingtheappeamceofelwwaveectbdtywaemported

(mm
139

:Iohnsm,
and
1956).

(In a later study these authors failed

replicate this study, suggesting that dosage factors or

population changes
[Johmcn

gel“,

“niece

may have

mntributed to different results

1980]).

observations provided the basis for studies with other

loom mticmolimrgic canpcunth (Pink, 1968, 1960).

The intravenous

injection of experimentally potent antidwolimrgic momds as

dietlmine. bemctyzine, the piperidylbenzilates JB-Bls,
and

.—

JB—329

(Ditm),

Wution.

VIN-2299 and

pmcyclidine induced

The EEG chmgea were

alerting, anxiety, trauma. illusions

and

JB—336

EEG

associated with behavioral

hallucinaticna in

peyduietric subjects . In patients with recent induced conwlsims
these «awards resulted in a reduction in 31m

useciated with a reversal of euphoria, denial

wave

and

activity

cmfmion.

.3

“‘11 i

a
5161,!
.

ﬁg?“

�“Rpm, .,,,,..( ,“_.,. ,..

,

N"

.37..

7”,.

v

Atropine was also

Md,

.

”a“,

N

mined in

y:~.uf..~r\v.“r

-

o—r-

.. n

«v

low doses,

maniac] by todnyouwdia,

“any "n www-mur
-

voltage,

poor-1y

organized delta activity with

activity

was

Mum.”

._..-t

m...

who

.er

ixﬂu’Joitor,

I)?!”

elicited high anplitude rapid

935;,

post-tmmtic states

1950; andHiwidx

5.3;.

m as

(mm

1950). These

3: 2.1.2.
m;

offoats won block-d by small doses of parenteral atropine .

Qutficld

Tho

-

“law‘vpm-x-

superimed beta

patterns similar to atatm epileptious, as

charges similar to those of

with

.--

slow waves . followed by lower

mumatarau

(di—isopmpyl flmmphooptute)

Hanson

.,.,,

associated with pmgnssive confusion and disorientation.

mo administmtimoof a

191:9;

,

nervousness and tension. At

hyporsynolm

£1qu

...,,.,..;.

dosynohmnizatim was

BEG

higher dosages,

BBC

V

and Dupscy (19“!) pmpamd exposed animal cortex

prostim

and evoked eleotmenoaphalogmphic spike

prior aministmtion of otmpinc

Hacked

this spiking, or

present, the abnormality could be olimiratcd
In contrast to those findings,

Mr

activity.

by

and

if

atmpim.
Darrin (19%),

applied topical aoetylobolino in concentrations of 2~ll2 to

to the exposed cortex of oats, and notedno effect

on

the

10%

«-

�ehatrmnaphlomxic
The

damages

after intravenous atropine

(1 mg/kg) .

concantmtims of acetylcholim in those encperimants, however,

were higher than the
and thc

topical gpplioatims (1-4

intraeistemal (0.2-10

gm

gm

pement)

percent) injections of

Bomstoin (19%) . Bmmmr and Merritt, also

made

note of electro-

enceplnlognphic affects similar to aoetyldxolim from nacholyl

(mtylbetmt‘m‘lmoline)
much

and doryl

(carbmldlolim) in concentrations

lower than the amtyldtolim concentrations . may ascribed

the increased effectiveness of these dnlimrgic drugs to their
lack of sensitivity to cambml dzolincsterases .

11qu
nativity
Mamie
The“.

W

and

war. 0‘ man,

mama

induced by autgzehaune

46

can

be.

backed

out

maﬁa, mama“,

of mtyloholim antebellum indicates that
an

oak“ as

Wed

a

imctiw

bound

by anti.-

etc.

(a) Cambrmghnl Fluid Anglcholine and

tissue in

that!»

topical application, M lintuéowm. with

chum-Amt activity
49M

studio» tuggeat that

it is

34513112.:

Ono View

fomdv in nervous

fem. Wing periods of activity,

mtyldxolinc is liberated at the cell

membrane, where

it

is

�.v.

.mTr,--m.,—,w..‘_-w..

”“51“,”,

wwryw

,

.

"a". 7.,“

-\‘-yuv;-vv—n—-,17'zr'~.m"--r mm.-- .ﬂ‘vv—‘r-

-

MW‘VW'v'bn-‘Imwx‘y

,.

..,,..‘v-_.v..—-u.-~,

,-

-10..

rapidly deactivated by molmesteme.
acetylcholim

is the remnant of oontinm

lihemtion and

brim.

rises dining sleep
was amputee!

and

mmt

The

and

It

processes of

synthsis,

has been postulated that the level

falls during activity. This hypothesis

in miml experiments

Elliott, Sunk

of bomd

by

Richter and Crosslmd (19%)

and Hmdemm (1950).

By

using liquid

air

quickffnezing methods, Richter and Grassland observed the level
of aoetyldmolim during metathesis and sleep (unsound as

W

per

levels.

mg.

The

basin tissue) to be

300$

micro—

higher thm post-seizure

difference in tissue levels is

tmsiont.

however,

as the msynthssis nuts for aoetyldaoline in net brain is high
(7

gum/Walnuts). Elliott 939;,

(1950) confirmed these

observetims. After utmsole convulsions they also noted that
free aoetyldaolim

in concentrations

m always demnstmble in the spinal fluid
up

to

3

gm

per cent.

In spine]. fluid studies in mm, Cme,

Tower and

(19%) and Tower and HcEsctnm (19am) reported

Wm

simificant

�quantities of free eoetyldwline in patients with epilepsy.
or

56

epileptic patients,

an (77%)

in quantities of 0.02 to 5.0

gm

per cent.

The

gm

mmted

free acetyldxolixu

per cent with at average of 1.0

eeetyldroline level

was

related to the

frequency of seizures, the extent of electroenceplulogephic

ehmlity,endtothetiusinoethelutseizm. Itboreno
relation to mdioetian, type of epilepsy or level of dmlimstemse

activity.
Mather

tr:

ecetylcholine appearing in the spinal ﬂuid is

e by~prudmt of the oonvuleim or Mather the increase in acetyl-

cholim is e eeuee of the seizure is pmblemeticel.
HeEeehem (19%») suggested

Tower and

that increased acetyleholine liberation

ismtdutotheseizureitselfbuttothepmoese

causingthe

eeimre. In e study of the hypatrueis that the mmlation of

mtyldtolim is causal for seizures.
in urinals

by

mmzole

m

(1953) induced convulsion

and determined the level of acetylcholine

in brain tissue before and during convulsions.
cmwleime are preceded

by

She

noted that

a rise in the acetylcholine content of

�M-

iv“... “.0".

,_

v

Hr.

“7 a.“ rm . .

~.—

,VT

.m",

...,.

‘mr—v-,~7..‘..v.»..

. ,

..,_

1mm-

’77.. .,

w.‘ .5,

1.

.w,

'TVV'WHP-‘ ‘(n'ry

Humannnruu ..

.

ww'" v-vm ‘r‘

~

,

1-v.‘.r—~-.-

r---v um”... mam-awn”

-12-

tissuc, abut the content fills during the convulsion,
below

and

that

curtain Invals of acetylcholinn,‘eonvulsions failed to

occur. She sugspstod that the

fall in tissun

aeotyldholine

during a canvulsion was due to inhibition of acutylcholine
oonc¥ntration
incroaéed
synthnsia by the
of mutaholitns/ such

as

ammonium

ions.

Seizunzb nan aceompanizd by an lacke¢4¢

{act aettytchclluc libeaatld

{Ann

(:3

in inteacnllutan

bound £03m,

Amucmybeumuedinmwud

(Md;

and’liit this

Mammal

nativity and Atizultb cnhanct acatyteholluc debthuction, lawtning
125£u¢

(cvelt as aettytchalilc; ukilc Attcp

W

and

ancsthetla

acaywwm wanton Alumnus tune. mm .

(d) Cuntral Nervous SystaEKCholinestcnanas: Oanoamitant

with their~obaervarions of changpa in aestylcholine, waor and
HhEaahorn (19kg) neasunod
Tho

spinal fluid cholinnstcraso activity.

types of cholinnatexuscs are normally found in the spinal

,,

-~a

1

Wm

"F-Ir «rm-“r Tau—w

�fluid: cholimter-ase-I
which has a high

Wm,"

”specific,” or mdnlyl-hydrolyzing) ,

specificity for acetyldzolme;

and

cholinesteme-II

”punch," "um-specific," or bemoyldiolim—hydmlyzing).

Bath

mama-uh hydrolyze wetylclnlim but have different rates of
»

hymolysil form‘mdiolyl and hmmyldxolim . This differential

rate permits qualitative distimticns .

By

reporting the cholinestemse

activity In a ratio of the activity with a maholyl substrate
with
two

on

Walnut»

substrate

mated

and

to substrate of wetylcholim,

ratios are found: dwlimstemso~1Iacetylcrwlim

and

oralinesteme-II/metyldaolim (with WM'IOO) . In Inch ratios

noml cambmepinel fluid contains estemes in the ratio

33:17
of

for dwlimtemee-I to eholimtemedl .
In patients with head

tram

Tower

md

Wan

reported an

inversion of the cholimstemee, with an increase in the

dxolimstemeI

fraction of the spinal fluid and a decrease in cholinesteme-IL.

(ctivity. me extent of the duelinestemee reversal

was

related

��u. wc-

15":

w“:

w—qggywww—mqw

'vwﬂvw‘r' w'w. ;~m«w

usedatcd with the

plum“)

.

we

“c-

,‘ rm-“ ,n, mvmr "W_.,“-..‘w .ﬂ.

appear-am: of variws isms (as potassium and

in the spinal ﬂuid follwing electrically

comm.

than was

electrolytes

u

cellular

an. ._-

~———~&gt;

also a significant increase in such nan-

music-acid splitting mama .

Minty

may

aluminum-41 in

md

madam
‘13:.

with the

and the

induced mixtures or hand

km
may be

in cholimstem activity should
of true mtyldxoline.

be associated

The

persistence

L

a“?

M

man md after

commas: relationships

1945; Tamar and

Wm,

mummtiom,

microseconds) but

Men

(Nadmnsm
and

”MA
n5

and

laser

matmﬁms,

contmt, the dzolimstemo-II—

5e

5

5744 (K

biz

k

4% 4:

Mute-h,

hydrolysis of mtyleholim

at higher

the activity falls off quidtly. In

19169;

.

é'dééﬂloéj“(.1

related to the sensitivity of me mtylahomu-v

1955) . At ”physiologic"
(3—43

(Tamr-

54’2“” [w

mid damnation

Murmurs,

is rapid

than

muse).

dmlimstcmsed system to
and

in

incmmd concentrations

of mtyldaolim in spinal fluid after hand

mum‘s

Oranges

thus provide the basis for th- high

cone-stations of matyldxolim
of

inctuoed

�.

“N-r

—~

n. 7., VFW..-” W _

a. ..

vw—w-‘w— 7..- .—-..~,-— :7

tm'w“‘n‘.mm"\

"Va-"er-rwswrwnh‘ Inwr'n'ra'"

.,

"mu-wmu» m y'WWW—m. w~~vw-'VI"-’wr11‘xn—n‘

~

.x v .

..

”rip-“73“‘miwl‘wuw1vv'1‘y;

NV”; —,—-.-r~.. .nr w "WWW,—

«.v

“

«mu—v..."- ‘

.

.15acctybholino rulaticnship

is non-specific

and the

rate of

hydrolysis inexact-a with cone-ntratian.

Mi

1‘“

;

Aum£-‘£o’%}4i

4;;

‘T
f?

dnatrcyud by tho spocific activity of cholinnsteraseol in faw

lasso-.aondn, an excessive concentration fallowing excitation
may

canned tho

by

cholinesterase-I.

The

L¢¢1¢4

A¢M4

‘

acixurn thrushold nay be reached and a noifnnu indueen, with

thc stizumi
f

i

rats of hydrolysis

Thu

itself

adding to the amount of free acetyldholine.

innrnanod acutylcholins diffnoos rapidly, affecting vascular

i

and cnllulnr poxlnability and increasing the concentrations of

various ions and cholinnstnrusc~11 in

CSP.

The

activity of

dholinnstoraao-II, though of law efficiency and depending

th-

mmmm kinetics,

Mass

on

the mtylcholim in the

tissuns in hours to days to lavels for tho physiologic action

of cholinnatonuae.1.

422;“
42351“

�‘vr , wwvw—M. . ‘ «ruuuv &lt;t—V'1vwv “—w—ww wwwmwrwwnw. raw—em: un.mnv:.-.Wm "WW—.1»

yrmlmx-N

ltd-www'ﬁa'wmw'guw‘I‘v

~

1..

—_

'~V"(—m'v

M.Wr&gt;‘\'m‘

.17-

Choumtmu «ppm in nu mind We! as a acumen
05

their. 41mm: in

Lu

ceu.

The

mm: gammy

ma

m

swam 6;;th
(e)

5mm»,

muting 5m

mentioned by

changes

1,2:qu Midtown.

momma; m pout of the eybmetéc mechanum

awn-(muting the
604

Ante/Lem

Me

05

«mama»:

at was mainland:

mu‘uy

WW9.

Mainline EEG!

and Induced Ccmvulsiam:

.

Almmtion in the blood~brain pemability barrier by the cmtiming

team of amtyldaolim

may be

the biodwmical substrate for the

post-ehetmshod: hypcmyndmmy of the alectxmnmphalogrmn.
Such

a possibility is avid-at in the report by Aird

«mutating an increase

W

23;

3141955)

in‘the concentration of cocaine in brain
.

tissues thme days after a series of

12 induced

omvulsiom. His

data Show the change in mnemtmtion of this large animals,

ominarily

abaerrgu:

inbrain tissue to

be

mociated with the

appeamnoa of hypnrsyndzmy (delta bursts) in the electm~

W.

,

�.

inn-ha

-'!SA‘-’-"—'r-.“

viva...

..».-~=v—-nn

,

wan-.wp» ‘ wn “-1....er ﬂ.”

.7,»

:w .r x»

In studies of induced convuleime,
many

ﬂaw-u.

we

WW“ -;

‘v w

"M”,Vrmm

“

w...

-wA.we--wﬁm~mvav" . _

‘1

dump-.—

have confirmed the

pmvioue reports that convulsive therapy induces electmgraphic

hypersyndxmny (Fiﬁ: and Kahn, 1956) .

Despite a constant applica-

tion of mutants, the time of appeamsoe, the dlmatim and the
extent of the electromphic slow

sensitivity to modificatim

by

wave

activity as well as its

alerting, hypemntilatim

barbiturates vary greatly in paydxiatrk: populations .
appear-awe of high degree hypereyndumy and

Too

and

early

its persistence

through-

out the txeatmnt name has been described as prerequisite to

iapmvemnt following electmehodc (Fink md Kahn, 1956).

The

failm of certain patients to develop hypemyndmmny may be
related to differences in the activity of central aeetylcholine
and dwlineetemeee. with the absence of free acetyld'xolim

beingmlatedtoninimalehangesincembmlfmctimmdﬂnm
precluding a clinical response to induced convuleime. Tower and
HeEaehem

(mum, in their

study of

Madembml trmma,

included observations of six peydmiatric patients mdergoing

mleive

therapy. Studying the patients after

3—7

treatments

"-

mpg-w“...

�.ww pwzwrn .
7

.19...

thay reported free
two

41lede

patients; and an

1mm

activity in the spinal fluid in

in duelimstemae-II md a

dome

in dummtomee-I with a mammal of the ratio of dwolixnstemes
in five of thn six patients.

ms

that the spinal fluid
like those of

From

mica-tubal

these observations they concluded

in induced convulsions

m

Ragar'dim the mo patient

were mom

than those found in epilepsy.

in the series

who

failed to

show

cithcr me mtylaholim or a cholimstomc ratio reversal in
the spinal fluid, thcy wmte: "It is interesting that this

paticnt

an

the only can of the six to

show no msponse

It a pawn that induce! mama»
£6

mmuu

i/

t:”PM/1AA
ﬂy

ff-WLL

AW

by

1.6

3

0‘

JA

mm,

sums.

Law

96

me

EEG

Fm «commune

hypwyueMony

mama“

and

1.6

mm

on:

mm

ascenumcngm. uuuueehuguzazmouummm-

AMM‘W

was that plowidc ﬂu.

biochemical.

60.be (on the pmaaut

V

WW)

mamnt."

mm mm pmabuuy

m Mug the. mam a; mumamu.

W
W
Wilma mm

“#19”
(

in

Wt

to

bchaviom changes {allowing inland canmuiau.

w;-

�(f) Choline-tomes
moss studies

may

and

th- Classification of

chosos:

also have spplicatim to the problem of

catatonic reactivity and the clmificntim of the psychoses .

Mkonstoinsndotlwrs(

)havsdsmxstmtedamlatiom

ug
ship botwun tin blood possum response to injectedﬂm)

(dd‘é’ﬂﬂ

and the

clinical mpomo of psychiatric patients to convulsive

W.

lbchclyl is a potent molimrgic agont which induces

vasoﬁmion, tachycardia, mating,

It is

and

harassed peristalsis.

mpidly hydrolyud by mournstoms-I and slowly by

clmlinutcmc-II .

M,

injoctod

m

m blood pmssum of subjects falls aftor

udulyl and 2‘th to the
five to

m

bssclinc

than

20

minutes. Patients

Mobloodpmsmmtxmtothbaulimwiﬂﬁnsmutos
are classificd as Groups
blood possum takos

2O

I, II, or III auctions;

arm

aszprIdeIImctims.
imprcvomnt

mactors a

minutes to

mum to baseline,

mexoupIrssctorshawa9%

rats with conwlsivs therapy,
35%

those whose

and the Group II—III

memory mtc. In contrast, the Group

VI

�_.__..

”(ya-v

——

. h\'~rvhl."ll'F

reactoreheveasstm'themupvnasﬂ recoveryme
(human-1n

35;.

Patients in
an patiente

in

1952).

“main Groups I to III may be looked upon

whm the

injected maholyl is rapidly hydrolyzed;
VI and VII patients heve
the
a slow hydrolysis rate.
41121311.
65‘ Weny
predict, themfoze, that an blood ahalimateme activity
levels of
I-III would be high; while the activity of

WV”
y

’

,-. u... V,._V.......,m--.-n—nw

’0

ﬂy”

6/”

W
W

hypersynchxuny and spinal

In studies of

EEG

fluid levels of acetylcholim.

ahengee {uncaring induced omvuleicne

subjects were identified in when e few seixme resulted in
e greet
of elm wave activity; mile other subjects exhibited

mat

few changes

to

my and to frequent seizures (Pink and Kuhn, 1956).
If electmgrephic hyper-gum in e reflection of incremd

(Conversely, in patients with short-lived hypereyndxrmy,

dwiineetense-I
be unusually

and

high).

-II in tissue
Thue

and

spinal ﬂuid

these epeauletime provide

may

�-22a basis

fcr a congruent hypothesis regarding central

nervous

system reactivity to clactroshock, and to peripheral éholinergic

CONCLUSION:

Ccntral dholincrzic nadhanismsqmpoar to be a significant
flycﬂu«’g

factor in the convulsive therapy process. ”Inc published data
{unrinriznlmymnandhto

indialté;that induced convulsions are

associated with an incruasa in intarcallular acetylcholinn tn
4L¢¢4Eygd4£5414¢¢¢délAbiﬂ—

lnvels greater than can be dustxoyed by choiéanoturuneéE—

nativity. Vascdilatian
follouod
and

and innnuasud callular'permnabilitylin«a4wc.

71L‘5@ﬁ¢.4;«xu&gt; g
aibcgérﬁyxapglugu‘542;;wmatvi
byﬂincrnascd amounts of~ehoiinnaﬂcuuao~¥l~ other'enzymas

clactrolytas in inturunllular fluids.

��n, w~. «v— ‘w—rr‘Y

.r uy-nmvv—mwum-mn "vv'.

rwzm—r w—uw-v-mw-wztwvm... a ~II'-v-'&lt;w-:'W.\1v;w'rku'svmv‘mv'nvﬂwv wwww

CEDLIWC

WV}:
mm.
MD mum

Max

w;—

.n»;_...v

W...

"on." ,vurw»;

M

Pink, H.D.

W

at th- Pﬂnmi Initiate of
-Pmthanapmntof
Psychiatry, admity of Miami School of Midas,
5800 Annual
St. Louis, Missouri. 63139.

attest,

W,
W
mm.
Wmismofthnwm"hinhnatimm
York.
Hillside Hospital in
Ethnic!”
at
mm
in part, 2:57
aunts iii-00927, iii-2715, W72“, md
$11380; and the Paydaiatric- Renard! Fantastic: 0!
New

-

-

w—n

mu,

mung—.w

an

�CHOLINEMIC

W,
AND

V:
CONVUISIVE

BHWIIOR

11W,

StudiuofinMdmwldmhnwmmmuﬂy
dwalopnntmdpmittmofsiguofutomdmwmmm
mpnmquiaitetoahmguinbahavinr (Maximum,

1956).

Wesleyanwmivitymfommm:
aimificmtinduxoflltondbxuinfmctim,andﬂndemmticn that

Mention

activity (015th

album-sic

and

Jdmm,

W.

mtylcmum and

with atropine inhihimd

tho

196’)

this

slow wave

muted a minim to

In the following review the

dwlimmruas in

mole

of

Waive ﬁnnpy is

discussed.

Mutyldnlimmwcmivelystudiedummive

amtintrnmmuimofmmusimluusimsmﬂm
It is a

dcnmiptions of Dale (191k) and Load. (1921).

mtitxmrtofmtium,uistinginaboundfommida

illibnmtcdmmwiutimmm.
)J
and
is
action
of
culimmme
specific
hydrolyud
m
Itiarupidly

W

rapidly

matitutcd

by the

cholimmtylau

cystem (Richter

8

sum-55

�wan-r”...

Grassland, 19%). In actual

autumnal

fluid has mtylclnlim

Emmanpitemupidmmofmmmm
(Town-mm,

Magmaoaofactivitymdcmitmt
19%;).

The

activity.

”Mimi

mm,

fluid does but

Inﬁnmoffm

19%).

matylahonm md undnr the conditions
than

cholimatcraso

principally of tho “tan” or medulla wdmlyzing

typemmsmwibﬁmbcrg.
fail to

gamble

Whoa,

cleatrunmpimhgrm

Witty.

(a) Effcct of

m Mint}:

W

hm:

hm acetylctnlim

mun-951151 ﬂuidwiﬁﬁnafwninuua after

demmmtsmdpmiuedforvmina
periods

2.»

m as hours

(Win,

1”).

The

qumtity of fun

gm
mtmmumdmthdumeofimmtrm.

mtylcholim vanhd between 2.? did 9.0

The

W

accord.

chcmewaphalogzu

um first filled with

percent. and th-

mutated patterned

W.

high voltage fast activity,

intorpmtad as alderman of an intern.

mm). diam, only

tobfoﬂmdbyadmtpexiodofﬂmingofmmcomod

ﬂuv

-

v

&gt;

..

�--

.vwru V.—.Ym'&gt;

electrical activity. Thou phuu wen then followed

-

'u-uwuﬂxm n.

ww-

by pmlmgod

mamamummmmmmmmms.
mwmsmnmwmthtothedameof
mmmmmtafmmdhumtyldnﬂm.
highs:- levuln of

mtyldnlim.

Romania

911‘th

"Modulator dew

ofmcmntymdmmrctmpsinmcimu. In
addiﬂm, apcntmn post-We aim wan also muted
totbmmtoffmmtylebomnapparingintmspiml
fluid.

Wain also :13le acntyldxolim to expound out 03:11me

W.

Mthommmimofmtyldmlimmlgm

pamtorhu,hnpwtodhighm11tudoshupwmoflm
fmmncyinthocloctmmmplulogﬁm.

mmmnoentmtim

mimmdtoZmpcmt,ﬂnchctm-naplulogm

Whafuhionpqﬂhlmﬂnpon—tmicm.
Parallel studios

m

wr

carried out in analogical patients

byrmmunsmnumw. Pmautyldnnmmfmxdin

-

r-w»

'

'c

.

' -'

'

�-

the

Main].

mount grand-ml

mtyldwlim

7...» 7w

wn&gt;wwv 'v'vcv’

ku-

w.

VII-"I'M‘WW

ﬂuiﬂ mly in patients withncmt head

1""!t-W'J"

\‘vv- "ram-V"

tram

301nm or afar convulsive trnmpy. Fun

vadedmeﬁtolOOgmpcmt.

Tomrmd

Wm

also assayed spinal fluid cholimstcme activity,

noting a

map rise in the mpocific cholimtcme factim

(WW-cpnttim)

and a drop

in the specific

mailman”

fmtim (metnlyl-splitting) in paticnts with had mm and
following

minim

W.

Followhu

sputum calm

the cornucopia-l fluid did not exhibit such

it comma {no mtyldmlixn.

inwaim,

Thay cmcluded

11W

that the lavel

of {no mtylcmnm varied d1mct1y with the dame of comm}.

Manama: mnnlofﬂnedlolimctem fmﬂmmam

with» indicator of Gambia].

m. madam,

talcmatvuyingintorvalsfonowingmm, mimic-med:

mhtionbctmcntkmdcmeofﬁmmntymdtheappem
of

In: mtylcholim
Thu. due

in the annbmspinal fluid.

want 0‘ We autylchounc my (me. in

the

‘mmgoummwwmmmmmog

'

'v

"F “'4‘“

�,

'V'lvw—‘U‘

w‘ war.-

—',~3

nan—-

u

,w--y_.n..-.

u.

‘

., .- ww,———w~.wm_w—w-q

‘1‘

wwm

“- v-~.-W . a..“.~,~.-u .

q.

.

WW

-..' .m “Fwy-Fumwyv,‘ “15;.” .w,

, .7

“mm

.-.»

7w.v--m»w~uu-——.

.3...
51m.

“Wotan,

abunuty,

MW.
(2))

«the

«glue

and type

mmmmgupuc

a;

mmummmmamumw

m,

WWMO m

and

m:

The EEG

aim ofmmnmmodadhyﬂu

behaviomlmdmmlogic

(Bnmstein,
pun-nun). examination of 0.5-1.0 ug/kg atropine

mmmmcunimmmmmmmmum
addition of

mmmu.

Ward (1950)

applied

mmmdmmmm.
We m, Wand
of

varying

ho

m'obumum

In20patiantswith
ntmpim

3W1)?

hduudOJq/kynothmdhﬁmliqmtinmmda
mutual of the

013:!ch

effects in

om.

In a

smdw.muﬁamwm¢Jmm
Loam

(1955)

meoph-‘logrn.

m1

W am
A

single

5.an

WW

in the pit-atrmmatic ghetto—
dose in forty patients with

resulted in normalizing in twenty-

),

was” w,

�two and marked

Wm:

In subjects

in

35.):

mm.

£011ng conwlsive

therapy the affect of atropine

inbloddmmappemotslmwmuﬁdtymmmd
(um and Jdmsm,

1956).

(In a Later smdy these

mﬁm failed

maplicmﬁxiastudy,suggastinsmatdouge facumuw

popnlldmdwgauyhmmtdhumdtodiffemntmulta
[Jemima

$5,

1960]).

Moumatimpmvidedtmmformwithm
hum “idioms: Wad: (Pink, 1958, 1960). me hummus
injection of

Wm,
and

Wm

“WW.
durum,

may,

We

mamas

mum-yum. thn piperldylbmzilnm JB-318,

(Dim),

JB—329

pan-m: mticholinergic

VIN-2299 and

an

JB-336

3%
1mm
mendim

MMWmm ammﬂﬁabduvioml
truism, illusion

whim.

and

mlminttims in

In patients with mount induaad mnvulsium

Mqultodinamdueﬁminslwm

activity

Wuiﬂzamdofmplmia,dmidmdommsim.

��-.

_«.w...-.——~.m. w, .u

.

.

r”

v

ﬂaw-v

v

"'wA“"‘f'N‘"

.

wrv-r-P

electmncepiulogmphic
The

concentrations of

were higher than

Win

W

arbor

_..

w-av. rwa-mvnw—wvm- v-.-~ TWZ'Awyvq-u'n‘Vtvmw‘T“ "Ann—w-

1::th

th- topiml appliantims (1-4

(19%).

atmpim (1

Myldlolim in these oxpeﬂmts,

imiatnml

and the

,

(—7.“ ~;—v—u~.~~.—.u—pv.—.—~nn:,+-ra.-w—u w...

(0.2-3.0

gm

pennant)

gm

'-‘a

nag/kg) .

however,

parent)

injectim of

Exam md thud“, also made

note of chat-.m-

axmptulngmphic effects similar to amtyldwlim ﬁrm mcholyl

mtmtiom
(WWW)
(mtylhetmﬂxxlmonne)
ascribed
mmh Mrthm tho amtyldnomn
M
Wm.
in

and duty).

Wimqffmimwmwmmcmmm
lack of

mitivity to rumba]. duality-sums .

ThuewmmmmmsuggutmuumWWWWWbyMWu/tmua
man

9‘

aqua,

tam Won, imam
on.

with

WW¢Mmbebum¢ueummdbgma~

WWHMAn-gmnmmdmw
«new

(c)

a mm,

mm.

etc.

Onoviw

«mlmuWMwa-smnnfomdiamm
Winnimatiwbmfom. Wyﬁnchofactivity,

WWhnmmdatthno-ummm.m1tia

r

umnnmv~wv yr.- -~

�“Hwy-v .7 m.

»

._v

.W”...w.— —...‘..r,.u...,...._...,-, Hm..."-

va,unlum‘w‘hi‘wv'mvmwv;'QX.‘""“

W ~n--

v

“w a”... ‘
,7

,v

W---w

mw_.-r—... Wt “‘1': run”...
--

-

ww»

v" ‘7. "‘ ww.-,-_p.w.~.wmw.

midlyduwtimdbydwlknmo. mamtofbomd

mm

is the resultant of continuum

1122mm lad

mm.

promotes of synthuis,

It has bun pastuhtad that the

rdmduuingslmmfnummuctivity.

level

Thishypaﬂmil

mwmmwwmrmmammum)
mm,mmmm(1asm.

Byusing

liquidair

qumumm.mmmmmmmmm
ofamtyldwlimdndngmﬂmiamdalup&lt;mamdumim

www.mmm)mhaocthigturthmpoum
hurls.

nudiffminmmmlaiatmsimt,hmm,

uthnmthaismforamtyldacliminmbminism
(7

gums/gallium). Elliott 539;, (1950) mnfimd than

obsorvntima.

Afﬁrm}. mum-ism Malacnated that

{no mtyldxolim am

always

«washable in the spinal fluid

mmwmagmparmnt.
Insphulﬂuidstuﬁuinm,ﬂam,lbwnrmdmm
(use) md fear and

Wm

(19m) “perm dwicam:

��m.uﬁumtfansmgﬁumnmdm,mdm
balmeevuin lawn of

mm,

convulsions failed to

om. Stunumudﬁntﬁnfanintium Winona:

Wamwhimmdummiﬂmofmtﬂdmnm
m‘md
mm byst-

anemia“.

We!

sud:
mtabolim,

Bummwwnmeumm

mmmmwwwmmwm
Wmuumam¢mm MW

mmm;mmmuuyzmuummmn,zmmg

rmumumzmum

W MW
WW

madam»

(d)

§xg~

an

MAMMWthuLa

W
(new:

tutu. Lena.
Cmocnitam:

wimﬂnirohamtiam ofchmm inuntyldaolim,

Wm

(1939)

Tutor-mt!

name! spinal fluid dolimtcrm activity.

Mtymofdnumemmmmnyfminﬁmspiml

�»

‘am-V ”II-"Iv

."V'a. ~,.1-

.

u -;— V’V~-¥'U'~‘v‘&lt;~u

Tam—xv... mw—uL-ww-"wv

Wanna-I

ﬂuid:
mich

.V

m

("pocudoﬁ

W

as

nu-mq-wnwh-..“ .,.,ﬂ_. ..

Um,"

sﬁociﬂcity
for
him

"rm-amiﬂc,”

ow

two

.,.

,... .. n.

..~-.

-

.

..- ’r .,.,_H. .\..v7,..,,..~—V.TM ,wv, .,.,.&lt;

V

.

a a

‘ , ,

v.“ .w: _v_

”specific," or manlyl—hydmlyzing) ,

Micheline;

and

“museum-II

WWHMWIM)

. Both

for udzolyl and bemoylduolim. This diffomtial

me panda qualitatiw dintimtims .

with 3

”a.“

hydmlyu amtylcmmn but have diffmnt arm: of

mm
activity

,.

By

I: a ratio of the activity with

MW!»

ratios an

found:

sub-mu

mind

mpovting the dwlimstumsc

a maholyl substrate and

to

mm

of amtylcholim,

mumm—I/amtyldxolim and

Wm-II/mtylcmnm

(with Adi/@8100). In

much

nudes

'mlm‘bmupimlﬂuidmuimuminttumioofﬂzu
for

Grantham-J to aluminum-II .

mpnﬁmwimmmmmﬂcﬁadmmdm
invasion of th-

daolimumu, with an

We

in the cholimammac-II

fmtim of tho spiral fluid and a dam in circumstance-I.
iathity.

m mam: of the

WW

maul was related

�we: --r"vr— mr

ww-

~r-r—vrm...‘ v .—-1«w‘ms¢—ae.—r ”"7.“ mgr-nus, r, mm, a."

'W nve- “w, -~. w n r...“ mwv “van"
e

w.—

‘1‘“ m‘r‘nvwvﬂﬁ‘l'v—vV-v

”Wuwx—m‘me - vuvax

wmmrityofmmmdmmawofﬁuem-

WWOWW.
Inpatim

with

eleveudspimlﬂuid acetyldxolim other

WW,Wr,mminmmioof
dulimetemesortommlimtem wdvitymfomd.
‘meimmindxsmnetemeactivitymbemdentood

mnmmmmmnmpemmmty.
mW-Ihfmmhimmtmﬁminﬁn
mud nervous system while duelineweme-II pram
inwartiam,upooianyb1mdsem. Hiﬂamimas
fin

atyldnnne m1: in intemelluler mum fluia

stimledm,

communion:

or

hm,

modiletim

oellulmpemeabilitymybepmdiotod,

Wﬁm

and

We!

withedewof

of wonder flunk into the inter-0011M spaces

vuyingwdmthemmddm'etimofthevasodimion

g g,

19:0). Spiml

pun-Ability

following

W

1953). may cheer-val

no Spinal-Molt

in

mm

(Rabat

m
mm

reports (19%, 19%. 19W, 19%.

memo mndactivity of the tissm

,

~~y-..‘.--~_~~.m-mm-v,

�av“ y."— ww_"v-w.w

.

w

«mum...»- a.

4

W cm van—n: .

Wwmwum

u wI-ww—t'h

wmw—wmew-mw ..-,m.— w --u-- mumps—m mum-PV- Hw'ms a: w :w-n r-

"rm

usociatadwithﬂaappemofvuiwsm (apotmiummd

W)

in the spiral fluid follwing chemically inducad

mm.

Mmdmasimiﬁmthmminsmhm-

electrolytes as madam-acid splitting

cums.

Chang-s

in

alluhrWilitywthmpmviwﬁabasisformhm

demmmmmmmm
ofdnumumeIinirmmdmoermmﬂw
MWIMQGJ.

mmmmmwuwmammm
with the

mid «instruction

of hue mtyldxolim. me punctuation

rammummspimnudmwmmm
aims

any be minted to the

dxolixastuaso-J syntax m
and

Wm,

19%;

mitivity of the mtyldzolinc-

Widen mummy (um

Tm

adﬁcﬁadam, 19%;

Burger: and

martian,
is rapid (3-H mama) but at high» and lunar
1955) . At ”physiologic”

helm-h,

hyckolyais of amtyldxonm

the activity falls off quidcly. In contrast, the

mm,

chainsaw-II-

�«.18..

“mum nhtimMpismn—spociﬁcmdﬁumof

mmmwiﬁzmmim.

mmammmsummmmm

WWWOfac-tyldmmnnmnmm

We

hy

the spadfin activity of

him,

an

massiv-

WW4

mﬁm

in

few

billowing excitation

mmmmdmmlmwmum-I.

The

uhmuthruhuldmhomadndnﬂamimindxmd,with

mmimuwngmﬂnmtoffnomtyldnﬁm.
n»
and

W

murmur: durum 'mpidly,

cellular pambﬂity

and

humming tho

vmmmdwlimm-Ilmw.

alum-II, W

affecting vaswlar

mmtim

of

'nnactivityof

of lowcfﬁcisxwy mt! chpcnding m

ﬂammﬂgmkhnua.mmm1mmm
dominhammdlyatohwhforﬁnphysiohgmmﬁm
of

&lt;21»me .

�“.1.

-.

_. n

"w' .~.

-»~ uv-

r—r-wu.

szﬂ‘”R—vu'w.vw w-W-wt

mm- W-w—mwwswwmwwrrwmxmm’mv-mwmmun-m

zmwm-Wm “W

A.

A.

V.

AW

mmmuWuM¢mmuaumm

_\_A_._V_-__‘__.__~V.A,__

‘-_,__,A__________

05mmc&amp;W.W,
Wad
“WWWW
m
put“
ma Wm“

waning smut-Maya

by

The

{named

the

waywam.

Wade. madam-u

ammmoguagmumauumw WW
‘MMWMAmMWW.
(a)

mymm.

HE‘S

MWintbblmd—bnin

mm
permeability

and Induced

000mm:

bmiwbytheconﬁmm

actimofmtymnmmybaﬁlebiodmimmtmfwﬁn

chphuogm.
_m.mmwuommmmmbymgggy(ms}
pout-electroshod: hypemymsm of

13m

Wmmmmmumormmmm
tummaysamrambfnmdmmm.

mmmmmmimufthismmhm,
ordinarilyabsmtinbnintissmtobemociamdwimm

W

orhyponyndm (delta bursts) in

W.

the electro-

at:

.

�-

Inmofﬁmmhm,whmcmﬁmdﬂn
mpmimnpmﬂthﬂmwhiwwmchcmmuc

Imp-W (Maxim,

1956).

myimamtmt applica-

www.mmaw,mmmm

Wtdﬂunhmmdcslmmaadvityuwnuim
sensitivity to mdiﬂwtim

by

muting. tamer-ventilation

whim‘ vary my in manta: Wow.

The

and

only

memwmmmiupu‘ismmghmumthmmasMupmmmium

W

1‘0le «loam-rm (Fink mm, 1955). m

«land in

diam

{dimofamainptdmtodnvolaphymymhmxymybo

Nahum.

1n

th- activity of annual mtyldxonm

withﬁnmoffmemtyldmlim

mmmmeWMmmm
mamammmemnmmmm.

W

(19‘8“),

inmiz‘ttudyofcz‘iimbml

Tmrmd

trauma.

imlududobumtimofdxpsyctﬂatricpaﬁm underpins

mad“ W.

Ming

the patimts

afar 3~7 mam-ms

u I'vv: WW7
~,--

a'ﬁr‘f

�mwmmtymummutymmspmunudm

mmmsmdmimmmmm-Hmdams
in

“11:33th

with a mammal of the ratio of

WW3

infiveofﬂnuixpatm. mmmWaﬂamﬂnyomclmed

wmspimlﬂuiddminhumdmhimsmm

mmwmmnbmmmmrmmcmy.
wmmpatimtinmududnfdhdmm
dmmmldnnmwacholimummmmalin
thespimlfluid,ﬁuymz“1tisinmtingﬁutﬂﬁa

WmmmlymnofﬂuaixtoﬂIwmmpm-emtm."

Itammwzmwmuuuzm¢m

mamgm,mmmm
mmmWoammu. 1%...qu

umbyupuudAumu. EEGhyme/uom

umo‘mmwumgzmmmmmwxy
at Mumwuqm. Radian muammmmmWMWWWWM‘MMMAM
6:!wa Mu 60W Mad «WM.

��-21-

WanamaeﬂmtthmaSﬂmmrym
1952).
93a].
(Wain

Patimtsinhmuinmltonlmybclmdupm

when
the
in
is
injected
rapidly hydmlyxed;
putientl
mdmlyl
u
uhiln ﬁn Groups VI and VII pctimts but a slow hydrolysis rate.
V. my pndiat, theni‘on, that tha bleed dulimatem activity

huhofWI-lemﬂdbohiﬂu mihﬂnaotivityof

WAdlihrunlysiouyboudumaxdingmtnlm
VI

-

VII walla be 1m.

mmmhofdwmmm-Iinﬁummtofm

Wynclumy

and

spinal ﬂuid

hwls of amtyldnlim.

Instadiosofﬁﬁﬂdumgu followingixducudmnvulsim
subject-wan idlntifiodinmmafwsoimmultedin
a mat mat of now an. activity; while othox- subjacts mind

mammmymmMu-Muim

(Pinkmdm,

1956).

IfWWionntbctimofmd
Inbjommuintainhypcnynm
in:

mm,
inwmitdiupp-m

them

did
mpidlynybccadﬁbitingdiffgmnccs

in th- kimtim of the dwiimntm-mtylmolim hydrolysis

mm. Panhtcnthypcnyndmyuymultfmamd
Mcofhydmlysinotmtyldwlim. mociatcdwithlow
I

mutation of cithcr choline-tumult or mummy-II .

(W13,

in

aheﬁrutcm-I
In

many

paints
and «II

high).

with

m—livod hypnmyndmmny.

in tissue and spinal fluid any

Thus

thou mutations provide

�.

..‘-.,—r

&gt;17

,...v v“

»

,

may .1

~w

~

v....&lt;~u-.~,nz‘y«.r.-~, w‘wrr'

,.

~_»w—-w-y-

ash-:1"

~

want »-.1N" vmn

www-z-‘w BMW-“‘1‘;- n ~wm~wvv

qu-w-m-w-

wrumrwS—V-‘a

W-xmp‘rvww

.22...

amumamhmnmmmmm
reactivity to

W
syntax:

em,

and

to poripmm dwlimrgic

WON:

mmmmmmawmt

_1’minﬁn mmiwﬁmupypmu.

1119me

whimdmiﬂmomtimdmmmm

Wummmmmmnmmmw
MhWMmbodntmyodbydmlimmI
nativity.

Vuodilatimaﬂimuodmllulupmbﬂityis

follmdbyimuodmxtsof diam-II, strut-am
and electrolytes

in int-”114mm ﬂuids.

-

"r' :1

Wyn-mu

wr “unawa- "I“

�mwmminmmdumm

mmmnmamswom.mwmm
Mmeiduﬁuminbiodmicalnﬂiwwhidz
alters cerebral «11.qu activities sufficient to Alter the

1m

behavior of subjects. Failure to

mountmim
electrolyte

dim.

of acetylebalimi lid

W,

high md pmismm:

{aim

to

1m

tht

results in a failun to produce behavioral

”mummuofdowlmntofmw

reflect differences in th-

63ch

of subjects «1 dour-remit:

admin”, or in their sensitivity to changes in acetylemlinc
lawn.
tim of

M
tho

diffcmm

ﬁnally in

W

by

Mountain

These observations provide a

the

mode

the Win for the classificaand by Pink and Kuhn (1960).

rational biochemical basis for

of action of induced convulsions in altering the behavior

of psychotic subjects. These views are consistent with the

more

general neurophysiologic—adaptive theory expressed earlier (Fink, 1957).

�IFn-&gt;"'v'—-'—vnu—w— w—r—v-r—u ”ﬁt—W‘- ".9.

‘- -.

u

»

V

.

WWII-.11“:

CI-DUINEIBIC

.

,

nv—

rm

mw-

WIN,
WWOR

Wmvw—qmvmmpwmw'm x.xm~.;w~ww-ww mum—w".

CONWLSIVB

AND

13%”,

Stalin of cerebral changes accounted with

(Pink and Kain, 1956).

convulsive trump}!

In these studies, electroencephalographic

slowing was the most siyzificant index of altered brain function.
The

dematmticn that premedicetim with

prevented the appearmce of slow
1956) suggested a

wave

high doses of atropine

activity (Ulett

relatim to ctnlimrgic meﬁiims.

and Johnson,
The

role of

acetylcholine and the dmlineatemaes in convulsive therapy is

mlified

in the following review

which summizes the published

am.
The

role of acetylcmline in the tmsmissicn of nervous

imulsea has been studied extensively since the first descriptions
of Dale (1914) and

Loewi (1921).

Acetylcholine

is a normal

which
form
bamd
is
in
a
tissue
existing
of
neurons
cmstituent

�.,, ~21-

'

-

"~va

":murmmrnur-v— «m

.

Ernie-'4

‘

,.

v

“War

W'r’W-erd

-

4wr‘; Wr' .w-nv 1'5“”uH-I'J.

.1m- ,.w;uwv‘.m,w.‘.

liberated mixing the excitation process.

It is

“m ...Y.,_.,. F“. -v-v—.ﬂ,

,.

.

t

.. 7 m" ,..,nvrv.w._,,m_1w V,.w.,‘.,.,.,,v

rapidly hydrolyzed

thrmgh the specific action of eholinestemee and as rapidly

reconstituted by the momﬁiaeetylase system (Richter
19“ 9) .

No

a

Croeslmd,

free ac}tylctoline has been reported in normal

mmbnospinal

fwd despite ﬂu rapid bmakdom of

bound acetyl—

eholine during perioa of activity and excitement (Tower and
McEechem, 19u9e).

The

oembmpinal fluid normally has measurable

cholinesterese activity, however, principally of the "true" or
mcholyl hydmlyzing type (Neelmensm and Rothenberg,

19115).

In the absence of free acetylcholine and under the conditions
described, electroenceprnlogxms

fail te

show any

consistent

ehxornality.
(a) Effect of Cranioeerebml Them: Free acetyleholine
was found

in the cambroepinel fluid within a few minutes after

experimental head trauma in cats and persisted for varying periods
up

to

#8 hours

(Bomstein 19%). The quantity of free aeetylcholine

varied between 2.7 and 9.0

gamma

related to degree of induced

percent, md the ammt was

tram.

N" ._.,

,

.

V.‘

,..

.

�F‘s—“ﬂ

4

w

.iv-IJ'n-urr'wlv'i-

\I'-w-v|n"r" ».v 21‘.- .IN w— rh-

W

Th! records were

u.

.

-

~~w~mvww. a?“

: aux-rum W...“ m“-

-

‘vv‘

w—a—E.ww~r_~w um... g‘vi- wn-rv-w mun»

r: 1-

K—‘Irw' «a...»

,.

w...

w” ‘quw u,- 1,- \w

electroencephalogms demonstrated pattern-d changes.

first filled with high
an

voltage fast activity,

intense neuronal discharge, only to

all

short period of flattening of

electrical activity. mesa

recorded

phases were men followed by prolonged

periods of high amplitude sharp waves in the delta frequencies.
The

to the

behavioral

wt

mrﬁzlated 13%:ng
of
clmges

trauma and

of seasoned free eoetylcholine. With higher levels

of eontyloholine, Bernstein reported greater degrees of
abnormality and greater charges in cmscicusmss.

spmtanecus

.

-3-

interpreted as evidence of
be followed by a

-~

post-tmmtic seizms

were also

EEG

In additim.

related to the

want

of free acetylcholine appearing in the spinal fluid.
Bernstein $31- applied

aoetylcholine to exposed cat cerebral

cortex. men the concentration of acetyloholixm was

or less, he observed high mlitude sharp
the electroencephalogram.

When

waves

1

gm

percent

of low frequency in

the concentration

was

increased to

�--

&lt;vw'x' &gt;1:-

2

'.‘W',WWV\Wmm/'FP a». an

gm

.

W

v- .n ‘n'uv

7

~m—w-w..».

v

m... .vvc'wTV-t or v'.‘.wwuwxnn_r'~u—l’v»wy wrv-suw‘ mw~wwn~w~mnpmmm .- »— -nnmmw—rr-muwawu nvre --u w

percent, the electmenoephalogm flattened in a fashion

parallel to the post-tramtic meant.

11.1% stndies

wemWin neurological patients by

Tour and Hohdmm (19am). Free aoatyloholine
the oumbmspinal fluid only in

mam,
The

1.: patients

was found

in

with recent head

mount grand-ml seizures or after omvulsive therapy.

free acetyloholinc varied from 0.2 to

Tower and HoEachem

of the spinal fluid.

100

gm percent.

also assayed the molimsterase activity
They noted a sharp

rise in the nonspecific

cholinesterase fraction (benzoyloholine-splitting) and a drop
in the specific cholinesteme

fmtim

both in patients with head .trmma
convulsive therapy.

amd

'me oembroSpinal

(moholyl—splitting)

in those following

fluid following spontaneous

seizures containing free aoetylcholine did not exhibit such
inversion.

3-2:. and-II:

concluded that the level of free

aoetylcholino varies directly with the dogma of cerebral damage

-

�that the reversal of the cholinestemse fraction
sensitive indicator of cerebral (image.

and

was

a more

Electroencephalogrem, taken at varying intervals following

mum in

most of these subjects, indicated a

degree of

EEG

relation

between the

abnormality and the appearance of free acetylcholine in

the cerebrospinal fluid.

‘hecstmﬁu

Watt. an to. mom 0‘

(no. aaetzﬂdwdne

m1

incuae in #:24me {Md 4011ng Macadam tum

and

me

a «wad: lactation my

mwowa,
duomug,
(b)

«in.

degm

and dumgo

Effect of

anathema“ ﬁe

and type as

in

Am

mount

05

ﬁne

demamcmuagmic

dialed bdrawloa.

on

ﬁb-traunatic

EEG

and Behavior:

Bernstein aministered 0.5-1.0 lag/kg atropine parentually after
head tram and denmstmted bloating of the EEG, behavioral and
homologies signs of

clinical

tram.

changes occurring

Similar

EEG

and

after the experimental addition of

intruciaternal aoetylcholine

were

also blocked

by

atropine.

�w. --r.-~r-v—~--ww- w-Im-vmm

'mm' "-W‘mmv'm"

Ward (1980)

'memnmw

applied tmse observations to the

hum cases of closed
dogmas of

tram,

head injury.

In

tremnt of

patients with varying

20

he aaninistamd atropine

subcutmzsly in

doses

immt

in

of 0.1 rug/kg. In saw‘oam he noted clinical

and

others a reversal of the eloctromoephalogmphic effects of the

tmma. In a study of

.1er

and

War

diethﬁf’ mother mtidmlimrgic drug,

(1955) reported

sigmificmt alterations in

the post-tmmtic elactmmoephalogm.
dose

in

1&amp;0

patients with

in normalizing in
The same

slow wave

22

A

single

1:1th

ahmal electroencephalogram

subjects

land marked

«act of atropine in

inmt

msul’cad

in six others.

blocking the appearance of

activity wm reported in subjects follwing convulsive

therapy (Ulett

and Johnson, 1956).. (In a

later study thé‘authors

failed to mplicate this study, suggesting that

dosage

factors

or population mass” may have omtributed to the different results

[Jdmm 559;,

19603).

M...

�8:
These obeervatiom provided the basis

for a series of studies

with other Imam mtidlolinemic ooepomde (Pink, 1958, 1960).

The

intuvenom injection of experimental patent antidmolinergic «mantis
es diethezim.

(Dim).

Maine,

the pipeddylbemiletes, Jana, J8336, and

pmoyclidine were shown to induce EEG
illusions
deeynotmiutim and behavioral alerting, mxiety.

J8329

WIN

2299 end

md helluoinetiom in nm—ehotmehodc subjects; and e reduction

in

allow

new ectivity associated with e mvemal of the

Wm;

euphoria, dmiel ma omfmion in these with prior meant induced

omvﬂsiom.
In these studies, atropine was also emineddn low doses,

EEG

desynohrmizetion was observed, eoooepmied by considerable peripheral

tachycardia, mmaenese and tension. At higher dosages, oonfmion
and

disorientation

min!

hypemyndzmm slow

a mduction

waves and

of-hmmiutiea

their replacement

by lower

voltage.

poorly organized delta activity with superimposed beta activity. .

�~.

.

a" ~~_,—vn~m«~p.-~W»

A

q

”We,"

W.

_

,_. 1..“

.,

,.

w."

.-—...n-r..

t ,,

.

u

,t.

.(

m...w-,V -—..~— _\|=V-\w:w.~a ~FVJH-ﬁ'u—p‘muwt

»‘wb‘wﬂ-

7.;r._‘,.,v,wr _ﬁuv;a_n.‘--,,.p‘m .w-wunw...

\

.,.—_,.....~

variety of experiments with a potent duolinesteme inhibitor,

D}? (di—isopmpyl

frequency

EEG

fluorophosphate) denmstmted high amplitude rapid

patterns similar to status epilepticus, as well as

lesser degrees of abnormality similar to that noted in post-tnunatic
states (Munich 333;,
1950).

1950; Pmdman 3331., 19:49; md Hampson 93.51,.

These electroencephalographic

doses of

effects were blocked

pumteml atropine. Chetfield md

Dempsey

by small

(19%) prepared

exposed mimal cortex with pmtigmine and evoked electroencephalo-

graphic spike activity. 'lha prior
blocked this spiking, or

ministration of atropine

if present,

the abnomality could be

eliminated by atropine.
In

contmt to these findings,

Brenner md Merritt (19%),

applied topical aoatylcholine in cmcmtmtiom of 2-1/2 to

to the

exposed cortex of

cats,

and noted no

10%

effect after intravenous

atropine (1 rig/kg) on the electmmcephelogmphic changes. The

montratims of

acetylcholine in these experinmts , hmever,

was

significmtly higher than the topical applicatims (1-4 game percent)

new v” rm— ‘7“ .wv-u-

�and the

intmcisteml

(0.2-10

gamma

percent) injections of

Bernstein (191.6). Bmmer and hmzitt, also made note of electroencephalogmphio effects similar to soatylduoline from macholyl

(aoetylbetmthuldsolinefmd Meryl (wbaxyldloline) in oonosntmtims
moh lower thm the aoetylcholine cmomtmtims.

inmd

They

ascribed the

effectiveness of those oholinergic drug to their lack of

sensitivity to oembml dualinsstemses.

FM a waist;
conduct: that

and

MAW“

Wencapdz Logaaﬁtic activity

Mu a a “nu
mu!

upwwtaz

06

as

deans tome.

Manama

agent

induced by acwjzdwu'm,

appuc'mon'og
Mam, topical

be.
backed
can
it
was;

a

(Lt/topaz,

we may

on.

Magma

Wand

by

humans, as.

(c) Carebmsginal Fluid Amylcholine md Seizures:
Aostyld'xolino

bomd form.

is nomally present in mrvous tissues in

an inactive

wring periods of activity, free acetylcholine is

�.

;

.m,

.

.. ..., ,

m .. .ﬂzwuwﬂurww—w 1....

y ..‘

,

v

".4

.4

..

J, vV—I-N‘r W.
.

.

._...

dwlimstorase.

The

v—-

"’W\‘,a(')~\ro" &gt;m»":qnaArv-n3l.!' 'r ~w.'vu.* '4.-:--wr~vr g~u~wr~a~~u~w&gt; www.1-v-u

mm it is

libemted at the cell madame,
by

K." w-

level of

“mum

rapidly deactivated

bound aoetyloholine

is thus

the resultant of the prooosses of synthesis, liberation and

It

breakdom.

may be

rise during shop

and

pootulatod, therafom, that the level will

fall

during activity. lhis hypothesis was

support“ in animal emunants
and

Elliott,

by Richter md Cmasland (19%)

Swank and Henderson

(1950).

By

using liquid

air

quick-frosting mthods, Richter and Crosslmd observed the

mtl'nsia and sleep

gm

per

levels.

mg.

The

level of aoatylcholim (masumd as

brain tissua) to be

300$

higher than poet seizure

difference in tissue levels is transient, however,

as the “synthesis rate for aootyloholinc in
(7

mimo—

mulmlﬁnute). Elliott gt 5;,

mt brain is high

(1950) omfimnd these

oheowatims. After- mtmzole oonwlsiom, they also noted

that free mtylcholine

was always

fluid in concentrations

up

to

3

domtmble in the spinal

gm

per cent.

v

-.~~v~

,

.

.-

�-

.... nut, v-wwgg—w mauw-Vr‘ u-~0'iv-a—. n...

mg.

._, -:Jpag-.'~vw1 4mv..l.‘N'-rv-~Vr‘-\ ﬁrm—um

r“ nmww-r w WM-

"—

w—rw"

.“ - -wmv~—-w--m.. -v.‘

F»; "-v-q

.~

www-rwt:.v—.m.-v

.10In spinal fluid studies in man, Cbne, waer and
(lSMB) and

waer

and McEachern (laugh) reported

McEanhern

significant

quantities of fro. acntyldholine in patients with epilepsy. 0f
56

apilnptic patients,

an (77%) dnmnnstrated measurable

acetylcholins in quantities of 0.02 to 5.0
«warns»

of 1.0

gamma

per cunt.

The

gamma

free

per cent with an

acntylcholine level was

directly related to the frequancy of seizures, the extent of
olnctronnccphalogruphic abnonunlity, and the relation of the
time of sampling to the

last seizure. It

home no

relation to

mndicatian, type of epilepsy or level of cholinesteruse activity.
Whethcr&gt;tho acutyldholino appearing

in the spinal fluid is

a byiproduet of the convulsion or whother the increase in acetyldholine

is a

Wu!!!

cause

is
of the seizure
prublamatical.

(1939b) suggested

Tower and

that the increased wetyloholine

liberation in not due to the seizura itself but is related to
the procnss causing the seizuma. In a study of the hypothesis that

�11

the acommlstim of acetylcholine

is basic to the seizure process,

Tonia (1953) induced convulsions in animals by mtmzolc and

dotsmined the level of acatyloholine in brain tissue before and
during comulsions.

She noted

that convulsions are pmcsded

a rise in the acetyldmolim contsnt of tissue;

Wily

falls during the cmvulsion;

levels, cmvulsims failed to occur.

and

an that

the content

that bolas curtain

She suggested

in tissue acotylctmline during a omwlsicn

by

was due

that the fall

to inhibition of

aootyloholins synthesis by increase! concentrations of metabolites
such as

In.

mim
Likely

ions.

#:215de m mmwbg

mm

{m

mam;

ohm

«:3;qu

an

wanted (m it

inmate in
bound

tat t3 isms my be inﬂected in sum 5%;
ands

wanes

«wanna:

do

5m,

and

that cumbmt

auction, taming

and
Leap
nhuu
an to in augment
Minoan;

tin no. touch

as

“mum“

pmduoaon imam ing “A as touch .

�v......,.,.w.,. ., 7.“..-

www. min-w: .~-.Twr-r.~a y: m

nvmw-m

...v

'Nwwmu‘agnar'

"n T“.1.,1~V;’§mm- ,M m...,

.

.u..." .“WWFV . m: or..‘m--.w-,.-W,‘_..&lt; WW. m.ﬁwl...

.V

w‘~...oww»..wm-_v

m_w,ﬁ WWW-A“

.12.
central nervous slaten Cholineetoraaeez Concomitant
with their observations or change: in ooetyioholine, Tower
(d)

fluid oholinoateraae

end noanhern (1949) mnaeured epinel

activity.

Two

types or oholinoetorenoe ere normally found

in the epinnl fluid:

oholinoetereee—I

('true," "specific,” or

neoholyl hydrolysing), whioh has e high specificity for

aoetyloholine:

til

oholineetereee—II ('peeudo.””non~epeoitio,”

or bensoylcholineohydrolyging).

Both compounds hydrolyze

eoetyioholine but have dirforont rate: of hydrolyeie for
This

meoholyi and tensoyoholine.

qualitative dietinotione.

activity as

a

By

differential rate permit:

reporting the oholinootoraee

ratio of the nativity

with meohdvl end with

bonzoyioholine outstrnten compared to an noetyloholine lubetrete
two

ratios are

round:

oholineeteresoai/aoetyicholine and

cholineoterooo-II/aootyioholine (with
retﬂoa

Initials!

norMul 08F

th/th:

100). In such

contains eeteroeeo in the ratio

of 53.17 for oholineatoreno-I to oholineotoroee-II. Thus. normal
08?

consist:

, ,»-.-

.-

�_.w.W—-« “mu-wow. arr-u-

ﬁmwmmm

"WW?“ me-‘Ww‘wmvjrimwmmrm

)5

s:
mainly of "specific"

estomes with a small mn~specific ostemse

want.
In patients with head

tram

Tower and McEnchem

report and

inversim of the dualinestsmos with a simificant increase in tbs
daolhnsts'mse-II fraction of the spinal ﬂuid

dualimstems-I activity.

They

and a

«mass

in

also observed a relation batman

the extant of the momentous” manual with the severity of

trans

and with the dogma of the olcctmmceprmlompie

In patients with

5.an

spinal fluid acetyldzoline as a

result of spmtmom saizms. howswr.
of cholincstsmss or total

Why.

no change

in the ratio

duelinsstss-ase activity was found.

Certain usunptions my be mad. mgmding changes in cell

mm

psmability

as explaining the humans in duelinsstcmse

contamination
in
found
in
highest
is
Gaolinsstcmse-I
activity.

the

antral mm systm mile molinestemse-II

in atlas:- tissues, especially blood sewn.

pmdminates

With an increase

in

�,7.

,.~.n_..._..‘..,.q—. 7.

v

.

...,~ “NW...

.

«g..- Wv-slv'n-nrrh

w-rw-muwwwmmmwwvaWmn-mmmmmv‘wvwrvhmv w -w~'r
v-

acutyloholim levels in interoellular cerebral fluids following
stimulation, convulsions or trauma, vaaodilatim md increased

cellular pomability

may be

pmdiotad, with a degree of

transudatim of vascular fluids into the inter cellular Spaces
dependant on the extent and duration of tha vmodilation (Kabat
33:.

9;, 19%). Spiegal

and SpiogebAdolf dummtmted such

pamability ohmgas in nmorma "ports
1953).

Thay

reported

inmmd

(19141.

19%, 198%,

19148,

oomhzctivity of the tissues

associated with tho
appearance of various ions as potassium and
phosphate in the spinal fluid following

convulsions.

more

was

also a significant

as
nucleic-acid
nm-clactmlytes

cellular pamability

mtmims

electrically inmoed

may

imam

in such

splitting mzyms. Chases in

thus provide the basis for the high

of acetyldxolino and the managed omoantmtions

of dwlinostorasaJIﬂTmr and Hoanhem muse) .

'5

�—

m‘ w «'7'- M-mrwrvva-mmmw.mw m

The

increase in ammnstcme activity should be associated

with the rapid

«stamina of free mtylcholim. Its persistence

in spinal fluid

afar tram ad 931m

related to the sensitivity

may be

mtmim

of the amtyldwlim—dmﬂmstm-I system to
ships

5mm

(mam

md Rathmbarg,

and lowar

Midtown

Mauritius,

ad

mo

mnemtmtims,

tha nativity falls off quickly. In contact,

of hydrolysis

mm

minimip

«sciatica

mm

who

in

few

isdestroyedbythe

udlliuomds.

where

bmoentmtim of mtyldwlim in

tiasun. tbs mm of hydrolysis by dwlixnstome-I is

W.
com.

m

WWW—I

to an

is nut—specific

with concentration. Thus, the

mlhwnbfmtyldxonmatmnmbm
specific activity of

Wm,

19kg;

is mpid (3-3 mimeoonds) but at higher

th- dnlimanmc—II-m‘tylcholino
the

m

and

At "physiologc"

and HacIntoah, 1955).

hydrolysis of

19445;

mktim~

mmmMMMmybemadndmdaseizm
me disaoaiatim in

ship nouns in a

pemiatm

amtylmoummﬁneamml relationof

mldwline.

The

seizure

may

�16

itself in

add

wt

to the

of free acetyloholine. 'lhe increased

mtylctnlim diffuses rapidly, affecting vascular and cellular permeability
and increasing the cmocntmticns of various ions and dmolincstemse—II

(SF.

activity of cholinsstemsc—II, though of

The

on the concentration

runs to

days

to

efficiency and dependant

kinetics, reduces the acetylcholine in the tissues in

in! levels

mm”

1c»:

for the physiologic action of cholinescemse-I.

#:1st
am Manuela manta 5M, «may 5m
«ppm in

{Add

dowsmaa

someway in.

«was

{on

mm

05

ma past

a a gestation
dzangm

“mad Mwouﬂne.

Mme. madman; om «toned by
(named

in

06 «he

:1ij

(ﬂ

05

in

cut

'hc

mechanism

mun-um at sou moms

nausea;

system sanctioning.

(c) Agglchclinc a

EEG

WNW

and Induced Convulsicns:

Altamtion in the blood brain permeability barrier by the continuing
action of acotyloholine

may

be the biochemical substrate

for the post-

olectmsbock hypemynchrmy of the electroencephalogram. Such a possibility

is oviduct in the upon
an increase
days

by Aird 93

9_1_,

1956,

W

denmstmting

in the cmocntmtion of cocaine in brain tissues three

afar a series

of

12 induood

convulsions. His data shows the change in

�-17concentration of this large molecule, ordinarily absent
in brein tissue to be seeocieted with the eppearence of
hypereynchrony (delts'burets) in the electroencephalogren.

In studies of induced convulsions.

we

have confirmed

the neny previous reports that convulsive therapy induces

electrcgrephic hypersynchrony (Pink and
a constant

Kuhn, 1956).

Despite

time
the
or
however,
or
treetncnts.
epplicetion

slow
the
and
of
extent
electrosrsphic
duration
eppearence.
wave activity; its sensitivity to modification by alerting,

hyperventilation and barbiturates

psychiatric populations.
degree hypersynchrcny. end

The

-

s11 vary greatly in

early appearsnce of high

its persistence

throughout the

treatment course, hes been described as prerequisite to
improvement following electroshock (Pink and Kuhn, 1956).
The

failure of certain patients to develcp hypersynchrony

may be

relatedto differences in activity of central

seetylehcline and cholineeteraees.
may

reflect

The degree

of hypereynchrcny

the level of tree ecetylchcline and should follow

s decay rate eqael to the

rate of ccetylcholine destruction.

�vuzvnc—v-w: —.

Since previous studies demonstrated thnt
ens prerequisite to the

it

may be

EEG

hypersynchrony

clinical response in convulsive therapy,

suggested that the absence of free soetylcholine

suggests minimal changes in cerebral function and thus

precludes s clinicsl response to induced convulsions.Touer snd

their study of creniocerebrsl trauma,

hoEedhern (1949s), in

included observstions of six psychistric pstients undergoing
convulsive therspy.

Studying the pstients

after 3.7 trestu

meats. they reported free soetylcholine activity in the

spinal fluid in ten pstients; and en increase in cholinestersse-II
and a decrease in cholinestersse~l with a reversal of the

ratio or cholinestersses in five of the six patients.

From

these observations they concluded that the spinsl fluid changes

in induced convulsions were more like those of creniooerebral
trsume than those found

Regsrding the one
show

in. ilepsyu

pstient in the series

who

thiled to

either free ocetylcholine or e cholinesterese ratio

reverssl in the spinal fluid, they wrote:
that this patient

was the only one

"It is interesting

of the six to

show no

_.,.

�7‘

response to treatment."

It is

I

probably that induced convulsions increase free acetylcholine

and
enhancing
cerebral
perniability
altering
fluids.
in intereellular

the appearance of cholinesterases. Free acetylcholine
by
JMAco

repeated seizures.

EEG

hypersynchrony

is

one

is maintained

reflection of altered

of
other
electrolytes.
and
altered
permiebility
of
acetylcholine
levels

It is

these changes in intercellulor electrolytes that provide

behavioral
changes
the
for
substrate
biochemical
persistent
the
following induced convulsions.

L/

(f)

Cholineatersaes and the Classification of Pezchoses:

These studies may also have

autonomic

reactivity

and the

Funkenstein and others

(

application to the problem of

classification of the psychoses.
)

have demonstrated a

relationship between the blood pressure response of patients

-“.:')l\w

-

w—w

- Fry-w M7.“

�rm, w.»

v—v-v-

ya—_ -7. -.

v'*a‘

1——.r

an ad“): ,

v-u

n.7,. y

~.

7'

V

..

- r—*yx:'\r‘~'7—‘ —..vwr

rhw- revues—WWI: a-m-x)

v aw. 'IIMIN'.WP1L _,.. wr—Mrn 'w .n-u- u ...-

nun-mun—u-wwwsrx—

I‘d 'fllr-nr-F-qlf r".:'m~

— - —» ~

to injected meoholyl and their clinical response to
convulsive therapy.
which induce!

Neoholyl

is

e potent oholinergie agent

Vlsodiletion, tachycardia, sweating, and

It is

inoreesed peristelsis.

rapidly hydrolysed by

cholinesterese-I and slowly by eholinestsrese-II.
blood pressure or subjects

tells etter injected

The

meeholyl

end returns to the baseline in a variable length of time,

2‘2;, five to

pressure returns to the hgaeline in
as Groups

Pstients

more than an minutes.

I. II,

or

III reactions:

5

whose blood

minutes ere olessitied

those whose blood pressure

takes so or more minutes to return to baseline, as Group
and VIII reactions. The Group I reactors here s 9%
improvement

reactors s

rate with convulsive therepy, and the

35%

recovery

rate. In contrast, the

reactors heve s

89%

(Punkenstein 35

3;, 1952).

petients In

whom

IInIII

Group VI

and the Group VII 3 9'71 recovery

Patients in Funkenstein Groups I to III
upon as

Group

VI

may be

rate

looked

the injected meeholyl 1s rqpidly

~

�.

. ”(Inni- rwlv‘v -.

v

-hr ~r. ‘r

Wﬂm‘r;vz.z

~~w~

‘

vmvrmm-mwvnvmwurr
.

.

.

.
-.n-

.

~v-cv rwwmvrrw-r ’Hm
.
,
.
warm-n'ku-w—w-vwvu-r‘mwm
’W'I-W‘WW
.

,

.,

.

‘23..
Groups
VII
v1
and
the
while
hydrolyzed;

slow hydrolysis

rste.

we may

patients

have

a.

the
therefore.
that
predict,

would
1.1!!
Groups
of
blood oholinestersse nativity levels

be high; while the setivity of Groups
A

VI-u-VII

would be low.

central
odds
nervous
be
rsgsrding
similsr analysis msy

devsIOpeent
of
the
in
system levels or oholinsstersse~l

EEG

of
soetyloholine.
levels
and
fluid
spinal
hypersyndhrony
In studies of

EEG

changes following indueed eonvulsions

resolted
in
seizures

subjects were identified in

whom a few

a great amount or slow save

activity; while other subjects

(Pink
seizures
and
to
frequent
exhibited few changes to many
and Kuhn. 1956).

If

electrogrsphio hypersynehrony is s

that
probable
is
refleetion of inoressed tree soetyloholine, it
subjeets

who

rapidly (the

usintain hypersynehrony end those in

whom

it

differences
be
exhibiting
hours) disappears nsy

hydrolysis
oholinestsrsseoseetyloholine
the
of
in the kinetics
systems. Persistent

hypersynehreny may be seen to

result

from

associated
of
soetyloholins.
s decreased rate of hydrolysis
with low

or
oholinestersse-I
either
oonomntrstions of

z

-

w

mv as ‘—
e

�nw—w—uurw—u-A

~

«wv-u . "Hp; v-r w: w-ws-u—mxw

—»

al’im'rw‘imﬂl'wnnmmﬁ.rww-‘wmm'

cholinesterasemII.

Conversely, in patients with

hyperaynchrony. cholinestoruaoul and

fluid

may be

a basin fbr
:yutom
1110111

:

unusually high).

wwwvvnwa &gt;vv'wwa-uww «VII-MWI—w-W

short~IIth

.1: in tissue

and spinal

Thus these speculations providn

congruent hypothesis rognrdlng central norvnua

ruaativity to electroshock, and parephoral ahelinergio

09‘.

�‘‘

r—

v»

-v «'1: -w:. .

~v~wr 1.». —.vn.~n—u

nvw .w is w,“ .
V

m

.,._v

you-um: v...“ .uw m...” w.
i.
(“Hwy
.

,

.

V

.

v—wr\wl~;r‘-V‘va"vwg

.

7-..,emu.,_,._c w‘,_pwmi,,”.w.'w.ww

rtr‘

.,

1”,.“

M

y

OOHGLUSIONI

be
to
e
neehsnisns
appear
Gentrel eholinergie
The
convulsive
the
therspy process.
dignifiesnt teeter in

induced
that
to
indioste
be
date
interpreted
any
published
Leonvulsione ere

ssseeisted with en increase in intereelluler

be
by
destroyed
than
esn
to
levels
greeter
seetyleholine

eholinestersseal activity. Vhsodilstion and increased

oellulsr pernisbility is relieved

by increased amounts of

eholineetsreeeoII, other

and electrolytes in

inter-

celluler fluids.

It is

these changes that ere reflected in the increased

electrical hypersynehreny

which

is recorded in scalp electrodes,

and which esn be modified by sntieholinergie drugs. as stropine,

beneotysine, dietheeine, proeyelidine, etc.

It

in these changes. else. thst provide the change in

biochemical milieu which

to

slter

alters cellular ectivities eufﬂ.eient

the behsvior of subjects.

Fhilure to induce high

and
failure
of
aoetyicholine,
concentrations
and persistent

(

. . 'W—vnww

�-

—-——--p~rm- ,v-vln’ .-. ‘w-m-w --v&lt;

w u-wv

«m

”uru-ewmmw‘ vat—rm,“

W'WV

-.

-

.

wwwm

mmnmnuw—wm

"wrrm,w—

"-1. Wm,

chengpe,
concomitant
results in a failure
to induce
electrolyte

to produce behavioral change.
Difference: in the rate 0! development of cerebral
chengee may
on

reflect differences in subjects in their reliance

cholinergic mechaniene, or in their sensitivity to changes

in acetylcholine levele. These differences provide the basic

fer the claeeificcticn cf the menilly
by

my: and

Kuhn

(1960).

111 by Funkenetein and

�.4

w

. .._u~mv —

\w"wxww

~

wlxmw-mwmmwwrlmmrrw

IV: 6-6-65

CI‘DIINEmIC

WISE,

CWVULSIVE
AND BBMVIOR

W,

Studies of cerebral changes associated with convulsive therapy
have indicated

that the development of early

and

persistent signs

of altered coronal fmctim are prerequisite to oranges in behavior
(Pink and Kern, 1956).

In these studies, electroencephalographic

slowing was the most sigmificent index of altered brain function.

Th demonstratim that premedication with high doses of atropine
and
Johnson,
(Ulett
slow
of
mve
the
activity
prevented
appearance
1956) suggested a

relation to cholinergio nechnisms.

The

role of

eoetylcholine and ﬂu cholinestemses in convulsive therapy is
amplified in the following review which

smrizes

the published

data.
The

mle of acetylcholine in the tmsmis sion of nervous

impulses has been studies extensively since the

of

Dale (19136) and Loewi (1921).

Acetylcholine

constituent of nervous tissue existing in a

first descriptions
is

bound

.21

normal

fans which

is

�. -~»-.-

cwlwx—Wm.m~mn mmmvwvx 'w'w-m‘ w'dnuev—Wn —-'-v.":'-v-yvl~&lt;-wmv -‘-w'-W"’mnrm"u'm’mmp '«ai-lu'vwv'w»; umpnw-so

w-wm'n

It is

liberated driving the excitatim process.

W

the specific action of ctnlimstemse and as rapidly

recmstituted
19:59).

mpidly hydrolyzed

by the

dwlimacetylase system (Richter

8

Welland,

free ac etylcmline has been reported in normal

No

cemhmspinal ﬂuid despite the rapid breakdom of bound acetyl—
choline during pariah of activity and excitement (Tower and
HcEechem, muse).

The

cembmspinel fluid normlly has resemble

chclinesteme activity, homver, principally of the "true" or
mechclyl hydrolyzing type (Nectmensm and Rcthmberg, 19u5).

In the absence of free acetyldxoline and under the cmditims
described, electroencephalogram

fail to

shm: any

mietent

abmmelity.
(1:)

was fmmd

Effect of Wiccambml

Mm:

Pme acetyldioline

in the cerebrmpirml fluid within a

experimtel

heed

tram

varied between 2.7 and 9.0

dew

after

in cats and persisted for varying periods

(Bernstein
19%).
an
hours
to
m

related to

few minutes

gamma

The

qumtity of free acetylchclim

percent, and the amount was

of induced trmrne.

-n way-a

---1-m'— «mu-w v;-

�v

‘

.v-vuwv—‘uwuwaI—r'm

mm

‘lh'une‘

“an”,

.

-

1W um van-mar ammw— mmmx($—‘Wv~ ~-;Www Ww-v' .wma a..- ‘nv‘w I'u

Commitmt electmemephalogme

Th records

were

first filhd with

mmted patterned dwxges.

high voltage fast activity,

interpreted as evidmoe of m intense manual disclmze, mly to

befollmdbyasrwrtperiodofﬂettmingofallmcomed
electrical activity.

'Ihese planes were then followed by pmlmged

periods of high amplitude sharp waves in the delta frequencies.
The

to the

beheviml enemas

were

mutant of measured fme

related to degree of

acetylcmlim.

tram and

With higmer

greater
of acetylcholine, Bernstein reported
degrees of
abnormality and greater- changes in

moiwmss.

levels

EEG

In addition,

spmtaneous poct~tmunatic seizures were also related to the

mt

of free eontylcholine appearing in the spinal fluid.
aoetylcholine
Bunstein later applied
to expomd out cerebral
cortex. mm the

cmmtmtim of acetyldaoline

was 1

gm

pement

orless, Mowemdhimmlitude sharpwavesoflwfmquencyin
the electmenoephalm.

When

the concentration

was

inmd to

w...

wal‘r-vunu

.,.. u

��min-u

.41.

-

v...

and

:—

»

-1~——

“Va-x v,m..,».«n—n ww'Al'wr‘w'nx‘xa'r ..

”-p- vwrn

'iwrylvv.-ws“ «ﬁrm-mu». tr'r'r—I‘lumm$1~I'm’w-VWW-Iv‘rn'wwu .~

that the reversal of the dwlinestemse fractim

sensitive indicator of cerebral

BMW
tram

Jag-Anny... ”a.“ r‘np‘woyppﬂ" v—y- x w— v—w-1,msw»: v.

was

a more

damage.

were takan

at varying intervals following

in most of these subjects. me authors reported the relation

homunmofﬁmahmmntymdtheappeammoffrm
mtyldwlim in the w‘bmspinal fluid.
Thu:

AW

my

We

and

that a

«the

mount

05

(m acdytcholxiuc

5mm summing Weenebmdtﬂawm

batman the mount 05
mayuuz
Won
W

Memory,

main

wind

In the

Micheline,

(1))

M

indicate

m

dcgm

and changes

Effect of

and typc 05

in

AM

mm
on

unﬁnisnmd 0.5-1.0

awomuphatogmmc
bchawéoa.

at-«mmtic

nag/kg

(an.

atropine

EEG

and Behavior:

pmtually after

mmummdmmmmdbmmofmeme. behaviomland
anatomic aims of tmuna. Atropine also blocked the
clinical

changes similar to head

mum

EEG

md

seen following the experi—

mtal additim of intracisterml aoetyldnline.

n-w

�.r .nwm-nuw

v

m,

1‘ x—~.wwrv-—um—mw“n-«WW«-Waqm
v

Ward (1950)

.

mm

dawn

c."

m

xwwuv—

m

‘- um

,r—m—xw

applied thase observations to the treatment of

hmm cases of closed head injury. In
of

a:

patients with varying

be administered atropine subcutaneously in doses

tram,

of 0.1 mg/kg. In

20

some

cam

he noted

clinical immanent

and in

others a reversal of the electmphalogruphic effects of the

tram.

In a study of dietlmint. another antidmolimrgic dmg,

Janknor and “dancer (1958) reported significant alterations in

the post~trmmntic olectmenoephalogzm.
dose

in

#0

slow

single intravenom

patients with ahmml electroencephalogram resulted

in normalizing in
The

A

22

subjects and marked immvemnt in six others.

sum elect of atropine in blocking the appearance of

um activity

convulsive
following
in
subjects
reported

was

1956);
(In a
therapy (Ulett md Johnson,

later study then authors

failed to mplioate this study, suggesting that
or population changes

may have

[Johnson 93.51., 1960]).

dosage

factors

cmtributed to the different results

.u-wmwm

�"rm—W .7,

.

.\.—.~

v‘

u.

w wr—

w'

w

--=»—-.--«-v-

'w'

nu.- "I

1-

nun.“ mm-‘Ivm’lwuu‘twr "uvmq-WIWVWW. “HM-:rv‘lwr."
1—

x—A

'i‘w'wwuvuwrwwn

uvvmw": «rung-w unmoun-

. aw awn:v-v—nnJ—m

variety of experimta with a potent dzolinestomo inhibitor,

A

DI? (di—iaopmpyl ﬂmmophosphatc)

fmqumcy

EEG

mutated hiya mpﬂttxde rapid

éimilar
pat-hams
to status epilepticus. as well as

dam
status (Md: 5331..

of abnormality similar to that noted in pmt—trmtic

looser

m

1950).

doses of

mad

1950;

W

ﬁg,

19139;

aid

Won 95%,

eleotmonoeptulomphic effects were blocked by small

pmteral atropine.

Chatﬂald md

miml com»: with proatignine

Way

(19142)

pmpamd

and evoked electmmoamalo-

graphic spike activity. The prior uninistmtion of atmpim
blodmd this spiking,

'cuminatod by

wif mat,

the abnomlity could be

mine.

what to these findings, Banner md Harri.“ (19152),
applied topical mimome in Momma of 2-1/2 to
In

10%

to tho

awed cortex of cats,

and noted no

effect after intravmous

WClm/kg)mﬂne1¢otmumphalommicdmges.

'Iho

mtmtims of acetyldnlim in those experimts , mm, was
significantly higher than the topical application:

(1—1;

gm meant)

m

"nm‘lV‘I-"WPX' mm»

�.9—

intmiﬁuml

and the

Bormtdn (19%).

(0.2—1.0

W

gm

percent) injections of

and Pbrz'itt, also made mate of

elmwuhgrmic effects similar to aoetydxolim from
ucholyl
1n

(mummyldwline)

commenting:

dam.

'33);

m

and dozyl (carbmayldloline)

later than the acutyldnlim

concentrau

”W th- inmmd offeetivomss of these

momma. drum to their

mitivity to animal

lack of

durum.
FmavWa‘WandWaMu
my
I

mama that Waupiwgwm «may mm by

«wane,
uau

we.

on

a

a

mutt 0‘ mm.

Magnum: with chaunutume

blocked M
(:3)

We):

Waxed bg We.

Role

mm

away

applied.-

can be

‘

of Oanbmsgg ﬂuid

@951me in Saizums:

Amtyldzolim is normally present in mrvous tissm in an inactive
bound

fem. Daring periods of activity, free amtyld'aoline is

��.

N...-

~mv nun-7‘ «mamwmw-nrwu-W-ww-m—mmw Yum—U" v2»: 'lwwvv Wx-uwww- vv'r‘wr-I w-ww ‘t‘I—L :\ mean-v1-

avast-Lo—

nary-row:

.10...

Inspimlﬂuidstudiesinm,
(19%) and Tower md

Warn

Cone.

TmrmndEadnm

(mush) reported significant

qumtitios of fun mtyldwlim in patients with epilepsy. 0f
56

cpilaptic patients,

an (77%)

demastmted ﬂammable free

Michelin in quantities of 0.02

mm

of 1.0

gm

to 5.0

gm

per cent with m

per cunt. The acetylcholine

11.3ch.

was

dinctlymlaudmﬂmfmqmcyofaeizm, theemntof

0W0

dun-normality, and

the

minim oflthe

It‘bom
lagt
seizure.
tha
to
angling
tingof

no

mmim to

of
Ila-dictum. type
epilepsy or lewd of dwlimtemse activity.

WW

a

W

61011110

Michelin: appearinginﬁn

of the

awn.

is a (mm of the

Madam

arlwhetha-r the

aim

fluid
is
spinal

W

is pmblmtical.

(mush) suggested that the

in acety1~

Tower md'

inmd acetyldwline

mlat§d
liberation is not due to the seizum itself but is
to
the process casing the seizum. In a study of the hypothesis that

v

w.

�' “W

"m’ W“"‘W*P"W‘ TW""-'“'M'rmz‘m-ww'

:

~&lt;I

w'l-w'

uzm-w-wwnw-rmr wrmnsa-mmrw

“my;

—nwu—n-»mrw—u-—r

w-w

w

n—w- wan-m

.mmw- n- -_w.—..——,aw—. mw'hmmrmw m «w

-11.
the accumulation of acctylcholine is basic to the seizure process,
and
animals
metrazole
convulsions
induced
in
(1953)
by
Tcrda

dctcrnined the level of aoetyldmlinc in bmin tissue befom and
during convulsions. She noted that convulsions are pmocoded by

tissue;
of
content
that the content
in
the
acotylcholinc
a rise
gradually falls during the convulsion; and that below certain

lcvols, convulsions foilod to occur.

fall in tissue acctyldholinc

She

suggested that the

during a convulsion was due to

inhibition of acctylcholinc synthesis

by increased concentrations

of notabolitcs such as alumniumicns.
Tho passagp

of electric current through brain substances

induces a change in

callular activity with

an increase

in free

aoatylcholinc to lnvcls sufficient to induce a grand mal soizumc.
Tho

prosenco of free aoctylcholinc in the interocllular fluids

is associated with electrical hyperoynchrcny, reflected the

EEG

as dolta slowing.
(d) Effcct of Electroahock on Acctxlcholinc and Cholin~

saturates:

Tower and McEachern (lShQa),

in their study of

cnanioocrcbnnl trauma, includcd obscrvations of six psychiatrin

�,

.—

“7 hin""'-"""""’n

w—xwwr‘W'wv-Wsmuwvw ”‘1.meer!. .,

.

A

a

.m

"Jaw-«v

7

wmr-

mm-

vmm:wwwq~mw‘m¢7~w 1"‘3-0! w

~12--

patients

attu-

3-7

Linda-going mmrulsive therapy} Studying

the patients

mam-atmﬂay upwind fm Micheline activity

an.incseaae
.ad
rxuia
in.two
in
in th. Spinal
patients;

dwlimsteWII
rawnrsal

a:

a damase in

and

mum-I

with a

the ratio of cholinesteruses in five of the six

obsewatims
time
has
paints.

W

they concluded that'the spinal

new;
convuisions
were
11kg those
tunic ahansps in induced

mm

a!

than those found in epilepsy.

Ragarding the ma

patimt in‘the series

who

failed to

show

01th» I’m mtylolnline or a dwlirastemao ratio reversal in
this
intsmsting
the spinal fluid, thoy smote: "It is
that

pstimtmﬂamlyaaoftrasistosmwnompameto

mamt."
WM than.

a

show: in «1mm,

cons/Lamb“ augment about ﬂu. note
1,:

1.6

05

“chaste that 7W!- acaytchaune

mwmgaammwmmuwsm
&lt;1“ch 4:.qu

and Adm/Lu enhance.

autyb
Ls

that

«sorghum damnation,

�“mu-w. v—

vaw &gt;W—Wrﬁww.vwam—.m .‘w'wwrr Mr“!!! wrwwumm'm WV
-

W9
augment

wmm

1WW"WYI3"W'FVI'W‘VW wwmmww-zw (”wan-vim

-13-

Lawn.

tww

05

“Midtown

whiz:

“up and auuthau

wetytchauu puduocéou inc/mum about. (was.

(2) Central Nervous Sygtem Cholinesterases: Cbneumitant with

their observatims of

W

(1939) muasumnd spinal

in acetycholine,

Towor

md Hcﬁadxem

fluid cholinesterase activity.

The types

of'dholinostoruscs art normally found in the spinal fluid:

momentum—I ("trm,” "specific,"
which has a

&lt;92"

mdmolyl hydrolyzing) .

big: specificity for amtylcholim; and duolinestemseoﬂ

("peeudo,” "um-specific,” or bonnoyldwlinc-hydmlyzing) .

wands hydrolyze mtylmolim but have different

Both

rates of

hydrolysis {bu-ulcholyl and banzaylcholine. This diffcrantial rate
permits

gamma distinctions.

By

ram-ting the cholimsternse

activity as a ratio of the activity with macholyl
bonaoyidaonm substrates
two

mama

and with

acetyldmbline
an
to-

substrate

ratios am fomd: momentum-Ilacetyldnlim md

alwlimstcmeII/amtylmolim (with
ratios normal

CS?

Ach/Aeh a 100) .

omtains ostemses in the. ratio of

cholimstcme—I to dmlincsteme-II. Thus, normal

In such
33: 17
CS?

for

consist.

�-.v

rmvs

'mm

l-F'W'WW

wmmmm

.mpr—w— rm

.

.

may of "specific" caucuses with a small now-spedfic estemae
coupon-mt.

In pathmts with hand

inmim of tho

cm

the

fluid
fraction of the spinal

activity.

dam

the

and

'mey also observed a

of tha dwlhmstomse

with
ad
mm

Wm

report and

daclizmtomes with a simifioant increase in the

“Wm-II
Wanna-I

mm

Tower and

of the

W

a decrease in

relation batman

with the severity of

cummpmlogmpic

mun.

In patients with increased spinal fluid amtyldxolim as a

multofspmm
of

Wm

warm

seizmu.‘hdnvor.

or total dwlinestcmo activity

in the made
was found.

metimmybomﬂomgamﬂngdmgeainmn

mm
activity.
tha

pemability as explaining the

WWW-I

m1 mm:

syatcm

is fomd

1n

imam

Wt

in dulimstemse

mnomtmtim in

mile dwlixmtemesﬂ pmdmimtes

in 0th:- tissuaa. especially blood scrum.

With an increase

in

�,- xw-

m-mmwm

m

anatylmolina lawla in intercollular cambml fluids following

atimlatim, convulaima or tram, vasodilaticn md
cellular pamability my

be

ﬁlmed

pndictod, with a dogma of

mmudaﬁm of vascular fluid: into the inter gallular spams

mtmmmtmdamimofmvmodimm(mt
g; g,

19%). Spiagal and Spiegal~Adolf

mutated such

pamabmty

W

1953).

marred inmaaad omchctivity of the tissues

Thay

associated with

W

than

in

mm

reports (19%; 19u2,

1m,

19%.

appaarmca of various ions as potassim and

in the spinal fluid following electrically indumd

commie».

Thom was also

a

simificmt-imm

in such

nm-aloctrolytaa as manic-acid splitting anzymas. (images in

of circumstance-11

(Tower and

Wm

lSth).

_

�wwlv

mun-am.- V‘r‘ww.\\.sm uwrvvu‘x'

..-

me—wwmvmvwn .q-zwuwm pawn-w ., cannwmuw

v-Mr-ru-m‘ovr

WWWWW

«um—a. -.--&lt;

www.mm

-15..

The

increase in dwlinsstsms activity should be associated

Its persistence

with the rapid dostmctim of free asstyldxolins.
'

in spinal fluid after trauma and seizure

of the amtyldxolins—dxolixnstsmsvl

may be

system

related to the sensitivity

to concentration relation-

ships (Nsdmsnsm and Bothsnbsrg, 19%; Tower and

3mm

and MscIntosh. 1955).

At “physiologic"

Wm,

19%;

oonosntmtims,

hydrolysis of aostyloholins is rapid (3-H mimosaoonds) but at higher
and

mosntmtims,
the activity falls off quickly. In
lomr

W,

the cl'nolimstsms-II-sestylohomm relationship is naiospscific
and the

rats of hydrolysis increases with concentration.

usual levels of sootyldxolim

stosll sambmms is

specific activity of cimlinsstemss-I in

Thus, the

destroyed by the

few milliseconds.

Wm

omosntmtion
of soatyldioline in
emsssivs
excitation leads to an

mm

tissue, the mm of hydrolysis

sxosedsd.

com.

The

ssizm threshold may

by cholinsstemss—I

is

be roamed and a seizure

me dissociation in mstylduolinwdxolinestemseul relation-

ship results in s psrsistsnos of aostyldaolﬁne. The seizure

may

�mm “a." "W.— .mﬂmpw

txm mm Wm-mmwmm—mwm

m

"m

.

amtyldiolixn diffunes rapidly, affecting vascular md cellular

pamability
and

and

Wins

catamaran-II

W

of

in

the concentrations of various ions

CSP.

The

nativity of dwlinostamse—II,

cfficimw md depuuhnt

low

on

the oonomtmtim kinetics,

mmmldnwninmetissmsinhwmtodaystolewls
for the physiologic action of dwlinostemse-I.
(I)
mo
md Classificatim of

mmm, gmmm
.

mamas: Altemtion in

the blood brain pemability barrier by

the continuing actim of mtyldmolim

may be

the biomenﬁcal sub-

strata for the

post-3W hypemyndumy of the electro-

mmpmom.

Such

mag,

1956

is
possibility
o

mom in the report by

Wmtingm 5.11m intha concentration of‘

miminbmintissmsmmdaysafteraserieaofuinduoed
Gambian.
this

His

dun

1m mlccmln,

aim

the change in

momtmion of

mutually absent in brain tissue to

be

��mm.

WV

wwwm'wmmww’rr‘v m (memwmw“'m'ww

.19-

my

be

mama“ in the. mum

nub/mug

ad the.

dwuuuthu—

hypmymmuy
Awwu.
my
mama
Whom
1’th
be.
oﬁ
acetyl—
dummzd
hyd/wtyau
to
as
a
mt:
{m
mm
an
Law
ma
mammom
wowed
mun,

u

Cthénutcmc-II.

Comma (Ly,

in

and
Wmmv!
WW,

my be

muddy

06,

mm
~11

ewwc

with 5h0u~uv¢d

in Mac,

to the

Wainwmmk
Mammy.

WW

and

spinal (laid

high) .

stat-ﬂea
’meae
may also have application

3

chaunutmvr

MM}:

between the blood

problem of

)have

pmsum mponse

of patients to initiated médblyl and their (minim). response to
I

convulsive

mm

tram.

which
is
cholinorgic
a
potent
hamlyl
amt

vaodilatim. tachycardia, mating,

axomestemeq
hydrolyzed
by
is
It midly
astemo—II.

"me

blood

and

hemmed peristalsis.

and slowly by

moun-

pmssm of subjects’fans after injgcted

manlylmdmtmmtoﬁnbmeuminavariablplmgﬁmofﬁm,

�-m. “...u.

“v ,,.. ‘mw you ,,,

d

.

”are". ‘V‘ --

m,

mus-www- I

vm‘

five to

W rm

www.- w. m 1 ”3.... v- .-r'l

w

-

way-vr—v-

.m-MWWWW. “gnaw-why
,

Patients

more than 20 minutos.

Mums to the baseline in

5

an

minutes

,,.mu(._“‘,_,m,“

.

whose blood

classified as

present.

Groups

I, II,’

arm
mmmmbaaoline, amHdeIImactions. MW]:

or III mactima; ﬁnes mean blood

rams hm

a 9i

Wt

the aroup II~III reactors a

35%

rate

pmsm

takes

minutes

20

and
convulsiva'thompy.
with.

unwary rate. In umtmst, the

MHmmmmmaast'mddnGmupsvnath-wverymu

(main 5; g,

1952).

Patimtsinmﬂcmaminmltolnmaybelmdm
as patimts in

whiu the
We

may

the injactgd mdaolyl is rapidly hydrolyzed;

Group Hand VII

predict,

hvels of

W

when:

Won,

W

H~Vii

a slaw hydrolysis rate.

that tha blood Esolimstemo activity

-I~III would be him; whim the activity of

ma

be low.

regarding the data for

eatcmenl, in

patina hm

We

recall hem a similarpmdictim

mntmlm

which the domiopumt

syntax: levels

of

cholin—

of early and sustaimd

EEG

lypamynclumy and elevated spinal fluid levels of aoetyldlolirm
was

minted to a

low

level of dwiineaterase activity. mus,

w-n —.

wu-

�,-.n I

‘

-21-

the data of paripiuml stimulation by dwlimrgic agents is

wt

to the hypothesis regarding mutual

“activity to electroshodc.

mm

system

m1?

m'.mrrw-uww

gum

�CIDLINBMIC PECHANISIS IN

WV}:

m

m M, NJ).

From

PM

the Departunt of
at the Missouri Institute of
Paydziatry. Lhimity of ransom School of Medicine,
5WD Arsenal Stunt, St. Louis, Missouri 63139.

Aided, in part, by usms grunts 1914-927, 11-1—2715, mmzus, and
Iii-11380; and the Psychiatric Renard: Fomdation of Missouri .

�VI: 7-17-65

GIOLINERGIC MICHANISI‘B IN CONVULSIVE

W

Despite extensive application and study, the

mode

of the oonwlaive therapy process “mains enigmatic.
has been devoted

to neurophysiological

social

) aspects ,

(

Much

study

l,

(

), clinical

psychologice1(

.

of action

),

(

elucidating the present neuro-

).

physiologioal-edeptive View of the process (
'me

wly

development and persistence of signs of

{motions were reported to be
(Pink and

m,

activity es the
The

this

and

muisite to

changes

altered cerebral
in behavior

1956), with electroencephalogramic slow wave
most

significant index of altered brain function.

demtmtion that pmdicetim with atropine inhibited
slow wave

activity (Ulett and Johnson,

1957) and the

report

that mtidaolinergic «wounds reversed these clinical as well
as electrogrephic menses (Fink, 1958) suggests that the
biochemical basis for the mvulaive therapy process

may be

in

the cholinergic mdmmisms of the central nervous system. This
review discusses the available data mending acetyldxoline and

�and the dualineetemsw

in the convulsive therapy process .

Acetylcmlim has been extensively studied w an active
agent in the transmissim of nervous impulses since the

deecziptiom of Dale (191») and Ioewi (1921).

It is

first

a

constituent of nervous tissue, existing in a bound form which

is liberated during the excitation pmoess . It is rapidly
hydrolyzed through the specific action of molimaterase and

is rapidly reconstituted by the choline-acetylase

system

(Ricmer and Crosslend, 19%). In normal cerebmspinal fluid,

free acetylcholine is not present despite the rapid breakdown of
bcmd acetylmolim during periow of activity and excitement (Tower
and Hailed-tern, wheel). The cerebmepinel

dwiimnteme activity,

however,

medxclyl hylmlyzing type

fluid does have maurnble

principally of the "true" or

(Madman md

Rothenberg, 19%) . In

the absence of free acetyldmline and under the conditions described,

electmenceplumgm fail to

show

elmozmlity.

�(a) Cholinemc Aspects of (kmiooembml Trams: Free
eontylcholine was found in the oerebmspinsl fluid within a few
minutes

after experimental

head tmuma in cats and persisted for

varying periods up to “8 hours (Bernstein, 191:6). The quantity of

gm

free acetyldloline varied between 2.7 and 9.0
the

wt

was

Wt

related to the degree of induced
electroencephalogram

menses. The records were

percent, and

tram.

demtmted pet-rm

first filled with

high voltage fast

activity, interpreted as evidence of

an intense neuronal

disdurge, soon to

short period of ﬂattening

of

all

recorded

he succeeded by e

electrical activity.

These phases were then

followed by prolonged periods of high saplitude sharp waves in

the delta frequencies .
Ihe behavioral changes were related both to the degree of

tum

and

to the want of measured free aoetyldwline. 9th

higher- levels of aoetylcholine. Bernstein imported greater- degrees

of

EEG

abnormality and greater damages in consciousness .

�Spmtanccm post-traumatic seizures mm also related to the

mmt

of free acetylcholine appearing in the spinal fluid.

Bernstein applied ccatylcholine to exposed cat cerebral

cortex.

M

the cmccntmtim of acutyldrolinc

WM 1

gm

low
frequency
of
waves
unplitudc
sharp
high
percent or loss,

appeared in the electroencephalogram. men the cmcantmticn
was

Wed

to

2

gm

percent, the electroencephalogram:

flattened in a fashim parallel to the pcatétmumatic records.

Pmllel investigations in neurological patients by
and

Madam

(191ml)

Tower

dammtmted free acctyldrcline in the

ccmbmspiml fluid only in patients with meant head trauma,
recent grmdoml seizures or after clactmconvulsivc therapy.
Free acetylchclim varied from

assaying spinal fluid

0

.2

to

100

gm

percent. In

drclimstemc activity, they noted a

sharp rise in the nonopecific cholincsterasc fraction

(benzoylcholimnsplitting) and a drop in the specific cholinestemse

fraction (maholyl-splitting) in patients with head trauma and
ﬁll-owing convulsive therapy. The cerebrcspinal fluid did not

�exhibit such inversion, althougz lit command free acetyldxolim.

after

Spontaneous

seams .

that the lavel of

They comluded

two watylcholim varied directly with the dame of cerebral
damage and

that reversal of the dzolimsteme fructims

a more sensitive indicator of mmbral dmaga.
taken

at varying intervals following

mlntim batman the

W

EEG

935;,

Ehcﬂmmaphalom,

also indicated a

abnormality and the

of fme mtg/10mm in

[Add 1 Kovach

Thu

dogma of

mm.

was

ﬁne

cerebmspiﬁal fluid.

1957]

mmummmuummcam

maumuuam WWWMdﬂwmo‘
(an

Widow,

the

ham

and. type.

0‘

WWch

abmmutg,

mmuummuuaappmu

Mandated

pm.

�Fwy-.. W, .,-

V

l .7..—

(wt‘ mm- M 1-... WWW“

'mw

.. :‘w ,v-

a.

,

, m1.

vv

vv-uw-u-,o-vw-w.w.w ‘V'I-V-t.mNrIV-WI

AntiohoMc

(b)

wry-urn

"I“ wv-mvww—w-wuam—run-mnw—uu—wxw

m

and

tram:

”myr—w—vm—wwwq

wrivlwmwwr-wﬂw v: ,«w-

me electmmphic,

beluvioml md nemlogic Sign of trauma were blocked by the

mutual ministration of

0. 5~1.0 ag/kg atropine (Bomatein,

19%). as were similar olinmel oranges occurring after the

inmatemel

additim of acetylcmline.

Word (1950)

applied

these observations to the Moment of closed head injuries.

In

20

patients with varying degrees of

amine

tram,

ministered

subcutaneously in done: of 0.1 ng/kg, mating clinical

improvamt in

some and

a reversal of the electmenoepmlogmphic

effeots in others. In a study of

dictum,

mm mticmlinergic drug,

Jenkner and warmer (1955) mpwted

electmmphalogxm.
the postnmtmtic
done

he

in forty patimts with

A

altemtims in

single intmvemua

em}. electroenceprulogrmne

resulted in normalizing in twenty—m and muted imminent

in six others.
Similar observations have been reported by Denisenko (1965)
using methylbmectyzim and
‘

meantin in

poet-trumatic ﬂock and cerebral edem.

animal

experimts of

‘

.

u—v. .

.mmrrmm

�-

.v

-'4In v'nvwr»vr Anew—Wt

nv

-V

“war w

rr v. I1wurwuu‘wv

gm" w'twv‘z'

'or‘

Ila-3

»,

~.,r-.mwm-w-—~ v.“ ,1,“ .‘ .v-y

m twinw-vp "Ivy" .m.‘ war. .r my rnm
~;

.

"mam—q .74- ..w

w.

....

,

Thee duet-mums wen eeueeed in the omwleive therapy
process by Ulett and Jornem (1957). Then workers eduiniotemd

doeegeaofatmpineupto
the patients received

that the
was

mt:

mper'daydm‘ingthemeke

«mm

of slow

wave

therapy. They

Wed

activity produced in these patients

significantly has then the omtrol

m

who had

not

mind

the atropine ministration.
(In

a.

later study these

eutm failed to replicate

this

etuiy, suggesting that douse factors or populatim changes
have

Wed

may

to different results [Jomem 3:311; 1960]).

These observations provided the basis

otlur 1cm mtieMlinergic

W

for studies with

(Fink. 1958, 1960). The

intmmue injection of

emerimentally active antiomlimrgid

comma es diethedm,

benectyzine. the piperidylbenziletes

JB-318, JB-336 and

JB—329

(Dim).

and wan-2299 induced

deemmmiution in psychiatric eubjects. These
were associated with bernvioml

ﬂirting, anxiety.

EEG

EEG

clmges

tram,

illusions and hallminetima. In patients um had recently

�,__.,,__,,.. .

V...

7)... W-

w

-—

....,... .

.V-r—w,

.wx-7'Uwiwt

~s|

'1‘

u

u

a...” ,.. w‘mmjwlm‘vwnmu‘m

.

"0...an

”mi—W- .thwuww.

‘

m.,.m-.-.,,, M_

"H". H,"

.,

,..

.w-.m.1,

,

a“,

r

.neqy..-mw—-;

- .r»

vr'."

received eleotmoonwnoive therapy. the eduinietmtim of

theseoomomdemeeaooietedwithemdmtioninslowmve
activity

and

meme]. of euphoria, denial

Atropine was also
EEG

emined in

desmlumiutim

WI

m

and tension.

and confusion.

low doses. and

obeemd

in these administratims,

mind

At higher

superimposed beta

tachycardia,

We, hyper-8mm

slow waves, followed by lower voltage, poorly

activity with

by

activity

mined delta

“mind

by progressive

confueim and disorimtatim.
Both

in oenbral

mm

and indumd omvulsime, the

ehotmﬁmphio clauses my be modified by the comm-rent

administmtim of micmmemic drugs, thus

Weed mt:

of aoetyloholine

or-

mating that

incmeeed cholimrgic

receptivity is eeeooieted with the high voltage slou’ wave

activity.
(o) 13min

mmnm

and

m!
mmm

:

SimilarEBGohmgeemdthblookingthmfheshenobmmd
following the direct application: of aoetyloholim to the centre).

mam.

-

.rml... ww—wu-uuwy

w—

“WY—r!

�'lho

anninismticn of a

chainsaw. inhibitor DP?

(di-isopmpyl fluomphocptute) elicited high maplitudo rapid
frequency

W

EEG

patterns similar to status cpilcptiws, as well as

similar to those of post~tzmmtic states

amen 23%,

19%,

1950; and

ma: gag,

(W
We

1950).

effocts'wom blodcad by small doses of pmntaral atropine.

mat
was

91; 5};
EEG

The

inmaso in acetyldaoline after tetmrdxyl pymphosphate

named

indumd

and

routed to the toxic mmisfostatims

(Wand

3m,

PM: 1952;

('11???)

and convulsims

1957;)

Chatfiold and Dummy (19h?) pmpamd exposed animal cortex
with
Tho

pmtimim

and

ma chmmlomic

spike activity.

prior administmtim of atmpino blodcod this spiking, or

pment, the mutuality could

he oliminatcd by

if

atropine.

In contrast to those findings, Bram” and Merritt (19%)
applied topics-.1 acctyloholim in

to the

expound cortex

mania-ts

of 2~1l2 to

10$

of cats. md mted no effect on the

electroencephalographic changes after intravenous atmpim
(1

Wits.)

'me concanmtims of

acatyldnlim in ﬁxes: cxperimanta,

�10

harem, wan higher than the topical applications
and the

inmoistomal

(0.2-4.0

Bernstein (19%). Exam» and

gm

(1-14 gamma

percent)

pennant) injections of

hwitt

also

made

note of electro-

m unholy].

onooplulogmphio effects similar to

Midtown

(nostylhotmﬁayloholine) and doryl

(Wlmlinoﬁn mantmtims

moh lowor than the acutyloholim oonoonmtiom. 'Ihoy ascribed

tho

imaged effoctivomos of

look of sensitivity

duolingio

those

drugs

to thoir

to oembml olnlimstemes.

Thou data one conflicting and

furthr study is masonry

to qualify this issue .

Gummyiml Fluid mglmlinc

(o)

of aoetyloholim mtabolism

and

inﬂates that it is

Selma:
found

in

One View

mm

tissuns in an inactivo band form, wring periods of activity,

mtyloholim is liberated at the call

midly

mum,

Mum

it is

deactiva‘ood by dzolimstomso. 'Iho mount of bomd

mtyloboline is the resultant of tho

oontinumas pmoosses of

synthesis, liberation and broakcbm.

It

the level

has been postulated that

rim timing sleep and falls during activity.

and Czomland, 19%;

Elliott,

(Richter

Sam): and Hmdorson, 1950; Gianna:

�,7...

,r‘ w .w..,» "gun-w WW,

_

w w"

Rpm. 1962).

.1,‘

A.

4w-

By

....-

a.

m

brain

mg.

higher than

3005

tissue levels is

mw. 1...,” wr'w".‘— wan

mama

basin

.v—w

tho love]. of

during

:-

"w

m:a..»=-v~&lt;wmu «we» u-m—v .fr'um-g v.~'mrw-"n—u'w .r‘xm

is high

mtylcmlim

(micro-

munch and sleep to b-

mm,

mini-It.

\‘w‘

,

air quick freezing Minds.

post-ulna! levels.

(7

Thu

diffm

in

as the msyntlnais mm for

gm/m/ndnuta). Elliot

$3;

omfimd these observations. also toting that after

nan-uncle aonwlaims

spinal

"Wu-1

tim)

wotylcmm in rat
(1950)

,

using liquid

Richter and Cmoclmd

per

‘v-‘w‘m

fm acetylcmlim m «ﬂammable

ﬂuidinmncmtmtimamtoagampermm.

Pepeu (1962) fomd an

qt central

mm

11mm in mtylclnlim

Wan depressants to

in the

mm

caused by a group

be roughly proportional

totindamoofdepmasimoftheemmlmmusmummm‘
mdmtim in
Prue

mm activity.

mtylcrolim

m

'fluid
in
mportad in‘tha spinal

patients with epilepsy (Cone, Tum“ md
and

mum.

mmud
5.0

m

19149

b). or

56

fm amtylcmlim

percent with

McEncMm, 19%;

epileptic patients,

an (77%)

in quantities of 0.02 to

an average of 1.0

TM:-

mm

cont.

�v—

v w. «...v..v,v

.-A—W.

,_.1,._,...V,. -v-.»-m—wv

—-.~

ammm‘ «wwwm

'y'vvx'v

u—wu.uw,n-w.-w.~:.wmw.1».

mu '1

“a“.

-

.vwruw—Nv-

l2

Maryldnlim levels wan related to the froqmncy of seizures,

mmdcmmmhmiomlﬂy,mdtoﬁm
1b zinc. the

lat

column, but bore no mlation to medication,

type of cpilopsy or level of
Tadcr and

Wm

($0th

(Hugh) Vimd tbs increased

acetyldmclim a lay-product of the

Stwying the hypothuis that the
inducod

aim. m

activity.

(1953)

301m,

and not causal.

mum

We!

of acotylcholine

the level of acatyldiolim

inbmintissucmotmaoh convulsion. Stumtcdarisoinﬂae
acetyldaolim content of brain, baton a sebum and a fall during
tho convulsion. Below curtain levels of acetyldmolino, convulsion

hind-to

comm.

She

smeared that the fall in tissue

can
due
acetylcholim during a cmvulsim

acetylcmlim synthesis
sue): on

by

Wed

to inhibition of

concentrations of natabolites

amnim 10m.

Wendhpoualsommdclmgosincenmlmm
systcn acetylcholim follauins

“rims stinulmts .

Only

after

�13

SMDutyhthyIMimte was there a

mcholyl and 3,

W

significant

dam

in the acutylcholim level. they noted a

in association with inmost! omvulsions.

drugs which may qumtifiad as

atiwlmts

1:me
maninaoetyldwlim
impmniazid

4»

and

no

W

mind

+ 1309A)

comma, them

in mtyleholim lava]. muss these

by convulsions.

(The

than

WWW

duspite int-mo excitation produced by those

mu

imam.

(LSD.

mpmma

level.

other

With

were

diffemnms in observations

mmmmmggmrmrmdmm
may

be related

mutants.

to the differences in
fm‘

methods

th: Lunar unwind

of biochemical

changes

in spinal fluid

nflcatingttnfmeaoetylmolim,whilnsiamamandhpeu‘

manna tatal Myldwlim in tissue uncaring bound

fm form
Thu:

an

and

of acetyldmlim.)

AW

W

Auggut ﬂux Apontaum

by an

u

induced

We 1mm
in

law

(no. acotyzchouue

�-, .4.‘ . rum- .1:.--—.-.

-.

‘T r. .l ~,w

':.»"-rx\~\I--«-~-v~’

‘mw"‘

m~.r...v.w—.m...~»-. .

.«m-n vyr
-.

.

1-.“

,

—;..-

r...» ,.r;«

“a

v.—~

1n

tummy-1 La
5pc“: (mid.

mmwe

bound

(on which my

Wag

dalmatian,

“up

and

mduaﬁon immune mane
(d) Oantml Nervous

activity.

(19%) also
‘mo

Austen/ted

6mm «cavity and Aazuu

mm:., m
Wm

be.

tum .

Sgt”

mama

enhance

Mae. Lama

masthead

in the

W

06

acetytdtoum

(holimstomaa: Tour

and

spinal fluid diolimstema

typas of duolimstarms we normally fund in

thc spinal fluid: dmlimstume-I ("tr-m," “specific," or
Molyl—hydmlyzing) , which has a high specificity for

acetyldiolim; and daonmstemo-II &lt;"imudo," "mspadfic,"

com

or benzeyldxolim-hydmlyzing) .

Both

mtyloholim but

rates of hydrolysis for

have diffamnt

hydrolym

diffcmtial rate

Molyl and bomoyldmolim .

This

qualitatiw distinctions.

reporting the duolimstemse

By

permits

activity as a ratio of the activity with a maholyl substrate
with a bemoyldxolim aubstmtc

mud

and

to a substrate of

mtyldmolim, ten mtios are found: dualﬁnatemeJ/mtyldmlim

�--

~

:4: 7r&gt;m\‘-Vrmwu~&lt;hvuwrr. n

&gt;--'rw.

aw, ww H'VJ’IW'W‘VCu-‘rm'"‘l ~w:wa-w-._,.rm unr—

w

.vumma .w. "- urﬁ ,. .... 0-» ‘wV.M-a&gt;vﬁ “Tr-aw -r-.-~,:-. 1m.” ~ m

15

and

Mm-II/mtyldmlim.

comm

fluid

:30an censuses

for “must-men! to

In such ratios

mall

in tho ratio of 33:17

dawn

.

Inpatimtswithhadtmm.mrmmmmmd
mimmimofﬂndnﬂmtmwiﬁ'minmeinm

W41
Mum-I

fraction of th- spinal fluid and a

activity.

‘11:.

W

in

what of tho cholimtomso

Wmmuudmtmmtyofmmmdmm

m

at the

In

:13qu

WW.

mints with owned spinal fluid acetyldxolino

m:mm,mvar,mm1nﬁnmioof
dwlimtm or total mun-statue activity was fomd._

mmmannmmmymmmamm
mumimmminanmpombiuty.
WWW-Ii:
antral mm system while Manama-II pmdminms

1’ththth

in other tissue. specially blood scum.

in mtyldmlim

hula

With an

inmue

in mnbml intcmauular fluids,

up“ .7.

7" .- »

-~

..,_,

,

u

�A

,

.

,_

=...V........ w...”

..l.._,

nv'rvxw

w."

.7

"Myw-IlI-Irwwaur- ‘7 ""Fvwmm“

v

raw-4‘7“-” ”Val n”,_~

-17

.

"A

«rum—u ﬂ,” "mum—.1,“ NW...

,

16

vasodilation and

Wei

with a degree of

umudatim of vascular fluids into the inter»

cellular permeability

cellular spaces varying with the extent
vaaodﬂataticn (Kabat
and

their

Wm

35.

_a_1_,

19%).

and

may be

pmdicted,

dmtion of the

81313301, Spiegel—Adolf,

(1981. 19%, 19%, 1938, 1953)

WWed

sud: permeability changes md maimed mndmtivity of the

tissue

associated with the appearance of various ions (as

potassium and prosphate) in the epiml fluid {alluring

electrically

induoud convulsions . Such

nucleicaoid splitting

cellular permeability

WWW

of

aims,

may

nm-elactmlytes, as

also ixmaaed.

Changes

thus pmvida the basis for the high

acetylde

and the

inmased

mntratims

of cholimsteme-II in induced animus or head tmuma
and

Wm
'Ihe

in

'

(Tamar-

1939c) .

persistm

of mtyldwlim in spinal fluid after

head trauma and

after aims daspita increased dwlinastemse

activity

related to the sensitivity of the aoetyldiolin'e-

may be

dwlimstarmd

system

to

Wmtim

relationships (Nadmansm

�,wn‘ww’

,..

i

. ..-..

_‘

“a...

n”. “

‘,,_ .3», .1.

m, .Vq‘r‘. am-rw

,

~,--‘V~rwtrm—Ww ..~.-—-~—..-w

wr".v\-4I"\9-rr"x““w-myrvwrmmwn'v

.(-,.‘v.,..._..-..‘_w,,,,rn.—.y~.—_-.r~,-

3“ .~.-.

17

and

Withers,

19'65; Towcr and

Wm,

HacIntosh, 1955) . At ”physiologic”

1909c; Burger: and

comtmticns,

hydrolysis

of acatylcholinc is rapid (34 micxmocondn) but at higher and
lower concentratims, the activity

what,

falls off quickly. In

the dmlincatnmo-II acctyldmolim mlatimship is

ad ﬁn

mn-cpociic

m

01’

hydrolysis

cmccntmtioc.

W

witl': increased.

anvimcfﬁnscmlatimhipc suggestsﬂmtwhilem
usual commtrwticns of acetyldmoline

t

cell

m:

are

dcstmyud by tbs specific activity of cholimsteme-J. in a

fut micro-cm, an emaive concentration following cxcitaticn
may

exceed the

rate of hydrolysis by cholimstemso-I.

seizure mmmm
the uixum

may be

mmd and a seizure

itself adding to

the

mm:

The

induced, with

of free amtylcmline.

1110

increased acetylcholinc diffuses rapidly, affacting vascular

and

cellular

minty

and increasing the

various ism and circumstance-II in the

of

dialimtcmc-II ,

mums

CSF.

The

of

activity

thaugh of low efficiency and depending on

�the

mien

kimtics, mamas tho watyldxolim in the

tissuns in hours to days to levols for the physiologic actim
of dwlimstame-I...

Chaumtemu «ppm is ﬂu.

camamemmmm
In
The.

am

5M cu a. gamma

gum, mating 5m

a“ when pmabuug “mined by imucd

changu

mm.

Wed mm“ me put “the hmmtéc Wm

“mucus the ants
(n ma

agate»:

05

Wu

manually

«mum.

(a) Amgzleholine,

Alumina in

MW

at cm

EEG

the. blood-brain

Mum

and Indumd Oomvulsiaw:

pemnbility barrier

winning action of mtyldwlim may be the

by the

biodmmioal substrate

for tha poatwlectmahock hypemyndmy of the eloctmanmpinlom.

3% a possibility is

evident in the

Mommim

of an immense

in the concentration of cocaine in brain tissms thme
a series of

12 induced convulsions (Aird

army in concentration of this

days

after

5331., 1956). The

1m mlecmle, ordinarily absent

�mnpr- rug—m.» r m «7 r.~L,-»---.--,V-...Ww.‘n

-

v

v

'.&gt;T4wmw‘m

.mw—z

,

ru71.,‘

mu

mr‘m—D'J.lr&gt;aw' yawn-vanquas,‘

‘w. -

p". yr. -., “wharf” .

WV.

”us-apt..." 1..

.19-

in brain tissue,

was

asaociatad with the appoarunoe of hyper»

synchrony (delta bursts)
We hIVD

in the electroencephalogram.

confirmed tbs many pruvious reports thut convulsive

thaxapy induces olectnngnlphic hyporuynchrcny (Pink and Kahn.
1956; Pink

33.3;, 1961). Duspite a constant application of

mmmmuammmty'mmtmo:
appoarunnn, the duration and tho cxmnnx of the electrogruphic
slow Haws
by

activity as wall as the sensitivity to modification

alnrting, hyporvuntilatian and barbiturates in psychiatric

(papulntians.

Tho

early appoarnnnn of high degxan hyper~

syndhmuny and

its

puraistnncn throughout a truatmant course

has been dnscribod an pmuruqnisite

M

(Roth, 1951; Roth

It is possible that
EEG

to

£11.,

impruwument ﬁollcwing

1933; Pink md M111, 1956).

the diffirnnces in tho degree of indncod

hyporuynchrcnv may bc

related to differances in the activity

or auntrul cholinnrgic mechanisms.

patients to davalop hyporsynahruny

The
may

failure of certain
thus be associatad

precluding a clinical rlsponse to induced convulsions. Tbuer

..

l

.

V

,

”.17

v

,, n

�w,

._‘_,._..._‘,|,,,

r.

Wm.

;.,,,,.__

m.

,. ~

"v.0... . (T W
.

r

r,

-_

"u . rw.par.-‘W-.~ .erz. .7.” , .1
.

_

y

.
.,
4.1-.

.

--

n v-uvnwwwv-wm‘uv “wave-«W.www—ur-p—, w-n—w—w M-ru- "n" .,-v
,

.

_

_

,

‘

v—av-um .

.

woun- 7 -w

v-_.

.-

m

20

and

Wm

(19%.), in

ﬂair study of

W231

tmm,

hcludcd observaﬁm of six psydtiatric patients mder'going

omwlsive mampy. Studying the patients after 3-7
tiny upon“! {me spinal fluid
and an

inmm

mutants

Minimum in two patients;

in mournstcmvn and a

dam

in

.mvemal
pith
of the ratio of dxonmatorms
a
dwiimstame-I

in five of the six patients.

From

mludad that the spinal fluid

these obscwations ﬂwy

We:

in

ma

commlsiom

mmﬁmmoofmioambmltmﬁmmof
sputum

epilepsy.

WWMpntientinﬂwmﬂaawhofanedtom
oither {no acetylomnm or a dmlimsteme ratio reversal in
iﬁtemsting
that this
the spinal ﬂuid, tiny. wrote: "It is

patimtwaaﬂnonlymafﬂnsixmshwmmsmoto

Wt."
‘

at

If alectmgraptdc

hyporsyndmrmy

increased free acetyldmolim, subjects

who

is a mﬂectim
maintain hyper-

syndmymdttmeinﬁmitdisappemmidlymybc

waiting

diffemnoas in the kinetim of the dmolimstemsw

»

, _ v—-— w
.

7

v

vamp-omen“ W
.

p

,.

.

V...
,

‘

�22

“I

(21011th

'mooo studios

and the

Classificatim of

a

:

malochm applioatimtotmpmblanof

atomic mootivity and the classification of the
Mountain

Po

mm

and

(

)

mlatimhip boom the

psychoses.

how dumstmted

blood possum response

to injected

ndxolyl and the clinical mpomo of psychiatric patients to
convulsive ﬁxaapy. Homolyl
which

W

is a percent cholinorgio agent

vaoodilation, taduyoudia, sweating, and

peristalsis. It is rapidly hydrolyzed
dxonmotorm-II .

slowly by

The blood

falls after injoctod Immolyl
within five to more than

9mm

and

takes

Group
20

Group VI and VII

oholimstemeel md

pussum of subjects

mtums to the baseline

minutes. Patients whose blood

{within
baseline
the
returns to

classiﬁed as

prawn

20

by

W

5

ndnutes have been

I, II, or III reactors;

those whose blood

ormminums tomtumto baseline,
reactors.

M

I

and

thp

III—III

as

mam

�..

pr 7: . -r

WW..."

.

.

.r.

.

n

..

7..

.-

-. mm».

.

1

unw-

u

.

“val

~

«

-

....._.

v ..

wiv'r—z-v .?-'a‘.v~'uV.—T{=n‘)("\ﬁlr-

-

,r., "saw--

wry-WW...» N. mv—ﬁ m—m ‘»-y-_I-sﬁ-vvvvx

,

23

have a 9 and a

35%

recovery

and Grow VII mentors
91;

gl__.

1952).

patients in

Group

whom

while Groups

VI

89%

rate, mspectivuly, while

and 97‘ recovery

I to III mactom

the injected mornlyl

Group VI

rates (Funkeastein

may he

looked upon as

is rapidly

hydrolymd;

md VII have a slow hydrolysis rate.

We

may

pmdiot, thcmfore, that the blood dxolinesteme activity
levels of Grow): I-III would
Groups VI
A

uystcm

-

bu high; while

the activity of

VII would be low.

similar analysis

may be mad:

regarding central nervous

levels of dwlinectemse—I in the duvelownnt of

EEG

hypersynchrmy and spinal fluid levels of aoetylcholim, providing

a basis for a omgment hypothesis regarding centml nervous
syntax:

reactivity to induced oonvulsims

cholinergic agents.

and

to peripheral

�-

~—-~vw=rr'u.

.

~

.

“,_ w-vvww

(“vwxx mu,

.-

v*'ul""‘v‘“""w“1-c-»w‘mlh-rtr"'4&lt;-Ia‘.—-vuz‘

--—

(—1

m-wry_._

7...," .V,

7

,_,

.

‘

my

—

.

w". ,.c_..,.. ..

u... w. Flaw—w.

v3.

‘~.,..,,‘w,-."

2‘4

CONCUISION:

Central cholinergic mechanism appear to be a significmt

factor in the convulsive therapy process.
may

The published

data

interpreted to indicate that induced convulsion: are

be

associated with on increased- in intercellular acetylcholine to

levels greater than can be destroyed

activity. Vaeodilatim

and increased

by

dmlimsterese—I

cellular pemability

are followed by increased ammte of clnlinestemee—II and

other

enzymes and

electrolytes in intercellular fluids.

These chmgea are

hypemynclu'my which
can be

mdified

by

reflected in the increased electrical

is

recorded in scalp electrodes, and which

mticholinergic drugs as atropine, benactyzine,

and ydieﬁuazine.
The changes

in the cerebral biochemical milieu alter cellular

activities sufficiently to

be associated with

altered behavior

of subjects. Failure to induce high and persistent cmoentrttions

of aoetylcmline and failure to induce concomitmt electrolyte
changes

results in a failure to produce behavioml change.

n: M

...1,.“‘..w.

“,4

_.

......

._

�25

Differences in the rates of development of

mm

reflect differences in their lependance of cubjects
mechanism-

changes

on chom'cergic

or in their sensitivity to chmges in acetylcholine

levels. mean differences provide the basis for the classification of the mentally

ill by kaenstein and by Pink md Kuhn

These observations provide

the

mode

a

Miami

(1961).

Mechanical basis for

of action of indmed nmvcﬂsims in altering the

behavior of psychotic subjects. These views are consistent with

the

more

earlier

general neurophysiclcgic-«iaptive theory expressed
(Rink, 1957) .

�"

-v~1r'-W4'VY—,‘V.'Z"V‘."-‘

w

"- ---'~-'

REFERENCES

Aim, R. 8., Strait, I... 1‘... Pace, J. W., Hmnofi', M. K. md
S
. C. Nemphysiclogic effects of electrically loaned
deitch,
convulsions. Aach. ucuxoz. Izyahtat. (catc.). 1956, 75: 37l~378.

Pmmoe and actim of coetyldwline in oxporinnntal

Box-cumin, M.D.

brain trauma. 1. Nounaphga£o£., 1986, 9:

3%9-366.

Brannon, C. and Merritt, H. H. Effect of certain choline derivatives
on electrical activity of the cortex. Moh. Newt. Pageant. (ChicJ.
19H2, M8: 382-395.

W,
of amtylcholim.
S.

A.

(Editors),

V. and

Hoolntcsh, F. C. ‘lhc physiological Biglificmoe

In

I.

K. A. C. Elliot,
C. C limos,

ummag.

H. Page and

J.

H.

Quutcl

Springfield, 111., 1955: 378-375.

Omtfiald, P. O. and Dagny, E. W. Effects of proatigmine and
acetylcholim on cortical potentials. Mn. 3. Phyaialu 1982,
135: 633-630.

Wm,

D. Acetylchclino and murmal
Corn, w. V.,-'l'cwcr, D. B. and
activity in cpilcpsy. J.A.M.A., lane. 73: 59-63.

Dab, H. H.

thoiz-

The

action of certain caters md others of choline, and

nlctim to maxim. J. Hamel.

Elliott,

Exp. The)!" 19114, 6:187.

C., Swank, R. L. and Henderson, N. Effects of
mostlutico and cmvulamts on acetylcholine content of brain.
MM. 1. Phytiol... 1950, 162: 888-1371;.
Pink,

H.

R. A.

A

mified theory of the cation of psychodynmic therapies.

Pink, H. Effect of mticholimrgic agent, dietmzinc, on
behavior: simificmcc for theory of convulsiw ﬂxcmpy.
Melt.
Pogohiat. (Chic). 1858, 88: 380487.

BBQ

and

mm.

Effect of mtichclimrgic compomdc on pat-mullahs
cloctmcnocphalom and bobcvior of pcydaiatric patimts.
Eltethoenctph. Cliu. Neukophg6£a£., 1960, 12 (2): 359-369.
Firm,

M.

Fink, H. and Kahn, R. L. Quantitative studies of slow wave activity
following electroshodc. Electuuceph. can. Newman!” 1958, 8:158.
Pink, 14., Kuhn, R. L., Karp, 3., Pallcck, M., Green, M. A., Alma, B.
and Infkowits, H. J. haunt—induced convulsions. Molt. Gen. Paychiatn
1961, “:259-266.

W,
m.

'

8

A. 14., Bales, P. 1).,

Willie,

Hiwich, H. E.
Exporimtcl production of electrical major omwlsivc patterns.
1. MM” 19kg, 1.35: 117’12“.
A. and

�'"WW.'I&lt;-.~;—--

-,

-‘—-'-a

. ..

r! _‘,',.."_'__m, ,- . ‘1).m. u ‘P. -

..~—.—.-a..nuu.~.~

.

‘~»~..ww*m‘m—. - v

w

W

.-w-rvu.wm.m .w, ”mu “.3 w-w WW..."— xw-mv-vrv at K

Ib‘mwv": “nun-ms?” u

mmic
mutt,
of
in
mlation
pmgnoatic
system
sigxifiomoa
to
test
mm
Maintain,

D. H.,

013011031106:

truatmant. Payclwaom. “ad” 1952, lb: 3u7~362.

.Giaman, N.

J.

wtyld‘tolim.

H. and Solomon, R. C.

ML,
F.,

Md Pepau, G.

W.

1.

Drug—inclined changes

in brain

1962, 19: 226-23“.

A.
and Hiwich, H. E.
Macaulay,
J.,
amen,
Effects of diwinopmpyl flmmplmsm (DE?) on ahatmenoepbalognm
and dwlimtama activity. methamph. can. ”Mphgunl.,
1950, 2: “1-48.

Basis, C.

Wm,

W,mm"

H. 3.. Basia, C. In,
J. I... Bales, P. D. and
A. H. Effect of trimathadiono (Tridimo) and other
drugs on mvulsims named by di~ioopmpyl fluorophosph'ata (DFP).
1950, 106: 816-820.
mu. 1.

Pﬁwidl,

Jamar-r. F. L. and bachnar, H. The effect of Dipamol on the

ehatmwmphalogminmmmlaubjcctminﬁmewith
Gambia].
7:

um.
303‘3050

Ehctaouuph. can. Namephgalatu

1955,

Jansen, L. C., Ulatt, G. A.. Johnson, 24., Smith, K. 31:! Sims, J. 0.
thanpy (with md wiﬂmt atmpim); affact on
alantrmioany Julyzad electroencephalogram. Malt. Gan.

WWW!

mm"

1960, 2: 323—336.

61mm, M. and Knaub, V. Quantitative estimation
ofﬁnalbminandgmglnbulininnomlmdpaﬁmlogic
cembmspinal fluid by imxmehamiml methods. Mu. J. Meet,
Kabat, E. A...

1938, k (5): 653-862.

Loud, 0. Fiber hwmrale {Ibertmgbarkait den Hennammiﬂnmg.
Mali. 5. d. an. ”quiet" 1921, 189: 239~2u2.

Wm,
mm,
spadficity mm in new
on

D. and

Studies on dualinestame:
tissue. J. Biol. (than,

H. A.

of

19%, 158: 653-666.

Richter. D. and unwind. J. Vaziatim in acetyleholim content
of the brain with physiological state. MM. 1 . Phyaiatu
19139, 189: 2157-455.

W

in the EEG mdar bubimmte Mmesia
pmdwad by alactm-omvulsiva tumult and thair significance
ECT
of
the
action.
Manuphguol.”
can.
Eumuuph.
may
to?
19 1, 3: 261-280.
Roth, H.

‘

W
mt. WW.

Ruth. 14.. Kay, D.

Pmtothal
omwlsiva

1957, 9: 225-437.

J. md amen, J. Prognosis and
ahetmphalogmphic changes in electroW. K...

Shae,

can. Memphyauln

Spiagel, E. A. and Spiagal-Adolf, H. Permability changes in the
brain induced by mm). and insulin convulsions. J. New. Matt. v.3...
19M, 93: 750-755.

�F

”

rum" ,

,7“...

T9,“

wm.~n..wr.”“.,.,r,.w ..;._‘.,..,_,Vk,»,mqr,..r. 14."... _.-..,.4,. r...“ ‘.

”um-um..." :w-"CRIWJEFIMI-‘wf‘t . .,»;r-,W—;.—‘m'w"Ir-E'WAn-‘n-vu-I 1”“7(IAHV«——l
._

-

n -.--~

7»-v—-———~r-—-n~—w-v-—.

-3Spicgol, E. A. and Spinal-Adolf, H. Physioochemiml effects of
ohctrically 1mm oonvulsiam (oembxospinal fluid studies) .
Tm. Mu. Haunt. AM” 19%, 70: 130-132.
Spiogel, E. A. and Spinal-Molt, M. Physiological and physioochemioal
mohanim in electroshock tmatmnt. Conga. Newt” 1953, 13: 38-63.

Wm

Spiegol, E. A., Spinal—Adolf,

We
dinning“.

in the brain

Tm. Mu.

and Kenny, G.

Haysiooodmﬁoal
electrically indumd omvulsiw
Nunez. AM" 19342, 68:
M.

m.

Wt

Spiegcl-Adolf. 21., Wilcox. P. H. and Spiegel, B. A. Oambmpinal
fluid
in elnctmehodc
of psychoses.
J.
19%, 10”: 697-706.

chm

W.

3ch”

Stem, W. E. The min of acetyldxolim in bmin metabolism and
ﬁmction. Man. J. ”13‘. “£41., 1957, 36: 222-455.
Torda. C. Effect of omwlaion ﬂaming agents on the acetyldmlim

content of the brain.

J. Phyaiol.,

Amen.

1953, 173: 179—183.

Tom,

C. Effects of single injection of oortiootrvpin (ACE!)
ion and acetyloholim content of brain.
on
I.
“watch,
1953, 173: 175-178.

mum

W.

and
nauronal
mtyldmline
activity. I.
Mr.
Wm.
Cholimterm patterns ma motyldwolim in the oambmspiml fluids
of patients with
Canad. J. Hum, 19mm,
tram.
27 (Seat. E): 105-419.
D.

a.

and

Wm

the omtmt md WMim of
W323,
in human cerebmcpinal fluids. Cam. 1.

Tower, D. B. and

cholimatcmes
191.9», 27

D.

D.

mm,

(Seat. E): 132-435.

Tower, D. B. and unis-clam, D. Mutyldxolima md

mama]. activity.

Motylcholine md daclimteme activity in the In”! osmbmspinal
II.
fluids of patients with epilepsy. Canal. J.
3.914%,
27

(Scat. E): 120-131.

mm,

Ulett, G. A. and Johnsm, H. w. Effect of atropine and soopolaminc
upm chotmonoeptnhgmphic changes induced by electm—oonwlsive
therapy. Eamomuph. can. Monophyunzn 1957, 9:

217—22u.

Hard, A. A. Atropine in the tmatmnt of closed hand injury,
J. Meano.ung., 1950,‘7: ass-noz.

.V.

.-

-

�(July 2, 1965)
Jan. 3, 1958
EDIE 0!" ACTION OF

TheCNS

BIWCAL

ms

IN EHAVIOR

indopendcntupmanmrofenzyne

for

systems

proper mtabolism and functim, including cholimstemae-

aoctylcholine, glucose-phosphatase, etc.
The

bahavior

variety of

is large,

in either direction

wt:

that affect

CNS

ﬁmcticn and, thereby,

since processes in equilibriun
by increasing

may be

shifted

or damaging the available

quantity of a metabolite.
A.

For drug action,

thanfom, tho following are cmsideraticns

in potency:

‘

(a)mescdrngaffectmmzymsyste1nina
reliable my?

it

(1:)

Can

(c)

What

get to

CNS

to affect the system?

defenses does organism process to block

or limit drug's actim mac in

CNS?

metabolism
the
affect
directly
amt
of a specific system, to that extmt is the CNS dependent upon the
system? Is the dafoct thm induced sigiificmt for the metabolism
B.

of

CNS

Secondly, while an

may

mderlying behavior? Rut Menace can body call into play

when system

has,

is affected to substitute other may system?

the variatim in drug effects in behavior depend upon:
(a) Beluvior at onset; and pmdispositim (personality)

to response;
(b) mug dosage

- availability to

has on m mzym system;

CNS

and the

effect

it

�W'wv‘mw n—m—.n-u.r:~wvmr

.v 4-:-

\I.’—:r~"!lwwmi‘ mama v; M'er‘ui'v-V-‘P 1‘2'.~vr1v-'wv—

(c) Depmdence of

war

"-3;*..)I(7'4&lt;~&lt;'I‘R,IWT~’:~.~HV~’V~W

~,

-

an.» :uru.r-owr:&lt; ,

.. mm?

a. mum

cvw

V:""\

1 &lt;

=-

1

w

-

-—-v.

again on specific enzyme

ommimic defenses (Le.
substitutim for affected system).
(d) Whether effect was gradual (allowing for
system

-—

defenses,

and

,r'ia

Le. , enema

metabolic system)

or acute (not allowing defense).
Individual differemes in meme may be due, thus, to differences
in:
(a) Dosage, ratio

8

mute of mainiatmtim

(b) dependence on the affected system

(c) adaptive ability to biochemical changes.
To

these changes,

EEG

is a

me

approximation and indicator,

reflecting the homeostatic balance in various
the

CNS.

enzyme systems

of

��21

mtylcholim hydrolysis system. Persistent

malt from a damned rate of hydrolysis

of aoetylomlme.

associated with low mmantmtim of either

or

Grantham-11 .

livcd

W,

hypemyndmany my

(immunised

(Oonvamly. in patients with shortcircumstance—I md «II in tissue and

spinal fluid my be mustang! high).

Fmthuc obawa‘ioumwouldcsuaudetmmduud

MW

”mam m «wanted
We.
and
in
cmbut
pmabuoty
5m. Wag

MW

mm
(at.
EEG

«the

hypwymmny

Wow
nu

06

wumwmu.

Mad
a
WW
and

426

in 6m

with as

on.

attend

by

amazon

9‘

WM

W

behauiuat dung“

the blockade“

50M

um

06

muted Mud bum.

pubabLgtMtuu the“. dungu

Lgtu that

The

We! men
06

ethyl.

05

campus“.

ammummamm-

mm

60!: the.

attuned wavubiana.

mam

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67514">
                <text>Files: Acetylcholine and Cholinesterase, 1956-1966 (folder title 3/4).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67515">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67516">
                <text>mfp-03-01-003-0-003</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67517">
                <text>1956-1968</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67518">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67519">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67520">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67521">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67522">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67523">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80954">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87515">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94076">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100637">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="6753" public="1" featured="0">
    <fileContainer>
      <file fileId="6539">
        <src>http://exhibits.library.stonybrook.edu/mfp/files/original/023fc3470d6cfddf7614342c86456639.pdf</src>
        <authentication>b07bb6498b31f3e58fe2ba4d191c8c0f</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="107144">
                    <text>l+/26/57
To:
Dr. Max Fink
From: Dr. H. Goldenberg

are contemplating a change in our cholinesterase
incubation system which would cause significant differences (5-15% increase) in the reported values for
true and pseudocholinesterase. This is the primary
reason we haven't fOrwarded your spinal fluid values
as well as the more recent serum analyses.
We

cholinesterase method (like all methods)
comprises 2 steps:
(1) incubation of enzyme with substrate under fixed
Our

conditions , and
(2) analysis of the reaction products, from which
enzyme activity is calculated. The second step employs
our new and efficient color procedure. Step 1 is
essentially that of earlier workers. On reinvestigating
step 1 we find objections to the large amount of salt
used by others in their system and may eliminate this

ingredient.

an apparent

As

salt is inhibitory, this

increase in

enzyme

would cause

concentration.

All our past analyses can be corrected for this
change by using appropriate factors, but the ultimate
decision whether we are to shift our medium will be
about 10 days in the making.

are naturally anxious to get some
idea of the relative changes in spinal fluid values
following EST, I will forward figures based on the
original salt system on Tuesday.
However, as you

will start running benzoylcholine
as well as the butyryl susbstrate to determine whether
there are 2 pseudocholinesterases in spinal fluid.
This should resolve our uncertainties on this point and
just might possibly lead to new findings.
Next Friday we

�February u , 1966
Dr. Harvey Robinson

WW
thimsity of

The

Baltim,

Bur

Dr.

Institute

Maryland
Maryland 21201

lbbimm:

In mid-October. I submitted the

muncript

”0101111132310

Marxism in vaulsiw 'mempy" for ymr mitigation for
publication in thc Jam 05 Havana and Mental Dame. I

Max
MP : jmh

Fink. NJ).

Promoter of Payduatry

�L45 SOL.‘NAL OF

/"

.Nervour and Mental Diyemc
‘

Harvey

A. Robinson}

Managing Edi'oy'
f

Psychiatric Instihne
u iv r re “’ofM—u‘ Ia d

The

\

82mm”, ,, M0250;

OCtOber 19, 1965
"’"-”‘\.:;,_. n—~L"""”"W‘m“‘“'°-—ﬂ

_

..._..

of
receipt
your
acknowledge
to
This is
Mechanisms
"Cholinergic
entitled
manuscript
"
in Convulsive Therapy.

�Max Fink, M. D.
Department of Psychiatry

Missouri Institute of Psychiatry
5400 Arsenal Street
St. Louis, Missouri 63139

�Wm'

~

-

.m

ﬂ 9 ..

w

w' ‘5w;

Hug-«m-

- ‘
nun—v- w-pr.

W

4mm‘w-q-w—I-sm
.

.

w wwwmvwmm w

“a -

.

m

.

,

,

an(rum

October 15, 1965

Dr. Harvey Robinam

Psychiatric Institute
adversity of Huylmd
The

Baltimn.

Maryland 21901

Dear Dr. Robinson:

mm
Pbdwﬁm in Convulsiw
at.

publication in the

two copios

The
Joanne 05

of the manuscript
"

"010111101310

for your midnmtim for

mm

and

W

Dame.

style of ﬂu citations follow those of this
imtitutim, we will aubdt
copies following your
stylc if the article mots your approval.
While the

mead

Sincumly yours ,
MIX

HF: jun

Pink,

M.D.

Professor of Psychiatry

.wW

'- 7k "-7“. m."-

�THE

N

JOURNAL

67/92/011

I

OF

6111

d M611 ta l

lcwrence

DifEdje

S. Kubie,

Editor-in-Chief

Harvey A. Robinson, Managing Editor
Eugene

B.

Brody, Consulting Editor

The Psychiatric Institute
F

0

U

N

D E D

| N

1

University of Maryland
Baltimore, Md. 21201

3 7 4

February 10, 1966

Dr. Max Fink
Department of Psychiatry

Missouri Institute of Psychiatry
University of Missouri
5400 Arsenal Street
St. Louis, Missouri 63139
Dear Doctor Fink:
I am very sorry to have to tell you that your manuscript
is still under editorial consideration. I do hope to be able to
be able to write to you about it very soon.

Sincerely our 8,

9V

5

W

H. A.‘ Robinson

HAR/sa

»'

�’4

THE

JOURNAL

OF

New/0m and Mei/Ital Diieme

lawrence

S. Kubie,

ZZZ:23:3,”;3.327.315?"
The Psychiatric

F

0

U

N

D E D

|

N

1

8 7 4

Editor-in-Chief

Institute

University of Maryland
Baltimore, Md. 21201

February

1 1,

1966

Dr. Max Fink

Missouri Institute of Psychiatry
5400 Arsenal Street
St. Louis, Missouri 63139
Dear Doctor Fink:
The Editorial Board has carefully considered your manu"
Convulsive
in
entitled
Mechanisms
"Cholinergic
Therapy.
script
Subject to your willingness to meet a number of minor criticisms
and to make some changes that have been suggested by our readers,
we should be very pleased to publish this article. This, then, is
in the nature of a provisional acceptance.

This consideration of brain cholinergic mechanisms and
their significance in convulsive therapy represents an interesting
and valuable point of view. Of course, other chemical changes
have been demonstrated after seizures and have been assigned
equally as important roles as acetylcholine. However, this position
is clearly dated, developed forcefully, and the argument is pertinently documented. We feel that the manuscript makes a definite
contribution.
Nonetheless the Editors are of the opinion that the report
embodies some weaknesses which if dealt with would significantly
improve the quality of the paper. No one doubts that acetylcholine
is important in neural function and that changes in acetylcholine and
cholinesterase occur with induced seizures. The assumption that
the handling of acetylcholine is fundamentally related to the amount
A
of hypersynchrony of the EEG is, we feel, an oversimplification.
Q)
in}. The thesis that the results of treatment by induced convulsions is
related to the sensitivity to changes in acetylcholine levels (pp. 18—19).]
has no information to substantiate it. Although you describe a
"rational biochemical theory" for the mode of action of induced con-

�Dr. Max Fink

February 11, 1966

2.

vulsions, you state only what is already known, that acetylcholine
decreases in the tissues and increases in the spinal fluid with
induced seizure and that the slow waves can be modified by anticholinergic drugs. Although you cite your own work for the effects ”I
of atropine in counteracting the acetylcholine effects of induced
seizures, you do not give evidence that the use of atropine changes 1
the therapeutic results in any confirmed study. There is no con— w
“7
of
evidence
in
for
differences
the
vincing
reactivity or sensitivity
(3)
central nervous system between psychotics and normals to
r"
acetylcholine or cholinesterase.
‘

recommend that you consider the following ideas for
inclusion in the summary:
We

There is as yet no consistent evidence for
differences in anticholinesterase or acetylcholine
senstivity or levels between the psychotic and the
normal brain.
1)

\/"

as yet no reproducible evidence that
anticholinesterases given before, during or after electroconvulsive therapy change the results of the treatment.
2) There is

3) Cholinesterase and acetylcholine levels change
in response to electroconvulsive treatment and in response
to trauma may be a result of other biochemical changes
resulting in vasodilation and increased cellular permeability
which affect the level of consciousness, EEG, and behavior

as well as acetylcholine distribution.

At a more superficial level, we should also recommend that
the manuscript be carefully scrutinized so as to ensure consistency
in drug terminology. We would recommend that the generic names
be used throughout the manuscript and that the capitalized trade
name be included in parentheses, e. g. , methacholine (Mecholyl).
We have indicated a few of these changes on p. 7, p. 9, and p. 10.

I regret to note that the references do not follow the style
we prefer to use. I am enclosing an information sheet, which may
be of some help. Please note that the references should be alphabetized, then numbered, and cited by number in parentheses in the

y

/

�Dr. Max Fink

February 11, 1966

3.

text. Please note, too, that the references should be typed
double-spaced. This enormously facilitates preparing copy
for the printer.
On the hopeful assumption that you will be of a mind to
undertake the recommended changes, I am returning one COpy
of the manuscript, and will retain the other for purposes of
reference. Please let me know how you feel about all of this.

Very sincerely,

H. A. Robinson

HAR/sa

Enclosures

�February 16, 1966

mwmmwm
Mm
Manny mm
Dmﬂuvoybmum
Psychiatric
of

mm.

Maryland 21201

M
3:321th
Myoum
andingm
W"ﬂwmﬂcmin0mwlsiwnunpyﬂ
MWWWmmWW
Ivdﬁuﬂacmaffwttompem
mum-mm.
including
meanwmmmmmmnwd.
ﬁndtatian following tin style: whidnmmmmud.
mmmmmmumamymwimmw
mks.
11'. Rabin-cm

’nunkyou

formant-aim.

Stanlyymm,
ﬂux Pink. NJ).

Professor of Paydﬁatry

fokp

�Harsh n, 1986

Hr. Haw-y A. Roux-won, Hanging Editor
1?. Journal a! Havana and Hmtal

Dim

Psychiatric Institute
m
Lhimdty of Maryland

Baltim'e. Manama
new it. Robina:

21201

My"
"(2le
Wthunofgmdcma,mdmdﬂiedmcitatima
toftttlnstyloottmjoumu.
than

Follovdngymmuwsﬂmn,1hvomdmfmdpmdmsuof
in Oanvulsiw

hernia:

apart

Mmemmhth
meunincludad,udngayomlmm.
Ihawdmdﬂntiﬂewdnhmdmmtimaddoh
wanemtmdiatm.

Ihopethntthiadmft.michI11hnmmttor,m
dthyumappzovnl.

M

you

for your

mu.

Stanly yams,
Fink, NJ).
Manor of Psychiatry

Max

31‘?

�‘5:

i

THE

N

JiOURNAL

or

I

67.120“

5‘

3'

Men ta

ﬂyld

lawrence

1

D1336“?

Harvey A. Robinson, Managing Editor
Eugene

B.

Brody, Consulting Editor

The Psychiatric
F

O

U

N D E D

| N

1

Editor-in-Chief

S. Kubie,

Institute

University of Maryland
Baltimore, Md. 21201

3 7 4

March 9, 1966

Dr. Max Fink

Missouri Institute of Psychiatry
5400 Arsenal Street
St. Louis, Missouri 63139
Dear Doctor Fink:

revision of your manuscript, for which
many thanks. This now looks perfectly fine in all respects,
and we shall be pleased to schedule it for publication.
We have the

best guess is that this material should get to the
printer in five weeks' time or so. Galley proof, then, should
come to you some time late in April.
My

When you receive the galley proof, I hope you will be
able to correct it and to return it to me promptly.

Very sincerely,

H. A.

HAR/sa

Robinson

02,9

8“!

�THE JOURNAL OF NERVOUS AND MENTAL DISEASE
Copyright © 1965 by The Williams &amp; Wilkins Co.

Vol. 140, No.

2

Printed in U.S.A.

Information for Authors
Manuscripts and correspondence pertaining thereto should be addressed to the Managing Editor: DR. H. A. ROBINSON, The Psychiatric Institute, University of Maryland,
Baltimore, Maryland 21201.
Manuscripts should be typed double spaced on one side only of 8% x
original and one clearly legible carbon copy should be submitted.

11

paper. The

It

is helpful if the author supplies a short title for use as a running head. This should
be typed on a separate sheet and be the ﬁrst page of manuscript. Type the complete title
of the article on a second sheet, and the authors’ names and afﬁliations on a third sheet.

Type double-spaced on separate sheets: tabular matter, case histories, quotations, formulas, and other subsidiary matter in the text, footnotes, bibliographies, and legends for
illustrations. Legends must not be attached to or written on the illustration copy. Positions
for tables and ﬁgures in the text should be indicated in the margin of the text page.

Manuscripts should be accompanied by two copies of an abstract of 300 words or less.
Illustrations should be drawn in India ink on white paper with clear lettering. Photographs should be glossy prints. The title Of the article, name of author, and number of
the ﬁgure should be written with a soft pencil on the back of each illustration, and the
top designated.
References should be designated in the text by number in parentheses, e.g., (7). The list
headed REFERENCES at the end of the paper should be arranged in alphabetical order
and numbered. Abbreviations should follow the style of the Index Medicus. Examples:

Book reference:
3. Critchley, M. The

Parietal Lobes, pp.

171—181.

Arnold, London, 1953.

Journal reference:
E., Mirsky, A. F. and Pribram, K. H. Inﬂuence of amygdalectomy
on social behavior in monkeys. J. Comp. Physiol. Psychol., 47: 173—178, 1954.

11. Rosvold, H.

Costs of author’s alterations of type or cuts, in excess of $1.00 per page, will be charged
to the author. Corrections of printer’s errors are not charged to the author. Also the
author will be charged with the cost of engravings in excess of $50.00. One invoice will
be sent covering cost of reprints, alterations and engravings.

The editorial ofﬁce should be notiﬁed promptly of any change of address.
Galley proofs are sent to the author, and should be returned with manuscript to the
editorial ofﬁce. A table of cost of reprints with an order slip. is sent with galley proof.

�runs-“mm”

w'u‘.
\

q.

WJ~F'WWWWMW'W rerI-Iw-um w-mrwmwwz—mr urn—rm—v- mmrﬂrvmuu

(HOMO ASPECTS

NIX

0?

rim,

mm W
HJ).

"mt—amt“:

�....‘.;v-

I-‘mm

..r.-- ..

... v

t

.

..

....

--

.

71-17”W‘

m

.wn -.-»r.-n---»

1'-

~

1*

~-

the Department of Psychiatry, Washingtm University School
and the Dapummt of Psychiatry at the
of
[ﬂasmri Institute of Paydmiatry, University of Missouri
Sdhool of Madicino, SHOO Arsenal St., St. Louis, Missouri 63139.

mam

Aidad, in

by usms grants m—sm, m—2715, menus, and
PEI-11380; and thc Psychiatric Ibsen-cm medatim of Missouri.

Ix:
65-8

part,

2—25-66

Ravisod

for the

Iowa 05 Nuvoua

and Mental

Dame.

�GiOLIhEIRGIC ASPECTS OF CONVULSIVE 'DiERAPY

While the mode

of action of convulsive therapies remains

enigmatic, one theory holds that the early development and

persistence of changes in brain function are rﬁquisite to change

in behavior (17, 20, 22). A useful index of murophysioloﬁical
changes is the appearance of high voltage electroencephalographic
slow wave activity (22, 23). While the biochemistry of this
activity is poorly understood, damstretims that it may be
inhibited by atropine premedicaticn (3k,66) or blocked by anticholiner-gic coepomds (18, 19) suggest that crolinergic system
may

play an active part.
'lhe

EEG

patterns and the response to anticholinergic drugs

issimilar-inexperdmntalmdclinicalheadtrmmamdtoa
lesser extent, in spontaneous seizures to that seen with convulsive
trerepy. 'Ihe activity and changes in concentration of cholinesterases
in brain and spinal fluid in head trams, spontaneous seizures and
convulsive therapy also slow many similarities . This review

discusses these observations to provide the basis for a
hypothesis of the role of oholinergic changes in the convulsive

therapy process .
Acetylcholine has been extensively studied as an agent in

the trensmissim of nervous impulses since

tion by Dale (12) and Load (38).

in a

bound form, acetylcholine

process .

It is

A

its early

identifica—

constituent of nervous tissue

is liberated during the excitaticm

rapidly hydrolyzed through the radiation of

acetylcholnesterase and is rapidly reconstituted by the cholineacetylase systemMS) . Free acetylcholine has not been measurable

�in normal oerebmspinal ﬂuid despite the rapid
bound aoetylcholine during periods

But

breakdown

of

of activity and excitementms) .

tl'e normal cerebrospinal fluid does have

mamble oholimstemse

activity, principally of the "tune" of mcholyl hydrolyzing type
ChoLéuuch Mpew 05 Wombat Tum. Free
acetylcholim was fomd in the oerebrospinal fluid of cats

(I41) .

within a few minutes after experimtal heed trauma and persisted

forvaryingperiodsuptouam. 'Ihequantityoffree
eostylomline varied between 2.7 and 9.0 game percent, and
the mmt was related to the degree of indmed trams (6).

Conctmnt electroencephalogram

first

denmstrated high

voltage fest activity, interpreted as evidence of an intense

mutualdismarge,whichwassomsumededbyasmmperiod
of flattening of all recorded electrical activity. 'Ihese phases
were followed by prolonged periods

of high mlitude sharp

waves

in the delta mquencies.
'Ihe behavioral changes

related to the degree of induced
of manned free aoetylcholine . With

to the aunt
higher levels of acetylcholine, Bernstein reported greater degrees
of EEG abmvrmlity and greater changes in mciousness.

trams

and

Spontaneous post~trmnnetic seizures were also

related to the

emunt of free acetylcholim appearing in the oerebrospmal ﬂuid.

�em
the concentration of ccctylcholim

Bomstcin applicd acetyloholinc to

cortex.

When

out oercbrul

m l gonna

porcentcrlcss,hizhmlitudosharpwavosof1wfmqucn¢m
appeared in tho doctmmceptulcgrm.
was

mm
in

flattened

to

2

gm:

When

tho concontmtim

percent, the cloctromcapmlogmm

a fashion parallel to the

post-mtic

records .

Investigatiom in neurological patients by Tower and
in
the
free
ccctylcholinc
com-Wmtod

Wm

spinal fluid only in patients with meant head trauma, meant
seizures or after olectroconvulsivc thwapy (63).

Mal
Fun

acctylcholim varied from 0.2 to

100

gm

pcrctmt. In

assaying spinal fluid circumstance activity, they noted a

rise in the mpccifio oholimstcmsc fructim (bcnzoyloholinc—
splitting) and a drop in tin swcific circumstance {motion
(unﬁmdnlim-splitting) in patimts with head tram and
sharp

following convulsive tmmpy. Artur spontmoms seizures,

fluid did not exhibit such inversim
contained free acctylcholim. They concluded that

however. the ccmbmapiml

although

it

with
the
varied
of
free
directly
acotyloholim
m1
and that mammal of the oholinestcmse
dome of cerebral
functions was a more mitivc indicator of ocmbml damage.

the

W

Bloctmencophalom. talent at varying intervals following
also indicated a relation betwum the degree of EEG

m.
abmmlitymdtmappwmocoffmcmtyldnlincintm
combmapinal fluid.

�-7-

1......»

um"...

——

u

r.

mﬁ"

57—..-

..

--

1"...” y-w.-u~m-v»- vows-r r, wlma-«w- ”a:

u .

...v

-

-.

mmased aoetylolnlim in net brain after trumatic
also reported by Kovach,
activity was inhibited in

was

to the

muscle preparation.

9:5};

m

.,

n

'-

e .

71‘

—_....

-

"MW“,

shock

(36). This aoetylcholine

by the

adninistmtion of atropine

eleotrogruphic,
behavioral and mmrologic signs of head
me
trauma were blocked by the parenteral administrvatim of

O.5-—1.0 tug/kg

atmpins, asweresimilar'clinicaldmgesooomringaftertm

inhmisterml additim of anetyloholine (6).
observations to the

mamnt of closed head

Ward

applied these

injtmies (67) . In

20

patients with varying degrees of trauma, he administered atropine
subcutamxsly in doses of 0.1 rug/kg, mting clinical inpmvemnt

in scan and a reversal of the electrogrephic effects in others.
‘Ihe some oranges in the post-trumtic electroencephalogrm were

mporhsdbyJemmerandDednmrinastmyofdieﬂnazim, another
mtidmolinergic drug (33). A single intravenous dose in forty
patients resulted in normalizing the abtmal electroencephalogram
in twenty—two and marksdnpmvementin six others.
of post-Wtic shock and
Similarly, in

Wm
oembraledemainminals, Denisenkorepor'tedablodcingofme
clinical changes

and

trunntin

by such

(13) .

Thu, the mount
Aptnat

(no.

mticholinergio ounpomds as mthylbenaltyzim

05

(up. acetytdwune my thymus 4'1: the
mum and the amount as

5w (cumming Wombat

“Layman,

the dzgue and type

abnalmauty, and changu in

demomcephatoguphtc

W mm“ Md
behavtm appm

pheuauena, which may be udueed by the
«Mugs.

05

«A

05

antéchounugtc

_,

t

,

�Bmu'n

eeetytchoune and

Mahounugic

dkugA .

The

effects

of the direct application of acetylcmline to the central nervous

systemmyalsobeblookedbymtidmlinergic drugs. The
aaninietntion of the clmlineeteme hmibitor diuisopmpyl
flmrophoaphate (DFP) elicited high amplitude mpid frequency
EEG patterns similar to status epileptiws and ecu post-traumatic
states (2!, 31, 32, 68). These EEG effects were blocked by small
doses of parenteral atropine and sccpolamine. The great increase

in acetylcholim after tetmethyl pyrophosphate ('13P?) was measumd
and related to the toxic effects and the induced cmwlsions (29, 59).

Wield and Denpsey prepared exposed animal cortex with
pmstignﬁne and evoked electroencephalographic spike activity.

prior ministration of atropine blocked the appeamoe of
spiking, or if present. this electrical activity could be

'Ihe

eliminated by atropine (9) .

In contrast to these findings, Brenner and Merritt applied

topical acetyloholirm in concentrations of
exposed cortex of cats , and noted no

encephalogmphic chmges
The

2—1/3

to

10%

to the

effect an the electro-

after intravemm atropine

(1 tug/kg) (7).

concentrations of coats/lemme in these experimnts, however,

were higher than the

topical applicatims (1-H gamma percent) and
the intmcietemal (0.240 game percent) injections of Bernstein (6).
Brenmr and Merritt also noted electroencePMJogr'aplﬁc effects
similar to acetyloholine after meﬁuolnline (rbctwlyl) and
car‘bmxyldlolim (Daryl) in concentrations mob lower than the

acetylcholine cmcentmticns . They asmibed the increased

�effectiveness of these choliner-gic drugs to their lack of
sensitivity to cerebral cholinasterases .
These data are

conﬂicting and
to qualify this issue.
Cmbnaepémc Fluid
View

Mar study is necessary

Amman

of aoetyloholine mtsbolism finds

and

it

Su'wuu.

One

in nervous tissues

in an bustive and bomd form. wring periods of activity,
sootyloholixnis libemtedattheoellmmbmwl'nmit is
rapidly deactivated by dnlinestemses . The mom“: of bound
acetyloholine is the resultant of the oontimnous processes of
syntl'nsis, liberation and
It has been postulated

mm.

that the level rises during sleep and falls during waking
activity (15, 29, #5, 60). Tobias egg};mported increased
free and total sootyldmoline after chloroform and nonbutal (ck)
anesthesia in net and frog brinui but no changes after
strychnine or piorotoxic oawulsims (60). Richter and

levels in transient, however, as the msynthesis rate for
aoetyloholim in rat brain is high (7 ganm/gm/minute) (as).
mass observations were confirmed by Elliot 51:. 514. (15) and
Ckossland and Merrick

(ll). Giarm

and Pepeu found the

increase in acetylolwline following various depressants to be

rwghtypr'oportimltomedogmeofdopmsimofthe
central

mus

system mad the redaction in motor

Rayner-t and Buck,

activity (29).
however, studying brain acetylcholine levels

�during sedation cone-1m that some sedatives were associated
with elevated bmin acetylcholine, but that no rigorous

mletimships

existed (39). In part, this may be related to the earlier
observations of
and Elliot that acetyldwline synthesis
assured in rat brain slices is accelerated by low dosages of

mm

narcotic drugs, but irhibited by high dosages (140).
Free acetyldaoline was reported in the spinal ﬂuid in
patients with epilepsy (10, 63). 0f 56 epileptic patients ,
m; demxsmtod free acetyldlolinc in
qumtiﬁes of 0.02 to 5.0
with
an average of 1.0:bgannn percent. Acetyldaoline
percent
gm
levels were related to the fmqmncy of seizms, the extent
of electroencephalographic abtmmlity, and to the time since
the last seizure, but bore no relation to medication, type of
epilepsy or level of cholinesterase activity. Elliot 9}; 114
also noted fme aoetylcholine in the spiral fluid in mundane
up

to

3

gm percent after pentylene tetremol

(Mammal)

convulsions (15) .

Mechem vimd the increased acetyloholine
as a by—pmchct of the seizure, and not came]. (63). Studying
the hypothesis that seizures were imhced by the commution of
mtyloholine, ’lbrde measured the level of acetylcholine in
hm tissue after pontylenetetmzcl convulsions. She noted a
Tower and

�rise in the acetylcholina content of
the conwlsion.
failed
.

to occur.

hash before and a

fall

during

certain levels of aoetyldwline, convulsions
suggested that the fall in tissue aoetylcholine

Below

She

during a convulsim was due to the inhibitim of acetylcholine

syntresie by increased concenmtions of metabolites such as
ammonium

ions (61, 62).

GiummmdPepeualsomeasmdclmges incenmlnewous
system acetylcholine following various

after mﬂadmlﬂle

stimlatts

(29) .

Only

and 3, 5-dimthylbutylethyl-baxbitm'ete was

there

a significant changein the acetyldmolim level . They noted a
decrease in association with induced convulsions . With other
drugs which they classified as

ipmniazid

+

stimnam

ipmiazid,

(LSD,

hydrmcytryptophan, and iprcniazid

+ DOPA)

there

in acetylcholine level . they concluded that
despite intense excitation produced by these conpomda, them
were no changes in acetylcholine hols unless these were
observations
('lhe
in
convulsions.
differemes
by
awarded

were no changes

betwentheseobservemandOomgtglﬁimdlbmrmdeadmem
related to the differences in mthods of biochemical
masummnts, for the latter measured chmges mflecting free

may be

acetylcholine only, while

Siam and Pepeu measured the total

acetylcholim. including

forms of

These

AW“

bound and

m

acetylcrmlineluol).

suggest that spontaneous an induced

mm

4;qu

in
5m. acetylehoLéne
an
abound 5m m bound 50m which my be Reﬂected in the
enhance
and
Auzuau
Cmbxal
acetylchoune
(Laid.
activity
spud
deemed“, teaming tum Levels 06 acexyzehoune, whue deep
and anesthesia augment Wicca“ plwduduon taming tame Levels .
accompanied by an inc/Lease

�t ~ .wr,
~

also
Two

,7

w“ in... gym. m.“

cm

u

,

.

.......w....w,,.,_

.7...

,

,

.7 ,

,...,.

“ﬂu..."

......._

,

». __‘

-7,

N-... .. n"...

-..—..

-

.u»...——..r.n Wm m

-gNuvom

3mm Chounutwuu.

m:- and Wm

maid spiral fluid momesternae activity (63,

types of

dumnstemes

614,

65).

whioh hydrolyze acetylcholine are

mutually found in the spixml fluid:

ctnlimstemse~1 ("trm,"

"amcific," or mom—hydrolyzing) which has a high
specificiw for anatyldnlino; and cholinestemse—II ("pseudo,"
"mnapccific," or bamyldmolimahydmlyzing) . The diffemt
rates of hydmlysis for nothao‘noline and benaoyloholim permits
qualitative distimtiom . By reporting tho dwlinestemse
activity as a ratio of the activity with mtrudloline and
huuoyldmlim substrates empamd to an acetyldxolim substrate

dnlimstomseJ/aoatylcholﬁxe and armlimstemse—II/ aoetyldnlim
ratios are derived. Normal oembxospinal fluid contains estemses

in the ratio of

33:17

for dnlixxestemsa-I to dmlimstemse-II .

In patients with head

mum.

'lbwer and McEac-Mm reported

m inwnion of the oholhnstemses with an shamans in the
okxolia‘IIstomean fraction of the spinal fluid and a decrease

in dxolimstemao-I activity.

11»

extent of the oholimstemse

malwasmlttadtoﬂmsewrityofmmmdtothedagzu
of the elootmumphalomphio abnormality.
In patients with elevated spinal fluid aoetyloholim after

ratio of
dolineatemoes or total oknlixmstemse activity was fomd.
spontaneous seizures, mwever, no chmge in the

�Following the recent denmstratims

that neurol stinmlation

produces changes in brain weight and acetylcholinesterase

(37,

), Pryor

M9,

induced

swims in

and Otis studied the

activity

effects of repeated

Wistar rats ('43). After as

little

as

u

weeks,

they observed increases in brain weight and in acetylcholinestemse

activity,

related to decrements in behavioral performance.
in cholinestemse activity may be related to

which was

Changes

changes in

cell

membrane

permeability. Qualinesterese-I is found

in highest concentration in the central nervous system while
cholinestemse—II predominates in other tissues, especially

cerebral acetylcholine, vesclilaticn

blood serum.

With immersed

and increased

cellular permeability

may

be predicted, with a

vucﬂai‘}uitrgnswatim
varying with the extent and duration
degree of

of the vasodilation (35). Spiegel, Spiegel-Adolf, and their coworkers

demtrated

such permeability changes and increased

conductivity of the tissues associated with the appearance of
various ions (as potassimn and phosphate) in the spinal fluid
following electrically induced convulsions (Bu-58) .

Such non-

electrolytes as nucleic—acid splitting enzymes also increased.
Changes in cellular permeability may be the basis for the
high concentrations of acetylcholine and increased concentrations

of cholinesterase-II after induced seizures or head trauma (65).
The

persistence of acetylcholine in spinal fluid after

trams and after seizures despite increased cholinestemse
activity may be related to the sensitivity of the acetylcholine—

head

cholinesterase-l system to concentration relationships (8, #1,

85) .

�.At

"physiologic" concentrations , hydrolysis of acetylcholine

is rapid

(34+ microseconds) but

at higher. and

lower comentrations,

the activity falls off quickly. In contrast, the cholinestemse-II

acetylchcline relationship is non-specific and the rate of hydrolysis
increases with increased concentratim.
'

relationships are related to the induction of seizures.
the usual concentrations of ecetylchcline at cell membranes

These
While

are destroyed by the specific activity of clmlimsterese-I in a
few microseconds, an excessive concentmtim following excitation
may exceed

the rate of hydrolysis by dualinesterase-I.

is

seizmre threshold

seizure

reached and a seizure induced, with the

wt
scetylcholine affects vascular

itself adding to the

increased

The

of free scetylcholine.
and

The

cellular pemeebility,

altering the concentrations of various ions, including dialinestemse-II,
in tissues and in the derebrospinel fluid. The activity of dwlinestemse-II,
though the low efficiency and depending on cmcentmtion

kinetics,
remces the acetylcholine in the tissues in hours to days to levels
for the physiologic action of chcljnestemse-I.

Chawutuase
theta ins/wade in

appeals.

in the spinal (ﬂuid as a uéueaon 06
ﬂuids, mulling (Item chaugu in

mm

sea numb/tans pumeaway occasioned by teamed aeetylehoune.
The teamed ehounutuasu Me paint 06 the homeostatic mechanism
canWLung the Leveu
6M. nmuoub

system

06

acetyzchaune at can mmbmu necessary

datum.

�-12..

t-!ypeluync/wny and Induced

EC?!

Canvuuiom.

The

significance

activity for the convulsive therapy process has been repeatedly stated (22, 23, SO, 51).
The early appearance of high degree hypersynchrony and its persisof the deVelopment of high voltage slow

wave

tence throughout a treatment course has been described as pre-

requisite to inpmvennnt. Both the electrograﬁiic and the
behavioral clunges of inde cmvulsions were transiently reversed
by the acute

aministmtion of experimntal anticholimx‘gic alnpomds

(18, 19). The intmvernus injection of diethazine, benactyzine,

the piperidylbenzilatea
and WIN-2299 induced
These

EEG

JB—318, JB-336 and JB-329

BBQ

(Ditran),

deayncruonizatim in psychiatric subjects.

changes were associated with behavioral

aka: alerting,

anxiety, tremors, illusions , and railucinatims. In patients
who had recently received electromnvulsive therapy, them was a
reduction in slow

wave

activity

and a

reversal of euphoria,

dnnial and oonfmion. Atropim in low doses was associated
with

EEG

desynolmnizatim accompanied by tachycardia, nervousness

and tension.

At higher dosages, hypersynchrmws slow

anes,

followed by lower voltage, poorly organized delta activity with

activity
fusion and diswientatim.

superimposed beta

was

associated with progressive con-

effect of anticholinergic drugs on slow wave activity
was also assessed in convulsive therapy by the chronic adminis—
tration of atropine (5 mam per day) and scapalomine (1 - 3 mg)
The

of-WW

during the weeks of tmatmmt. The

�-13..

mm

of

group who

alwing was significantly less than in a cmtrol
had not moiived the amine adminietretim (66).
EEG

The sasnples were

too small for

clinictl correlation, but the date

is maistent with a definite blocking of the clinical effect.
Marked improvement was seen

of

5

in

2

of

'7

atropine treated, none

scapolmnine treated and in four of the six

waiving mmdified
authors
may have
Ad

who

ECT.

cmtmls

this study we not replicated

by the

suggest that dosage factors or population changes

contributed to the different results (34).

in

mam Mam, the demoguphic changed

induced continuum my be modiﬁed by the
06

muchounugic

06

acctywzounz ad

anou’ated

9W1.

dlmgd, dugguzéng
inc/Lead ed

that

WWO):
anemia

inc/Lead ed

chaunctgic adaptivity

the high wattage

Mow wave

05

x16

activity.

AcetyMaune and Induced Couvwionc. Despite a
constant application of

mm

, however, there

is a

greet variability in the time of eppeardnce, the duration and
the exxent of the electmgrephic slow ween activity as well
as the sensitivity of to modification by alerting, hyperventilation
and

barbiturates in psychiatric populations(30).
The differences in the demo. of induced EEG hypersyncmrcny may

related to differences in central duelinergic activity.
The failure of certain patients to develop hypersynchmny

be

may be

associated with the absence of free acetylcholine and

with minimal clmxges in cerebral function, thus precluding a

clinical response to induced convulsions.

Tower and HcEachem,

�-33..

in their study of omniooerebml

tram,

included observations

of six psychiatric patients undergoing convulsive therapy (63).

after 3-? treatments they reported free
spinal fluid acetylcholine in two patients; and an increase in
clnlinestemseull and a decrease in cholinestemse-I with a
reversal of the ratio of oholinestemses in five of the six
Studying the patients

patients. the one patient in the series who failed to show
either free aoetyloholine or a oholinestemoe ratio reversal
in the spinal fluid was described as: "It is interesting that

this patient

was

tmtmt.“

From

the only one of the six to

show no

response to

these observations they omeluded that the

spinal fluid changes in induced convulsions were

more

like those

of cmniooerebml trams than those of spontaneous epilepsy.
Other evidence of altemtimas in the pemability barrier
seen in the

damstmtions of an increased cmoentmtim
ofoooaineinbmintissues threedays aftersseriesole
induced omvulsions (l). The change in concentration of this
large molecule, ordinarily absent in briin tissue, was associated

may be

with the appearance of hypersynohmny (delta btmsts) in the

elect'oenoephslogram.

Fm thus obsmvauam we would conducts that induced
command, Like mucouebmﬁ Mama and spontaneoua balm/ms,

an

associated with an inc/Laue in ﬁne. acetyzchoune in

am,
mey
enhancing the. «:2qu as chaunutmuu. The Level. 05 ﬁne

Macadam

sawing

«mm

and

�a
hypUuynchlwny a one mama 06 mend Leveu 05 magichouue
maintained by upewted induced Aazwlu.

acetytchaune
and the.

melted

mey

including chewable/(Mu.

05
The

momma»,
changu in

Lym, including acetytchoune (that
Aubamue 504 the.

pwutent

EEG

and 04‘.th Aubetancu,

mmummm

elect/w-

H movide

the

behavioml. changu and

EEG

hypn-

the.

Maﬁa

Aynchhong ﬁauomlng induced convulsions.
An

05

application

the medic/tan

Medication

06

05

05

«than couoquonA

424

(men

in

the convuuive zhmpy aupome and the

paychoeu (21.).

Chounuteluuu and the Medication 05 Peychaeu. Funkenetein
g_t_ g}: demnstr‘ated a relationship between the blood pressure
response to methocholine, an active cholinergic agent, the and the

clinical response to omvuleive therapy (25-27). Inmdiately
after the injection of methaoholine, blood pressure falls,
usually returning to the baseline within 5-20 minutes. A return
within 5 minutes places in the patients in Groups I, II or III;
while a return after 20 minutes places the patient in Groups VI
and VII. Group I and Group II-III have a 9 and a 35% recovery
89%
VI
VII
and
while
Group
Group
respectively,
motors
rate,
and 97% recovery rates to induced convulsions (27). Group I
to III reactors may be looked upon as patients in whom
methecholine is rapidly hydrolyzed; while Groups VI and VII
have a slow hydrolysis rate. (The response to injected
epinephrine was suggested as a second criteria in the

�-16..
While
(H8).
value
of
limited
but
discriminating
is
classificatim,
we

have no biochemical explanation of the differences

metabolism of nethachcline in these psychiatric

in the

it
M8,

is possible that the blood and tissue cholinestemse activity
levels of Groups I-III is high, while that of Groups VIJII is
to genera psychiatric populations.
differences in blood oholinestemse levels in normal and

low ccnpared
The

ill

subjects have been extensively titled studied. Despite
differences in methods ('4, 5) , elevated cholinesterase levels

mntally

ccupared to normal populations have been reported for depressive

subjects (W, #6,

H7,

52), schizOphrenic subjects (1“, 28, 53)

and a mixed psychiatric population (#2) .

Alpem reported

lowered cholinestemse levels in schizophrenic subjects (2).

mile these studies appear inconclusive, they provide data that
the variations in blood cholinesterase levels are generally greater
and frequently elevated in the

mntally

ill.

Negative reports

include the failure by Bllman and Callaway (16) to confirm
Rubin's study; and Altschule's review of the data suggesting
no abnormality of cholinesterase

Conclusion.

levels in the mentally

ill

(3).

This review stunnerizes sane of the available

data suggesting that cholinergic mechanism

may

be

central to

the convulsive therapy process. Induced convulsions are associated
with vasodilation and increased cellular permeability, followed by
the pppeamnce of increased amomts of enzymes and electrolytes in

�intercellular

and cerebrospinal

fluids.

Amng

the changes are

immase in intercellular acetylcholine to levels greater
than can be destroyed by aoetylcholinestemse activity, and
enhanced amounts of butyrylcholinestemse. The increase in
an

acetylcholine, vasodilation, and increased cellular permeability
appear as interrelated phenomena associated with trauma,

seizures and induced convulsions.
These biochemical changes are associated with increased

electrical hypersynohmny which is recorded as EEG slow wave
activity in scalp electrodes, and which can be modified by
acute and chronic ediﬁnistmtims of many anticholinergic dmgs,
including atropine. benactyzine, diethazine, pmcyclidine and
various piperidylbenzilatus.

In these regards, induced convulsions are more similar to

cerebral trauma. than to spontaneous seizures.

in cerebral biochemistry alter cellular activity
sufficiently to affect consciousness and the behavior of subjects.
Failure to induce persistent biochemical changes , including the
concentration of acetyloholine, results in failure to produce
The changes

behavioral change.
Thin!

is,

as yet , no consistent evidence for differences in

the sensitivity or dependence of populations on cholinergic medianisms;
the differences in the rate of development of cerebral changes to the
same number and frequency

of induced convulsions and the classification

based on the blood pressure response to mthacholim suggest,
however,

that

such differences may be important in the

pathogenesis of different psychoses.

����E'

U

‘6

:6

_J!

U
m

3:
=

g

0

D.

YOUR

:3
I)

Ta.

41:

E

O

°

8

:

z

a

£3

'u

E

as.

WITH

.-

g
o
5

.—

‘E

3

e

“

n:&lt;3
0?

DESK

£5

:a:
“1’"
=
0

0)|.um
:3?
1:5a
o

‘ﬂ

:1:

III

z....a)

co

n—

.I

I)
o-

'.

”-0

c:

:3

0

&gt;~

3:

5

” 9

'23:

:2
a
-

c:
1.:
U
an

3..
0&gt;§

E

"E

g0

"
L

D.

a;

0w
a0

£5

z13

(g

i:

(U

.—l

._
\—

3
13
U!
w

e
13
U
&lt;

.g

23

at-

3

0
o

-

ac

il

,~

3"
:2

'3

E

PRESENT

ea

"

‘-

2'5o

AT

o

5"
a»5

°E

n.—O
mi
1:8
m
“
Ex
a
Illa

REGISTRATION

“"
”'7

a:

c c

q,

u:3

32:)
«n-

m

'0
C
m

&gt;‘

3:

Q

h”
o:

a:
0&lt;
c

E

5‘:
h

o55

ON
Eucu

0

1

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIII|IIIIIIIIIIII|IIIIIIIIIIIIIIIIlllllIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

122nd ANNUAL MEETING
AMERICAN PSYCHIATRIC ASSOCIATION
ATLANTIC CITY, N. J.—MAY 9-13, 1966
HIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIHIL_

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

First Name

City

state

Last Name

�CHOLINERGIC ASPECTS OF CONVULSIVE THERAPY

Max

Read

M.D.

at the
May

Now,

Fink,

l22nd ﬂeeting of the American Psychiatric Association,
12, 1966, Atlantic City.

Proféssor of Psychiatry,

5-9-66.

New York

Medical College,

New York

City.

�The mode

of action of induced convulsions is

still

puzzling.

Various theories have been proposed, including those best described

as wholly psychological in scope, and those wholly biological or
Neither
extreme
point of view is consistent
organic - structural.
with the available facts, and the neurophysiological - adaptive
models

—

combining, as they do, both the biological data and the

personality historical facts - are the most satisfactory today.
One of the neurophysiological - adaptive theories suggests that

persistent alterations in brain fUnction are a necessary condition
fOr behavioral change and inprovement in the convulsive therapies.
While many measures of altered brain function have been studied,
similar relationship of change in measure
to behavioral change, the appearance of high voltage slow wave
and each has shown a

activity in the scalp recorded electroencephalogram.has been the
The
induced delta activity
most useful index in these studies.
is readily observed, easily quantified and the amount, distribution
over the scalp, amplitude and persistence are each directly related

the frequency of the induced seizures and are
independent of the mode of induction of the seizure.

to the

number and

While the biochemical

basis for these

EEG

changesgii=3 poorly

understood, observations that the induced slow wave activity was

inhibited by the intravenous administration of anticholinergic

that cholinergic mechanisms may play an
active part not only in the EEG activity but in the therapeutic
compounds, suggested

process as well.

�patterns and the response to anticholinergic drugs
M.
in convulsive therapy were—seen to be similar to the EEG and
The EEG

behavioral changes in experimental and clinical head trauma and

to a lesser extent, in spontaneous seizures. This was clearly
reflected in measures of the cholinesterases in brain and spinal

fluid in these conditions.

These observations led

to a review

of the neurological and biochemical data in induced convulsions,
head trauma and spontaneous seizures, to attempt to

relate the

available observations to the neurophysiological and therapeutic
changes observed in the convulsive therapy process.
The

activity of acetylcholine in the transmission of nervous

impulses has been extensively sutdied since the early descriptions
by Dale and Loewi.in 1914 and 1921.

A

constituent of nervous

tissue in a bound ﬁorm, acetylcholine is liberated during the
excitation process. It is rapidly hydrolyzed through the mediation
of acetylcholinesterase and is rapidly reconstituted by cholineacetylase. Free acetylcholine has not been measurable in normal
breakdown
of bound
the
fluid
despite
cerebrospinal
rapid
acetylcholine during periods of activity and excitement.

But

the normal cerebrospinal fluid does have measurable cholinesterase

activity.

�In_exparimenta&amp;—trauma—ie—eaes,

free acetylcholine

was found

in the cerebrospinal fluid within a few minutes after head trauma lk.(4T$
and

persisted for varying periods

up

to

#8

hours. The quantity

of free acetylcholine varied between 2.7 and 9.0
and the amount was

gamma

percent

directly related to the degree of induced trauma -

the greater the induced head trauma, the higher the amount of
neasured acetylcholine.
Concurrent electroencephalograms

first

demonstrated high

voltage fast activity, interpreted as evidence of an intense
neuronal discharge, which was soon succeeded by short periods

of flattening of

all

recorded electrical activity.

were fbllowed by prolonged and

These phases

persistent periods of high amplitude

sharp waves in the delta frequencies.
The

degree to which the animal's behavior was disorganized

related both to the degree of induced trauma and to the amount
of measured free acetylcholine. The higher the observed levels-

was

of acetylcholine, the greater the degree of EEG abnormality and
the greater the changes in consciousness. The development and
the persistence of spontaneous post—traumatic seizures were also

related to the

amount

of free acetylcholine measured in the

cerebrospinal fluid.
In a parallel study, acetylcholine was applied directly to

the exposed cat cerebral cortex.

acetylcholine was

1 gamma

When

the concentration of

percent or less, high amplitude sharp

�waves

of low frequency appeared in the electroencephalogram.

the concentration was increased to

2 gamma

When

percent, the electro-

encephalogram flattened in a fashion

parallel to the post-traumatic
a relationship between the EEG changes

records, thus again showing
and the concentration of free acetylcholine.

Investigations in neurological patients by

in

1948 demonstrated

Tower and McEachern

free acetylcholine in the cerebrospinal fluid

only in patients with recent head trauma and recent grand-mal

seizures, but also after electroconvulsive therapy. Free acetylcholine
varied fron10.2 to

100 gamma

percent.

In parallel studies they measured the spinal fluid cholinesterase

a sharp rise in the butyrylcholinesterase
(non-specific) fraction and a fall in the acetylcholinesterase

activity.

They noted

(specific) fraction both in the patients with head trauma and in
those fbllowing convulsive therapy. After spontaneous seizures,
however, the cerebrospinal

of cholinesterases although

fluid did not exhibit such

it

an inversion

did contain free acetylcholine. They

that the level of free acetylcholine varied directly with
the degree of cerebral damage and that the reversal of cholinesterase
fractions was a more sensitive indicator of cerebral damage.
concluded

Electroencephalograms taken at varying intervals following
trauma also indicated a relation between the degree of

EEG

abnormality and the appearance of free acetylcholine in the

cerebrospinal fluid.

�Continuing a review of head trauma, we note

behavioral and neurologic signs of head trauma

that the

may be

EEG,

blocked by

the parenteral administration of atropine. ward applied these
observations to the treatment of closed head injuries. In

20

degrees
with
of trauma, the subcutaneous
varying
patients

administration of atropine

in

some and

was

a reversal of the

associated with clinical improvement
EEG

effects in others.

The same

changes in the post—traumatic electroencephalogram.were reported
by Jenkner and Lechner

cholinergic drug.

A

in a study of diethazine, another anti—

single intravenous dose in forty patients

resulted in normalizing the abnormal electroencephalogram in
twenty-two and marked improvement in six others.
That, the amount 06 ghee acetylchouhe may the/LeaAe tn the

Aptnat
ﬁhee

Mia/Cd

5031.0th Wicca/Lewd Mama and the amount

acetytchotthe, the

deg/Lee and

abrzolunaLity, ahd‘changeé

type

05 etect/Loeneephaﬂog/Laphéc

tn euntcat behautot

phenomena, whtch may be ILeduced by

the

05

appea/L a4

ammmmon

06

ate/mutated

anti-

ehotéhejtgtc d/mgb.

3W

acetytchoune and antéehouhugtc

d/LugA.

While the

data is not as clear, the effects of the direct application of
acetylcholine to the central nervous system
by

anticholinergic drugs.

The

may

also be blocked

administration of cholinesterase

inhibitor di-isopropyl fluorophysphate

(DFP)

elicits

high amplitude

�patterns similar to status epilepticus and posttraumatic states. These EEG effects have been blocked by small

rapid frequency

EEG

doses of parenteral atropine and scopolamine.

Chatfield and

Dempsey

prepared exposed animal cortex with

prostigmine and evoked electroencephalographic spike activity.

prior adndnistration of atropine blocked the appearance of
spiking, or if present, thes electrical activity could be
eliminated by atropine.
The

Bornstein also reported that the parenteral administration

of atropine

to modify the behavioral and neurological signs
observed after the intracisternal addition of acetylcholine.
seemed

In contrast to these findings, Brenner and Merritt applied

topical acetylcholine in concentrations of 2-1/2 to 10% to the
exposed cortex of cats and noted no effect on the electro-

after intravenous atropine.
not deﬁthtte, the obeehvattone éuggebt that atnoptne

encephalographic changes
White
may bzoch

the behautotat and

EEG

eﬁﬁecté 06 ghee tntaoduced

acetytchottne tn the Aptnat glutd.
CehebhOAptnat Ftutd Acetytchotthe and Setzuheb.

to free acetylcholine and spontaneous seizures
ship.

One view

we

of acetylcholine metabolism finds

tissues in an inactive and

bound fornn

Turning

again note a relation-

it in nervous

During periods of

activity,

�acetylcholine is said to be liberated at cell membranes where

it

is rapidly hydrolyzed

The amount

and deactivated by

cholinesterases.

of bound acetylcholine is thus the resultant of the

continuous processes of synthesis, liberation and breakdown.

It

has been postulated

falls during

waking

that the level rises during sleep

and

activity.

Free ace: Icholine was reported in the spinal

fluid in

patients with epilepsy. Of 56 epileptic patients, HM
denonstrated free acetylcholine in quantities of 0.02 to 5.0
gamma percent with an average of 1.0 gamma percent. Acetylcholine
levels were related to the frequency of siezures, the extent of
electroencephalographic abnormality, and to the time since
the last seizure but bore no relation to medication, type of

epilepsy or level of cholinesterase activity. Elliott at aﬁ.

also noted free acetylcholine in the spinal fluid in concentrations up to 3 gamma percent after pentylenetetrazol (Metrazol)
convulsions.

the increased acetylcholine
as a by-producifof the seizure and not causal. Studying
Tower and MCEachern viewed

the hypothesis that seizures were induced by the accumulation

of acetylcholine, Torda noted a rise in the acetylcholine content
of brain before and a fall during pentylenetetrazol convulsions.

certain levels of acetylcholine, convulsions failed to
occur. She suggested that the fall in tissue acetylcholine
during a convulsion was due to the inhibition of acetylcholine
Below

synthesis by increased concentrations of metabolites such as
ammonium

ions.

�that AponianeOuA on induced Aeizunei
incneaie in inieiceiiuian ﬁnee aceiyichoiine

Theee etudicb AuggeAi

ane accompanied by an

iibenaied
5iuid.

gnom

iii

Ceaebnai

bound 50am which may be neﬁiecied

activity

in the Apinai

and Aeizuneé enhance aceiyichoiine

deeinuciion, iowening iiAAue ieueiA

05

aceiyichoiine, whiie bicep

and anebihebia augment aceiyichoiine pnoduciion incneaAing iibéue

£evw .
EEG

Hypenbynchnong and Induced ConuuiAionA.

of high voltage

EEG

slow wave

The

significance

activity for the convulsive therapy

process has been repeatedly described, with numerous observers

indicating that increased slowing is associated with behavioral
In the usual course of convulSive therapy, inter-

improvement.

treatment electroencephalogram record progressive increases in
amplitude and in theta activity and a reduction in beta activity.
As

treatment continues, delta activity appears in bursts and

is
the dominant activity in all leads. These changes
eventually
are directly related to the number and rate of induced convulsions,
and is not specific ﬁor a method ofinduction. While some relationships to type of electrical current has been observed, all
_

seizure inducing methods
or inhalant

——

—-

exhibit the

electrical, intravenous
same

type of

EEG

chemical

pattern changes.

�early appearance of high degree hypersynchrony and its
persistence throughout a tre-tment course has—bean—éeuné4834xr
The

«Milan...

prerequisite to inprovement.

Both the

electrographic and the

betavioral changes ofincuced conVulsions are transiently
reversed by the acute administration of experimental anticholinergic
compounds.

The

intravenous injection of diethazine, benactyzine,

the piperidylbenzilates JB—318,JB—336 and JB- 329 (Ditran),
WIN-2299

These

EEG

induced

EEG

desynchronization in psychiatric subjects.

changes were associated with behavioral

alerting,

anxiety, tremors, 'llusions and hallucinations. In patients
had recently received electroconvulsive therapy there was a
reduction in slow wave activity and a reversal of euphoria,

who

denial and constion. Adztpine, in low doses, was also associated
with EEG desynchronization accompanied by tachycardia, nervousness and tension. At higher dosages, hypersynchronous slow
waves followed by lower

voltage, pooly organized delta activity

with superimposed beta activity was accompanied by progressive

constion

and

disorientation.

effect of anticholinergic dimugs on the slow wave
convulsive
of
activity
therLapy was also assessed by the chronic
administration of atropine (5 mgm per day) and scopolamine (1-3
The

during the weeks of treatment.

The amount

of

EEG

slowing was

significantly less than in a control group. The samples were
too small fora dinical correlation but the data is consistent

mg)

�-10with blocking of the clinical effects of electroconvulsive

therapy.

treated,

Marked improvement was

none

of

5

scopolamine-treated and in

controls receiving unnodified

replicated

ECT.

of

2

u

atropine-

7

of the

6

This study was not

that dosage factors
have contributed to the different

by the authors who suggest

or population changes may
results in a second study.
A6

reported in

tn eeaebaat thauma, the eteetnognaphtc

changeb 05

thduced convutttont may be modtﬁted by the adhthtbthatton
06

anttchottnehgte dnugt buggeétthg that tncheabed

05

acetytehottne

on

amountb

tncneated chottnehgte necepttvtty t4

abboctated with the htgh wattage atow wave aettuttg.
Convutttonb.
Aeetytchottne and INduced

Despite a constant

application of treatments, however, there is great variability
in the time of appearance, the duration, amount, and sensitivity
to modification by alerting, hyperventilation and barbiturates

activity in psychiatric
populations. we would suggest that these differences may relate
to differences in central cholinergic activity. The failure of
of the electrographic 81

w

wave

certain patients to develop hypersynchrony

may be

associated

with the failure to liberate excessive amounts of free

acetylcholine, and with the minimal changes in cerebral fUnction

��-11a clinical response to induced convulsions is precluded.

in their study of patients with head trauma,
included observations of six psychiatric patients undergoing

Tower and MCEachern

after

to 7 treatments they reported free spinal fluid acetylcholine in two
convulsive therapy.

Studying the patients

3

patients; and a reversal of the ratio of cholinesterase ratio
reversal in the spinal fluid, the authors stated: "It is interesting
that this patient was the only one of the six to show no response
to treatment."

From

these observations they concluded that the

spinal fluid changes in induced convulsions were

more

like those

of craniocerebral trauma than those of spontaneous epilepsy.
Fnom thete obtenvattont we woutd conctude that induced
convutétont, tthe chantocenebnat tnauma and Apontaneout tetzuneé,

ate attoctated wtth an tncneate tn

ﬁnee

acetytchottne tn tnten-

cettutun gtutdb, attentng cehebnat penmeabttttg and enhanctng
the appeanance

05

chottnettenateb.

The

tevet

t4 matntatned by nepeated tnduced tetzunet.
tA one

ncétectton

05

attened penmeabtttty

attened tevett
05

06

06 ghee
EEG

acetytchottne

hypenégnchhony

acetytchottne and the

etectnotgtet and othen Aubttanceb;

tnctudtng ehottnebtehabet.

The changeé

tn tntencettutan etectno-

tyte4,'tnctudtng acetytchottne, ptoutde the btochemtcat Aubttnate
ﬂat the penttbtent behautonat changeA and EEG hypeneynchhony
ﬂottawtng induced convutetont.

��-12-

CONCLUSIONS

This review summarizes some of the available data suggesting

that cholinergic

central to the convulsive
have observed that induced convulsions are

mechanisms may be

therapy process.

We

associated with cerebral vasodilation and increased cellular

perneability, fbllowed
of

by

the appearance of increased amounts

electrolytes in intercellular and cerebrospinal
increase in acetylcholine, vasodilation and increased

enzymes and

fluids.

The

permeability appear as interrelated phenomena associated with
trauma, seizures and induced convulsions.
These biochemical changes accompany increased

hypersynchrony which

is recorded

as

EEG

slow wave

electrical
activity in

scalp electrodes and which can be modified by the acute and
chronic administration of anticholinergic drugs as atropine,
benactyzine, diethazine, procyclidine and various piperidyl-

benzilates.
In these regards, induced convulsions are more similar to

cerebral trauma than to spontaneous seizures.
The changes in cerebral biochemistry alter cellular activity

sufficiently to affect consciousness

and the behavior

of subjects.

Failure to induce persistent biochemical changes, including the
concentration of acetleholine, results in failure to produce
behavioral change.

�-13There

is,

as yet, no consistent evidence for differences in

the sensitivity or dependence of the cerebral mechanisms underlying

interpersonal behavior of populations on Cholinergic mechanisms.
Differences in the rate of development of cerebral changes to the
sane number and frequency of induced convulsions and

of the mentally

ill

classifications

based on the blodo pressure response to methacholine

suggest, however, that such differences

may

exist

and may be

related to the pathogenesis of different types of psychoses, as
well as the success or failure of our present varieties of biologiCal
treatments .

�CHOLINERGIC ASPECTS OF CONVULSIVE THERAPY

max

Read

at the

Now,

Professor of Psychiatry,

Fink,

M.D.

122nd meeting of the American
may 12, 1966, Atlantic City.

5—9~66.

New York

Psychiatric Association,

Medical College,

New York

City.

�of action of induced convulsions is still puzzling.
Various theories have been proposed, including those best described
The mode

-

as wholly psychological in scope, and those wholly biological or
Neither
organic - structural.
extreme point of view is consistent
with the available facts, and the neurophysiological
models

—

—

adaptive

combining, as they do, both the biological data and the

personality historical facts - are the most satisfactory today.
One of the neurophysiological - adaptive theories suggests that

persistent alterations in brain fUnction are a necessary condition
fbr behavioral change and improvement in the convulsive therapies.
While many measures of altered brain fUnction have been studied,
and each has shown a

similar relationship of change in measure

to behavioral change, the appearance of high voltage slow wave
activity in the scalp recorded electroencephalogram has been the
useful index in these studies.

delta activity
is readily observed, easily quantified and the amount, distribution

most

The induced

over the scalp, amplitude and persistence are each directly related
to the number and the frequency of the induced seizures and are
independent of the

mode

of induction of the seizure.

While the biochemical

basis for these

EEG

changes were poorly

understood, observations that the induced slow wave activity was
inhibited by the intravenous administration of anticholinergic

that cholinergic mechanisms may play an
active part not only in the EEG activity but in the therapeutic
compounds, suggested

process as well.

�patterns and the response to anticholinergic drugs
in convulsive therapy were seen to be similar to the EEG and
The EEG

behavioral changes in experimental and clinical head trauma and

to a lesser extent, in spontaneous seizures. This was clearly
reflected in measures of the cholinesterases in brain and spinal

fluid in these conditions.

These observations led

to a review

of the neurological and biochemical data in induced convulsions,
head trauma and spontaneous seizures, to attempt to

relate the

available observations to the neurophysiological and therapeutic
changes observed in the convulsive therapy process.
The

activity of acetylcholine in the transmission of nervous

impulses has been extensively sutdied since the early descriptions
by Dale and Loewi,in 191” and 1921.

A

constituent of nervous

tissue in a bound form, acetylcholine is liberated during the
excitation process. It is rapidly hydrolyzed through the mediation
of acetylcholinesterase and is rapidly reconstituted by cholineacetylase. Free acetylcholine has not been measurable in normal
breakdown
fluid
the
of bound
cerebrospinal
despite
rapid
acetylcholine during periods of activity and excitement.

But

the normal cerebrospinal fluid does have measurable cholinesterase

activity.

�In experimental trauma in cats, free acetylcholine was found

in the cerebrospinal fluid within a few minutes after head trauma

persisted for varying periods up to H8 hours. The quantity
of free acetylcholine varied between 2.7 and 9.0 gamma percent
and

and the amount was

directly related to the degree of induced trauma the greater the induced head trauma, the higher the amount of
measured acetylcholine.

Concurrent electroencephalograms

first

demonstrated high

voltage fast activity, interpreted as evidence of an intense
neuronal discharge, which was soon succeeded by short periods

of flattening of all recorded electrical activity. These phases
were fbllowed by prolonged and

persistent periods of high amplitude

sharp waves in the delta frequencies.
The

degree to Which the animal's behavior was disorganized

related both to the degree of induced trauma and to the amount
of measured free acetylcholine. The higher the observed levels

was

of acetylcholine, the greater the degree of EEG abnormality and
the greater the changes in consciousness. The development and
the persistence of spontaneous post-traumatic seizures were also

related to the

amount

of free acetyldholine measured in the

cerebrospinal fluid.
In a parallel study, acetylcholine was applied directly to

the exposed cat cerebral cortex.

acetylcholine

was 1 gamma

When

the concentration of

percent or less, high amplitude sharp

�waves

of low frequency appeared in the electroencephalogram.

the concentration was increased to

2 gamma

When

percent, the electro-

encephalogram flattened in a fashion

records, thus again showing

parallel to the post—traumatic
a relationship between the EEG changes

and the concentration of free acetylcholine.

Investigations in neurological patients by
in

19H8

Tower and MeEachern

demonstrated free acetylcholine in the cerebrospinal fluid

only in patients with recent head trauma and recent grand-mal

seizures, but also after electroconvulsive therapy. Free acetylcholine
varied from.0.2 to

100 gamma

percent.

In parallel studies they measured the spinal fluid cholinesterase

activity.

They noted a sharp

(non—specific) fraction and a

rise in the butyrylcholinesterase

fall in the aeetyldholinesterase

(specific) fraction both in the patients with head trauma and in
those fellowing convulsive therapy. After spontaneous seizures,
however, the cerebrospinal

of cholinesterases although

fluid did not exhibit such

it

an inversion

did contain free acetylcholine. They

that the level of free acetylcholine varied directly with
the degree of cerebral damage and that the reversal of cholinesterase
fractions was a more sensitive indicator of cerebral damage.
concluded

Electroencephalograms taken at varying intervals following
trauma also indicated a relation between the degree of

EEG

abnormality and the appearance of free acetylcholine in the

cerebrospinal fluid.

�Continuing a review of head trauma, we note that the

behavioral and neurologic signs of head trauma

may be

EEG,

blocked by

the parenteral administration of atropine. ward applied these
observations to the treatment of closed head injuries.

In

20

patients with varying degrees of trauma, the subcutaneous
administration of atropine was associated with clinical improvement
in

some and

a reversal of the

EEG

effects in others.

The sane

changes in the post-traumatic electroencephalogram were reported
by Jenkner and Lechner

cholinergic drug.

in a study of diethazine, another anti—

single intravenous dose in fbrty patients
resulted in normalizing the abnormal electroencephalogram in
A

twenty-two and marked improvement in six others.
That, the amount 06 ﬁnee acetytchottne may tncneabe tn the

Aptnat ﬁtutd ﬁottownng enatnoeenebaat thauma and the amount 06
ghee aeetytchottne,

the degnee and type

06

eteetaoencephatogaaphte

abnoamattty, and changeA tn cttnteat behavton appeah ab tnteanetated
phenomena, which may be deduced by

the athntAtnatton

06

anti-

ehottnengte dnugb.
Baatn acetytchottne and antichottnengtc daugA.

While the

data is not as clear, the effects of the direct application of

acetylcholine to the central nervous system
by

anticholinergic drugs.

The

may

also be blocked

administration of cholinesterase

inhibitor di-isopropyl fluorophysphate

(DFP)

elicits

high amplitude

�patterns similar to status epilepticus and post—
traumatic states. These EEG effects have been blocked by small

rapid frequency

EEG

doses of parenteral atropine and scopolamine.

Chatfield and

Dempsey

prepared exposed animal cortex with

prostigmine and evoked electroencephalographic spike activity.

prior administration of atropine blocked the appearance of
spiking, or if present, thes electrical activity could be

The

eliminated by atropine.
Bornstein also reported that the parenteral administration

of atropine seemed to modify the behavioral and neurological signs
observed after the intracisternal addition of acetylcholine.
In contrast to these findings, Brenner and Merritt applied

topical acetylcholine in concentrations of 2-1/2 to 10% to the
exposed cortex of cats and noted no effect on the electro—

after intravenous atropine.
not deﬁtntte, the obbchvat£0n4 tuggebt that ataoptne

encephalographic changes
White
may

btoch the behautoaat and

EEG

eﬁﬁeeté 06 ﬁaee tntaodueed

aeetytehottne tn the Aptnat ﬁtutd.
CeaebaaAptnat Ftuid Aeetytchottne and Setzuaea.

Turning

to free acetylcholine and spontaneous seizures we again note a relationship. One view of acetylcholine metabolism finds it in nervous
tissues in an inactive and bound fbrnn During periods of activity,

�acetylcholine is said to be liberated at cell membranes where

it

is rapidly hydrolyzed

The amount

and deactivated by

cholinesterases.

of bound acetylcholine is thus the resultant of the

continuous processes of synthesis, liberation and breakdown.

It

that the level rises during sleep and
falls during waking activity.
Free acetylcholine was reported in the spinal fluid in
has been postulated

patients with epilepsy.

epileptic patients,
denonstrated free acetylcholine in quantities of 0.02 to 5.0
gamma percent with an average of 1.0 gamma percent. Acetylcholine
Of 56

HM

levels were related to the frequency of siezures, the extent of
electroencephalographic abnormality, and to the time since
the

last seizure but

bore no relation to medication, type of

epilepsy or level of cholinesterase activity. Elliott et al.

also noted free acetylcholine in the spinal fluid in concentra—

tions

up

to

3 gamma

percent after pentylenetetrazol (Metrazol)

convulsions.
Tower and MCEachern viewed

the increased acetylcholine

as a by-produce of the seizure and not causal.

Studying

the hypothesis that seizures were induced by the accumulation

of acetylcholine, Tbrda noted a rise in the acetylcholine content
of brain befbre and a fall during pentylenetetrazol convulsions.

certain levels of acetylcholine, convulsions failed to
occur. She suggested that the fall in tissue acetylcholine
Below

during a convulsion was due to the inhibition of acetylcholine

synthesis by increased concentrations of metabolites such as
anmonium

ions.

�ane accompanied by an

tibenated
ﬁiuid.

that Apontaneoub an induced Aeizuneé
incneaAe in intetceiiuian ﬁnee acetyichoiine

Atudiei buggeét

TheAe

iib

gnom

Cenebnai

in the Apinai

bound 60km which may be neﬁiected

activity

and Aeizunei enhance acetyichoiine

duuuctéon, tom/ting tame Lewis
and aneatnebia augment

acetytchome, white deep
acetyichoiine pnoduction incneaeing tiibue
06

ieveii.
EEG

Hypenaynchnony and Induced Convuiiioni.

of high voltage

EEG

slow wave

The

significance

activity for the convulsive therapy

process has been repeatedly described, with numerous observers

indicating that increased slowing is associated with behavioral
In the usual course of convulsive therapy,

improvement.

inter-

treatment electroencephalograms record progressive increases in
amplitude and in theta

activity and a reduction in beta activity.
As treatment continues, delta activity appears in bursts and
eventually is the dominant activity in all leads. These changes
are directly related to the number and rate of induced convulsions,
and is not specific fbr a method ofinduction. While some relation—
ships to type of electrical current has been observed,

seizure inducing methods

or inhalant

-—

-—

electrical, intravenous

eXhibit the same type of

EEG

all

chemical

pattern changes.

�early appearance of high degree hypersynchrony and

The

its

persistence throughout a treatment course has been fbund to be

prerequisite to inprovement.

Both the

electrographic and the

behavioral changes of hduced convulsions are transiently
reversed by the acute administration of experimental anticholinergic
compounds.

The

intravenous injection of diethazine, benactyzine,

the piperidylbenzilates JB-318,
induced

WIN—2299

These

EEG

EEG

JB—336

and JB-329 (Ditran), and

desynchronization in psychiatric subjects.

changes were associated with behavioral

anxiety, tremors, illusions and hallucinations.

alerting,
In patients

who

recently received electroconvulsive therapy there was a
reduction in slow wave activity and a reversal of euphoria,
had

denial and confusion. Atropine, in low doses,
with

EEG

was

also associated

desynchronization accompanied by tachycardia, nervous-

ness and tension. At higher dosages, hypersynchronous slow
waves fbllowed by lower

voltage, poorly organized delta activity

with superimposed beta activity was accompanied by progressive

constion
The

and

disorientation.

effect of anticholinergic drugs

activity of convulsive therapy
administration of atropine (5

was

mgm

on the slow wave

also assessed by the chronic
per day) and scopolamine

during the weeks of treatment. The amount of

EEG

(1—3 mg)

slowing was

significantly less than in a control group. The samples were
too small fbr a clinical correlation but the data is consistent

�-10with blocking of the clinical effects of electroconvulsive

therapy. Marked improvement

treated, none of

5

was

of

2

scopolamine-treated and in

controls receiving unmodified

replicated

reported in

of the

6

This study was not

ECT.

by the authors who suggest

or population changes

u

atropine-

7

that dosage factors

contributed to the different

may have

results in a second study.
A4 tn cehebhat thauma, the eteetnoghaphte

changeb 06

tnduced eonkutows may be modiﬁed by the achntnatjwtéon
06

anttchottnehgtc

06

acetytchottne

dhugA

Auggebttng

on tnmeazsed

that tncneabed

amountA

choltnetgtc heceptéw’ty t6

aAAoctated with the htgh voltage Atow wave

activity.

Acetytchotthe and INduced Convutbtoné. Despite a constant

application of treatuents, however, there is great variability
in the time of appearance, the duration, amount, and sensitivity

to modification

by

alerting, hyperventilation

of the electrographic slow

and

barbiturates

activity in psydhiatric
populations. we would suggest that these differences may relate
to differences in central cholinergic activity. The failure of
certain patients to develop hypersynchrony may be associated
with the failure to liberate excessive amounts of free
wave

acetyldholine, and with the minimal changes in cerebral function

�-11a clinical response to induced convulsions is precluded.

in their study of patients with head trauma,
included observations of six psychiatric patients undergoing

Tower and MCEachern

convulsive therapy.

Studying the patients

after

3

to

7

treat-

ments they reported free spinal

fluid acetylcholine in two
patients; and a reversal of the ratio of cholinesterase ratio
reversal in the spinal fluid, the authors stated: "It is interesting

that this patient was the only one of the six to show no response
to treatnent." From these observations they concluded that the
spinal fluid changes in induced convulsions were more like those
of craniocerebral trauma than those of spontaneous epilepsy.
Fnom

theée obAenvationA

convuibionc,

we wouid

tihe cnaniocenebnai

ane aAAociated with an inn/Lease

eonctude

that induced

tnauma and Apontaneoui beizuneb,

in

ﬁnee

acetytchotine in inten-

cettuian ﬁtuidb, ditching cenebnat penmeubiiity and enhancing
the appeanance 06 choiinebtenabei. The tevet 06 ﬁnee acetyichotine
i2:

maintained by nepeated induced bunt/(.66.

i6 one neﬁiection

06

attened penmeabiiity

ditched ieveté
05

06

EEG

hypeuynchnony

acetyichotine and the

eiectnoiytea and othen iabAt‘ance/s,

inciuding choiineAtenaAeA. The

changeA

in intencetiuian etectno-

iyteb, inciuding acetyichoiine, pnouide the biochemicat bubbtnate
50h the penAiAtent behavionai changeé and EEG hypenaynchnony
ﬁattowing induced canvutbionb.

�-12-

CONCLUSIONS

This review summarizes some of the available data suggesting

that cholinergic

medhanisms may be

central to the convulsive

that induced convulsions are
associated with cerebral vasodilation and increased cellular

therapy process.

we

have observed

perneability, followed
of

by the appearance

of increased amounts

electrolytes in intercellular and cerebrospinal
increase in acetylcholine, vasodilation and increased

enzymes and

fluids.

The

permeability appear as interrelated phenomena associated with
trauma, seizures and induced convulsions.
These biochemical changes accompany increased

hypersynchrony which

is recorded

as

EEG

slow wave

electrical
activity in

scalp electrodes and which can be modified by the acute and
Chronic administration of anticholinergic drugs as atropine,

benactyzine, diethazine, procyclidine and various piperidyl—

benzilates.
In these regards, induced convulsions are more

sinilar to

cerebral trauma than to spontaneous seizures.
The changes

in cerebral biochemistry alter cellular activity

sufficiently to affect consciousness

and the behavior

of subjects.

Failure to induce persistent biochemical changes, including the
concentration of acetylcholine, results in failure to produce
behavioral change.

�-13‘5

There

is,

as yet,

no

consistent evidence for differences in

the sensitivity or dependence of the cerebral mechanisms underlying

interpersonal behavior of populations

on

cholinergic mechanisms.

Differences in the rate of development of cerebral Changes to the
sane number and frequency of induced convulsions and

of the mentally

ill based on the

classifications

blodo pressure response to methacholine

suggest, however, that such differences

may

exist

and may be

related to the pathogenesis of different types of psychoses, as
well as the success or failure of our present varieties of biological
treatnents.

�CHOLINERGIC MECHANISMS IN

CONVULSIVE THERAPY

MAX

FINK, M.D.

DEPARTMENT OF PSYCHIATRY AT THE MISSOURI INSTITUTE OF PSYCHIATRY
UNIVERSITY OF MISSOURI SCHOOL OF MEDICINE
54-00 Arsenal Street

St. Louis, Missouri 63139

PSYCHIATRIC RESEARCH FOUNDATION OF MISSOURI

Pulilicntion No.

65 - 8

�CHOLINERGIC MECHANISMS IN CONVULSIVE THERAPY

Max

Fink, M.D.

Psychiatric Research Foundation
Publication 65—8
September, 1965

�From

the Department of Psychiatry, washington University School of
Medicine and the Department of Psychiatry at the Missouri
Institute of Psychiatry, university of Missouri School of
Medicine, 5400 Arsenal Street, St. Louis, Missouri 63139

Aided, in

part,

by USPHS grants MEI—927, NIH-2715, MH-o72u9, and
MH—ll380; and the Psychiatric Research Foundation of Missouri.

VIII: 8/21/65
65-8

�CHOLINERGIC MECHANISMS IN CONVULSIVE THERAPY

Despite extensive use, the mode of action of the convulsive therapy

process remains enigmatic. The neurophysiologicalradaptive theory
attempts an assimalation of neurophysiological, psychological, clinical,

social aspects of the process (Fink, 1957, 1962)° In this View, the early
development*and persistence of signs of altered cerebral function are
and

requisite to changes in behavior (Pink and

Kahn, 1956), with

electroc

encephalographic slow wave activity as the most significant index

of altered brain function, Demonstrations that premedication with
atropine inhibited this slow

activity (Ulett and Johnson, 1957)
and that-anticholinergic compounds reversed clinical as well as electrographic changes (Fink, 1958) suggests that the biochemical basis fbr
wave

“the convulsive therapy process may be

of the central nervous system.

The

in the cholinergic mechanisms

role of acetylcholine and the

cholinesterases in the convulsiVe therapy process is discussed in

this review,
Acetylcholine has been extensively studied as an active agent

in the transmission of nervous impulses since the first descriptions
by Dale (191%) and Loewi (1921); It is a constituent of nervous tissue.
existing in a
processa

bound form Which

It is rapidly

is liberated during the excitation

hydrolyzed through the specific action

of cholinesterase and is rapidly reconstituted by the choline—
acetylase system&lt;Richter

andessland.

191:9)w

In normal.

�cerebrospinal fluid, free aoetylcholine is not present despite
the rapid breakdown of bound acetylcholine during periods of

activity

and excitement (Tower and McEachern, 19u9a)°

The

cerebrospinal fluid does have measurable cholinesterase activity,

principally of the "true" or mecholyl hydrolyzing type (Nachmanson
In the absence of free acetylcholine and
Rothenberg, 19MB),
under’resting conditions, electroencephalograms fail to
(a)

Cholinergic Aspects of Craniocerebral Trauma:

acetylcholine

was found

after experimental
up

to

H8

show

and

abnormality.

Free

in the cerebrospinal fluid within a

few minutes

head trauma in cats and persisted for varying periods

hours (Bornstein, 1946)o

varied between 2,7 and 9,0

gamma

The

quantity of free acetylcholine

percent, and the

amount was

related to

the degree of induced trauma,
Concurrent electroencephalograms demonstrated records

first filled

with high voltage fast activity, interpreted as evidence of an intense

neuronal discharge,which was soon succeeded by a short period of flattening

of

all

recorded electrical activity,

by prolonged periods

These phases were then fOIlowed

of high amplitude sharp waves in the delta

frequencies,
The behavioral changes were related both to the degree of trauma
and to the amount of measured free acetylcholine,

With higher

of acetylcholine, Bornstein reported greater degrees of

EEG

levels

abnormality

greater changes in consciousness, Spontaneous post-traumatic
seizures were also related to the amount of free acetylcholine
and

�appearing in the spinal fluid.

Bornstein applied acetylcholine to exposed cat cerebral

cortex,

the concentration of acetylcholine

When

was 1 gamma

percent or less, high amplitude sharp waves of low frequency
appeared in the electroencephalogramo When the concentration
increased to

2 gamma

was

percent, the electroencephalogram flattened

in a fashion parallel to the post-traumatic records°

Investigations in neurological patients
McEachern (19M9a) demonstrated

by Tower and

free acetylcholine in the cerebro—

spinal fluid only in patients with recent head trauma, recent
grand—mal seizures or after electroconvulsive therapy° Free
acetylcholine varied from 0,2 to

100 gamma

percent, In assaying

spinal fluid cholinesterase activity, they noted a sharp rise in the
nonSpecific cholinesterase fraction (benzoylcholine—splitting) and
a drop in the specific cholinesterase fraction (mecholyl—splitting)

in patients with head trauma and following convulsive therapy.
After spontaneous seizures, however, the cerebrospinal fluid did
not exhibit such inversion although

it

contained free acetylcholine.

that the level of free acetylcholine varied directly
with the degree of cerebral damage and that reversal of the cholinesterase
fractions was a more sensitive indicator of cerebral damage. ElectroThey concluded

encephalograms, taken

at varying intervals following trauma, also

indicated a relation between the degree of EEG abnormality and the
appearance of free acetylcholine in the cerebrospinal fluid.

�These observations were recently confirmed by Kovach,
Who

recorded increased acetylcholine in rat brain

inhibition of this activity

and an

by

gt_§l. (1957)

after traumatic

shock

the administration of atropine

to the muscle preparationo
ThuA the amount 06 ﬁnee acetytchottne

may tncneaAe

tn the

Aptnat ﬁtutd ﬂattening chantacehebnat tnauma and the amount 06 ﬁnee

aeetytchottne, the degnee and type
changed

tn cttnteat behavton appean

(b)

06
a4

eteetnaencephatognaphtc abnonmattty, and

tntennetated

Anticholinergic drugs and trauma:

The

phenomena°

electrographic,

behavioral and neurologic signs of head trauma were blocked by
the parenteral administration of 095-100 mg/kg atropine (Bornstein,
19u6), as were similar

clinical

changes occurring

after the

intracisternal addition of acetylcholine. Ward (1950) applied
these observations to the treatment of closed head injurieso
In 20 patients with varying degrees of trauma, he administered
atropine subcutaneously in doses of 001 mg/kg, noting clinical
improvement

in

some and

a reversal of the electrographic effects

in otherso Similar alterations in the post—traumatic electroencephalogram were reported by Jenkner and Lechner (1955) in a study of

diethazine, another anticholinergic drugl A single intravenous
dose in forty patients resulted in nornalizing the abnormal
electroencephalogram in twenty~two and marked improvement in six
otherso

�Similar observations have been reported with methylbenactyzine
and

trasentin in animal experiments of post—traumatic shock

cerebral
The

and

edema (Denisenko, 1965),

effect of atropine

was

assessed in the convulsive therapy

process by Ulett and Johnson (1957), With the administration of

to

per day during the weeks the patients
received electroshock therapy, the amount of slow wave activity
atropine
was

up

5 mgm

significantly less than in a control group

received the atropine administration.

who

had not

(These authors

failed to

replicate this study, suggesting that dosage factors or population
changes may have contributed to different results [Johnson et_al.,
1960])o
Both the

electrographic and the behavioral changes of induced

convulsions were also reversed by the administration of experimental

anticholinergic

compounds

(Fink, 1958, 1960),

The

intravenous

injection of diethazine, benactyzine, the piperidylbenzilates
JB-336 and JB-329

(Ditran), and

in psychiatric subjects, These

WIN—2299
EEG

induced

EEG

JB—3l8,

desynchronization

changes were associated with

behavioral alerting, anxiety, tremors, illusions, and hallucinations.

recently received electroconvulsive therapy,
a reduction in slow wave activity and a reversal of euphoria,

In patients

there

was

who had

denial and confusion, Atropine in low doses,

was

associated with

BEG

desynchronization accompanied by tachycardia, nervousness and tension.

�At higher dosages, hypersynchronous slow waves, followed by lower

voltage, poorly organized delta activity with superimposed beta activity
was associated with progressive confusion and disorientation,
Both

in eenebhat

eteethoghaphte changeA
06

thauma and induced convutétOhA, the
may be modtﬁted by

the adhinttthatton

anttchottnehgte dnugb, buggebtthg that tncheabed

amountb

aeetgtehottne on thcaeabed ehottnehgtc heeepttvtty t5
aMoctated with the high wattage stow wave aetéuttg,
06

Brain acetylcholine and anticholinergic drugs:

(c)

Similar

EEG

changes and

similar blocking

by

anticholinergic drugs

has been observed following the direct application of acetylcholine to

the central nervous system, The administration of a cholinesterase

inhibitor

DFP

(di-isopropyl fluorophosphate) elicited high amplitude

patterns similar to status epilepticus, as well as
changes similar to those of post—traumatic states (Freedman et_al., 19H93

rapid frequency

EEG

et_alf,
EEG effects

Himwich

Hampson

1950;

These

were blocked by small doses of

scopolamineo

The

3:.Els’

1950; and Wescoe

et_al,,

1948).

parenteral atropine and

great increase in acetylcholine after tetraethyl

pyrophosphate (TEPP) was measured and related to the toxic
and convulsions induced (Giarman and Pepeu, 1952; Stone, 1957).

Chatfield and

Dempsey (1942)

prepared exposed animal cortex

with prostigmine and evoked electroencephalographic spike activity.
The

prior administration of atropine blocked this spiking, or

the abnormality could be eliminated by atropine.

if present,

�In contrast to these findings, Brenner and Merritt (19u2)

applied topical acetylcholine in concentrations of 2-1/2 to

to the exposed cortex of cats,

and noted no

effect

10%

on the

electroencephalographic changes after intravenous atropine

(l

mg/kg)o

The

concentrations of acetylcholine in these experiments,

however, were higher than the

topical applications

percent) and the intracisternal

(002—10 gamma

(l—M gamma

percent) injections

of Bornstein (19%)° Brenner and Merritt also

made

note of

electroencephalographic effects similar to acetylcholine from
mecholyl Cacetylbetamethylcholine) and doryl (carbamylcholine)

in concentrations
They

much

lower than the acetylcholine concentrations.

ascribed the increased effectiveness of these cholinergic

their lack of sensitivity to cerebral cholinesterases.
These data are conflicting and further study is necessary
to qualify this issue°
drugs to

(d)
View

Cerebrospinal Fluid Acetylcholine and Seizures:

of acetylcholine metabolism indicates that

nervous tissues in an inactive bound fornn

it

is

One

found in

During periods of

activity, acetylcholine is liberated at the cell membrane where
it is rapidly deactivated by cholinesterasea The amount of bound
acetylcholine is the resultant of the continuous processes of
synthesis, liberation and breakdown.

that the level rises during sleep
(Tobias

gt_al.,

19u6; Richter and

It

has been postulated

falls during activity.
Crossland, 19u9; Elliot, Swankt

and

and Henderson, 1950; Giarman and Pepeu, 1962).

Tobias

et_al. found

�8

increased free and total acetylcholine after chloroform and nembutal

anesthesia in rat and frog brain, but no significant changes after
strychnine or picrotoxin convulsions.

Richter and Crossland measured

the level of acetylcholine (micro-gamma per

anesthesia and sleep in rat brain to be
seizure levels,

The

brain tissue) during

higher than postdifference in tissue levels is transient,

however, as the resynthesis

high (7 gamma/gm/minute)o

Elliot et_§1f

mg,

300%

rate for acetylcholine in rat brain is
These observations were confirmed by

(1950) and Crossland and Merrick (195M).

Pepeu (1962) found the increase

Giarman and

in acetylcholine following various

depressants to be roughly proportional to the degree of depression
of the central nervous system and the reduction in motor activity.
Maynert and Buck (196”), however, studying brain acetylcholine

and sedation concluded

that

some

levels

sedating agents are associated with

elevated brain acetylcholine, but that no rigorous relationships

existed. In part, this may be related to the earlier observations
of Melennan and Elliot (1951) that acetylcholine synthesis measured
in rat brain slices is accelerated

by low dosages

of narcotic drugs,

but inhibited by high dosageso
Free acetylcholine was reported in the spinal

patients with epilepsy (Cone,

fluid in

Tower and McEachern, 19MB; Tower

epileptic patinets, nu demonstrated
free acetylcholine in quantities of 0.02 to 5.0 gamma percent with

and McEachern, 19u9b),

an average

of 1,0

gamma

Of 56

percent. Acetylcholine levels were related

�to the frequency of seizures, the extent of electroencephalographic
abnormality, and to the time since the

last seizure, but

bore no

relation to medication, type of epilepsy or level of cholinesterase
activityo Elliot §t_al3 (1950) also noted free acetylcholine
in the spinal fluid in concentrations up to 3 gamma percent after
metrazole convulsions,
Tower and McEachern (19u9b) viewed the

increased acetylcholine

as a by—produce of the seizure, and not causal,

Studying the

hypothesis that seizures were induced by the accumulation of

acetylcholine, Torda (1953) measured the level of acetylcholine in
brain tissue after metrazole convulsions,

She

noted a rise in the

acetylcholine content of brain befbre a seizure and a

fall

during

the convulsion° Below certain levels of acetylcholine, convulsions

failed to occur°

that the fall in tissue acetylcholine
to inhibition of acetylcholine synthesis

She suggested

during a convulsion was due
by increased concentrations

of metabolites such as ammonium ions.
Giarnen and Pepeu also measured changes in central nervous

system acetylcholine following various stimulants.

Only

after

mecholyl and 3, 5-dimethylbutylethyl-barbiturate was there a

significant change in theacetylcholinelevel° They noted a
decrease in association with induced convulsions. With other
drugs which they

iproniazid

+

classified as stimulants

iproniazid,
hydroxytryptoghan, and iproniazid + DOPA) there

were no changes

in acetylcholine level.

(LSD,

They concluded

that

�10

despite intense excitation produced by these compounds, there
were no changes in acetylcholine levels unless these were accompanied

differences in observations between these

by convulsions,

(The

workers and Cone

gt ale

and Tower and McEachern may be

related to

the differences in methods of biodhemical measurements, for the

latter measured

changes

reflecting free acetylcholine only, while

total acetylcholine reflecting bound
and free forms of acetylcholine, [McLennan and Elliot, 1951]).
TheAe AiudieA Auggebi that Aponianeoui an induced beizuheb
ane accompanied by an incheaAe in inienceiiuian ﬁnee aceiyichoiine
iibenaied ﬁnom ii» bound 60am which may be neglected in the
Apinai ﬁiuido Cehebnai aciiviiy and Aeizuneb enhance aceiyichoiine
Giarman and Pepeu measured the

debtnuction, iowehing iiAAue ieveii

06

acetyichoiine, whiie Aieep

and aneéiheéia may augment aceiyichoiine pnoduciion incneaiing

iiiéue ieueiie
(e)

Central Nervous System Cholinesterases:

Tower and McEachern

also measured spinal fluid cholinesterase activity. TWO
types of cholinesterases are normally found in the spinal fluid:
(19H9)

cholinesterase—I ("true," "specific," 0r mecholyl-hydrolyzing),
which has a high

specificity for acetylcholine;

and

cholinesterase-II

("pseudo," "non—specific," or benzoyldholine—hydrolyzing)o
compounds hydrolyze

Both

acetylcholine but have different rates of

hydrolysis for mecholyl and benzoylcholine. This differential

rate perndts qualitative distinctions.

By

reporting the cholinesterase

�11

activity as a ratio of the activity with a mecholyl substrate and
with a benzoylcholine substrate compared to a substrate of
acetylcholine, two ratios are found: cholinesterase—I/acetylcholine
and

cholinesterase-IIlacetylcholineo In sudh ratios normal

cerebrospinal fluid contains esterases in the ratio of 33:17 for

cholinesterase-I to eholinesterase—IIo
with
In patients
head trauma, Tower and McEachern reported
an inversion of the cholinesterases with a increase

in the

cholinesterase-II fraction of the spinal fluid and a decrease in
cholinesterase-I activity. The extent of the cholinesterase
reversal

was

related to the severity of trauma and to the degree

of the electroencephalographic abnormality.
In patients with elevated spinal fluid acetylcholine
spontaneous seizures, however, no change in the

cholinesterases or total cholinesterase activity

in cholinesterase activity

after

ratio of
was found.

related to
changes in cell membrane perneability. Cholinesterase-I is found
in highest concentration in the central nervous system while
cholinesterase-II predominates in other tissues, especially
The change

may be

blood serumo With an increase in acetylcholine levels in cerebral

intercellular fluids, vasodilation

cellular permeability
may be predicted, with a degree of transudation of vascular fluids
into the intercellular spaces varying with the extent and duration
and increased

of the vasodilation (Kabat et_alo, 19u8). Spiegel, Spiegel—Adolf,

�12

and

their

co-workers (19u1, 19u2, lguu, 19H8, 1953) demonstrated

such perneability changes and increased conductivity of the

tissues

associated with the appearance of various ions (as potassium and
phosphate) in the spinal fluid following

convulsions°

electrically induced

Such non—electrolytes as nucleic—acid

also increased, Changes in cellular perneability

Splitting enzynes

may

thus provide

the basis for the high concentrations of acetylcholine and the

increased concentrations of cholinesterase-II in induced seizures or
head trauma (Tower and MCEachern, 19H9c)o
The

persistance of acetylcholine in spinal fluid after head

trauma and

after seizures despite increased Cholinesterase

activity may be related to the sensitivity of the acetylcholinecholinesterase-I system to concentration relationships (Nachmanson
and Rothenberg, lQHS; Tower and McEachern, 19u90; Burgen and MacIntosh,
1955)o

At "physiologic"

is rapid

concentrations, hydrolysis of acetylcholine

(3-H microseconds) but

the activity falls off quicklyc

at higher

and lower concentrations,

In contrast, the cholinesterase—II

acetylcholine relationship is non-specific and the rate of hydrolysis
increases with increased concentration;
These

relationships are related to the induction of seizures.

at cell membranes
are destroyed by the specific activity of cholinesterase-I in a
few microseconds, an excessive concentration following excitation

While the usual concentrations of acetylcholine

may

exceed the rate of hydrolysis by cholinesterase-I.

The

seizure

�13

threshold is reached and a seizure induced, with the seizure

itself

adding to the amount of free acetylcholine. The increased acetylcholine

diffuses rapidly, affecting vascular and cellular perneability and
increasing the concentrations of various ions, including cholinesterase—II,

in tissues

and

in the cerebrospinal fluid,

The

activity of cholinesterase-II,

though of low efficiency and depending on concentration

the acetylcholine in the tissues in hours to days

kinetics, reduces
to levels fbr the

physiologic action of cholinesterase—I.

Chounutemu

appeal:

in the meme Maid

Iheih anheaee in Lhzeheeﬂluiah ﬁﬁuidb, hebuﬁting

in cell

memblume

The Una/Leaded

a4 a heﬁKeetéon 05
ghom

changee

pumeabLU/ty oeeaAioned by incheaeed aeetyZehoLéne.

emanate/wees

connotahg the [evea
50h rte/wow byAtem

05

ahe pant 06

the homeozstauc mechahbsm

acetyzehouhe at eeu membhahu heme/54mg

activity,

(f) Acetylcholine, EEG Hypersynchrony and Induced Convulsions:
Alteration in the blood-brain perneability barrier by the continuing
action of acetylcholine may be a biochemical substrate for the postelectroshock hypersyndhrony of the electroencephalogram, Such a possi-

bility is evident in the

demonstration of an increase in the concen-

tration of cocaine in brain tissues threeidays after a series of

12

induced convulsions (Aird et_§lo, 1956)o The change in concentration

of this large molecule, ordinarily absent in brain tissue, was

associated with the appearance of hypersynchrony(delta bursts) in the
electroencephalogram°

�11+

We

have confirmed the many previous reports

that convulsive thrapy

induces electrographic hypersynchrony (Pink and Kahn, 1956; Fink
1951)°

Despite a constant application of treatments there

is

§t_al.,

a great

variability in the time of appearance, the duration and the extent of
the electrographic slow wave activity as well as the sensitivity to
modification by alerting, hyperventilation and barbiturates in
psychiatric populations (Green, 1957).
degree hypersynchrony and
has been described as

(Roth, 1951; Roth

its persistence

prerequisite to

stain,

in the degree of induced

The

early appearance of high

throughout a treatment course

improvement following electroshock

1957; Pink and Kahn, 1956)o
EEG

The

differences

hypersynchrony may be related to differences

in central cholinergic activity,

The

failure of certain patients to

develop hypersynchrony may be associated with the absence of free

acetylcholine and with minimal changes in cerebral function, thus
precluding a clinical response to induced convulsions° Tower and
McEachern (19H9a),

in their study of craniocerebral trauma, included

observations of six psychiatric patients undergoing convulsive therapy.
Studying the patients after 3—7 treatments they reported free Spinal

fluid acetylcholine in two patients; and an increase in cholinesterase—II
and a decrease in cholinesterase-I with a reversal of the ratio of cholinesterases in five of the six patients, The one patient in the series
Who failed to show either free
acetylcholine or a cholinesterase ratio
reversal in the spinal fluid was described as: "It is interesting that

this patient

was

the only one of the six to show no response to treatment."

�15

From

these observations they concluded that the spinal fluid changes in

induced convulsions were more like those of creniocerebral trauma than

those of spontaneous epilepsy°

If electrographic

hypersynchrony

free acetylcholine, subjects
whom

it

disappears rapidly

who

may be

is a reflection of increased

maintain hypersynchrony and those in

exhibiting differences in the

kinetics of the cholinesterase~acetylcholine hydrolysis systems.
Persistent hypersynchrony may result from.a decreased rate of
hydrolysis of acetylcholine, associated with low concentrations of

either cholinesterase—I or cholinesterase—II. (Conversely, in
patients with short—lived hypersynchrony, cholinesterase—I and
in tissue and spinal fluid may be unusually higho)
Fnom

—II

these obaehvationi uh uuuid conciude that induced

convuiiionb ahe accociated with an incheaie in ghee acetyichotine

in intehceiiuian ﬁiuidt, aitehing cehebhai pehmeabiiity
enhancing the appeahance 05 choiinettehatei. The ieuei

and
06 ﬁnee

it maintained by nepeated induced beizuneb. EEG
hypencynchhony it one heﬁiection 06 aiteaed ieveii 06 acetyichoiine

acetyichoiine

and attehed penmeabiiity 06 otheh eiectnoiyteb°

that

theAe changec

It

i4 phobabie

in intenceiiuiah eiectnoigteb phovide the

biochemicai Aubcthate ﬂan the penAiAtent behavionai changei ﬁoiiowing
induced convuitionia

�16

t.‘

Cg)

wfi

0.

as.

oses=

studies have application to the problem of autonomic
reactivity and the classification of the psychoseso Funkenstein
These

between
1952)
have
demonstrated
1951,
a
relationship
E£;,(19”89
g:
the blood pressure response to injected methacholine (Mecholyl) and

the clinical response of psychiatric patients to convulsive therapy.

is a potent cholinergic agent which induces vasodilation,
tachycardia9 sweating, and increased peristalsiso It is rapidly
Methacholine

hydrolyzed by cholinesterasedI and slowly by cholinesterase-IIo

falls after injected

blood pressure of subjects

to the baseline within five to

20 minuteso

returns to the baseline within

5

II, or III reactors;
and Group

have a

VI and Group VII

(Funkenstein EE.E£;9 1952)o
upon as

patients in

while Groups

VI

Patients

whom

9

and a

reactors
Group

VI

89%

20

or

and VII reactorso

35%

pressure
Group

I,

more
Group

I

recovery rate, respectively,

and

97%

recovery rates

I to III reactors

mecholyl
the injected

may be

looked

is rapidly hydrolyzed;

and VII have a slow hydrolysis rateo

It is possible that the
cholinesterase activity levels of Groups I-III is

review, see Rose9 19620]

whose blood

classified as

those whose blood pressure takes

IIuIII reactors

while Group

mecholyl and returns

minutes have been

minutes to return to baseline, as Group

The

[For a recent

blood and tissue

high, while that

of Groups VI-VII is low compared to general psychiatric populations°
The

mentally

differences in blood cholinesterase levels in normal and

ill

subjects have been extensively studiedo Despite differences

�17

in methods (Augustinsson, 1955, 1957) elevated cholinesterase levels
compared

to normal populations have been reported for depressive

subjects (Richter and Lee, 1942; Rowntree e£_al;, 1950; Ravin and
Altshule9 1952)? schizophrenic subjects (Early 33
Gal9 1963) and a mixed

iii,

psychiatric population (Plum,

1999; Rubin, 1958;

1960)o

Alpern (1956)

reported lowered cholinesterase levels in schizophrenic subjectso

studies appear inconclusive, they provide data that
the variations in blood cholinesterase levels are generally greater
While these

and frequently elevated in the mentally

illo Negative reports

include the failure by Ellman and Callaway (1961) to confirm Rubin's
study; and Altschule“s (1953) review of the data suggesting no abnormality

of cholinesterase levels in the mentally illo
A

similar analysis

may be made

regarding the relation of central

nervous system levels of cholinesterase in the development of

EEG

hyper-

fluid levels of acetylcholine, thus providing a
congruent hypothesis regarding central nervous system reactivity to
induced convulsions and to peripheral cholinergic agents°
synchrony and spinal

�Dig-

CONCLUSION:

This review indicates

that central cholinergic

mechanisms

are significant in the convulsive therapy processo Induced convulsions
are associated with an increase in intercellular acetylcholine to levels

greater than can be destroyed

by

acetylcholinesterase activityo

Vasodilation and increased cellular permeability are followed by the
appearance of increased amounts of butyrylcholinesterase and other
enzymes and

electrolytes in intercellular fluidso

These biochemical changes are associated with increased

hypersynchrony which

is recorded

as

EEG

electrodess and which can be modified by

slow wave
many

electrical

activity in scalp

anticholinergic drugs,

including atropine9 benactyzine, diethazine, procyclidine and

piperidylbenzilateso
In these regards, induced convulsions are more similar to

cerebral trauma than to spontaneous seizures°

in cerebral biochemistry alter cellular recovery
and firing rates sufficiently to alter the behavior of subjectso
Failure to induce high and persistent concentrations of acetylcholine
These changes

or failure to induce concomitant electrolyte changes.does not alter
cerebral cellular activities and results in a failure to produce
behavioral changeo
Differences in the rate of development of cerebral changes to

the

same number and

frequency of induced convulsions

may

reflect

differences in the dependence of subjects on cholinergic mechanisms or

�:19-

in.their sensitivity to

changes in acetylcholine levelso

These

differences provide the basis for the classifications of the mentally

ill

based on neurophysiological responsitivity by Funkenstein and

by Pink and Kahno

These data on cholinergic mechanisms provide a

theory for the

mode

rational biochemical

of action of induced convulsions in altering the

behavior of psychotic subjects9 and are consistent with the more

general neurophysiologicmadaptive theory of the convulsive therapy
process expressed earliero

�REFERENCES

J

W9, Hrenoff, M9 K9 and BowditchLS. C9
Aird, R9 139, Striit’ L A9, Pace,
of electrically induced convulsions ﬁnch. Neel/1.0L
effects
Neurophys1ologg§§
(1959. )19: 371— 378
”WW

I
Aktivnost kholinesterasy

99999

Alpern, D90
i kholinergicheskaya reaktsiya
krovi pri shizofrenii9 [Cholinesterase activity and choliner 10 reaction
of the blood in schizophrenia ”J; Fizzéoh 2%{719575 .57 87- Pg\
9

3%;

J

1/9 .9

Vitamins, enzyme systems, and trace elements9 Bodéﬂy
Phyzsioﬁogy in Mental. and Emotional Duoadefvs) Grune 8 Stratton, New York,
It
1953!
.1

Altschule,

‘

W
M9

W

Augustinsson,

V

D9

New

913$“.

f\

M

for cholinesterases9 In WGlick
05 Biochemical Ana/Emu) Interscience Publishers, 3‘,We 5’
1‘1” [103
Presence and action of acetylcholine in experimental

5%

Method/s

Bornstein, M9 D9
brain trauma9 J; NewLophyAwL,

Wig:

J

399— 399

Merritt, H9 H9 Effect of certain choline derivatives
ctrical acti ity of the cortex. Aach9 Neww£9 PAychia/t.
99: 382 395,

Brenner,
91942.

#4..

'

Assay methods

K9-B9

York, 1957,

f”

________

Augustinsson K '-B9 The normal variation of human blood cholinesterase
activity9 A1199 PhyALOL Scand9,\l955 \3__5_: 90——52}/

'/

arr”

C9

and

'

‘

M

physiological significance
of acetylcholine9 In K9 A9 C9 Elliot, I9 H9 Page and J9 H Quastel)116(/y)
Thomas, Springfield, 4-1-12, 1955],)
NeuaochenuADLy)
jam-939911
27s“.
M99949»,
309
my,
and acetyl;2
Chatfield, P909 and Dempsey, E9 W9~ Effects of
prostig%ne
choline on cortical potentials, (Ame/L9 .79 PhyAzéofw',
1992 135: 633-6M0.
)9]
Burgen,

Cone,

.,

9

,1

99,

W9

A9 S9 V9

and MacIntosh,

F9 C9

The

W

V9, Toner,

D9 B9

and McEachern,

D9

Acetylcholine and neuronal

{j

activity in epilepsy9 (.79A9 M9A9,119u8 73: 59 63
A9
and Merrick,
Crossland,
The effect of anaesthesia on the
acetylcholine content of the brain9 .79 Phybioh ,\¥l95lt.9125 56- 66 9,!
.11 1.
(/JJ’j)
Dale, H9 H9 The action of certain esters and ethers of choline, and
their relation to muscarine. V] Phwunacoh Exp9 Them, 1911+,
1195/
Denisenko, P P9 Pharmacological blocking of central cholinoreactive
systems and the possibilities of its therapeutic applicatiom In G B
,
Koelle, w W. Douglas and A9 Carlssogffzheereﬁ Phamnacoﬂogy 06 ChoLLneJLgnc
V”
and Adaeneagxec Mammmwn. Vol 3 o Glen»

J

J

,

J

_6_:

9

pj’
9

Paoceed/cngb 05

W

Rascovaﬁenm
I‘M"
'
and
Investigations

the Second Inxunaﬁonaz’ Pha/unacoﬁogicaf. Meetcngjgjgb
New
York, 1965/

Macmillan)9%
D9
F9 ,Hemphill,
Early,
9

R9 E9

,Reiss,

M9

Brummel, E9

2499199

into cholinesterase levels in serum and cerebrospinal fluid of psychotic

patients (Biochem.
”Li/V“)
/

.7 ,Fl—E9,

M5:

556
-552- DJ

a”
,

I

9.

�Elliott, K

‘A Co, Swank, Ro

L

and convulsants on acetylcholine content of

{@93sz

brain

JiwﬂhgéLQ£»¢T//’”//JK
(AMeagl

1469—44781

_....—_,—.—

A

.

1

Ellman, G be and Cal.laway,E E1 throcyte cholinesterase—levels in
mental patie.nts Natuhe (Land )@961.J192: l2l§)j

w'v-xﬂ

8.

rI/J&gt;-~/

Effects of anesthetics

and Henderson,_Ng

-/7

unifiedtheory of the ac.tion of physiodynamic therapies°
HstLde
6:
197
(J
206
H08p)(i1967
(116.,
“37"
“m1
F1nk, Mo Effect of anticholinergic agent, diethazine, on EEG and
behavior: significance for theory of convulsive therapy (AﬁkM
(Neon/L01: PbyWaL—WH‘J’IQFM3803875J
F1nk M

A

W

F1nk,M Effect of anticholinergic compounds on post onvulsive electro:
encephalogram and behavior of psydhiatric patients Lectaoenceph CLLn.-~~
NeuhuphyéLOL Jl§66;JlEW(2); 359— 369
convulsive
The
M
mode of action of
Fink,
therapy: the neurophysiologicadaptive View (9: NeuhopAychLato,J1962Jc3: 231—~233)\
\

)J

[AK—y...

7!

um:

17%
A,
m

"lat/"M1-

Fink, Mo and Kahn, Ru L Quantitative studies of slow wave activity
following electroshock ELecLLoenceph CLLn NeuaophyALOLO, @ﬁﬁﬁiq:_;;l58?J
Fink, Mo, Kahn,
Lefkowits, H

1961,u:

R0

J
259 266

Le, Karp,E o, Pollack, Mo, Green, M AC, Alan, B and
Inhalant-induced convulsions (:Ahch Geno PAychLa§&gt;((3K;
.

Freedman, A Mo, Bales,

P D, Willis,

AG

production of electrical major convulsive
117— 121%

fIgﬁé'Jﬁ—J:
“£11-“.V./
FUnkenstein,D

and Himwich,

Ho

Ea

J.

,Ameao

patterns

—

Experimental,€$§£;7
PhgoLoLo,
,.

,

”kw—.-Wn

J

Greenblatt, M and Solomon, H C Autonomic nervous
Nehvo MenM 0L6
system changes following electric shock treatment
:yatt77M
Ho,

[1988,L108: 1109422,

FUnkenstein,

DOH a,

J

Greenblatt,

Solomon,
M and

paralleling psychologic changes in mentally

1

ill

H C Autonomic changes
patients 5:T Neav Mani.”’ﬁ
.

1951.
011%“
18,.I
Funkenstein, DQH o, Greenblatt, Mo and Solomon, Ho Co Autonomic nervous
system test of prognostic si ificance in relation to electroshock
Made,
{Pbychozsomo
treatmento
13:
1952,
3u7—3629”
{as
1__1___~u

Gal, E0 M8 Cholinesterase activity of who blood from healthy and
Sohizophrenic individuals° (Natune"
1963. 19821118-1119&gt;

WW

(M)
)

\9=*"
,

5 6%-,“

V

�and Pepeu, Go Drug-induced changes in brain acetylcholineo
Jo Phanmac0£o," [meg/1&amp;1: 226—2311, 5

Qiarman,

(But,

J

M,

o

Signi ficance of individual variability in
Home, :19574 ﬁg, 229-21104;
electroshocko NJ,
Green,

A,

MD

Hampscn,

w
Jo

wae

"

Essig,

Co

1:1,

((muuw;
and
McCauley,

f luorophosphate

Himwich,

A0

EEG

response to

Effects of

H9 Ea

electroencephalogram and cholinesterase
asvivityo_(Ekectaoencepho Ciino Neuhophybio£0,f1950, g; ulgug&gt; /
div-isop‘ropyl

(DFP) on

Hinwich, Ho E0, Essig, Co Po, X-Iampson, Jo Lo, Bales, Po Do and
Freedman, AU Mo Effect of trimetnadione (Tridione) and other drugs on
convulsions caused by di—isopropyl fluorophosphate (DFP) Amen. J.
R\“””
““1950,‘1062 816-829)
o

*

fM

W

.

”

”rm

Lo and Lechner, Ho
The effect of Diparcol on the electroencephalogram
Jenkner,
and in those with cerebral trauma, E£eot2wenceph. can.
in the normal
1E"o

ﬂax

iwx

subject
/”Neun0phy4£o£o,{1955,LZE 303-6053
1M,
Johnson,

Ulett,

Co,

Lu

J

“3 '7

-

A0, Johnson,

Go

Smith,

MD,

K0

and Sines, Jo

Electroconvulsive therapy (with and without atropine); effect on
electronically analyzed electroencephalogram Allah, Geno Pbychj.

1/

WM"'
Kabat, E0 A0, Glusman,

0%.,

0/

&gt;

and Knaub, V0 Quantitative estimation of the
albumin and gamma globulin in normal and atholo ic cerebrospinal fluid by
immunochemical methodso Wells 10 Mada, [194845;E
653—66253

‘

“NW

Mo

/

brain

of
the
content
Acetylcholine
’
Hung, if E53,: 13; 1—H &gt;J
1;::11
t I44wéhjié.
humorale Ubertragbarkeit der Herznervenwirkungo

Fonyo, A0 and Halmagyi'
in traumatic shocko (Aota Pkg/31.0

Kovach, A,

Ga Bo
,

Mo

,1

‘\

’

‘

_

,

§’

Loewi,
Anch,

O.)

55

Maynert,

Ube

ﬁts,

E0 W;

Ho

and Buck,

1319:

239-292,

Effects of

Eo Go

onacetylcholine synthesﬁgofjo Phwumcoz,
Nachmansohn,

specificity
Plum,

(cum

/.
f;
I,

iﬂw

0‘

depressants on brain
.

convuls

and

narcotic drugd/

Expo ThULo, 1951, 103:_

35,5433

{

and Rothenberg, M, A, Studies on cholinesterase: on
of enzymes in nerve tissueo (J. Mob Chmo,ffgu5.} _]_._5_8: 653—666“;
Do

Study of cholinesterase
Chemo, 1960; pg: 332-390,

Co Mo

activity in nervous

Serum

cholinesterase activity in mental

&gt;M195

,

}

and mental disorders.

R

Ravin, H, A, and Altschule, Mo Do
diseaseo /AItho Newwﬁc Pbychiaxo
a

CDNIOSO

thacolagi£t,, 1961+, g; 191,
and Elliott, K A 9C, Effects;

"adetylcholineo
Mcbennan,

Phybiozo, 1921,

. §§: 616-650)

�1

Richter, D and Cmssland, J Variation in acetylcho ine content of the
Phybioio, 19891159: 2887— 255 a,
brain with physiological stateo /Ame8)L88

J

0

M

Richter, D and

Mo

leeI
838
£882,188821

than
yfI8828188
,J’

"T“.

&lt;72:

D and Lee,

1-

Rose ,

MD

835~83gfj
The

,

W.

Ment. 306,8“,

0/1,”
0\
Serum choline esterase and depresmon.
13° Mani. Soc.)
f“‘p‘.

.

7,

Punkenstein est-57K review of the

&amp;;8§dand
P3ym
,j19625138

,

o

esterase and anxietyc J.

Serum choline

(,4

128—153, /

”W

i

literature.

Aota

».

in the EEG under barbiturate anaesthesia produced by
electroa-convulsive treatment and their significance for the theory of
Roth, M

Changes

C228.
action
fEZectaoenceph
ECT
Roth, Ma, Kay, D W Ko , Shaw,

)
W28”

NeuhophyéLOKO,[1951,[__w261—280

J

J

and Green,
Prognosis and ﬁPentothal
induced electroencephalographic changes in electroyzonvulsive treatment ..
Eﬁemoenceph can NewzophyA/ZOLO, 8f‘1957.;___9: 225- 237 7’

A

S

[/80

ofd1d1opmpyl——°

i

and Wilson, A, The effects
aﬂcorophosphonate in schizophrenic-1and manic depre sive psychosis.
Newwz NQMOAU/tgo Paychiwto, 1950.313: 87-62,

Romtree, D

J

Rubln,

°

We, Nev1n,

°

°

WW“
Acetylcholine hydrolysis in psychiatric patients

Lo So

/.1958,,Ll2___8258-25858) 7

7;

/1881,

‘~‘

:

8

.x'

)1

Spiegel, E A and Spiegel—Adolf, M Physioochemical effects of electrically
induced convulsions (cerebrospinal fluid studies) K Titan/.5 Ame/r.° NewwL AM.,
81888.70: 130132

@1111):

Spiegel, E A and Spiegel-Adolf, M Physiological and physicochemical
mechanisms in electroshock treatment Canéin Weuhoz [195’‘13, 38-63/

A

changes
Go
M
and
Spiegel—Adolf,
Spiegel, E
Physicochemical
Henry,
in the brain accompanying electrically induced convulsive discharges

W/TW
Spiegel-Adolf,
Arnuo

,____

Newwz MAM/Tmﬁﬁﬁ:

81783811

,Wilcox, P H and Spiegel, E
changes in electroshock treatment of psychoses
1988, gg_; 697 706);
Stwone W

E

90] Pkg/8
Amm

M

A.

Cerebrospinal fluid

Amen.

J Paych/éaio,
o

role of acetylcholine in brain metabolism and functiom
Med ,f19'7'; 3‘6: 222——255&gt;/

The

m._._

.

’1qu ,,,,,

~

'~'"

-

if!

Suence,

Spiegel, E A and Spiegel—Adolf, M Permeability changes in the brain
induced by Metrazol and insulin convulsions (Jo NULU. Manx. 0125:,
83; 750 755

/0

%%

.

y“

,2.

'

�Lipton,
Tobias, J
and convulsants on brain acetylcholine contento

*,

Med“;

’7

(KS

Me

MW

0

1:. 51—515

and IJepinat,

A,

A0 A,

Effect of anesthetics

Phone Soco Expo BLO£./;~“

'

"I"

1

“t”

"‘1’ r7
_

and McEachern, Do Acetylcholine and neuronal activity. I.
Cholinesterase patterns and acetylcholine in the cerebrospinal fluids
of— patients with craniocerebral traumao x/“Ctinado J Ru ea/Lch
m cm 5,,
Towem

7.

{ﬁn/x”, '

CO

‘

Wm.

_,

Wk

Effect of convulsion inducing a ents on the acetylcholine
Ame/Lo
Jo Pkg/Maze; 1953, ;l73: 179—183,
brain;
of
the
content
(ACTH)
on
of
Cc
corticotropin
Effects of single injection
Torda,
Jo
PhyMLoL,
braim,gj'ArrIe/Lo
of
content
and
ion
acetylcholine
ammonium
1953, ll}: 175—178j /
Torda,

-

,3-

a

Do

Bo

Q:W105=1195

W

Towem

Do Ba

191M313o

2],:

and McEachern,

molinesterases in

jettg
)
content and characterization of
.,

human

Do

The

cerebrospinal fluidso

(f'fCanado

l32=~ll+53j

a
«QC/t;
Ruea/Lch,
J.
é)'

Do
and
neuronal
and
activity. II.
Acetylcholine
McEachem,
B
Acetylcholme and cholinesterase activity in the cerebrospinal fluids
C’a‘nado p]
of patients with epilepsy», \_’\

Tower, D;

&lt;

120~l3l&gt; IVWL

a

Ruem&amp;9?%27“m
$0
’5)

and
Wo
M,
of
Effect
scopolamine upon
Johnson,
atropine
Ulett,
electroencephalographic changes induced by electro-ccnvulsive therapy.
Ezecthoencepm Cum Neu/Lophyaiozo,fI§S’7‘g"ig_: 217-221;}
Go

A, and

’/wt"

1

WardiAu AU, tropine
(1950, E3 3984020) 1
‘

in the treatment of closed head injuryoﬁJo

Co, Green,

RC

_

V

:1:

r7?“ ,

.

V___“,_,,_-..._.

W0

1

Neu/LOAu/Lg.,

E0, McNamara, Bo Po and Krop, So The influence
J. -7“~Phalmmroi. Exp.
(”of atropine and scopolamine on the central effects of DFP°_ "»»».N..r
lgu8'5‘_9_‘2;: 63-720

We‘oea

'

/’

(“L-9““

The/Lo

,

�.l
mI

,l

I
II,

.I
Al.

_I

”I

.l
.I

,l

'l

I
JI

I
_l

�SET
DuPQCAaTE
MAY

24 1966

(m

(FINAL

EG—J 68

HR

�(mm

(FINAL

EG—J 68
EG—J 68
(CL

oE-NMD-Mar 5-20-5D
(COG

6131
MAX FINK
MAX FINK
MAX FINK
MAX FINK
MAX FINK

(READ

660

BY

PROVE!)

MAX FINK
THERAPY
CONVULSIVE
OF
ASPECTS
CHOLINERGIC
THERAPY
CONVULSIVE
OF
ASPECTS
CHOLINERGIC
THERAPY
CONVULSIVE
OF
ASPECTS
CHOLINERGIC
THERAPY
CONVULSIVE
OF
ASPECTS
CHOLINERGIC
THERAPY
CHOLINERGIC ASPECTS OF CONVULSIVE
THERAPY
CONVULSIVE
OF
ASPECTS
CHOLINERGIC

THERAPY
CONVULSIVE
OF
CHOLINERGIC ASPECTS
MAX FINK, MD.1

�ﬁUPLECﬁzTE SILT
MAY

24

1966

EG—J 71

W
Ward-BMW
Gal 2

%E-NMD-Mar 5/20-5Gx
6131 P. 15 5/19/66 722(3)

'E]li“l"

1Department of Psychiatry,
...

.

’

-

H'

i

I

I

.o

E

u

-

This study was aided, in part, by USPHS grants
MH-927, MH—2715, MH-07249 and MH-11380;
and by the Psychiatric Research Foundation of
Missouri.

While the mode of action of convulsive
therapies remains enigmatic, one theory
holds that the early development and persistence of changes in brain function are
requisite to changes in behavior (18, 21,
22). A useful index of neurophysiological
change is the appearance of high voltage
electroencephalographic slow wave activ—
ity (22, 23). While the biochemistry of this
activity is poorly understood, demonstrations that it is inhibited by anticholinergic compounds (19, 20, 34, 66) suggest
that cholinergic systems may play an active

part.

(m

(FINAL

The EEG patterns and the response to
anticholinergic drugs in convulsive therapy
are similar to experimental and clinical
head trauma and, to a lesser extent, spontaneous seizures. Changes in concentration
of cholinesterases in brain and spinal ﬂuid
also show many similarities in these conditions. This review discusses these observations to provide a hypothesis for the role
of cholinergic changes in convulsive therapy.
The activity of acetylcholine in the
transmission of nervous impulses has been
extensively studied since the early descriptions by Dale (12) and Loewi (38). A
constituent of nervous tissue in a bound
form, acetylcholine, is liberated during the
excitation process. It is rapidly hydrolyzed
through the mediation of acetylcholinesterase and is rapidly reconstituted by the
choline-acetylase system (45). Free ace—
tylcholine has not been measurable in normal cerebrospinal ﬂuid despite the rapid
breakdown of bound acetylcholine during
periods of activity and excitement (63).

///"L.i//&gt;{{
I

"'4 1/.

,1/

:J

Waéff?.__

�part.

mm

(FINAL

(CL

(GOG

The EEG patterns and the response to
anticholinergic drugs in convulsive therapy
are similar to experimental and clinical
head trauma and, to a lesser extent, spontaneous seizures. Changes in concentration
of cholinesterases in brain and spinal ﬂuid
also show many similarities in these conditions. This review discusses these observations to provide a hypothesis for the role
of cholinergic changes in convulsive therapy.
The activity of acetylcholine in the
transmission of nervous impulses has been
extensively studied since the early descriptions by Dale (12) and Loewi (38). A
constituent of nervous tissue in a bound
form, acetylcholine, is liberated during the
excitation process. It is rapidly hydrolyzed
through the mediation of acetylcholinesterase and is rapidly reconstituted by the
choline-acetylase system (45). Free acetylcholine has not been measurable in normal cerebrospinal ﬂuid despite the rapid
breakdown of bound acetylcholine during
periods of activity and excitement (63).
But the normal cerebrospinal ﬂuid does
have measurable cholinesterase activity
(41).
CHOLINERGIC ASPECTS OF CRANIOCEREBRAL
TRAUMA

(READ

660

BY

PROVE!)

Free acetylcholine was found in the
cerebrospinal ﬂuid of cats within a few
minutes after experimental head trauma
and persisted for varying periods up to 48
hours. The quantity of free acetylcholine
varied between 2.7 and 9.0 ga /100 cc,
and the amount was related to t e degree
of induced trauma (6).
Concurrent electroencephalograms ﬁrst
demonstrated high voltage fast activity,
interpreted as evidence of an intense
neuronal discharge, which was succeeded
by a short period of ﬂattening of all recorded electrical activity. These phases
were followed by prolonged periods of

�f.’u

”1:
$3.:

.gsi
1:..n‘1'

24

1955

EG—J 71
%E-NMD-Mar 5/20-5Fx
6131 P. 15 5/19/66 722(1)

Gal 3

high amplitude sharp waves in the
delta
frequencies.

The behavioral changes related
to the
degree of induced trauma and
to the
amount of measured free acetylcholine.
With higher levels of
acetylcholine, Bornstein (6) reported greater degrees
of EEG
abnormality and greater changes in consciousness. Spontaneous
post-traumatic
seizures were also related to the
amount of
free acetylcholine measured in
the cerebrospinal ﬂuid.
Bornstein applied acetylcholine to
exposed cat cerebral cortex. When the
concentration of acetylcholine
was one
gamma/100 cc or less, high amplitude
sharp waves of low frequency
appeared in
the electroencephalogram. When
the concentration was increased to two
100
gamma/
cc, the electroencephalogram ﬂattened
in
a fashion parallel to the
post-traumatic
records.
by Tower and McEachern (63)
demonstrated free acetylcholine in the
cerebrospinal ﬂuid only in patients with
recent
head trauma, recent grand-mal
seizures or
after electroconvulsive therapy. Free
acetylcholine varied from 0.2 to 100
gamma/
100 cc. In assaying spinal
ﬂuid cholinesterase activity, they noted a sharp rise in
the
butyrylcholinesterase fraction and a fall in
the acetylcholinesterase fraction in
patients
with head trauma and following
convulsive
therapy. After spontaneous seizures, however, the cerebrospinal ﬂuid did not exhibit
such inversion although it
contained free
acetylcholine. They concluded that the leve
0f free acetVlChnll‘np

(FINAL

((1

�Bornstein applied acetylcholine to
exposed cat cerebral cortex. When the
concentration of acetylcholine
was one
gamma/100 cc or less, high amplitude
sharp waves of low frequency
appeared in
the electroencephalogram. When
the concentration was increased to two
100
gamma/
cc, the electroencephalogram ﬂattened in
a fashion parallel to the
post-traumatic
records.
Investigations in neurological patients
by Tower and McEachern (63) demonstrated free acetylcholine in the
cerebrospinal ﬂuid only in patients with
recent
head trauma, recent grand-mal seizures
or
after electroconvulsive therapy. Free
acetylcholine varied from 0.2 to 100
gamma/
100 cc. In assaying spinal ﬂuid
cholinesterase activity, they noted a sharp rise in
the
butyrylcholinesterase fraction and a fall in
the acetylcholinesterase fraction in
patients
with head trauma and following
convulsive
therapy. After spontaneous seizures, however, the cerebrospinal ﬂuid did not exhibit
such inversion although it
contained free
acetylcholine. They concluded that the level
of free acetylcholine varied
directly with
the degree of cerebral damage and
that reversal of cholinesterase fractions
was a
more sensitive indicator of cerebral
damage.
Electroencephalograms taken at
varying
intervals following trauma also indicated
a relation between the degree of
EEG abnormality and the appearance of free
acetylcholine in the cerebrospinal ﬂuid.
Increased acetylcholine in rat brain
after
traumatic shock was also reported
by
Kovach et al. (36). This
acetylcholine activity was inhibited by the administration
of atropine in vitro.
The electrographic, behavioral
and neurologic signs of head trauma
were blocked
by the parenteral administration
of 0.5—
1.0 mg/kg atropine,
as were similar clinical
changes occurring after the intracisternal
addition of acetylcholine (6). Ward
applied
these observations to the
treatment of
closed head injuries. In 20
patients with
varying degrees of trauma, he administered
atropine subcutaneously in doses of 0.1
mg/kg, noting clinical improvement in
some and a reversal of the
electrographic
effects in others (67). The
same changes in
the post-traumatic
electroencephalogram
were reported by Jenkner and Lechner in
a
study of diethazine, another anticholinergic drug. A single intravenous
dose in 40
patients resulted in normalizing the
abnormal electroencephalogram in 22
and
marked improvement in six others
(33).

(READ

“660

mom

�2'

on

I'-.-..AY

24

'“

1965

EG—J 84
OE-NMD-Mar 5/20-5E
GAL 4
6131 P. 18 5/19/66 722(1)
Similarly, in experiments of post-trauma-

tic shock and cerebral edema in animals,
Denisenko (13) reported a blocking of
the clinical changes by such anticholinergic
compounds as methylbenactyzine and
adiphenine (Trasentin).
Thus, the amount of free acetylcholine
ma increase in the spinal ﬂuid following
craﬁicerebral trauma and the amount of
free acetylcholine, the degree and type of
electroencephalographic abnormality, and
changes in clinical behavior appear as interrelated phenomena, which may be reduced by the administration of anticholinergic drugs.
BRAIN ACETYLCHOLINE AND
ANTICHOLINERGIC DRUGS

(REV

(FINAL

(CL

(00G

(READ

660

BY

PIOVID

The effects of the direct application of
acetylcholine to the central nervous system
may also be blocked by anticholinergic
drugs. The administration of the cholinesterase inhibitor di-isopropyl ﬂuoroph sphate (DFP) elicited high amplitude rapid
frequency EEG patterns similar to status
epilepticus and some post-traumatic states
(24, 31, 32, 68). These EEG eﬂ'ects were
blocked by small doses of parenteral
atropine and scopolamine. The great increase in acetylcholine after tetraethyl
pyrophosphate (TEPP) was measured and
related to the toxic effects and the induced
convulsions (29, 59).
Chatﬁeld and Dempsey (9) prepared
exposed animal cortex with prostigmine
and evoked electroencephalographic spike
activity. The prior administration of
atropine blocked the appearance of spiking,
or if present, this electrical activity could
be eliminated by atropine.
In contrast to these ﬁndings, Brenner
and Merritt (7) applied topical acetylcholine in concentrations of two and onehalf to ten per cent to the exposed cortex
of cats and noted no effect on the electroencephalographic changes after intravenous atropine (one mg/kg). The concentrations of acetylcholine in these experiments,
however, were higher than the topical applications (one to four gamma/100 cc)
and the intracisternal (0.2—10 gamma/100
cc) injections of Bornstein (6). Brenner
and Merritt (7) also noted electroencephalographic effects similar to acetylcholine
after methacholine (Mecholyl) and carbamylcholine (Doryl) in concentrations
much lower than the acetylcholine concentrations. They ascribed the increased
effectiveness of these cholinergic drugs to
their lack of sensitivity to cerebral cholinesterases.
These data are conﬂicting and further
study is necessary to qualify this issue.

, 0

�(FINA!

(CL

(COG

(READ

660

BY

PROVE!)

atropine blocked the appearance of spiking,
or if present, this electrical activity could
be eliminated by atropine.
In contrast to these ﬁndings, Brenner
and Merritt (7) applied topical acetylcholine in concentrations of two and onehalf to ten per cent to the exposed cortex
of cats and noted no effect on the electroencephalographic changes after intravenous atropine (one mg/kg). The concentrations of acetylcholine in these experiments,
however, were higher than the topical applications (one to four gamma/100 cc)
and the intracisternal (0.2—10 gamma/100
cc) injections of Bornstein (6). Brenner
and Merritt (7) also noted electroenceph—
alographic effects similar to acetylcholine
after methacholine (Mecholyl) and carbamylcholine (Doryl) in concentrations
much lower than the acetylcholine concentrations. They ascribed the increased
effectiveness of these cholinergic drugs to
their lack of sensitivity to cerebral ch0linesterases.
These data are conﬂicting and further
study is necessary to qualify this issue.
CEREBROSPINAL FLUID ACETYLCHOLINE
AND SEIZURES

One View of acetylcholine metabolism
ﬁnds it in nervous tissues in an inactive
and bound form. During periods of activity,
acetylcholine is liberated at the cell membrane where it is rapidly deactivated by
cholinesterases. The amount of bound
acetylcholine is the resultant of the continuous processes of synthesis, liberation
and breakdown (15). It has been postulated that the level rises during sleep and
falls during waking activity (16, 29, 45,

60).
Tobias et al. (60) reported increased free
and total acetylcholine after chloroform
and pentobarbital anesthesia in rat and
frog brain but no changes after strychnine
or pictrotoxin convulsions. Richter and
Crossland (45) measured the level of acetylcholine (microgamma per mg brain tis—
sue) during anesthesia and sleep in rat
brain to be 300 per cent higher than postseizure levels. The difference in tissue levels
is transient, however, as the resynthesis
rate for acetylcholine in rat brain is high
(seven gamma/gm/minute). These observations were conﬁrmed by Elliott et al.
(16) and Crossland and Merrick (11).
Giarman and Pepeu reported the increase in acetylcholine following various
depressants to be roughly proportional to
the degree of depression of the central
nervous system and the reduction in motor
activity (29). Maynert and Buck, however, studying brain acetylcholine levels
during sedation concluded that some sedatives were associated with elevated brain
acetylcholine but that no rigorous relationships existed (39). In part, this may
be related to the earlier observations of
McLennan and Elliott (40) that acetylcholine synthesis measured in rat brain
slices is accelerated by low dosages of narcotic drugs, but inhibited by high dosages.

�£.;__1
-C£HTE
rJdJl “‘
.

2-59—11!

RAY

24 l966
EG—J 84
OE—NMD-Mar 5/20-5E
6131 P. 21 5/19/66 722(3)

A)

GAL

5

Free acetylcholine was reported in the
spinal ﬂuid in patients with epilepsy (10,
63). Of 56 epileptic patients, 44 demonstrated free acetylcholine in quantities of
0.02 to 5.0 gamma/ 100 cc with an average
of 1.0 gamma/ 100 cc. Acetylcholine levels
were related to the frequency of seizures,
the extent of electoencephalographic abmality, and to the time since the last
sféizlmre but bore no relation to medication,
type of epilepsy or level of cholinesterase
activity Elliott et al. (16) also noted free
acetylcholine in the spinal ﬂuid in concentrations up to three gamma/100 cc after
pentylenetetrazol (Metrazol) convulsions.
Tower and McEachern (63) viewed
the increased acetylcholine as a by-product
of the seizure and not causal. Studying the
hypothesis that seizures were induced by
the accumulation of acetylcholine, Torda
(61, 62) measured the level of acetylcholine
in brain tissue after pentylenetetrazol convulsions. She noted a rise in the acetylcholine content of brain before and a fall during the convulsion. Below certain levels of
acetylcholine, convulsions failed to occur.
She suggested that the fall in tissue acetylcholine during a convulsion was due to the
inhibition of acetylcholine synthesis by increased concentrations of metabolites such
as ammonium ions.
Giarman and Pepeu also measured
changes in central nervous system acetylcholine following various stimulants
(29). Only after methacholine and 3,5dimethylbutylethyl-barbiturate was there
a signiﬁcant change in the acetylcholine
level. They noted a decrease in association with induced convulsions. With other
drugs which they classiﬁed as stimulants
(LSD, iproniazid, iproniazid plus hydroxytryptophan, and iproniazid plus DOPA)
there were no changes in the acetylcholine
level. They concluded that despite intense
excitation produced by these compounds,
there were no changes in acetylcholine
levels unless these were accompanied by
convulsions. (The differences in observations between these observers and Gone et
al. (10) and Tower and McEachern (
may be related to the differences in methods of biochemical measurements, for the
latter measured changes reﬂecting free
only, While Giarman and
) measured total acetylcholine
Pepeu
includin_ bound and free forms of acetyl-

K

ya

.7;

Mageline

”ﬁl-

These studies suggest that spontaneous
or induced seizures are accompanied by
an increase in intercellular free acetyl
choline liberated from its bound form
which may be reﬂected in the spinal
ﬂuid. Cerebral activity and seizures enhance acetylcholine destruction, lowering
tissue levels of acetylcholine, while sleep
and anesthesia augment acetylcholine production increasing tissue levels.

(REV

(FINAL

206((1

CENTRAL NERVOUS SYSTEM

�bllUl‘U

l/oi

’/—\,
C/

were

LlU

Guanges

111

we acetylcnoune

level. They concluded that despite intense
excitation produced by these compounds,
there were no changes in acetylcholine
levels unless these were accompanied by
convulsions. (The differences in observations between these observers and Cone et
all. (10) and Tower and McEachern (
may be related to the differences in methods of biochemical measurements, for the
latter measured changes reﬂecting free
holine only, while Giarman and
ce
) measured total acetylcholine
includin bound and free forms of acetyl-

K

m
“Tho

(«3

in).

These studies suggest that spontaneous
or induced seizures are accompanied by
an increase in intercellular free acetyl
choline liberated from its bound form
which may be reﬂected in the spinal
ﬂuid. Cerebral activity and seizures enhance acetylcholine destruction, lowering
tissue levels of acetylcholine, while sleep
and anesthesia augment acetylcholine production increasing tissue levels.

(REV

(FINAL

(CL

CENTRAL NERVOUS SYSTEM
CHOLINESTERASES

Tower and McEachern (63, 64, 65) also
measured spinal ﬂuid cholinesterase activity. By reporting cholinesterase activity as
a ratio of the rate of hydrolysis with two
substrates compared to an acetylcholine

substrate, acetylcholinesterase/acetylcholine and butyrylcholinesterase/acetylcholine ratios are derived. Normal cerebrospinal ﬂuid contains these esterases in the
ratio of 33:17.
In patients with head trauma, Tower and
McEachern reported an inversion of the
cholinesterases with an increase in the
butyrylcholinesterase of the spinal ﬂuid
and a decrease in acetylcholinesterase activity. The extent of the cholinesterase
reversal was related to the severity of
trauma and to the degree of EEG abnormality. A similar reversal was observed in
patients undergoing convulsive therapy.
In patients with elevated spinal ﬂuid
acetylcholine after spontaneous seizures,
however, no change in the ratio of cholinesterases or total cholinesterase activity was

found.
Changes in cholinesterase activity may
be related to changes in cell membrane
permeability. Acetylcholinesterase is found
in highest concentration in the central nervous system. while butyrylcholinesterase predominates in other tissues, especially blood
serum. With increased cerebral acetylcholine, vasodilation and increased cellular
permeability may be predicted, with vascular ﬂuid transudation varying with the
extent and duration of the vasodilation
(35). Spiegel, Spiegel-Adolf and their
coworkers (54—58) demonstrated such permeability changes and increased conductivity of the tissues associated with the appearance of various ions (as potassium
and phosphate) in the spinal ﬂuid following electrically induced convulsions. Such
non-electrolytes as nucleic-acid splitting
enzymes also increased. Changes in cellular
permeability may be the basis for the high

(ooc

(nun

660

8!

mom

�..._.l!_ﬁ$

.0"de

"

;CF;TE

MAY

24

55-12%”?

1965

That changes in cholinesterases
may be
large and measurable is
suggested by the

acetylcholinesterase activity which
was related to decrements in be
havioral perform-

ance.
The persistance‘ of
acetylcholine
in spinal
ﬂuid after head
trauma and after seizures
despite increased cholinesterase
activity
may be related to the
sensitivity of the
acetylcholine~acetylcholinesterase

ip is non-speciﬁc, and

(m

the rate of hydrolysis
increases with increased concentration.
These relationships
relate
to theories
of the induction of
seizures. While the usual
concentrations of acetylcholine
at cell
destroyed by the speciﬁc
activity of acetylcholinesterase
in a few
microseconds, an excessive
concentration
following excitation
may exceed its rate of
hydrolysis. The seizure
threshold may be

(FINAL

altering the concentr
including butyrylcholinesterase
in
tissues
and in the cerebrospinal
ﬂuid.
Through
the activity of this
esterase, though of low
efﬁciency and depending
on concentration
kinetics, acetylchol'
'

J

(CL

(GOG

”J

(nun

660

BY

mom

acetylcholinesterase.
Cholinesterases appear in
the spinal
ﬂuid as a reﬂection of
their increase in intercellular ﬂuids resulting fr
om
changes in
cell membrane
permeabilit y accompanying increased acetylcholine.
EEG HYPERSYN
CHRON Y AND INDUCED
CON VULSIONS

onvulsive therapy process has been
repeatedly
described
(22, 23, 50, 51). In the
usual course of convulsive therapy,
inter-treatment electro~
encephalograms record
progressive
increases in amplitude and in
theta
activity
and a reduction in beta
activity.
As
treatment

�(FINAL

(CL

(GOG

(READ

660

BY

PROVE!)

Name wscu adding to the amount of free
acetylcholine.

Increased acetylcholine
affects vascular and
cellular permeability
altering the concentrations of
various
ions,
including butyrylcholinesterase
in
tissues
and in the cerebrospinal
ﬂuid.
Through
the activity of this
esterase, though of low
efﬁciency and depending
on concentration
kinetics, acetylcholine is
reduced in tis-

acetylcholinesterase.
"" ”My
Cholinesterases appear
ﬂuid as a reﬂection of
their '
tercellular ﬂuids resulting fr
om changes in
cell membrane
permeabilit y accompanying increased acetylcholine.
EEG HYPERSYN
CHRON Y AND INDUCED
CON VULSIONS

onvulsive therapy process has been
(22, 23, 50, 51). In the repeatedly described
usual course of convulsive therapy,
inter-treatment electroencephalograms record
progressive
increases in amplitude and in
theta
activity
and a reduction in beta

activity. As treatelta activity appears in

methods~electrical, intravenous
chemical
or inhalant—exhibit the
same type of EEG
pattern changes (21, 22, 23,
30).
The early appearance of
high degree hypersynchrony and its persistence
throughout a treatment course has
been
found to
be prerequisite to
improvement. Both the
electrographic and th e behavioral
changes
of induced convulsio
us are transiently
reversed by the acute
administration of experimental anticholinergic
compounds
19
20). The intravenou
injec
ion
0 diethazine, benactyzine, t
e piperidylbenzilates
JB—318, JB—336 and
JB—329 (Ditran),
and
WIN—2299 induced
EEG desynchronization in psychiatric
subjects. These EEG
changes were associated
with behavioral
alerting, anxiety, tremors,
illusions and
hallucinations. In patients
cently received electroconvu
lsive
therapy
there was a reduction in
slow
and a reversal of
'

euphoria, d
fusion. Atropine, in low
doses, was also associated with EEG
desynchronization accompanied by tachycardia,
nervousness
and tension. At higher
dosages, hypersynchronous slow waves
followed by lower
voltage, poorly organized
delta
activity
with superimposed beta
activity
companied by progressive
confusion and
disorientation.
The effect of
anticholinergic
drugs on
the slow wave
activity of convulsive therapy was also assessed by the
chronic administration of atropine
(ﬁve mgm per
day) and scopolamine (one
to three mg)
during the Weeks of treatment.
The
amount
of EEG slowing
was signiﬁcantly less

than

S

�J

anaema

WKY

,—

24

("f

“"

-'

1965

EG—J 85
OE-NMD-Mar 5—20-5Fx
Gal. 7
6131 P. 28 5/19/66 722(3)
Marked improvement was reported in two
of seven atropine-treated,
norx of ﬁve

scopolamine-treated and in four of the six
controls receiving unmodiﬁed ECT. This
study was not replicated by the authors
who suggest that dosage factors
or population changes may have contributed
to the
different results in a second study
(34).
As in cerebral trauma, the
electrographic
changes of induced convulsions
be
may
modiﬁed by the administration of
anticholinergic drugs suggesting that increased
amounts of acetylcholine or increased
cholinergic receptivity is associated with
the high voltage slow wave activity.
ACETYLC‘HOLINE AND INDUCED
CON VULSIONS

Despite a constant application of treatments, however, there is great variability
in the time of
appearance, the duration,
amount, and sensitivity to modiﬁcation
by alerting, hyperventilation and barbiturates of the electrographic slow
wave
activity in psychiatric populations (30).
These differences relate to differences in
central cholinergic activity. The failure of
certain patients to develop hypersynchrony
may be associated with the absence of
free acetylcholine and with
minimal
changes in cerebral function, thus precluding a clinical response to induced convulsions. Tower and McEachern
(63), in their
study of craniocerebral trauma, included
observations of six psychiatric patients
undergoing convulsive therapy. Studying
the patients after three to
seven treatments they reported free spinal ﬂuid
acetylcholine in two patients, and an increase
in butyrylcholinesterase and
a decrease in
acetylcholinesterase with a reversal of the
ratio of cholinesterases in ﬁve of the six
patients. Only one patient in the series
failed to show either free acetylcholine
or
a cholinesterase ratio reversal in the
spinal
ﬂui They concluded that the
spinal ﬂuid
anges in induced convulsions were more
like those of craniocerebral trauma
than
those of spontaneous epilepsy.
Other evidence of alterations in the
permeability barrier may be seen in the demonstrations of an increased concentration
of cocaine in brain tissues three
days after
a series of 12 induced convulsions ( 1).
The
change in concentration of this large molecule, ordinarily absent in brain tissue,
was
associated with the appearance of hypersynchrony (delta bursts) in the electroencephalogram.
From these observations we would
conclude that induced convulsions, like
craniocerebral trauma and spontaneous
seizures,
are associated with an increase in free
acetylcholine in intercellular ﬂuids,
altering
cerebral permeability and enhancing
the
‘

(FINAL

06((1

�”renown; m cm; patients, and an increase
in butyrylcholinesterase and
a decrease in
acetylcholinesterase with a reversal of the
ratio of cholinesterases in ﬁve of the six
patients. Only one patient in the series
failed to show either free acetylcholine
or
a cholinesterase ratio reversal in the
spinal
ﬂui They concluded that the
spinal ﬂuid

anges in induced convulsions were more
like those of craniocerebral trauma
than
those of spontaneous epilepsy.
Other evidence of alterations in the
permeability barrier may be seen in the demonstrations of an increased concentration
of cocaine in brain tissues three
days after
a series of 12 induced convulsions (1). The
change in concentration of this large molecule, ordinarily absent in brain tissue,
was
associated with the appearance of
hypersynchrony (delta bursts) in the electroencephalogram.
From these observations we would
conclude that induced convulsions, like
craniocerebral trauma and spontaneous
seizures,
are associated with an increase in free
acetylcholine in intercellular ﬂuids, altering
cerebral permeability and enhancing the
appearance of cholinesterases. The level of
free acetylcholine is maintained
by repeated induced seizures. EEG hypersyn—
chrony is one reﬂection of altered levels of
acetylcholine and the altered permeability
of electrolytes and other
substances, including cholinesterases. The changes in intercellular electrolytes, including
acetylcholine, provide the biochemical substrate
for the persistent behavioral changes
and
EEG hypersynchrony following induced
conv
onsM.
An application WM““WWWM‘MMMK
of these conclusions is
seen in the studies of the prediction of the
convulsive therapy response and the claspsychoses.
I

.,

/

l
\\

W

CHOLINESTERASES AND THE CLASSIFICATION
OF PSYCHOSES

69‘

/

Funkenstein et al. (25—27) reported
a
relationship between the blood pressure response to methacholine and the clinical
response to convulsive therapy. Immediately after the injection of methacholine
the blood pressure falls, usually
returning
to the baseline within ﬁve to 20 minutes.
A return within ﬁve minutes
places the patients in Groups I, II or III; while
a return after 20 minutes place the patients in
roups VI and VII. Group I and Group
II have a nine per cent and a 35
per
ent recovery rate, respectively, while
Group VI and Group VII subjects have
89 per cent and 97
per cent recovery rates
to induced convulsions (27). Group
I, II
and III reactors may be looked
upon as
patients in whom methacholine is rapidly
hydrolyzed; while Groups VI and VII have
a slow hydrolysis rate. (The
response to injected epinephrine was suggested as
a
second criteria in the classiﬁcation, but is
of limited discriminating value
[48].) While
we have no biochemical explanation for
the differences in the metabolism of
methacholine in these psychiatric
groups, it is
possible that the blood and tissue choline—
sterase activity levels of Groups I—III is

I/

high while that of Groups VI—VII is low
compared to general psychiatric populations.

(m

(FINAL

(CL

(COG

�1»:er

24 1966

EG—K 5
%E-NMD-(March) 5/20-5FX
6131 P. 31 5/19/66 722(1)

a»

(mm
/’
'

J

(run.
,

(CL

(GOG

(READ

660

BY

PROVE!)

Gal.

8

The differences in blood cholinesterase
levels in normal and mentally ill
subjects
have been extensively studied. Despite differences in methods (4, 5), elevated cholinesterase levels compared to normal populations have been reported for
depressive
subjects (44, 46, 47, 52), schizophrenic subjects (14, 28, 53) and a mixed psychiatric
population (42). Alpern reported lowered
cholinesterase levels in schizophrenic subjects (2). While these studies
appear inconclusive, they provide data that the variations in blood cholinesterase levels
are
generally greater and frequently elevated in
the mentally ill. Negative
reports include
the failure by Ellman and
Callaway (17)
to conﬁrm Rubin’s study; and Altchule’s
review of the data suggesting no abnormality of cholinesterase levels in the
mentally
ill (3).
-. ..-_-- _
HeSe studies suggest that cholinergic
measures may play a signiﬁcant role in
the therapeutic response to
convulsive
therapy and in the pathogenesis of
psychoses.

.,

'
,

7

CONCLUSION

This review summarizes some of the
available data suggesting that cholinergic
mechanisms may be central to the convulsive therapy process. Induced convulsions
are associated with cerebral vasodilation
and increased cellular permeability, followed by the appearance of increased
amounts of enzymes and electrolytes in
intercellular and cerebrospinal ﬂuids. The
increase in acetylcholine, vasodilation
and
increased permeability appear as interrelated phenomena associated with
trauma,
seizures and induced convulsions.
These biochemical changes
accompany
increased electrical hypersynchrony which
is recorded as EEG slow
wave activity in
scalp electrodes and which can be modiﬁed
by the acute and chronic administration of
anticholinergic drugs as atropine, benactyzine, diethazine, procyclidine and various
DineridVI-hﬂnzilnqu

�“lose stuures suggesr, that cholinergic
measures may play a signiﬁcant role in

/

(
(CL

((IJG

(READ

660

BY

PROVE!)

the therapeutic response to convulsive
therapy and in the pathogenesis of psy-

{

choses.

,

,-

'

’

CONCLUSION

This review summarizes some of the
available data suggesting that cholinergic
mechanisms may be central to the convul—
sive therapy process. Induced convulsions
are associated with cerebral vasodilation
and increased cellular permeability, followed by the appearance of increased
amounts of enzymes and electrolytes in
intercellular and cerebrospinal ﬂuids. The
increase in acetylcholine, vasodilation
and
increased permeability appear as interrelated phenomena associated with
trauma,
seizures and induced convulsions.
These biochemical changes
accompany
increased electrical hypersynchrony which
is recorded as EEG slow
wave activity in
scalp electrodes and which can be modiﬁed
by the acute and chronic administration of
anticholinergic drugs as atropine, benactyzine, diethazine, procyclidine and various
piperidyl-benzilates.
In these regards, induced convulsions
are more similar to cerebral trauma than
to spontaneous seizures.
The changes in cerebral
biochemistry
alter cellular activity sufﬁciently to affect
consciousness and the behavior of subjects.
Failure to induce persistent biochemical
changes, including the concentration of
acetylcholine, results in failure to produce
behavioral change.
There is, as yet, no consistent evidence
for differences in the sensitivity
or dependence of populations on cholinergic mechanisms. Differences in the rate of develop—
ment of cerebral changes to the
same
number and frequency of induced convulsions and classiﬁcations of the
mentally ill
based on the blood pressure
response to
methacholine suggest, however, that such
differences may be signiﬁcant in the
pathogenesis of different psychoses.
1.

REFERENCES
Aird, R. B., Strait, L. A., Pace, J. W.,
HrenoH,
M. K.

and Bowditch, S. C. Neurophysiological effect of electrically induced
A.M.A. Arch. Neurol. Psychiat.,convulsions.
75: 371—

2.

378, 1956.

Alpern, D. O. Aktivnost kholinesterasy i kho—
linergicheskaya reaktsiya krovi pri shizofrenii. (Cholinesterase activity and choliner—
gic reaction of the blood in
schizophrenia.)
Fiziol. Zh. (Kiev), 4: 87—90, 1956.
3. Altschule, M. D.,
Bodily Physiology in Mental
and Emotional Disorders,
pp. 169—172. Grune
&amp; Stratton, New
York, 1953.
4. Augustinsson, K.-B.
The normal variation of
human blood cholinesterase
activity.
Acta
Physiol. Scand., 35: 40—52, 1955.
5. Augustinsson, K.—B.
Assay methods for cholinesterase. In Glick, D., ed. Methods
Bioof
Chemical Analysis, vol. 5,
1—63. Interpp.
science Publishers, New York, 1957.
6. Bernstein, M. D. Presence
and action of acetylcholine in experimental brain
trauma. J.
neurophysiol., 9: 349—366, 1946.
7. BFe'hner, C. and
Merritt, H. H. Effect of certain choline derivatives on electrical
of the cortex. A.M.A. Arch. Neurol. activity
Psychiat.,
48: 382—395, 1942.
8. Burgen, A. S. V. and
MacIntosh, F. C. The
physiological signiﬁcance of acetylcholine.
In Elliot, K. A. C., Page, I. H. and Quastel,
J. H., eds. Nem‘ochemistry,
pp. 374—375.
Thomas, Springﬁeld, Illinois, 1955.

l
l

l
|

�SET
aumscmi-Z
MAY

24

1966

EG—K 5
%E-NMD-Mar 5/20-5Fx

Gal

6131 p. 7 5-20-66 640
9. Chatﬂeld, P. O.

9

(4)
and Dempsey, E. W. Effects
of prostigmine and acetylcholine
potentials. Amer. J. Physiol., 135:on cortical
633—640,
1942.

10.

Cone, W. V., Tower, D. B. and
Acetylcholine and neuronal McEachern, D.
activity in epilepsy. J.A.M.A., 73: 59—63, 1948.
11. Crossland, J. and
Merrick, A. J. The effect of
anaesthesia on the acetylcholine
content of
the brain. J. Physiol.
(London), 125: 56—66,
1954.

12.

carine. J. Parmacol. Exp.
Ther., 6: 147, 1914.
Denisenko, P. P. Pharmacological
blocking of
central cholinoreactive systems and
the possibilities of its therapeutic
application. In

13.

14.

Early, D. F., Hemphill, R. E.,
Reiss, M. and
Brummel,
Investigations into cholinesterase levels in serum and cerebrospinal
ﬂuid of
psychotic patients. Biochem. J
45: 552—556,
.

.,

1949.

15.

Eccles, J. C. The Physiology
Academic Press, New York, 1964.of Synapses.
16. Elliott, K. A.
C., Swank, R. L. and
Henderson,
N. Effects of anesthetics
and convulsants on
acetylcholine content of brain.
Amer.
J.
Physiol., 162: 469—474, 1950.
17. Ellman, G. L.
and Callaway, E. Erythrocyte
cholinesterase-levels in mental
patients. Na-

ture (London), 1.92: 1216, 1961.
18. Fink, M. A uniﬁed
theory of the action of
physiodynamic therapies. J. Hillside
Hosp.
(Glen Oaks), 6: 197—206, 1957.
19. Fink, M. Eﬁ‘ect
of anticholinergic
ethazine, on EEG and behavior: agent, diSigniﬁcance
for theory of convulsive
Arch. Neurol. Psychiat., 80:therapy. A.M.A.
380—387, 1958.
20. Fink, M. Effect of
anticholinergic compounds
on post convulsive electroencephalogram
and
behavior of psychiatric
patients. Electroenceph. Clin. Neurophysiol., 12:
359—369,
1960.

21.

Fink, M. The mode of action of
convulsive
therapy: The neurophysiologic-adaptive
View. J. Neuropsychiat.,
3: 231—233, 1962.
22. Fink, M. and
Kahn, R. L. Quantitative studies
of slow wave activity
following electroshock.
23.

1956.

'

'

i

’

Fink, M., Kahn, R. L., Karp, E.,
Pollack, M.,
Green, M. A., Alan, B. and
Lefkowits, H. J.
Inhalant-induced convulsions.
Arch. Gen.
Psychiat. (ChicagO), 4: 259—266, 1961.
24. Freedman, A. M.,
Bales, P. D., Willis, A. and
Himwich, H. E. Experimental
production of
electrical major convulsive
J. Physiol., 156‘: 117—124, 1949.patterns. Amer.
25. Funkenstein, D.
H., Greenblatt, M. and Solo26.

mon, H. C. Autonomic changes
psychologic changes in mentally illparalleling
J. Nerv. Ment. Dis, 114: 1—18, 1951. patients.
27. Funkenstein, D.
H., Greenblatt, M. and Solomon, H. C. Autonomic nervous
system test
of prognostic signiﬁcance in
relation to electroshock treatment. Psychosom.
Med., 14:
347—362, 1952.

28. Gal,

E. M. Cholinesterase
blood from healthy and activity of whole
schizophrenic
individuals. Nature (London), 198:

29.

1963.

1118—1119,

Giarman, M. J. and Pepeu, G.
Drug-induced
changes in brain acetylcholine.
Brit. J.
Pharmacol., 19: 226—234, 1962.
30. Green, M. A. Signiﬁcance
of individual variability in EEG response to electroshock.
J.
Hillside Hosp. (Glen Oaks), 6‘:
229—240, 1957.
31. Hampson, J. L.,
Essig, C. F., McCauley, A. and
Himwich, H. E. Effects of di-isopropyl
ﬂuorophosphate (DFP) on electroencephalogram
and cholinesterase activity.
Electroenceph.
Clin. Neurophysiol., 2: 41—48, 1950.
32. Himwich, H. E.,
Essig, C. F., Hampson, J. L.,
Bales, P. D. and Freedman, A. M.
Effect of
trimethadione (Tridinmn)
A—--~—

(REV

(FINAL

:OG(CL

�“““““““ vuuvululULlS. Arch. Gen.
Psychiat. (Chicago), 4: 259—266, 1961.
24. Freedman, A. M.,
Bales, P. D., Willis, A. and
Himwich, H. E. Experimental
production of
electrical major convulsive
J. Physiol., 156': 117—124, 1949.patterns. Amer.
25. Funkenstein, D.
H., Greenblatt, M. and Solo—

347—362, 1952.

28. Gal,

E. M. Cholinesterase
blood from healthy and activity of whole
schizophrenic individuals. Nature (London),
198:

29.

1118—1119,

1963.

Giarman, M. J. and Pepeu, G.
Drug-induced
changes in brain acetylcholine.
Brit. J.
Pharmacol, 19: 226—234, 1962.
30. Green, M. A. Signiﬁcance
of individual variability in EEG response to electroshock.
J.
Hillside Hosp. (Glen Oaks),
6: 229-240, 1957.
31. Hampson, J. L.,
Essig, C. F., McCauley, A. and
Himwich, H. E. Effects of di-isopropyl
ﬂuorophosphate (DFP) on electroencephalogram
and cholinesterase activity.
Electroenceph.
Clin. Neurophysiol., 2: 41—48, 1950.
32. Himwich, H. E.,
Essig, C. F., Hampson, J. L.,
Bales, P. D. and Freedman, A. M.
trimethadione (Tridione) and other Effect of
convulsions caused by di-isopropyldrugs on
ﬂuorophosphate (DFP). Amer. J.
Psychiat, 106:
33.

(mm

(FINAL

(CL

(COG

816—820, 1950.

Jenkner, F. L. and Lechner, H. The
effect of
Diparcol on the electroencephalogram
in
the
normal subject and in those with
cerebral
trauma. Electroenceph. Clin.
Neurophysiol.,
7: 303—305, 1955.
34. Johnson, L. C.,
ilett, G. A., Johnson, M.,

660

B!
35.

324—336, 1960.

i

'

’

Kabat, E. A., Glusman, M. and
V.
Knaub,
Quantitative estimation of the albumin
and
gamma globulin in normal and
pathologic
cerebrospinal ﬂuid by immunochemical
methods. Amer. J. Med., 4: 653—662,
1948.
36. Kovach, A. G. B.,
Fonyo, A. and Halmagyi,
M. Acetylcholine content of
the brain in
traumatic shock. Acta Physiol. Acad.
Sci.
Hung, 13: 1—4, 1957.
37. Krech, D., Rosenzweig,
M. R. and Bennett,
E. L. Effects of environmental
and training on brain chemistry.complexity
J. Comp.
Physiol. Bsychol., 53: 5093519, 1960.
38. Loewi, O. Uber humorale
Ubertragbarkeit der
Herznervenwirkung. Pﬂueger Arch. Ges.

Physiol., 189: 239—242, 1921.
39. Maynert, E. W.
and Buck, E. G. Effects of
CNS. depressants on brain acetylcholine.
Pharmacologist, 6: 191, 1964.
40. McLennan, H. and
Elliott, K. A. C. Effects of
convulsant and narcotic drugs
choline synthesis. J. Pharmacol. on acetylExp. Ther.,
103.- 35—43, 1951.
41. N achmansohn, D.
and Rothenberg, M. A.
Studies on cholinesterase: On
speciﬁcity of
in
enzymes
nerve tissue. J. Biol. Chem., 158:
653—666, 1945.
42. Plum, C. M. Study
of cholinesterase activity
in nervous and mental disorders.
Clin. Chem.,
43.

6’: 332—340, 1960.

Pryor, G. T. and Otis, L. S. Effects of
chronic
administration of electroconvulsive shock
on
behavior, brain weight and brain
chemistry.
Paper presented at the American Association
for the Advancement of
Science, Berkeley,
1965.
44. Ravin, H. A. and
Altschule, M. D. Serum
cholinesterase activity in mental
disease.
A.M.A. Arch. Neurol. Psychiat.,
58:
645—650,
1952.

45.

46.

Richter, D. and Crossland, J. Variation
in
acetylcholine content of the brain
with
physiological state. Amer. J. Physiol.,
159:
247—255, 1949.
Richter, D. and Lee, M. Serum choline
esterase
and anxiety. J. Ment. Sci.
(London), 88:
428—434, 1942.

PROVE!)

�Dupucmr.
MAY

SET

241966

EG—K 6

EG~K

6

%E-NMD6131

p. 12 5-20-66 640 (4)
47.R h
M.
ee,
Serum choline
and depression.
esterase
J
Ment.
Sci.
435—439, 1942.
(London), 88:

extension. J.

429—437, 1962.
50. Roth M.
,
Changes

in the EEG
under barbiturate anaesthesia
vulsive treatment pro duced by electro-conand their signiﬁcance
the theory of ECT
for
a ction. Electroenceph.
Clin. N
51. Roth, M.,europhysiol., 3: 261—280, 1951.
K

physiol., .9: 225—237, 195
.
52. R
owntree, D. W., Nevin,
:I‘he eifects

53.

Rub'

54.
(REV

55. Spiegel. E.
(FINAL

(CL

�J.

,

.,Kay,
'

.W.K

SI

52. Rowntree,
D. W.,

The effects of Nevin, S. and Wilson, A.
in schizophreniadiisopropylﬂuorophosphonate
and
manic depressive
chosis. J. Neurol.
psyNeurosurg.
47—62, 1950.
Psychiat., 13:
53. Rubin,
.
.

.

..

/W_g3,
v

logical and
. Physio,
physiocochemical mechanisms
lectroshock treatment.
in
C
. N
'
1953.
57. Spiegel, E.
A., Spiegel-Adolf,
M. and Henr
G. Physicochemical
Chan

of psychoses. Amer.
J. Psychiat., 104: 697—706, 1948.
59. Stone, W.
.E' Th

brain acetylcholine
Biol. Med., 61: 51—54,content. Proc. Soc. Exp.
1946.
61. Torda, C.
'
Effect of
'
Amer. J. Physiol., 173: ontent of the brain.
179—183, 1953.
62. Torda, C.
Effects of single
injection of corticotropin (ACTH) on
ammonium ion and
acetylcholine content of
Physiol., 173: 176—178, 1953. brain. Amer. J.
63. Tower, D. B.
and McE achern, D.
Acetylcholine
and neuronal activit
y. I. Cholinesterase
terns and acetylcholin
'
patﬂuid
Canad. J. Res. Sect
E,
64. Tower, D. B
and McEachern, D.
The content
and characterization
human cerebrospinal of cholinesterases in
Sect. E, 97: 132—145, ﬂuids. Canad. J. Res.
1949.
65. Tower, D. B.
and

convulsive thera anges induced by electroNeurophysiol., .9: y. Electroenceph. Clin.
217—224, 1957.
67. Ward, A.
A., Jr. Atropine in
the treatment of
closed head injury.
J. Neurosurg., 7:
402, 1950.
398—

v
h

I

E

a

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3">
                  <text>Research Files and Unpublished Works</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67524">
                <text>Files: Acetylcholine and Cholinesterase, 1956-1966 (folder title 4/4).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67525">
                <text>Text</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="67526">
                <text>mfp-03-01-003-0-004</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67527">
                <text>1956-1969</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67528">
                <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67529">
                <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="46">
            <name>Relation</name>
            <description>A related resource</description>
            <elementTextContainer>
              <elementText elementTextId="67530">
                <text>The Max Fink Collection</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67531">
                <text>Research papers, files, and related correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67532">
                <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="67533">
                <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="80955">
                <text>en-US</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="87516">
                <text>application/pdf</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="94077">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="37">
            <name>Contributor</name>
            <description>An entity responsible for making contributions to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="100638">
                <text/>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="3">
        <name>Research</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
